[["Human rhinoviruses (HRVs) belong to the Picornaviridae family with high similarity to human enteroviruses (HEVs).", {"entities": []}], ["Limited data is available from Latin America regarding the clinical presentation and strains of these viruses in respiratory disease.", {"entities": []}], ["We collected nasopharyngeal swabs at clinics located in eight Latin American countries from 3,375 subjects aged 25\u00a0years or younger who presented with influenza-like illness.", {"entities": [[151, 160, "DISEASE"]]}], ["Our subjects had a median age of 3\u00a0years and a 1.2:1.0 male:female ratio.", {"entities": []}], ["HRV was identified in 16% and HEV was identified in 3%.", {"entities": []}], ["HRVs accounted for a higher frequency of isolates in those of younger age, in particular children\u2009<\u20091\u00a0years old.", {"entities": []}], ["HRV-C accounted for 38% of all HRVs detected.", {"entities": []}], ["Phylogenetic analysis revealed a high proportion of recombinant strains between HRV-A/HRV-C and between HEV-A/HEV-B.", {"entities": []}], ["In addition, both EV-D68 and EV-A71 were identified.", {"entities": []}], ["In Latin America as in other regions, HRVs and HEVs account for a substantial proportion of respiratory viruses identified in young people with ILI, a finding that provides additional support for the development of pharmaceuticals and vaccines targeting these pathogens.", {"entities": []}], ["Long-acting \u03b22-agonists (LABAs) have demonstrated efficacy in patients with COPD in clinical trials.", {"entities": []}], ["The purpose of this study was to assess the comparative efficacy of all available dosages of all LABA monotherapies using a network meta-analysis.", {"entities": []}], ["A systematic literature review identified 33 randomized controlled trials of LABA monotherapies (salmeterol 50 \u03bcg twice daily [BID]; formoterol 12 \u03bcg BID; indacaterol 75, 150, and 300 \u03bcg once daily [OD]; olodaterol 5 and 10 \u03bcg OD, and vilanterol 25 \u03bcg OD).", {"entities": []}], ["Clinical efficacy was evaluated at 12 and 24 weeks in terms of trough forced expiratory volume in 1 second (FEV 1 ), transition dyspnea index focal score, St George\u2019s Respiratory Questionnaire total score, and rate of COPD exacerbations.", {"entities": [[108, 111, "GENE"]]}], ["The relative effectiveness of all LABA monotherapies was estimated by Bayesian network meta-analysis.", {"entities": []}], ["At 12 and 24 weeks, indacaterol 300 and 150 \u03bcg OD were associated with statistically significant improvement in trough FEV 1 compared to all other LABA monotherapies; vilanterol 25 \u03bcg OD was superior to formoterol 12 \u03bcg BID.", {"entities": [[119, 122, "GENE"]]}], ["At 12 weeks, indacaterol 75 \u03bcg OD was associated with significant improvement in trough FEV 1 compared to formoterol 12 \u03bcg BID and olodaterol (5 and 10 \u03bcg OD); salmeterol 50 \u03bcg BID was superior to formoterol 12 \u03bcg BID and olodaterol 5 \u03bcg OD.", {"entities": [[88, 91, "GENE"]]}], ["Indacaterol 300 \u03bcg OD was also associated with significant improvement in transition dyspnea index focal score compared to all other LABAs at 12 or 24 weeks.", {"entities": []}], ["Indacaterol 150 \u03bcg OD had significantly better results in exacerbation rates than olodaterol 5 \u03bcg and olodaterol 10 \u03bcg OD.", {"entities": []}], ["Indacaterol 300 \u03bcg, followed by 150 and 75 \u03bcg, were the most effective LABA monotherapies for moderate to severe COPD.", {"entities": []}], ["Background Previous research has examined the number and extent of medicines taking in pregnant women but not their beliefs and risk perception surrounding their use.", {"entities": []}], ["Objective To describe beliefs and risk perception associated with medicines use for the treatment of common acute conditions among UK women and explore whether this is related to actual medicines use.", {"entities": []}], ["Settings Cross-sectional, web-based study in the UK.", {"entities": []}], ["Methods Pregnant women and mothers within 1\u00a0year of giving birth were invited to participate in an online cross-sectional questionnaire-based study via a pregnancy website in the UK.", {"entities": []}], ["Anonymous data were collected from women regarding their use of medicines (both over-the-counter and prescribed) and their beliefs regarding medicines use during pregnancy.", {"entities": []}], ["Main outcome measures Pregnant women\u2019s beliefs about medicines and their relation to pharmacological treatment of acute conditions in pregnancy.", {"entities": []}], ["Results Pharmacological treatment of conditions in pregnancy ranged from 65.4\u00a0% for urinary tract infections (UTIs) to 1.1\u00a0% for sleeping problems.", {"entities": []}], ["Almost three out of ten women avoided using some medications during pregnancy.", {"entities": []}], ["For heartburn and UTIs, women who did not treat the condition viewed medicines in general as being overused, more harmful and less beneficial, than those who treated the condition.", {"entities": []}], ["In general, UK pregnant women perceived medicines to be beneficial and slightly overused.", {"entities": []}], ["Conclusions Women\u2019s beliefs about medications impact on treatment of specific conditions in pregnancy such as heartburn and UTIs.", {"entities": []}], ["Healthcare professionals should explore patient\u2019s beliefs regarding medication at the first maternity care visit to promote appropriate medication use in pregnancy.", {"entities": []}], ["The online version of this article (doi:10.1007/s11096-016-0322-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objective To evaluate the effect of financial incentives on four clinical quality indicators common to pay for performance plans in the United Kingdom and at Kaiser Permanente in California.", {"entities": []}], ["Design Longitudinal analysis.", {"entities": []}], ["Setting 35 medical facilities of Kaiser Permanente Northern California, 1997-2007.", {"entities": []}], ["Participants 2\u2009523\u2009659 adult members of Kaiser Permanente Northern California.", {"entities": []}], ["Main outcomes measures Yearly assessment of patient level glycaemic control (HbA 1c <8%), screening for diabetic retinopathy, control of hypertension (systolic blood pressure <140 mm Hg), and screening for cervical cancer.", {"entities": [[104, 124, "DISEASE"], [137, 149, "DISEASE"], [215, 221, "DISEASE"], [206, 221, "DISEASE"]]}], ["Results Incentives for two indicators\u2014screening for diabetic retinopathy and for cervical cancer\u2014were removed during the study period.", {"entities": [[52, 72, "DISEASE"], [90, 96, "DISEASE"], [81, 96, "DISEASE"]]}], ["During the five consecutive years when financial incentives were attached to screening for diabetic retinopathy (1999-2003), the rate rose from 84.9% to 88.1%.", {"entities": [[91, 111, "DISEASE"]]}], ["This was followed by four years without incentives when the rate fell year on year to 80.5%.", {"entities": []}], ["During the two initial years when financial incentives were attached to cervical cancer screening (1999-2000), the screening rate rose slightly, from 77.4% to 78.0%.", {"entities": [[81, 87, "DISEASE"], [72, 87, "DISEASE"]]}], ["During the next five years when financial incentives were removed, screening rates fell year on year to 74.3%.", {"entities": []}], ["Incentives were then reattached for two years (2006-7) and screening rates began to increase.", {"entities": []}], ["Across the 35 facilities, the removal of incentives was associated with a decrease in performance of about 3% per year on average for screening for diabetic retinopathy and about 1.6% per year for cervical cancer screening.", {"entities": [[148, 168, "DISEASE"], [206, 212, "DISEASE"], [197, 212, "DISEASE"]]}], ["Conclusion Policy makers and clinicians should be aware that removing facility directed financial incentives from clinical indicators may mean that performance levels decline.", {"entities": []}], ["The expectations of nanoparticle (NP)-based targeted drug delivery systems in cancer, when compared with convectional therapeutic methods, are greater efficacy and reduced drug side effects due to specific cellular-level interactions.", {"entities": [[78, 84, "DISEASE"]]}], ["However, there are conflicting literature reports on enhanced tumor accumulation of targeted NPs, which is essential for translating their applications as improved drug-delivery systems and contrast agents in cancer imaging.", {"entities": [[209, 215, "DISEASE"], [93, 96, "GENE"]]}], ["In this study, we characterized biodegradable NPs conjugated with an anti-CD20 antibody for in vivo imaging and drug delivery onto tumor cells.", {"entities": [[46, 49, "GENE"]]}], ["NPs\u2019 binding specificity mediated by anti-CD20 antibody was evaluated on MEC1 cells and chronic lymphocytic leukemia patients\u2019 cells.", {"entities": [[88, 116, "DISEASE"], [108, 116, "DISEASE"], [0, 3, "GENE"]]}], ["The whole-body distribution of untargeted NPs and anti-CD20 NPs were compared by time-domain optical imaging in a localized human/mouse model of B-cell malignancy.", {"entities": [[42, 45, "GENE"], [60, 63, "GENE"], [42, 45, "GENE"], [60, 63, "GENE"]]}], ["These studies provided evidence that NPs\u2019 functionalization by an anti-CD20 antibody improves tumor pharmacokinetic profiles in vivo after systemic administration and increases in vivo imaging of tumor mass compared to non-targeted NPs.", {"entities": [[37, 40, "GENE"], [232, 235, "GENE"], [37, 40, "GENE"], [232, 235, "GENE"]]}], ["Together, drug delivery and imaging probe represents a promising theranostics tool for targeting B-cell malignancies.", {"entities": []}], ["Gut microbiota dysbiosis and metabolic dysfunction in infancy precedes childhood atopy and asthma development.", {"entities": [[91, 97, "DISEASE"]]}], ["Here we examined gut microbiota maturation over the first year of life in infants at high risk for asthma (HR), and whether it is modifiable by early-life Lactobacillus supplementation.", {"entities": [[99, 105, "DISEASE"], [107, 109, "GENE"]]}], ["We performed a longitudinal comparison of stool samples collected from HR infants randomized to daily oral Lactobacillus rhamnosus GG (HRLGG) or placebo (HRP) for 6 months, and healthy (HC) infants.", {"entities": [[71, 73, "GENE"]]}], ["Meconium microbiota of HRP participants is distinct, follows a delayed developmental trajectory, and is primarily glycolytic and depleted of a range of anti-inflammatory lipids at 6 months of age.", {"entities": []}], ["These deficits are partly rescued in HRLGG infants, but this effect was lost at 12 months of age, 6 months after cessation of supplementation.", {"entities": []}], ["Thus we show that early-life gut microbial development is distinct, but plastic, in HR infants.", {"entities": [[84, 86, "GENE"]]}], ["Our findings offer a novel strategy for early-life preventative interventions.", {"entities": []}], ["Gut microbial dysbiosis in infancy is associated with childhood atopy and the development of asthma.", {"entities": [[93, 99, "DISEASE"]]}], ["Here, the authors show that gut microbiota perturbation is evident in the very earliest stages of postnatal life, continues throughout infancy, and can be partially rescued by Lactobacillus supplementation in high-risk for asthma infants.", {"entities": [[223, 229, "DISEASE"]]}], ["Combination of the inhaled long-acting muscarinic antagonist umeclidinium (UMEC; GSK573719) with the long-acting \u03b2 2 -agonist vilanterol (VI) is an approved maintenance treatment for COPD in the US and EU.", {"entities": []}], ["We compared the efficacy and safety of UMEC/VI with placebo in patients with COPD of Asian ancestry.", {"entities": []}], ["In this 24-week, Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, patients were randomized 1:1:1 to UMEC/VI 125/25 \u03bcg, UMEC/VI 62.5/25 \u03bcg, or placebo.", {"entities": []}], ["The primary efficacy end point was trough forced expiratory volume in 1 second (FEV 1 ) on day 169; secondary end points were Transition Dyspnea Index (TDI) focal score at week 24 and weighted mean (WM) FEV 1 over 0\u20136 hours postdose on day 1.", {"entities": [[80, 83, "GENE"], [203, 206, "GENE"], [80, 83, "GENE"], [203, 206, "GENE"]]}], ["Additional end points and safety were also assessed.", {"entities": []}], ["Both UMEC/VI 125/25 \u03bcg and UMEC/VI 62.5/25 \u03bcg statistically significantly improved trough FEV 1 at day 169 versus placebo (UMEC/VI 125/25 \u03bcg, 0.216 L, [95% confidence interval [CI] 0.175\u20130.257]; UMEC/VI 62.5/25 \u03bcg, 0.151 L, 95% CI 0.110\u20130.191; both P <0.001).", {"entities": [[90, 93, "GENE"]]}], ["Statistically significant improvements in TDI score were observed for both UMEC/VI groups versus placebo (UMEC/VI 125/25 \u03bcg, 0.9, 95% CI 0.3\u20131.4, P =0.002; UMEC/VI 62.5/25 \u03bcg, 0.7, 95% CI 0.1\u20131.2, P =0.016).", {"entities": []}], ["On day 1, both UMEC/VI groups improved 0\u20136-hour WM FEV 1 versus placebo (UMEC/VI 125/25 \u03bcg, 0.182 L 95% CI 0.161\u20130.203; UMEC/VI 62.5/25 \u03bcg, 0.160 L, 95% CI 0.139\u20130.181; both P <0.001).", {"entities": [[51, 54, "GENE"]]}], ["Statistically significant improvements for UMEC/VI groups versus placebo were observed for rescue albuterol use at weeks 1\u201324 (puffs/day, both P <0.001).", {"entities": []}], ["The incidence of adverse events was similar across groups.", {"entities": []}], ["In Asian patients with COPD, once-daily UMEC/VI 125/25 \u03bcg and UMEC 62.5/25 \u03bcg resulted in clinically meaningful and statistically significant improvements in lung-function end points versus placebo.", {"entities": []}], ["Symptomatic and quality of life measures also improved.", {"entities": []}], ["The safety profile of UMEC/VI was consistent with previous studies.", {"entities": []}], ["Algae and cyanobacteria are present in all aquatic environments.", {"entities": []}], ["We do not have a good sense of the extent of human and animal exposures to cyanobacteria or their toxins, nor do we understand the public health impacts from acute exposures associated with recreational activities or chronic exposures associated with drinking water.", {"entities": []}], ["We describe the Harmful Algal Bloom-related Illness Surveillance System (HABISS) and summarize the collected reports describing bloom events and associated adverse human and animal health events.", {"entities": []}], ["For the period of 2007\u20132011, Departments of Health and/or Environment from 11 states funded by the National Center for Environmental Health (NCEH), Centers for Disease Control and Prevention contributed reports for 4534 events.", {"entities": []}], ["For 2007, states contributed 173 reports from historical data.", {"entities": []}], ["The states participating in the HABISS program built response capacity through targeted public outreach and prevention activities, including supporting routine cyanobacteria monitoring for public recreation waters.", {"entities": []}], ["During 2007\u20132010, states used monitoring data to support196 public health advisories or beach closures.", {"entities": []}], ["The information recorded in HABISS and the application of these data to develop a wide range of public health prevention and response activities indicate that cyanobacteria and algae blooms are an environmental public health issue that needs continuing attention.", {"entities": []}], ["Comprehensive Cancer Control (CCC) plans address cancer burden at the state level through consolidation of activities and collaboration among stakeholders.", {"entities": [[14, 20, "DISEASE"], [49, 55, "DISEASE"]]}], ["Public health genomics strategies are increasingly important in prevention and treatment of cancer.", {"entities": [[92, 98, "DISEASE"]]}], ["The objectives of this study were to assess the extent to which CCC plans have incorporated genomics-related terms since 2005, determine which of the 3 core public health functions were fulfilled by genomics components, and identify facilitators of and barriers to integration of genomics.", {"entities": []}], ["We reviewed 50 CCC plans in 2010 to assess use of 22 genomics-related terms.", {"entities": []}], ["Among plans that used the term genetics or genomics , we examined the plan for inclusion of genomics-related goals, objectives, or strategies and documented the 3 core public health functions (assessment, policy development, and assurance) fulfilled by them.", {"entities": []}], ["We surveyed plan coordinators about factors affecting incorporation of genomic strategies into plans.", {"entities": []}], ["Forty-seven of 50 (94%) plans included at least 1 genomics-related term.", {"entities": []}], ["Thirty-two of 50 (64%) plans included at least 1 genomics-related goal, objective, or strategy, most encompassing the core function of assurance; 6 state plans encompassed all 3 core functions.", {"entities": []}], ["Plan coordinators indicated that genomics is a low priority in state public health; barriers to incorporation included lack of sufficient staff and funding.", {"entities": []}], ["Incorporation of genomic terms into state CCC plans increased from 60% in 2005 to 94% in 2010, but according to plan coordinators, genomics has not grown as a priority.", {"entities": []}], ["Identification of partnerships and resources may help increase the priority, encourage incorporation, and guide the eventual success of public health genomics in state plans.", {"entities": []}], ["Strong partnerships with state public health departments, health care providers, and the research community are useful for integration.", {"entities": []}], ["The EQ-5D is a widely-used, standardised, quality of life measure producing health profiles, indices and states.", {"entities": []}], ["The aims of this study were to assess the role of various factors in how people with Multiple Sclerosis rate their quality of life, based on responses to the EQ-5D received via the web portal of the UK MS Register.", {"entities": []}], ["The 4516 responses to the EQ-5D (between May 2011 and April 2012) were collated with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS (v.20).", {"entities": []}], ["The mean health state for people with MS was 59.73 (SD 22.4, median 61), compared to the UK population mean of 82.48 (which is approximately 1SD above the cohort mean).", {"entities": []}], ["The characteristics of respondents with high health states (at or above +1SD) were: better health profiles (most predictive dimension: Usual Activities), higher health indices, younger age, shorter durations of MS, female gender, relapsing-remitting MS, higher educational attainment and being in paid employment (all p -values<0.001).", {"entities": []}], ["Conversely, the characteristics of respondents with low health states (at or below -1SD) were: poorer health profiles (most predictive dimension: Mobility), lower health indices, older age, longer durations of MS, male gender, progressive MS, lower educational attainment and having an employment status of sick/disabled ( p \u200a=\u200a0.0014 for age, all other p -values<0.001).", {"entities": []}], ["Particular living arrangements were not associated with either the high or low health status groups.", {"entities": []}], ["This large-scale study has enabled in-depth analyses on how people with MS rate their quality of life, and it provides new knowledge on the various factors that contribute to their self-assessed health status.", {"entities": []}], ["These findings demonstrate the impact of MS on quality of life, and they can be used to inform care provision and further research, to work towards enhancing the quality of life of people with MS.", {"entities": []}], ["We investigated the relationship between neurological outcomes and duration from cardiac arrest (CA) to the initiation of extracorporeal membrane oxygenation (ECMO) (CA-to-ECMO) in patients with out-of-hospital cardiac arrest (OHCA) treated with extracorporeal cardiopulmonary resuscitation (ECPR) and determined the ideal time at which ECPR should be performed.", {"entities": []}], ["During the time period in which this study was conducted, 3451 patients experienced OHCA.", {"entities": []}], ["This study finally included 79 patients aged 18\u00a0years or older whose OHCA had been witnessed and who underwent ECPR in the emergency room between January 2011 and December 2015.", {"entities": []}], ["Our primary endpoint was survival to hospital discharge with good neurological outcomes (a cerebral performance category of 1 or 2).", {"entities": []}], ["Of the 79 patients included, 11 had good neurological outcomes.", {"entities": []}], ["The median duration from CA-to-ECMO was significantly shorter in the good neurological outcome group (33\u00a0min, interquartile range [IQR], 27\u201350 vs. 46\u00a0min, IQR, 42\u201356: p \u00a0=\u00a00.03).", {"entities": []}], ["After controlling for potential confounders, we found that the adjusted odds ratio of CA-to-ECMO time for a good neurological outcome was 0.92 (95% confidence interval: 0.87\u20130.98, p \u00a0=\u00a00.007).", {"entities": []}], ["The area under the receiver operating characteristic curve of CA-to-ECMO for predicting a good neurological outcome was 0.71, and the optimal CA-to-ECMO cutoff time was 40\u00a0min.", {"entities": []}], ["The dynamic probability of survival with good neurological outcomes based on CA-to-ECMO time showed that the survival rate with good neurological outcome decreased abruptly from over 30% to approximately 15% when the CA-to-ECMO time exceeded 40\u00a0min.", {"entities": []}], ["In this study, CA-to-ECMO time was significantly shorter among patients with good neurological outcomes, and significantly associated with good neurological outcomes at hospital discharge.", {"entities": []}], ["In addition, the probability of survival with good neurological outcome decreased when the CA-to-ECMO time exceeded 40 minutes.", {"entities": []}], ["The indication for ECPR for patients with OHCA should include several factors.", {"entities": []}], ["However, the duration of CPR before the initiation of ECMO is a key factor and an independent factor for good neurological outcomes in patients with OHCA treated with ECPR.", {"entities": []}], ["Therefore, the upper limit of CA-to-ECMO time should be inevitably included in the indication for ECPR for patients with OHCA.", {"entities": []}], ["In the present study, there was a large difference in the rate of survival to hospital discharge with good neurological outcome between the patients with a CA-to-ECMO time within 40 minutes and those whose time was over 40 minutes.", {"entities": []}], ["Based on the present study, the time limit of the duration of CPR before the initiation of ECMO might be around 40 minutes.", {"entities": []}], ["We should consider ECPR in patients with OHCA if they are relatively young, have a witness and no terminal disease, and the initiation of ECMO is presumed to be within this time period.", {"entities": []}], ["The duration from CA-to-ECMO was significantly associated with good neurological outcomes.", {"entities": []}], ["The indication for patients with OHCA should include a criterion for the ideal time to initiate ECPR.", {"entities": []}], ["Susceptibility variants identified by genome-wide association studies (GWAS) have modest effect sizes.", {"entities": []}], ["Whether such variants provide incremental information in assessing risk for common 'complex' diseases is unclear.", {"entities": []}], ["We investigated whether measured and imputed genotypes from a GWAS dataset linked to the electronic medical record alter estimates of coronary heart disease (CHD) risk.", {"entities": [[143, 156, "DISEASE"], [134, 156, "DISEASE"]]}], ["Study participants ( n = 1243) had no known cardiovascular disease and were considered to be at high, intermediate, or low 10-year risk of CHD based on the Framingham risk score (FRS) which includes age, sex, total and HDL cholesterol, blood pressure, diabetes, and smoking status.", {"entities": []}], ["Of twelve SNPs identified in prior GWAS to be associated with CHD, four were genotyped in the participants as part of a GWAS.", {"entities": []}], ["Genotypes for seven SNPs were imputed from HapMap CEU population using the program MACH.", {"entities": []}], ["We calculated a multiplex genetic risk score for each patient based on the odds ratios of the susceptibility SNPs and incorporated this into the FRS.", {"entities": []}], ["The mean (SD) number of risk alleles was 12.31 (1.95), range 6-18.", {"entities": []}], ["The mean (SD) of the weighted genetic risk score was 12.64 (2.05), range 5.75-18.20.", {"entities": []}], ["The CHD genetic risk score was not correlated with the FRS ( P = 0.78).", {"entities": []}], ["After incorporating the genetic risk score into the FRS, a total of 380 individuals (30.6%) were reclassified into higher-(188) or lower-risk groups (192).", {"entities": []}], ["A genetic risk score based on measured/imputed genotypes at 11 susceptibility SNPs, led to significant reclassification in the 10-y CHD risk categories.", {"entities": []}], ["Additional prospective studies are needed to assess accuracy and clinical utility of such reclassification.", {"entities": []}], ["To explore the prevalence of secondhand tobacco smoke (SHS) exposure of college students at two locations, i.e.", {"entities": []}], [", on campus and in the home, and to identify factors associated with SHS exposure at each location, a preliminary cross-sectional study was conducted on 1754 nonsmoking students from two universities in Korea.", {"entities": []}], ["In total, 83.1% were exposed to SHS at least once a week on campus or at home; the average SHS exposure was 3.4 times per week.", {"entities": []}], ["Specifically, 79.7% and 23.5% were exposed to SHS on campus and in the home, respectively.", {"entities": []}], ["On campus, SHS exposure was significantly more prevalent in freshmen and sophomore students.", {"entities": []}], ["In the home, SHS exposure was significantly more prevalent among females, those with smokers in their families, and those who rated their health as poor.", {"entities": []}], ["SHS exposure was common among nonsmoking college students, with more than two-thirds exposed on campus.", {"entities": []}], ["The prevalence of SHS exposure was greater on campus than in the home; the factors associated with SHS exposure were location-specific.", {"entities": []}], ["Metal oxide nanoparticles such as ZnO are used in sunscreens as they improve their optical properties against the UV-light that causes dermal damage and skin cancer.", {"entities": [[153, 164, "DISEASE"], [158, 164, "DISEASE"]]}], ["However, the hazardous properties of the particles used as UV-filters in the sunscreens and applied to the skin have remained uncharacterized.", {"entities": []}], ["Here we investigated whether different sized ZnO particles would be able to penetrate injured skin and injured allergic skin in the mouse atopic dermatitis model after repeated topical application of ZnO particles.", {"entities": [[138, 155, "DISEASE"], [145, 155, "DISEASE"]]}], ["Nano-sized ZnO (nZnO) and bulk-sized ZnO (bZnO) were applied to mechanically damaged mouse skin with or without allergen/superantigen sensitization.", {"entities": []}], ["Allergen/superantigen sensitization evokes local inflammation and allergy in the skin and is used as a disease model of atopic dermatitis (AD).", {"entities": [[120, 137, "DISEASE"], [127, 137, "DISEASE"]]}], ["Our results demonstrate that only nZnO is able to reach into the deep layers of the allergic skin whereas bZnO stays in the upper layers of both damaged and allergic skin.", {"entities": []}], ["In addition, both types of particles diminish the local skin inflammation induced in the mouse model of AD; however, nZnO has a higher potential to suppress the local effects.", {"entities": []}], ["In addition, especially nZnO induces systemic production of IgE antibodies, evidence of allergy promoting adjuvant properties for topically applied nZnO.", {"entities": []}], ["These results provide new hazard characterization data about the metal oxide nanoparticles commonly used in cosmetic products and provide new insights into the dermal exposure and hazard assessment of these materials in injured skin.", {"entities": []}], ["The management of hypertension is a key challenge in modern health systems.", {"entities": [[18, 30, "DISEASE"]]}], ["This study aimed to investigate hypertension treatment strategies among physicians specialized in complementary and alternative medicine (CAM) in Germany by analysing prescribing patterns and comparing these to the current treatment guidelines issued by the German Hypertension Society.", {"entities": [[32, 44, "DISEASE"], [265, 277, "DISEASE"]]}], ["In this prospective, multicentre observational study, which included 25 primary care physicians specialized in CAM treatment, prescriptions and diagnoses were analysed for each consecutive hypertensive patient using routine electronic data.", {"entities": []}], ["Data analysis was performed using univariate statistical tests (Chi square test, Cochran-Armitage trend test).", {"entities": []}], ["Multiple logistic regression was used to determine factors associated with antihypertensive medication.", {"entities": []}], ["In the year 2005, 1320 patients with 3278 prescriptions were included (mean age = 64.2 years (SD = 14.5), 63.5% women).", {"entities": []}], ["Most patients were treated with conventional antihypertensive monotherapies (n = 838, 63.5%).", {"entities": []}], ["Beta-blockers were the most commonly prescribed monotherapy (30.7%), followed by ACE inhibitors (24.0%).", {"entities": []}], ["Combination treatment usually consisted of two antihypertensive drugs administered either as separate agents or as a coformulation.", {"entities": []}], ["The most common combination was a diuretic plus an ACE inhibitor (31.2% of dual therapies).", {"entities": []}], ["Patient gender, age, and comorbidities significantly influenced which treatment was prescribed.", {"entities": []}], ["187 patients (14.2%) received one or more CAM remedies, most of which were administered in addition to classic monotherapies (n = 104).", {"entities": []}], ["Men (OR = 0.66; 95% CI: 0.54-0.80) and patients with diabetes (OR = 0.55; 95% CI: 0.42-0.0.73), hypercholesterolaemia (OR = 0.59; 95% CI: 0.47-0.75), obesity (OR = 0.74; 95% CI: 0.57-0.97), stroke (OR = 0.54; 95% CI: 0.40-0.74), or prior myocardial infarction (OR = 0.37; 95% CI: 0.17-0.81) were less likely to receive CAM treatment.", {"entities": [[150, 157, "DISEASE"], [238, 259, "DISEASE"]]}], ["The large majority of antihypertensive treatments prescribed by CAM physicians in the present study complied with the current German Hypertension Society treatment guidelines.", {"entities": [[133, 145, "DISEASE"]]}], ["Deviations from the guidelines were observed in one of every seven patients receiving some form of CAM treatment.", {"entities": []}], ["CD4 H cells.", {"entities": [[0, 3, "GENE"]]}], ["Decreasing PU.1 expression either by conditional deletion in murine T cells or siRNA in human T cells impaired IL-9 production, while ectopic PU.1 expression promoted IL-9 production.", {"entities": []}], ["Mice with PU.1-deficient T cells developed normal T H 2 responses in vivo , but exhibited attenuated allergic pulmonary inflammation corresponding to decreased Il9 and chemokine expression in peripheral T cells and in lungs as compared to wild-type mice.", {"entities": [[160, 163, "GENE"]]}], ["Together, these data suggest a critical role for PU.1 in generating the T H 9 phenotype and in the development of allergic inflammation.", {"entities": []}], ["Surfactant protein D (SP-D), an innate immune molecule, has an indispensable role in host defense and regulation of inflammation.", {"entities": []}], ["Immune related functions regulated by SP-D include agglutination of pathogens, phagocytosis, oxidative burst, antigen presentation, T lymphocyte proliferation, cytokine secretion, induction of apoptosis and clearance of apoptotic cells.", {"entities": []}], ["The present study unravels a novel ability of SP-D to reduce the viability of leukemic cells (eosinophilic leukemic cell line, AML14.3D10; acute myeloid leukemia cell line, THP-1; acute lymphoid leukemia cell lines, Jurkat, Raji; and human breast epithelial cell line, MCF-7), and explains the underlying mechanisms.", {"entities": [[186, 203, "DISEASE"], [145, 161, "DISEASE"], [139, 161, "DISEASE"], [153, 161, "DISEASE"], [195, 203, "DISEASE"]]}], ["SP-D and a recombinant fragment of human SP-D (rhSP-D) induced G2/M phase cell cycle arrest, and dose and time-dependent apoptosis in the AML14.3D10 eosinophilic leukemia cell line.", {"entities": [[162, 170, "DISEASE"]]}], ["Levels of various apoptotic markers viz.", {"entities": []}], ["activated p53, cleaved caspase-9 and PARP, along with G2/M checkpoints (p21 and Tyr15 phosphorylation of cdc2) showed significant increase in these cells.", {"entities": []}], ["We further attempted to elucidate the underlying mechanisms of rhSP-D induced apoptosis using proteomic analysis.", {"entities": []}], ["This approach identified large scale molecular changes initiated by SP-D in a human cell for the first time.", {"entities": []}], ["Among others, the proteomics analysis highlighted a decreased expression of survival related proteins such as HMGA1, overexpression of proteins to protect the cells from oxidative burst, while a drastic decrease in mitochondrial antioxidant defense system.", {"entities": [[110, 115, "GENE"]]}], ["rhSP-D mediated enhanced oxidative burst in AML14.3D10 cells was confirmed, while antioxidant, N-acetyl-L-cysteine, abrogated the rhSP-D induced apoptosis.", {"entities": []}], ["The rhSP-D mediated reduced viability was specific to the cancer cell lines and viability of human PBMCs from healthy controls was not affected.", {"entities": [[58, 64, "DISEASE"]]}], ["The study suggests involvement of SP-D in host\u2019s immunosurveillance and therapeutic potential of rhSP-D in the eosinophilic leukemia and cancers of other origins.", {"entities": [[124, 132, "DISEASE"]]}], ["To estimate the attributable costs of multimorbidity and assess whether the association between the level of multimorbidity and health system costs varies by socio-demographic factors in young (<65 years) and older (\u226565 years) adults living in Ontario, Canada.", {"entities": []}], ["A population-based, retrospective cohort study The province of Ontario, Canada 6 639 089 Ontarians who were diagnosed with at least one of 16 selected medical conditions on 1 April 2009.", {"entities": []}], ["From the perspective of the publicly funded healthcare system, total annual healthcare costs were derived from linked provincial health administrative databases using a person-level costing method.", {"entities": []}], ["We used generalised linear models to examine the association between the level of multimorbidity and healthcare costs and the extent to which socio-demographic variables modified this association.", {"entities": []}], ["Attributable total costs of multimorbidity ranged from C$377 to C$2073 for young individuals and C$1026 to C$3831 for older adults.", {"entities": []}], ["The association between the degree of multimorbidity and healthcare costs was significantly modified by age (p<0.001), sex (p<0.001) and neighbourhood income (p<0.001) in both age groups, and the positive association between healthcare costs and levels of multimorbidity was statistically stronger for older than younger adults.", {"entities": []}], ["For individuals aged 65 years or younger, the increase in healthcare costs was more gradual in women than in their male counterparts, however, for those aged 65 years or older, the increase in healthcare costs was significantly greater among women than men.", {"entities": []}], ["Lastly, we also observed that the positive association between the level of multimorbidity and healthcare costs was significantly greater at higher levels of marginalisation.", {"entities": []}], ["Socio-demographic factors are important effect modifiers of the relationship between multimorbidity and healthcare costs and should therefore be considered in any discussion of the implementation of healthcare policies and the organisation of healthcare services aimed at controlling healthcare costs associated with multimorbidity.", {"entities": []}], ["Karenia brevis (formerly Gymnodinium breve ) is a marine dinoflagellate responsible for red tides that form in the Gulf of Mexico.", {"entities": []}], ["K. brevis produces brevetoxins, the potent toxins that cause neurotoxic shellfish poisoning.", {"entities": []}], ["There is also limited information describing human health effects from environmental exposures to brevetoxins.", {"entities": []}], ["Our objective was to examine the impact of inhaling aerosolized brevetoxins during red tide events on self-reported symptoms and pulmonary function.", {"entities": []}], ["We recruited a group of 28 healthy lifeguards who are occupationally exposed to red tide toxins during their daily work-related activities.", {"entities": []}], ["They performed spirometry tests and reported symptoms before and after their 8-hr shifts during a time when there was no red tide (unexposed period) and again when there was a red tide (exposed period).", {"entities": []}], ["We also examined how mild exercise affected the reported symptoms and spirometry tests during unexposed and exposed periods with a subgroup of the same lifeguards.", {"entities": []}], ["Environmental sampling ( K. brevis cell concentrations in seawater and brevetoxin concentrations in seawater and air) was used to confirm unexposed/exposed status.", {"entities": []}], ["Compared with unexposed periods, the group of lifeguards reported more upper respiratory symptoms during the exposed periods.", {"entities": []}], ["We did not observe any impact of exposure to aerosolized brevetoxins, with or without mild exercise, on pulmonary function.", {"entities": []}], ["Although proxies of patients with chronic obstructive pulmonary disease (COPD) need health-related knowledge to support patients in managing their disease, their current level of knowledge remains unknown.", {"entities": [[34, 71, "DISEASE"]]}], ["We aimed to compare health-related knowledge (generic and COPD-related knowledge) between patients with COPD and their resident proxies.", {"entities": []}], ["In this cross-sectional study, we included stable patients with moderate to very severe COPD and their resident proxies ( n \u00a0=\u00a0194 couples).", {"entities": []}], ["Thirty-four statements about generic health and COPD-related topics were assessed in patients and proxies separately.", {"entities": []}], ["Statements could be answered by \u2018true\u2019, \u2018false\u2019, or \u2018do not know\u2019.", {"entities": []}], ["This study is approved by the Medical Research Ethics Committees United (MEC-U), the Netherlands (NL42721.060.12/M12\u20131280).", {"entities": []}], ["Patients answered on average 17% of the statements incorrect, and 19% with \u2018do not know\u2019.", {"entities": []}], ["The same figure (19%) for the incorrect and unknown statements was shown by proxies.", {"entities": []}], ["Patients who attended pulmonary rehabilitation previously answered more statements correct (about three) compared to patients who did not attend pulmonary rehabilitation.", {"entities": []}], ["More correct answers were reported by: younger patients, patients with a higher level of education, patients who previously participated in pulmonary rehabilitation, patients with better cognitive functioning, and patients with a COPD diagnosis longer ago.", {"entities": []}], ["Proxies of patients with COPD as well as patients themselves answer about two third of 34 knowledge statements about COPD correct.", {"entities": []}], ["So, both patients and proxies seem to have an incomplete knowledge about COPD and general health.", {"entities": []}], ["Therefore, education about general health and COPD should be offered to all subgroups of patients with COPD and their proxies.", {"entities": []}], ["This study is registered in the Dutch Trial Register ( NTR3941 ).", {"entities": []}], ["Registered 19 April 2013.", {"entities": []}], ["Dermatologic conditions have different presentation and management in pediatric age group from that in adult; this to be studied separately for statistical and population based analysis.", {"entities": []}], ["To study the pattern of various dermatoses in infants and children in tertiary health care center in South Gujarat region.", {"entities": []}], ["This is a prospective study; various dermatoses were studied in pediatric patients up to 14 years of age attending the Dermatology OPD of New Civil Hospital, Surat, Gujarat over a period of 12 months from June 2009 to June 2010.", {"entities": []}], ["All patients were divided into four different study groups: <1 month (neonates), 1 month to 1 year, >1 to 6 years and 7 to 14 years.", {"entities": []}], ["There were 596 boys and 425 girls in total 1021 study populations.", {"entities": []}], ["Majority of the skin conditions in neonates were erythema toxicum neonatorum (12.97%), scabies (9.92%), mongolian spot (9.16%), and seborrheic dermatitis (7.63%).", {"entities": [[87, 94, "DISEASE"], [104, 118, "DISEASE"], [132, 153, "DISEASE"], [143, 153, "DISEASE"]]}], ["In > 1 month to 14 years age group of children among infectious disorder, children were found to be affected most by scabies (24.49%), impetigo (5.96%), pyoderma (5.62%), molluscum contagiosum (5.39%), tinea capitis (4.49%), leprosy (2.02%), and viral warts (1.35%) while among non-infectious disorders, they were affected by atopic dermatitis (4.27%), pityriasis alba (4.16%), seborrheic dermatitis (3.60%), pityriasis rosea (3.15%), others (3.01%), phrynoderma (2.70%), lichen planus (2.58%), contact dermatitis (1.57%) and ichthyosis (1.45%).", {"entities": [[409, 425, "DISEASE"], [117, 124, "DISEASE"], [495, 513, "DISEASE"], [225, 232, "DISEASE"], [135, 143, "DISEASE"], [326, 343, "DISEASE"], [153, 161, "DISEASE"], [472, 485, "DISEASE"], [202, 215, "DISEASE"], [171, 192, "DISEASE"], [378, 399, "DISEASE"], [333, 343, "DISEASE"], [389, 399, "DISEASE"], [503, 513, "DISEASE"]]}], ["There is a need to emphasize on training the management of common pediatric dermatoses to dermatologists, general practitioners and pediatricians for early treatment.", {"entities": []}], ["Obesity and depression are two prevalent conditions that are costly to individuals and society.", {"entities": [[0, 7, "DISEASE"]]}], ["The bidirectional association of obesity with depression, in which unhealthy dietary patterns may play an important role, has been well established.", {"entities": [[33, 40, "DISEASE"]]}], ["Few experimental studies have been conducted to investigate whether supplementing specific nutrients or improving diet and food-related behaviors can prevent depression in overweight persons.", {"entities": []}], ["The MooDFOOD prevention trial examines the feasibility and effectiveness of two different nutritional strategies [multi-nutrient supplementation and food-related behavioral change therapy (FBC)] to prevent depression in individuals who are overweight and have elevated depressive symptoms but who are not currently or in the last 6\u00a0months meeting criteria for an episode of major depressive disorder (MDD).", {"entities": [[374, 399, "DISEASE"]]}], ["The randomized controlled prevention trial has a two-by-two factorial design: participants are randomized to daily multi-nutrient supplement (omega-3 fatty acids, calcium, selenium, B-11 vitamin and D-3 vitamin) versus placebo, and/or FBC therapy sessions versus usual care.", {"entities": []}], ["Interventions last 12\u00a0months.", {"entities": []}], ["In total 1000 participants aged 18\u201375 years with body mass index between 25\u201340\u00a0kg/m The trial aims to provide a better understanding of the causal role of specific nutrients, overall diet, and food-related behavior change with respect to the incidence of MDD episodes.", {"entities": []}], ["This knowledge will be used to develop and disseminate innovative evidence-based, feasible, and effective nutritional public health strategies for the prevention of clinical depression.", {"entities": []}], ["ClinicalTrials.gov.", {"entities": []}], ["Number of identification: NCT02529423 .", {"entities": []}], ["August 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s12888-016-0900-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Epidemiological studies have suggested that the encounter with commensal microorganisms during the neonatal period is essential for normal development of the host immune system.", {"entities": []}], ["Basic research involving gnotobiotic mice has demonstrated that colonization at the age of 5\u2009weeks is too late to reconstitute normal immune function.", {"entities": []}], ["In this study, we examined the transcriptome profiles of the large intestine (LI), small intestine (SI), liver (LIV), and spleen (SPL) of 3 bacterial colonization models\u2014specific pathogen - free mice (SPF), ex-germ-free mice with bacterial reconstitution at the time of delivery (0WexGF) , and ex-germ-free mice with bacterial reconstitution at 5\u2009weeks of age (5WexGF)\u2014and compared them with those of germ-free (GF) mice.", {"entities": []}], ["Hundreds of genes were affected in all tissues in each of the colonized models; however, a gene set enrichment analysis method, MetaGene Profiler (MGP) , demonstrated that the specific changes of Gene Ontology (GO) categories occurred predominantly in 0WexGF LI, SPF SI , and 5WexGF SPL, respectively.", {"entities": [[147, 150, "GENE"]]}], ["MGP analysis on signal pathways revealed prominent changes in toll-like receptor (TLR)- and type 1 interferon (IFN)-signaling in LI of 0WexGF and SPF mice, but not 5WexGF mice, while 5WexGF mice showed specific changes in chemokine signaling.", {"entities": [[0, 3, "GENE"]]}], ["RT-PCR analysis of TLR-related genes showed that the expression of interferon regulatory factor 3 (Irf3), a crucial rate-limiting transcription factor in the induction of type 1 IFN, prominently decreased in 0WexGF and SPF mice but not in 5WexGF and GF mice.", {"entities": [[99, 103, "GENE"]]}], ["The present study provides important new information regarding the molecular mechanisms of the so-called \"hygiene hypothesis\".", {"entities": []}], ["Alterations in surfactant phospholipid compositions are a recognized feature of many acute and chronic lung diseases.", {"entities": []}], ["Investigation of underlying mechanisms requires assessment of surfactant phospholipid molecular composition and kinetics of synthesis and turnover.", {"entities": []}], ["Such studies have recently become possible in humans due to the development of stable isotope labelling combined with advances in analytical methods in lipidomics.", {"entities": []}], ["The objectives of this study are to compare phospholipid molecular species composition and phosphatidylcholine synthesis and turnover in surfactant isolated from various endobronchial compartments in healthy adults.", {"entities": []}], ["Healthy adults (N =\u200910) were infused with methyl -D 9 -choline chloride and samples of induced sputum, tracheal wash and small volume bronchoalveolar lavage fluid were obtained subsequently at intervals up to 96\u00a0hours.", {"entities": []}], ["Surfactant phospholipid composition and incorporation of stable isotope into surfactant phosphatidylcholine were determined by electrospray ionisation mass spectrometry.", {"entities": []}], ["While molecular species compositions of phospholipids were similar for all three sample types, dipalmitoylphosphatidylcholine content was highest in lavage, intermediate in tracheal wash and lowest in sputum.", {"entities": []}], ["Methyl -D 9 -choline incorporation into surfactant phosphatidylcholine was lower for sputum at 24\u00a0hours but reached equilibrium with other sample types by 48\u00a0hours.", {"entities": []}], ["Fractional methyl -D 9 -dipalmitoylphosphatidylcholine incorporation for all sample types was about 0.5% of the endogenous composition.", {"entities": []}], ["Lysophosphatidylcholine enrichment was twice than that of phosphatidylcholine.", {"entities": []}], ["Tracheal secretions may be of value as a surrogate to assess bronchoalveolar lavage fluid surfactant molecular composition and metabolism in healthy people.", {"entities": []}], ["Despite minor differences, the phospholipid molecular composition of induced sputum also showed similarities to that of bronchoalveolar lavage fluid.", {"entities": []}], ["Detailed analysis of newly synthesized individual phosphatidylcholine species provided novel insights into mechanisms of surfactant synthesis and acyl remodelling.", {"entities": []}], ["Lysophosphatidylcholine methyl -D 9 incorporation patterns suggest that these species are secreted together with other surfactant phospholipids and are not generated in the air spaces by hydrolysis of secreted surfactant phosphatidylcholine.", {"entities": []}], ["Application into patient populations may elucidate potential underlying pathophysiological mechanisms that lead to surfactant alterations in disease states.", {"entities": []}], ["Despite a growing body of epidemiological evidence in recent years documenting the health impacts of racism, the cumulative evidence base has yet to be synthesized in a comprehensive meta-analysis focused specifically on racism as a determinant of health.", {"entities": []}], ["This meta-analysis reviewed the literature focusing on the relationship between reported racism and mental and physical health outcomes.", {"entities": []}], ["Data from 293 studies reported in 333 articles published between 1983 and 2013, and conducted predominately in the U.S., were analysed using random effects models and mean weighted effect sizes.", {"entities": []}], ["Racism was associated with poorer mental health (negative mental health: r = -.23, 95% CI [-.24,-.21], k = 227; positive mental health: r = -.13, 95% CI [-.16,-.10], k = 113), including depression, anxiety, psychological stress and various other outcomes.", {"entities": []}], ["Racism was also associated with poorer general health ( r = -.13 (95% CI [-.18,-.09], k = 30), and poorer physical health ( r = -.09, 95% CI [-.12,-.06], k = 50).", {"entities": []}], ["Moderation effects were found for some outcomes with regard to study and exposure characteristics.", {"entities": []}], ["Effect sizes of racism on mental health were stronger in cross-sectional compared with longitudinal data and in non-representative samples compared with representative samples.", {"entities": []}], ["Age, sex, birthplace and education level did not moderate the effects of racism on health.", {"entities": []}], ["Ethnicity significantly moderated the effect of racism on negative mental health and physical health: the association between racism and negative mental health was significantly stronger for Asian American and Latino(a) American participants compared with African American participants, and the association between racism and physical health was significantly stronger for Latino(a) American participants compared with African American participants.", {"entities": []}], ["Protocol PROSPERO registration number: CRD42013005464.", {"entities": []}], ["In this study, we report one case of a three-year-old boy infected with Mycoplasma pneumonia (MP) and presenting concomitant multiple organ damage of the heart, kidney, lung and liver, among others, together with a brief review for the diagnosis and treatment of MP infection with multiple organ dysfunction syndrome (MODS).", {"entities": [[83, 92, "DISEASE"], [308, 316, "DISEASE"]]}], ["The evidence that higher levels of physical activity and/or lower levels of physical inactivity are associated with beneficial health-related outcomes stems mainly from observational studies.", {"entities": []}], ["Findings from these studies often differ from randomised controlled trials and systematic reviews currently demonstrate mixed results, due partly to heterogeneity in physical activity interventions, methodologies used and populations studied.", {"entities": []}], ["As a result, translation into clinical practice has been difficult.", {"entities": []}], ["It is therefore essential that an overview is carried out to compare and contrast systematic reviews, and to identify those physical activity interventions that are the most effective in preventing and/or treating major chronic disease.", {"entities": []}], ["This protocol has been registered on PROSPERO 2013: CRD42013003523.", {"entities": []}], ["We will carry out an overview of Cochrane systematic reviews.", {"entities": []}], ["We will search the Cochrane Database of Systematic Reviews for systematic reviews of randomised controlled trials that have a primary focus on disease-related outcomes.", {"entities": []}], ["We will restrict reviews to those in selected major chronic diseases.", {"entities": []}], ["Two authors will independently screen search outputs, select studies, extract data and assess the quality of included reviews using the assessment of multiple systematic reviews tool; all discrepancies will be resolved by discussing and reaching a consensus, or by arbitration with a third author.", {"entities": []}], ["The data extraction form will summarise key information from each review, including details of the population(s) (for example, disease condition), the context (for example, prevention, treatment or management), the participants, the intervention(s), the comparison(s) and the outcomes.", {"entities": []}], ["The primary outcomes of interest are the prevention of chronic disease and/or improved outcomes, in the treatment or management of chronic disease.", {"entities": []}], ["These outcomes will be summarised and presented for individual chronic diseases (for example, any change in blood pressure in hypertension or glucose control in diabetes).", {"entities": [[126, 138, "DISEASE"]]}], ["Secondary outcomes of interest are to describe the structure and delivery of physical activity interventions across chronic disease conditions and adverse events associated with physical activity.", {"entities": []}], ["We anticipate that our results could inform researchers, guideline groups and policymakers of the most efficacious physical activity interventions in preventing and/or managing major chronic disease.", {"entities": []}], ["Patients with acute respiratory problems poses a diagnostic challenge because similar symptoms can be caused by various pathological conditions.", {"entities": []}], ["Focused ultrasound examination (f-US) of the heart and lungs has proven to increase the diagnostic accuracy in these patients.", {"entities": []}], ["In this protocol of a randomised multicentre trial, we study the effect of f-US of the heart and lungs in patients with respiratory problems performed by emergency physicians (EP) as soon as the patient arrives to the emergency department (ED).", {"entities": []}], ["The primary outcome is the number of patients with a correct presumptive diagnosis at 4\u2005hours from admission.", {"entities": []}], ["This is a semiblinded randomised prospective study.", {"entities": []}], ["288 patients will be included and randomised into the control or intervention group.", {"entities": []}], ["All patients receive a standard diagnostic evaluation by the EP to assess the primary presumptive diagnosis.", {"entities": []}], ["Investigators are EP, with varying degrees of experience in f-US, who perform an f-US of the heart and lungs in patients in both treatment arms.", {"entities": []}], ["f-US results in the intervention group are non-blinded to the treating EP to be included in the assessment of the 4-hour presumptive diagnosis.", {"entities": []}], ["As standard for correct diagnosis, we perform a blinded journal audit after discharge.", {"entities": []}], ["As primary analysis, we use the intention-to-treat analysis.", {"entities": []}], ["This study is the first multicentre trial in EDs to investigate whether f-US, in the hands of the EP, increases the proportion of correct diagnosis at 4\u2005hours after arrival when performed on patients with respiratory problems.", {"entities": []}], ["This trial is conducted in accordance with the Helsinki II Declaration and approved by the Danish Data Protection Agency and the Committee on Biomedical Research Ethics for the Region of Southern Denmark.", {"entities": []}], ["Results will be published in accordance with the CONSORT statement in a peer-reviewed scientific journal regardless of the outcome.", {"entities": []}], ["NCT02550184 ; Pre-results.", {"entities": []}], ["The persistent influx of neutrophils into the lung and subsequent tissue damage are characteristics of COPD, cystic fibrosis and acute lung inflammation.", {"entities": [[109, 124, "DISEASE"]]}], ["VAP-1/SSAO is an endothelial bound adhesion molecule with amine oxidase activity that is reported to be involved in neutrophil egress from the microvasculature during inflammation.", {"entities": []}], ["This study explored the role of VAP-1/SSAO in neutrophilic lung mediated diseases and examined the therapeutic potential of the selective inhibitor PXS-4728A.", {"entities": []}], ["Mice treated with PXS-4728A underwent intra-vital microscopy visualization of the cremaster muscle upon CXCL1/KC stimulation.", {"entities": []}], ["LPS inflammation, Klebsiella pneumoniae infection, cecal ligation and puncture as well as rhinovirus exacerbated asthma models were also assessed using PXS-4728A.", {"entities": [[113, 119, "DISEASE"]]}], ["Selective VAP-1/SSAO inhibition by PXS-4728A diminished leukocyte rolling and adherence induced by CXCL1/KC.", {"entities": []}], ["Inhibition of VAP-1/SSAO also dampened the migration of neutrophils to the lungs in response to LPS, Klebsiella pneumoniae lung infection and CLP induced sepsis; whilst still allowing for normal neutrophil defense function, resulting in increased survival.", {"entities": []}], ["The functional effects of this inhibition were demonstrated in the RV exacerbated asthma model, with a reduction in cellular infiltrate correlating with a reduction in airways hyperractivity.", {"entities": [[82, 88, "DISEASE"]]}], ["This study demonstrates that the endothelial cell ligand VAP-1/SSAO contributes to the migration of neutrophils during acute lung inflammation, pulmonary infection and airway hyperractivity.", {"entities": []}], ["These results highlight the potential of inhibiting of VAP-1/SSAO enzymatic function, by PXS-4728A, as a novel therapeutic approach in lung diseases that are characterized by neutrophilic pattern of inflammation.", {"entities": []}], ["Background : The vast majority of deaths in the health and\u00a0Kombewa demographic surveillance system (HDSS) study area are not registered and reported through official systems of vital registration.", {"entities": []}], ["As a result, few data are available regarding causes of death in this population.", {"entities": []}], ["Objectives : To describe causes of death among residents of all ages in the Kombewa HDSS, located in rural Western Kenya.", {"entities": []}], ["Methods : Verbal autopsy (VA) interviews at the site were conducted using the modified 2007 and later 2012 standardized WHO questionnaires.", {"entities": []}], ["Assignment of causes of death was made using the InterVA-4 model version 4.02.", {"entities": []}], ["Cox regression model, adjusted for sex, was built to evaluate the influence of age on mortality.", {"entities": []}], ["Results : There were a total of 5196 deaths recorded between 2011 and 2015 at the site.", {"entities": []}], ["VA interviews were successfully completed for 3903 of these deaths (75.1%).", {"entities": []}], ["Mortality rates were highest among neonates HR\u00a0=\u00a038.54 (<0.001) and among Infants HR\u00a0=\u00a02.07 (<0.006) in the Kombewa HDSS.", {"entities": [[44, 46, "GENE"], [82, 84, "GENE"], [44, 46, "GENE"], [82, 84, "GENE"]]}], ["Among those deaths in which VA was performed, the top causes of death were HIV/AIDS (12.6%), Malaria (10.3%), Pneumonia (10.1%), Acute abdomen (7.0%), Stroke (5.2%) and TB (4.9%) for the whole population in general.", {"entities": []}], ["Stroke, acute abdomen heart diseases and Pneumonia were common causes of death (CODs) among the elderly over the age of 65.", {"entities": []}], ["Conclusions : The analysis established the main CODs among people of all ages within the area served by the Kombewa HDSS.", {"entities": []}], ["We hope that information generated from this study will help better address preventable deaths in the surveyed community as well as help mitigate negative health impacts in other rural communities throughout the Western Kenya region.", {"entities": []}], ["Seasonal allergic rhinitis (hayfever) is common and can contribute to a considerable reduction in the quality of life of adolescents.", {"entities": [[9, 26, "DISEASE"], [18, 26, "DISEASE"]]}], ["This study aims to examine the effectiveness of standardised allergy training for healthcare professionals in improving disease-specific quality of life in adolescents with hayfever.", {"entities": []}], ["Adolescents with a history of hayfever registered in general practices in Scotland and England were invited to participate in a cluster randomised controlled trial.", {"entities": []}], ["The unit of randomisation is general practices.", {"entities": []}], ["The educational intervention for healthcare professionals consists of a short standardised educational course, which focuses on the management of allergic rhinitis.", {"entities": [[146, 163, "DISEASE"], [155, 163, "DISEASE"]]}], ["Patients in the intervention arm of this cluster randomised controlled trial will have a clinic appointment with their healthcare professional who has attended the training course.", {"entities": []}], ["Patients in the control arm will have a clinic appointment with their healthcare professional and will receive usual care.", {"entities": []}], ["The primary outcome measure is the change in the Rhinoconjunctivitis Quality of Life Questionnaire with Standardised Activities (RQLQ(S)) score between baseline and six weeks post-intervention in the patient intervention and control groups.", {"entities": []}], ["Secondary outcome measures relate to healthcare professionals' understanding and confidence in managing allergic rhinitis, changes in clinical practice, numbers of consultations for hayfever and adolescent exam performance.", {"entities": [[104, 121, "DISEASE"], [113, 121, "DISEASE"]]}], ["A minimum of 11 practices in each arm of the trial (10 patients per cluster) will provide at least 80% power to demonstrate a minimal clinically important difference of 0.5 in RQLQ(S) score at a significance level of 5% based on an Intraclass Correlation Coefficient (ICC) of 0.02.", {"entities": []}], ["At the time of submission, 24 general practices have been recruited (12 in each arm of the trial) and the interventions have been delivered.", {"entities": []}], ["Follow-up data collection is complete.", {"entities": []}], ["230 children consented to take part in the trial; however complete primary outcome data are only available for 160.", {"entities": []}], ["Further recruitment of general practices and patients will therefore take place in the summer of 2010.", {"entities": []}], ["Current Controlled Trials ISRCTN95538067", {"entities": []}], ["The design and analysis of studies that investigate the effect of exposure to ozone on health outcomes need to define carefully the methods for the assessment of the exposure and to determine precisely which is the outcome of biological relevance.", {"entities": []}], ["The estimation of sample size for longitudinal studies requires the expected rates of change among the exposed and unexposed, the variance of the outcome, and the correlation of measurements taken within an individual.", {"entities": []}], ["Methods of analysis whose primary interest is in the combination of cross-sectional studies for the determination of the marginal distribution of the outcome are particularly appropriate for biological processes where the effect of exposure is acute.", {"entities": []}], ["Conditional models are particularly useful for investigating the effect of changes in exposure on changes in outcome at the individual level.", {"entities": []}], ["In addition, conditional models incorporate a dampening effect of exposure that may provide a reasonable agreement with several biological mechanisms.", {"entities": []}], ["The identification of susceptible individuals and the description of the behavior of their outcomes over time may be better accomplished by using the within-individual variance as the outcome of interest.", {"entities": []}], ["Discrepancies of the within- and between-individual regressions may be suggestive of chronic effects, and methodological research in this area is needed.", {"entities": []}], ["Studies of the health effects of ozone exposure need to address the incorporation of missing data, measurement error, and the combination of complementary studies.", {"entities": []}], ["MicroRNAs (MiRNA) are small non-coding RNAs that regulate gene expression.", {"entities": []}], ["The aim of this study was to identify miRNAs differentially expressed between mild and moderately emphysematous lung, as well as their functional target mRNAs.", {"entities": []}], ["Resected lung from patients with COPD undergoing lung cancer surgery was profiled using miRNA (Agilent Human miRNA profiler G4470 V1.01) and mRNA (OperonV2.0) microarrays.", {"entities": [[49, 60, "DISEASE"], [54, 60, "DISEASE"]]}], ["Cells of lung origin (BEAS-2B and HFL1) were profiled using mRNA microarrays (Illumina HumanHT-12\u00a0V3) after in vitro manipulation.", {"entities": []}], ["COPD patients had mean (SD) age 68 (6) years, FEV 1 72 (17)% predicted and gas transfer (KCO) 70 (10)% predicted.", {"entities": [[46, 49, "GENE"]]}], ["Five miRNAs ( miR-34c , miR-34b , miR-149 , miR-133a and miR-133b ) were significantly down-regulated in lung from patients with moderate compared to mild emphysema as defined by gas transfer ( p \u2009<\u20090.01).", {"entities": [[24, 31, "GENE"], [34, 41, "GENE"], [44, 52, "GENE"], [57, 65, "GENE"]]}], ["In vitro upregulation of miR-34c in respiratory cells led to down-regulation of predicted target mRNAs, including SERPINE1 , MAP4K4 , ZNF3 , ALDOA and HNF4A .", {"entities": [[114, 122, "GENE"], [125, 131, "GENE"], [134, 138, "GENE"], [141, 146, "GENE"], [151, 156, "GENE"]]}], ["The fold change in ex-vivo expression of all five predicted target genes inversely correlated with that of miR-34c in emphysematous lung, but this relationship was strongest for SERPINE1 (p\u2009=\u20090.05).", {"entities": [[178, 186, "GENE"]]}], ["Differences in miRNA expression are associated with emphysema severity in COPD patients.", {"entities": []}], ["MiR-34c modulates expression of its putative target gene, SERPINE1 , in vitro in respiratory cell lines and ex vivo in emphysematous lung tissue.", {"entities": [[58, 66, "GENE"]]}], ["This article is part of a series written for people responsible for making decisions about health policies and programmes and for those who support these decision makers .", {"entities": []}], ["The reliability of systematic reviews of the effects of health interventions is variable.", {"entities": []}], ["Consequently, policymakers and others need to assess how much confidence can be placed in such evidence.", {"entities": []}], ["The use of systematic and transparent processes to determine such decisions can help to prevent the introduction of errors and bias in these judgements.", {"entities": []}], ["In this article, we suggest five questions that can be considered when deciding how much confidence to place in the findings of a systematic review of the effects of an intervention.", {"entities": []}], ["These are: 1.", {"entities": []}], ["Did the review explicitly address an appropriate policy or management question?", {"entities": []}], ["Were appropriate criteria used when considering studies for the review?", {"entities": []}], ["Was the search for relevant studies detailed and reasonably comprehensive?", {"entities": []}], ["Were assessments of the studies' relevance to the review topic and of their risk of bias reproducible?", {"entities": []}], ["Were the results similar from study to study?", {"entities": []}], ["According to previous KCNQ1 (potassium channel, voltage gated, KQT-like subfamily, member 1) gene screening studies, missense variants, but not nonsense or frame-shift variants, cause the majority of long QT syndrome (LQTS; Romano-Ward syndrome [RWS]) 1 cases.", {"entities": [[208, 216, "DISEASE"], [236, 244, "DISEASE"], [22, 27, "GENE"]]}], ["Several missense variants are reported to cause RWS by a dominant-negative mechanism, and some KCNQ1 variants can cause both Jervell and Lange-Nielsen Syndrome (JLNS; in an autosomal recessive manner) and LQTS1 (in an autosomal dominant manner), while other KCNQ1 variants cause only JLNS.", {"entities": [[151, 159, "DISEASE"], [95, 100, "GENE"], [258, 263, "GENE"], [95, 100, "GENE"], [258, 263, "GENE"]]}], ["The human KCNQ1 gene is known to have two transcript isoforms (kidney isoform and pancreas isoform), and both isoforms can form a functional cardiac potassium channel.", {"entities": [[10, 15, "GENE"]]}], ["Here, we report a novel nonsense KCNQ1 variant causing not only JLNS, but also significant QTc prolongation identical to RWS in an autosomal dominant manner.", {"entities": [[33, 38, "GENE"]]}], ["Our case study supports that haploinsufficiency in the KCNQ1 gene is causative of significant QTc prolongation identical to RWS.", {"entities": [[55, 60, "GENE"]]}], ["Interestingly, the nonsense variant (NM_000218.2:c.115G\u2009>\u2009T [p.Glu39X]) locates in exon 1a of KCNQ1, which is a kidney-isoform specific exon.", {"entities": [[94, 99, "GENE"]]}], ["The variant is located closer to the N-terminus than previously identified nonsense or frame-shift variants.", {"entities": []}], ["To the best of our knowledge, this is the first report showing that a nonsense variant in exon 1a of KCNQ1, which is the kidney-isoform specific exon, causes JLNS.", {"entities": [[101, 106, "GENE"]]}], ["Our findings may be informative to the genetic pathogenesis of RWS and JLNS caused by KCNQ1 variants.", {"entities": [[86, 91, "GENE"]]}], ["The online version of this article (doi:10.1186/s12881-017-0430-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Globally, rhinitis is one of the most common chronic disorders.", {"entities": [[10, 18, "DISEASE"]]}], ["Despite availability of drugs to manage the symptomatology of rhinitis, researchers still focus on identification of novel molecular targets for better management.", {"entities": [[62, 70, "DISEASE"]]}], ["MicroRNAs are implicated in many biological and pathological processes.", {"entities": []}], ["However, the role of miR-17-5p in rhinitis remains unexplored.", {"entities": [[34, 42, "DISEASE"]]}], ["This study aimed to explore the role of miR-17-5p in lipopolysaccharide (LPS)-induced injury of nasal epithelial RPMI2650 cells and to elucidate the possible underlying molecular mechanism.", {"entities": []}], ["LPS damaged RPMI2650 cells by inhibiting cell proliferation, promoting apoptosis, and stimulating the release of inflammatory cytokines.", {"entities": []}], ["miR-17-5p expression was significantly increased in RPMI2650 cells following treatment with LPS.", {"entities": []}], ["Furthermore, it was found that overexpression of miR-17-5p led to aggravation of LPS-induced injury.", {"entities": []}], ["miR-17-5p negatively regulated expression of Smad7; overexpression of Smad7 protected the RPMI2650 cells by inactivating NF-\u03baB and Wnt/\u03b2 catenin pathways and vice versa.", {"entities": [[45, 50, "GENE"], [70, 75, "GENE"], [45, 50, "GENE"], [70, 75, "GENE"]]}], ["Overexpression of miR-17-5p aggravated LPS-induced damage of RPMI2650 cells.", {"entities": []}], ["Expression of Smad7 was negatively regulated by miR-17-5p; Smad7 expression inactivated NF-\u03baB and Wnt/\u03b2 catenin pathways.", {"entities": [[14, 19, "GENE"], [59, 64, "GENE"], [14, 19, "GENE"], [59, 64, "GENE"]]}], ["Aberrant immune responses to environmental allergens including insect allergens from house dust mites and cockroaches contribute to allergic inflammatory diseases such as asthma in susceptible individuals.", {"entities": [[171, 177, "DISEASE"]]}], ["Airway epithelial cells (AECs) play a critical role in this process by sensing the proteolytic activity of allergens via protease-activated receptors (PAR2) to initiate inflammatory and immune responses in the airway.", {"entities": []}], ["Elevation of cytosolic Ca", {"entities": []}], ["Premature infants frequently develop bronchopulmonary dysplasia (BPD).", {"entities": []}], ["Lung immaturity and impaired epithelial differentiation contribute together with invasive oxygen treatment to BPD onset and disease progression.", {"entities": []}], ["Substantial evidence suggests that prematurity is associated with long term pulmonary consequences.", {"entities": []}], ["Moreover, there is increasing concern that lung immaturity at birth may increase the risk of developing chronic obstructive pulmonary disease (COPD).", {"entities": [[104, 141, "DISEASE"]]}], ["The mechanisms contributing to this phenomenon remains unknown, largely as a consequence of inadequate experimental models and clinical follow-up studies.", {"entities": []}], ["Recent evidence suggests that defective transcriptional regulation of epithelial differentiation and maturation may contribute to BPD pathogenesis as well as early onset of COPD.", {"entities": []}], ["The transcriptional regulators CCAAT/enhancer-binding protein (C/EBP) \u03b1 and C/EBP \u03b2 , SMAD family member (Smad)3, GATA binding protein (GATA)6, and NK2 homeobox (NKX)2-1 are reported to be involved in processes contributing to pathogenesis of both BPD and COPD.", {"entities": []}], ["Increased knowledge of the mechanisms contributing to early onset COPD among BPD survivors could translate into improved treatment strategies and reduced frequency of respiratory disorders among adult survivors of BPD.", {"entities": []}], ["In this paper, we introduce critical transcriptional regulators in epithelial differentiation and summarize the current knowledge on the contribution of impaired epithelial maturation to the pathogenesis of inflammatory lung disorders.", {"entities": []}], ["The lacrimal gland (LG) of the CD25 CD25 The greatest total LG infiltration at 8 W was seen in CD25 IFN-\u03b3 is critical for LG destruction and secretory dysfunction in the CD25", {"entities": []}], ["Flexible laryngeal mask airways (FLMAs) have been widely used in thyroidectomy as well as cleft palate, nasal, upper chest, head and neck oncoplastic surgeries.", {"entities": [[90, 102, "DISEASE"]]}], ["This systematic review aims to compare the incidence of airway complications that occur during and after general anesthesia when using the FLMA and endotracheal intubation (ETT).", {"entities": []}], ["We performed a quantitative meta-analysis of the results of randomized trials.", {"entities": []}], ["A comprehensive search of the PubMed, Embase and Cochrane Library databases was conducted using the key words \"flexible laryngeal mask airway\" and \"endotracheal intubation\".", {"entities": []}], ["Only prospective randomized controlled trials (RCTs) that compared the FLMA and ETT were included.", {"entities": []}], ["The relative risks (RRs) and the corresponding 95% confidence intervals (95% CIs) were calculated using a quality effects model in MetaXL 1.3 software to analyze the outcome data.", {"entities": []}], ["Ten RCTs were included in this meta-analysis.", {"entities": []}], ["There were no significant differences between the FLMA and ETT groups in the incidence of difficulty in positioning the airway [RR = 1.75, 95% CI = (0.70\u20134.40)]; the occurrence of sore throat at one hour and 24 hours postoperative [RR = 0.90, 95% CI = (0.13\u20136.18) and RR = 0.95, 95% CI = (0.81\u20131.13), respectively]; laryngospasms [RR = 0.58, 95% CI = (0.27\u20131.23)]; airway displacement [RR = 2.88, 95% CI = (0.58\u201314.33)]; aspiration [RR = 0.76, 95% CI = (0.06\u20138.88)]; or laryngotracheal soiling [RR = 0.34, 95% CI = (0.10\u20131.06)].", {"entities": []}], ["Patients treated with the FLMA had a lower incidence of hoarseness [RR = 0.31, 95% CI = (0.15\u20130.62)]; coughing [RR = 0.28, 95% CI = (0.15\u20130.51)] during recovery in the postanesthesia care unit (PACU); and oxygen desaturation [RR = 0.43, 95% CI = (0.26\u20130.72)] than did patients treated with ETT.", {"entities": []}], ["However, the incidence of partial upper airway obstruction in FLMA patients was significantly greater than it was for ETT patients [RR = 4.01, 95% CI = (1.44\u201311.18)].", {"entities": []}], ["This systematic review showed that the FLMA has some advantages over ETT because it results in a lower incidence of hoarseness, coughing and oxygen desaturation.", {"entities": []}], ["There were no statistically significant differences in the difficulty of intubation or in the occurrence of laryngospasms, postoperative sore throat, airway displacement, aspiration or laryngotracheal soiling.", {"entities": []}], ["However, there was a higher incidence of partial upper airway obstruction in the FLMA than in the ETT group.", {"entities": []}], ["We conclude that the FLMA has some advantages over ETT, but surgeons and anesthesiologists should be cautious when applying the mouth gag, moving the head and neck, or performing oropharyngeal procedures to avoid partial upper airway obstruction and airway displacement.", {"entities": []}], ["The FLMA should not be used on patients at high risk for aspiration.", {"entities": []}], ["In the generation of a traditional immune response against invading pathogens, innate cells guide T cells by programming their differentiation.", {"entities": []}], ["However, here we demonstrate that \u03b1\u03b2 T cells play an essential role in priming innate immunity in the lung after Staphylococcus aureus enterotoxin A (SEA) inhalation.", {"entities": []}], ["We found that SEA induces waves of cellular activation, cytokine production, and migration into the lung tissue and airways.", {"entities": []}], ["However, this innate response was completely inhibited in the absence of \u03b1\u03b2 T cells.", {"entities": []}], ["Specifically, we found that IL-17A was required for the recruitment of neutrophils and monocytes into the lung.", {"entities": []}], ["The cellular source of IL-17A was \u03b3\u03b4 T cells, which increased their IL-17A production following SEA, but only in an \u03b1\u03b2 T cell-dependent manner.", {"entities": []}], ["Thus, rapid T cell activation orchestrates innate immunity and may be a new point of therapeutic intervention for acute lung injury.", {"entities": []}], ["To evaluate the reproducibility of indices of lung microstructure and function derived from Preliminary data were collected from five volunteers on three occasions, using two implementations of the CSSR sequence.", {"entities": []}], ["Separately, three volunteers each underwent CSSR at three different lung inflation levels.", {"entities": []}], ["After analysis of these preliminary data, five COPD patients were scanned on three separate days, and nine age\u2010matched volunteers were scanned three times on one day, to assess reproducibility.", {"entities": []}], ["CSSR\u2010derived alveolar septal thickness (ST) and surface\u2010area\u2010to\u2010volume (S/V) ratio values decreased with lung inflation level ( P \u2009<\u20090.001; P \u2009=\u20090.057, respectively).", {"entities": []}], ["Intra\u2010subject standard deviations of ST were lower than the previously measured differences between volunteers and subjects with interstitial lung disease.", {"entities": [[129, 154, "DISEASE"], [142, 154, "DISEASE"]]}], ["The mean coefficient of variation (CV) values of ST were 3.9\u2009\u00b1\u20091.9% and 6.0\u2009\u00b1\u20094.5% in volunteers and COPD patients, respectively, similar to CV values for whole\u2010lung carbon monoxide diffusing capacity.", {"entities": []}], ["The mean CV of S/V in volunteers and patients was 14.1\u2009\u00b1\u20098.0% and 18.0\u2009\u00b1\u200919.3%, respectively.", {"entities": []}], ["Mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a protein with anti-inflammatory properties and the archetypal member of the dual-specificity phosphatases (DUSPs) family that have emerged over the past decade as playing an instrumental role in the regulation of airway inflammation.", {"entities": []}], ["Not only does MKP-1 serve a critical role as a negative feedback effector, controlling the extent and duration of pro-inflammatory MAPK signalling in airway cells, upregulation of this endogenous phosphatase has also emerged as being one of the key cellular mechanism responsible for the beneficial actions of clinically-used respiratory medicines, including \u03b2 2 -agonists, phosphodiesterase inhibitors and corticosteroids.", {"entities": []}], ["Herein, we review the role and regulation of MKP-1 in the context of airway inflammation.", {"entities": []}], ["We initially outline the structure and biochemistry of MKP-1 and summarise the multi-layered molecular mechanisms responsible for MKP-1 production more generally.", {"entities": []}], ["We then focus in on some of the key in vitro studies in cell types relevant to airway disease that explain how MKP-1 can be regulated in airway inflammation at the transcriptional, post-translation and post-translational level.", {"entities": []}], ["And finally, we address some of the potential challenges with MKP-1 upregulation that need to be explored further to fully exploit the potential of MKP-1 to repress airway inflammation in chronic respiratory disease.", {"entities": []}], ["Phytochemicals from fruit and vegetables reduce systemic inflammation.", {"entities": []}], ["This study examined the effects of an encapsulated fruit and vegetable (F&V) juice concentrate on systemic inflammation and other risk factors for chronic disease in overweight and obese adults.", {"entities": []}], ["A double-blinded, parallel, randomized placebo-controlled trial was conducted in 56 adults aged \u226540 years with a body mass index (BMI) \u226528 kg/m n = 16), these effects were greater, with decreased total cholesterol, LDL cholesterol and plasma TNF\u03b1 and increased total lean mass; plasma CRP was unchanged by the F&V juice concentrate following both analyses.", {"entities": [[285, 288, "GENE"]]}], ["The expression of several genes involved in lipogenesis, the nuclear factor-\u03baB (NF-\u03baB) and 5\u2032 adenosine monophosphate-activated protein kinase (AMPK) signalling pathways was altered, including phosphomevalonate kinase (PMVK), zinc finger AN1-type containing 5 (ZFAND5) and calcium binding protein 39 (CAB39), respectively.", {"entities": [[219, 223, "GENE"], [261, 267, "GENE"], [301, 306, "GENE"]]}], ["Therefore, F&V juice concentrate improves the metabolic profile, by reducing systemic inflammation and blood lipid profiles and, thus, may be useful in reducing the risk of obesity-induced chronic disease.", {"entities": [[173, 180, "DISEASE"]]}], ["We examined whether maternal exposure to food antigens during lactation and maternal allergic status would affect the development of food allergy in offspring.", {"entities": [[133, 145, "DISEASE"]]}], ["OVA-sensitized or OVA-nonsensitized BALB/c female mice were exposed or unexposed to OVA during lactation.", {"entities": []}], ["After weaning, their offspring were systemically sensitized twice with OVA and repeatedly given OVA by oral intubation.", {"entities": []}], ["While 97.1% of the mice breastfed by OVA-nonsensitized and OVA-unexposed mothers developed allergic diarrhea, 59.7% of the mice breastfed by OVA-exposed nonallergic mothers during lactation and 24.6% of the mice breastfed by OVA-exposed allergic mothers during lactation developed food allergy.", {"entities": [[100, 108, "DISEASE"], [281, 293, "DISEASE"]]}], ["Furthermore, OVA was detected in breast-milk from OVA-exposed nonallergic mothers during lactation (4.6 \u00b1 0.5\u2009 \u03bc g/mL).", {"entities": []}], ["In addition, OVA-specific IgG1 titers were markedly increased in breast milk from allergic mothers (OVA-sensitized and OVA-unexposed mother: 11.0 \u00b1 0.5, OVA-sensitized and OVA-exposed mother: 12.3 \u00b1 0.3).", {"entities": []}], ["Our results suggest that oral tolerance induced by breast milk-mediated transfer of dietary antigens along with their specific immunoglobulins to offspring leads to antigen-specific protection from food allergy.", {"entities": [[198, 210, "DISEASE"]]}], ["Only a small fraction of coronary artery disease (CAD) heritability has been explained by common variants identified to date.", {"entities": []}], ["Interactions between genes of importance to cardiovascular regulation may account for some of the missing heritability of CAD.", {"entities": []}], ["This study aimed to investigate the role of gene-gene interactions in common variants in candidate cardiovascular genes in CAD.", {"entities": []}], ["2,101 patients with CAD from the British Heart Foundation Family Heart Study and 2,426 CAD-free controls were included in the discovery cohort.", {"entities": []}], ["All subjects were genotyped with the Illumina HumanCVD BeadChip enriched for genes and pathways relevant to the cardiovascular system and disease.", {"entities": []}], ["The primary analysis in the discovery cohort examined pairwise interactions among 913 common (minor allele frequency >0.1) independent single nucleotide polymorphisms (SNPs) with at least nominal association with CAD in single locus analysis.", {"entities": []}], ["A secondary exploratory interaction analysis was performed among all 11,332 independent common SNPs surviving quality control criteria.", {"entities": []}], ["Replication analyses were conducted in 2,967 patients and 3,075 controls from the Myocardial Infarction Genetics Consortium.", {"entities": []}], ["None of the interactions amongst 913 SNPs analysed in the primary analysis was statistically significant after correction for multiple testing (required P<1.2x10 Moderately large additive interactions between common SNPs in genes relevant to cardiovascular disease do not appear to play a major role in genetic predisposition to CAD.", {"entities": []}], ["The role of genetic interactions amongst less common SNPs and with medium and small magnitude effects remain to be investigated.", {"entities": []}], ["Periodic outbreaks of dengue fever occur in the United States Virgin Islands.", {"entities": []}], ["In June 2005, an outbreak of dengue virus (DENV) serotype-2 with cases of dengue hemorrhagic fever (DHF) was detected in St. Croix, US Virgin Islands.", {"entities": [[74, 98, "DISEASE"]]}], ["The objective of this report is to describe this outbreak of DENV-2 and the findings of a case-control study examining risk factors for DHF.", {"entities": []}], ["This is the largest dengue outbreak ever recorded in St. Croix, with 331 suspected dengue cases reported island-wide during 2005 (62.2 cases/10,000 population); 54% were hospitalized, 21% had at least one hemorrhagic manifestation, 28% had thrombocytopenia, 5% had DHF and 1 patient died.", {"entities": [[240, 256, "DISEASE"]]}], ["Eighty-nine laboratory-positive hospitalized patients were identified.", {"entities": []}], ["Of these, there were 15 (17%) who met the WHO criteria for DHF (cases) and 74 (83%) who did not (controls).", {"entities": []}], ["The only variable significantly associated with DHF on bivariate or multivariable analysis was age, with an adjusted odds ratio (95% confidence interval) of 1.033 (1.003,1.064).", {"entities": []}], ["During this outbreak of DENV-2, a high proportion of cases developed DHF and increasing age was significantly associated with DHF.", {"entities": []}], ["Efforts to reduce unnecessary Cesarean sections (CS) in high and middle income countries have focused on changing hospital cultures and policies, care provider attitudes and behaviors, and increasing women\u2019s knowledge about the benefits of vaginal birth.", {"entities": [[49, 51, "GENE"]]}], ["These strategies have been largely ineffective.", {"entities": []}], ["Despite evidence that women have well-developed preferences for mode of delivery prior to conceiving their first child, few studies and no interventions have targeted the next generation of maternity care consumers.", {"entities": []}], ["The objectives of the study were to identify how many women prefer Cesarean section in a hypothetical healthy pregnancy, why they prefer CS and whether women report knowledge gaps about pregnancy and childbirth that can inform educational interventions.", {"entities": [[137, 139, "GENE"]]}], ["Data was collected via an online survey at colleges and universities in 8 OECD countries (Australia, Canada, Chile, England, Germany, Iceland, New Zealand, United States) in 2014/2015.", {"entities": []}], ["Childless young men and women between 18 and 40\u00a0years of age who planned to have at least one child in the future were eligible to participate.", {"entities": []}], ["The current analysis is focused on the attitudes of women ( n \u00a0=\u00a03616); rates of CS preference across countries are compared, using a standardized cohort of women aged 18\u201325\u00a0years, who were born in the survey country and did not study health sciences ( n \u00a0=\u00a01390).", {"entities": [[81, 83, "GENE"]]}], ["One in ten young women in our study preferred CS, ranging from 7.6% in Iceland to 18.4% in Australia.", {"entities": [[46, 48, "GENE"]]}], ["Fear of uncontrollable labor pain and fear of physical damage were primary reasons for preferring a CS.", {"entities": [[100, 102, "GENE"]]}], ["Both fear of childbirth and preferences for CS declined as the level of confidence in women\u2019s knowledge of pregnancy and birth increased.", {"entities": [[44, 46, "GENE"]]}], ["Education sessions delivered online, through social media, and face-to-face using drama and stories told by peers (young women who have recently had babies) or celebrities could be designed to maximize young women\u2019s capacity to understand the physiology of labor and birth, and the range of methods available to support them in coping with labor pain and to minimize invasive procedures, therefore reducing fear of pain, bodily damage, and loss of control.", {"entities": []}], ["The most efficacious designs and content for such education for young women and girls remains to be tested in future studies.", {"entities": []}], ["Platelet-derived growth factor-BB (PDGF-BB) has been implicated in the proliferation, migration and synthetic activities of smooth muscle cells that characterize physiologic and pathologic tissue remodeling in hollow organs.", {"entities": []}], ["However, neither the molecular basis of PDGFR-regulated signaling webs, nor the extent to which specific components within these networks could be exploited for therapeutic benefit has been fully elucidated.", {"entities": []}], ["Expression profiling and quantitative proteomics analysis of PDGF-treated primary human bladder smooth muscle cells identified 1,695 genes and 241 proteins as differentially expressed versus non-treated cells.", {"entities": []}], ["Analysis of gene expression data revealed MYC, JUN, EGR1, MYB, RUNX1, as the transcription factors most significantly networked with up-regulated genes.", {"entities": [[42, 45, "GENE"], [47, 50, "GENE"], [52, 56, "GENE"], [58, 61, "GENE"], [63, 68, "GENE"]]}], ["Forty targets were significantly altered at both the mRNA and protein levels.", {"entities": []}], ["Proliferation, migration and angiogenesis were the biological processes most significantly associated with this signature, and MYC was the most highly networked master regulator.", {"entities": [[127, 130, "GENE"]]}], ["Alterations in master regulators and gene targets were validated in PDGF-stimulated smooth muscle cells in vitro and in a model of bladder injury in vivo.", {"entities": []}], ["Pharmacologic inhibition of MYC and JUN confirmed their role in SMC proliferation and migration.", {"entities": [[28, 31, "GENE"], [36, 39, "GENE"]]}], ["Network analysis identified the diaphanous-related formin 3 as a novel PDGF target regulated by MYC and JUN, which was necessary for PDGF-stimulated lamellipodium formation.", {"entities": [[96, 99, "GENE"], [104, 107, "GENE"]]}], ["These findings provide the first systems-level analysis of the PDGF-regulated transcriptome and proteome in normal smooth muscle cells.", {"entities": []}], ["The analyses revealed an extensive cohort of PDGF-dependent biological processes and connected key transcriptional effectors to their regulation, significantly expanding current knowledge of PDGF-stimulated signaling cascades.", {"entities": []}], ["These observations also implicate MYC as a novel target for pharmacological intervention in fibroproliferative expansion of smooth muscle, and potentially in cancers in which PDGFR-dependent signaling or MYC activation promote tumor progression.", {"entities": [[34, 37, "GENE"], [204, 207, "GENE"], [34, 37, "GENE"], [204, 207, "GENE"]]}], ["Lead (Pb) and methyl mercury (MeHg) are well established neurodevelopmental toxicants (NDTs), but joint exposure to chemical and nonchemical (e.g., maternal stress) stressors has rarely been considered.", {"entities": []}], ["We characterized exposure to Pb, MeHg and a measure of physiological dysregulation associated with chronic stress and examined race/ethnicity as a predictor of joint NDT exposure.", {"entities": []}], ["Using data from the 2003\u22122004 NHANES, potential chronic stress exposure was estimated using allostatic load (AL), a quantitative measure of physiological dysregulation.", {"entities": []}], ["A Hazard Index was calculated for joint exposure to Pb and MeHg (HI NDT ).", {"entities": []}], ["Logistic regression was used to assess the relationship between an indicator of elevated joint NDT exposures (HI NDT > 1) and race/ethnicity.", {"entities": []}], ["The multivariate model was stratified by AL groups to examine effect measure modification.", {"entities": []}], ["African American (adjusted odds ratio [OR] [95% confidence interval] = 2.2 [1.4, 3.3]) and Mexican American (1.4 [0.7, 2.6]) women were more likely to have an HI NDT > 1 compared to Caucasian women.", {"entities": []}], ["Chronic stress was identified as an effect measure modifier with the largest ORs among women with high AL scores (African Americans = 4.3 [2.0, 9.5]; Mexican Americans = 4.2 [1.3, 14.1]).", {"entities": []}], ["Chronic stress was found to modify the association between elevated joint NDT exposure and race/ethnicity, highlighting the importance of evaluating chemical and nonchemical stressor exposures leading to a common endpoint.", {"entities": []}], ["Cigarette smoking during pregnancy is associated with numerous obstetrical, fetal, and developmental complications, as well as an increased risk of adverse health consequences in the adult offspring.", {"entities": []}], ["Nicotine replacement therapy (NRT) has been developed as a pharmacotherapy for smoking cessation and is considered to be a safer alternative for women to smoking during pregnancy.", {"entities": []}], ["The safety of NRT use during pregnancy has been evaluated in a limited number of short-term human trials, but there is currently no information on the long-term effects of developmental nicotine exposure in humans.", {"entities": []}], ["However, animal studies suggest that nicotine alone may be a key chemical responsible for many of the long-term effects associated with maternal cigarette smoking on the offspring, such as impaired fertility, type 2 diabetes, obesity, hypertension, neurobehavioral defects, and respiratory dysfunction.", {"entities": [[235, 247, "DISEASE"], [226, 233, "DISEASE"]]}], ["This review will examine the long-term effects of fetal and neonatal nicotine exposure on postnatal health.", {"entities": []}], ["The severity and outcome of malaria is influenced by host immunity in which chemokines such as Regulated upon Activation, Normal T cell Expressed and Secreted (RANTES) play an important role.", {"entities": [[28, 35, "DISEASE"]]}], ["Previous studies show that variations in the RANTES gene affect RANTES protein production, hence altering host immunity.", {"entities": []}], ["In this study, the relationship between presence of mutations in RANTES and incidence of malaria in a cohort of children living in a malaria-endemic area of Uganda was determined.", {"entities": [[89, 96, "DISEASE"], [133, 140, "DISEASE"]]}], ["This was a longitudinal study comprising of 423 children aged between 6\u00a0months and 9\u00a0years, who were actively followed up for 1\u00a0year.", {"entities": []}], ["Malaria episodes occurring in the cohort children were detected and the affected children treated with national policy drug regimen.", {"entities": [[0, 7, "DISEASE"]]}], ["Mutations in the RANTES gene were determined by PCR\u2013RFLP method and their frequencies were calculated.", {"entities": []}], ["A multivariate negative binomial regression model was used to estimate the impact of RANTES mutations on malaria incidence.", {"entities": [[105, 112, "DISEASE"]]}], ["In all statistical tests, a P-value of <0.05 was considered as significant.", {"entities": []}], ["The frequencies of the \u2212403A and In1.1C allele were 53.7 and 19.2\u00a0%, respectively.", {"entities": []}], ["No mutations were found at the \u221228 locus.", {"entities": []}], ["After adjustment of incidence rates for age, blood group, insecticide-treated bed net (ITN) use, malaria history and the sickle cell trait, 1n1.1T/C heterozygotes and homozygotes showed a non-significant trend towards higher incidence rates compared to wild-type individuals (IRR\u00a0=\u00a01.10; P\u00a0=\u00a00.55 and IRR\u00a0=\u00a01.25; P\u00a0=\u00a00.60, respectively).", {"entities": [[97, 104, "DISEASE"]]}], ["Similarly, there was no significant difference in malaria incidence rates between RANTES \u2212403G/A heterozygotes or homozygotes and those without mutations (IRR\u00a0=\u00a01.09; P\u00a0=\u00a00.66 and IRR\u00a0=\u00a01.16; P\u00a0=\u00a00.50, respectively).", {"entities": [[50, 57, "DISEASE"]]}], ["No relation was seen between RANTES polymorphisms, baseline parasite densities and the time to first re-infection after administration of anti-malaria drugs.", {"entities": [[143, 150, "DISEASE"]]}], ["This study showed that the \u2212403A mutation occurs in nearly half of the study population and the In1.1C allele occurs in one in every four children.", {"entities": []}], ["Despite the high frequency of these mutations, there was no clear association with malaria incidence.", {"entities": [[83, 90, "DISEASE"]]}], ["Other studies evaluating more markers, that could potentially modulate RANTES gene transcription alongside other genetic modifiers of malaria susceptibility, may provide further explanations to these less dramatic findings.", {"entities": [[134, 141, "DISEASE"]]}], ["Low birth weight (LBW) and environmental tobacco smoke (ETS) exposure are each associated with wheezing in children.", {"entities": []}], ["This study was designed to examine the combined association of LBW and ETS with wheezing.", {"entities": []}], ["A retrospective birth cohort analysis linked with a national survey of allergic disorders among 1,018,031 junior high school students in Taiwan (1995\u20131996) was analyzed.", {"entities": []}], ["The reported incidence of wheezing (yes or no) and ETS exposure (4 categories: 0, 1\u201320, 21\u201340 and greater than or equal to 41 household cigarettes per day) were obtained from validated questionnaires.", {"entities": []}], ["Multiple logistic regression models were used to assess the associations of interest.", {"entities": []}], ["There were 844,003 (83%) subjects analyzed after the exclusion criteria.", {"entities": []}], ["LBW was associated with an increased risk of reporting ever wheezing (odds ratio [OR]\u2009=\u20091.08, 95% confidence interval [CI]\u2009=\u20091.01\u20131.16), current wheezing (OR\u2009=\u20091.09, 95% CI\u2009=\u20091.00\u20131.20) and wheezing with exercise (OR\u2009=\u20091.11, 95% CI\u2009=\u20091.02\u20131.21) within the smoke-free cohort.", {"entities": []}], ["Higher ETS exposure correlated to a higher risk of wheezing (ever, current and with exercise).", {"entities": []}], ["With ETS exposure, adolescents from the lowest birth weight cohorts were more likely to report wheezing (ever, current and with exercise).", {"entities": []}], ["ETS and LBW each has been related to increasing public health risk for respiratory symptoms among adolescents.", {"entities": []}], ["Furthermore, LBW may aggravate the risk among those exposed to ETS.", {"entities": []}], ["LBW, ETS and associated respiratory impairments may deserve special attention as part of a comprehensive environmental health risk assessment directed toward prevention and intervention.", {"entities": []}], ["Persons with schizophrenia may face barriers to high quality primary care due to communication difficulties, cognitive impairment, lack of social support, and fragmentation of healthcare delivery services.", {"entities": [[13, 26, "DISEASE"]]}], ["As a result, this group may be at high risk for ambulatory care sensitive (ACS) hospitalizations, defined as hospitalizations potentially preventable by timely primary care.", {"entities": []}], ["The goal of this study was to determine if schizophrenia is associated with overall, acute, and chronic ACS hospitalizations in the United States (US).", {"entities": [[43, 56, "DISEASE"]]}], ["We conducted a retrospective cross-sectional study.", {"entities": []}], ["Hospitalization data for the US were obtained from the Nationwide Inpatient Sample for years 2003\u20132008.", {"entities": []}], ["We examined 15,275,337 medical and surgical discharges for adults aged 18\u201364, 182,423 of which had a secondary diagnosis of schizophrenia.", {"entities": [[124, 137, "DISEASE"]]}], ["ACS hospitalizations were measured using the Agency for Healthcare Research and Quality\u2019s Prevention Quality Indicators (PQIs).", {"entities": []}], ["We developed logistic regression models to obtain nationally-weighted odds ratios (OR) for ACS hospitalizations, comparing those with and without a secondary diagnosis of schizophrenia after adjusting for patient, hospitalization, and hospital characteristics.", {"entities": [[171, 184, "DISEASE"]]}], ["Schizophrenia was associated with increased odds of hospitalization for acute ACS conditions (OR\u2009=\u20091.34; 95% CI: 1.31, 1.38), as well as for chronic ACS conditions characterized by short-term exacerbations.", {"entities": [[0, 13, "DISEASE"]]}], ["Schizophrenia was associated with decreased odds of hospitalization for diabetes mellitus long-term complications and diabetes-related lower extremity amputation, conditions characterized by long-term deterioration.", {"entities": [[0, 13, "DISEASE"], [72, 89, "DISEASE"]]}], ["Additional research is needed to determine which individual and health systems factors contribute to the increased odds of hospitalization for acute PQIs in schizophrenia.", {"entities": [[157, 170, "DISEASE"]]}], ["The aim of this study was to investigate if 2 common single nucleotide polymorphisms (SNPs) in the interleukin-13 (IL-13) gene, rs1800925 and rs20541 are associated with chronic obstructive pulmonary disease (COPD) risk.", {"entities": [[170, 207, "DISEASE"]]}], ["Case\u2013control association studies were retrieved systematically from PubMed, Scopus, ISI Web of Science, China National Knowledge Infrastructure, and Wanfang databases using standardized subject terms.", {"entities": []}], ["Eleven studies including 3077 participants (1896 cases and 1181 controls) were analyzed.", {"entities": []}], ["Evidence for a positive association between the T allele of the IL-13 SNP rs1800925 and COPD risk was found in the overall population (odds ratio [OR]\u200a=\u200a1.57, 95% confidence interval [95% CI]: 1.21\u20132.04, P z \u200a=\u200a.001).", {"entities": []}], ["In subgroup analysis according to ethnicity, the T allele of rs1800925 was associated with an increased risk of COPD in Asians (OR\u200a=\u200a1.88, 95% CI: 1.23\u20132.87, P z \u200a=\u200a.004) and Caucasians (OR\u200a=\u200a1.30, 95% CI: 1.01\u20131.67, P z \u200a=\u200a.041), respectively.", {"entities": []}], ["For rs20541, the results suggested an association between rs20541 and COPD risk in Caucasians under the recessive model (OR\u200a=\u200a2.79, 95% CI: 1.13\u20136.92, P z \u200a=\u200a.026), whereas this SNP was not associated with COPD in Asians.", {"entities": []}], ["This meta-analysis suggests that the T allele of rs1800925 is associated with the increased risk of COPD in both Asians and Caucasians, whereas rs20541 is associated with the risk of COPD in Caucasians but not in Asians.", {"entities": []}], ["Sampling various compartments within the lower airways to examine human bronchial epithelial cells (HBEC) is essential for understanding numerous lung diseases.", {"entities": []}], ["Conventional methods to identify HBEC in bronchoalveolar lavage (BAL) and wash (BW) have throughput limitations in terms of efficiency and ensuring adequate cell numbers for quantification.", {"entities": []}], ["Flow cytometry can provide high-throughput quantification of cell number and function in BAL and BW samples, while requiring low cell numbers.", {"entities": []}], ["To date, a flow cytometric method to identify HBEC recovered from lower human airway samples is unavailable.", {"entities": []}], ["In this study we present a flow cytometric method identifying HBEC as CD45 negative, EpCAM/pan-cytokeratin (pan-CK) double-positive population after excluding debris, doublets and dead cells from the analysis.", {"entities": []}], ["For validation, the HBEC panel was applied to primary HBEC resulting in 98.6% of live cells.", {"entities": []}], ["In healthy volunteers, HBEC recovered from BAL (2.3% of live cells), BW (32.5%) and bronchial brushing samples (88.9%) correlated significantly (p\u2009=\u20090.0001) with the manual microscopy counts with an overall Pearson correlation of 0.96 across the three sample types.", {"entities": []}], ["We therefore have developed, validated, and applied a flow cytometric method that will be useful to interrogate the role of the respiratory epithelium in multiple lung diseases.", {"entities": []}], ["Background Electronic health records (EHRs) are increasingly used for clinical and translational research through the creation of phenotype algorithms.", {"entities": []}], ["Currently, phenotype algorithms are most commonly represented as noncomputable descriptive documents and knowledge artifacts that detail the protocols for querying diagnoses, symptoms, procedures, medications, and/or text-driven medical concepts, and are primarily meant for human comprehension.", {"entities": []}], ["We present desiderata for developing a computable phenotype representation model (PheRM).", {"entities": []}], ["Methods A team of clinicians and informaticians reviewed common features for multisite phenotype algorithms published in PheKB.org and existing phenotype representation platforms.", {"entities": []}], ["We also evaluated well-known diagnostic criteria and clinical decision-making guidelines to encompass a broader category of algorithms.", {"entities": []}], ["Results We propose 10 desired characteristics for a flexible, computable PheRM: (1) structure clinical data into queryable forms; (2) recommend use of a common data model, but also support customization for the variability and availability of EHR data among sites; (3) support both human-readable and computable representations of phenotype algorithms; (4) implement set operations and relational algebra for modeling phenotype algorithms; (5) represent phenotype criteria with structured rules; (6) support defining temporal relations between events; (7) use standardized terminologies and ontologies, and facilitate reuse of value sets; (8) define representations for text searching and natural language processing; (9) provide interfaces for external software algorithms; and (10) maintain backward compatibility.", {"entities": []}], ["Conclusion A computable PheRM is needed for true phenotype portability and reliability across different EHR products and healthcare systems.", {"entities": []}], ["These desiderata are a guide to inform the establishment and evolution of EHR phenotype algorithm authoring platforms and languages.", {"entities": []}], ["Studies on school students are indicating that somatic complaints and pain have increased during the past decades.", {"entities": []}], ["Throughout this period there has been a change in methodology from proxy reports by parents to having the students themselves act as the respondents, possible explaining some of the increase in prevalence.", {"entities": []}], ["The aim of this study was to compare the agreement of answers from students with answers given by their parents regarding the students' medical background and subjective rating of perceived health with specific focus on frequency of headache, musculoskeletal pain and tiredness.", {"entities": []}], ["The participating students came from eleven different schools in Sweden.", {"entities": []}], ["The schools were a sub sample of randomly selected schools originally participating in a larger multidisciplinary base study.", {"entities": []}], ["Those 8 When a child is in good health, in absence of diseases, pain and injuries, his or her assessment matches up with their parent.", {"entities": []}], ["Children and parents also showed agreement in cases of severe injuries and frequent (daily) complaints of knee pain.", {"entities": []}], ["Less frequent headaches, back- and musculoskeletal pain and other complaints of minor injuries and less wellbeing, such as students' tiredness, were all under-reported and under-rated by their parents.", {"entities": []}], ["When assessing the perceived health and wellbeing of students, their own expressions should be the basis for the data collection and analysis rather than relying entirely on parental reports.", {"entities": []}], ["Cell division is closely related to telomerase activity (hTERT mRNA).", {"entities": []}], ["Lower expression of lymphocitic hTERT mRNA may easily cause cell aging, which is not beneficial to maintaining a durable lymphocyte division.", {"entities": []}], ["To date, there is no study to investigate IFN \u03b1 therapy on hTERT mRNA expression in PBMCs of patients with chronic hepatitis B (CHB).", {"entities": [[115, 124, "DISEASE"]]}], ["We quantitatively detected hTERT mRNA from study subjects and made each hTERT mRNA normalized (NhTERT mRNA).", {"entities": []}], ["Mean NhTERT mRNA level was lower in either CHB group, but it significantly increased in IFN \u03b1 -treated group compared with CHB control group, and a longer duration of IFN \u03b1 therapy could increase the level.", {"entities": []}], ["Moreover, the mean NhTERT mRNA in subgroup with HBeAg loss was significantly higher than that in subgroup without.", {"entities": []}], ["NhTERT mRNA was markedly correlated with CD3 \u03b1 therapy could upregulate the expression of hTERT mRNA in PBMCs.", {"entities": []}], ["Burning biomass fuels indoors for cooking is associated with high concentrations of particulate matter (PM) and carbon monoxide (CO).", {"entities": []}], ["More efficient biomass-burning stoves and chimneys for ventilation have been proposed as solutions to reduce indoor pollution.", {"entities": []}], ["We sought to quantify indoor PM and CO exposures in urban and rural households and determine factors associated with higher exposures.", {"entities": []}], ["A secondary objective was to identify chronic vs. acute changes in cardiopulmonary biomarkers associated with exposure to biomass smoke.", {"entities": []}], ["We conducted a census survey followed by a cross-sectional study of indoor environmental exposures and cardiopulmonary biomarkers in the main household cook in Puno, Peru.", {"entities": []}], ["We measured 24-hour indoor PM and CO concentrations in 86 households.", {"entities": []}], ["We also measured PM 2.5 and PM 10 concentrations gravimetrically for 24\u00a0hours in urban households and during cook times in rural households, and generated a calibration equation using PM 2.5 measurements.", {"entities": []}], ["In a census of 4903 households, 93% vs. 16% of rural vs. urban households used an open-fire stove; 22% of rural households had a homemade chimney; and <3% of rural households participated in a national program encouraging installation of a chimney.", {"entities": []}], ["Median 24-hour indoor PM 2.5 and CO concentrations were 130 vs. 22 \u03bcg/m 2.5 (119 vs. 137 \u03bcg/m 2.5 (360 vs. 298 \u03bcg/m Indoor air concentrations associated with biomass smoke were six-fold greater in rural vs. urban households.", {"entities": []}], ["Having a homemade chimney did not reduce environmental exposures significantly.", {"entities": []}], ["Measures of exhaled CO provide useful cardiopulmonary biomarkers for chronic exposure to biomass smoke.", {"entities": []}], ["Expressed Sequence Tag-based gene expression profiling can be used to discover functionally associated genes on a large scale.", {"entities": []}], ["Currently available web servers and tools focus on finding differentially expressed genes in different samples or tissues rather than finding co-expressed genes.", {"entities": []}], ["To fill this gap, we have developed a web server that implements the GBA (Guilt-by-Association) co-expression algorithm, which has been successfully used in finding disease-related genes.", {"entities": [[69, 72, "GENE"]]}], ["We have also annotated UniGene clusters with links to several important databases such as GO, KEGG, OMIM, Gene, IPI and HomoloGene.", {"entities": []}], ["The GBA server can be accessed and downloaded at .", {"entities": [[4, 7, "GENE"]]}], ["Bronchial asthma is a common disease caused by interplay between multiple determinants, including genetic and immune variations.", {"entities": [[10, 16, "DISEASE"]]}], ["To investigate the main indices of humoral and cellular branches of immunity, features of cytokine regulation and cytokine genes in children with atopic bronchial asthma (BA) with different levels of disease control.", {"entities": [[163, 169, "DISEASE"]]}], ["Fifty children with controlled BA (CBA) and 50 with uncontrolled BA (UBA) were analyzed.", {"entities": []}], ["Mean age in the sample was 13.36\u00b12.24 years.", {"entities": []}], ["A control group of healthy children (n=50) was also studied.", {"entities": []}], ["All individuals were Russians (Eastern Slavs) from the Krasnoyarsk Territory, West Siberia.", {"entities": []}], ["Diagnoses, severity and level of disease control were defined according to the Global Initiative for Asthma (GINA) recommendations.", {"entities": [[101, 107, "DISEASE"]]}], ["The lymphocytes were counted in blood using fluorescent microscopy.", {"entities": []}], ["Humoral branch indices and cytokine levels (IL-2, IL-4, IL-10 and TNF-\u03b1) in blood serum were measured by ELISA.", {"entities": []}], ["Genotyping of single-nucleotide polymorphism (SNP) in \u2212590 position of the IL4 and \u2212597 position of the IL10 gene was performed by restriction fragment length analysis.", {"entities": [[75, 78, "GENE"], [104, 108, "GENE"]]}], ["No statistically significant differences in total IgE and cytokines blood levels were found in CBA and UBA.", {"entities": []}], ["However, significant differences between the groups were found for CD T-590 allele of the IL4 gene, which is responsible for an increased serum level of IL-4, showed a tendency to an association with UBA.", {"entities": [[90, 93, "GENE"]]}], ["A decreased level of IL-10 enhances control over BA, which proves its association with the allelic variant A-597 IL10 .", {"entities": [[113, 117, "GENE"]]}], ["Our data show that children with UBA have higher counts of CD IL4 and IL10 genes are associated with allergic inflammation in UBA.", {"entities": [[62, 65, "GENE"], [70, 74, "GENE"]]}], ["The purpose of this study was to investigate whether there is an association between stage of incident breast cancer (BC) and personal income three years after diagnosis.", {"entities": [[103, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["The analysis further considered whether the association differed among educational groups.", {"entities": []}], ["The study was based on information from Danish nationwide registers.", {"entities": []}], ["A total of 7,372 women aged 30\u201360 years diagnosed with BC, 48% with metastasis, were compared to 213,276 controls.", {"entities": []}], ["Generalised linear models were used to estimate the effect of a cancer diagnosis on personal gross income three years after diagnosis, stratified by education and stage of cancer.", {"entities": [[64, 70, "DISEASE"], [172, 178, "DISEASE"]]}], ["The models were adjusted for income two years prior to cancer diagnosis and demographic, geographic and co-morbidity covariates.", {"entities": [[55, 61, "DISEASE"]]}], ["Adjusting for income two years prior to cancer diagnosis and other baseline covariates (see above), cancer had a minor effect on personal income three years after diagnosis.", {"entities": [[40, 46, "DISEASE"], [100, 106, "DISEASE"]]}], ["The effect of metastatic BC was a statistically significant reduction in income three years after diagnosis of \u22123.4% (95% CI \u22124.8;-2.0), \u22122.8% (95% CI \u22124.3;-1.3) and \u22124.1 (95% CI \u22125.9;-2.3) among further, vocational and low educated women, respectively.", {"entities": []}], ["The corresponding estimates for the effect of localised BC were \u22122.5% (95% CI \u22123.8; \u22121.2), \u22121.6% (95% CI \u22123.0; \u22120.2) and \u22121.7% (95% CI \u22123.7; 0.3); the latter estimate (for the low-educated) was not statistically different from zero.", {"entities": []}], ["We found no statistically significant educational gradient in the effect of cancer stage on income.", {"entities": [[76, 82, "DISEASE"]]}], ["In a Danish context, the very small negative effect of BC on personal income may be explained by different types of compensation in low- and high-income groups.", {"entities": []}], ["The public income transfers are equal for all income groups and cover a relatively high compensation among low-income groups.", {"entities": []}], ["However, high-income groups additionally receive pay-outs from private pension and insurance schemes, which typically provide higher coverage for high-income workers.", {"entities": []}], ["Although interleukin (IL)-7 is mostly known as a key regulator of lymphocyte homeostasis, we recently demonstrated that it also contributes to body weight regulation through a hypothalamic control.", {"entities": []}], ["Previous studies have shown that IL-7 is produced by the human obese white adipose tissue (WAT) yet its potential role on WAT development and function in obesity remains unknown.", {"entities": [[154, 161, "DISEASE"]]}], ["Here, we first show that transgenic mice overexpressing IL-7 have reduced adipose tissue mass associated with glucose and insulin resistance.", {"entities": []}], ["Moreover, in the high-fat diet (HFD)-induced obesity model, a single administration of IL-7 to C57BL/6 mice is sufficient to prevent HFD-induced WAT mass increase and glucose intolerance.", {"entities": [[167, 186, "DISEASE"], [45, 52, "DISEASE"]]}], ["This metabolic protective effect is accompanied by a significant decreased inflammation in WAT.", {"entities": []}], ["In lymphocyte-deficient HFD-fed SCID mice, IL-7 injection still protects from WAT mass gain.", {"entities": []}], ["However, IL-7-triggered resistance against WAT inflammation and glucose intolerance is lost in SCID mice.", {"entities": [[64, 83, "DISEASE"]]}], ["These results suggest that IL-7 regulates adipose tissue mass through a lymphocyte-independent mechanism while its protective role on glucose homeostasis would be relayed by immune cells that participate to WAT inflammation.", {"entities": []}], ["Our observations establish a key role for IL-7 in the complex mechanisms by which immune mediators modulate metabolic functions.", {"entities": []}], ["The lung is an important open organ and the primary site of respiration.", {"entities": []}], ["Many life-threatening diseases develop in the lung, e.g., pneumonia, asthma, chronic obstructive pulmonary diseases (COPDs), pulmonary fibrosis, and lung cancer.", {"entities": [[149, 160, "DISEASE"], [58, 67, "DISEASE"], [125, 143, "DISEASE"], [69, 75, "DISEASE"], [154, 160, "DISEASE"]]}], ["In the lung, innate immunity serves as the frontline in both anti-irritant response and anti-tumor defense and is also critical for mucosal homeostasis; thus, it plays an important role in containing these pulmonary diseases.", {"entities": []}], ["Innate lymphoid cells (ILCs), characterized by their strict tissue residence and distinct function in the mucosa, are attracting increased attention in innate immunity.", {"entities": []}], ["Upon sensing the danger signals from damaged epithelium, ILCs activate, proliferate, and release numerous cytokines with specific local functions; they also participate in mucosal immune-surveillance, immune-regulation, and homeostasis.", {"entities": []}], ["However, when their functions become uncontrolled, ILCs can enhance pathological states and induce diseases.", {"entities": []}], ["In this review, we discuss the physiological and pathological functions of ILC subsets 1 to 3 in the lung, and how the pathogenic environment affects the function and plasticity of ILCs.", {"entities": []}], ["The biomarker value of circulating microRNAs (miRNAs) has been extensively addressed in patients with acute coronary syndrome.", {"entities": [[117, 125, "DISEASE"]]}], ["However, prognostic performances of miRNAs in patients with acute heart failure (AHF) has received less attention.", {"entities": []}], ["A test cohort of 294 patients with acute dyspnea (236 AHF and 58 non-AHF) and 44 patients with stable chronic heart failure (CHF), and an independent validation cohort of 711 AHF patients, were used.", {"entities": []}], ["Admission levels of miR-1/-21/-23/-126/-423-5p were assessed in plasma samples.", {"entities": []}], ["In the test cohort, admission levels of miR-1 were lower in AHF and stable CHF patients compared to non-AHF patients (p = 0.0016).", {"entities": []}], ["Levels of miR-126 and miR-423-5p were lower in AHF and in non-AHF patients compared to stable CHF patients (both p<0.001).", {"entities": [[10, 17, "GENE"], [22, 32, "GENE"]]}], ["Interestingly, admission levels of miR-423-5p were lower in patients who were re-admitted to the hospital in the year following the index hospitalization compared to patients who were not (p = 0.0001).", {"entities": [[35, 45, "GENE"]]}], ["Adjusted odds ratio [95% confidence interval] for one-year readmission was 0.70 [0.53\u20130.93] for miR-423-5p (p = 0.01).", {"entities": [[96, 106, "GENE"]]}], ["In the validation cohort, admission levels of miR-423-5p predicted 1-year mortality with an adjusted odds ratio [95% confidence interval] of 0.54 [0.36\u20130.82], p = 0.004.", {"entities": [[46, 56, "GENE"]]}], ["Patients within the lowest quartile of miR-423-5p were at high risk of long-term mortality (p = 0.02).", {"entities": [[39, 49, "GENE"]]}], ["In AHF patients, low circulating levels of miR-423-5p at presentation are associated with a poor long-term outcome.", {"entities": [[43, 53, "GENE"]]}], ["This study supports the value of miR-423-5p as a prognostic biomarker of AHF.", {"entities": [[33, 43, "GENE"]]}], ["Although zinc oxide nanoparticles (ZnONPs) are recognized to cause systemic disorders, little is known about the mechanisms that underlie the time-dependent differences that occur after exposure.", {"entities": []}], ["The objective of this study was to investigate the mechanistic differences at 24 hours and 28 days after the exposure of BALB/c mice to ZnONPs via intratracheal instillation.", {"entities": []}], ["An isobaric tag for the relative and absolute quantitation coupled with liquid chromatography/tandem mass spectrometry was used to identify the differential protein expression, biological processes, molecular functions, and pathways.", {"entities": []}], ["A total of 18 and 14 proteins displayed significant changes in the lung tissues at 24 hours and 28 days after exposure, respectively, with the most striking changes being observed for S100-A9 protein.", {"entities": []}], ["Metabolic processes and catalytic activity were the main biological processes and molecular functions, respectively, in the responses at the 24-hour and 28-day follow-up times.", {"entities": []}], ["The glycolysis/gluconeogenesis pathway was continuously downregulated from 24 hours to 28 days, whereas detoxification pathways were activated at the 28-day time-point after exposure.", {"entities": []}], ["A comprehensive understanding of the potential time-dependent effects of exposure to ZnONPs was provided, which highlights the metabolic mechanisms that may be important in the responses to ZnONP.", {"entities": []}], ["Extracellular adenosine (Ade) interacts with cells by two pathways: by activating cell surface receptors at nanomolar/micromolar concentrations; and by interfering with the homeostasis of the intracellular nucleotide pool at millimolar concentrations.", {"entities": []}], ["Ade shows both cytotoxic and cytoprotective effects; however, the underlying mechanisms remain unclear.", {"entities": []}], ["In the present study, the effects of adenosine-mediated ATP on cell viability were investigated.", {"entities": []}], ["Adenosine treatment was found to be cytoprotective in the low intracellular ATP state, but cytotoxic under the normal ATP state.", {"entities": []}], ["Adenosine-mediated cytotoxicity and cytoprotection rely on adenosine-derived ATP formation, but not via the adenosine receptor pathway.", {"entities": []}], ["Ade enhanced proteasome inhibition-induced cell death mediated by ATP generation.", {"entities": []}], ["These data provide a new pathway by which adenosine exerts dual biological effects on cell viability, suggesting an important role for adenosine as an ATP precursor besides the adenosine receptor pathway.", {"entities": []}], ["It is unclear whether an \u2018obesity survival paradox\u2019 exists for pneumonia.", {"entities": [[63, 72, "DISEASE"], [26, 33, "DISEASE"]]}], ["Therefore, we conducted a meta-analysis to assess the associations between increased body mass index (BMI), pneumonia risk, and mortality risk.", {"entities": [[108, 117, "DISEASE"]]}], ["Cohort studies were identified from the PubMed and Embase databases.", {"entities": []}], ["Summary relative risks (RRs) with their corresponding 95% confidence intervals (CIs) were calculated using a random effects model.", {"entities": []}], ["Thirteen cohort studies on pneumonia risk (n\u2009=\u20091,536,623), and ten cohort studies on mortality (n\u2009=\u20091,375,482) were included.", {"entities": [[27, 36, "DISEASE"]]}], ["Overweight and obese individuals were significantly associated with an increased risk of pneumonia (RR\u2009=\u20091.33, 95% CI 1.04 to 1.71, P \u2009=\u20090.02, I P \u2009=\u20090.01, I P \u2009<\u20090.01, I P \u2009<\u20090.01, I This meta-analysis suggests that an \u2018obesity survival paradox\u2019 exists for pneumonia.", {"entities": [[89, 98, "DISEASE"], [258, 267, "DISEASE"], [221, 228, "DISEASE"]]}], ["Because this meta-analysis is based on observational studies, more studies are required to confirm the results.", {"entities": []}], ["The aim of this paper was to overview existing knowledge on foreign body (FB) injuries in children, with particular focus on FB types and anatomical locations, clinical presentation and complications.", {"entities": []}], ["FB injuries represent a severe public health problem in childhood.", {"entities": []}], ["The fact that the highest prevalence of FB injuries is reported for children between 0 and 3 years of age depends primarily on the fact that they explore objects using their mouth and are also not able to distinguish edible objects from non-edible ones.", {"entities": []}], ["Types of FB causing injuries depend on the symptoms related to FB ingestion/inhalation/insertion (providing an early diagnosis of FB injuries) and complications related to the FB characteristics (type, shape, dimensions).", {"entities": []}], ["The analysis of the Susy Safe database showed that in 10,564 cases, in which the object type was available, 74% of objects were inorganic and were mostly represented by pearls and balls, followed by coins.", {"entities": []}], ["The main concerning about FB injuries is the fact that they may be asymptomatic or that symptoms may be non-specific.", {"entities": []}], ["Consequently, the FB injury can be misinterpreted as a gastrointestinal or respiratory infection.", {"entities": []}], ["The absence of specific symptoms indicating the occurrence of FB injury can lead to delays in diagnosis, thereby increasing the risk of complications.", {"entities": []}], ["Symptoms seem to mostly depend on the anatomical location.", {"entities": []}], ["Many ingested FBs pass naturally through the gastrointestinal tract without complications or damage.", {"entities": []}], ["However, severe complications can occur depending on the characteristics of the FB, its anatomical location, the child's age and delays in diagnosis.", {"entities": []}], ["To translate the Asthma Control and Communication Instrument (ACCI) to Portuguese and adapt it for use in Brazil.", {"entities": [[17, 23, "DISEASE"]]}], ["The ACCI was translated to Portuguese and adapted for use in Brazil in accordance with internationally accepted guidelines.", {"entities": []}], ["The protocol included the following steps: permission and rights of use granted by the original author; translation of the ACCI from English to Portuguese; reconciliation; back-translation; review and harmonization of the back-translation; approval from the original author; review of the Portuguese version of the ACCI by an expert panel; cognitive debriefing (the clarity, understandability, and acceptability of the translated version being tested in a sample of the target population); and reconciliation and preparation of the final version.", {"entities": []}], ["During the cognitive debriefing process, 41 asthma patients meeting the inclusion criteria completed the ACCI and evaluated the clarity of the questions/statements.", {"entities": [[44, 50, "DISEASE"]]}], ["The clarity index for all ACCI items was > 0.9, meaning that all items were considered to be clear.", {"entities": []}], ["The ACCI was successfully translated to Portuguese and culturally adapted for use in Brazil, the translated version maintaining the psychometric properties of the original version.", {"entities": []}], ["The ACCI can be used in clinical practice because it is easy to understand and easily applied.", {"entities": []}], ["Little is known about the long-term outcomes of severe acute respiratory distress syndrome (ARDS) patients requiring extracorporeal membrane oxygenation (ECMO).", {"entities": [[82, 90, "DISEASE"]]}], ["This study aimed to investigate the 1-year outcomes of these patients or patients receiving mechanical ventilation (MV) and compare their health-related quality of life (HRQoL) to the general population.", {"entities": []}], ["Severe ARDS survivors admitted to two ICUs in China between January 2012 and January 2014 were enrolled.", {"entities": []}], ["Of the severe ARDS survivors enrolled, 1-year postdischarge, HRQoL assessment using the Short-Form 36 (SF-36) and EuroQol questionnaire dimensions, 6-min walking distance, chest computed tomography scan, pulmonary function, and arterial blood gas analysis were compared for ARDS patients with or without ECMO.", {"entities": []}], ["ARDS patients receiving ECMO had a significantly higher Acute Physiology and Chronic Health Evaluation II score (30.3 \u00b1 6.7 vs. 26.5 \u00b1 7.3, P = 0.036), lung injury score (3.3 \u00b1 0.4 vs. 2.8 \u00b1 0.5, P = 0.000), Sequential Organ Failure Assessment score (10.8 \u00b1 3.5 vs. 7.9 \u00b1 3.1, P = 0.000), lower PaO 2 /FiO 2 ratio ([mmHg, 1 mmHg = 0.133 kPa], 68.3 \u00b1 16.1 vs. 84.8 \u00b1 16.5, P = 0.000), and increased extrapulmonary organ failure (2 [1, 3] vs. 1 [1, 1], P = 0.025) compared with patients not receiving ECMO.", {"entities": []}], ["ECMO and non-ECMO survivors showed similar pulmonary function, morphological abnormalities, resting arterial blood gas values, and 6-min walking distance.", {"entities": []}], ["Mild pulmonary dysfunction and abnormal morphology were observed in a few survivors.", {"entities": []}], ["In addition, ECMO and non-ECMO survivors showed a similar quality of life.", {"entities": []}], ["ECMO survivors showed lower SF-36 physical functioning and role-physical domain scores (minimum clinically significant difference at least 5 points), and non-ECMO survivors had similar outcome.", {"entities": []}], ["One-year posthospital discharge, severe ARDS survivors receiving ECMO or MV demonstrated comparable outcomes.", {"entities": []}], ["Compared with the general population, ARDS survivors showed reduced HRQoL.", {"entities": []}], ["Pulmonary function and lung morphology revealed sufficient recovery with minor lung impairment.", {"entities": []}], ["Cardiovascular complications are the leading cause of mortality and morbidity in Marfan syndrome (MFS), a dominantly inherited disorder caused by mutations in the gene that encodes fibrillin-1.", {"entities": [[88, 96, "DISEASE"]]}], ["There are approximately 18,000 patients in the UK with MFS.", {"entities": []}], ["Current treatment includes careful follow-up, beta blockers, and prophylactic surgical intervention; however, there is no known treatment which effectively prevents the rate of aortic dilatation in MFS.", {"entities": []}], ["Preclinical, neonatal, and pediatric studies have indicated that angiotensin receptor blockers (ARBs) may reduce the rate of aortic dilatation.", {"entities": []}], ["This trial will investigate the effects of irbesartan on aortic dilatation in Marfan syndrome.", {"entities": [[85, 93, "DISEASE"]]}], ["The Aortic Irbesartan Marfan Study (AIMS) is an investigator-led, prospective, randomized, placebo-controlled, double-blind, phase III, multicenter trial.", {"entities": []}], ["Currently, 26 centers in the UK will recruit 490 clinically confirmed MFS patients (aged \u22656 to \u226440\u00a0years) using the revised Ghent diagnostic criteria.", {"entities": []}], ["Patients will be randomized to irbesartan or placebo.", {"entities": []}], ["Aortic root dilatation will be measured by transthoracic echocardiography at baseline and annually thereafter.", {"entities": []}], ["The primary outcome is the absolute change in aortic root diameter per year measured by echocardiography.", {"entities": []}], ["The follow-up period will be a minimum of 36\u00a0months with an expected mean follow-up period of 48\u00a0months.", {"entities": []}], ["This is the first clinical trial to evaluate the ARB irbesartan versus placebo in reducing the rate of aortic root dilatation in MFS.", {"entities": []}], ["Not only will this provide useful information on the safety and efficacy of ARBs in MFS, it will also provide a rationale basis for potentially lifesaving therapy for MFS patients.", {"entities": []}], ["ISRCTN, 90011794", {"entities": []}], ["Fucaceae is the most dominant algae family along the intertidal areas of the Northern Hemisphere shorelines, being part of human customs for centuries with applications as a food source either for humans or animals, in agriculture and as remedies in folk medicine.", {"entities": []}], ["These macroalgae are endowed with several phytochemicals of great industrial interest from which phlorotannins, a class of marine-exclusive polyphenols, have gathered much attention during the last few years due to their numerous possible therapeutic properties.", {"entities": []}], ["These compounds are very abundant in brown seaweeds such as Fucaceae and have been demonstrated to possess numerous health-promoting properties, including antioxidant effects through scavenging of reactive oxygen species (ROS) or enhancement of intracellular antioxidant defenses, antidiabetic properties through their acarbose-like activity, stimulation of adipocytes glucose uptake and protection of \u03b2-pancreatic cells against high-glucose oxidative stress; anti-inflammatory effects through inhibition of several pro-inflammatory mediators; antitumor properties by activation of apoptosis on cancerous cells and metastasis inhibition, among others.", {"entities": []}], ["These multiple health properties render phlorotannins great potential for application in numerous therapeutical approaches.", {"entities": []}], ["This review addresses the major contribution of phlototannins for the biological effects that have been described for seaweeds from Fucaceae.", {"entities": []}], ["In addition, the bioavailability of this group of phenolic compounds is discussed.", {"entities": []}], ["Airway mucin secretion studies have focused on goblet cell responses to exogenous agonists almost to the exclusion of baseline mucin secretion (BLMS).", {"entities": []}], ["In human bronchial epithelial cell cultures (HBECCs), maximal agonist-stimulated secretion exceeds baseline by ~3-fold as measured over hour-long periods, but mucin stores are discharged completely and require 24 h for full restoration.", {"entities": []}], ["Hence, over 24 h, total baseline exceeds agonist-induced secretion by several-fold.", {"entities": []}], ["Studies with HBECCs and mouse tracheas showed that BLMS is highly sensitive to mechanical stresses.", {"entities": []}], ["Harvesting three consecutive 1 h baseline luminal incubations with HBECCs yielded equal rates of BLMS; however, lengthening the middle period to 72 h decreased the respective rate significantly, suggesting a stimulation of BLMS by the gentle washes of HBECC luminal surfaces.", {"entities": []}], ["BLMS declined exponentially after washing HBECCs ( t 1/2 = 2.75 h), to rates approaching zero.", {"entities": []}], ["HBECCs exposed to low perfusion rates exhibited spike-like increases in BLMS when flow was jumped 5-fold: BLMS increased >4 fold, then decreased within 5 min to a stable plateau at 1.5\u20132-fold over control.", {"entities": []}], ["Higher flow jumps induced proportionally higher BLMS increases.", {"entities": []}], ["Inducing mucous hyperplasia in HBECCs increased mucin production, BLMS and agonist-induced secretion.", {"entities": []}], ["Mouse tracheal BLMS was ~6-fold higher during perfusion, than when flow was stopped.", {"entities": []}], ["Munc13-2 null mouse tracheas, with their defect of accumulated cellular mucins, exhibited similar BLMS as WT, contrary to predictions of lower values.", {"entities": []}], ["Graded mucous metaplasia induced in WT and Munc13-2 null tracheas with IL-13, caused proportional increases in BLMS, suggesting that na\u00efve Munc13-2 mouse BLMS is elevated by increased mucin stores.", {"entities": []}], ["We conclude that BLMS is, [i] a major component of mucin secretion in the lung, [ii] sustained by the mechanical activity of a dynamic lung, [iii] proportional to levels of mucin stores, and [iv] regulated differentially from agonist-induced mucin secretion.", {"entities": []}], ["Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-\u03b1 blocking treatment (anti-TNF), but about one third do not respond.", {"entities": [[19, 39, "DISEASE"], [30, 39, "DISEASE"]]}], ["The objective of this study was to replicate and extend previously found associations between anti-TNF treatment response and genetic variation in the TNF-, NF-\u03baB- and pattern recognition receptor signalling pathways.", {"entities": []}], ["Forty-one single nucleotide polymorphisms (SNPs), including 34 functional, in 28 genes involved in inflammatory pathways were assessed in 538 anti-TNF naive Danish RA patients with clinical data.", {"entities": []}], ["Multivariable logistic regression analyses were performed to test associations between genotypes and treatment response at 3\u20136 months using the European League Against Rheumatism (EULAR) response criterion.", {"entities": []}], ["American College of Rheumatology treatment response (ACR50) and relative change in 28-joint disease activity score (relDAS28) were used as secondary outcomes.", {"entities": []}], ["Subgroup analyses were stratified according to smoking status, type of anti-TNF drug and IgM-Rheumatoid Factor (IgM-RF) status.", {"entities": []}], ["False discovery rate (FDR) controlling was used to adjust for multiple testing.", {"entities": []}], ["Statistically significant associations with EULAR response were found for two SNPs in NLRP3 (rs4612666) (OR (odds ratio) for good/moderate response\u200a=\u200a0.64 (95% confidence interval: 0.44\u20130.95), p\u200a=\u200a0.025, q\u200a=\u200a0.95) and INFG (rs2430561) (OR\u200a=\u200a0.40 (0.21\u20130.76), p\u200a=\u200a0.005, q\u200a=\u200a0.18) and among IgM-RF positive patients for TNFRS1A (rs4149570) (0.59 (0.36\u20130.98), p\u200a=\u200a0.040, q\u200a=\u200a0.76).", {"entities": [[86, 91, "GENE"]]}], ["Current smokers who carried the NLRP3 (rs4612666) variant allele were less likely to benefit from anti-TNF treatment (OR\u200a=\u200a0.24 (0.10\u20130.56), p\u200a=\u200a0.001, q\u200a=\u200a0.04).", {"entities": [[32, 37, "GENE"]]}], ["In a population of Danish RA patients, we confirm the NLRP3 gene as associated with EULAR anti-TNF response as previously reported.", {"entities": [[54, 59, "GENE"]]}], ["The NLRP3 variant (T) allele is associated with lower treatment response, in particular among current smokers.", {"entities": [[4, 9, "GENE"]]}], ["Furthermore, we find that a functional polymorphism in the interferon-\u03b3 gene is associated with anti-TNF response.", {"entities": []}], ["All findings should be tested by replication in independent validation cohorts and augmented by assessing cytokine levels and activities of the relevant gene products.", {"entities": []}], ["Mycobacterium tuberculosis ( M .", {"entities": [[14, 26, "DISEASE"]]}], ["tb ) infection is initiated by the few bacilli inhaled into the alveolus.", {"entities": []}], ["Studies in lungs of aerosol-infected mice provided evidence for extensive replication of M .", {"entities": []}], ["tb in non-migrating, non-antigen-presenting cells in the alveoli during the first 2\u20133 weeks post-infection.", {"entities": []}], ["Alveoli are lined by type II and type I alveolar epithelial cells (AEC) which outnumber alveolar macrophages by several hundred-fold.", {"entities": []}], ["tb DNA and viable M .", {"entities": []}], ["tb have been demonstrated in AEC and other non-macrophage cells of the kidney, liver, and spleen in autopsied tissues from latently-infected subjects from TB-endemic regions indicating systemic bacterial dissemination during primary infection.", {"entities": []}], ["tb have also been demonstrated to replicate rapidly in A549 cells (type II AEC line) and acquire increased invasiveness for endothelial cells.", {"entities": []}], ["Together, these results suggest that AEC could provide an important niche for bacterial expansion and development of a phenotype that promotes dissemination during primary infection.", {"entities": []}], ["In the current studies, we have compared the transcriptional profile of M .", {"entities": []}], ["tb replicating intracellularly in A549 cells to that of M .", {"entities": []}], ["tb replicating in laboratory broth, by microarray analysis.", {"entities": []}], ["Genes significantly upregulated during intracellular residence were consistent with an active, replicative, metabolic, and aerobic state, as were genes for tryptophan synthesis and for increased virulence (ESAT-6, and ESAT-6-like genes, esxH , esxJ , esxK , esxP , and esxW ).", {"entities": []}], ["In contrast, significant downregulation of the DevR (DosR) regulon and several hypoxia-induced genes was observed.", {"entities": []}], ["Stress response genes were either not differentially expressed or were downregulated with the exception of the heat shock response and those induced by low pH.", {"entities": []}], ["The intra-type II AEC M .", {"entities": []}], ["tb transcriptome strongly suggests that AEC could provide a safe haven in which M .", {"entities": []}], ["tb can expand dramatically and disseminate from the lung prior to the elicitation of adaptive immune responses.", {"entities": []}], ["High-dose inactivated split-virus influenza vaccine showed higher immunogenicity and relative efficacy compared with standard-dose inactivated split-virus influenza vaccine, irrespective of type of vaccine used the preceding year.", {"entities": [[34, 43, "DISEASE"], [155, 164, "DISEASE"]]}], ["The safety profile was also unaffected by previous-year vaccine.", {"entities": []}], ["Background.", {"entities": []}], ["High-dose inactivated influenza vaccine (IIV-HD) is an alternative to the standard-dose inactivated influenza vaccine (IIV-SD) in the United States for influenza prevention in older adults.", {"entities": [[22, 31, "DISEASE"], [100, 109, "DISEASE"], [152, 161, "DISEASE"]]}], ["IIV-HD improved efficacy relative to IIV-SD in a randomized controlled trial.", {"entities": []}], ["Recent observational studies suggest that previous influenza vaccination may influence the immunogenicity and effectiveness of current-season vaccination.", {"entities": [[51, 60, "DISEASE"]]}], ["The original study was a double-blind, randomized trial comparing IIV-HD to IIV-SD in adults aged \u226565 years over 2 influenza seasons.", {"entities": [[115, 124, "DISEASE"]]}], ["A subset of year 1 (Y1) participants reenrolled in year 2 (Y2), receiving vaccine by random assignment in both years.", {"entities": []}], ["We evaluated the effect of Y1 vaccination on Y2 relative vaccine efficacy (VE), immunogenicity (hemagglutination inhibition [HAI] titers), and safety among reenrolled participants.", {"entities": []}], ["Of 14 500 Y1 participants, 7643 reenrolled in Y2.", {"entities": []}], ["Relative to participants who received IIV-SD both seasons, VE was higher for IIV-HD vaccinees in Y2 (28.3% overall; 25.1% for Y1 IIV-HD, Y2 IIV-HD; and 31.6% for Y1 IIV-SD, Y2 IIV-HD).", {"entities": []}], ["In multivariate logistic regression models, Y1 vaccine was not a significant modifier of Y2 VE ( P = .43), whereas Y2 IIV-HD remained significantly associated with lower influenza risk ( P = .043).", {"entities": [[170, 179, "DISEASE"]]}], ["Compared to administration of IIV-SD in both years, postvaccination HAI titers were significantly higher for patterns that included IIV-HD in Y2.", {"entities": []}], ["No safety concerns were raised with IIV-HD revaccination.", {"entities": []}], ["Conclusions.", {"entities": []}], ["IIV-HD is likely to provide clinical benefit over IIV-SD irrespective of previous-season vaccination with IIV-HD or IIV-SD.", {"entities": []}], ["IIV-HD consistently improved immune responses, and no safety concerns emerged in the context of IIV-HD revaccination.", {"entities": []}], ["In sub-Saharan Africa, chronic kidney disease (CKD) is being recognized as a non-communicable disease (NCD) with high morbidity and mortality.", {"entities": [[31, 45, "DISEASE"]]}], ["In countries like Tanzania, people access many sources, including traditional medicines, to meet their healthcare needs for NCDs, but little is known about traditional medicine practices among people with CKD.", {"entities": []}], ["Therefore, we sought to characterize these practices among community members with CKD in northern Tanzania.", {"entities": []}], ["Between December 2013 and June 2014, we administered a previously-developed survey to a random sample of adult community-members from the Kilimanjaro Region; the survey was designed to measure traditional medicine practices such as types, frequencies, reasons, and modes.", {"entities": []}], ["Participants were also tested for CKD, diabetes, hypertension, and HIV as part of the CKD-AFRiKA study.", {"entities": [[49, 61, "DISEASE"]]}], ["To identify traditional medicines used in the local treatment of kidney disease, we reviewed the qualitative sessions which had previously been conducted with key informants.", {"entities": [[65, 79, "DISEASE"]]}], ["We enrolled 481 adults of whom 57 (11.9\u00a0%) had CKD.", {"entities": []}], ["The prevalence of traditional medicine use among adults with CKD was 70.3\u00a0% (95\u00a0% CI 50.0\u201384.9\u00a0%), and among those at risk for CKD ( n \u2009=\u2009147; 30.6\u00a0%), it was 49.0\u00a0% (95\u00a0% CI 33.1\u201365.0\u00a0%).", {"entities": []}], ["Among adults with CKD, the prevalence of concurrent use of traditional medicine and biomedicine was 33.2\u00a0% (11.4\u201365.6\u00a0%).", {"entities": []}], ["Symptomatic ailments (66.7\u00a0%; 95\u00a0% CI 17.3\u201354.3), malaria/febrile illnesses (64.0\u00a0%; 95\u00a0% CI 44.1\u201379.9), and chronic diseases (49.6\u00a0%; 95\u00a0% CI 28.6\u201370.6) were the most prevalent uses for traditional medicines.", {"entities": [[50, 57, "DISEASE"]]}], ["We identified five plant\u2013based traditional medicines used for the treatment of kidney disease: Aloe vera , Commifora africana , Cymbopogon citrullus , Persea americana , and Zanthoxylum chalybeum .", {"entities": [[79, 93, "DISEASE"]]}], ["The prevalence of traditional medicine use is high among adults with and at risk for CKD in northern Tanzania where they use them for a variety of conditions including other NCDs.", {"entities": []}], ["Additionally, many of these same people access biomedicine and traditional medicines concurrently.", {"entities": []}], ["The traditional medicines used for the local treatment of kidney disease have a variety of activities, and people with CKD may be particularly vulnerable to adverse effects.", {"entities": [[58, 72, "DISEASE"]]}], ["Recognizing these traditional medicine practices will be important in shaping CKD treatment programs and public health policies aimed at addressing CKD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12882-015-0161-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma leads to structural changes in the airways, including the modification of extracellular matrix proteins such as tenascin-C.", {"entities": [[0, 6, "DISEASE"]]}], ["The role of tenascin-C is unclear, but it might act as an early initiator of airway wall remodelling, as its expression is increased in the mouse and human airways during allergic inflammation.", {"entities": []}], ["In this study, we examined whether Th1 or Th2 cells are important regulators of tenascin-C in experimental allergic asthma utilizing mice with impaired Th1 (STAT4-/-) or Th2 (STAT6-/-) immunity.", {"entities": [[107, 122, "DISEASE"], [116, 122, "DISEASE"]]}], ["Balb/c wildtype (WT), STAT4-/- and STAT6-/- mice were sensitized with intraperitoneally injected ovalbumin (OVA) followed by OVA or PBS airway challenge.", {"entities": []}], ["Airway hyperreactivity (AHR) was measured and samples were collected.", {"entities": [[24, 27, "GENE"]]}], ["Real time PCR and immunohistochemistry were used to study cytokines and differences in the expression of tenascin-C. Tenascin-C expression was measured in human fibroblasts after treatment with TNF-\u03b1 and IFN-\u03b3 in vitro .", {"entities": []}], ["OVA-challenged WT mice showed allergic inflammation and AHR in the airways along with increased expression of TNF-\u03b1, IFN-\u03b3, IL-4 and tenascin-C in the lungs.", {"entities": [[56, 59, "GENE"]]}], ["OVA-challenged STAT4-/- mice exhibited elevated AHR and pulmonary eosinophilia.", {"entities": [[66, 78, "DISEASE"], [56, 78, "DISEASE"], [48, 51, "GENE"]]}], ["The mRNA expression of TNF-\u03b1 and IFN-\u03b3 was low, but the expression of IL-4 was significantly elevated in these mice.", {"entities": []}], ["OVA-challenged STAT6-/- mice had neither AHR nor pulmonary eosinophilia, but had increased expression of mRNA for TNF-\u03b1, IFN-\u03b3 and IL-4.", {"entities": [[59, 71, "DISEASE"], [49, 71, "DISEASE"], [41, 44, "GENE"]]}], ["The expression of tenascin-C in the lungs of OVA-challenged STAT4-/- mice was weaker than in those of OVA-challenged WT and STAT6-/- mice suggesting that TNF-\u03b1 and IFN-\u03b3 may regulate tenascin-C expression in vivo .", {"entities": []}], ["The stimulation of human fibroblasts with TNF-\u03b1 and IFN-\u03b3 induced the expression of tenascin-C confirming our in vivo findings.", {"entities": []}], ["Expression of tenascin-C is significantly attenuated in the airways of STAT4-/- mice, which may be due to the impaired secretion of TNF-\u03b1 and IFN-\u03b3 in these mice.", {"entities": []}], ["Present and future challenges for wild partridge populations include the resistance against possible disease transmission after restocking with captive-reared individuals, and the need to cope with the stress prompted by new dynamic and challenging scenarios.", {"entities": []}], ["Selection of individuals with the best immune ability may be a good strategy to improve general immunity, and hence adaptation to stress.", {"entities": []}], ["In this study, non-infectious challenges with phytohemagglutinin (PHA) and sheep red blood cells allowed the classification of red-legged partridges ( Alectoris rufa ) according to their overall immune responses (IR).", {"entities": []}], ["Skin from the area of injection of PHA and spleen, both from animals showing extreme high and low IR, were selected to investigate the transcriptional profiles underlying the different ability to cope with pathogens and external aggressions.", {"entities": []}], ["RNA-seq yielded 97 million raw reads from eight sequencing libraries and approximately 84% of the processed reads were mapped to the reference chicken genome.", {"entities": []}], ["Differential expression analysis identified 1488 up- and 107 down-regulated loci in individuals with high IR versus low IR.", {"entities": []}], ["Partridges displaying higher innate IR show an enhanced activation of host defence gene pathways complemented with a tightly controlled desensitization that facilitates the return to cellular homeostasis.", {"entities": []}], ["These findings indicate that the immune system ability to respond to aggressions (either diseases or stress produced by environmental changes) involves extensive transcriptional and post-transcriptional regulations, and expand our understanding on the molecular mechanisms of the avian immune system, opening the possibility of improving disease resistance or robustness using genome assisted selection (GAS) approaches for increased IR in partridges by using genes such as AVN or BF2 as markers.", {"entities": []}], ["This study provides the first transcriptome sequencing data of the Alectoris genus, a resource for molecular ecology that enables integration of genomic tools in further studies.", {"entities": []}], ["Asthma is a respiratory tract disorder characterized by airway hyper-reactivity and chronic inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["Allergic asthma is associated with the production of allergen-specific IgE and expansion of allergen-specific T-cell populations.", {"entities": [[0, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["Progression of allergic inflammation is driven by T-helper type 2 (Th2) mediators and is associated with alterations in the levels of lipid mediators.", {"entities": []}], ["Responses of the respiratory system to birch allergen provocation in allergic asthmatics were investigated.", {"entities": []}], ["Eicosanoids and other oxylipins were quantified in the bronchoalveolar lumen to provide a measure of shifts in lipid mediators associated with allergen challenge in allergic asthmatics.", {"entities": []}], ["Eighty-seven lipid mediators representing the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP) metabolic pathways were screened via LC-MS/MS following off-line extraction of bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["Multivariate statistics using OPLS were employed to interrogate acquired oxylipin data in combination with immunological markers.", {"entities": []}], ["Thirty-two oxylipins were quantified, with baseline asthmatics possessing a different oxylipin profile relative to healthy individuals that became more distinct following allergen provocation.", {"entities": []}], ["The most prominent differences included 15-LOX-derived \u03c9-3 and \u03c9-6 oxylipins.", {"entities": []}], ["Shared-and-Unique-Structures (SUS)-plot modeling showed a correlation (R 4 and 6- trans -LTB 4 ), CYP-derivatives of linoleic acid (epoxides/diols), and IL-10.", {"entities": []}], ["Differences in asthmatic relative to healthy profiles suggest a role for 15-LOX products of both \u03c9-6 and \u03c9-3 origin in allergic inflammation.", {"entities": []}], ["Prominent differences at baseline levels indicate that non-symptomatic asthmatics are subject to an underlying inflammatory condition not observed with other traditional mediators.", {"entities": []}], ["Results suggest that oxylipin profiling may provide a sensitive means of characterizing low-level inflammation and that even individuals with mild disease display distinct phenotypic profiles, which may have clinical ramifications for disease.", {"entities": []}], ["Inflammation and ageing are intertwined in chronic obstructive pulmonary disease ( COPD ).", {"entities": [[43, 80, "DISEASE"]]}], ["The histone deacetylase SIRT 1 and the related activation of FoxO3 protect from ageing and regulate inflammation.", {"entities": [[61, 66, "GENE"]]}], ["The role of SIRT 1/FoxO3 in COPD is largely unknown.", {"entities": []}], ["This study evaluated whether cigarette smoke, by modulating the SIRT 1/FoxO3 axis, affects airway epithelial pro\u2010inflammatory responses.", {"entities": []}], ["Human bronchial epithelial cells (16 HBE ) and primary bronchial epithelial cells ( PBEC s) from COPD patients and controls were treated with/without cigarette smoke extract ( CSE ), Sirtinol or FoxO3 si RNA .", {"entities": [[195, 200, "GENE"]]}], ["SIRT 1, FoxO3 and NF \u2010\u03baB nuclear accumulation, SIRT 1 deacetylase activity, IL \u20108 and CCL 20 expression/release and the release of 12 cytokines, neutrophil and lymphocyte chemotaxis were assessed.", {"entities": [[8, 13, "GENE"]]}], ["In PBEC s, the constitutive FoxO3 expression was lower in patients with COPD than in controls.", {"entities": [[28, 33, "GENE"]]}], ["Furthermore, CSE reduced FoxO3 expression only in PBEC s from controls.", {"entities": [[25, 30, "GENE"]]}], ["In 16 HBE , CSE decreased SIRT 1 activity and nuclear expression, enhanced NF \u2010\u03baB binding to the IL \u20108 gene promoter thus increasing IL \u20108 expression, decreased CCL 20 expression, increased the neutrophil chemotaxis and decreased lymphocyte chemotaxis.", {"entities": []}], ["Similarly, SIRT 1 inhibition reduced FoxO3 expression and increased nuclear NF \u2010\u03baB.", {"entities": [[37, 42, "GENE"]]}], ["FoxO3 si RNA treatment increased IL \u20108 and decreased CCL 20 expression in 16 HBE .", {"entities": [[0, 5, "GENE"]]}], ["In conclusion, CSE impairs the function of SIRT 1/FoxO3 axis in bronchial epithelium, dysregulating NF \u2010\u03baB activity and inducing pro\u2010inflammatory responses.", {"entities": []}], ["Since the first description in 1989 of CD4-Fc-fusion antagonists that inhibit human immune deficiency virus entry into T cells, Fc-fusion proteins have been intensely investigated for their effectiveness to curb a range of pathologies, with several notable recent successes coming to market.", {"entities": []}], ["These promising outcomes have stimulated the development of novel approaches to improve their efficacy and safety, while also broadening their clinical remit to other uses such as vaccines and intravenous immunoglobulin therapy.", {"entities": []}], ["This increased attention has also led to non-clinical applications of Fc-fusions, such as affinity reagents in microarray devices.", {"entities": []}], ["Here we discuss recent results and more generally applicable strategies to improve Fc-fusion proteins for each application, with particular attention to the newer, less charted areas.", {"entities": []}], ["The nutrition and health of horses is closely tied to their gastrointestinal microflora.", {"entities": []}], ["Gut bacteria break down plant structural carbohydrates and produce volatile fatty acids, which are a major source of energy for horses.", {"entities": []}], ["Bacterial communities are also essential for maintaining gut homeostasis and have been hypothesized to contribute to various diseases including laminitis.", {"entities": []}], ["We performed pyrosequencing of 16S rRNA bacterial genes isolated from fecal material to characterize hindgut bacterial communities in healthy horses and those with chronic laminitis.", {"entities": []}], ["Fecal samples were collected from 10 normal horses and 8 horses with chronic laminitis.", {"entities": []}], ["Genomic DNA was extracted and the V4-V5 segment of the 16S rRNA gene was PCR amplified and sequenced on the 454 platform generating a mean of 2,425 reads per sample after quality trimming.", {"entities": []}], ["The bacterial communities were dominated by Firmicutes (69.21% control, 56.72% laminitis) and Verrucomicrobia (18.13% control, 27.63% laminitis), followed by Bacteroidetes, Proteobacteria, and Spirochaetes.", {"entities": []}], ["We observed more OTUs per individual in the laminitis group than the control group (419.6 and 355.2, respectively, P = 0.019) along with a difference in the abundance of two unassigned Clostridiales genera (P = 0.03 and P = 0.01).", {"entities": []}], ["The most abundant bacteria were Streptococcus spp.", {"entities": []}], [", Clostridium spp ., and Treponema spp.", {"entities": []}], ["; along with unassigned genera from Subdivision 5 of Verrucomicrobia, Ruminococcaceae, and Clostridiaceae, which together constituted ~ 80% of all OTUs.", {"entities": []}], ["There was a high level of individual variation across all taxonomic ranks.", {"entities": []}], ["Our exploration of the equine fecal microflora revealed higher bacterial diversity in horses with chronic laminitis and identification of two Clostridiales genera that differed in abundance from control horses.", {"entities": []}], ["There was large individual variation in bacterial communities that was not explained in our study.", {"entities": []}], ["The core hindgut microflora was dominated by Streptococcus spp., several cellulytic genera, and a large proportion of uncharacterized OTUs that warrant further investigation regarding their function.", {"entities": []}], ["Our data provide a foundation for future investigations of hindgut bacterial factors that may influence the development and progression of chronic laminitis.", {"entities": []}], ["Presentation of peptide:MHCII by ROR\u03b3-expressing group 3 innate lymphoid cells (ILC3s), which are enriched within gut tissue, is required for control of CD4 T-cell responses to commensal bacteria.", {"entities": [[153, 156, "GENE"]]}], ["It is not known whether ILC populations migrate from their mucosal and peripheral sites to local draining secondary lymphoid tissues.", {"entities": []}], ["Here we demonstrate that ILC3s reside within the interfollicular areas of mucosal draining lymph nodes, forming a distinct microenvironment not observed in peripheral lymph nodes.", {"entities": []}], ["By photoconverting intestinal cells in Kaede mice we reveal constitutive trafficking of ILCs from the intestine to the draining mesenteric lymph nodes, which specifically for the LTi-like ILC3s was CCR7-dependent.", {"entities": []}], ["Thus, ILC populations traffic to draining lymph nodes using different mechanisms.", {"entities": []}], ["Innate lymphoid cells have an important role in mucosal immunity and present peptide:MHCII to CD4 T cells.", {"entities": [[94, 97, "GENE"]]}], ["Here the authors show that innate lymphoid cell subsets migrate from the gut mucosa to the draining lymph nodes via different mechanisms, where they form distinct microenvironments.", {"entities": []}], ["Asthma and obesity represent one of the most crucial public and health problems of modern society that frequently begin in childhood and have some mutual elements of risk.", {"entities": [[11, 18, "DISEASE"], [0, 6, "DISEASE"]]}], ["Abdominal distribution of connective tissue is important determinant which brings to decrease of lungs function.", {"entities": []}], ["Multiple influence of overweight on function of the lungs would clearly manifest over reduction of forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC).", {"entities": []}], ["Examining was conducted at Pediatric Clinic of University Clinical Hospital Tuzla during the year 2013/2014.", {"entities": []}], ["Research included 60 children with diagnosed asthma who were in relation to BMI were divided in 3 groups.", {"entities": [[45, 51, "DISEASE"]]}], ["The first group was children with BMI ranging from 5 to 85 percentile, the second were children with 85 to 95 percentile and the third was 95 percentile.", {"entities": []}], ["By prospective study, compared identical pulmonary variable for all three age group of asthma patients were analyzed, the children with normal body mass a well as the overweight and the obese.", {"entities": [[87, 93, "DISEASE"]]}], ["At the beginning of testing, the frequency of normal spirometric findings was significantly lower in the obese group in comparison with other two observed groups (p<0,05).", {"entities": []}], ["The only cases of mixed and restrictive disorder of ventilation were registered in the obese group of tested at the beginning of the examined (p<r0,001).", {"entities": []}], ["When being compared the values of spirometric parameters before and after the research, the only significant difference was in the obese group, the values after tests were significantly higher, with the exception of relation FEV1/FVC, that had the same distribution of values before and after research.", {"entities": []}], ["However, the group with normal body mass and overweight, had all the spirometric parameters with equal distribution before and after research (p>0,05 for all measurements).", {"entities": []}], ["The fibrocytes are thought to serve as a source of newly deposited collagens I and III during reparative processes and in certain fibrotic disorders, but their matrix remodelling properties are incompletely understood.", {"entities": []}], ["We evaluated their ability to produce several extracellular matrix (ECM) components, in comparison with fibroblasts, and to participate in collagen turnover.", {"entities": []}], ["The collagen gene expression profile of fibrocytes differed from that of fibroblasts because fibrocytes constitutively expressed relatively high levels of the mRNA encoding collagen VI and significantly lower levels of the mRNA encoding collagens I, III and V. The proteoglycan (PG) gene expression profile was also different in fibrocytes and fibroblasts because fibrocytes constitutively expressed the mRNA encoding perlecan and versican at relatively high levels and the mRNA encoding biglycan and decorin at low and very low levels, respectively.", {"entities": []}], ["Moreover, fibrocytes expressed the mRNA for hyaluronan synthase 2 at higher level than fibroblasts.", {"entities": []}], ["Significant differences between the two cell populations were also demonstrated by metabolic labelling and analysis of the secreted collagenous proteins, PGs and hyaluronan.", {"entities": []}], ["Fibrocytes constitutively expressed the scavenger receptors CD163 and CD204 as well as the mannose receptors CD206 and Endo180, and internalized and degraded collagen fragments through an Endo180-mediated mechanism.", {"entities": [[60, 65, "GENE"]]}], ["The results of this study demonstrate that human fibrocytes exhibit ECM remodelling properties previously unexplored, including the ability to participate in collagen turnover.", {"entities": []}], ["The observed differences in collagen and PG expression profile between fibrocytes and fibroblasts suggest that fibrocytes may predominantly have a matrix-stabilizing function.", {"entities": []}], ["This report examines the effect of an anti-VLA-4 monoclonal antibody (mAb) HP1/2 on antigen-induced bronchial hyperreactivity to methacholine, and on eosinophil and T lymphocyte infiltration in the airways of guinea pigs sensitized and challenged by aerosolized ovalbumin and used 24 h thereafter.", {"entities": []}], ["The intravenous administration of 2.5 mg/kg of HP1/2, but not of its isotype-matched mAb 1E6, 1 h before and 4 h after antigen inhalation, markedly inhibited the increased bronchopulmonary responses to intravenous methacholine, as well as airway eosinophilia in bronchoalveolar lavage (BAL) fluid and in bronchial tissue.", {"entities": [[246, 258, "DISEASE"]]}], ["HP1/2 also suppressed the antigen-induced infiltration of the bronchial wall by CD4+ and CD8+ T lymphocytes, identified by immunohistochemical technique using specific mAbs that recognize antigenic epitopes of guinea pig T cells.", {"entities": []}], ["Treatment with HP1/2 also resulted in a significant increase in the number of blood eosinophils, suggesting that inhibition by anti-VLA-4 mAb of eosinophil recruitment to the alveolar compartment may partially account for their accumulation in the circulation.", {"entities": []}], ["These findings indicate that eosinophil and lymphocyte adhesion and subsequent infiltration into the guinea pig airways that follow antigen challenge are mediated by VLA-4.", {"entities": []}], ["Furthermore, concomitant inhibition of antigen-induced bronchial hyperreactivity and of cellular infiltration by anti-VLA-4 mAb suggests a relationship between airway inflammation and modifications in the bronchopulmonary function.", {"entities": []}], ["Vagus nerve stimulation is increasingly applied to treat epilepsy, psychiatric conditions and potentially chronic heart failure.", {"entities": []}], ["After implanting vagus nerve electrodes to the cervical vagus nerve, side effects such as voice alterations and dyspnea or missing therapeutic effects are observed at different frequencies.", {"entities": []}], ["Cervical vagus nerve branching might partly be responsible for these effects.", {"entities": []}], ["However, vagus nerve branching has not yet been described in the context of vagus nerve stimulation.", {"entities": []}], ["Branching of the cervical vagus nerve was investigated macroscopically in 35 body donors (66 cervical sides) in the carotid sheath.", {"entities": []}], ["After X-ray imaging for determining the vertebral levels of cervical vagus nerve branching, samples were removed to confirm histologically the nerve and to calculate cervical vagus nerve diameters and cross-sections.", {"entities": []}], ["Cervical vagus nerve branching was observed in 29% of all cases (26% unilaterally, 3% bilaterally) and proven histologically in all cases.", {"entities": []}], ["Right-sided branching (22%) was more common than left-sided branching (12%) and occurred on the level of the fourth and fifth vertebra on the left and on the level of the second to fifth vertebra on the right side.", {"entities": []}], ["Vagus nerves without branching were significantly larger than vagus nerves with branches, concerning their diameters (4.79 mm vs. 3.78 mm) and cross-sections (7.24 mm Cervical vagus nerve branching is considerably more frequent than described previously.", {"entities": []}], ["The side-dependent differences of vagus nerve branching may be linked to the asymmetric effects of the vagus nerve.", {"entities": []}], ["Cervical vagus nerve branching should be taken into account when identifying main trunk of the vagus nerve for implanting electrodes to minimize potential side effects or lacking therapeutic benefits of vagus nerve stimulation.", {"entities": []}], ["Amyotrophic lateral sclerosis (ALS) is a devastating late-onset neurodegenerative disorder in which only a small proportion of patients carry an identifiable causative genetic lesion.", {"entities": [[12, 29, "DISEASE"]]}], ["Despite high heritability estimates, a genetic etiology for most sporadic ALS remains elusive.", {"entities": []}], ["Here we report the epigenetic profiling of five monozygotic twin pairs discordant for ALS, four with classic ALS and one with the progressive muscular atrophy ALS variant, in whom previous whole genome sequencing failed to uncover a genetic basis for their disease discordance.", {"entities": [[142, 158, "DISEASE"], [130, 158, "DISEASE"]]}], ["By studying cytosine methylation patterns in peripheral blood DNA we identified thousands of large between-twin differences at individual CpGs.", {"entities": []}], ["While the specific sites of differences were mostly idiosyncratic to a twin pair, a proportion involving GABA signalling were common to all ALS individuals.", {"entities": []}], ["For both idiosyncratic and common sites the differences occurred within genes and pathways related to neurobiological functions or dysfunctions, some of particular relevance to ALS such as glutamate metabolism and the Golgi apparatus.", {"entities": []}], ["All four classic ALS patients were epigenetically older than their unaffected co-twins, suggesting accelerated aging in multiple tissues in this disease.", {"entities": []}], ["In conclusion, widespread changes in methylation patterns were found in ALS-affected co-twins, consistent with an epigenetic contribution to disease.", {"entities": []}], ["These DNA methylation findings could be used to develop blood-based ALS biomarkers, gain insights into disease pathogenesis, and provide a reference for future large-scale ALS epigenetic studies.", {"entities": []}], ["A coronary artery aneurysm is an uncommon disorder and is seen as a characteristic dilatation of a localized portion of the coronary artery.", {"entities": []}], ["Clinical manifestation of a coronary artery aneurysm varies from an asymptomatic presentation to sudden death of a patient.", {"entities": []}], ["Although coronary aneurysms are typically diagnosed by the use of coronary angiography, a new generation of coronary 64-slice multidetector computed tomography (64-MDCT) scanners have successfully been used for evaluating this abnormality in a noninvasive manner.", {"entities": []}], ["In the present case, we performed coronary 64-MDCT scanning preoperatively and postoperatively on a patient with multiple giant coronary aneurysms.", {"entities": []}], ["The use of coronary 64-MDCT may provide an evaluation technique not only for diagnosis but also for follow-up after surgery for this condition.", {"entities": []}], ["The aim of this study was to measure HrQoL during acute exacerbations of COPD using generic and disease-specific instruments, and to assess completeness, proportion with best or worst health state, sensitivity to change and discriminative ability for each instrument.", {"entities": []}], ["EQ-5D, SF-12 and SGRQ were obtained from COPD patients with GOLD stage III and IV hospitalized for an acute exacerbation both at admission and discharge.", {"entities": []}], ["To assess the instruments' properties, utility values were calculated for EQ-5D and SF-12, and a total score was derived from the SGRQ.", {"entities": []}], ["Mean utilities ranged from 0.54 (SF-12, stage IV) to 0.62 (EQ-5D, stage III) at admission, and from 0.58 (SF-12, stage IV) to 0.84 (EQ-5D, stage III) at discharge.", {"entities": []}], ["Completeness was best for EQ-5D and SGRQ, while no utility value for the SF-12 could be calculated for more than 30%.", {"entities": []}], ["For SGRQ subscales, the minimal score occurred in up to 11% at admission, while full health was observed for the EQ-5D at discharge in 13%.", {"entities": []}], ["Sensitivity to change was generally good, whereas discrimination between COPD stages was low for the EQ-5D.", {"entities": []}], ["Acute exacerbations seriously impair health status and quality of life.", {"entities": []}], ["The EQ-5D is generally suitable to measure HrQoL in exacerbations of severe COPD, although the high proportion of patients reporting full health at discharge poses a problem.", {"entities": []}], ["The main issue with the SF-12 is the high proportion of missing values in a self-assessed setting.", {"entities": []}], ["Properties of the SGRQ were satisfactory.", {"entities": []}], ["However, since no utility values can be derived from this disease-specific instrument, it is not suitable for cost-utility analyses in health-economic evaluations.", {"entities": []}], ["There is controversy in the literature over whether the selenium (Se) influences cellular immune responses, and the mechanisms possibly underlying these effects are unclear.", {"entities": []}], ["In this study, the effects of Se on T-cell proliferation and IL-2 production were studied in primary porcine splenocytes.", {"entities": []}], ["Splenocytes were treated with different mitogens in the presence of 0.5\u20134 \u00b5mol/L sodium selenite.", {"entities": []}], ["Se significantly promoted T-cell receptor (TCR) or concanavalin A (ConA)-induced T-cell proliferation and IL-2 production but failed to regulate T-cell response to phytohemagglutinin (PHA).", {"entities": []}], ["In addition, Se significantly increased the levels of cytosolic glutathione peroxidase (GPx1) and thioredoxin reductase 1 (TR1) mRNA, the activity of GPx1 and the concentration of reduced glutathione (GSH) in the unstimulated, or activated splenocytes.", {"entities": [[88, 92, "GENE"], [150, 154, "GENE"], [88, 92, "GENE"], [150, 154, "GENE"]]}], ["These results indicated that Se improved the redox status in all splenocytes, including unstimulated, TCR, ConA and PHA -stimulated, but only TCR and ConA-induced T-cell activation was affected by the redox status.", {"entities": []}], ["N-acetylcysteine (NAC), a pharmacological antioxidant, increased T-cell proliferation and IL-2 production by TCR and ConA stimulated splenocytes but had no effect on the response to PHA in primary porcine splenocytes confirming that PHA-induced T-cell activation is insensitive to the redox status.", {"entities": []}], ["We conclude that Se promotes GPx1 and TR1 expression and increases antioxidative capacity in porcine splenocytes, which enhances TCR or ConA -induced T-cell activation but not PHA-induced T-cell activation.", {"entities": [[29, 33, "GENE"]]}], ["The different susceptibilities to Se between the TCR, ConA and PHA -induced T-cell activation may help to explain the controversy in the literature over whether or not Se boosts immune responses.", {"entities": []}], ["This article has supplementary material on the web site: www.jdbp.org .", {"entities": []}], ["To derive latent classes (longitudinal \u201cphenotypes\u201d) of frequency of bedwetting from 4 to 9 years and to examine their association with developmental delay, parental history of bedwetting, length of gestation and birth weight.", {"entities": []}], ["The authors used data from 8,769 children from the UK Avon Longitudinal Study of Parents and Children cohort.", {"entities": []}], ["Mothers provided repeated reports on their child's frequency of bedwetting from 4 to 9 years.", {"entities": []}], ["The authors used longitudinal latent class analysis to derive latent classes of bedwetting and examined their association with sex, developmental level at 18 months, parental history of wetting, birth weight, and gestational length.", {"entities": []}], ["The authors identified 5 latent classes: (1) \u201cnormative\u201d\u2014low probability of bedwetting; (2) \u201cinfrequent delayed\u201d\u2014delayed attainment of nighttime bladder control with bedwetting <twice a week; (3) \u201cfrequent delayed\u201d\u2014delayed attainment of nighttime bladder control with bedwetting\u00a0\u2265\u00a0twice a week; (4) \u201cinfrequent persistent\u201d\u2014persistent bedwetting < twice a week; and (5) \u201cfrequent persistent\u201d\u2014persistent bedwetting\u00a0\u2265\u00a0twice a week.", {"entities": []}], ["Male gender (odds ratio = 3.20 [95% confidence interval = 2.36\u20134.34]), developmental delay, for example, delayed social skills (1.33 [1.11\u20131.58]), and maternal history of wetting (3.91 [2.60\u20135.88]) were associated with an increase in the odds of bedwetting at 4 to 9 years.", {"entities": []}], ["There was little evidence that low birth weight and shorter gestation period were associated with bedwetting.", {"entities": []}], ["The authors described patterns of development of nighttime bladder control and found evidence for factors that predict continuation of bedwetting at school age.", {"entities": []}], ["Increased knowledge of risk factors for bedwetting is needed to identify children at risk of future problems attaining and maintaining continence.", {"entities": []}], ["LL-37 is an immune peptide that regulates innate and adaptive immune responses in the upper airways.", {"entities": []}], ["Elevated levels of LL-37 have been linked to cell death and inflammatory diseases, such as chronic rhinosinusitis (CRS).", {"entities": []}], ["Glycosaminoglycans (GAGs) are polysaccharides that are found on respiratory epithelial cells and serve important roles in mucosal surface repair.", {"entities": []}], ["Recent findings suggest that a synthetic glycosaminoglycan (GM-0111) can protect against LL-37-induced sinonasal mucosal inflammation and cell death in a murine model of acute RS.", {"entities": []}], ["Herein, we elucidated the mechanisms by which LL-37 causes sinonasal inflammation and how GM-0111 can prevent these mechanisms.", {"entities": []}], ["When challenged with LL-37, human nasal epithelial cells (HNEpCs) and mouse macrophages (J774.2) demonstrated increased release of adenosine triphosphate (ATP) and interleukin (IL)-6 and -8, as well as cell death and lysis.", {"entities": []}], ["These cellular responses were all blocked dose-dependently by pre-treatment with GM-0111.", {"entities": []}], ["We identified that LL-37-induced cell death is associated with caspase-1 and -8 activation, but not activation of caspase-3/7.", {"entities": []}], ["These responses were again blocked by GM-0111.", {"entities": []}], ["Our data suggest that LL-37 causes cellular death of HNEpCs and macrophages through the pro-inflammatory necrotic and/or pyroptotic pathways rather than apoptosis, and that a GM-0111 is capable of inhibiting these pro-inflammatory cellular events.", {"entities": []}], ["We describe a patient with severe acute respiratory syndrome (SARS) whose clinical symptoms were masked by Escherichia coli bacteremia.", {"entities": [[52, 60, "DISEASE"], [27, 60, "DISEASE"], [62, 66, "GENE"]]}], ["SARS developed in a cluster of healthcare workers who had contact with this patient.", {"entities": [[0, 4, "GENE"]]}], ["SARS was diagnosed when a chest infiltrate developed and when the patient\u2019s brother was hospitalized with acute respiratory failure.", {"entities": [[112, 131, "DISEASE"], [0, 4, "GENE"]]}], ["We highlight problems in atypical cases and offer infection control suggestions.", {"entities": []}], ["Over 50 investigational monoclonal antibody (mAb) therapeutics are currently undergoing evaluation in late-stage clinical studies, which is expected to drive a trend toward first marketing approvals of at least 6\u20139\u00a0mAbs per year in the near-term.", {"entities": []}], ["In the United States (US), a total of 6 and 9 mAbs were granted first approvals during 2014 and 2015, respectively; all these products are also approved in the European Union (EU).", {"entities": []}], ["As of December 1, 2016, 6\u00a0mAbs (atezolizumab, olaratumab, reslizumab, ixekizumab, bezlotoxumab, oblitoxaximab) had been granted first approvals during 2016 in either the EU or US.", {"entities": []}], ["Brodalumab, was granted a first approval in Japan in July 2016.", {"entities": []}], ["Regulatory actions on marketing applications for brodalumab in the EU and US are not expected until 2017.", {"entities": []}], ["In 2017, first EU or US approvals may also be granted for at least nine mAbs (ocrelizumab, avelumab, Xilonix, inotuzumab ozogamicin, dupilumab, sirukumab, sarilumab, guselkumab, romosozumab) that are not yet approved in any country.", {"entities": []}], ["Based on announcements of company plans for regulatory submissions and the estimated completion dates for late-stage clinical studies, and assuming the study results are positive, marketing applications for at least 6 antibody therapeutics (benralizumab, tildrakizumab, emicizumab, galcanezumab, ibalizumab, PRO-140) that are now being evaluated in late-stage clinical studies may be submitted during December 2016* or 2017.", {"entities": []}], ["Other \u2018antibodies to watch' in 2017 include 20 mAbs are undergoing evaluation in pivotal studies that have estimated primary completion dates in late 2016 or during 2017.", {"entities": []}], ["Of these, 5 mAbs are for cancer (durvalumab, JNJ-56022473, ublituximab, anetumab ravtansine, glembatumumab vedotin) and 15 mAbs are for non-cancer indications (caplacizumab, lanadelumab, roledumab, tralokinumab, risankizumab, SA237, emapalumab, suptavumab, erenumab, eptinezumab, fremanezumab, fasinumab, tanezumab, lampalizumab, brolucizumab).", {"entities": [[25, 31, "DISEASE"], [140, 146, "DISEASE"]]}], ["Positive results from these studies may enable submission of marketing applications in 2017 or 2018, or provide justification for additional studies.", {"entities": []}], ["*See note added in proof for update through December 31, 2016.", {"entities": []}], ["The burden of chronic conditions is high in low- and middle-income countries and poses a significant challenge to already weak healthcare delivery systems in these countries.", {"entities": []}], ["Studies investigating chronic conditions among the urban poor remain few and focused on specific chronic conditions rather than providing overall profile of chronic conditions in a given community, which is critical for planning and managing services within local health systems.", {"entities": []}], ["We aimed to assess the prevalence and health- seeking behaviour for self-reported chronic conditions in a poor neighbourhood of a metropolitan city in India.", {"entities": []}], ["We conducted a house-to-house survey covering 9299 households (44514 individuals) using a structured questionnaire.", {"entities": []}], ["We relied on self-report by respondents to assess presence of any chronic conditions, including diabetes and hypertension.", {"entities": [[109, 121, "DISEASE"]]}], ["Multivariable logistic regression was used to analyse the prevalence and health-seeking behaviour for self-reported chronic conditions in general as well as for diabetes and hypertension in particular.", {"entities": [[174, 186, "DISEASE"]]}], ["The predictor variables included age, sex, income, religion, household poverty status, presence of comorbid chronic conditions, and tiers in the local health care system.", {"entities": []}], ["Overall, the prevalence of self-reported chronic conditions was 13.8% (95% CI = 13.4, 14.2) among adults, with hypertension (10%) and diabetes (6.4%) being the most commonly reported conditions.", {"entities": [[111, 123, "DISEASE"]]}], ["Older people and women were more likely to report chronic conditions.", {"entities": []}], ["We found reversal of socioeconomic gradient with people living below the poverty line at significantly greater odds of reporting chronic conditions than people living above the poverty line (OR = 3, 95% CI = 1.5, 5.8).", {"entities": []}], ["Private healthcare providers managed over 80% of patients.", {"entities": []}], ["A majority of patients were managed at the clinic/health centre level (42.9%), followed by the referral hospital (38.9%) and the super-specialty hospital (18.2%) level.", {"entities": []}], ["An increase in income was positively associated with the use of private facilities.", {"entities": []}], ["However, elderly people, people below the poverty line, and those seeking care from hospitals were more likely to use government services.", {"entities": []}], ["Our findings provide further evidence of the urgent need to improve care for chronic conditions for urban poor, with a preferential focus on improving service delivery in government health facilities.", {"entities": []}], ["Chiropractic technique systems have been historically documented to advocate overutilization of radiography.", {"entities": []}], ["Various rationales for this have been explored in the literature.", {"entities": []}], ["However, little consideration has been given to the possibility that the healthcare belief system of prominent early chiropractors may have influenced the use of the diagnostic modality through the years.", {"entities": []}], ["The original rationale was the visualisation of chiropractic subluxations, defined as bones slightly out of place, pressing on nerves, and ultimately causing disease.", {"entities": []}], ["This paradigm of radiography has survived in parts of the chiropractic profession, despite lacking evidence of clinical validity.", {"entities": []}], ["The purpose of this paper is to compare the characteristics of the chiropractic technique systems that have utilised radiography for subluxation detection with the characteristics of religion, and to discover potential historical links that may have facilitated the development of those characteristics.", {"entities": []}], ["Twenty-three currently or previously existing technique systems requiring radiography for subluxation analysis were found using a search of the internet, books and consultation with experts.", {"entities": []}], ["Evidence of religiosity from the early founders\u2019 writings was compared with textbooks, published papers, and websites of subsequently developed systems.", {"entities": []}], ["Six criteria denoting religious thinking were developed using definitions from various sources.", {"entities": []}], ["They are: supernatural concepts, claims of supremacy, rules and rituals, sacred artefacts, sacred stories, and special language.", {"entities": []}], ["All of these were found to a greater or lesser degree in the publicly available documents of all the subluxation-based chiropractic x-ray systems.", {"entities": []}], ["The founders and early pioneers of chiropractic did not benefit from the current understanding of science and research, and therefore substituted deductive and inductive reasoning to arrive at conclusions about health and disease in the human body.", {"entities": []}], ["Some of this thinking and rationalisation demonstrably followed a religion-like pattern, including BJ Palmer\u2019s use of radiography.", {"entities": []}], ["Although access to scientific methods and research education became much advanced and more accessible during the past few decades, the publicly available documents of technique systems that used radiography for chiropractic subluxation detection examined in this paper employed a historically derived paradigm for radiography that displayed characteristics in common with religion.", {"entities": []}], ["The online version of this article (doi:10.1186/s12998-014-0036-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recent studies have emphasized the role of psychosocial stressors as a determinant of asthma, and neighborhoods can be a potential source of such stressors.", {"entities": [[86, 92, "DISEASE"]]}], ["We investigated the association between parental perception of neighborhood safety and reported lifetime asthma among children.", {"entities": [[105, 111, "DISEASE"]]}], ["Data for the study came from the 2003\u201304 National Survey of Children Health (NSCH); a nationally representative cross-sectional sample of children aged 0\u201317 years.", {"entities": []}], ["Demographic, socioeconomic and behavioral covariates were included in the study.", {"entities": []}], ["Models were estimated after taking account of weighting and complex survey design.", {"entities": []}], ["Parental report of whether the child has ever been diagnosed with asthma by a physician was used to define the outcome.", {"entities": [[66, 72, "DISEASE"]]}], ["Parental report of perception of neighborhood safety was the main exposure.", {"entities": []}], ["In unadjusted models, the odds ratio (OR) for reporting asthma associated with living in neighborhoods that were perceived to be sometimes or never safe was 1.36 (95% confidence intervals [CI] 1.21, 1.53) compared to living in neighborhoods that were perceived to be always safe.", {"entities": [[56, 62, "DISEASE"]]}], ["Adjusting for covariates including exposure to second hand tobacco smoke, mother's self-rated health, child's physical activity and television viewing attenuated this association (OR 1.25, 95% CI 1.08, 1.43).", {"entities": []}], ["In adjusted models, the increased odds ratio for reporting asthma was also higher among those who perceived neighborhoods as being usually safe (OR 1.15 95% CI 1.06, 1.26), as compared to always safe, suggestive of a dose-response relationship, with the differentials for usually safe and never safe being statistically significant (p\u200a=\u200a0.009).", {"entities": [[59, 65, "DISEASE"]]}], ["Psychosocial stressors may be important risk factors that may impact the pathogenesis of asthma and/or contribute to asthma morbidity by triggering exacerbations through neuroimmunologic mechanisms, as well as social mechanisms.", {"entities": [[89, 95, "DISEASE"], [117, 123, "DISEASE"]]}], ["Objective To investigate the validity of recommendations in treatment guidelines to use higher than approved doses of oseltamivir in patients with severe influenza.", {"entities": [[154, 163, "DISEASE"]]}], ["Design Double blind randomised trial.", {"entities": []}], ["Setting Thirteen hospitals in Indonesia, Singapore, Thailand, and Vietnam.", {"entities": []}], ["Participants Patients aged \u22651 year admitted to hospital with confirmed severe influenza.", {"entities": [[78, 87, "DISEASE"]]}], ["Interventions Oral oseltamivir at double dose (150 mg twice a day/paediatric equivalent) versus standard dose (75 mg twice a day/paediatric equivalent).", {"entities": []}], ["Main outcome measure Viral status according to reverse transcriptase polymerase chain reaction (RT-PCR) for influenza RNA in nasal and throat swabs on day five.", {"entities": [[108, 117, "DISEASE"]]}], ["Results Of 326 patients (including 246 (75.5%) children aged <15), 165 and 161 were randomised to double or standard dose oseltamivir, respectively.", {"entities": []}], ["Of these, 260 (79.8%) were infected with influenza virus A (133 (40.8%) with A/H3N2, 72 (22.1%) with A/H1N1-pdm09, 38 (11.7%) with seasonal A/H1N1, 17 (5.2%) with A/H5N1) and 53 (16.2%) with influenza virus B.", {"entities": [[41, 50, "DISEASE"], [191, 200, "DISEASE"]]}], ["A further 3.9% (13) were false positive by rapid antigen test (negative by RT-PCR and no rise in convalescent haemagglutination inhibition titers).", {"entities": []}], ["Similar proportions of patients were negative for RT-PCR on day five of treatment: 115/159 (72.3%, 95% confidence interval 64.9% to 78.7%) double dose recipients versus 105/154 (68.2%, 60.5% to 75.0%) standard dose recipients; difference 4.2% (\u22125.9 to 14.2); P=0.42.", {"entities": []}], ["No differences were found in clearance of virus in subgroup analyses by virus type/subtype, age, and duration of illness before randomisation.", {"entities": []}], ["Mortality was similar: 12/165 (7.3%, 4.2% to 12.3%) in double dose recipients versus 9/161 (5.6%, 3.0% to 10.3%) in standard dose recipients.", {"entities": []}], ["No differences were found between double and standard dose arms in median days on supplemental oxygen (3 (interquartile range 2-5) v 3.5 (2-7)), in intensive care (4.5 (3-6) v 5 (2-11), and on mechanical ventilation (2.5 (1-16) v 8 (1-16)), respectively.", {"entities": []}], ["No important differences in tolerability were found.", {"entities": []}], ["Conclusions There were no virological or clinical advantages with double dose oseltamivir compared with standard dose in patients with severe influenza admitted to hospital.", {"entities": [[142, 151, "DISEASE"]]}], ["Registration Clinical Trials NCT00298233", {"entities": []}], ["This study investigated sex and gender differences in cardinal symptoms of exposure to a mixture of ambient pollutants.", {"entities": []}], ["A cross sectional population-based study design was utilized in Sarnia, ON, Canada.", {"entities": []}], ["Stratified random sampling in census tracts of residents aged 18 and over recruited 804 respondents.", {"entities": []}], ["Respondents completed a community health survey of chronic disease, general health, and socioeconomic indicators.", {"entities": []}], ["Residential concentrations of NO 2 , SO 2 , benzene, toluene, ethylbenzene and o/m/p -xylene were estimated by land use regression on data collected through environmental monitoring.", {"entities": []}], ["Classification and Regression Tree (CART) analysis was used to identify variables that interacted with sex and cardinal symptoms of exposure, and a series of logistic regression models were built to predict the reporting of five or more cardinal symptoms (5+ CS).", {"entities": [[259, 261, "GENE"]]}], ["Without controlling for confounders, higher pollution ranks increased the odds ratio (OR) of reporting 5+ CS by 28% ( p < 0.01; Confidence Interval (CI): 1.07\u20131.54).", {"entities": [[106, 108, "GENE"]]}], ["Females were 1.52 ( p < 0.05; CI: 1.03\u20132.26) times more likely more likely to report 5+ CS after controlling for income, age and chronic diseases.", {"entities": [[88, 90, "GENE"]]}], ["The CART analysis showed that allergies and occupational exposure classified the sample into the most homogenous groups of males and females.", {"entities": []}], ["The likelihood of reporting 5+ CS among females was higher after stratifying the sample based on occupational exposure.", {"entities": [[31, 33, "GENE"]]}], ["However, stratifying by allergic disease resulted in no significant sex difference in symptom reporting.", {"entities": []}], ["The results confirmed previous research that found pre-existing health conditions to increase susceptibility to ambient air pollution, but additionally indicated that stronger effects on females is partly due to autoimmune disorders.", {"entities": []}], ["Furthermore, gender differences in occupational exposure confound the effect size of exposure in studies based on residential levels of air pollution.", {"entities": []}], ["Recent studies have suggested that Helicobacter pylori could prevent allergic disease, particularly in children.", {"entities": []}], ["However, whether this is true in adults is controversial.", {"entities": []}], ["The aim of this study was to investigate whether there is negative association between H. pylori infection and asthma among adults in an area with a high prevalence of H. pylori .", {"entities": [[111, 117, "DISEASE"]]}], ["This was a cross-sectional study using 2011 health surveillance data.", {"entities": []}], ["Blood samples were taken from all participants to measure serum H. pylori IgG status.", {"entities": []}], ["Information on demographics, socioeconomic status, and medical history, including asthma and other allergic conditions were collected by a questionnaire.", {"entities": [[82, 88, "DISEASE"]]}], ["Of the 15,032 patients, 9492 (63.1%) had a history of H. pylori infection, 359 (2.4%) had asthma, and 3277 (21.8%) had other allergic conditions.", {"entities": [[90, 96, "DISEASE"]]}], ["H. pylori infection was positively correlated with age (OR, 1.050; 95% CI, 1.047\u20131.053, P \u200a<\u200a0.001).", {"entities": []}], ["Asthma history was positively correlated with age (OR, 1.022; 95% CI, 1.013\u20131.032, P \u200a<\u200a0.001).", {"entities": [[0, 6, "DISEASE"]]}], ["H. pylori and age were shown to have interaction on asthma in the total participants (OR, 1.041; 95% CI, 1.021\u20131.062, P \u200a<\u200a0.001).", {"entities": [[52, 58, "DISEASE"]]}], ["In subgroup analysis, H. pylori infection among those\u200a<\u200a40 years old was inversely correlated with asthma (OR, 0.503; 95% CI, 0.280\u20130.904, P \u200a=\u200a0.021).", {"entities": [[99, 105, "DISEASE"]]}], ["Other allergic conditions were not related with H. pylori infection among the total and those <40 years old.", {"entities": []}], ["The inverse association between H. pylori infection and asthma among young adults suggests that the underlying immune mechanism induced by H. pylori infection may affect allergic reactions associated with asthma in young adults.", {"entities": [[56, 62, "DISEASE"], [205, 211, "DISEASE"]]}], ["Particulate matter (PM) is regulated in various parts of the world based on specific size cut offs, often expressed as 10 or 2.5\u2009\u00b5m mass median aerodynamic diameter.", {"entities": []}], ["This pollutant is deemed one of the most dangerous to health and moreover, problems persist with high ambient concentrations.", {"entities": []}], ["Continuing pressure to re-evaluate ambient air quality standards stems from research that not only has identified effects at low levels of PM but which also has revealed that reductions in certain components, sources and size fractions may best protect public health.", {"entities": []}], ["Considerable amount of published information have emerged from toxicological research in recent years.", {"entities": []}], ["Accumulating evidence has identified additional air quality metrics (e.g.", {"entities": []}], ["black carbon, secondary organic and inorganic aerosols) that may be valuable in evaluating the health risks of, for example, primary combustion particles from traffic emissions, which are not fully taken into account with PM 2.5 mass.", {"entities": []}], ["Most of the evidence accumulated so far is for an adverse effect on health of carbonaceous material from traffic.", {"entities": []}], ["Traffic-generated dust, including road, brake and tire wear, also contribute to the adverse effects on health.", {"entities": []}], ["Exposure durations from a few minutes up to a year have been linked with adverse effects.", {"entities": []}], ["The new evidence collected supports the scientific conclusions of the World Health Organization Air Quality Guidelines and also provides scientific arguments for taking decisive actions to improve air quality and reduce the global burden of disease associated with air pollution.", {"entities": []}], ["Chronic kidney disease (CKD) is prevalent in Taiwan and it is associated with high all-cause mortality.", {"entities": [[8, 22, "DISEASE"]]}], ["We have shown in a previous paper that a fourth-generation telehealth program is associated with lower all-cause mortality compared to usual care with a hazard ratio of 0.866 (95% CI 0.837-0.896).", {"entities": []}], ["This study aimed to evaluate the effect of renal function status on hospitalization among patients receiving this program and to evaluate the relationship between contract compliance rate to the program and risk of hospitalization in patients with CKD.", {"entities": []}], ["We retrospectively analyzed 715 patients receiving the telehealth care program.", {"entities": []}], ["Contract compliance rate was defined as the percentage of days covered by the telehealth service before hospitalization.", {"entities": []}], ["Patients were stratified into three groups according to renal function status: (1) normal renal function, (2) CKD, or (3) end-stage renal disease (ESRD) and on maintenance dialysis.", {"entities": []}], ["The outcome measurements were first cardiovascular and all-cause hospitalizations.", {"entities": []}], ["The association between contract compliance rate, renal function status, and hospitalization risk was analyzed with a Cox proportional hazards model with time-dependent covariates.", {"entities": []}], ["The median follow-up duration was 694 days (IQR 338-1163).", {"entities": []}], ["Contract compliance rate had a triphasic relationship with cardiovascular and all-cause hospitalizations.", {"entities": []}], ["Patients with low or very high contract compliance rates were associated with a higher risk of hospitalization.", {"entities": []}], ["Patients with CKD or ESRD were also associated with a higher risk of hospitalization.", {"entities": []}], ["Moreover, we observed a significant interaction between the effects of renal function status and contract compliance rate on the risk of hospitalization: patients with ESRD, who were on dialysis, had an increased risk of hospitalization at a lower contract compliance rate, compared with patients with normal renal function or CKD.", {"entities": []}], ["Our study showed that there was a triphasic relationship between contract compliance rate to the telehealth program and risk of hospitalization.", {"entities": []}], ["Renal function status was associated with risk of hospitalization among these patients, and there was a significant interaction with contract compliance rate.", {"entities": []}], ["We tested an electronic cause-of-death query system at a hospital in New York City to evaluate clinicians\u2019 reporting of cause of death.", {"entities": []}], ["We used the system to query clinicians about all deaths assigned International Classification of Disease code J189 (pneumonia, unspecified) as the underlying cause of death.", {"entities": [[116, 125, "DISEASE"]]}], ["Of 29 death certificates that generated queries, 28 were updated with additional information, which led to revisions in the underlying cause of 27 deaths.", {"entities": []}], ["The electronic system for querying reported cause of death was feasible and enabled quicker than usual responses; however, follow-up with clinicians to ensure timely, accurate, and complete responses was labor-intensive.", {"entities": []}], ["Educating clinicians and enforcing reporting standards would reduce the time and effort required to ensure accurate and timely cause-of-death reporting.", {"entities": []}], ["Stanford type A aortic dissections often present to the hospital requiring emergent surgical intervention.", {"entities": []}], ["Initial diagnosis is usually made by computed tomography; however transesophageal echocardiography (TEE) can further characterize aortic dissections with specific advantages: It may be performed on an unstable patient, it can be used intra-operatively, and it has the ability to provide continuous real-time information.", {"entities": []}], ["Three-dimensional (3D) TEE has become more accessible over recent years allowing it to serve as an additional tool in the operating room.", {"entities": []}], ["We present a case series of three patients presenting with type A aortic dissections and the advantages of intra-operative 3D TEE to diagnose the extent of dissection in each case.", {"entities": []}], ["Prior case reports have demonstrated the use of 3D TEE in type A aortic dissections to characterize the extent of dissection and involvement of neighboring structures.", {"entities": []}], ["In our three cases described, 3D TEE provided additional understanding of spatial relationships between the dissection flap and neighboring structures such as the aortic valve and coronary orifices that were not fully appreciated with two-dimensional TEE, which affected surgical decisions in the operating room.", {"entities": []}], ["This case series demonstrates the utility and benefit of real-time 3D TEE during intra-operative management of a type A aortic dissection.", {"entities": []}], ["Psoriasis is a common inflammatory skin disease characterized by abnormal keratinocyte inflammation and differentiation that has a major impact on patients' quality of life.", {"entities": [[0, 9, "DISEASE"], [35, 47, "DISEASE"]]}], ["IL-36\u03b3, a member of IL-36 cytokine family, is highly expressed in psoriasis and plays an important role in inflammation response and differentiation.", {"entities": [[66, 75, "DISEASE"]]}], ["However, the function of IL-36\u03b3 in differentiation and inflammation of keratinocyte in psoriasis has not been clearly identified.", {"entities": [[87, 96, "DISEASE"]]}], ["Thus, this study aimed to investigate the role of IL-36\u03b3 on differentiation and inflammation in HaCaT cells.", {"entities": []}], ["HaCaT cells were divided into three groups: (1) Control group; (2) IL-36\u03b3 (100 ng/mL) group; (3) IL-36\u03b3 (100 ng/mL) + IWP-2 (1\u03bcM) group.", {"entities": []}], ["Real time PCR was used to detect gene expression; the inflammation cytokines were examined by ELISA.", {"entities": []}], ["We showed that treatment of HaCaT cells with IL-36\u03b3 significantly upregulated the expression levels of \u03b2-catenin, cyclin D1, and ki-67.", {"entities": []}], ["IL-36\u03b3 also promoted the production of the inflammatory cytokines IFN-\u03b3, IL-1\u03b2 and IL-6, suppressed the expression of filaggrin, involucrin, keratin 1 and keratin 5.", {"entities": []}], ["Meanwhile, we demonstrated the role of IWP-2, an inhibitor of the Wnt signaling pathway, in IL-36\u03b3-treated HaCaT cells.", {"entities": []}], ["Collectively, our findings suggest that IL-36\u03b3 inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis, this indicated that downregulation of IL-36\u03b3 may be a potential therapeutic option in psoriasis.", {"entities": [[142, 151, "DISEASE"], [239, 248, "DISEASE"]]}], ["Objective .", {"entities": []}], ["Evaluate the human abuse potential (HAP) of an experimental, microsphere-in-capsule formulation of extended-release oxycodone (oxycodone DETERx\u00ae) (herein \u201cDETERx\u201d).", {"entities": []}], ["Randomized, double-blind, double-dummy, positive- and placebo-controlled, single-dose, four-phase, four-treatment, crossover study.", {"entities": []}], ["Clinical research site.", {"entities": []}], ["There were 39 qualifying subjects (72% male, 85% white, mean age of 27 years) with 36 completing all four Double-blind Treatment Periods.", {"entities": []}], ["The four phases encompassed: 1) Screening; 2) Drug Discrimination; 3) Double-blind Treatment; and 4) Follow-up.", {"entities": []}], ["Drug Discrimination tests ensured that subjects could distinguish placebo from opioid.", {"entities": []}], ["The four Double-blind Treatments compared DETERx\u2014administered as either a crushed intranasal (IN) or an intact oral (PO) preparation\u2014with immediate-release oxycodone IN (OXY-IR IN) and with an intact IN and PO placebo DETERx control.", {"entities": []}], ["For primary pharmacokinetic (PK) assessments, abuse quotient (C max /T max ) was lower with DETERx IN than DETERx PO; both treatments were substantially lower than OXY-IR IN (6.24, 8.60, and 69.6 ng/mL/h, respectively).", {"entities": [[64, 67, "GENE"], [71, 74, "GENE"], [64, 67, "GENE"], [71, 74, "GENE"]]}], ["For drug liking, the primary subjective pharmacodynamic (PD) endpoint, both DETERx IN and DETERx PO produced significantly lower scores than OXY-IR IN ( P \u2009\u2264\u20090.0001 for each); DETERx IN was less liked than DETERx PO ( P \u2009\u2264\u20090.05), mirroring the PK relationships.", {"entities": []}], ["Objectively assessed pupillometry corroborated the more rapid and significantly greater effect of OXY-IR IN than either DETERx IN or DETERx PO ( P \u2009\u2264\u20090.007 for each).", {"entities": []}], ["Overall safety profiles of DETERx and OXY-IR were comparable and both were well tolerated.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Pharmacokinetic and pharmacodynamic outcomes suggest that DETERx IN has relatively low HAP; continued research in larger populations is suggested.", {"entities": []}], ["Data on differences in clinical characteristics and management of COPD in different countries and settings are limited.", {"entities": []}], ["We aimed to characterize the profile of patients with COPD in a number of countries and their treatment in order to evaluate adherence to recommendations of international guidelines.", {"entities": []}], ["This was an observational, international, cross-sectional study on patients with physician-diagnosed COPD.", {"entities": []}], ["Demographic and clinical characteristics, risk factors, and treatment were collected by their physician via an internet web-based questionnaire developed for the study.", {"entities": []}], ["A total of 77 investigators from 17 countries provided data on 833 patients.", {"entities": []}], ["The countries with the highest number of patients included were: Argentina (128), Ecuador (134), Spain (162), and Hong Kong (153).", {"entities": []}], ["Overall, 79.3% were men and 81% former smokers, with a mean FEV 1 = 42.7%, ranging from 34.3% in Hong Kong to 58.8% in Ecuador.", {"entities": [[60, 63, "GENE"]]}], ["Patients reported a mean of 1.6 exacerbations the previous year, with this frequency being significantly and negatively correlated with FEV 1 (%) (r = \u22120.256; p < 0.0001).", {"entities": [[136, 139, "GENE"]]}], ["Treatment with short-acting bronchodilators and theophyllines was more frequent in Ecuador and Hong Kong compared with Spain and Argentina, and in patients belonging to lower socioeconomic levels (p < 0.0001 for all comparisons).", {"entities": []}], ["Inadequacy of treatment with inhaled corticosteroids and theophyllines was high, with significant differences among countries.", {"entities": []}], ["Differences in the clinical characteristics and management of COPD were significant across countries.", {"entities": []}], ["Adherence to international guidelines appears to be low.", {"entities": []}], ["Efforts should be made to disseminate and adapt guidelines to the socioeconomic reality of different settings.", {"entities": []}], ["To translate the Leicester Cough Questionnaire (LCQ) to Portuguese and adapt it for use in Brazil.", {"entities": []}], ["Cross-cultural adaptation of a quality of life questionnaire requires a translated version that is conceptually equivalent to the original version and culturally acceptable in the target country.", {"entities": []}], ["The protocol used consisted of the translation of the LCQ to Portuguese by three Brazilian translators who were fluent in English and its back-translation to English by another translator who was a native speaker of English and fluent in Portuguese.", {"entities": []}], ["The back-translated version was evaluated by one of the authors of the original questionnaire in order to verify its equivalence.", {"entities": []}], ["Later in the process, a provisional Portuguese-language version was thoroughly reviewed by an expert committee.", {"entities": []}], ["In 10 patients with chronic cough, cognitive debriefing was carried out in order to test the understandability, clarity, and acceptability of the translated questionnaire in the target population.", {"entities": []}], ["On that basis, the final Portuguese-language version of the LCQ was produced and approved by the committee.", {"entities": []}], ["Few items were questioned by the source author and revised by the committee of experts.", {"entities": []}], ["During the cognitive debriefing phase, the Portuguese-language version of the LCQ proved to be well accepted and understood by all of the respondents, which demonstrates the robustness of the process of translation and cross-cultural adaptation.", {"entities": []}], ["The final version of the LCQ adapted for use in Brazil was found to be easy to understand and easily applied.", {"entities": []}], ["Traduzir e adaptar culturalmente o Leicester Cough Questionnaire (LCQ) para a l\u00edngua portuguesa falada no Brasil.", {"entities": []}], ["A adapta\u00e7\u00e3o cultural de um question\u00e1rio de qualidade de vida envolve a tradu\u00e7\u00e3o conceitualmente equivalente \u00e0 vers\u00e3o original e culturalmente aceit\u00e1vel ao pa\u00eds em que ser\u00e1 utilizado.", {"entities": []}], ["O protocolo aplicado consistiu na tradu\u00e7\u00e3o do LCQ para a l\u00edngua portuguesa por tr\u00eas tradutores brasileiros com flu\u00eancia na l\u00edngua inglesa e sua retradu\u00e7\u00e3o para a l\u00edngua original por um tradutor nascido em um pa\u00eds de l\u00edngua inglesa e com flu\u00eancia na l\u00edngua portuguesa.", {"entities": [[75, 78, "GENE"], [178, 181, "GENE"], [75, 78, "GENE"], [178, 181, "GENE"]]}], ["A vers\u00e3o retraduzida foi avaliada por um dos autores do question\u00e1rio original para assegurar sua equival\u00eancia e, posteriormente, o question\u00e1rio foi revisado por um comit\u00ea de especialistas que realizou ampla revis\u00e3o do instrumento.", {"entities": [[34, 37, "GENE"], [157, 160, "GENE"], [34, 37, "GENE"], [157, 160, "GENE"]]}], ["O desdobramento cognitivo consistiu em testar a compreens\u00e3o, clareza e aceitabilidade do question\u00e1rio traduzido na popula\u00e7\u00e3o alvo, aplicando-o em dez pacientes portadores de tosse cr\u00f4nica.", {"entities": []}], ["Com base nisso, foi realizada a formula\u00e7\u00e3o da vers\u00e3o brasileira final do LCQ ap\u00f3s sua aprova\u00e7\u00e3o pelo comit\u00ea.", {"entities": [[96, 100, "GENE"]]}], ["Poucos itens foram questionados pelo autor da vers\u00e3o original e revistos pelo comit\u00ea de especialistas.", {"entities": [[32, 36, "GENE"], [73, 77, "GENE"], [32, 36, "GENE"], [73, 77, "GENE"]]}], ["A vers\u00e3o portuguesa do LCQ apresentou boa aceitabilidade e compreens\u00e3o por todos os entrevistados no desdobramento cognitivo, demonstrando a robustez do processo de tradu\u00e7\u00e3o e adapta\u00e7\u00e3o cultural.", {"entities": [[71, 74, "GENE"]]}], ["A vers\u00e3o final traduzida e adaptada para uso no Brasil mostrou ser de f\u00e1cil compreens\u00e3o e aplica\u00e7\u00e3o.", {"entities": []}], ["Although the importance of rational prescribing is generally accepted, the teaching of pharmacotherapy to undergraduate medical students is still unsatisfactory.", {"entities": []}], ["Because clinical teachers are an important role model for medical students, it is of interest to know whether this extends to therapeutic decision-making.", {"entities": []}], ["The aim of this study was to find out which factors contribute to the drug choices made by medical students and their teachers (general practitioners and clinical specialists).", {"entities": []}], ["Final-year medical students ( n \u2009=\u200932), and general practitioners ( n \u2009=\u200929), lung specialists ( n \u2009=\u200926), orthopaedic surgeons ( n \u2009=\u200924), and internists ( n \u2009=\u200924) serving as medical teachers from all eight medical schools in the Netherlands participated in the study.", {"entities": []}], ["They were asked to prescribe treatment (drug or otherwise) for uncomplicated (A) and complicated (B) written patient cases and to indicate which factors influenced their choice of treatment, using a list of factors reported in the literature to influence drug prescribing.", {"entities": []}], ["Final-year medical students primarily based their drug choice on the factors \u2018effectiveness of the drugs\u2019 and \u2018examples from medical teachers\u2019.", {"entities": []}], ["In contrast, clinical teachers primarily based their drug choice on the factors \u2018clinical experience\u2019, \u2018effectiveness of the drugs\u2019, \u2018side effects of the drugs\u2019, \u2018standard treatment guidelines\u2019, and \u2018scientific literature\u2019.", {"entities": []}], ["Medical teachers would appear to base their drug choice mainly on clinical experience and drug-related factors, whereas final-year medical students base their drug choice mainly on examples provided by their medical teachers.", {"entities": []}], ["It is essential that medical teachers clearly explain to their students how they arrive at a specific choice of medication since medical students tend to copy the therapeutic drug choices from their teachers, mainly because of a lack of experience.", {"entities": []}], ["Presenting students with clinical therapeutic problems early during undergraduate training will not only give them a chance to gain experience in solving medical problems but will also give meaning to what they are studying as opposed to merely reproducing what they learn or copying what they are told.", {"entities": []}], ["Depression is commonly comorbid with chronic physical illnesses and is associated with a range of adverse clinical outcomes.", {"entities": []}], ["Currently, the literature on the role of depression in determining the course and outcome of tuberculosis (TB) is very limited.", {"entities": [[93, 105, "DISEASE"]]}], ["Our aim is to examine the relationship between depression and TB among people newly diagnosed and accessing care for TB in a rural Ethiopian setting.", {"entities": []}], ["Our objectives are to investigate: the prevalence and determinants of probable depression, the role of depression in influencing pathways to treatment of TB, the incidence of depression during treatment, the impact of anti-TB treatment on the prognosis of depression and the impact of depression on the outcomes of TB treatment.", {"entities": []}], ["We will use a prospective cohort design.", {"entities": []}], ["703 newly diagnosed cases of TB (469 without depression and 234 with depression) will be consecutively recruited from primary care health centres.", {"entities": []}], ["Data collection will take place at baseline, 2 and 6\u2005months after treatment initiation.", {"entities": []}], ["The primary exposure variable is probable depression measured using the Patient Health Questionnaire-9.", {"entities": []}], ["Outcome variables include: pathways to treatment, classical outcomes for anti-TB treatment quality of life and disability.", {"entities": []}], ["Descriptive statistics, logistic regression and multilevel mixed-effect analysis will be used to test the study hypotheses.", {"entities": []}], ["Ethical approval has been obtained from the Institutional Review Board (IRB) of the College of Health Sciences, Addis Ababa University.", {"entities": []}], ["Findings will be disseminated through scientific publications, conference presentations, community meetings and policy briefs.", {"entities": []}], ["Findings will contribute to a sparse evidence base on comorbidity of depression and TB.", {"entities": []}], ["We hope the dissemination of findings will raise awareness of comorbidity among clinicians and service providers, and contribute to ongoing debates regarding the delivery of mental healthcare in primary care in Ethiopia.", {"entities": []}], ["Human hemokinin-1 (hHK-1) and endokinins are peptides of the tachykinin family encoded by the TAC4 gene.", {"entities": [[94, 98, "GENE"]]}], ["TAC4 and hHK-1 expression as well as effects of hHK-1 in the lung and airways remain however unknown and were explored in this study.", {"entities": [[0, 4, "GENE"]]}], ["RT-PCR analysis was performed on human bronchi to assess expression of tachykinin and tachykinin receptors genes.", {"entities": []}], ["Enzyme immunoassay was used to quantify hHK-1, and effects of hHK-1 and endokinins on contraction of human and guinea pig airways were then evaluated, as well as the role of hHK-1 on cytokines production by human lung parenchyma or bronchi explants and by lung macrophages.", {"entities": []}], ["In human bronchi, expression of the genes that encode for hHK-1, tachykinin NK 1 -and NK 2 -receptors was demonstrated.", {"entities": []}], ["hHK-1 protein was found in supernatants from explants of human bronchi, lung parenchyma and lung macrophages.", {"entities": []}], ["Exogenous hHK-1 caused a contractile response in human bronchi mainly through the activation of NK 2 -receptors, which blockade unmasked a NK 1 -receptor involvement, subject to a rapid desensitization.", {"entities": []}], ["In the guinea pig trachea, hHK-1 caused a concentration-dependant contraction mainly mediated through the activation of NK 1 -receptors.", {"entities": []}], ["Endokinin A/B exerted similar effects to hHK-1 on both human bronchi and guinea pig trachea, whereas endokinins C and D were inactive.", {"entities": []}], ["hHK-1 had no impact on the production of cytokines by explants of human bronchi or lung parenchyma, or by human lung macrophages.", {"entities": []}], ["We demonstrate endogenous expression of TAC4 in human bronchi, the encoded peptide hHK-1 being expressed and involved in contraction of human and guinea pig airways.", {"entities": [[40, 44, "GENE"]]}], ["S100A12 is involved in the inflammatory response and is considered an important marker for many inflammatory diseases in humans.", {"entities": [[0, 7, "GENE"]]}], ["Our previous studies indicated that the S100A12 gene was abundant in the immune tissues of pigs and was significantly upregulated during infection with Haemophilus parasuis (HPS) or porcine circovirus type 2 (PCV2).", {"entities": [[40, 47, "GENE"]]}], ["In this study, the mechanism of transcriptional regulation of S100A12 was investigated in pigs.", {"entities": [[62, 69, "GENE"]]}], ["Our results showed that S100A12, CCAAT/enhancer-binding protein beta (C/EBP\u03b2) and activator protein-1 (AP-1) genes were up-regulated in PK-15 (ATCC, CCL-33) cells when treated with LPS or Poly I: C. Additionally, the promoter activity and expression level of the S100A12 gene were significantly upregulated when C/EBP\u03b2 or AP-1 were overexpressed.", {"entities": [[24, 31, "GENE"], [263, 270, "GENE"], [24, 31, "GENE"], [263, 270, "GENE"]]}], ["We utilized electromobility shift assays (EMSA) to confirm that C/EBP\u03b2 and AP-1 could directly bind the S100A12 gene promoter.", {"entities": [[104, 111, "GENE"]]}], ["We also found that the transcriptional activity and expression levels of C/EBP\u03b2 and AP-1 could positively regulate each other.", {"entities": []}], ["Furthermore, the promoter activity of the S100A12 gene was higher when C/EBP\u03b2 and AP-1 were cotransfected than when they were transfected individually.", {"entities": [[42, 49, "GENE"]]}], ["We concluded that the S100A12 gene was cooperatively and positively regulated by C/EBP\u03b2 and AP-1 in pigs.", {"entities": [[22, 29, "GENE"]]}], ["Our study offers new insight into the transcriptional regulation of the S100A12 gene.", {"entities": [[72, 79, "GENE"]]}], ["The objective of this study was to evaluate the local effects of statins as adjuvants for treatment by scaling and root planing (SRP) of periodontal disease induced in rats.", {"entities": [[137, 156, "DISEASE"]]}], ["Ninety rats were used in the present experiment.", {"entities": []}], ["Periodontal disease was induced in all animals using a cotton thread placed in the left first mandibular molar.", {"entities": [[0, 19, "DISEASE"]]}], ["After 7 days of induction, the bandage was removed and the animals were divided into three groups: 1) NT group (n=30), no treatment; 2) SRP group (n=30): SRP and irrigation with control gel; 3) S group (n=30) - SRP and irrigation with Simvastatin.", {"entities": []}], ["Ten animals from each group were euthanized at 7, 15 and 30 days after treatment.", {"entities": []}], ["Gingival biopsy specimens were processed to analyze the expression of matrix metalloproteinase 8 (MMP-8).", {"entities": []}], ["The mandibles were removed and submitted to radiographic and laboratory processing for histometric analysis.", {"entities": []}], ["The S group showed a significantly lower expression of MMP-8 compared to NT and SRP groups in all experimental periods.", {"entities": []}], ["In the radiographic and histometric analyses between the groups, S group showed a significantly lower bone loss (BL) compared to NT and SRP groups in all experimental periods.", {"entities": []}], ["Within the limits of this study, it can be concluded that locally applied statin was effective as an adjuvant treatment for SRP in rats with induced periodontal disease.", {"entities": [[149, 168, "DISEASE"]]}], ["Sarcoidosis (OMIM 181000) is a multi-systemic granulomatous disorder of unknown origin.", {"entities": [[0, 11, "DISEASE"]]}], ["Despite multiple genome-wide association (GWAS) studies, no major pathogenic pathways have been identified to date.", {"entities": []}], ["To find out relevant sarcoidosis predisposing genes, we searched for de novo and recessive mutations in 3 young probands with sarcoidosis and their healthy parents using a whole-exome sequencing (WES) methodology.", {"entities": [[21, 32, "DISEASE"], [126, 137, "DISEASE"]]}], ["From the SARCFAM project based on a national network collecting familial cases of sarcoidosis, we selected three families (trios) in which a child, despite healthy parents, develop the disease before age 15\u00a0yr. Each trio was genotyped by WES (Illumina HiSEQ 2500) and we selected the gene variants segregating as 1) new mutations only occurring in affected children and 2) as recessive traits transmitted from each parents.", {"entities": [[82, 93, "DISEASE"]]}], ["The identified coding variants were compared between the three families.", {"entities": []}], ["Allelic frequencies and in silico functional results were analyzed using ExAC, SIFT and Polyphenv2 databases.", {"entities": []}], ["The clinical and genetic studies were registered by the ClinicalTrials.gov - Protocol Registration and Results System (PRS)\u00a0( https://clinicaltrials.gov ) receipt under the reference NCT02829853 and has been approved by the ethical committee (CPP LYON SUD EST \u2013 2 \u2013 REF IRB 00009118 \u2013 September 21, 2016).", {"entities": []}], ["We identified 37 genes sharing coding variants occurring either as recessive mutations in at least 2 trios or de novo mutations in one of the three affected children.", {"entities": []}], ["The genes were classified according to their potential roles in immunity related pathways: 9 to autophagy and intracellular trafficking, 6 to G-proteins regulation, 4 to T-cell activation, 4 to cell cycle and immune synapse, 2 to innate immunity.", {"entities": []}], ["Ten of the 37 genes were studied in a bibliographic way to evaluate the functional link with sarcoidosis.", {"entities": [[93, 104, "DISEASE"]]}], ["Whole exome analysis of case-parent trios is useful for the identification of genes predisposing to complex genetic diseases as sarcoidosis.", {"entities": [[128, 139, "DISEASE"]]}], ["Our data identified 37 genes that could be putatively linked to a pediatric form of sarcoidosis in three trios.", {"entities": [[84, 95, "DISEASE"]]}], ["Our in-depth focus on 10 of these 37 genes may suggest that the formation of the characteristic lesion in sarcoidosis, granuloma, results from combined deficits in autophagy and intracellular trafficking (ex: Sec16A, AP5B1 and RREB1), G-proteins regulation (ex: OBSCN, CTTND2 and DNAH11), T-cell activation (ex: IDO2, IGSF3), mitosis and/or immune synapse (ex: SPICE1 and KNL1).", {"entities": [[106, 117, "DISEASE"], [209, 215, "GENE"], [227, 232, "GENE"], [262, 267, "GENE"], [280, 286, "GENE"], [318, 323, "GENE"]]}], ["The significance of these findings needs to be confirmed by functional tests on selected gene variants.", {"entities": []}], ["The online version of this article (10.1186/s12920-018-0338-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dichlorodiphenyldichloroethylene ( p , p \u2032-DDE), the most persistent metabolite of dichlorodiphenyltrichloroethane (DDT), is still present in the human population.", {"entities": []}], ["Both are present in the bone marrow of patients with bone marrow disorders, but thus far there are no studies that assess the capability of p , p \u2032-DDE to affect myeloid cells.", {"entities": []}], ["The aim of this study was to determine the effect of p , p \u2032-DDE on promyelocytic cell differentiation and intracellular pathways related to this event.", {"entities": []}], ["p , p \u2032-DDE induced morphological changes compatible with promyelocytic differentiation in a concentration-dependent manner.", {"entities": []}], ["The p , p \u2032-DDE effect on [Ca i , C/EBP \u03b2 protein levels, PKC \u03b1 and p38 activation, and the role of oxidative stress or PLA2 was assayed.", {"entities": []}], ["Exposure to 1.9\u2009 \u03bc g/mL of p , p \u2032-DDE increased [Ca i , PKC \u03b1 , p38, and C/EBP \u03b2 protein levels; the increase of nuclear C/EBP \u03b2 protein was dependent on p38.", {"entities": []}], ["PKC \u03b1 phosphorylation was dependent on PLA2 and p , p \u2032-DDE-induced oxidative stress.", {"entities": []}], ["p38 phosphorylation induced by p , p \u2032-DDE was dependent on PLA2, PKC activation, and oxidative stress.", {"entities": []}], ["These effects of p , p \u2032-DDE at concentrations found in human bone marrow may induce alterations in immature myeloid cells and could affect their cellular homeostasis.", {"entities": []}], ["In order to establish the risk from exposure to p , p \u2032-DDE on the development of bone marrow disorders in humans, these effects deserve further study.", {"entities": []}], ["A nebulized formulation of formoterol, Perforomist 1 peak, AUC 0\u201312 , and trough levels similar to FA.", {"entities": []}], ["No loss of efficacy, tachyphylaxis, was observed over 12 weeks of regular administration.", {"entities": []}], ["In placebo-controlled studies in COPD patients receiving maintenance tiotropium, the addition of FFIS significantly augmented bronchodilation over the 6-week treatment duration, signifying that nebulized formoterol can further improve lung function in patients who are receiving tiotropium without an observed increase in adverse reactions.", {"entities": []}], ["The safety profile of FFIS during 12-week and 1-year studies revealed adverse events that were similar to those of placebo and FA.", {"entities": []}], ["Cardiac rhythm studies, including frequent ECGs and Holter monitoring, did not indicate any increase in rate or rhythm disturbances greater than placebo or FA.", {"entities": []}], ["We conclude that maintenance use of Perforomist", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients.", {"entities": []}], ["Since there is no cure, the goal of treating COPD is to maintain or improve quality of life.", {"entities": []}], ["We have developed a new tool, the Assessment of Burden of COPD (ABC) tool, to assess and visualize the integrated health status of patients with COPD, and to provide patients and healthcare providers with a treatment algorithm.", {"entities": []}], ["This tool may be used during consultations to monitor the burden of COPD and to adjust treatment if necessary.", {"entities": []}], ["The aim of the current study is to analyse the effectiveness of the ABC tool compared with usual care on health related quality of life among COPD patients over a period of 18\u00a0months.", {"entities": []}], ["A cluster randomised controlled trial will be conducted in COPD patients in both primary and secondary care throughout the Netherlands.", {"entities": []}], ["An intervention group, receiving care based on the ABC tool, will be compared with a control group receiving usual care.", {"entities": []}], ["The primary outcome will be the change in score on a disease-specific-quality-of-life questionnaire, the Saint George Respiratory Questionnaire.", {"entities": []}], ["Secondary outcomes will be a different questionnaire (the COPD Assessment Test), lung function and number of exacerbations.", {"entities": []}], ["During the 18\u00a0months follow-up, seven measurements will be conducted, including a baseline and final measurement.", {"entities": []}], ["Patients will receive questionnaires to be completed at home.", {"entities": []}], ["Additional data, such as number of exacerbations, will be recorded by the patients\u2019 healthcare providers.", {"entities": []}], ["A total of 360 patients will be recruited by 40 general practitioners and 20 pulmonologists.", {"entities": []}], ["Additionally, a process evaluation will be performed among patients and healthcare providers.", {"entities": []}], ["The new ABC tool complies with the 2014 Global Initiative for Chronic Obstructive Lung Disease guidelines, which describe the necessity to classify patients on both their airway obstruction and a comprehensive symptom assessment.", {"entities": []}], ["It has been developed to classify patients, but also to provide visual insight into the burden of COPD and to provide treatment advice.", {"entities": []}], ["Netherlands Trial Register, NTR3788 .", {"entities": []}], ["Gram-positive bacteria are important nosocomial pathogens.", {"entities": []}], ["The objective of this study was to estimate the frequencies and resistance rates of gram-positive pathogens isolated from hospitals in Makkah, Saudi Arabia.", {"entities": []}], ["Prospective study at three Makkah hospitals from May 2008 to April 2009.", {"entities": []}], ["Clinical isolates were collected and demographic and laboratory data were recorded.", {"entities": []}], ["Standard microbiological methods were used to identify the organisms and test for antimicrobial susceptibility.", {"entities": []}], ["The results were interpreted according to the Clinical Laboratory Standards Institute (CLSI) guidelines.", {"entities": []}], ["Clinical isolates were collected from 1087 patients.", {"entities": []}], ["Gram-positive pathogens infected all age groups, but had no gender predominance.", {"entities": []}], ["Staphylococcus aureus was the most common cause of wound infection and accounted for more than half of the clinical isolates (688 cases).", {"entities": []}], ["Coagulase-negative staphylococcus (CONS) was a common isolate from blood cultures.", {"entities": []}], ["Wounds were the most common site of infection (37.6%).", {"entities": []}], ["Enterococcus spp .", {"entities": []}], ["and Streptococcus agalactiae were the second most common bacteria (26%).", {"entities": []}], ["The resistance rates of S aureus and CONS isolates were 39.4% and 82.4% for oxacillin, respectively.", {"entities": []}], ["Among the streptococci, the resistance rates of Streptococcus pneumoniae were 21.1% and 16.7% for ampicillin and erythromycin, respectively.", {"entities": []}], ["S aureus infections were found to be very common in the Makkah hospitals.", {"entities": []}], ["Infection prevention, control measures and continuous monitoring for antibiotic susceptibility are necessary to reduce these and other nosocomial infections.", {"entities": []}], ["Allergic rhinitis is a global health problem that is often treated with homeopathy.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["The objective of this review will be to evaluate the effectiveness of homeopathic treatment of allergic rhinitis.", {"entities": [[95, 112, "DISEASE"], [104, 112, "DISEASE"]]}], ["The authors will conduct a systematic review.", {"entities": []}], ["We will search Medline, CENTRAL, CINAHL, EMBASE, AMED, CAM-Quest, Google Scholar and reference lists of identified studies up to December 2013.", {"entities": []}], ["The review will include randomized controlled trials that evaluate homeopathic treatment of allergic rhinitis.", {"entities": [[92, 109, "DISEASE"], [101, 109, "DISEASE"]]}], ["Studies with participants of all ages, with acute or chronic comorbidities will be included.", {"entities": []}], ["Patients with immunodeficiency will not be included.", {"entities": []}], ["The diagnosis will be based on the published guidelines of diagnosis and classification.", {"entities": []}], ["Studies of all homeopathy modalities (clinical, complex and classical homeopathy, and isopathy) will be included.", {"entities": []}], ["We will include trials with both active controls (conventional therapy, standard care) and placebo controls.", {"entities": []}], ["The primary outcomes are: an improvement of global symptoms recorded in validated daily or weekly diaries and any scores from validated visual analogue scales; the total Quality of Life Score (such as the Juniper RQLQ);individual symptoms scores which include any appropriate measures of nasal obstruction, runny nose, sneezing, itching, and eye symptoms; and number of days requiring medication.", {"entities": []}], ["Secondary outcomes selected will include serum immunoglobin E (IgE) levels, individual ocular symptoms, adverse events, and the use of rescue medication.", {"entities": []}], ["Treatment effects will be measured by calculating the mean difference and the standardized mean difference with 95% confidence interval (CI) for continuous data.", {"entities": []}], ["Risk ratio or, if feasible, odds ratio will be calculated with 95% CI for dichotomous data.", {"entities": []}], ["After assessing clinical and statistical heterogeneity, meta-analysis will be performed, if appropriate.", {"entities": []}], ["The individual participant will be the unit of analysis.", {"entities": []}], ["Descriptive information on missing data will be included about participants missing due to drop out, whether there was intention to treat or per protocol analysis and missing statistics.", {"entities": []}], ["A number of subgroups, homeopathic potency, age groups, and types of allergic rhinitis (seasonal or perennial) will be analyzed.", {"entities": [[69, 86, "DISEASE"], [78, 86, "DISEASE"]]}], ["Sensitivity analysis will be performed to explore the impact of risk of bias on overall treatment effect.", {"entities": []}], ["PROSPERO CRD42013006741", {"entities": []}], ["Background .", {"entities": []}], ["Macrolides have received considerable attention for their anti-inflammatory and immunomodulatory actions beyond the antibacterial effect.", {"entities": []}], ["These two properties may ensure some efficacy in a wide spectrum of respiratory viral infections.", {"entities": []}], ["We aimed to summarize the properties of macrolides and their efficacy in a range of respiratory viral infection.", {"entities": []}], ["A search of electronic journal articles through PubMed was performed using combinations of the following keywords including macrolides and respiratory viral infection.", {"entities": []}], ["Both in vitro and in vivo studies have provided evidence of their efficacy in respiratory viral infections including rhinovirus (RV), respiratory syncytial virus (RSV), and influenza virus.", {"entities": [[173, 182, "DISEASE"]]}], ["Much data showed that macrolides reduced viral titers of RV ICAM-1, which is the receptor for RV, and RV infection-induced cytokines including IL-1 \u03b2 , IL-6, IL-8, and TNF- \u03b1 .", {"entities": []}], ["Macrolides also reduced the release of proinflammatory cytokines which were induced by RSV infection, viral titers, RNA of RSV replication, and the susceptibility to RSV infection partly through the reduced expression of activated RhoA which is an RSV receptor.", {"entities": [[231, 235, "GENE"]]}], ["Similar effects of macrolides on the influenza virus infection and augmentation of the IL-12 by macrolides which is essential in reducing virus yield were revealed.", {"entities": [[37, 46, "DISEASE"]]}], ["Conclusion .", {"entities": []}], ["This paper provides an overview on the properties of macrolides and their efficacy in various respiratory diseases.", {"entities": []}], ["Endogenous cannabinoids [endocannabinoids] are lipid signaling molecules that have been shown to modulate immune functions.", {"entities": []}], ["However, their role in the regulation of Th17 cells has not been studied previously.", {"entities": []}], ["In the current study, we used methylated Bovine Serum Albumin [mBSA]-induced delayed type hypersensitivity [DTH] response in C57BL/6 mice, mediated by Th17 cells, as a model to test the anti-inflammatory effects of endocannabinoids.", {"entities": []}], ["Administration of anandamide [AEA], a member of the endocannabinoid family, into mice resulted in significant mitigation of mBSA-induced inflammation, including foot pad swelling, cell infiltration, and cell proliferation in the draining lymph nodes [LN].", {"entities": []}], ["AEA treatment significantly reduced IL-17 and IFN-\u03b3 production, as well as decreased ROR\u03b3t expression while causing significant induction of IL-10 in the draining LNs.", {"entities": []}], ["IL-10 was critical for the AEA-induced mitigation of DTH response inasmuch as neutralization of IL-10 reversed the effects of AEA.", {"entities": []}], ["We next analyzed miRNA from the LN cells and found that 100 out of 609 miRNA species were differentially regulated in AEA-treated mice when compared to controls.", {"entities": []}], ["Several of these miRNAs targeted proinflammatory mediators.", {"entities": []}], ["Interestingly, many of these miRNA were also upregulated upon in vitro treatment of LN cells with IL-10.", {"entities": []}], ["Together, the current study demonstrates that AEA may suppress Th-17 cell\u2013mediated DTH response by inducing IL-10 which in turn triggers miRNA that target proinflammatory pathways.", {"entities": []}], ["Participatory research (PR) is the co-construction of research through partnerships between researchers and people affected by and/or responsible for action on the issues under study.", {"entities": []}], ["Evaluating the benefits of PR is challenging for a number of reasons: the research topics, methods, and study designs are heterogeneous; the extent of collaborative involvement may vary over the duration of a project and from one project to the next; and partnership activities may generate a complex array of both short- and long-term outcomes.", {"entities": []}], ["Our review team consisted of a collaboration among researchers and decision makers in public health, research funding, ethics review, and community-engaged scholarship.", {"entities": []}], ["We identified, selected, and appraised a large-variety sample of primary studies describing PR partnerships, and in each stage, two team members independently reviewed and coded the literature.", {"entities": []}], ["We used key realist review concepts (middle-range theory, demi-regularity, and context-mechanism-outcome configurations [CMO]) to analyze and synthesize the data, using the PR partnership as the main unit of analysis.", {"entities": []}], ["From 7,167 abstracts and 591 full-text papers, we distilled for synthesis a final sample of twenty-three PR partnerships described in 276 publications.", {"entities": []}], ["The link between process and outcome in these partnerships was best explained using the middle-range theory of partnership synergy, which demonstrates how PR can (1) ensure culturally and logistically appropriate research, (2) enhance recruitment capacity, (3) generate professional capacity and competence in stakeholder groups, (4) result in productive conflicts followed by useful negotiation, (5) increase the quality of outputs and outcomes over time, (6) increase the sustainability of project goals beyond funded time frames and during gaps in external funding, and (7) create system changes and new unanticipated projects and activities.", {"entities": []}], ["Negative examples illustrated why these outcomes were not a guaranteed product of PR partnerships but were contingent on key aspects of context.", {"entities": []}], ["We used a realist approach to embrace the heterogeneity and complexity of the PR literature.", {"entities": []}], ["This theory-driven synthesis identified mechanisms by which PR may add value to the research process.", {"entities": []}], ["Using the middle-range theory of partnership synergy, our review confirmed findings from previous PR reviews, documented and explained some negative outcomes, and generated new insights into the benefits of PR regarding conflicts and negotiation between stakeholders, program sustainability and advancement, unanticipated project activity, and the generation of systemic change.", {"entities": []}], ["Rhinovirus infection is associated with the majority of asthma exacerbations.", {"entities": [[56, 62, "DISEASE"]]}], ["The role of fractalkine in anti-viral (type 1) and pathogenic (type 2) responses to rhinovirus infection in allergic asthma is unknown.", {"entities": [[108, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["To determine whether (1) fractalkine is produced in airway cells and in peripheral blood leucocytes, (2) rhinovirus infection increases production of fractalkine and (3) levels of fractalkine differ in asthmatic compared to non-asthmatic subjects.", {"entities": []}], ["Fractalkine protein and mRNA levels were measured in bronchoalveolar lavage (BAL) cells and peripheral blood mononuclear cells (PBMCs) from non-asthmatic controls (n = 15) and mild allergic asthmatic (n = 15) subjects.", {"entities": []}], ["Protein levels of fractalkine were also measured in macrophages polarised ex vivo to give M1 (type 1) and M2 (type 2) macrophages and in BAL fluid obtained from mild (n = 11) and moderate (n = 14) allergic asthmatic and non-asthmatic control (n = 10) subjects pre and post in vivo rhinovirus infection.", {"entities": []}], ["BAL cells produced significantly greater levels of fractalkine than PBMCs.", {"entities": []}], ["Rhinovirus infection increased production of fractalkine by BAL cells from non-asthmatic controls ( P <0.01) and in M1-polarised macrophages ( P <0.05), but not in BAL cells from mild asthmatics or in M2 polarised macrophages.", {"entities": []}], ["Rhinovirus induced fractalkine in PBMCs from asthmatic ( P <0.001) and healthy control subjects ( P <0.05).", {"entities": []}], ["Trends towards induction of fractalkine in moderate asthmatic subjects during in vivo rhinovirus infection failed to reach statistical significance.", {"entities": []}], ["Fractalkine may be involved in both immunopathological and anti-viral immune responses to rhinovirus infection.", {"entities": []}], ["Further investigation into how fractalkine is regulated across different cell types and into the effect of stimulation including rhinovirus infection is warranted to better understand the precise role of this unique dual adhesion factor and chemokine in immune cell recruitment.", {"entities": []}], ["Although erythropoietin has been used for decades in the treatment of anemia, data regarding endogenous levels in the general population are scarce.", {"entities": [[70, 76, "DISEASE"]]}], ["Therefore, we determined erythropoietin reference ranges and its clinical, biochemical and genetic associations in the general population.", {"entities": []}], ["We used data from 6,777 subjects enrolled in the Prevention of REnal and Vascular ENd-stage Disease (PREVEND) study.", {"entities": []}], ["Fasting venous blood samples were obtained in the morning from all participants from 2001\u20132003.", {"entities": []}], ["Serum erythropoietin concentrations were measured using a fully automated chemiluminescent enzyme-labeled immunometric assay.", {"entities": []}], ["A genome-wide association study was performed to identify genetic determinants.", {"entities": []}], ["Mean age (\u00b1 SD) was 53 \u00b1 12 years and 50% were female.", {"entities": []}], ["Median (IQR) erythropoietin concentrations were 7.6 (5.8\u20139.9) IU/L in men and 7.9 (6.0\u201310.6) IU/L in women.", {"entities": []}], ["A strong positive correlation was found between erythropoietin and waist circumference, glucose and systolic blood pressure (all P < 0.05).", {"entities": []}], ["In subjects with normal renal function there was a strong exponential relation between hemoglobin and erythropoietin, whereas in renal impairment (eGFR < 60 mL/min/1.73m HBS1L-MYB locus were shown to be related to erythropoietin levels (P < 9x10 We provide age-specific reference ranges for endogenous serum erythropoietin.", {"entities": [[147, 151, "GENE"]]}], ["Erythropoietin levels are positively associated with the components of the metabolic syndrome, except cholesterol.", {"entities": [[85, 93, "DISEASE"]]}], ["We show that even mild renal failure blunts erythropoietin production and propose the HBS1L-MYB locus as a regulator of erythropoietin.", {"entities": []}], ["To provide information of semen quality among normal young Japanese men and indicate the frequency of reduced semen quality.", {"entities": []}], ["Cross-sectional, coordinated studies of Japanese young men included from university areas.", {"entities": []}], ["The men had to be 18\u201324\u2005years, and both the man and his mother had to be born in Japan.", {"entities": []}], ["Background information was obtained from questionnaires.", {"entities": []}], ["Standardised and quality-controlled semen analyses were performed, reproductive hormones analysed centrally and results adjusted for confounding factors.", {"entities": []}], ["Four study centres in Japan (Kawasaki, Osaka, Kanazawa and Nagasaki).", {"entities": []}], ["1559 men, median age 21.1\u2005years, included during 1999\u20132003.", {"entities": []}], ["Semen volume, sperm concentration, total sperm count, sperm motility, sperm morphology and reproductive hormone levels.", {"entities": []}], ["Median sperm concentration was 59 (95% CI 52 to 68) million/ml, and 9% and 31.9% had less than 15 and 40 million/ml, respectively.", {"entities": []}], ["Median percentage of morphologically normal spermatozoa was 9.6 (8.8 to 10.3)%.", {"entities": []}], ["Small, but statistically significant, differences were detected for both semen and reproductive hormone variables between men from the four cities.", {"entities": []}], ["Overall, the semen values were lower than those of a reference population of 792 fertile Japanese men.", {"entities": []}], ["Assuming that the investigated men were representative for young Japanese men, a significant proportion of the population had suboptimal semen quality with reduced fertility potential, and as a group they had lower semen quality than fertile men.", {"entities": []}], ["However, the definitive role\u2014if any\u2014of low semen quality for subfertility and low fertility rates remain to be investigated.", {"entities": []}], ["Blood-brain barrier (BBB) dysfunction/disruption followed by leukocyte infiltration into the brain causes neuroinflammation and contributes to morbidity in multiple sclerosis, encephalitis, traumatic brain injury, and stroke.", {"entities": [[156, 174, "DISEASE"], [176, 188, "DISEASE"]]}], ["The identification of pathways that decreases the inflammatory potential of leukocytes would prevent such injury.", {"entities": []}], ["Poly(ADP-ribose) polymerase 1 (PARP) controls various genes via its interaction with myriad transcription factors.", {"entities": []}], ["Selective PARP inhibitors have appeared lately as potent anti-inflammatory tools.", {"entities": []}], ["Their effects are outside the recognized PARP functions in DNA repair and transcriptional regulation.", {"entities": []}], ["In this study, we explored the idea that selective inhibition of PARP in leukocytes would diminish their engagement of the brain endothelium.", {"entities": []}], ["Cerebral vascular changes and leukocyte-endothelium interactions were surveyed by intravital videomicroscopy utilizing a novel in vivo model of localized aseptic meningitis when TNF\u03b1 was introduced intracerebrally in wild-type (PARP PARP suppression in monocytes diminished their adhesion to and migration across BBB in vitro models and prevented barrier injury.", {"entities": [[154, 172, "DISEASE"], [162, 172, "DISEASE"]]}], ["In monocytes, PARP inactivation decreased conformational activation of integrins that plays a key role in their tissue infiltration.", {"entities": []}], ["Such changes were mediated by suppression of activation of small Rho GTPases and cytoskeletal rearrangements in monocytes.", {"entities": []}], ["In vitro observations were confirmed in vivo showing diminished leukocyte-endothelial interaction after selective PARP suppression in leukocytes accompanied by BBB protection.", {"entities": []}], ["PARP knockout animals demonstrated a substantial diminution of inflammatory responses in brain microvasculature and a decrease in BBB permeability.", {"entities": []}], ["These results suggest PARP inhibition in leukocytes as a novel approach to BBB protection in the setting of endothelial dysfunction caused by inflammation-induced leukocyte engagement.", {"entities": []}], ["The online version of this article (doi:10.1186/s12974-016-0729-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Damp and mould in homes have been established as risk factors for respiratory health.", {"entities": []}], ["There is a need for a relatively straightforward assessment of the home that quantifies this risk.", {"entities": []}], ["Using data from 891 New Zealand houses, the utility of a Respiratory Hazard Index quantifying key attributes related to damp and mould was tested by studying its associations with self-reported respiratory symptoms.", {"entities": []}], ["A dose\u2013response relationship was found whereby each unit increase in the Respiratory Hazard Index was associated with an 11% increase in the odds of at least one episode of wheezing/whistling in the chest over the last 12\u2009months (relative odds of 1.11 with a 95% CI 1.04%\u20131.20%).", {"entities": []}], ["An 11% increase in the odds of an asthma attack over the last 12\u2009months was estimated (relative odds of 1.11 with a 95% CI 1.01%\u20131.22%).", {"entities": [[34, 40, "DISEASE"]]}], ["These estimates were adjusted for household crowding levels, age, sex and smoking status.", {"entities": []}], ["There was suggestive evidence of more steeply increasing odds of respiratory symptoms with increasing levels of the Respiratory Hazard Index for children aged under 7.", {"entities": []}], ["In the worst performing houses according to the Index, a 33% reduction in the number of people experiencing respiratory symptoms (relative risk 0.67 with 95% CI 0.53 to 0.85) could be expected if people were housed in the best performing houses.", {"entities": []}], ["This study showed that increased evidence of housing conditions supporting dampness and mould was associated with increased odds of respiratory symptoms.", {"entities": []}], ["A valid housing assessment tool can provide a rational basis for investment in improved housing quality to improve respiratory health.", {"entities": []}], ["The blood and lymphatic vasculature play an important role in skin homeostasis.", {"entities": []}], ["Angiogenesis and lymphangiogenesis \u2013 the growth of new vessels from existing ones - have received tremendous interest because of their role in promoting cancer spread.", {"entities": [[153, 159, "DISEASE"]]}], ["However, there is increasing evidence that both vessel types also play a major role in acute and chronic inflammatory disorders.", {"entities": []}], ["Vessels change their phenotype in inflammation (vascular remodeling).", {"entities": []}], ["In inflamed skin, vascular remodeling consists of a hyperpermeable, enlarged network of vessels with increased blood flow, and influx of inflammatory cells.", {"entities": []}], ["During chronic inflammation, the activated endothelium expresses adhesion molecules, cytokines, and other molecules that lead to leukocyte rolling, attachment and migration into the skin.", {"entities": []}], ["Recent studies reveal that inhibition of blood vessel activation exerts potent anti-inflammatory properties.", {"entities": []}], ["Thus, anti-angiogenic drugs might be used to treat inflammatory conditions.", {"entities": []}], ["In particular, topical application of anti-angiogenic drugs might be ideally suited to circumvent the adverse effects of systemic therapy with angiogenesis inhibitors.", {"entities": []}], ["Our recent results indicate that stimulation of lymphatic vessel growth and function unexpectedly represents a novel approach for treating chronic inflammatory disorders.", {"entities": []}], ["IL-4 and IL-13 play a critical yet poorly understood role in orchestrating the recruitment and activation of effector cells of the asthmatic response and driving the pathophysiology of allergic asthma.", {"entities": [[185, 200, "DISEASE"], [194, 200, "DISEASE"]]}], ["The house dust mite (HDM) sheep asthma model displays many features of the human condition and is an ideal model to further elucidate the involvement of these critical Th 2 cytokines.", {"entities": [[32, 38, "DISEASE"]]}], ["We hypothesized that airway exposure to HDM allergen would induce or elevate the expression profile of IL-4 and IL-13 during the allergic airway response in this large animal model of asthma.", {"entities": [[184, 190, "DISEASE"]]}], ["Bronchoalveolar lavage (BAL) samples were collected from saline-\u00a0and house dust mite (HDM)-\u00a0challenged lung lobes of sensitized sheep from 0 to 48\u00a0h post-challenge.", {"entities": []}], ["BAL cytokines (IL-4, IL-13, IL-6, IL-10, TNF-\u03b1) were each measured by ELISA.", {"entities": []}], ["IL-4 and IL-13 expression was assessed in BAL leukocytes by flow cytometry and in airway tissue sections by immunohistology.", {"entities": []}], ["IL-4 and IL-13 were increased in BAL samples following airway allergen challenge.", {"entities": []}], ["HDM challenge resulted in a significant increase in BAL IL-4 levels at 4\u00a0h compared to saline-challenged airways, while BAL IL-13 levels were elevated at all time-points after allergen challenge.", {"entities": []}], ["IL-6 levels were maintained following HDM challenge but declined after saline challenge, while HDM administration resulted in an acute elevation in IL-10 at 4\u00a0h but no change in TNF-\u03b1 levels over time.", {"entities": []}], ["Lymphocytes were the main early source of IL-4, with IL-4 release by alveolar macrophages (AMs) prominent from 24\u00a0h post-allergen challenge.", {"entities": []}], ["IL-13 producing AMs were increased at 4 and 24\u00a0h following HDM compared to saline challenge, and tissue staining provided evidence of IL-13 expression in airway epithelium as well as immune cells in airway tissue.", {"entities": []}], ["In a sheep model of allergic asthma, airway inflammation is accompanied by the temporal release of key cytokines following allergen exposure that primarily reflects the Th 2 -driven nature of the immune response in asthma.", {"entities": [[20, 35, "DISEASE"], [29, 35, "DISEASE"], [215, 221, "DISEASE"]]}], ["The present study demonstrates for the first time the involvement of IL-4 and IL-13 in a relevant large animal model of allergic airways disease.", {"entities": []}], ["Although the mechanisms of airborne particulate matter (PM) related health effects remain incompletely understood, one emerging hypothesis is that these adverse effects derive from oxidative stress, initiated by the formation of reactive oxygen species (ROS) within affected cells.", {"entities": []}], ["Typically, ROS are formed in cells through the reduction of oxygen by biological reducing agents, with the catalytic assistance of electron transfer enzymes and redox active chemical species such as redox active organic chemicals and metals.", {"entities": []}], ["The purpose of this study was to relate the electron transfer ability, or redox activity, of the PM samples to their content in polycyclic aromatic hydrocarbons and various inorganic species.", {"entities": []}], ["The redox activity of the samples has been shown to correlate with the induction of the stress protein, hemeoxygenase-1.", {"entities": []}], ["Size-fractionated (i.e.", {"entities": []}], ["< 0.15; < 2.5 and 2.5 \u2013 10 \u03bcm in diameter) ambient PM samples were collected from four different locations in the period from June 2003 to July 2005, and were chemically analyzed for elemental and organic carbon, ions, elements and trace metals and polycyclic aromatic hydrocarbons.", {"entities": []}], ["The redox activity of the samples was evaluated by means of the dithiothreitol activity assay and was related to their chemical speciation by means of correlation analysis.", {"entities": []}], ["Our analysis indicated a higher redox activity on a per PM mass basis for ultrafine (< 0.15 \u03bcm) particles compared to those of larger sizes.", {"entities": []}], ["The PM redox activity was highly correlated with the organic carbon (OC) content of PM as well as the mass fractions of species such as polycyclic aromatic hydrocarbons (PAH), and selected metals.", {"entities": []}], ["The results of this work demonstrate the utility of the dithiothreitol assay for quantitatively assessing the redox potential of airborne particulate matter from a wide range of sources.", {"entities": []}], ["Studies to characterize the redox activity of PM from various sources throughout the Los Angeles basin are currently underway.", {"entities": []}], ["Metoclopramide is the only medication widely used to promote gastrointestinal motility in the USA.", {"entities": []}], ["Despite its appreciable risk of central nervous system complications, it continues to be prescribed to children for chronic use.", {"entities": []}], ["We sought to estimate the prevalence of chronic metoclopramide use among US children and identify the diagnoses that may have prompted this use.", {"entities": []}], ["The US metoclopramide label lists only two indications in adults: symptomatic gastroesophageal reflux (GERD) and diabetic gastroparesis.", {"entities": [[122, 135, "DISEASE"]]}], ["The latter is rare in children so, in examining the indications likely to have prompted chronic metoclopramide use, we focused on GERD.", {"entities": []}], ["From two health services databases representing privately and publically insured children, respectively, we estimated the number of US children who used metoclopramide chronically and identified the diagnoses recorded at approximately the time when the chronic use began.", {"entities": []}], ["We defined chronic use liberally as \u226535\u00a0days\u2019 supply, or conservatively as \u2265130\u00a0days\u2019 supply in a 6-month period.", {"entities": []}], ["For each chronic-use definition, insurance type, and age group, we estimated the proportion of children using metoclopramide chronically.", {"entities": []}], ["We applied these proportions to US population estimates.", {"entities": []}], ["Under the liberal and conservative definitions, respectively, 89,020 and 28,222 US children used metoclopramide chronically.", {"entities": []}], ["In spite of its risk, substantial numbers of US children use metoclopramide chronically for symptoms suggestive of GERD.", {"entities": []}], ["The online version of this article (doi:10.1007/s40272-015-0136-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Severe mental illness (SMI) has considerable excess morbidity and mortality, a proportion of which is explained by cardiovascular diseases, caused in part by antipsychotic (AP) induced QT-related arrhythmias and sudden death by Torsade de Point (TdP).", {"entities": []}], ["The implementation of evidence-based recommendations for cardiac function monitoring might reduce the incidence of these AP-related adverse events.", {"entities": []}], ["To investigate clinicians\u2019 adherence to cardiac function monitoring before and after starting AP, we performed a retrospective assessment of 434 AP-treated SMI patients longitudinally followed-up for 5\u00a0years at an academic community mental health center.", {"entities": []}], ["We classified antipsychotics according to their risk of inducing QT-related arrhythmias and TdP (Center for Research on Therapeutics, University of Arizona).", {"entities": []}], ["We used univariate tests and multinomial or binary logistic regression model for data analysis.", {"entities": []}], ["Univariate and multinomial regression analysis showed that psychiatrists were more likely to perform pre-treatment electrocardiogram (ECG) and electrolyte testing with AP carrying higher cardiovascular risk, but not on the basis of AP pharmacological class.", {"entities": []}], ["Univariate and binomial regression analysis showed that cardiac function parameters (ECG and electrolyte balance) were more frequently monitored during treatment with second generation AP than with first generation AP.", {"entities": []}], ["Our data show the presence of weaknesses in the cardiac function monitoring of AP-treated SMI patients, and might guide future interventions to tackle them.", {"entities": []}], ["Studies suggest that poor physical health might be associated with increased depression and anxiety recurrence.", {"entities": []}], ["The objectives of this study were to determine whether specific chronic diseases and pain characteristics are associated with depression and anxiety recurrence and to examine whether such associations are mediated by subthreshold depressive or anxiety symptoms.", {"entities": []}], ["1122 individuals with remitted depressive or anxiety disorder (Netherlands Study of Depression and Anxiety) were followed up for a period of four years.", {"entities": [[45, 61, "DISEASE"]]}], ["The impact of specific chronic diseases and pain characteristics on recurrence was assessed using Cox regression and mediation analyses.", {"entities": []}], ["Chronic diseases were not associated with recurrence.", {"entities": []}], ["Neck (HR 1.45, p\u2009<\u2009.01), chest (HR 1.65, p\u2009<\u2009.01), abdominal (HR 1.52, p\u2009<\u2009.01) pain, an increase in the number of pain locations (HR 1.10, p\u2009<\u2009.01) and pain severity (HR 1.18, p\u2009=\u2009.01) were associated with an increased risk of depression recurrence but not anxiety.", {"entities": [[6, 8, "GENE"], [32, 34, "GENE"], [62, 64, "GENE"], [131, 133, "GENE"], [168, 170, "GENE"], [6, 8, "GENE"], [32, 34, "GENE"], [62, 64, "GENE"], [131, 133, "GENE"], [168, 170, "GENE"], [6, 8, "GENE"], [32, 34, "GENE"], [62, 64, "GENE"], [131, 133, "GENE"], [168, 170, "GENE"], [6, 8, "GENE"], [32, 34, "GENE"], [62, 64, "GENE"], [131, 133, "GENE"], [168, 170, "GENE"], [6, 8, "GENE"], [32, 34, "GENE"], [62, 64, "GENE"], [131, 133, "GENE"], [168, 170, "GENE"]]}], ["Subthreshold depressive symptoms mediated the associations between pain and depression recurrence.", {"entities": []}], ["Pain, not chronic disease, increases the likelihood of depression recurrence, largely through its association with aggravated subthreshold depressive symptoms.", {"entities": []}], ["These findings support the idea of the existence of a mutually reinforcing mechanism between pain and depression and are indicative of the importance of shedding light on neurobiological links in order to optimize pain and depression management.", {"entities": []}], ["Osteoporosis (OP) increases the risk of bone fractures and other complications, and is thus a major clinical problem.", {"entities": []}], ["In this study, we examined the effect of isopsoralen on the differentiation of bone-derived marrow mesenchymal stem cells (BMSCs) into osteoblasts and adipocytes, as well as bone formation under osteoporotic conditions.", {"entities": []}], ["Primary femoral BMSCs isolated from C57BL/6 mice were used to evaluate the isopsoralen-mediated regulation of the expression of alkaline phosphatase (ALP), osteocalcin (OCN) and runt-related transcription factor 2 (RUNX2) during osteogenesis 2 weeks.", {"entities": [[215, 220, "GENE"]]}], ["We also examined the expression of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and CCAAT/enhancer binding protein \u03b2 (C/EBP\u03b2) under adipogenic conditions for 1 and 2 weeks.", {"entities": []}], ["In addition, ovariectomized (OVX) mice were used to examine the effects of isopsoralen on bone formation for 2 months.", {"entities": []}], ["Finally, mammalian target of rapamycin complex 1 (mTORC1) signaling was examined under osteogenic and adipogenic conditions.", {"entities": []}], ["We found that following treatment with isopsoralen, the expression levels of ALP, OCN and RUNX2 were upregulated, whereas those of PPAR\u03b3 and C/EBP\u03b2 were downregulated.", {"entities": [[90, 95, "GENE"]]}], ["mTORC1 signaling was also inhibited in vitro and in vivo .", {"entities": []}], ["In the OVX mice that were intragastrically administered isopsoralen, bone parameters (trabecular thickness, bone volume/total volume and trabecular number) in the distal femoral metaphysis were significantly increased and the adipocyte number was decreased.", {"entities": []}], ["On the whole, our findings demonstrate that isopsoralen promoted BMSC differentiation into osteoblasts and suppressed differentiation into adipocytes.", {"entities": []}], ["The influence of reoperation on long-term prognosis is unknown.", {"entities": []}], ["In this large population-based cohort study, it was aimed to investigate the influence of a reoperation within 30\u2005days of oesophageal cancer resection on survival even after excluding the initial postoperative period.", {"entities": [[134, 140, "DISEASE"]]}], ["This was a nationwide population-based retrospective cohort study.", {"entities": []}], ["All hospitals performing oesophageal cancer resections during the study period (1987\u20132010) in Sweden.", {"entities": [[37, 43, "DISEASE"]]}], ["Patients operated for oesophageal cancer with curative intent in 1987\u20132010.", {"entities": [[34, 40, "DISEASE"]]}], ["Adjusted HRs of all cause, early and late mortality up to 5\u2005years after reoperation following oesophageal cancer resection.", {"entities": [[106, 112, "DISEASE"]]}], ["Among 1822 included patients, the 200 (11%) who were reoperated had a 27% increased HR of all-cause mortality (adjusted HR 1.27, 95% CI 1.05 to 1.53) and 28% increased HR of disease-specific mortality (adjusted HR 1.28, 95% CI 1.04 to 1.59), compared to those not reoperated.", {"entities": [[84, 86, "GENE"], [120, 122, "GENE"], [168, 170, "GENE"], [211, 213, "GENE"], [84, 86, "GENE"], [120, 122, "GENE"], [168, 170, "GENE"], [211, 213, "GENE"], [84, 86, "GENE"], [120, 122, "GENE"], [168, 170, "GENE"], [211, 213, "GENE"], [84, 86, "GENE"], [120, 122, "GENE"], [168, 170, "GENE"], [211, 213, "GENE"]]}], ["Reoperation for anastomotic insufficiency in particular was followed by an increased mortality (adjusted HR 1.82, 95% CI 1.19 to 2.76).", {"entities": [[105, 107, "GENE"]]}], ["This large and population-based nationwide cohort study shows that reoperation within 30\u2005days after primary oesophageal resection was associated with increased mortality, even after excluding the initial 3\u2005months after surgery.", {"entities": []}], ["This finding stresses the need to consider any actions that might prevent complications and reoperation after oesophageal cancer resection.", {"entities": [[122, 128, "DISEASE"]]}], ["Diets which emphasize intakes of plant-based foods are recommended to reduce disease risk and for promoting healthy weight.", {"entities": []}], ["The aim of this study was to examine the association between fruit, vegetables, pulses and nut intake and body mass index (BMI) across countries in adolescents (13\u201314 years) and children (6\u20137 years).", {"entities": []}], ["Data from the International Study of Asthma and Allergies in Childhood; 77,243 children\u2019s parents and 201,871 adolescents was used to examine the association between dietary intake (Food Frequency Questionnaire) and BMI using general linear models, adjusting for country gross national index.", {"entities": []}], ["Adolescents who consumed fruit, vegetables, pulses and nuts three or more times a week had a lower BMI than the never or occasional group; eating nuts three or more times a week, was associated with a BMI value of 0.274 kg/m p < 0.001).", {"entities": []}], ["Compared to children who never or occasionally reported eating vegetables, those reporting that they ate vegetables three or more times per week had a lower BMI of \u22120.079 kg/m", {"entities": []}], ["In the actively sensitized rabbit eye a sterile inflammation may develop after the introduction of the homologous antigen into the gastrointestinal tract.", {"entities": []}], ["Scales for aiding physicians diagnose gastro-oesophageal reflux disease (GERD) have not been evaluated in terms of their ability to discriminate between troublesome symptoms (TS) and non-troublesome symptoms (NTS).", {"entities": [[209, 212, "GENE"]]}], ["Our objective is to evaluate the ability of the Reflux Disease Questionnaire (RDQ) to identify GERD according to referral of TS, in patients without previous proton pump inhibitor (PPI) treatment and in patients on PPI treatment.", {"entities": []}], ["Patients consulting physicians because of heartburn or acid regurgitation were recruited at 926 primary-care centres in Spain.", {"entities": []}], ["They were asked to complete several questionnaires including the RDQ, and to define which of their symptoms were troublesome.", {"entities": []}], ["Information on drug treatment was collected by the physician.", {"entities": []}], ["We performed a receiver operating characteristic (ROC) curve analysis to ascertain the RDQ's optimum cut-point for identifying TS.", {"entities": []}], ["4574 patients were included, 1887 without PPI and 2596 on PPI treatment.", {"entities": []}], ["Among those without PPI treatment, 1722 reported TS.", {"entities": []}], ["The area under the curve (AUC) was 0.79 for the RDQ, and the optimum RDQ cut-point for identifying TS was 3.18 (sensitivity, 63.2%; specificity, 80.2%).", {"entities": []}], ["A total of 2367 patients on PPI treatment reported TS, and the optimum RDQ cut-off value was 3.06 (sensitivity, 65.4%; specificity, 71.8%).", {"entities": []}], ["An RDQ score higher than 3 shows good sensitivity and specificity for differentiating TS from NTS among patients without PPI or on PPI treatment.", {"entities": [[94, 97, "GENE"]]}], ["The RDQ is useful in primary care for diagnosis of GERD based on the Montreal definition.", {"entities": []}], ["To synthesize the evidence for using interactive digital interventions (IDIs) to support patient self-management of hypertension, and to determine their impact on control and reduction of blood pressure.", {"entities": [[116, 128, "DISEASE"]]}], ["Systematic review with meta-analysis was undertaken with a search performed in MEDLINE, EMBASE, CINAHL, PsycINFO, ERIC, Cochrane Library, DoPHER, TROPHI, Social Science Citation Index and Science Citation Index.", {"entities": []}], ["The population was adults (>18 years) with hypertension, intervention was an IDI and the comparator was usual care.", {"entities": [[43, 55, "DISEASE"]]}], ["Primary outcomes were change in SBP and DBP.", {"entities": [[40, 43, "GENE"]]}], ["Only randomized controlled trials and studies published in journals and in English were eligible.", {"entities": []}], ["Eligible IDIs included interventions accessed through a computer, smartphone or other hand-held device.", {"entities": []}], ["Four out of seven studies showed a significantly greater reduction for intervention compared to usual care for SBP, with no difference found for three.", {"entities": []}], ["Overall, IDIs significantly reduced SBP, with the weighted mean difference being \u22123.74\u200ammHg [95% confidence interval (CI) \u22122.19 to \u22122.58] with no heterogeneity observed (I-squared\u200a=\u200a0.0%, P \u200a=\u200a0.990).", {"entities": []}], ["For DBP, four out of six studies indicated a greater reduction for intervention compared to controls, with no difference found for two.", {"entities": [[4, 7, "GENE"]]}], ["For DBP, a significant reduction of \u22122.37\u200ammHg (95% CI \u22120.40 to \u22124.35) was found, but considerable heterogeneity was noted (I-squared\u200a=\u200a80.1%, P \u200a=\u200a<0.001).", {"entities": [[4, 7, "GENE"]]}], ["IDIs lower both SBP and DBP compared to usual care.", {"entities": [[24, 27, "GENE"]]}], ["Results suggest these findings can be applied to a wide range of healthcare systems and populations.", {"entities": []}], ["However, sustainability and long-term clinical effectiveness of these interventions remain uncertain.", {"entities": []}], ["We used a morphometric and autoradiographic approach to analyze changes in specific cytoplasmic granules and cytoplasmic lipid bodies associated with human lung mast cell degranulation.", {"entities": []}], ["Mast cells were dissociated from lung tissue by enzymatic digestion and were then enriched to purities of up to 99% by countercurrent centrifugation elutriation and recovery from columns containing specific antigen bound to Sepharose 6 MB.", {"entities": [[236, 238, "GENE"]]}], ["Degranulation was induced by goat anti-IgE.", {"entities": []}], ["At various intervals after stimulation, parallel aliquots of cells were recovered for determination of histamine release or were fixed for transmission electron microscopy.", {"entities": []}], ["We found that lipid bodies, electron- dense structures that lack unit membranes, were present in both control and stimulated mast cells.", {"entities": []}], ["Autoradiographic analysis showed that lipid bodies represented the major repository of 3H-label derived from [3H]arachidonic acid taken up from the external milieu.", {"entities": []}], ["By contrast, the specific cytoplasmic granules contained no detectable 3H-label.", {"entities": []}], ["In addition, lipid bodies occurred in intimate association with degranulation channels during mast cell activation, but the total volume of lipid bodies did not change during the 20 min after stimulation with anti-IgE.", {"entities": []}], ["This result stands in striking contrast to the behavior of specific cytoplasmic granules, the great majority of which (77% according to aggregate volume) exhibited ultrastructural alterations during the first 20 min of mast cell activation.", {"entities": []}], ["These observations establish that mast cell cytoplasmic granules and cytoplasmic lipid bodies are distinct organelles that differ in ultrastructure, biochemistry, and behavior during mast cell activation.", {"entities": []}], ["Patients with advanced chronic obstructive pulmonary disease (COPD) have poor quality of life.", {"entities": [[23, 60, "DISEASE"]]}], ["The aim of this study was to assess the effects of proactive palliative care on the well-being of these patients.", {"entities": []}], ["This trial is registered with the Netherlands Trial Register, NTR4037.", {"entities": []}], ["A pragmatic cluster controlled trial (quasi-experimental design) was performed with hospitals as cluster (three intervention and three control) and a pretrial assessment was performed.", {"entities": []}], ["Hospitals were selected for the intervention group based on the presence of a specialized palliative care team (SPCT).", {"entities": []}], ["To control for confounders, a pretrial assessment was performed in which hospitals were compared on baseline characteristics.", {"entities": []}], ["Patients with COPD with poor prognosis were recruited during hospitalization for acute exacerbation.", {"entities": []}], ["All patients received usual care while patients in the intervention group received additional proactive palliative care in monthly meetings with an SPCT.", {"entities": []}], ["Our primary outcome was change in quality of life score after 3 months, which was measured using the St George Respiratory Questionnaire (SGRQ).", {"entities": []}], ["Secondary outcomes were, among others, quality of life at 6, 9 and 12 months; readmissions: survival; and having made advance care planning (ACP) choices.", {"entities": []}], ["All analyses were performed following the principle of intention to treat.", {"entities": []}], ["During the year 2014, 228 patients (90 intervention and 138 control) were recruited and at 3 months, 163 patients (67 intervention and 96 control) completed the SGRQ.", {"entities": []}], ["There was no significant difference in change scores of the SGRQ total at 3 months between groups (\u22120.79 [95% CI, \u22124.61 to 3.34], p =0.70).", {"entities": []}], ["However, patients who received proactive palliative care experienced less impact of their COPD (SGRQ impact subscale) at 6 months (\u22126.22 [\u221211.73 to \u22120.71], p =0.04) and had more often made ACP choices (adjusted odds ratio 3.26 [1.49\u20137.14], p =0.003).", {"entities": []}], ["Other secondary outcomes were not significantly different.", {"entities": []}], ["Proactive palliative care did not improve the overall quality of life of patients with COPD.", {"entities": []}], ["However, patients more often made ACP choices which may lead to better quality of care toward the end of life.", {"entities": []}], ["Screening for prostate cancer (PC) may save lives, but overdiagnosis and overtreatment are serious drawbacks.", {"entities": [[23, 29, "DISEASE"], [14, 29, "DISEASE"], [31, 33, "GENE"]]}], ["We aimed to determine men's preferences for PC screening, and to elicit the trade-offs they make.", {"entities": [[44, 46, "GENE"]]}], ["A discrete choice experiment (DCE) was conducted among a population-based random sample of 1000 elderly men (55\u201375-years-old).", {"entities": []}], ["Trade-offs were quantified with a panel latent class model between five PC screening aspects: risk reduction of PC-related death, screening interval, risk of unnecessary biopsies, risk of unnecessary treatments, and out-of-pocket costs.", {"entities": [[72, 74, "GENE"], [112, 114, "GENE"]]}], ["The response rate was 46% (459/1000).", {"entities": []}], ["Men were willing to trade-off 2.0% (CI: 1.6%\u20132.4%) or 1.8% (CI: 1.3%\u20132.3%) risk reduction of PC-related death to decrease their risk of unnecessary treatment or biopsy with 10%, respectively.", {"entities": []}], ["They were willing to pay \u20ac188 per year (CI: \u20ac141\u2013\u20ac258) to reduce their relative risk of PC-related death with 10%.", {"entities": []}], ["Preference heterogeneity was substantial, with men with higher educational levels having a lower probability to opt for PC screening than men with lower educational levels.", {"entities": [[120, 122, "GENE"]]}], ["Men were willing to trade-off some risk reduction of PC-related death to be relieved of the burden of biopsies or unnecessary treatments.", {"entities": []}], ["Increasing knowledge on overdiagnosis and overtreatment, especially for men with lower educational levels, is warranted to prevent unrealistic expectations from PC screening.", {"entities": [[161, 163, "GENE"]]}], ["In the healthy lung, ventilation is distributed heterogeneously due to factors such as anatomical asymmetry and gravity.", {"entities": []}], ["This ventilation heterogeneity increases pathologically in conditions such as asthma, chronic obstructive lung disease, and cystic fibrosis.", {"entities": [[94, 118, "DISEASE"], [124, 139, "DISEASE"], [78, 84, "DISEASE"], [106, 118, "DISEASE"]]}], ["In chronic heart failure, lung biopsy demonstrates evidence of peripheral lung fibrosis and small airways narrowing and distortion.", {"entities": []}], ["We hypothesized that this would lead to increased ventilation heterogeneity.", {"entities": []}], ["Furthermore, we proposed that rostral fluid shifts when seated patients lie supine would further increase ventilation heterogeneity.", {"entities": []}], ["We recruited 30 ambulatory chronic heart failure patients (57\u00a0\u00b1\u00a010\u00a0years, 83% male, left ventricular ejection fraction 31\u00a0\u00b1\u00a012%) as well as 10 healthy controls (51\u00a0\u00b1\u00a013\u00a0years, 90% male).", {"entities": []}], ["Heart failure patients were clinically euvolemic.", {"entities": []}], ["Subjects underwent measurement of ventilation heterogeneity using the multiple-breath nitrogen washout technique in the seated position, followed by repeat measurements after 5 and 45\u00a0min in the supine position.", {"entities": []}], ["Ventilation heterogeneity was calculated using the lung clearance index (LCI), Sacin and Scond which represent overall, acinar, and small conducting airway function, respectively.", {"entities": []}], ["Lung clearance index (9.6\u00a0\u00b1\u00a01.2 vs. 8.6\u00a0\u00b1\u00a01.4 lung turnovers, P \u00a0=\u00a00.034) and Scond (0.029\u00a0\u00b1\u00a00.014 vs. 0.006\u00a0\u00b1\u00a00.016/L, P \u00a0=\u00a00.007) were higher in the heart failure patients.", {"entities": []}], ["There was no difference in Sacin (0.197\u00a0\u00b1\u00a00.171 vs. 0.125\u00a0\u00b1\u00a00.081/L, P \u00a0=\u00a00.214).", {"entities": []}], ["Measures of ventilation heterogeneity did not change in the supine position.", {"entities": []}], ["This study confirms the presence of peripheral airway pathology in patients with chronic heart failure.", {"entities": []}], ["This leads to subtle but detectable functional abnormalities which do not change after 45\u00a0min in the supine position.", {"entities": []}], ["The objective of our study was to evaluate the impact of sex and age on the prevalence of sensitization to inhalant allergens.", {"entities": []}], ["The study was performed as a part of Polish Epidemiology of Allergic Diseases study, and data concerning citizens of Wroclaw were analyzed.", {"entities": []}], ["The participants were divided into three age groups (6\u20137, 13\u201314, and 20\u201344\u00a0years) with a subdivision according to sex.", {"entities": []}], ["We randomly selected 1409 individuals, 439 people complied; the complete set of tests was performed on 421 of them.", {"entities": []}], ["We found that 37.7\u00a0% of the study population demonstrated sensitization to at least one of the allergens tested.", {"entities": []}], ["Positive skin tests were found more frequently in males than in females ( p \u00a0=\u00a00.003); among 6\u20137-year-old children, the sensitization was independent of sex ( p \u00a0=\u00a00.26), while in two other groups, it was higher in males ( p \u00a0=\u00a00.002 and p \u00a0=\u00a00.03, respectively).", {"entities": []}], ["Clinically asymptomatic sensitization (AS) was found more often in females than in males ( p \u00a0=\u00a00.04).", {"entities": []}], ["The higher rate of AS in women was observed only in the two younger age groups, while in the 20\u201344-year-old group AS did not differ between the sexes ( p \u00a0=\u00a00.72).", {"entities": []}], ["Female sex hormones may contribute to a later change in the nature of sensitization from clinically asymptomatic to symptomatic.", {"entities": []}], ["Further studies are needed to confirm the results of our study.", {"entities": []}], ["Tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic obstructive pulmonary disease (COPD) patients.", {"entities": [[73, 97, "DISEASE"], [101, 138, "DISEASE"]]}], ["However, its effect on the sympathetic activation response to exercise is unknown.", {"entities": []}], ["This study aimed to determine whether tiotropium use results in a sustained reduction in sympathetic activation during exercise.", {"entities": []}], ["We conducted a 12-week, open-label (treatments: tiotropium 18 \u03bcg or oxitropium 0.2 mg \u00d7 3 mg), crossover study in 17 COPD patients.", {"entities": []}], ["Treatment order was randomized across subjects.", {"entities": []}], ["The subjects underwent a pulmonary function test and two modes of cardiopulmonary exercise (constant work rate and incremental exercise) testing using a cycle ergometer, with measurement of arterial catecholamines after each treatment period.", {"entities": []}], ["Forced expiratory volume in 1 second and forced vital capacity were significantly larger in the tiotropium treatment group.", {"entities": []}], ["In constant exercise testing, exercise endurance time was longer, with improvement in dyspnea during exercise and reduction in dynamic hyperinflation in the tiotropium treatment group.", {"entities": []}], ["Similarly, in incremental exercise testing, exercise time, carbon dioxide production, and minute ventilation at peak exercise were significantly higher in the tiotropium treatment group.", {"entities": []}], ["Plasma norepinephrine concentrations and dyspnea intensity were also lower during submaximal isotime exercise and throughout the incremental workload exercise in the tiotropium treatment group.", {"entities": []}], ["Tiotropium suppressed the increase of sympathetic activation during exercise at the end of the 6-week treatment, as compared with the effect of oxipropium.", {"entities": []}], ["This effect might be attributed to improvement in lung function and exercise capacity and reduction in exertional dyspnea, which were associated with decreases in respiratory frequency and heart rate and reduced progression of arterial acidosis.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease is the third leading cause of death in the US, and is associated with periodic exacerbations, which account for the largest proportion of health care utilization, and lead to significant morbidity, mortality, and worsening lung function.", {"entities": []}], ["A subset of patients with COPD have frequent exacerbations, occurring 2 or more times per year.", {"entities": []}], ["Despite many interventions to reduce COPD exacerbations, there is a significant lack of knowledge in regards to their mechanisms and predisposing factors.", {"entities": []}], ["We describe here an important observation that defines antibody deficiency as a potential risk factor for frequent COPD exacerbations.", {"entities": []}], ["We report a case series of patients who have frequent COPD exacerbations, and who were found to have an underlying primary antibody deficiency syndrome.", {"entities": [[143, 151, "DISEASE"]]}], ["We also report on the outcome of COPD exacerbations following treatment in a subset with of these patients with antibody deficiency.", {"entities": []}], ["We identified patients with COPD who had 2 or more moderate to severe exacerbations per year; immune evaluation including serum immunoglobulin levels and pneumococcal IgG titers was performed.", {"entities": []}], ["Patients diagnosed with an antibody deficiency syndrome were treated with either immunoglobulin replacement therapy or prophylactic antibiotics, and their COPD exacerbations were monitored over time.", {"entities": [[47, 55, "DISEASE"]]}], ["A total of 42 patients were identified who had 2 or more moderate to severe COPD exacerbations per year.", {"entities": []}], ["Twenty-nine patients had an underlying antibody deficiency syndrome: common variable immunodeficiency (8), specific antibody deficiency (20), and selective IgA deficiency (1).", {"entities": [[69, 101, "DISEASE"], [59, 67, "DISEASE"]]}], ["Twenty-two patients had a follow-up for at least 1 year after treatment of their antibody deficiency, which resulted in a significant reduction of COPD exacerbations, courses of oral corticosteroid use and cumulative annual dose of oral corticosteroid use, rescue antibiotic use, and hospitalizations for COPD exacerbations.", {"entities": []}], ["This case series identifies antibody deficiency as a potentially treatable risk factor for frequent COPD exacerbations; testing for antibody deficiency should be considered in difficult to manage frequently exacerbating COPD patients.", {"entities": []}], ["Further prospective studies are warranted to further test this hypothesis.", {"entities": []}], ["Chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cell (CRTh2) receptor antagonists is being investigated for asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["The aim of this study was to assess the effects of the CRTh2 receptor antagonist, AZD1981 (with/without inhaled corticosteroids [ICSs]), on lung function and asthma control.", {"entities": [[158, 164, "DISEASE"]]}], ["Adults aged 18\u201360 years were enrolled in two randomized, placebo-controlled, parallel-group trials (protocol number: D9830C00003 [study 1, n=209] and protocol number: D9830C00004 [study 2, n=510]).", {"entities": []}], ["In study 1, patients with stable asthma (forced expiratory volume in 1 second [FEV 1 ]: 65%\u2212110%) were withdrawn from ICS (<400 \u00b5g/d) and randomized to AZD1981 1,000 mg twice daily (bid) or placebo.", {"entities": [[33, 39, "DISEASE"], [79, 82, "GENE"]]}], ["In study 2, patients with uncontrolled asthma (FEV 1 : 40%\u221285%) despite ICS therapy (\u2265500 \u00b5g/d) were randomized to 50 mg, 400 mg, or 1,000 mg bid AZD1981 or placebo.", {"entities": [[39, 45, "DISEASE"], [47, 50, "GENE"]]}], ["The primary efficacy variable for both trials was the change in morning peak expiratory flow after 4 weeks of treatment.", {"entities": []}], ["Secondary variables included Asthma Control Questionnaire (ACQ-5) scores, FEV 1 assessments, safety, and tolerability.", {"entities": [[29, 35, "DISEASE"], [74, 77, "GENE"]]}], ["In study 2, efficacy was also assessed according to atopic status.", {"entities": []}], ["Following 4 weeks of treatment, there was a nonsignificant increase in morning peak expiratory flow on AZD1981 1,000 mg bid (9.5 L/min vs placebo, P =0.086 [study 1] and 12 L/min vs placebo, P =0.16 [study 2]).", {"entities": []}], ["In study 2, all doses of AZD1981 provided significant improvements in ACQ-5 scores (0.26\u20130.3 units vs placebo, P =0.010\u20130.022); however, there was no dose\u2013response relationship.", {"entities": []}], ["Improved ACQ-5 scores and FEV 1 were observed in the majority of atopic patients treated with AZD1981.", {"entities": [[26, 29, "GENE"]]}], ["AZD1981 was well tolerated across treatment groups.", {"entities": []}], ["Further research may be warranted in atopic patients to fully evaluate the clinical efficacy of AZD1981.", {"entities": []}], ["Chronic airway inflammatory disorders, such as asthma, are characterized by airway inflammation and remodeling.", {"entities": [[47, 53, "DISEASE"]]}], ["Chronic inflammation and damage to the airway epithelium cause airway remodeling, which is associated with improper epithelial repair, and is characterized by elevated expression of transforming growth factor-\u03b2 (TGF-\u03b2).", {"entities": []}], ["Epithelial-mesenchymal transition (EMT) is an important mechanism during embryonic development and tissue remodeling whereby epithelial cells gain the capacity to increase motility by down-regulation of epithelial markers and up-regulation of mesenchymal markers.", {"entities": []}], ["TGF-\u03b2 is a central inducer of EMT, and TGF-\u03b2-induced EMT is enhanced by pro-inflammatory cytokines, including tumor necrosis factor-\u03b1 (TNF-\u03b1) and interleukin-1\u03b2.", {"entities": []}], ["We investigated whether the pro-inflammatory cytokine TWEAK (TNF-like weak inducer of apoptosis) enhanced TGF-\u03b21-induced EMT in the human bronchial epithelial cell line BEAS-2B.", {"entities": []}], ["Quantitative RT-PCR and western blotting were used to define alterations in epithelial and mesenchymal marker expression in BEAS-2B cells.", {"entities": []}], ["The cells were assessed for 48\u00a0h after stimulation with TGF-\u03b21 alone or in combination with TWEAK.", {"entities": []}], ["TGF-\u03b21 induced spindle-like morphology and loss of cell contact, and reduced the expression of epithelial marker E-cadherin and increased the expression of mesenchymal markers N-cadherin and vimentin.", {"entities": []}], ["Our data, for the first time, show that TWEAK reduced the expression of E-cadherin, and that co-treatment with TGF-\u03b21 and TWEAK enhanced the TGF-\u03b21-induced features of EMT.", {"entities": []}], ["Moreover, hyaluronan synthase 2 expression was up-regulated by a combination with TGF-\u03b21 and TWEAK, but not TNF-\u03b1.", {"entities": []}], ["We also demonstrated that the Smad, p38 MAPK, and NF-\u03baB signaling pathways, and the transcriptional repressor ZEB2 might mediate N-cadherin up-regulation by TGF-\u03b21 in combination with TWEAK.", {"entities": [[110, 114, "GENE"]]}], ["These findings suggest that the pro-inflammatory cytokine TWEAK and TGF-\u03b21 have synergistic effects in EMT and may contribute to chronic airway changes and remodeling.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0207-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Medical Priority Dispatch System (MPDS) is a type of Emergency Medical Dispatch (EMD) system used to prioritize 9-1-1 calls and optimize resource allocation.", {"entities": [[81, 84, "GENE"]]}], ["Dispatchers use a series of scripted questions to assign determinants to calls based on chief complaint and acuity.", {"entities": []}], ["We analyzed the prehospital interventions performed on patients with MPDS determinants for breathing problems, chest pain, unknown problem (man down), seizures, fainting (unconscious) and falls for transport status and interventions.", {"entities": []}], ["We matched all prehospital patients in complaint-based categories for breathing problems, chest pain, unknown problem (man down), seizures, fainting (unconscious) and falls from January 1, 2004, to December 31, 2006, with their prehospital record.", {"entities": []}], ["Calls were queried for the following prehospital interventions: Basic Life Support care only, intravenous line placement only, medication given, procedures or non-transport.", {"entities": []}], ["We defined Advanced Life Support (ALS) interventions as the administration of a medication or a procedure.", {"entities": []}], ["Of the 77,394 MPDS calls during this period, 31,318 (40%) patients met inclusion criteria.", {"entities": []}], ["Breathing problems made up 12.2%, chest pain 6%, unknown problem 1.4%, seizures 3%, falls 9% and unconscious/fainting 9% of the total number of MPDS calls.", {"entities": []}], ["Patients with breathing problem had a low rate of procedures (0.7%) and cardiac arrest medications (1.6%) with 38% receiving some medication.", {"entities": []}], ["Chest pain patients had a similar distribution; procedures (0.5%), cardiac arrest medication (1.5%) and any medication (64%).", {"entities": []}], ["Unknown problem: procedures (1%), cardiac arrest medication (1.3%), any medication (18%).", {"entities": []}], ["Patients with Seizures had a low rate of procedures (1.1%) and cardiac arrest medications (0.6%) with 20% receiving some medication.", {"entities": []}], ["Fall patients had a lower rate of severe illness with more medication, mostly morphine: procedures (0.2%), cardiac arrest medication (0.2%), all medications (28%).", {"entities": []}], ["Unconscious/fainting patients received the following interventions: procedures (0.3%), cardiac arrest medication (1.9%), all medications (32%).", {"entities": []}], ["Few stepwise increases in the rate of procedures or medications were seen as determinants increased in acuity.", {"entities": []}], ["Among these common MPDS complaint-based categories, the rates of advanced procedures and cardiac arrest medications were low.", {"entities": []}], ["ALS medications were common in all categories and most determinants.", {"entities": []}], ["Multiple determinants were rarely used and did not show higher rates of interventions with increasing acuity.", {"entities": []}], ["Many MPDS determinants are of modest use to predict ALS intervention.", {"entities": []}], ["Increases in \u03b1-synuclein protein expression are suspected to increase the risk of the development of Parkinson\u2019s disease (PD).", {"entities": []}], ["A recent study has demonstrated that \u03b22-adrenergic receptor (\u03b22AR) agonists decrease histone acetylation in the \u03b1-synuclein gene and suppress transcription.", {"entities": []}], ["Coupled with the anti-inflammatory effects that are associated with \u03b22AR activation, this two-pronged attack holds promise for PD treatment and the development of new therapeutic approaches for this disease.", {"entities": []}], ["The development of functional limitations among adults aged 65 or older has profound effects on individual and population resources.", {"entities": []}], ["Improved understanding of the relationship between functional limitations and co-occurring chronic diseases (multimorbidity) is an emerging area of interest.", {"entities": []}], ["The objective of this study was to investigate the association between multimorbidity and functional limitations among community-dwelling adults 65 or older in the United States and explore factors that modify this association.", {"entities": []}], ["We conducted a cross-sectional analysis of adults aged 65 or older using data from the National Health and Nutrition Examination Survey (NHANES) from 2005 through 2012.", {"entities": []}], ["We used negative binomial regression to estimate the association between multimorbidity (\u22652 concurrent diseases) and functional limitations and to determine whether the association differed by sex or age.", {"entities": []}], ["The prevalence of multimorbidity in this population was 67% (95% confidence interval [CI], 65%\u201368%).", {"entities": []}], ["Each additional chronic condition was associated with an increase in the number of functional limitations, and the association was stronger among those aged 75 or older than among those aged 65 to 74.", {"entities": []}], ["For those aged 65 to 74, each additional chronic condition was associated with 1.35 (95% CI, 1.27\u20131.43) times the number of functional limitations for men and 1.62 times (95% CI, 1.31\u20132.02) the number of functional limitations for women.", {"entities": []}], ["For those 75 or older, the associations increased to 1.71 (95% CI, 1.35\u20132.16) for men and 2.06 (95% CI, 1.51\u20132.81) for women for each additional chronic condition.", {"entities": []}], ["Multimorbidity was associated with increases in functional limitations, and the associations were stronger among women than among men and among adults aged 75 or older than among those aged 65 to 74.", {"entities": []}], ["These findings underscore the importance of addressing age and sex differences when formulating prevention strategies.", {"entities": []}], ["To our knowledge, no meta-analysis to date has assessed the efficacy of mobile phone apps to promote weight loss and increase physical activity.", {"entities": []}], ["To perform a systematic review and meta-analysis of studies to compare the efficacy of mobile phone apps compared with other approaches to promote weight loss and increase physical activity.", {"entities": []}], ["We conducted a systematic review and meta-analysis of relevant studies identified by a search of PubMed, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Scopus from their inception through to August 2015.", {"entities": []}], ["Two members of the study team (EG-F, GF-M) independently screened studies for inclusion criteria and extracted data.", {"entities": []}], ["We included all controlled studies that assessed a mobile phone app intervention with weight-related health measures (ie, body weight, body mass index, or waist circumference) or physical activity outcomes.", {"entities": [[64, 67, "GENE"]]}], ["Net change estimates comparing the intervention group with the control group were pooled across studies using random-effects models.", {"entities": []}], ["We included 12 articles in this systematic review and meta-analysis.", {"entities": []}], ["Compared with the control group, use of a mobile phone app was associated with significant changes in body weight (kg) and body mass index (kg/m Evidence from this study shows that mobile phone app-based interventions may be useful tools for weight loss.", {"entities": [[55, 58, "GENE"], [194, 197, "GENE"]]}], ["The acyclic retinoid, peretinoin, has been shown to be effective for suppressing hepatocellular carcinoma (HCC) recurrence after definitive treatment in a small-scale randomized clinical trial.", {"entities": [[81, 105, "DISEASE"], [96, 105, "DISEASE"]]}], ["However, little has been documented about the mechanism by which peretinoin exerts its inhibitory effects against recurrent HCC in humans in vivo .", {"entities": []}], ["Twelve hepatitis C virus-positive patients whose HCC had been eradicated through curative resection or ablation underwent liver biopsy at baseline and week 8 of treatment with either a daily dose of 300 or 600 mg peretinoin.", {"entities": [[7, 16, "DISEASE"]]}], ["RNA isolated from biopsy samples was subjected to gene expression profile analysis.", {"entities": []}], ["Peretinoin treatment elevated the expression levels of IGFBP6 , RBP1 , PRB4 , CEBPA , G0S2 , TGM2 , GPRC5A, CYP26B1 , and many other retinoid target genes.", {"entities": [[55, 61, "GENE"], [64, 68, "GENE"], [71, 75, "GENE"], [86, 90, "GENE"], [93, 97, "GENE"], [100, 106, "GENE"], [108, 115, "GENE"]]}], ["Elevated expression was also observed for interferon-, Wnt-, and tumor suppressor-related genes.", {"entities": []}], ["By contrast, decreased expression levels were found for mTOR- and tumor progression-related genes.", {"entities": []}], ["Interestingly, gene expression profiles for week 8 of peretinoin treatment could be classified into two groups of recurrence and non-recurrence with a prediction accuracy rate of 79.6% ( P <0.05).", {"entities": []}], ["In the liver of patients with non-recurrence, expression of PDGFC and other angiogenesis genes, cancer stem cell marker genes, and genes related to tumor progression was down-regulated, while expression of genes related to hepatocyte differentiation , tumor suppression genes, and other genes related to apoptosis induction was up-regulated.", {"entities": [[96, 102, "DISEASE"], [60, 65, "GENE"]]}], ["Gene expression profiling at week 8 of peretinoin treatment could successfully predict HCC recurrence within 2 years.", {"entities": []}], ["This study is the first to show the effect of peretinoin in suppressing HCC recurrence in vivo based on gene expression profiles and provides a molecular basis for understanding the efficacy of peretinoin.", {"entities": []}], ["Besides atherosclerosis and lung cancer, smoking is considered to play a major role in the pathogenesis of autoimmune diseases.", {"entities": [[8, 23, "DISEASE"], [28, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["It has long been known that there is a connection between rheumatoid factor-positive rheumatoid arthritis and cigarette smoking.", {"entities": [[85, 105, "DISEASE"], [96, 105, "DISEASE"]]}], ["Recently, an important gene\u2013environment interaction has been revealed; that is, carrying specific HLA-DRB1 alleles encoding the shared epitope and smoking establish a significant risk for anti-citrullinated protein antibody-positive rheumatoid arthritis.", {"entities": [[233, 253, "DISEASE"], [244, 253, "DISEASE"], [98, 106, "GENE"]]}], ["We summarize how smoking-related alteration of the cytokine balance, the increased risk of infections (the possibility of cross-reactivity) and modifications of autoantigens by citrullination may contribute to the development of rheumatoid arthritis.", {"entities": [[229, 249, "DISEASE"], [240, 249, "DISEASE"]]}], ["To explain the use of feedback reports for quality improvements by the reasons to participate in quality measuring projects and to identify barriers and facilitators.", {"entities": []}], ["Mixed methods design.", {"entities": []}], ["In 2009\u20132011 a national audit and feedback system for physical therapy (Qualiphy) was initiated in the Netherlands.", {"entities": []}], ["After each data collection round, an evaluation survey was held amongst its participants.", {"entities": []}], ["The evaluation survey data was used to explain the use of feedback reports by studying the reasons to participate with Qualiphy with correlation measures and logistic regression.", {"entities": []}], ["Semi-structured interviews with PTs served to seek confirmation and disentangle barriers and facilitators.", {"entities": [[32, 35, "GENE"]]}], ["Analysis of 257 surveys (response rate: 42.8%) showed that therapists with only financial reasons were less likely to use feedback reports (OR = 0.24;95%CI = 0.11\u20130.52) compared to therapists with a mixture of reasons.", {"entities": []}], ["PTs in 2009 and 2010 were more likely to use the feedback reports for quality improvement than PTs in 2011 (OR = 2.41;95%CI = 1.25\u20134.64 respectively OR = 3.28;95%CI = 1.51\u20137.10).", {"entities": [[0, 3, "GENE"], [95, 98, "GENE"], [0, 3, "GENE"], [95, 98, "GENE"]]}], ["Changing circumstances in 2011, i.e.", {"entities": []}], ["using EHRs and financial incentives, had a negative effect on the use of feedback reports (OR = 0.40, 95%CI = 0.20\u20130.78).", {"entities": []}], ["Interviews with 12 physical therapists showed that feedback reports could serve as a tool to support and structure quality improvement plans.", {"entities": []}], ["Barriers were distrust and perceived self-reporting bias on indicator scores.", {"entities": []}], ["Implementing financial incentives that are not well-specified and well-targeted can have an adverse effect on using feedback reports to improve quality of care.", {"entities": []}], ["Distrust is a major barrier to implementing quality systems.", {"entities": []}], ["Flight attendants who worked on commercial aircraft before the smoking ban in flights (pre-ban FAs) were exposed to high levels of secondhand smoke (SHS).", {"entities": [[95, 98, "GENE"]]}], ["We previously showed never-smoking pre-ban FAs to have reduced diffusing capacity (Dco) at rest.", {"entities": [[43, 46, "GENE"]]}], ["To determine whether pre-ban FAs increase their Dco and pulmonary blood flow ( ) during exercise, we administered a symptom-limited supine-posture progressively increasing cycle exercise test to determine the maximum work (watts) and oxygen uptake ( ) achieved by FAs.", {"entities": [[29, 32, "GENE"], [264, 267, "GENE"], [29, 32, "GENE"], [264, 267, "GENE"]]}], ["After 30 min rest, we then measured Dco and at 20, 40, 60, and 80 percent of maximum observed work.", {"entities": []}], ["The FAs with abnormal resting Dco achieved a lower level of maximum predicted work and compared to those with normal resting Dco (mean\u00b1SEM; 88.7\u00b12.9 vs. 102.5\u00b13.1%predicted ; p\u200a=\u200a0.001).", {"entities": [[4, 7, "GENE"]]}], ["Exercise limitation was associated with the FAs' FEV 1 (r\u200a=\u200a0.33; p\u200a=\u200a0.003).", {"entities": [[44, 47, "GENE"], [49, 52, "GENE"]]}], ["The Dco increased less with exercise in those with abnormal resting Dco (mean\u00b1SEM: 1.36\u00b10.16 vs. 1.90\u00b10.16 ml/min/mmHg per 20% increase in predicted watts; p\u200a=\u200a0.020), and amongst all FAs, the increase with exercise seemed to be incrementally lower in those with lower resting Dco.", {"entities": [[184, 187, "GENE"]]}], ["Exercise-induced increase in was not different in the two groups.", {"entities": []}], ["However, the FAs with abnormal resting Dco had less augmentation of their Dco with increase in during exercise (mean\u00b1SEM: 0.93\u00b10.06 vs. 1.47\u00b10.09 ml/min/mmHg per L/min; p<0.0001).", {"entities": [[13, 16, "GENE"]]}], ["The Dco during exercise was inversely associated with years of exposure to SHS in those FAs with \u226510 years of pre-ban experience (r\u200a=\u200a\u22120.32; p\u200a=\u200a0.032).", {"entities": [[88, 91, "GENE"]]}], ["This cohort of never-smoking FAs with SHS exposure showed exercise limitation based on their resting Dco.", {"entities": [[29, 32, "GENE"]]}], ["Those with lower resting Dco had reduced pulmonary capillary recruitment.", {"entities": []}], ["Exposure to SHS in the aircraft cabin seemed to be a predictor for lower Dco during exercise.", {"entities": []}], ["Although consumer and community engagement (CCE) in health care is receiving increasing attention, research and practice in this area are hampered by the variability of concepts and terminology commonly employed.", {"entities": []}], ["This scoping meta-review aims to identify key CCE concepts and examine terminology used to describe them.", {"entities": []}], ["In a scoping meta-review, an extensive list of 47 phrases and 11 Medical Subject Headings (MeSH) was used to undertake a comprehensive and systematic search in PubMed Central, Embase, EBM reviews, CINAHL, APAPsycNET, and Scopus.", {"entities": []}], ["59 systematic reviews met the selection criteria and were included in the final analysis.", {"entities": []}], ["The analysis identified nine different concepts related to CCE: shared decision making, self-management, CCE in health care systems, community-based health promotion, providing access to health care, rehabilitation, participation in research, collaboration in research design and conduct, and peer support.", {"entities": []}], ["The identified concepts differ from each other in many aspects including the aim of the activity, the role of consumers and the type of professionals\u2019 involvement.", {"entities": []}], ["Each concept was described by a range of terms, with some terms shared by different concepts.", {"entities": []}], ["In addition, two overlapping concepts of patient-centeredness and patient empowerment were recognised.", {"entities": []}], ["This study describes CCE-related key concepts and provides new insight into their relationship with different CCE-related terms.", {"entities": []}], ["Identification of key CCE-related concepts and terms will be useful to focus future studies and initiatives and enhance production of CCE-related evidence.", {"entities": []}], ["P2X7 receptors, ATP-gated cation channels, are specifically expressed in alveolar epithelial cells.", {"entities": []}], ["The pathophysiological function of this lung cell type, except a recently reported putative involvement in surfactant secretion, is unknown.", {"entities": []}], ["In addition, P2X7 receptor-deficient mice show reduced inflammation and lung fibrosis after exposure with bleomycin.", {"entities": []}], ["To elucidate the role of the P2X7 receptor in alveolar epithelial type I cells we characterized the pulmonary phenotype of P2X7 receptor knockout mice by using immunohistochemistry, western blot analysis and real-time RT PCR.", {"entities": []}], ["No pathomorphological signs of fibrosis were found.", {"entities": []}], ["Results revealed, however, a remarkable loss of aquaporin-5 protein and mRNA in young knockout animals.", {"entities": []}], ["Additional in vitro experiments with bleomycin treated precision cut lung slices showed a greater sensitivity of the P2X7 receptor knockout mice in terms of aquaporin-5 reduction as wild type animals.", {"entities": []}], ["Finally, P2X7 receptor function was examined by using the alveolar epithelial cell lines E10 and MLE-12 for stimulation experiments with bleomycin.", {"entities": []}], ["The in vitro activation of P2X7 receptor was connected with an increase of aquaporin-5, whereas the inhibition of the receptor with oxidized ATP resulted in down regulation of aquaporin-5.", {"entities": []}], ["The early loss of aquaporin-5 which can be found in different pulmonary fibrosis models does not implicate a specific pathogenetic role during fibrogenesis.", {"entities": [[62, 80, "DISEASE"]]}], ["Approximately 40,000 rescue and recovery workers were exposed to caustic dust and toxic pollutants following the 11 September 2001 attacks on the World Trade Center (WTC).", {"entities": []}], ["These workers included traditional first responders, such as firefighters and police, and a diverse population of construction, utility, and public sector workers.", {"entities": []}], ["To characterize WTC-related health effects, the WTC Worker and Volunteer Medical Screening Program was established.", {"entities": []}], ["This multicenter clinical program provides free standardized examinations to responders.", {"entities": []}], ["Examinations include medical, mental health, and exposure assessment questionnaires; physical examinations; spirometry; and chest X rays.", {"entities": []}], ["Of 9,442 responders examined between July 2002 and April 2004, 69% reported new or worsened respiratory symptoms while performing WTC work.", {"entities": []}], ["Symptoms persisted to the time of examination in 59% of these workers.", {"entities": []}], ["Among those who had been asymptomatic before September 11, 61% developed respiratory symptoms while performing WTC work.", {"entities": []}], ["Twenty-eight percent had abnormal spirometry; forced vital capacity (FVC) was low in 21%; and obstruction was present in 5%.", {"entities": []}], ["Among nonsmokers, 27% had abnormal spirometry compared with 13% in the general U.S. population.", {"entities": []}], ["Prevalence of low FVC among nonsmokers was 5-fold greater than in the U.S. population (20% vs. 4%).", {"entities": []}], ["Respiratory symptoms and spirometry abnormalities were significantly associated with early arrival at the site.", {"entities": []}], ["WTC responders had exposure-related increases in respiratory symptoms and pulmonary function test abnormalities that persisted up to 2.5 years after the attacks.", {"entities": []}], ["Long-term medical monitoring is required to track persistence of these abnormalities and identify late effects, including possible malignancies.", {"entities": []}], ["Lessons learned should guide future responses to civil disasters.", {"entities": []}], ["Several studies have shown that prison is characterized by a higher prevalence of chronic diseases than unconfined settings.", {"entities": []}], ["The aim of this study was to describe the characteristics and health of inmates, focusing on internal diseases.", {"entities": []}], ["We designed a specific clinical record using the Python programming language.", {"entities": []}], ["We considered all of the diagnoses according to the ICD-9-CM.", {"entities": []}], ["Of a total of 17,086 inmates, 15,751 were enrolled in our study (M\u2009=\u200914,835; F\u2009=\u2009869), corresponding to 92.2% of the entire inmate population (mean age of 39.6\u00a0years).", {"entities": []}], ["The project involved a total of 57 detention facilities in six Italian regions (for a total of 28% of all detainees in Italy), as counted in a census taken on February 3, 2014.", {"entities": []}], ["From the entire study sample, 32.5% of prisoners did not present any disorders, while 67.5% suffered from at least one disease.", {"entities": []}], ["The most frequent pathologies were psychiatric (41.3%), digestive (14.5%), infectious (11.5%), cardiovascular (11.4%), endocrine, metabolic, and immune (8.6%), and respiratory (5.4%).", {"entities": []}], ["The findings showed that a large number of detainees were affected by several chronic conditions such as hypertension, dyslipidemia and type 2 diabetes mellitus, with an unusually high prevalence for such a young population.", {"entities": [[105, 117, "DISEASE"], [143, 160, "DISEASE"], [136, 160, "DISEASE"]]}], ["Therefore, a series of preventive measures is recommended to strengthen the entire care process and improve the health and living conditions of prisoners.", {"entities": []}], ["Latex from the dandelion species Taraxacum brevicorniculatum contains many high-value isoprenoid end products, e.g.", {"entities": []}], ["triterpenes and polyisoprenes such as natural rubber.", {"entities": []}], ["The isopentenyl pyrophosphate units required as precursors for these isoprenoids are provided by the mevalonate (MVA) pathway.", {"entities": []}], ["The key enzyme in this pathway is 3-hydroxy-methyl-glutaryl-CoA reductase (HMGR) and its activity has been thoroughly characterized in many plant species including dandelion.", {"entities": []}], ["However, two enzymes acting upstream of HMGR have not been characterized in dandelion latex: ATP citrate lyase (ACL), which provides the acetyl-CoA utilized in the MVA pathway, and acetoacetyl-CoA thiolase (AACT), which catalyzes the first step in the pathway to produce acetoacetyl-CoA.", {"entities": []}], ["Here we isolated ACL and AACT genes from T. brevicorniculatum latex and characterized their expression profiles.", {"entities": []}], ["We also overexpressed the well-characterized HMGR , ACL and AACT genes from Arabidopsis thaliana in T. brevicorniculatum to determine their impact on isoprenoid end products in the latex.", {"entities": []}], ["The spatial and temporal expression profiles of T. brevicorniculatum ACL and AACT revealed their pivotal role in the synthesis of precursors necessary for isoprenoid biosynthesis in latex.", {"entities": []}], ["The overexpression of A. thaliana ACL and AACT and HMGR in T. brevicorniculatum latex resulted in the accumulation of all three enzymes, increased the corresponding enzymatic activities and ultimately increased sterol levels by ~5-fold and pentacyclic triterpene and cis -1,4-isoprene levels by ~2-fold.", {"entities": []}], ["Remarkably high levels of the triterpene precursor squalene were also detected in the triple-transgenic lines (up to 32\u00a0mg/g root dry weight) leading to the formation of numerous lipid droplets which were observed in root cross-sections.", {"entities": []}], ["We could show the effective expression of up to three transgenes in T. brevicorniculatum latex which led to increased enzymatic activity and resulted in high level squalene accumulation in the dandelion roots up to an industrially relevant amount.", {"entities": []}], ["Our data provide insight into the regulation of the MVA pathway in dandelion latex and can be used as a basis for metabolic engineering to enhance the production of isoprenoid end products in this specialized tissue.", {"entities": []}], ["The online version of this article (doi:10.1186/s12870-017-1036-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In Western contexts nut consumption is associated with better health.", {"entities": []}], ["We examined the associations of nut consumption with cardiovascular disease risk in the non-Western setting of Southern China.", {"entities": []}], ["In the Guangzhou Biobank Cohort Study we used multivariable linear regression to examine the associations of baseline nut (mainly peanuts) consumption (none (n = 6688), <3 portions/week (n = 2596) and \u22653 portions/week (n = 2444)) with follow-up assessment of Framingham cardiovascular disease score (excluding smoking) and its components in older Chinese (\u226550 years) (follow-up 57.8%).", {"entities": []}], ["Nut consumption was not associated with Framingham score (\u22653 portions/week compared to none: 0.02 95% confidence interval (CI) -0.11 to 0.15), systolic blood pressure (-0.66 mmHg 95% CI -1.94, 0.62), diastolic blood pressure (-0.69 mmHg 95% CI -1.44, 0.07), HDL-cholesterol (-0.01 mmol/L 95% CI -0.02, 0.005), LDL-cholesterol (-0.01 mmol/L 95% CI -0.05, 0.02) or fasting glucose (0.04 mmol/L 95% CI -0.02, 0.09), adjusted for baseline values, energy intake, age, sex, phase of recruitment, socio-economic position, lifestyle and baseline health status.", {"entities": []}], ["Observations concerning the benefits of nut consumption may be contextually specific, perhaps depending on the type of nut consumed.", {"entities": []}], ["Innate immunity is regulated by cholinergic signalling through nicotinic acetylcholine receptors.", {"entities": []}], ["We show here that signalling through the M3 muscarinic acetylcholine receptor (M3R) plays an important role in adaptive immunity to both Nippostrongylus brasiliensis and Salmonella enterica serovar Typhimurium, as M3R N. brasiliensis was severely impaired, with reduced cytokine responses in M3R N. brasiliensis and S. typhimurium with muscarinic agonists resulted in enhanced production of IL-13 and IFN-\u03b3 respectively, which was blocked by an M3R-selective antagonist.", {"entities": []}], ["Our data therefore indicate that cholinergic signalling via the M3R is essential for optimal Th1 and Th2 adaptive immunity to infection.", {"entities": []}], ["Recent data indicate that acetylcholine (ACh), a neurotransmitter which regulates a variety of physiological functions, also influences the immune system, and that lymphocytes have the capacity to synthesise and release ACh, controlling local innate immune responses and suppressing inflammation.", {"entities": []}], ["Thus far however there has been little evidence to suggest that ACh influences adaptive immunity, characterised by activation and effector functions of lymphocytes.", {"entities": []}], ["We show here that during the immune response to two different pathogens, ACh signals through muscarinic receptors, and the M3 receptor subtype specifically, resulting in enhanced activation and cytokine production by \u2018helper\u2019 T lymphocytes which protect the host against infection.", {"entities": []}], ["Depression and anxiety adversely affects outcomes in systemic lupus erythematosus (SLE) and healthcare utilization is high for pediatric SLE.", {"entities": [[62, 81, "DISEASE"], [53, 81, "DISEASE"]]}], ["We aimed to characterize the prevalence of depression and anxiety in pediatric SLE, and their association with healthcare utilization.", {"entities": []}], ["We conducted a cross-sectional analysis of pediatric SLE and mixed connective tissue disease (MCTD) subjects and healthy controls aged 8\u00a0years and above.", {"entities": [[61, 92, "DISEASE"], [67, 92, "DISEASE"]]}], ["We used the Patient Health Questionnaire 9 (PHQ-9) and the Screen for Childhood Anxiety Related Disorders (SCARED) to identify depression, suicidal ideation and anxiety symptoms, respectively.", {"entities": []}], ["We compared symptom prevalence in SLE/MCTD and healthy subjects using logistic regression.", {"entities": []}], ["For SLE/MCTD subjects, we calculated the rate of annual outpatient visits [rheumatology/nephrology, primary care provider (PCP) and emergency department], hospitalizations and rheumatology/nephrology telephone consultations in the preceding year.", {"entities": []}], ["We compared these outcomes in those with and without depression and anxiety using negative binomial regression.", {"entities": []}], ["We identified depression symptoms in 10 (20%) SLE/MCTD and 4 (8%) healthy subjects, representing a trend towards increased prevalence in unadjusted analysis (OR\u2009=\u20092.9, 95% CI 0.8-9.9, p\u2009=\u20090.09).", {"entities": []}], ["Adjusted analysis did not show a significant difference; however, non-white race was a statistically significant independent risk factor for depression symptoms compared to white race (OR\u2009=\u20095.4, 95% CI 1.1-27.2, p\u2009=\u20090.04).", {"entities": []}], ["We identified anxiety symptoms in 11 (22%) SLE/MCTD and 13 (26%) healthy subjects, which was not statistically different.", {"entities": []}], ["Suicidal ideation was present in 7 (14%) SLE/MCTD and 2 (4%) healthy subjects, which was a statistically significant difference (OR\u2009=\u20095.4, 95% CI 1.02-28.3, p\u2009=\u20090.047).", {"entities": []}], ["Of the 34% of SLE/MCTD subjects with any symptoms, only 24% had previous mental health care.", {"entities": []}], ["Those with depression symptoms had a statistically significant lower rate of visits to the PCP (IRR\u2009=\u20090.38, 95% CI 0.19-0.76, p\u2009<\u20090.001).", {"entities": []}], ["Anxiety symptoms were not associated with the healthcare utilization outcomes.", {"entities": []}], ["Depression and anxiety symptoms were prevalent, and suicidal ideation significantly more common in SLE/MCTD than in healthy subjects.", {"entities": []}], ["Non-white race was an independent risk factor for depression.", {"entities": []}], ["Despite prevalent symptoms, there were poor rates of prior mental health treatment, and less frequent PCP visits among those with depression symptoms.", {"entities": []}], ["Further investigation of barriers to mental health care and interventional strategies for symptomatic youth with SLE/MCTD is needed.", {"entities": []}], ["Treatment with sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be efficacious in the MRL/lpr and NZB \u00d7 NZW F1 mouse models of lupus nephritis, indicating a critical role for the mTOR pathway in both models.", {"entities": [[163, 172, "DISEASE"], [59, 63, "GENE"], [209, 213, "GENE"], [59, 63, "GENE"], [209, 213, "GENE"]]}], ["This type of demonstration of efficacy in animal models is usually a pre-requisite for advancement into clinical development.", {"entities": []}], ["However, efficacy in an animal model often has not translated to the desired activity in the clinic.", {"entities": []}], ["Therefore, a more profound understanding of the mechanistic similarities and differences between various animal models and human diseases is highly desirable.", {"entities": []}], ["Transcriptional profiling was performed on kidneys from mice with lupus nephritis; from mice who had efficacious drug treatment; and from mice before they developed nephritis.", {"entities": [[72, 81, "DISEASE"], [165, 174, "DISEASE"]]}], ["Analysis of variance with false discovery rate adjusted to p < 0.05 and an average fold change of two or more was used to identify transcripts significantly associated with disease and response to therapy.", {"entities": []}], ["Pathway analyses (using various bioinformatics tools) were carried out to understand the basis for drug efficacy in the mouse model.", {"entities": []}], ["The relevance in human lupus of the pathways identified in the mouse model was explored using information from several databases derived from the published literature.", {"entities": []}], ["We identified a set of nephritis-associated genes in mouse kidney.", {"entities": [[23, 32, "DISEASE"]]}], ["Expression of the majority of these returned to asymptomatic levels on sirolimus treatment, confirming the correlation between expression levels and symptoms of nephritis.", {"entities": [[161, 170, "DISEASE"]]}], ["Network analysis showed that many of these nephritis genes are known to interact with the mTOR pathway.", {"entities": [[43, 52, "DISEASE"], [90, 94, "GENE"]]}], ["This led us to ask what human diseases are linked to the mTOR pathway.", {"entities": [[57, 61, "GENE"]]}], ["We constructed the mTOR pathway interactome consisting of proteins that interact with members of the mTOR pathway and identified a strong association between mTOR pathway genes and genes reported in the literature as being involved in human lupus.", {"entities": [[19, 23, "GENE"], [101, 105, "GENE"], [158, 162, "GENE"], [19, 23, "GENE"], [101, 105, "GENE"], [158, 162, "GENE"], [19, 23, "GENE"], [101, 105, "GENE"], [158, 162, "GENE"]]}], ["Our findings implicate the mTOR pathway as a critical contributor to human lupus.", {"entities": [[27, 31, "GENE"]]}], ["This broad pathway-based approach to understanding the similarities in, and differences between, animal models and human diseases may have broader utility.", {"entities": []}], ["GPBAR1/TGR5 is a novel plasma membrane-bound G protein\u2013coupled bile acid (BA) receptor.", {"entities": []}], ["BAs are known to induce the expression of inflammatory cytokines in the liver with unknown mechanism.", {"entities": []}], ["Here we show that without other external stimuli, TGR5 activation alone induced the expression of interleukin 1\u03b2 (IL-1\u03b2) and tumor necrosis factor-\u03b1 (TNF-\u03b1) in murine macrophage cell line RAW264.7 or murine Kupffer cells.", {"entities": []}], ["The TGR5-mediated increase of pro-inflammatory cytokine expression was suppressed by JNK inhibition.", {"entities": []}], ["Moreover, the induced pro-inflammatory cytokine expression in mouse liver by 1% cholic acid (CA) diet was blunted in JNK", {"entities": []}], ["Inflammatory M1 spectrum macrophages protect from infection but can cause inflammatory disease and tissue damage, whereas alternatively activated/M2 spectrum macrophages reduce inflammation and promote tissue repair.", {"entities": []}], ["Modulation of macrophage phenotype may be therapeutically beneficial and requires further understanding of the molecular programs that control macrophage differentiation.", {"entities": []}], ["A potential mechanism by which macrophages differentiate may be through microRNA (miRNA), which bind to messenger RNA and post-transcriptionally modify gene expression, cell phenotype and function.", {"entities": []}], ["We hypothesized that the inflammation-associated miRNA, miR-155, would be required for typical development of macrophage inflammatory state.", {"entities": [[56, 63, "GENE"]]}], ["miR-155 was rapidly up-regulated over 100-fold in inflammatory M1(LPS + IFN-\u03b3), but not M2(IL-4), macrophages.", {"entities": [[0, 7, "GENE"]]}], ["Inflammatory genes Inos , Il1b and Tnfa and their corresponding protein or enzymatic products were reduced up to 72% in miR-155 knockout mouse M1(LPS + IFN-\u03b3) macrophages, but miR-155 deficiency did not affect expression of the M2-associated gene Arg1 in M2(IL-4) macrophages.", {"entities": [[26, 30, "GENE"], [120, 127, "GENE"], [176, 183, "GENE"], [120, 127, "GENE"], [176, 183, "GENE"], [247, 251, "GENE"]]}], ["Additionally, a miR-155 oligonucleotide inhibitor efficiently suppressed Inos and Tnfa gene expression in wild-type M1(LPS + IFN-\u03b3) macrophages.", {"entities": [[16, 23, "GENE"]]}], ["Comparative transcriptional profiling of unstimulated and M1(LPS + IFN-\u03b3) macrophages derived from wild-type (WT) and miR-155 knockout (KO) mice revealed that half (approximately 650 genes) of the signature we previously identified in WT M1(LPS + IFN-\u03b3) macrophages was dependent on miR-155.", {"entities": [[118, 125, "GENE"], [283, 290, "GENE"], [118, 125, "GENE"], [283, 290, "GENE"]]}], ["Real-Time PCR of independent datasets confirmed that miR-155 contributed to suppression of its validated mRNA targets Inpp5d , Tspan14 , Ptprj and Mafb and induction of Inos , Il1b , Tnfa , Il6 and Il12 .", {"entities": [[53, 60, "GENE"], [118, 124, "GENE"], [127, 134, "GENE"], [137, 142, "GENE"], [147, 151, "GENE"], [176, 180, "GENE"], [190, 193, "GENE"]]}], ["Overall, these data indicate that miR-155 plays an essential role in driving the inflammatory phenotype of M1(LPS+ IFN-\u03b3) macrophages.", {"entities": [[34, 41, "GENE"]]}], ["Cigarette smoke is a profound pro-inflammatory stimulus that contributes to acute lung injuries and to chronic lung disease including COPD (emphysema and chronic bronchitis).", {"entities": [[111, 123, "DISEASE"], [162, 172, "DISEASE"]]}], ["Until recently, it was assumed that resolution of inflammation was a passive process that occurred once the inflammatory stimulus was removed.", {"entities": []}], ["It is now recognized that resolution of inflammation is a bioactive process, mediated by specialized lipid mediators, and that normal homeostasis is maintained by a balance between pro-inflammatory and pro-resolving pathways.", {"entities": []}], ["These novel small lipid mediators, including the resolvins, protectins and maresins, are bioactive products mainly derived from dietary omega-3 and omega-6 polyunsaturated fatty acids (PUFA).", {"entities": []}], ["We hypothesize that resolvin D1 (RvD1) has potent anti-inflammatory and pro-resolving effects in a model of cigarette smoke-induced lung inflammation.", {"entities": []}], ["Primary human lung fibroblasts, small airway epithelial cells and blood monocytes were treated with IL-1\u03b2 or cigarette smoke extract in combination with RvD1 in vitro , production of pro-inflammatory mediators was measured.", {"entities": []}], ["Mice were exposed to dilute mainstream cigarette smoke and treated with RvD1 either concurrently with smoke or after smoking cessation.", {"entities": []}], ["The effects on lung inflammation and lung macrophage populations were assessed.", {"entities": []}], ["RvD1 suppressed production of pro-inflammatory mediators by primary human cells in a dose-dependent manner.", {"entities": []}], ["Treatment of mice with RvD1 concurrently with cigarette smoke exposure significantly reduced neutrophilic lung inflammation and production of pro-inflammatory cytokines, while upregulating the anti-inflammatory cytokine IL-10.", {"entities": []}], ["RvD1 promoted differentiation of alternatively activated (M2) macrophages and neutrophil efferocytosis.", {"entities": []}], ["RvD1 also accelerated the resolution of lung inflammation when given after the final smoke exposure.", {"entities": []}], ["RvD1 has potent anti-inflammatory and pro-resolving effects in cells and mice exposed to cigarette smoke.", {"entities": []}], ["Resolvins have strong potential as a novel therapeutic approach to resolve lung injury caused by smoke and pulmonary toxicants.", {"entities": []}], ["Heart failure (HF) is one of the leading causes of morbidity and mortality in South Korea.", {"entities": []}], ["With the rapidly aging population in the country, the prevalence of HF and its associated costs are expected to rise continuously.", {"entities": []}], ["This study was carried out to estimate the prevalence and economic burden of HF in order to understand its impact on our society.", {"entities": []}], ["A prevalence-based, cost-of-illness study was conducted using the 2014 Health Insurance Review and Assessment Service-National Patients Sample (HIRA-NPS) data.", {"entities": []}], ["Adult HF patients were defined as those aged \u226519\u00a0years who had at least one insurance claim record with a primary or secondary diagnosis of HF (ICD-10 codes of I11.0, I13.0, I13.2, and I50.x).", {"entities": []}], ["The costs consist of direct costs (i.e., medical and non-medical costs) and indirect costs (i.e., productivity loss cost due to morbidity and premature death).", {"entities": []}], ["Subgroup analyses were conducted by age group, history of HF hospitalization, and type of universal health security program enrolled in.", {"entities": []}], ["A total of 475,019 adults were identified to have HF in 2014.", {"entities": []}], ["The estimated prevalence rate of HF was 12.4 persons per 1,000 adults.", {"entities": []}], ["According to the base cases and the extended definition of the cases, the annual economic burden of HF from a societal perspective ranges from USD 1,414.0 to 1,560.5 for individual patients, and from USD 752.8 million to 1,085.6 million for the country.", {"entities": []}], ["A high percentage (68.5\u00a0%) of this socioeconomic burden consist of medical costs, followed by caregiver\u2019s cost (13.2\u00a0%), productivity loss costs due to premature death (10.8\u00a0%) and morbidity (4.2\u00a0%), and transportation costs (3.4\u00a0%).", {"entities": []}], ["The HF patients with prior hospitalization due to HF annually spent 9.7 times more for National-Health-Insurance-covered medical costs compared to HF patients who were not previously hospitalized.", {"entities": []}], ["In the present study, HF patients who were older and had a history of prior hospitalization for HF as well as an indigent status were shown at high risk of spending more for healthcare to treat their HF.", {"entities": []}], ["An effective disease management protocol should be employed to target this patient group.", {"entities": []}], ["Using a standardized instrument to evaluate patients\u2019 stress reactions has become more important in daily clinical routines.", {"entities": []}], ["Different signs or symptoms of stress are often unilaterally explored: the physiological, psychological or social aspects of stress disorders are each viewed on a single dimension.", {"entities": []}], ["However, all dimensions afflict patients who have persistent health problems due to chronic stress.", {"entities": []}], ["Therefore, it is important to use a multidimensional approach to acquire data.", {"entities": []}], ["The \u2018Psycho-Physiological-Stress-Test\u2019 (PPST) was established to achieve a comprehensive understanding of stress and was further developed at the Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin in collaboration with the Psychological Department of Freie Universit\u00e4t Berlin.", {"entities": []}], ["The PPST includes a series of varying stress phases, embedded in two periods of rest.", {"entities": []}], ["Physiological and psychological parameters are simultaneously measured throughout the test session.", {"entities": []}], ["Specifically, the PPST activates the sympathetic stress axis, which is measured by heart rate, blood pressure, respiration depth and rate, electro dermal activation and muscle tension (frontalis, masseter, trapezius).", {"entities": []}], ["Psychological data are simultaneously collected, and include performance, motivation, emotion and behavior.", {"entities": []}], ["After conducting this diagnostic test, it is possible to identify individual stress patterns that can be discussed with the individual patient to develop and recommend (outpatient) treatment strategies.", {"entities": []}], ["This paper introduces the PPST as a standardized way to evaluate stress reactions by presenting the results from a sample of psychosomatic inpatients (n = 139) who were treated in Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Germany.", {"entities": []}], ["We observed that the varying testing conditions provoked adjusted changes in the different physiological parameters and psychological levels.", {"entities": []}], ["The exact function of interleukin-19 (IL-19) on immune response is poorly understood.", {"entities": []}], ["In mice, IL-19 up-regulates TNF\u03b1 and IL-6 expression and its deficiency increases susceptibility to DSS-induced colitis.", {"entities": []}], ["In humans, IL-19 favors a Th2 response and is elevated in several diseases.", {"entities": []}], ["We here investigate the expression and effects of IL-19 on cells from active Crohn\u2019s disease (CD) patient.", {"entities": []}], ["Twenty-three active CD patients and 20 healthy controls (HC) were included.", {"entities": []}], ["mRNA and protein IL-19 levels were analyzed in monocytes.", {"entities": []}], ["IL-19 effects were determined in vitro on the T cell phenotype and in the production of cytokines by immune cells.", {"entities": []}], ["We observed that unstimulated and TLR-activated monocytes expressed significantly lower IL-19 mRNA in active CD patients than in HC (logFC\u200a=\u200a\u22121.97 unstimulated; \u22121.88 with Pam3CSK4; and \u22121.91 with FSL-1; p<0.001).", {"entities": []}], ["These results were confirmed at protein level.", {"entities": []}], ["Exogenous IL-19 had an anti-inflammatory effect on HC but not on CD patients.", {"entities": []}], ["IL-19 decreased TNF\u03b1 production in PBMC (850.7\u00b175.29 pg/ml vs 2626.0\u00b1350 pg/ml; p<0.01) and increased CTLA4 expression (22.04\u00b11.55% vs 13.98\u00b12.05%; p<0.05) and IL-4 production (32.5\u00b18.9 pg/ml vs 13.5\u00b12.9 pg/ml; p<0.05) in T cells from HC.", {"entities": [[102, 107, "GENE"]]}], ["IL-10 regulated IL-19 production in both active CD patients and HC.", {"entities": []}], ["We observed that three of the miRNAs that can modulate IL-19 mRNA expression, were up-regulated in monocytes from active CD patients.", {"entities": []}], ["These results suggested that IL-19 had an anti-inflammatory role in this study.", {"entities": []}], ["Defects in IL-19 expression and the lack of response to this cytokine could contribute to inflammatory mechanisms in active CD patients.", {"entities": []}], ["Persistent respiratory syncytial virus (RSV) infections have been associated with the exacerbation of chronic inflammatory diseases, including chronic obstructive pulmonary disease (COPD).", {"entities": [[143, 180, "DISEASE"]]}], ["This virus infects the respiratory epithelium, leading to chronic inflammation, and induces the release of mucins and the loss of cilia activity, two factors that determine mucus clearance and the increase in sputum volume.", {"entities": []}], ["These alterations involve reactive oxygen species-dependent mechanisms.", {"entities": []}], ["The antioxidant N-acetylcysteine (NAC) has proven useful in the management of COPD, reducing symptoms, exacerbations, and accelerated lung function decline.", {"entities": []}], ["NAC inhibits RSV infection and mucin release in human A549 cells.", {"entities": []}], ["The main objective of this study was to analyze the effects of NAC in modulating ciliary activity, ciliagenesis, and metaplasia in primary normal human bronchial epithelial cell (NHBEC) cultures infected with RSV.", {"entities": []}], ["Our results indicated that RSV induced ultrastructural abnormalities in axonemal basal bodies and decreased the expression of \u03b2-tubulin as well as two genes involved in ciliagenesis, FOXJ1 and DNAI2 .", {"entities": [[183, 188, "GENE"], [193, 198, "GENE"]]}], ["These alterations led to a decrease in ciliary activity.", {"entities": []}], ["Furthermore, RSV induced metaplastic changes to the epithelium and increased the number of goblet cells and the expression of MUC5AC and GOB5 .", {"entities": []}], ["NAC restored the normal functions of the epithelium, inhibiting ICAM1 expression, subsequent RSV infection through mechanisms involving nuclear receptor factor 2, and the expression of heme oxygenase 1, which correlated with the restoration of the antioxidant capacity, the intracellular H 2 O 2 levels and glutathione content of NHBECs.", {"entities": [[64, 69, "GENE"]]}], ["The results presented in this study support the therapeutic use of NAC for the management of chronic respiratory diseases, including COPD.", {"entities": []}], ["Erucin, an isothiocyanate, is a hydrolysis product of glucoerucin found in arugula and has recently been reported to have anti-cancer properties in various cancer cells.", {"entities": [[127, 133, "DISEASE"], [156, 162, "DISEASE"]]}], ["In this study, we assessed the anti-inflammatory effects of erucin and the underlying mechanisms, using lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages and 12- O -tetradecanoylphorbol-13-acetate-treated mouse skin.", {"entities": []}], ["In RAW 264.7 cells, erucin (2.5, 5 \u03bcmol/L) inhibited LPS-induced production of nitric oxide and prostaglandin E 2 .", {"entities": []}], ["Erucin inhibited LPS-induced degradation of the inhibitor of \u03baB\u03b1 and translocation of p65 to the nucleus and, subsequently, reduced LPS-induced nuclear factor \u03baB (NF\u03baB) DNA binding activities, as well as the transcriptional activity of NF\u03baB, leading to the decreased expression of NF\u03baB-target genes, including tumor necrosis factor-\u03b1, interleukin (IL)-6, IL-1\u03b2, inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2, as well as transcriptional activity of iNOS and COX-2.", {"entities": []}], ["In mice, erucin (100, 300 nmoles) treatment significantly inhibited phorbol ester-induced formation of ear edema and expression of iNOS and COX-2 proteins.", {"entities": []}], ["These results indicate that erucin exerts a potent anti-inflammatory activity by inhibiting the pro-inflammatory enzymes and cytokines, which may be mediated, at least in part, via the inhibition of NF\u03baB signaling.", {"entities": []}], ["Activated fibroblasts, which have previously been obtained from bronchoalveolar lavage fluid (BALF), are proposed to be important cells in the fibrotic processes of asthma and scleroderma (SSc).", {"entities": [[165, 171, "DISEASE"], [176, 187, "DISEASE"]]}], ["We have studied the motility for BALF derived fibroblasts in patients with SSc that may explain the presence of these cells in the airway lumen.", {"entities": []}], ["Furthermore, we have compared phenotypic alterations in activated fibroblasts from BALF and bronchial biopsies from patients with mild asthma and SSc that may account for the distinct fibrotic responses.", {"entities": [[135, 141, "DISEASE"]]}], ["Fibroblasts were cultured from BALF and bronchial biopsies from patients with mild asthma and SSc.", {"entities": [[83, 89, "DISEASE"]]}], ["The motility was studied using a cell migration assay.", {"entities": []}], ["Western Blotting was used to study the expression of alpha-smooth muscle actin (\u03b1-SMA), ED-A fibronectin, and serine arginine splicing factor 20 (SRp20).", {"entities": []}], ["The protein expression pattern was analyzed to reveal potential biomarkers using two-dimensional electrophoresis (2-DE) and sequencing dual matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-TOF).", {"entities": []}], ["The Mann-Whitney method was used to calculate statistical significance.", {"entities": []}], ["Increased migration and levels of ED-A fibronectin were observed in BALF fibroblasts from both groups of patients, supported by increased expression of RhoA, Rac1, and the splicing factor SRp20.", {"entities": [[152, 156, "GENE"], [158, 162, "GENE"]]}], ["However, these observations were exclusively accompanied by increased expression of \u03b1-SMA in patients with mild asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["Compared to BALF fibroblasts in mild asthma, fibroblasts in SSc displayed a differential protein expression pattern of cytoskeletal- and scavenger proteins.", {"entities": [[37, 43, "DISEASE"]]}], ["These identified proteins facilitate cell migration, oxidative stress, and the excessive deposition of extracellular matrix observed in patients with SSc.", {"entities": []}], ["This study demonstrates a possible origin for fibroblasts in the airway lumen in patients with SSc and important differences between fibroblast phenotypes in mild asthma and SSc.", {"entities": [[163, 169, "DISEASE"]]}], ["The findings may explain the distinct fibrotic processes and highlight the motile BALF fibroblast as a potential target cell in these disorders.", {"entities": []}], ["Potentially inappropriate medication (PIM) prescribing in older adults is quite prevalent and is associated with an increased risk for adverse drug events, morbidity, and utilization of health care resources.", {"entities": []}], ["In the acute care setting, PIM prescribing can be even more problematic due to multiple physicians and specialists who may be prescribing for a single patient as well as difficulty with medication reconciliation at transitions and limitations imposed by hospital formularies.", {"entities": []}], ["This article highlights critical issues surrounding PIM prescribing in the acute care setting such as risk factors, screening tools, and potential strategies to minimize this significant public health problem.", {"entities": []}], ["Allergic rhinitis is a common disease whose genetic basis is incompletely explained.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["We report an integrated genomic analysis of allergic rhinitis.", {"entities": [[44, 61, "DISEASE"], [53, 61, "DISEASE"]]}], ["We performed genome wide association studies (GWAS) of allergic rhinitis in 5633 ethnically diverse North American subjects.", {"entities": [[55, 72, "DISEASE"], [64, 72, "DISEASE"]]}], ["Next, we profiled gene expression in disease-relevant tissue (peripheral blood CD4+ lymphocytes) collected from subjects who had been genotyped.", {"entities": []}], ["We then integrated the GWAS and gene expression data using expression single nucleotide (eSNP), coexpression network, and pathway approaches to identify the biologic relevance of our GWAS.", {"entities": []}], ["GWAS revealed ethnicity-specific findings, with 4 genome-wide significant loci among Latinos and 1 genome-wide significant locus in the GWAS meta-analysis across ethnic groups.", {"entities": []}], ["To identify biologic context for these results, we constructed a coexpression network to define modules of genes with similar patterns of CD4+ gene expression (coexpression modules) that could serve as constructs of broader gene expression.", {"entities": []}], ["6 of the 22 GWAS loci with P-value\u2009\u2264\u20091x10 Our results highlight mitochondrial pathways as a target for further investigation of allergic rhinitis mechanism and treatment.", {"entities": [[128, 145, "DISEASE"], [137, 145, "DISEASE"]]}], ["Our integrated approach can be applied to provide biologic context for GWAS of other diseases.", {"entities": []}], ["COPD is well known to frequently coexist with osteoporosis.", {"entities": [[46, 58, "DISEASE"]]}], ["Bone fractures often occur and may affect mortality in COPD patients.", {"entities": []}], ["However, in-hospital mortality related to bone fractures in COPD patients has been poorly studied.", {"entities": []}], ["This retrospective study investigated in-hospital mortality of COPD patients with bone fractures using a national inpatient database in Japan.", {"entities": []}], ["Data of COPD patients admitted with bone fractures, including hip, vertebra, shoulder, and forearm fractures to 1,165 hospitals in Japan between July 2010 and March 2013, were extracted from the Diagnosis Procedure Combination database.", {"entities": []}], ["The clinical characteristics and mortalities of the patients were determined.", {"entities": []}], ["Multivariable logistic regression analysis was also performed to determine the factors associated with in-hospital mortality of COPD patients with hip fractures.", {"entities": []}], ["Among 5,975 eligible patients, those with hip fractures (n=4,059) were older, had lower body mass index (BMI), and had poorer general condition than those with vertebral (n=1,477), shoulder (n=281), or forearm (n=158) fractures.", {"entities": []}], ["In-hospital mortality was 7.4%, 5.2%, 3.9%, and 1.3%, respectively.", {"entities": []}], ["Among the hip fracture group, surgical treatment was significantly associated with lower mortality (adjusted odds ratio, 0.43; 95% confidence interval, 0.32\u20130.56) after adjustment for patient backgrounds.", {"entities": []}], ["Higher in-hospital mortality was associated with male sex, lower BMI, lower level of consciousness, and having several comorbidities, including pneumonia, lung cancer, congestive heart failure, chronic liver disease, and chronic renal failure.", {"entities": [[168, 192, "DISEASE"], [155, 166, "DISEASE"], [202, 215, "DISEASE"], [144, 153, "DISEASE"], [160, 166, "DISEASE"]]}], ["COPD patients with hip fractures had higher mortality than COPD patients with other types of fracture.", {"entities": []}], ["Surgery for hip fracture was associated with lower mortality than conservative treatment.", {"entities": []}], ["ZAP-70 is a cytoplasmic protein tyrosine kinase that is required for T cell antigen receptor (TCR) signaling.", {"entities": []}], ["Both mice and humans deficient in ZAP-70 fail to develop functional T cells, thus demonstrating its necessity for T cell development and function.", {"entities": []}], ["There is currently no highly specific, cell-permeable, small molecule inhibitor for ZAP-70; therefore, we generated a mutant ZAP-70 allele that retains kinase activity but is sensitive to inhibition by a mutant-specific inhibitor.", {"entities": []}], ["We validated the chemical genetic inhibitor system in Jurkat T cell lines, where the inhibitor blocked ZAP-70-dependent TCR signaling in cells expressing the analog-sensitive allele.", {"entities": []}], ["Interestingly, the inhibitor also ablated CD28 superagonist signaling, thereby demonstrating the utility of this system in dissecting the requirement for ZAP-70 in alternative mechanisms of T cell activation.", {"entities": [[42, 46, "GENE"]]}], ["Thus, we have developed the first specific chemical means of inhibiting ZAP-70 in cells, which serves as a valuable tool for studying the function of ZAP-70 in T cells.", {"entities": []}], ["Objectives To understand the perspectives of people with severe chronic obstructive pulmonary disease (COPD) as their illness progresses, and of their informal and professional carers, to inform provision of care for people living and dying with COPD.", {"entities": [[64, 101, "DISEASE"]]}], ["Design Up to four serial qualitative interviews were conducted with each patient and nominated carer over 18 months.", {"entities": []}], ["Interviews were transcribed and analysed both thematically and as narratives.", {"entities": []}], ["Participants 21 patients, and 13 informal carers (a family member, friend, or neighbour) and 18 professional carers (a key health or social care professional) nominated by the patients.", {"entities": []}], ["Setting Primary and secondary care in Lothian, Tayside, and Forth Valley, Scotland, during 2007-9.", {"entities": []}], ["Results Eleven patients died during the study period.", {"entities": []}], ["Our final dataset comprised 92 interviews (23 conducted with patient and informal carer together).", {"entities": []}], ["Severe symptoms that caused major disruption to normal life were described, often in terms implying acceptance of the situation as a \u201cway of life\u201d rather than an \u201cillness.\u201d Patients and their informal carers adapted to and accepted the debilitating symptoms of a lifelong condition.", {"entities": []}], ["Professional carers\u2019 familiarity with the patients\u2019 condition, typically over many years, and prognostic uncertainty contributed to the difficulty of recognising and actively managing end stage disease.", {"entities": []}], ["Overall, patients told a \u201cchaos narrative\u201d of their illness that was indistinguishable from their life story, with no clear beginning and an unanticipated end described in terms comparable with attitudes to death in a normal elderly population.", {"entities": []}], ["Conclusions Our findings challenge current assumptions underpinning provision of end of life care for people with COPD.", {"entities": []}], ["The policy focus on identifying a time point for transition to palliative care has little resonance for people with COPD or their clinicians and is counter productive if it distracts from early phased introduction of supportive care.", {"entities": []}], ["Careful assessment of possible supportive and palliative care needs should be triggered at key disease milestones along a lifetime journey with COPD, in particular after hospital admission for an exacerbation.", {"entities": []}], ["Gemcitabine, an effective agent in treatment of cancer of pancreas, has undergone failures in many instances after multiple cycles of therapy due to emergence of drug resistance.", {"entities": [[48, 54, "DISEASE"]]}], ["Combination of dietary compounds with clinically validated drugs has emerged as an effective therapeutic approach to treat pancreatic tumors, refractory to gemcitabine therapy.", {"entities": []}], ["In order to optimize a possible synergistic combination of Gemcitabine (GCB) with dietary molecules, Betuilnic acid (BA) and Thymoquinone (TQ), stand-alone IC 50 dose of GCB, BA and TQ was calculated for pancreatic cancer cell lines.", {"entities": [[204, 221, "DISEASE"], [215, 221, "DISEASE"]]}], ["Fixed IC 50 dose ratio of the dietary molecules in combination with reduced IC 50 dose of GCB was tested on GCB resistant PANC-1 and sensitive MIA PaCa-2 cells for synergism, additive response and antagonism, using calcusyn.", {"entities": [[143, 146, "GENE"]]}], ["Combination index (CI) revealed that pre-treatment of BA and TQ along with GCB synergistically inhibited the cancer cell proliferation in in-vitro experiments.", {"entities": [[109, 115, "DISEASE"]]}], ["Pyruvate kinase (PK) M2 isoform, a promising target involved in cancer cell metabolism, showed down-regulation in presence of TQ or BA in combination with GCB.", {"entities": [[64, 70, "DISEASE"]]}], ["GCB with BA acted preferentially on tumor mitochondria and triggered mitochondrial permeability transition.", {"entities": []}], ["Pre-exposure of the cell lines, MIA PaCa-2 and PANC-1, to TQ in combination with GCB induced apoptosis.", {"entities": [[32, 35, "GENE"]]}], ["Thus, the effectiveness of BA or TQ in combination with GCB to inhibit cell proliferation, induce apoptosis and down-regulate the expression of PKM2, reflects promise in pancreatic cancer treatment.", {"entities": [[170, 187, "DISEASE"], [181, 187, "DISEASE"], [144, 148, "GENE"]]}], ["The relevance of lysophosphatidylcholine acyltransferase1 (LPCAT1), a cytosolic enzyme in the remodeling pathway of phosphatidylcholine metabolism, in oral squamous cell carcinoma (OSCC) is unknown.", {"entities": [[170, 179, "DISEASE"], [156, 179, "DISEASE"], [59, 65, "GENE"]]}], ["We investigated LPCAT1 expression and its functional mechanism in OSCCs.", {"entities": [[16, 22, "GENE"]]}], ["We analyzed LPCAT1 mRNA and protein expression levels in OSCC-derived cell lines.", {"entities": [[12, 18, "GENE"]]}], ["Immunohistochemistry was performed to identify correlations between LPCAT1 expression levels and primary OSCCs clinicopathological status.", {"entities": [[68, 74, "GENE"]]}], ["We established LPCAT1 knockdown models of the OSCC-derived cell lines (SAS, Ca9-22) for functional analysis and examined the association between LPCAT1 expression and the platelet-activating factor (PAF) concentration and PAF-receptor (PAFR) expression.", {"entities": [[15, 21, "GENE"], [145, 151, "GENE"], [15, 21, "GENE"], [145, 151, "GENE"]]}], ["LPCAT1 mRNA and protein were up-regulated significantly (p<0.05) in OSCC-derived cell lines compared with human normal oral keratinocytes.", {"entities": [[0, 6, "GENE"]]}], ["Immunohistochemistry showed significantly (p<0.05) elevated LPCAT1 expression in primary OSCCs compared with normal counterparts and a strong correlation between LPCAT1-positive OSCCs and tumoral size and regional lymph node metastasis.", {"entities": [[60, 66, "GENE"], [162, 168, "GENE"]]}], ["In LPCAT1 knockdown cells, cellular proliferation and invasiveness decreased significantly (p<0.05); cellular migration was inhibited compared with control cells.", {"entities": [[3, 9, "GENE"]]}], ["Down-regulation of LPCAT1 resulted in a decreased intercellular PAF concentration and PAFR expression.", {"entities": [[19, 25, "GENE"]]}], ["LPCAT1 was overexpressed in OSCCs and correlated with cellular invasiveness and migration.", {"entities": [[0, 6, "GENE"]]}], ["LPCAT1 may contribute to tumoral growth and metastasis in oral cancer.", {"entities": [[63, 69, "DISEASE"], [0, 6, "GENE"]]}], ["House dust mite (HDM) is a predominant source of indoor aeroallergen worldwide, which induces allergic diseases including allergic rhinoconjunctivitis, allergic asthma, atopic eczema and other allergic skin diseases.", {"entities": [[152, 167, "DISEASE"], [161, 167, "DISEASE"]]}], ["Allergen specific immunotherapy (AIT) is the only potential disease-modifying treatment of HDM allergic subjects.", {"entities": []}], ["However, AIT remains underused due to no universally accepted allergen standardization and a shortage of rigorous clinical studies to confirm safety and efficacy.", {"entities": []}], ["With the effort of doctors and researchers in allergy field, efficacy, safety, standardization and strategy of AIT are being continuously developed.", {"entities": []}], ["This review presents the updated research based on recently published trials and meta-analyses.", {"entities": []}], ["Occupational exposure to formaldehyde has been linked to nasopharyngeal carcinoma.", {"entities": [[72, 81, "DISEASE"]]}], ["To date, mechanistic explanations for this association have primarily focused on formaldehyde-induced cytotoxicity, regenerative hyperplasia and DNA damage.", {"entities": []}], ["However, recent studies broaden the potential mechanisms as it is now well established that formaldehyde dehydrogenase, identical to S -nitrosoglutathione reductase, is an important mediator of cGMP-independent nitric oxide signaling pathways.", {"entities": []}], ["We have previously described mechanisms by which formaldehyde can influence nitrosothiol homeostasis thereby leading to changes in pulmonary physiology.", {"entities": []}], ["Considering evidences that nitrosothiols govern the Epstein-Barr virus infection cycle, and that the virus is strongly implicated in the etiology of nasopharyngeal carcinoma, studies are needed to examine the potential for formaldehyde to reactivate the Epstein-Barr virus as well as additively or synergistically interact with the virus to potentiate epithelial cell transformation.", {"entities": [[164, 173, "DISEASE"]]}], ["Although the dispersion model approach has been used in some epidemiologic studies to examine health effects of traffic-specific air pollution, no study has evaluated the model predictions vigorously.", {"entities": []}], ["We evaluated total and traffic-specific particulate matter < 10 and < 2.5 \u03bcm in aero-dynamic diameter (PM 10 , PM 2.5 ), nitrogren dioxide, and nitrogen oxide concentrations predicted by Gaussian dispersion models against fixed-site measurements at different locations, including traffic-impacted, urban-background, and alpine settings between and across cities.", {"entities": []}], ["The model predictions were then used to estimate individual subjects\u2019 historical and cumulative exposures with a temporal trend model.", {"entities": []}], ["Modeled PM 10 and NO 2 predicted at least 55% and 72% of the variability of the measured PM 10 and NO 2 , respectively.", {"entities": []}], ["Traffic-specific pollution estimates correlated with the NO x measurements ( R 10 accounted for most PM 10 mass in all cities.", {"entities": []}], ["Whereas traffic PM 10 accounted for < 20% of the total PM 10 , it varied significantly within cities.", {"entities": []}], ["The modeling error for PM 10 was similar within and between cities.", {"entities": []}], ["Traffic NO x accounted for the majority of NO x mass in urban areas, whereas background NO x accounted for the majority of NO x in rural areas.", {"entities": []}], ["The within-city NO 2 modeling error was larger than that between cities.", {"entities": []}], ["The dispersion model predicted well the total PM 10 , NO x , and NO 2 and traffic-specific pollution at background sites.", {"entities": []}], ["However, the model underpredicted traffic NO x and NO 2 at traffic sites and needs refinement to reflect local conditions.", {"entities": []}], ["The dispersion model predictions for PM 10 are suitable for examining individual exposures and health effects within and between cities.", {"entities": []}], ["Suprachoroidal hemorrhage is a complication associated with intraocular surgery that can occur both intraoperatively and postoperatively.", {"entities": []}], ["Several intraoperative or postoperative risk factors have been indentified.", {"entities": []}], ["The use of low-molecular weight heparin (LMWH) is considered one of the risk factors in surgical cases (ocular or non ocular) and non-surgical cases.", {"entities": []}], ["Here we present a case of suprachoroidal hemorrhage in a glaucoma patient that occurred after preoperative prophylactic LMWH for deep venous thrombosis.", {"entities": [[57, 65, "DISEASE"]]}], ["The use of LMWH has been reported to cause suprachoroidal hemorrhage even in patients without any risk factors.", {"entities": []}], ["The use of LMWH continues to increase, hence it is important to be aware of the possibility of suprachoroidal hemorrhage and to determine the risk/benefit ratio, especially in patients with other risk factors.", {"entities": []}], ["Existing evidence about the impact of retirement on physical activity (PA) has primarily focused on the average change in PA level after retirement in group-based studies.", {"entities": []}], ["It is unclear whether findings regarding the direction of PA change after retirement from group-based studies apply to individuals.", {"entities": []}], ["This study aimed to explore changes in PA, PA determinants and their inter-relationships during the retirement transition at the individual level.", {"entities": []}], ["A series of n-of-1 natural experiments were conducted with seven individuals who were aged 55\u201376\u00a0years and approaching retirement.", {"entities": []}], ["PA was measured by tri-axial accelerometry.", {"entities": []}], ["Twice-daily self-report and ecological momentary assessments of evidence- and theory-based determinants of PA (e.g.", {"entities": []}], ["sleep length/quality, happiness, tiredness, stress, time pressure, pain, intention, perceived behavioural control, priority, goal conflict and goal facilitation) were collected via a questionnaire for a period of between 3 and 7 months, which included time before and after the participant\u2019s retirement date.", {"entities": []}], ["A personalised PA determinant was also identified by each participant and measured daily for the duration of the study.", {"entities": []}], ["Dynamic regression models for discrete time binary data were used to analyse data for each individual participant.", {"entities": []}], ["Two participants showed a statistically\u00a0significant increase in the probability of engaging in PA bouts after retirement and two participants showed a significant time trend for a decrease and increase in PA bouts\u00a0over time during\u00a0the pre- to post-retirement\u00a0period, respectively.", {"entities": []}], ["There was no statistically significant change in PA after retirement for the remaining participants.", {"entities": []}], ["Most of the daily questionnaire variables were significantly associated with PA for one or more participants but there were no consistent pattern of\u00a0PA predictors across participants.", {"entities": []}], ["For some participants, the relationship between questionnaire variables and PA changed from pre- to post-retirement.", {"entities": []}], ["The findings from this study demonstrate the impact of retirement on individual PA trajectories.", {"entities": []}], ["Using n-of-1 methods can provide information about unique patterns and determinants of individual behaviour over time, which has been obscured in previous research.", {"entities": []}], ["N-of-1 methods can be used as a tool to inform personalised PA interventions for individuals within the retirement transition.", {"entities": []}], ["The online version of this article (10.1186/s12966-017-0623-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is a chronic inflammatory disease of the airways but recent studies have shown that alveoli are also subject to pathophysiological changes.", {"entities": [[0, 6, "DISEASE"]]}], ["This study was undertaken to compare hydrogen peroxide (H 2 O 2 ) concentrations in different parts of the lung using a new technique of fractioned breath condensate sampling.", {"entities": []}], ["In 52 children (9-17 years, 32 asthmatic patients, 20 controls) measurements of exhaled nitric oxide (FE NO ), lung function, H 2 O 2 in exhaled breath condensate (EBC) and the asthma control test (ACT) were performed.", {"entities": [[177, 183, "DISEASE"]]}], ["Exhaled breath condensate was collected in two different fractions, representing mainly either the airways or the alveoli.", {"entities": []}], ["H 2 O 2 was analysed in the airway and alveolar fractions and compared to clinical parameters.", {"entities": []}], ["The exhaled H 2 O 2 concentration was significantly higher in the airway fraction than in the alveolar fraction comparing each single pair (p = 0.003, 0.032 and 0.040 for the whole study group, the asthmatic group and the control group, respectively).", {"entities": []}], ["Asthma control, measured by the asthma control test (ACT), correlated significantly with the H 2 O 2 concentrations in the alveolar fraction (r = 0.606, p = 0.004) but not with those in the airway fraction in the group of children above 12 years.", {"entities": [[0, 6, "DISEASE"], [32, 38, "DISEASE"]]}], ["FE NO values and lung function parameters did not correlate to the H 2 O 2 concentrations of each fraction.", {"entities": []}], ["The new technique of fractionated H 2 O 2 measurement may differentiate H 2 O 2 concentrations in different parts of the lung in asthmatic and control children.", {"entities": []}], ["H 2 O 2 concentrations of the alveolar fraction may be related to the asthma control test in children.", {"entities": [[70, 76, "DISEASE"]]}], ["C5a, one of the most potent inflammatory peptides, induces its inflammatory functions by interacting with C5a receptor (C5aR) that belongs to the rhodopsin family of seven-transmembrane G protein-coupled receptors.", {"entities": []}], ["C5a/C5aR signaling has been implicated in the pathogenesis of many inflammatory and immunological diseases such as sepsis and acute lung injury.", {"entities": []}], ["Widespread upregulation of C5aR has been seen at both the protein level and transcriptional level under pathological conditions.", {"entities": []}], ["Here, we show that C5aR gene expression can be specifically suppressed by siRNA, both in vitro and in vivo.", {"entities": []}], ["A panel of chemically siRNA oligonucleotides was first synthesized to identify the functional siRNA sequences.", {"entities": []}], ["The short hairpin RNAs (shRNAs) were also designed, cloned, and tested for the silencing effects in C5aR transfected cells.", {"entities": []}], ["The effective shRNA expression cassettes were then transferred to an adenovirus DNA vector.", {"entities": []}], ["ShRNA-expressing adenoviruses were intratracheally administered into mouse lung, and a significant in vivo silencing of C5aR was obtained four days after administration.", {"entities": []}], ["Thus, C5aR shRNA-expressing adenoviruses appear to be an alternative strategy for the treatment of complement-induced disorders.", {"entities": []}], ["Although rates of tobacco use and exposure to second-hand smoke (SHS) are declining in Canada, SHS exposure among non-smoking adolescents remains high.", {"entities": []}], ["This study aimed to describe frequency, locations, and avoidance behavior related to SHS exposure among adolescent girls in British Columbia, Canada.", {"entities": []}], ["Data were analyzed from 841 adolescent girls aged 13 to 15\u00a0years old who completed an internet-delivered survey as part of a cohort study examining SHS exposure and substance use.", {"entities": []}], ["Measures assessed demographics, smoking behavior and intentions, frequency and locations of SHS exposure, and avoidance behavior related to SHS.", {"entities": []}], ["Excluding their own smoking, 27% of girls reported exposure at least once a week and an additional 17% reported daily or almost daily exposure over the past month.", {"entities": []}], ["Among girls who reported daily or almost daily exposure, the locations of most frequent levels of high exposure were in the home, at or near school, inside a vehicle, and outdoor public places.", {"entities": []}], ["Avoidance behavior related to SHS exposure significantly differed by overall SHS exposure in the past month.", {"entities": []}], ["Despite historically low smoking rates, many adolescent girls continue to report regular SHS exposure in multiple locations in British Columbia.", {"entities": []}], ["Girls with the most frequent exposure were significantly less likely to report habitual avoidance behavior related to SHS compared to those less frequently exposed.", {"entities": []}], ["This study elucidates settings of high SHS exposure among adolescent girls that could be targeted in future policy interventions.", {"entities": []}], ["Additionally, future interventions could target adolescent girls who are frequently exposed to SHS and report infrequent avoidance behavior around their SHS exposure.", {"entities": []}], ["Diabetes has previously been linked to mental health problems in adolescents, but more recent studies have yielded mixed findings.", {"entities": []}], ["The aim of the current study was to compare symptoms of mental health problems, sleep and eating disturbances in adolescents with and without Type 1 diabetes in a population based sample.", {"entities": []}], ["Data were taken from the youth@hordaland study, a large population based study in Hordaland County in Norway conducted in 2012.", {"entities": []}], ["In all, 9883 adolescents aged 16\u201319 years (53% girls) provided self-reported data on both diabetes and a range of instruments assessing mental health symptoms, including depression, anxiety, obsessive-compulsive behaviours, hyperactivity, impulsivity, inattention, perfectionism, resilience, sleep problems and eating behaviour.", {"entities": []}], ["40 adolescents were classified as having Type 1 diabetes (prevalence 0.4%).", {"entities": []}], ["We found that adolescents with Type 1 diabetes did not differ from their peers on any of the mental health measures.", {"entities": []}], ["This is one of the first population-based studies to examine mental health of adolescents with Type 1 diabetes.", {"entities": []}], ["There was no evidence of increased psychopathology across a wide range of mental health measures.", {"entities": []}], ["These findings contradict previous studies, and suggest that Type 1 diabetes is not associated with an increased risk of psychosocial problems.", {"entities": []}], ["We conducted a meta-analysis to assess the association between patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) and its subtypes simple steatosis(SS) and nonalcoholic steatohepatitis (NASH).", {"entities": [[158, 177, "DISEASE"], [164, 177, "DISEASE"], [111, 117, "GENE"]]}], ["The study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using fixed-effects or random-effects models, with assessment for heterogeneity and publication bias.", {"entities": []}], ["Twenty-three case-control studies involving 6071 NAFLD patients and 10366 controls were identified.", {"entities": []}], ["The combined results showed a significant association between NAFLD risk and the rs738409 polymorphism in all genetic models (additive model: OR = 3.41, 95% CI = 2.57\u20134.52; P < 0.00001).", {"entities": []}], ["In addition, evidence indicated that the rs738409 polymorphism was significantly associated with NASH in all genetic models (additive model: OR = 4.44, 95% CI = 3.39\u20135.82; P < 0.00001).", {"entities": []}], ["The subgroup and sensitivity analyses showed that these changes were not influenced by the ethnicities and ages of subjects or by the source of controls.", {"entities": []}], ["The rs738409 polymorphism was only significantly associated with risk of simple steatosis in the allele contrast and had no effect in the other genetic models.", {"entities": []}], ["These findings suggest that the rs738409 polymorphism in PNPLA3 gene confers high cross-ethnicity risk for NAFLD and NASH development.", {"entities": [[57, 63, "GENE"]]}], ["Meningiomas are the most common brain tumours; however, little is known regarding their aetiology.", {"entities": []}], ["The data are inconsistent concerning atopic disease and the risk of developing meningioma.", {"entities": [[79, 89, "DISEASE"]]}], ["Thus, we conducted a meta-analysis to investigate the association between allergic conditions and the risk of developing meningioma.", {"entities": [[121, 131, "DISEASE"]]}], ["A systematic literature search was conducted using PubMed and Web of SCI from Jan 1979 to Feb 2016.", {"entities": []}], ["Two investigators independently selected the relevant articles according to the inclusion criteria.", {"entities": []}], ["Eight case-control studies and 2 cohort studies were included in the final analysis, comprising 5,679 meningioma cases and 55,621 control subjects.", {"entities": [[102, 112, "DISEASE"]]}], ["Compared with no history of allergy, the pooled odds ratio (OR) for allergic conditions was 0.81 (0.70\u20130.94) for meningioma in a random-effects meta-analysis.", {"entities": [[113, 123, "DISEASE"]]}], ["Inverse correlations of meningioma occurrence were also identified for asthma and eczema, in which the pooled ORs were 0.78 (0.70\u20130.86) and 0.78 (0.69\u20130.87), respectively.", {"entities": [[71, 77, "DISEASE"], [24, 34, "DISEASE"]]}], ["A reduced risk of meningioma occurrence was identified in hay fever; however, the association was weak (0.88, 95% CI\u2009=\u20090.78\u20130.99).", {"entities": [[18, 28, "DISEASE"]]}], ["The source of this heterogeneity could be the various confounding variables in individual studies.", {"entities": []}], ["Overall, the current meta-analysis indicated that allergy reduced the risk of developing meningiomas.", {"entities": []}], ["Large cohort studies are required to investigate this relationship.", {"entities": []}], ["Objectives .", {"entities": []}], ["To investigate the association between the maternal alcohol consumption during pregnancy and early age leukemia (EAL) in offspring.", {"entities": [[103, 111, "DISEASE"]]}], ["Datasets were analyzed from a case-control study carried out in Brazil during 1999\u20132007.", {"entities": []}], ["Data were obtained by maternal interviews using a standardized questionnaire.", {"entities": []}], ["The present study included 675 children (193 acute lymphoid leukemia (ALL), 59 acute myeloid leukemia (AML), and 423 controls).", {"entities": [[51, 68, "DISEASE"], [85, 101, "DISEASE"], [79, 101, "DISEASE"], [60, 68, "DISEASE"], [93, 101, "DISEASE"]]}], ["Unconditional logistic regression was performed, and adjusted odds ratios (adj.", {"entities": []}], ["OR) on the association between alcohol consumption and EAL were ascertained.", {"entities": []}], ["Alcohol consumption was reported by 43% of ALL and 39% of AML case mothers and 35.5% of controls'.", {"entities": []}], ["Beer consumption before and during pregnancy was associated with ALL in crude analysis (OR = 1.54, 95% CI, 1.08\u20132.19), although in adjusted analysis no statistical significance was found.", {"entities": []}], ["For weekly intake of \u22641 glass (adj.", {"entities": []}], ["OR = 1.30, 95% CI, 0.71\u20132.36) and \u22651 glass/week (adj.", {"entities": []}], ["OR = 1.47, 95% CI, 0.88\u20132.46) a potential dose-response was observed ( P trend < 0.03).", {"entities": []}], ["Conclusion .", {"entities": []}], ["This study failed to support the hypothesis of an increased risk of EAL associated with maternal alcohol intake during pregnancy, neither with the interaction with tobacco nor with alcohol consumption.", {"entities": []}], ["The normal function of Syk in epithelium of the developing or adult breast is not known, however, Syk suppresses tumor growth, invasion, and metastasis in breast cancer cells.", {"entities": [[155, 168, "DISEASE"], [162, 168, "DISEASE"], [23, 26, "GENE"], [98, 101, "GENE"], [23, 26, "GENE"], [98, 101, "GENE"]]}], ["Here, we demonstrate that in the mouse mammary gland, loss of one Syk allele profoundly increases proliferation and ductal branching and invasion of epithelial cells through the mammary fat pad during puberty.", {"entities": [[66, 69, "GENE"]]}], ["Mammary carcinomas develop by one year.", {"entities": []}], ["Syk also suppresses proliferation and invasion in vitro .", {"entities": [[0, 3, "GENE"]]}], ["siRNA or shRNA knockdown of Syk in MCF10A breast epithelial cells dramatically increased proliferation, anchorage independent growth, cellular motility, and invasion, with formation of functional, extracellular matrix-degrading invadopodia.", {"entities": [[28, 31, "GENE"]]}], ["Morphological and gene microarray analysis following Syk knockdown revealed a loss of luminal and differentiated epithelial features with epithelial to mesenchymal transition and a gain in invadopodial cell surface markers CD44, CD49F, and MMP14.", {"entities": [[53, 56, "GENE"], [223, 227, "GENE"], [240, 245, "GENE"]]}], ["These results support the role of Syk in limiting proliferation and invasion of epithelial cells during normal morphogenesis, and emphasize the critical role of Syk as a tumor suppressor for breast cancer.", {"entities": [[191, 204, "DISEASE"], [198, 204, "DISEASE"], [34, 37, "GENE"], [161, 164, "GENE"], [34, 37, "GENE"], [161, 164, "GENE"]]}], ["The question of breast cancer risk following systemic anti-Syk therapy is raised since only partial loss of Syk was sufficient to induce mammary carcinomas.", {"entities": [[16, 29, "DISEASE"], [23, 29, "DISEASE"], [59, 62, "GENE"], [108, 111, "GENE"]]}], ["Asthma is a common disease that affects people of all ages and has significant morbidity and mortality.", {"entities": [[0, 6, "DISEASE"]]}], ["Poor outcomes and health disparities related to asthma result in part from the difficulty of disseminating new evidence and care delivery methods such as shared decision making (SDM) into clinical practice.", {"entities": [[48, 54, "DISEASE"]]}], ["This 3-year study explores the ideal framework for rapid dissemination of an evidence-based SDM toolkit for asthma management.", {"entities": [[108, 114, "DISEASE"]]}], ["The study leverages a partnership between the North Carolina (NC) statewide Medicaid network and the NC Network Consortium of practice-based research networks (PBRNs).", {"entities": []}], ["This non-blinded study will randomize 30 primary care clinics in NC stratified by four PBRNs.", {"entities": []}], ["We will test dissemination across these practices using a facilitator-led participatory approach to dissemination (FLOW), a novel method of participatory dissemination involving key principles of community-based participatory research, and a more typical \u201clunch and learn\u201d dissemination method.", {"entities": []}], ["Specifically, we will use cluster randomization to assign each of the 30 practices to one of three arms: (1) control, no dissemination; (2) traditional dissemination, one didactic session a year and distribution of educational material; and (3) FLOW dissemination.", {"entities": []}], ["We hypothesize that at the unit of randomization, the clinic, patients in the FLOW dissemination arm will be more likely to share in their treatment decisions compared to patients in the traditional dissemination or control arms.", {"entities": []}], ["All outcomes will be measured at the level of the clinic.", {"entities": []}], ["Adoption of the SDM approach will be evaluated by 1) asthma exacerbations, 2) level of patient involvement in the decision making process, and 3) qualitative assessments from patients and providers.", {"entities": [[53, 59, "DISEASE"]]}], ["The research question is: What dissemination strategy most effectively increases practice level adoption of a shared decision making approach to asthma management?", {"entities": [[145, 151, "DISEASE"]]}], ["This study will provide important data to support best practices in dissemination of an evidence-based toolkit and implementation of shared decision making into primary care practices.", {"entities": []}], ["The trial was registered on January 27, 2014 through the United States National Institutes of Health\u2019s ClinicalTrials.gov NCT02047929 and funded by the Patient-Centered Outcomes Research Institute (PCORI).", {"entities": []}], ["Recent studies have suggested that eosinophils may have a direct effect on airway smooth muscle cells (ASMC), causing their proliferation in patients with asthma, but the precise mechanism of the interaction between these cells remains unknown.", {"entities": [[155, 161, "DISEASE"]]}], ["We propose that changes in Wnt signaling activity and extracellular matrix (ECM) production may help explain these findings.", {"entities": []}], ["Therefore, the aim of this study was to investigate the effect of eosinophils from asthmatic and non-asthmatic subjects on Wnt-5a, transforming growth factor \u03b2 1 (TGF-\u03b2 1 ), and ECM protein (fibronectin and collagen) gene expression and ASMC proliferation.", {"entities": []}], ["A total of 18 subjects were involved in the study: 8 steroid-free asthma patients and 10 healthy subjects.", {"entities": [[66, 72, "DISEASE"]]}], ["Peripheral blood eosinophils were isolated using centrifugation and magnetic separation.", {"entities": []}], ["An individual co-culture of eosinophils with human ASMC was prepared for each study subject.", {"entities": []}], ["Adhesion of eosinophils to ASMC (evaluated by assaying eosinophil peroxidase activity) was determined following various incubation periods (30, 45, 60, 120, and 240\u00a0min).", {"entities": []}], ["The expression of Wnt-5a, TGF-\u03b2 1 , and ECM protein genes in ASMC was measured using quantitative real-time polymerase chain reaction (PCR) after 24\u00a0h of co-culture.", {"entities": []}], ["Proliferation of ASMC was measured using the Alamar blue method after 48\u00a0h and 72\u00a0h of co-culture with eosinophils.", {"entities": []}], ["Eosinophils from asthmatic subjects demonstrated increased adhesion to ASMC compared with eosinophils from healthy subjects ( p \u2009<\u20090.05) in vitro.", {"entities": []}], ["The expression of Wnt-5a, TGF-\u03b2 1 , collagen, and fibronectin genes in ASMC was significantly higher after 24\u00a0h of co-culture with eosinophils from asthmatic subjects, while co-culture of ASMC with eosinophils from healthy subjects increased only TGF-\u03b2 1 and fibronectin gene expression.", {"entities": []}], ["ASMC proliferation was augmented after co-culture with eosinophils from asthma patients compared with co-culture with eosinophils from healthy subjects ( p \u2009<\u20090.05).", {"entities": [[72, 78, "DISEASE"]]}], ["Eosinophils enhance Wnt-5a, TGF-\u03b2 1 , fibronectin, and collagen gene expression in ASMC and promote proliferation of these cells in asthma.", {"entities": [[132, 138, "DISEASE"]]}], ["ClinicalTrials.gov Identifier: NCT02648074 .", {"entities": []}], ["Several symptoms are classically thought to be suggestive of pertussis in children, but the diagnostic value of these symptoms in adolescent and adult patients is unclear.", {"entities": [[61, 70, "DISEASE"]]}], ["We evaluated the accuracy of the clinical findings for the early presumptive diagnosis of pertussis in adolescent and adult patients.", {"entities": [[90, 99, "DISEASE"]]}], ["Furthermore, we measured fractional exhaled nitric oxide (FeNO) with regard to whether we could distinguish eosinophilic inflammation of the airway and pertussis.", {"entities": [[152, 161, "DISEASE"]]}], ["FeNO is not expected to be associated with pertussis.", {"entities": [[43, 52, "DISEASE"]]}], ["We compared 183 cases with laboratory-confirmed pertussis using serology and polymerase chain reaction and 1,132 cases without laboratory-confirmed pertussis.", {"entities": [[48, 57, "DISEASE"], [148, 157, "DISEASE"]]}], ["Among pertussis patients, paroxysmal cough was common with 90% sensitivity, but the specificity was low (25%).", {"entities": [[6, 15, "DISEASE"]]}], ["Posttussive vomiting and whoop were less common (sensitivity 25% and 19%, respectively), but both showed greater specificity for pertussis (80% and 86%, respectively).", {"entities": [[129, 138, "DISEASE"]]}], ["Posttussive gagging was observed with intermediate frequency and provided greater specificity (49% and 77%, respectively).", {"entities": []}], ["Pertussis cases were most frequent between May and August with a peak in June.", {"entities": [[0, 9, "DISEASE"]]}], ["The mean FeNO value for the pertussis patients was 18.2\u2009\u00b1\u20099.2\u00a0ppb, which was significantly lower than that in asthma patients (56.9\u2009\u00b1\u200920.3\u00a0ppb, p <0.001).", {"entities": [[28, 37, "DISEASE"], [110, 116, "DISEASE"]]}], ["The most useful definition was posttussive vomiting and/or gagging, and a plus normal FeNO value, which had a sensitivity of 72% and a specificity of 70%.", {"entities": []}], ["Clinical symptoms and laboratory data are of limited value in making the diagnosis of pertussis, and it was clinically difficult to differentiate adolescent and adult patients with or without pertussis.", {"entities": [[86, 95, "DISEASE"], [192, 201, "DISEASE"]]}], ["However, pertussis should be considered if patients have posttussive vomiting and/or gagging and a normal FeNO concentration.", {"entities": [[9, 18, "DISEASE"]]}], ["Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide.", {"entities": []}], ["Studies suggest that the use of misoprostol may be beneficial in clinical settings where oxytocin is unavailable.", {"entities": []}], ["The aim of this study was to compare the safety and efficacy of oxytocin and misoprostol when used in the prevention of PPH.", {"entities": []}], ["In a double-blind randomized controlled trial, 400 pregnant women who had a vaginal delivery were assigned into two groups: to receive either 20 IU of oxytocin in 1000\u2009mL Ringer's solution and two placebo tablets or 400\u2009mcg oral misoprostol (as two tablets) and 2\u2009mL normal saline in 1000\u2009mL Ringer's solution.", {"entities": []}], ["The quantity of blood loss was higher in the oxytocin group in comparison to the misoprostol group.", {"entities": []}], ["There was no significant difference in the decrease in hematocrit and hemoglobin between the two groups.", {"entities": []}], ["Although there was no significant difference in the need for transfusions between the two groups, the patients in the oxytocin group had greater need for additional oxytocin.", {"entities": []}], ["Results from this study indicate that it may be considered as an alternative for oxytocin in low resource clinical settings.", {"entities": []}], ["This study is registered with ClinicalTrials.gov NCT01863706 .", {"entities": []}], ["Hantaan virus (HTNV) causes a severe lethal haemorrhagic fever with renal syndrome (HFRS) in humans.", {"entities": [[74, 82, "DISEASE"]]}], ["Despite a limited understanding of the pathogenesis of HFRS, the importance of the abundant production of pro-inflammatory cytokines has been widely recognized.", {"entities": []}], ["Interleukin 33 (IL-33) has been demonstrated to play an important role in physiological and pathological immune responses.", {"entities": []}], ["After binding to its receptor ST2L, IL-33 stimulates the Th2-type immune response and promotes cytokine production.", {"entities": []}], ["Depending on the disease model, IL-33 either protects against infection or exacerbates inflammatory disease, but it is unknown how the IL-33/ST2 axis regulates the immune response during HTNV infection.", {"entities": []}], ["Blood samples were collected from 23 hospitalized patients and 28 healthy controls.", {"entities": []}], ["The levels of IL-33 and soluble ST2 (sST2) in plasma were quantified by ELISA, and the relationship between IL-33, sST2 and the disease severity was analyzed.", {"entities": []}], ["The role of IL-33/sST2 axis in the production of pro-inflammatory cytokines was studied on HTNV-infected endothelial cells.", {"entities": []}], ["The results showed that the plasma IL-33 and sST2 were significantly higher in patients than in healthy controls.", {"entities": []}], ["Spearman analysis showed that elevated IL-33 and sST2 levels were positively correlated with white blood cell count and viral load, while negatively correlated with platelet count.", {"entities": []}], ["Furthermore, we found that IL-33 enhanced the production of pro-inflammatory cytokines in HTNV-infected endothelial cells through NF-\u03baB pathway and that this process was inhibited by the recombinant sST2.", {"entities": []}], ["Our results indicate that the IL-33 acts as an initiator of the \u201ccytokine storm\u201d during HTNV infection, while sST2 can inhibit this process.", {"entities": []}], ["Our findings could provide a promising immunotherapeutic target for the disease control.", {"entities": []}], ["Hantaan virus (HTNV) causes human hemorrhagic fever with renal syndrome (HFRS) with a mortality rate of approximately 15% in Asia.", {"entities": [[63, 71, "DISEASE"], [34, 71, "DISEASE"]]}], ["At present, the primary treatment for HFRS is limited to critical care management and the use of anti-viral drugs, such as Ribavirin.", {"entities": []}], ["However, the cytokine storm at the acute phase of HFRS, which is thought to contribute to the development of the disease, is still lacking an effective way to prevent.", {"entities": []}], ["An alternative way to prevent the development of cytokine storm is of priority to overcome the problem.", {"entities": []}], ["We found that IL-33 and sST2 levels were higher in the plasma of HFRS patients, especially in their acute phase.", {"entities": []}], ["Although both of them were positively correlated with the severity of the diseases, they acted in different roles in the regulation of the immune response during HTNV infection.", {"entities": []}], ["In vitro study showed that IL-33 acted as an initiator of the cytokine storm in HTNV-infected endothelial cells, while sST2 acted as an inhibitor of the process.", {"entities": []}], ["For the first time, we defined the IL-33/ST2 axis as inflammatory regulators during HTNV infection.", {"entities": []}], ["Our results may provide a novel therapeutic target of HTNV infections.", {"entities": []}], ["This crossover, randomized, double-blind study (conducted over a 32-week period) was performed to determine, in clinically stable Cystic fibrosis (CF) preschool children: the effects of 7% inhaled hypertonic saline on spirometry and interrupter resistance technique (Rint), and the possible side effects.", {"entities": []}], ["Twelve CF children (6M, mean age\u00a0\u00b1\u00a0SD: 5.7\u00a0\u00b1\u00a00.8\u00a0yrs) were enrolled and randomly assigned to receive hypertonic saline (HS-4\u00a0ml 7% sodium chloride), or normal saline (NS-0.9% sodium chloride) twice a day.", {"entities": []}], ["After a 16\u00a0weeks period, therapy was exchanged to allow all the patients enrolled in the study to carry out both treatments.", {"entities": []}], ["Monitoring visits, spirometry (COSMED Quark PFT4 ergo) and Rint were scheduled at 0,4,16,20,32\u00a0weeks.", {"entities": []}], ["At T0, spirometric measurements and Rint were performed immediately before and 30\u00a0min after the inhalation therapy.", {"entities": []}], ["Salbutamol (400 mcg) was administered before the drug at each visit.", {"entities": []}], ["After a 16-weeks treatment with HS an improvement of FVC ( p \u00a0=\u00a00.02) and a favorable trend of FEV1 were registered.", {"entities": []}], ["A worsening of FEV 1 ( p \u00a0<\u00a00.0001) and of FEF25-75 ( p \u00a0=\u00a00.019) were found in NS group.", {"entities": [[15, 18, "GENE"]]}], ["No differences were found in expiratory and inspiratory Rint in both groups.", {"entities": []}], ["No serious adverse events occurred.", {"entities": []}], ["Seven percent hypertonic saline therapy proved to be a useful and safe treatment in young CF children with clinically stable conditions.", {"entities": []}], ["ISRCTN12345678 .", {"entities": []}], ["Analysis of exhaled breath condensate (EBC) is a noninvasive method to access the epithelial lining fluid of the lungs.", {"entities": []}], ["Due to standardization problems the method has not entered clinical practice.", {"entities": []}], ["The aim of the study was to assess the comparability for two commercially available devices in healthy controls.", {"entities": []}], ["In addition, we assessed different breathing patterns in healthy controls with protein markers to analyze the source of the EBC.", {"entities": []}], ["EBC was collected from ten subjects using the RTube and ECoScreen Turbo in a randomized crossover design, twice with every device - once in tidal breathing and once in hyperventilation.", {"entities": []}], ["EBC conductivity, pH, surfactant protein A, Clara cell secretory protein and total protein were assessed.", {"entities": []}], ["Bland-Altman plots were constructed to display the influence of different devices or breathing patterns and the intra-class correlation coefficient (ICC) was calculated.", {"entities": []}], ["The volatile organic compound profile was measured using the electronic nose Cyranose 320.", {"entities": []}], ["For the analysis of these data, the linear discriminant analysis, the Mahalanobis distances and the cross-validation values (CVV) were calculated.", {"entities": []}], ["Neither the device nor the breathing pattern significantly altered EBC pH or conductivity.", {"entities": []}], ["ICCs ranged from 0.61 to 0.92 demonstrating moderate to very good agreement.", {"entities": []}], ["Protein measurements were greatly influenced by breathing pattern, the device used, and the way in which the results were reported.", {"entities": []}], ["The electronic nose could distinguish between different breathing patterns and devices, resulting in Mahalanobis distances greater than 2 and CVVs ranging from 64% to 87%.", {"entities": []}], ["EBC pH and (to a lesser extent) EBC conductivity are stable parameters that are not influenced by either the device or the breathing patterns.", {"entities": []}], ["Protein measurements remain uncertain due to problems of standardization.", {"entities": []}], ["We conclude that the influence of the breathing maneuver translates into the necessity to keep the volume of ventilated air constant in further studies.", {"entities": []}], ["Inflammasome-activated IL-1\u03b2 plays a major role in lung neutrophilic inflammation induced by inhaled silica.", {"entities": []}], ["However, the exact mechanisms that contribute to the initial production of precursor IL-1\u03b2 (pro-IL-1\u03b2) are still unclear.", {"entities": []}], ["Here, we assessed the implication of alarmins (IL-1\u03b1, IL-33 and HMGB1) in the lung response to silica particles and found that IL-1\u03b1 is a master cytokine that regulates IL-1\u03b2 expression.", {"entities": [[64, 69, "GENE"]]}], ["Pro- and mature IL-1\u03b2 as well as alarmins were assessed by ELISA, Western Blot or qRT-PCR in macrophage cultures and in mouse lung following nano- and micrometric silica exposure.", {"entities": []}], ["Implication of these immune mediators in the establishment of lung inflammatory responses to silica was investigated in knock-out mice or after antibody blockade by evaluating pulmonary neutrophil counts, CXCR2 expression and degree of histological injury.", {"entities": [[205, 210, "GENE"]]}], ["We found that the early release of IL-1\u03b1 and IL-33, but not HMGB1 in alveolar space preceded the lung expression of pro-IL-1\u03b2 and neutrophilic inflammation in silica-treated mice.", {"entities": [[60, 65, "GENE"]]}], ["In vitro , the production of pro-IL-1\u03b2 by alveolar macrophages was significantly induced by recombinant IL-1\u03b1 but not by IL-33.", {"entities": []}], ["Neutralization or deletion of IL-1\u03b1 reduced IL-1\u03b2 production and neutrophil accumulation after silica in mice.", {"entities": []}], ["Finally, IL-1\u03b1 released by J774 macrophages after in vitro exposure to a range of micro- and nanoparticles of silica was correlated with the degree of lung inflammation induced in vivo by these particles.", {"entities": []}], ["We demonstrated that in response to silica exposure, IL-1\u03b1 is rapidly released from pre-existing stocks in alveolar macrophages and promotes subsequent lung inflammation through the stimulation of IL-1\u03b2 production.", {"entities": []}], ["Moreover, we demonstrated that in vitro IL-1\u03b1 release from macrophages can be used to predict the acute inflammogenic activity of silica micro- and nanoparticles.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-014-0069-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Caspase Recruitment Domain (CARD) from the innate immune receptor NOD1 was crystallized with Ubiquitin (Ub).", {"entities": [[70, 74, "GENE"]]}], ["NOD1 CARD was present as a helix-swapped homodimer similar to other structures of NOD1 CARD, and Ub monomers formed a homodimer similar in conformation to Lys48-linked di-Ub.", {"entities": [[0, 4, "GENE"], [82, 86, "GENE"], [0, 4, "GENE"], [82, 86, "GENE"]]}], ["The interaction between NOD1 CARD and Ub in the crystal was mediated by novel binding sites on each molecule.", {"entities": [[24, 28, "GENE"]]}], ["Comparisons of these sites to previously identified interaction surfaces on both molecules were made along with discussion of their potential functional significance.", {"entities": []}], ["Human coronavirus 229E (HCoV-229E) infection in infants, elderly people, and immunocompromised patients can cause severe disease, thus calling for the development of effective and safe therapeutics to treat it.", {"entities": []}], ["Here we reported the design, synthesis and characterization of two peptide-based membrane fusion inhibitors targeting HCoV-229E spike protein heptad repeat 1 (HR1) and heptad repeat 2 (HR2) domains, 229E-HR1P and 229E-HR2P, respectively.", {"entities": []}], ["We found that 229E-HR1P and 229E-HR2P could interact to form a stable six-helix bundle and inhibit HCoV-229E spike protein-mediated cell-cell fusion with IC 50 of 5.7 and 0.3 \u00b5M, respectively.", {"entities": []}], ["229E-HR2P effectively inhibited pseudotyped and live HCoV-229E infection with IC 50 of 0.5 and 1.7 \u00b5M, respectively.", {"entities": []}], ["In a mouse model, 229E-HR2P administered intranasally could widely distribute in the upper and lower respiratory tracts and maintain its fusion-inhibitory activity.", {"entities": []}], ["Therefore, 229E-HR2P is a promising candidate for further development as an antiviral agent for the treatment and prevention of HCoV-229E infection.", {"entities": []}], ["Macrophages play pleiotropic, niche-specific roles in all tissues and organs.", {"entities": []}], ["As immune sentinels, tissue macrophages regulate immune activation and inflammation; in turn, their function is modulated by inflammatory mediators deriving from such activation.", {"entities": []}], ["Recent papers have established unanticipated roles for interleukin 4 and the alternative activation of tissue macrophages in the organismal response to diverse environmental stressors.", {"entities": []}], ["Background.", {"entities": []}], ["There is limited literature available identifying and describing the instruments that measure cultural competence in nursing students and nursing professionals.", {"entities": []}], ["An integrative review was undertaken to identify the characteristics common to these instruments, examine their psychometric properties, and identify the concepts these instruments are designed to measure.", {"entities": []}], ["There were eleven instruments identified that measure cultural competence in nursing.", {"entities": []}], ["Of these eleven instruments, four had been thoroughly tested in either initial development or in subsequent testing, with developers providing extensive details of the testing.", {"entities": []}], ["The current literature identifies that the instruments to assess cultural competence in nurses and nursing students are self-administered and based on individuals' perceptions.", {"entities": []}], ["The instruments are commonly utilized to test the effectiveness of educational programs designed to increase cultural competence.", {"entities": []}], ["Conclusions.", {"entities": []}], ["The reviewed instruments measure nurses' self-perceptions or self-reported level of cultural competence but offer no objective measure of culturally competent care from a patient's perspective which can be problematic.", {"entities": []}], ["Comparison of instruments reveals that they are based on a variety of conceptual frameworks and that multiple factors should be considered when deciding which instrument to use.", {"entities": []}], ["Multimorbidity becomes increasingly prevalent with ageing.", {"entities": []}], ["Polypharmacy is often associated with multimorbidity because patients accrue medications to treat each individual disease; however, there is uncertainty around the generalisability of disease-specific guidelines.", {"entities": []}], ["Namely, the extrapolation of results from studies conducted in younger patients to older adults with multimorbidity.", {"entities": []}], ["The main objective of this scoping review is to explore our current knowledge of the outcomes that older adults with multimorbidity experience from taking prescribed medications.", {"entities": []}], ["A scoping review will be conducted to explore what is known about the outcomes experienced by older adults with multimorbidity who are taking guideline-recommended medications and to identify areas for future research.", {"entities": []}], ["In addition to searching the grey literature, the following databases will be searched from 1990 onward: MEDLINE, EMBASE, PsycINFO and the Cochrane Library.", {"entities": []}], ["Experimental, quasi-experimental and non-experimental studies consisting of patients \u226565\u2005years old who have two or more comorbid conditions (explicitly grouped together for the purpose of analysis) and who are being prescribed a guideline-recommended prescription medication for a chronic condition will be considered for inclusion in our scoping review.", {"entities": []}], ["We will describe patient (eg, mortality, morbidity, quality of life) and health system (eg, number of emergency department visits or hospitalisations, cost to third-party payer) outcomes associated with the prescription of medications for older adults who have two or more chronic comorbid conditions.", {"entities": []}], ["Two reviewers will complete all screening and data abstraction independently.", {"entities": []}], ["Data will be synthesised with descriptive statistics.", {"entities": []}], ["Ethics approval is not required because this is a scoping review of published literature.", {"entities": []}], ["Results will be disseminated through conference presentations and publication in a peer-reviewed journal.", {"entities": []}], ["Antineutrophil cytoplasm antibody-associated vasculitis (AAV) is a form of systemic vasculitis.", {"entities": [[45, 55, "DISEASE"], [84, 94, "DISEASE"]]}], ["The current standard induction therapy with the combination of high-dose glucocorticoids and cyclophosphamide or rituximab has high remission rates of 80%\u201390%.", {"entities": []}], ["However, it is also associated with various side effects, including death due to infection or cardiovascular disease.", {"entities": []}], ["There is an unmet medical need of a new therapy to reduce side effects.", {"entities": []}], ["This is a phase IV multicentre, open-label, randomised controlled trial that aims to evaluate the efficacy and safety of a new remission induction regimen with the combination of low-dose glucocorticoids and rituximab.", {"entities": []}], ["Newly diagnosed patients with AAV will be assessed for eligibility at 34 tertiary rheumatology/nephrology centres in Japan.", {"entities": []}], ["One hundred and forty patients will be randomised (1:1) to receive low-dose prednisolone (0.5\u2009mg/kg daily) plus rituximab (375\u2009mg/m The protocol was first approved by the Institutional Review Board of Chiba University Hospital (reference number: G25051), and then approved by each participating site.", {"entities": []}], ["The trial was registered at the University hospital Medical Information Network (UMIN) clinical registry (UMIN000014222) and ClinicalTrials.gov registry (NCT02198248).", {"entities": []}], ["The Low-dose Glucocorticoid Vasculitis Induction Study (LoVAS) trial is currently ongoing and is due to finish in September 2019.", {"entities": [[28, 38, "DISEASE"]]}], ["The findings of this trial will be disseminated to participants through peer-reviewed publications and presented at national and international conferences in accordance with the Consolidated Standards of Reporting Trials (CONSORT) Statement.", {"entities": []}], ["UMIN000014222; NCT02198248.", {"entities": []}], ["Atrial fibrillation (AF) is a common, growing, and costly medical condition.", {"entities": []}], ["We aimed to evaluate the impact of a management algorithm for symptomatic AF that used an emergency department observation unit on hospital admission rates and patient outcomes.", {"entities": []}], ["This retrospective cohort study compared 563 patients who presented consecutively in the year after implementation of the algorithm, from July 2013 through June 2014 (intervention group), with 627 patients in a historical cohort (preintervention group) who presented consecutively from July 2011 through June 2012.", {"entities": []}], ["All patients who consented to have their records used for chart review were included if they had a primary final emergency department diagnosis of AF .", {"entities": []}], ["We observed no significant differences in age, sex, vital signs, body mass index, or CHADS 2 (congestive heart failure, hypertension, age, diabetes mellitus, and prior stroke or transient ischemic attack) score between the preintervention and intervention groups.", {"entities": [[94, 118, "DISEASE"], [120, 132, "DISEASE"], [139, 156, "DISEASE"]]}], ["The rate of inpatient admission was significantly lower in the intervention group (from 45% to 36%; P <0.001).", {"entities": []}], ["The groups were not significantly different with regard to rates of return emergency department visits (19% versus 17%; P =0.48), hospitalization (18% versus 16%; P =0.22), or adverse events (2% versus 2%; P =0.95) within 30\u00a0days.", {"entities": []}], ["Emergency department observation unit admissions were 40% ( P <0.001) less costly than inpatient hospital admissions of \u22641\u00a0day's duration.", {"entities": []}], ["Implementation of an emergency department observation unit AF algorithm was associated with significantly decreased hospital admissions without increasing the rates of return emergency department visits, hospitalization, or adverse events within 30\u00a0days.", {"entities": []}], ["A >7-year, time-series, epidemiologic study is ongoing in Spokane, Washington, to examine the associations between ambient particulate constituents or sources and health outcomes such as emergency department (ED) visits for asthma or respiratory problems.", {"entities": [[224, 230, "DISEASE"]]}], ["One of the hypotheses being tested is that particulate toxic metals are associated with these health outcomes.", {"entities": []}], ["Spokane is a desirable city in which to conduct this study because of its relatively high concentrations of particulate matter, low concentrations of potentially confounding air pollutants, variability of particulate sources, and presence of several potential particulate metals sources.", {"entities": []}], ["Daily fine- and coarse-fraction particulate samples are analyzed for metals via energy-dispersive X-ray fluorescence (EDXRF) and instrumental neutron activation analysis.", {"entities": []}], ["Particulate sources are determined using receptor modeling, including chemical mass balancing and positive matrix factorization coupled with partial source contribution function analysis.", {"entities": []}], ["Principal component analysis has also been used to examine the influence of sources on the daily variability of the chemical composition of particulate samples.", {"entities": []}], ["Based upon initial analyses using the EDXRF elemental analyses, statistically significant associations were observed between ED visits for asthma and increased combustion products, air stagnation, and fine particulate Zn.", {"entities": [[139, 145, "DISEASE"]]}], ["Although there is a significant soil particulate component, increased crustal particulate levels were not found to be associated with ED visits for asthma.", {"entities": [[148, 154, "DISEASE"]]}], ["Further research will clarify whether there is an association between specific health outcomes and either coarse or fine particulate metal species.", {"entities": []}], ["Approximately 5-10% of persons infected with M. tuberculosis develop tuberculosis, but the factors associated with disease progression are incompletely understood.", {"entities": [[48, 60, "DISEASE"], [69, 81, "DISEASE"]]}], ["Both linkage and association studies have identified human genetic variants associated with susceptibility to pulmonary tuberculosis, but few genetic studies have evaluated extrapulmonary disease.", {"entities": [[120, 132, "DISEASE"], [110, 132, "DISEASE"]]}], ["Because extrapulmonary and pulmonary tuberculosis likely have different underlying pathophysiology, identification of genetic mutations associated with extrapulmonary disease is important.", {"entities": [[37, 49, "DISEASE"], [27, 49, "DISEASE"]]}], ["We performed a pilot genome-wide association study among 24 persons with previous extrapulmonary tuberculosis and well-characterized immune defects; 24 pulmonary tuberculosis patients and 57 patients with M. tuberculosis infection served as controls.", {"entities": [[97, 109, "DISEASE"], [162, 174, "DISEASE"], [208, 220, "DISEASE"], [82, 109, "DISEASE"], [152, 174, "DISEASE"]]}], ["The Affymetrix GeneChip Human Mapping Xba Array was used for genotyping; after careful quality control, genotypes at 44,175 single nucleotide polymorphisms (SNPs) were available for analysis.", {"entities": []}], ["Eigenstrat quantified population stratification within our sample; logistic regression, using results of the Eigenstrat analysis as a covariate, identified significant associations between groups.", {"entities": []}], ["Permutation testing controlled the family-wise error rate for each comparison between groups.", {"entities": []}], ["Four SNPs were significantly associated with extrapulmonary tuberculosis compared to controls with M. tuberculosis infection; one (rs4893980) in the gene PDE11A, one (rs10488286) in KCND2, and one (rs2026414) in PCDH15; one was in chromosome 7 but not associated with a known gene.", {"entities": [[60, 72, "DISEASE"], [102, 114, "DISEASE"], [45, 72, "DISEASE"], [154, 160, "GENE"], [182, 187, "GENE"], [212, 218, "GENE"]]}], ["Two additional variants were significantly associated with extrapulmonary tuberculosis compared with pulmonary tuberculosis; one (rs340708) in the gene FAM135B and one in chromosome 13 but not associated with a known gene.", {"entities": [[74, 86, "DISEASE"], [111, 123, "DISEASE"], [59, 86, "DISEASE"], [101, 123, "DISEASE"], [152, 159, "GENE"]]}], ["The function of all four genes affects cell signaling and activity, including in the brain.", {"entities": []}], ["In this pilot study, we identified 6 novel variants not previously known to be associated with extrapulmonary tuberculosis, including two SNPs more common in persons with extrapulmonary than pulmonary tuberculosis.", {"entities": [[110, 122, "DISEASE"], [201, 213, "DISEASE"], [95, 122, "DISEASE"], [191, 213, "DISEASE"]]}], ["This provides some support for the hypothesis that the pathogenesis and genetic predisposition to extrapulmonary tuberculosis differs from pulmonary tuberculosis.", {"entities": [[113, 125, "DISEASE"], [149, 161, "DISEASE"], [98, 125, "DISEASE"], [139, 161, "DISEASE"]]}], ["Further study of these novel SNPs, and more well-powered genome-wide studies of extrapulmonary tuberculosis, is warranted.", {"entities": [[95, 107, "DISEASE"], [80, 107, "DISEASE"]]}], ["The role of neutrophil and lymphocyte counts in blood as prognosis predictors in Community Acquired Pneumonia (CAP) has not been adequately studied.", {"entities": []}], ["This was a derivation-validation retrospective study in hospitalized patients with CAP and no prior immunosuppression.", {"entities": []}], ["We evaluated by multivariate analysis the association between neutrophil and lymphocyte counts and mortality risk at 30-days post hospital admission in these patients.", {"entities": []}], ["The derivation cohort (n\u00a0=\u00a01550 patients) was recruited in a multi-site study.", {"entities": []}], ["The validation cohort (n\u00a0=\u00a02846 patients) was recruited in a single-site study.", {"entities": []}], ["In the derivation cohort, a sub-group of lymphopenic patients, those with <\u00a0724\u00a0lymphocytes/mm \u2022 Lymphopenia is a frequent finding in hospitalized patients with CAP, affecting approximately 50% of the patients.", {"entities": [[97, 108, "DISEASE"]]}], ["\u2022 Lymphopenic CAP (L-CAP) with <\u00a0724 lymphocytes/mm \u2022 Assessing lymphocyte counts at hospital admission could contribute to personalized clinical management and treatment in CAP.", {"entities": []}], ["Lymphopenia is a frequent finding in hospitalized patients with CAP, affecting approximately 50% of the patients.", {"entities": [[0, 11, "DISEASE"]]}], ["Lymphopenic CAP (L-CAP) with <\u00a0724 lymphocytes/mm Assessing lymphocyte counts at hospital admission could contribute to personalized clinical management and treatment in CAP.", {"entities": []}], ["Our study reveals the existence of lymphopenia (<\u00a01000 lymphocytes/mm", {"entities": [[35, 46, "DISEASE"]]}], ["Bickerstaff\u2019s brainstem encephalitis (BBE), together with Miller Fisher syndrome (MFS) and Guillain-Barr\u00e9 syndrome (GBS) were considered to form a continuous clinical spectrum.", {"entities": [[72, 80, "DISEASE"], [106, 114, "DISEASE"], [24, 36, "DISEASE"]]}], ["An anti-GQ1b antibody syndrome has been proposed to underlie the common pathophysiology for the three disorders; however, other studies have found a positive anti-GM1 instead of anti-GQ1b antibody.", {"entities": [[22, 30, "DISEASE"]]}], ["Here we report a 20-year-old male patient with overlapping BBE, MFS and GBS.", {"entities": []}], ["The patient had a positive family history of bronchial asthma and had suffered from the condition for over 15\u2009years.", {"entities": [[55, 61, "DISEASE"]]}], ["He developed BBE symptoms nine days after an asthma exacerbation.", {"entities": [[45, 51, "DISEASE"]]}], ["During the course of illness, he had significantly elevated IgE levels in both serum and cerebrospinal fluid.", {"entities": []}], ["Serologic analysis of antibodies against ganglioside complexes (anti-GDIa, anti-GDIb, anti-GM1, anti-GM2, anti-GM3, anti-GQIb and anti-GTIb antibodies) showed negative results.", {"entities": []}], ["Since asthma has recently been related to autoimmune disease, our case supports an autoimmune mechanism underlying the clinical spectrum composed of BBE, MFS and GBS.", {"entities": [[6, 12, "DISEASE"]]}], ["However, contrary to a proposed anti-GQ1b antibody syndrome, we would suggest that pathogenesis of this clinical spectrum is not limited to anti-ganglioside antibodies.", {"entities": [[51, 59, "DISEASE"]]}], ["Purely epistatic multi-locus interactions cannot generally be detected via single-locus analysis in case-control studies of complex diseases.", {"entities": []}], ["Recently, many two-locus and multi-locus analysis techniques have been shown to be promising for the epistasis detection.", {"entities": []}], ["However, exhaustive multi-locus analysis requires prohibitively large computational efforts when problems involve large-scale or genome-wide data.", {"entities": []}], ["Furthermore, there is no explicit proof that a combination of multiple two-locus analyses can lead to the correct identification of multi-locus interactions.", {"entities": []}], ["The proposed 2LOmb algorithm performs an omnibus permutation test on ensembles of two-locus analyses.", {"entities": []}], ["The algorithm consists of four main steps: two-locus analysis, a permutation test, global p -value determination and a progressive search for the best ensemble.", {"entities": []}], ["2LOmb is benchmarked against an exhaustive two-locus analysis technique, a set association approach, a correlation-based feature selection (CFS) technique and a tuned ReliefF (TuRF) technique.", {"entities": []}], ["The simulation results indicate that 2LOmb produces a low false-positive error.", {"entities": []}], ["Moreover, 2LOmb has the best performance in terms of an ability to identify all causative single nucleotide polymorphisms (SNPs) and a low number of output SNPs in purely epistatic two-, three- and four-locus interaction problems.", {"entities": []}], ["The interaction models constructed from the 2LOmb outputs via a multifactor dimensionality reduction (MDR) method are also included for the confirmation of epistasis detection.", {"entities": []}], ["2LOmb is subsequently applied to a type 2 diabetes mellitus (T2D) data set, which is obtained as a part of the UK genome-wide genetic epidemiology study by the Wellcome Trust Case Control Consortium (WTCCC).", {"entities": [[42, 59, "DISEASE"], [35, 59, "DISEASE"]]}], ["After primarily screening for SNPs that locate within or near 372 candidate genes and exhibit no marginal single-locus effects, the T2D data set is reduced to 7,065 SNPs from 370 genes.", {"entities": []}], ["The 2LOmb search in the reduced T2D data reveals that four intronic SNPs in PGM1 (phosphoglucomutase 1), two intronic SNPs in LMX1A (LIM homeobox transcription factor 1, alpha), two intronic SNPs in PARK2 (Parkinson disease (autosomal recessive, juvenile) 2, parkin) and three intronic SNPs in GYS2 (glycogen synthase 2 (liver)) are associated with the disease.", {"entities": [[76, 80, "GENE"], [126, 131, "GENE"], [199, 204, "GENE"], [294, 298, "GENE"]]}], ["The 2LOmb result suggests that there is no interaction between each pair of the identified genes that can be described by purely epistatic two-locus interaction models.", {"entities": []}], ["Moreover, there are no interactions between these four genes that can be described by purely epistatic multi-locus interaction models with marginal two-locus effects.", {"entities": []}], ["The findings provide an alternative explanation for the aetiology of T2D in a UK population.", {"entities": []}], ["An omnibus permutation test on ensembles of two-locus analyses can detect purely epistatic multi-locus interactions with marginal two-locus effects.", {"entities": []}], ["The study also reveals that SNPs from large-scale or genome-wide case-control data which are discarded after single-locus analysis detects no association can still be useful for genetic epidemiology studies.", {"entities": []}], ["Asthma-related mortality has been decreasing due to inhaled corticosteroid use, but severe asthma remains a major clinical problem.", {"entities": [[0, 6, "DISEASE"], [91, 97, "DISEASE"]]}], ["One characteristic of severe asthma is resistance to steroid therapy, which is related to neutrophilic inflammation.", {"entities": [[29, 35, "DISEASE"]]}], ["Recently, the tumor necrosis factor superfamily member (TNFSF) 14/LIGHT has been recognized as a key mediator in severe asthmatic airway inflammation.", {"entities": []}], ["However, the profiles and intracellular mechanisms of cytokine/chemokine production induced in cells by LIGHT are poorly understood.", {"entities": []}], ["We aimed to elucidate the molecular mechanism of LIGHT-induced cytokine/chemokine production by bronchial epithelial cells.", {"entities": []}], ["Human bronchial epithelial cells express lymphotoxin \u03b2 receptor (LT\u03b2R), but not herpesvirus entry mediator, which are receptors for LIGHT.", {"entities": []}], ["LIGHT induced various cytokines/chemokines, such as interleukin (IL)-6, oncostatin M, monocyte chemotactic protein-1, growth-regulated protein \u03b1 and IL-8.", {"entities": []}], ["Specific siRNA for LT\u03b2R attenuated IL-6 and IL-8 production by BEAS-2B and normal human bronchial epithelial cells.", {"entities": []}], ["LIGHT activated intracellular signaling, such as mitogen-activated protein kinase and nuclear factor-\u03baB (NF-\u03baB) signaling.", {"entities": []}], ["LIGHT also induced luciferase activity of NF-\u03baB response element, but not of activator protein-1 or serum response element.", {"entities": []}], ["Specific inhibitors of phosphorylation of extracellular signal-regulated kinase (Erk) and that of inhibitor \u03baB attenuated IL-8 production, suggesting that LIGHT-LT\u03b2R signaling induces IL-8 production via the Erk and NF-\u03baB pathways.", {"entities": []}], ["LIGHT, via LT\u03b2R signaling, may contribute to exacerbation of airway neutrophilic inflammation through cytokine and chemokine production by bronchial epithelial cells.", {"entities": []}], ["The selective, high affinity A 2B adenosine receptor (AdoR) antagonists that were synthesized by several research groups should aid in determining the role of the A 2B AdoR in inflammatory diseases like asthma or rheumatoid arthritis (RA) and angiogenic diseases like diabetic retinopathy or cancer.", {"entities": [[268, 288, "DISEASE"], [213, 233, "DISEASE"], [224, 233, "DISEASE"], [203, 209, "DISEASE"], [292, 298, "DISEASE"]]}], ["CV Therapeutics scientists discovered the selective, high affinity A 2B AdoR antagonist 10 , a 8-(4-pyrazolyl)-xanthine derivative [CVT-6883, K i (hA 2B )\u2009=\u200922\u00a0nM; K i (hA 1 )\u2009=\u20091,940\u00a0nM; K i (hA 2A )\u2009=\u20093,280; and K i (hA 3 )\u2009=\u20091,070\u00a0nM] that has favorable pharmacokinetic (PK) properties ( t 1/2 \u2009=\u20094\u00a0h and F \u2009>\u200935% rat).", {"entities": []}], ["Compound 10 demonstrated functional antagonism at the A 2B AdoR (K B \u2009=\u20096\u00a0nM) and efficacy in a mouse model of asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["In two phase 1 clinical trials, CVT-6883 was found to be safe, well tolerated, and suitable for once daily dosing.", {"entities": []}], ["A second compound 20 , 8-(5-pyrazolyl)-xanthine, has been nominated for development from Baraldi\u2019s group in conjunction with King Pharmaceuticals that has favorable A 2B AdoR affinity and selectivity [K i (hA 2B )\u2009=\u20095.5\u00a0nM; K i (hA 1 ) >\u20091,000\u00a0nM; K i (hA 2A ) >\u20091,000; and K i (hA 3 ) >\u20091,000\u00a0nM], and it has been demonstrated to be a functional antagonist.", {"entities": []}], ["A third compound 32 , a 2-aminopyrimidine, from the Almirall group has high A 2B AdoR affinity and selectivity [K i (hA 2B )\u2009=\u200917\u00a0nM; K i (hA 1 ) >\u20091,000\u00a0nM; K i (hA 2A ) >\u20092,500; and K i (hA 3 ) >\u20091,000\u00a0nM], and 32 has been moved into preclinical safety testing.", {"entities": []}], ["Since three highly selective, high affinity A 2B AdoR antagonists have been nominated for development with 10 (CVT-6883) being the furthest along in the development process, the role of the A 2B AdoR in various disease states will soon be established.", {"entities": []}], ["As dengue spreads to new geographical regions and the force of infection changes in existing endemic areas, a greater breadth of clinical presentations is being recognised.", {"entities": []}], ["Clinical experience suggests that adults manifest a pattern of complications different from those observed in children, but few reports have described the age-related spectrum of disease in contemporaneous groups of patients recruited at the same geographical location.", {"entities": []}], ["Using detailed prospectively collected information from ongoing studies that encompass the full spectrum of hospitalised dengue cases admitted to a single hospital in southern Vietnam, we compared clinical and laboratory features, management, and outcome for 647 adults and 881 children with confirmed dengue.", {"entities": []}], ["Signs of vascular leakage and shock were more frequent and more severe in children than adults, while bleeding manifestations and organ involvement were more common in adults.", {"entities": []}], ["Additionally, adults experienced significantly more severe thrombocytopenia.", {"entities": [[59, 75, "DISEASE"]]}], ["Secondary infection but not serotype was independently associated with greater thrombocytopenia, although with a smaller effect than age-group.", {"entities": [[79, 95, "DISEASE"]]}], ["The effect of age-group on platelet count was also apparent in the values obtained several weeks after recovery, indicating that healthy adults have intrinsically lower counts compared to children.", {"entities": []}], ["There are clear distinctions between adults and children in the pattern of complications seen in association with dengue infection, and these depend partly on intrinsic age-dependent physiological differences.", {"entities": []}], ["Knowledge of such differences is important to inform research on disease pathogenesis, as well as to encourage development of management guidelines that are appropriate to the age-groups at risk.", {"entities": []}], ["Dengue is a common and potentially serious viral illness.", {"entities": []}], ["Complications include plasma leakage from small blood vessels causing shock and dysfunction of the systems that control blood clotting, resulting in bleeding.", {"entities": []}], ["The disease used to affect children predominantly, but in recent years, the number of adult patients has been increasing.", {"entities": []}], ["As there is limited data describing the patterns of complications by age, we performed this study to compare clinical and laboratory features, management, and outcomes of the disease for over 1,500 children and adults with confirmed dengue recruited at the same time at a single hospital in the Southern Vietnam.", {"entities": []}], ["We found that plasma leakage and shock were more common and severe in children than adults, while bleeding and organ dysfunction were more frequent in adults.", {"entities": []}], ["Adults had lower platelet counts throughout the illness course as well as at a follow-up visit several weeks after recovery.", {"entities": []}], ["Platelets are a crucial element in controlling bleeding, and the intrinsically lower counts in adults compared to children may contribute to the greater risk for bleeding in this patient group.", {"entities": []}], ["Knowledge about differences in the patterns of dengue-related complications between children and adults should help clinicians to diagnose and treat patients more effectively.", {"entities": []}], ["Multilineage differentiating stress enduring (Muse) cells, discovered in the spring of 2010 at Tohoku University in Sendai, Japan, were quickly recognized by scientists as a possible source of pluripotent cells naturally present within mesenchymal tissues.", {"entities": []}], ["Muse cells normally exist in a quiescent state, singularly activated by severe cellular stress in vitro and in vivo.", {"entities": []}], ["Muse cells have the capacity for self-renewal while maintaining pluripotent cell characteristics indicated by the expression of pluripotent stem cell markers.", {"entities": []}], ["Muse cells differentiate into cells representative of all three germ cell layers both spontaneously and under media-specific induction.", {"entities": []}], ["In contrast to embryonic stem and induced pluripotent stem cells, Muse cells exhibit low telomerase activity, a normal karyotype, and do not undergo tumorigenesis once implanted in SCID mice.", {"entities": []}], ["Muse cells efficiently home into damaged tissues and differentiate into specific cells leading to tissue regeneration and functional recovery as described in different animal disease models (i.e., fulminant hepatitis, muscle degeneration, skin ulcers, liver cirrhosis, cerebral stroke, vitiligo, and focal segmental glomerulosclerosis).", {"entities": [[286, 294, "DISEASE"], [300, 334, "DISEASE"], [252, 267, "DISEASE"], [207, 216, "DISEASE"]]}], ["Circulating Muse cells have been detected in peripheral blood, with higher levels present in stroke patients during the acute phase.", {"entities": []}], ["Furthermore, Muse cells have inherent immunomodulatory properties, which could contribute to tissue generation and functional repair in vivo.", {"entities": []}], ["Genetic studies in Muse cells indicate a highly conserved cellular mechanism as seen in more primitive organisms (yeast, Saccharomyces cerevisiae , Caenorhabditis elegans , chlamydomonas , Torpedo californica , drosophila , etc.)", {"entities": []}], ["in response to cellular stress and acute injury.", {"entities": []}], ["This review details the molecular and cellular properties of Muse cells as well as their capacity for tissue repair and functional recovery, highlighting their potential for clinical application in regenerative medicine.", {"entities": []}], ["The online version of this article (10.1186/s13287-017-0674-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Socioeconomic inequalities in smoking habits have stabilized in many Western countries.", {"entities": []}], ["This study aimed at evaluating whether socioeconomic disparities in smoking habits are still enlarging in Italy and at comparing the impact of education and occupation.", {"entities": []}], ["In the frame of the GEIRD study (Gene Environment Interactions in Respiratory Diseases) 10,494 subjects, randomly selected from the general population aged 20\u201344 years in seven Italian centres, answered a screening questionnaire between 2007 and 2010 (response percentage\u2009=\u200957.2%).", {"entities": []}], ["In four centres a repeated cross-sectional survey was performed: smoking prevalence recorded in GEIRD was compared with prevalence recorded between 1998 and 2000 in the Italian Study of Asthma in Young Adults (ISAYA).", {"entities": []}], ["Current smoking was twice as prevalent in people with a primary/secondary school certificate (40-43%) compared with people with an academic degree (20%), and among unemployed and workmen (39%) compared with managers and clerks (20-22%).", {"entities": []}], ["In multivariable analysis smoking habits were more affected by education level than by occupation.", {"entities": []}], ["From the first to the second survey the prevalence of ever smokers markedly decreased among housewives, managers, businessmen and free-lancers, while ever smoking became even more common among unemployed (time-occupation interaction: p\u2009=\u20090.047).", {"entities": []}], ["At variance, the increasing trend in smoking cessation was not modified by occupation.", {"entities": []}], ["Smoking prevalence has declined in Italy during the last decade among the higher socioeconomic classes, but not among the lower.", {"entities": []}], ["This enlarging socioeconomic inequality mainly reflects a different trend in smoking initiation.", {"entities": []}], ["Human rhinovirus (HRV) infections are associated with the common cold, occasionally with more serious lower respiratory tract illnesses, and frequently with asthma exacerbations.", {"entities": [[58, 69, "DISEASE"], [157, 163, "DISEASE"]]}], ["The clinical features of HRV infection and its association with asthma exacerbation suggest that some HRV disease results from virus-induced host immune responses to infection.", {"entities": [[64, 70, "DISEASE"]]}], ["To study the HRV-infection-induced host responses and the contribution of these responses to disease, we have developed an in vitro model of HRV infection of human airway epithelial cells (Calu-3 cells) and subsequent exposure of human peripheral blood mononuclear cells (PBMCs) to these infected cells in a two-chamber trans-well tissue culture system.", {"entities": []}], ["Using this model, we studied HRV 14 (species B) and HRV 16 (species A) induced cytokine and chemokine responses with PBMCs from four healthy adults.", {"entities": []}], ["Infection of Calu-3 cells with either virus induced HRV-associated increases in FGF-Basic, IL-15, IL-6, IL-28A, ENA-78 and IP-10.", {"entities": []}], ["The addition of PBMCs to HRV 14-infected cells gave significant increases in MIP-1\u03b2, IL-28A, MCP-2, and IFN-\u03b1 as compared with mock-infected cells.", {"entities": []}], ["Interestingly, ENA-78 levels were reduced in HRV 14 infected cells that were exposed to PBMCs.", {"entities": []}], ["Addition of PBMCs to HRV 16-infected cells did not induce MIP-1\u03b2, IL-28A and IFN-\u03b1 efficiently nor did it decrease ENA-78 levels.", {"entities": []}], ["Our results demonstrate a clear difference between HRV 14 and HRV 16 and the source of PBMCs, in up or down regulation of several cytokines including those that are linked to airway inflammation.", {"entities": []}], ["Such differences might be one of the reasons for variation in disease associated with different HRV species including variation in their link to asthma exacerbations as suggested by other studies.", {"entities": [[145, 151, "DISEASE"]]}], ["Further study of immune responses associated with different HRVs and PBMCs from different patient groups, and the mechanisms leading to these differences, should help characterize pathogenesis of HRV disease and generate novel approaches to its treatment.", {"entities": []}], ["Surface major histocompatibility complex class I-related chain (MIC) A and B molecules are increased by IL-15 and have a role in the activation of natural killer group 2 member D-positive natural killer and CD8 T cells.", {"entities": []}], ["MICA and MICB also exist in soluble forms (sMICA and sMICB).", {"entities": [[9, 13, "GENE"]]}], ["Rhinoviruses (RVs) are the major cause of asthma exacerbations, and IL-15 levels are decreased in the airways of subjects with asthma.", {"entities": [[42, 48, "DISEASE"], [127, 133, "DISEASE"]]}], ["The role of MIC molecules in immune responses in the lung has not been studied.", {"entities": []}], ["Here, we determine the relationship between MICA and MICB and RV infection in vitro in respiratory epithelial cells and in vivo in healthy subjects and subjects with asthma.", {"entities": [[166, 172, "DISEASE"], [53, 57, "GENE"]]}], ["Surface MICA and MICB, as well as sMICA and sMICB, in respiratory epithelial cells were measured in vitro in response to RV infection and exposure to IL-15.", {"entities": [[17, 21, "GENE"]]}], ["Levels of sMICA and sMICB in serum, sputum, and BAL were measured and correlated with blood and bronchoalveolar immune cells in healthy subjects and subjects with asthma before and during RV infection.", {"entities": [[163, 169, "DISEASE"]]}], ["RV increased MICA and MICB in vitro in epithelial cells.", {"entities": [[22, 26, "GENE"]]}], ["Exogenous IL-15 upregulated sMICB levels in RV-infected epithelial cells.", {"entities": []}], ["Levels of sMICB molecules in serum were increased in healthy subjects compared with subjects with stable asthma.", {"entities": [[105, 111, "DISEASE"]]}], ["Following RV infection, airway levels of sMIC are upregulated, and there are positive correlations between sputum MICB levels and the percentage of bronchoalveolar natural killer cells in healthy subjects but not subjects with asthma.", {"entities": [[227, 233, "DISEASE"], [114, 118, "GENE"]]}], ["RV infection induces MIC molecules in respiratory epithelial cells in vitro and in vivo.", {"entities": []}], ["Induction of MICB molecules is impaired in subjects with asthma, suggesting these molecules may have a role in the antiviral immune response to RV infections.", {"entities": [[57, 63, "DISEASE"], [13, 17, "GENE"]]}], ["The historical development of a scientific knowledge on calcium orthophosphates from the 1770s until 1940 is described.", {"entities": []}], ["Many forgotten and poorly known historical facts and approaches have been extracted from old publications and then they have been analyzed, systematized and reconsidered from the modern point of view.", {"entities": []}], ["The chosen time scale starts with the earliest available studies of 1770s (to the best of my findings, calcium orthophosphates had been unknown before), passes through the entire 19th century and finishes in 1940, because since then the amount of publications on calcium orthophosphates rapidly increases and the subject becomes too broad.", {"entities": []}], ["Furthermore, since publications of the second half of the 20th century are easily accessible, a substantial amount of them have already been reviewed by other researchers.", {"entities": []}], ["The reported historical findings clearly demonstrate that the substantial amount of the scientific facts and experimental approaches have been known for very many decades and, in fact, the considerable quantity of relatively recent investigations on calcium orthophosphates is just either a further development of the earlier studies or a rediscovery of the already forgotten knowledge.", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["To identify psychological covariates of longitudinal changes in back-related disability in patients undergoing acupuncture.", {"entities": []}], ["A longitudinal postal questionnaire study was conducted with data collection at baseline (pretreatment), 2 weeks, 3, and 6 months later.", {"entities": []}], ["A total of 485 patients were recruited from 83 acupuncturists before commencing acupuncture for back pain.", {"entities": []}], ["Questionnaires measured variables from 4 theories (fear-avoidance model, common-sense model, expectancy theory, social-cognitive theory), clinical and sociodemographic characteristics, and disability.", {"entities": []}], ["Longitudinal multilevel models were constructed with disability over time as the outcome.", {"entities": []}], ["Within individuals, reductions in disability (compared with the person\u2019s individual mean) were associated with reductions in: fear-avoidance beliefs about physical activity (\u03b2=0.11, P <0.01) and work (\u03b2=0.03, P <0.05), catastrophizing (\u03b2=0.28, P <0.05), consequences (\u03b2=0.28, P <0.01), concerns (\u03b2=0.17, P <0.05), emotions (\u03b2=0.16, P <0.05), and pain identity (\u03b2=0.43, P <0.01).", {"entities": []}], ["Within-person reductions in disability were associated with increases in: personal control (\u03b2=\u22120.17, P <0.01), comprehension (\u03b2=\u22120.11, P <0.05) and self-efficacy for coping (\u03b2=\u22120.04, P <0.01).", {"entities": []}], ["Between individuals, people who were less disabled had weaker fear-avoidance beliefs about physical activity (\u03b2=0.12, P <0.01), had more self-efficacy for coping (\u03b2=\u22120.07, P <0.01), perceived less severe consequences of back pain (\u03b2=0.87, P <0.01), had more positive outcome expectancies (\u03b2=\u22120.30, P <0.05), and appraised acupuncture appointments as less convenient (\u03b2=0.92, P <0.05).", {"entities": []}], ["Illness perceptions and, to a lesser extent, self-efficacy and expectancies can usefully supplement variables from the fear-avoidance model in theorizing pain-related disability.", {"entities": []}], ["Positive changes in patients\u2019 beliefs about back pain might underpin the large nonspecific effects of acupuncture seen in trials and could be targeted clinically.", {"entities": []}], ["The club cell secretory protein (CCSP) is a regulator of lung inflammation following acute respiratory infection or lung injury.", {"entities": []}], ["Recently, the relationship between CCSP and COPD has been reported.", {"entities": []}], ["Since COPD results from an abnormal inflammatory response, we hypothesized that CCSP could have a protective role against chronic inflammation-induced lung damage.", {"entities": []}], ["To address this issue, the pathophysiology of chronic lung inflammation induced by Pseudomonas aeruginosa in CCSP-deficient mice was determined.", {"entities": []}], ["A tube of 5 mm in length was soaked in a fluid containing P. aeruginosa (PAO01 strain) for 1 week and inserted into the trachea of CCSP-deficient mice.", {"entities": []}], ["One week later, P. aeruginosa was administered into the trachea.", {"entities": []}], ["Five weeks after insertion of tube, the mice were sacrificed.", {"entities": []}], ["Bronchoalveolar lavage fluids were collected to determine the bacterial growth, and the lung histology and physiology were also examined.", {"entities": []}], ["P. aeruginosa was continuously detected in bronchoalveolar lavage fluids during the study.", {"entities": []}], ["Neutrophils were increased in the bronchoalveolar lavage fluids from the CCSP-deficient mice in comparison to wild-type mice.", {"entities": []}], ["A histological study demonstrated chronic inflammation around bronchus, serious bronchial stenosis, and alveolar enlargement in the CCSP-deficient mice.", {"entities": []}], ["The lung physiology study demonstrated an increase in the lung compliance of the CCSP-deficient mice.", {"entities": []}], ["Chronic P. aeruginosa inflammation resulted in chronic bronchitis and emphysematous changes in the CCSP-deficient mice.", {"entities": [[55, 65, "DISEASE"]]}], ["CCSP could play an important role in protecting the host from the chronic inflammation-induced lung damage.", {"entities": []}], ["The assessment of lung function is of considerable importance in the diagnosis of respiratory diseases, normal reference values need to be determined.", {"entities": []}], ["The peak expiratory flow (PEF) is a simple, reproducible and easily affordable test of lung function which has been used in resource poor countries like Nigeria.", {"entities": []}], ["A study PEF was carried out in medical students of the University of Maiduguri and the result was compared with various prediction equations calculated in other parts of Nigeria.", {"entities": []}], ["It was a cross-sectional study involving 255 medical students.", {"entities": []}], ["Data was collected between March and June 2010 using MicroPeak\u2122 peak flow meter (Micromedical MEI 2A2 Kent) as the instrument.", {"entities": []}], ["There was a statistically significant difference between the measured PEF and the predicted values based on different formulae derived from the different parts of Nigeria.", {"entities": []}], ["However, the values in females in this study was consistent with the one obtained by one investigator in the north western part of the country.", {"entities": []}], ["PEF positively correlated with the measured anthropometric parameters and age.", {"entities": []}], ["The result of the study showed that the prediction formulae of Njoku et al and Salisu et al may be used in the assessment of PEF of individuals in this environment; however, further studies with larger sample size may be needed.", {"entities": []}], ["Spontaneous globe luxation is a rarely reported condition which can lead to complications like optic neuropathy.", {"entities": [[101, 111, "DISEASE"]]}], ["Common causes are thyroid eye disease, shallow orbit and floppy eyelid syndrome.", {"entities": [[71, 79, "DISEASE"], [26, 37, "DISEASE"]]}], ["We report a case of spontaneous globe luxation with the onset and severity associated with chronic obstructive pulmonary disease (COPD).", {"entities": [[91, 128, "DISEASE"]]}], ["To our knowledge, this is the first case of spontaneous globe luxation associated with COPD.", {"entities": []}], ["The two main components of the stress system are the hypothalamic-pituitary-adrenal (HPA) and sympathetic-adrenal-medullary (SAM) axes.", {"entities": []}], ["While cortisol has been commonly used as a biomarker of HPA functioning, much less attention has been paid to the role of the SAM in this context.", {"entities": []}], ["Studies have shown that long-term breast cancer survivors display abnormal reactive cortisol patterns, suggesting a dysregulation of their HPA axis.", {"entities": [[34, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["To fully understand the integrity of the stress response in this population, this paper explored the diurnal and acute alpha-amylase profiles of 22 breast cancer survivors and 26 women with no history of cancer.", {"entities": [[148, 161, "DISEASE"], [155, 161, "DISEASE"], [204, 210, "DISEASE"]]}], ["Results revealed that breast cancer survivors displayed identical but elevated patterns of alpha-amylase concentrations in both diurnal and acute profiles relative to that of healthy women, F (1, 39) = 17.95, p < 0.001 and F (1, 37) = 7.29, p = 0.010, respectively.", {"entities": [[22, 35, "DISEASE"], [29, 35, "DISEASE"]]}], ["The average area under the curve for the diurnal and reactive profiles was 631.54 \u00b1 66.94 SEM and 1238.78 \u00b1 111.84 SEM, respectively.", {"entities": []}], ["This is in sharp contrast to their cortisol results, which showed normal diurnal and blunted acute patterns.", {"entities": []}], ["The complexity of the stress system necessitates further investigation to understand the synergistic relationship of the HPA and SAM axes.", {"entities": []}], ["Adolescent weight status is a cumulative effect of health and nutritional problems.", {"entities": []}], ["Adolescent weight problems often go unnoticed as weight assessment is not considered a priority in adolescents.", {"entities": []}], ["To determine the weight status of adolescents using BMI and to identify the contributing factors to adolescent weight problems.", {"entities": []}], ["In April 2010, 960 adolescents aged 10\u201319\u2009years in secondary schools in Port Harcourt were selected for the study using a stratified multi-staged sampling method.", {"entities": []}], ["Structured questionnaires were filled by the investigators while weight and height were measured.", {"entities": []}], ["BMI was calculated using the formula weight/height The prevalence of underweight, overweight, obesity and stunting were 6.4%, 6.3%, 1.8% and 5.4% respectively.", {"entities": [[94, 101, "DISEASE"]]}], ["Factors which were commoner in overweight adolescents were high socioeconomic class, higher maternal education, spending > 3 hours a day watching television and frequent ingestion of snacks.", {"entities": []}], ["There is a need for periodic weight assessment of adolescents and health education to promote healthy eating habits and regular physical exercise as part of the School Health Programme.", {"entities": []}], ["Privacy concerns by providers have been a barrier to disclosing patient information for public health purposes.", {"entities": []}], ["This is the case even for mandated notifiable disease reporting.", {"entities": []}], ["In the context of a pandemic it has been argued that the public good should supersede an individual's right to privacy.", {"entities": []}], ["The precise nature of these provider privacy concerns, and whether they are diluted in the context of a pandemic are not known.", {"entities": []}], ["Our objective was to understand the privacy barriers which could potentially influence family physicians' reporting of patient-level surveillance data to public health agencies during the Fall 2009 pandemic H1N1 influenza outbreak.", {"entities": [[212, 221, "DISEASE"]]}], ["Thirty seven family doctors participated in a series of five focus groups between October 29-31 2009.", {"entities": []}], ["They also completed a survey about the data they were willing to disclose to public health units.", {"entities": []}], ["Descriptive statistics were used to summarize the amount of patient detail the participants were willing to disclose, factors that would facilitate data disclosure, and the consensus on those factors.", {"entities": []}], ["The analysis of the qualitative data was based on grounded theory.", {"entities": []}], ["The family doctors were reluctant to disclose patient data to public health units.", {"entities": []}], ["This was due to concerns about the extent to which public health agencies are dependable to protect health information (trusting beliefs), and the possibility of loss due to disclosing health information (risk beliefs).", {"entities": []}], ["We identified six specific actions that public health units can take which would affect these beliefs, and potentially increase the willingness to disclose patient information for public health purposes.", {"entities": []}], ["The uncertainty surrounding a pandemic of a new strain of influenza has not changed the privacy concerns of physicians about disclosing patient data.", {"entities": [[58, 67, "DISEASE"]]}], ["It is important to address these concerns to ensure reliable reporting during future outbreaks.", {"entities": []}], ["Fractional exhaled NO (FENO) is a marker of airway inflammation.", {"entities": []}], ["For successful use of this marker it is important to have reference ranges from different healthy populations.", {"entities": []}], ["The aim of this study was to establish these in healthy Tibetan adults who had always lived at high altitude on the Qinghai-Tibet Plateau.", {"entities": []}], ["The study included 145 healthy Tibetan subjects, aged 18 to 75 years, who were non-smokers.", {"entities": []}], ["FENO was measured at a flow rate of 50 mL/s using a chemiluminescence analyzer.", {"entities": []}], ["Residential altitude was classified as: Grade 1 (3678\u20133800 m), Grade 2 (3800\u20134200 m), or Grade 3 (>4200 m).", {"entities": []}], ["Correlations between subject characteristics (age, sex, height, and weight), altitude, and FENO were investigated.", {"entities": []}], ["The geometric mean FENO (95% CI) was 15.4 (7.0, 35.0) parts per billion (ppb).", {"entities": []}], ["The 95% upper limit of the log-transformed data was 33.0 ppb, which was slightly lower than that for Han Chinese, and much lower than in the Northwest Han population.", {"entities": []}], ["Mean FENO values were higher in males (16.8 ppb) than females (14.3 ppb) and inversely related to altitude.", {"entities": []}], ["Multiple linear regression analysis showed that FENO was predicted by the equation Ln (FENO)=[2.844+0.161 \u00d7 sex (1 for male; 0 for female) \u22120.111 \u00d7 altitude grade].", {"entities": []}], ["The residual standard deviation (SD) was 0.048, and the explanatory value was 7%.", {"entities": []}], ["The upper limit of FENO in healthy Tibetan adults is 33 ppb.", {"entities": []}], ["This value can be predicted on the basis of sex and altitude.", {"entities": []}], ["Self-management interventions for chronic obstructive pulmonary disease (COPD) can improve quality of life, reduce hospital admissions, and improve symptoms.", {"entities": [[34, 71, "DISEASE"]]}], ["However, many factors impede engagement for patients and practitioners.", {"entities": []}], ["Qualitative research, with its focus on subjective experience, can provide invaluable insights into such factors.", {"entities": []}], ["Therefore, a systematic review and synthesis of qualitative evidence on COPD self-management from the perspective of patients, carers, and practitioners was conducted.", {"entities": []}], ["Following a systematic search and screening, 31 studies were appraised and data extracted for analysis.", {"entities": []}], ["This review found that patients can adapt to COPD; however, learning to self-manage is often a protracted process.", {"entities": []}], ["Emotional needs are considerable; frustration, depression, and anxiety are common.", {"entities": []}], ["In addition, patients can face an assortment of losses and limitations on their lifestyle and social interaction.", {"entities": []}], ["Over time, COPD can consume their existence, reducing motivation.", {"entities": []}], ["Support from family can prove vital, yet tinged with ambivalence and burden.", {"entities": []}], ["Practitioners may not have sufficient time, resources, or appropriate skills or confidence to provide effective self-management support, particularly in regard to patients\u2019 psychosocial needs.", {"entities": []}], ["This can compound patients\u2019 capability to engage in self-management.", {"entities": []}], ["For COPD self-management to be effective, patients\u2019 psychosocial needs must be prioritised alongside medication and exacerbation management.", {"entities": []}], ["In addition, patients\u2019 personal beliefs regarding COPD and its management should be reviewed periodically to avoid problematic behaviours and enhance positive adaptions to the disease.", {"entities": []}], ["Patients with COPD are not a homogenous group and no one intervention will prove effective for all.", {"entities": []}], ["Finally, practitioners require greater education, training, and support to successfully assist patients.", {"entities": []}], ["The inhalation of allergens by allergic asthmatics results in the early asthmatic response (EAR), which is characterized by acute airway obstruction beginning within a few minutes.", {"entities": []}], ["The EAR is the earliest indicator of the pathological progression of allergic asthma.", {"entities": [[69, 84, "DISEASE"], [78, 84, "DISEASE"]]}], ["Because the molecular mechanism underlying the EAR is not fully defined, this study will contribute to a better understanding of asthma.", {"entities": [[129, 135, "DISEASE"]]}], ["In order to gain insight into the molecular basis of the EAR, we examined changes in protein expression patterns in the lung tissue of asthmatic rats during the EAR using 2-DE/MS-based proteomic techniques.", {"entities": []}], ["Bioinformatic analysis of the proteomic data was then performed using PPI Spider and KEGG Spider to investigate the underlying molecular mechanism.", {"entities": []}], ["In total, 44 differentially expressed protein spots were detected in the 2-DE gels.", {"entities": []}], ["Of these 44 protein spots, 42 corresponded to 36 unique proteins successfully identified using mass spectrometry.", {"entities": []}], ["During subsequent bioinformatic analysis, the gene ontology classification, the protein-protein interaction networking and the biological pathway exploration demonstrated that the identified proteins were mainly involved in glycolysis, calcium binding and mitochondrial activity.", {"entities": []}], ["Using western blot and semi-quantitative RT-PCR, we confirmed the changes in expression of five selected proteins, which further supports our proteomic and bioinformatic analyses.", {"entities": []}], ["Our results reveal that the allergen-induced EAR in asthmatic rats is associated with glycolysis, calcium binding and mitochondrial activity, which could establish a functional network in which calcium binding may play a central role in promoting the progression of asthma.", {"entities": [[266, 272, "DISEASE"]]}], ["A number of observational studies have been conducted to investigate the association of the IL-10 gene polymorphisms with systemic lupus erythematosus (SLE) susceptibility.", {"entities": [[131, 150, "DISEASE"], [122, 150, "DISEASE"]]}], ["However, their results are conflicting.", {"entities": []}], ["We searched published case-control studies on the IL-10 polymorphisms and SLE in PubMed, EMBASE and Chinese Biomedical Literature Database.", {"entities": []}], ["A meta-analysis was conducted using a fixed-effect or random-effect model based on between-study heterogeneity.", {"entities": []}], ["A total of 42 studies with 7948 cases and 11866 controls were included in this meta-analysis.", {"entities": []}], ["Among Caucasians, the CA27 allele of the IL10.G microsatellites (OR 2.38, 95% CI 1.01\u20135.62), the G allele of the IL-10 -1082G/A polymorphism (G vs. A: OR 1.21, 95% CI 1.02\u20131.44; GG vs. AA: OR 1.45, 95% CI 1.16\u20131.82; GG+GA vs. AA: OR 1.16, 95% CI 1.03\u20131.29) and its associated haplotype -1082G/\u2212819C/\u2212592C (OR 1.25, 95% CI 1.10\u20131.42) were associated with increased SLE susceptibility without or with unimportant between-study heterogeneity.", {"entities": []}], ["Removing studies deviating from Hardy-Weinberg equilibrium (HWE) hardly changed these results.", {"entities": []}], ["Among Asians, the CA21 allele of the IL-10.G microsatellites (OR 1.28, 95% CI 1.02\u20131.60) and the -1082G/\u2212819C/\u2212592C haplotype (OR 1.24, 95% CI 1.00\u20131.53) were associated with increased SLE susceptibility, but with substantial between-study heterogeneity or sensitive to HWE status.", {"entities": []}], ["Removing studies deviating from HWE also produced statistically significant associations of the IL-10 -1082G/A (GG vs. AA: OR 3.21, 95% CI 1.24\u20138.28; GG vs. AA+GA: OR 2.85, 95% CI 1.19\u20136.79) and -592C/A polymorphisms (CC+CA vs. AA: OR 0.69, 95% CI 0.51\u20130.94) with SLE among Asians.", {"entities": []}], ["This meta-analysis showed that the IL10.G microsatellites, the IL-10 -1082G/A and -592C/A polymorphisms and the haplotype -1082G/\u2212819C/\u2212592C are associated with SLE susceptibility.", {"entities": []}], ["Besides, this is the first time to report an association between the CA27 allele of the IL-10.G microsatellites and SLE among Caucasians.", {"entities": []}], ["Further studies are needed to confirm these findings.", {"entities": []}], ["From October 2010 through February 2016, Arizona conducted surveillance for severe acute respiratory infections (SARI) among adults hospitalized in the Arizona-Mexico border region.", {"entities": []}], ["There are few accurate mortality estimates in SARI patients, particularly in adults \u2265\u200965\u00a0years old.", {"entities": []}], ["The purpose of this study was to generate mortality estimates among SARI patients that include deaths occurring shortly after hospital discharge and identify risk factors for mortality.", {"entities": []}], ["Patients admitted to two sentinel hospitals between 2010 and 2014 who met the SARI case definition were enrolled.", {"entities": []}], ["Demographic data were used to link SARI patients to Arizona death certificates.", {"entities": []}], ["Mortality within 30\u00a0days after the date of admission was calculated and risk factors were identified using logistic regression models.", {"entities": []}], ["Among 258 SARI patients, 47% were females, 51% were white, non-Hispanic and 39% were Hispanic.", {"entities": []}], ["The median age was 63\u00a0years (range, 19 to 97\u00a0years) and 80% had one or more pre-existing health condition; 9% died in hospital.", {"entities": []}], ["Mortality increased to 12% (30/258, 30% increase) when electronic vital records and a 30-day post-hospitalization time frame were used.", {"entities": []}], ["Being age\u2009\u2265\u200965\u00a0years (OR\u2009=\u20094.0; 95% CI: 1.6\u20139.9) and having an intensive care unit admission (OR\u2009=\u20097.4; 95% CI: 3.0\u201317.9) were independently associated with mortality.", {"entities": []}], ["The use of electronic vital records increased SARI-associated mortality estimates by 30%.", {"entities": []}], ["These findings may help guide prevention and treatment measures, particularly in high-risk persons in this highly fluid border population.", {"entities": []}], ["The role of diet-associated inflammation in colorectal cancer is of interest.", {"entities": [[44, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["Accordingly, we aimed to examine whether the dietary inflammatory index (DII) was associated with the risk of colorectal cancer in a case-control study conducted in Korea.", {"entities": [[110, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["The DII was based on dietary intake, which was determined by a 106-item semi-quantitative food frequency questionnaire completed by 923 colorectal cancer cases and 1846 controls.", {"entities": [[136, 153, "DISEASE"], [147, 153, "DISEASE"]]}], ["Logistic regression was used to estimate odd ratios (ORs) and 95% confidence intervals (CIs).", {"entities": []}], ["Subgroup analyses were conducted by the anatomical site of the cancer, sex, and other risk factors.", {"entities": [[63, 69, "DISEASE"]]}], ["Higher DII scores were associated with an increased incidence of colorectal cancer (OR (95% CI) = 2.16 (1.71, 2.73) for highest vs. lowest tertile).", {"entities": [[65, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["The magnitude differed by anatomical site and sex.", {"entities": []}], ["This association was slightly weaker in subjects with proximal colon cancer (1.68 (1.08, 2.61)) and was stronger in women (2.50 (1.64, 3.82)).", {"entities": [[63, 75, "DISEASE"], [69, 75, "DISEASE"]]}], ["Additionally, stronger associations were observed in subjects who were older than 50 years ( p for interaction = 0.004) and engaged in physical activity ( p for interaction < 0.001).", {"entities": []}], ["Results from this study suggest that diet-associated inflammation may increase the risk of colorectal cancer, and this effect may differ by certain factors, such as anatomical site, age, sex, and lifestyle.", {"entities": [[91, 108, "DISEASE"], [102, 108, "DISEASE"]]}], ["Epithelial and especially mucosal immunity represents the first line of defence against the plethora of potential pathogens trying to invade via the gastrointestinal tract.", {"entities": []}], ["The salivary glands of the fruit fly are an indispensable part of the gastrointestinal tract, but their contribution to the mucosal immunity has almost completely been neglected.", {"entities": []}], ["Our major goal was to elucidate if the fly's salivary glands are able to mount an immune response and what the major characteristics of this immune response are.", {"entities": []}], ["Ectopic activation of the IMD-pathway within the salivary gland cells is able to induce an immune response, indicating that the salivary glands are indeed immune competent.", {"entities": []}], ["This reaction is characterized by the concurrent expression of numerous antimicrobial peptide genes.", {"entities": []}], ["In addition, ectopic activation of the salivary gland's immune response induces morphological changes such as dwarfism throughout all developmental stages and a significantly decreased length of the salivary glands themselves.", {"entities": []}], ["DNA-microarray analyses of the reaction revealed a complex pattern of up- and downregulated genes.", {"entities": []}], ["Gene ontology analyses of regulated genes revealed a significant increase in genes associated with ribosomal and proteasomal function.", {"entities": []}], ["On the other hand, genes coding for peptide receptors and some potassium channels are downregulated.", {"entities": []}], ["In addition, the comparison of the transcriptional events induced following IMD-activation in the trachea and the salivary glands shows also only a small overlap, indicating that the general IMD-activated core transcriptome is rather small and that the tissue specific component of this response is dominating.", {"entities": []}], ["Among the regulated genes, those that code for signaling associated protease activity are significantly modulated.", {"entities": []}], ["The salivary glands are immune-competent and they contribute to the overall intestinal immune system.", {"entities": []}], ["Although they produce antimicrobial peptides, their overall response is highly tissue-specific.", {"entities": []}], ["Our analysis indicates that chronic activation of the salivary gland's immune system is costly, as it induces severe reduction in growth throughout development.", {"entities": []}], ["The IMD-regulated increase in expression levels of the fly's presenilin representatives opens the opportunity to use the salivary glands for studying the physiological and pathophysiological role of these genes in a simple but functional environment.", {"entities": []}], ["In the last decade we have been working on standardization of propolis extract and determination of active constituents of wine those are rich in polyphenolics and have nutritional as well as therapeutic value.", {"entities": []}], ["Here we are summarizing our results and providing overview on systematic approach how to analyse natural products rich in flavonoids and phenolic acids.", {"entities": []}], ["Chromatographic methods (thin layer chromatography and high performance liquid chromatography) were used for identification, quantification, and characterization of individual flavonoid or phenolic acid.", {"entities": []}], ["Total content of active constituents and antioxidant activity were determined by spectrophotometry.", {"entities": []}], ["Pharmacokinetic parameters were determined by high performance liquid chromatography and using appropriate software.", {"entities": []}], ["Quantitative structure-activity relationship study of antioxidant activity was conducted, as well as assessment of prolonged propolis supplementation on antioxidative status of organism.", {"entities": []}], ["Thin layer chromatography-densitometry has been proven as quick and reliable method for standard analysis of propolis and wine; the best mobile phase being chloroform \u2013 methanol \u2013 formic acid (98\u2013100%) in ratio 44 : 3.5 : 2.5 ( v/v ).", {"entities": []}], ["Higher number of polyphenolics was determined by high performance liquid chromatography; 15 compared to 9 by thin layer chromatography.", {"entities": []}], ["Interactions in situ with acetylsalicylic acid were detected with most of polyphenolics analysed.", {"entities": []}], ["Plasma protein binding and blood-barrier penetration was greatest for flavone.", {"entities": []}], ["The interactions with human serum albumin have been grater than 95% for all flavonoids analysed.", {"entities": []}], ["The prolonged propolis consumption increased superoxide dismutase activity.", {"entities": []}], ["The necessity of standardization of natural products and their registration as functional nutraceuticals demand easy, quick and inexpensive methods of analysis.", {"entities": []}], ["In this work we provided overview of analytical part for polyphenolics that could be used as data for possible registration of final products either as functional food or medicinal product.", {"entities": []}], ["This feature introduces the readers to the authors' research through a concise overview of the selected topic.", {"entities": []}], ["Reference to important work from others in the field is included.", {"entities": []}], ["Reactive oxygen species (ROS) are generated as a consequence of metabolic reactions in the mitochondria of eukaryotic cells.", {"entities": []}], ["This work describes the role of the manganese superoxide dismutase (MnSOD) as a biomarker of different human diseases and proposes a new therapeutic application for the prevention of cancer and its treatment.", {"entities": [[183, 189, "DISEASE"]]}], ["The paper also describes how a new form of human MnSOD was discovered, its initial application, and its clinical potentials.", {"entities": []}], ["The MnSOD isolated from a human liposarcoma cell line (LSA) was able to kill cancer cells expressing estrogen receptors, but it did not have cytotoxic effects on normal cells.", {"entities": [[32, 43, "DISEASE"], [77, 83, "DISEASE"]]}], ["Together with its oncotoxic activity, the recombinant MnSOD (rMnSOD) exerts a radioprotective effect on normal cells irradiated with X-rays.", {"entities": []}], ["The rMnSOD is characterized by the presence of a leader peptide, which allows the protein to enter cells: this unique property can be used in the radiodiagnosis of cancer or chemotherapy, conjugating radioactive substances or chemotherapic drugs to the leader peptide of the MnSOD.", {"entities": [[164, 170, "DISEASE"]]}], ["Compared to traditional chemotherapic agents, the drugs conjugated with the leader peptide of MnSOD can selectively reach and enter cancer cells, thus reducing the side effects of traditional treatments.", {"entities": [[132, 138, "DISEASE"]]}], ["Human eosinophil cationic protein (ECP) and eosinophil derived neurotoxin (EDN) are two ribonuclease A (RNaseA) family members secreted by activated eosinophils.", {"entities": []}], ["They share conserved catalytic triad and similar three dimensional structures.", {"entities": []}], ["ECP and EDN are heparin binding proteins with diverse biological functions.", {"entities": []}], ["We predicted a novel molecular model for ECP binding of heparin hexasaccharide (Hep6), [GlcNS(6S)-IdoA(2S)] 3 , and residues Gln in silico and in vitro data together demonstrate that ECP uses not only major heparin binding region but also use other surrounding residues to interact with heparin.", {"entities": []}], ["Such correlation in sequence, structure, and function is a unique feature of only higher primate ECP, but not EDN.", {"entities": []}], ["The use of guidelines in general practice is not optimal.", {"entities": []}], ["Although evidence-based methods to improve guideline adherence are available, variation in physician adherence to general practice guidelines remains relatively high.", {"entities": []}], ["The objective for this study is to transfer a quality improvement strategy based on audit, feedback, educational materials, and peer group discussion moderated by local opinion leaders to the field.", {"entities": []}], ["The research questions are: is the multifaceted strategy implemented on a large scale as planned?", {"entities": []}], ["; what is the effect on general practitioners' (GPs) test ordering and prescribing behaviour?", {"entities": []}], ["; and what are the costs of implementing the strategy?", {"entities": []}], ["In order to evaluate the effects, costs and feasibility of this new strategy we plan a multi-centre cluster randomized controlled trial (RCT) with a balanced incomplete block design.", {"entities": []}], ["Local GP groups in the south of the Netherlands already taking part in pharmacotherapeutic audit meeting groups, will be recruited by regional health officers.", {"entities": []}], ["Approximately 50 groups of GPs will be randomly allocated to two arms.", {"entities": []}], ["These GPs will be offered two different balanced sets of clinical topics.", {"entities": []}], ["Each GP within a group will receive comparative feedback on test ordering and prescribing performance.", {"entities": []}], ["The feedback will be discussed in the group and working agreements will be created after discussion of the guidelines and barriers to change.", {"entities": []}], ["The data for the feedback will be collected from existing and newly formed databases, both at baseline and after one year.", {"entities": []}], ["We are not aware of published studies on successes and failures of attempts to transfer to the stakeholders in the field a multifaceted strategy aimed at GPs' test ordering and prescribing behaviour.", {"entities": []}], ["This pragmatic study will focus on compatibility with existing infrastructure, while permitting a certain degree of adaptation to local needs and routines.", {"entities": []}], ["Nederlands Trial Register ISRCTN40008171", {"entities": []}], ["Decreased muscle strength, fitness and well-being are common in children and adolescents with juvenile idiopathic arthritis (JIA) compared to healthy peers.", {"entities": [[114, 123, "DISEASE"]]}], ["Biological drugs have improved health in children with JIA, but despite this pain is still a major symptom and bone health is reported as decreased in the group.", {"entities": []}], ["The improvement made by the biological drugs makes it possible to more demanding exercises.", {"entities": []}], ["To jump is an exercise that can improve bone heath, fitness and muscle strength.", {"entities": []}], ["The aim of the study was to see if an exercise programme with jumps had an effect on muscle strength, physical fitness and well-being and how it was tolerated.", {"entities": []}], ["Muscle strength and well-being were studied before and after a 12-week exercise programme in 54 children and adolescents with JIA, 9\u201321\u00a0years old.", {"entities": []}], ["The participants were randomized into an exercise and a control group.", {"entities": []}], ["Muscle strength, fitness and well-being were documented before and after the training period and at follow-up after 6\u00a0months.", {"entities": []}], ["Physical activity in leisure time was documented in diaries.", {"entities": []}], ["The fitness/exercise programme was performed at home three times a week and included rope skipping and muscle strength training exercises.", {"entities": []}], ["Assessment included measurement of muscle strength with a handheld device, and with Grip-it, step-test for fitness with documentation of heart rate and pain perception and two questionnaires (CHAQ, CHQ) on well-being.", {"entities": []}], ["There were no differences between exercise and control group regarding muscle strength, grip strength, fitness or well-being at base line.", {"entities": []}], ["Muscle weakness was present in hip extensors, hip abductors and handgrip.", {"entities": []}], ["For the exercise group muscle strength in hip and knee extensors increased after the 12-week exercise programme and was maintained in knee extensors at follow-up.", {"entities": []}], ["There was no change in fitness tested with the individually adapted step-test.", {"entities": []}], ["The CHQ questionnaire showed that pain was common in the exercise group and in the control group.", {"entities": []}], ["There were only small changes in the CHAQ and CHQ after the training period.", {"entities": []}], ["The fitness/exercise programme was well tolerated and pain did not increase during the study.", {"entities": []}], ["A weight bearing exercise programme, with muscle strength training with free weights and rope skipping was well tolerated without negative consequences on pain.", {"entities": []}], ["It also improved muscle strength in the legs and can be recommended for children and adolescents with JIA.", {"entities": []}], ["Blended behavior change interventions combine therapeutic guidance with online care.", {"entities": []}], ["This new way of delivering health care is supposed to stimulate patients with chronic somatic disorders in taking an active role in their disease management.", {"entities": []}], ["However, knowledge about the effectiveness of blended behavior change interventions and how they should be composed is scattered.", {"entities": []}], ["This comprehensive systematic review aimed to provide an overview of characteristics and effectiveness of blended behavior change interventions for patients with chronic somatic disorders.", {"entities": []}], ["We searched for randomized controlled trials published from 2000 to April 2017 in PubMed, Embase, CINAHL, and Cochrane Central Register of Controlled Trials.", {"entities": []}], ["Risk of bias was assessed using the Cochrane Collaboration tool.", {"entities": []}], ["Study characteristics, intervention characteristics, and outcome data were extracted.", {"entities": []}], ["Studies were sorted based on their comparison group.", {"entities": []}], ["A best-evidence synthesis was conducted to summarize the effectiveness.", {"entities": []}], ["A total of 25 out of the 29 included studies were of high quality.", {"entities": []}], ["Most studies (n=21; 72%) compared a blended intervention with no intervention.", {"entities": []}], ["The majority of interventions focused on changing pain behavior (n=17; 59%), and the other interventions focused on lifestyle change (n=12; 41%).", {"entities": []}], ["In addition, 26 studies (90%) focused on one type of behavior, whereas 3 studies (10%) focused on multiple behaviors.", {"entities": []}], ["A total of 23 studies (79%) mentioned a theory as basis for the intervention.", {"entities": []}], ["The therapeutic guidance in most studies (n=18; 62%) was non face-to-face by using email, phone, or videoconferencing, and in the other studies (partly), it was face-to-face (n=11; 38%).", {"entities": []}], ["In 26 studies (90%), the online care was provided via a website, and in 3 studies (10%) via an app.", {"entities": [[95, 98, "GENE"]]}], ["In 22 studies (76%), the therapeutic guidance and online care were integrated instead of two separate aspects.", {"entities": []}], ["A total of 26 outcome measures were included in the evidence synthesis comparing blended interventions with no intervention: for the coping strategy catastrophizing, we found strong evidence for a significant effect.", {"entities": []}], ["In addition, 1 outcome measure was included in the evidence synthesis comparing blended interventions with face-to-face interventions, but no evidence for a significant effect was found.", {"entities": []}], ["A total of 6 outcome measures were included in the evidence synthesis comparing blended interventions with online interventions, but no evidence for a significant effect was found.", {"entities": []}], ["Blended behavior change interventions for patients with chronic somatic disorders show variety in the type of therapeutic guidance, the type of online care, and how these two delivery modes are integrated.", {"entities": []}], ["The evidence of the effectiveness of blended interventions is inconsistent and nonsignificant for most outcome measures.", {"entities": []}], ["Future research should focus on which type of blended intervention works for whom.", {"entities": []}], ["Hereditary angioedema due to C1 inhibitor (C1 esterase inhibitor) deficiency (types I and II HAE-C1-INH) is a rare disease that usually presents during childhood or adolescence with intermittent episodes of potentially life-threatening angioedema.", {"entities": [[11, 21, "DISEASE"], [236, 246, "DISEASE"]]}], ["Diagnosis as early as possible is important to avoid ineffective therapies and to properly treat swelling attacks.", {"entities": []}], ["At a consensus meeting in June 2011, pediatricians and dermatologists from Germany, Austria, and Switzerland reviewed the currently available literature, including published international consensus recommendations for HAE therapy across all age groups.", {"entities": []}], ["Published recommendations cannot be unconditionally adopted for pediatric patients in German-speaking countries given the current approval status of HAE drugs.", {"entities": []}], ["This article provides an overview and discusses drugs available for HAE therapy, their approval status, and study results obtained in adult and pediatric patients.", {"entities": []}], ["Recommendations for developing appropriate treatment strategies in the management of HAE in pediatric patients in German-speaking countries are provided.", {"entities": []}], ["Conclusion Currently, plasma-derived C1 inhibitor concentrate is considered the best available option for the treatment of acute HAE-C1-INH attacks in pediatric patients in German-speaking countries, as well as for short-term and long-term prophylaxis.", {"entities": []}], ["We introduce a new form of regression that has many applications to environmental studies.", {"entities": []}], ["For a sequence composed of key variates with prototypic value chi, this form differs from the estimation of a location parameter-based curve, mu(chi), a scale parameter-based curve, sigma(chi), or other currently used types of regression.", {"entities": []}], ["Instead of estimating a curve location, scale, or alpha-quantile parameter, it assumes that there are two or more population subgroups; for example, consisting of unsensitized and sensitized individuals, respectively.", {"entities": []}], ["Although within each subgroup the relationships mu(chi) or sigma(chi) may or may not be horizontal, these relationships are not deemed to be of primary importance.", {"entities": []}], ["Instead, the mixing parameter P that indexes the proportions of the two subgroups is treated as being related to the key variate value chi.", {"entities": []}], ["In the sense that its goal is the estimation of a proportion, the new procedure resembles logit regression.", {"entities": []}], ["But, in terms of the continuous spectrum of values attained by the response variate, the means used to attain its goal are dissimilar from those of logit regression.", {"entities": []}], ["Specifically, group membership is not known directly but is determined from a proxy continuous variate whose values overlap between groups.", {"entities": []}], ["Examples are given with simulated and natural data where this new form of regression is applied.", {"entities": []}], ["We believe that conditional switching regression is a particularly valuable research tool when chemical level chi of an induced asthma attack or birthweight chi measured in a study of the biomarker cotinine's effect on pregnancy outcomes determines whether an attack or a negative outcome occurs.", {"entities": [[128, 134, "DISEASE"]]}], ["(ABSTRACT TRUNCATED AT 250 WORDS)", {"entities": []}], ["CCL18 has been reported to be present constitutively at high levels in the circulation, and is further elevated during inflammatory diseases.", {"entities": [[0, 5, "GENE"]]}], ["Since it is a rather poor chemoattractant, we wondered if it may have a regulatory role.", {"entities": []}], ["CCL18 has been reported to inhibit cellular recruitment mediated by CCR3, and we have shown that whilst it is a competitive functional antagonist as assessed by Schild plot analysis, it only binds to a subset of CCR3 receptor populations.", {"entities": [[0, 5, "GENE"], [68, 72, "GENE"], [212, 216, "GENE"], [68, 72, "GENE"], [212, 216, "GENE"]]}], ["We have extended this inhibitory activity to other receptors and have shown that CCL18 is able to inhibit CCR1, CCR2, CCR4 and CCR5 mediated chemotaxis, but has no effect on CCR7 and CCR9, nor the CXC receptors that we have tested.", {"entities": [[81, 86, "GENE"], [106, 110, "GENE"], [112, 116, "GENE"], [118, 122, "GENE"], [127, 131, "GENE"], [174, 178, "GENE"], [183, 187, "GENE"]]}], ["Whilst CCL18 is able to bind to CCR3, it does not bind to the other receptors that it inhibits.", {"entities": [[7, 12, "GENE"], [32, 36, "GENE"]]}], ["We therefore tested the hypothesis that it may displace glycosaminoglycan (GAG) chemokines bound either in cis- on the leukocyte, or in trans-presentation on the endothelial surface, thereby inhibiting the recruitment of leukocytes into the site of inflammation.", {"entities": []}], ["We show that CCL18 selectivity displaces heparin bound chemokines, and that chemokines from all four chemokine sub-classes displace cell bound CCL18.", {"entities": [[13, 18, "GENE"], [143, 148, "GENE"], [13, 18, "GENE"], [143, 148, "GENE"]]}], ["We propose that CCL18 has regulatory properties inhibiting chemokine function when GAG-mediated presentation plays a role in receptor activation.", {"entities": [[16, 21, "GENE"]]}], ["Increasing evidence supports associations between periodontal disease and various chronic conditions.", {"entities": [[50, 69, "DISEASE"]]}], ["Possible explanations include chronic inflammatory processes, shared pathogens, and shared risk factors, such as smoking and psychosocial stress.", {"entities": []}], ["The objective of this study was to assess associations of periodontal disease with metabolic syndrome and number of chronic diseases.", {"entities": [[93, 101, "DISEASE"], [58, 77, "DISEASE"]]}], ["As part of the Washington Adult Health Survey, a household-based cross-sectional study conducted during 2006-2007 among adults aged 25 years or older in Washington State, we collected questionnaire data, blood samples, and anthropometric measures.", {"entities": []}], ["We used these data to assess associations of periodontal disease with metabolic syndrome and the number of self-reported chronic diseases, controlling for age, sex, annual household income, smoking, and psychosocial stress.", {"entities": [[80, 88, "DISEASE"], [45, 64, "DISEASE"]]}], ["We used both complete case and multiple imputation Poisson regression analyses.", {"entities": []}], ["In the adjusted complete case analysis, 1.4 times as many chronic conditions were found among people with severe compared with no periodontal disease, and people with severe periodontal disease were 1.5 times more likely to have metabolic syndrome than people with no periodontal disease.", {"entities": [[239, 247, "DISEASE"], [130, 149, "DISEASE"], [174, 193, "DISEASE"], [268, 287, "DISEASE"]]}], ["Arthritis and liver disease were individually associated with severe periodontal disease.", {"entities": [[14, 27, "DISEASE"], [69, 88, "DISEASE"]]}], ["Results of the multiple imputation analyses were similar.", {"entities": []}], ["These results suggest that people with severe periodontal disease are likely to have more chronic diseases and are more likely to have metabolic syndrome compared with people without periodontal disease.", {"entities": [[145, 153, "DISEASE"], [46, 65, "DISEASE"], [183, 202, "DISEASE"]]}], ["Research about the effectiveness of periodontal treatment to help prevent or control chronic diseases is needed.", {"entities": []}], ["Cytokines play important roles in antiviral action.", {"entities": []}], ["We examined whether polymorphisms of interleukin (IL)-12 receptor B 1 ( IL-12RB1) affect the susceptibility to and outcome of severe acute respiratory syndrome (SARS).", {"entities": [[151, 159, "DISEASE"], [126, 159, "DISEASE"], [161, 165, "GENE"]]}], ["A case-control study was carried out in Chinese SARS patients and healthy controls.", {"entities": [[48, 52, "GENE"]]}], ["The genotypes of 4SNPs on IL-12 RB1 gene, +705A/G,+1158T/C, +1196G/C and +1664 C/T, were determined by PCR-RFLP.", {"entities": [[32, 35, "GENE"]]}], ["Haplotypes were estimated from the genotype data using the expectation-maximisation algorithm.", {"entities": []}], ["Comparison between patients and close contacts showed that individuals with the +1664 C/T (CT and TT) genotype had a 2.09-fold (95% confidence interval [CI], 1.90\u20137.16) and 2.34-fold (95% CI, 1.79\u201313.37) increased risk of developing SARS, respectively.", {"entities": [[233, 237, "GENE"]]}], ["For any of the other three polymorphisms, however, no significant difference can be detected in allele or genotype frequencies between patients and controls.", {"entities": []}], ["Additionally, estimation of the frequencies of multiple-locus haplotypes revealed potential risk haplotypes (GCCT) for SARS infection.", {"entities": [[119, 123, "GENE"]]}], ["Our data indicate that genetic variants of IL12RB1 confer genetic susceptibility to SARS infection, but not necessary associated with the progression of the disease in Chinese population.", {"entities": [[43, 50, "GENE"], [84, 88, "GENE"]]}], ["To investigate the effect of a simplified prevention bundle with alcohol-based, dual hand hygiene (HH) audit on the incidence of early-onset ventilation-associated pneumonia (VAP).", {"entities": [[164, 173, "DISEASE"]]}], ["This 3-year, quasi-experimental study with interrupted time-series analysis was conducted in two cardiovascular surgery intensive care units in a medical center.", {"entities": []}], ["Unaware external HH audit (eHH) performed by non-unit-based observers was a routine task before and after bundle implementation.", {"entities": []}], ["Based on the realistic ICU settings, we implemented a 3-component bundle, which included: a compulsory education program, a knowing internal HH audit (iHH) performed by unit-based observers, and a standardized oral care (OC) protocol with 0.1% chlorhexidine gluconate.", {"entities": [[151, 154, "GENE"]]}], ["The study periods comprised 4 phases: 12-month pre-implementation phase 1 (eHH+/education-/iHH-/OC-), 3-month run-in phase 2 (eHH+/education+/iHH+/OC+), 15-month implementation phase 3 (eHH+/education+/iHH+/OC+), and 6-month post-implementation phase 4 (eHH+/education-/iHH+/OC-).", {"entities": []}], ["A total of 2553 ventilator-days were observed.", {"entities": []}], ["VAP incidences (events/1000 ventilator days) in phase 1\u20134 were 39.1, 40.5, 15.9, and 20.4, respectively.", {"entities": []}], ["VAP was significantly reduced by 59% in phase 3 ( vs .", {"entities": []}], ["phase 1, incidence rate ratio [IRR] 0.41, P = 0.002), but rebounded in phase 4.", {"entities": []}], ["Moreover, VAP incidence was inversely correlated to compliance of OC (r P = 0.001) and eHH (r P < 0.001), but not applied for iHH, despite iHH compliance was higher than eHH compliance during phase 2 to 4.", {"entities": [[126, 129, "GENE"], [139, 142, "GENE"], [126, 129, "GENE"], [139, 142, "GENE"]]}], ["Compared to eHH, iHH provided more efficient and faster improvements for standard HH practice.", {"entities": [[17, 20, "GENE"]]}], ["The minimal compliances required for significant VAP reduction were 85% and 75% for OC and eHH (both P < 0.05, IRR 0.28 and 0.42, respectively).", {"entities": []}], ["This simplified prevention bundle effectively reduces early-onset VAP incidence.", {"entities": []}], ["An unaware HH compliance correlates with VAP incidence.", {"entities": []}], ["A knowing HH audit provides better improvement in HH practice.", {"entities": []}], ["Accordingly, we suggest dual HH audit and consistent bundle performance does matter in quality-of-care VAP prevention.", {"entities": []}], ["Respiratory syncytial virus (RSV) is one of the most important causes of acute lower respiratory tract infections (ALRTI) in infants and young children.", {"entities": []}], ["This study was conducted to describe the epidemiology of ALRTI associated with RSV among children \u2264 5 years old in Egypt.", {"entities": []}], ["We enrolled 427 children \u2264 5 years old diagnosed with ALRTI attending the outpatient clinic or Emergency Department (ED) of Children Hospital, Cairo University during a one- year period.", {"entities": []}], ["Nasopharyngeal aspirates were obtained from the patients, kept on ice and processed within 2 hours of collection.", {"entities": []}], ["Immunoflourescent assay (IFA) for RSV was performed.", {"entities": []}], ["91 cases (21.3%) had viral etiology with RSV antigens detected in 70 cases (16.4%).", {"entities": []}], ["The RSV positive cases were significantly younger than other non-RSV cases (mean age 8.2 months versus 14.2 months, p <0.001).", {"entities": []}], ["RSV cases had significantly higher respiratory rate in the age group between 2-11 months (mean 58.4 versus 52.7/minute, p < 0.001) and no significant difference in the mean respiratory rate in the age group between 12-59 months.", {"entities": []}], ["More RSV cases required supplemental oxygen (46% versus 23.5%, p < 0.001) with higher rate of hospitalization (37.1% versus 11.2%, p < 0.001) than the non-RSV cases.", {"entities": []}], ["97% of RSV cases occurred in winter season (p < 0.001).", {"entities": []}], ["RSV is the most common viral etiology of ALRTI in children below 5 years of age, especially in young infants below 6 months of age.", {"entities": []}], ["It is more prevalent in winter and tends to cause severe infection.", {"entities": []}], ["Chronic inflammation is a critical component of atherogenesis, however, reliable human translational models aimed at characterizing these mechanisms are lacking.", {"entities": []}], ["Psoriasis, a chronic inflammatory skin disease associated with increased susceptibility to atherosclerosis, provides a clinical human model that can be utilized to investigate the links between chronic inflammation and atherosclerosis development.", {"entities": [[91, 106, "DISEASE"], [219, 234, "DISEASE"], [0, 9, "DISEASE"], [34, 46, "DISEASE"]]}], ["We sought to investigate key biological processes in psoriasis skin and human vascular tissue to identify biological components that may promote atherosclerosis in chronic inflammatory conditions.", {"entities": [[145, 160, "DISEASE"], [53, 62, "DISEASE"]]}], ["Using a bioinformatics approach of human skin and vascular tissue, we determined IFN-\u03b3 and TNF-\u03b1 are the dominant pro-inflammatory signals linking atherosclerosis and psoriasis.", {"entities": [[147, 162, "DISEASE"], [167, 176, "DISEASE"]]}], ["We then stimulated primary aortic endothelial cells and ex-vivo atherosclerotic tissue with IFN-\u03b3 and TNF-\u03b1 and found they synergistically increased monocyte and T-cell chemoattractants, expression of adhesion molecules on the endothelial cell surface, and decreased endothelial barrier integrity in vitro , therefore increasing permeability.", {"entities": []}], ["Our data provide strong evidence of synergism between IFN-\u03b3 and TNF- \u03b1 in inflammatory atherogenesis and provide rationale for dual cytokine antagonism in future studies.", {"entities": []}], ["Drug-induced liver injury (DILI) is a frequent cause of pediatric liver disease; however, the data on DILI are remarkably limited.", {"entities": [[66, 79, "DISEASE"]]}], ["All 69 children hospitalized with DILI between January 2009 and December 2011 were retrospectively studied.", {"entities": []}], ["A total of 37.7% of the children had medical histories of respiratory infection.", {"entities": []}], ["The clinical injury patterns were as follows: hepatocellular 89.9%, cholestatic 2.9%, and mixed 7.2%.", {"entities": []}], ["Liver biopsies from 55 children most frequently demonstrated chronic (47.3%) and acute (27.3%) hepatitis.", {"entities": [[95, 104, "DISEASE"]]}], ["Hypersensitivity features, namely, fever (31.9%), rash (21.7%), and eosinophilia (1.4%), were found.", {"entities": [[68, 80, "DISEASE"]]}], ["Twenty-four children (34.8%) developed chronic DILI.", {"entities": []}], ["Antibiotics (26.1%) were the most common Western medicines (WMs) causing DILI, and the major implicated herbs were Ephedra sinica and Polygonum multiflorum .", {"entities": []}], ["Compared with WM, the children whose injuries were caused by Chinese herbal medicine (CHM) showed a higher level of total bilirubin (1.4 mg/dL vs 16.6 mg/dL, p=0.004) and a longer prothrombin time (11.8 seconds vs 17.3 seconds, p=0.012), but they exhibited less chronic DILI (2/15 vs 18/39, p=0.031).", {"entities": [[86, 89, "GENE"]]}], ["Most cases of DILI in children are caused by antibiotics or CHM used to treat respiratory infection and present with hepatocellular injury.", {"entities": [[60, 63, "GENE"]]}], ["Compared with WM, CHM is more likely to cause severe liver injury, but liver injury caused by CHM is curable.", {"entities": [[18, 21, "GENE"], [94, 97, "GENE"], [18, 21, "GENE"], [94, 97, "GENE"]]}], ["To analyze factors associated with low adherence to drug treatment for chronic diseases in Brazil.", {"entities": []}], ["Analysis of data from Pesquisa Nacional sobre Acesso, Utiliza\u00e7\u00e3o e Promo\u00e7\u00e3o do Uso Racional de Medicamentos (PNAUM - Brazilian Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based cross-sectional household survey, based on a probabilistic sample of the Brazilian population.", {"entities": []}], ["We analyzed the association between low adherence to drug treatment measured by the Brief Medication Questionnaire and demographic, socioeconomic, health, care and prescription factors.", {"entities": []}], ["We used Poisson regression model to estimate crude and adjusted prevalence ratios, their respective 95% confidence interval (95%CI) and p-value (Wald test).", {"entities": []}], ["The prevalence of low adherence to drug treatment for chronic diseases was 30.8% (95%CI 28.8-33.0).", {"entities": []}], ["The highest prevalence of low adherence was associated with individuals: young adults; no education; resident in the Northeast and Midwest Regions of Brazil; paying part of the treatment; poor self-perceived health; three or more diseases; reported limitations caused by a chronic disease; using five drugs or more.", {"entities": []}], ["Low adherence to drug treatment for chronic diseases in Brazil is relevant, and regional and demographic differences and those related to patients\u2019 health care and therapy regime require coordinated action between health professionals, researchers, managers and policy makers.", {"entities": []}], ["Introduction .", {"entities": []}], ["The aim of the study was to compare the breath-holding test and single-breath carbon dioxide test in evaluation of the peripheral chemoreflex sensitivity to carbon dioxide in healthy subjects of different age.", {"entities": []}], ["The study involved 47 healthy volunteers between ages of 25 and 85 years.", {"entities": []}], ["All participants were divided into 4 groups according to age: 25 to 44 years ( n = 14), 45 to 60 years ( n = 13), 60 to 75 years ( n = 12), and older than 75 years ( n = 8).", {"entities": []}], ["Breath-holding test was performed in the morning before breakfast.", {"entities": []}], ["The single-breath carbon dioxide (SB-CO 2 ) test was performed the following day.", {"entities": []}], ["No correlation was found between age and duration of breath-holding ( r = 0.13) and between age and peripheral chemoreflex sensitivity to CO 2 ( r = 0.07).", {"entities": []}], ["In all age groups there were no significant differences in the mean values from the breath-holding test and peripheral chemoreflex sensitivity tests.", {"entities": []}], ["In all groups there was a strong significant inverse correlation between breath-holding test and SB-CO 2 test.", {"entities": []}], ["Conclusion .", {"entities": []}], ["A breath-holding test reflects the sensitivity of the peripheral chemoreflex to carbon dioxide in healthy elderly humans.", {"entities": []}], ["Increasing age alone does not alter the peripheral ventilatory response to hypercapnia.", {"entities": []}], ["Genetic counseling for hereditary breast or colon cancer has implications for both counselees and their relatives.", {"entities": [[44, 56, "DISEASE"], [50, 56, "DISEASE"]]}], ["Although counselees are encouraged by genetic counselors to disclose genetic cancer risk information, they do not always share this information with their at-risk relatives.", {"entities": [[77, 83, "DISEASE"]]}], ["Reasons for not informing relatives may be generally categorized as a lack of knowledge, motivation and/or self-efficacy.", {"entities": []}], ["Presented here is the protocol of a randomized controlled trial that aims to establish the effectiveness of an intervention focused on supporting counselees in their disclosure of genetic cancer information to their relatives.", {"entities": [[188, 194, "DISEASE"]]}], ["A multicenter randomized controlled trial with parallel group design will be used to compare the effects of an additional telephone counseling session performed by psychosocial workers to enhance the disclosure of genetic cancer information to at-risk relatives (intervention group) with a control group of standard care.", {"entities": [[222, 228, "DISEASE"]]}], ["Consecutive index patients with relatives at risk for hereditary or familial breast and/or ovarian cancer or colon cancer, are randomly assigned (block size: 8; 1:1 allocation ratio) to the intervention (n\u2009=\u2009132) or control group (n\u2009=\u2009132, standard care).", {"entities": [[91, 105, "DISEASE"], [109, 121, "DISEASE"], [99, 105, "DISEASE"], [115, 121, "DISEASE"]]}], ["Primary outcomes are counselees\u2019 knowledge, motivation and self-efficacy regarding informing their relatives.", {"entities": []}], ["This intervention may prove important in supporting counselees to disclose hereditary and/or familial cancer risk information to at-risk relatives and may enable more at-risk relatives to make a well-informed decision regarding genetic services and/or screening.", {"entities": [[102, 108, "DISEASE"]]}], ["This trial is registered in the Netherlands National Trial Register (NTR) with trial ID number NTR3745 .", {"entities": []}], ["To evaluate the association of a specific type of lower urinary tract symptom (LUTS) and the depression in community-dwelling elderly Korean men.", {"entities": []}], ["A total of 392 men aged 65 years or older, who completed urological and psychiatric evaluations as a participant of the Korean Longitudinal Study on Health and Aging, were included.", {"entities": []}], ["From each subject, an interview on the demographic characteristics and medical history, IPSS, and psychiatric questionnaire were taken.", {"entities": []}], ["Subjects were divided into two groups; depression and euthymic.", {"entities": []}], ["Subjects with IPSS subscore more than 3 points was considered 'high' subscore.", {"entities": []}], ["IPSS subscores were compared between the two groups, and the relationship between depression and LUTS severity was assessed.", {"entities": []}], ["The mean age of the subjects was 75, and 6.4% of the subjects were diagnosed to have major depressive disorders.", {"entities": []}], ["The depression group showed higher IPSS scores than the euthymic group (16.1\u00b19.9 vs. 11.6\u00b18.6, p=0.01).", {"entities": []}], ["IPSS subscores of question 1 (incomplete empty), question 3 (intermittency), question 4 (urgency) and question 6 (straining to void) were higher in the depression group compared with the euthymic group.", {"entities": []}], ["Chi-square test revealed subjects with high IPSS 1, 3, 4, and 6 score were associated with depression, but multivariate analysis identified only high IPSS question 4 as a significant prognostic factor for depression.", {"entities": []}], ["Elderly population with depression is more likely to have more severe LUTS than population without depression.", {"entities": []}], ["Among the urinary symptoms, urgency was strongly associated with depression.", {"entities": []}], ["Patients with moderate to severe LUTS and especially urgency may need their mental health status evaluation.", {"entities": []}], ["Patients with influenza A (H1N1)v infection have developed rapidly progressive lower respiratory tract disease resulting in respiratory failure.", {"entities": [[124, 143, "DISEASE"], [14, 23, "DISEASE"], [79, 110, "DISEASE"]]}], ["We describe the clinical and epidemiologic characteristics of the first 32 persons reported to be admitted to the intensive care unit (ICU) due to influenza A (H1N1)v infection in Spain.", {"entities": [[147, 156, "DISEASE"]]}], ["We used medical chart reviews to collect data on ICU adult patients reported in a standardized form.", {"entities": []}], ["Influenza A (H1N1)v infection was confirmed in specimens using real-time reverse transcriptase-polymerase-chain-reaction (RT PCR) assay.", {"entities": [[0, 9, "DISEASE"]]}], ["Illness onset of the 32 patients occurred between 23 June and 31 July, 2009.", {"entities": []}], ["The median age was 36 years (IQR = 31 - 52).", {"entities": []}], ["Ten (31.2%) were obese, 2 (6.3%) pregnant and 16 (50%) had pre-existing medical complications.", {"entities": []}], ["Twenty-nine (90.6%) had primary viral pneumonitis, 2 (6.3%) exacerbation of structural respiratory disease and 1 (3.1%) secondary bacterial pneumonia.", {"entities": [[140, 149, "DISEASE"], [130, 149, "DISEASE"]]}], ["Twenty-four patients (75.0%) developed multiorgan dysfunction, 7 (21.9%) received renal replacement techniques and 24 (75.0%) required mechanical ventilation.", {"entities": []}], ["Six patients died within 28 days, with two additional late deaths.", {"entities": []}], ["Oseltamivir administration delay ranged from 2 to 8 days after illness onset, 31.2% received high-dose (300 mg/day), and treatment duration ranged from 5 to 10 days (mean 8.0 \u00b1 3.3).", {"entities": []}], ["Over a 5-week period, influenza A (H1N1)v infection led to ICU admission in 32 adult patients, with frequently observed severe hypoxemia and a relatively high case-fatality rate.", {"entities": [[22, 31, "DISEASE"]]}], ["Clinicians should be aware of pulmonary complications of influenza A (H1N1)v infection, particularly in pregnant and young obese but previously healthy persons.", {"entities": [[57, 66, "DISEASE"]]}], ["To increase discriminatory accuracy (DA) for emergency cesarean sections (ECSs).", {"entities": []}], ["We prospectively collected data on and studied all 6,157 births occurring in 2014 at four public hospitals located in three different autonomous communities of Spain.", {"entities": []}], ["To identify risk factors (RFs) for ECS, we used likelihood ratios and logistic regression, fitted a classification tree (CTREE), and analyzed a random forest model (RFM).", {"entities": []}], ["We used the areas under the receiver-operating-characteristic (ROC) curves (AUCs) to assess their DA.", {"entities": []}], ["The magnitude of the LR+ for all putative individual RFs and ORs in the logistic regression models was low to moderate.", {"entities": []}], ["Except for parity, all putative RFs were positively associated with ECS, including hospital fixed-effects and night-shift delivery.", {"entities": []}], ["The DA of all logistic models ranged from 0.74 to 0.81.", {"entities": []}], ["The most relevant RFs (pH, induction, and previous C-section) in the CTREEs showed the highest ORs in the logistic models.", {"entities": []}], ["The DA of the RFM and its most relevant interaction terms was even higher (AUC = 0.94; 95% CI: 0.93\u20130.95).", {"entities": []}], ["Putative fetal, maternal, and contextual RFs alone fail to achieve reasonable DA for ECS.", {"entities": []}], ["It is the combination of these RFs and the interactions between them at each hospital that make it possible to improve the DA for the type of delivery and tailor interventions through prediction to improve the appropriateness of ECS indications.", {"entities": []}], ["Analysis of data on the effects of passive smoking obtained in preadolescent children from the Harvard Six-Cities Study demonstrates an exposure-response relationship between the number of smokers in the household and the reporting rates for doctor-diagnosed respiratory illness before age 2, history of bronchitis, wheeze most days and nights apart from colds, and a composite of symptoms defined as the lower respiratory index.", {"entities": [[304, 314, "DISEASE"]]}], ["Similarly, when only the amount currently smoked by the mother was used, the data indicated a relatively uniform increase in each of the reported diseases and symptoms.", {"entities": []}], ["FEV1 was lower in children with smoking mothers compared to children of nonsmoking mothers.", {"entities": []}], ["Rate of increases in FEV1 after adjusting for normal growth was significantly smaller in children of smoking mothers and was related also to amount smoked.", {"entities": []}], ["Notably the effect on level of FVC was not seen and this finding, consistent in several studies, remains unexplained.", {"entities": []}], ["Although children of smoking mothers were shorter on the average than children of nonsmoking mothers, no on-going passive smoking effect on height growth can be ascertained.", {"entities": []}], ["All these differences are small and their medical significance remains to be defined.", {"entities": []}], ["Cyclophilins are prolyl isomerases with multitude of functions in different cellular processes and pathological conditions.", {"entities": []}], ["Cyclophilin A (PpiA) of Mycobacterium tuberculosis is secreted during infection in intraphagosomal niche.", {"entities": [[38, 50, "DISEASE"], [15, 19, "GENE"]]}], ["However, our understanding about the evolutionary origin, secretory mechanism or the interactome of M. tuberculosis PpiA is limited.", {"entities": [[103, 115, "DISEASE"], [116, 120, "GENE"]]}], ["This study demonstrates through phylogenetic and structural analyses that PpiA has more proximity to human cyclophilins than the prokaryotic counterparts.", {"entities": [[74, 78, "GENE"]]}], ["We report a unique N-terminal sequence (MADCDSVTNSP) present in pathogenic mycobacterial PpiA and absent in non-pathogenic strains.", {"entities": [[89, 93, "GENE"]]}], ["This sequence stretch was shown to be essential for PpiA secretion.", {"entities": [[52, 56, "GENE"]]}], ["The overexpression of full-length PpiA from M. tuberculosis in non-pathogenic Mycobacterium smegmatis resulted in PpiA secretion while truncation of the N-terminal stretch obstructed the secretion.", {"entities": [[47, 59, "DISEASE"], [34, 38, "GENE"], [114, 118, "GENE"], [34, 38, "GENE"], [114, 118, "GENE"]]}], ["In addition, presence of an ESX pathway substrate motif in M. tuberculosis PpiA suggested possible involvement of Type VII secretion system.", {"entities": [[62, 74, "DISEASE"], [75, 79, "GENE"]]}], ["Site-directed mutagenesis of key residues in this motif in full-length PpiA also hindered the secretion in M. smegmatis .", {"entities": [[71, 75, "GENE"]]}], ["Bacterial two-hybrid screens with human lung cDNA library as target were utilized to identify interaction partners of PpiA from host repertoire, and a number of substrates with functional representation in iron storage, signal transduction and immune responses were detected.", {"entities": [[118, 122, "GENE"]]}], ["The extensive host interactome coupled with the sequence and structural similarity to human cyclophilins is strongly suggestive of PpiA being deployed by M. tuberculosis as an effector mimic against the host cyclophilins.", {"entities": [[157, 169, "DISEASE"], [131, 135, "GENE"]]}], ["The circadian clock in peripheral tissues can be entrained by restricted feeding (RF), a regimen that restricts the duration of food availability with no calorie restriction (CR).", {"entities": []}], ["However, it is not known whether RF can delay the occurrence of age-associated changes similar to CR.", {"entities": []}], ["We measured circadian expression of clock genes, disease marker genes, metabolic factors and inflammatory and allergy markers in mouse serum, liver, jejunum and white adipose tissue (WAT) after long-term RF of 4 months.", {"entities": []}], ["We found that circadian rhythmicity is more robust and is phase advanced in most of the genes and proteins tested under RF.", {"entities": []}], ["In addition, average daily levels of some disease and inflammatory markers were reduced under RF, including liver Il-6 mRNA, tumour necrosis factor (TNF)-\u03b1 and nuclear factor \u03baB (NF-\u03baB) protein; jejunum Arginase, Afp, Gadd45\u03b2, Il-1 \u03b1 and Il-1 \u03b2 mRNA, and interleukin (IL)-6 and TNF-\u03b1 protein and WAT Il-6, Il-1\u03b2, Tnf \u03b1 and Nf \u03ba b mRNA.", {"entities": [[149, 152, "GENE"], [278, 281, "GENE"], [313, 316, "GENE"], [213, 216, "GENE"], [149, 152, "GENE"], [278, 281, "GENE"], [313, 316, "GENE"]]}], ["In contrast, the anti-inflammatory cytokine Il-10 mRNA increased in the liver and jejunum.", {"entities": []}], ["Our results suggest that RF may share some benefits with those of CR.", {"entities": []}], ["As RF is a less harsh regimen to follow than CR, the data suggest it could be proposed for individuals seeking to improve their health.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide.", {"entities": []}], ["The study aimed to determine and compare the prevalence of COPD in the general population aged 45-74\u00a0years old according to fixed ratio and lower limit of normal (LLN) thresholds in four cities in the Southern Cone of Latin America.", {"entities": []}], ["The Pulmonary Risk in South America (PRISA) study used a 4-stage stratified sampling method to select 5814 participants from 4 cities in the Southern Cone of Latin America (Bariloche and Marcos Paz, Argentina; Temuco, Chile; and Pando-Barros Blancos, Uruguay).", {"entities": []}], ["Data on demographic information, medical history, risk factors, pre-bronchodilator and post-bronchodilator spirometry were obtained using a standard protocol.", {"entities": []}], ["According to GOLD, COPD was defined as a post-bronchodilator ratio of forced expiratory volume in one second (FEV1) over forced vital capacity (FVC) less than 70%.", {"entities": []}], ["The LLN threshold was defined as the lower fifth percentile for predicted FEV1/FVC, and was evaluated as an alternative COPD definition.", {"entities": []}], ["Overall COPD prevalence was 9.3% (95% CI 8.4, 10.2%), and men had a higher prevalence [11.8% (95% CI 10.3, 13.3%)] than women [7.3% (95% CI 6.2, 8.3%)] with the fixed ratio.", {"entities": []}], ["Overall COPD prevalence using LLN was 4.7% (95% CI 4.1, 5.3%), higher in men: 5.8% (95% CI 4.7, 6.8%) than women: 3.9% (95% CI 3.1, 4.7%).", {"entities": []}], ["COPD prevalence was significantly higher among those who were older, had <high-school education and lower body-mass index, were cigarette smokers, and had self-reported history of asthma and tuberculosis.", {"entities": [[191, 203, "DISEASE"], [180, 186, "DISEASE"]]}], ["First , COPD and its risk factors are highly prevalent in the general population of Argentina, Chile, and Uruguay.", {"entities": []}], ["Second, the prevalence of COPD by LLN criterion was significantly lower with lesser degrees of severity compared to fixed ratio of FEV1/FVC.", {"entities": []}], ["Implementing LLN criterion instead of fixed ratio of FEV1/FVC may reduce the risk of over-diagnosis of COPD, although further prognostic studies of COPD adverse outcomes should be conducted using both definitions.", {"entities": []}], ["Third, these data suggest that national efforts on the prevention, treatment, and control of COPD should be a public health priority in the Southern Cone of Latin America.", {"entities": []}], ["The online version of this article (10.1186/s12890-017-0537-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Isoquercitrin, a flavonoid compound that is widely distributed in medicinal and dietary plants, possesses many biological activities, including inhibition of adipocyte differentiation.", {"entities": []}], ["In this study, we investigated the effect of isoquercitrin on lipid accumulation and its molecular mechanisms in rat hepatoma H4IIE cells.", {"entities": []}], ["To investigate the effect of isoquercitrin on lipid accumulation, H4IIE cells were induced by FFA and the total lipid levels were detected by Oil Red O staining.", {"entities": []}], ["Furthermore, The protein levels of AMPK and acetyl-CoA carboxylase (ACC), the gene expressions of transcriptional factor, lipogenic genes, and adiponectin receptor 1 (AdipoR1) were analyzed by Western blotting and quantitative real-time PCR.", {"entities": [[167, 174, "GENE"]]}], ["To further confirm the pathway of isoquercitrin-mediated hepatic lipid metabolism, H4IIE cells were treated with an AMPK inhibitor and AdipoR1 siRNA.", {"entities": [[135, 142, "GENE"]]}], ["Isoquercitrin significantly enhances AMPK phosphorylation, downregulates sterol regulatory element binding protein transcription factor 1 (SREBP-1) and fatty acid synthase (FAS) gene expressions.", {"entities": [[173, 176, "GENE"]]}], ["Pretreatment with AMPK inhibitor, significantly decreased the AMPK phosphorylation and increased FAS expression stimulated by isoquercitrin.", {"entities": [[97, 100, "GENE"]]}], ["Isoquercitrin might also upregulate the expression of AdipoR1 dose-dependently via AMPK in the presence of an AMPK inhibitor and AdipoR1 siRNA.", {"entities": [[54, 61, "GENE"], [129, 136, "GENE"], [54, 61, "GENE"], [129, 136, "GENE"]]}], ["Isoquercitrin appears to regulate AMPK activation, thereby enhancing AdipoR1 expression, suppressing SREBP-1 and FAS expressions, and resulting in the regulation of lipid accumulation.", {"entities": [[69, 76, "GENE"], [113, 116, "GENE"]]}], ["These results suggest that isoquercitrin is a novel dietary compound that can be potentially be used to prevent lipid metabolic disorder and nonalcoholic fatty liver disease.", {"entities": [[154, 173, "DISEASE"], [160, 173, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is characterised by pulmonary and systemic inflammation which flare-up during episodes of acute exacerbation (AECOPD).", {"entities": []}], ["Given the role of Toll-like receptors (TLRs) in the induction of inflammatory responses we investigated the involvement of TLRs in COPD pathogenesis.", {"entities": []}], ["The expression of TLR-2, TLR-4 and CD14 in monocytes was analyzed by flow cytometry.", {"entities": [[35, 39, "GENE"]]}], ["To study the functional responses of these receptors, monocytes were stimulated with peptidoglycan or lipopolysaccharide and the amounts of TNF\u03b1 and IL-6 secreted were determined by ELISA.", {"entities": []}], ["We found that the expression of TLR-2 was up-regulated in peripheral blood monocytes from COPD patients, either clinically stable or during AECOPD, as compared to never smokers or smokers with normal lung function.", {"entities": []}], ["Upon stimulation with TLR-2 ligand monocytes from COPD patients secreted increased amounts of cytokines than similarly stimulated monocytes from never smokers and smokers.", {"entities": []}], ["In contrast, the expressions of TLR-4 and CD14 were not significantly different between groups, and the response to lipopolysaccharide (a TLR-4 ligand) stimulation was not significantly different either.", {"entities": [[42, 46, "GENE"]]}], ["At discharge from hospital TLR-2 expression was down-regulated in peripheral blood monocytes from AECOPD patients.", {"entities": []}], ["This could be due to the treatment with systemic steroids because, in vitro , steroids down-regulated TLR-2 expression in a dose-dependent manner.", {"entities": []}], ["Finally, we demonstrated that IL-6, whose plasma levels are elevated in patients, up-regulated in vitro TLR-2 expression in monocytes from never smokers.", {"entities": []}], ["Our results reveal abnormalities in TLRs expression in COPD patients and highlight its potential relationship with systemic inflammation in these patients.", {"entities": []}], ["Intestinal microfold (M) cells are epithelial cells primarily present on Peyer's patches (PPs) in the small intestine.", {"entities": []}], ["The ability of M cells to shuttle antigens into the PP for appropriate immune responses makes M cells a target for next-generation oral vaccine delivery.", {"entities": []}], ["In this regard, discovery of M cell-specific receptors are of great interest, which could act as molecular tags for targeted delivery of cargo to M cells.", {"entities": []}], ["Here, using a monoclonal antibody we generated to the Sialic acid-binding immunoglobulin-like lectin F (Siglec-F), we show that Siglec-F is expressed on mouse M cells in the small intestine.", {"entities": []}], ["Immunohistochemical analysis of the PP tissue sections shows that Siglec-F is expressed on the surface of the M cell membrane exposed to the intestinal lumen.", {"entities": []}], ["Anti-Siglec-F antibody injected into the mouse small intestine bound to M cells, demonstrating the potential to target M cells via Siglec-F. \u2022 A new monoclonal antibody recognizing Siglec-F has been established.", {"entities": []}], ["\u2022 Siglec-F is expressed on mouse Peyer's patch microfold (M) cells.", {"entities": []}], ["\u2022 Siglec-F antibody binds to PP M cells in\u00a0vivo.", {"entities": []}], ["A new monoclonal antibody recognizing Siglec-F has been established.", {"entities": []}], ["Siglec-F is expressed on mouse Peyer's patch microfold (M) cells.", {"entities": []}], ["Siglec-F antibody binds to PP M cells in\u00a0vivo.", {"entities": []}], ["Steroid-responsive meningitis-arteritis (SRMA) is an immune-mediated disorder characterized by neutrophilic pleocytosis and an arteritis particularly in the cervical leptomeninges.", {"entities": [[19, 29, "DISEASE"]]}], ["Previous studies of the disease have shown increased levels of IL-6 and TGF-\u00df 1 in cerebrospinal fluid (CSF).", {"entities": []}], ["In the presence of these cytokines, naive CD4+ cells differentiate into Th17 lymphocytes which synthesize interleukin 17 (IL-17).", {"entities": []}], ["It has been shown that IL-17 plays an active role in autoimmune diseases, it induces and mediates inflammatory responses and has an important role in recruitment of neutrophils.", {"entities": []}], ["The hypothesis of a Th17-skewed immune response in SRMA should be supported by evaluating IL-17 and CD40L, inducing the vasculitis.", {"entities": [[120, 130, "DISEASE"]]}], ["An enzyme-linked immunosorbent assay (ELISA) was performed to measure IL-17 and CD40L in serum and CSF from a total of 79 dogs.", {"entities": []}], ["Measurements of patients suffering from SRMA in the acute state (SRMA A) were compared with levels of patients under treatment with steroids (SRMA T), recurrence of the disease (SRMA R), other neurological disorders, and healthy dogs, using the two-part test.", {"entities": []}], ["Additionally, secretion of IL-17 and interferon gamma (IFN-\u03b3) from the peripheral blood mononuclear cells (PBMCs) was confirmed by an enzyme-linked immunospot (ELISpot) assay.", {"entities": []}], ["Significant higher levels of IL-17 were found in CSF of dogs with SRMA A compared with SRMA T, other neurological disorders and healthy dogs ( p \u2009<\u20090.0001).", {"entities": []}], ["In addition, levels of CD40L in CSF in dogs with SRMA A and SRMA R were significantly higher than in those with SRMA T ( p \u2009=\u20090.0004) and healthy controls ( p \u2009=\u20090.014).", {"entities": []}], ["Furthermore, CSF concentrations of IL-17 and CD40L showed a strong positive correlation among each other (rSpear\u2009=\u20090.6601; p \u2009<\u20090.0001) and with the degree of pleocytosis (rSpear\u2009=\u20090.8842; p \u2009<\u20090.0001 and rSpear\u2009=\u20090.6649; p \u2009<\u20090.0001, respectively).", {"entities": []}], ["IL-17 synthesis from PBMCs in SRMA patients was confirmed; however, IL-17 is mainly intrathecally produced.", {"entities": []}], ["These results imply that Th17 cells are inducing the autoimmune response in SRMA and are involved in the severe neutrophilic pleocytosis and disruption of the blood-brain barrier (BBB).", {"entities": []}], ["CD-40L intrathecal synthesis might be involved in the striking vasculitis.", {"entities": [[63, 73, "DISEASE"]]}], ["The investigation of the role of IL-17 in SRMA might elucidate important pathomechanism and open new therapeutic strategies.", {"entities": []}], ["Exposure to secondhand smoke is problematic for residents living in multiunit housing, as the smoke migrates through shared ventilation systems, unsealed cracks, and door spaces.", {"entities": []}], ["The objective of our research was to assess resident exposure to secondhand smoke, support for no-smoking policies, and the health impacts of no-smoking policies in multiunit housing.", {"entities": []}], ["Surveys of 312 heads of households who resided in 1 of 3 multiunit buildings managed by a Colorado public housing authority were administered before and after implementation of a no-smoking policy that prohibited smoking in all resident apartments and all indoor common areas.", {"entities": []}], ["A matched-pairs analysis of initial surveys and 15-month post-policy implementation surveys for 115 respondents was conducted.", {"entities": []}], ["Decreases were found in the number and percentage of smokers who smoked every day and the number of cigarettes smoked per day, and 30% had quit smoking 15 months after policy implementation.", {"entities": []}], ["The percentage of residents who smelled secondhand smoke indoors declined significantly.", {"entities": []}], ["A significant decrease in breathing problems was found after policy implementation.", {"entities": []}], ["Although decreases were found in the incidence of asthma attacks, emphysema/chronic obstructive pulmonary disease, eye irritation, colds, nasal congestion, and ear/sinus infections, these decreases were not significant.", {"entities": [[76, 113, "DISEASE"], [50, 56, "DISEASE"]]}], ["Consistent findings across nearly all variables tested suggest that no-smoking policies reduce resident exposure to secondhand smoke, lower the incidence of secondhand smoke\u2013associated breathing problems, decrease daily smoking and cigarette consumption, encourage smoking cessation, and increase quit attempts.", {"entities": []}], ["If implemented in all multiunit housing, these policies could reduce exposure to secondhand smoke and health problems associated with secondhand smoke, promote smoking cessation, and reduce cigarette consumption.", {"entities": []}], ["Information leaflets have been shown to positively or negatively impact adherence, depending on their content.", {"entities": []}], ["The objective of this study was to perform an appraisal of the consumer information provided in COPD inhaler monographs.", {"entities": []}], ["COPD inhalers were identified from the Health Canada Drug Product Database.", {"entities": []}], ["Medication information and instructions for inhaler use were analyzed for readability by seven formulas, with an acceptability threshold of grades 6\u20138.", {"entities": []}], ["Three researchers rated suitability using a modified Suitability Assessment of Materials (SAM) tool and assessed leaflets for explicit warnings.", {"entities": []}], ["Twenty-six inhalers with a COPD indication were evaluated.", {"entities": []}], ["Medication information sections were rated as \u201cdifficult to read\u201d or \u201chard,\u201d and 85% (22/26) had a reading level above grade 8.", {"entities": []}], ["The instructions for inhaler use were rated as \u201ceasy\u201d or \u201cfairly easy\u201d to read and 63% (16/26) met the threshold by all formulas.", {"entities": []}], ["While all leaflets achieved superior suitability ratings, extreme warnings included risk of premature death ( n = 12), risks of serious injury ( n = 26), serious interactions ( n = 26), and statements that convey a serious consequence to therapy ( n = 26).", {"entities": []}], ["While COPD information leaflets in Canada performed well in terms of readability and suitability, overemphasis on side effects, warnings, and precautions may contribute to patient fear and nonadherence.", {"entities": []}], ["Settled airborne dust is used as a surrogate for airborne exposure in studies that explore indoor microbes.", {"entities": []}], ["In order to determine whether detecting differences in dust environments would depend on the sampler type, we compared different passive, settled dust sampling approaches with respect to displaying qualitative and quantitative aspects of the bacterial and fungal indoor microbiota.", {"entities": []}], ["Settled dust sampling approaches\u2014utilizing plastic petri dishes, TefTex material, and electrostatic dustfall collectors (EDCs)\u2014were evaluated in indoor spaces in the USA and Finland and in an experimental chamber study.", {"entities": []}], ["The microbial content was analyzed with quantitative PCR (qPCR) to quantify total bacterial and fungal biomass and through high-throughput sequencing to examine bacterial community composition.", {"entities": []}], ["Bacterial composition and diversity were similar within a sampling environment regardless of the sampler type.", {"entities": []}], ["The sampling environment was the single largest predictor of microbial community composition within a study, while sampler type was found to have much less predictive power.", {"entities": []}], ["Quantitative analyses in indoor spaces indicated highest yields using a petri dish approach, followed by sampling with EDCs and TefTex.", {"entities": []}], ["The highest correlations between duplicate samples were observed for EDC and petri dish approaches, indicating greater experimental repeatability for these sampler types.", {"entities": []}], ["For the EDC samples, it became apparent that, due to the fibrous nature of the material, a rigorous extraction protocol is crucial to obtain optimal yields and stable, repeatable results.", {"entities": []}], ["Correlations between sampler types were strong both in compositional and quantitative terms, and thus, the particular choice of passive settled dust sampler is not likely to strongly alter the overall conclusion of a study that aims to characterize dust across different environments.", {"entities": []}], ["Microbial cell abundances determined from settled dust varied with the use of different sampling approaches, and thus, consistency in the method is necessary to allow for absolute comparisons within and among studies.", {"entities": []}], ["Considering practical aspects, petri dishes were found to be an inexpensive, simple, and feasible approach that showed the highest quantitative determinations under typical building conditions, though the choice of sampler will ultimately depend on study logistics and characteristics such as low- or high-exposure settings.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-015-0112-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to report the characteristics and treatment strategies of all patients with acute bronchospasm who were presented to the emergency departments of Ahvaz, Iran, following the occurrence of a thunderstorm on November 2, 2013.", {"entities": []}], ["A total of 2000 patients presenting with asthma attacks triggered by thunderstorm were interviewed and an initial questionnaire was completed for each individual.", {"entities": [[41, 47, "DISEASE"]]}], ["After twenty days, patients were asked to complete a supplementary questionnaire, but only 800 of them accepted to do so.", {"entities": []}], ["The majority of subjects was aged 20\u201340 years (60.5%) and had no history of asthma in most cases (60.0%).", {"entities": [[76, 82, "DISEASE"]]}], ["The symptoms had started outdoors for 60.0% of the participants.", {"entities": []}], ["In most patients, the onset of the condition was on November 2.", {"entities": []}], ["Short-acting \u03b2 2 -agonist (salbutamol) and aminophylline were the most commonly prescribed medications in the emergency department.", {"entities": []}], ["Upon the second interview, 85.3% of the patients were still symptomatic.", {"entities": []}], ["Overall, 63.6% did not have a follow-up visit after hospital discharge, although all of them were referred to the specialist.", {"entities": []}], ["The findings of the present study suggest that thunderstorm-associated asthma could affect young adults with no gender priority, with or without asthma history, which put a strain on emergency medical services.", {"entities": [[71, 77, "DISEASE"], [145, 151, "DISEASE"]]}], ["Perlite is a generic name for an amorphous volcanic alumina\u2013silicate rock that expands by a factor of 4\u201320 when rapidly heated to 1400\u20131800\u2009\u00b0F (760\u2013980\u2009\u00b0C).", {"entities": []}], ["Both the ore and the expanded product have extensive and widespread commercial applications.", {"entities": []}], ["Limited data on the toxicology of perlite in animal studies indicate that the LD 50 (oral ingestion) is more than 10\u2009g/kg and, from a chronic inhalation study in guinea pigs and rats, that the NOAEL for the inhalation pathway is 226\u2009mg/m", {"entities": []}], ["Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine (LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV).", {"entities": [[54, 63, "DISEASE"], [142, 151, "DISEASE"]]}], ["The immune responses elicted by LAIV mimic natural infection and have been found to provide broader clinical protection in children compared to the IIVs.", {"entities": []}], ["However, our knowledge of the detailed immunological mechanisims induced by LAIV remain to be fully elucidated, and despite 14\u00a0years on the global market, there exists no correlate of protection.", {"entities": []}], ["Recently, matters are further complicated by differing efficacy data from the US and Europe which are not understood.", {"entities": []}], ["Better understanding of the immune responses after LAIV may aid in achieving the ultimate goal of a future \u201cuniversal influenza vaccine\u201d.", {"entities": [[118, 127, "DISEASE"]]}], ["In this review we aim to cover the current understanding of the immune responses induced after LAIV.", {"entities": []}], ["Sida cordata , a member of Family Malvaceae is used in folk medicine for various ailments including liver diseases.", {"entities": []}], ["In this study we investigated, its flavonoid constituents, in vitro antioxidant potential against different free radicals and hepatoprotection against carbon tetrachloride (CCl 4 )-induced liver damage in rat.", {"entities": []}], ["Dried powder of S. cordata whole plant was extracted with methanol and the resultant (SCME) obtained was fractionated with escalating polarity to obtain n -hexane fraction (SCHE), ethyl acetate fraction (SCEE), n -butanol fraction (SCBE) and the remaining soluble portion as aqueous fraction (SCAE).", {"entities": []}], ["Diverse in vitro antioxidants assays such as DPPH, H 2 O 2 , \u2022OH, ABTS, \u03b2-carotene bleaching assay, superoxide radical, lipid peroxidation, reducing power, and total antioxidant capacity were studied to assess scavenging potential of methanol extract and its derived fractions.", {"entities": []}], ["On account of marked scavenging activity SCEE was selected to investigate the hepatoprotective potential against CCl 4 induced toxicity in Sprague\u2013Dawley male rats by assessing the level of serum markers (alkaline phosphatase, alanine transaminase, aspartate transaminase, lactate dehydrogenase, bilirubin, and \u03b3-glutamyltransferase) and of liver antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), peroxidase (POD), glutathione-S-transfers (GST), glutathione reductase (GSR), glutathione peroxidase (GSH-Px), and reduced glutathione (GSH) and lipid peroxidation (TBARS).", {"entities": [[491, 494, "GENE"]]}], ["Histology of the liver was performed to study alteration in histoarchitecture.", {"entities": []}], ["Existence of active flavonoids was established by thin layer chromatographic studies.", {"entities": []}], ["Considerable amount of flavonoid and phenolic contents were recorded in the methanol extract and its derived fractions.", {"entities": []}], ["Although the extract and all its derived fractions exhibited good antioxidant activities however, the most distinguished scavenging potential was observed for SCEE.", {"entities": []}], ["Treatment of SCEE decreased the elevated level of serum marker enzymes induced with CCl 4 administration whereas increased the activity of hepatic antioxidant enzymes (CAT, SOD, POD, GST, GSR and GSH-Px).", {"entities": [[188, 191, "GENE"]]}], ["Hepatic concentration of GSH was increased while lipid peroxidation was decreased with SCEE administration in CCl 4 intoxicated rats.", {"entities": []}], ["Presence of apigenin with some unknown compounds was observed in SCEE by using thin layer chromatography.", {"entities": []}], ["These results revealed the presence of some bioactive compound in the ethyl acetate fraction, confirming the utility of S. cordata against liver diseases in folk medicine.", {"entities": []}], ["High leptin concentration, low-grade inflammation, and insulin resistance often coexist in obese subjects; this adverse metabolic milieu may be the main culprit for increased fracture risk and impaired bone quality seen in patients with type 2 diabetes.", {"entities": []}], ["We examined the associations of leptin, hs (high sensitivity)- CRP and insulin resistance with bone turnover markers (BTMs) and bone characteristics in 55 young obese adults (median BMI 40 kg/m", {"entities": [[63, 66, "GENE"]]}], ["Dexmedetomidine can be used for the prevention of emergence agitation (EA) in children.", {"entities": []}], ["However, an inadequate dose of dexmedetomidine can induce prolonged sedation and cardiovascular complications.", {"entities": []}], ["The aim of this study was to evaluate the effective dose of dexmedetomidine for the prevention of EA after desflurane anesthesia for patients undergoing a tonsillectomy or adenoidectomy.", {"entities": []}], ["We enrolled 21 unpremedicated children, between 2 and 12\u00a0years, undergoing either a tonsillectomy or an adenoidectomy.", {"entities": []}], ["General anesthesia was induced using sevoflurane and oxygen, and dexmedetomidine was administered before surgery.", {"entities": []}], ["Anesthesia was maintained using desflurane resulting in a BIS range of 40\u201360.", {"entities": []}], ["In the postanesthetic care unit (PACU), EA (agitation measured at level 4 or more at least once) was assessed on arrival in the PACU,15\u00a0min later, and 30\u00a0min later.", {"entities": []}], ["The dose of dexmedetomidine for consecutive patients was determined by the response of the previous patient, using an increment or decrement of 0.1\u00a0\u03bcg/kg.", {"entities": []}], ["The 50\u00a0% effective dose of dexmedetomidine for prevention of EA was 0.25\u00a0\u03bcg/kg (95\u00a0% confidence limits, 0.17\u20130.33\u00a0\u03bcg/kg), and the 95\u00a0% effective dose was 0.38\u00a0\u03bcg/kg (95\u00a0% confidence limits, 0.29\u20130.39\u00a0\u03bcg/kg).", {"entities": []}], ["For prevention of EA after desflurane anesthesia for 50\u00a0% and 95\u00a0% of children undergoing tonsillectomies or adenoidectomies, 0.25\u00a0\u03bcg/kg or 0.38\u00a0\u03bcg/kg of dexmedetomidine is suggested.", {"entities": []}], ["Further study is needed to validate the suggested dose of dexmedetomidine to prevent the EA that was identified in the present study.", {"entities": []}], ["Clinical Research Information Service KCT0000126 .", {"entities": []}], ["The precise mechanism of the very effective therapeutic effect of gastrointestinal nematodes on some autoimmune diseases is not clearly understood and is currently being intensively investigated.", {"entities": []}], ["Treatment with living helminths has been initiated to reverse intestinal immune-mediated diseases in humans.", {"entities": []}], ["However, little attention has been paid to the phenotype of nematodes in the IBD-affected gut and the consequences of nematode adaptation.", {"entities": []}], ["In the present study, exposure of Heligmosomoides polygyrus larvae to the changed cytokine milieu of the intestine during colitis reduced inflammation in an experimental model of dextran sulphate sodium (DSS)- induced colitis, but increased nematode establishment in the moderate-responder BALB/c mouse strain.", {"entities": []}], ["We used mass spectrometry in combination with two-dimensional Western blotting to determine changes in protein expression and changes in nematode antigens recognized by IgG1 in mice with colitis.", {"entities": []}], ["We show that nematode larvae immunogenicity is changed by colitis as soon as 6 days post-infection; IgG1 did not recognize highly conserved proteins Lev-11 (isoform 1 of tropomyosin \u03b11 chain), actin-4 isoform or FTT-2 isoform a ( 14-3-3 family ) protein.", {"entities": []}], ["These results indicate that changes in the small intestine provoked by colitis directly influence the nematode proteome.", {"entities": []}], ["The unrecognized proteins seem to be key antigenic epitopes able to induce protective immune responses.", {"entities": []}], ["The proteome changes were associated with weak immune recognition and increased larval adaptation and worm growth, altered localization in the intestine and increased survival of males but reduced worm fecundity.", {"entities": []}], ["In this report, the mechanisms influencing nematode survival and the consequences of changed immunogenicity that reflect the immune response at the site colonized by the parasite in mice with colitis are described.", {"entities": []}], ["The results are relevant to the use of live parasites to ameliorate IBD.", {"entities": []}], ["A number of studies have suggested the benefits of pet ownership to human health, including cardiovascular disease (CVD).", {"entities": []}], ["However, there are few findings regarding pet ownership and coronary artery disease (CAD).", {"entities": []}], ["The objective of this study is to investigate the association between pet ownership and CAD in a Chinese population.", {"entities": []}], ["From October 2015 to May 2016, a survey consisting of 561 consecutive patients was done in Nanjing, China.", {"entities": []}], ["Based on the results of coronary arteriography for the first time, participants were divided into 2 groups (non-CAD and CAD groups).", {"entities": []}], ["Pet ownership information was collected by using a questionnaire.", {"entities": []}], ["After multivariate adjustments, pet ownership was associated with a decreased CAD risk (odds ratios [OR]: 0.504, 95% confidence intervals [CIs]: 0.310\u20130.819).", {"entities": []}], ["There was a reduced CAD risk among dog owners (OR: 0.420, 95% CI: 0.242\u20130.728) when compared with the cat group (OR: 0.738, 95% CI: 0.240\u20132.266) and the cat and dog group (OR: 1.052, 95% CI: 0.330\u20133.355).", {"entities": []}], ["With the increase of pet ownership duration, there was a decreased tendency of CAD risk, including years of keeping pets ( P for trend\u200a=\u200a0.008) and time of playing with pets per day ( P for trend\u200a=\u200a0.001).", {"entities": []}], ["In addition, similar dose\u2013response relationship was observed for starting age of keeping pets ( P for trend\u200a=\u200a0.002).", {"entities": []}], ["Pet ownership, especially dog ownership, can be a protective factor for CAD in Chinese patients.", {"entities": []}], ["The reduction in the deaths of millions of children who die from infectious diseases requires early initiation of treatment and improved access to care available in health facilities.", {"entities": []}], ["A major challenge is the lack of objective evidence to guide front line health workers in the community to recognize critical illness in children earlier in their course.", {"entities": []}], ["We undertook a prospective observational study of children less than 5 years of age presenting at the outpatient or emergency department of a rural tertiary care hospital between October 2012 and April 2013.", {"entities": []}], ["Study physicians collected clinical signs and symptoms from the facility records, and with a mobile application performed recordings of oxygen saturation, heart rate and respiratory rate.", {"entities": []}], ["Facility physicians decided the need for hospital admission without knowledge of the oxygen saturation.", {"entities": []}], ["Multiple logistic predictive models were tested.", {"entities": []}], ["Twenty-five percent of the 3374 assessed children, with a median (interquartile range) age of 1.02 (0.42\u20132.24), were admitted to hospital.", {"entities": []}], ["We were unable to contact 20% of subjects after their visit.", {"entities": []}], ["A logistic regression model using continuous oxygen saturation, respiratory rate, temperature and age combined with dichotomous signs of chest indrawing, lethargy, irritability and symptoms of cough, diarrhea and fast or difficult breathing predicted admission to hospital with an area under the receiver operating characteristic curve of 0.89 (95% confidence interval -CI: 0.87 to 0.90).", {"entities": [[200, 208, "DISEASE"]]}], ["At a risk threshold of 25% for admission, the sensitivity was 77% (95% CI: 74% to 80%), specificity was 87% (95% CI: 86% to 88%), positive predictive value was 70% (95% CI: 67% to 73%) and negative predictive value was 91% (95% CI: 90% to 92%).", {"entities": []}], ["A model using oxygen saturation, respiratory rate and temperature in combination with readily obtained clinical signs and symptoms predicted the need for hospitalization of critically ill children.", {"entities": []}], ["External validation of this model in a community setting will be required before adoption into clinical practice.", {"entities": []}], ["Atopic dermatitis is a complex disease of heterogeneous pathogenesis, in particular, genetic predisposition, environmental triggers, and their interactions.", {"entities": [[0, 17, "DISEASE"], [7, 17, "DISEASE"]]}], ["Indoor air pollution, increasing with urbanization, plays a role as environmental risk factor in the development of AD.", {"entities": []}], ["However, we still lack a detailed picture of the role of air pollution in the development of the disease.", {"entities": []}], ["Here, we examined the effect of formaldehyde (FA) exposure on the manifestation of atopic dermatitis and the underlying molecular mechanism in naive rats and in a rat model of atopic dermatitis (AD) produced by neonatal capsaicin treatment.", {"entities": [[83, 100, "DISEASE"], [176, 193, "DISEASE"], [90, 100, "DISEASE"], [183, 193, "DISEASE"]]}], ["The AD and naive rats were exposed to 0.8 ppm FA, 1.2 ppm FA, or fresh air (Air) for 6 weeks (2 hours/day and 5 days/week).", {"entities": []}], ["So, six groups, namely the 1.2 FA-AD, 0.8 FA-AD, Air-AD, 1.2 FA-naive, 0.8 FA-naive and Air-naive groups, were established.", {"entities": []}], ["Pruritus and dermatitis, two major symptoms of atopic dermatitis, were evaluated every week for 6 weeks.", {"entities": [[47, 64, "DISEASE"], [13, 23, "DISEASE"], [54, 64, "DISEASE"]]}], ["After that, samples of the blood, the skin and the thymus were collected from the 1.2 FA-AD, the Air-AD, the 1.2 FA-naive and the Air-naive groups.", {"entities": []}], ["Serum IgE levels were quantified with ELISA, and mRNA expression levels of inflammatory cytokines from extracts of the skin and the thymus were calculated with qRT-PCR.", {"entities": []}], ["The dermatitis and pruritus significantly worsened in 1.2 FA-AD group, but not in 0.8 FA-AD, compared to the Air-AD animals, whereas FA didn't induce any symptoms in naive rats.", {"entities": [[4, 14, "DISEASE"]]}], ["Consistently, the levels of serum IgE were significantly higher in 1.2 FA-AD than in air-AD, however, there was no significant difference following FA exposure in naive animals.", {"entities": []}], ["In the skin, mRNA expression levels of Th1 cytokines such as TNF-\u03b1 and IL-1\u03b2 were significantly higher in the 1.2 FA-AD rats compared to the air-AD rats, whereas mRNA expression levels of Th2 cytokines (IL-4, IL-5, IL-13), IL-17A and TSLP were significantly higher in 1.2 FA-naive group than in the Air-naive group.", {"entities": [[234, 238, "GENE"]]}], ["These results suggested that 1.2 ppm of FA penetrated the injured skin barrier, and exacerbated Th1 responses and serum IgE level in the AD rats so that dermatitis and pruritus were aggravated, while the elevated expression of Th2 cytokines by 1.2 ppm of FA in naive rats was probably insufficient for clinical manifestation.", {"entities": [[153, 163, "DISEASE"]]}], ["In conclusion, in a rat model of atopic dermatitis, exposure to 1.2 ppm of FA aggravated pruritus and skin inflammation, which was associated with the elevated expression of Th1 cytokines.", {"entities": [[33, 50, "DISEASE"], [40, 50, "DISEASE"]]}], ["Glaucoma is characterized by the loss of retinal ganglion cells ( RGC s) and optic nerve fibres.", {"entities": [[0, 8, "DISEASE"]]}], ["Previous studies noted fewer RGC s after immunization with ocular antigens at 28 days.", {"entities": []}], ["It is known that changes in extracellular matrix ( ECM ) components conduct retina and optic nerve degeneration.", {"entities": []}], ["Here, we focused on the remodelling of tenascin\u2010C and phosphacan/receptor protein tyrosine phosphatase \u03b2/\u03b6 in an autoimmune glaucoma model.", {"entities": [[124, 132, "DISEASE"]]}], ["Rats were immunized with optic nerve homogenate ( ONA ) or S100B protein (S100).", {"entities": [[59, 64, "GENE"]]}], ["Controls received sodium chloride (Co).", {"entities": []}], ["After 14 days, no changes in RGC number were noted in all groups.", {"entities": []}], ["An increase in GFAP mRNA expression was observed in the S100 group, whereas no alterations were noted via immunohistochemistry in both groups.", {"entities": [[15, 19, "GENE"]]}], ["Extracellular matrix remodelling was analyzed after 3, 7, 14 and 28 days.", {"entities": []}], ["Tenascin\u2010C and 473 HD immunoreactivity in retinae and optic nerves was unaltered in both immunized groups at 3 days.", {"entities": []}], ["At 7 days, tenascin\u2010C staining increased in both tissues in the ONA group.", {"entities": []}], ["Also, in the optic nerves of the S100 group, an intense tenascin\u2010C staining could be shown.", {"entities": []}], ["In the retina, an increased tenascin\u2010C expression was also observed in ONA animals via Western blot.", {"entities": []}], ["473 HD immunoreactivity was elevated in the ONA group in both tissues and in the S100 optic nerves at 7 days.", {"entities": []}], ["At 14 days, tenascin\u2010C and 473 HD immunoreactivity was up\u2010regulated in the ONA retinae, whereas phosphacan expression was up\u2010regulated in both groups.", {"entities": []}], ["We conclude that remodelling of tenascin\u2010C and phosphacan occurred shortly after immunization, already before RGC loss.", {"entities": []}], ["We assume that both ECM molecules represent early indicators of neurodegeneration.", {"entities": []}], ["Inhalation of diesel exhaust particles (DEP) induces an inflammatory reaction in the lung.", {"entities": []}], ["However, the underlying mechanisms remain to be elucidated.", {"entities": []}], ["Tumor necrosis factor alpha (TNF-\u03b1) is a pro-inflammatory cytokine that operates by binding to tumor necrosis factor receptor 1 (TNFR1) and tumor necrosis factor receptor 2 (TNFR2).", {"entities": []}], ["The role of TNF-\u03b1 signaling and the importance of either TNFR1 or TNFR2 in the DEP-induced inflammatory response has not yet been elucidated.", {"entities": []}], ["TNF-\u03b1 knockout (KO), TNFR1 KO, TNFR2 KO, TNFR1/TNFR2 double KO (TNFR-DKO) and wild type (WT) mice were intratracheally exposed to saline or DEP.", {"entities": []}], ["Pro-inflammatory cells and cytokines were assessed in the bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["Exposure to DEP induced a dose-dependent inflammation in the BALF in WT mice.", {"entities": []}], ["In addition, levels of TNF-\u03b1 and its soluble receptors were increased upon exposure to DEP.", {"entities": []}], ["The DEP-induced inflammation in the BALF was decreased in TNF-\u03b1 KO, TNFR-DKO and TNFR2 KO mice.", {"entities": []}], ["In contrast, the inflammatory response in the BALF of DEP-exposed TNFR1 KO mice was largely comparable with WT controls.", {"entities": []}], ["In conclusion, these data provide evidence for a regulatory role of TNF-\u03b1 in DEP-induced pulmonary inflammation and identify TNFR2 as the most important receptor in mediating these inflammatory effects.", {"entities": []}], ["While DNA methylation plays a role in T-helper (Th) cell maturation, its potential dysregulation in the non-atopic Th1-polarized systemic inflammation observed in obesity-associated asthma is unknown.", {"entities": [[163, 170, "DISEASE"], [182, 188, "DISEASE"]]}], ["We studied DNA methylation epigenome-wide in peripheral blood mononuclear cells (PBMCs) from 8 obese asthmatic pre-adolescent children and compared it to methylation in PBMCs from 8 children with asthma alone, obesity alone and healthy controls.", {"entities": [[210, 217, "DISEASE"], [196, 202, "DISEASE"]]}], ["Differentially methylated loci implicated certain biologically relevant molecules and pathways.", {"entities": []}], ["PBMCs from obese asthmatic children had distinctive DNA methylation patterns, with decreased promoter methylation of CCL5 , IL2RA and TBX21 , genes encoding proteins linked with Th1 polarization, and increased promoter methylation of FCER2 , a low-affinity receptor for IgE, and of TGFB1, inhibitor of Th cell activation.", {"entities": [[117, 121, "GENE"], [124, 129, "GENE"], [134, 139, "GENE"], [234, 239, "GENE"], [282, 287, "GENE"]]}], ["T-cell signaling and macrophage activation were the two primary pathways that were selectively hypomethylated in obese asthmatics.", {"entities": []}], ["These findings suggest that dysregulated DNA methylation is associated with non-atopic inflammation observed in pediatric obesity-associated asthma.", {"entities": [[122, 129, "DISEASE"], [141, 147, "DISEASE"]]}], ["Achyranthes aspera (AA) has been used traditionally for the cure of various disorders.", {"entities": []}], ["However, the action of root extracts of AA as anticancer agent and its cellular mechanism remain unclear.", {"entities": []}], ["The aim was to screen the antitumor effect of ethanolic (EAA) and aqueous (AAA) root extracts on the growth of colon cancer COLO-205 cells by testing their cytotoxicity, followed by their effect on clonogenicity, migration, and induction of apoptosis.", {"entities": [[111, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["Mechanisms leading to apoptosis and cell cycle arrest were also investigated by expression studies of caspase-9, caspase-3, Bax, Bcl-2, p16, p21, and p27 genes, followed by flow cytometric analysis for cell cycle distribution.", {"entities": [[124, 127, "GENE"]]}], ["Cytotoxicity screening of AA extracts indicated greater cytotoxic activity of AAA extract against COLO-205 cells.", {"entities": []}], ["A series of events marked by apoptosis revealed loss of cell viability, chromatin condensation, and DNA fragmentation in AAA treated cells to a greater extent.", {"entities": []}], ["The mRNA expression levels of caspase-9, caspase-3, Bax, p16, p21, and p27 were markedly increased in the AAA treated cells, along with decreased Bcl-2 expression.", {"entities": [[52, 55, "GENE"]]}], ["The cell cycle arrest at S phase was detected by flow cytometric analysis after treatment with AAA.", {"entities": []}], ["Overall the study signifies the aqueous extracts as a promising therapeutic candidate against cancer.", {"entities": [[94, 100, "DISEASE"]]}], ["Infection with the helminth Schistosoma (S . )", {"entities": []}], ["mansoni drives the development of interleukin (IL)-10-producing regulatory B (Breg) cells in mice and man, which have the capacity to reduce experimental allergic airway inflammation and are thus of high therapeutic interest.", {"entities": []}], ["However, both the involved antigen and cellular mechanisms that drive Breg cell development remain to be elucidated.", {"entities": []}], ["Therefore, we investigated whether S .", {"entities": []}], ["mansoni soluble egg antigens (SEA) directly interact with B cells to enhance their regulatory potential, or act indirectly on B cells via SEA-modulated macrophage subsets.", {"entities": []}], ["Intraperitoneal injections of S .", {"entities": []}], ["mansoni eggs or SEA significantly upregulated IL-10 and CD86 expression by marginal zone B cells.", {"entities": [[56, 60, "GENE"]]}], ["Both B cells as well as macrophages of the splenic marginal zone efficiently bound SEA in vivo , but macrophages were dispensable for Breg cell induction as shown by macrophage depletion with clodronate liposomes.", {"entities": []}], ["SEA was internalized into acidic cell compartments of B cells and induced a 3-fold increase of IL-10, which was dependent on endosomal acidification and was further enhanced by CD40 ligation.", {"entities": [[177, 181, "GENE"]]}], ["IPSE/alpha-1, one of the major antigens in SEA, was also capable of inducing IL-10 in na\u00efve B cells, which was reproduced by tobacco plant-derived recombinant IPSE.", {"entities": []}], ["Other major schistosomal antigens, omega-1 and kappa-5, had no effect.", {"entities": []}], ["SEA depleted of IPSE/alpha-1 was still able to induce Breg cells indicating that SEA contains more Breg cell-inducing components.", {"entities": []}], ["Importantly, SEA- and IPSE-induced Breg cells triggered regulatory T cell development in vitro .", {"entities": []}], ["SEA and recombinant IPSE/alpha-1 also induced IL-10 production in human CD1d S .", {"entities": [[72, 76, "GENE"]]}], ["mansoni -induced Breg cell development involves a direct targeting of B cells by SEA components such as the secretory glycoprotein IPSE/alpha-1.", {"entities": []}], ["Infection with helminth parasites is known to be inversely associated with hyper-inflammatory disorders.", {"entities": []}], ["While Schistosoma (S . )", {"entities": []}], ["mansoni has been described to exert its down-modulatory effects on inflammation by inducing a network of regulatory immune cells such as regulatory B (Breg), the mechanisms of Breg cell induction remain unclear.", {"entities": []}], ["Here, we use in vivo and in vitro approaches to show that antigens from S .", {"entities": []}], ["mansoni eggs, among which the major glycoprotein IPSE/alpha-1, directly interact with splenic marginal zone B cells of mice which triggers them to produce the anti-inflammatory cytokine IL-10 and their capacity to induce regulatory T (Treg) cells.", {"entities": []}], ["We also found that IPSE/alpha-1 induces IL-10 in human CD1d", {"entities": [[55, 59, "GENE"]]}], ["The apparent decline in the age at puberty in the United States raises a general level of concern because of the potential clinical and social consequences of such an event.", {"entities": []}], ["Nutritional status, genetic predisposition (race/ethnicity), and environmental chemicals are associated with altered age at puberty.", {"entities": []}], ["The Exposure to Chemical Agents Working Group of the National Children\u2019s Study (NCS) presents an approach to assess exposure for chemicals that may affect the age of maturity in children.", {"entities": []}], ["The process involves conducting the assessment by life stages (i.e., in utero , postnatal, peripubertal), adopting a general categorization of the environmental chemicals by biologic persistence, and collecting and storing biologic specimens that are most likely to yield meaningful information.", {"entities": []}], ["The analysis of environmental samples and use of questionnaire data are essential in the assessment of chemicals that cannot be measured in biologic specimens, and they can assist in the evaluation of exposure to nonpersistent chemicals.", {"entities": []}], ["Food and dietary data may be used to determine the extent to which nutrients and chemicals from this pathway contribute to the variance in the timing of puberty.", {"entities": []}], ["Additional research is necessary in several of these areas and is ongoing.", {"entities": []}], ["The NCS is uniquely poised to evaluate the effects of environmental chemicals on the age at puberty, and the above approach will allow the NCS to accomplish this task.", {"entities": []}], ["Tourette\u2019s syndrome (TS) is a poorly understood neurodevelopmental disorder consistently associated with impaired peer relationships.", {"entities": [[11, 19, "DISEASE"]]}], ["This research aimed to investigate the relationship between TS and the ability of diagnosed youth to form secure attachment relationships with peers.", {"entities": []}], ["A quantitative study examined differences between youth with TS and typically developing peers in social functioning, relationship problems and attachment security.", {"entities": []}], ["Qualitative studies sought to identify factors that enhanced or impeded the ability to form secure peer relationships, including the impact of tic severity, comorbidity and personality traits.", {"entities": []}], ["All research was conducted from the parental perspective.", {"entities": []}], ["The research consisted of a controlled, survey-based qualitative and quantitative study (Study One) of parents of youth with TS ( n \u2009=\u200986) and control group peers ( n \u2009=\u2009108), and a qualitative telephone interview-based study of TS group parents (Study Two, n \u2009=\u200922).", {"entities": []}], ["Quantitative assessment of social functioning, peer problems and peer attachment security was conducted using the Paediatric Quality of Life inventory, the Strengths and Difficulties Questionnaire and the Attachment Questionnaire for Children.", {"entities": []}], ["Qualitative data relating to personality was classified using the Five Factor Model.", {"entities": []}], ["Results revealed significantly higher rates of insecure peer attachment, problems in peer relationships, difficulty making friends, stigmatisation and lower levels of social functioning for the TS group.", {"entities": []}], ["Significant between-group differences in number and type of factors impacting peer relationships were also determined with \u2018personality\u2019 emerging as the most prevalent factor.", {"entities": []}], ["Whilst Extraversion and Agreeableness facilitated friendships for both groups, higher rates of Neuroticism were barriers to friendship for individuals with TS.", {"entities": []}], ["The TS group also identified multiple \u2018non-personality\u2019 factors impacting peer relationships, including TS and comorbid symptom severity, the child\u2019s psychological and behavioural adjustment to their disorder, coping strategies and the behaviour and attitudes of peers.", {"entities": []}], ["Our findings suggest that, whilst Extraversion and Agreeableness facilitated friendships for both groups, higher rates of Neuroticism were barriers to friendship for individuals with TS.", {"entities": []}], ["Notwithstanding the fact that these findings are based on parental report and not the perceptions of youth themselves, this study may help clinicians to identify youth at increased risk of developing insecure peer relationships and guide the development of targeted supports.", {"entities": []}], ["The findings from the study may help clinicians, parents and individuals with TS to better understand and cope with the difficulties experienced in interactions with peers.", {"entities": []}], ["The online version of this article (doi:10.1186/s40359-015-0090-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Despite widespread availability of clinical practice guidelines (CPGs), considerable gaps continue between the care that is recommended (\u2018appropriate care\u2019) and the care provided.", {"entities": []}], ["Problems with current CPGs are commonly cited as barriers to providing \u2019appropriate care'.", {"entities": []}], ["Our study aims to develop and test an alternative method to keep CPGs accessible and up to date.", {"entities": []}], ["This method aims to mitigate existing problems by using a single process to develop clinical standards (embodied in clinical indicators) collaboratively with researchers, healthcare professionals, patients and consumers.", {"entities": []}], ["A transparent and inclusive online curated (purpose-designed, custom-built, wiki-type) system will use an ongoing and iterative documentation process to facilitate synthesis of up-to-date information and make available its provenance.", {"entities": []}], ["All participants are required to declare conflicts of interest.", {"entities": []}], ["This protocol describes three phases: engagement of relevant stakeholders; design of a process to develop clinical standards (embodied in indicators) for \u2018appropriate care\u2019 for common medical conditions; and evaluation of our processes, products and feasibility.", {"entities": []}], ["A modified e-Delphi process will be used to gain consensus on \u2018appropriate care\u2019 for a range of common medical conditions.", {"entities": []}], ["Clinical standards and indicators will be developed through searches of national and international guidelines, and formulated with explicit criteria for inclusion, exclusion, time frame and setting.", {"entities": []}], ["Healthcare professionals and consumers will review the indicators via the wiki-based modified e-Delphi process.", {"entities": []}], ["Reviewers will declare conflicts of interest which will be recorded and managed according to an established protocol.", {"entities": []}], ["The provenance of all indicators and suggestions included or excluded will be logged from indicator inception to finalisation.", {"entities": []}], ["A mixed-methods formative evaluation of our research methodology will be undertaken.", {"entities": []}], ["Human Research Ethics Committee approval has been received from the University of South Australia.", {"entities": []}], ["We will submit the results of the study to relevant journals and offer national and international presentations.", {"entities": []}], ["Oxygen, haemoglobin and cardiac output are integrated components of oxygen transport: each gram of haemoglobin transports 1.34 mls of oxygen in the blood.", {"entities": []}], ["Low arterial partial pressure of oxygen (PaO 2 ), and haemoglobin saturation (SaO 2 ), are the indices used in clinical assessments, and usually result from low inspired oxygen concentrations, or alveolar/airways disease.", {"entities": []}], ["Our objective was to examine low blood oxygen/haemoglobin relationships in chronically compensated states without concurrent hypoxic pulmonary vasoreactivity.", {"entities": []}], ["165 consecutive unselected patients with pulmonary arteriovenous malformations were studied, in 98 cases, pre/post embolisation treatment.", {"entities": []}], ["159 (96%) had hereditary haemorrhagic telangiectasia.", {"entities": []}], ["Arterial oxygen content was calculated by SaO 2 x haemoglobin x 1.34/100 .", {"entities": []}], ["There was wide variation in SaO 2 on air (78.5\u201399, median 95)% but due to secondary erythrocytosis and resultant polycythaemia, SaO 2 explained only 0.1% of the variance in arterial oxygen content per unit blood volume.", {"entities": []}], ["Secondary erythrocytosis was achievable with low iron stores, but only if serum iron was high-normal: Low serum iron levels were associated with reduced haemoglobin per erythrocyte, and overall arterial oxygen content was lower in iron deficient patients (median 16.0 [IQR 14.9, 17.4]mls/dL compared to 18.8 [IQR 17.4, 20.1]mls/dL, p<0.0001).", {"entities": []}], ["Exercise tolerance appeared unrelated to SaO 2 but was significantly worse in patients with lower oxygen content (p<0.0001).", {"entities": []}], ["A pre-defined athletic group had higher Hb:SaO 2 and serum iron:ferritin ratios than non-athletes with normal exercise capacity.", {"entities": []}], ["PAVM embolisation increased SaO 2 , but arterial oxygen content was precisely restored by a subsequent fall in haemoglobin: 86 (87.8%) patients reported no change in exercise tolerance at post-embolisation follow-up.", {"entities": []}], ["Haemoglobin and oxygen measurements in isolation do not indicate the more physiologically relevant oxygen content per unit blood volume.", {"entities": []}], ["This can be maintained for SaO 2 \u226578.5%, and resets to the same arterial oxygen content after correction of hypoxaemia.", {"entities": []}], ["Serum iron concentrations, not ferritin, seem to predict more successful polycythaemic responses.", {"entities": []}], ["Oral antipyretics are commonly used to treat pediatric patients who develop fevers.", {"entities": []}], ["However, patients presenting to the emergency department or undergoing surgery are frequently unable to tolerate oral antipyretics.", {"entities": []}], ["Rectal formulations are available; however, this route of administration is unpredictable.", {"entities": []}], ["The main objectives of this randomized controlled study was to evaluate the efficacy and safety of single or multiple doses of intravenous ibuprofen to acetaminophen (oral or suppository) in pediatric patients with fever and to assess plasma ibuprofen concentrations.", {"entities": []}], ["This multi-center study was conducted in hospitalized patients, \u2264 16 years, with a new onset of fever \u2265 38.3\u00b0C.", {"entities": []}], ["Patients were randomly assigned to receive either 10 mg/kg intravenous ibuprofen or acetaminophen.", {"entities": []}], ["Study drug was administered at hour 0, and thereafter every 4 h as needed, up to 5 days.", {"entities": []}], ["The primary outcome was to evaluate the effect of a single dose of intravenous ibuprofen compared to acetaminophen in reducing temperature in the first 2 h after administration.", {"entities": []}], ["Data were compared using an analysis of variance model for continuous measurements and Cochran-Mantel-Haenszel test of general association for categorical data.", {"entities": []}], ["A two-sided testing was used and a p -value \u2264 0.05 was considered significant.", {"entities": []}], ["A total of 103 patients received study medication.", {"entities": []}], ["Intravenous ibuprofen resulted in a greater reduction in temperature as measured by the area under the change from baseline at 2 h ( p = 0.005) and 4 h (<0.001); in a greater reduction in change from baseline temperature compared to treatment with acetaminophen, and it reduced fever throughout a 24 h dosing period.", {"entities": []}], ["There were no differences in safety parameters or serious adverse events.", {"entities": []}], ["A single 10 mg/kg dose of intravenous ibuprofen provided a significant reduction of temperature for febrile pediatric patients compared to those that received 10 mg/kg acetaminophen at 2 h and 4 h post-treatment.", {"entities": []}], ["A reduction in temperature was also demonstrated over 24 h; however the reduction was not considered statically significant.", {"entities": []}], ["Intravenous ibuprofen provides an effective option for reducing fever in hospitalized pediatric patients.", {"entities": []}], ["The study was registered on ClinicalTrials.gov on 26 October 2009, Study Identifier: NCT01002573 The online version of this article (doi:10.1186/s12887-017-0795-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Probiotics have been studied as immunomodulatory agents of allergy.", {"entities": []}], ["Several human probiotic trials tracking the development of eczema and other forms of allergy have yielded inconsistent results.", {"entities": []}], ["A recent infant study demonstrated that pre and postnatal Lactobacillus rhamnosus HN001 (HN001) supplementation decreased the prevalence of eczema and IgE associated eczema.", {"entities": []}], ["However, the influence of HN001 on the incidence of wheeze, asthma, and/or other allergic manifestations has yet to be reported.", {"entities": [[60, 66, "DISEASE"]]}], ["This study was conducted to determine the effects of the probiotic HN001 on the development of allergic lung disease in a pig model.", {"entities": [[104, 116, "DISEASE"]]}], ["Allergy was induced by a series of subcutaneous and intratracheal sensitizations with Ascaris suum allergen (ASA) during a six week time frame in post-weanling pigs supplemented daily with HN001, or without supplementation.", {"entities": []}], ["One week following final sensitization intradermal skin tests and respiratory challenges were conducted.", {"entities": []}], ["In response to intradermal and respiratory challenges, ASA-sensitized pigs fed HN001 had less severe skin flare reactions, smaller increases in pleural pressure, and trends towards lower changes in arterial oxygen and carbon dioxide partial pressure levels compared to control pigs.", {"entities": []}], ["The frequency of ASA-specific IFN-\u03b3-secreting peripheral blood mononuclear cells, as well as the amount of IL-10 produced by ASA-specific cells, was of greater magnitude in probiotic-fed pigs compared to control animals.", {"entities": []}], ["These observations suggest that differences in clinical responses to the allergen challenges may be related to probiotic-induced modulation of Th1 (IFN-\u03b3) and regulatory (IL-10) cytokine expression.", {"entities": []}], ["Probiotic supplementation decreased the severity of allergic skin and lung responses in allergen-sensitized pigs with a corresponding increase in IFN-\u03b3 expression.", {"entities": []}], ["A similar correlation between certain allergic responses and increased IFN-\u03b3 expression has been reported in human clinical studies of allergy; this pig model of allergy may be indicative of potential probiotic modulation of allergic lung disease in humans.", {"entities": [[234, 246, "DISEASE"]]}], ["Although extensive epidemiological and laboratory studies have been performed to identify the environmental and immunological causes of atopy, genetic predisposition seems to be the biggest risk factor for allergic diseases.", {"entities": []}], ["The onset of atopic diseases may be the result of heritable changes of gene expression, without any alteration in DNA sequences occurring in response to early environmental stimuli.", {"entities": []}], ["Findings suggest that the establishment of a peculiar epigenetic pattern may also be generated by oxidative stress (OS) and perpetuated by the activation of OS-related genes.", {"entities": []}], ["Analyzing the role of maternal and neonatal oxidative stress and oxidative stress-inducible genes, the purpose of this review was to summarize what is known about the relationship between maternal and neonatal OS-related genes and the development of atopic diseases.", {"entities": []}], ["Prospective studies establishing the temporal relationship between the degree of inflammation and human influenza disease progression are scarce.", {"entities": [[104, 113, "DISEASE"]]}], ["To assess predictors of disease progression among patients with influenza A(H1N1)pdm09 infection, 25 inflammatory biomarkers measured at enrollment were analyzed in two international observational cohort studies.", {"entities": [[64, 73, "DISEASE"]]}], ["Among patients with RT-PCR-confirmed influenza A(H1N1)pdm09 virus infection, odds ratios (ORs) estimated by logistic regression were used to summarize the associations of biomarkers measured at enrollment with worsened disease outcome or death after 14 days of follow-up for those seeking outpatient care (FLU 002) or after 60 days for those hospitalized with influenza complications (FLU 003).", {"entities": [[37, 46, "DISEASE"], [360, 369, "DISEASE"]]}], ["Biomarkers that were significantly associated with progression in both studies (p<0.05) or only in one (p<0.002 after Bonferroni correction) were identified.", {"entities": []}], ["In FLU 002 28/528 (5.3%) outpatients had influenza A(H1N1)pdm09 virus infection that progressed to a study endpoint of complications, hospitalization or death, whereas in FLU 003 28/170 (16.5%) inpatients enrolled from the general ward and 21/39 (53.8%) inpatients enrolled directly from the ICU experienced disease progression.", {"entities": [[41, 50, "DISEASE"]]}], ["Higher levels of 12 of the 25 markers were significantly associated with subsequent disease progression.", {"entities": []}], ["Of these, 7 markers (IL-6, CD163, IL-10, LBP, IL-2, MCP-1, and IP-10), all with ORs for the 3 In patients presenting with varying severities of influenza A(H1N1)pdm09 virus infection, a baseline elevation in several biomarkers associated with inflammation, coagulation, or immune function strongly predicted a higher risk of disease progression.", {"entities": [[144, 153, "DISEASE"], [27, 32, "GENE"], [41, 44, "GENE"]]}], ["It is conceivable that interventions designed to abrogate these baseline elevations might affect disease outcome.", {"entities": []}], ["The vastness of clinical data and the progressing specialization of medical knowledge may lead to misinterpretation of medication efficacy.", {"entities": []}], ["To show a realistic perspective on drug efficacy we present meta-analyses on some of the most commonly used pharmacological interventions.", {"entities": []}], ["For each pharmacological intervention we present statistical indexes (absolute risk or response difference, percentage response ratio, mean difference, standardized mean difference) that are often used to represent efficacy.", {"entities": []}], ["We found that some of the medications have relatively low effect sizes with only 11 out of 17 of them showing a minimal clinically important difference.", {"entities": []}], ["Efficacy was often established based on surrogate outcomes and not the more relevant patient-oriented outcomes.", {"entities": []}], ["As the interpretation of the efficacy of medication is complex, more training for physicians might be needed to get a more realistic view of drug efficacy.", {"entities": []}], ["That could help prevent harmful overtreatment and reinforce an evidence-based, but personalized medicine.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-015-0494-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Among patients with cystic fibrosis (CF), females have worse pulmonary function and survival than males, primarily due to chronic lung inflammation and infection with Pseudomonas aeruginosa ( P. aeruginosa ).", {"entities": [[20, 35, "DISEASE"]]}], ["A role for gender hormones in the causation of the CF \"gender gap\" has been proposed.", {"entities": []}], ["The female gender hormone 17\u03b2-estradiol (E2) plays a complex immunomodulatory role in humans and in animal models of disease, suppressing inflammation in some situations while enhancing it in others.", {"entities": []}], ["Helper T-cells were long thought to belong exclusively to either T helper type 1 (Th1) or type 2 (Th2) lineages.", {"entities": []}], ["However, a distinct lineage named Th17 is now recognized that is induced by interleukin (IL)-23 to produce IL-17 and other pro-inflammatory Th17 effector molecules.", {"entities": []}], ["Recent evidence suggests a central role for the IL-23/IL-17 pathway in the pathogenesis of CF lung inflammation.", {"entities": []}], ["We used a mouse model to test the hypothesis that E2 aggravates the CF lung inflammation that occurs in response to airway infection with P. aeruginosa by a Th17-mediated mechanism.", {"entities": []}], ["Exogenous E2 caused adult male CF mice with pneumonia due to a mucoid CF clinical isolate, the P. aeruginosa strain PA508 (PA508), to develop more severe manifestations of inflammation in both lung tissue and in bronchial alveolar lavage (BAL) fluid, with increased total white blood cell counts and differential and absolute cell counts of polymorphonuclear leukocytes (neutrophils).", {"entities": [[44, 53, "DISEASE"]]}], ["Inflammatory infiltrates and mucin production were increased on histology.", {"entities": []}], ["Increased lung tissue mRNA levels for IL-23 and IL-17 were accompanied by elevated protein levels of Th17-associated pro-inflammatory mediators in BAL fluid.", {"entities": []}], ["The burden of PA508 bacteria was increased in lung tissue homogenate and in BAL fluid, and there was a virtual elimination in lung tissue of mRNA for lactoferrin, an antimicrobial peptide active against P. aeruginosa in vitro.", {"entities": []}], ["Our data show that E2 increases the severity of PA508 pneumonia in adult CF male mice, and suggest two potential mechanisms: enhancement of Th17-regulated inflammation and suppression of innate antibacterial defences.", {"entities": [[54, 63, "DISEASE"]]}], ["Although this animal model does not recapitulate all aspects of human CF lung disease, our present findings argue for further investigation of the effects of E2 on inflammation and infection with P. aeruginosa in the CF lung.", {"entities": [[73, 85, "DISEASE"]]}], ["Regulatory T cells (Tregs) play a non-redundant role in maintenance of immune homeostasis.", {"entities": []}], ["This is achieved by suppressing both, priming of na\u00efve cells and effector cell functions.", {"entities": []}], ["Although Tregs have been implicated in modulating allergic immune responses, their influence on distinct phases of development of allergies remains unclear.", {"entities": []}], ["In this study, by using bacterial artificial chromosome (BAC)-transgenic Foxp3-DTR (DEREG) mice we demonstrate that the absence of Foxp3", {"entities": [[73, 78, "GENE"], [131, 136, "GENE"]]}], ["Combining outcomes and the use of standardized effect measures such as effect size and standardized response mean across instruments allows more comprehensive meta-analyses and should avoid selection bias.", {"entities": []}], ["However, such analysis ideally requires that the instruments correlate strongly and that the underlying assumption of similar responsiveness is fulfilled.", {"entities": []}], ["The aim of the study was to assess the correlation between two widely used health-related quality of life instruments for patients with chronic obstructive pulmonary disease and to compare the instruments' responsiveness on a study level.", {"entities": [[136, 173, "DISEASE"]]}], ["We systematically identified all longitudinal studies that used both the Chronic Respiratory Questionnaire (CRQ) and the St. George's Respiratory Questionnaire (SGRQ) through electronic searches of MEDLINE, EMBASE, CENTRAL and PubMed.", {"entities": []}], ["We assessed the correlation between CRQ (scale 1 \u2013 7) and SGRQ (scale 1 \u2013 100) change scores and compared responsiveness of the two instruments by comparing standardized response means (change scores divided by their standard deviation).", {"entities": []}], ["We identified 15 studies with 23 patient groups.", {"entities": []}], ["CRQ change scores ranged from -0.19 to 1.87 (median 0.35, IQR 0.14\u20130.68) and from -16.00 to 3.00 (median -3.00, IQR -4.73\u20130.25) for SGRQ change scores.", {"entities": []}], ["The correlation between CRQ and SGRQ change scores was 0.88.", {"entities": []}], ["Standardized response means of the CRQ (median 0.51, IQR 0.19\u20130.98) were significantly higher (p < 0.001) than for the SGRQ (median 0.26, IQR -0.03\u20130.40).", {"entities": []}], ["Investigators should be cautious about pooling the results from different instruments in meta-analysis even if they appear to measure similar constructs.", {"entities": []}], ["Despite high correlation in changes scores, responsiveness of instruments may differ substantially and could lead to important between-study heterogeneity and biased meta-analyses.", {"entities": []}], ["Inhaled ambient particulate matter (PM) causes adverse health effects, possibly by generating reactive oxygen species (ROS), including hydrogen peroxide (HOOH), in the lung lining fluid.", {"entities": []}], ["There are conflicting reports in the literature as to which chemical components of PM can chemically generate HOOH in lung fluid mimics.", {"entities": []}], ["It is also unclear which redox-active species are most important for HOOH formation at concentrations relevant to ambient PM.", {"entities": []}], ["To address this, we use a cell-free, surrogate lung fluid (SLF) to quantify the initial rate of HOOH formation from 10 transition metals and 4 quinones commonly identified in PM.", {"entities": []}], ["Copper, 1,2-naphthoquinone, 1,4-naphthoquinone, and phenanthrenequinone all form HOOH in a SLF, but only copper and 1,2-naphthoquinone are likely important at ambient concentrations.", {"entities": []}], ["Iron suppresses HOOH formation in laboratory solutions, but has a smaller effect in ambient PM extracts, possibly because organic ligands in the particles reduce the reactivity of iron.", {"entities": []}], ["Overall, copper produces the majority of HOOH chemically generated from typical ambient PM while 1,2-naphthoquinone generally makes a small contribution.", {"entities": []}], ["However, measured rates of HOOH formation in ambient particle extracts are lower than rates calculated from soluble copper by an average (\u00b11\u03c3) of 44 \u00b1 22%; this underestimate is likely due to either HOOH destruction by Fe or a reduction in Cu reactivity due to organic ligands from the PM.", {"entities": []}], ["Current measures of pain assess the relative contribution of pain in different body regions to the overall impact of pain.", {"entities": []}], ["We developed a series of questions to measure the relative 'troublesomeness' of pain in different body regions (the \"troublesomeness grid\").", {"entities": []}], ["The study aimed to determine whether the \"troublesomeness grid\" is an appropriate measure to assess the severity of pain in different body regions, allowing the comparative severity of pain in different body regions to be assessed.", {"entities": []}], ["We used data from a pilot for a population survey of pain (N = 205) and from the population survey itself (N = 2504) to assess the 'troublesomeness grid's performance.", {"entities": []}], ["Specifically, its face and content validity using overall and item non-completion rates; its criterion related validity by exploring the relationship between troublesomeness and standard measures of pain, disability, distress and health utility for the five body regions most commonly affected by chronic pain; and its reliability and reproducibility in a test/re-test study.", {"entities": []}], ["The troublesomeness grid appeared to have good face validity as it had good completion rates.", {"entities": []}], ["It also appeared to have good content validity as the percentage agreement between the grid and the pain manikin was high (over 90%).", {"entities": []}], ["In terms of criterion related validity, troublesomeness was most strongly correlated with pain intensity and health related quality of life, but less with disability and distress.", {"entities": []}], ["The test-retest reliability was between 80% and 90% for the majority of body regions examined.", {"entities": []}], ["The troublesomeness grid is well completed and appears to be an appropriate tool to assess the comparative severity of pain in different body regions.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) prevalence in Canada has risen over time.", {"entities": []}], ["COPD-related exacerbations contribute to the increased health care utilization (HCU) in this population.", {"entities": []}], ["This study investigated the impact of exacerbations on COPD-related HCU.", {"entities": []}], ["This retrospective observational cohort study used patient data from the Qu\u00e9bec provincial health insurance databases.", {"entities": []}], ["Eligible patients with a new HCU claim with a diagnostic billing for COPD during 2001\u20132010 were followed until March 31, 2011.", {"entities": []}], ["Exacerbation rates and time to first exacerbation were assessed.", {"entities": []}], ["Unadjusted analyses and multivariable models compared the rate of HCU by exacerbation classification (any [moderate/severe], moderate, or severe).", {"entities": []}], ["The exacerbation event rate in patients with an exacerbation was 34.3 events/100 patient-years (22.7 for moderate exacerbations and 11.6 for severe exacerbations).", {"entities": []}], ["Median time to first exacerbation of any classification was 37 months.", {"entities": []}], ["In unadjusted analyses, COPD-related HCU significantly increased with exacerbation severity.", {"entities": []}], ["In the multivariable, HCU rates were significantly higher after exacerbation versus before exacerbation ( p < 0.01) for patients with an exacerbation or moderate exacerbations.", {"entities": []}], ["For severe exacerbations, general practitioner, respiratory specialist, emergency room, and hospital visits were significantly higher after exacerbation versus before exacerbation ( p < 0.001).", {"entities": []}], ["Exacerbations were associated with increased HCU, which was more pronounced for patients with severe exacerbations.", {"entities": []}], ["Interventions to reduce the risk of exacerbations in patients with COPD may reduce disease burden.", {"entities": []}], ["We performed a comprehensive review and meta-analysis to evaluate the diagnostic values of serum single and multiplex tumor-associated autoantibodies (TAAbs) in patients with lung cancer (LC).", {"entities": [[175, 186, "DISEASE"], [180, 186, "DISEASE"]]}], ["We searched the MEDLINE and EMBASE databases for relevant studies investigating serum TAAbs for the diagnosis of LC.", {"entities": []}], ["The primary outcomes included sensitivity, specificity and accuracy of the test.", {"entities": []}], ["The systematic review and meta-analysis included 31 articles with single autoantibody and 39 with multiplex autoantibodies.", {"entities": []}], ["Enzyme-linked immunosorbent assay (ELISA) was the most common detection method.", {"entities": []}], ["For the diagnosis of patients with all stages and early-stage LC, different single or combinations of TAAbs demonstrated different diagnostic values.", {"entities": []}], ["Although individual TAAbs showed low diagnostic sensitivity, the combination of multiplex autoantibodies offered relatively high sensitivity.", {"entities": []}], ["For the meta-analysis of a same panel of autoantibodies in patients at all stages of LC, the pooled results of the panel of 6 TAAbs (p53, NY-ESO-1, CAGE, GBU4-5, Annexin 1 and SOX2) were: sensitivity 38% (95% CI 0.35\u20130.40), specificity 89% (95% CI 0.86\u20130.91), diagnostic accuracy 65.9% (range 62.5\u201381.8%), AUC 0.52 (0.48\u20130.57), while the summary estimates of 7 TAAbs (p53, CAGE, NY-ESO-1, GBU4-5, SOX2, MAGE A4 and Hu-D) were: sensitivity 47% (95% CI 0.34\u20130.60), specificity 90% (95% CI 0.89\u20130.92), diagnostic accuracy 78.4% (range 67.5\u201388.8%), AUC 0.90 (0.87\u20130.93).", {"entities": [[176, 180, "GENE"], [397, 401, "GENE"], [176, 180, "GENE"], [397, 401, "GENE"]]}], ["For the meta-analysis of the same panel of autoantibodies in patients at early-stage of LC, the sensitivities of both panels of 7 TAAbs and 6 TAAbs were 40% and 29.7%, while their specificities were 91% and 87%, respectively.", {"entities": []}], ["Serum single or combinations of multiplex autoantibodies can be used as a tool for the diagnosis of LC patients at all stages or early-stage, but the combination of multiplex autoantibodies shows a higher detection capacity; the diagnostic value of the panel of 7 TAAbs is higher than the panel of 6 TAAbs, which may be used as potential biomarkers for the early detection of LC.", {"entities": []}], ["Medicinal and food plants in the Basque Country are an integral part of a fast changing culture.", {"entities": []}], ["With a distinct tradition and language, this region of Europe provides an important example demonstrating the changing role of local and traditional knowledge in industrial countries.", {"entities": []}], ["As other Mediterranean regions it preserves a rich heritage of using plants as medicine and food, offering a unique opportunity for studying the medicine food interface in an ethnopharmacological context.", {"entities": []}], ["Therefore, the key goal of this study has been to contribute to an understanding of local and traditional plant usage, to evaluate their uses as food and medicine as well as to critically assess the role of these plants in the south of the Basque Country contributing to an understanding of how foods and medicines are used.", {"entities": []}], ["A mixed methods approach, including participant observation; open and semi structured interviews was used.", {"entities": []}], ["Ethnobotanical field work included 183 people, ages ranged from 24 to 98 years old with a majority being between 70 and 80 years old (mean age 71) from 31 towns of three different regions.", {"entities": []}], ["The basic interview was a one-to-one meeting, which often included field walking and collection of samples as directed by the informants.", {"entities": []}], ["700 voucher specimens (most of them with duplicates) were collected for the data obtained.", {"entities": []}], ["Using SPSS version 20 the gathered information was processed and the replies of the different informants were subsequently organised in variables like medicine and food plants, part of the plants used, forms of preparations, zones preferred for collecting these plants.", {"entities": []}], ["The data were analysed based on the frequency of records.", {"entities": []}], ["This type of approach allows us to understand the way the informant\u2019s categorize the species, and how these categories are distributed along the sample.", {"entities": []}], ["In order to analyse the data three main categories of use were distinguished: Medicine (M), Food (F) and an intermediate Health-Food (H-F).", {"entities": []}], ["The three categories were divided in 27 subcategories (common uses).", {"entities": []}], ["The informants recognise and use a total of 184 species from 49 families.", {"entities": []}], ["During interviews, 5658 individual use-reports were collected relating to three use-categories \u2013 as medicines, food and health-food.", {"entities": []}], ["The two main groups with almost the same number of species each are health-food (75 species) and (locally gathered) food only (73), with medicinal uses only (36) being the smallest group.", {"entities": []}], ["This highlights the important overlap between food and medicines.", {"entities": []}], ["Overall, three core families were identified (based on the number of use reports and in the number of species): Asteraceae (25 species), Lamiaceae and Rosaceae (24 each).", {"entities": []}], ["The most frequently reported species are Jasonia glutinosa , Chamaemelum nobile, Prunus spinosa and Quercus ilex subsp.", {"entities": []}], ["The most important general use-subcategories are as raw vegetables (27.43% of the use-reports and including 81 species), infusions (14.74%/42) and gastrointestinal (12.53%/42).", {"entities": []}], ["Conceptually foods and medicines are clearly distinguished but the intermediate group of health foods is more ambiguous.", {"entities": []}], ["Food and medicinal uses of plants are culturally closely linked.", {"entities": []}], ["A wide range of plants are known and many still used.", {"entities": []}], ["The analysis shows that the Basques use a wide range of species which are typical for Western European cultures.", {"entities": []}], ["In comparison to other studies in the Mediterranean countries there are many similarities in the uses of different families, species of plants and their use and preparations.", {"entities": []}], ["Some of these plants are key Mediterranean species, often used for a multitude of uses as food and medicine.", {"entities": []}], ["Objective: Identity is an important influence on behavior.", {"entities": []}], ["To identify potential targets for smoking cessation interventions in young adults, we synthesized findings from qualitative studies on smoker identity and potential influences on smoking and smoking cessation.", {"entities": []}], ["Methods: A systematic search of 4 electronic databases up to September 19, 2013, was conducted to identify qualitative studies on smoker identity in smokers and ex-smokers aged 16\u201334.", {"entities": []}], ["Key concepts were extracted from individual studies and synthesized into higher-order interpretations by following the principles of meta-ethnography.", {"entities": []}], ["Results: Seventeen relevant papers were identified.", {"entities": []}], ["At the highest level of interpretation, we identified 4 types of findings: (a) contributory factors to identity, (b) identity in relation to smoking, (c) contextual and temporal patterning, and (d) behavior in relation to smoking.", {"entities": []}], ["Contributory factors included the desire to establish aspirational individual and social identities, enact a smoker identity appropriate to the momentary social context, and alter personal nonsmoking rules when consuming alcohol.", {"entities": []}], ["Smoker identity was multifaceted and incorporated individuals\u2019 defensive rationalizations, and both positive and negative feelings attached to it.", {"entities": []}], ["Smoker identities took time to develop, were subject to change, and were context dependent.", {"entities": []}], ["Identity was found to play a role in quit attempts.", {"entities": []}], ["Conclusions: Qualitative research into the identity of young adult smokers has established it as a multifaceted phenomenon serving important functions but also involving conflict and defensive rationalizations.", {"entities": []}], ["It develops over time and contextual factors influence its expression.", {"entities": []}], ["The nature of a smoker\u2019s identity can play an important role in smoking cessation.", {"entities": []}], ["Accumulating evidence indicate a role for the immune system particularly inflammation and autoimmunity in the aetiology of major psychiatric disorders such as depression and schizophrenia.", {"entities": [[174, 187, "DISEASE"]]}], ["In this paper, we discuss some of the key advances in immunopsychiatry in order to highlight to psychiatrists and other health professionals how an increased understanding of this field might enhance our knowledge of illness mechanism and approaches to treatment.", {"entities": []}], ["We present a brief overview of clinical research that link inflammation and autoimmunity with depression and psychosis, including potential role of inflammation in treatment response, current evidence for the effectiveness of immune-modulating treatment for depression and psychosis, and possible role of inflammation in common physical comorbidities for these disorders such as coronary heart disease and diabetes mellitus.", {"entities": [[388, 401, "DISEASE"], [379, 401, "DISEASE"], [406, 423, "DISEASE"]]}], ["Gaining a better understanding of the role of immune system could be paradigm changing for psychiatry.", {"entities": []}], ["We need collaborations between clinicians and scientists to deliver high-quality translational research in order to fully realise the clinical potential of this exciting and rapidly expanding field.", {"entities": []}], ["Epidemiological studies have provided enough evidence that genetic factors have an important role in determining susceptibility to IBD.", {"entities": []}], ["The most significant finding in the IBD research has been identification of mutations in the gene that encodes Nod2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.", {"entities": [[111, 115, "GENE"]]}], ["However, a very similar gene encoding Nod1 protein still has not been well documented for its association with Ulcerative colitis patients.", {"entities": [[111, 129, "DISEASE"], [38, 42, "GENE"]]}], ["Detection of polymorphism in NOD1 gene using SNP analysis has been attempted in the present study.", {"entities": [[29, 33, "GENE"]]}], ["We evaluated frequency and significance of mutations present in the nucleotide-binding domain (NBD) of NOD1 gene in context to Indian population.", {"entities": [[103, 107, "GENE"]]}], ["A total of 95 patients with ulcerative colitis and 102 controls enrolled in the Gastroenterology department of All India Institute of Medical Sciences, New Delhi were screened for SNPs by DHPLC and RFLP techniques.", {"entities": [[28, 46, "DISEASE"]]}], ["Exon 6 locus in the NBD domain of NOD1 gene was amplified and sequenced.", {"entities": [[34, 38, "GENE"]]}], ["Genotype and allele frequencies of the patients and controls were calculated by the Pearson's \u03c7 We have demonstrated DHPLC screening technique to show the presence of SNPs in Exon 6 locus of NBD domain of NOD1 gene.", {"entities": [[205, 209, "GENE"]]}], ["The DHPLC analysis has proven suitable for rapid detection of base pair changes.", {"entities": []}], ["The data was validated by sequencing of clones and subsequently by RFLP analysis.", {"entities": []}], ["Analyses of SNP data revealed 3 significant mutations (W219R, p = 0.002; L349P, p = 0.002 and L370R, p = 0.039) out of 5 in the Exon 6 locus of NBD domain of the gene that encompasses ATP and Mg We propose that the location of mutations in the Exon 6 spanning the ATP and Mg NOD1 gene may affect the process of oligomerization and subsequent function of the LRR domain.", {"entities": [[275, 279, "GENE"]]}], ["Further studies are been conducted at the protein level to prove this possibility.", {"entities": []}], ["Exposure to ambient air pollution increases morbidity and mortality, and is a leading contributor to global disease burden.", {"entities": []}], ["We explored spatial and temporal trends in mortality and burden of disease attributable to ambient air pollution from 1990 to 2015 at global, regional, and country levels.", {"entities": []}], ["We estimated global population-weighted mean concentrations of particle mass with aerodynamic diameter less than 2\u00b75 \u03bcm (PM 2\u00b75 ) and ozone at an approximate 11 km\u2008\u00d7\u200811 km resolution with satellite-based estimates, chemical transport models, and ground-level measurements.", {"entities": []}], ["Using integrated exposure\u2013response functions for each cause of death, we estimated the relative risk of mortality from ischaemic heart disease, cerebrovascular disease, chronic obstructive pulmonary disease, lung cancer, and lower respiratory infections from epidemiological studies using non-linear exposure\u2013response functions spanning the global range of exposure.", {"entities": [[144, 167, "DISEASE"], [208, 219, "DISEASE"], [129, 142, "DISEASE"], [169, 206, "DISEASE"], [213, 219, "DISEASE"]]}], ["Ambient PM 2\u00b75 was the fifth-ranking mortality risk factor in 2015.", {"entities": []}], ["Exposure to PM 2\u00b75 caused 4\u00b72 million (95% uncertainty interval [UI] 3\u00b77 million to 4\u00b78 million) deaths and 103\u00b71 million (90\u00b78 million 115\u00b71 million) disability-adjusted life-years (DALYs) in 2015, representing 7\u00b76% of total global deaths and 4\u00b72% of global DALYs, 59% of these in east and south Asia.", {"entities": []}], ["Deaths attributable to ambient PM 2\u00b75 increased from 3\u00b75 million (95% UI 3\u00b70 million to 4\u00b70 million) in 1990 to 4\u00b72 million (3\u00b77 million to 4\u00b78 million) in 2015.", {"entities": []}], ["Exposure to ozone caused an additional 254\u2008000 (95% UI 97\u2008000\u2013422\u2008000) deaths and a loss of 4\u00b71 million (1\u00b76 million to 6\u00b78 million) DALYs from chronic obstructive pulmonary disease in 2015.", {"entities": [[144, 181, "DISEASE"]]}], ["Ambient air pollution contributed substantially to the global burden of disease in 2015, which increased over the past 25 years, due to population ageing, changes in non-communicable disease rates, and increasing air pollution in low-income and middle-income countries.", {"entities": []}], ["Modest reductions in burden will occur in the most polluted countries unless PM 2\u00b75 values are decreased substantially, but there is potential for substantial health benefits from exposure reduction.", {"entities": []}], ["Bill & Melinda Gates Foundation and Health Effects Institute.", {"entities": []}], ["Pulmonary artery hypertension (PAH) is an incurable disease associated with the proliferation of pulmonary artery smooth muscle cells (PASMCs) and vascular remodeling.", {"entities": [[17, 29, "DISEASE"]]}], ["The present study examined whether TRAM-34, a highly selective blocker of calcium-activated potassium channel 3.1 (Kca3.1), can help prevent such hypertension by reducing proliferation in PASMCs.", {"entities": [[146, 158, "DISEASE"]]}], ["Rats were exposed to hypoxia (10% O 2 ) for 3 weeks and treated daily with TRAM-34 intraperitoneally from the first day of hypoxia.", {"entities": []}], ["Animals were killed and examined for vascular hypertrophy, Kca3.1 expression, and downstream signaling pathways.", {"entities": []}], ["In addition, primary cultures of rat PASMCs were exposed to hypoxia (3% O 2 ) or normoxia (21% O 2 ) for 24 h in the presence of TRAM-34 or siRNA against Kca3.1.", {"entities": []}], ["Activation of cell signaling pathways was examined using Western blot analysis.", {"entities": []}], ["In animal experiments, hypoxia triggered significant medial hypertrophy of pulmonary arterioles and right ventricular hypertrophy, and it significantly increased pulmonary artery pressure, Kca3.1 mRNA levels and ERK/p38 MAP kinase signaling.", {"entities": []}], ["These effects were attenuated in the presence of TRAM-34.", {"entities": []}], ["In cell culture experiments, blocking Kca3.1 using TRAM-34 or siRNA inhibited hypoxia-induced ERK/p38 signaling.", {"entities": []}], ["Kca3.1 may play a role in the development of PAH by activating ERK/p38 MAP kinase signaling, which may then contribute to hypoxia-induced pulmonary vascular remodeling.", {"entities": []}], ["TRAM-34 may protect against hypoxia-induced PAH.", {"entities": []}], ["The study was planned to evaluate modulatory effect of aqueous extract of Piper betle leaf (PBL) on ionizing radiation mediated oxidative stress leading to normal tissues damage during radiotherapy and other radiation exposures.", {"entities": []}], ["The total polyphenols and flavonoids known as free radical scavenger (chelators) were measured in the extract.", {"entities": []}], ["To ascertain antioxidant potential of PBL extract, we studied free radical scavenging, metal chelation, reducing power, lipid peroxidation inhibition and ferric reducing antioxidant properties (FRAP ) using in vitro assays.", {"entities": []}], ["Mice were exposed to varied radiation doses administered with the same extract prior to irradiation to confirm its oxidative stress minimizing efficacy by evaluating ferric reducing ability of plasma, reduced glutathione, lipid peroxidation and micro-nuclei frequency.", {"entities": []}], ["PBL extract was effective in scavenging DPPH (up to 92% at 100 \u00b5g/ml) and superoxide radicals (up to 95% at 80 \u00b5g/ml), chelated metal ions (up to 83% at 50 \u00b5g/ml) and inhibited lipid peroxidation (up to 45.65% at 500 \u00b5g/ml) in a dose dependant manner using in vitro model.", {"entities": []}], ["Oral administration of PBL extract (225 mg/kg body weight) 1 hr before irradiation in mice significantly enhanced (p < 0.01) radiation abated antioxidant potential of plasma and GSH level in all the observed organs.", {"entities": [[61, 63, "GENE"]]}], ["The treatment with extract effectively lowered the radiation induced lipid peroxidation at 24 hrs in all the selected organs with maximum inhibition in thymus (p < 0.01).", {"entities": []}], ["After 48 hrs, lipid peroxidation was maximally inhibited in the group treated with the extract.", {"entities": []}], ["Frequency of radiation induced micronucleated cells declined significantly (34.78%, p < 0.01) at 24 hrs post-irradiation interval by PBL extract administration.", {"entities": []}], ["The results suggest that PBL extract has high antioxidant potential and relatively non-toxic and thus could be assertively used to mitigate radiotherapy inflicted normal tissues damage and also injuries caused by moderate doses of radiation during unplanned exposures.", {"entities": []}], ["The mechanisms of sustained overproduction of eosinophils in the idiopathic hypereosinophilic syndrome and in some human immunodeficiency virus (HIV)-1-infected individuals are largely unknown.", {"entities": [[94, 102, "DISEASE"]]}], ["We hypothesized that T cells may release soluble products that regulate eosinophilia in these patients, as has been previously shown in bronchial asthma.", {"entities": [[72, 84, "DISEASE"], [146, 152, "DISEASE"]]}], ["We identified one patient with idiopathic hypereosinophilic syndrome and one HIV-1-infected individual with associated hypereosinophilia who demonstrated high numbers of CD4-CD8- T cells in peripheral blood.", {"entities": [[60, 68, "DISEASE"]]}], ["CD4-CD8- T cells from both patients, although highly activated, did not express functional Fas receptors.", {"entities": [[91, 94, "GENE"]]}], ["In one case, the lack of functional Fas receptors was associated with failure of Fas mRNA and protein expression, and in another, expression of a soluble form of the Fas molecule that may have antagonized normal signaling of Fas ligand.", {"entities": [[36, 39, "GENE"], [81, 84, "GENE"], [166, 169, "GENE"], [225, 228, "GENE"], [36, 39, "GENE"], [81, 84, "GENE"], [166, 169, "GENE"], [225, 228, "GENE"], [36, 39, "GENE"], [81, 84, "GENE"], [166, 169, "GENE"], [225, 228, "GENE"], [36, 39, "GENE"], [81, 84, "GENE"], [166, 169, "GENE"], [225, 228, "GENE"]]}], ["In contrast to the recently described lymphoproliferative/autoimmune syndrome, which is characterized by accumulation of CD4-CD8- T cells and mutations within the Fas gene, this study suggests somatic variations in Fas expression and function quite late in life.", {"entities": [[69, 77, "DISEASE"], [163, 166, "GENE"], [215, 218, "GENE"], [163, 166, "GENE"], [215, 218, "GENE"]]}], ["Both genetic and somatic abnormalities in regulation of the Fas gene are therefore associated with failures to undergo T cell apoptosis.", {"entities": [[60, 63, "GENE"]]}], ["Furthermore, the expanded population of CD4- CD8- T cells from both patients elaborated cytokines with antiapoptotic properties for eosinophils, indicating a major role of these T cells in the development of eosinophilia.", {"entities": [[208, 220, "DISEASE"]]}], ["Thus, this study demonstrates a sequential dysregulation of apoptosis in different cell types.", {"entities": []}], ["The prevalence of obesity is increasing rapidly in low- and middle-income countries (LMICs) as their populations become exposed to obesogenic environments.", {"entities": [[18, 25, "DISEASE"]]}], ["The transition from an agrarian to an industrial and service-based economy results in important lifestyle changes.", {"entities": []}], ["Yet different socioeconomic groups may experience and respond to these changes differently.", {"entities": []}], ["Investigating the socioeconomic distribution of obesity in LMICs is key to understanding the causes of obesity but the field is limited by the scarcity of data and a uni-dimensional approach to socioeconomic status (SES).", {"entities": [[48, 55, "DISEASE"], [103, 110, "DISEASE"]]}], ["This study splits socioeconomic status into two dimensions to investigate how educated women may have lower levels of obesity in a context where labour market opportunities have shifted away from agriculture to other forms of employment.", {"entities": [[118, 125, "DISEASE"]]}], ["The Four Provinces Study in China 2008/09 is a household-based community survey of 4,314 people aged \u226560 \u00a0years (2,465 women).", {"entities": []}], ["It was used to investigate an interaction between education (none/any) and occupation (agricultural/non-agricultural) on high-risk central obesity defined as a waist circumference \u226580\u00a0cm.", {"entities": [[139, 146, "DISEASE"]]}], ["An interaction term between education and occupation was incorporated in a multivariate logistic regression model, and the estimates adjusted for age, parity, urban/rural residence and health behaviours (smoking, alcohol, meat and fruit & vegetable consumption).", {"entities": []}], ["Complete case analyses were undertaken and results confirmed using multiple imputation to impute missing data.", {"entities": []}], ["An interaction between occupation and education was present ( P \u2009=\u20090.02).", {"entities": []}], ["In the group with no education, the odds of central obesity in the sedentary occupation group were more than double those of the agricultural occupation group even after taking age group and parity into account (OR; 95%CI: 2.21; 1.52, 3.21), while in the group with any education there was no evidence of such a relationship (OR; 95%CI: 1.25; 0.92, 1.70).", {"entities": [[52, 59, "DISEASE"]]}], ["Health behaviours appeared to account for some of the association.", {"entities": []}], ["These findings suggest that education may have a protective role in women against the higher odds of obesity associated with occupational shifts in middle-income countries, and that investment in women\u2019s education may present an important long term investment in obesity prevention.", {"entities": [[101, 108, "DISEASE"], [263, 270, "DISEASE"]]}], ["Further research could elucidate the mechanisms behind this association.", {"entities": []}], ["The association between asthma\u2013chronic obstructive pulmonary diseases (COPD) overlap syndrome (ACOS) and tuberculosis (TB) has yet to be studied.", {"entities": [[105, 117, "DISEASE"], [85, 93, "DISEASE"], [24, 30, "DISEASE"]]}], ["The newly diagnosed TB patients (age > 20 y) treated from January 2000 to December 2008 were included (ACOS cohort, n = 10 751; non-ACOS cohort, n = 42 966).", {"entities": []}], ["The non-ACOS cohort involved patients with confirmed absence of ACOS.", {"entities": []}], ["We calculated incidence rate ratios (IRRs) for TB in the ACOS and non-ACOS cohorts by using poisson regression analysis.", {"entities": []}], ["Cox proportional hazards regression models were used to determine the adjusted HR (aHR) for TB in the ACOS cohort compared with the non-ACOS cohort.", {"entities": [[79, 81, "GENE"], [83, 86, "GENE"]]}], ["The aHR for TB was 2.41 (95% confidence interval [CI], 2.19\u20132.66) in the ACOS cohort.", {"entities": [[4, 7, "GENE"]]}], ["The TB risk was significantly higher in the ACOS cohort than in the non-ACOS cohort when stratified by age, sex, comorbidities, and atopy.", {"entities": []}], ["Within the ACOS cohort, the aHR was higher among patients receiving SABAs+SAMAs, LABAs+LAMAs, and ICSs (aHR [95% CI]: 3.06 [2.75\u20133.41], 3.68 [2.93\u20134.61], and 2.79 [1.25\u20136.22], respectively; all P < .05).", {"entities": [[28, 31, "GENE"], [104, 107, "GENE"], [28, 31, "GENE"], [104, 107, "GENE"]]}], ["Furthermore, patients with more than 15 outpatient visits and hospitalizations per year demonstrated the highest aHR (8.09; 95% CI, 6.85\u20139.56).", {"entities": [[113, 116, "GENE"]]}], ["ACOS cohort potentially develop incident TB, regardless of the age,sex, comorbidities and atopy; even without receiving the inhalers.This risk is higher, especially in the ACOS cohort have a high frequency of medical services or receiving the inhalers such as SABAs+SAMAs, LABAs+LAMAs and ICSs.", {"entities": []}], ["Current trends in US population growth, age distribution, and disease dynamics foretell rises in the prevalence of chronic diseases and other chronic conditions.", {"entities": []}], ["These trends include the rapidly growing population of older adults, the increasing life expectancy associated with advances in public health and clinical medicine, the persistently high prevalence of some risk factors, and the emerging high prevalence of multiple chronic conditions.", {"entities": []}], ["Although preventing and mitigating the effect of chronic conditions requires sufficient measurement capacities, such measurement has been constrained by lack of consistency in definitions and diagnostic classification schemes and by heterogeneity in data systems and methods of data collection.", {"entities": []}], ["We outline a conceptual model for improving understanding of and standardizing approaches to defining, identifying, and using information about chronic conditions in the United States.", {"entities": []}], ["We illustrate this model\u2019s operation by applying a standard classification scheme for chronic conditions to 5 national-level data systems.", {"entities": []}], ["Cancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves.", {"entities": [[0, 6, "DISEASE"], [73, 79, "DISEASE"]]}], ["There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support.", {"entities": []}], ["The purpose of this study was to assess self-efficacy to manage problems in the year following primary treatment.", {"entities": []}], ["This cross-sectional online survey included cancer survivors who had completed their treatment within the past 12\u00a0months.", {"entities": [[44, 50, "DISEASE"]]}], ["Self-efficacy was assessed and variables expected to be associated with self-efficacy were measured using validated scales including quality of life, well-being, illness perceptions, depression and social support.", {"entities": []}], ["One hundred eighty-two respondents (mean age 50; 81\u00a0% female) completed the survey.", {"entities": []}], ["They had been treated for a range of cancers; most commonly breast (45\u00a0%).", {"entities": []}], ["Self-efficacy scores varied between individuals and according to the illness-related task to be managed.", {"entities": []}], ["Respondents were least confident in managing fatigue and most confident in accessing information about their cancer.", {"entities": [[109, 115, "DISEASE"]]}], ["Individuals most likely to report low self-efficacy were women, those experiencing higher levels of pain and/or depression, lower well-being scores, lower socio-economic status, low levels of social support, or a more negative perception of cancer.", {"entities": [[241, 247, "DISEASE"]]}], ["Self-efficacy to self-manage problems faced as a consequence of cancer and its treatment can vary widely in the year following treatment.", {"entities": [[64, 70, "DISEASE"]]}], ["Fatigue may be particularly difficult to manage.", {"entities": []}], ["Variations in self-efficacy highlight the importance of assessing specific problems faced and people\u2019s confidence to manage them in order to tailor appropriate self-management support.", {"entities": []}], ["Altered DNA methylation patterns in CD4 N patients \u200a=\u200a8, N controls \u200a=\u200a8) and gene expression ( N patients \u200a=\u200a9, N controls \u200a=\u200a10) profiles of CD4 N patients \u200a=\u200a12, N controls \u200a=\u200a12), but not by gene expression ( N patients \u200a=\u200a21, N controls \u200a=\u200a21) was also observed in an in vitro model system in which purified PBMCs from patients and healthy controls were challenged with allergen.", {"entities": [[36, 39, "GENE"], [143, 146, "GENE"], [36, 39, "GENE"], [143, 146, "GENE"]]}], ["We observed changes in the proportions of memory T-cell populations between patients ( N patients \u200a=\u200a35) and controls ( N controls \u200a=\u200a12), which could explain the observed difference in DNA methylation.", {"entities": []}], ["Our data highlight the potential of epigenomics in the stratification of immune disease and represents the first successful molecular classification of SAR using CD4 T-cells, a type of white blood cell, are an important part of the immune-system in humans.", {"entities": [[162, 165, "GENE"]]}], ["T-cells allow us to adapt our immune-response to the various infectious agents we encounter during life.", {"entities": []}], ["However, T-cells can also cause disease when they target the body's own cells, e.g.", {"entities": []}], ["Psoriasis, or when they react to a harmless particle or \u2018antigen\u2019, i.e.", {"entities": []}], ["Much evidence supports an environmental, or \u2018epigenetic\u2019, component to allergy.", {"entities": []}], ["Surprisingly, although allergy is viewed as a T-cell disease with an epigenetic component, no studies have identified epigenetic differences between healthy individuals and allergic individuals.", {"entities": []}], ["Using a state-of-the-art genome-wide approach, we found that we could clearly and robustly separate allergic patients from healthy controls.", {"entities": []}], ["It is often assumed that these changes reflect changes in DNA methylation in a given type of cell; however such differences can also result from different mixtures of T-cell subtypes in the samples.", {"entities": []}], ["Indeed, we found that allergic patients had different proportions of T-cell sub-types compared to healthy controls.", {"entities": []}], ["These changes in T-cell proportions may explain the difference in DNA methylation profile we observed between patients and controls.", {"entities": []}], ["Our study is the first successful molecular classification of allergy using CD4", {"entities": [[76, 79, "GENE"]]}], ["Most patients with type 2 diabetes have suboptimal control of their glucose, blood pressure (BP), and lipids \u2013 three risk factors for diabetes complications.", {"entities": []}], ["Although the chronic care model (CCM) provides a roadmap for improving these outcomes, developing theoretically sound implementation strategies that will work across diverse primary care settings has been challenging.", {"entities": []}], ["One explanation for this difficulty may be that most strategies do not account for the complex adaptive system (CAS) characteristics of the primary care setting.", {"entities": []}], ["A CAS is comprised of individuals who can learn, interconnect, self-organize, and interact with their environment in a way that demonstrates non-linear dynamic behavior.", {"entities": []}], ["One implementation strategy that may be used to leverage these properties is practice facilitation (PF).", {"entities": []}], ["PF creates time for learning and reflection by members of the team in each clinic, improves their communication, and promotes an individualized approach to implement a strategy to improve patient outcomes.", {"entities": []}], ["The specific objectives of this protocol are to: evaluate the effectiveness and sustainability of PF to improve risk factor control in patients with type 2 diabetes across a variety of primary care settings; assess the implementation of the CCM in response to the intervention; examine the relationship between communication within the practice team and the implementation of the CCM; and determine the cost of the intervention both from the perspective of the organization conducting the PF intervention and from the perspective of the primary care practice.", {"entities": []}], ["The study will be a group randomized trial conducted in 40 primary care clinics.", {"entities": []}], ["Data will be collected on all clinics, with 60 patients in each clinic, using a multi-method assessment process at baseline, 12, and 24 months.", {"entities": []}], ["The intervention, PF, will consist of a series of practice improvement team meetings led by trained facilitators over 12 months.", {"entities": []}], ["Primary hypotheses will be tested with 12-month outcome data.", {"entities": []}], ["Sustainability of the intervention will be tested using 24 month data.", {"entities": []}], ["Insights gained will be included in a delayed intervention conducted in control practices and evaluated in a pre-post design.", {"entities": []}], ["To test hypotheses, the unit of randomization will be the clinic.", {"entities": []}], ["The unit of analysis will be the repeated measure of each risk factor for each patient, nested within the clinic.", {"entities": []}], ["The repeated measure of glycosylated hemoglobin A1c will be the primary outcome, with BP and Low Density Lipoprotein (LDL) cholesterol as secondary outcomes.", {"entities": []}], ["To study change in risk factor level, a hierarchical or random effect model will be used to account for the nesting of repeated measurement of risk factor within patients and patients within clinics.", {"entities": []}], ["This protocol follows the CONSORT guidelines and is registered per ICMJE guidelines: NCT00482768", {"entities": []}], ["Cigarette smoking is the most important risk factor for obstruction of airflow in chronic obstructive pulmonary disease (COPD).", {"entities": [[82, 119, "DISEASE"]]}], ["Matrix metalloproteinases (MMPs) or an imbalance between MMPs and their inhibitors, the tissue inhibitors of MMP (TIMPs), is considered to play a role in the pathogenesis of COPD.", {"entities": []}], ["We investigated whether the MMPs expression or the imbalance between MMPs and TIMP-1 is associated with the amount of cigarette smoking and the FEV1 value, in the lung parenchyma of 26 subjects (6 non-smokers and 20 cigarette smokers).", {"entities": []}], ["First, we performed zymographic analysis to identify the profile of the MMPs, which revealed gelatinolytic bands mainly equivalent to MMP-9 in the smokers.", {"entities": []}], ["We then measured, using enzyme immunoassay, the concentrations of MMP-9 and its inhibitor, TIMP-1.", {"entities": []}], ["Correlation analysis revealed that both the MMP-9 concentrations and the molar ratios of MMP-9 to TIMP-1 (MMP-9/TIMP-1) were correlated with the amount of cigarette smoking.", {"entities": []}], ["Furthermore, MMP-9 concentrations were inversely correlated with FEV1.", {"entities": []}], ["In conclusion, this study shows that MMP-9 expression in human lung parenchyma is associated with cigarette smoking and also with the obstruction of airflow, suggesting that MMP-9 may play a role in the pathogenesis of the cigarette smoke-induced obstruction of airflow known as the characteristic of COPD.", {"entities": []}], ["While aspirin is a well\u2010established and generally effective anti\u2010platelet agent, considerable inter\u2010individual variation in drug response exists, for which mechanisms are not completely understood.", {"entities": []}], ["Metabolomics allows for extensive measurement of small molecules in biological samples, enabling detailed mapping of pathways involved in drug response.", {"entities": []}], ["We used a mass\u2010spectrometry\u2010based metabolomics platform to investigate the changes in the serum oxylipid metabolome induced by an aspirin intervention (14\u00a0days, 81\u00a0mg/day) in healthy subjects (n=156).", {"entities": []}], ["We observed a global decrease in serum oxylipids in response to aspirin (25 metabolites decreased out of 30 measured) regardless of sex.", {"entities": []}], ["This decrease was concomitant with a significant decrease in serum linoleic acid levels (\u221219%, P =1.3\u00d710 Together, these results suggest that linoleic acid\u2010derived oxylipids may contribute to the non\u2010 COX 1 mediated variability in response to aspirin.", {"entities": []}], ["Pharmacometabolomics allowed for more comprehensive interrogation of mechanisms of action of low dose aspirin and of variation in aspirin response.", {"entities": []}], ["Early intervention in schizophrenia is important for patient prognosis and quality of life.", {"entities": [[22, 35, "DISEASE"]]}], ["At the time of the first episode, quality of life is influenced by identification of symptoms and by medical help-seeking behavior.", {"entities": []}], ["In this prospective cohort study, we investigated help-seeking among 2690 parents of junior and senior high school students before and after the parents viewed a newly developed web-based education program aimed at improving knowledge of schizophrenia.", {"entities": [[238, 251, "DISEASE"]]}], ["Our web-based education program aimed to improve understanding of schizophrenia, including promotion of help-seeking.", {"entities": [[66, 79, "DISEASE"]]}], ["Many parents (33.1%-50.0%) consulted a physician in a department of psychosomatic medicine when their child experienced symptoms.", {"entities": []}], ["Characteristics that predicted a decision not to seek psychiatric medical help were having child with all symptoms, younger parent age, and lower family income (p<0.05).", {"entities": []}], ["After the education program, the rate of parents who sought medical help within 1 week was significantly higher for all symptom categories except sleeplessness (p=0.001).", {"entities": []}], ["These findings suggest that the present web-based education program was useful in promoting medical help-seeking behavior among parents of junior and senior high school students in Japan.", {"entities": []}], ["Overnight incubation of human eosinophils (E\u00f8s) with the glucocorticoid hormone dexamethasone (DEX; 0.1 \u03bcM) resulted in lower expression of the CD11b, but not CD49d, antigen on their plasma membrane, as assessed by flow cytometry.", {"entities": []}], ["DEX produced a consistent inhibitory effect (ranging from 16% to 20%) when tested at a concentration of 0.1 \u03bcM.", {"entities": []}], ["E\u00f8 stimulation with 100 ng/ml eotaxin produced an increase in CD11b (+26%), but not CD11c, levels and concomitantly a reduction (\u201325%) on CD62L expression.", {"entities": []}], ["The inhibition exerted by DEX upon CD11b levels was also evident following eotaxin upregulation, with a degree of inhibition similar to that seen on basal levels.", {"entities": []}], ["These data highlight a novel mechanism of action by which glucocorticoid hormones may be effective in reducing E\u00f8 accumulation during allergic inflammation in man.", {"entities": []}], ["OBJECTIVE: To study the effectiveness and morbidity of adding hygroscopic cervical dilators to prostaglandin gel for cervical ripening and labor induction.", {"entities": []}], ["STUDY DESIGN: Patients of at least 34 weeks' gestation with a medical indication for induction of labor and with a modified Bishop score of 5 or less were randomized to receive either prostaglandin gel or prostaglandin gel with hygroscopic cervical dilators.", {"entities": []}], ["Primary outcomes were time to delivery, change in cervical score, and infection.", {"entities": []}], ["Secondary outcomes included cesarean delivery rate and deliveries before 24 hours of induction.", {"entities": []}], ["Continuous variables were analyzed by Wilcoxon sum rank test and categorical data by chi-square or Fisher exact test, with P < 0.05 being significant.", {"entities": []}], ["RESULTS: Seventeen patients were randomized to intracervical prostaglandin alone and 23 patients received intracervical prostaglandin plus hygroscopic dilators.", {"entities": []}], ["No demographic differences were noted between the groups.", {"entities": []}], ["After six hours of ripening, the combined group achieved a greater change in Bishop score (3.6 vs. 2.1, P = 0.007) and tended to have a shorter induction time (21.7 vs. 26.4 hours, P = 0.085).", {"entities": []}], ["The combined therapy group had a higher infection rate than the prostaglandin-only group (59% vs. 12%, P = 0.003).", {"entities": []}], ["CONCLUSION: Combining cervical dilators with prostaglandin gel provides more effective cervical ripening and a more rapid induction to delivery interval than prostaglandin alone but with a significant and prohibitive rate of infection.", {"entities": []}], ["The epidemic of allergic disease in early life is one of the clearest indicators that the developing immune system is vulnerable to modern environmental changes.", {"entities": []}], ["A range of environmental exposures epidemiologically associated with allergic disease have been shown to have effects on the foetal immune function in pregnancy, including microbial burden, dietary changes and environmental pollutants.", {"entities": []}], ["Preliminary studies now suggest that these early effects on immune development may be mediated epigenetically through a variety of processes that collectively modify gene expression and allergic susceptibility and that these effects are potentially heritable across generations.", {"entities": []}], ["It is also possible that rising rates of maternal allergy, a recognised direct risk factor for infant allergic disease, may be further amplifying the effects of environmental changes.", {"entities": []}], ["Whilst effective prevention strategies are the ultimate goal in reversing the allergy epidemic, the specific environmental drivers, target genes, and intracellular pathways and mechanisms of early life immune programming are still unclear.", {"entities": []}], ["It is hoped that identifying genes that are differentially regulated in association with subsequent allergic disease will assist in identifying causal pathways and upstream contributing environmental factors.", {"entities": []}], ["In this way, epigenetic paradigms are likely to provide valuable insights into how the early environment can be modified to more favourably drive immune development and reverse the allergic epidemic.", {"entities": []}], ["Less intensive treatment for heart failure with reduced ejection fraction (HFrEF) may be appropriate for patients in long-term care settings because of limited life expectancy, frailty, comorbidities, and emphasis on quality of life.", {"entities": []}], ["We compared treatment patterns between REasons for Geographic And Racial Differences in Stroke (REGARDS) study participants discharged to long-term care versus home following HFrEF hospitalizations.", {"entities": []}], ["We examined medical records and Medicare pharmacy claims for 147 HFrEF hospitalizations among 80 participants to obtain information about discharge disposition and medication prescriptions and fills.", {"entities": []}], ["Discharge to long-term care followed 22 of 147 HFrEF hospitalizations (15%).", {"entities": []}], ["Participants discharged to long-term care were more likely to be prescribed beta-blockers and less likely to be prescribed aldosterone receptor antagonists and hydralazine/isosorbide dinitrate (96%, 14%, and 5%, respectively) compared to participants discharged home (81%, 22%, and 23%, respectively).", {"entities": []}], ["The percentages of participants discharged to long-term care and home who had claims for filled prescriptions were similar for beta-blockers (68% versus 66%) and angiotensin converting enzyme inhibitors or angiotensin receptor blockers (ACEI/ARBs) (45% versus 47%) after 1\u00a0year.", {"entities": []}], ["Smaller percentages of participants discharged to long-term care had claims for filled prescriptions of other medications compared to participants discharged home (diuretics: long-term care-50%, home-72%; hydralazine/isosorbide dinitrate: long-term care-5%, home-23%; aldosterone receptor antagonists: long-term care-5%, home-23%).", {"entities": []}], ["Differences in medication prescriptions and fills among individuals with HFrEF discharged to long-term care versus home may reflect prioritization of some medical therapies over others for patients in long-term care.", {"entities": []}], ["Inhalation of endotoxin (LPS) induces a predominantly neutrophilic airway inflammation and has been used as model to test the anti-inflammatory activity of novel drugs.", {"entities": []}], ["In the past, a dose exceeding 15\u201350\u2009\u03bcg was generally needed to induce a sufficient inflammatory response.", {"entities": []}], ["For human studies, regulatory authorities in some countries now request the use of GMP-grade LPS, which is of limited availability.", {"entities": []}], ["It was therefore the aim of this study to test the effect and reproducibility of a low-dose LPS challenge (20,000 E.U.", {"entities": []}], ["; 2\u2009\u03bcg) using a flow- and volume-controlled inhalation technique to increase LPS deposition.", {"entities": []}], ["Two to four weeks after a baseline sputum induction, 12 non-smoking healthy volunteers inhaled LPS on three occasions, separated by at least 4\u2009weeks.", {"entities": []}], ["To modulate the inflammatory effect of LPS, a 5-day PDE4 inhibitor (Roflumilast) treatment preceded the last challenge.", {"entities": []}], ["Six hours after each LPS inhalation, sputum induction was performed.", {"entities": []}], ["The low-dose LPS inhalation was well tolerated and increased the mean percentage of sputum neutrophils from 25% to 72%.", {"entities": []}], ["After the second LPS challenge, 62% neutrophils and an increased percentage of monocytes were observed.", {"entities": []}], ["The LPS induced influx of neutrophils and the cumulative inflammatory response compared with baseline were reproducible.", {"entities": []}], ["Treatment with Roflumilast for 5\u2009days did not have a significant effect on sputum composition.", {"entities": []}], ["The controlled inhalation of 2\u2009\u03bcg GMP-grade LPS is sufficient to induce a significant neutrophilic airway inflammation in healthy volunteers.", {"entities": []}], ["Repeated low-dose LPS challenges potentially result in a small shift of the neutrophil/monocyte ratio; however, the cumulative response is reproducible, enabling the use of this model for \u201cproof-of-concept\u201d studies for anti-inflammatory compounds during early drug development.", {"entities": []}], ["Clinicaltrials.gov: NCT01400568", {"entities": []}], ["Enhanced cough response has been frequently observed in chronic cough.", {"entities": []}], ["Recently, extrathoracic airway constriction to inhaled histamine was demonstrated in some chronic cough patients.", {"entities": []}], ["However, relation between extrathoracic airway hyperresponsiveness (EAHR) and cough sensitivity determined by capsaicin inhalation is unclear in each etiological entity of chronic cough.", {"entities": []}], ["Seventy-seven patients, with dry cough persisting for 3 or more weeks, normal spirometry and chest radiography, and 15 controls, underwent methacholine bronchial provocation test and capsaicin cough provocation test.", {"entities": []}], ["Elicited cough number and flow-volume curve was examined after inhalation of capsaicin to evaluate cough sensitivity and EAHR.", {"entities": []}], ["Thirty-three patients, with postnasal drip, showed normal extrathoracic airway responsiveness, and 27 of them showed normal cough sensitivity to capsaicin.", {"entities": []}], ["Cough sensitivity was enhanced in 14 patients with cough variant asthma (CVA) who showed bronchial hyperresponsiveness; EAHR to inhaled capsaicin was present in 12 of them.", {"entities": [[51, 71, "DISEASE"], [65, 71, "DISEASE"]]}], ["The remaining 30 patients were tentatively diagnosed as idiopathic chronic cough (ICC).", {"entities": []}], ["Eleven ICC patients showed enhanced cough sensitivity and EAHR to inhaled capsaicin while 19 patients showed normal values.", {"entities": []}], ["These results indicate that cough sensitivity is closely related with extrathoracic airway responsiveness during capsaicin provocation in some chronic cough patients.", {"entities": []}], ["EAHR and enhanced cough sensitivity to inhaled capsaicin may be a part of mechanism developing chronic cough.", {"entities": []}], ["The clinical role of community pharmacists is expanding, as is the use of clinical guidelines in this setting.", {"entities": []}], ["However, it is unclear which strategies are successful in implementing clinical guidelines and what outcomes can be achieved.", {"entities": []}], ["The aim of this systematic review is to synthesise the literature on the implementation of clinical guidelines to community pharmacy.", {"entities": []}], ["The objectives are to describe the implementation strategies used, describe the resulting outcomes and to assess the effectiveness of the strategies.", {"entities": []}], ["A systematic search was performed in six electronic databases (Medline, EMBASE, CINAHL, Web of Science, Informit, Cochrane Library) for relevant articles.", {"entities": []}], ["Studies were included if they reported on clinical guidelines implementation strategies in the community pharmacy setting.", {"entities": []}], ["Two researchers completed the full-search strategy, data abstraction and quality assessments, independently.", {"entities": []}], ["A third researcher acted as a moderator.", {"entities": []}], ["Quality assessments were completed with three validated tools.", {"entities": []}], ["A narrative synthesis was performed to analyse results.", {"entities": []}], ["A total of 1937 articles were retrieved and the titles and abstracts were screened.", {"entities": []}], ["Full-text screening was completed for 36 articles resulting in 19 articles (reporting on 22 studies) included for review.", {"entities": []}], ["Implementation strategies were categorised according to a modified version of the EPOC taxonomy.", {"entities": []}], ["Educational interventions were the most commonly utilised strategy ( n \u2009=\u200920), and computerised decision support systems demonstrated the greatest effect ( n \u2009=\u20094).", {"entities": []}], ["Most studies were multifaceted and used more than one implementation strategy ( n \u2009=\u200918).", {"entities": []}], ["Overall outcomes were moderately positive ( n \u2009=\u200917) but focused on process ( n \u2009=\u200922) rather than patient ( n \u2009=\u20093) or economic outcomes ( n \u2009=\u20093).", {"entities": []}], ["Most studies ( n \u2009=\u200920) were rated as being of low methodological quality and having low or very low quality of evidence for outcomes.", {"entities": []}], ["Studies in this review did not generally have a well thought-out rationale for the choice of implementation strategy.", {"entities": []}], ["Most utilised educational strategies, but the greatest effect on outcomes was demonstrated using computerised clinical decision support systems.", {"entities": []}], ["Poor methodology, in the majority of the research, provided insufficient evidence to be conclusive about the best implementation strategies or the benefit of clinical guidelines in this setting.", {"entities": []}], ["However, the generally positive outcomes across studies and strategies indicate that implementing clinical guidelines to community pharmacy might be beneficial.", {"entities": []}], ["Improved methodological rigour in future research is required to strengthen the evidence for this hypothesis.", {"entities": []}], ["PROSPERO 2012: CRD42012003019 .", {"entities": []}], ["The online version of this article (doi:10.1186/s13012-015-0337-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Medication review has been advocated to address the challenge of polypharmacy in older patients, yet there is no consensus on how best to evaluate its efficacy.", {"entities": []}], ["Heterogeneity of outcomes reported in clinical trials can hinder the comparison of clinical trial findings in systematic reviews.", {"entities": []}], ["Moreover, the outcomes that matter most to older patients might be under-reported or disregarded altogether.", {"entities": []}], ["A core outcome set can address this issue as it defines a minimum set of outcomes that should be reported in all clinical trials in any particular field of research.", {"entities": []}], ["As part of the European Commission-funded project, called OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly, this paper describes the methods used to develop a core outcome set for clinical trials of medication review in older patients with multimorbidity.", {"entities": []}], ["The study was designed in several steps.", {"entities": []}], ["First, a systematic review established which outcomes were measured in published and ongoing clinical trials of medication review in older patients.", {"entities": []}], ["Second, we undertook semistructured interviews with older patients and carers aimed at identifying additional relevant outcomes.", {"entities": []}], ["Then, a multilanguage European Delphi survey adapted to older patients was designed.", {"entities": []}], ["The international Delphi survey was conducted with older patients, health care professionals, researchers, and clinical experts in geriatric pharmacotherapy to validate outcomes to be included in the core outcome set.", {"entities": []}], ["Consensus meetings were conducted to validate the results.", {"entities": []}], ["We present the method for developing a core outcome set for medication review in older patients with multimorbidity.", {"entities": []}], ["This study protocol could be used as a basis to develop core outcome sets in other fields of geriatric research.", {"entities": []}], ["Person-centred care (PCC) emphasizes a partnership in care between patients and healthcare professionals and is advocated by WHO as a key component of quality health care.", {"entities": []}], ["We evaluated outcomes of PCC in hospitalized patients with chronic heart failure (CHF) with respect to the length of hospital stay (LOS), activities of daily living (ADL), health-related quality of life (HRQL) and 6-month readmission rate.", {"entities": []}], ["During 2008\u20132010, 248 consecutive patients hospitalized for symptoms of worsening CHF were enrolled in a controlled before and after designed study.", {"entities": []}], ["A Usual care group ( n = 123) was recruited according to pre-defined criteria to map usual CHF care and assess outcomes at five designated hospital wards.", {"entities": []}], ["Based on the mapping, a panel of in-house clinicians and researchers developed measures aimed at aligning usual care with basic PCC principles.", {"entities": []}], ["These measures were incorporated into a study protocol to guide care procedures at the same five wards.", {"entities": []}], ["Person-centred care was then implemented at these wards and evaluated in 125 patients.", {"entities": []}], ["Both length of hospital stay and 6-month readmission were extracted from patient records.", {"entities": []}], ["Activities of daily living were evaluated at baseline and discharge and HRQL was evaluated at baseline and after 3 months.", {"entities": []}], ["In the analysis of all patients, the LOS was reduced by 1 day ( P = 0.16) while retaining ADL ( P = 0.07).", {"entities": []}], ["When PCC was fully implemented (per protocol analysis), LOS was reduced by 2.5 days ( P = 0.01) and the ADL-level better preserved ( P = 0.04).", {"entities": []}], ["Health-related quality of life and time-to-first readmission did not differ.", {"entities": []}], ["In this proof-of-concept study, our findings suggest that a fully implemented PCC approach shortens hospital stay and maintains functional performance in patients hospitalized for worsening CHF, without increasing risk for readmission or jeopardizing patients' HRQL.", {"entities": []}], ["Human communities consistently develop a detailed knowledge of the therapeutical and medicinal properties of the local flora and fauna, and these folk remedies often substitute medicines produced by the pharmaceutical industry.", {"entities": []}], ["Animals (and their derived products) are essential ingredients in the preparation of many traditional remedies.", {"entities": []}], ["The present work prepared an inventory of the animals sold in public markets in the cities of Crato and Juazeiro do Norte, Cear\u00e1 State, Brazil.", {"entities": []}], ["Information was obtained through the use of semi-structured questionnaires in interviews held with 27 merchants of medicinal animals (18 in the municipality of Juazeiro do Norte [11 men and 7 women] and 9 people in the municipality of Crato [6 men and 3 women]).", {"entities": []}], ["We calculated the Informant Consensus Factor (ICF) to determine the consensus over which species are effective for particular ailments, as well as the species Use Value (UV) to determine the extent of utilization of each species.", {"entities": []}], ["A total of 31 animal species, distributed among 21 families were identified as being used medicinally.", {"entities": []}], ["The taxa most represented were: insects (8 species), mammals (7), fish (5), reptiles (5) and birds (4).", {"entities": []}], ["The animals sold in these markets are used to treat a total of 24 ailments, with rheumatism, asthma, and inflammations having the largest numbers of citations.", {"entities": [[93, 99, "DISEASE"]]}], ["Three species not previously reported as having medicinal use were encountered: Leporinus steindachneri (utilized for treating cholesterol problems), Gryllus assimilis (utilized in treating urinary infections), and Phrynops tuberosus (used to treat asthma, rheumatism and bruises).", {"entities": [[249, 255, "DISEASE"]]}], ["The composition of the local fauna, the popular culture, and commercial considerations are factors that maintain and drive the market for therapeutic animal products \u2013 and the lack of monitoring and regulation of this commerce is worrisome from a conservationist perspective.", {"entities": []}], ["A detailed knowledge of the fauna utilized in alternative medicine is fundamental to the conservation and rational use of the Brazilian fauna.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation, the severity of which is assessed using forced expiratory volume in 1\u2009sec (FEV 1 , % predicted).", {"entities": [[171, 174, "GENE"]]}], ["Cohort studies have confirmed that COPD patients with similar levels of airflow limitation showed marked heterogeneity in clinical manifestations and outcomes.", {"entities": []}], ["Chronic coexisting diseases, also called comorbidities, are highly prevalent in COPD patients and likely contribute to this heterogeneity.", {"entities": []}], ["In recent years, investigators have used innovative statistical methods (e.g., cluster analyses) to examine the hypothesis that subgroups of COPD patients sharing clinically relevant characteristics (phenotypes) can be identified.", {"entities": []}], ["The objectives of the present paper are to review recent studies that have used cluster analyses for defining phenotypes in observational cohorts of COPD patients.", {"entities": []}], ["Strengths and weaknesses of these statistical approaches are briefly described.", {"entities": []}], ["Description of the phenotypes that were reasonably reproducible across studies and received prospective validation in at least one study is provided, with a special focus on differences in age and comorbidities (including cardiovascular diseases).", {"entities": []}], ["Finally, gaps in current knowledge are described, leading to proposals for future studies.", {"entities": []}], ["Hypereosinophilic syndrome is defined as a prolonged state (more than six months) of eosinophilia (greater than 1500 cells/\u03bcL), without an apparent etiology and with end-organ damage.", {"entities": [[18, 26, "DISEASE"], [85, 97, "DISEASE"]]}], ["Hypereosinophilic syndrome can cause coagulation abnormalities.", {"entities": [[18, 26, "DISEASE"]]}], ["Among hypereosinophilic syndrome types, the lymphocytic variant (lymphocytic hypereosinophilic syndrome) is derived from a monoclonal proliferation of T lymphocytes.", {"entities": [[24, 32, "DISEASE"], [95, 103, "DISEASE"]]}], ["Here, we describe the case of a patient with lymphocytic hypereosinophilic syndrome who presented with a coagulation abnormality.", {"entities": [[75, 83, "DISEASE"]]}], ["To the best of our knowledge, this is the first such report including a detailed clinical picture and temporal cytokine profile.", {"entities": []}], ["A 77-year-old Japanese man presented to our facility with massive hematuria and hypereosinophilia (greater than 2600 cells/\u03bcl).", {"entities": []}], ["His eosinophilia first appeared five years earlier when he developed femoral artery occlusion.", {"entities": [[4, 16, "DISEASE"]]}], ["He manifested with multiple hematomas and prolonged activated partial thromboplastin time.", {"entities": []}], ["His IgG4 level was remarkably elevated (greater than 2000 mg/dL).", {"entities": []}], ["Polymerase chain reaction tests of peripheral blood and bone marrow identified lymphocytic hypereosinophilic syndrome.", {"entities": [[109, 117, "DISEASE"]]}], ["His prolonged activated partial thromboplastin time was found to be due to acquired hemophilia.", {"entities": []}], ["Glucocorticoids suppressed both the hypereosinophilia and coagulation abnormality.", {"entities": []}], ["However, tapering of glucocorticoids led to a relapse of the coagulation abnormality alone, without eosinophilia.", {"entities": [[100, 112, "DISEASE"]]}], ["Tumor necrosis factor \u03b1, interleukin-5, and/or eotaxin-3 may have caused the hypereosinophilia, and interleukin-10 was correlated with the coagulation abnormality.", {"entities": []}], ["To the best of our knowledge, this is the first case in which lymphocytic hypereosinophilic syndrome and IgG4-related disease have overlapped.", {"entities": [[92, 100, "DISEASE"]]}], ["In addition, our patient is only the second case of hypereosinophilic disease that manifested with acquired hemophilia.", {"entities": []}], ["Our patient relapsed with the coagulation abnormality alone, without eosinophilia.", {"entities": [[69, 81, "DISEASE"]]}], ["This report shows that the link between eosinophilia, IgG4, and clinical manifestations is not simple and provides useful insight into the immunopathology of hypereosinophilic syndrome and IgG4-related disease.", {"entities": [[176, 184, "DISEASE"], [40, 52, "DISEASE"]]}], ["The infection of CD4+ cells by HIV leads to the progressive destruction of CD4+ T lymphocytes and, after a severe reduction of CD4+ cells, to AIDS.", {"entities": []}], ["The aim of the study was to investigate whether HIV-infected patients with CD4 cell counts <200 cells/\u00b5l can suffer from symptoms of IgE-mediated allergy, produce allergen-specific IgE antibody responses and show boosts of allergen-specific IgE production.", {"entities": [[75, 78, "GENE"]]}], ["HIV-infected patients with CD4 counts \u2264200 cells/\u00b5l suffering from AIDS and from IgE-mediated allergy were studied.", {"entities": [[27, 30, "GENE"]]}], ["Allergy was diagnosed according to case history, physical examination, skin prick testing (SPT), and serological analyses including allergen microarrays.", {"entities": []}], ["HIV infection was confirmed serologically and the disease was staged clinically.", {"entities": []}], ["The predominant allergic symptoms in the studied patients were acute allergic rhinitis (73%) followed by asthma (27%) due to IgE-mediated mast cell activation whereas no late phase allergic symptoms such as atopic dermatitis, a mainly T cell-mediated skin manifestation, were found in patients suffering from AIDS.", {"entities": [[69, 86, "DISEASE"], [207, 224, "DISEASE"], [78, 86, "DISEASE"], [105, 111, "DISEASE"], [214, 224, "DISEASE"]]}], ["According to IgE serology allergies to house dust mites and grass pollen were most common besides IgE sensitizations to various food allergens.", {"entities": []}], ["Interestingly, pollen allergen-specific IgE antibody levels in the patients with AIDS and in additional ten IgE-sensitized patients with HIV infections and low CD4 counts appeared to be boosted by seasonal allergen exposure and were not associated with CD4 counts.", {"entities": [[160, 163, "GENE"], [253, 256, "GENE"], [160, 163, "GENE"], [253, 256, "GENE"]]}], ["Our results indicate that secondary allergen-specific IgE production and IgE-mediated allergic inflammation do not require a fully functional CD4+ T lymphocyte repertoire.", {"entities": []}], ["Objectives .", {"entities": []}], ["To identify the major allergenic proteins of clam ( Paphia textile ) and to investigate the effect of different cooking methods on the allergenicity of these identified proteins.", {"entities": []}], ["Clam protein extracts were separated by denaturing polyacrylamide gel electrophoresis.", {"entities": []}], ["IgE reactive proteins were then analyzed by immunoblotting with sera from patients with positive skin prick tests (SPT) to the raw clam extract.", {"entities": []}], ["Mass spectrometry was used to identify the major allergenic proteins of this clam.", {"entities": []}], ["Raw extract showed 12 protein bands (18\u2013150\u2009kDa).", {"entities": []}], ["In contrast, fewer protein bands were seen in the boiled extract; those ranging from 40 to 150\u2009kDa were denatured.", {"entities": []}], ["The protein profiles were similarly altered by frying or roasting.", {"entities": []}], ["The immunoblots of raw and boiled extracts yielded 10 and 2 IgE-binding proteins, respectively.", {"entities": []}], ["The fried and roasted extracts showed only a single IgE-binding protein at 37\u2009kDa.", {"entities": []}], ["Mass spectrometry analysis of the 37 and 42\u2009kDa major allergens indicated that these spots were tropomyosin and actin, respectively.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The two major allergens of Paphia textile were identified as the thermostable tropomyosin and a new thermolabile allergen actin.", {"entities": []}], ["Improving the quality of health care requires a range of evidence-based activities.", {"entities": []}], ["Audit and feedback is commonly used as a quality improvement tool in the UK National Health Service [NHS].", {"entities": [[101, 104, "GENE"]]}], ["We set out to assess whether current guidance and systematic review evidence can sufficiently inform practical decisions about how to use audit and feedback to improve quality of care.", {"entities": []}], ["We selected an important chronic disease encountered in primary care: diabetes mellitus.", {"entities": [[70, 87, "DISEASE"]]}], ["We identified recommendations from National Institute for Clinical Excellence (NICE) guidance on conducting audit and generated questions which would be relevant to any attempt to operationalise audit and feedback in a healthcare service setting.", {"entities": []}], ["We explored the extent to which a systematic review of audit and feedback could provide practical guidance about whether audit and feedback should be used to improve quality of diabetes care and, if so, how audit and feedback could be optimised.", {"entities": []}], ["National guidance suggests the importance of securing the right organisational conditions and processes.", {"entities": []}], ["Review evidence suggests that audit and feedback can be effective in changing healthcare professional practice.", {"entities": []}], ["However, the available evidence says relatively little about the detail of how to use audit and feedback most efficiently.", {"entities": []}], ["Audit and feedback will continue to be an unreliable approach to quality improvement until we learn how and when it works best.", {"entities": []}], ["Conceptualising audit and feedback within a theoretical framework offers a way forward.", {"entities": []}], ["Clinical research informatics is the rapidly evolving sub-discipline within biomedical informatics that focuses on developing new informatics theories, tools, and solutions to accelerate the full translational continuum: basic research to clinical trials (T1), clinical trials to academic health center practice (T2), diffusion and implementation to community practice (T3), and \u2018real world\u2019 outcomes (T4).", {"entities": []}], ["We present a conceptual model based on an informatics-enabled clinical research workflow, integration across heterogeneous data sources, and core informatics tools and platforms.", {"entities": []}], ["We use this conceptual model to highlight 18 new articles in the JAMIA special issue on clinical research informatics.", {"entities": []}], ["We evaluated if exposure to RF-EMF was associated with reported quality of sleep in 2,361 children, aged 7 years.", {"entities": []}], ["This study was embedded in the Amsterdam Born Children and their Development (ABCD) birth cohort study.", {"entities": []}], ["When children were about five years old, school and residential exposure to RF-EMF from base stations was assessed with a geospatial model (NISMap) and from indoor sources (cordless phone/WiFi) using parental self-reports.", {"entities": []}], ["Parents also reported their children\u2019s use of mobile or cordless phones.", {"entities": []}], ["When children were seven years old, we evaluated sleep quality as measured with the Child Sleep Habits Questionnaire (CSHQ) filled in by parents.", {"entities": []}], ["Of eight CSHQ subscales, we evaluated sleep onset delay, sleep duration, night wakenings, parasomnias and daytime sleepiness with logistic or negative binomial regression models, adjusting for child\u2019s age and sex and indicators of socio-economic position of the parents.", {"entities": []}], ["We evaluated the remaining three subscales (bedtime resistance, sleep anxiety, sleep disordered breathing) as unrelated outcomes (negative control) because these were a priori hypothesised not to be associated with RF-EMF.", {"entities": []}], ["Sleep onset delay, night wakenings, parasomnias and daytime sleepiness were not associated with residential exposure to RF-EMF from base stations.", {"entities": []}], ["Sleep duration scores were associated with RF-EMF levels from base stations.", {"entities": []}], ["Higher use mobile phones was associated with less favourable sleep duration, night wakenings and parasomnias, and also with bedtime resistance.", {"entities": []}], ["Cordless phone use was not related to any of the sleeping scores.", {"entities": []}], ["Given the different results across the evaluated RF-EMF exposure sources and the observed association between mobile phone use and the negative control sleep scale, our study does not support the hypothesis that it is the exposure to RF-EMF that is detrimental to sleep quality in 7-year old children, but potentially other factors that are related to mobile phone usage.", {"entities": []}], ["Community-acquired pneumonia (CAP) is one of the five leading causes of death among children in developing countries, accounting for approximately three million deaths per year.", {"entities": [[19, 28, "DISEASE"]]}], ["Identification of the modifiable risk factors of CAP may help to reduce the burden of this disease.", {"entities": []}], ["In this study, the impact of the socioeconomic status (SES) on the severity and outcome of CAP among Egyptian children was studied.", {"entities": []}], ["This was a prospective longitudinal cohort study which included 1,470 children diagnosed with CAP, aged two to 15\u00a0years (median age 5.4\u00a0years).", {"entities": []}], ["The diagnosis of CAP was based on clinical and radiological findings.", {"entities": []}], ["A structured questionnaire and the patients\u2019 medical records were used for the data collection.", {"entities": []}], ["The subjects were divided into two groups: mild and severe CAP.", {"entities": []}], ["Social and demographic variables were compared, and a multivariate logistic regression analysis was performed.", {"entities": []}], ["The multivariate analysis showed that a low maternal education level (OR: 3.8; 95% CI: 2.12 \u20136.70; P \u2009=\u2009.0001), unavailability of adequate medical care (OR: 3.1; 95% CI: 1.99 \u20134.88; P \u2009=\u2009.0001), a low family income (OR: 2.2; 95% CI: 0.99 \u20134.78; P \u2009=\u2009.047), and parents\u2019 smoking habits (OR: 2.0; 95% CI: 1.15 \u20133.55; P \u2009=\u2009.014) were significant independent predictive risk factors for severe CAP among Egyptian children.", {"entities": []}], ["Public health measures against these socio-demographic risk factors should be identified as priorities in order to help reduce the disease burden of deaths from severe CAP among Egyptian children.", {"entities": []}], ["Fifty years after the implementation of universal newborn screening programs for phenylketonuria, the first disease identified through newborn screening and considered a success story of newborn screening, a cohort of adults with phenylketonuria treated from birth provides valuable information about effects of long-term treatment for inborn errors of metabolism in general, and phenylketonuria specifically.", {"entities": [[81, 96, "DISEASE"], [230, 245, "DISEASE"], [380, 395, "DISEASE"]]}], ["For phenylketonuria, newborn screening allows early implementation of the phenylalanine-restricted diet, eliminating the severe neurocognitive and neuromotor impairment associated with untreated phenylketonuria.", {"entities": [[4, 19, "DISEASE"], [195, 210, "DISEASE"]]}], ["However, executive function impairments and psychiatric problems are frequently reported even for those treated early and continuously with the phenylalanine-restricted diet alone.", {"entities": []}], ["Moreover, a large percentage of adults with phenylketonuria are reported as lost to follow-up by metabolic clinics.", {"entities": [[44, 59, "DISEASE"]]}], ["While a group of experts identified by the National Institutes of Health convenes to update treatment guidelines for phenylketonuria, we explore individual patient, social, and economic factors preventing >70% of adult phenylketonuria patients in the United States from accessing treatment.", {"entities": [[117, 132, "DISEASE"], [219, 234, "DISEASE"]]}], ["As more conditions are identified through newborn screening, factors affecting access to treatment grow in importance, and we must continue to be vigilant in assessing and addressing factors that affect patient treatment outcomes and not just celebrate amelioration of the most severe manifestations of disease.", {"entities": []}], ["Genet Med 2013:15(8):591\u2013599", {"entities": []}], ["Acne vulgaris has an important genetic predisposition, as well as keratosis pilaris.", {"entities": [[0, 4, "DISEASE"], [66, 75, "DISEASE"]]}], ["Clinical observations suggest that patients with keratosis pilaris have less frequent or less severe acne breakouts; however, we found no studies on this regard To determine if the presence of keratosis pilaris is associated with lower prevalence and severity of acne.", {"entities": [[101, 105, "DISEASE"], [263, 267, "DISEASE"], [49, 58, "DISEASE"], [193, 202, "DISEASE"]]}], ["A cross-sectional study was conducted with dermatology outpatients aged between 14 and 35 years.", {"entities": []}], ["We evaluated history and clinical grade of acne, demographic variables, history of atopy, smoking, and use of hormonal contraceptives.", {"entities": [[43, 47, "DISEASE"]]}], ["Two groups were defined by the presence or absence of moderate to severe keratosis pilaris on the arms and were compared by bivariate analysis and by conditional multiple logistic regression.", {"entities": [[73, 82, "DISEASE"]]}], ["We included 158 patients (66% women), with a median age of 23\u00b111 years.", {"entities": []}], ["Twenty-six percent of them had keratosis pilaris, which was associated with a history of atopy (odds ratio [OR]=2.80 [1.36 to 5.75]; p<0.01).", {"entities": [[31, 40, "DISEASE"]]}], ["Acne was present in 66% of subjects, and was related to family history of acne (OR=5.75 [2.47 to 13.37]; p<0.01).", {"entities": [[0, 4, "DISEASE"], [74, 78, "DISEASE"]]}], ["In bivariate and multivariate analysis, the group with keratosis pilaris had a less frequent history of acne (OR=0.32 [0.14 to 0.70]; p<0.01).", {"entities": [[104, 108, "DISEASE"], [55, 64, "DISEASE"]]}], ["The presence of moderate to severe keratosis pilaris on the arms was associated with lower prevalence of acne vulgaris and lower severity of facial lesions in adolescents and young adults.", {"entities": [[105, 109, "DISEASE"], [35, 44, "DISEASE"]]}], ["Notch ligands and receptors have been implicated in helper T cell (Th cell) differentiation.", {"entities": []}], ["Whether Notch signals are involved in differentiation of T helper type 1 (Th1) cells, Th2 cells, or both, however, remains unresolved.", {"entities": []}], ["To clarify the role of Notch in Th cell differentiation, we generated mice that conditionally inactivate Notch signaling in mature T cells.", {"entities": []}], ["Mice that lack Notch signaling in CD4 Trichuris muris.", {"entities": [[34, 37, "GENE"]]}], ["In contrast, they exhibit effective Th1 cell responses and are able to control Leishmania major infection.", {"entities": []}], ["These data demonstrate that Notch signaling is a regulator of type 2 immunity.", {"entities": []}], ["Cardiopulmonary response to unloaded cycling may be related to higher workloads.", {"entities": []}], ["This was assessed in male subjects: 18 healthy sedentary subjects (controls), 14 hypoxemic patients with chronic obstructive pulmonary disease (COPD), and 31 overweight individuals (twelve were hypoxemic).", {"entities": [[105, 142, "DISEASE"]]}], ["They underwent an incremental exercise up to the maximal oxygen uptake (VO 2 max), preceded by a 2\u2009min unloaded cycling period.", {"entities": [[77, 80, "GENE"]]}], ["Oxygen uptake (VO 2 ), heart rate (HR), minute ventilation (VE), and respiratory frequency (fR) were averaged every 10\u2009s. At the end of unloaded cycling period, HR increase was significantly accentuated in COPD and hypoxemic overweight subjects (resp., +14 \u00b1 2 and +13 \u00b1 1.5\u2009min 2 max.", {"entities": [[35, 37, "GENE"], [161, 163, "GENE"], [35, 37, "GENE"], [161, 163, "GENE"], [281, 284, "GENE"]]}], ["Measurement of ventilation during unloaded cycling may serve to predict the ventilatory performance of COPD patients and overweight subjects during an exercise rehabilitation program.", {"entities": []}], ["Airflow limitation frequently leads to the interruption of activities of daily living (ADL) in patients with Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["These patients commonly show absence of ventilatory reserve, reduced inspiratory reserve volume, and dynamic hyperinflation (DH).", {"entities": []}], ["To investigate ventilatory response and DH induced by three ADL-based protocols in COPD patients and compare them to healthy subjects.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["COPD group: 23 patients (65\u00b16 years, FEV 1 37.2\u00b115.4%pred); control group: 14 healthy subjects (64\u00b14 years) matched for age, sex, and body mass index.", {"entities": [[37, 40, "GENE"]]}], ["Both groups performed all three tests: Glittre-ADL test; an activity test that involved moving objects on a shelf (T SHELF ); and a modified shelf protocol isolating activity with upper limbs (T SHELF-M ).", {"entities": []}], ["Ventilatory response and inspiratory capacity were evaluated.", {"entities": []}], ["Baseline ventilatory variables were similar between groups (p>0.05).", {"entities": []}], ["The ventilatory demand increased and the inspiratory capacity decreased significantly at the end of the tests in the COPD group.", {"entities": []}], ["Ventilatory demand and DH were higher (p<0.05) in the T SHELF than in the T SHELF\u2013M in the COPD group (p<0.05).", {"entities": []}], ["There were no differences in DH between the three tests in the control group (p>0.05) and ventilatory demand increased at the end of the tests (p<0.05) but to a lower extent than the COPD group.", {"entities": []}], ["The T SHELF induces similar ventilatory responses to the Glittre-ADL test in COPD patients with higher ventilatory demand and DH.", {"entities": []}], ["In contrast, the ventilatory response was attenuated in the T SHELF-M , suggesting that squatting and bending down during the Glittre-ADL test could trigger significant ventilatory overload.", {"entities": []}], ["Spices traditionally have been used as coloring agents, flavoring agents, preservatives, food additives and medicine in Bangladesh.", {"entities": []}], ["The present work aimed to find out the antimicrobial activity of natural spices on multi-drug resistant Escherichia coli isolates.", {"entities": []}], ["Anti-bacterial potentials of six crude plant extracts ( Allium sativum , Zingiber officinale , Allium cepa , Coriandrum sativum , Piper nigrum and Citrus aurantifolia ) were tested against five Escherichia coli isolated from potable water sources at kushtia, Bangladesh.", {"entities": []}], ["All the bacterial isolates were susceptible to undiluted lime-juice.", {"entities": []}], ["None of them were found to be susceptible against the aqueous extracts of garlic, onion, coriander, pepper and ginger alone.", {"entities": []}], ["However, all the isolates were susceptible when subjected to 1:1:1 aqueous extract of lime, garlic and ginger.", {"entities": []}], ["The highest inhibition zone was observed with lime (11 mm).", {"entities": []}], ["Natural spices might have anti-bacterial activity against enteric pathogens and could be used for prevention of diarrheal diseases.", {"entities": []}], ["Further evaluation is necessary.", {"entities": []}], ["The purpose of this study is to determine whether Hispanic ethnic concentration is associated with a higher prevalence of obesity and, if this relationship exists, whether it is affected by the socioeconomic environment.", {"entities": [[122, 129, "DISEASE"]]}], ["The study uses the Texas Behavioral Risk Factor Surveillance System (BRFSS) linked to 2000 census data to access the relationship between prevalence of obesity, Hispanic ethnic concentration, poverty and level of education at a county-level.", {"entities": [[152, 159, "DISEASE"]]}], ["The findings suggest that the association of Hispanic ethnic concentration and obesity varies by socioeconomic environment.", {"entities": [[79, 86, "DISEASE"]]}], ["Although little influence was observed for % poverty, the relationship between Hispanic ethnic concentration and obesity differed by county-level educational attainment.", {"entities": [[113, 120, "DISEASE"]]}], ["High proportion of residents with a bachelor\u2019s degree is associated with a low prevalence of obesity; counties with both high % Hispanic and high % with Bachelor\u2019s degrees had the lowest prevalence of obesity.", {"entities": [[93, 100, "DISEASE"], [201, 208, "DISEASE"]]}], ["Our results suggest that promoting and improving education, perhaps including training on healthful living, may serve as an effective means of curbing current obesity trends and associated health problems in Hispanic and possibly other ethnic communities.", {"entities": [[159, 166, "DISEASE"]]}], ["Animal models published within the past 18 months on asthma, food allergy and anaphylaxis, all conditions of rising public health concern, were reviewed.", {"entities": [[61, 73, "DISEASE"], [53, 59, "DISEASE"]]}], ["While domestic animals spontaneously develop asthma, food allergy and anaphylaxis, in animal models, divergent sensitization and challenge routes, dosages, intervals and antigens are used to induce asthmatic, food allergic or anaphylactic phenotypes.", {"entities": [[53, 65, "DISEASE"], [45, 51, "DISEASE"]]}], ["This must be considered in the interpretation of results.", {"entities": []}], ["Instead of model antigens, gradually relevant allergens such as house dust mite in asthma, and food allergens like peanut, apple and peach in food allergy research were used.", {"entities": [[142, 154, "DISEASE"], [83, 89, "DISEASE"]]}], ["Novel engineered mouse models such as a mouse with a T-cell receptor for house dust mite allergen Der p 1, or with transgenic human hFc\u03b3R genes, facilitated the investigation of single molecules of interest.", {"entities": []}], ["Whole-body plethysmography has become a state-of-the-art in-vivo readout in asthma research.", {"entities": [[76, 82, "DISEASE"]]}], ["In food allergy and anaphylaxis research, novel techniques were developed allowing real-time monitoring of in-vivo effects following allergen challenge.", {"entities": [[3, 15, "DISEASE"]]}], ["Networks to share tissues were established as an effort to reduce animal experiments in allergy which cannot be replaced by in-vitro measures.", {"entities": []}], ["Natural and artificial animal models were used to explore the pathophysiology of asthma, food allergy and anaphylaxis and to improve prophylactic and therapeutic measures.", {"entities": [[89, 101, "DISEASE"], [81, 87, "DISEASE"]]}], ["Especially the novel mouse models mimicking molecular aspects of the complex immune network in asthma, food allergy and anaphylaxis will facilitate proof-of-concept studies under controlled conditions.", {"entities": [[103, 115, "DISEASE"], [95, 101, "DISEASE"]]}], ["We demonstrated that angiotensin II type 2 (AT 2 ) receptor-interacting protein (ATIP) 1 ameliorates inflammation-mediated vascular remodeling independent of the AT 2 receptor, leading us to explore the possibility of whether ATIP1 could exert anti-inflammatory effects and play a role in other pathophysiological conditions.", {"entities": []}], ["We examined the possible anti-inflammatory effects of ATIP1 in adipose tissue associated with amelioration of insulin resistance.", {"entities": []}], ["In mice fed a high-cholesterol diet, adipose tissue macrophage (ATM) infiltration and M1-to-M2 ratio were decreased in ATIP1 transgenic mice (ATIP1-Tg) compared with wild-type mice (WT), with decreased expression of inflammatory cytokines such as tumor necrosis factor-\u03b1 and monocyte chemoattractant protein-1 in white adipose tissue (WAT), but an increase in interleukin-10, an anti-inflammatory cytokine.", {"entities": [[64, 67, "GENE"]]}], ["Moreover, 2-[", {"entities": []}], ["Since 2007 the Danish Health and Medicines Authority has advised total alcohol abstinence from the time of trying to conceive and throughout pregnancy.", {"entities": []}], ["The prevalence of binge drinking among pregnant Danish women has nevertheless been reported to be up to 48\u00a0% during early pregnancy.", {"entities": []}], ["Since the introduction of the recommendation of total abstinence, no studies have examined pre-pregnancy lifestyle and reproductive risk factors associated with this behaviour in a Danish context.", {"entities": []}], ["The aims of this study were therefore to describe the prevalence of weekly alcohol consumption and binge drinking in early pregnancy among women living in the capital of Denmark.", {"entities": []}], ["Secondly to identify pre-pregnancy lifestyle and reproductive risk factors associated with binge drinking during early pregnancy.", {"entities": []}], ["Data were collected from September 2012 to August 2013 at the Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.", {"entities": []}], ["Self-reported information on each woman\u2019s socio-demographic characteristics, medical history, and lifestyle factors including alcohol habits was obtained from an electronic questionnaire filled out as part of the individual medical record.", {"entities": []}], ["Descriptive analysis was conducted and multivariate logistic regression analysis was used to assess the potential associated risk factors (adjusted odds ratio (aOR)).", {"entities": []}], ["Questionnaires from 3,238 women were included.", {"entities": []}], ["A majority of 70\u00a0%, reported weekly alcohol consumption before pregnancy.", {"entities": []}], ["The prevalence decreased to 3\u00a0% during early pregnancy.", {"entities": []}], ["The overall proportion of women reporting binge drinking during early pregnancy was 35\u00a0% ( n\u2009= \u20091,134).", {"entities": []}], ["The following independent risk factors for binge drinking in early pregnancy were identified: lower degree of planned pregnancy, smoking and alcohol habits before pregnancy ((1 unit/weekly aOR 4.48, CI: 3.14 - 6.40), (2\u20137 units aOR 10.23, CI: 7.44-14.06), (\u22658 units aOR 33.18, CI: 19.53-56.36)).", {"entities": []}], ["Multiparity and the use of assisted reproductive technology were associated with lower odds of binge drinking in early pregnancy.", {"entities": []}], ["The prevalence of weekly alcohol consumption decreased considerably during early pregnancy compared with pre-pregnancy levels.", {"entities": []}], ["Nevertheless one third of the pregnant women engaged in binge drinking.", {"entities": []}], ["Identification of risk factors for this behaviour renders it possible not only to design prevention strategies, but also to target those most at risk.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-015-0757-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Citral, eucalyptol, and linalool are widely used as flavorings, fragrances, and cosmetics.", {"entities": []}], ["Here, we examined their effects on electrophysiological and binding properties of human 5-HT 3 receptors expressed in Xenopus oocytes and human embryonic kidney 293 cells, respectively.", {"entities": []}], ["Data were analyzed using nonlinear mixed-effects modeling to account for random variance in the peak current response between oocytes.", {"entities": []}], ["The oils caused an insurmountable inhibition of 5\u2010HT\u2013evoked currents (citral IC 50 = 120 \u00b5 M; eucalyptol = 258 \u00b5 M; linalool = 141 \u00b5 M) and did not compete with fluorescently labeled granisetron, suggesting a noncompetitive mechanism of action.", {"entities": []}], ["Inhibition was not use\u2010dependent but required a 30-second preapplication.", {"entities": []}], ["Compound washout caused a slow (\u223c180 seconds) but complete recovery.", {"entities": []}], ["Coapplication of the oils with bilobalide or diltiazem indicated they did not bind at the same locations as these channel blockers.", {"entities": []}], ["Homology modeling and ligand docking predicted binding to a transmembrane cavity at the interface of adjacent subunits.", {"entities": []}], ["Liquid chromatography coupled to mass spectrometry showed that an essential oil extracted from Lippia alba contained 75.9% citral.", {"entities": []}], ["This inhibited expressed 5\u2010HT 3 receptors (IC 50 = 45 \u00b5 g ml 50 = 200 \u00b5 g ml 50 = 20 \u00b5 g ml 3 receptors, and their binding to a conserved cavity suggests a valuable target for novel allosteric modulators.", {"entities": []}], ["To our knowledge, no studies of the possible association of early life environment with snoring in adulthood have been published.", {"entities": []}], ["We aimed to investigate whether early life environment is associated with snoring later in life.", {"entities": []}], ["A questionnaire including snoring frequency in adulthood and environmental factors in early life was obtained from 16,190 randomly selected men and women, aged 25\u201354 years, in Sweden, Norway, Iceland, Denmark and Estonia (response rate 74%).", {"entities": []}], ["A total of 15,556 subjects answered the questions on snoring.", {"entities": []}], ["Habitual snoring, defined as loud and disturbing snoring at least 3 nights a week, was reported by 18%.", {"entities": []}], ["Being hospitalized for a respiratory infection before the age of two years (adjusted odds ratio (OR) = 1.27; 95% confidence interval (CI) 1.01\u20131.59), suffering from recurrent otitis as a child (OR = 1.18; 95%CI 1.05\u20131.33), growing up in a large family (OR = 1.04; 95%CI 1.002\u20131.07) and being exposed to a dog at home as a newborn (OR = 1.26; 95%CI 1.12\u20131.42) were independently related to snoring later in life and independent of a number of possible confounders in adulthood.", {"entities": []}], ["The same childhood environmental factors except household size were also related with snoring and daytime sleepiness combined.", {"entities": []}], ["The predisposition for adult snoring may be partly established early in life.", {"entities": []}], ["Having had severe airway infections or recurrent otitis in childhood, being exposed to a dog as a newborn and growing up in a large family are environmental factors associated with snoring in adulthood.", {"entities": []}], ["Through characterising the geographic and functional spectrum of human genetic variation, the 1000 Genomes Project aims to build a resource to help understand the genetic contribution to disease.", {"entities": []}], ["We describe the genomes of 1,092 individuals from 14 populations, constructed using a combination of low-coverage whole-genome and exome sequencing.", {"entities": []}], ["By developing methodologies to integrate information across multiple algorithms and diverse data sources we provide a validated haplotype map of 38 million SNPs, 1.4 million indels and over 14 thousand larger deletions.", {"entities": []}], ["We show that individuals from different populations carry different profiles of rare and common variants and that low-frequency variants show substantial geographic differentiation, which is further increased by the action of purifying selection.", {"entities": []}], ["We show that evolutionary conservation and coding consequence are key determinants of the strength of purifying selection, that rare-variant load varies substantially across biological pathways and that each individual harbours hundreds of rare non-coding variants at conserved sites, such as transcription-factor-motif disrupting changes.", {"entities": []}], ["This resource, which captures up to 98% of accessible SNPs at a frequency of 1% in populations of medical genetics focus, enables analysis of common and low-frequency variants in individuals from diverse, including admixed, populations.", {"entities": []}], ["Circulating levels of the inflammatory marker YKL-40 are elevated in cardiovascular disease and obesity-related type 2 diabetes (T2D), and serum YKL-40 levels are related to elements of dyslipidaemia.", {"entities": [[96, 103, "DISEASE"]]}], ["We aimed to investigate the associations between serum YKL-40 and obesity-related traits in a Danish sample of non-diabetic relatives to T2D patients and, furthermore, to estimate the heritability of YKL-40.", {"entities": [[66, 73, "DISEASE"]]}], ["324 non-diabetic individuals with family relation to a T2D patient were included in the study.", {"entities": []}], ["The participants underwent oral- and intravenous glucose tolerance tests for estimation of glucose tolerance and surrogate measures of insulin sensitivity.", {"entities": []}], ["Anthropometric measures were retrieved and biochemical measures of the plasma lipid profile and serum YKL-40 levels were obtained.", {"entities": []}], ["Association-analyses between serum YKL-40 and obesity-related traits and estimates of the narrow sense heritability of YKL-40 were based on a polygenic variance component model.", {"entities": [[46, 53, "DISEASE"]]}], ["Fasting serum levels of YKL-40 were positively associated with waist-hip-ratio (p<0.001) and fasting plasma triglyceride levels (p<0.001).", {"entities": []}], ["None of the insulin sensitivity indexes were significantly associated with YKL-40.", {"entities": []}], ["According to the AE model, the familiality-estimate h h Our results suggest a role of serum YKL-40 in obesity-related low grade inflammation, but do not indicate that YKL-40 is directly involved in the development of T2D.", {"entities": [[102, 109, "DISEASE"]]}], ["TSLP has been shown to be associated with eosinophilic esophagitis (EoE).", {"entities": [[55, 66, "DISEASE"], [42, 66, "DISEASE"], [0, 4, "GENE"]]}], ["Specifically, children with EoE often have the nucleotides AA or AG instead of GG at the single nucleotide polymorphism position RS3806932.", {"entities": []}], ["Presently, the phenotypic characteristics in EoE children with the TSLP EoE risk allele are unknown.", {"entities": [[67, 71, "GENE"]]}], ["A retrospective analysis was performed of all children with EoE who had TSLP genotyping at The Children\u2019s Hospital of Philadelphia from 2008\u20132014.", {"entities": [[72, 76, "GENE"]]}], ["EoE food allergen triggers, presence of atopic features, IgE mediated food allergy and skin prick testing results were reviewed.", {"entities": [[70, 82, "DISEASE"]]}], ["The number and type of EoE food allergen triggers were compared with genotype using chi-square analysis.", {"entities": []}], ["Primary cell cultures from EoE patients with or without the risk allele were stimulated with ovalbumin and TSLP secretion was measured by ELISA.", {"entities": [[107, 111, "GENE"]]}], ["Fifty three of 309 patients were found to have no copies of the TSLP risk allele, whereas 256 patients were found to have one or more copies of the risk allele.", {"entities": [[64, 68, "GENE"]]}], ["There was an increase in the number of patients with three or more EoE food allergens among those who were either homozygous or heterozygous for the risk allele compared to those without the risk allele ( P \u2009<\u20090.0001).", {"entities": []}], ["This was independent of their atopic background.", {"entities": []}], ["Primary cultures from patients homozygous for the risk allele had greater TSLP secretion than those isolated from heterozygous patients.", {"entities": [[74, 78, "GENE"]]}], ["The TSLP risk allele is associated with having multiple EoE food allergen triggers.", {"entities": [[4, 8, "GENE"]]}], ["This novel EoE genotypic-phenotypic correlation may guide future treatment for those with the TSLP risk allele.", {"entities": [[94, 98, "GENE"]]}], ["Influenza vaccine effectiveness (VE) and coverage data for sub-Saharan Africa are scarce.", {"entities": [[0, 9, "DISEASE"]]}], ["Using a test-negative case\u2013control design, we estimated influenza VE annually among individuals with influenza-like illness presenting to an outpatient sentinel surveillance programme in South Africa from 2010 to 2013.", {"entities": [[56, 65, "DISEASE"], [101, 110, "DISEASE"]]}], ["A knowledge, attitudes and practices (KAP) influenza vaccine survey of programme clinicians was conducted in 2013.", {"entities": [[43, 52, "DISEASE"]]}], ["In total, 9420 patients were enrolled in surveillance of whom 5344 (56.7%) were included in the VE analysis: 2678 (50.1%) were classified as controls (influenza test-negative) and 2666 (49.9%) as cases (influenza test-positive).", {"entities": [[151, 160, "DISEASE"], [203, 212, "DISEASE"]]}], ["Mean annual influenza vaccine coverage among controls was 4.5% for the four years.", {"entities": [[12, 21, "DISEASE"]]}], ["Annual VE estimates adjusted for age, underlying medical conditions and seasonality for 2010-2013 were 54.2% (95% confidence interval (CI): 2.4\u201378.6%), 57.1% (95% CI: 15.5\u201378.2%), 38.4% (95% CI: \u221271.7\u201378.1%) and 87.2% (95% CI: 67.2\u201395.0%), respectively.", {"entities": []}], ["The KAP survey showed that >90% of clinicians were familiar with the indications for and the benefits of influenza vaccination.", {"entities": [[105, 114, "DISEASE"]]}], ["Our study showed that the vaccine was significantly protective in 2010, 2011 and 2013, but not in 2012 when the circulating A(H3N2) strain showed genetic drift.", {"entities": []}], ["Vaccine coverage was low despite good clinician knowledge of vaccination indications.", {"entities": []}], ["Further studies are needed to investigate the reason for the low uptake of influenza vaccine.", {"entities": [[75, 84, "DISEASE"]]}], ["Cancer cells exist in a state of Darwinian selection using mechanisms that produce changes in gene expression through genetic and epigenetic alteration to facilitate their survival.", {"entities": [[0, 6, "DISEASE"]]}], ["Cellular plasticity, or the ability to alter cellular phenotype, can assist in survival of premalignant cells as they progress to full malignancy by providing another mechanism of adaptation.", {"entities": []}], ["The connection between cellular stress and the progression of cancer has been established, although the details of the mechanisms have yet to be fully elucidated.", {"entities": [[62, 68, "DISEASE"]]}], ["The molecular chaperone HSP90 is often upregulated in cancers as they progress, presumably to allow cancer cells to deal with misfolded proteins and cellular stress associated with transformation.", {"entities": [[100, 106, "DISEASE"]]}], ["The objective of this work is to test the hypothesis that inhibition of HSP90 results in increased cell plasticity in mammalian systems that can confer a greater adaptability to selective pressures.", {"entities": []}], ["The approach used is a murine in vitro model system of hematopoietic differentiation that utilizes a murine hematopoietic stem cell line, erythroid myeloid lymphoid (EML) clone 1, during their maturation from stem cells to granulocytic progenitors.", {"entities": []}], ["During the differentiation protocol, 80%\u201390% of the cells die when placed in medium where the major growth factor is granulocyte\u2013macrophage-colony stimulating factor.", {"entities": []}], ["Using this selection point model, EML cells exhibit increases in cellular plasticity when they are better able to adapt to this medium and survive.", {"entities": []}], ["Increases in cellular plasticity were found to occur upon exposure to geldanamycin to inhibit HSP90, when subjected to various forms of cellular stress, or inhibition of histone acetylation.", {"entities": []}], ["Furthermore, we provide evidence that the cellular plasticity associated with inhibition of HSP90 in this model involves epigenetic mechanisms and is dependent upon high levels of stem cell factor signaling.", {"entities": []}], ["This work provides evidence for a role of HSP90 and cellular stress in inducing phenotypic plasticity in mammalian systems that has new implications for cellular stress in progression and evolution of cancer.", {"entities": [[201, 207, "DISEASE"]]}], ["Extracellular nucleotides are ubiquitous signalling molecules, acting via the P2 class of surface receptors.", {"entities": []}], ["Platelets express three P2 receptor subtypes, ADP-dependent P2Y1 and P2Y12 G-protein-coupled receptors and the ATP-gated P2X1 non-selective cation channel.", {"entities": []}], ["Platelet P2X1 receptors can generate significant increases in intracellular Ca IIb \u03b2 3 integrin activation.", {"entities": []}], ["P2X1 can also synergise with several other receptors to amplify signalling and functional events in the platelet.", {"entities": []}], ["In particular, activation of P2X1 receptors by ATP released from dense granules amplifies the aggregation responses to low levels of the major agonists, collagen and thrombin.", {"entities": []}], ["In vivo studies using transgenic murine models show that P2X1 receptors amplify localised thrombosis following damage of small arteries and arterioles and also contribute to thromboembolism induced by intravenous co-injection of collagen and adrenaline.", {"entities": []}], ["In vitro, under flow conditions, P2X1 receptors contribute more to aggregate formation on collagen-coated surfaces as the shear rate is increased, which may explain their greater contribution to localised thrombosis in arterioles compared to venules within in vivo models.", {"entities": []}], ["Since shear increases substantially near sites of stenosis, anti-P2X1 therapy represents a potential means of reducing thrombotic events at atherosclerotic plaques.", {"entities": []}], ["Obstructive respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) are currently treated by inhaled anti-inflammatory and bronchodilator drugs.", {"entities": [[49, 86, "DISEASE"], [38, 44, "DISEASE"]]}], ["Despite the availability of multiple treatments, both diseases are growing public health concerns.", {"entities": []}], ["The majority of asthma patients are well controlled on current inhaled therapies but a substantial number of patients with severe asthma are not.", {"entities": [[16, 22, "DISEASE"], [130, 136, "DISEASE"]]}], ["Asthma affects an estimated 300 million people worldwide and approximately 20 percent have a severe form of the disease.", {"entities": [[0, 6, "DISEASE"]]}], ["In contrast to asthma, there are few effective therapies for COPD.", {"entities": [[15, 21, "DISEASE"]]}], ["An estimated 10% of the population has COPD and the trend in death rates is increasing for COPD while decreasing for other major diseases.", {"entities": []}], ["Although developing drugs for inhaled delivery is challenging, the nose-only inhalation unit enables direct delivery of novel drugs to the lung of rodents for pre-clinical efficacy and safety/toxicology studies.", {"entities": []}], ["Inhaled drug delivery has multiple advantages for respiratory diseases, where high concentration in the lung improves efficacy and minimizes systemic side effects.", {"entities": []}], ["Inhaled corticosteroids and bronchodilators benefit from these advantages and inhaled delivery may also hold potential for future biologic therapies.", {"entities": []}], ["The inhalation unit described herein can generate, sample for characterization, and uniformly deposit a drug aerosol in the lungs of rodents.", {"entities": []}], ["This enables the pre-clinical determination of the efficacy and safety of drug doses deposited in the lungs of rodents, key data required before initiating clinical development.", {"entities": []}], ["Respiratory rate (RR) is an important vital sign which is strongly correlated with in-hospital mortality.", {"entities": []}], ["At the same time, RR is the most likely vital sign to be omitted when assessing a patient.", {"entities": []}], ["We believe that one reason for this could be the difficulty in measure the RR, since it is not read off a monitor, but counted manually.", {"entities": []}], ["Also there is the possibility of assessment bias and the inter-observer reliability becomes important.", {"entities": []}], ["We therefore set out to investigate how the nursing staff counting the actual number of respirations per minute would agree with the nursing staff using a predefined ordinal scale.", {"entities": []}], ["For this prospective study, we recorded five videos of a young healthy man breathing approximately 5, 10, 15, 30 and 60 times per minute.", {"entities": []}], ["The videos were shown in a random order to a suitable sample of the nursing staff.", {"entities": []}], ["The participants were randomized into two groups; one to count the exact number of breaths per minute, and one to use a predefined ordinal scale.", {"entities": []}], ["Comparing the exact number of breaths per minute, the Intra Class Coefficient (ICC) was 0.99 (95% CI: 0.97\u20131.00).", {"entities": []}], ["Comparing the RR using the predefined scale, the overall Kappa Fleiss Coefficient was 0.75.", {"entities": []}], ["The inter-observer agreement was high when comparing the use of the actual number of breaths per minute and substantial when comparing the use of the predefined scale.", {"entities": []}], ["This is the largest inter-observer study on RR to date.", {"entities": []}], ["However, further studies on the use of scaled comparisons of RR are needed.", {"entities": []}], ["Neutrophil-dominated inflammation plays an important role in many airway diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis and cystic fibrosis.", {"entities": [[100, 137, "DISEASE"], [164, 179, "DISEASE"], [92, 98, "DISEASE"], [146, 159, "DISEASE"]]}], ["In cases of asthma where neutrophil-dominated inflammation is a major contributing factor to the disease, treatment with corticosteroids can be problematic as corticosteroids have been shown to promote neutrophil survival which, in turn, accentuates neutrophilic inflammation.", {"entities": [[12, 18, "DISEASE"]]}], ["In light of such cases, novel targeted medications must be developed that could control neutrophilic inflammation while still maintaining their antibacterial/anti-fungal properties, thus allowing individuals to maintain effective innate immune responses to invading pathogens.", {"entities": []}], ["The aim of this review is to describe the molecular mechanisms of neutrophil apoptosis and how these pathways are modulated by glucocorticoids.", {"entities": []}], ["These new findings are of potential clinical value and provide further insight into treatment of neutrophilic inflammation in lung disease.", {"entities": [[126, 138, "DISEASE"]]}], ["The fast pace of technological improvement and the rapid development and adoption of healthcare applications present crucial challenges for clinicians, users and policy makers.", {"entities": []}], ["Some of the most pressing dilemmas include the need to ensure the safety of applications and establish their cost-effectiveness while engaging patients and users to optimize their integration into health decision-making.", {"entities": []}], ["Healthcare organizations need to consider the risk of fragmenting clinical practice within the organization as a result of too many apps being developed or used, as well as mechanisms for app integration into the wider electronic health records through development of governance framework for their use.", {"entities": [[188, 191, "GENE"]]}], ["The impact of app use on the interactions between clinicians and patients needs to be explored, together with the skills required for both groups to benefit from the use of apps.", {"entities": [[14, 17, "GENE"]]}], ["Although healthcare and academic institutions should support the improvements offered by technological advances, they must strive to do so within robust governance frameworks, after sound evaluation of clinical outcomes and examination of potential unintended consequences.", {"entities": []}], ["Legionella pneumonia can appear with different levels of severity and it can often present with complications such as acute respiratory distress syndrome.", {"entities": [[11, 20, "DISEASE"], [145, 153, "DISEASE"]]}], ["We report the case of a 44-year-old Caucasian man with Legionella pneumonia with successive development of severe acute respiratory distress syndrome.", {"entities": [[66, 75, "DISEASE"], [141, 149, "DISEASE"]]}], ["During his stay in intensive care the clinical and radiological situation of the previously observed acute respiratory distress syndrome unexpectedly worsened due to acute pulmonary eosinophilic infiltrate of iatrogenic origin.", {"entities": [[128, 136, "DISEASE"]]}], ["Levofloxacin treatment caused the occurrence of acute eosinophilic infiltrate.", {"entities": []}], ["Diagnosis was possible following bronchoscopic examination using bronchoaspirate and transbronchial biopsy.", {"entities": []}], ["Supplemental Digital Content is available in the text Transit buses are used by millions of commuters every day, but they emit toxic diesel fumes.", {"entities": []}], ["In 1988, the U.S. Environmental Protection Agency implemented emission standards for transit buses, which have been continually updated.", {"entities": []}], ["Yet there is no quantitative evidence of the health benefits from these bus pollution policies due to data constraints and confounding variables.", {"entities": []}], ["In this study, a quasi-experiment is used to exploit the geographic and temporal variation in emission standards by using bus vintage as a proxy for bus emissions.", {"entities": []}], ["This is accomplished using a unique, rich panel data set, which includes daily information on bus vintage and route for the New York City Transit bus fleet between 2006 and 2009.", {"entities": []}], ["This information is merged with daily data on emergency department (ED) visits for respiratory illnesses, which include patients\u2019 residences at the census block level and exact admission date.", {"entities": []}], ["Economic benefits resulting from these bus pollution policies are then estimated.", {"entities": []}], ["Results show that stricter transit bus emission standards by the U.S. Environmental Protection Agency for particulate matter are associated with reduced ED visits for respiratory diseases for patients living within a few hundred feet of a bus route.", {"entities": []}], ["These findings demonstrate that bus pollution policies have made critical improvements to public health.", {"entities": []}], ["Sulfonation is one of the most abundant cellular reactions modifying a wide range of xenobiotics as well as endogenous molecules which regulate important biological processes including blood clotting, formation of connective tissues, and functionality of secreted proteins, hormones, and signaling molecules.", {"entities": []}], ["Sulfonation is ubiquitous in all tissues and widespread in nature (plants, animals, and microorganisms).", {"entities": []}], ["Although sulfoconjugates were discovered over a century ago when, in 1875, Baumann isolated phenyl sulfate in the urine of a patient given phenol as an antiseptic, the significance of sulfonation and its roles in human diseases have been underappreciated until recent years.", {"entities": []}], ["Here, we provide a current overview of the significance of sulfonation reactions in a variety of biological functions and medical conditions (with emphasis on cancer).", {"entities": [[159, 165, "DISEASE"]]}], ["We also discuss research areas that warrant further attention if we are to fully understand how deficiencies in sulfonation could impact human health which, in turn, could help define treatments to effect improvements in health.", {"entities": []}], ["Variable decelerations are the most frequent fetal heart rate changes that are related to labor.", {"entities": []}], ["The objective of the study was to estimate the impact of non-significant variable decelerations (NSV) appearing during the latent phase of labor on delivery mode and neonatal outcome.", {"entities": []}], ["Women at term, who were in the latent phase of labor and had a singleton pregnancy, were prospectively included.", {"entities": []}], ["Women were divided into three groups.", {"entities": []}], ["All had a fetal heart rate tracing with normal baseline and variability.", {"entities": []}], ["The study group was composed of women who had in addition NSV, Category II, according to the National Institute of Child Health and Human Development categorization system.", {"entities": []}], ["Women who had Category I tracings composed the control group.", {"entities": []}], ["Women who had non-repetitive severe variables (SV) composed a second control group (Category II-SV).", {"entities": []}], ["Main outcome compared was mode of delivery.", {"entities": []}], ["Secondary outcome was cord pH.", {"entities": []}], ["One-way analysis of variance was used to compare the continuous demographic and clinical variables of the three groups.", {"entities": []}], ["Backwards stepwise logistic regression using significant univariables was performed to determine which predicted operative delivery.", {"entities": []}], ["P < 0.05 was considered significant.", {"entities": []}], ["Of 1005 women who delivered during the study period 186 had Category II- NSV tracings (study group), 76 had Category II-SV and 251 had Category I tracings.", {"entities": []}], ["Mode of delivery and indications for operative delivery were similar between women in Category II-NSV compared to Category I.", {"entities": []}], ["In addition mean cord pH did not differ between the two groups.", {"entities": []}], ["Conversely, women in Category II-SV, had a higher rate of cesarean or vacuum deliveries compared to the other groups (p = 0.0001).", {"entities": []}], ["Beside, they had a significantly higher number of neonates born with cord pH between 7.0 to 7.1 (p = 0.03).", {"entities": []}], ["Non-significant variable decelerations in early stages of labor are probably a non-ominous sign for neonatal outcome and have no impact on delivery mode.", {"entities": []}], ["The proteolytic activity of a disintegrin and metalloproteinase 10 (ADAM10) regulates cell-fate decisions in Drosophila and mouse embryos.", {"entities": [[68, 74, "GENE"]]}], ["However, in utero lethality of ADAM10", {"entities": [[31, 37, "GENE"]]}], ["Better insights into health care utilization and out-of-pocket expenditures for non-communicable chronic diseases (NCCD) are needed to develop accessible health care and limit the increasing financial burden of NCCDs in Sub-Saharan Africa.", {"entities": []}], ["A household survey was conducted in rural Kwara State, Nigeria, among 5,761 individuals.", {"entities": []}], ["Data were obtained using biomedical and socio-economic questionnaires.", {"entities": []}], ["Health care utilization, NCCD-related health expenditures and distances to health care providers were compared by sex and by wealth quintile, and a Heckman regression model was used to estimate health expenditures taking selection bias in health care utilization into account.", {"entities": []}], ["The prevalence of NCCDs in our sample was 6.2%.", {"entities": []}], ["NCCD-affected individuals from the wealthiest quintile utilized formal health care nearly twice as often as those from the lowest quintile (87.8% vs 46.2%, p = 0.002).", {"entities": []}], ["Women reported foregone formal care more often than men (43.5% vs. 27.0%, p = 0.058).", {"entities": []}], ["Health expenditures relative to annual consumption of the poorest quintile exceeded those of the highest quintile 2.2-fold, and the poorest quintile exhibited a higher rate of catastrophic health spending (10.8% among NCCD-affected households) than the three upper quintiles (4.2% to 6.7%).", {"entities": []}], ["Long travel distances to the nearest provider, highest for the poorest quintile, were a significant deterrent to seeking care.", {"entities": []}], ["Using distance to the nearest facility as instrument to account for selection into health care utilization, we estimated out-of-pocket health care expenditures for NCCDs to be significantly higher in the lowest wealth quintile compared to the three upper quintiles.", {"entities": []}], ["Facing potentially high health care costs and poor accessibility of health care facilities, many individuals suffering from NCCDs\u2014particularly women and the poor\u2014forego formal care, thereby increasing the risk of more severe illness in the future.", {"entities": []}], ["When seeking care, the poor spend less on treatment than the rich, suggestive of lower quality care, while their expenditures represent a higher share of their annual household consumption.", {"entities": []}], ["This calls for targeted interventions that enhance health care accessibility and provide financial protection from the consequences of NCCDs, especially for vulnerable populations.", {"entities": []}], ["The 23-valent polysaccharide pneumococcal vaccine (PPV) is currently recommended in elderly and high-risk adults.", {"entities": []}], ["However, its efficacy in preventing pneumococcal infections remains controversial.", {"entities": []}], ["This study assessed the clinical effectiveness of vaccination against invasive pneumococcal disease (IPD) among people over 60 years.", {"entities": []}], ["Population-based case-control study that included 88 case patients over 60 years-old with a laboratory-confirmed IPD (bacteraemic pneumonia, meningitis or sepsis) and 176 outpatient control subjects who were matched by primary care centre, age, sex and risk stratum.", {"entities": [[130, 139, "DISEASE"], [141, 151, "DISEASE"]]}], ["Adjusted odds ratios (ORs) for vaccination were calculated using conditional logistic regression, controlling for underlying conditions.", {"entities": []}], ["Vaccine effectiveness was estimated as (1 - OR) \u00d7100.", {"entities": []}], ["Pneumococcal vaccination rate was significantly lower in cases than in control subjects (38.6% vs 59.1%; p = 0.002).", {"entities": []}], ["The adjusted vaccine effectiveness was 72% (OR: 0.28; 95% CI: 0.15-0.54) against all IPD and 77% (OR: 0.23; 95% CI: 0.08-0.60) against vaccine-type IPD.", {"entities": []}], ["Vaccination was significantly effective against all IPD in both age groups: 60-79 years-old (OR 0.32; 95% CI: 0.14-0.74) and people 80 years or older (OR: 0.29; 95% CI: 0.09-0.91).", {"entities": []}], ["Vaccination appears significantly effective as for high-risk immunocompetent subjects (OR: 0.29; 95% CI: 0.11-0.79) as well as for immunocompromised subjects (OR: 0.12; 95% CI: 0.03-0.53).", {"entities": []}], ["These findings confirm the effectiveness of the 23-valent PPV against IPD, and they also support the benefit of vaccination in preventing invasive infections among high-risk and older people.", {"entities": []}], ["The aim of the research was to analyze the relationships of religious comfort and struggle with state anxiety and satisfaction with life in homosexual and heterosexual samples of men.", {"entities": []}], ["A hundred and eight men aged between 18 and 43 participated in the research in total, 54 declared themselves as homosexual and 54 as heterosexual.", {"entities": []}], ["The Religious Comfort and Strain Scale, the State-Trait Anxiety Inventory and the Satisfaction with Life Scale were applied to the research.", {"entities": []}], ["The results of hierarchical multiple regression analyses revealed that sexual orientation moderated the relationships of religious comfort and struggle with state anxiety and satisfaction with life.", {"entities": []}], ["The highest state anxiety was observed in homosexual participants with high negative social interactions surrounding religion scores.", {"entities": []}], ["Negative religious social interactions with fellow congregants and religious leaders, including disapproval and criticism, create anxiety among homosexual people.", {"entities": []}], ["It seems that homosexual participants are engaged in a trade-off between valued and necessary religious engagement and the harassment and persecution they may be forced to endure in order to access that engagement.", {"entities": []}], ["T-helper cell type 1 (Th1) polarization in chronic immune thrombocytopenia (cITP) has been reported at the protein and mRNA levels.", {"entities": [[58, 74, "DISEASE"]]}], ["We evaluated the impact of Th1/Th2 cytokine and cytokine receptor functional polymorphisms on both susceptibility to, and severity of, cITP.", {"entities": []}], ["We analysed IFN-\u03b3 \u2009+\u2009874\u00a0T/A, IFN-\u03b3R -611G/A, IL-4 -590C/T, and IL-4R\u03b1 Q576R polymorphisms in 126 cITP patients (male/female: 34/92; median age: 47.7\u00a0years) and 202 healthy control donors.", {"entities": []}], ["Genotyping was determined by PCR and direct sequencing.", {"entities": []}], ["The Th1/Th2 ratio was detected in peripheral blood mononuclear cells via flow cytometry.", {"entities": []}], ["cITP patients had a higher frequency of the IL-4R\u03b1 576 non-QQ genotype compared to healthy subjects ( P \u2009=\u20090.04).", {"entities": []}], ["cITP patients with the IFN-\u03b3 +874 non-AA genotype (high expression type) showed more severe thrombocytopenia than those with the AA genotype ( P\u2009< \u20090.05).", {"entities": [[92, 108, "DISEASE"]]}], ["cITP patients had a significantly higher Th1/Th2 ratio than control patients ( P \u2009<\u20090.01); this ratio was inversely correlated with platelet counts.", {"entities": []}], ["Furthermore, patients with both IFN-\u03b3 +874 non-AA genotype (high expression type) and IFN-\u03b3R \u2212 611 non-AA genotype (high-function type) had a significantly higher Th1/Th2 ratio ( P \u2009<\u20090.05).", {"entities": []}], ["The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP.", {"entities": []}], ["Asthma is a chronic disease associated with hyper-responsiveness, obstruction and remodeling of the airways.", {"entities": [[0, 6, "DISEASE"]]}], ["Epithelial-mesenchymal transition (EMT) has an important role in these alterations and may account for the accumulation of subepithelial mesenchymal cells, thus contributing to airway hyperresponsiveness and remodeling.", {"entities": []}], ["Epigallo-catechin-3-gallate (EGCG), which is a type of polyphenol, is the most potent ingredient in green tea, and exhibits antibacterial, antiviral, antioxidative, anticancer and chemopreventive activities.", {"entities": []}], ["Recently, numerous studies have investigated the protective effects of EGCG against asthma and other lung diseases.", {"entities": [[84, 90, "DISEASE"]]}], ["In the present study, the role of EGCG in ovalbumin (OVA)-challenged asthmatic mice was determined.", {"entities": []}], ["In addition, the inhibitory effects of EGCG against transforming growth factor (TGF)-\u03b21-induced EMT and migration of 16HBE cells, and the underlying mechanisms of the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway, were investigated by immunofluorescence, Transwell, wound healing assay and western blot analysis, respectively.", {"entities": []}], ["The results indicated that EGCG may suppress inflammation and inflammatory cell infiltration into the lungs of OVA-challenged asthmatic mice, and may also inhibit EMT via the PI3K/AKT signaling pathway through upregulating the expression of phosphatase and tensin homolog (PTEN) in vivo and in vitro .", {"entities": [[273, 277, "GENE"]]}], ["The present study also revealed the anti-migratory effects of EGCG in TGF-\u03b21-induced 16HBE cells, thus suggesting it may reduce airway remodeling.", {"entities": []}], ["The present study provides a novel insight into understanding the protective effects of EGCG on airway remodeling in asthma, and indicates that EGCG may be useful as an adjuvant therapy for bronchial asthma.", {"entities": [[117, 123, "DISEASE"], [200, 206, "DISEASE"]]}], ["Evaluation of the efficacy of nebulized magnesium sulfate (MgSO 4 ) alone and in combination with salbutamol in acute asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["A double-blind randomized controlled study was conducted in Chest and Emergency Departments.", {"entities": []}], ["Thirty patients of acute attack of bronchial asthma were randomized into three groups: MgSO 4 nebulization (group A), salbutamol nebulization (group B), and their combination (group C).", {"entities": [[45, 51, "DISEASE"]]}], ["All patients were monitored before and after nebulization (each 20 minutes) for peak expiratory flow rate (PEFR), respiratory rate (RR), heart rate (HR), blood pressure, pulsus paradoxus, oxygen saturation, clinical examination, and Fischl index.", {"entities": [[149, 151, "GENE"]]}], ["A highly significant improvement in PEFR, PEFR percentage, and Fischl index and significant decrease in RR and HR was observed in all groups.", {"entities": [[111, 113, "GENE"]]}], ["A similar improvement in PEFR was observed in group A and group B ( P =0.389).", {"entities": []}], ["The difference in peak expiratory flow (PEF) improvement was insignificant between group B and group C ( P =0.101), while there was a significant difference between group A and group C ( P =0.014) in favor of group C. Nebulized MgSO 4 alone or combined with salbutamol has a clinically significant bronchodilator effect in acute asthma and leads to clinical improvement, increase in PEFR, reduction in HR, and reduction in RR.", {"entities": [[329, 335, "DISEASE"], [402, 404, "GENE"]]}], ["The response to nebulized MgSO 4 alone (PEFR improvement 54\u00b135.6 L/min, P =0.001) is comparable ( P =0.389) to that of nebulized salbutamol (PEFR improvement 67.0\u00b141.9 L/min, P =0.001) and is significantly less than ( P =0.014) that of nebulized combination (PEFR improvement 92.0\u00b126.9 L/min, P =0.000).", {"entities": []}], ["Clinical interventions based on collaborative models require effective communication between primary care providers (PCPs) and collaborative support teams.", {"entities": []}], ["Despite growing interest in collaborative care, we have identified no published studies describing how PCPs prefer to communicate and interact with collaborative support teams.", {"entities": []}], ["This manuscript examines the communication and interaction preferences of PCPs participating in an ongoing randomized clinical trial of a collaborative intervention for chronic pain and depression.", {"entities": []}], ["The trial is being conducted in five primary care clinics of a Veterans Affairs Medical Center.", {"entities": []}], ["Twenty-one PCPs randomized to the study intervention completed a survey regarding preferences for interacting with the collaborative support team.", {"entities": []}], ["A majority of PCPs identified email (95%) and telephone calls (68%) as preferred modes for communicating with members of the support team.", {"entities": []}], ["In contrast, only 29% identified in-person communications as preferred.", {"entities": []}], ["Most PCPs preferred that the care manager and physician pain specialist assess patients (76%) and make initial treatment changes (71%) without first conferring with the PCP.", {"entities": []}], ["One-half wanted to be designated cosigners of all support team notes in the electronic medical record, one-half wanted to receive brief and focused information rather than in-depth information about their patients, and one-half wanted their practice nurses automatically included in communications.", {"entities": []}], ["Panel size was strongly associated (p < 0.001) with preference for brief, to-the-point discussions about patients.", {"entities": []}], ["The substantial variation in PCP communication preferences suggests the need for knowledge of these preferences when designing and implementing collaborative interventions.", {"entities": []}], ["Additional research is needed to understand relationships between clinician and practice characteristics and interaction preferences.", {"entities": []}], ["Health outcomes throughout the life course have been linked to fetal growth restriction and low birthweight.", {"entities": []}], ["A variety of measures exist to define low birthweight, with a lack of consensus regarding which predict adverse outcome.", {"entities": []}], ["To evaluate the relationship between birthweight standards and childhood and adult outcomes in term-born infants (\u226537 weeks' gestation).", {"entities": []}], ["MEDLINE (1966\u2013January 2011), EMBASE (1980\u2013January 2011), and the Cochrane Library (2011:1) and MEDION were included.", {"entities": []}], ["Studies comprising live term-born infants (gestation \u226537 completed weeks), with weight or other anthropometric measurements recorded at birth along with childhood and adult outcomes.", {"entities": []}], ["Data were extracted to populate 2 \u00d7 2 tables relating birthweight standard with outcome, and meta-analysis was performed where possible.", {"entities": []}], ["Fifty-nine articles (2 600 383 individuals) were selected.", {"entities": []}], ["There was no significant relationship between birthweight <2.5 kg (odds ratio [OR] 0.98, 95% confidence intervals [CI] 0.87\u20131.10) and composite measure of childhood morbidity.", {"entities": []}], ["Weight <10th centile on the population nomogram showed a small association (OR 1.49, 95% CI 1.02\u20132.19) for the same outcome.", {"entities": []}], ["There was no significant association between either of the above measures and adult morbidity.", {"entities": []}], ["The relationship between other measures and individual outcomes varied.", {"entities": []}], ["The association between low birthweight, by any definition, and childhood and adult morbidity was inconsistent.", {"entities": []}], ["None of the current standards of low birthweight was a good predictor of adverse outcome.", {"entities": []}], ["Introduction.", {"entities": []}], ["Antiepileptic drugs are effective in the treatment of epilepsy to the extent that about 70% of people with epilepsy can be seizure-free, but poor adherence to medication is major problem to sustained remission and functional restoration.", {"entities": []}], ["The aim of this study was to assess the prevalence and associated factors of antiepileptic drug nonadherence.", {"entities": []}], ["Cross-sectional study was conducted on 450 individuals who were selected by systematic random sampling method.", {"entities": []}], ["Antiepileptic drug nonadherence was measured by Morisky Medication Adherence Scale (MMAS) and logistic regression was used to look for significant associations.", {"entities": []}], ["The prevalence of AEDs nonadherence was 37.8%.", {"entities": []}], ["Being on treatment for 6 years and above [AOR = 3.47, 95% CI: 1.88, 6.40], payment for AEDs [AOR = 2.76, 95% CI: 1.73, 4.42], lack of health information [AOR = 2.20, 95% CI: 1.41,3.43], poor social support [AOR = 1.88, 95%, CI: 1.01, 3.50], perceived stigma [AOR = 2.27, 95% CI: 1.45, 3.56], and experience side effect [AOR = 1.70, 95% CI: 1.06, 2.72] were significantly associated with antiepileptic drug nonadherence.", {"entities": []}], ["Conclusion.", {"entities": []}], ["More than one-third of people with epilepsy were not compliant with their AEDs.", {"entities": []}], ["Giving health information about epilepsy and its management and consequent reduction in stigma will help for medication adherence.", {"entities": []}], ["Mycobacterium avium complex (MAC) lung diseases generally cause chronic disease in immunocompetent hosts.", {"entities": []}], ["Although a few studies have examined health-related quality of life (HRQL) in patients with MAC lung disease, there have been no large studies.", {"entities": [[96, 108, "DISEASE"]]}], ["This study aimed to evaluate HRQL and its correlation with clinical outcomes in MAC lung disease.", {"entities": [[84, 96, "DISEASE"]]}], ["A cross-sectional study was conducted at Keio University Hospital to investigate the factors associated with HRQL in pulmonary nontuberculous mycobacterial diseases.", {"entities": []}], ["MAC lung diseases were diagnosed according to the 2007 ATS/IDSA guidelines for nontuberculous mycobacterial diseases.", {"entities": []}], ["The 36-item short form health survey (SF-36) was administered to assess clinical outcomes.", {"entities": []}], ["Clinical variables included treatment status, latest haematological data, and bacterial smear and culture results.", {"entities": []}], ["The SF-36 scores for the 235 patients (median age, 69\u00a0years; 45 men and 190 women) with MAC lung disease, except for the bodily pain and mental health subscale scores, were significantly lower than the Japanese population norms.", {"entities": [[92, 104, "DISEASE"]]}], ["In the multivariable analyses, current treatment for MAC and a positive sputum smear or culture within the past year were significantly associated with lower SF-36 scores.", {"entities": []}], ["C-reactive protein (CRP) and age showed stronger inverse correlations with SF-36 scores.", {"entities": [[20, 23, "GENE"]]}], ["HRQL, especially the physical component, was impaired in patients with MAC lung diseases; this appears to be related with current treatment status, positive sputum smear or culture within the previous year, and particularly CRP and age.", {"entities": [[224, 227, "GENE"]]}], ["Further studies including qualitative assessments are needed to investigate the efficacy of CRP as a marker for progression or treatment response in MAC lung disease.", {"entities": [[153, 165, "DISEASE"], [92, 95, "GENE"]]}], ["Clinical trial registered with UMIN ( UMIN000007964 ).", {"entities": []}], ["The periods of fetal and child development arguably represent the stages of greatest vulnerability to the dual impacts of fossil fuel combustion: the multiple toxic effects of emitted pollutants (polycyclic aromatic hydrocarbons, particles, sulfur oxides, nitrogen oxides, metals) and the broad health impacts of global climate change attributable in large part to carbon dioxide released by fossil fuel burning.", {"entities": []}], ["In this commentary I highlight current scientific evidence indicating that the fetus and young child are at heightened risk of developmental impairment, asthma, and cancer from fossil fuel pollutants and from the predicted effects of climate disruption such as heat waves, flooding, infectious disease, malnutrition, and trauma.", {"entities": [[153, 159, "DISEASE"], [165, 171, "DISEASE"]]}], ["Increased risk during early development derives from the inherently greater biologic vulnerability of the developing fetus and child and from their long future lifetime, during which early insults can potentially manifest as adult as well as childhood disease.", {"entities": []}], ["I cite recent reports concluding that reducing dependence on fossil fuel and promoting clean and sustainable energy is economically feasible.", {"entities": []}], ["Although much has been written separately about the toxicity of fossil fuel burning emissions and the effects of climate change on health, these two faces of the problem have not been viewed together with a focus on the developing fetus and child.", {"entities": []}], ["Adolescence and old age are also periods of vulnerability, but the potential for both immediate and long-term adverse effects is greatest when exposure occurs prenatally or in the early years.", {"entities": []}], ["Consideration of the full spectrum of health risks to children from fossil fuel combustion underscores the urgent need for environmental and energy policies to reduce fossil fuel dependence and maximize the health benefits to this susceptible population.", {"entities": []}], ["We do not have to leave our children a double legacy of ill health and ecologic disaster.", {"entities": []}], ["Nursing assistants (NAs) make up a large share of the healthcare provider workforce and their numbers are expected to grow.", {"entities": []}], ["NAs are predominantly women who earn a low wage and report financial, work, and family demands.", {"entities": []}], ["Working as a NA is hazardous; this manuscript specifically examines the biological/infectious, chemical, enviromechanical, physical and psychosocial hazards that appear in the literature to date.", {"entities": []}], ["A focused search strategy was used to review literature about hazards that fell into each of the five aforementioned domains.", {"entities": []}], ["While some hazards that were documented were clear, such as exposure to influenza because of close contact with patients (biological/infectious), or exposure to hazardous drugs (chemical), literature was limited.", {"entities": [[72, 81, "DISEASE"]]}], ["The majority of the literature we reviewed fell into the domain of psychosocial hazards and centered on stress from workplace organization issues (such as mandatory overtime, lack of managerial support, and feeling rushed).", {"entities": []}], ["More research is needed to understand which hazards NAs identify as most concerning and tailored interventions are needed for risk mitigation.", {"entities": []}], ["In Mexico, herbal products are commonly used as therapeutic tools.", {"entities": []}], ["The analysis of several publications reveals that there are dozens of different herbs and herbal products used for different reasons, some of which have been implicated in causing toxic liver disease.", {"entities": [[186, 199, "DISEASE"]]}], ["However, methodological aspects limit the attribution of causality, and the precise incidence and clinical manifestations of herb-induced liver injury have not been well characterized.", {"entities": []}], ["This review outlines the history of traditional herbal medicine in Mexico, critically summarizes the mechanisms and adverse effects of commonly used herbal plants, and examines the regulatory issues regarding the legal use of these products.", {"entities": []}], ["Rheumatoid arthritis (RA) is a systemic autoimmune disease manifesting in joint destruction.", {"entities": [[11, 20, "DISEASE"]]}], ["The recognized hallmark of RA pathogenesis is the involvement of immune cells which produce many mediators potentiating an inflammatory environment.", {"entities": []}], ["RA synovial fibroblasts (RASFs) contribute significantly to disease progression by initiating and regulating many pathways of joint destruction.", {"entities": []}], ["Detailed molecular insights into RASF biology may lead to identification of important therapeutic targets.", {"entities": []}], ["The discovery of common molecular targets for joint resident and inflammatory cells may help to develop the most effective therapeutic strategy.", {"entities": []}], ["One such pathway includes semaphorin 4A as reported in a recent article in Arthritis Research & Therapy .", {"entities": [[75, 84, "DISEASE"]]}], ["There is increasing evidence that cell elastic properties should change considerably in response to chemical agents affecting the physiological state of the endothelium.", {"entities": []}], ["In this work, a novel assay for testing prospective endothelium-targeted agents in vitro is presented.", {"entities": []}], ["The proposed methodology is based on nanoindentation spectroscopy using an atomic force microscope tip, which allows for quantitative evaluation of cell stiffness.", {"entities": []}], ["As an example, we chose a pyridine derivative, 1-methylnicotinamide chloride (MNA), known to have antithrombotic and anti-inflammatory properties, as reported in recent in vivo experiments.", {"entities": []}], ["First, we determined a concentration range of MNA in which physiological parameters of the endothelial cells in vitro are not affected.", {"entities": []}], ["Then, cell dysfunction was induced by incubation with tumor necrosis factor-alpha (TNF-\u03b1) and the cellular response to MNA treatment after TNF-\u03b1 incubation was studied.", {"entities": []}], ["In parallel to the nanoindentation spectroscopy, the endothelium phenotype was characterized using a fluorescence spectroscopy with F-actin labeling, and biochemical methods, such as secretion measurements of both nitric oxide (NO), and prostacyclin (PGI 2 ) regulatory agents.", {"entities": []}], ["We found that MNA could reverse the dysfunction of the endothelium caused by inflammation, if applied in the proper time and to the concentration scheme established in our investigations.", {"entities": []}], ["A surprisingly close correlation was found between effective Young\u2019s modulus of the cells and actin polymerization/depolymerization processes in the endothelium cortical cytoskeleton, as well as NO and PGI 2 levels.", {"entities": []}], ["These results allow us to construct the physiological model of sequential intracellular pathways activated in the endothelium by MNA.", {"entities": []}], ["Understanding the regulatory mechanisms for the NF-\u03baB transcription factor is key to control inflammation.", {"entities": []}], ["I\u03baB\u03b1 maintains NF-\u03baB in an inactive form in the cytoplasm of unstimulated cells, whereas nuclear NF-\u03baB in activated cells is degraded by PDLIM2, a nuclear ubiquitin E3 ligase that belongs to a LIM protein family.", {"entities": [[137, 143, "GENE"]]}], ["How NF-\u03baB activation is negatively controlled, however, is not completely understood.", {"entities": []}], ["Here we show that PDLIM1, another member of LIM proteins, negatively regulates NF-\u03baB-mediated signaling in the cytoplasm.", {"entities": [[18, 24, "GENE"]]}], ["PDLIM1 sequestered p65 subunit of NF-\u03baB in the cytoplasm and suppressed its nuclear translocation in an I\u03baB\u03b1-independent, but \u03b1-actinin-4-dependent manner.", {"entities": [[0, 6, "GENE"]]}], ["Consistently, PDLIM1 deficiency lead to increased levels of nuclear p65 protein, and thus enhanced proinflammatory cytokine production in response to innate stimuli.", {"entities": [[14, 20, "GENE"]]}], ["These studies reveal an essential role of PDLIM1 in suppressing NF-\u03baB activation and suggest that LIM proteins comprise a new family of negative regulators of NF-\u03baB signaling through different mechanisms.", {"entities": [[42, 48, "GENE"]]}], ["In the late twentieth century, emergence of high rates of treatment failure with antimonial compounds (SSG) for visceral leishmaniasis (VL) caused a public health crisis in Bihar, India.", {"entities": [[112, 134, "DISEASE"], [121, 134, "DISEASE"]]}], ["We hypothesize that exposure to arsenic through drinking contaminated groundwater may be associated with SSG treatment failure due to the development of antimony-resistant parasites.", {"entities": []}], ["A retrospective cohort design was employed, as antimony treatment is no longer in routine use.", {"entities": []}], ["The study was performed on patients treated with SSG between 2006 and 2010.", {"entities": []}], ["Outcomes of treatment were assessed through a field questionnaire and treatment failure used as a proxy for parasite resistance.", {"entities": []}], ["Arsenic exposure was quantified through analysis of 5 water samples from within and surrounding the patient\u2019s home.", {"entities": []}], ["A logistic regression model was used to evaluate the association between arsenic exposure and treatment failure.", {"entities": []}], ["In a secondary analysis survival curves and Cox regression models were applied to assess the risk of mortality in VL patients exposed to arsenic.", {"entities": []}], ["One hundred and ten VL patients treated with SSG were analysed.", {"entities": []}], ["The failure rate with SSG was 59%.", {"entities": []}], ["Patients with high mean local arsenic level had a non-statistically significant higher risk of treatment failure (OR = 1.78, 95% CI: 0.7\u20134.6, p = 0.23) than patients using wells with arsenic concentration <10 \u03bcg/L.", {"entities": []}], ["Twenty one patients died in our cohort, 16 directly as a result of VL.", {"entities": []}], ["Arsenic levels \u2265 10 \u03bcg/L increased the risk of all-cause (HR 3.27; 95% CI: 1.4\u20138.1) and VL related (HR 2.65; 95% CI: 0.96\u20137.65) deaths.", {"entities": [[58, 60, "GENE"], [100, 102, "GENE"], [58, 60, "GENE"], [100, 102, "GENE"]]}], ["This was time dependent: 3 months post VL symptom development, elevated risks of all-cause mortality (HR 8.56; 95% CI: 2.5\u201329.1) and of VL related mortality (HR 9.27; 95% CI: 1.8\u201349.0) were detected.", {"entities": [[102, 104, "GENE"], [158, 160, "GENE"], [102, 104, "GENE"], [158, 160, "GENE"]]}], ["This study indicates a trend towards increased treatment failure in arsenic exposed patients.", {"entities": []}], ["The limitations of the retrospective study design may have masked a strong association between arsenic exposure and selection for antimonial resistance in the field.", {"entities": []}], ["The unanticipated strong correlation between arsenic exposure and VL mortality warrants further investigation.", {"entities": []}], ["The parasitic disease visceral leishmaniasis (VL) causes a significant burden of illness and death in India.", {"entities": [[22, 44, "DISEASE"], [31, 44, "DISEASE"]]}], ["The main drug used to treat VL, which is based on the chemical element antimony, stopped working well in about half of all patients in the late twentieth century.", {"entities": []}], ["We hypothesised that arsenic exposure of the Indian population, through contaminated groundwater, was contributing to treatment failure with antimony based drugs.", {"entities": []}], ["Arsenic and antimony are similar chemical elements and exposure of the parasite to arsenic within the liver of arsenic-exposed patients could allow the parasite to become resistant to treatment with antimony.", {"entities": []}], ["Using a field-based questionnaire study we retrospectively evaluated whether arsenic exposure was linked to antimonial treatment failure in a cohort of 110 antimonial treated patients.", {"entities": []}], ["No significant association was found, although this may be because the number of patients in the study was low as antimony use was officially discontinued in 2005 due to high rates of treatment failure.", {"entities": []}], ["However, arsenic exposure was found to increase risk of mortality from VL particularly if death occurred more than 3 months after the symptoms of VL developed.", {"entities": []}], ["More research into the relationship between arsenic exposure and mortality in VL is warranted.", {"entities": []}], ["The aim of prenatal care is to promote good maternal and foetal health and to identify risk factors for adverse pregnancy outcomes in an attempt to promptly manage and solve them.", {"entities": []}], ["Although high prenatal care attendance is reported in most areas in Brazil, perinatal and neonatal mortalities are disproportionally high, raising doubts about the quality and performance of the care provided.", {"entities": []}], ["The objective of the present study was to evaluate the adequacy of prenatal care use and the risk factors involved in inadequate prenatal care utilization in the metropolitan area of Aracaju, Northeast Brazil.", {"entities": []}], ["A survey was carried out with puerperal women who delivered singleton liveborns in all four maternity hospitals of Aracaju.", {"entities": []}], ["A total of 4552 singleton liveborns were studied.", {"entities": []}], ["The Adequacy of Prenatal Care Utilization Index, modified according to the guidelines of the Prenatal Care and Birth Humanization Programme, was applied.", {"entities": []}], ["Socioeconomic, demographic, biological, life style and health service factors were evaluated by multiple logistic regression.", {"entities": []}], ["Results: Prenatal care coverage in Aracaju was high (98.3%), with a mean number of 6.24 visits.", {"entities": []}], ["Prenatal care was considered to be adequate or intensive in 66.1% of cases, while 33.9% were considered to have inadequate usage.", {"entities": []}], ["Age < 18 to 34 years at delivery, low maternal schooling, low family income, two or more previous deliveries, maternal smoking during pregnancy, having no partner and prenatal care obtained outside Aracaju were associated with inadequate prenatal care use.", {"entities": []}], ["In contrast, private service attendance protected from inadequate prenatal care use.", {"entities": []}], ["Prenatal care coverage was high.", {"entities": []}], ["However, a significant number of women still had inadequate prenatal care use.", {"entities": []}], ["Socioeconomic inequalities, demographic factors and behavioural risk factors are still important factors associated with inadequate prenatal care use.", {"entities": []}], ["To identify practices that do not add value, cause harm, or subject patients with chronic obstructive pulmonary disease (COPD) to a level of risk that outweighs possible benefits (overuse).", {"entities": [[82, 119, "DISEASE"]]}], ["A qualitative approach was applied.", {"entities": []}], ["First, a multidisciplinary group of healthcare professionals used the Metaplan technique to draft and rank a list of overused procedures as well as self-care practices in patients with stable and exacerbated COPD.", {"entities": []}], ["Second, in successive consensus-building rounds, description files were created for each \u201cdo not do\u201d (DND) recommendation, consisting of a definition, description, quality of supporting evidence for the recommendation, and the indicator used to measure the degree of overuse.", {"entities": []}], ["The consensus group comprised 6 pulmonologists, 2 general practitioners, 1 nurse, and 1 physiotherapist.", {"entities": []}], ["In total, 16 DND recommendations were made for patients with COPD: 6 for stable COPD, 6 for exacerbated COPD, and 4 concerning self-care.", {"entities": []}], ["Overuse poses a risk for patients and jeopardizes care quality.", {"entities": []}], ["These 16 DND recommendations for COPD will lower care risks and improve disease management, facilitate communication between physicians and patients, and bolster patient ability to provide self-care.", {"entities": []}], ["Pleural separation, the \u201csplit pleura\u201d sign, has been reported in patients with empyema.", {"entities": []}], ["However, the diagnostic yield of the split pleura sign for complicated parapneumonic effusion (CPPE)/empyema and its utility for differentiating CPPE/empyema from parapneumonic effusion (PPE) remains unclear.", {"entities": []}], ["This differentiation is important because CPPE/empyema patients need thoracic drainage.", {"entities": []}], ["In this regard, the aim of this study was to develop a simple method to distinguish CPPE/empyema from PPE using computed tomography (CT) focusing on the split pleura sign, fluid attenuation values (HU: Hounsfield units), and amount of fluid collection measured on thoracic CT prior to diagnostic thoracentesis.", {"entities": []}], ["A total of 83 consecutive patients who underwent chest CT and were diagnosed with CPPE (n=18)/empyema (n=18) or PPE (n=47) based on the diagnostic thoracentesis were retrospectively analyzed.", {"entities": []}], ["On univariate analysis, the split pleura sign (odds ratio (OR), 12.1; p <0.001), total amount of pleural effusion (\u226530 mm) (OR, 6.13; p <0.001), HU value\u226510 (OR, 5.94; p =0.001), and the presence of septum (OR, 6.43; p =0.018), atelectasis (OR, 6.83; p =0.002), or air (OR, 9.90; p =0.002) in pleural fluid were significantly higher in the CPPE/empyema group than in the PPE group.", {"entities": []}], ["On multivariate analysis, only the split pleura sign (hazard ratio (HR), 6.70; 95% confidence interval (CI), 1.91-23.5; p =0.003) and total amount of pleural effusion (\u226530 mm) on thoracic CT (HR, 7.48; 95%CI, 1.76-31.8; p =0.006) were risk factors for empyema.", {"entities": [[68, 70, "GENE"], [192, 194, "GENE"], [68, 70, "GENE"], [192, 194, "GENE"]]}], ["Sensitivity, specificity, positive predictive value, and negative predictive value of the presence of both split pleura sign and total amount of pleural effusion (\u226530 mm) on thoracic CT for CPPE/empyema were 79.4%, 80.9%, 75%, and 84.4%, respectively, with an area under the curve of 0.801 on receiver operating characteristic curve analysis.", {"entities": []}], ["This study showed a high diagnostic yield of the split pleura sign and total amount of pleural fluid (\u226530 mm) on thoracic CT that is useful and simple for discriminating between CPPE/empyema and PPE prior to diagnostic thoracentesis.", {"entities": []}], ["Transient leukemia (TL) is evident in 5\u201310% of all neonates with Down syndrome (DS) and associated with N-terminal truncating GATA1-mutations (GATA1s).", {"entities": [[70, 78, "DISEASE"], [10, 18, "DISEASE"]]}], ["Here we report that TL cell clones generate abundant eosinophils in a substantial fraction of patients.", {"entities": []}], ["Sorted eosinophils from patients with TL and eosinophilia carried the same GATA1s-mutation as sorted TL-blasts, consistent with their clonal origin.", {"entities": [[45, 57, "DISEASE"]]}], ["TL-blasts exhibited a genetic program characteristic of eosinophils and differentiated along the eosinophil lineage in vitro.", {"entities": []}], ["Similarly, ectopic expression of Gata1s, but not Gata1, in wild-type CD34 Gata1 knockin mice, exclusively expressing Gata1s, leading to accumulation of eosinophil precursors in blood and bone marrow.", {"entities": [[49, 54, "GENE"], [74, 79, "GENE"], [69, 73, "GENE"], [49, 54, "GENE"], [74, 79, "GENE"]]}], ["These data suggest a direct relationship between the N-terminal truncating mutations of GATA1 and clonal eosinophilia in DS patients.", {"entities": [[105, 117, "DISEASE"], [88, 93, "GENE"]]}], ["Multimorbidity is the co-occurrence of long-term conditions.", {"entities": []}], ["Obesity is associated with an increased risk of long-term conditions including type 2 diabetes and depression.", {"entities": [[0, 7, "DISEASE"]]}], ["To quantify the association between body mass index (BMI) category and multimorbidity in a large cohort registered in primary care.", {"entities": []}], ["The sample comprised primary care electronic health records of adults aged \u226530 years, sampled from the Clinical Practice Research Datalink between 2005 and 2011.", {"entities": []}], ["Multimorbidity was defined as the co-occurrence of \u22652 of 11 conditions affecting seven organ systems.", {"entities": []}], ["Age- and sex-standardized prevalence of multimorbidity was estimated by BMI category.", {"entities": []}], ["Adjusted odds ratios associating BMI with additional morbidity were estimated adjusting for socioeconomic deprivation and smoking.", {"entities": []}], ["The sample comprised 300 006 adults.", {"entities": []}], ["After excluding participants with BMI never recorded, data were analysed for 223 089 (74%) contributing 1 374 109 person\u2013years.", {"entities": []}], ["In normal weight men, the standardized prevalence of multimorbidity was 23%, rising to 27% in overweight, 33% in category I obesity, 38% in category II and 44% in category III obesity.", {"entities": [[124, 131, "DISEASE"], [176, 183, "DISEASE"]]}], ["In women, the corresponding values were 28%, 34%, 41%, 45% and 51%.", {"entities": []}], ["In category III obesity, the adjusted odds, relative to normal BMI, were 2.24 (2.13\u20132.36) for a first condition; 2.63 (2.51\u20132.76) for a second condition and 3.09 (2.92\u20133.28) for three or more conditions.", {"entities": [[16, 23, "DISEASE"]]}], ["In a cross-sectional analysis, 32% of multimorbidity was attributable to overweight and obesity.", {"entities": [[88, 95, "DISEASE"]]}], ["Multiple morbidity is highly associated with increasing BMI category and obesity, highlighting the potential for targeted primary and secondary prevention interventions in primary care.", {"entities": [[73, 80, "DISEASE"]]}], ["The estuarine tapertail anchovy ( Coilia nasus ) is widely distributed in the Yangtze River, the coastal waters of China, Korea, and the Ariake Sound of Japan.", {"entities": []}], ["It is a commercially important species owing to its nutritional value and delicate flavor.", {"entities": []}], ["However, Coilia nasus is strongly responsive to stress, this often results in death, which causes huge losses.", {"entities": []}], ["In this study, we used next-generation sequencing technologies to study changes in gene expression in response to loading stress and the mechanism of death caused by loading stress in Coilia nasus .", {"entities": []}], ["Using next-generation RNA-seq technologies on an Illumina HiSeq 2000 platform, we assembled a de novo transcriptome and tested for differential expression in response to stress.", {"entities": []}], ["A total of 65,129 unigenes were generated, the mean unigene size and N50 were 607\u00a0bp and 813\u00a0bp, respectively.", {"entities": []}], ["Of the assembled unigenes, we identified 2,990 genes that were significantly up-regulated, while 3,416 genes were significantly down-regulated in response to loading stress.", {"entities": []}], ["Pathway enrichment analysis based on loading stress-responsive unigenes identified significantly stress related pathways.", {"entities": []}], ["\u201cMetabolism\u201d and \u201cimmunity\u201d were the two most frequently represented categories.", {"entities": []}], ["In the \u201cmetabolism\u201d category, \u201cglucose metabolism\u201d and \u201clipid metabolism\u201d were major subclasses.", {"entities": []}], ["The transcriptional expression of rate-limiting enzymes in \u201cglucose metabolism\u201d and \u201clipid metabolism\u201d was detected by RT-qPCR, all were significantly increased after stress.", {"entities": []}], ["Apoptosis associated proteins tumor necrosis factor alpha (TNF-\u03b1), caspase 9, cytochrome c and caspase 3 in the stress group were significantly elevated, moreover, liver injury indicators (Alanine aminotransferase, ALT, and aspartate transaminase, AST) were also significantly elevated, which indicates that loading stress induced liver injury.", {"entities": []}], ["This study provided abundant unigenes that could contribute greatly to the discovery of novel genes in fish.", {"entities": []}], ["The alterations in predicted gene expression patterns reflected possible responses to stress.", {"entities": []}], ["Loading stress may induce liver injury through the mitochondrial apoptosis pathway, which was activated by TNF-\u03b1.", {"entities": []}], ["Taken together, our data not only provide information that will aid the identification of novel genes from fish, but also shed new light on the understanding of mechanisms by which physical stressors cause death in fish.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2164-15-558) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The research on natural snake venom metalloendopeptidase inhibitors (SVMPIs) began in the 18th century with the pioneering work of Fontana on the resistance that vipers exhibited to their own venom.", {"entities": []}], ["During the past 40 years, SVMPIs have been isolated mainly from the sera of resistant animals, and characterized to different extents.", {"entities": []}], ["They are acidic oligomeric glycoproteins that remain biologically active over a wide range of pH and temperature values.", {"entities": []}], ["Based on primary structure determination, mammalian plasmatic SVMPIs are classified as members of the immunoglobulin (Ig) supergene protein family, while the one isolated from muscle belongs to the ficolin/opsonin P35 family.", {"entities": []}], ["On the other hand, SVMPIs from snake plasma have been placed in the cystatin superfamily.", {"entities": []}], ["These natural antitoxins constitute the first line of defense against snake venoms, inhibiting the catalytic activities of snake venom metalloendopeptidases through the establishment of high-affinity, non-covalent interactions.", {"entities": []}], ["This review presents a historical account of the field of natural resistance, summarizing its main discoveries and current challenges, which are mostly related to the limitations that preclude three-dimensional structural determinations of these inhibitors using \u201cgold-standard\u201d methods; perspectives on how to circumvent such limitations are presented.", {"entities": []}], ["Potential applications of these SVMPIs in medicine are also highlighted.", {"entities": []}], ["Independent replication is vital for study findings drawn from Electronic Health Records (EHR).", {"entities": []}], ["This replication study evaluates the relationship between seasonal effects at birth and lifetime cardiovascular condition risk.", {"entities": []}], ["We performed a Season-wide Association Study on 1,169,599 patients from Mount Sinai Hospital (MSH) to compute phenome-wide associations between birth month and CVD.", {"entities": []}], ["We then evaluated if seasonal patterns found at MSH matched those reported at Columbia University Medical Center.", {"entities": []}], ["Coronary arteriosclerosis, essential hypertension, angina, and pre-infarction syndrome passed phenome-wide significance and their seasonal patterns matched those previously reported.", {"entities": [[37, 49, "DISEASE"], [27, 49, "DISEASE"], [78, 86, "DISEASE"], [9, 25, "DISEASE"]]}], ["Atrial fibrillation, cardiomyopathy, and chronic myocardial ischemia had consistent patterns but were not phenome-wide significant.", {"entities": [[21, 35, "DISEASE"], [60, 68, "DISEASE"]]}], ["We confirm that CVD risk peaks for those born in the late winter/early spring among the evaluated patient populations.", {"entities": []}], ["The replication findings bolster evidence for a seasonal birth month effect in CVD.", {"entities": []}], ["Further study is required to identify the environmental and developmental mechanisms.", {"entities": []}], ["Previous expression quantitative trait loci (eQTL) studies have performed genetic association studies for gene expression, but most of these studies examined lymphoblastoid cell lines from non-diseased individuals.", {"entities": []}], ["We examined the genetics of gene expression in a relevant disease tissue from chronic obstructive pulmonary disease (COPD) patients to identify functional effects of known susceptibility genes and to find novel disease genes.", {"entities": [[78, 115, "DISEASE"]]}], ["By combining gene expression profiling on induced sputum samples from 131 COPD cases from the ECLIPSE Study with genomewide single nucleotide polymorphism (SNP) data, we found 4315 significant cis-eQTL SNP-probe set associations (3309 unique SNPs).", {"entities": []}], ["The 3309 SNPs were tested for association with COPD in a genomewide association study (GWAS) dataset, which included 2940 COPD cases and 1380 controls.", {"entities": []}], ["Adjusting for 3309 tests (p<1.5e-5), the two SNPs which were significantly associated with COPD were located in two separate genes in a known COPD locus on chromosome 15: CHRNA5 and IREB2 .", {"entities": [[171, 177, "GENE"], [182, 187, "GENE"]]}], ["Detailed analysis of chromosome 15 demonstrated additional eQTLs for IREB2 mapping to that gene.", {"entities": [[69, 74, "GENE"]]}], ["eQTL SNPs for CHRNA5 mapped to multiple linkage disequilibrium (LD) bins.", {"entities": [[14, 20, "GENE"]]}], ["The eQTLs for IREB2 and CHRNA5 were not in LD.", {"entities": [[14, 19, "GENE"], [24, 30, "GENE"]]}], ["Seventy-four additional eQTL SNPs were associated with COPD at p<0.01.", {"entities": []}], ["These were genotyped in two COPD populations, finding replicated associations with a SNP in PSORS1C1 , in the HLA-C region on chromosome 6.", {"entities": [[92, 100, "GENE"], [110, 115, "GENE"]]}], ["Integrative analysis of GWAS and gene expression data from relevant tissue from diseased subjects has located potential functional variants in two known COPD genes and has identified a novel COPD susceptibility locus.", {"entities": []}], ["Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a leading cause of hospitalizations and readmissions in the US.", {"entities": [[22, 59, "DISEASE"]]}], ["Reducing the frequency of hospital readmission is a high priority of US health care organizations and government agencies.", {"entities": []}], ["This study evaluated the risk factors associated with readmissions among commercially insured adults aged 40\u201365 years in the US who were hospitalized for COPD.", {"entities": []}], ["This retrospective cohort study used anonymized claims data from the Truven Health MarketScan\u00ae Commercial Claims and Encounters database.", {"entities": []}], ["The patients included were aged 40\u201365 years, had an index hospitalization with a primary diagnosis of COPD between July 1, 2008 and June 30, 2010 (continuously enrolled 12 months before and after), and were alive at hospital discharge.", {"entities": []}], ["Patients with cystic fibrosis or tuberculosis or who were transferred to another inpatient facility after hospital discharge were excluded.", {"entities": [[33, 45, "DISEASE"], [14, 29, "DISEASE"]]}], ["All readmissions regardless of diagnosis, and separately a subset of all readmissions that had COPD as a primary or secondary diagnosis (COPD-related), were examined.", {"entities": []}], ["Univariate descriptive statistics and multivariable regression methods were used.", {"entities": []}], ["Of the 18,568 patients with index COPD hospitalizations, 6,095 (32.83%) met the eligibility criteria.", {"entities": []}], ["Of those, 503 (8.25%) were readmitted within the first 30 days post-index hospitalization and 2,527 (41.46%) within the first year (COPD-related 340 [5.58%] and 1,681 [27.58%], respectively).", {"entities": []}], ["The median time to the first readmission post initial discharge was 4.0 months, with a mean of 5.0 \u00b1 3.4 months.", {"entities": []}], ["Multivariable regression analyses showed that comorbid conditions and health care utilization in the pre-index period were significant predictors for readmission both 30 and 90 days following index hospitalization.", {"entities": []}], ["A relatively high readmission rate was observed for patients aged 40\u201365 years.", {"entities": []}], ["The results suggest that attention to patient comorbidities and pre-index/index health care service utilization may help identify hospitalized COPD patients at higher risk for readmission.", {"entities": []}], ["COPD, asthma, and asthma\u2013COPD overlap increase health care resource consumption, predominantly because of hospitalization for exacerbations and also increased visits to general practitioners (GPs) or specialists.", {"entities": [[6, 12, "DISEASE"], [18, 24, "DISEASE"]]}], ["Little information is available regarding this in the primary care setting.", {"entities": []}], ["To describe the prevalence and number of GP and specialist visits for any cause or due to exacerbations in patients with COPD, asthma, and asthma\u2013COPD overlap.", {"entities": [[127, 133, "DISEASE"], [139, 145, "DISEASE"]]}], ["COPD was defined as post-bronchodilator forced expiratory volume in 1 second/forced vital capacity (FEV 1 /FVC) ratio <0.70; asthma was defined as prior medical diagnosis, wheezing in the last 12 months, or wheezing plus reversibility (post-bronchodilator FEV 1 or FVC increase \u2265200 mL and \u226512%); asthma\u2013COPD overlap was defined as post-bronchodilator FEV 1 /FVC <0.70 plus prior asthma diagnosis.", {"entities": [[125, 131, "DISEASE"], [297, 303, "DISEASE"], [380, 386, "DISEASE"], [100, 103, "GENE"], [256, 259, "GENE"], [352, 355, "GENE"], [100, 103, "GENE"], [256, 259, "GENE"], [352, 355, "GENE"], [100, 103, "GENE"], [256, 259, "GENE"], [352, 355, "GENE"]]}], ["Health care utilization was evaluated as GP and/or specialist visits in the previous year.", {"entities": []}], ["Among the 1,743 individuals who completed the questionnaire, 1,540 performed acceptable spirometry.", {"entities": []}], ["COPD patients had a higher prevalence of any medical visits to any physician versus those without COPD (37.2% vs 21.8%, respectively) and exacerbations doubled the number of visits.", {"entities": []}], ["The prevalence of any medical visits to any physician was also higher in asthma patients versus those without asthma (wheezing: 47.2% vs 22.7%; medical diagnosis: 54.6% vs 21.6%; wheezing plus reversibility: 46.2% vs 23.8%, respectively).", {"entities": [[73, 79, "DISEASE"], [110, 116, "DISEASE"]]}], ["Asthma patients with exacerbations had twice the number of visits versus those without an exacerbation.", {"entities": [[0, 6, "DISEASE"]]}], ["The number of visits was higher (2.8 times) in asthma\u2013COPD overlap, asthma (1.9 times), or COPD (1.4 times) patients versus those without these respiratory diseases; the number of visits due to exacerbation was also higher (4.9 times) in asthma\u2013COPD overlap, asthma (3.5 times), and COPD (3.8 times) patients.", {"entities": [[47, 53, "DISEASE"], [68, 74, "DISEASE"], [238, 244, "DISEASE"], [259, 265, "DISEASE"]]}], ["COPD, asthma, and asthma\u2013COPD overlap increase the prevalence of medical visits and, therefore, health care resource utilization.", {"entities": [[6, 12, "DISEASE"], [18, 24, "DISEASE"]]}], ["Attempts to reduce health care resource use in these patients require interventions aimed at preventing exacerbations.", {"entities": []}], ["Oxidative stress and inflammation play crucial role in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[75, 112, "DISEASE"]]}], ["Most patients with COPD show a poor response to corticosteroids.", {"entities": []}], ["Hydrogen sulfide (H 2 S ) has been implicated in the pathogenesis of COPD, but its expression and effects in lung tissue from COPD patients are not clear.", {"entities": []}], ["In peripheral lung tissue samples from 24 patients, we found that compared with nonsmokers, the protein level of cystathionine-\u03b3-lyase (CSE) was decreased in smokers and COPD patients.", {"entities": []}], ["CSE mRNA increased but cystathionine-\u03b2-synthase (CBS) mRNA decreased in COPD patients.", {"entities": [[49, 52, "GENE"]]}], ["H 2 S donors increased glutathione and superoxide dismutase in CS exposed U937 cells and inhibited CS-induced TNF-\u03b1 and IL-8 secretion.", {"entities": [[63, 65, "GENE"], [99, 101, "GENE"]]}], ["Dexamethasone alone had no effect on lipopolysaccharide (LPS) induced TNF-\u03b1 release by alveolar macrophages from CS exposed rats, however the combination of dexamethasone and H 2 S donor significantly inhibited TNF-\u03b1 release.", {"entities": [[113, 115, "GENE"]]}], ["Thus, H 2 S metabolism is altered in lung tissue of smokers and COPD patients.", {"entities": []}], ["Supplementation of H 2 S protects against CS-induced oxidative stress and inflammation in macrophages and H 2 S on steroid sensitivity deserves further investigation.", {"entities": []}], ["In this study we investigated whether polymorphisms in the folate pathway influenced the risk of childhood acute lymphoblastic leukemia (ALL) or the survival rate of the patients.", {"entities": [[127, 135, "DISEASE"], [113, 135, "DISEASE"]]}], ["For this we selected and genotyped 67 SNPs in 15 genes in the folate pathway in 543 children with ALL and 529 controls.", {"entities": []}], ["The results were evaluated by gender adjusted logistic regression and by the Bayesian network based Bayesian multilevel analysis of relevance (BN-BMLA) methods.", {"entities": []}], ["Bayesian structure based odds ratios for the relevant variables and interactions were also calculated.", {"entities": []}], ["Altogether 9 SNPs in 8 genes were associated with altered susceptibility to ALL.", {"entities": []}], ["After correction for multiple testing, two associations remained significant.", {"entities": []}], ["The genotype distribution of the MTHFD1 rs1076991 differed significantly between the ALL and control population.", {"entities": [[33, 39, "GENE"]]}], ["Analyzing the subtypes of the disease the GG genotype increased only the risk of B-cell ALL (p\u200a=\u200a3.52\u00d710 MTRR gene was associated with a significantly reduced risk to ALL (p\u200a=\u200a1.21\u00d710 SHMT1 gene was associated with a lower survival rate comparing it to the TT genotype (80.2% vs. 88.8%; p\u200a=\u200a0.01).", {"entities": [[105, 109, "GENE"], [184, 189, "GENE"]]}], ["The BN-BMLA confirmed the main findings of the frequentist-based analysis and showed structural interactional maps and the probabilities of the different structural association types of the relevant SNPs especially in the hyperdiploid-ALL, involving additional SNPs in genes like TYMS , DHFR and GGH .", {"entities": [[280, 284, "GENE"], [287, 291, "GENE"], [296, 299, "GENE"]]}], ["We also investigated the statistical interactions and redundancies using structural model properties.", {"entities": []}], ["These results gave further evidence that polymorphisms in the folate pathway could influence the ALL risk and the effectiveness of the therapy.", {"entities": []}], ["It was also shown that in gene association studies the BN-BMLA could be a useful supplementary to the traditional frequentist-based statistical method.", {"entities": []}], ["Inhabitants of rural areas can be tempted to migrate to urban areas for the type and range of facilities available.", {"entities": []}], ["Although urban inhabitants may benefit from greater access to human and social services, living in a big city can also bring disadvantages to some residents due to changes in social and physical environments.", {"entities": []}], ["We analysed data from 4,208 women aged >15 years old participating in the fourth wave of the Indonesia Family Life Survey.", {"entities": []}], ["Chronic condition risk factors \u2013 systolic and diastolic blood pressure (SBP and DBP), body mass index (BMI), and tobacco use \u2013 among women in four major cities in Indonesia (Jakarta, Surabaya, Medan, and Bandung) were compared against other cities.", {"entities": [[80, 83, "GENE"]]}], ["Fractional polynomial regression models were applied to examine the association between living in the major cities and SBP, DBP, BMI, and tobacco use.", {"entities": [[124, 127, "GENE"]]}], ["The models were also adjusted for age, education, employment status, migration status, ethnic groups, and religion.", {"entities": []}], ["The patterns of SBP, DBP, and BMI were plotted and contrasted between groups of cities.", {"entities": [[21, 24, "GENE"]]}], ["Chronic condition prevalence was higher for women in major cities than in contrasting cities ( p <0.005).", {"entities": []}], ["Living in major cities increased the risk of having higher SBP, DBP, BMI and being a current smoker.", {"entities": [[64, 67, "GENE"]]}], ["Chronic disease risk factors in major cities were evident from younger ages.", {"entities": []}], ["Women residing in Indonesia's major cities have a higher risk of developing chronic conditions, starting at younger ages.", {"entities": []}], ["The findings highlight the challenges inherent in providing long-term healthcare with its associated cost within major Indonesian cities and the importance of chronic disease prevention programmes targeting women at an early age.", {"entities": []}], ["This paper provides a brief overview of software currently available for the genetic analysis of quantitative traits in humans.", {"entities": []}], ["Programs that implement variance components, Markov Chain Monte Carlo (MCMC), Haseman-Elston (H-E) and penetrance model-based linkage analyses are discussed, as are programs for measured genotype association analyses and quantitative trait transmission disequilibrium tests.", {"entities": []}], ["The software compared includes LINKAGE, FASTLINK, PAP, SOLAR, SEGPATH, ACT, Mx, MERLIN, GENEHUNTER, Loki, Mendel, SAGE, QTDT and FBAT.", {"entities": []}], ["Where possible, the paper provides URLs for acquiring these programs through the internet, details of the platforms for which the software is available and the types of analyses performed.", {"entities": []}], ["Dermatitis herpetiformis (DH), bullous pemphigoid (BP), and pemphigus vulgaris (PV) are autoimmune bullous skin conditions with eosinophilic and neutrophilic infiltrations.", {"entities": [[31, 49, "DISEASE"]]}], ["While cytokines are crucial for the affinity and activation of different leukocyte cells in the inflammation and blister formation, there are no studies concerning a role of IL-36.", {"entities": []}], ["The goal of the study was to analyze whether interleukin 36 is involved in pathogenesis of DH, BP, and PV.", {"entities": []}], ["And the second aim of the study was the estimation of correlation between Il-36 and IL-17 and titers of specific antibodies in these diseases.", {"entities": []}], ["Expression of IL-36 and IL-17 was detected in serum in all DH, BP, and PV samples.", {"entities": []}], ["Serum levels of IL-36 and IL-17 \u03b1 were statistically higher in DH, BP, and PV groups as compared to the control group.", {"entities": []}], ["IL-36 \u03b1 levels were statistically higher in DH patients, as compared to patients with PV and BP.", {"entities": []}], ["Our results showed that IL-36 may be helpful in the diagnostic and monitoring of the activity of the disease.", {"entities": []}], ["IL 36 may play a relevant role of enrolling eosinophils and neutrophils in DH, BP, and PV and finally provoke tissue injury.", {"entities": []}], ["UDP-GalNAc:polypeptide \u03b1- N -acetylgalactosaminyltransferases (GalNAc-Ts) constitute a family of up to 20 transferases that initiate mucin-type O- glycosylation.", {"entities": []}], ["The transferases are structurally composed of catalytic and lectin domains.", {"entities": []}], ["Two modes have been identified for the selection of glycosylation sites by GalNAc-Ts: confined sequence recognition by the catalytic domain alone, and concerted recognition of acceptor sites and adjacent GalNAc-glycosylated sites by the catalytic and lectin domains, respectively.", {"entities": []}], ["Thus far, only the catalytic domain has been shown to have peptide sequence specificity, whereas the primary function of the lectin domain is to increase affinity to previously glycosylated substrates.", {"entities": []}], ["Whether the lectin domain also has peptide sequence selectivity has remained unclear.", {"entities": []}], ["Using a glycopeptide array with a library of synthetic and recombinant glycopeptides based on sequences of mucins MUC1, MUC2, MUC4, MUC5AC, MUC6, and MUC7 as well as a random glycopeptide bead library, we examined the binding properties of four different lectin domains.", {"entities": [[114, 118, "GENE"], [120, 124, "GENE"], [126, 130, "GENE"], [140, 144, "GENE"], [150, 154, "GENE"]]}], ["The lectin domains of GalNAc-T1, -T2, -T3, and -T4 bound different subsets of small glycopeptides.", {"entities": []}], ["These results indicate an additional level of complexity in the initiation step of O- glycosylation by GalNAc-Ts.", {"entities": []}], ["Indicators of potentially preventable hospitalisations have been adopted internationally as a measure of health system performance; however, few assess appropriate processes of care around medication use, that if followed may prevent hospitalisation.", {"entities": []}], ["The aim of this study was to develop and validate evidence-based medication-related indicators of potentially preventable hospitalisations.", {"entities": []}], ["Australian primary healthcare.", {"entities": []}], ["Medical specialists, general practitioners and pharmacists.", {"entities": []}], ["A modified RAND appropriateness method was used for the development of medication-related indicators of potentially preventable hospitalisations, which included a literature review, assessment of the strength of the supporting evidence base, an initial face and content validity by an expert panel, followed by an independent assessment of indicators by an expert clinical panel across various disciplines, using an online survey.", {"entities": []}], ["Analysis of ratings was performed on the four key elements of preventability; the medication-related problem must be recognisable, the adverse outcomes foreseeable and the causes and outcomes identifiable and controllable.", {"entities": []}], ["A total of 48 potential indicators across all major disease groupings were developed based on level III evidence or greater, that were independently assessed by 78 expert clinicians (22.1% response rate).", {"entities": []}], ["The expert panel considered 29 of these (60.4%) sufficiently valid.", {"entities": []}], ["Of these, 21 (72.4%) were based on level I evidence.", {"entities": []}], ["This study provides a set of face and content validated indicators of medication-related potentially preventable hospitalisations, linking suboptimal processes of care and medication use with subsequent hospitalisation.", {"entities": []}], ["Further analysis is required to establish operational validity in a population-based sample, using an administrative health database.", {"entities": []}], ["Implementation of these indicators within routine monitoring of healthcare systems will highlight those conditions where hospitalisations could potentially be avoided through improved medication management.", {"entities": []}], ["Physical activity has proven to be beneficial for physical functioning, cognition, depression, anxiety, rest-activity rhythm, quality of life (QoL), activities of daily living (ADL) and pain in older people.", {"entities": []}], ["The aim of this study is to investigate the effect of walking regularly on physical functioning, the progressive cognitive decline, level of depression, anxiety, rest-activity rhythm, QoL, ADL and pain in older people with dementia.", {"entities": [[223, 231, "DISEASE"]]}], ["This study is a longitudinal randomized controlled, single blind study.", {"entities": []}], ["Ambulatory older people with dementia, who are regular visitors of daily care or living in a home for the elderly or nursing home in the Netherlands, will be randomly allocated to the experimental or control condition.", {"entities": [[29, 37, "DISEASE"]]}], ["Participants of the experimental group make supervised walks of 30 minutes a day, 5 days a week, as part of their daily nursing care.", {"entities": []}], ["Participants of the control group will come together three times a week for tea or other sedentary activities to control for possible positive effects of social interaction.", {"entities": []}], ["All dependent variables will be assessed at baseline and after 6 weeks, and 3, 6, 9, 12 and 18 months of intervention.", {"entities": []}], ["The dependent variables include neuropsychological tests to assess cognition, physical tests to determine physical functioning, questionnaires to assess ADL, QoL, level of depression and anxiety, actigraphy to assess rest-activity rhythm and pain scales to determine pain levels.", {"entities": []}], ["Potential moderating variables at baseline are: socio-demographic characteristics, body mass index, subtype of dementia, apolipoprotein E (ApoE) genotype, medication use and comorbidities.", {"entities": [[111, 119, "DISEASE"], [139, 143, "GENE"]]}], ["This study evaluates the effect of regular walking as a treatment for older people with dementia.", {"entities": [[88, 96, "DISEASE"]]}], ["The strength of this study is that 1) it has a longitudinal design with multiple repeated measurements, 2) we assess many different health aspects, 3) the intervention is not performed by research staff, but by nursing staff which enables it to become a routine in usual care.", {"entities": []}], ["Possible limitations of the study are that 1) only active minded institutions are willing to participate creating a selection bias, 2) the drop-out rate will be high in this population, 3) not all participants will be able to perform/understand all tests.", {"entities": []}], ["TB remains a very significant global health burden.", {"entities": []}], ["There is an urgent need for better tools for TB control, which include an effective vaccine.", {"entities": []}], ["Bacillus Calmette\u2013Gu\u00e9rin (BCG), the currently licensed vaccine, confers highly variable protection against pulmonary TB, the main source of TB transmission.", {"entities": []}], ["Replacing BCG completely or boosting BCG with another vaccine are the two current strategies for TB vaccine development.", {"entities": []}], ["Delivering a vaccine by aerosol represents a way to match the route of vaccination to the route of infection.", {"entities": []}], ["This route of immunisation offers not only the scientific advantage of delivering the vaccine directly to the respiratory mucosa, but also practical and logistical advantages.", {"entities": []}], ["This review summarises the state of current TB vaccine candidates in the pipeline, reviews current progress in aerosol administration of vaccines in general and evaluates the potential for TB vaccine candidates to be administered by the aerosol route.", {"entities": []}], ["Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) is associated with clinical treatment failure.", {"entities": []}], ["However, the resistance mechanism of hVISA has not been fully clarified.", {"entities": []}], ["In the present study, comparative proteomics analysis of two pairs of isogenic vancomycin-susceptible S. aureus (VSSA) and hVISA strains isolated from two patients identified five differentially expressed proteins, IsaA, MsrA2, Asp23, GpmA, and AhpC, present in both isolate pairs.", {"entities": []}], ["All the proteins were up-regulated in the hVISA strains.", {"entities": []}], ["These proteins were analyzed in six pairs of isogenic VSSA and hVISA strains, and unrelated VSSA (n\u200a=\u200a30) and hVISA (n\u200a=\u200a24) by real-time quantitative reverse transcriptase\u2013PCR (qRT\u2013PCR).", {"entities": []}], ["Of the six pairs of isogenic strains, isaA , msrA2 and ahpC were up-regulated in all six hVISA strains; whereas asp23 and gpmA were up-regulated in five hVISA strains compared with the VSSA parental strains.", {"entities": []}], ["In the unrelated strains, statistical analyses showed that only isaA was significantly up-regulated in the hVISA strains.", {"entities": []}], ["Analysis of the five differentially expressed proteins in 15 pairs of persistent VSSA strains by qRT\u2013PCR showed no differences in the expression of the five genes among the persistent strains, suggesting that these genes are not associated with persistence infection.", {"entities": []}], ["Our results indicate that increased expression of isaA may be related to hVISA resistance.", {"entities": []}], ["The twelve-item Self-Report Habit Index (SRHI) is the most popular measure of energy-balance related habits.", {"entities": []}], ["This measure characterises habit by automatic activation, behavioural frequency, and relevance to self-identity.", {"entities": []}], ["Previous empirical research suggests that the SRHI may be abbreviated with no losses in reliability or predictive utility.", {"entities": []}], ["Drawing on recent theorising suggesting that automaticity is the \u2018active ingredient\u2019 of habit-behaviour relationships, we tested whether an automaticity-specific SRHI subscale could capture habit-based behaviour patterns in self-report data.", {"entities": []}], ["A content validity task was undertaken to identify a subset of automaticity indicators within the SRHI.", {"entities": []}], ["The reliability, convergent validity and predictive validity of the automaticity item subset was subsequently tested in secondary analyses of all previous SRHI applications, identified via systematic review, and in primary analyses of four raw datasets relating to energy\u2010balance relevant behaviours (inactive travel, active travel, snacking, and alcohol consumption).", {"entities": []}], ["A four-item automaticity subscale (the \u2018Self-Report Behavioural Automaticity Index\u2019; \u2018SRBAI\u2019) was found to be reliable and sensitive to two hypothesised effects of habit on behaviour: a habit-behaviour correlation, and a moderating effect of habit on the intention-behaviour relationship.", {"entities": []}], ["The SRBAI offers a parsimonious measure that adequately captures habitual behaviour patterns.", {"entities": []}], ["The SRBAI may be of particular utility in predicting future behaviour and in studies tracking habit formation or disruption.", {"entities": []}], ["Leprosy reversal reactions type 1 (T1R) are acute immune episodes that affect a subset of leprosy patients and remain a major cause of nerve damage.", {"entities": [[0, 7, "DISEASE"], [90, 97, "DISEASE"]]}], ["Little is known about the relative importance of innate versus environmental factors in the pathogenesis of T1R.", {"entities": []}], ["In a retrospective design, we evaluated innate differences in response to Mycobacterium leprae between healthy individuals and former leprosy patients affected or free of T1R by analyzing the transcriptome response of whole blood to M. leprae sonicate.", {"entities": [[134, 141, "DISEASE"]]}], ["Validation of results was conducted in a subsequent prospective study.", {"entities": []}], ["We observed the differential expression of 581 genes upon exposure of whole blood to M. leprae sonicate in the retrospective study.", {"entities": []}], ["We defined a 44 T1R gene set signature of differentially regulated genes.", {"entities": []}], ["The majority of the T1R set genes were represented by three functional groups: i) pro-inflammatory regulators; ii) arachidonic acid metabolism mediators; and iii) regulators of anti-inflammation.", {"entities": []}], ["The validity of the T1R gene set signature was replicated in the prospective arm of the study.", {"entities": []}], ["The T1R genetic signature encompasses genes encoding pro- and anti-inflammatory mediators of innate immunity.", {"entities": []}], ["This suggests an innate defect in the regulation of the inflammatory response to M. leprae antigens.", {"entities": []}], ["The identified T1R gene set represents a critical first step towards a genetic profile of leprosy patients who are at increased risk of T1R and concomitant nerve damage.", {"entities": [[90, 97, "DISEASE"]]}], ["Leprosy type 1 reversal reactions (T1R) are an important cause of nerve damage in leprosy patients and accurate prediction of patients at increased risk of T1R is a major challenge of current leprosy control.", {"entities": [[0, 7, "DISEASE"], [82, 89, "DISEASE"], [192, 199, "DISEASE"]]}], ["The incidence of T1R differs widely from 6% to 67% of leprosy patients in different leprosy endemic settings.", {"entities": [[54, 61, "DISEASE"], [84, 91, "DISEASE"]]}], ["Whether or not this reflects the impact of unknown environmental triggers or differences in the genetic background across ethnicities is not known.", {"entities": []}], ["We performed a comparative transcriptome analysis between leprosy patients affected and free of T1R in response to M. leprae antigens.", {"entities": [[58, 65, "DISEASE"]]}], ["As the discovery sample we enrolled cured leprosy patients who had been diagnosed with T1R at the time of leprosy diagnosis and leprosy patients who had never undergone T1R (retrospective arm).", {"entities": [[42, 49, "DISEASE"], [106, 113, "DISEASE"], [128, 135, "DISEASE"]]}], ["Whole genome transcriptome analysis after stimulation of blood with M. leprae antigen resulted in the definition of a T1R signature gene set.", {"entities": []}], ["We validated the T1R gene set in RNA samples obtained from T1R-free patients at the time of leprosy diagnosis and followed for 3 years for development of T1R (prospective arm).", {"entities": [[92, 99, "DISEASE"]]}], ["These results confirm the role of innate factors in T1R and are a first step towards a predictive genetic T1R signature.", {"entities": []}], ["A great deal of attention has been focused on adverse effects of tobacco smoking on conception, pregnancy, fetal, and child health.", {"entities": []}], ["The aim of this paper is to discuss the current evidence regarding short and long-term health effects on child health of parental smoking during pregnancy and lactation and the potential underlying mechanisms.", {"entities": []}], ["Studies were searched on MEDLINE", {"entities": []}], ["The oral pathogen Tannerella forsythia is implicated in the development of periodontitis, a common inflammatory disease that leads to the destruction of the gum and tooth supporting tissues, often leading to tooth loss.", {"entities": [[75, 88, "DISEASE"]]}], ["forsythia is a unique Gram-negative organism endowed with an elaborate protein O-glycosylation system that allows the bacterium to express a glycosylated surface (S)-layer comprising two high molecular weight glycoproteins modified with O-linked oligosaccharides.", {"entities": []}], ["forsythia S-layer has been implicated in the modulation of cytokine responses of antigen presenting cells, such as macrophages, that play a significant role during inflammation associated with periodontitis.", {"entities": [[193, 206, "DISEASE"]]}], ["The macrophage-inducible C-type lectin receptor (Mincle) is an FcR\u03b3-coupled pathogen recognition receptor that recognizes a wide variety of sugar containing ligands from fungal and bacterial pathogens.", {"entities": []}], ["In this study, we aimed to determine if Mincle might be involved in the recognition of T .", {"entities": []}], ["forsythia S-layer and modulation of cytokine response of macrophages against the bacterium.", {"entities": []}], ["Binding studies using recombinant Mincle-Fc fusion protein indicated a specific Ca T .", {"entities": []}], ["forsythia S-layer.", {"entities": []}], ["Subsequent experiments with Mincle-expressing and Mincle-knockdown macrophages revealed a role for Mincle/S-layer interaction in the induction of both pro- and anti-inflammatory cytokine secretion in macrophages stimulated with T .", {"entities": []}], ["forsythia as well as its S-layer.", {"entities": []}], ["Together, these studies revealed Mincle as an important macrophage receptor involved in the modulation of cytokine responses of macrophages against T .", {"entities": []}], ["forsythia , and thus may play a critical role in orchestrating the host immune response against the bacterium.", {"entities": []}], ["Previous studies have demonstrated that chronic obstructive pulmonary disease (COPD) causes increased mortality in the general population.", {"entities": [[40, 77, "DISEASE"]]}], ["But life expectancy and the years of life lost have not been reported.", {"entities": []}], ["To quantify mortality, examine how it varies with age, sex, and other risk factors, and determine how life expectancy is affected.", {"entities": []}], ["We constructed mortality models using the Third National Health and Nutrition Examination Survey, adjusting for age, sex, race, and major medical conditions.", {"entities": []}], ["We used these to compute life expectancy and the years of life lost.", {"entities": []}], ["Pulmonary function testing classified patients as having Global Initiative on Obstructive Lung Disease (GOLD) stage 0, 1, 2, 3 or 4 COPD or restriction.", {"entities": []}], ["COPD is associated with only a modest reduction in life expectancy for never smokers, but with a very large reduction for current and former smokers.", {"entities": []}], ["At age 65, the reductions in male life expectancy for stage 1, stage 2, and stages 3 or 4 disease in current smokers are 0.3 years, 2.2 years, and 5.8 years.", {"entities": []}], ["These are in addition to the 3.5 years lost due to smoking.", {"entities": []}], ["In former smokers the reductions are 1.4 years and 5.6 years for stage 2 and stages 3 or 4 disease, and in never smokers they are 0.7 and 1.3 years.", {"entities": []}], ["Persons with COPD have an increased risk of mortality compared to those who do not, with consequent reduction in life expectancy.", {"entities": []}], ["The effect is most marked in current smokers, and this is further reason for smokers to quit.", {"entities": []}], ["Colorectal cancer is a major cause of morbidity and mortality globally and its incidence is increasing in developing countries.", {"entities": [[0, 17, "DISEASE"], [11, 17, "DISEASE"]]}], ["This study determined the incidence, clinical features and the histopathological patterns of colorectal cancer at Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana.", {"entities": [[93, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["A retrospective review of all colorectal cancer cases over a six year period from (2009-2015) presented to the Surgical and Oncological Department of KATH.", {"entities": [[30, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["Patients' records were retrieved and information on their demographics, clinical and pathological presentations recorded.", {"entities": []}], ["In all, 221 cases of colorectal cancer were identified over the study period.", {"entities": [[21, 38, "DISEASE"], [32, 38, "DISEASE"]]}], ["The mean age was 54 \u00b1 16.8 and ranged from 16 to 90 years.", {"entities": []}], ["Sixteen (7.24%) had family history of cancer and the prevalence of comorbidities was (24.89%).", {"entities": [[38, 44, "DISEASE"]]}], ["The commonest clinical symptoms presented were weight loss (44.80%), bleeding per rectum (39.82%) and abdominal pain (38.91%) Majority of the patients presented with rectal cancers (48.87%).", {"entities": []}], ["Microscopically, adenocarcinoma (68.33%) was the most common histopathological type.", {"entities": [[17, 31, "DISEASE"]]}], ["According to Tumour Node Metastasis (TNM) staging of cancer, majority of the patients 89(40.27%) were identified as being in late stage (TNM Stage III).", {"entities": [[53, 59, "DISEASE"]]}], ["The overall crude annual incidence was 4.62 per 100000 populations.", {"entities": []}], ["The age specific standardized incidence rate was 7.93 per 100,000 population This study has clearly showed a high incidence in colorectal cancer at KATH, with similar trends in clinico-pathological patterns comparable to that of most African countries.", {"entities": [[127, 144, "DISEASE"], [138, 144, "DISEASE"]]}], ["These include predominance of rectal cancers, high incidence among younger people and delayed presentation of the disease at advanced stage.", {"entities": []}], ["Les objectifs \u00e9taient de dresser le profil \u00e9pid\u00e9miologique des patients indemnis\u00e9s pour asthme professionnel dans le centre tunisien, identifier leurs caract\u00e9ristiques professionnelles et \u00e9valuer les pratiques d\u2019indemnisation de cette maladie professionnelle.", {"entities": [[59, 62, "GENE"]]}], ["\u00c9tude exhaustive r\u00e9trospective, men\u00e9e sur une p\u00e9riode de huit ans, \u00e0 propos des cas d'asthme professionnel reconnus et indemnis\u00e9s au centre tunisien par les deux seules commissions m\u00e9dicales habilit\u00e9es \u00e0 fixer le taux d\u2019incapacit\u00e9 partielle permanente aux victimes des accidents de travail et des maladies professionnelles dans les sept gouvernorats du centre.", {"entities": [[76, 79, "GENE"], [265, 268, "GENE"], [293, 296, "GENE"], [76, 79, "GENE"], [265, 268, "GENE"], [293, 296, "GENE"], [76, 79, "GENE"], [265, 268, "GENE"], [293, 296, "GENE"]]}], ["Au total, 129 travailleurs, d\u2019\u00e2ge moyen \u00e9gal \u00e0 40,6 \u00b1 7,75 ans \u00e9taient indemnis\u00e9s pour asthme professionnel durant la p\u00e9riode d\u2019\u00e9tude.", {"entities": []}], ["Le sexe ratio \u00e9tait de 0,66.", {"entities": []}], ["Les agents \u00e9tiologiques les plus incrimin\u00e9s ont \u00e9t\u00e9 les poussi\u00e8res v\u00e9g\u00e9tales textiles (75,2%), les poussi\u00e8res de bois, la farine et les isocyanates.", {"entities": []}], ["Une hyperr\u00e9activit\u00e9 bronchique non sp\u00e9cifique a \u00e9t\u00e9 retrouv\u00e9e dans 38%, un taux \u00e9lev\u00e9 d\u2019IgE dans 14% et des prick tests positifs dans 10,9% des cas.", {"entities": [[104, 107, "GENE"], [140, 143, "GENE"], [104, 107, "GENE"], [140, 143, "GENE"]]}], ["Le taux moyen d\u2019incapacit\u00e9 partielle permanente \u00e9tait de 25,6\u00b114,2%.", {"entities": []}], ["Ce taux \u00e9tait corr\u00e9l\u00e9, selon l\u2019analyse analytique, \u00e0 l\u2019\u00e2ge du patient et \u00e0 la commission m\u00e9dicale ayant fix\u00e9 ce taux.", {"entities": []}], ["L\u2019\u00e9tude des cas d\u2019asthme professionnels indemnis\u00e9s, apportent des donn\u00e9es pertinentes \u00e0 propos des caract\u00e9ristiques \u00e9pid\u00e9miologiques et cliniques des patients atteints et des pratiques des comit\u00e9s notamment, en terme d\u2019application du bar\u00e8me indicatif, mais ne permet pas l'appr\u00e9ciation de la pr\u00e9valence, souvent sous-estim\u00e9e de cette pathologie.", {"entities": [[8, 11, "GENE"], [62, 65, "GENE"], [95, 98, "GENE"], [146, 149, "GENE"], [171, 174, "GENE"], [185, 188, "GENE"], [8, 11, "GENE"], [62, 65, "GENE"], [95, 98, "GENE"], [146, 149, "GENE"], [171, 174, "GENE"], [185, 188, "GENE"], [8, 11, "GENE"], [62, 65, "GENE"], [95, 98, "GENE"], [146, 149, "GENE"], [171, 174, "GENE"], [185, 188, "GENE"], [8, 11, "GENE"], [62, 65, "GENE"], [95, 98, "GENE"], [146, 149, "GENE"], [171, 174, "GENE"], [185, 188, "GENE"], [8, 11, "GENE"], [62, 65, "GENE"], [95, 98, "GENE"], [146, 149, "GENE"], [171, 174, "GENE"], [185, 188, "GENE"], [8, 11, "GENE"], [62, 65, "GENE"], [95, 98, "GENE"], [146, 149, "GENE"], [171, 174, "GENE"], [185, 188, "GENE"]]}], ["Bacterial meningitis is caused by a variety of pathogens and displays an important public health threat all over the world.", {"entities": [[10, 20, "DISEASE"], [0, 20, "DISEASE"]]}], ["Despite the necessity to develop customized public health-related research projects, a thorough study of global meningitis research is not present, so far.", {"entities": [[112, 122, "DISEASE"]]}], ["Therefore, the aim of this study was a combined density-equalizing and scientometric study.", {"entities": []}], ["To evaluate the scientific efforts of bibliometric methods, density-equalizing algorithms and large-scale data analysis of the Web of Science were applied in the period between 1900 and 2007.", {"entities": []}], ["From this, 7998 publications on bacterial meningitis have been found.", {"entities": [[42, 52, "DISEASE"], [32, 52, "DISEASE"]]}], ["With a number of 2698, most publications have been written by U.S. authors, followed by the UK (912), Germany (749) and France (620).", {"entities": []}], ["This dominance can also be shown in the international cooperation.", {"entities": []}], ["The specific citation analyses reveal that the nation with the highest average citation rate (citations per publications) was Norway (26.36), followed by Finland (24.16) and the U.S. (24.06).", {"entities": []}], ["This study illustrates the architecture of global research on bacterial meningitis and points to the need for customized research programs with a focus on local public health issues in countries with a low development index, but high incidences, to target this global public health problem.", {"entities": [[72, 82, "DISEASE"], [62, 82, "DISEASE"]]}], ["Person-centered information and communication technology (ICT) could encourage patients to take an active part in their health care and decision-making process, and make it possible for patients to interact directly with health care providers and services about their personal health concerns.", {"entities": []}], ["Yet, little is known about which ICT interventions dedicated to person-centered care (PCC) and connected-care interactions have been studied, especially for shared care management of chronic diseases.", {"entities": []}], ["The aim of this research is to investigate the extent, range, and nature of these research activities and identify research gaps in the evidence base of health studies regarding the \u201cbig 5\u201d chronic diseases: diabetes mellitus, cardiovascular disease, chronic respiratory disease, cancer, and stroke.", {"entities": [[280, 286, "DISEASE"], [208, 225, "DISEASE"]]}], ["The objective of this paper was to review the literature and to scope the field with respect to 2 questions: (1) which ICT interventions have been used to support patients and health care professionals in PCC management of the big 5 chronic diseases?", {"entities": []}], ["and (2) what is the impact of these interventions, such as on health-related quality of life and cost efficiency?", {"entities": []}], ["This research adopted a scoping review method.", {"entities": []}], ["Three electronic medical databases were accessed: PubMed, EMBASE, and Cochrane Library.", {"entities": []}], ["The research reviewed studies published between January 1989 and December 2013.", {"entities": []}], ["In 5 stages of systematic scanning and reviewing, relevant studies were identified, selected, and charted.", {"entities": []}], ["Then we collated, summarized, and reported the results.", {"entities": []}], ["From the initial 9380 search results, we identified 350 studies that qualified for inclusion: diabetes mellitus (n=103), cardiovascular disease (n=89), chronic respiratory disease (n=73), cancer (n=67), and stroke (n=18).", {"entities": [[188, 194, "DISEASE"], [94, 111, "DISEASE"]]}], ["Persons with one of these chronic conditions used ICT primarily for self-measurement of the body, when interacting with health care providers, with the highest rates of use seen in chronic respiratory (63%, 46/73) and cardiovascular (53%, 47/89) diseases.", {"entities": []}], ["We found 60 relevant studies (17.1%, 60/350) on person-centered shared management ICT, primarily using telemedicine systems as personalized ICT.", {"entities": []}], ["The highest impact measured related to the increase in empowerment (15.4%, 54/350).", {"entities": []}], ["Health-related quality of life accounted for 8%.", {"entities": []}], ["The highest impact connected to health professionals was an increase in clinical outcome (11.7%, 41/350).", {"entities": []}], ["The impacts on organization outcomes were decrease in hospitalization (12.3%, 43/350) and increase of cost efficiency (10.9%, 38/350).", {"entities": []}], ["This scoping review outlined ICT-enabled PCC in chronic disease management.", {"entities": []}], ["Persons with a chronic disease could benefit from an ICT-enabled PCC approach, but ICT-PCC also yields organizational paybacks.", {"entities": []}], ["It could lead to an increase in health care usage, as reported in some studies.", {"entities": []}], ["Few interventions could be regarded as \u201cfully\u201d addressing PCC.", {"entities": []}], ["This review will be especially helpful to those deciding on areas where further development of research or implementation of ICT-enabled PCC may be warranted.", {"entities": []}], ["Airborne particulate matter (PM) may lead to increased cardiac risk through an inflammatory pathway.", {"entities": []}], ["Therefore, we investigated associations between ambient PM and markers of systemic inflammation among repeated measures from 44 senior citizens (\u2265 60 years of age) and examined susceptibility by conditions linked to chronic inflammation.", {"entities": []}], ["Mixed models were used to identify associations between concentrations of fine PM [aerodynamic diameter \u2264 2.5 \u03bcm (PM 2.5 )] averaged over 1\u20137 days and measures of C-reactive protein (CRP), interleukin-6 (IL-6), and white blood cells (WBCs).", {"entities": [[183, 186, "GENE"]]}], ["Effect modification was investigated for diabetes, obesity, hypertension, and elevated mean inflammatory markers.", {"entities": [[60, 72, "DISEASE"], [51, 58, "DISEASE"]]}], ["We found positive associations between longer moving averages of PM 2.5 and WBCs across all participants, with a 5.5% [95% confidence interval (CI), 0.10 to 11%] increase per interquartile increase (5.4 \u03bcg/m 2.5 averaged over the previous week.", {"entities": []}], ["PM 2.5 and CRP also exhibited positive associations among all individuals for averages longer than 1 day, with the largest associations for persons with diabetes, obesity, and hypertension.", {"entities": [[176, 188, "DISEASE"], [163, 170, "DISEASE"], [11, 14, "GENE"]]}], ["For example, an interquartile increase in the 5-day mean PM 2.5 (6.1 \u03bcg/m 2.5 and IL-6.", {"entities": []}], ["Individuals with elevated mean inflammatory markers exhibited enhanced associations with CRP, IL-6, and WBCs.", {"entities": [[89, 92, "GENE"]]}], ["We found modest positive associations between PM 2.5 and indicators of systemic inflammation, with larger associations suggested for individuals with diabetes, obesity, hypertension, and elevated mean inflammatory markers.", {"entities": [[169, 181, "DISEASE"], [160, 167, "DISEASE"]]}], ["To improve population health, one must put emphasis on reducing health inequities and enhancing health protection and disease prevention, and early diagnosis and treatment of diseases by tackling the determinants of health at the downstream, midstream, and upstream levels.", {"entities": []}], ["There is strong theoretical and empirical evidence for the association between strong national primary care systems and improved health indicators.", {"entities": []}], ["The setting approach to promote health such as healthy schools, healthy cities also aims to address the determinants of health and build the capacity of individuals, families, and communities to create strong human and social capitals.", {"entities": []}], ["The notion of human and social capitals begins to offer explanations why certain communities are unable to achieve better health than other communities with similar demography.", {"entities": []}], ["In this paper, a review of studies conducted in different countries illustrate how a well-developed primary health care system would reduce all causes of mortalities, improve health status, reduce hospitalization, and be cost saving despite a disparity in socioeconomic conditions.", {"entities": []}], ["The intervention strategy recommended in this paper is developing a model of comprehensive primary health care system by joining up different settings integrating the efforts of different parties within and outside the health sector.", {"entities": []}], ["Different components of primary health care team would then work more closely with individuals and families and different healthy settings.", {"entities": []}], ["This synergistic effect would help to strengthen human and social capital development.", {"entities": []}], ["The model can then combine the efforts of upstream, midstream, and downstream approaches to improve population health and reduce health inequity.", {"entities": []}], ["Otherwise, health would easily be jeopardized as a result of rapid urbanization.", {"entities": []}], ["The Korea Chronic Obstructive Pulmonary Disorders Subgroup Study Team (Korea COPD Subgroup Study team, KOCOSS) is a multicenter observational study that includes 956 patients (mean age 69.9 \u00b1 7.8 years) who were enrolled from 45 tertiary and university-affiliated hospitals from December 2011 to October 2014.", {"entities": []}], ["The initial evaluation for all patients included pulmonary function tests (PFT), 6-minute walk distance (6MWD), COPD Assessment Test (CAT), modified Medical Research Council (mMRC) dyspnea scale, and the COPD-specific version of St. George\u2019s Respiratory Questionnaire (SGRQ-C).", {"entities": []}], ["Here, we report the comparison of baseline characteristics between patients with early- (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage I and II/groups A and B) and late-stage COPD (GOLD stage III and IV/groups C and D).", {"entities": []}], ["Among all patients, the mean post-bronchodilator FEV 1 was 55.8% \u00b1 16.7% of the predicted value, and most of the patients were in GOLD stage II (520, 56.9%) and group B (399, 42.0%).", {"entities": [[49, 52, "GENE"]]}], ["The number of exacerbations during one year prior to the first visit was significantly lower in patients with early COPD (0.4 vs. 0.9/0.1 vs. 1.2), as were the CAT score (13.9 vs. 18.3/13.5 vs. 18.1), mMRC (1.4 vs. 2.0/1.3 vs.1.9), and SGRQ-C total score (30.4 vs. 42.9/29.1 vs. 42.6) compared to late-stage COPD (all P < 0.001).", {"entities": []}], ["Common comorbidities among all patients were hypertension (323, 37.7%), diabetes mellitus (139, 14.8%), and depression (207, 23.6%).", {"entities": [[45, 57, "DISEASE"], [72, 89, "DISEASE"]]}], ["The data from patients with early COPD will provide important information towards early detection, proper initial management, and design of future studies.", {"entities": []}], ["Cigarette exposure increases brain oxidative stress.", {"entities": []}], ["The literature showed that increased brain oxidative stress affects cardiovascular regulation.", {"entities": []}], ["However, no previous study investigated the involvement of brain oxidative stress in animals exposed to cigarette and its relationship with cardiovascular regulation.", {"entities": []}], ["We aimed to evaluate the effects of central catalase inhibition on baroreflex and cardiovascular responses in rats exposed to sidestream cigarette smoke (SSCS).", {"entities": []}], ["We evaluated males Wistar rats (320-370 g), which were implanted with a stainless steel guide cannula into the fourth cerebral ventricle (4th V).", {"entities": []}], ["Femoral artery and vein were cannulated for mean arterial pressure (MAP) and heart rate (HR) measurement and drug infusion, respectively.", {"entities": [[89, 91, "GENE"]]}], ["Rats were exposed to SSCS during three weeks, 180 minutes, 5 days/week (CO: 100-300 ppm).", {"entities": []}], ["Baroreflex was tested with a pressor dose of phenylephrine (PHE, 8 \u03bcg/kg, bolus) to induce bradycardic reflex and a depressor dose of sodium nitroprusside (SNP, 50 \u03bcg/kg, bolus) to induce tachycardic reflex.", {"entities": []}], ["Cardiovascular responses were evaluated before, 5, 15, 30 and 60 minutes after 3-amino-1,2,4-triazole (ATZ, catalase inhibitor, 0.001 g/100 \u03bcL) injection into the 4th V. Central catalase inhibition increased basal HR in the control group during the first 5 minutes.", {"entities": [[214, 216, "GENE"]]}], ["SSCS exposure increased basal HR and attenuated bradycardic peak during the first 15 minutes.", {"entities": [[30, 32, "GENE"]]}], ["We suggest that SSCS exposure affects cardiovascular regulation through its influence on catalase activity.", {"entities": []}], ["RIG-I is a pivotal receptor that detects numerous RNA and DNA viruses.", {"entities": []}], ["Thus, its defectiveness may strongly impair the host antiviral immunity.", {"entities": []}], ["Remarkably, very little information is available on RIG-I single-nucleotide polymorphisms (SNPs) presenting a functional impact on the host response.", {"entities": []}], ["Here, we studied all non-synonymous SNPs of RIG-I using biochemical and structural modeling approaches.", {"entities": []}], ["We identified two important variants: ( i ) a frameshift mutation (P 229 fs) that generates a truncated, constitutively active receptor and ( ii ) a serine to isoleucine mutation (S 183 I), which drastically inhibits antiviral signaling and exerts a down-regulatory effect, due to unintended stable complexes of RIG-I with itself and with MAVS, a key downstream adapter protein.", {"entities": [[339, 343, "GENE"]]}], ["Hence, this study characterized P 229 fs and S 183 I SNPs as major functional RIG-I variants and potential genetic determinants of viral susceptibility.", {"entities": []}], ["This work also demonstrated that serine 183 is a residue that critically regulates RIG-I-induced antiviral signaling.", {"entities": []}], ["Diaphragm dysfunction in mechanically ventilated patients is associated with poor outcome.", {"entities": []}], ["Maximal inspiratory pressure (MIP) can be used to evaluate inspiratory muscle function.", {"entities": [[30, 33, "GENE"]]}], ["However, it is unclear whether respiratory weakness is independently associated with long-term mortality.", {"entities": []}], ["The aim of this study was to determine if low MIP is independently associated with one-year mortality.", {"entities": [[46, 49, "GENE"]]}], ["We conducted a prospective observational cohort study in an 18-bed ICU.", {"entities": []}], ["Adults requiring at least 24\u00a0hours of mechanical ventilation with scheduled extubation and no evidence of pre-existing muscle weakness underwent MIP evaluation just before extubation.", {"entities": [[145, 148, "GENE"]]}], ["Patients were divided into two groups: low MIP (MIP \u226430 cmH 2 O) and high MIP (MIP >30 cmH 2 O).", {"entities": [[43, 46, "GENE"], [48, 51, "GENE"], [74, 77, "GENE"], [79, 82, "GENE"], [43, 46, "GENE"], [48, 51, "GENE"], [74, 77, "GENE"], [79, 82, "GENE"], [43, 46, "GENE"], [48, 51, "GENE"], [74, 77, "GENE"], [79, 82, "GENE"], [43, 46, "GENE"], [48, 51, "GENE"], [74, 77, "GENE"], [79, 82, "GENE"]]}], ["Mortality was recorded for one year after extubation.", {"entities": []}], ["For the survival analysis, the effect of low MIP was assessed using the log-rank test.", {"entities": [[45, 48, "GENE"]]}], ["The independent effect of low MIP on post mechanical ventilation mortality was analyzed using a multivariable Cox regression model.", {"entities": [[30, 33, "GENE"]]}], ["One hundred and twenty-four patients underwent MIP evaluation (median age 66\u00a0years (25 p \u2009=\u20090.007).", {"entities": [[47, 50, "GENE"]]}], ["Extubation failure was also associated with low MIP (relative risk 3.0, 95\u00a0% CI 1, -9.6; p \u2009=\u20090.03) but tracheostomy and ICU length of stay were not.", {"entities": [[48, 51, "GENE"]]}], ["Low MIP is frequent in patients on mechanical ventilation and is an independent risk factor for long-term mortality in ICU patients requiring mechanical ventilation.", {"entities": [[4, 7, "GENE"]]}], ["MIP is easily evaluated at the patient\u2019s bedside.", {"entities": [[0, 3, "GENE"]]}], ["This study was retrospectively registered in www.clinicaltrials.gov (NCT02363231) in February 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-016-1418-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Research is one of the cornerstones of environmental health, providing the foundation for sound public policy and for appropriate education of communities and professionals in a myriad of disciplines.", {"entities": []}], ["Until very recently, little research in environmental health focused on exposure patterns and health outcomes for children.", {"entities": []}], ["Pediatric medicine shows that children are not just little adults; they are uniquely vulnerable.", {"entities": []}], ["Analgesics are among the most commonly consumed drugs by the world populations.", {"entities": []}], ["Within the broader context of self-medication, pain relief occupies a prominent position.", {"entities": []}], ["Our study was to ascertain the prevalence of self-medication with analgesics among the Spanish population and to identify predictors of self-medication, including psychological disorders, psychological dysfunction, mental health status, and sociodemographic and health-related variables.", {"entities": []}], ["We used individualized secondary data retrieved from the 2009 European Health Interview Survey (EHIS) for Spain to conduct a nationwide, descriptive, cross-sectional pharmacoepidemiology study on self-medication with analgesics among adults (individuals aged at least 16\u2009years) of both genders living in Spain.", {"entities": []}], ["A total of 7,606 interviews were analysed.", {"entities": []}], ["The dichotomous dependent variables chosen were the answers \u201cyes\u201d or \u201cno\u201d to the question In the last 2\u2009weeks have you taken the medicines not prescribed for you by a doctor for joint pain, headache, or low back pain?\u201d Independent variables were sociodemographic, comorbidity, and healthcare resources.", {"entities": []}], ["A total of 7,606 individuals reported pain in any of the locations (23.7%).", {"entities": []}], ["In addition, analgesic consumption was self-prescribed in 23.7% (1,481) of these subjects.", {"entities": []}], ["Forty percent (40.1%) of patients self-medicated for headache, 15.1% for low back pain, and 6.7% for joint pain.", {"entities": []}], ["The variables significantly associated with a greater likelihood of self-medication of analgesics, independently of pain location were: age 16\u201339 years (2.36\u2009<\u2009AOR\u2009<\u20093.68), higher educational level (1.80\u2009<\u2009AOR <2.21), psychological disorders (1.56\u2009<\u2009AOR\u2009<\u20091.98), and excellent/good perception of health status (1.74\u2009<\u2009AOR\u2009<\u20092.68).", {"entities": []}], ["In subjects suffering headache, self-prescription was associated with male gender (AOR 2.13) and absence of other comorbid condition (AOR 4.65).", {"entities": []}], ["This pharmacoepidemiology study constitutes an adequate approach to analgesic self-medication use in the Spanish population, based on a representative nationwide sample.", {"entities": []}], ["Self-prescribed analgesic consumption was higher in young people with higher educational level, higher income, smoker, and with psychological disorders and with a good perception of their health status independently of the location of pain.", {"entities": []}], ["The increase in forced expiratory volume in one second (FEV 1 ) effected by a bronchodilator is routinely assessed when patients undertake pulmonary function testing (PFT).", {"entities": [[56, 59, "GENE"]]}], ["Several drug classes can theoretically affect the magnitude of the increase in FEV 1 .", {"entities": [[79, 82, "GENE"]]}], ["Withholding periods are advised for many but not all such drugs.", {"entities": []}], ["Anecdotally, many subjects presenting for PFT are found to have taken drugs that might affect the test.", {"entities": []}], ["We did an audit of patients presenting for PFT to assess the frequency with which FEV 1 reversibility might be affected by drugs.", {"entities": [[82, 85, "GENE"]]}], ["One hundred subjects presenting to the laboratory for PFT were questioned about recent drug consumption by an independent pharmacy intern.", {"entities": []}], ["Reversibility of FEV 1 was assumed to have been affected if drugs of interest were consumed within defined withholding periods or two half-lives for drugs without such data.", {"entities": [[17, 20, "GENE"]]}], ["Sixty-three subjects were prescribed drugs likely to affect FEV 1 reversibility.", {"entities": [[60, 63, "GENE"]]}], ["Thirty-six subjects consumed at least one such drug within the withholding period.", {"entities": []}], ["Half (18) of these patients consumed \u03b2-blockers with or without \u03b2-agonists.", {"entities": []}], ["Sixty-five subjects did not recall receiving any advice about withholding drugs prior to the test and only 10 recalled receiving advice from their clinician or pulmonary function technician.", {"entities": []}], ["Subjects presenting for PFT are infrequently advised to withhold drugs that may affect FEV 1 reversibility, and consequently, often take such drugs close to the time of the test.", {"entities": [[87, 90, "GENE"]]}], ["Therefore, it is likely that the increase in FEV 1 is frequently affected by interference from drugs and this might impact on diagnosis and/or treatment options.", {"entities": [[45, 48, "GENE"]]}], ["The impact of patient physiology on cancer-specific survival is poorly documented.", {"entities": [[36, 42, "DISEASE"]]}], ["Patient physiology predicted overall, cancer-specific (Physiology Score > 30; HR 8.64 (95% CI 3.00\u201324.92); P =0.0005) and recurrence-free survival (Physiology Score > 30; HR 7.44 (95% CI 1.99\u201327.73); P =0.003) independent of Dukes stage following potentially curative surgery for colorectal cancer.", {"entities": [[280, 297, "DISEASE"], [38, 44, "DISEASE"], [291, 297, "DISEASE"], [78, 80, "GENE"], [171, 173, "GENE"], [78, 80, "GENE"], [171, 173, "GENE"]]}], ["This independent negative association with survival is a novel observation.", {"entities": []}], ["A common characteristic of health systems in most developing countries is unequal access to health services.", {"entities": []}], ["As a result, members of the poorest population groups often do not receive formal attention for health services, because they cannot afford it.", {"entities": []}], ["In 2001 in Mexico, to address income-related differences in the use of health services, the government launched a major healthcare reform, which includes a health insurance program called Seguro Popular , aimed at improving healthcare access among poor, uninsured residents.", {"entities": []}], ["This paper analyzes the before and after changes in the demand for curative ambulatory health services focusing on the association of income-related characteristics and the utilization of formal healthcare providers vs. no healthcare service utilization.", {"entities": []}], ["By using two nationally representative health surveys (ENSA-2000 and ENSANUT-2006), we modeled an individual's decision when experiencing an illness to use services provided by the (1) Ministry of Health (MoH), (2) social security, (3) private entities, or (4) to not use formal services (no healthcare service utilization).", {"entities": []}], ["Poorer individuals were more likely in 2006 than in 2000 to respond to an illness by using formal healthcare providers.", {"entities": []}], ["Trends in provider selection differed, however.", {"entities": []}], ["The probability of using public services from the MoH increased among the poorest population, while the findings indicated an increase in utilization of private health services among members of low- and middle-income groups.", {"entities": []}], ["No significant change was seen among formal workers -covered by social security services-, regardless of socioeconomic status.", {"entities": []}], ["Overall, for 2006 the Mexican population appears less differentiated in using healthcare across economic groups than in 2000.", {"entities": []}], ["This may be related, in part, to the implementation of Seguro Popular , which seems to be stimulating healthcare demand among the poorest and previously uninsured segment of the population.", {"entities": []}], ["Still, public health authorities need to address the remaining income-related healthcare utilization differences, the differences in quality between public and private health services, and the general perception that MoH facilities offer inferior services.", {"entities": []}], ["Primary cardiac spindle cell sarcomas are extremely rare and have poor prognosis.", {"entities": []}], ["Complete surgical resection represents the only treatment option proven to work.", {"entities": []}], ["We report a case of a 28-year-old man who was referred to our cardiothoracic unit with a right ventricular mass extending to the main pulmonary artery with a provisional diagnosis of a thrombus or a right ventricular myxoma.", {"entities": []}], ["He sought medical attention after experiencing shortness of breath, cough, chest pain, abdominal pain and bilateral leg swelling for about 6\u00a0weeks.", {"entities": []}], ["Two dimensional transthoracic echocardiogram showed a mass arising from the right ventricle and extending into the main pulmonary artery; findings that were confirmed with contrast chest CT scan.", {"entities": []}], ["He underwent extensive resection of the mass and had uneventful postoperative period with immediate symptomatic relieve.", {"entities": []}], ["He is on adjuvant chemotherapy using vincristine, adriamycin and cyclophosphamide (VAC).", {"entities": []}], ["Right ventricular sarcoma is a very rare cause of right sided heart failure, a very aggressive tumour whose only chance of successful treatment is complete surgical excision.", {"entities": [[18, 25, "DISEASE"]]}], ["Theophylline has been used for decades to treat both acute and chronic asthma.", {"entities": [[71, 77, "DISEASE"]]}], ["Despite its longevity in the practitioner\u2019s formulary, no detailed meta-analysis has been performed to determine the conditions, including concomitant medications, under which theophylline should be used for acute exacerbations of asthma.", {"entities": [[231, 237, "DISEASE"]]}], ["We aimed to quantify the usefulness and side effects of theophylline with or without ethylene diamine (aminophylline) in acute asthma, with particular emphasis on patient subgroups, such as children, adults, and concomitant medications.", {"entities": [[127, 133, "DISEASE"]]}], ["We searched PubMed, EMBASE, The Cochrane Library, ClinicalTrials.gov , and the WHO Clinical Trials Registry for randomized, controlled clinical trials.", {"entities": []}], ["We planned a priori subgroup analyses by time post-medication, concomitant medication, control type, and age.", {"entities": []}], ["We included 52 study arms from 42 individual trials.", {"entities": []}], ["Of these, 29 study arms included an active control, such as adrenaline, beta-2 agonists, or leukotriene receptor antagonists, and 23 study arms compared theophylline (with or without ethylene diamine) with placebo or no drug.", {"entities": []}], ["Theophylline significantly reduced heart rate when compared with active control ( p =0.01) and overall duration of stay ( p =0.002), but beta-2 agonists were superior to theophylline at improving forced expiratory volume in one second (FEV1) ( p =0.002).", {"entities": []}], ["Theophylline was not significantly different from other drugs in its effects on respiratory rate, forced vital capacity (FVC), peak expiratory flow rate, admission rate, use of rescue medication, oxygen saturation, or symptom score.", {"entities": []}], ["Closer examination of the data revealed that the medications given in addition to theophylline or control significantly changed the effectiveness of theophylline (subgroup difference: p <0.00001).", {"entities": []}], ["Given the low cost of theophylline, and its similar efficacy and rate of side effects compared with other drugs, we suggest that theophylline, when given with bronchodilators with or without steroids, is a cost-effective and safe choice for acute asthma exacerbations.", {"entities": [[247, 253, "DISEASE"]]}], ["Electronic waste (e-waste) has been an emerging environmental health issue in both developed and developing countries, but its current management practice may result in unintended developmental neurotoxicity in vulnerable populations.", {"entities": []}], ["To provide updated information about the scope of the issue, presence of known and suspected neurotoxicants, toxicologic mechanisms, and current data gaps, we conducted this literature review.", {"entities": []}], ["We reviewed original articles and review papers in PubMed and Web of Science regarding e-waste toxicants and their potential developmental neurotoxicity.", {"entities": []}], ["We also searched published reports of intergovernmental and governmental agencies and nongovernmental organizations on e-waste production and management practice.", {"entities": []}], ["We focused on the potential exposure to e-waste toxicants in vulnerable populations\u2014that is, pregnant women and developing children\u2014and neurodevelopmental outcomes.", {"entities": []}], ["In addition, we summarize experimental evidence of developmental neurotoxicity and mechanisms.", {"entities": []}], ["In developing countries where most informal and primitive e-waste recycling occurs, environmental exposure to lead, cadmium, chromium, polybrominated diphenyl ethers, polychlorinated biphenyls, and polycyclic aromatic hydrocarbons is prevalent at high concentrations in pregnant women and young children.", {"entities": []}], ["Developmental neurotoxicity is a serious concern in these regions, but human studies of adverse effects and potential mechanisms are scarce.", {"entities": []}], ["The unprecedented mixture of exposure to heavy metals and persistent organic pollutants warrants further studies and necessitates effective pollution control measures.", {"entities": []}], ["Pregnant women and young children living close to informal e-waste recycling sites are at risk of possible perturbations of fetus and child neurodevelopment.", {"entities": []}], ["Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and scarring as well as a broad spectrum of signs and symptoms.", {"entities": []}], ["It is caused by an autoimmune response to self-antigens in a genetically susceptible individual induced by unknown environmental factors.", {"entities": []}], ["Principal cells of the immune system that drive the immunopathological processes are T cells, especially of T H 1 and T H 17 subsets.", {"entities": []}], ["However, in recent years, it was disclosed that regulatory T cells took part in, too.", {"entities": []}], ["Subsequently, there was endeavour to develop ways how to re-establish their physiological functions.", {"entities": []}], ["In this review, we describe known mechanisms of action, efficacy, and side-effects of contemporary and emerging MS immunotherapeutical agents on Treg cells and other cells of the immune system involved in the immunopathogenesis of the disease.", {"entities": []}], ["Furthermore, we discuss how laboratory immunology can offer physicians its help in the diagnosis process and decisions what kind of biological therapy should be used.", {"entities": []}], ["This paper examines the ethnic and gender differentials in high blood pressure (HBP), diabetes, coronary heart disease (CHD), arthritis and asthma among older people in Malaysia, and how these diseases along with other factors affect self-rated health.", {"entities": [[105, 118, "DISEASE"], [96, 118, "DISEASE"], [126, 135, "DISEASE"], [140, 146, "DISEASE"]]}], ["Differentials in the prevalence of non-communicable diseases among older people are examined in the context of socio-cultural perspectives in multi-ethnic Malaysia.", {"entities": []}], ["Data for this paper are obtained from the 2004 Malaysian Population and Family Survey.", {"entities": []}], ["The survey covered a nationally representative sample of 3,406 persons aged 50 and over, comprising three main ethnic groups (Malays, Chinese and Indians) and all other indigenous groups.", {"entities": []}], ["Bivariate analyses and hierarchical logistic regression were used in the analyses.", {"entities": []}], ["Arthritis was the most common non-communicable disease (NCD), followed by HBP, diabetes, asthma and CHD.", {"entities": [[0, 9, "DISEASE"], [89, 95, "DISEASE"]]}], ["Older females were more likely than males to have arthritis and HBP, but males were more likely to have asthma.", {"entities": [[50, 59, "DISEASE"], [104, 110, "DISEASE"]]}], ["Diabetes and CHD were most prevalent among Indians, while arthritis and HBP were most prevalent among the Indigenous groups.", {"entities": [[58, 67, "DISEASE"]]}], ["Older people were more likely to report poor health if they suffered from NCD, especially CHD.", {"entities": []}], ["Controlling for socio-economic, health and lifestyle factors, Chinese were least likely to report poor health, whereas Indians and Indigenous people were more likely to do so.", {"entities": []}], ["Chinese that had HBP were more likely to report poor health compared to other ethnic groups with the same disease.", {"entities": []}], ["Among those with arthritis, Indians were more likely to report poor health.", {"entities": [[17, 26, "DISEASE"]]}], ["Perceived health status and prevalence of arthritis, HBP, diabetes, asthma and CHD varied widely across ethnic groups.", {"entities": [[42, 51, "DISEASE"], [68, 74, "DISEASE"]]}], ["Promotion of healthy lifestyle, early detection and timely intervention of NCDs affecting different ethnic groups and gender with socio-cultural orientations would go a long way in alleviating the debilitating effects of the common NCDs among older people.", {"entities": []}], ["The C-C chemokines RANTES and monocyte chemotactic protein-3 (MCP-3) are potent chemoattractants in vitro for eosinophils and other cell types associated with allergic reactions.", {"entities": []}], ["We tested the hypothesis that the allergen-induced infiltration of eosinophils, T cells, and macrophages in the skin of atopic subjects is accompanied by the appearance of mRNA+ cells for RANTES and MCP-3.", {"entities": []}], ["Cryostat sections were obtained from skin biopsies from six subjects 6, 24, and 48 h after allergen challenge.", {"entities": []}], ["Tissue was processed for immunocytochemistry (ICC) and for in situ hybridization using 35S-labeled riboprobes for RANTES and MCP-3.", {"entities": []}], ["In contrast to diluent controls, allergen provoked a significant increase in mRNA+ cells for MCP-3, which peaked at 6 h and progressively declined at 24 and 48 h. This paralleled the kinetics of total (major basic protein positive [MBP]+) and activated (cleaved form of eosinophil cationic protein [EG2]+) eosinophil infiltration.", {"entities": [[232, 235, "GENE"]]}], ["The allergen-induced expression of cells mRNA+ for RANTES was also clearly demonstrable at 6 h. However, the numbers were maximal at 24 h and declined slightly at the 48-h time point.", {"entities": []}], ["The number of mRNA+ cells for RANTES paralleled the kinetics of infiltration of CD3+, CD4+, and CD8+ T cells whereas the number of CD68+ macrophages was still increasing at 48 h. These data support the view that MCP-3 is involved in the regulation of the early eosinophil response to specific allergen, whereas RANTES may have more relevance to the later accumulation of T cells and macrophages.", {"entities": []}], ["Transforming growth factor-beta 1(TGF-\u03b21) is involved in the development of acute rejection (AR) episodes in solid organ transplant recipients; and a number of studies have been conducted to investigate the combined effects of human TGF-\u03b21 gene ( TGFB1 ) +869 T/C and +915 G/C polymorphisms on AR risk.", {"entities": [[247, 252, "GENE"]]}], ["However, the results obtained are inconclusive.", {"entities": []}], ["Eligible studies that investigated the haplotypic association between TGFB1 +869 T/C and +915 G/C polymorphisms and AR risk were comprehensively searched in the PUBMED, EMBASE, China National Knowledge Infrastructure, and Wanfang Database.", {"entities": [[70, 75, "GENE"]]}], ["Statistical analyses were performed by using STATA 12.0 and Review Manager 5.0.", {"entities": []}], ["Fourteen eligible studies with 565 AR cases and 1219 non-AR cases were included.", {"entities": []}], ["Overall, a significantly decreased risk was detected in patients carried with intermediate producer (IP) haplotypes (T/C G/C, T/T G/C, and C/C G/G) and/or low producer (LP) haplotypes (C/C G/C, C/C C/C, T/T C/C, and T/C C/C) compared with high producer (HP) haplotypes (T/T G/G and T/C G/G; IP vs. HP: OR\u200a=\u200a0.75, 95% CI, 0.58\u20130.96, P heterogeneity \u200a=\u200a0.238; IP/LP vs. HP: OR \u200a=\u200a0.77, 95% CI, 0.61\u20130.98, P heterogeneity \u200a=\u200a0.144).", {"entities": [[254, 256, "GENE"], [298, 300, "GENE"], [368, 370, "GENE"], [254, 256, "GENE"], [298, 300, "GENE"], [368, 370, "GENE"], [254, 256, "GENE"], [298, 300, "GENE"], [368, 370, "GENE"]]}], ["In addition, subgroup analysis by transplant types demonstrated a similar association in patients receiving heart transplant (IP vs. HP: OR \u200a=\u200a0.32, 95% CI, 0.14\u20130.73, P heterogeneity \u200a=\u200a0.790; IP/LP vs. HP: OR \u200a=\u200a0.41, 95% CI, 0.20\u20130.85, P heterogeneity \u200a=\u200a0.320).", {"entities": [[133, 135, "GENE"], [204, 206, "GENE"], [133, 135, "GENE"], [204, 206, "GENE"]]}], ["The current meta-analysis and systematic review indicated that recipient TGFB1 HP haplotypes were significantly associated with an increased risk for AR in solid organ transplant recipients, particularly patients receiving cardiac allograft.", {"entities": [[73, 78, "GENE"], [79, 81, "GENE"]]}], ["Health care personnel need access to updated information anywhere and at any time, and a Personal Digital Assistant (PDA) has the potential to meet these requirements.", {"entities": []}], ["A PDA is a mobile tool which has been employed widely for various purposes in health care practice, and the level of its use is expected to increase.", {"entities": []}], ["Loaded with suitable functions and software applications, a PDA might qualify as the tool that personnel and students in health care need.", {"entities": []}], ["In Sweden today, despite its leadership role in mobile technologies, PDAs are not commonly used, and there is a lack of suitable functions and software applications.", {"entities": []}], ["The aim of the present review was to obtain an overview of existing research on the use of PDAs among personnel and students in health care.", {"entities": []}], ["The literature search included original peer-reviewed research articles written in English and published from 1996 to 2008.", {"entities": []}], ["All study designs were considered for inclusion.", {"entities": []}], ["We excluded reviews and studies focusing on the use of PDAs in classroom situations.", {"entities": []}], ["From March 2006 to the last update in May 2008, we searched PubMed, CINAHL, Cochrane, IngentaConnect, and a local search engine (ELIN@Kalmar).", {"entities": []}], ["We conducted a content analysis, using Nielsen\u2019s Model of System Acceptability as a theoretical framework in structuring and presenting the results.", {"entities": []}], ["From the 900 references initially screened, 172 articles were selected and critically assessed until 48 articles remained.", {"entities": []}], ["The majority originated in North-America (USA: n=24, Canada: n=11).", {"entities": []}], ["The categories which emerged from our content analysis coincided to a certain extent to Nielsen\u2019s Model of System Acceptability (social and practical acceptability), including usefulness (utility and usability) subcategories such as learnability, efficiency, errors, and satisfaction.", {"entities": []}], ["The studies showed that health care personnel and students used PDAs in patient care with varied frequency.", {"entities": []}], ["Most of the users were physicians.", {"entities": []}], ["There is some evidence that the use of a PDA in health care settings might improve decision-making, reduce the numbers of medical errors, and enhance learning for both students and professionals, but the evidence is not strong, with most studies being descriptive, and only 6 randomized controlled trials.", {"entities": []}], ["Several special software programs have been created and tested for PDAs, and a wide range of situations for their use have been reported for different patient groups.", {"entities": []}], ["Drug and medical information were commonly accessed by PDA users, and the PDA was often viewed as the preferred tool when compared to paper-based documents.", {"entities": []}], ["Some users regarded the PDA easy to operate, while others found it difficult in the beginning.", {"entities": []}], ["This overview of the use of PDAs revealed a positive attitude towards the PDA, which was regarded as a feasible and convenient tool.", {"entities": []}], ["The possibility of immediate access to medical information has the potential to improve patient care.", {"entities": []}], ["The PDA seems to be a valuable tool for personnel and students in health care, but there is a need for further intervention studies, randomized controlled trials, action research, and studies with various health care groups in order to identify its appropriate functions and software applications.", {"entities": []}], ["Immunological markers (CD4 count) are used in developing countries to decide on initiation of antiretroviral therapy and monitor HIV/AIDS disease progression.", {"entities": [[23, 26, "GENE"]]}], ["HIV is an incurable chronic illness, making quality of life paramount.", {"entities": []}], ["The direct relationship between quality of life and CD4 count is unclear.", {"entities": [[52, 55, "GENE"]]}], ["The purpose of this study is to determine the relationship between change in CD4 count and quality of life measures in a Ugandan cohort of people living with HIV.", {"entities": [[77, 80, "GENE"]]}], ["We prospectively assessed quality of life among 1274 HIV patients attending an HIV clinic within a national referral hospital over a period of 6\u00a0months.", {"entities": []}], ["Quality of life was measured using an objective measure, the Medical Outcomes Study HIV health survey summarized as Physical Health Score and Mental Health Score and a subjective measure, the Global Person Generated Index.", {"entities": []}], ["Generalized estimating equations were used to analyze the data.", {"entities": []}], ["The primary predictor variable was change in CD4 count, and the outcome was quality of life scores.", {"entities": [[45, 48, "GENE"]]}], ["We controlled for sociodemographic characteristics, clinical factors and behavioral factors.", {"entities": []}], ["Twenty in-depth interviews were conducted to assess patient perception of quality of life and factors influencing quality of life.", {"entities": []}], ["Of the 1274 patients enrolled 1159 had CD4 count at baseline and six months and 586 (51\u00a0%) received antiretroviral therapy.", {"entities": [[39, 42, "GENE"]]}], ["There was no association found between change in CD4 count and quality of life scores at univariate and multivariate analysis among the study participants whether on or not on antiretroviral therapy.", {"entities": [[49, 52, "GENE"]]}], ["Participants perceived quality of life as happiness and well-being, influenced by economic status, psychosocial factors, and health status.", {"entities": []}], ["Clinicians and policy makers cannot rely on change in immunological markers to predict quality of life in this era of initiating antiretroviral therapy among relatively healthy patients.", {"entities": []}], ["In addition to monitoring immunological markers, socioeconomic and psychosocial factors should be underscored in management of HIV patients.", {"entities": []}], ["Few longitudinal data exist on the incidence of asthma in young adults and on the overall mortality risk due to asthma.", {"entities": [[48, 54, "DISEASE"], [112, 118, "DISEASE"]]}], ["A 7-year follow-up prospective study was performed to assess the incidence of asthma and mortality from all causes in a cohort of young adults.", {"entities": [[78, 84, "DISEASE"]]}], ["The life status of a cohort of 6031 subjects, aged 20\u201344 years, who replied to a respiratory screening questionnaire between 1991 and 1992, was ascertained in 1999.", {"entities": []}], ["A new questionnaire investigating the history of asthma was subsequently sent to the 5236 subjects who were still alive and residents in the areas of the study.", {"entities": [[49, 55, "DISEASE"]]}], ["3880 subjects (74%) replied to the second questionnaire.", {"entities": []}], ["The incidence of adult-onset asthma was 15.3/10,000/year (95%CI:11.2\u201320.8).", {"entities": [[29, 35, "DISEASE"]]}], ["The presence of asthma-like symptoms (IRR:4.17; 95%CI:2.20\u20137.87) and allergic rhinitis (IRR:3.30; 95%CI:1.71\u20136.36) at baseline were independent predictors of the onset of asthma, which was more frequent in women (IRR:2.32; 95%CI:1.16\u20134.67) and increased in the younger generations.", {"entities": [[69, 86, "DISEASE"], [78, 86, "DISEASE"], [16, 22, "DISEASE"], [171, 177, "DISEASE"]]}], ["The subjects who reported asthma attacks or nocturnal asthma symptoms at baseline had an excess mortality risk from all causes (SMR = 2.05; 95%CI:1.06\u20133.58) in the subsequent seven years.", {"entities": [[26, 32, "DISEASE"], [54, 60, "DISEASE"]]}], ["The excess mortality was mainly due to causes not related to respiratory diseases.", {"entities": []}], ["Asthma occurrence is a relevant public health problem even in young adults.", {"entities": [[0, 6, "DISEASE"]]}], ["The likelihood of developing adult onset asthma is significantly higher in people suffering from allergic rhinitis, in women and in more recent generations.", {"entities": [[97, 114, "DISEASE"], [106, 114, "DISEASE"], [41, 47, "DISEASE"]]}], ["The presence of asthma attacks and nocturnal symptoms seems to be associated with a potential excess risk of all causes mortality.", {"entities": [[16, 22, "DISEASE"]]}], ["Childhood asthma is a recurring health burden and symptoms of severe asthma in children are also emerging as a health and economic issue.", {"entities": [[10, 16, "DISEASE"], [69, 75, "DISEASE"]]}], ["This study examined changing patterns in symptoms of severe asthma and allergies (ever eczema and hay fever), using the Irish International Study of Asthma and Allergies in Childhood (ISAAC) protocol.", {"entities": [[60, 66, "DISEASE"], [149, 155, "DISEASE"]]}], ["ISAAC is a cross-sectional self-administered questionnaire survey of randomly selected representative post-primary schools.", {"entities": []}], ["Children aged 13\u201314 years were studied: 2,670 (in 1995), 2,273 (in 1998), 2,892 (in 2002\u20132003), and 2,805 (in 2007).", {"entities": []}], ["Generalized linear modelling using Poisson distribution was employed to compute adjusted prevalence ratios (PR).", {"entities": []}], ["A 39% significant increase in symptoms of severe asthma was estimated in 2007 relative to the baseline year 1995 (adjusted PR: 1.39 [95% CI: 1.14\u20131.69]) increasing from 12% in 1995 to 15.3% in 2007.", {"entities": [[49, 55, "DISEASE"]]}], ["Opposite trends were observed for allergies, showing a decline in 2007, with an initial rise.", {"entities": []}], ["The potential explanations for such a complex disease pattern whose aetiological hypothesis is still evolving are speculative.", {"entities": []}], ["Changing environmental factors may be a factor, for instance, an improvement in both outdoor and indoor air quality further reinforcing the hygiene hypothesis but obesity as a disease modifier must also be considered.", {"entities": [[163, 170, "DISEASE"]]}], ["Housing has been a relatively neglected site for public health action.", {"entities": []}], ["However, it remains a place where human beings spend the most part of their day.", {"entities": []}], ["As a result, the quality of housing has consequences for human health.", {"entities": []}], ["We investigate residential characteristics associated with self-rated occupant health in five neighbourhoods in the Greater Accra Region, Ghana.", {"entities": []}], ["A cross sectional study using a semi-structured questionnaire was conducted among 500 informed adults aged 18 years and above to investigate residential characteristics associated with self-rated occupant health in five neighbourhoods in the Greater Accra Region, Ghana.", {"entities": []}], ["Correlates of occupant rated health were determined using Pearson chi-square test and binary logistic regression.", {"entities": []}], ["Forty-two per cent of houses were rented, 44% required repair and 46% shared sanitation facilities.", {"entities": []}], ["One in twenty occupants reported poor health.", {"entities": []}], ["Gender, employment status, income, ventilation, house wall material, odours, stale air, privacy, shared facilities, hand washing facility, type of house and house repair status were associated with poor health in the bivariate analysis.", {"entities": []}], ["Only two variables were independently associated with poor self-rated health: occupants who lacked privacy were eight times more likely to report poor self-rated health when compared to peers who did not lack privacy [OR = 8.16, 95% CI 2.86-23.26] and women were three times more likely than men to report poor health [OR = 2.98, 95% CI 1.06-8.35].", {"entities": []}], ["The results provide further evidence of housing as a determinant of occupants\u2019 health, and identify housing characteristics and living conditions as issues for public health action in Ghana.", {"entities": []}], ["Studies indicate a relationship between cost and quality of life (QOL) in diabetes care, however, the interaction is complex and the relationship is not well understood.", {"entities": []}], ["The aim of this study was to 1) examine the relationship of quartiles of QOL on cost amongst U.S. adults with diabetes, 2) investigate how the relationship may change over time, and 3) examine the incremental effect of QOL on cost while controlling for other relevant covariates.", {"entities": []}], ["Data from 2002\u20132011 Medical Expenditure Panel Survey (MEPS) was used to examine the association between QOL and medical expenditures among adults with diabetes (aged \u226518 years) N \u2009=\u200920,442.", {"entities": []}], ["Unadjusted means were computed to compare total healthcare expenditure and the out-of-pocket expenses by QOL quartile categories.", {"entities": []}], ["QOL measures were Physical Component Summary (PCS) and Mental Component Summary (MCS) derived from the Short-Form 12.", {"entities": []}], ["A two-part model was then used to estimate adjusted incremental total healthcare expenditure and out-of-pocket expenses adjusting for relevant covariates.", {"entities": []}], ["Differences between the highest and lowest quartiles totaled $11,801 for total expenditures and $989 for out-of-pocket expenses.", {"entities": []}], ["Over time, total expenditures remained stable, while out-of-pocket expenses decreased, particularly for the lowest quartile of physical component of QOL.", {"entities": []}], ["Similar trends were seen in the mental component, however, differences between quartiles were smaller (average $5,727 in total expenses; $287 in out-of-pocket).", {"entities": []}], ["After adjusting for covariates, those in the highest quartile of physical component of QOL spent $7,500 less, and those in the highest quartile of mental component spent $3,000 less than those in the lowest quartiles.", {"entities": []}], ["A clear gradient between QOL and cost with increasing physical and mental QOL associated with lower expenditures and out-of-pocket expenses was found.", {"entities": []}], ["Over a 10-year time period those with the highest physical QOL had significantly less medical expenditures compared to those with the lowest physical QOL.", {"entities": []}], ["This study demonstrates the significant individual and societal impact poor QOL has on patients with diabetes.", {"entities": []}], ["Understanding how differences in a subjective measure of health, such as QOL, has on healthcare expenditures helps reveal the burden of disease not reflected by using only behavioral and physiological measures.", {"entities": []}], ["The majority of people with dementia have other long-term diseases, the presence of which may affect the progression and management of dementia.", {"entities": [[28, 36, "DISEASE"], [135, 143, "DISEASE"]]}], ["This study aimed to identify subgroups with higher healthcare needs, by analysing how primary care consultations, number of prescriptions and hospital admissions by people with dementia varies with having additional long-term diseases (comorbidity).", {"entities": [[177, 185, "DISEASE"]]}], ["A retrospective cohort study based on health data from the Clinical Practice Research Datalink (CPRD) was conducted.", {"entities": []}], ["Incident cases of dementia diagnosed in the year starting 1/3/2008 were selected and followed for up to 5\u2005years.", {"entities": [[18, 26, "DISEASE"]]}], ["The number of comorbidities was obtained from a set of 34 chronic health conditions.", {"entities": []}], ["Service usage (primary care consultations, hospitalisations and prescriptions) and time-to-death were determined during follow-up.", {"entities": []}], ["Multilevel negative binomial regression and Cox regression, adjusted for age and gender, were used to model differences in service usage and death between differing numbers of comorbidities.", {"entities": []}], ["Data from 4999 people (14\u2005866 person-years of follow-up) were analysed.", {"entities": []}], ["Overall, 91.7% of people had 1 or more additional comorbidities.", {"entities": []}], ["Compared with those with 2 or 3 comorbidities, people with \u22656 comorbidities had higher rates of primary care consultations (rate ratio (RR) 1.31, 95% CI 1.25 to 1.36), prescriptions (RR 1.68, 95% CI 1.57 to 1.81), and hospitalisation (RR 1.62, 95% CI 1.44 to 1.83), and higher risk of death (HR 1.56, 95% CI 1.37 to 1.78).", {"entities": [[292, 294, "GENE"]]}], ["In the UK, people with dementia with higher numbers of comorbidities die earlier and have considerably higher health service usage in terms of primary care consultations, hospital admissions and prescribing.", {"entities": [[23, 31, "DISEASE"]]}], ["This study provides strong evidence that comorbidity is a key factor that should be considered when allocating resources and planning care for people with dementia.", {"entities": [[155, 163, "DISEASE"]]}], ["The discovery of the T helper (Th) 17 lineage, involved in the protection against fungal and extracellular bacterial infections, has profoundly revolutionized our current understanding of T cell-mediated responses in autoimmune diseases, including multiple sclerosis (MS).", {"entities": [[248, 266, "DISEASE"]]}], ["Indeed, recent data demonstrate the pathogenic role of Th17 cells in autoimmune disorders.", {"entities": []}], ["In particular, studies in MS and in its animal model (EAE, experimental autoimmune encephalomyelitis) have revealed a crucial role of Th17 cells in the pathogenesis of autoimmune demyelinating diseases in both mice and humans.", {"entities": [[83, 100, "DISEASE"]]}], ["Over the past years, several important aspects concerning Th17 cells have been elucidated, such as the factors which promote or inhibit their differentiation and the effector cytokines which mediate their responses.", {"entities": []}], ["The identification of the features endowing Th17 cells with high pathogenicity in MS is of particular interest, and discoveries in Th17 cell biology and function could lead to the design of new strategies aimed at modulating the immune response in MS.", {"entities": []}], ["Here, we will discuss recent advances in this field, with particular focus on the mechanisms conferring pathogenicity in MS and their potential modulation.", {"entities": []}], ["Patients' health related quality of life (HRQoL) has rarely been systematically monitored in general practice.", {"entities": []}], ["Electronic tools and practice training might facilitate the routine application of HRQoL questionnaires.", {"entities": []}], ["Thorough piloting of innovative procedures is strongly recommended before the conduction of large-scale studies.", {"entities": []}], ["Therefore, we aimed to assess i) the feasibility and acceptance of HRQoL assessment using tablet computers in general practice, ii) the perceived practical utility of HRQoL results and iii) to identify possible barriers hindering wider application of this approach.", {"entities": []}], ["Two HRQoL questionnaires (St. George's Respiratory Questionnaire SGRQ and EORTC QLQ-C30) were electronically presented on portable tablet computers.", {"entities": []}], ["Wireless network (WLAN) integration into practice computer systems of 14 German general practices with varying infrastructure allowed automatic data exchange and the generation of a printout or a PDF file.", {"entities": []}], ["General practitioners (GPs) and practice assistants were trained in a 1-hour course, after which they could invite patients with chronic diseases to fill in the electronic questionnaire during their waiting time.", {"entities": []}], ["We surveyed patients, practice assistants and GPs regarding their acceptance of this tool in semi-structured telephone interviews.", {"entities": []}], ["The number of assessments, HRQoL results and interview responses were analysed using quantitative and qualitative methods.", {"entities": []}], ["Over the course of 1 year, 523 patients filled in the electronic questionnaires (1\u20135 times; 664 total assessments).", {"entities": []}], ["On average, results showed specific HRQoL impairments, e.g.", {"entities": []}], ["with respect to fatigue, pain and sleep disturbances.", {"entities": []}], ["The number of electronic assessments varied substantially between practices.", {"entities": []}], ["A total of 280 patients, 27 practice assistants and 17 GPs participated in the telephone interviews.", {"entities": []}], ["Almost all GPs (16/17 = 94%; 95% CI = 73\u201399%), most practice assistants (19/27 = 70%; 95% CI = 50\u201386%) and the majority of patients (240/280 = 86%; 95% CI = 82\u201391%) indicated that they would welcome the use of electronic HRQoL questionnaires in the future.", {"entities": []}], ["GPs mentioned availability of local health services (e.g.", {"entities": []}], ["supportive, physiotherapy) (mean: 9.4 \u00b1 1.0 SD; scale: 1 \u2013 10), sufficient extra time (8.9 \u00b1 1.5) and easy interpretation of HRQoL results (8.6 \u00b1 1.6) as the most important prerequisites for their use.", {"entities": []}], ["They believed HRQoL assessment facilitated both communication and follow up of patients' conditions.", {"entities": []}], ["Practice assistants emphasised that this process demonstrated an extra commitment to patient centred care; patients viewed it as a tool, which contributed to the physicians' understanding of their personal condition and circumstances.", {"entities": []}], ["This pilot study indicates that electronic HRQoL assessment is technically feasible in general practices.", {"entities": []}], ["It can provide clinically significant information, which can either be used in the consultation for routine care, or for research purposes.", {"entities": []}], ["While GPs, practice assistants and patients were generally positive about the electronic procedure, several barriers (e.g.", {"entities": []}], ["practices' lack of time and routine in HRQoL assessment) need to be overcome to enable broader application of electronic questionnaires in every day medical practice.", {"entities": []}], ["Cardiovascular disease (CVD) is a common comorbidity in people with asthma.", {"entities": [[68, 74, "DISEASE"]]}], ["However, safety concerns have caused heterogeneity in clinical guideline recommendations over the use of cardioselective beta-blockers in people with asthma and CVD, partly because risk in the general population has been poorly quantified.", {"entities": [[150, 156, "DISEASE"]]}], ["The aim of this study was to measure the risk of asthma exacerbations with beta-blockers prescribed to a general population with asthma and CVD.", {"entities": [[49, 55, "DISEASE"], [129, 135, "DISEASE"]]}], ["Linked data from the UK Clinical Practice Research Datalink was used to perform nested case-control studies among people with asthma and CVD matched on age, sex and calendar time.", {"entities": [[126, 132, "DISEASE"]]}], ["Adjusted incidence rate ratios (IRR) were calculated for the association between oral beta-blocker use and moderate asthma exacerbations (rescue oral steroids) or severe asthma exacerbations (hospitalisation or death) using conditional logistic regression.", {"entities": [[116, 122, "DISEASE"], [170, 176, "DISEASE"]]}], ["The cohort consisted of 35,502 people identified with active asthma and CVD, of which 14.1% and 1.2% were prescribed cardioselective and non-selective beta-blockers, respectively, during follow-up.", {"entities": [[61, 67, "DISEASE"]]}], ["Cardioselective beta-blocker use was not associated with a significantly increased risk of moderate or severe asthma exacerbations.", {"entities": [[110, 116, "DISEASE"]]}], ["Consistent results were obtained following sensitivity analyses and a self-controlled case series approach.", {"entities": []}], ["In contrast, non-selective beta-blockers were associated with a significantly increased risk of moderate asthma exacerbations when initiated at low to moderate doses (IRR 5.16, 95% CI 1.83\u201314.54, P \u2009=\u20090.002), and both moderate and severe exacerbations when prescribed chronically at high dose (IRR 2.68, 95% CI 1.08\u20136.64, P \u2009=\u20090.033 and IRR 12.11, 95% CI 1.02\u2013144.11, P \u2009=\u20090.048, respectively).", {"entities": [[105, 111, "DISEASE"]]}], ["Cardioselective beta-blockers prescribed to people with asthma and CVD were not associated with a significantly increased risk of moderate or severe asthma exacerbations and potentially could be used more widely when strongly indicated.", {"entities": [[56, 62, "DISEASE"], [149, 155, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12916-017-0781-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["29 autoimmune diseases, including Rheumatoid Arthritis, gout, Crohn\u2019s Disease, and Systematic Lupus Erythematosus affect 7.6-9.4% of the population.", {"entities": [[56, 60, "DISEASE"]]}], ["While effective therapy is available, many patients do not follow treatment or use medications as directed.", {"entities": []}], ["Digital health and Web 2.0 interventions have demonstrated much promise in increasing medication and treatment adherence, but to date many Internet tools have proven disappointing.", {"entities": []}], ["In fact, most digital interventions continue to suffer from high attrition in patient populations, are burdensome for healthcare professionals, and have relatively short life spans.", {"entities": []}], ["Digital health tools have traditionally centered on the transformation of existing interventions (such as diaries, trackers, stage-based or cognitive behavioral therapy programs, coupons, or symptom checklists) to electronic format.", {"entities": []}], ["Advanced digital interventions have also incorporated attributes of Web 2.0 such as social networking, text messaging, and the use of video.", {"entities": []}], ["Despite these efforts, there has not been little measurable impact in non-adherence for illnesses that require medical interventions, and research must look to other strategies or development methodologies.", {"entities": []}], ["As a first step in investigating the feasibility of developing such a tool, the objective of the current study is to systematically rate factors of non-adherence that have been reported in past research studies.", {"entities": []}], ["Grounded Theory, recognized as a rigorous method that facilitates the emergence of new themes through systematic analysis, data collection and coding, was used to analyze quantitative, qualitative and mixed method studies addressing the following autoimmune diseases: Rheumatoid Arthritis, gout, Crohn\u2019s Disease, Systematic Lupus Erythematosus, and inflammatory bowel disease.", {"entities": [[349, 375, "DISEASE"], [290, 294, "DISEASE"]]}], ["Studies were only included if they contained primary data addressing the relationship with non-adherence.", {"entities": []}], ["Out of the 27 studies, four non-modifiable and 11 modifiable risk factors were discovered.", {"entities": []}], ["Over one third of articles identified the following risk factors as common contributors to medication non-adherence (percent of studies reporting): patients not understanding treatment (44%), side effects (41%), age (37%), dose regimen (33%), and perceived medication ineffectiveness (33%).", {"entities": []}], ["An unanticipated finding that emerged was the need for risk stratification tools (81%) with patient-centric approaches (67%).", {"entities": []}], ["This study systematically identifies and categorizes medication non-adherence risk factors in select autoimmune diseases.", {"entities": []}], ["Findings indicate that patients understanding of their disease and the role of medication are paramount.", {"entities": []}], ["An unexpected finding was that the majority of research articles called for the creation of tailored, patient-centric interventions that dispel personal misconceptions about disease, pharmacotherapy, and how the body responds to treatment.", {"entities": []}], ["To our knowledge, these interventions do not yet exist in digital format.", {"entities": []}], ["Rather than adopting a systems level approach, digital health programs should focus on cohorts with heterogeneous needs, and develop tailored interventions based on individual non-adherence patterns.", {"entities": []}], ["Microbiota-derived short-chain fatty acids (SCFAs) and organic acids produced by the fermentation of non-digestible fibre can communicate from the microbiome to host tissues and modulate homeostasis in mammals.", {"entities": []}], ["The microbiome has circadian rhythmicity and helps the host circadian clock function.", {"entities": []}], ["We investigated the effect of SCFA or fibre-containing diets on circadian clock phase adjustment in mouse peripheral tissues (liver, kidney, and submandibular gland).", {"entities": []}], ["Initially, caecal SCFA concentrations, particularly acetate and butyrate, induced significant day-night differences at high concentrations during the active period, which were correlated with lower caecal pH.", {"entities": []}], ["By monitoring luciferase activity correlated with the clock gene Period2 in vivo , we found that oral administration of mixed SCFA (acetate, butyrate, and propionate) and an organic acid (lactate), or single administration of each SCFA or lactate for three days, caused phase changes in the peripheral clocks with stimulation timing dependency.", {"entities": []}], ["However, this effect was not detected in cultured fibroblasts or cultured liver slices with SCFA applied to the culture medium, suggesting SCFA-induced indirect modulation of circadian clocks in vivo .", {"entities": []}], ["Finally, cellobiose-containing diets facilitated SCFA production and refeeding-induced peripheral clock entrainment.", {"entities": []}], ["SCFA oral gavage and prebiotic supplementation can facilitate peripheral clock adjustment, suggesting prebiotics as novel therapeutic candidates for misalignment.", {"entities": []}], ["In response to environmental cues the human pathogen Staphylococcus aureus synthesizes and releases proteinaceous enterotoxins.", {"entities": []}], ["These enterotoxins are natural etiologic entities of severe food poisoning, toxic shock syndrome, and acute diseases.", {"entities": [[88, 96, "DISEASE"], [76, 96, "DISEASE"]]}], ["Staphylococcal enterotoxins are currently listed as Category B Bioterrorism Agents by the Center for Disease Control and Prevention.", {"entities": []}], ["They are associated with respiratory illnesses, and may contribute to exacerbation of pulmonary disease.", {"entities": []}], ["This likely stems from the ability of Staphylococcal enterotoxins to elicit powerful episodes of T cell stimulation resulting in release of pro-inflammatory cytokines.", {"entities": []}], ["Here, we discuss the role of the immune system and potential mechanisms of disease initiation and progression.", {"entities": []}], ["Several studies highlight a key involvement of endocannabinoid (EC) system in autism pathophysiology.", {"entities": []}], ["The EC system is a complex network of lipid signaling pathways comprised of arachidonic acid-derived compounds (anandamide, AEA) and 2-arachidonoyl glycerol (2-AG), their G-protein-coupled receptors (cannabinoid receptors CB1 and CB2) and the associated enzymes.", {"entities": []}], ["In addition to autism, the EC system is also involved in several other psychiatric disorders (i.e., anxiety, major depression, bipolar disorder and schizophrenia).", {"entities": [[148, 161, "DISEASE"], [127, 143, "DISEASE"]]}], ["This system is a key regulator of metabolic and cellular pathways involved in autism, such as food intake, energy metabolism and immune system control.", {"entities": []}], ["Early studies in autism animal models have demonstrated alterations in the brain\u2019s EC system.", {"entities": []}], ["Autism is also characterized by immune system dysregulation.", {"entities": []}], ["This alteration includes differential monocyte and macrophage responses, and abnormal cytokine and T cell levels.", {"entities": []}], ["EC system dysfunction in a monocyte and macrophagic cellular model of autism has been demonstrated by showing that the mRNA and protein for CB2 receptor and EC enzymes were significantly dysregulated, further indicating the involvement of the EC system in autism-associated immunological disruptions.", {"entities": []}], ["Taken together, these new findings offer a novel perspective in autism research and indicate that the EC system could represent a novel target option for autism pharmacotherapy.", {"entities": []}], ["Most of the studies investigating the prevalence of asthma in various countries have focused on children below the age of 15 years or adults above the age of 18 years.", {"entities": [[52, 58, "DISEASE"]]}], ["There is limited knowledge concerning the prevalence of asthma in 16- to 18-year-old adolescents.", {"entities": [[56, 62, "DISEASE"]]}], ["Our objective was to study the prevalence of asthma and associated symptoms in 16- to 18-year-old adolescents in Saudi Arabia.", {"entities": [[45, 51, "DISEASE"]]}], ["A cross-sectional study was conducted in secondary (high) schools in the city of Riyadh utilizing the International Study of Asthma and Allergies in Children (ISAAC) questionnaire tool.", {"entities": [[125, 131, "DISEASE"]]}], ["Out of 3073 students (1504 boys and 1569 girls), the prevalence of lifetime wheeze, wheeze during the past 12 months and physician-diagnosed asthma was 25.3%, 18.5% and 19.6%, respectively.", {"entities": [[141, 147, "DISEASE"]]}], ["The prevalence of exercise-induced wheezing and night coughing in the past 12 months was 20.2% and 25.7%, respectively.", {"entities": []}], ["The prevalence of rhinitis symptoms in students with lifetime wheeze, physician-diagnosed asthma and exercise-induced wheeze was 61.1%, 59.9% and 57.4%, respectively.", {"entities": [[18, 26, "DISEASE"], [90, 96, "DISEASE"]]}], ["Rhinitis symptoms were significantly associated with lifetime wheeze (OR = 2.5, p value < 0.001), physician-diagnosed asthma (OR = 2.2, p < 0.001), and exercise-induced wheeze (OR = 1.9, p value < 0.001).", {"entities": [[0, 8, "DISEASE"], [118, 124, "DISEASE"]]}], ["The prevalence of asthma and associated symptoms in 16- to 18-year-old adolescents in Saudi Arabia is high, although it is within range of reported prevalence rates from various parts of the world.", {"entities": [[18, 24, "DISEASE"]]}], ["Many breast cancer patients suffer from hot flush and medical menopause as side effects of treatment.", {"entities": [[5, 18, "DISEASE"], [12, 18, "DISEASE"]]}], ["Some patients undergo acupuncture, rather than hormone therapy, to relieve these symptoms, but the efficacy of acupuncture is uncertain.", {"entities": []}], ["This meta-analysis evaluated the efficacy of acupuncture on hot flush and menopause symptoms in women with breast cancer.", {"entities": [[107, 120, "DISEASE"], [114, 120, "DISEASE"]]}], ["A literature search was performed, following the PRISMA Statement and without language restrictions, of 7 databases from inception through March 2017.", {"entities": []}], ["All selected studies were randomized clinical trials (RCTs) that examined the effect of needle acupuncture on hot flush and menopause symptoms in patients with breast cancer.", {"entities": [[160, 173, "DISEASE"], [167, 173, "DISEASE"]]}], ["The methodological quality of these trials was assessed using Cochrane criteria, and meta-analysis software (RevMan 5.2) was used to analyze the data.", {"entities": []}], ["We examined 844 breast cancer patients (average age: 58 years-old) from 13 RCTs.", {"entities": [[16, 29, "DISEASE"], [23, 29, "DISEASE"]]}], ["The trials had medium-to-high quality, based on the modified Jadad scale.", {"entities": []}], ["The meta-analysis showed that acupuncture had no significant effect on the frequency and the severity of hot flush ( p = 0.34; p = 0.33), but significantly ameliorated menopause symptoms ( p = 0.009).", {"entities": []}], ["None of the studies reported severe adverse events.", {"entities": []}], ["Acupuncture significantly alleviated menopause symptoms, but had no effect on hot flush.", {"entities": []}], ["Breast cancer patients concerned about the adverse effects of hormone therapy should consider acupuncture.", {"entities": [[0, 13, "DISEASE"], [7, 13, "DISEASE"]]}], ["Further large-scale studies that also measure biomarkers or cytokines may help to elucidate the mechanism by which acupuncture alleviates menopause symptoms in patients with breast cancer.", {"entities": [[174, 187, "DISEASE"], [181, 187, "DISEASE"]]}], ["Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance LDLR ), carriers of rare, damaging mutations (3.1% of cases versus 1.3% of controls) were at 2.4-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference).", {"entities": [[113, 117, "GENE"], [266, 270, "GENE"], [113, 117, "GENE"], [266, 270, "GENE"]]}], ["This sequence-based estimate of the proportion of early MI cases due to LDLR mutations is remarkably similar to an estimate made more than 40 years ago using total cholesterol APOA5 ), carriers of rare nonsynonymous mutations (1.4% of cases versus 0.6% of controls) were at 2.2-fold increased risk for MI.", {"entities": [[72, 76, "GENE"], [176, 181, "GENE"]]}], ["When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol whereas APOA5 mutation carriers had higher plasma triglycerides.", {"entities": [[33, 37, "GENE"], [98, 103, "GENE"]]}], ["Recent evidence has connected MI risk with coding sequence mutations at two genes functionally related to APOA5 , namely lipoprotein lipase", {"entities": [[106, 111, "GENE"]]}], ["Excessive caloric intake is a contributing risk factor for human metabolic disorders.", {"entities": []}], ["Caloric restriction may prolong a person\u2019s life by lowering the incidence of deadly diseases.", {"entities": []}], ["Reactive oxygen species (ROS) in peripheral blood mononuclear cells (PBMC) have been associated with the biochemical basis of the relationship between caloric intake and pathophysiologic processes.", {"entities": []}], ["Polymorphisms associated with ROS generation genes are being increasingly implicated in inter-individual responses to daily caloric intake alterations.", {"entities": []}], ["In the current study, a single nucleotide polymorphism, rs1836882, in the nicotinamide adenine dinucleotide phosphate oxidase 4 ( NOX4 ) gene\u2019s promoter region was found to modulate associations between dietary caloric intake and ROS levels in PBMC.", {"entities": [[130, 134, "GENE"]]}], ["Based on rs1836882, 656 Chinese Han participants were classified into CC, CT and TT genotypes.", {"entities": []}], ["ROS levels in PBMC were significantly higher in the CC or CT genotypes compared with the TT genotype with the same increases in daily caloric intake.", {"entities": []}], ["Using an electrophoretic mobility shift assay, NOX4 promoter region with rs1836882 (T) was observed to have a higher affinity for hepatocyte nuclear factor gamma (HNF3\u03b3) protein than rs1836882 (C).", {"entities": [[47, 51, "GENE"]]}], ["HNF3\u03b3 protein over-expression decreased NOX4 gene transcriptional activity in the TT genotype more than in the CC genotype (5.68% vs. 2.12%, P <0.05) in a dual luciferase reporter assay.", {"entities": [[40, 44, "GENE"]]}], ["By silencing the NOX4 gene using small interfering RNA or over-expressing HNF3\u03b3 using an expression plasmid, serum from high dietary caloric intake participants decreased ROS levels in PBMC of the TT genotype more than in the CC or CT genotype via HNF3\u03b3 down-regulating the NOX4 gene expression signaling pathway.", {"entities": [[17, 21, "GENE"], [274, 278, "GENE"], [17, 21, "GENE"], [274, 278, "GENE"]]}], ["This is the first study to report on the functions of phenotypes of rs1836882 in the NOX4 gene, and it suggests rs1836882 as a candidate gene for interpreting inter-individual ROS levels differences in PBMC induced by alterations in daily caloric intake.", {"entities": [[85, 89, "GENE"]]}], ["Air pollutants are associated with inflammatory diseases such as otitis media (OM).", {"entities": [[65, 77, "DISEASE"]]}], ["Significantly higher incidence rates of OM are reported in regions with air pollution.", {"entities": []}], ["Diesel exhaust particles (DEPs) comprise a major class of contaminants among numerous air pollutants, and they are characterized by a carbonic mixture of polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs, and small amounts of sulfate, nitrate, metals and other trace elements.", {"entities": []}], ["DEP exposure is a risk factor for inflammatory diseases.", {"entities": []}], ["Our previous study identified potential biomarkers using gene expression microarray and pathway analyses in an in vitro system.", {"entities": []}], ["Although in vitro investigations have been conducted to elucidate plausible biomarkers and molecular mechanisms related to DEP exposure, in vivo studies are necessary to identify the exact biological relevance regarding the incidence of OM caused by DEP exposure.", {"entities": []}], ["In this study, we identified potential molecular biomarkers and pathways triggered by DEP exposure in a rodent model.", {"entities": []}], ["Transcriptomic analysis was employed to identify novel potential biomarkers in the middle ear of DEP-exposed mice.", {"entities": []}], ["A total of 697 genes were differentially expressed in the DEP-exposed mice; 424 genes were upregulated and 273 downregulated.", {"entities": []}], ["In addition, signaling pathways among the differentially expressed genes mediated by DEP exposure were predicted.", {"entities": []}], ["Several key molecular biomarkers were identified including cholinergic receptor muscarinic 1 (CHRM1), erythropoietin (EPO), son of sevenless homolog 1 (SOS1), estrogen receptor 1 (ESR1), cluster of differentiation 4 (CD4) and interferon alpha-1 (IFNA1).", {"entities": [[94, 99, "GENE"], [118, 121, "GENE"], [152, 156, "GENE"], [180, 184, "GENE"], [217, 220, "GENE"], [246, 251, "GENE"]]}], ["Our results shed light on the related cell processes and gene signaling pathways affected by DEP exposure.", {"entities": []}], ["The identified biomarkers might be potential candidates for determining early diagnoses and effective treatment strategies for DEP-mediated disorders.", {"entities": []}], ["Vitamin D is well known for its role in calcium regulation and bone health, but emerging literature tells of vitamin D\u2019s central role in other vital body processes, such as: signaling gene response, protein synthesis, hormone synthesis, immune response, plus, cell turnover and regeneration.", {"entities": []}], ["The discovery of the vitamin D receptor within the muscle suggested a significant role for vitamin D in muscle tissue function.", {"entities": []}], ["This discovery led researchers to question the impact that vitamin D deficiency could have on athletic performance and injury.", {"entities": []}], ["With over 77% of the general population considered vitamin D insufficient, it\u2019s likely that many athletes fall into the same category.", {"entities": []}], ["Research has suggested vitamin D to have a significant effect on muscle weakness, pain, balance, and fractures in the aging population; still, the athletic population is yet to be fully examined.", {"entities": []}], ["There are few studies to date that have examined the relationship between vitamin D status and performance, therefore, this review will focus on the bodily roles of vitamin D, recommended 25(OH)D levels, vitamin D intake guidelines and risk factors for vitamin D insufficiency in athletes.", {"entities": []}], ["In addition, the preliminary findings regarding vitamin D\u2019s impact on athletic performance will be examined.", {"entities": []}], ["The lung is divided into two major compartments: the alveolar space and the parenchyma.", {"entities": []}], ["The alveolar macrophages are the first line of leukocytes in the lung taking up incoming microbes or microbial antigens whereas the parenchymal dendritic cells (DCs) are believed to be the sole potent antigen presenting cells (APCs) in the lung.", {"entities": [[227, 231, "GENE"]]}], ["Both resting alveolar macrophages and parenchymal DCs express CD11c.", {"entities": []}], ["Several important questions remain to be elucidated: 1] to which extent the alveolar space and lung parenchymal CD11c+ APCs differ in their phenotype and ability to activate na\u00efve T cells; 2] whether they differ in their ability to activate antigen-experienced or -primed T cells; and 3] whether these lung CD11c+ APC populations differ from the splenic CD11c+ APCs which have been commonly used for understanding APC biology.", {"entities": [[119, 123, "GENE"], [361, 365, "GENE"], [314, 317, "GENE"], [414, 417, "GENE"], [119, 123, "GENE"], [361, 365, "GENE"], [314, 317, "GENE"], [414, 417, "GENE"]]}], ["CD11c+ APCs from the alveolar space, lung parenchyma, and the spleen display differential co-stimulatory molecule expression and cytokine responsiveness upon stimulation.", {"entities": [[7, 11, "GENE"]]}], ["Alveolar space APCs are weak activators of na\u00efve T cells compared to lung parenchymal and splenic CD11c+ APC populations.", {"entities": [[15, 19, "GENE"], [105, 108, "GENE"]]}], ["However, alveolar space APCs are able to potently activate the in vivo microbial antigen-primed T cells to a similar extent as lung parenchymal and splenic APCs.", {"entities": [[24, 28, "GENE"], [156, 160, "GENE"], [24, 28, "GENE"], [156, 160, "GENE"]]}], ["Together our findings indicate that alveolar CD11c+ APCs have a specialized T cell-activating function, capable of activating antigen-primed, but not na\u00efve, T cells whereas lung CD11c+ APCs are capable of activating both the na\u00efve and antigen-primed T cell populations.", {"entities": [[52, 56, "GENE"], [185, 189, "GENE"], [52, 56, "GENE"], [185, 189, "GENE"]]}], ["People assess the quality of the air indoors primarily on the basis of its odors and on their perception of associated health risk.", {"entities": []}], ["The major current contributors to indoor odorants are human occupant odors (body odor), environmental tobacco smoke, volatile building materials, bio-odorants (particularly mold and animal-derived materials), air fresheners, deodorants, and perfumes.", {"entities": []}], ["These are most often present as complex mixtures, making measurement of the total odorant problem difficult.", {"entities": []}], ["There is no current method of measuring human body odor, other than by human panel studies of expert judges of air quality.", {"entities": []}], ["Human body odors have been quantitated in terms of the \"olf\" which is the amount of air pollution produced by the average person.", {"entities": []}], ["Another quantitative unit of odorants is the \"decipol,\" which is the perceived level of pollution produced by the average human ventilated by 10 L/sec of unpolluted air or its equivalent level of dissatisfaction from nonhuman air pollutants.", {"entities": []}], ["The standard regulatory approach, focusing on individual constituents or chemicals, is not likely to be successful in adequately controlling odorants in indoor air.", {"entities": []}], ["Besides the current approach of setting minimum ventilation standards to prevent health effects due to indoor air pollution, a standard based on the olf or decipol unit might be more efficacious as well as simpler to measure.", {"entities": []}], ["To explore the relationship between the prevalence of sleep disordered breathing (SDB) and face shape morphology in a large cohort of 15-year-old children.", {"entities": []}], ["Observational longitudinal cohort study Avon Longitudinal Study of Parents and Children (ALSPAC), South West of England.", {"entities": []}], ["Three-dimensional surface laser scans were taken for 4784 white British children from the ALSPAC during a follow-up clinic.", {"entities": []}], ["A total of 1724 children with sleep disordered breathing (SDB) and 1862 healthy children were identified via parents\u2019 report of sleep disordered symptoms for their children.", {"entities": []}], ["We excluded from the original cohort all children identified as having congenital abnormalities, diagnoses associated with poor growth and children with adenoidectomy and/or tonsillectomy.", {"entities": []}], ["Parents in the ALSPAC reported sleep disordered symptoms (snoring, mouth breathing and apnoea) for their children at 6, 18, 30, 42, 57, 69 and 81\u2005months.", {"entities": []}], ["Average facial shells were created for children with and without SDB in order to explore surface differences.", {"entities": []}], ["Differences in facial measurements were found between the children with and without SDB throughout early childhood.", {"entities": []}], ["The mean differences included an increase in face height in SDB children of 0.3\u2005mm (95% CI \u22120.52 to \u22120.05); a decrease in mandibular prominence of 0.9\u00b0 (95% CI \u22121.30 to \u22120.42) in SDB children; and a decrease in nose prominence and width of 0.12\u2005mm (95% CI 0.00 to 0.24) and 0.72\u2005mm (95% CI \u22120.10 to \u22120.25), respectively, in SDB children.", {"entities": []}], ["The odds of children exhibiting symptoms of SDB increased significantly with respect to increased face height and mandible angle, but reduced with increased nose width and prominence.", {"entities": []}], ["The combination of a long face, reduced nose prominence and width, and a retrognathic mandible may be diagnostic facial features of SBD that may warrant a referral to specialists for the evaluation of other clinical symptoms of SDB.", {"entities": []}], ["Accumulating evidence suggests that dysfunction in the glutamatergic system may underlie the pathophysiology of autism.", {"entities": []}], ["The anterior cingulate cortex (ACC) has been implicated in autism as well as in glutamatergic neurotransmission.", {"entities": []}], ["We hypothesized that alterations in the glutamate-glutamine cycle in the ACC might play a role in the pathophysiology of autism.", {"entities": []}], ["We performed Western blot analyses for the protein expression levels of enzymes in the glutamate-glutamine cycle, including glutamine synthetase, kidney-type glutaminase, liver-type glutaminase, and glutamate dehydrogenases 1 and 2, in the ACC of postmortem brain of individuals with autism (n\u2009=\u20097) and control subjects (n\u2009=\u200913).", {"entities": []}], ["We found that the protein levels of kidney-type glutaminase, but not those of the other enzymes measured, in the ACC were significantly lower in subjects with autism than in controls.", {"entities": []}], ["The results suggest that reduced expression of kidney-type glutaminase may account for putative alterations in glutamatergic neurotransmission in the ACC in autism.", {"entities": []}], ["The aim of this study was to evaluate the influence of the intake of l -arginine alone and of l -arginine with vitamin C on mineral concentration in rats fed with a high-fat diet, and to assess the lipid glucose, insulin, and total antioxidant status (TAS) and tumor necrosis factor (TNF) alpha serum levels that result.", {"entities": [[284, 287, "GENE"]]}], ["Wistar rats were assigned to groups fed with either a standard control diet (C), a diet high in fat (FD), a diet high in fat with l -arginine, or a diet high in fat with l -arginine and vitamin C. After 6\u00a0weeks, the length and weight of the rats were measured, and the animals were euthanized.", {"entities": []}], ["The liver, spleen, kidneys, pancreas, heart, and gonads were collected, as were blood samples.", {"entities": []}], ["The total serum cholesterol, triglyceride, fasting glucose, insulin, TAS, and TNF alpha levels were measured.", {"entities": [[78, 81, "GENE"]]}], ["The tissue calcium, magnesium, iron, zinc, and copper concentrations were determined.", {"entities": []}], ["It was found that l -arginine supplementation diminished the effect of the modified diet on the concentration of iron in the liver and spleen and of copper in heart.", {"entities": []}], ["At the same time, it was observed that l -arginine supplementation reduced the effect of the high-fat diet on insulin, TNF alpha, and TAS.", {"entities": [[119, 122, "GENE"]]}], ["The combination of l -arginine and vitamin C produced a similar effect on the mineral levels in the tissues as did l -arginine used alone.", {"entities": []}], ["Moreover, positive correlations between serum insulin and iron in the liver, between TNF alpha and iron in the liver, and between TNF alpha and copper in the heart were observed.", {"entities": [[85, 88, "GENE"], [130, 133, "GENE"], [85, 88, "GENE"], [130, 133, "GENE"]]}], ["The level of TAS in serum was inversely correlated with the copper level in the heart and the iron level in the liver.", {"entities": []}], ["We concluded that the beneficial influence of l -arginine on insulin, TAS, and TNF alpha serum level is associated with changes in the iron and copper status in rats fed with a high-fat diet.", {"entities": [[79, 82, "GENE"]]}], ["No synergistic effect of l -arginine and vitamin C in the biochemical parameters or in the mineral status in rats fed with the modified diet was observed.", {"entities": []}], ["Coronary computed tomography angiography (CCTA) is an established method for ruling out coronary artery disease (CAD).", {"entities": []}], ["Most patients referred for CCTA do not have CAD and only approximately 20\u201330 % of patients are subsequently referred to further testing by invasive coronary angiography (ICA) or non-invasive perfusion evaluation due to suspected obstructive CAD.", {"entities": []}], ["In cases with severe calcifications, a discrepancy between CCTA and ICA often occurs, leading to the well-described, low-diagnostic specificity of CCTA.", {"entities": []}], ["As ICA is cost consuming and involves a risk of complications, an optimized algorithm would be valuable and could decrease the number of ICAs that do not lead to revascularization.", {"entities": []}], ["The primary objective of the Dan-NICAD study is to determine the diagnostic accuracy of cardiac magnetic resonance imaging (CMRI) and myocardial perfusion scintigraphy (MPS) as secondary tests after a primary CCTA where CAD could not be ruled out.", {"entities": []}], ["The secondary objective includes an evaluation of the diagnostic precision of an acoustic technology that analyses the sound of coronary blood flow.", {"entities": []}], ["It may potentially provide better stratification prior to CCTA than clinical risk stratification scores alone.", {"entities": []}], ["Dan-NICAD is a multi-centre, randomised, cross-sectional trial, which will include approximately 2,000 patients without known CAD, who were referred to CCTA due to a history of symptoms suggestive of CAD and a low-risk to intermediate-risk profile, as evaluated by a cardiologist.", {"entities": []}], ["Patient interview, sound recordings, and blood samples are obtained in connection with the CCTA.", {"entities": []}], ["All patients with suspected obstructive CAD by CCTA are randomised to either stress CMRI or stress MPS, followed by ICA with fractional flow reserve (FFR) measurements.", {"entities": []}], ["Obstructive CAD is defined as an FFR below 0.80 or as high-grade stenosis (>90 % diameter stenosis) by visual assessment.", {"entities": []}], ["Diagnostic performance is evaluated as sensitivity, specificity, predictive values, likelihood ratios, and C statistics.", {"entities": []}], ["Enrolment commenced in September 2014 and is expected to be complete in May 2016.", {"entities": []}], ["Dan-NICAD is designed to assess whether a secondary perfusion examination after CCTA could safely reduce the number of ICAs where revascularization is not required.", {"entities": []}], ["The results are expected to add knowledge about the optimal algorithm for diagnosing CAD.", {"entities": []}], ["Clinicaltrials.gov identifier, NCT02264717 .", {"entities": []}], ["Registered on 26 September 2014.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1388-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A major issue with Schistosoma mansoni infection is the development of periportal fibrosis, which is predominantly caused by the host immune response to egg antigens.", {"entities": []}], ["Experimental studies have pointed to the participation of monocytes in the pathogenesis of liver fibrosis.", {"entities": []}], ["The aim of this study was to characterize the subsets of monocytes in individuals with different degrees of periportal fibrosis secondary to schistosomiasis.", {"entities": [[141, 156, "DISEASE"]]}], ["Monocytes were classified into classical (CD14 \u03b1 , and TGF- \u03b2 was higher in monocytes from individuals with moderate to severe fibrosis as compared to other groups.", {"entities": [[42, 46, "GENE"]]}], ["Although no differences were observed in receptors expression (IL-4R and IL-10R) between groups of patients, the expression of IL-12 was lower in monocytes from individuals with moderate to severe fibrosis, suggesting a protective role of this cytokine in the development of fibrosis.", {"entities": []}], ["Our data support the hypothesis that the three different monocyte populations participate in the immunopathogenesis of periportal fibrosis, since they express high levels of proinflammatory and profibrotic cytokines and low levels of regulatory markers.", {"entities": []}], ["Variability in drug efficacy and adverse effects are observed in clinical practice.", {"entities": []}], ["While the extent of genetic variability in classic pharmacokinetic genes is rather well understood, the role of genetic variation in drug targets is typically less studied.", {"entities": []}], ["Based on 60,706 human exomes from the ExAC dataset, we performed an in-depth computational analysis of the prevalence of functional variants in 806 drug-related genes, including 628 known drug targets.", {"entities": []}], ["We further computed the likelihood of 1236 FDA-approved drugs to be affected by functional variants in their targets in the whole ExAC population as well as different geographic sub-populations.", {"entities": []}], ["We find that most genetic variants in drug-related genes are very rare (f\u2009<\u20090.1%) and thus will likely not be observed in clinical trials.", {"entities": []}], ["Furthermore, we show that patient risk varies for many drugs and with respect to geographic ancestry.", {"entities": []}], ["A focused analysis of oncological drug targets indicates that the probability of a patient carrying germline variants in oncological drug targets is, at 44%, high enough to suggest that not only somatic alterations but also germline variants carried over into the tumor genome could affect the response to antineoplastic agents.", {"entities": []}], ["This study indicates that even though many variants are very rare and thus likely not observed in clinical trials, four in five patients are likely to carry a variant with possibly functional effects in a target for commonly prescribed drugs.", {"entities": []}], ["Such variants could potentially alter drug efficacy.", {"entities": []}], ["The online version of this article (doi:10.1186/s13073-017-0502-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Influenza is a global public health problem.", {"entities": [[0, 9, "DISEASE"]]}], ["However, severe influenza only recently has been addressed in routine surveillance.", {"entities": [[16, 25, "DISEASE"]]}], ["The Global Influenza Hospital Surveillance Network (GIHSN) was established to study the epidemiology of severe influenza in consecutive seasons in different countries.", {"entities": [[11, 20, "DISEASE"], [111, 120, "DISEASE"]]}], ["Our objective is to describe the GIHSN approach and methods.", {"entities": []}], ["The GIHSN uses prospective active surveillance to identify consecutive influenza admissions in permanent residents of well-defined geographic areas in sites around the world.", {"entities": [[71, 80, "DISEASE"]]}], ["A core common protocol is followed.", {"entities": []}], ["After consent, data are collected on patient characteristics and clinical outcomes, respiratory swabs are obtained, and the presence of influenza virus and subtype or lineage is ascertained by polymerase chain reaction.", {"entities": [[136, 145, "DISEASE"]]}], ["Data are collated and analyzed at the GIHSN coordination center.", {"entities": []}], ["The GIHSN has run its activities for two consecutive influenza seasons, 2012\u20132013 and 2013\u20132014, and hospitals in Brazil, China, France, Russian Federation, Turkey, and Spain have been involved in one or both seasons.", {"entities": [[53, 62, "DISEASE"]]}], ["Consistency on the application of the protocol and heterogeneity for the first season have been addressed in two previous publications.", {"entities": []}], ["During both seasons, 19\u00a0677 eligible admissions were recorded; 11\u00a0843 (60%) were included and tested, and 2713 (23%) were positive for influenza: 991 (37%) A(H1N1); 807 (30%) A(H3N2); 583 (21%) B/Yamagata; 56 (2%) B/Victoria and 151 (6%) influenza A; and 125 (5%) influenza B were not characterized.", {"entities": [[135, 144, "DISEASE"], [238, 247, "DISEASE"], [264, 273, "DISEASE"]]}], ["The GIHSN is a platform that provides information on severe influenza worldwide, applying a common core protocol and a consistent case definition.", {"entities": [[60, 69, "DISEASE"]]}], ["This study sought to evaluate associations between sleep time and bicycle accidents, falls under various circumstances, and dental injuries in adolescents.", {"entities": []}], ["A total of 61,696 participants ranging from 12 to 18 years of age who completed the Korea Youth Risk Behavior Web-based Survey (KYRBWS) in 2013 were enrolled in this study.", {"entities": []}], ["Bicycle riding accidents were analyzed for 17,232 bicycle-riding participants.", {"entities": []}], ["Data were collected regarding the weekday sleep duration for the most recent 7 days, which was categorized as < 5.5 h, 5.5\u20136.5 h, 6.5\u20137.5 h, or \u2265 7.5 h per day, and the incidence of bicycle accidents, slips and falls under various circumstances, and dental injuries in the most recent 12 months.", {"entities": []}], ["Adjusted odds ratios (aORs) were calculated among sleep groups for bicycle accidents, slips and falls, and dental injuries using simple and multiple logistic regression analyses with complex sampling.", {"entities": []}], ["Bicycle riding accidents and slips and falls in classrooms, corridors, the ground, toilets, stairs, and other unspecified situations showed positive correlations with sleep deprivation.", {"entities": []}], ["Comparisons of groups with \u2265 7.5 h sleep, < 5.5 h, 5.5\u20136.5 h sleep, and 6.5\u20137.5 h sleep revealed increased associations with slips and falls under various circumstances.", {"entities": []}], ["In particular, the aORs were higher in the groups with less sleep (aOR of the 5.5 h group > the 5.5\u20136.5 h group > the 6.5\u20137.5 h group).", {"entities": []}], ["There was no significant relationship between sleep deprivation and dental injury.", {"entities": []}], ["This study demonstrated that sleep deprivation among Korean adolescents was associated with bicycle accidents and falls at home and school.", {"entities": []}], ["Thus, adequate sleep may be needed to prevent accidents and falls.", {"entities": []}], ["Growing evidence shows that interleukin 13 (IL-13) may play an essential role in the development of airway inflammation and bronchial hyper-responsiveness (BHR), two defining features of asthma.", {"entities": [[187, 193, "DISEASE"]]}], ["Although the underlying mechanisms remain unknown, a number of reports have shown that IL-13 may exert its deleterious effects in asthma by directly acting on airway resident cells, including epithelial cells and airway smooth muscle cells.", {"entities": [[130, 136, "DISEASE"]]}], ["In this report, we hypothesize that IL-13 may participate in the pathogenesis of asthma by activating a set of \"pro-asthmatic\" genes in airway smooth muscle (ASM) cells.", {"entities": [[81, 87, "DISEASE"]]}], ["Microarray technology was used to study the modulation of gene expression of airway smooth muscle by IL-13 and IL-13R130Q.", {"entities": []}], ["TaqMan\u2122 Real Time PCR and flow cytometry was used to validate the gene array data.", {"entities": []}], ["IL-13 and the IL-13 polymorphism IL-13R130Q (Arg130Gln), recently associated with allergic asthma, seem to modulate the same set of genes, which encode many potentially interesting proteins including vascular cellular adhesion molecule (VCAM)-1, IL-13R\u03b12, Tenascin C and Histamine Receptor H1, that may be relevant for the pathogenesis of asthma.", {"entities": [[82, 97, "DISEASE"], [91, 97, "DISEASE"], [339, 345, "DISEASE"]]}], ["The data supports the hypothesis that gene modulation by IL-13 in ASM may be essential for the events leading to the development of allergic asthma.", {"entities": [[132, 147, "DISEASE"], [141, 147, "DISEASE"]]}], ["Although pertussis has been considered a disease of childhood, it is also recognized as an important respiratory tract infection in adolescents and adults.", {"entities": [[9, 18, "DISEASE"]]}], ["However, in countries with routine vaccination against pertussis with high coverage, pertussis is not usually taken into consideration for the etiology of prolonged cough in adults.", {"entities": [[55, 64, "DISEASE"], [85, 94, "DISEASE"]]}], ["Previous studies in a variety of populations in developed countries have documented that pertussis is quite common, ranging from 2.9 to 32\u00a0% of adolescents and adults with prolonged cough.", {"entities": [[89, 98, "DISEASE"]]}], ["The anticipation and early recognition of this change in the epidemiology is important because the affected adolescents and adults act as reservoirs of the disease and source of infection to the vulnerable population of infants, for whom the disease can be life threatening.", {"entities": []}], ["We conducted a prospective study to determine the prevalence of pertussis in Thai adults with prolonged cough.", {"entities": [[64, 73, "DISEASE"]]}], ["Seventy-six adult patients with a cough lasting for more than 2\u00a0weeks (range, 14\u2013180 days) were included in the present study.", {"entities": []}], ["The data regarding medical history and physical examination were carefully analyzed.", {"entities": []}], ["Nasopharyngeal swabs from all patients were obtained for the detection of deoxyribonucleic acid of Bordetella pertussis by the polymerase chain reaction (PCR) method.", {"entities": [[110, 119, "DISEASE"]]}], ["Paired serum samples were collected and tested for IgG antibody against pertussis toxin by using an ELISA method.", {"entities": [[72, 81, "DISEASE"]]}], ["Of 76 adult patients, 14 patients (18.4\u00a0%) with the mean age of 59 (range, 28\u201385) years and the mean duration of cough of 34 (range, 14\u2013120) days had laboratory evidence of acute pertussis infection.", {"entities": [[179, 188, "DISEASE"]]}], ["One patient was diagnosed by the PCR method, while the rest had serological diagnosis.", {"entities": []}], ["Whooping cough is a significantly associated symptom of patients with chronic cough who had laboratory evidence of pertussis.", {"entities": [[115, 124, "DISEASE"]]}], ["( p \u2009<\u2009.05, odds ratio 3.75, 95\u00a0% confidence interval: 1.00,14.06) Pertussis is being increasingly recognized as a cause of prolonged, distressing cough among adults in Thailand.", {"entities": [[67, 76, "DISEASE"]]}], ["This result addresses the need of pertussis vaccination in Thai adults for preventing transmission to a high risk group such as newborn infants.", {"entities": [[34, 43, "DISEASE"]]}], ["Whether age at onset influences Alzheimer\u2019s disease (AD) progression and the effectiveness of cholinesterase inhibitor (ChEI) therapy is not clear.", {"entities": []}], ["We aimed to compare longitudinal cognitive and global outcomes in ChEI-treated patients with early-onset Alzheimer\u2019s disease (EOAD) versus late-onset Alzheimer\u2019s disease (LOAD) in clinical practice.", {"entities": []}], ["This 3-year, prospective, observational, multicentre study included 1017 participants with mild to moderate AD; 143 had EOAD (age at onset\u2009<\u200965\u00a0years) and 874 had LOAD (age at onset\u2009\u2265\u200965\u00a0years).", {"entities": []}], ["At baseline and semi-annually, patients were assessed using cognitive, global and activities of daily living (ADL) scales, and the dose of ChEI was recorded.", {"entities": []}], ["Potential predictors of decline were analysed using mixed-effects models.", {"entities": []}], ["Six-month response to ChEI therapy and long-term prognosis in cognitive and global performance were similar between the age-at-onset groups.", {"entities": []}], ["However, deterioration was significantly faster when using the Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive subscale (ADAS-Cog) over 3\u00a0years in participants with EOAD than in those with LOAD; hence, prediction models for the mean ADAS-Cog trajectories are presented.", {"entities": []}], ["The younger cohort had a larger proportion of homozygote apolipoprotein E (APOE) \u03b54 allele carriers than the older cohort; however, APOE genotype was not a significant predictor of cognitive impairment in the multivariate models.", {"entities": [[75, 79, "GENE"], [132, 136, "GENE"], [75, 79, "GENE"], [132, 136, "GENE"]]}], ["A slower rate of cognitive progression was related to initiation of ChEIs at an earlier stage of AD, higher ChEI dose and fewer years of education in both groups.", {"entities": []}], ["In LOAD, male sex, better instrumental ADL ability and no antipsychotic drug use were additional protective characteristics.", {"entities": []}], ["The older patients received a lower ChEI dose than the younger individuals during most of the study period.", {"entities": []}], ["Although the participants with EOAD showed a faster decline in ADAS-Cog, had a longer duration of AD before diagnosis, and had a higher frequency of two APOE \u03b54 alleles than those with LOAD, the cognitive and global responses to ChEI treatment and the longitudinal outcomes after 3\u00a0years were similar between the age-at-onset groups.", {"entities": [[153, 157, "GENE"]]}], ["A higher mean dose of ChEI and better cognitive status at the start of therapy were independent protective factors in both groups, stressing the importance of early treatment in adequate doses for all patients with AD.", {"entities": []}], ["For secreted proteins, proper protein folding is essential not only for biological function but also for secretion itself.", {"entities": []}], ["Proteins with folding problems are trapped in the endoplasmic reticulum (ER) and are eventually degraded in the cytoplasm.", {"entities": []}], ["In this study, we exploited co-expression of an artificial fusion protein, based on the sequence of a DnaJ protein, which could interact as co-chaperones in the Hsp70-based protein-folding system, with target recombinant secreted proteins to enhance their production and secretion.", {"entities": []}], ["The J-domain sequence or a fragment thereof was conjugated to a target protein\u2013binding domain that was capable of binding to a portion of the target-protein sequence.", {"entities": []}], ["Production of many of the target proteins was significantly upregulated when co-expressed with the J-domain fusion protein.", {"entities": []}], ["Surprisingly, the enhancement of secretion was observed even when the J-domain had a mutation in the HPD motif, which is necessary for J-protein\u2013Hsp70 interactions, suggesting the phenomenon observed is independent on functional J-protein\u2013Hsp70 interactions.", {"entities": [[101, 104, "GENE"]]}], ["This technology has great potential for not only enhancing the production of recombinant proteins, but also to treat conformational diseases such as cystic fibrosis, and Alpha-1 antitrypsin deficiency.", {"entities": [[149, 164, "DISEASE"]]}], ["The environmental contributions to autism spectrum disorder (ASD) and their informative content for diagnosing the condition are still largely unknown.", {"entities": [[35, 59, "DISEASE"]]}], ["The objective of this study was to investigate associations between early medical events and ASD, as well as autistic traits, in twins, to test the hypothesis of a cumulative environmental effect on ASD risk.", {"entities": []}], ["A total of 80 monozygotic (MZ) twin pairs (including a rare sample of 13 twin pairs discordant for clinical ASD) and 46 dizygotic (DZ) twin pairs with varying autistic traits, were examined for intra-pair differences in early medical events (for example, obstetric and neonatal factors, first year infections).", {"entities": []}], ["First, differences in early medical events were investigated using multisource medical records in pairs qualitatively discordant for ASD.", {"entities": []}], ["The significant intra-pair differences identified were then tested in relation to autistic traits in the remaining sample of 100 pairs, applying generalized estimating equations analyses.", {"entities": []}], ["Significant association of the intra-pair differences in the MZ pairs were found for the cumulative load of early medical events and clinical ASD ( Z =\u22122.85, P =0.004) and autistic traits ( \u03b2 =78.18, P =0.002), as well as infant dysregulation (feeding, sleeping abnormalities, excessive crying and worriedness), when controlling for intelligence quotient and attention deficit hyperactivity disorder comorbidity.", {"entities": [[359, 399, "DISEASE"]]}], ["The cumulative load of early medical events in general, and infant dysregulation in particular, may index children at risk of ASD owing to non-shared environmental contributions.", {"entities": []}], ["In clinical practice, these findings may facilitate screening and early detection of ASD.", {"entities": []}], ["Among birch pollen allergic patients up to 70% develop allergic reactions to Bet v 1-homologue food allergens such as Api g 1 (celery) or Dau c 1 (carrot), termed as birch pollen-related food allergy.", {"entities": [[187, 199, "DISEASE"]]}], ["In most cases, specific immunotherapy with birch pollen extracts does not reduce allergic symptoms to the homologue food allergens.", {"entities": []}], ["We therefore genetically engineered a multi-allergen chimer and tested if mucosal treatment with this construct could represent a novel approach for prevention of birch pollen-related food allergy.", {"entities": [[184, 196, "DISEASE"]]}], ["BALB/c mice were poly-sensitized with a mixture of Bet v 1, Api g 1 and Dau c 1 followed by a sublingual challenge with carrot, celery and birch pollen extracts.", {"entities": []}], ["For prevention of allergy sensitization an allergen chimer composed of immunodominant T cell epitopes of Api g 1 and Dau c 1 linked to the whole Bet v 1 allergen, was intranasally applied prior to sensitization.", {"entities": []}], ["Intranasal pretreatment with the allergen chimer led to significantly decreased antigen-specific IgE-dependent \u03b2-hexosaminidase release, but enhanced allergen-specific IgG2a and IgA antibodies.", {"entities": []}], ["Accordingly, IL-4 levels in spleen cell cultures and IL-5 levels in restimulated spleen and cervical lymph node cell cultures were markedly reduced, while IFN-\u03b3 levels were increased.", {"entities": []}], ["Immunomodulation was associated with increased IL-10, TGF-\u03b2 and Foxp3 mRNA levels in NALT and Foxp3 in oral mucosal tissues.", {"entities": [[64, 69, "GENE"], [94, 99, "GENE"], [64, 69, "GENE"], [94, 99, "GENE"]]}], ["Treatment with anti-TGF-\u03b2, anti-IL10R or anti-CD25 antibodies abrogated the suppression of allergic responses induced by the chimer.", {"entities": []}], ["Our results indicate that mucosal application of the allergen chimer led to decreased Th2 immune responses against Bet v 1 and its homologue food allergens Api g 1 and Dau c 1 by regulatory and Th1-biased immune responses.", {"entities": []}], ["These data suggest that mucosal treatment with a multi-allergen vaccine could be a promising treatment strategy to prevent birch pollen-related food allergy.", {"entities": [[144, 156, "DISEASE"]]}], ["Pulmonary fibrosis can be experimentally induced in small rodents by bleomycin.", {"entities": []}], ["The antibiotic is usually administered via the intratracheal or intranasal routes.", {"entities": []}], ["In the present study, we investigated the oropharyngeal aspiration of bleomycin as an alternative route for the induction of lung fibrosis in rats and mice.", {"entities": []}], ["The development of lung injury was followed in vivo by ultrashort echo time magnetic resonance imaging (UTE-MRI) and by post-mortem analyses (histology of collagen, hydroxyproline determination, and qRT-PCR).", {"entities": []}], ["In C57BL/6 mice, oropharyngeal aspiration of bleomycin led to more prominent lung fibrosis as compared to intranasal administration.", {"entities": []}], ["Consequently, the oropharyngeal aspiration route allowed a dose reduction of bleomycin and, therewith, a model refinement.", {"entities": []}], ["Moreover, the distribution of collagen after oropharyngeal aspiration of bleomycin was more homogenous than after intranasal administration: for the oropharyngeal aspiration route, fibrotic areas appeared all over the lung lobes, while for the intranasal route fibrotic lesions appeared mainly around the largest superior airways.", {"entities": []}], ["Thus, oropharyngeal aspiration of bleomycin induced morphological changes that were more comparable to the human disease than the intranasal administration route did.", {"entities": []}], ["Oropharyngeal aspiration of bleomycin led to a homogeneous fibrotic injury also in rat lungs.", {"entities": []}], ["The present data suggest oropharyngeal aspiration of bleomycin as a less invasive means to induce homogeneous and sustained fibrosis in the lungs of mice and rats.", {"entities": []}], ["In the U.S. small-area health services research studies are often based on the hospital service areas (HSAs) defined by the Dartmouth Atlas of Healthcare project.", {"entities": []}], ["These areas are based on the geographic origins of Medicare Part A hospital patients, the great majority of whom are seniors.", {"entities": []}], ["It is reasonable to question whether the geographic system so defined is appropriate for health services research for all ages, particularly for children, who have a very different system of healthcare financing and provision in the U.S.", {"entities": []}], ["This article assesses the need for a unique system of HSAs to support pediatric small-area analyses.", {"entities": []}], ["It is a cross-sectional analysis of California hospital discharges for two age groups \u2013 non-newborns 0\u201317 years old, and seniors.", {"entities": []}], ["The measure of interest was index of localization , which is the percentage of HSA residents hospitalized in their home HSA.", {"entities": []}], ["Indices were computed separately for each age group, and index agreement was assessed for 219 of the state's HSAs.", {"entities": []}], ["We examined the effect of local pediatric inpatient volume and pediatric inpatient resources on the divergence of the age group indices.", {"entities": []}], ["We also created a new system of HSAs based solely on pediatric patient origins, and visually compared maps of the traditional and the new system.", {"entities": []}], ["The mean localization index for pediatric discharges was 20 percentage points lower than for Medicare cases, indicating a poorer fit of the traditional geographic system for children.", {"entities": []}], ["The volume of pediatric cases did not appear to be associated with the magnitude of index divergence between the two age groups.", {"entities": []}], ["Pediatric medical and surgical case subgroups gave very similar results, and both groups differed substantially from seniors.", {"entities": []}], ["Location of children's hospitals and local pediatric bed supply were associated with Medicare-pediatric divergence.", {"entities": []}], ["There was little visual correspondence between the maps of traditional and pediatric-specific HSAs.", {"entities": []}], ["Children and seniors have significantly different geographic patterns of hospitalization in California.", {"entities": []}], ["Medicare-based HSAs may not be appropriate for all age groups and service types throughout the U.S.", {"entities": []}], ["Basophil activation was observed in patients with a history of carboplatin-induced severe hypersensitivity reaction (HR).", {"entities": [[117, 119, "GENE"]]}], ["However, the precise mechanism by which carboplatin induces basophil activation and the associated surrogate markers remains to be elucidated.", {"entities": []}], ["To investigate whether IgE-dependent mechanisms, including the overexpression of Fc\u03b5RI, participate in carboplatin-induced basophil activation, 13 ovarian cancer patients were enrolled: 5 with a history of carboplatin-induced severe hypersensitivity reaction within the past 2 years, and 8 with no such history.", {"entities": [[147, 161, "DISEASE"], [155, 161, "DISEASE"]]}], ["The expression levels of Fc\u03b5RI, IgE, and CD203c on basophils were measured using a flow cytometer.", {"entities": []}], ["Immunoglobulin E-dependent basophil activation was evaluated by testing for IgE passive sensitization using lactic acid, and by testing for phosphatidylinositol 3-kinase inhibition, using wortmannin.", {"entities": []}], ["In three patients positive for carboplatin hypersensitivity, pretreatment with wortmannin almost completely inhibited carboplatin-induced basophil activation ( P < 0.05).", {"entities": []}], ["In a healthy control subject, whose own IgE showed no response to carboplatin, acquired reactivity to carboplatin when exposed to plasma from patients positive for carboplatin hypersensitivity.", {"entities": []}], ["This did not occur when the same experiment was carried out using plasma from the patients negative for carboplatin hypersensitivity.", {"entities": []}], ["Moreover, pretreatment with omalizumab, a monoclonal anti-IgE antibody, almost completely blocked carboplatin-induced basophil activation in the plasma of patients positive for carboplatin hypersensitivity.", {"entities": []}], ["On further investigation, the HR-positive group had significantly higher levels of Fc\u03b5RI compared with the negative group (P < 0.05).", {"entities": []}], ["In conclusion, an IgE-dependent mechanism incorporating Fc\u03b5RI overexpression participates in carboplatin-induced severe HR.", {"entities": [[120, 122, "GENE"]]}], ["These results establish the relevance of monitoring the pharmacodynamic changes of basophils to prevent carboplatin-induced severe HR.", {"entities": [[131, 133, "GENE"]]}], ["Specialised epithelia such as mucociliary, secretory and transporting epithelia line all major organs, including the lung, gut and kidney.", {"entities": []}], ["Malfunction of these epithelia is associated with many human diseases.", {"entities": []}], ["The frog embryonic epidermis possesses mucus-secreting and multiciliated cells, and has served as an excellent model system for the biogenesis of cilia.", {"entities": []}], ["However, ionic regulation is important for the function of all specialised epithelia and it is not clear how this is achieved in the embryonic frog epidermis.", {"entities": []}], ["Here, we show that a third cell type develops alongside ciliated and mucus-secreting cells in the tadpole skin.", {"entities": []}], ["These cells express high levels of ion channels and transporters; therefore, we suggest that they are analogous to ionocytes found in transporting epithelia such as the mammalian kidney.", {"entities": []}], ["We show that frog ionocytes express the transcription factor foxi1e, which is required for the development of these cells.", {"entities": []}], ["Depletion of ionocytes by foxi1e knockdown has detrimental effects on the development of multiciliated cells, which show fewer and aberrantly beating cilia.", {"entities": []}], ["These results reveal a newly identified role for ionocytes and suggest that the frog embryonic skin is a model system that is particularly suited to studying the interactions of different cell types in mucociliary, as well as in secretory and transporting, epithelia.", {"entities": []}], ["The ability to respond to injury with tissue repair is a fundamental property of all multicellular organisms.", {"entities": []}], ["The extracellular matrix (ECM), composed of fibrillar collagens as well as a number of other components is dis-regulated during repair in many organs.", {"entities": []}], ["In many tissues, scaring results when the balance is lost between ECM synthesis and degradation.", {"entities": []}], ["Investigating what disrupts this balance and what effect this can have on tissue function remains an active area of research.", {"entities": []}], ["Recent advances in the imaging of fibrillar collagen using second harmonic generation (SHG) imaging have proven useful in enhancing our understanding of the supramolecular changes that occur during scar formation and disease progression.", {"entities": []}], ["Here, we review the physical properties of SHG, and the current nonlinear optical microscopy imaging (NLOM) systems that are used for SHG imaging.", {"entities": []}], ["We provide an extensive review of studies that have used SHG in skin, lung, cardiovascular, tendon and ligaments, and eye tissue to understand alterations in fibrillar collagens in scar tissue.", {"entities": []}], ["Lastly, we review the current methods of image analysis that are used to extract important information about the role of fibrillar collagens in scar formation.", {"entities": []}], ["A major cause of death in patients undergoing long-term domiciliary oxygen therapy (LTOT) is lung cancer progression.", {"entities": [[93, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["In our institution, we actively perform stereotactic body radiotherapy (SBRT) on patients with early-stage non\u2013small-cell lung cancer undergoing LTOT.", {"entities": [[122, 133, "DISEASE"], [127, 133, "DISEASE"]]}], ["In this study, we retrospectively analyzed the treatment efficacy and safety of SBRT for patients with T1-3N0M0 non\u2013small-cell lung cancer who had been prescribed LTOT for treatment of chronic obstructive pulmonary disease (COPD).", {"entities": [[127, 138, "DISEASE"], [185, 222, "DISEASE"], [132, 138, "DISEASE"]]}], ["A total of 24 patients were studied.", {"entities": []}], ["Their median age was 74 years (range, 63\u201387 years).", {"entities": []}], ["The median duration from the start of LTOT to SBRT was 23 months (range, 0\u201385 months).", {"entities": []}], ["Four of the 24 patients underwent lobectomy due to lung cancer.", {"entities": [[51, 62, "DISEASE"], [56, 62, "DISEASE"]]}], ["The median follow-up duration was 29 months (range, 5\u201379 months).", {"entities": []}], ["One patient had a local recurrence.", {"entities": []}], ["The median survival time was 30 months.", {"entities": []}], ["The 3-year overall survival was 49%.", {"entities": []}], ["In 6 of the 24 patients (25%), COPD presented with interstitial pneumonia.", {"entities": [[64, 73, "DISEASE"]]}], ["The 3-year overall survival for patients with COPD without interstitial pneumonia was significantly better than that for patients with both COPD and interstitial pneumonia (67% and 0%, respectively; P < 0.0001).", {"entities": [[72, 81, "DISEASE"], [162, 171, "DISEASE"]]}], ["Grade 5 radiation pneumonitis occurred in one patient (4%) with COPD with interstitial pneumonia.", {"entities": [[87, 96, "DISEASE"]]}], ["SBRT was tolerated by patients with early-stage non\u2013small-cell lung cancer undergoing LTOT.", {"entities": [[63, 74, "DISEASE"], [68, 74, "DISEASE"]]}], ["SBRT should be considered for patients undergoing LTOT.", {"entities": []}], ["However, clinicians should consider the risk of severe radiation pneumonitis in patients with interstitial pneumonia.", {"entities": [[107, 116, "DISEASE"]]}], ["Malaria is a serious problem in the countries of the developing world.", {"entities": [[0, 7, "DISEASE"]]}], ["As the malaria parasite has become resistant to most of the antimalaria drugs available currently, there is a need to search for newer drugs.", {"entities": [[7, 14, "DISEASE"]]}], ["This study reports the pharmaceutical quality and in vivo antimalarial activities of a polyherbal formulation (SAABMAL The antiplasmodial activity of SAABMAL Plasmodium berghei -infected mice.", {"entities": []}], ["The formulation was tried on three different experimental animal models for in vivo antimalarial activities, which are prophylactic, suppressive and curative in mice.", {"entities": []}], ["Chloroquine and pyrimethamine were used as standard drugs for comparison.", {"entities": []}], ["The suppressive study showed that, SAABMAL P <0.01) produced a suppression (29.39 - 100%) of parasitaemia in a dose-dependent manner, while the curative study showed that SAABMAL P <0.01) reduced (95.80%) parasitaemia compared with controls.", {"entities": []}], ["The mean survival time of SAABMAL The results obtained in this study showed the efficacy of SAABMAL", {"entities": []}], ["Pulmonary exacerbations (PEx), frequently associated with airway infection and inflammation, are the leading cause of morbidity in cystic fibrosis (CF).", {"entities": [[131, 146, "DISEASE"]]}], ["Molecular microbiologic approaches detect complex microbiota from CF airway samples taken during PEx.", {"entities": []}], ["The relationship between airway microbiota, inflammation, and lung function during CF PEx is not well understood.", {"entities": []}], ["To determine the relationships between airway microbiota, inflammation, and lung function in CF subjects treated for PEx.", {"entities": []}], ["Expectorated sputum and blood were collected and lung function testing performed in CF subjects during early (0\u20133d.)", {"entities": []}], ["and late treatment (>7d.)", {"entities": []}], ["Sputum was analyzed by culture, pyrosequencing of 16S rRNA amplicons, and quantitative PCR for total and specific bacteria.", {"entities": []}], ["Sputum IL-8 and neutrophil elastase (NE); and circulating C-reactive protein (CRP) were measured.", {"entities": [[78, 81, "GENE"]]}], ["Thirty-seven sputum samples were collected from 21 CF subjects.", {"entities": []}], ["At early treatment, lower diversity was associated with high relative abundance (RA) of Pseudomonas (r\u200a=\u200a\u22120.67, p<0.001), decreased FEV 1% predicted (r\u200a=\u200a0.49, p\u200a=\u200a0.03) and increased CRP (r\u200a=\u200a\u22120.58, p\u200a=\u200a0.01).", {"entities": [[132, 135, "GENE"], [184, 187, "GENE"]]}], ["In contrast to Pseudomonas , obligate and facultative anaerobic genera were associated with less inflammation and higher FEV 1 .", {"entities": [[121, 124, "GENE"]]}], ["With treatment, Pseudomonas RA and P. aeruginosa by qPCR decreased while anaerobic genera showed marked variability in response.", {"entities": []}], ["Change in RA of Prevotella was associated with more variability in FEV 1 response to treatment than Pseudomonas or Staphylococcus .", {"entities": [[67, 70, "GENE"]]}], ["Anaerobes identified from sputum by sequencing are associated with less inflammation and higher lung function compared to Pseudomonas at early exacerbation.", {"entities": []}], ["CF PEx treatment results in variable changes of anaerobic genera suggesting the need for larger studies particularly of patients without traditional CF pathogens.", {"entities": []}], ["In this study, we examined the relationship between the endothelial selectins (P-selectin and E-selectin) and whether they are critical for \u03b1 4 -integrin\u2013dependent leukocyte recruitment in inflamed (late phase response), cremasteric postcapillary venules.", {"entities": []}], ["Animals were systemically sensitized and 2 wk later challenged intrascrotally with chicken ovalbumin.", {"entities": []}], ["Leukocyte rolling flux, adhesion, and emigration were assessed at baseline and 4 and 8 h postantigen challenge.", {"entities": []}], ["There was a significant increase in leukocyte rolling flux, adhesion, and emigration in sensitized and challenged mice at both 4 and 8 h. At 8 h, the increase in leukocyte rolling flux was \u223c50% inhibitable by an anti\u2013\u03b1 4 -integrin antibody, 98% inhibitable by fucoidin (a selectin-binding carbohydrate), and 100% inhibitable by an anti\u2013P-selectin antibody.", {"entities": []}], ["P-selectin\u2013deficient animals displayed no leukocyte rolling or adhesion at 8 h after challenge.", {"entities": []}], ["However, at 8 h there were many emigrated leukocytes in the perivascular space suggesting P-selectin\u2013independent rolling at an earlier time point.", {"entities": []}], ["Indeed, at 4 h postantigen challenge in P-selectin\u2013deficient mice, there was increased leukocyte rolling, adhesion, and emigration.", {"entities": []}], ["The rolling in the P-selectin\u2013 deficient mice at 4 h was largely \u03b1 4 -integrin dependent.", {"entities": []}], ["However, there was an essential E-selectin\u2013 dependent component inasmuch as an anti\u2013E-selectin antibody completely reversed the rolling, and in E-selectin and P-selectin double deficient mice rolling, adhesion and emigration were completely absent.", {"entities": []}], ["These results illustrate that P-selectin underlies all of the antigen-induced rolling with a brief transient contribution from E-selectin in the P-selectin\u2013deficient animals.", {"entities": []}], ["Finally, the antigen-induced \u03b1 4 -integrin\u2013mediated leukocyte recruitment is entirely dependent upon endothelial selectins.", {"entities": []}], ["Candidate genes associated with idiopathic forms of autism overlap with other disorders including fragile X syndrome.", {"entities": [[108, 116, "DISEASE"]]}], ["Our laboratory has previously shown reduction in fragile X mental retardation protein (FMRP) and increase in metabotropic glutamate receptor 5 (mGluR5) in cerebellar vermis and superior frontal cortex (BA9) of individuals with autism.", {"entities": []}], ["In the current study we have investigated expression of four targets of FMRP and mGluR5 signaling - homer 1, amyloid beta A4 precursor protein (APP), ras-related C3 botulinum toxin substrate 1 (RAC1), and striatal-enriched protein tyrosine phosphatase (STEP) - in the cerebellar vermis and superior frontal cortex (BA9) via SDS-PAGE and western blotting.", {"entities": [[144, 147, "GENE"], [162, 164, "GENE"], [194, 198, "GENE"]]}], ["Data were analyzed based on stratification with respect to age (children and adolescents vs. adults), anatomic region of the brain (BA9 vs. cerebellar vermis), and impact of medications (children and adolescents on medications (n = 4) vs. total children and adolescents (n = 12); adults on medications (n = 6) vs. total adults (n = 12)).", {"entities": []}], ["There were significant increases in RAC1, APP 120 kDa and APP 80 kDa proteins in BA9 of children with autism vs. healthy controls.", {"entities": [[36, 40, "GENE"], [42, 45, "GENE"], [58, 61, "GENE"], [42, 45, "GENE"], [58, 61, "GENE"]]}], ["None of the same proteins were significantly affected in cerebellar vermis of children with autism.", {"entities": []}], ["In BA9 of adults with autism there were significant increases in RAC1 and STEP 46 kDa and a significant decrease in homer 1 vs. controls.", {"entities": [[65, 69, "GENE"]]}], ["In the vermis of adult subjects with autism, RAC1 was significantly increased while APP 120, STEP 66 kDa, STEP 27 kDa, and homer 1 were significantly decreased when compared with healthy controls.", {"entities": [[45, 49, "GENE"], [84, 87, "GENE"]]}], ["No changes were observed in vermis of children with autism.", {"entities": []}], ["There was a significant effect of anticonvulsant use on STEP 46 kDa/\u03b2-actin and a potential effect on homer 1/NSE, in BA9 of adults with autism.", {"entities": []}], ["However, no other significant confound effects were observed in this study.", {"entities": []}], ["Our findings provide further evidence of abnormalities in FMRP and mGluR5 signaling partners in brains of individuals with autism and open the door to potential targeted treatments which could help ameliorate the symptoms of autism.", {"entities": []}], ["In Togo, about half of health care costs are paid at the point of service, which reduces access to health care and exposes households to catastrophic health expenditure (CHE).", {"entities": []}], ["To address this situation, the Togolese government introduced a National Health Insurance Scheme (NHIS) in 2011.", {"entities": []}], ["This insurance currently covers only employees and retirees of the State as well as their dependents, although plans for extension exist.", {"entities": []}], ["This study is the first attempt to examine the extent to which Togo\u2019s NHIS protects its members financially against the consequences of ill-health.", {"entities": []}], ["Data was obtained from a cross-sectional representative households\u2019 survey involving 1180 insured households that had reported illness in the household in the 4 weeks preceding the survey or hospitalization in the 12 months preceding the survey.", {"entities": []}], ["The incidence and intensity of CHE were measured by the catastrophic health payment method.", {"entities": []}], ["A logistic regression was used to analyse determinants of CHE.", {"entities": []}], ["The results indicate that the proportion of insured households with CHE varies widely between 3.94% and 75.60%, depending on the method and the threshold used.", {"entities": []}], ["At the 40% threshold, health care cost represents 60.95% of insured households\u2019 total monthly non-food expenditure.", {"entities": []}], ["This study showed that the socioeconomic status, the type of health facility used, hospitalization and household size were the highest predictors of CHE.", {"entities": []}], ["Whatever the chosen threshold, care in referral and district hospitals significantly increases the likelihood of CHE.", {"entities": []}], ["In addition, the proportion of households facing CHE is higher in the lowest income groups.", {"entities": []}], ["The behaviour of health care providers, poor quality of care and long waiting time were the main factors leading to CHE.", {"entities": []}], ["A sizable proportion of insured households face CHE, suggesting gaps in the coverage.", {"entities": []}], ["To limit the impoverishment of insured households with low income, policies for free or heavily subsidized hospital services should be considered.", {"entities": []}], ["The results call for an equitable health insurance scheme, which is affordable for all insured households.", {"entities": []}], ["To elucidate the regulation of glucocorticoid receptor (GR) signaling under pro-asthmatic conditions, cultured human airway smooth muscle (HASM) cells were treated with proinflammatory cytokines or GR ligands alone and in combination, and then examined for induced changes in ligand-dependent and -independent GR activation and downstream signaling events.", {"entities": []}], ["Ligand stimulation with either cortisone or dexamethsone (DEX) acutely elicited GR translocation to the nucleus and, comparably, ligand-independent stimulation either with the Th2 cytokine, IL-13, or the pleiotropic cytokine combination, IL-1\u03b2/TNF\u03b1, also acutely evoked GR translocation.", {"entities": []}], ["The latter response was potentiated by combined exposure of cells to GR ligand and cytokine.", {"entities": []}], ["Similarly, treatment with either DEX or IL-13 alone induced GR phosphorylation at its serine-211 residue (GR", {"entities": []}], ["To compare the safety and effectiveness of long-acting \u03b2-antagonists (LABA), long-acting antimuscarinic agents (LAMA) and inhaled corticosteroids (ICS) for managing chronic obstructive pulmonary disease (COPD).", {"entities": [[165, 202, "DISEASE"]]}], ["Systematic review and network meta-analysis (NMA).", {"entities": []}], ["208 randomised clinical trials (RCTs) including 134\u2005692 adults with COPD.", {"entities": []}], ["LABA, LAMA and/or ICS, alone or in combination, versus each other or placebo.", {"entities": []}], ["The proportion of patients with moderate-to-severe exacerbations.", {"entities": []}], ["The number of patients experiencing mortality, pneumonia, serious arrhythmia and cardiovascular-related mortality (CVM) were secondary outcomes.", {"entities": [[47, 56, "DISEASE"]]}], ["NMA was conducted including 20 RCTs for moderate-to-severe exacerbations for 26\u2005141 patients with an exacerbation in the past year.", {"entities": []}], ["32 treatments were effective versus placebo including: tiotropium, budesonide/formoterol, salmeterol, indacaterol, fluticasone/salmeterol, indacaterol/glycopyrronium, tiotropium/fluticasone/salmeterol and tiotropium/budesonide/formoterol.", {"entities": []}], ["Tiotropium/budesonide/formoterol was most effective (99.2% probability of being the most effective according to the Surface Under the Cumulative RAnking (SUCRA) curve).", {"entities": []}], ["NMA was conducted on mortality (88 RCTs, 97\u2005526 patients); fluticasone/salmeterol was more effective in reducing mortality than placebo, formoterol and fluticasone alone, and was the most effective (SUCRA=71%).", {"entities": []}], ["NMA was conducted on CVM (37 RCTs, 55\u2005156 patients) and the following were safest: salmeterol versus each OF placebo, tiotropium and tiotropium (Soft Mist Inhaler (SMR)); fluticasone versus tiotropium (SMR); and salmeterol/fluticasone versus tiotropium and tiotropium (SMR).", {"entities": []}], ["Triamcinolone acetonide was the most harmful (SUCRA=81%).", {"entities": []}], ["NMA was conducted on pneumonia occurrence (54 RCTs, 61\u2005551 patients).", {"entities": [[21, 30, "DISEASE"]]}], ["24 treatments were more harmful, including 2 that increased risk of pneumonia versus placebo; fluticasone and fluticasone/salmeterol.", {"entities": [[68, 77, "DISEASE"]]}], ["The most harmful agent was fluticasone/salmeterol (SUCRA=89%).", {"entities": []}], ["NMA was conducted for arrhythmia; no statistically significant differences between agents were identified.", {"entities": []}], ["Many inhaled agents are available for COPD, some are safer and more effective than others.", {"entities": []}], ["Our results can be used by patients and physicians to tailor administration of these agents.", {"entities": []}], ["PROSPERO # CRD42013006725.", {"entities": []}], ["Minocycline, which has long been used as a broad-spectrum antibiotic, also exhibits non-antibiotic properties such as inhibition of inflammation and angiogenesis.", {"entities": []}], ["In this study, we show that minocycline significantly enhances the generation of dendritic cells (DCs) from mouse bone marrow (BM) cells when used together with GM-CSF and IL-4.", {"entities": []}], ["DCs generated from BM cells in the presence of minocycline (Mino-DCs) demonstrate the characteristics of regulatory DCs.", {"entities": []}], ["Compared with control DCs, Mino-DCs are resistant to subsequent maturation stimuli, impaired in MHC class II-restricted exogenous Ag presentation, and show decreased cytokine secretion.", {"entities": []}], ["Mino-DCs also show decreased ability to prime allogeneic-specific T cells, while increasing the expansion of CD4 in vitro and in vivo .", {"entities": [[109, 112, "GENE"]]}], ["In addition, pretreatment with MOG35-55 peptide-pulsed Mino-DCs ameliorates clinical signs of experimental autoimmune encephalitis induced by MOG peptide injection.", {"entities": [[118, 130, "DISEASE"]]}], ["Our study identifies minocycline as a new pharmacological agent that could be potentially used to increase the production of regulatory DCs for cell therapy to treat autoimmune disorders, allergy, and transplant rejection.", {"entities": []}], ["In a cohort of children in Cyprus, we recently reported low levels of high density lipoprotein cholesterol (HDL-C) to be associated with asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["We examined whether genetic polymorphisms that were previously linked individually to asthma, obesity, or HDL-C are associated with both asthma and HDL-C levels in the Cyprus cohort.", {"entities": [[94, 101, "DISEASE"], [86, 92, "DISEASE"], [137, 143, "DISEASE"]]}], ["We assessed genotypes frequencies in current-wheezers ( n \u2009=\u2009190) and non-asthmatic controls ( n \u2009=\u2009671) and HDL-C levels across several genotypes.", {"entities": []}], ["Binary logistic regression models were used to assess the effect of genotypes on wheezing risk and examined whether this effect is carried out through changes of HDL\u2013C.", {"entities": []}], ["Of the 16 polymorphisms tested, two polymorphisms TNFa rs3093664 and PRKCA rs9892651 presented significant differences in genotype distribution among current-wheezers and controls.", {"entities": [[69, 74, "GENE"]]}], ["Higher HDL-C levels were noted in carriers of genotype GG of polymorphism TNFa rs3093664 that was protective for wheezing Vs AG and AA genotypes (65.3 Vs 51.8 and 53.3\u00a0mg/dl, p -value\u2009<\u20090.001 and p -value for trend\u2009=\u20090.028).", {"entities": []}], ["In polymorphism PRKCA rs9892651 , HDL-C levels were lower in carriers of CC and TC genotypes that were more frequent in current-wheezers Vs TT genotype (52.2 and 52.7 Vs 55.2\u00a0mg/dl, p -value\u2009=\u20090.042 and p -value for trend\u2009=\u20090.02).", {"entities": [[16, 21, "GENE"]]}], ["The association of TNFa rs3093664 with wheezing is partly mediated by its effect on HDL-C whereas association of PRKCA rs9892651 with wheezing appeared to be independent of HDL-C. We found evidence that two SNPs located in different genetic loci, are associated with both wheezing and HDL-C levels, although more studies in other populations are needed to confirm our results.", {"entities": [[113, 118, "GENE"]]}], ["The online version of this article (doi:10.1186/s13052-016-0276-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Antenatal administration of synthetic glucocorticoids (sGC) is the standard of care for women at risk for preterm labor before 34 gestational weeks.", {"entities": []}], ["Despite their widespread use, the type of sGC used and their dose or the dosing regimens are not standardized in the United States of America or worldwide.", {"entities": []}], ["Several studies have identified neural deficits and the increased risk for cognitive and psychiatric disease later in life for children administered sGC prenatally.", {"entities": []}], ["However, the precise molecular and cellular targets of GC action in the developing brain remain largely undefined.", {"entities": [[55, 57, "GENE"]]}], ["In this study, we demonstrate that a single dose of glucocorticoid during mid-gestation in mice leads to enhanced proliferation in select cerebral cortical neural stem/progenitor cell populations.", {"entities": []}], ["These alterations are mediated by dose-dependent changes in the expression of cell cycle inhibitors and in genes that promote cell cycle re-entry.", {"entities": []}], ["This leads to changes in neuronal number and density in the cerebral cortex at birth, coupled to long-term alterations in neurite complexity in the prefrontal cortex and hippocampus in adolescents, and changes in anxiety and depressive-like behaviors in adults.", {"entities": []}], ["Macrolide resistance in Mycoplasma pneumoniae is often found in Asia but is rare elsewhere.", {"entities": []}], ["We report the emergence of macrolide-resistant M. pneumoniae in Israel and the in vivo evolution of such resistance during the treatment of a 6-year-old boy with pneumonia.", {"entities": [[162, 171, "DISEASE"]]}], ["Obstructive sleep apnoea syndrome (OSAS) is a disorder that leads to metabolic abnormalities and increased cardiovascular risk.", {"entities": [[25, 33, "DISEASE"]]}], ["The aim of this study was to identify early laboratory markers of cardiovascular disease through analysis of oxidative stress in normal subjects and patients with OSAS.", {"entities": []}], ["A prospective study was designed to compare outcomes of oxidative stress laboratory tests in 20 adult patients with OSAS and a control group of 20 normal subjects.", {"entities": []}], ["Laboratory techniques for detecting and quantifying free radical damage must be targeted to assess the pro-oxidant component and the antioxidant in order to obtain an overall picture of oxidative balance.", {"entities": []}], ["No statistical differences in age, sex distribution, or BMI were found between the two groups (p>0.05).", {"entities": []}], ["There were significant differences in the apnoea/hypopnoea index (AHI) between OSAS patients and the control group (p<0.05).", {"entities": []}], ["Statistically significant differences in isoprostane, advanced oxidation protein products (AOPP) and non-protein bound iron (NPBI) levels were found between the study and control groups.", {"entities": []}], ["No significant difference in the levels of thiol biomarkers was found between the two groups.", {"entities": []}], ["The main finding of the present study was increased production of oxidative stress biomarkers in OSAS patients.", {"entities": []}], ["The major difference between thiols and other oxidative stress biomarkers is that thiols are antioxidants, while the others are expressions of oxidative damage.", {"entities": []}], ["The findings of the present study indicate that biomarkers of oxidative stress in OSAS may be used as a marker of upper airway obstructive episodes due to mechanical trauma, as well as a marker of hypoxaemia causing local oropharyngeal inflammation.", {"entities": []}], ["Chronic hepatitis C virus (HCV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma.", {"entities": [[82, 106, "DISEASE"], [97, 106, "DISEASE"], [62, 77, "DISEASE"], [8, 17, "DISEASE"]]}], ["Combination therapy of pegylated interferon-alpha (PEG-IFN-\u03b1) and ribavirin (RBV) is a current standard treatment for chronic HCV infection in Korea, which has considerable adverse effects.", {"entities": []}], ["Acute pancreatitis is a rare complication of PEG-IFN-\u03b1 administration.", {"entities": [[6, 18, "DISEASE"], [0, 18, "DISEASE"]]}], ["We report a case of a 62-year-old female who experienced acute pancreatitis after 4 weeks of PEG-IFN-\u03b1-2a and RBV combination therapy for chronic HCV infection.", {"entities": [[63, 75, "DISEASE"], [57, 75, "DISEASE"]]}], ["The main cause of the acute pancreatitis in this case was probably PEG-IFN-\u03b1 rather than RBV for several reasons.", {"entities": [[28, 40, "DISEASE"], [22, 40, "DISEASE"]]}], ["A few cases have been reported in which acute pancreatitis occurred during treatment with PEG-IFN-\u03b1-2b.", {"entities": [[46, 58, "DISEASE"], [40, 58, "DISEASE"]]}], ["This is the first report of acute pancreatitis associated with PEG-IFN-\u03b1-2a in Korea.", {"entities": [[34, 46, "DISEASE"], [28, 46, "DISEASE"]]}], ["A recent health economic survey in Europe has suggested that migraine is the costliest among the neurological disorders.", {"entities": [[61, 69, "DISEASE"]]}], ["According to many studies, migraine and other disorders lead to widespread suffering, reduction of quality of life, and marked impairment of participation, both in work and social activities.", {"entities": [[27, 35, "DISEASE"]]}], ["The present literature survey was made in order to summarize what is known on the subject, as a preparation for a EU-supported study to assess the impact in several EU countries with similar methodology and the same research instrument.", {"entities": []}], ["Previous studies have yielded relatively reliable data only for migraine, whereas the impact of tension-type headache is virtually unknown or only very incompletely known for most dimensions of headache impact.", {"entities": [[64, 72, "DISEASE"]]}], ["Some data do suggest, however, that this headache may be as important from a health economic and a public health perspective as migraine.", {"entities": [[128, 136, "DISEASE"]]}], ["In future studies it is important to get population-based data from various countries relevant for estimation of indirect (mostly absenteeism from work and reduced working efficiency when having headache) and direct costs (related to medication, consultations, investigations and hospitalisations).", {"entities": []}], ["Also, the impact on ability to get education and participate in the workforce is very relevant, as is the impact on love life and family planning.", {"entities": []}], ["The quality of life of headache patients should be measured by validated instruments.", {"entities": []}], ["To get a complete picture, one should also ask about the effect on the life of partners and children, and on the possible impact even when headache-free (e.g.", {"entities": []}], ["fear of the next attack).", {"entities": []}], ["The use of potentially inappropriate medications (PIMs) may pose more risks than benefits to patients and is a major factor contributing to the likelihood of serious adverse drug reactions and negative health outcomes among older patients.", {"entities": []}], ["A retrospective chart review was conducted in a tertiary care center in USA where home medications of the older patients were reviewed and analyzed upon hospital admission over three months, from March till May 2016.", {"entities": []}], ["Inclusion criteria were age of 65\u00a0years and above, history of cardiovascular disease, and admission to the cardiology service.", {"entities": []}], ["The aim of our study was to determine the frequency and factors associated with PIMs, by applying the updated Beers 2015 criteria.", {"entities": []}], ["A total of 404 patients were included in the study and were taking a total of 4669 medications at home, an average of 11.6\u00a0\u00b1\u00a04.5 medications per patient.", {"entities": []}], ["The proportion of PIMS was 20% of all medications reported, with an average of 2.4 PIM per patient, and 87.4% of patients were receiving at least one PIM.", {"entities": []}], ["Significant association was found between use of PIMs and number of home medications, female gender, and number and types of comorbidities.", {"entities": []}], ["Comorbidities associated with more PIMs were heart failure, atrial fibrillation/flutter, history of falls/fractures, cerebrovascular accident, and depression.", {"entities": [[117, 141, "DISEASE"]]}], ["The most commonly prescribed PIMs were: drugs that may exacerbate or cause syndrome of inappropriate antidiuretic hormone secretion or hyponatremia (29.7%), scheduled use of proton pump inhibitors (PPIs)\u00a0>\u00a08\u00a0weeks in non-high-risk patients (11.3%), and benzodiazepines (8.1%).", {"entities": [[75, 83, "DISEASE"]]}], ["A high prevalence of PIMs in older patients with cardiovascular disease was observed.", {"entities": []}], ["Provider education and detailed assessment of medication lists upon hospital admission by multidisciplinary teams can help in preventing the use of PIMs.", {"entities": []}], ["Folate is vital for fetal development.", {"entities": []}], ["Periconceptional folic acid supplementation and food fortification are recommended to prevent neural tube defects.", {"entities": []}], ["Mechanisms whereby periconceptional folate influences normal development and disease are poorly understood: epigenetics may be involved.", {"entities": []}], ["We examine the association between maternal plasma folate during pregnancy and epigenome-wide DNA methylation using Illumina's HumanMethyl450 Beadchip in 1,988 newborns from two European cohorts.", {"entities": []}], ["Here we report the combined covariate-adjusted results using meta-analysis and employ pathway and gene expression analyses.", {"entities": []}], ["Four-hundred forty-three CpGs (320 genes) are significantly associated with maternal plasma folate levels during pregnancy (false discovery rate 5%); 48 are significant after Bonferroni correction.", {"entities": []}], ["Most genes are not known for folate biology, including APC2 , GRM8 , SLC16A12 , OPCML , PRPH , LHX1 , KLK4 and PRSS21.", {"entities": [[55, 59, "GENE"], [62, 66, "GENE"], [69, 77, "GENE"], [80, 85, "GENE"], [95, 99, "GENE"], [102, 106, "GENE"], [111, 117, "GENE"]]}], ["Some relate to birth defects other than neural tube defects, neurological functions or varied aspects of embryonic development.", {"entities": []}], ["These findings may inform how maternal folate impacts the developing epigenome and health outcomes in offspring.", {"entities": []}], ["Folic acid is routinely recommended for women trying to conceive to ensure proper fetal development.", {"entities": []}], ["Here, the authors perform a large epigenomics study to examine which fetal epigenetic changes are associated with varied maternal plasma folate levels.", {"entities": []}], ["The Indian Genome Variation Consortium (IGVC) project, an initiative of the Council for Scientific and Industrial Research, has been the first large-scale comprehensive study of the Indian population.", {"entities": []}], ["One of the major aims of the project is to study and catalog the variations in nearly thousand candidate genes related to diseases and drug response for predictive marker discovery, founder identification and also to address questions related to ethnic diversity, migrations, extent and relatedness with other world population.", {"entities": []}], ["The Phase I of the project aimed at providing a set of reference populations that would represent the entire genetic spectrum of India in terms of language, ethnicity and geography and Phase II in providing variation data on candidate genes and genome wide neutral markers on these reference set of populations.", {"entities": []}], ["We report here development of the IGVBrowser that provides allele and genotype frequency data generated in the IGVC project.", {"entities": []}], ["The database harbors 4229 SNPs from more than 900 candidate genes in contrasting Indian populations.", {"entities": []}], ["Analysis shows that most of the markers are from genic regions.", {"entities": []}], ["Further, a large fraction of genes are implicated in cardiovascular, metabolic, cancer and immune system-related diseases.", {"entities": [[80, 86, "DISEASE"]]}], ["Thus, the IGVC data provide a basal level variation data in Indian population to study genetic diseases and pharmacology.", {"entities": []}], ["Additionally, it also houses data on \u223c50\u2009000 (Affy 50\u2009K array) genome wide neutral markers in these reference populations.", {"entities": []}], ["In IGVBrowser one can analyze and compare genomic variations in Indian population with those reported in HapMap along with annotation information from various primary data sources.", {"entities": []}], ["Database URL: http://igvbrowser.igib.res.in", {"entities": []}], ["Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant cause of mortality of COPD patients, and pose a huge burden on healthcare.", {"entities": [[23, 60, "DISEASE"]]}], ["One of the major causes of AECOPD is airway bacterial (e.g.", {"entities": []}], ["nontypeable Haemophilus influenzae [NTHi]) infection.", {"entities": []}], ["However, the mechanisms underlying bacterial infections during AECOPD remain poorly understood.", {"entities": []}], ["As neutrophilic inflammation including increased release of human neutrophil elastase (HNE) is a salient feature of AECOPD, we hypothesized that HNE impairs airway epithelial defense against NTHi by degrading airway epithelial host defense proteins such as short palate, lung, and nasal epithelium clone 1 (SPLUNC1).", {"entities": []}], ["Recombinant human SPLUNC1 protein was incubated with HNE to confirm SPLUNC1 degradation by HNE.", {"entities": []}], ["To determine if HNE-mediated impairment of host defense against NTHi was SPLUNC1-dependent, SPLUNC1 protein was added to HNE-treated primary normal human airway epithelial cells.", {"entities": []}], ["The in vivo function of SPLUNC1 in NTHi defense was investigated by infecting SPLUNC1 knockout and wild-type mice intranasally with NTHi.", {"entities": []}], ["We found that: (1) HNE directly increased NTHi load in human airway epithelial cells; (2) HNE degraded human SPLUNC1 protein; (3) Recombinant SPLUNC1 protein reduced NTHi levels in HNE-treated human airway epithelial cells; (4) NTHi levels in lungs of SPLUNC1 knockout mice were increased compared to wild-type mice; and (5) SPLUNC1 was reduced in lungs of COPD patients.", {"entities": []}], ["Our findings suggest that SPLUNC1 degradation by neutrophil elastase may increase airway susceptibility to bacterial infections.", {"entities": []}], ["SPLUNC1 therapy likely attenuates bacterial infections during AECOPD.", {"entities": []}], ["The mechanisms by which chronic inflammatory lung diseases, particularly chronic obstructive pulmonary disease (COPD), confer enhanced risk for lung cancer are not well defined.", {"entities": [[144, 155, "DISEASE"], [73, 110, "DISEASE"], [149, 155, "DISEASE"]]}], ["To investigate whether nuclear factor (NF)-\u03baB, a key mediator of immune and inflammatory responses, provides an interface between persistent lung inflammation and carcinogenesis, we utilized tetracycline-inducible transgenic mice expressing, constitutively active I\u03baB kinase \u03b2 in airway epithelium ( IKTA mice).", {"entities": []}], ["Intraperitoneal injection of ethyl carbamate (urethane) or 3-methylcholanthrene (MCA) and butylated hydroxytoluene (BHT) was used to induce lung tumorigenesis.", {"entities": []}], ["Doxycycline-treated IKTA mice developed chronic airway inflammation and markedly increased numbers of lung tumors in response to urethane, even when transgene expression (and therefore epithelial NF-\u03baB activation) was begun after exposure to carcinogen.", {"entities": []}], ["Studies using a separate tumor initiator/promoter model (MCA+BHT) indicated that NF-\u03baB functions as an independent tumor promoter.", {"entities": []}], ["Enhanced tumor formation in IKTA mice was preceded by increased proliferation and reduced apoptosis of alveolar epithelium, resulting in increased formation of premalignant lesions.", {"entities": []}], ["Investigation of inflammatory cells in lungs of IKTA mice revealed a substantial increase in macrophages and lymphocytes, including functional CD4+/CD25+/FoxP3+ regulatory T lymphocytes (Tregs).", {"entities": []}], ["Importantly, Treg depletion using repetitive injections of anti-CD25 antibodies limited excessive tumor formation in IKTA mice.", {"entities": []}], ["At 6 weeks following urethane injection, antibody-mediated Treg depletion in IKTA mice reduced the number of premalignant lesions in the lungs in association with an increase in CD8 lymphocytes.", {"entities": []}], ["Thus, persistent NF-\u03baB signaling in airway epithelium facilitates carcinogenesis by sculpting the immune/inflammatory environment in the lungs.", {"entities": []}], ["Emerging studies suggest that dominant peripheral tolerance is a major mechanism of immune escape in disseminated leukemia.", {"entities": [[114, 122, "DISEASE"]]}], ["Using an established murine acute myeloid leukemia (AML) model, we here show that systemic administration of recombinant IL-33 dramatically inhibits the leukemia growth and prolongs the survival of leukemia-bearing mice in a CD8", {"entities": [[34, 50, "DISEASE"], [28, 50, "DISEASE"], [42, 50, "DISEASE"], [153, 161, "DISEASE"], [198, 206, "DISEASE"]]}], ["Parathyroidectomy is the only curative therapy for patients with primary hyperparathyroidism.", {"entities": [[65, 92, "DISEASE"], [73, 92, "DISEASE"]]}], ["However, the incidence, correlates and consequences of parathyroidectomy for primary hyperparathyroidism across the entire US population are unknown.", {"entities": [[77, 104, "DISEASE"], [85, 104, "DISEASE"]]}], ["We evaluated temporal trends in rates of inpatient parathyroidectomy for primary hyperparathyroidism, and associated in-hospital mortality, length of stay, and costs.", {"entities": [[73, 100, "DISEASE"], [81, 100, "DISEASE"]]}], ["We used the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) from 2002\u20132011.", {"entities": []}], ["Parathyroidectomies for primary hyperparathyroidism were identified using International Classification of Diseases, Ninth Revision codes.", {"entities": [[24, 51, "DISEASE"], [32, 51, "DISEASE"]]}], ["Unadjusted and age- and sex- adjusted rates of inpatient parathyroidectomy for primary hyperparathyroidism were derived from the NIS and the annual US Census.", {"entities": [[79, 106, "DISEASE"], [87, 106, "DISEASE"]]}], ["We estimated 109,583 parathyroidectomies for primary hyperparathyroidism between 2002 and 2011.", {"entities": [[45, 72, "DISEASE"], [53, 72, "DISEASE"]]}], ["More than half (55.4%) of patients were younger than age 65, and more than three-quarters (76.8%) were female.", {"entities": []}], ["The overall rate of inpatient parathyroidectomy was 32.3 cases per million person-years.", {"entities": []}], ["The adjusted rate decreased from 2004 (48.3 cases/million person-years) to 2007 (31.7 cases/million person-years) and was sustained thereafter.", {"entities": []}], ["Although inpatient parathyroidectomy rates declined over time across all geographic regions, a steeper decline was observed in the South compared to other regions.", {"entities": []}], ["Overall in-hospital mortality rates were 0.08%: 0.02% in patients younger than 65 years and 0.14% in patients 65 years and older.", {"entities": []}], ["Inpatient parathyroidectomy rates for primary hyperparathyroidism have declined in recent years.", {"entities": [[38, 65, "DISEASE"], [46, 65, "DISEASE"]]}], ["O1 Regulation of genes by telomere length over long distances Jerry W. Shay O2 The microtubule destabilizer KIF2A regulates the postnatal establishment of neuronal circuits in addition to prenatal cell survival, cell migration, and axon elongation, and its loss leading to malformation of cortical development and severe epilepsy Noriko Homma, Ruyun Zhou, Muhammad Imran Naseer, Adeel G. Chaudhary, Mohammed Al-Qahtani, Nobutaka Hirokawa O3 Integration of metagenomics and metabolomics in gut microbiome research Maryam Goudarzi, Albert J. Fornace Jr. O4 A unique integrated system to discern pathogenesis of central nervous system tumors Saleh Baeesa, Deema Hussain, Mohammed Bangash, Fahad Alghamdi, Hans-Juergen Schulten, Angel Carracedo, Ishaq Khan, Hanadi Qashqari, Nawal Madkhali, Mohamad Saka, Kulvinder S. Saini, Awatif Jamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Adeel Chaudhary, Mohammed Al Qahtani, Ghazi Damanhouri O5 RPL27A is a target of miR-595 and deficiency contributes to ribosomal dysgenesis Heba Alkhatabi O6 Next generation DNA sequencing panels for haemostatic and platelet disorders and for Fanconi anaemia in routine diagnostic service Anne Goodeve, Laura Crookes, Nikolas Niksic, Nicholas Beauchamp O7 Targeted sequencing panels and their utilization in personalized medicine Adel M. Abuzenadah O8 International biobanking in the era of precision medicine Jim Vaught O9 Biobank and biodata for clinical and forensic applications Bruce Budowle, Mourad Assidi, Abdelbaset Buhmeida O10 Tissue microarray technique: a powerful adjunct tool for molecular profiling of solid tumors Jaudah Al-Maghrabi O11 The CEGMR biobanking unit: achievements, challenges and future plans Abdelbaset Buhmeida, Mourad Assidi, Leena Merdad O12 Phylomedicine of tumors Sudhir Kumar, Sayaka Miura, Karen Gomez O13 Clinical implementation of pharmacogenomics for colorectal cancer treatment Angel Carracedo, Mahmood Rasool O14 From association to causality: translation of GWAS findings for genomic medicine Ahmed Rebai O15 E-GRASP: an interactive database and web application for efficient analysis of disease-associated genetic information Sajjad Karim, Hend F Nour Eldin, Heba Abusamra, Elham M Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar O16 The supercomputer facility \u201cAZIZ\u201d at KAU: utility and future prospects Hossam Faheem O17 New research into the causes of male infertility Ashok Agarwa O18 The Klinefelter syndrome: recent progress in pathophysiology and management Eberhard Nieschlag, Joachim Wistuba, Oliver S. Damm, Mohd A. Beg, Taha A. Abdel-Meguid, Hisham A. Mosli, Osama S. Bajouh, Adel M. Abuzenadah, Mohammed H. Al-Qahtani O19 A new look to reproductive medicine in the era of genomics Serdar Coskun P1 Wnt signalling receptors expression in Saudi breast cancer patients Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Ashraf Dallol, Jaudah Al-Maghrabi, Sahar Hakamy, Wejdan Al-Qahtani, Asia Al-Harbi, Shireen Hussain, Mourad Assidi, Mohammed Al-Qahtani, Adel Abuzenadah P2 Analysis of oxidative stress interactome during spermatogenesis: a systems biology approach to reproduction Burak Ozkosem, Rick DuBois P3 Interleukin-18 gene variants are strongly associated with idiopathic recurrent pregnancy loss.", {"entities": [[2380, 2396, "DISEASE"], [1862, 1879, "DISEASE"], [2780, 2793, "DISEASE"], [2430, 2438, "DISEASE"], [2385, 2396, "DISEASE"], [1873, 1879, "DISEASE"], [2787, 2793, "DISEASE"], [108, 113, "GENE"], [930, 936, "GENE"], [952, 959, "GENE"]]}], ["Safia S Messaoudi, Maryam T Dandana, Touhami Mahjoub, Wassim Y Almawi P4 Effect of environmental factors on gene-gene and gene-environment reactions: model and theoretical study applied to environmental interventions using genotype S. Abdalla, M. Nabil Al-Aama P5 Genomics and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumor Asmaa Elzawahry, Tsuyoshi Takahashi, Sachiyo Mimaki, Eisaku Furukawa, Rie Nakatsuka, Isao Kurosaka, Takahiko Nishigaki, Hiromi Nakamura, Satoshi Serada, Tetsuji Naka, Seiichi Hirota, Tatsuhiro Shibata, Katsuya Tsuchihara, Toshirou Nishida, Mamoru Kato P6 In-Silico analysis of putative HCV epitopes against Pakistani human leukocyte antigen background: an approach towards development of future vaccines for Pakistani population Sajid Mehmood, Naeem Mahmood Ashraf, Awais Asif, Muhammad Bilal, Malik Siddique Mehmood, Aadil Hussain P7 Inhibition of AChE and BuChE with the natural compounds of Bacopa monerri for the treatment of Alzheimer\u2019s disease: a bioinformatics approach Qazi Mohammad Sajid Jamal, Mughees Uddin Siddiqui, Mohammad A. Alzohairy, Mohammad A. Al Karaawi P8 Her2 expression in urothelial cell carcinoma of the bladder in Saudi Arabia Taoufik Nedjadi, Jaudah Al-Maghrabi, Mourad Assidi, Heba Al-Khattabi, Adel Al-Ammari, Ahmed Al-Sayyad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P9 Association of angiotensinogen single nucleotide polymorphisms with Preeclampsia in patients from North Africa H\u00e9dia Zitouni, Nozha Raguema, Marwa Ben Ali, Wided Malah, Raja Lfalah, Wassim Almawi, Touhami Mahjoub P10 Systems biology analysis reveals relations between normal skin, benign nevi and malignant melanoma Mohammed Elanbari, Andrey Ptitsyn P11 The apoptotic effect of thymoquinone in Jurkat cells Sana Mahjoub, Rabeb El Ghali, Bechir Achour, Nidhal Ben Amor, Mourad Assidi, Brahim N'siri, Hamid Morjani P12 Sonic hedgehog contributes in bladder cancer invasion in Saudi Arabia Taoufik Nedjadi, Adel Al-Ammari, Ahmed Al-Sayyad, Nada Salem, Esam Azhar, Jaudah Al-Maghrabi P13 Association of Interleukin 18 gene promoter polymorphisms - 607A/C and -137\u00a0G/C with colorectal cancer onset in a sample of Tunisian population Vera Chayeb, Maryam Dendena, Hedia Zitouni, Khedija Zouari-Limayem, Touhami Mahjoub P14 Pathological expression of interleukin-6, -11, leukemia inhibitory factor and their receptors in tubal gestation with and without tubal cytomegalovirus infection Bassem Refaat, Ahmed M Ashshi, Sarah A Batwa P15 Phenotypic and genetic profiling of avian pathogenic and human diarrhegenic Escherichia coli in Egypt Hazem Ramadan, Amal Awad, Ahmed Ateya P16 Cancer-targeting dual gene virotherapy as a promising therapeutic strategy for treatment of hepatocellular carcinoma Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok YUN P17 Cancer dual gene therapy with oncolytic adenoviruses expressing TRAIL and IL-12 transgenes markedly eradicated human hepatocellular carcinoma both in vitro and in vivo Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok Yun P18 Therapy with paricalcitol attenuates tumor growth and augments tumoricidal and anti-oncogenic effects of 5-fluorouracil on animal model of colon cancer Adel Galal El-Shemi, Bassem Refaat, Osama Kensara, Amr Abdelfattah P19 The effects of Rubus idaeus extract on normal human lymphocytes and cancer cell line Batol Imran Dheeb, Mohammed M. F. Al-Halbosiy, Rghad Kadhim Al lihabi, Basim Mohammed Khashman P20 Etanercept, a TNF-alpha inhibitor, alleviates mechanical hypersensitivity and spontaneous pain in a rat model of chemotherapy-induced neuropathic pain Djouhri, Laiche, Chaudhary Adeel, Nedjadi, Taoufik P21 Sleeping beauty mutagenesis system identified genes and neuronal transcription factor network involved in pediatric solid tumour (medulloblastoma) Hani Al-Afghani, Maria \u0141astowska, Haya H Al-Balool, Harsh Sheth, Emma Mercer, Jonathan M Coxhead, Chris PF Redfern, Heiko Peters, Alastair D Burt, Mauro Santibanez-Koref, Chris M Bacon, Louis Chesler, Alistair G Rust, David J Adams, Daniel Williamson, Steven C Clifford, Michael S Jackson P22 Involvement of interleukin-1 in vitiligo pathogenesis Mala Singh, Mohmmad Shoab Mansuri, Shahnawaz D. Jadeja, Hima Patel, Yogesh S. Marfatia, Rasheedunnisa Begum P23 Cytogenetics abnormalities in 12,884 referred population for chromosomal analysis and the role of FISH in refining the diagnosis (cytogenetic experience 2004-2013) Amal M Mohamed, Alaa K Kamel, Nivin A Helmy, Sayda A Hammad, Hesham F Kayed, Marwa I Shehab, Assad El Gerzawy, Maha M. Ead, Ola M Ead, Mona Mekkawy, Innas Mazen, Mona El-Ruby P24 Analysis of binding properties of angiotensin-converting enzyme 2 through in silico method S. M. A. Shahid, Qazi Mohammad Sajid Jamal, J. M. Arif, Mohtashim Lohani P25 Relationship of genetics markers cis and trans to the \u03b2-S globin gene with fetal hemoglobin expression in Tunisian sickle cell patients Moumni Imen, Chaouch Leila, Ouragini Houyem, Douzi Kais, Chaouachi Dorra Mellouli Fethi, Bejaoui Mohamed, Abbes Salem P26 Analysis of estrogen receptor alpha gene polymorphisms in breast cancer: link to genetic predisposition in Sudanese women Areeg Faggad, Amanuel T Gebreslasie, Hani Y Zaki, Badreldin E Abdalla P27 KCNQI gene polymorphism and its association with CVD and T2DM in the Saudi population Maha S AlShammari, Rhaya Al-Ali, Nader Al-Balawi , Mansour Al-Enazi, Ali Al-Muraikhi, Fadi Busaleh, Ali Al-Sahwan, Francis Borgio, Abdulazeez Sayyed, Amein Al-Ali, Sadananda Acharya P28 Clinical, neuroimaging and cytogenetic study of a patient with microcephaly capillary malformation syndrome Maha S. Zaki, Hala T. El-Bassyouni, Marwa I. Shehab P29 Altered expression of CD200R1 on dendritic cells of patients with inflammatory bowel diseases: in silico investigations and clinical evaluations Mohammed F. Elshal, Kaleemuddin M., Alia M. Aldahlawi, Omar Saadah, J. Philip McCoy P30 Development of real time PCR diagnostic protocol specific for the Saudi Arabian H1N1 viral strains Adel E El-Tarras, Nabil S Awad, Abdulla A Alharthi, Mohamed M M Ibrahim P31 Identification of novel genetic variations affecting Osteoarthritis patients Haneen S Alsehli, Ashraf Dallol, Abdullah M Gari, Mohammed M Abbas, Roaa A Kadam, Mazen M. Gari, Mohmmed H Alkaff, Adel M Abuzenadah, Mamdooh A Gari P32 An integrated database of GWAS SNVs and their evolutionary properties Heba Abusamra, Sajjad Karim, Hend F Nour eldin, Elham M Alhathli, Nada Salem, Sudhir Kumar, Mohammed H Al-Qahtani P33 Familial hypercholesterolemia in Saudi Arabia: prime time for a national registry and genetic analysis Fatima A. Moradi, Omran M. Rashidi, Zuhier A. Awan P34 Comparative genomics and network-based analyses of early hepatocellular carcinoma Ibrahim Hamza Kaya, Olfat Al-Harazi, Dilek Colak P35 A TALEN-based oncolytic viral vector approach to knock out ABCB1 gene mediated chemoresistance in cancer stem cells Nabila A Alkousi, Takis Athanasopoulos P36 Cartilage differentiation and gene expression of synovial fluid mesenchymal stem cells derived from osteoarthritis patients Afnan O Bahmaid, Etimad A Alhwait, Mamdooh A Gari, Haneen S Alsehli, Mohammed M Abbas, Mohammed H Alkaf, Roaa Kadam, Ashraf Dallol, Gauthaman Kalamegam P37 E-GRASP: Adding an evolutionary component to the genome-wide repository of associations (GRASP) resource Hend F Nour Eldin, Sajjad Karim, Heba Abusamra, Elham Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar P38 Screening of AGL gene mutation in Saudi family with glycogen storage disease Type III Salma N Alsayed, Fawziah H Aljohani, Samaher M Habeeb, Rawan A Almashali, Sulman Basit, Samia M Ahmed P39 High throughput proteomic data suggest modulation of cAMP dependent protein kinase A and mitochondrial function in infertile patients with varicocele Rakesh Sharma, Ashok Agarwal, Damayanthi Durairajanayagam, Luna Samanta, Muhammad Abu-Elmagd, Adel M. Abuzenadah, Edmund S. Sabanegh, Mourad Assidi, Mohammed Al-Qahtani P40 Significant protein profile alterations in men with primary and secondary infertility Ashok Agarwal, Rakesh Sharma, Luna Samanta, Damayanthi Durairajanayagam, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani, Adel M. Abuzenadah, Edmund S. Sabanegh P41 Spermatozoa maturation in infertile patients involves compromised expression of heat shock proteins Luna Samanta, Ashok Agarwal, Rakesh Sharma, Zhihong Cui, Mourad Assidi, Adel M. Abuzenadah, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P42 Array comparative genomic hybridization approach to search genomic answers for spontaneous recurrent abortion in Saudi Arabia Alaa A Alboogmi, Nuha A Alansari, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Hasan S Jamal, Abdullraheem Rozi , Zeenat Mirza, Adel M Abuzenadah, Sajjad Karim, Mohammed H Al-Qahtani P43 Global gene expression profiling of Saudi kidney cancer patients Sajjad Karim, Hans-Juergen Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Zeenat Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P44 Downregulated StAR gene and male reproductive dysfunction caused by nifedipine and ethosuximide Rasha A Ebiya, Samia M Darwish, Metwally M. Montaser P45 Clustering based gene expression feature selection method: A computational approach to enrich the classifier efficiency of differentially expressed genes Heba Abusamra, Vladimir B. Bajic P46 Prognostic significance of Osteopontin expression profile in colorectal carcinoma Jaudah Al-Maghrabi, Wafaey Gomaa, Mehenaz Hanbazazh, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Saher Hakamy, Ghali Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P47 High Glypican-3 expression pattern predicts longer disease-specific survival in colorectal carcinoma Jaudah Al-Maghrabi, Abdullah Al-Harbi, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Sahar Hakamy, Ghalia Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P48 An evolutionary re-assessment of GWAS single nucleotide variants implicated in the Cholesterol traits Elham M Alhathli, Sajjad Karim, Nada Salem, Hend Nour Eldin, Heba Abusamra, Sudhir Kumar, Mohammed H Al-Qahtani P49 Derivation and characterization of human Wharton\u2019s jelly stem cells (hWJSCs) in vitro for future therapeutic applications Aisha A Alyamani, Gauthaman Kalamegam, Etimad A Alhwait, Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa A Kadam, Mohammed Al-Qahtani P50 Attitudes of healthcare students toward biomedical research in the post-genomic era Rawan Gadi, Abdelbaset Buhmeida, Mourad Assidi , Adeel Chaudhary, Leena Merdad P51 Evaluation of the immunomodulatory effects of thymoquinone on human bone marrow mesenchymal stem cells (BM-MSCs) from osteoarthritic patients Saadiah M Alfakeeh, Etimad A Alhwait, Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa Kadam, Gauthaman Kalamegam P52 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M.Haroon Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P53 Selection of flavonoids against obesity protein (FTO) using in silico and in vitro approaches Shilu Mathew, Lobna Mira, Manal Shaabad, Shireen Hussain, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P54 Computational selection and in vitro validation of flavonoids as new antidepressant agents Shilu Mathew, Manal Shaabad, Lobna Mira, Shireen Hussain, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P55 In Silico prediction and prioritization of aging candidate genes associated with progressive telomere shortening Ahmed Rebai, Mourad Assidi, Abdelbaset Buhmeida, Muhammad Abu-Elmagd, Ashraf Dallol, Jerry W Shay P56 Identification of new cancer testis antigen genes in diverse types of malignant human tumour cells Mikhlid H Almutairi P57 More comprehensive forensic genetic marker analyses for accurate human remains identification using massively parallel sequencing (MPS) Angie Ambers, Jennifer Churchill, Jonathan King, Monika Stoljarova, Harrell Gill-King, Mourad Assidi, Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Muhammad Al-Qatani, Bruce Budowle P58 Flow cytometry approach towards treatment men infertility in Saudi Arabia Muhammad Abu-Elmagd, Farid Ahmed, Ashraf Dallol, Mourad Assidi, Taha Abo Almagd, Sahar Hakamy, Ashok Agarwal, Muhammad Al-Qahtani, Adel Abuzenadah P59 Tissue microarray based validation of CyclinD1 expression in renal cell carcinoma of Saudi kidney patients Sajjad Karim, Hans-Juergen Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Abdelbaset Buhmaida, Zeenat Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P60 Assessment of gold nanoparticles in molecular diagnostics and DNA damage studies Rukhsana Satar, Mahmood Rasool, Waseem Ahmad, Nazia Nazam, Mohamad I Lone, Muhammad I Naseer, Mohammad S Jamal, Syed K Zaidi, Peter N Pushparaj, Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani P61 Surfing the biospecimen management and processing workflow at CEGMR Biobank Hanan Bashier, Abrar Al Qahtani, Shilu Mathew, Amal M. Nour, Heba Alkhatabi, Adel M. Abu Zenadah, Abdelbaset Buhmeida, Mourad Assidi, Muhammed Al Qahtani P62 Autism Spectrum Disorder: knowledge, attitude and awareness in Jeddah, Kingdom of Saudi Arabia Muhammad Faheem, Shilu Mathew, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P63 Simultaneous genetic screening of the coagulation pathway genes using the Thromboscan targeted sequencing panel Hani A. Alhadrami, Ashraf Dallol, Adel Abuzenadah P64 Genome wide array comparative genomic hybridization analysis in patients with syndromic congenital heart defects Ibtessam R. Hussein, Adeel G. Chaudhary, Rima S Bader, Randa Bassiouni, Maha Alquaiti, Fai Ashgan, Hans Schulten, Mohamed Nabil Alama, Mohammad H. Al Qahtani P65 Toxocogenetic evaluation of 1, 2-Dichloroethane in bone marrow, blood and cells of immune system using conventional, molecular and flowcytometric approaches Mohammad I Lone, Nazia Nizam, Waseem Ahmad, Mohammad A Jafri, Mahmood Rasool, Shakeel A Ansari, Muhammed H Al-Qahtani P66 Molecular cytogenetic diagnosis of sexual development disorders in newborn: A case of ambiguous genitalia Eradah Alshihri, Muhammad Abu-Elmagd, Lina Alharbi, Mourad Assidi, Mohammed Al-Qahtani P67 Identification of disease specific gene expression clusters and pathways in hepatocellular carcinoma using In Silico methodologies Shilu Mathew, Peter Pushparaj Natesan, Muhammed Al Qahtani P68 Human Wharton\u2019s Jelly stem cell conditioned medium inhibits primary ovarian cancer cells in vitro: Identification of probable targets and mechanisms using systems biology Gauthaman Kalamegam, Peter Natesan Pushparaj, Fazal Khan, Roaa Kadam, Farid Ahmed, Mourad Assidi, Khalid Hussain Wali Sait, Nisreen Anfinan, Mohammed Al Qahtani P69 Mutation spectrum of ASPM (Abnormal Spindle-like, Microcephaly-associated) gene in Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Mohammad S Jamal, Shilu Mathew, Lobna S Mira, Peter N Pushparaj, Shakeel A Ansari, Mahmood Rasool, Mohammed H AlQahtani P70 Identification and characterization of novel genes and mutations of primary microcephaly in Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Shilu Mathew, Lobna S Mira, Mohammad S Jamal, Sameera Sogaty, Randa I Bassiouni, Mahmood Rasool, Mohammed H AlQahtani P71 Molecular genetic analysis of hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Saudi Arabian population Mahmood Rasool, Shakeel A Ansari, Mohammad S Jamal, Peter N Pushparaj, Abdulrahman MS Sibiani, Waseem Ahmad, Abdelbaset Buhmeida, Mohammad A Jafri, Mohiuddin K Warsi, Muhammad I Naseer, Mohammed H Al-Qahtani P72 Function predication of hypothetical proteins from genome database of chlamydia trachomatis Rubi, Kundan Kumar, Ahmad AT Naqvi, Faizan Ahmad, Md I Hassan, Mohammad S Jamal, Mahmood Rasool, Mohammed H AlQahtani P73 Transcription factors as novel molecular targets for skin cancer Ashraf Ali, Jummanah Jarullah, Mahmood Rasool, Abdelbasit Buhmeida, Shahida Khan, Ghufrana Abdussami, Maryam Mahfooz, Mohammad A Kamal, Ghazi A Damanhouri, Mohammad S Jamal P74 An In Silico analysis of Plumbagin binding to apoptosis executioner: Caspase-3 and Caspase-7 Bushra Jarullah, Jummanah Jarullah, Mohammad SS Jarullah, Ashraf Ali, Mahmood Rasool, Mohammad S Jamal P75 Single cell genomics applications for preimplantation genetic screening optimization: Comparative analysis of whole genome amplification technologies Mourad Assidi, Muhammad Abu-Elmagd, Osama Bajouh, Peter Natesan Pushparaj, Mohammed Al-Qahtani, Adel Abuzenadah P76 ZFP36 regulates miRs-34a in anti-IgM triggered immature B cells Mohammad S Jamal, Jummanah Jarullah, Abdulah EA Mathkoor, Hashim MA Alsalmi, Anas MM Oun, Ghazi A Damanhauri, Mahmood Rasool, Mohammed H AlQahtani P77 Identification of a novel mutation in the STAMBP gene in a family with microcephaly-capillary malformation syndrome Muhammad I. Naseer, Mahmood Rasool, Sameera Sogaty, Adeel G. Chudhary, Yousif A. Abutalib, Daniele Merico, Susan Walker, Christian R. Marshall, Mehdi Zarrei, Stephen W. Scherer, Mohammad H. Al-Qahtani P78 Copy number variations in Saudi patients with intellectual disability and epilepsy Muhammad I. Naseer, Muhammad Faheem, Adeel G. Chaudhary, Mahmood Rasool, Gauthaman Kalamegam, Fai Talal Ashgan, Mourad Assidi, Farid Ahmed, Syed Kashif Zaidi, Mohammed M. Jan, Mohammad H. Al-Qahtani P79 Prognostic significance of CD44 expression profile in colorectal carcinoma Maryam Al-Zahrani, Sahira Lary, Sahar Hakamy, Ashraf Dallol, Mahmoud Al-Ahwal, Jaudah Al-Maghrabi, Emmanuel Dermitzakis, Adel Abuzenadah, Abdelbaset Buhmeida, Mohammed Al-Qahtani P80 Association of the endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications Abeer A Al-refai, Mona Saleh, Rehab I Yassien, Mahmmoud Kamel, Rabab M Habeb P81 SNPs array to screen genetic variation among diabetic patients Najlaa Filimban, Ashraf Dallol, Nadia Ghannam, Mohammed Al-Qahtani, Adel Mohammed Abuzenadah P82 Detection and genotyping of Helicobacter pylori among gastric cancer patients from Saudi Arabian population Fehmida Bibi, Sana Akhtar, Esam I. Azhar, Muhammad Yasir, Muhammad I. Nasser, Asif A. Jiman-Fatani, Ali Sawan P83 Antimicrobial drug resistance and molecular detection of susceptibility to Fluoroquinolones among clinical isolates of Salmonella species from Jeddah-Saudi Arabia Ruaa A Lahzah, Asho Ali P84 Identification of the toxic and virulence nature of MAP1138c protein of Mycobacterium avium subsp.", {"entities": [[17941, 17953, "DISEASE"], [7541, 7565, "DISEASE"], [327, 357, "DISEASE"], [6536, 6565, "DISEASE"], [7820, 7830, "DISEASE"], [4175, 4183, "DISEASE"], [2721, 2745, "DISEASE"], [2951, 2975, "DISEASE"], [6751, 6775, "DISEASE"], [14520, 14544, "DISEASE"], [3833, 3848, "DISEASE"], [14706, 14720, "DISEASE"], [8856, 8869, "DISEASE"], [2127, 2144, "DISEASE"], [15575, 15592, "DISEASE"], [17354, 17377, "DISEASE"], [1170, 1179, "DISEASE"], [2736, 2745, "DISEASE"], [2966, 2975, "DISEASE"], [6766, 6775, "DISEASE"], [9538, 9547, "DISEASE"], [9815, 9824, "DISEASE"], [12515, 12524, "DISEASE"], [14535, 14544, "DISEASE"], [17659, 17668, "DISEASE"], [16117, 16128, "DISEASE"], [5136, 5149, "DISEASE"], [11173, 11180, "DISEASE"], [5645, 5653, "DISEASE"], [15600, 15608, "DISEASE"], [17094, 17102, "DISEASE"], [13335, 13359, "DISEASE"], [3229, 3241, "DISEASE"], [2321, 2329, "DISEASE"], [1665, 1673, "DISEASE"], [5609, 5621, "DISEASE"], [15024, 15036, "DISEASE"], [15320, 15332, "DISEASE"], [17058, 17070, "DISEASE"], [6171, 6185, "DISEASE"], [7088, 7102, "DISEASE"], [8078, 8089, "DISEASE"], [12264, 12275, "DISEASE"], [12504, 12524, "DISEASE"], [1913, 1919, "DISEASE"], [2138, 2144, "DISEASE"], [2629, 2635, "DISEASE"], [2834, 2840, "DISEASE"], [3235, 3241, "DISEASE"], [3381, 3387, "DISEASE"], [5143, 5149, "DISEASE"], [6927, 6933, "DISEASE"], [8863, 8869, "DISEASE"], [11799, 11805, "DISEASE"], [14714, 14720, "DISEASE"], [15586, 15592, "DISEASE"], [16122, 16128, "DISEASE"], [18280, 18286, "DISEASE"], [2007, 2011, "GENE"], [18353, 18357, "GENE"], [2270, 2273, "GENE"], [5732, 5739, "GENE"], [6888, 6893, "GENE"], [7502, 7505, "GENE"], [11190, 11193, "GENE"], [12361, 12364, "GENE"], [14995, 14999, "GENE"], [16772, 16777, "GENE"], [17029, 17035, "GENE"], [17621, 17625, "GENE"], [2007, 2011, "GENE"], [18353, 18357, "GENE"]]}], ["paratuberculosis Syed A Hassan, Seyed E Hasnain, Iftikhar A Tayubi, Hamza A Abujabal, Alaa O Magrabi P85 In vitro and in silico evaluation of miR137 in human breast cancer Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj, Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour, Mohammed Al-Qahtani P86 Auruka gene is over-expressed in Saudi breast cancer Manal Shabaad, Shilu Mathew, Ashraf Dallol, Adnan Merdad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P87 The potential of immunogenomics in personalized healthcare Mourad Assidi, Muhammad Abu-Elmagd, Kalamegam Gauthaman, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P88 In Silico physiochemical and structural characterization of a putative ORF MAP0591 and its implication in the pathogenesis of Mycobacterium paratuberculosis in ruminants and humans Syed A Hassan, Iftikhar A Tayubi, Hani MA Aljahdali P89 Effects of heat shock on human bone marrow mesenchymal stem cells (BM-MSCs): Implications in regenerative medicine Reham Al Nono, Mamdooh Gari, Haneen Alsehli, Farid Ahmed, Mohammed Abbas, Gauthaman Kalamegam, Mohammed Al-Qahtani P90 In Silico analyses of the molecular targets of Resveratrol unravels its importance in mast cell mediated allergic responses Shilu Mathew, Fazal Khan, Mahmood Rasool, Mohammed Sarwar Jamal, Muhammad Imran Naseer, Zeenat Mirza, Sajjad Karim, Shakeel Ansari, Mourad Assidi, Gauthaman Kalamegam, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P91 Effects of environmental particulate matter on bone-marrow mesenchymal stem cells Muhammad Abu-Elmagd, Gauthaman Kalamegam, Roaa Kadam, Mansour A Alghamdi, Magdy Shamy, Max Costa, Mamdouh I Khoder, Mourad Assidi, Peter Natesan Pushparaj, Mamdooh Gari, Mohammed Al-Qahtani P92 Distinctive charge clusters in human virus proteomes Najla Kharrat, Sabrine Belmabrouk, Rania Abdelhedi, Riadh Benmarzoug, Mourad Assidi, Mohammed H. Al Qahtani, Ahmed Rebai P93 In vitro experimental model and approach in identification of new biomarkers of inflammatory forms of arthritis Ghazi Dhamanhouri, Peter Natesan Pushparaj, Abdelwahab Noorwali, Mohammad Khalid Alwasiyah, Afnan Bahamaid, Saadiah Alfakeeh, Aisha Alyamani, Haneen Alsehli, Mohammed Abbas, Mamdooh Gari, Ali Mobasheri, Gauthaman Kalamegam, Mohammed Al-Qahtani P94 Molecular docking of GABA A receptor subunit \u03b3-2 with novel anti-epileptic compounds Muhammad Faheem, Shilu Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P95 Breast cancer knowledge, awareness, and practices among Saudi females residing in Jeddah Shilu Mathew, Muhammad Faheem, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P96 Anti-inflammatory role of Sesamin by Attenuation of Iba1/TNF-\u03b1/ICAM-1/iNOS signaling in Diabetic Retinopathy Mohammad Sarwar Jamal, Syed Kashif Zaidi, Raziuddin Khan, Kanchan Bhatia, Mohammed H. Al-Qahtani, Saif Ahmad P97 Identification of drug lead molecule against vp35 protein of Ebola virus: An In-Silico approach Iftikhar AslamTayubi, Manish Tripathi, Syed Asif Hassan, Rahul Shrivastava P98 An approach to personalized medicine from SNP-calling through disease analysis using whole exome-sequencing of three sub-continental populations Iftikhar A Tayubi, Syed Hassan, Hamza A.S Abujabal P99 Low versus high frequency of Glucose \u20136 \u2013 Phosphate Dehydrogenase (G6PD) deficiency in urban against tribal population of Gujarat \u2013 A signal to natural selection Ishani Shah, Bushra Jarullah, Mohammad S Jamal, Jummanah Jarullah P100 Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent update Ishfaq A Sheikh, Ejaz Ahmad, Mohammad S Jamal, Mohd Rehan, Muhammad Abu-Elmagd, Iftikhar A Tayubi, Samera F AlBasri, Osama S Bajouh, Rola F Turki, Adel M Abuzenadah, Ghazi A Damanhouri, Mohd A Beg, Mohammed Al-Qahtani P101 Prevalence of congenital heart diseases among Down syndrome cases in Saudi Arabia: role of molecular genetics in the pathogenesis Sahar AF Hammoudah, Khalid M AlHarbi, Lama M El-Attar, Ahmed MZ Darwish P102 Combinatorial efficacy of specific pathway inhibitors in breast cancer cells Sara M Ibrahim, Ashraf Dallol , Hani Choudhry, Adel Abuzenadah, Jalaludden Awlia, Adeel Chaudhary, Farid Ahmed, Mohammed Al-Qahtani P103 MiR-143 and miR-145 cluster as potential replacement medicine for the treatment of cancer Mohammad A Jafri, Muhammad Abu-Elmagd, Mourad Assidi, Mohammed Al-Qahtani P104 Metagenomic profile of gut microbiota during pregnancy in Saudi population Imran khan, Muhammad Yasir, Esam I. Azhar, Sameera Al-basri, Elie Barbour, Taha Kumosani P105 Exploration of anticancer targets of selected metabolites of Phoenix dactylifera L. using systems biological approaches Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj, Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour P106 CD226 and CD40 gene polymorphism in susceptibility to Juvenile rheumatoid arthritis in Egyptian patients Heba M. EL Sayed, Eman A. Hafez P107 Paediatric exome sequencing in autism spectrum disorder ascertained in Saudi families Hans-Juergen Schulten, Aisha Hassan Elaimi, Ibtessam R Hussein, Randa Ibrahim Bassiouni, Mohammad Khalid Alwasiyah, Richard F Wintle, Adeel Chaudhary, Stephen W Scherer, Mohammed Al-Qahtani P108 Crystal structure of the complex formed between Phospholipase A 2 and the central core hydrophobic fragment of Alzheimer\u2019s \u03b2- amyloid peptide: a reductionist approach Zeenat Mirza, Vikram Gopalakrishna Pillai, Sajjad Karim, Sujata Sharma, Punit Kaur, Alagiri Srinivasan, Tej P Singh, Mohammed Al-Qahtani P109 Differential expression profiling between meningiomas from female and male patients Reem Alotibi, Alaa Al-Ahmadi, Fatima Al-Adwani, Deema Hussein, Sajjad Karim, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen Schulten, Mohammed Al-Qahtani P110 Neurospheres as models of early brain development and therapeutics Muhammad Faheem, Peter Natesan Pushparaj, Shilu Mathew, Taha Abdullah Kumosani, Gauthaman Kalamegam, Mohammed Al-Qahtani P111 Identification of a recurrent causative missense mutation p.(W577C) at the LDLR exon 12 in familial hypercholesterolemia affected Saudi families Faisal A Al-Allaf, Zainularifeen Abduljaleel, Abdullah Alashwal, Mohiuddin M. Taher, Abdellatif Bouazzaoui, Halah Abalkhail, Faisal A. Ba-Hammam, Mohammad Athar P112 Epithelial ovarian carcinoma (EOC): Systems oncological approach to identify diagnostic, prognostic and therapeutic biomarkers Gauthaman Kalamegam, Peter Natesan Pushparaj, Muhammad Abu-Elmagd, Farid Ahmed Khalid HussainWali Sait, Nisreen Anfinan, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Mourad Assidi, Mohammed Al-Qahtani P113 Crohn\u2019s disease phenotype in northern Tunisian population Naira Ben Mami, Yosr Z Haffani, Mouna Medhioub, Lamine Hamzaoui, Ameur Cherif, Msadok Azouz P114 Establishment of In Silico approaches to decipher the potential toxicity and mechanism of action of drug candidates and environmental agents Gauthaman Kalamegam, Fazal Khan, Shilu Mathew, Mohammed Imran Nasser, Mahmood Rasool, Farid Ahmed, Peter Natesan Pushparaj, Mohammed Al-Qahtani P115 1q Gain predicts poor prognosis marker for young breast cancer patients Shereen A Turkistany, Lina M Al-harbi, Ashraf Dallol, Jamal Sabir, Adeel Chaudhary, Adel Abuzenadah P116 Disorders of sex chromosomes in a diagnostic genomic medicine unit in Saudi Arabia: Prevalence, diagnosis and future guidelines Basmah Al-Madoudi, Bayan Al-Aslani, Khulud Al-Harbi, Rwan Al-Jahdali, Hanadi Qudaih, Emad Al Hamzy, Mourad Assidi, Mohammed Al Qahtani P117 Combination of WYE354 and Sunitinib demonstrate synergistic inhibition of acute myeloid leukemia in vitro Asad M Ilyas, Youssri Ahmed, Mamdooh Gari, Farid Ahmed, Mohammed Alqahtani P118 Integrated use of evolutionary information in GWAS reveals important SNPs in Asthma Nada Salem, Sajjad Karim, Elham M Alhathli, Heba Abusamra, Hend F Nour Eldin, Mohammed H Al-Qahtani, Sudhir Kumar P119 Assessment of BRAF , IDH1 , IDH2 , and EGFR mutations in a series of primary brain tumors Fatima Al-Adwani, Deema Hussein, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Mohammed Al-Qahtani, Hans-Juergen Schulten P120 Expression profiles distinguish oligodendrogliomas from glioblastoma multiformes with or without oligodendroglioma component Alaa Alamandi, Reem Alotibi, Deema Hussein, Sajjad Karim, Jaudah Al-Maghrabi, Fahad Al-Ghamdi, Awatif Jamal, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen Schulten, Mohammed Al-Qahtani P121 Hierarchical clustering in thyroid goiters and hyperplastic lesions Ohoud Subhi, Nadia Bagatian, Sajjad Karim, Adel Al-Johari, Osman Abdel Al-Hamour, Hosam Al-Aradati, Abdulmonem Al-Mutawa, Faisal Al-Mashat, Jaudah Al-Maghrabi, Hans-Juergen Schulten, Mohammad Al-Qahtani P122 Differential expression analysis in thyroiditis and papillary thyroid carcinomas with or without coexisting thyroiditis Nadia Bagatian, Ohoud Subhi, Sajjad Karim, Adel Al-Johari, Osman Abdel Al-Hamour, Abdulmonem Al-Mutawa, Hosam Al-Aradati, Faisal Al-Mashat, Mohammad Al-Qahtani, Hans-Juergen Schulten, Jaudah Al-Maghrabi P123 Metagenomic analysis of waste water microbiome in Sausdi Arabia Muhammad W shah, Muhammad Yasir, Esam I Azhar, Saad Al-Masoodi P124 Molecular characterization of Helicobacter pylori from faecal samples of Tunisian patients with gastric cancer Yosr Z Haffani, Msadok Azouz, Emna Khamla, Chaima Jlassi, Ahmed S. Masmoudi, Ameur Cherif, Lassaad Belbahri P125 Diagnostic application of the oncoscan Shadi Al-Khayyat, Roba Attas, Atlal Abu-Sanad, Mohammed Abuzinadah, Adnan MerdadAshraf Dallol, Adeel Chaudhary, Mohammed Al-Qahtani, Adel Abuzenadah P126 Characterization of clinical and neurocognitive features in a family with a novel OGT gene missense mutation c. 1193G\u2009>\u2009A/ (p. Ala319Thr) Habib Bouazzi, Carlos Trujillo, Mohammad Khalid Alwasiyah, Mohammed Al-Qahtani P127 Case report: a rare homozygous deletion mutation of TMEM70 gene associated with 3-Methylglutaconic Aciduria and cataract in a Saudi patient Maha Alotaibi, Rami Nassir P128 Isolation and purification of antimicrobial milk proteins Ishfaq A Sheikh, Mohammad A Kamal, Essam H Jiffri, Ghulam M Ashraf, Mohd A Beg P129 Integrated analysis reveals association of ATP8B1 gene with colorectal cancer Mohammad A Aziz, Rizwan Ali, Mahmood Rasool, Mohammad S Jamal, Nusaibah samman, Ghufrana Abdussami, Sathish Periyasamy, Mohiuddin K Warsi, Mohammed Aldress, Majed Al Otaibi, Zeyad Al Yousef, Mohamed Boudjelal, Abdelbasit Buhmeida, Mohammed H Al-Qahtani, Ibrahim AlAbdulkarim P130 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M. Haroon Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P131 Interactions of endocrine disruptor di-(2-ethylhexyl) phthalate (DEHP) and its metabolite mono-2-ethylhexyl phthalate (MEHP) with progesterone receptor Ishfaq A Sheikh, Muhammad Abu-Elmagd, Rola F Turki, Ghazi A Damanhouri, Mohd A. Beg P132 Association of HCV nucleotide polymorphism in the development of hepatocellular carcinoma Mohd Suhail, Abid Qureshi, Adil Jamal, Peter Natesan Pushparaj, Mohammad Al-Qahtani, Ishtiaq Qadri P133 Gene expression profiling by DNA microarrays in colon cancer treated with chelidonine alkaloid Mahmoud Z El-Readi, Safaa Y Eid, Michael Wink P134 Successful in vitro fertilization after eight failed trials Ahmed M. Isa, Lulu Alnuaim, Johara Almutawa, Basim Abu-Rafae, Saleh Alasiri, Saleh Binsaleh P135 Genetic sensitivity analysis using SCGE, cell cycle and mitochondrial membrane potential in OPs stressed leukocytes in Rattus norvegicus through flow cytometric input Nazia Nazam, Mohamad I Lone, Waseem Ahmad, Shakeel A Ansari, Mohamed H Alqahtani", {"entities": [[6182, 6211, "DISEASE"], [8362, 8374, "DISEASE"], [10126, 10134, "DISEASE"], [11189, 11213, "DISEASE"], [4902, 4922, "DISEASE"], [10388, 10405, "DISEASE"], [8951, 8962, "DISEASE"], [9023, 9034, "DISEASE"], [6421, 6430, "DISEASE"], [11204, 11213, "DISEASE"], [6413, 6430, "DISEASE"], [158, 171, "DISEASE"], [348, 361, "DISEASE"], [2520, 2533, "DISEASE"], [4107, 4120, "DISEASE"], [7232, 7245, "DISEASE"], [7708, 7724, "DISEASE"], [3894, 3902, "DISEASE"], [5012, 5036, "DISEASE"], [11366, 11378, "DISEASE"], [7702, 7724, "DISEASE"], [2094, 2103, "DISEASE"], [4913, 4922, "DISEASE"], [7716, 7724, "DISEASE"], [8403, 8420, "DISEASE"], [165, 171, "DISEASE"], [355, 361, "DISEASE"], [2527, 2533, "DISEASE"], [4114, 4120, "DISEASE"], [4347, 4353, "DISEASE"], [7239, 7245, "DISEASE"], [9479, 9485, "DISEASE"], [10399, 10405, "DISEASE"], [11372, 11378, "DISEASE"], [1039, 1043, "GENE"], [1707, 1710, "GENE"], [3370, 3374, "GENE"], [4264, 4271, "GENE"], [4276, 4283, "GENE"], [4536, 4540, "GENE"], [9340, 9344, "GENE"], [4839, 4844, "GENE"], [4849, 4853, "GENE"], [6166, 6170, "GENE"], [8031, 8035, "GENE"], [8038, 8042, "GENE"], [8045, 8049, "GENE"], [8056, 8060, "GENE"], [4536, 4540, "GENE"], [9340, 9344, "GENE"], [9874, 9877, "GENE"], [10066, 10072, "GENE"], [10371, 10377, "GENE"]]}], ["To reduce the burden on injury survivors and their supporters, factors associated with poor outcomes need to be identified so that timely post-injury interventions can be implemented.", {"entities": []}], ["To date, few studies have investigated outcomes for both those who were hospitalised and those who were not.", {"entities": []}], ["To describe the prevalence and to identify pre-injury and injury-related predictors of disability among hospitalised and non-hospitalised people, three months after injury.", {"entities": []}], ["Participants in the Prospective Outcomes of Injury Study were aged 18\u201364 years and on an injury entitlement claims register with New Zealand's no-fault injury compensation insurer, following referral by healthcare professionals.", {"entities": []}], ["A wide range of pre-injury demographic, health and injury-related characteristics were collected at interview.", {"entities": []}], ["Participants were categorised as \u2018hospitalised\u2019 if they were placed on New Zealand's National Minimum Data Set within seven days of the injury event.", {"entities": []}], ["Injury severity scores (NISS) and 12 injury categories were derived from ICD-10 codes.", {"entities": []}], ["WHODAS assessed disability.", {"entities": []}], ["Multivariable analyses examined relationships between explanatory variables and disability.", {"entities": []}], ["Of 2856 participants, 2752 (96%) had WHODAS scores available for multivariable analysis; 673 were hospitalised; 2079 were not.", {"entities": []}], ["Disability was highly prevalent among hospitalised (53.6%) and non-hospitalised (39.4%) participants, three-months after injury.", {"entities": []}], ["In both groups, pre-injury disability, obesity and higher injury severity were associated with increased odds of post-injury disability.", {"entities": [[39, 46, "DISEASE"]]}], ["A range of other factors were associated with disability in only one group: e.g.", {"entities": []}], ["female, \u22652 chronic conditions and leg fracture among hospitalised; aged 35\u201354 years, trouble accessing healthcare, spine or lower extremity sprains/dislocations and assault among non-hospitalised.", {"entities": []}], ["Disability was highly prevalent among both groups yet, with a few exceptions, factors associated with disability were not common to both groups.", {"entities": []}], ["Where possible, including a range of injured people in studies, hospitalised and not, will increase understanding of the burden of disability in the sub-acute phase.", {"entities": []}], ["Over the last few years, differential ion mobility spectroscopy (DMS) has become an important tool in medical research.", {"entities": []}], ["There are attempts to find markers for specific diseases in exhaled air, using this technology as a non-invasive early diagnosis.", {"entities": []}], ["In the present research, exhaled air from 78 patients with known diagnosis and 39 control persons were tested with a DMS system from Sionex.", {"entities": []}], ["Bronchial asthma showed a pattern of 6 characteristic points in a discriminant analysis.", {"entities": [[10, 16, "DISEASE"]]}], ["Patients with diagnosed hypertension showed a characteristic pattern with 4 points, hypothyroidism 2 points; increased LDL cholesterol 3 points, and type II diabetics treated with insulin 4 spots.", {"entities": [[24, 36, "DISEASE"], [84, 98, "DISEASE"]]}], ["No significant differences with respect to the control group were found in chronic obstructive pulmonary disease patients.", {"entities": [[75, 112, "DISEASE"]]}], ["The DMS pattern in the tested asthmatics showed a partial change depending on different medications used.", {"entities": []}], ["Differential ion mobility spectroscopy offers promise as a helpful diagnostic tool.", {"entities": []}], ["The presence of any age-related differences in gingival pigmentation associated with smoking, particularly in a young population, remains to be fully investigated.", {"entities": []}], ["The purpose of this study was to determine the age-related differences in smoking gingival pigmentation.", {"entities": []}], ["Gingival pigmentation was analyzed using the gingival melanosis record (GMR) and Hedin\u2019s classification with frontal oral photographs taken at 16 dental offices in Japan.", {"entities": []}], ["Participants were categorized into 10-year age groups, and their baseline photographs were compared.", {"entities": []}], ["In addition, to evaluate the effect of smoking cessation on gingival pigmentation, subjects were divided into a former smoker group (stopped smoking) and current smoker group.", {"entities": []}], ["A total of 259 patients 19 to 79 years of age were analyzed.", {"entities": []}], ["People in their 30s showed the most widespread gingival pigmentation.", {"entities": []}], ["In addition, subjects in their 20s showed a weak effect of smoking cessation on gingival pigmentation.", {"entities": []}], ["These findings suggested that the gingival pigmentation induced by smoking was more remarkable in young people than in middle-aged people.", {"entities": []}], ["This information may be useful for anti-smoking education, especially among young populations with a high affinity for smoking.", {"entities": []}], ["The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients\u2019 conditions and respiratory symptoms.", {"entities": [[27, 33, "DISEASE"]]}], ["Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings.", {"entities": [[57, 63, "DISEASE"]]}], ["A simple predictive marker used in combination with spirometry for AL is expected to be established.", {"entities": []}], ["In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD.", {"entities": [[83, 87, "DISEASE"], [189, 195, "DISEASE"]]}], ["However, whether s-UA influences the development of AL remains unclear.", {"entities": []}], ["Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups.", {"entities": []}], ["A total of 8,662 subjects aged >40 years were included.", {"entities": []}], ["They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings.", {"entities": []}], ["One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms.", {"entities": []}], ["The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL.", {"entities": []}], ["Forced expiratory volume in 1 second (FEV 1 ) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol.", {"entities": [[38, 41, "GENE"]]}], ["In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL.", {"entities": []}], ["In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk.", {"entities": []}], ["Glucocorticoids (GCs) block inflammation via interference of the liganded glucocorticoid receptor (GR) with the activity of pro-inflammatory transcription factors NF-\u03baB and AP-1, a mechanism known as transrepression.", {"entities": []}], ["This mechanism is believed to involve the activity of GR monomers.", {"entities": []}], ["Here, we explored how the GR monomer-favoring Compound A (CpdA) affects AP-1 activation and activity.", {"entities": []}], ["Our results demonstrate that non-steroidal CpdA, unlike classic steroidal GCs, blocks NF-\u03baB- but not AP-1-driven gene expression.", {"entities": []}], ["CpdA rather sustains AP-1-driven gene expression, a result which could mechanistically be explained by the failure of CpdA to block upstream JNK kinase activation and concomitantly also phosphorylation of c-Jun.", {"entities": []}], ["In concordance and in contrast to DEX, CpdA maintained the expression of the activated AP-1 target gene c - jun , as well as the production of the c-Jun protein.", {"entities": [[108, 111, "GENE"], [149, 152, "GENE"]]}], ["As for the underlying mechanism, GR is a necessary intermediate in the CpdA-mediated gene expression of AP-1-regulated genes, but seems to be superfluous to CpdA-mediated JNK phosphorylation prolongation.", {"entities": []}], ["The latter phenomenon concurs with the inability of CpdA to stimulate DUSP1 gene expression.", {"entities": [[70, 75, "GENE"]]}], ["ChIP analysis demonstrates that DEX-activated GR, but not CpdA-activated GR, is recruited to AP-1-driven promoters.", {"entities": []}], ["Furthermore, in mice we observed that CpdA instigates a strong enhancement of TNF-induced AP-1-driven gene expression.", {"entities": []}], ["Finally, we demonstrate that this phenomenon coincides with an increased sensitivity towards TNF lethality, and implicate again a role for JNK2.", {"entities": [[93, 96, "GENE"]]}], ["In conclusion, our data support the hypothesis that a ligand-induced differential conformation of GR yields a different transcription factor cross-talk profile.", {"entities": []}], ["The online version of this article (doi:10.1007/s00018-013-1367-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Data that provide clinical criteria for the identification of patients likely to respond to high-frequency oscillatory ventilation (HFOV) are scarce.", {"entities": []}], ["Our aim was to describe physiological predictors of survival during HFOV in adults with severe acute respiratory distress syndrome (ARDS) admitted to a respiratory failure center in the United Kingdom.", {"entities": [[152, 171, "DISEASE"], [122, 130, "DISEASE"]]}], ["Electronic records of 102 adults treated with HFOV were reviewed retrospectively.", {"entities": []}], ["We used logistic regression and receiving-operator characteristics curve to test associations with oxygenation and mortality.", {"entities": []}], ["Patients had severe ARDS with a mean (SD) Murray's score of 2.98 (0.7).", {"entities": []}], ["Partial pressure of oxygen in arterial blood to fraction of inspired oxygen (PaO 2 /FiO 2 ) ratio and oxygenation index improved only in survivors.", {"entities": []}], ["The earliest time point at which the two groups differed was at three hours after commencing HFOV.", {"entities": []}], ["An improvement of >38% in PaO 2 /FiO 2 occurring at any time within the first 72 hours, was the best predictor of survival at 30 days (area under the curve (AUC) of 0.83, sensitivity 93%, specificity 78% and a positive likelihood ratio (LR) of 4.3).", {"entities": []}], ["These patients also had a 3.5 fold greater reduction in partial pressure of carbon dioxide in arterial blood (PaCO 2 ).", {"entities": []}], ["Multivariate analysis showed that HFOV was more effective in younger patients, when instituted early, and in patients with milder respiratory acidosis.", {"entities": []}], ["HFOV is effective in improving oxygenation in adults with ARDS, particularly when instituted early.", {"entities": []}], ["Changes in PaO 2 /FiO 2 during the first three hours of HFOV can identify those patients more likely to survive.", {"entities": []}], ["Interruptin B has been isolated from Cyclosorus terminans , however, its pharamcological effect has not been fully identified.", {"entities": []}], ["In the present study, the effects of interruptin B, from C. terminans , on brown adipocyte differentiation and glucose uptake in adipose-derived stem cells (ASCs) were investigated.", {"entities": []}], ["The results revealed that interruptin B dose-dependently enhanced the adipogenic differentiation of ASCs, with an induction in the mRNA expression levels of peroxisome proliferator-activated receptor (PPAR)-\u03b1 and PPAR-\u03b3.", {"entities": []}], ["In addition, interruptin B efficiently increased the number and the membrane potential of mitochondria and upregulated the mRNA expression levels of uncoupling protein (UCP)-1 and cyclooxygenase (COX)-2, which are all predominantly expressed in brown adipocytes.", {"entities": []}], ["Interruptin B increased glucose consumption in differentiated ASCs, accompanied by the upregulation in the mRNA expression levels of glucose transporter (GLUT)-1 and GLUT-4.", {"entities": []}], ["The computational analysis of molecular docking, a luciferase reporter assay and surface plasmon resonance confirmed the marked binding affinity of interruptin B to PPAR-\u03b1 and PPAR-\u03b3 (K D values of 5.32 and 0.10 \u00b5 M, respectively).", {"entities": []}], ["To the best of our knowledge, the present study is the first report to show the stimulatory effects of interruptin B on brown adipocyte differentiation and glucose uptake in ASCs, through its role as a dual PPAR-\u03b1 and PPAR-\u03b3 ligand.", {"entities": []}], ["Therefore, interruptin B could be further developed as a therapeutic agent for the treatment of diabetes.", {"entities": []}], ["The cadmium (Cd) present in air pollutants and cigarette smoke has the potential of causing multiple adverse health outcomes involving damage to pulmonary and cardiovascular tissue.", {"entities": []}], ["Injury to pulmonary epithelium may include alterations in tight junction (TJ) integrity, resulting in impaired epithelial barrier function and enhanced penetration of chemicals and biomolecules.", {"entities": []}], ["Herein, we investigated mechanisms involved in the disruption of TJ integrity by Cd exposure using an in vitro human air-liquid-interface (ALI) airway tissue model derived from normal primary human bronchial epithelial cells.", {"entities": []}], ["ALI cultures were exposed to noncytotoxic doses of CdCl 2 basolaterally and TJ integrity was measured by Trans-Epithelial Electrical Resistance (TEER) and immunofluorescence staining with TJ markers.", {"entities": []}], ["PCR array analysis was used to identify genes involved with TJ collapse.", {"entities": []}], ["To explore the involvement of kinase signaling pathways, cultures were treated with CdCl 2 in the presence of kinase inhibitors specific for cellular Src or Protein Kinase C (PKC).", {"entities": [[150, 153, "GENE"]]}], ["Noncytotoxic doses of CdCl 2 resulted in the collapse of barrier function, as demonstrated by TEER measurements and Zonula occludens-1 (ZO-1) and occludin staining.", {"entities": []}], ["CdCl 2 exposure altered the expression of several groups of genes encoding proteins involved in TJ homeostasis.", {"entities": []}], ["In particular, down-regulation of select junction-interacting proteins suggested that a possible mechanism for Cd toxicity involves disruption of the peripheral junctional complexes implicated in connecting membrane-bound TJ components to the actin cytoskeleton.", {"entities": []}], ["Inhibition of kinase signaling using inhibitors specific for cellular Src or PKC preserved the integrity of TJs, possibly by preventing occludin tyrosine hyperphosphorylation, rather than reversing the down-regulation of the junction-interacting proteins.", {"entities": [[70, 73, "GENE"]]}], ["Our findings indicate that acute doses of Cd likely disrupt TJ integrity in human ALI airway cultures both through occludin hyperphosphorylation via kinase activation and by direct disruption of the junction-interacting complex.", {"entities": []}], ["Reasons for the highly variable and often poor protection conferred by the Mycobacterium bovis bacille Calmette\u2013Gu\u00e9rin (BCG) vaccine are multifaceted and poorly understood.", {"entities": []}], ["We aimed to determine whether early-life exposure to PCBs (polychlorinated biphenyls) and DDE [1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene] reduces 6-month infant BCG vaccine response.", {"entities": []}], ["Data came from families participating in a prospective birth cohort in eastern Slovakia.", {"entities": []}], ["At birth, maternal and cord blood were collected for chemical analyses, and infants were immunized with BCG.", {"entities": []}], ["Blood was collected from infants for chemical analyses and to determine 6-month BCG-specific immunoglobulin (Ig) G and IgA levels.", {"entities": []}], ["Multivariable linear regression models were fit to examine chemical\u2013BCG associations among approximately 500 mother\u2013infant pairs, with adjustment for confounders.", {"entities": []}], ["The median 6-month infant concentration of the prevalent congener PCB-153 was 113 ng/g lipid [interquartile range (IQR): 37\u2013248], and 388 ng/g lipid (IQR: 115\u2013847) for DDE.", {"entities": []}], ["Higher 6-month infant concentrations of PCB-153 and DDE were strongly associated with lower 6-month BCG-specific antibody levels.", {"entities": []}], ["For instance, BCG-specific IgG levels were 37% lower for infants with PCB-153 concentrations at the 75th percentile compared to the 25th percentile (95% CI: \u201342, \u201332; p < 0.001).", {"entities": []}], ["Results were similar in magnitude and precision for DDE.", {"entities": []}], ["There was also evidence of PCB\u2013DDE additivity, where exposure to both compounds reduced anti-BCG levels more than exposure to either compound alone.", {"entities": []}], ["The associations observed in this study indicate that environmental exposures may be overlooked contributors to poorer responses to BCG vaccine.", {"entities": []}], ["The overall association between these exposures and tuberculosis incidence is unknown.", {"entities": [[52, 64, "DISEASE"]]}], ["Jusko TA, De Roos AJ, Lee SY, Thevenet-Morrison K, Schwartz SM, Verner MA, Palkovicova Murinova L, Drobn\u00e1 B, Ko\u010dan A, Fabi\u0161ikov\u00e1 A, \u010conka K, Trnovec T, Hertz-Picciotto I, Lawrence BP.", {"entities": []}], ["A birth cohort study of maternal and infant serum PCB-153 and DDE concentrations and responses to infant tuberculosis vaccination.", {"entities": [[105, 117, "DISEASE"]]}], ["Environ Health Perspect 124:813\u2013821;\u2002http://dx.doi.org/10.1289/ehp.1510101", {"entities": []}], ["Cytokines expression can be influenced by polymorphisms in their respective coding genes.", {"entities": []}], ["We associated the CTI/TTD haplotype (Hap-1) and TCI/CCI haplotype (Hap-2) in the IL4 gene formed by the \u2212590, +33 and variable number of tandem repeat polymorphisms with the severity of chronic periodontitis in humans.", {"entities": [[194, 207, "DISEASE"], [81, 84, "GENE"]]}], ["The functionality of these IL4 haplotypes in the response of immune cells to phorbol 12-myristate 13-acetate (PMA) with Ionomycin and IL-1\u03b2 (as inflammatory stimuli) was evaluated.", {"entities": [[27, 30, "GENE"]]}], ["Gene expression (quantitative real-time PCR), profile of secreted cytokines (multiplex) and phenotypic polarization of T cells (flow cytometry) were the outcomes assessed.", {"entities": []}], ["Green fluorescent protein reporter plasmid constructs containing specific IL4 haplotype were transiently transfected into JM cells to assess the influence of the individual haplotypes on promoter activity.", {"entities": [[74, 77, "GENE"]]}], ["In response to inflammatory stimuli the immune cells from Hap-1 haplotype had increased expression of anti-inflammatory IL4 ; conversely, the Hap-2 haplotype showed higher levels of pro-inflammatory cytokines.", {"entities": [[120, 123, "GENE"]]}], ["The haplotype CTI proved to be the most important for the regulation of IL4 promoter, regardless of the nature of the inflammatory stimulation; whereas the polymorphism in the promoter region had the least functional effect.", {"entities": [[72, 75, "GENE"]]}], ["In conclusion, IL4 haplotypes studied are functional and trigger opposite immune responses: anti-inflammatory (Hap-1) and pro-inflammatory (Hap-2).", {"entities": [[15, 18, "GENE"]]}], ["In addition, we identified the CTI haplotype as the main responsible for the regulation of IL4 transcriptional activity.", {"entities": [[91, 94, "GENE"]]}], ["Airway epithelial cells (AEC) from patients with asthma, appear to have an impaired interferon (IFN)-\u03b2 and -\u03bb response to infection with rhinovirus.", {"entities": [[49, 55, "DISEASE"]]}], ["To determine if impaired IFN responses can be identified in young children at risk of developing asthma due to atopy and/or early life wheeze, and if the site of infection or the infecting virus influence the antiviral response.", {"entities": [[97, 103, "DISEASE"]]}], ["Nasal (N) and tracheal (T) epithelial cells (EC) were collected from children categorised with atopy and/or wheeze based on specific IgE to locally common aeroallergens and a questionnaire concerning respiratory health.", {"entities": []}], ["Submerged primary cultures were infected with respiratory syncytial virus (RSV) or human metapneumovirus (hMPV), and IFN production, inflammatory cytokine expression and viral replication quantified.", {"entities": []}], ["Nasal epithelial cells (NEC), but not tracheal epithelial cells (TEC), from children with wheeze and/or atopy produced less IFN-\u03b2, but not IFN-\u03bb, in response to RSV infection; this was associated with higher viral shedding.", {"entities": []}], ["However, IFN-regulated factors IRF-7, Mx-1 and CXCL-10, and inflammatory cytokines were not differentially regulated.", {"entities": []}], ["NECs and TECs from children with wheeze and/or atopy demonstrated no impairment of the IFN response (\u03b2 or \u03bb) to hMPV infection.", {"entities": []}], ["Despite this, more hMPV was shed from these cells.", {"entities": []}], ["AECs from children with wheeze and/or atopy do not have an intrinsic defect in the production of IFN-\u03b2 or -\u03bb, however, this response is influenced by the infecting virus.", {"entities": []}], ["Higher viral load is associated with atopy and wheeze suggesting an impaired antiviral response to RSV and hMPV that is not influenced by production of IFNs.", {"entities": []}], ["Difficult biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) can result in failure of common bile duct (CBD) stone removal and pancreatitis.", {"entities": [[153, 165, "DISEASE"]]}], ["The present study aimed to report the efficacy and safety of limited precut sphincterotomy (PS) combined with endoscopic papillary balloon dilation (EPBD) for CBD stone removal in patients with difficult biliary cannulation, and the complications associated with this combined procedure.", {"entities": []}], ["A total of 3305 patients underwent ERCP in our hospital between October 2009 and September 2014 and 258 were diagnosed with difficult biliary cannulation.", {"entities": []}], ["Of these 258 patients, 58 underwent limited PS combined with EPBD for CBD stone removal, and these 58 patients were included in this retrospective study.", {"entities": []}], ["The overall success rate was 94.8\u00a0% (55/58), and the success rate for single-session removal was 87.9\u00a0% (51/58).", {"entities": []}], ["The mean procedure time was 41\u2009\u00b1\u200911.48\u00a0min (range, 20\u201372\u00a0min).", {"entities": []}], ["Mechanical lithotripsy was needed in 10.3\u00a0% (6/58) of patients.", {"entities": []}], ["Procedure-related complications included bleeding in 3.4\u00a0% (2/58), pancreatitis in 8.6\u00a0% (5/58) and biliary tract infection (BTI) in 1.7\u00a0% (1/58) of patients.", {"entities": [[67, 79, "DISEASE"]]}], ["The therapeutic outcome of limited PS combined with EPBD for CBD stone removal in patients with difficult biliary cannulation was good with an acceptable complication rate.", {"entities": []}], ["It could be an alternative to PS and \u201cearly\u201d limited PS should be used for prompt identification of the bile duct.", {"entities": []}], ["Limited PS combined with EPBD is safe and effective for CBD stone removal in patients with difficult biliary cannulation.", {"entities": []}], ["Eosinophilic pneumonia (EP) is an important subset of patients who present with pulmonary infiltrates and eosinophilia (PIE).", {"entities": [[13, 22, "DISEASE"], [106, 118, "DISEASE"]]}], ["EP is classified by chronicity and etiology and drug-induced EP is the main cause of secondary EP.", {"entities": []}], ["The primary goal of this review was to examine all the case reports published since the syndrome was defined in 1990.", {"entities": [[88, 96, "DISEASE"]]}], ["It remains unclear whether acute or chronic EP (AEP or CEP) represent different diseases, and the secondary goal of this review is to determine if there are factors that may help distinguish these 2 entities.", {"entities": []}], ["PubMed (MEDLINE and Medical Subject Headings) was searched for case reports of drug-induced EP or PIE syndrome published between 1990 and 2017.", {"entities": [[102, 110, "DISEASE"]]}], ["Case reports were only included if the diagnostic criteria for AEP or CEP were fulfilled.", {"entities": []}], ["For each case, data were extracted pertaining to age, sex, type of medication associated with the disease, time from the onset of symptoms to diagnosis, eosinophil counts in the blood, eosinophil fractions in bronchoalveolar lavage (BAL) fluid, initial chest radiograph and computed tomography results, use of mechanical ventilation, and use of steroid treatment and recurrence.", {"entities": []}], ["We found 196 case reports describing drug-induced EP.", {"entities": []}], ["The leading cause was daptomycin.", {"entities": []}], ["From our review, we found that AEP is more common in younger patients with no gender preference.", {"entities": []}], ["Eosinophilia in the blood at the time of diagnosis characterized only the CEP patients (80% in CEP vs. 20% in AEP).", {"entities": [[0, 12, "DISEASE"]]}], ["Abnormal findings on radiographic imagine was similar in both syndromes.", {"entities": []}], ["A significant portion of AEP patients (20%) presented with acute respiratory failure requiring mechanical ventilation.", {"entities": [[65, 84, "DISEASE"]]}], ["Most patients with EP were treated with steroids with a higher rate of relapse observed in patients with CEP.", {"entities": []}], ["AEP is a much more fulminant and severe disease than the gradual onset and slowly progressive nature of CEP.", {"entities": []}], ["The pathogenesis of AEP and CEP remains unclear.", {"entities": []}], ["However, there is significant clinical overlap among AEP and CEP that are associated with drug toxicity, suggesting the possibility that AEP and CEP are distinct clinical presentations that share a common pathogenic pathway.", {"entities": []}], ["Few studies have been conducted to investigate the acute health effects of visibility and haze, which may be regarded as proxy indicators of ambient air pollution.", {"entities": []}], ["We used a distributed lag non-linear model (DLNM) combined with quasi-Poisson regression to estimate the relationship between visibility, haze and mortality in Ningbo, a coastal city of China.", {"entities": []}], ["We found that the mortality risk of visibility was statistically significant only on the current day, while the risk of haze and PM 10 peaked on the second day and could last for three days.", {"entities": []}], ["When the visibility was less than 10 km, each 1 km decrease of visibility at lag 0 day was associated with a 0.78% (95% CI: 0.22\u20131.36%) increase in total mortality and a 1.61% (95% CI: 0.39\u20132.85%) increase in respiratory mortality.", {"entities": []}], ["The excess risk of haze at lag 0\u20132 days on total mortality, cardiovascular and respiratory mortality was 7.76% (95% CI: 3.29\u201312.42%), 7.73% (95% CI: 0.12\u201315.92%) and 17.77% (95% CI: 7.64\u201328.86%), respectively.", {"entities": []}], ["Greater effects of air pollution were observed during the cold season than in the warm season, and the elderly were at higher risk compared to youths.", {"entities": []}], ["The effects of visibility and haze were attenuated by single pollutants.", {"entities": []}], ["These findings suggest that visibility and haze could be used as surrogates of air quality where pollutant data are scarce, and strengthen the evidence to develop policy to control air pollution and protect vulnerable populations.", {"entities": []}], ["To describe the cause of death together with emergency department presentations and hospital admissions in the last year of life of people with intellectual disability.", {"entities": [[144, 167, "DISEASE"]]}], ["A retrospective matched cohort study using de-identified linked data of people aged 20 years or over, with and without intellectual disability who died during 2009 to 2013 in Western Australia.", {"entities": [[119, 142, "DISEASE"]]}], ["Emergency department presentations and hospital admissions in the last year of life of people with intellectual disability are described along with cause of death.", {"entities": [[99, 122, "DISEASE"]]}], ["Of the 63\u2009508 deaths in Western Australia from 2009 to 2013, there were 591 (0.93%) decedents with a history of intellectual disability.", {"entities": [[112, 135, "DISEASE"]]}], ["Decedents with intellectual disability tended to be younger, lived in areas of more social disadvantage, did not have a partner and were Australian born compared with all other decedents.", {"entities": [[15, 38, "DISEASE"]]}], ["A matched comparison cohort of decedents without intellectual disability (n=29\u2009713) was identified from the general population to improve covariate balance.", {"entities": [[49, 72, "DISEASE"]]}], ["Decedents with intellectual disability attended emergency departments more frequently than the matched cohort (mean visits 3.2 vs 2.5) and on average were admitted to hospital less frequently (mean admissions 4.1 vs 6.1), but once admitted stayed longer (average length of stay 5.2 days vs 4.3 days).", {"entities": [[15, 38, "DISEASE"]]}], ["People with intellectual disability had increased odds of presentation, admission or death from conditions that have been defined as ambulatory care sensitive and are potentially preventable.", {"entities": [[12, 35, "DISEASE"]]}], ["These included vaccine-preventable respiratory disease, asthma, cellulitis and convulsions and epilepsy.", {"entities": [[64, 74, "DISEASE"], [56, 62, "DISEASE"]]}], ["People with intellectual disability were more likely to experience potentially preventable conditions at the end of their lives.", {"entities": [[12, 35, "DISEASE"]]}], ["This indicates a need for further improvements in access, quality and coordination of healthcare to provide optimal health for this group.", {"entities": []}], ["This study evaluated patterns of pharmacotherapy in chronic obstructive pulmonary disease (COPD) as they relate to recommended guidelines in a prevalent COPD patient population with employer-sponsored health insurance in the US.", {"entities": [[52, 89, "DISEASE"]]}], ["Health care claims data from 2007 and 2008 were retrospectively analyzed for the study population defined as patients aged 40 years and older, continuously enrolled during the study period, and having at least one inpatient or one emergency department (ED) visit, or at least two outpatient claims coded with COPD (International Classification of Diseases, 9th Revision, Clinical Modification code 491.xx, 492.xx, 496.xx).", {"entities": []}], ["Rates of any pharmacotherapy (both maintenance and reliever), long-acting maintenance pharmacotherapy in patients with an exacerbation history, and short-term treatment of acute exacerbations of COPD were evaluated in the overall population, newly diagnosed, and previously diagnosed patients (including maintenance-na\u00efve and maintenance-experienced).", {"entities": []}], ["Stratified analyses were also conducted by age group (40\u201364 years, \u226565 years) and physician specialty.", {"entities": []}], ["A total of 55,361 patients met study criteria of whom 39% were newly diagnosed.", {"entities": []}], ["The mean age was 66 years, and 46% were male.", {"entities": []}], ["Three-fourths (74%) of all COPD patients had some pharmacotherapy (maintenance or reliever) with less than half (45%) being treated with maintenance medications.", {"entities": []}], ["The combination of an inhaled corticosteroid and a long-acting beta-agonist was the most prevalent drug class for maintenance treatment followed by tiotropium.", {"entities": []}], ["Only 64% of patients with an exacerbation history had a prescription for a long-acting maintenance medication, and short-term treatment with oral corticosteroids or antibiotics was higher for hospitalization exacerbations compared to ED visit exacerbations (68% vs 44%).", {"entities": []}], ["In general, the rates of pharmacotherapy were highest in patients who were maintenance-experienced followed by newly diagnosed and maintenance-na\u00efve.", {"entities": []}], ["The majority of COPD patients received maintenance or reliever COPD medications, but less than half received guideline-recommended care, especially those with an exacerbation history or receiving short-term treatment for acute exacerbations.", {"entities": []}], ["This study aimed to compare the influence of lead on the non-enzymatic antioxidant defenses and the levels of chemokines in workers subchronically and chronically exposed to lead.", {"entities": []}], ["The study population was divided into three groups.", {"entities": []}], ["The first group consisted of male workers subchronically exposed to lead for 40\u00a0\u00b1\u00a03.2\u00a0days, while the second group included male workers chronically exposed to lead.", {"entities": []}], ["The third group was a control group.", {"entities": []}], ["The levels of uric acid and bilirubin were significantly higher after a subchronic exposure to lead compared to the baseline by 22 and 35\u00a0%, respectively.", {"entities": []}], ["Similarly, the values of total antioxidant capacity (TAC), total oxidant status (TOS), and oxidative stress index (OSI) increased by 15, 50, and 33\u00a0%, respectively.", {"entities": []}], ["At the same time, the levels of thiol groups and albumin decreased by 5 and 8\u00a0%, respectively.", {"entities": []}], ["Additionally, the levels of interleukin-8 (IL-8) and macrophage inflammatory protein-1\u03b2 (MIP-1\u03b2) were significantly higher after a subchronic exposure to lead compared to the baseline by 34 and 20\u00a0%, respectively.", {"entities": []}], ["Moreover, IL-8 level was significantly higher by 40\u00a0% in the group of workers chronically exposed to lead than in the control group, while the level of interferon gamma-induced protein-10 (IP-10) was significantly lower by 28\u00a0%.", {"entities": []}], ["Similar to chronic lead exposure, subchronic exposure to lead is associated with elevated blood levels of uric acid and bilirubin in humans.", {"entities": []}], ["This probably results in increased TAC value despite thiol depletion.", {"entities": []}], ["However, the compensatory activation of non-enzymatic antioxidant defenses seems to be insufficient to protect against lead-induced oxidative stress, which may be additively enhanced by the pro-inflammatory action of chemokines, especially IL-8.", {"entities": []}], ["This study aimed to discuss the pathogenesis, clinical manifestation, diagnosis, and treatment of anti- N -methyl-D-aspartate receptor (NMDAR) encephalitis.", {"entities": [[143, 155, "DISEASE"]]}], ["The diagnosis and treatment of 2 cases with teratoma-associated anti-NMDAR encephalitis were summarized and the clinical data of patients reported by domestic and international studies were reviewed in this study.", {"entities": [[44, 52, "DISEASE"], [75, 87, "DISEASE"]]}], ["The 2 cases were both adolescent females who showed mental abnormalities as their main clinical manifestation.", {"entities": []}], ["The patients were positive for anti-NMDAR antibody in their serum and cerebrospinal fluid, and gynecologic ultrasound detected ovarian teratoma.", {"entities": [[135, 143, "DISEASE"]]}], ["After diagnosis, the patients underwent teratoma resection, followed by pulse therapy of hormones and gamma globulin.", {"entities": [[40, 48, "DISEASE"]]}], ["Chemotherapy was performed to prevent tumor recurrence, and patients were in a stable condition.", {"entities": []}], ["Teratoma-associated anti-NMDAR encephalitis is commonly seen in young women.", {"entities": [[0, 8, "DISEASE"], [31, 43, "DISEASE"]]}], ["The clinical manifestation of this disease is nonspecific, and the patients mainly have fever, psychosis, and seizure.", {"entities": []}], ["Tumor resection and immune therapy are effective treatment strategies, and standardized chemotherapy should also be performed to prevent recurrence.", {"entities": []}], ["With increasing interest in the use of urban green space to promote human health, there is a need to understand the extent to which park users conceptualize these places as a resource for health and well-being.", {"entities": []}], ["This study sought to examine park users\u2019 own reasons for and benefits from green space usage and compare these with concepts and constructs in existing person-environment-health theories and models of health.", {"entities": []}], ["Conducted in 13 public green spaces in Sheffield, UK, we undertook a qualitative content analysis of 312 park users\u2019 responses to open-ended interview questions and identified a breadth, depth and salience of visit motivators and derived effects.", {"entities": []}], ["Findings highlight a discrepancy between reasons for visiting and derived effects from the use of urban green space.", {"entities": []}], ["Motivations emphasized walking, green space qualities, and children.", {"entities": []}], ["Derived effects highlighted relaxation, positive emotions within the self and towards the place, and spiritual well-being.", {"entities": []}], ["We generate a taxonomy of motivations and derived effects that could facilitate operationalization within empirical research and articulate a conceptual framework linking motivators to outcomes for investigating green space as a resource for human health and well-being.", {"entities": []}], ["Objectives .", {"entities": []}], ["To report the pharyngeal colonization rate of \u03b2 -hemolytic streptococci and changes in the value of antistreptolysin O (ASO) and anti-DNase B serology titers during pregnancy.", {"entities": []}], ["Healthy pregnant women were recruited and blood was drawn in each trimester.", {"entities": []}], ["The upper limit of normal (ULN) values for ASO and anti-DNase B was calculated for each trimester.", {"entities": []}], ["Throat swabs were collected for culture and positive cultures were further assessed for the identification of serogroup of the isolated \u03b2 -hemolytic streptococcus.", {"entities": []}], ["Out of a total of 126 pregnant women, 34.1% had positive throat cultures.", {"entities": []}], ["Group C and group G strains were isolated in 18.2% of throat cultures while group F was detected in 13.5% of cases.", {"entities": []}], ["The rate of colonization with GAS was 1.6%.", {"entities": []}], ["There was an overall drop in ASO titer during pregnancy while anti-DNase B titers remained relatively unchanged.", {"entities": []}], ["ULN values of 164 Conclusions .", {"entities": []}], ["These results show that pregnant women act as a reservoir for spreading potentially immunogenic (groups C and G) and disease producing (group F) virulent strains of streptococci.", {"entities": []}], ["Influenza is a highly contagious and debilitating disease that imposes an excess burden of complications and mortality.", {"entities": [[0, 9, "DISEASE"]]}], ["Antiviral therapy is the primary intervention for treatment and post\u2010exposure prophylaxis (PEP) of influenza.", {"entities": [[99, 108, "DISEASE"]]}], ["Amantadine and rimantadine are members of the M2 class of antiviral agents and are moderately effective in influenza management.", {"entities": [[107, 116, "DISEASE"]]}], ["However, their utility is compromised by high levels of resistance, tolerability concerns and a lack of efficacy against influenza B.", {"entities": [[121, 130, "DISEASE"]]}], ["An alternative class of agents, the neuraminidase inhibitors (NIs), represent the most advanced form of antiviral therapy available, and act by specifically inhibiting the neuraminidase enzymes that are present on all influenza subtypes.", {"entities": [[218, 227, "DISEASE"]]}], ["Two NIs, oseltamivir and zanamivir, are currently available for clinical use.", {"entities": []}], ["Oseltamivir, the most widely used NI, is administered orally as a prodrug (oseltamivir carboxylate) and systemically distributed to all potential infection sites.", {"entities": []}], ["Zanamivir, a second NI, is administered by inhalation via a disk inhaler and deposited primarily in the respiratory tract.", {"entities": []}], ["When administered within 48 hours of symptom onset, both agents significantly reduce illness duration and symptom severity, and decrease the rate of influenza\u2010associated complications.", {"entities": [[149, 158, "DISEASE"]]}], ["With oseltamivir, greater benefits are detected with earlier treatment initiation (<12 hours).", {"entities": []}], ["In PEP, both NIs effectively protect the close contacts of index cases from symptomatic influenza.", {"entities": [[88, 97, "DISEASE"]]}], ["Oseltamivir and zanamivir are generally well tolerated and associated with a low level of resistance.", {"entities": []}], ["Emerging evidence supports the activity of both NIs against the H5N1avian influenza infection, which is a pandemic candidate.", {"entities": [[74, 83, "DISEASE"]]}], ["However, the WHO currently recommends the use of oseltamivir for the management of suspected cases, given the systemic nature of the H5N1 challenge.", {"entities": []}], ["Ongoing studies are exploring the effectiveness of oseltamivir, zanamivir and other NIs for pandemic management.", {"entities": []}], ["Human leukocytes maintained in culture are induced to release histamine when exposed to ragweed antigen E or anti-IgE.", {"entities": []}], ["Leukocyte cultures incubated with virus (i.e.", {"entities": []}], ["HSV-1, Influenza A, and Adeno-1) but not exposed to ragweed antigen E or anti-IgE fail to release histamine.", {"entities": []}], ["If, however, leukocyte cultures are first exposed to virus and then to ragweed antigen E or anti-IgE, significant enhancement of histamine release occurs.", {"entities": []}], ["Both infectious and inactivated virus enhance histamine release and the degree of enhancement is related to the concentration of virus and the length of the incubation.", {"entities": []}], ["Tissue culture fluid harvested 8 h after exposure of leukocytes to virus contains a soluble factor which is capable of enhancing histamine release when added to fresh leukocyte cultures.", {"entities": []}], ["This factor has all the properties of interferon including species specificity and cannot be dissociated from the antiviral activity of interferon.", {"entities": []}], ["Moreover, both known inducers of interferon (poly I:poly C) and standard preparations of interferon are capable of enhancing histamine release.", {"entities": []}], ["The enhancement of histamine release by interferon represents a new biological role for interferon.", {"entities": []}], ["Montelukast (MT) is a leukotriene D4 antagonist.", {"entities": []}], ["It is an effective and safe medicine for the prophylaxis and treatment of chronic asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["It is also used to prevent acute exercise-induced bronchoconstriction and as a symptomatic relief of seasonal allergic rhinitis and perennial allergic rhinitis.", {"entities": [[110, 127, "DISEASE"], [142, 159, "DISEASE"], [119, 127, "DISEASE"], [151, 159, "DISEASE"]]}], ["The aim of this study was to evaluate the bioequivalence (BE) of two drug products: generic MT 5 mg chewable tablets versus the branded drug Singulair An open-label, randomized two-period crossover BE design was conducted in 32 healthy male volunteers with a 9-day washout period between doses and under fasting conditions.", {"entities": []}], ["The drug concentrations in plasma were quantified by using a newly developed and fully validated liquid chromatography tandem mass spectrometry method, and the pharmacokinetic parameters were calculated using a non-compartmental model.", {"entities": []}], ["The ratio for generic/branded tablets using geometric least squares means was calculated for both the MT products.", {"entities": []}], ["The relationship between concentration and peak area ratio was found to be linear within the range 6.098\u2013365.855 ng/mL.", {"entities": []}], ["The correlation coefficient ( R 0\u2192last , AUC 0\u2192inf , and C max , respectively.", {"entities": [[59, 62, "GENE"]]}], ["The 90% confidence intervals were within the predefined limits of 80.00%\u2013125.00% as specified by the US Food and Drug Administration and European Medicines Agency for BE studies.", {"entities": []}], ["Evidence suggests that providers are not adhering to current testosterone replacement therapy guidelines when treating male hypogonadism.", {"entities": [[124, 136, "DISEASE"]]}], ["Understanding the diagnosis and management of this condition is further complicated by conflicting recommendations among available guidelines.", {"entities": []}], ["NPs must select and follow the best guideline recommendations available to optimally treat male hypogonadism.", {"entities": [[96, 108, "DISEASE"], [0, 3, "GENE"]]}], ["Evidence suggests that providers are not adhering to current testosterone replacement therapy guidelines when treating male hypogonadism.", {"entities": [[124, 136, "DISEASE"]]}], ["Understanding diagnosis and management is further complicated by conflicting recommendations among available guidelines.", {"entities": []}], ["NPs must select and follow the best guideline recommendations available to optimally treat this condition.", {"entities": [[0, 3, "GENE"]]}], ["The study was conducted at Mulago Hospital, Kampala, Uganda.", {"entities": []}], ["As chronic respiratory disease (CRD) is a huge, growing burden in Africa, with few available treatments, we aimed to design and evaluate a culturally appropriate pulmonary rehabilitation (PR) program in Uganda for people with post-tuberculosis lung disorder (p-TBLD).", {"entities": [[231, 243, "DISEASE"]]}], ["In a pre\u2013post intervention study, a 6-week, twice-weekly PR program was designed for people with p-TBLD.", {"entities": []}], ["Outcome measures included recruitment, retention, the Clinical COPD Questionnaire (CCQ), tests of exercise capacity, and biometrics.", {"entities": []}], ["Given this was a developmental study, no formal statistical significance testing was undertaken.", {"entities": []}], ["In all, 34 participants started PR and 29 (85%) completed all data collection.", {"entities": []}], ["The mean age of the 29 participants was 45 years, and 52% were female.", {"entities": []}], ["The mean (95% confidence interval) CCQ score at baseline was 1.8 (1.5, 2.0), at the end of PR was 1.0 (0.8, 1.2), and at 6 weeks after the end of PR was 0.8 (0.7, 1.0).", {"entities": []}], ["The Incremental Shuttle Walking Test (ISWT) was 299 m (268.5, 329.4) at baseline, 377 (339.6, 413.8) at the end of PR, and 374 (334.2, 413.5) at 6 weeks after the end of PR.", {"entities": []}], ["Improvements were seen in measures of chest pain; 13/29 (45%) participants reported chest pain at baseline but only 7/29 (24%) at the end of PR, and in those with persistent pain, the mean pain scores decreased.", {"entities": []}], ["Mild hemoptysis was reported in 4/29 (17%) participants at baseline and in 2/29 (7%) at the end of PR.", {"entities": []}], ["PR for people with p-TBLD in Uganda was feasible and associated with clinically important improvements in quality of life, exercise capacity, and respiratory outcomes.", {"entities": []}], ["PR uses local resources, requires little investment, and offers a new, sustainable therapy for p-TBLD in resource-limited settings.", {"entities": []}], ["With the rising global burden of CRD, further studies are needed to assess the value of PR in p-TBLD and other prevalent forms of CRD.", {"entities": []}], [": Obstructive sleep apnea syndrome (OSAS) has a high prevalence and carries significant cardiovascular risks.", {"entities": [[26, 34, "DISEASE"]]}], ["It is important to study new therapeutic approaches to this disease.", {"entities": []}], ["Positional therapy might be beneficial in reducing the apnea-hypopnea index (AHI).", {"entities": []}], ["Imaging methods have been employed in order to facilitate the evaluation of the airways of OSAS patients and can be used in order to determine the effectiveness of certain treatments.", {"entities": []}], ["This study was aimed at determining the influence that upper airway volume, as measured by cervical CT, has in patients diagnosed with OSAS.", {"entities": []}], [": This was a quantitative, observational, cross-sectional study.", {"entities": []}], ["We evaluated 10 patients who had been diagnosed with OSAS by polysomnography and on the basis of the clinical evaluation.", {"entities": []}], ["All of the patients underwent conventional cervical CT in the supine position.", {"entities": []}], ["Scans were obtained with the head of the patient in two positions (neutral and at a 44\u00b0 upward inclination), and the upper airway volume was compared between the two.", {"entities": []}], [": The mean age, BMI, and neck circumference were 48.9 \u00b1 14.4 years, 30.5 \u00b1 3.5 kg/m : Elevating the head appears to result in a significant increase in the caliber of the upper airways in OSAS patients.", {"entities": []}], [": A s\u00edndrome de apneia obstrutiva do sono (SAOS) tem uma alta preval\u00eancia e riscos cardiovasculares significativos.", {"entities": []}], ["\u00c9 importante estudar novas abordagens terap\u00eauticas para essa doen\u00e7a.", {"entities": []}], ["A terapia posicional pode ser ben\u00e9fica na redu\u00e7\u00e3o do \u00edndice de apneia-hipopneia (IAH).", {"entities": []}], ["M\u00e9todos de imagem t\u00eam sido utilizados para facilitar a avalia\u00e7\u00e3o das vias a\u00e9reas em pacientes com SAOS e podem ser utilizados para determinar a efic\u00e1cia de determinados tratamentos.", {"entities": []}], ["O objetivo desse estudo foi determinar a influ\u00eancia do volume das vias a\u00e9reas superiores, mensurado por TC cervical, em pacientes diagnosticados com SAOS.", {"entities": [[100, 103, "GENE"]]}], [": Estudo observacional transversal com abordagem quantitativa.", {"entities": []}], ["Dez pacientes com diagn\u00f3stico de SAOS por polissonografia e avalia\u00e7\u00e3o cl\u00ednica foram submetidos a TC cervical convencional em posi\u00e7\u00e3o supina com a cabe\u00e7a em posi\u00e7\u00e3o neutra e com inclina\u00e7\u00e3o de 44\u00b0 para comparar os volumes das vias a\u00e9reas superiores.", {"entities": [[38, 41, "GENE"]]}], [": As m\u00e9dias de idade, IMC e circunfer\u00eancia cervical foram de 48,9 \u00b1 14,4 anos, 30,5 \u00b1 3,5 kg/m : A eleva\u00e7\u00e3o cervical parece resultar em um aumento significativo do calibre das vias a\u00e9reas superiores em pacientes com SAOS.", {"entities": []}], ["National guidelines state that health care professionals (HCPs) should advise patients on the importance of maintaining a healthy weight.", {"entities": []}], ["Firefighters have high rates of obesity, and cardiovascular events are the leading cause of line-of-duty deaths in firefighters.", {"entities": [[32, 39, "DISEASE"]]}], ["This study assessed the association of age and body mass index (BMI) with HCP weight recommendations among male firefighters.", {"entities": []}], ["We used data on self-reported HCP weight recommendations and measured BMI from a 2011\u20132012 national sample of male firefighters (N = 1,002).", {"entities": []}], ["HCP recommendations were recorded as no advice, maintain, gain, or lose weight, and BMI was categorized as normal (<25.0 kg/m Most firefighters (96%) reported visiting an HCP in the past year.", {"entities": []}], ["Most (69%) firefighters and 48% of class I to III obese firefighters reported receiving no weight advice.", {"entities": []}], ["Higher BMI predicted HCP advice to lose weight (odds ratio class I obese vs normal weight: 12.98; 95% confidence interval: 5.38\u201331.34).", {"entities": []}], ["Younger firefighters were less likely to receive weight loss advice than older firefighters, except among those who were class II or III obese.", {"entities": []}], ["HCPs are important sources of health information for firefighters.", {"entities": []}], ["Overweight and obese firefighters, particularly those who are younger, do not consistently receive HCP advice to lose weight.", {"entities": []}], ["This marks a missed opportunity to prevent further weight gain and reduce obesity-related health outcomes.", {"entities": [[74, 81, "DISEASE"]]}], ["A seasonal suicide peak in spring is highly replicated, but its specific cause is unknown.", {"entities": []}], ["We reviewed the literature on suicide risk factors which can be associated with seasonal variation of suicide rates, assessing published articles from 1979 to 2011.", {"entities": []}], ["Such risk factors include environmental determinants, including physical, chemical, and biological factors.", {"entities": []}], ["We also summarized the influence of potential demographic and clinical characteristics such as age, gender, month of birth, socioeconomic status, methods of prior suicide attempt, and comorbid psychiatric and medical diseases.", {"entities": []}], ["Comprehensive evaluation of risk factors which could be linked to the seasonal variation in suicide is important, not only to identify the major driving force for the seasonality of suicide, but also could lead to better suicide prevention in general.", {"entities": []}], ["The aim of this study was to evaluate the relationships of CYP2C9 and COX-2 genetic polymorphisms with therapeutic efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) in treatment of ankylosing spondylitis (AS).", {"entities": [[201, 212, "DISEASE"], [190, 212, "DISEASE"], [59, 65, "GENE"]]}], ["We enrolled 130 AS inpatients and outpatients in the Arthritis and Rheumatism Department of Peking University First Hospital and 106 healthy people getting routine check-ups between September 2013 and July 2014.", {"entities": []}], ["CYP2C9 and COX-2 genetic polymorphisms were detected by PCR-RFLP.", {"entities": [[0, 6, "GENE"]]}], ["All AS patients underwent medical treatment and 12-week follow-up treatment.", {"entities": []}], ["Score differences of BASDAI, ASAS20, ASAS50, and ASAS70 for AS patients with different genotypes before and after treatment were compared.", {"entities": []}], ["In terms of COX-2- 1290A/G and -1195G/A gene polymorphism genotype and allele frequency, the case group and control group were obviously different (all P <0.05), but CYP2C9*3 polymorphism genotype and allele frequency were not statistically different between the 2 groups ( P >0.05).", {"entities": []}], ["AS patients had improved BASDAI, ASAS20, ASAS50, and ASAS70 scores after they received NSAID treatment (all P <0.05).", {"entities": []}], ["Furthermore, the efficacy of NSAID in treatment of AS and COX-2 gene \u22121290A/G and \u22121195G/A polymorphism were associated (all P <0.05), but it is not associated with CYP2C9 *3 polymorphism (all P >0.05).", {"entities": [[165, 171, "GENE"]]}], ["COX-2 -1290A/G and -1195G/A polymorphism may increase AS risk and they both can be considered as biological indicators for prediction of efficacy of NSAIDs in treatment of AS.", {"entities": []}], ["Receptor for advanced glycation end products (RAGE) plays a role in inflammatory reactions.", {"entities": []}], ["The soluble form of RAGE (sRAGE) acts as a decoy to inhibit interactions of RAGE with advanced glycation end products such as High mobility group box 1 (HMGB1).", {"entities": [[153, 158, "GENE"]]}], ["We have demonstrated that HMGB1 directs Th17 skewing by regulating dendritic cell (DC) functions in a previous study.", {"entities": [[26, 31, "GENE"]]}], ["However, the protective effects of HMGB1 blockade with sRAGE in the development of neutrophilic asthma remain unclear.", {"entities": [[96, 102, "DISEASE"], [35, 40, "GENE"]]}], ["Here, we showed that allergen challenge decreased expression of sRAGE in a murine model of neutrophilic asthma, correlating well with neutrophil counts and interleukin (IL)-17 production.", {"entities": [[104, 110, "DISEASE"]]}], ["When HMGB1 signalling was blocked by intratracheal administration of sRAGE before sensitisation, HMGB1 expression, neutrophilic inflammation, and Th17-type responses were reduced significantly.", {"entities": [[5, 10, "GENE"], [97, 102, "GENE"], [5, 10, "GENE"], [97, 102, "GENE"]]}], ["Anti-asthma effects of sRAGE were achieved by inhibition of RAGE and IL-23 expression in airway CD11c in vitro .", {"entities": [[5, 11, "DISEASE"]]}], ["Adoptive transfer of rHMGB1-activated DCs was sufficient to restore airway inflammation, whereas transfer of rHMGB1 plus sRAGE-activated DCs significantly reduced neutrophilic inflammation.", {"entities": []}], ["Thus, sRAGE prevents Th17-mediated airway inflammation in neutrophilic asthma at least partly by blocking HMGB1/RAGE signalling in DCs.", {"entities": [[71, 77, "DISEASE"]]}], ["Chronic cardiorespiratory disease is associated with low birthweight suggesting the importance of the developmental environment.", {"entities": []}], ["Prenatal factors affecting fetal growth are believed important, but the underlying mechanisms are unknown.", {"entities": []}], ["The influence of developmental programming on bronchial hyperreactivity is investigated in an animal model and evidence for comparable associations is sought in humans.", {"entities": []}], ["Pregnant Wistar rats were fed either control or protein-restricted diets throughout pregnancy.", {"entities": []}], ["Bronchoconstrictor responses were recorded from offspring bronchial segments.", {"entities": []}], ["Morphometric analysis of paraffin-embedded lung sections was conducted.", {"entities": []}], ["In a human mother-child cohort ultrasound measurements of fetal growth were related to bronchial hyperreactivity, measured at age six years using methacholine.", {"entities": []}], ["Protein-restricted rats' offspring demonstrated greater bronchoconstriction than controls.", {"entities": []}], ["Airway structure was not altered.", {"entities": []}], ["Children with lesser abdominal circumference growth during 11\u201319 weeks' gestation had greater bronchial hyperreactivity than those with more rapid abdominal growth.", {"entities": []}], ["Imbalanced maternal nutrition during pregnancy results in offspring bronchial hyperreactivity.", {"entities": []}], ["Prenatal environmental influences might play a comparable role in humans.", {"entities": []}], ["The genetic mechanism of aspirin intolerant acute urticaria (AIAU) is unknown.", {"entities": [[50, 59, "DISEASE"]]}], ["To demonstrate an association between the \u03b22 adrenergic receptor (ADRB2) polymorphism and the phenotype of AIAU, one hundred fourteen patients with AIAU, 110 patients with aspirin intolerant chronic urticaria (AICU), and 498 normal healthy controls (NC) based on a Korean population were enrolled.", {"entities": [[199, 208, "DISEASE"], [66, 71, "GENE"]]}], ["The genotype of ADRB2 at 46 A > G was analyzed using a direct sequencing method.", {"entities": [[16, 21, "GENE"]]}], ["The ADRB2 polymorphism at 46 A > G showed a significant difference between AIAU and NC; the frequency of the major genotype was significantly higher in the AIAU group ( p = 0.017 in recessive model), while no differences were noted in allele and genotype frequencies between AICU and NC.", {"entities": [[4, 9, "GENE"]]}], ["In conclusion, the ADRB2 (46 A > G) gene polymorphism may contribute to the development of the phenotype of AIAU.", {"entities": [[19, 24, "GENE"]]}], ["The Neurotrauma Evidence Translation (NET) Trial aims to design and evaluate the effectiveness of a targeted theory-and evidence-informed intervention to increase the uptake of evidence-based recommended practices for the management of patients who present to an emergency department (ED) with mild head injuries.", {"entities": []}], ["When designing interventions to bring about change in organisational settings such as the ED, it is important to understand the impact of the context to ensure successful implementation of practice change.", {"entities": []}], ["Few studies explicitly use organisational theory to study which factors are likely to be most important to address when planning change processes in the ED.", {"entities": []}], ["Yet, this setting may have a unique set of organisational pressures that need to be taken into account when implementing new clinical practices.", {"entities": []}], ["This paper aims to provide an in depth analysis of the organisational context in which ED management of mild head injuries and implementation of new practices occurs, drawing upon organisational level theory.", {"entities": []}], ["Semi-structured interviews were conducted with ED staff in Australia.", {"entities": []}], ["The interviews explored the organisational context in relation to change and organisational factors influencing the management of patients presenting with mild head injuries.", {"entities": []}], ["Two researchers coded the interview transcripts using thematic content analysis.", {"entities": []}], ["The \u201cmodel of diffusion in service organisations\u201d was used to guide analyses and organisation of the results.", {"entities": []}], ["Nine directors, 20 doctors and 13 nurses of 13 hospitals were interviewed.", {"entities": []}], ["With regard to characteristics of the innovation (i.e.", {"entities": []}], ["the recommended practices) the most important factor was whether they were perceived as being in line with values and needs.", {"entities": []}], ["Tension for change (the degree to which stakeholders perceive the current situation as intolerable or needing change) was relatively low for managing acute mild head injury symptoms, and mixed for managing longer-term symptoms (higher change commitment, but relatively low change efficacy).", {"entities": []}], ["Regarding implementation processes, the importance of (visible) senior leadership for all professions involved was identified as a critical factor.", {"entities": []}], ["An unpredictable and hectic environment brings challenges in creating an environment in which team-based and organisational learning can thrive (system antecedents for innovation).", {"entities": []}], ["In addition, the position of the ED as the entry-point of the hospital points to the relevance of securing buy-in from other units.", {"entities": []}], ["We identified several organisational factors relevant to realising change in ED management of patients who present with mild head injuries.", {"entities": []}], ["These factors will inform the intervention design and process evaluation in a trial evaluating the effectiveness of our implementation intervention.", {"entities": []}], ["In vitro studies suggest that reactive oxygen species contribute to the cardiopulmonary toxicity of particulate air pollution.", {"entities": []}], ["To evaluate the ability of particulate air pollution to promote oxidative stress and tissue damage in vivo, we studied a rat model of short-term exposure to concentrated ambient particles (CAPs).", {"entities": [[189, 193, "GENE"]]}], ["We exposed adult Sprague-Dawley rats to either CAPs aerosols (group 1; average CAPs mass concentration, 300 +/- 60 micro g/m3) or filtered air (sham controls) for periods of 1-5 hr.", {"entities": [[47, 51, "GENE"], [79, 83, "GENE"], [47, 51, "GENE"], [79, 83, "GENE"], [178, 180, "GENE"]]}], ["Rats breathing CAPs aerosols for 5 hr showed significant oxidative stress, determined as in situ chemiluminescence in the lung [group 1, 41 +/- 4; sham, 24 +/- 1 counts per second (cps)/cm2] and heart (group 1, 45 +/- 4; sham, 24 +/- 2 cps/cm2) but not liver (group 1, 10 +/- 3; sham, 13 +/- 3 cps/cm2).", {"entities": [[15, 19, "GENE"], [35, 37, "GENE"]]}], ["Increases in oxidant levels were also triggered by highly toxic residual oil fly ash particles (lung chemiluminescence, 90 +/- 10 cps/cm2; heart chemiluminescence, 50 +/- 3 cps/cm2) but not by particle-free air or by inert carbon black aerosols (control particles).", {"entities": []}], ["Increases in chemiluminescence showed strong associations with the CAPs content of iron, manganese, copper, and zinc in the lung and with Fe, aluminum, silicon, and titanium in the heart.", {"entities": [[67, 71, "GENE"]]}], ["The oxidant stress imposed by 5-hr exposure to CAPs was associated with slight but significant increases in the lung and heart water content (approximately 5% in both tissues, p < 0.05) and with increased serum levels of lactate dehydrogenase (approximately 80%), indicating mild damage to both tissues.", {"entities": [[47, 51, "GENE"]]}], ["Strikingly, CAPs inhalation also led to tissue-specific increases in the activities of the antioxidant enzymes superoxide dismutase and catalase, suggesting that episodes of increased particulate air pollution not only have potential for oxidant injurious effects but may also trigger adaptive responses.", {"entities": [[12, 16, "GENE"]]}], ["In the last times, focus on plant research has increased all over the world.", {"entities": []}], ["Euphorbia tirucalli L., a plant known popularly as Aveloz, and originally used in Africa, has been drawing attention for its use in the United States and Latin America, both for use as an ornamental plant and as a medicinal plant.", {"entities": []}], ["E. tirucalli L. is a member of the family Euphorbiaceae and contains many diterpenoids and triterpenoids, in particular phorbol esters, apparently the main constituent of this plant, which are assumed to be responsible for their activities in vivo and in vitro .", {"entities": []}], ["The in vitro antifungal activities of Euphorbia tirucalli (L.) against opportunistic yeasts were studied using microbroth dilution assay.", {"entities": []}], ["The results showed that aqueous extract and latex preparation were effective against ten clinical strains of Cryptococcus neoformans in vitro (Latex and extract MIC range of 3.2 \u2013 > 411 \u03bcg/mL).", {"entities": []}], ["Aiming the safe use in humans, the genotoxic effects of E. tirucalli were evaluated in human leukocytes cells.", {"entities": []}], ["Our data show that both aqueous extract and latex preparation have no genotoxic effect in human leukocytes cells in vitro .", {"entities": []}], ["Although the results cannot be extrapolated by itself for use in vivo , they suggest a good perspective for a therapeutic application in future.", {"entities": []}], ["In conclusion, our results show that the aqueous extract and latex preparation from E. tirucalli L .", {"entities": []}], ["are antifungal agents effectives against several strains of C. neoformans and do not provoke DNA damage in human leukocyte cells, considering the concentrations tested.", {"entities": []}], ["The American College of Chest Physicians and Canadian Thoracic Society have jointly produced evidence-based guidelines for the prevention of exacerbations in chronic obstructive pulmonary disease (COPD).", {"entities": [[158, 195, "DISEASE"]]}], ["This educational article gives four perspectives on how these guidelines apply to the practical management of people with COPD.", {"entities": []}], ["A current smoker with frequent exacerbations will benefit from support to quit, and from optimisation of his inhaled treatment.", {"entities": []}], ["For a man with very severe COPD and multiple co-morbidities living in a remote community, tele-health care may enable provision of multidisciplinary care.", {"entities": []}], ["A woman who is admitted for the third time in a year needs a structured assessment of her care with a view to stepping up pharmacological and non-pharmacological treatment as required.", {"entities": []}], ["The overlap between asthma and COPD challenges both diagnostic and management strategies for a lady smoker with a history of asthma since childhood.", {"entities": [[20, 26, "DISEASE"], [125, 131, "DISEASE"]]}], ["Common threads in all these cases are the importance of advising on smoking cessation, offering (and encouraging people to attend) pulmonary rehabilitation, and the importance of self-management, including an action plan supported by multidisciplinary teams.", {"entities": []}], ["It is increasingly acknowledged that delays in the diagnosis of chronic inflammatory lung conditions have hampered our understanding of pathogenesis and thus our ability to design efficacious therapies.", {"entities": []}], ["This is particularly true for COPD, where most patients are diagnosed with moderate-to-severe airflow obstruction and little is known about the inflammatory processes present in early disease.", {"entities": []}], ["There is great interest in developing screening tests that can identify those most at risk of developing COPD before airflow obstruction has developed for the purpose of research and clinical care.", {"entities": []}], ["Landmark pathology studies have suggested that damage to the small airways precedes the development of airflow obstruction and emphysema and, thus, presents an opportunity to identify those at risk of COPD.", {"entities": []}], ["However, despite a number of physiological tests being available to assess small airways function, none have been adopted into routine care in COPD.", {"entities": []}], ["The reasons that tests of small airways have not been utilized widely include variability in test results and a lack of validated reference ranges from which to compare results for some methodologies.", {"entities": []}], ["Furthermore, population studies have not consistently demonstrated their ability to diagnose disease.", {"entities": []}], ["However, the landscape may be changing.", {"entities": []}], ["As the equipment that delivers tests of small airways become more widely available, reference ranges are emerging and newer methodologies specifically seek to address variability and difficulty in test performance.", {"entities": []}], ["Moreover, there is evidence that while tests of small airways may not be helpful across the full range of established disease severity, there may be specific groups (particularly those with early disease) where they might be informative.", {"entities": []}], ["In this review, commonly utilized tests of small airways are critically appraised to highlight why these tests may be important, how they can be used and what knowledge gaps remain for their use in COPD.", {"entities": []}], ["The present paper is a narrative review focusing on the psychological impact, identification of protective factors, and interventions minimizing the psychological burdens of chronic obstructive pulmonary disease (COPD).", {"entities": [[174, 211, "DISEASE"]]}], ["The research reviews studies on neurocognitive functions, personality, emotional problems, and health-related quality of life.", {"entities": []}], ["This is done with regard to resources as well as activities enabling or enhancing a patient\u2019s adaptation.", {"entities": []}], ["PubMed and PsychArticles databases were searched for relevant medical (eg, CODP, emphysema), psychopathology (eg, depression), and psychological (eg, personality) keywords, followed by hand search.", {"entities": []}], ["After application of the inclusion and exclusion criteria, the search resulted in 82 articles and book chapters.", {"entities": []}], ["The choice was based on evidence accepted by evidence-based medicine, although at different levels of strength.", {"entities": []}], ["Psychological experiencing of COPD appears to be very unequally represented with scientific research on emotional problems and functioning decrease significantly outnumbering those addressing resources or effective interventions.", {"entities": []}], ["As our initial literature search called for an urgent need for further exploration, we have carefully pointed out numerous areas where the knowledge on how to protect or restore psychological well-being among COPD patients should be broadened.", {"entities": []}], ["Clinical practice guidelines give recommendations about what to do in various medical situations, including therapeutical recommendations for drug prescription.", {"entities": []}], ["An effective way to computerize these recommendations is to design critiquing decision support systems, i.e .", {"entities": []}], ["systems that criticize the physician's prescription when it does not conform to the guidelines.", {"entities": []}], ["These systems are commonly based on a list of \"if conditions then criticism\" rules.", {"entities": []}], ["However, writing these rules from the guidelines is not a trivial task.", {"entities": []}], ["The objective of this article is to propose methods that (1) simplify the implementation of guidelines' therapeutical recommendations in critiquing systems by automatically translating structured therapeutical recommendations into a list of \"if conditions then criticize\" rules, and (2) can generate an appropriate textual label to explain to the physician why his/her prescription is not recommended.", {"entities": []}], ["We worked on the therapeutic recommendations in five clinical practice guidelines concerning chronic diseases related to the management of cardiovascular risk.", {"entities": []}], ["We evaluated the system using a test base of more than 2000 cases.", {"entities": []}], ["Algorithms for automatically translating therapeutical recommendations into \"if conditions then criticize\" rules are presented.", {"entities": []}], ["Eight generic recommendations are also proposed; they are guideline-independent, and can be used as default behaviour for handling various situations that are usually implicit in the guidelines, such as decreasing the dose of a poorly tolerated drug.", {"entities": []}], ["Finally, we provide models and methods for generating a human-readable textual critique.", {"entities": []}], ["The system was successfully evaluated on the test base.", {"entities": []}], ["We show that it is possible to criticize physicians' prescriptions starting from a structured clinical guideline, and to provide clear explanations.", {"entities": []}], ["We are now planning a randomized clinical trial to evaluate the impact of the system on practices.", {"entities": []}], ["The complement system, which contains some of the most potent pro-inflammatory mediators in the tissue including the anaphylatoxins C3a and C5a are the vital parts of innate immunity.", {"entities": []}], ["Complement activation seems to play a more critical role in tumor development, but little attention has been given to the angiogenic balance of the activated complement mediators and macrophage polarization during tumor progression.", {"entities": []}], ["The tumor growth mainly supported by the infiltration of M2- tumor-associated macrophages, and high levels of C3a and C5a, whereas M1-macrophages contribute to immune-mediated tumor suppression.", {"entities": []}], ["Macrophages express a cognate receptors for both C3a and C5a on their cell surface, and specific binding of C3a and C5a affects the functional modulation and angiogenic properties.", {"entities": []}], ["Activation of complement mediators induce angiogenesis, favors an immunosuppressive microenvironment, and activate cancer-associated signaling pathways to assist chronic inflammation.", {"entities": [[115, 121, "DISEASE"]]}], ["In this review manuscript, we highlighted the specific roles of complement activation and macrophage polarization during uncontrolled angiogenesis in tumor progression, and therefore blocking of complement mediators would be an alternative therapeutic option for treating cancer.", {"entities": [[272, 278, "DISEASE"]]}], ["Rat pups treated with sodium selenite are typically used as an in vivo model to mimic age-related nuclear cataract.", {"entities": [[106, 114, "DISEASE"]]}], ["Reactive oxygen species (ROS) production, lipid peroxidation, reduction of antioxidant enzymes, crystalline proteolysis, and apoptosis are considered factors that contribute to pathogenesis of age-related nuclear cataract.", {"entities": [[213, 221, "DISEASE"]]}], ["In the present study, we investigated whether Pinus densiflora bark extract has potential to prevent cataract formation and elucidated the underlying mechanism.", {"entities": [[101, 109, "DISEASE"]]}], ["Sprague Dawley rats were divided into six groups (n=10).", {"entities": []}], ["Group 1 rat pups (the control) were treated with only normal saline.", {"entities": []}], ["The rat pups in groups 2 to 6 were given a subcutaneous injection with sodium selenite (18 \u03bcmol/kg bodyweight) on postnatal (P) day 10.", {"entities": []}], ["Group 3 rat pups (the positive control) were given gastric intubation with curcumin (80 mg/kg bodyweight) on P9, P10, and P11.", {"entities": []}], ["The rat pups in groups 4 to 6 were given gastric intubation with P. densiflora bark extract 40 mg/kg, 80 mg/kg, and 120 mg/kg, respectively, on P9, P10, and P11.", {"entities": []}], ["This study showed that P. densiflora bark extract dose-dependently prevented cataract formation.", {"entities": [[77, 85, "DISEASE"]]}], ["Water-soluble protein, glutathione, superoxide dismutase, glutathione peroxidase, and catalase activity levels were found to be high, and conversely, water-insoluble protein, malondialdehyde, and Ca P. densiflora bark extract compared to group 2.", {"entities": []}], ["Real-time PCR analysis showed \u03b1A-crystalline, lens-specific m-calpain ( Lp84 ), lens-specific intermediates (filensin and phakinin), and antiapoptotic factor ( Bcl-2 ) were downregulated, and the apoptotic factors (caspase-3 and Bax) and plasma membrane Ca PMCA-1 ) were upregulated in group 2 compared to group 1.", {"entities": [[229, 232, "GENE"]]}], ["P. densiflora bark extract regulated the imbalance of these genes.", {"entities": []}], ["The increased cleavage form of caspase-3 was lowered in the groups treated with P. densiflora bark extract.", {"entities": []}], ["In conclusion, P. densiflora bark extract prevented selenite-induced cataract formation via regulating antioxidant enzymes, inhibiting m -calpain-induced proteolysis, and apoptosis, and thus, maintained the transparency of the lens.", {"entities": [[69, 77, "DISEASE"]]}], ["These results suggested that P. densiflora bark extract could be a new agent for preventing age-related nuclear cataract.", {"entities": [[112, 120, "DISEASE"]]}], ["Epithelial renewal in skin is achieved by the constant turnover and differentiation of keratinocytes.", {"entities": []}], ["Three popular hypotheses have been proposed to explain basal keratinocyte regeneration and epidermal homeostasis: 1) asymmetric division (stem-transit amplifying cell); 2) populational asymmetry (progenitor cell with stochastic fate); and 3) populational asymmetry with stem cells.", {"entities": []}], ["In this study, we investigated lineage dynamics using these hypotheses with a 3D agent-based model of the epidermis.", {"entities": []}], ["The model simulated the growth and maintenance of the epidermis over three years.", {"entities": []}], ["The offspring of each proliferative cell was traced.", {"entities": []}], ["While all lineages were preserved in asymmetric division, the vast majority were lost when assuming populational asymmetry.", {"entities": []}], ["The third hypothesis provided the most reliable mechanism for self-renewal by preserving genetic heterogeneity in quiescent stem cells, and also inherent mechanisms for skin ageing and the accumulation of genetic mutation.", {"entities": []}], ["To review and synthesise qualitative literature relating to the longer-term needs of community dwelling stroke survivors with communication difficulties including aphasia, dysarthria and apraxia of speech.", {"entities": [[163, 170, "DISEASE"], [187, 194, "DISEASE"]]}], ["Systematic review and thematic synthesis.", {"entities": []}], ["We included studies employing qualitative methodology which focused on the perceived or expressed needs, views or experiences of stroke survivors with communication difficulties in relation to the day-to-day management of their condition following hospital discharge.", {"entities": []}], ["We searched MEDLINE, EMBASE, PsycINFO, CINAHL, The Cochrane Library, International Bibliography of the Social Sciences and AMED and undertook grey literature searches.", {"entities": []}], ["Studies were assessed for methodological quality by two researchers independently and the findings were combined using thematic synthesis.", {"entities": []}], ["Thirty-two studies were included in the thematic synthesis.", {"entities": []}], ["The synthesis reveals the ongoing difficulties stroke survivors can experience in coming to terms with the loss of communication and in adapting to life with a communication difficulty.", {"entities": []}], ["While some were able to adjust, others struggled to maintain their social networks and to participate in activities which were meaningful to them.", {"entities": []}], ["The challenges experienced by stroke survivors with communication difficulties persisted for many years poststroke.", {"entities": []}], ["Four themes relating to longer-term need were developed: managing communication outside of the home, creating a meaningful role, creating or maintaining a support network and taking control and actively moving forward with life.", {"entities": []}], ["Understanding the experiences of stroke survivors with communication difficulties is vital for ensuring that longer-term care is designed according to their needs.", {"entities": []}], ["Wider psychosocial factors must be considered in the rehabilitation of people with poststroke communication difficulties.", {"entities": []}], ["Self-management interventions may be appropriate to help this subgroup of stroke survivors manage their condition in the longer-term; however, such approaches must be designed to help survivors to manage the unique psychosocial consequences of poststroke communication difficulties.", {"entities": []}], ["Peripheral T cell lymphoma (PTCL) is an aggressive form of non-Hodgkin's lymphoma characterized by a poor prognosis.", {"entities": [[18, 26, "DISEASE"], [73, 81, "DISEASE"]]}], ["In this study, we examined the prognostic value of two T-cell-specific transcription factors, GATA3 and T-bet, in PTCL, uncovered the pathogenesis of PTCL, and investigated new PTCL therapeutic targets.", {"entities": [[94, 99, "GENE"]]}], ["Samples from 109 PTCL patients were examined for expression of GATA3, T-bet and CD68.", {"entities": [[63, 68, "GENE"], [80, 84, "GENE"]]}], ["High GATA3 expression correlated with poor survival in PTCL patients and with tumor-associated macrophage (TAM) infiltration, as indicated by the presence of CD68-positive cells.", {"entities": [[5, 10, "GENE"]]}], ["Multivariate analysis further confirmed that high GATA3 expression and Eastern Cooperative Oncology Group (ECOG) scores higher than 2 were independent predictors of patient survival.", {"entities": [[50, 55, "GENE"]]}], ["Using lentiviral transfection to induce stable GATA3 knockdown in a PTCL cell line, we observed that GATA-3 knockdown in Hut78 cells decreased levels of IL4 , IL5 , IL13 and VEGF mRNA and reduced the number of co-cultured U937 cells that differentiated towards the M2 phenotype.", {"entities": [[47, 52, "GENE"], [153, 156, "GENE"], [159, 162, "GENE"], [165, 169, "GENE"]]}], ["These results suggest that high GATA3 expression is a predictor of a poor prognosis in PTCL, and that T lymphoma cells promote M2-type macrophage differentiation through a GATA3-dependent mechanism.", {"entities": [[104, 112, "DISEASE"], [32, 37, "GENE"], [172, 177, "GENE"]]}], ["Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disorder that strongly impacts patients' quality of life.", {"entities": []}], ["CRSwNP is still a challenge for ENT specialists due to its unknown pathogenesis, difficult control and frequent relapse.", {"entities": []}], ["We tested the hypothesis that a new standardised therapeutic approach based on individual clinical-cytological grading (CCG), may improve control of the disease and prevent the needing for surgery.", {"entities": []}], ["We analysed 204 patients suffering from bilateral CRSwNP, 145 patients of whom regularly assumed therapy, respecting the planned check-up, and were considered cases; 59 patients were not assuming therapy as indicated and were considered as controls.", {"entities": []}], ["After five years of standardised treatment, 15 of 145 (10.5%) improved endoscopic staging, 61 of 145 (42%) did not change their endoscopic staging, and 69 of 145 (47.5%) were worse.", {"entities": []}], ["In the control group, 49 of 59 (83%) were worse by at least two stages (p < 0.05).", {"entities": []}], ["Patients and controls were stratified basing on clinical and cytological grading as mild, moderate and severe.", {"entities": []}], ["After patient stratification, in the mild group (n = 27) 92% patients had a constant trend, with no worsening and no need for surgery over a 5-year period, whereas in the mild CCG control group 1 of 59 (1.6%) required surgery (p < 0.05).", {"entities": []}], ["In moderate GCC (n = 83), 44% of patients did not modify or improve endoscopic staging and 3.6% needed surgery, compared to 13.6% of controls with moderate GCC (p < 0.05).", {"entities": []}], ["In severe CCG (n = 35), even though no patients achieved significant amelioration of endoscopic grading, 40% of patients were considered as \"clinically controlled\" and 5.7% of patients underwent surgery, but the percentage was significantly higher (49%) in the control group significant (p = 0.0000).", {"entities": []}], ["Finally, statistical analyses revealed a clear trend that polyp size increased at a faster rate in the control group than in the treatment group and for each subgroup (low, moderate and severe).", {"entities": []}], ["The present study suggests a new approach in the management of CRS according to clinical cytological grading that allows defining the grade of CRSwNP severity and to adapt the intensity of treatment.", {"entities": []}], ["This approach limited the use of systemic corticosteroids to only moderate-severe CRSwNP with a low corticosteroid dosage in comparison with those previously suggested.", {"entities": []}], ["Our protocol seems to improve the adherence by patients, control of disease and the need for surgery in the long-term.", {"entities": []}], ["The objective of the study was to estimate the self-reported prevalence of chronic obstructive pulmonary disease (COPD) in Greece and to quantify its burden on patients\u2019 daily activities, productivity, and psychological status.", {"entities": [[75, 112, "DISEASE"]]}], ["A population-based, random digit-dialed telephone nationwide survey was conducted between July 10, 2015 and July 31, 2015 in order to recruit patients with COPD in Greece.", {"entities": []}], ["Among the 11,471 persons contacted, 3,414 met the inclusion criterion of age \u226540 years and completed the screening questions regarding COPD.", {"entities": []}], ["Of the 362 subjects who reported that they had been diagnosed with COPD, 351 completed the survey.", {"entities": []}], ["Data on demographic and lifestyle characteristics, comorbidities, disease history, perceived disease severity, breathlessness severity, symptoms severity, limitations in daily activities, psychological distress, and productivity were collected.", {"entities": []}], ["All data were collected through the telephone interview method using a structured questionnaire.", {"entities": []}], ["The overall self-reported COPD prevalence was 10.6%.", {"entities": []}], ["Among 351 participants, only 9% reported that they suffered from severe breathlessness.", {"entities": []}], ["The mean COPD assessment test score was 19.0, with 84% of participants having a COPD assessment test score \u226510.", {"entities": []}], ["As for the perceived severity of COPD, the majority of subjects considered that their respiratory condition was of moderate (34.2%) or mild severity (33.9%).", {"entities": []}], ["Overall, the participants reported a significant impact of COPD on their daily life.", {"entities": []}], ["For instance, 61.5% of them reported that their respiratory condition has affected their sports activities.", {"entities": []}], ["Moreover, 73% of subjects considered that the health care system could do more for them than it actually does.", {"entities": []}], ["Almost one-fourth of the participants reported that they had missed work during the past 12 months due to their respiratory symptoms, with the mean number of days lost being 10.", {"entities": []}], ["This survey provides insightful data regarding the impact of COPD on Greek patients\u2019 everyday life, psychology, and productivity, revealing the increased individual morbidity and the significant burden of this condition on society.", {"entities": []}], ["Short-acting b2-adrenergic receptor agonists are commonly used bronchodilators for symptom relief in asthmatics.", {"entities": []}], ["The aim of this study was to test whether genetic variants in PDE4D gene, a key regulator of b2-adrenoceptor-induced cAMP turnover in airway smooth muscle cells, affect the response to short-acting b2-agonists.", {"entities": [[62, 67, "GENE"]]}], ["Bronchodilator responsiveness was assessed in 133 asthmatic children by % change in baseline forced expiratory volume in one second (FEV 1 ) after administration of albuterol.", {"entities": [[133, 136, "GENE"]]}], ["The analyses were performed in patients with airway obstruction (FEV 1 /FVC ratio below 90%, n = 93).", {"entities": [[65, 68, "GENE"]]}], ["FEV 1 \u2009\u2009% change adjusted for baseline FEV 1 values was significantly different between genotypes of rs1544791 G/A polymorphism ( P = 0.006) and \u22121345 C/T (rs1504982) promoter variation ( P = 0.03).", {"entities": [[0, 3, "GENE"], [39, 42, "GENE"], [0, 3, "GENE"], [39, 42, "GENE"]]}], ["The association remained significant with inclusion of age, sex, atopy, and controller medication into multivariate model ( P = 0.004 and P = 0.02, resp.).", {"entities": []}], ["Our work identifies new genetic variants implicated in modulation of asthma treatment, one of them (rs1544791) previously associated with asthma phenotype.", {"entities": [[69, 75, "DISEASE"], [138, 144, "DISEASE"]]}], ["In utero and early-life experienced environmental exposures are suggested to play an important role in many multifactorial diseases potentially mediated through lasting effects on the epigenome.", {"entities": []}], ["As the epigenome in addition remains modifiable throughout life, identifying specific disease-relevant biomarkers may prove challenging.", {"entities": []}], ["This has led to an increased interest in epigenome-wide association studies using dried blood spots (DBS) routinely collected in perinatal screening programs.", {"entities": []}], ["Such programs are in place in numerous countries around the world producing large and unique biobanks.", {"entities": []}], ["However, availability of this biological material is highly limited as each DBS is made only from a few droplets of blood and storage conditions may be suboptimal for epigenetic studies.", {"entities": []}], ["Furthermore, as relevant markers may reside outside gene bodies, epigenome-wide interrogation is needed.", {"entities": []}], ["Here we demonstrate, as a proof of principle, that genome-wide interrogation of the methylome based on methylated DNA immunoprecipitation coupled with next-generation sequencing (MeDIP-seq) is feasible using a single 3.2 mm DBS punch (60\u00a0ng DNA) from filter cards archived for up to 16\u00a0years.", {"entities": []}], ["The enrichment profile, sequence quality and distribution of reads across genetic regions were comparable between samples archived 16\u00a0years, 4\u00a0years and a freshly prepared control sample.", {"entities": []}], ["In summary, we show that high-quality MeDIP-seq data is achievable from neonatal screening filter cards stored at room temperature, thereby providing information on annotated as well as on non-RefSeq genes and repetitive elements.", {"entities": []}], ["Moreover, the quantity of DNA from one DBS punch proved sufficient allowing for multiple epigenome studies using one single DBS.", {"entities": []}], ["The online version of this article (doi:10.1186/s13148-016-0242-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objective : To examine the association between serum HDL-cholesterol concentration (HDL-C) and self rated health (SRH) in several age groups of men and women.", {"entities": []}], ["Study design and setting: The study had a cross-sectional design and included 18,770 men and women of the Oslo Health Study aged 30; 40 and 45; 69-60; 75-76 years.", {"entities": []}], ["Results : In both sexes and all age groups, SRH (3 categories: poor, good, very good) was positively correlated with HDL-C. Logistic regression analysis on dichotomized values of SRH (i.e.", {"entities": []}], ["poor vs. good health) in each age group of men and women showed that increasing HDL-C values were associated with increasing odds for reporting good health; the odds ratio (OR) was highest in young men, and was generally lower in women than in men.", {"entities": []}], ["Odds ratios in the 4 age groups of men were 4.94 (2.63-9.29), 2.25 (1.63-3.09), 2.12 (1.58-2.86), 1.87 (1.37-2.54); and in women: 3.58 (2.46-5.21), 2.81 (2.23-3.53), 2.28 (1.84-2.82), 1.61 (1.31-1.99).", {"entities": []}], ["In the whole material, 1 mmol/L increase in HDL-C increased the odds for reporting good health by 2.27 (2.06-2.50; p<0.001), when adjusting for sex, age group, time since food intake and use of cholesterol lowering drugs.", {"entities": []}], ["Chronic diseases, pain, psychological distress, smoking, alcohol, length of education, and dietary items did not have any major influence on the pattern of the HDL-C vs. SRH association.", {"entities": []}], ["Conclusion: There was a consistent positive association between HDL-C and SRH, in both men and women in four different age groups, with the strongest association in young people.", {"entities": []}], ["Acute otitis media (OM) is a common disease which often develops through complex interactions between the host, the pathogen and environmental factors.", {"entities": [[6, 18, "DISEASE"]]}], ["We studied single nucleotide polymorphisms (SNPs) of genes involved in innate and adaptive immunity, and other host and environmental factors for their role in OM.", {"entities": []}], ["Using Sequenom Massarray platform, 21 SNPs were studied in 653 children from prospective (n\u200a=\u200a202) and retrospective (n\u200a=\u200a451) cohorts.", {"entities": []}], ["Data were analyzed for the relationship between SNPs and upper respiratory infection (URI) frequency, risk of acute OM during URI episodes, and proneness to recurrent OM.", {"entities": []}], ["Increased risk for OM proneness was associated with CX3CR1 (Thr280Met) SNP and with a jointly interactive group of IL-10 (\u22121082) SNP, IL-1\u03b2 (\u2212511) wild type genotype and white race.", {"entities": [[52, 58, "GENE"]]}], ["Family history of OM proneness independently increased the risk for frequent URIs, OM occurrence during URI, and OM proneness.", {"entities": []}], ["Additionally, IL-1\u03b2 (\u221231) SNP was associated with increased risk for frequent URIs, but IL-10 (\u2212592), IL-1\u03b2 (\u2212511), IL-5 (\u2212746) and IL-8 (\u2212251) SNPs were associated with decreased risk of URI.", {"entities": []}], ["IL-1\u03b2 (\u221231), CX3CR1 (Thr280Met), IL-10 (\u22121082) and IL-1\u03b2 (\u2212511) SNPs were associated with increased risk for frequent URIs or OM proneness.", {"entities": [[13, 19, "GENE"]]}], ["Psychological stress has been claimed to contribute to the onset of cancer and to increase mortality from a number of non-malignant diseases.", {"entities": [[68, 74, "DISEASE"]]}], ["We investigated the effect of a genuine psychological stressor, i.e.", {"entities": []}], ["cancer in a child, on the incidence of cancer and mortality from non-malignant diseases of 11,231 parents in a Danish nationwide population-based study.", {"entities": [[0, 6, "DISEASE"], [39, 45, "DISEASE"]]}], ["The children were identified from records in the Danish Cancer Registry for the period 1943-85; their parents were identified from population registers.", {"entities": [[56, 62, "DISEASE"]]}], ["Overall, 1665 parental malignancies were diagnosed from the date the cancer of the child was reported until 1992, compared with 1702 expected from national incidence rates, yielding standardized incidence ratios of 1.0 (95% confidence interval, 0.9-1.0) for all parents, 1.0 for mothers and 1.0 for fathers.", {"entities": [[69, 75, "DISEASE"]]}], ["No statistically significant deviation of the relative risk from unity was seen for any period of follow-up after the stressful event, and no excess risk was seen for any particular type of cancer.", {"entities": [[190, 196, "DISEASE"]]}], ["Moreover, a total of 2137 parental deaths were observed over the period 1974-92, compared with 2333 expected from national mortality rates, giving an overall standardized mortality ratio of 0.9 (range 0.9-1.0).", {"entities": []}], ["No excess mortality was seen from causes associated with allergic illness, autoimmune conditions, chronic illness or changes in behaviour.", {"entities": []}], ["Our data provide no support for the hypothesis of an association between psychological stress and the incidence of cancer or mortality from non-malignant diseases.", {"entities": [[115, 121, "DISEASE"]]}], ["We conclude that the human organism is highly adaptable, even to extreme psychological stress.", {"entities": []}], ["The purpose of the present work was to design and optimize compression coated floating pulsatile drug delivery systems of bisoprolol.", {"entities": []}], ["Floating pulsatile concept was applied to increase the gastric residence of the dosage form having lag phase followed by a burst release.", {"entities": []}], ["The prepared system consisted of two parts: a core tablet containing the active ingredient and an erodible outer shell with gas generating agent.", {"entities": []}], ["The rapid release core tablet (RRCT) was prepared by using superdisintegrants with active ingredient.", {"entities": []}], ["Press coating of optimized RRCT was done by polymer.", {"entities": []}], ["A 3 P < 0.05 was statistically significant.", {"entities": []}], ["Release kinetics of the optimized formulation best fitted the zero order model.", {"entities": []}], ["In vivo study confirms burst effect at 4\u2009h in indicating the optimization of the dosage form.", {"entities": []}], ["The aim of the current study was to investigate the protective effect of naringin on bleomycin-induced pulmonary fibrosis in rats.", {"entities": [[103, 121, "DISEASE"]]}], ["Twenty-four Wistar rats randomly divided into four groups (control, bleomycin alone, bleomycin + naringin 40, and bleomycin + naringin 80) were used.", {"entities": []}], ["Rats were administered a single dose of bleomycin (5\u2009mg/kg; via the tracheal cannula) alone or followed by either naringin 40\u2009mg/kg (orally) or naringin 80\u2009mg/kg (orally) or water (1\u2009mL, orally) for 14 days.", {"entities": []}], ["Rats and lung tissue were weighed to determine the lung index.", {"entities": []}], ["TNF- \u03b1 and IL-1 \u03b2 levels, hydroxyproline content, and malondialdehyde (MDA) levels were assayed.", {"entities": []}], ["Glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities were determined.", {"entities": []}], ["Tissue sections were stained with hematoxylin-eosin, Masson's trichrome, and 0.1% toluidine blue.", {"entities": []}], ["TNF- \u03b1 , IL-1 \u03b2 , and MDA levels and hydroxyproline content significantly increased ( p < 0.01) and GPx and SOD activities significantly decreased in bleomycin group ( p < 0.01).", {"entities": []}], ["Naringin at a dose of 80\u2009mg/kg body weight significantly decreased TNF- \u03b1 and IL-1 \u03b2 activity, hydroxyproline content, and MDA level ( p < 0.01) and increased GPx and SOD activities ( p < 0.05).", {"entities": []}], ["Histological evidence supported the results.", {"entities": []}], ["These results show that naringin has the potential of reducing the toxic effects of bleomycin and may provide supportive therapy for conventional treatment methods for idiopathic pulmonary fibrosis.", {"entities": [[179, 197, "DISEASE"], [168, 197, "DISEASE"]]}], ["Twins in Africa may be at increased risk of metabolic disorders due to strained conditions in utero, including high exposure to infections.", {"entities": []}], ["We studied metabolic syndrome (MS) and diabetes mellitus (DM) among young twins and singletons in Guinea-Bissau.", {"entities": [[21, 29, "DISEASE"], [39, 56, "DISEASE"]]}], ["The study was cross-sectional and occurred from October 2009 until August 2011 at the Bandim Health Project, a demographic surveillance site in the capital Bissau.", {"entities": []}], ["Twins and singleton controls between 5 and 32 years were visited at home.", {"entities": []}], ["Fasting blood samples for metabolic measurements were collected.", {"entities": []}], ["Zygosity was established genetically for a subset.", {"entities": []}], ["DM was defined as HbA 1c \u22656.5% (48 mmol/mol) and MS by the International Diabetes Federation criteria.", {"entities": []}], ["HbA 1c was available for 574 twins and 463 singletons.", {"entities": []}], ["Mean age was 15.3 years versus 15.8 years, respectively.", {"entities": []}], ["Eighteen percent of twins were monozygotic.", {"entities": []}], ["There were no DM cases among twins but one among singletons.", {"entities": []}], ["A total of 1.4% (8 of 574) of twins had elevated HbA 1c (6.0\u20136.4%, 42\u201346 mmol/mol) compared with 2.4% (11 of 463) of singletons ( P = 0.28).", {"entities": []}], ["Mean HbA 1c was 5.3% (34 mmol/mol) for both groups.", {"entities": []}], ["MS data were available for 364 twins and 360 singletons.", {"entities": []}], ["The MS prevalence was 3.0% (11 of 364) among twins and 3.6% (13 of 360) among singletons ( P = 0.66).", {"entities": []}], ["The prevalence of fasting blood glucose (F-glucose) \u22655.6 mmol/L was 34.9% (127 of 364) for twins versus 24.7% (89 of 360) for singletons ( P = 0.003).", {"entities": []}], ["Median homeostasis model assessment\u2013insulin resistance did not differ ( P = 0.34).", {"entities": []}], ["The MS and DM prevalences among young individuals in Guinea-Bissau were low.", {"entities": []}], ["Twins did not have a higher MS and DM burden than singletons, though elevated F-glucose was more common among twins.", {"entities": []}], ["Biomarkers of organochlorine pesticides were measured in both venous and umbilical cord blood from 35 pregnant Hispanic women living in Brownsville, Texas, USA.", {"entities": []}], ["Gas chromatography with an electron capture detector was used to analyze specimens for 30 individual pesticides or their metabolites.", {"entities": []}], ["Results indicate that blood concentrations were relatively low for most individual compounds, but that high-end (upper 10th percentile) values for total DDT were comparatively high.", {"entities": []}], ["Although health effects associated with measured blood concentrations are uncertain, there is concern that fetal exposure to low levels of these OC compounds, either individually or in combination, might contribute to subsequent health problems, including neurodevelopmental effects, cancer, endocrine disruption, obesity and diabetes.", {"entities": [[314, 321, "DISEASE"], [284, 290, "DISEASE"]]}], ["In 2002, a pneumococcal conjugate vaccine (PCV) was introduced to French infants and toddlers.", {"entities": []}], ["A change has been witnessed in the incidence of pneumococcal diseases in adults: the incidence of invasive pneumococcal disease (IPD) of serotypes covered by PCV decreased, and serotypes not covered by PCV increased.", {"entities": []}], ["This study aimed to quantify the public health and budget impact of pneumococcal vaccination strategies in at-risk adults in France over 5\u00a0years.", {"entities": []}], ["A previously published population-based Markov model was adapted to the French situation.", {"entities": []}], ["At-risk adults received either PPV23 (pneumococcal polysaccharide vaccine; for the immunocompetent) or PCV13 (for the immunosuppressed).", {"entities": []}], ["The strategy was compared to PCV13 alone.", {"entities": []}], ["Uncertainty was addressed using extreme scenario analyses.", {"entities": []}], ["Between 2014 and 2018, vaccination with PPV23/PCV13 led to a higher reduction in terms of IPD and non-bacteremic pneumococcal pneumonia cases avoided in most scenarios analyzed when compared to PCV13 alone.", {"entities": [[126, 135, "DISEASE"]]}], ["For budget impact, none of the scenarios was in favor of PCV13.", {"entities": []}], ["Under conservative coverage assumptions, the total incremental budget impact ranged from \u20ac 39.8 million to \u20ac 69.3 million if PCV13 were to replace PPV23 in the immunocompetent.", {"entities": []}], ["With the epidemiological changes of pneumococcal diseases and the broader serotype coverage of PPV23, the current program remains an optimal strategy from public health perspective.", {"entities": []}], ["Given the additional budget required for the use of PCV13 alone and its uncertain public health benefits, vaccination with PPV23 remains the preferred strategy.", {"entities": []}], ["The number of elderly patients with asthma has been increasing in Japan.", {"entities": [[36, 42, "DISEASE"]]}], ["Treatment for these patients should be provided based on the condition of individual patients.", {"entities": []}], ["This study was performed to clarify the relationship between inhalation procedure and sex difference in elderly patients with asthma.", {"entities": [[126, 132, "DISEASE"]]}], ["The inhalation procedure was examined in 155 elderly patients with asthma (male: n=66, average age \u00b1 standard deviation: 75.5\u00b15.65 years old; female: n=89, average age \u00b1 standard deviation: 78.7\u00b16.87 years old) during a medical examination.", {"entities": [[67, 73, "DISEASE"]]}], ["For the three items that were common to all devices, the percentages of the 155 patients who could/could not perform the actions were examined by separate Fisher\u2019s exact tests for males and females.", {"entities": []}], ["A statistically significant difference ( P =0.007) was observed for \u201cbreath holding\u201d, and more females than males were not able to hold their breath.", {"entities": []}], ["Although no significant difference was seen in the \u201caccurate number of times of inhalation\u201d, females tended to not be able to inhale accurately compared to males ( P =0.072).", {"entities": []}], ["Our results suggest that elderly female patients with asthma have less understanding of inhaled steroid therapy, compared to elderly male patients.", {"entities": [[54, 60, "DISEASE"]]}], ["Therefore, it is particularly important to confirm that the correct inhalation procedure is used by elderly female patients with asthma.", {"entities": [[129, 135, "DISEASE"]]}], ["Due to the spread of resistance, antibiotic exposure receives increasing attention.", {"entities": []}], ["Ecological consequences for the different niches of individual microbiomes are, however, largely ignored.", {"entities": []}], ["Here, we report the effects of widely used antibiotics (clindamycin, ciprofloxacin, amoxicillin, and minocycline) with different modes of action on the ecology of both the gut and the oral microbiomes in 66 healthy adults from the United Kingdom and Sweden in a two-center randomized placebo-controlled clinical trial.", {"entities": []}], ["Feces and saliva were collected at baseline, immediately after exposure, and 1, 2, 4, and 12 months after administration of antibiotics or placebo.", {"entities": []}], ["Sequences of 16S rRNA gene amplicons from all samples and metagenomic shotgun sequences from selected baseline and post-antibiotic-treatment sample pairs were analyzed.", {"entities": []}], ["Additionally, metagenomic predictions based on 16S rRNA gene amplicon data were performed using PICRUSt.", {"entities": []}], ["The salivary microbiome was found to be significantly more robust, whereas the antibiotics negatively affected the fecal microbiome: in particular, health-associated butyrate-producing species became strongly underrepresented.", {"entities": []}], ["Additionally, exposure to different antibiotics enriched genes associated with antibiotic resistance.", {"entities": []}], ["In conclusion, healthy individuals, exposed to a single antibiotic treatment, undergo considerable microbial shifts and enrichment in antibiotic resistance in their feces, while their salivary microbiome composition remains unexpectedly stable.", {"entities": []}], ["The health-related consequences for the gut microbiome should increase the awareness of the individual risks involved with antibiotic use, especially in a (diseased) population with an already dysregulated microbiome.", {"entities": []}], ["On the other hand, understanding the mechanisms behind the resilience of the oral microbiome toward ecological collapse might prove useful in combating microbial dysbiosis elsewhere in the body.", {"entities": []}], ["Many health care professionals use antibiotic prophylaxis strategies to prevent infection after surgery.", {"entities": []}], ["This practice is under debate since it enhances the spread of antibiotic resistance.", {"entities": []}], ["Another important reason to avoid nonessential use of antibiotics, the impact on our microbiome, has hardly received attention.", {"entities": []}], ["In this study, we assessed the impact of antibiotics on the human microbial ecology at two niches.", {"entities": []}], ["We followed the oral and gut microbiomes in 66 individuals from before, immediately after, and up to 12\u00a0months after exposure to different antibiotic classes.", {"entities": []}], ["The salivary microbiome recovered quickly and was surprisingly robust toward antibiotic-induced disturbance.", {"entities": []}], ["The fecal microbiome was severely affected by most antibiotics: for months, health-associated butyrate-producing species became strongly underrepresented.", {"entities": []}], ["Additionally, there was an enrichment of genes associated with antibiotic resistance.", {"entities": []}], ["Clearly, even a single antibiotic treatment in healthy individuals contributes to the risk of resistance development and leads to long-lasting detrimental shifts in the gut microbiome.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases (CRDs) have significant impacts on quality of life including psychomotor domain.", {"entities": []}], ["To evaluate three major affective disorders in subjects with COPD compared with other CRDs and nonill population.", {"entities": []}], ["The Thai version of Mini International Neuropsychiatric Interview (MINI) was used as a diagnostic instrument for three major affective disorders (generalized anxiety disorder, major depressive disorder, and panic disorder) by face-to-face interview in assessing patients with CRDs [COPD, asthma, rhinasthma, all asthma (asthma and rhinasthma), and chronic rhinitis], and nonill subjects.", {"entities": [[176, 201, "DISEASE"], [207, 221, "DISEASE"], [356, 364, "DISEASE"], [146, 174, "DISEASE"], [158, 174, "DISEASE"], [348, 364, "DISEASE"], [288, 294, "DISEASE"], [312, 318, "DISEASE"], [320, 326, "DISEASE"]]}], ["Logistic regression analyses were used to determine the relation between major affective disorders and CRDs adjusting for age, sex, and disease severity.", {"entities": []}], ["Major affective disorders were more prevalent in CRDs than nonill groups (adjusted OR =2.6 [95% CI, 1.8\u22123.9], P <0.001).", {"entities": []}], ["COPD patients had significantly more generalized anxiety and panic disorder (adjusted OR =4.0 [95% CI, 1.4\u221211.9], P =0.011, and 4.4 [95% CI, 1.1\u221218.1], P =0.038, respectively) but not major depressive disorder (adjusted OR =2.7 [95% CI, 0.8\u22129.0, P =0.105]) than nonill group.", {"entities": [[184, 209, "DISEASE"], [61, 75, "DISEASE"]]}], ["Comparing with all asthma, COPD patients had lower occurrence of major depressive and panic disorders (adjusted OR =0.1 [95% CI, 0.0\u22120.4], P =0.002, and 0.1 [95% CI, 0.0\u22120.9], P =0.043, respectively).", {"entities": [[19, 25, "DISEASE"]]}], ["There was no difference in major mood disorders in COPD, rhinasthma, and chronic rhinitis patients.", {"entities": [[81, 89, "DISEASE"], [73, 89, "DISEASE"]]}], ["Major affective disorders were not increased by disease severity in COPD.", {"entities": []}], ["Major affective disorders were significantly higher in CRDs than nonill population.", {"entities": []}], ["Generalized anxiety and panic disorders were significantly high in COPD patients.", {"entities": []}], ["Moreover, major depressive and panic disorders in COPD were significantly lower than all asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["The prevalence of major affective disorders may not be related to severity of COPD.", {"entities": []}], ["Hazardous biochemical agents in animal husbandry indoor environments are known to promote the occurrence of various illnesses among workers and animals.", {"entities": []}], ["The relationship between endotoxin levels in dust collected from chicken farms and various immunological markers was investigated.", {"entities": []}], ["Peripheral blood was obtained from 20 broiler chickens and 20 laying hens from four different chicken farms in Korea.", {"entities": []}], ["Concentrations of total or respirable dust in the inside the chicken farm buildings were measured using a polyvinyl chloride membrane filter and mini volume sampler.", {"entities": []}], ["Endotoxin levels in the dust were determined by the Limulus Amebocyte Lysate Kinetic method.", {"entities": []}], ["Interferon-\u03b3 production by peripheral blood mononuclear cells stimulated with concanavalin A was significantly lower in broilers or layers from the farms with higher endotoxin concentrations than the chickens from the farms with lower endotoxin levels.", {"entities": []}], ["An opposite pattern was observed for plasma cortisol concentrations with higher cortisol levels found in chickens from the farms with higher endotoxin levels.", {"entities": []}], ["When peripheral lymphocytes were examined, the percentage of CD3", {"entities": []}], ["The Ocean, which is called the \u2018mother of origin of life\u2019, is also the source of structurally unique natural products that are mainly accumulated in living organisms.", {"entities": []}], ["Several of these compounds show pharmacological activities and are helpful for the invention and discovery of bioactive compounds, primarily for deadly diseases like cancer, acquired immuno-deficiency syndrome (AIDS), arthritis, etc., while other compounds have been developed as analgesics or to treat inflammation, etc.", {"entities": [[201, 209, "DISEASE"], [218, 227, "DISEASE"], [166, 172, "DISEASE"]]}], ["The life-saving drugs are mainly found abundantly in microorganisms, algae and invertebrates, while they are scarce in vertebrates.", {"entities": []}], ["Modern technologies have opened vast areas of research for the extraction of biomedical compounds from oceans and seas.", {"entities": []}], ["When used during extracorporeal membrane oxygenation (ECMO), jugular venous bulb catheters, known as cephalad cannulae, increase venous drainage, augment circuit flow and decompress cerebral venous pressure.", {"entities": []}], ["Optimized cerebral oxygen delivery during ECMO may contribute to a reduction in neurological morbidity.", {"entities": []}], ["This study describes the use of cephalad cannulae and identifies rudimentary data for jugular venous oxygen saturation (JVO 2 ) and arterial to jugular venous oxygen saturation difference (AVDO 2 ) in this patient population.", {"entities": []}], ["Patients on venoarterial (VA) ECMO displayed higher JVO 2 ( P < 0.01) and lower AVDO 2 ( P = 0.01) than patients on venovenous (VV) ECMO ( P < 0.01).", {"entities": []}], ["During VV ECMO, JVO 2 was higher and AVDO 2 lower when systemic pH was < 7.35 rather than > 7.4 ( P = 0.01).", {"entities": []}], ["During VA ECMO, similar differences in AVDO 2 but not in JVO 2 were observed at different pH levels ( P = 0.01).", {"entities": []}], ["Jugular venous saturation and AVDO 2 were influenced by systemic pH, ECMO type and patient age.", {"entities": []}], ["These data provide the foundation for normative values of JVO 2 and AVDO 2 in neonates and children treated with ECMO.", {"entities": []}], ["The field of exosome research is rapidly expanding, with a dramatic increase in publications in recent years.", {"entities": []}], ["These small vesicles (30-100 nm) of endocytic origin were first proposed to function as a way for reticulocytes to eradicate the transferrin receptor while maturing into erythrocytes", {"entities": []}], ["Influenza is rarely confirmed with laboratory testing and accurate assessment of the overall burden of influenza is difficult.", {"entities": [[0, 9, "DISEASE"], [103, 112, "DISEASE"]]}], ["We used statistical modelling methods to generate updated, granular estimates of the number/rate of influenza-attributable hospitalisations and deaths in the United Kingdom.", {"entities": [[100, 109, "DISEASE"]]}], ["Such data are needed on a continuing basis to inform on cost-benefit analyses of treatment interventions, including vaccination.", {"entities": []}], ["Weekly age specific data on hospital admissions (1997\u20132009) and on deaths (1997\u20132009) were obtained from national databases.", {"entities": []}], ["Virology reports (1996\u20132009) of influenza and respiratory syncytial virus detections were provided by Public Health England.", {"entities": [[32, 41, "DISEASE"]]}], ["We used an expanded set of ICD-codes to estimate the burden of illness attributable to influenza which we refer to as \u2018respiratory disease broadly defined\u2019.", {"entities": [[87, 96, "DISEASE"]]}], ["These codes were chosen to optimise the balance between sensitivity and specificity.", {"entities": []}], ["A multiple linear regression model controlled for respiratory syncytial virus circulation, with stratification by age and the presence of comorbid risk status (conditions associated with severe influenza outcomes).", {"entities": [[194, 203, "DISEASE"]]}], ["In the United Kingdom there were 28,516 hospitalisations and 7163 deaths estimated to be attributable to influenza respiratory disease in a mean season, with marked variability between seasons.", {"entities": [[105, 114, "DISEASE"]]}], ["The highest incidence rates of influenza-attributable hospitalisations and deaths were observed in adults aged 75+ years (252/100,000 and 131/100,000 population, respectively).", {"entities": [[31, 40, "DISEASE"]]}], ["Influenza B hospitalisations were highest among 5\u201317\u00a0year olds (12/100,000 population).", {"entities": [[0, 9, "DISEASE"]]}], ["Of all estimated influenza respiratory deaths in 75+ year olds, 50\u00a0% occurred out of hospital, and 25\u00a0% in 50\u201364\u00a0year olds.", {"entities": [[17, 26, "DISEASE"]]}], ["Rates of hospitalisations and death due to influenza-attributable respiratory disease were increased in adults identified as at-risk.", {"entities": [[43, 52, "DISEASE"]]}], ["Our study points to a substantial but highly variable seasonal influenza burden in all age groups, particularly affecting 75+ year olds.", {"entities": [[63, 72, "DISEASE"]]}], ["Effective influenza prevention or early intervention with anti-viral treatment in this age group may substantially impact the disease burden and associated healthcare costs.", {"entities": [[10, 19, "DISEASE"]]}], ["The high burden of influenza B hospitalisation among 5\u201317\u00a0year olds supports current United Kingdom vaccine policy to extend quadrivalent seasonal influenza vaccination to this age group.", {"entities": [[19, 28, "DISEASE"], [147, 156, "DISEASE"]]}], ["ClinicalTrial.gov, NCT01520935 The online version of this article (doi:10.1186/s12889-016-3128-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Immune signatures of sheep acutely-infected with Fasciola hepatica , an important pathogen of livestock and humans were analysed within the peritoneal compartment to investigate early infection.", {"entities": []}], ["Within the peritoneum, F. hepatica antibodies coincided with an intense innate and adaptive cellular immune response, with infiltrating leukocytes and a marked eosinophilia (49%).", {"entities": [[160, 172, "DISEASE"]]}], ["However, while cytokine qPCR analysis revealed IL-10, IL-12, IL-13, IL-23 and TGF\u03b2 were elevated, these were not statistically different at 18 days post-infection compared to uninfected animals indicating that the immune response is muted and not yet skewed to a Th2 type response that is associated with chronic disease.", {"entities": [[233, 238, "GENE"]]}], ["Proteomic analysis of the peritoneal fluid identified infection-related proteins, including several structural proteins derived from the liver extracellular matrix, connective tissue and epithelium, and proteins related to the immune system.", {"entities": []}], ["Periostin and vascular cell adhesion protein 1 (VCAM-1), molecules that mediate leukocyte infiltration and are associated with inflammatory disorders involving marked eosinophilia (e.g.", {"entities": [[167, 179, "DISEASE"]]}], ["asthma), were particularly elevated in the peritoneum.", {"entities": [[0, 6, "DISEASE"]]}], ["Immuno-histochemical studies indicated that the source of periostin and VCAM-1 was the inflamed sheep liver tissue.", {"entities": []}], ["This study has revealed previously unknown aspects of the immunology and pathogenesis associated with acute fascioliasis in the peritoneum and liver.", {"entities": [[108, 120, "DISEASE"]]}], ["Chronic monosodium glutamate (MSG) intake causes kidney dysfunction and renal oxidative stress in the animal model.", {"entities": []}], ["To gain insight into the renal changes induced by MSG, proteomic analysis of the kidneys was performed.", {"entities": []}], ["Six week old male Wistar rats were given drinking water with or without MSG (2 mg/g body weight, n\u200a=\u200a10 per group) for 9 months.", {"entities": []}], ["Kidneys were removed, frozen, and stored at \u201375\u00b0C.", {"entities": []}], ["After protein extraction, 2-D gel electrophoresis was performed and renal proteome profiles were examined with Colloidal Coomassie Brilliant Blue staining.", {"entities": []}], ["Statistically significant protein spots (ANOVA, p <0.05) with 1.2-fold difference were excised and analyzed by LC-MS. Proteomic data were confirmed by immunohistochemistry and Western blot analyses.", {"entities": []}], ["The differential image analysis showed 157 changed spots, of which 71 spots were higher and 86 spots were lower in the MSG-treated group compared with those in the control group.", {"entities": []}], ["Eight statistically significant and differentially expressed proteins were identified: glutathione S-transferase class-pi, heat shock cognate 71 kDa, phosphoserine phosphatase, phosphoglycerate kinase, cytosolic glycerol-3-phosphate dehydrogenase, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, \u03b1-ketoglutarate dehydrogenase and succinyl-CoA ligase.", {"entities": []}], ["The identified proteins are mainly related to oxidative stress and metabolism.", {"entities": []}], ["They provide a valuable clue to explore the mechanism of renal handling and toxicity on chronic MSG intake.", {"entities": []}], ["The main objective of the study was to determine the degree of sensitization to Anisakis spp.", {"entities": []}], ["antigens in healthy coastal population of Dalmatia given the high thermally unprocessed fish intake rate present in this area, suggested as a significant risk factor for anisakiasis.", {"entities": [[170, 181, "DISEASE"]]}], ["We performed a monocenter, cross-sectional pilot study stratified by geographic area of residence, conducted at the County secondary healthcare provider Medicine-biochemical Laboratory in Split (Croatia), from November 2010 till December 2011, on 500 unpaid volunteer subjects undergoing routine blood analysis and belonging to the south coast of the Adriatic Sea.", {"entities": []}], ["We studied the IgE seroprevalence to Anisakis spp.", {"entities": []}], ["Ani s l and Ani s 7 allergens by indirect ELISA in healthy subjects, which were selected at random in the region of Dalmatia (Southern Croatia), among islands, coastal urban and inland rural populations.", {"entities": []}], ["In order to detect possible cross-reactivity to other human helminthes, serum samples were tested also for the presence of IgG antibodies to Ascaris lumbricoides and Toxocara canis .", {"entities": []}], ["The overall and coastal Anisakis seroprevalences for the sampled population were 2% and 2.5%, respectively.", {"entities": []}], ["The logistic univariate regression analysis confirmed that regarding anti- Anisakis IgE seroprevalence, raw fish intake, daily fish intake, homemade origin of fish dish and occupational contact (professional, artisanal or hobby contact with fishery or fish industry) were risk factors associated to Anisakis spp.", {"entities": []}], ["sensitization, but neither of the variables was exclusive for a particular seropositive population.", {"entities": []}], ["Also, a significant difference was observed between seropositive and seronegative subjects that had stated allergy or symptoms associated with allergy (atopic dermatitis, asthma or rhinitis) in their previous history.", {"entities": [[152, 169, "DISEASE"], [181, 189, "DISEASE"], [171, 177, "DISEASE"], [159, 169, "DISEASE"]]}], ["Being the first in Croatia, our study underlines the necessity of incorporating Anisakis spp.", {"entities": []}], ["allergens in routine hypersensitivity testing of coastal population.", {"entities": []}], ["Anisakiasis is a zoonosis induced by infection with the Anisakis third-stage larvae, contracted through consumption of thermally unprocessed or lightly processed seafood.", {"entities": [[0, 11, "DISEASE"]]}], ["Its diagnosis is difficult to suspect in countries where the illness was not previously reported, where it is infrequent, or in the cases of subclinical infections.", {"entities": []}], ["Therefore, it is of great relevance to conduct epidemiological studies to assess the seroprevalence of anti- Anisakis IgE in populations where this zoonosis is more probable.", {"entities": []}], ["A cross-sectional pilot study was performed on 500 subjects undergoing routine blood analysis and belonging to the south coast of the Adriatic Sea.", {"entities": []}], ["The results showed that IgE sensitization to Anisakis , tested by indirect ELISA using recombinant Ani s 1 or Ani s 7 allergens, reached 3.5% in the population of higher fish consumers (islands).", {"entities": []}], ["All Anisakis positive subjects were high fish consumers, mostly of raw and homemade thermally unprocessed fish prepared in the traditional manner.", {"entities": []}], ["Most of them reported professional or hobby occupational contact with fishery or fish industry.", {"entities": []}], ["We demonstrated that in coastal Croatian populations there is a relevant prevalence of Anisakis infections, mainly related to the ingestion of home-made raw fish, underlining the necessity to carry out a wider epidemiological study of Anisakis -induced allergy.", {"entities": []}], ["To assess the relationships between golf and health.", {"entities": []}], ["Scoping review.", {"entities": []}], ["Published and unpublished reports of any age or language, identified by searching electronic databases, platforms, reference lists, websites and from consulting experts.", {"entities": []}], ["A 3-step search strategy identified relevant published primary and secondary studies as well as grey literature.", {"entities": []}], ["Identified studies were screened for final inclusion.", {"entities": []}], ["Data were extracted using a standardised tool, to form (1) a descriptive analysis and (2) a thematic summary.", {"entities": []}], ["4944 records were identified with an initial search.", {"entities": []}], ["301 studies met criteria for the scoping review.", {"entities": []}], ["Golf can provide moderate intensity physical activity and is associated with physical health benefits that include improved cardiovascular, respiratory and metabolic profiles, and improved wellness.", {"entities": []}], ["There is limited evidence related to golf and mental health.", {"entities": []}], ["The incidence of golfing injury is moderate, with back injuries the most frequent.", {"entities": []}], ["Accidental head injuries are rare, but can have serious consequences.", {"entities": []}], ["Practitioners and policymakers can be encouraged to support more people to play golf, due to associated improved physical health and mental well-being, and a potential contribution to increased life expectancy.", {"entities": []}], ["Injuries and illnesses associated with golf have been identified, and risk reduction strategies are warranted.", {"entities": []}], ["Further research priorities include systematic reviews to further explore the cause and effect nature of the relationships described.", {"entities": []}], ["Research characterising golf's contribution to muscular strengthening, balance and falls prevention as well as further assessing the associations and effects between golf and mental health are also indicated.", {"entities": []}], ["The concurrent management of allergic rhinitis and asthma (ARA) has been recommended by Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines.", {"entities": [[29, 46, "DISEASE"], [88, 105, "DISEASE"], [38, 46, "DISEASE"], [97, 105, "DISEASE"], [51, 57, "DISEASE"], [124, 130, "DISEASE"]]}], ["However, a tool capable of assessing simultaneously the control of upper and lower airways diseases is lacking.", {"entities": []}], ["To describe the studies conducted to design the control of ARA test (CARAT) questionnaire.", {"entities": []}], ["We performed a literature review to generate a list of potentially important items for the assessment of control of ARA.", {"entities": []}], ["A formal consensus development process, that used an innovative web-based application, was designed \u2013 111 experts in ARA and 60 patients participated.", {"entities": []}], ["At the final consensus meeting, 25 primary and secondary care physicians formulated the questions and response options.", {"entities": []}], ["A qualitative feasibility study (n = 31 patients) was conducted to evaluate the comprehensibility of the questionnaire while testing two different designs.", {"entities": []}], ["Thirty-four potentially important items were identified.", {"entities": []}], ["All the steps of the consensus process were completed in 2.5 months.", {"entities": []}], ["The opinions of experts and patients lead to the formulation of 17 questions.", {"entities": []}], ["At the feasibility study the instructions and wording problems were corrected and a semi-tabular format was chosen.", {"entities": []}], ["A tool to measure the control of allergic rhinitis and asthma was developed using a comprehensive set of methodological steps ensuring the design quality and the face and content validity.", {"entities": [[33, 50, "DISEASE"], [42, 50, "DISEASE"], [55, 61, "DISEASE"]]}], ["Additional validation studies to assess the psychometric properties of the questionnaire have started.", {"entities": []}], ["In tropical areas, a major concern regarding snakebites treatment effectiveness relates to the failure in liquid antivenom (AV) distribution due to the lack of an adequate cold chain in remote areas.", {"entities": []}], ["To minimize this problem, freeze-drying has been suggested to improve AV stability.", {"entities": []}], ["This study compares the safety and efficacy of a freeze-dried trivalent antivenom (FDTAV) and the standard liquid AV provided by the Brazilian Ministry of Health (SLAV) to treat Bothrops , Lachesis and Crotalus snakebites.", {"entities": []}], ["This was a prospective, randomized, open, phase IIb trial, carried out from June 2005 to May 2008 in the Brazilian Amazon.", {"entities": []}], ["Primary efficacy endpoints were the suppression of clinical manifestations and return of hemostasis and renal function markers to normal ranges within the first 24 hours of follow-up.", {"entities": []}], ["Primary safety endpoint was the presence of early adverse reactions (EAR) in the first 24 hours after treatment.", {"entities": []}], ["FDTAV thermal stability was determined by estimating AV potency over one year at 56\u00b0C.", {"entities": []}], ["Of the patients recruited, 65 and 51 were assigned to FDTAV and SLAV groups, respectively.", {"entities": []}], ["Only mild EARs were reported, and they were not different between groups.", {"entities": []}], ["There were no differences in fibrinogen (p = 0.911) and clotting time (p = 0.982) recovery between FDTAV and SLAV treated groups for Bothrops snakebites.", {"entities": []}], ["For Lachesis and Crotalus snakebites, coagulation parameters and creatine phosphokinase presented normal values 24 hours after AV therapy for both antivenoms.", {"entities": []}], ["Since promising results were observed for efficacy, safety and thermal stability, our results indicate that FDTAV is suitable for a larger phase III trial.", {"entities": []}], ["ISRCTNregistry: ISRCTN12845255; DOI: 10.1186/ISRCTN12845255 ( http://www.isrctn.com/ISRCTN12845255 ).", {"entities": []}], ["Antivenoms (AV) are included in the WHO List of Essential Medicines, being the only treatment available for snakebites envenomings.", {"entities": []}], ["In Brazil, five types of liquid snake AVs are distributed by the Ministry of Health for national use free of charge to patients.", {"entities": []}], ["In remote areas, lack of an adequate cold chain impairs AV distribution to health facilities resulting in delay in patient care and, ultimately, in higher complication and case fatality rate.", {"entities": []}], ["To minimize this problem, a freeze-drying process has been suggested to improve the stability of AVs, but freeze-dried AVs efficacy and safety evidence obtained from clinical trials is still very limited.", {"entities": []}], ["Freeze-drying is a process by which water is removed from a sample without the need to apply heat.", {"entities": []}], ["Benefits of lyophilization are: a) Samples are processed in aseptic conditions; b) Process does not use heat, ensuring formulation stability; c) Increases shelf life; d) Samples can be stored at room temperature for a long time; and e) Reduces weight and volume of samples, which is ideal for distribution.", {"entities": []}], ["In this study, a freeze-dryed formulation is presented as a good alternative for a more stable trivalent antivenom in regions of the Amazon where high temperatures are common and the cold chain is poor.", {"entities": []}], ["Our results suggest that such a product is adequate for a phase III trial.", {"entities": []}], ["Lung function is an important predictor of morbidity and mortality, with accelerated lung function decline reported to have immense consequences for the world\u2019s healthcare systems.", {"entities": []}], ["The lung function decline across individual\u2019s lifetime is a consequence of age-related changes in lung anatomical structure and combination of various environmental factors; however, the exact molecular mechanisms contributing to this decline are not fully understood.", {"entities": []}], ["DNA methylation is an epigenetic modification that changes across individual\u2019s lifetime, as well as allows for interplay between environmental and genetic factors.", {"entities": []}], ["DNA methylation plays a crucial role in regulation of gene expression, with increasing evidence linking aberrant DNA methylation levels with a number of common human diseases.", {"entities": []}], ["In this study, we investigated possible associations between genome-wide DNA methylation levels and lung function in 169 pairs of middle-aged monozygotic twins (86 male pairs: mean age (min-max)\u2009=\u200966\u00a0years (57\u201379); 83 female pairs: mean age (min-max)\u2009=\u200966\u00a0years (56\u201378)).", {"entities": []}], ["The twins were collected from the Danish Twin Registry and were examined at baseline (1998\u20131999) and follow-up (2008\u20132011) visits.", {"entities": []}], ["Using the twin design, we correlated intra-pair differences in cross-sectional and longitudinal lung function with intra-pair blood DNA methylation differences at follow-up by linear regression analyses adjusted for sex, age, BMI, smoking, and blood cell composition measured for each individual with the use of flow cytometry.", {"entities": []}], ["We identified several differentially methylated CpG sites associated with forced expiratory volume the first second (FEV1) and forced vital capacity (FVC).", {"entities": []}], ["Three probes identified for level of FVC were located in GLIPR1L2 gene (lowest p value\u2009=\u20097.14\u2009\u00d7\u200910\u22128), involved in innate immunity and tumour-suppressor/pro-oncogenic mechanisms.", {"entities": [[57, 65, "GENE"]]}], ["Change in FEV1 during the 11-year follow-up period was associated with blood DNA methylation level in TRIM27 gene ( p value\u2009=\u20091.55\u2009\u00d7\u200910 adj p value\u2009=\u20090.045), the receptor for TGF\u03b2, a growth factor involved in normal lung tissue repair through pro-fibrotic effects.", {"entities": [[102, 108, "GENE"]]}], ["Our findings suggest that\u00a0epigenetic regulation of immunological- and cancer-related genes, as well as TGF-\u03b2-receptor-related genes, may be involved in the cross-sectional level and longitudinal change in lung function in middle-aged monozygotic twins.", {"entities": [[70, 76, "DISEASE"]]}], ["The online version of this article (10.1186/s13148-017-0427-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Scientists face growing pressure to move away from using traditional animal toxicity tests to determine whether manufactured chemicals are safe.", {"entities": []}], ["Numerous ethical, scientific, business, and legislative incentives will help to drive this shift.", {"entities": []}], ["However, a number of hurdles must be overcome in the coming years before non-animal methods are adopted into widespread practice, particularly from regulatory, scientific, and global perspectives.", {"entities": []}], ["Several initiatives are nevertheless underway that promise to increase the confidence in newer alternative methods, which will support the move towards a future in which less data from animal tests is required in the assessment of chemical safety.", {"entities": []}], ["Scientists face growing pressures to move away from using traditional animal toxicity tests to determine whether manufactured chemicals are safe.", {"entities": []}], ["This essay explores the incentives, hurdles, and ongoing initiatives towards a reduced reliance on such tests.", {"entities": []}], ["Secondhand smoke (SHS) exposure causes disease and death among nonsmokers.", {"entities": []}], ["With a plethora of smoke-free legislation implemented and a steady decrease in cigarette consumption noted over the past decade in the U.S., this study assessed trends in indoor SHS exposure among U.S. adolescents in grades 6\u201312 during 2000\u20132009.", {"entities": []}], ["Data were obtained from the 2000\u20132009 National Youth Tobacco Survey \u2013 a national survey of U.S. middle and high school students.", {"entities": []}], ["SHS exposure within an indoor area within the past seven days was self-reported.", {"entities": []}], ["Trends in indoor SHS exposure during 2000\u20132009 were assessed overall and by socio-demographic characteristics, using the Wald's test in a binary logistic regression.", {"entities": []}], ["Within-group comparisons were performed using chi-squared statistics ( p <0.05).", {"entities": []}], ["The proportion of U.S. middle and high school students who were exposed to indoor SHS declined from 65.5% in 2000 to 40.5% in 2009 ( p <0.05 for linear trend).", {"entities": []}], ["Significant declines were also observed across all population subgroups.", {"entities": []}], ["Between 2000 and 2009, prevalence of indoor SHS exposure declined significantly among both middle (58.5% to 34.3%) and high school (71.5% to 45.4%) students.", {"entities": []}], ["Prevalence of indoor SHS exposure was significantly higher among girls (44.0% in 2009) compared to boys (37.2% in 2009) during each survey year.", {"entities": []}], ["Similarly, prevalence of indoor SHS exposure during 2000\u20132009 was highest among non-Hispanic whites (44.2% in 2009) and lowest among non-Hispanic Asians (30.2% in 2009).", {"entities": []}], ["During each survey year, prevalence was highest among the oldest age group (\u226518 years) and lowest among the youngest (9\u201311 years).", {"entities": []}], ["Also, prevalence was significantly higher among current cigarette smokers (83.8% in 2009) compared to nonsmokers (34.0% in 2009).", {"entities": []}], ["Significant declines in indoor SHS exposure among U.S. middle and high school students occurred during 2000\u20132009.", {"entities": []}], ["While the results are encouraging, additional efforts are needed to further reduce youth indoor SHS exposure.", {"entities": []}], ["Hand, foot, and mouth disease (HFMD) affects infant and young children.", {"entities": [[16, 29, "DISEASE"]]}], ["A viral metagenomic approach was used to identify the eukaryotic viruses in fecal samples from 29 Thai children with clinical diagnosis of HFMD collected during the 2012 outbreak.", {"entities": []}], ["These children had previously tested negative by PCR for enterovirus 71 and coxsackievirus A16 and A6.", {"entities": []}], ["Deep sequencing revealed nine virus families: Picornaviridae , Astroviridae , Parvoviridae , Caliciviridae , Paramyxoviridae , Adenoviridae , Reoviridae , Picobirnaviridae , and Polyomaviridae .", {"entities": []}], ["The highest number of viral sequences belonged to human rhinovirus C, astrovirus-MLB2, and coxsackievirus A21.", {"entities": []}], ["Our study provides an overview of virus community and highlights a broad diversity of viruses found in feces from children with HFMD.", {"entities": []}], ["The exact prevalence of food allergy in the general population is unknown, but almost 12% of pediatric population refers a suspicion of food allergy.", {"entities": [[24, 36, "DISEASE"], [136, 148, "DISEASE"]]}], ["IgE mediated reactions to food are actually the best-characterized types of allergy, and they might be particularly harmful especially in children.", {"entities": []}], ["According to the \u201chygiene hypothesis\u201d low or no exposure to exogenous antigens in early life may increase the risk of allergic diseases by both delaying the development of the immune tolerance and limiting the Th2/Th1 switch.", {"entities": []}], ["The critical role of intestinal microbiota in the development of immune tolerance improved recently the interest on probiotics, prebiotics, antioxidants, polyunsaturated fatty acid, folate and vitamins, which seem to have positive effects on the immune functions.", {"entities": []}], ["Probiotics consist in bacteria or yeast, able to re-colonize and restore microflora symbiosis in intestinal tract.", {"entities": []}], ["One of the most important characteristics of probiotics is their safety for human health.", {"entities": []}], ["Thanks to their ability to adhere to intestinal epithelial cells and to modulate and stabilize the composition of gut microflora, probiotics bacteria may play an important role in the regulation of intestinal and systemic immunity.", {"entities": []}], ["They actually seem capable of restoring the intestinal microbic equilibrium and modulating the activation of immune cells.", {"entities": []}], ["Several studies have been recently conducted on the role of probiotics in preventing and/or treating allergic disorders, but the results are often quite contradictory, probably because of the heterogeneity of strains, the duration of therapy and the doses administered to patients.", {"entities": []}], ["Therefore, new studies are needed in order to clarify the functions and the utility of probiotics in food allergies and ion other types of allergic disorders.", {"entities": []}], ["Population-based studies have consistently shown that our diet has an influence on health.", {"entities": []}], ["Therefore, the aim of our study was to analyze differences between different dietary habit groups in terms of health-related variables.", {"entities": []}], ["The sample used for this cross-sectional study was taken from the Austrian Health Interview Survey AT-HIS 2006/07.", {"entities": []}], ["In a first step, subjects were matched according to their age, sex, and socioeconomic status (SES).", {"entities": []}], ["After matching, the total number of subjects included in the analysis was 1320 (N\u200a=\u200a330 for each form of diet \u2013 vegetarian, carnivorous diet rich in fruits and vegetables, carnivorous diet less rich in meat, and carnivorous diet rich in meat).", {"entities": []}], ["Analyses of variance were conducted controlling for lifestyle factors in the following domains: health (self-assessed health, impairment, number of chronic conditions, vascular risk), health care (medical treatment, vaccinations, preventive check-ups), and quality of life.", {"entities": []}], ["In addition, differences concerning the presence of 18 chronic conditions were analyzed by means of Chi-square tests.", {"entities": []}], ["Overall, 76.4% of all subjects were female.", {"entities": []}], ["40.0% of the individuals were younger than 30 years, 35.4% between 30 and 49 years, and 24.0% older than 50 years.", {"entities": []}], ["30.3% of the subjects had a low SES, 48.8% a middle one, and 20.9% had a high SES.", {"entities": []}], ["Our results revealed that a vegetarian diet is related to a lower BMI and less frequent alcohol consumption.", {"entities": []}], ["Moreover, our results showed that a vegetarian diet is associated with poorer health (higher incidences of cancer, allergies, and mental health disorders), a higher need for health care, and poorer quality of life.", {"entities": [[107, 113, "DISEASE"]]}], ["Therefore, public health programs are needed in order to reduce the health risk due to nutritional factors.", {"entities": []}], ["Gastrointestinal symptoms are common in children with autism spectrum disorder (ASD).", {"entities": [[54, 78, "DISEASE"]]}], ["A significant proportion of children with ASD and gastrointestinal symptoms have histologic evidence of ileocolitis (inflammation of the terminal ileum and/or colon).", {"entities": []}], ["We previously reported the molecular characterization of gastrointestinal biopsy tissue from ASD children with ileocolitis (ASD", {"entities": []}], ["Mesenchymal stem cells (MSCs) have been investigated in the treatment of numerous autoimmune diseases.", {"entities": []}], ["However, the immune properties of MSCs on the development of asthma have remained to be fully elucidated.", {"entities": [[61, 67, "DISEASE"]]}], ["Airway dendritic cells (DCs) have an important role in the pathogenesis of allergic asthma, and disrupting their function may be a novel therapeutic approach.", {"entities": [[75, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["The present study used a mouse model of asthma to demonstrate that transplantation of MSCs suppressed features of asthma by targeting the function of lung myeloid DCs.", {"entities": [[40, 46, "DISEASE"], [114, 120, "DISEASE"]]}], ["MSCs suppressed the maturation and migration of lung DCs to the mediastinal lymph nodes, and thereby reducing the allergen-specific T helper type 2 (Th2) response in the nodes.", {"entities": []}], ["In addition, MSC-treated DCs were less potent in activating naive and effector Th2 cells and the capacity of producing chemokine (C-C motif) ligand 17 (CCL17) and CCL22, which are chemokines attracting Th2 cells, to the airways was reduced.", {"entities": [[152, 157, "GENE"], [163, 168, "GENE"]]}], ["These results supported that MSCs may be used as a potential treatment for asthma.", {"entities": [[75, 81, "DISEASE"]]}], ["Nonadherence to inhalation therapy is very common in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[67, 104, "DISEASE"]]}], ["Few data are available to support the role of community pharmacists in optimizing inhalation therapy in COPD patients.", {"entities": []}], ["Since 2007, the Kitano Hospital and the Kita-ku Pharmaceutical Association have provided a network system for delivering correct inhalation techniques through certified community pharmacists.", {"entities": []}], ["The effects of this network system on clinical outcomes in COPD patients were examined.", {"entities": []}], ["A total of 88 consecutive outpatients with COPD at baseline and 82 of those 4 years later were recruited from the respiratory clinic of Kitano Hospital Medical Research Institute.", {"entities": []}], ["Measurements included the frequency of COPD exacerbations, patients\u2019 adherence to inhalation therapy using a five-point Likert scale questionnaire, and patients\u2019 health status both prior to this system and 4 years later.", {"entities": []}], ["Usable information was obtained from 55 patients with COPD at baseline, and from 51 patients 4 years later.", {"entities": []}], ["Compared with baseline values, a significant decrease was observed in the frequency of COPD exacerbations (1.5 \u00b1 1.6 versus 0.8 \u00b1 1.4 times/year, P = 0.017).", {"entities": []}], ["Adherence to the inhalation regimen increased significantly (4.1 \u00b1 0.7 versus 4.4 \u00b1 0.8, P = 0.024), but health status was unchanged.", {"entities": []}], ["At 4 years, of 51 COPD patients, 39 (76%) patients who visited the certified pharmacies showed significantly higher medication adherence than those who did not (4.6 \u00b1 0.6 versus 3.9 \u00b1 1.0, P = 0.022).", {"entities": []}], ["The network system may improve COPD control and adherence to inhalation regimens.", {"entities": []}], ["Objectives .", {"entities": []}], ["To review surgical techniques used in the treatment of laryngoceles over the last two decades and point out developments and trends.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["PubMed, the Cochrane Library, and the JBI Library of Systematic Reviews were searched using the term \u201claryngocele.\u201d Demographic data, type of laryngocele, presence of a laryngopyocele, type of treatment and need for a tracheotomy were assessed.", {"entities": []}], ["Overall, data on 86 patients were analyzed, culled from 50 articles, of which 41 were case reports and 9 were case series.", {"entities": []}], ["No single systematic review or meta-analysis or randomized controlled trial has been published on the topic.", {"entities": []}], ["Altogether, 71 laryngoceles in 63 patients met the criteria for further analysis focusing on surgical treatment.", {"entities": []}], ["An external approach was selected in 25/29 (86.2%) cases of combined laryngoceles.", {"entities": []}], ["Microlaryngoscopic resection using a CO 2 laser was performed in three cases and endoscopic robotic surgery in one case.", {"entities": []}], ["The majority of patients with an internal laryngocele, 31/42 (73.8%), were treated using the microlaryngoscopy approach.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Microlaryngoscopy involving the use of a CO 2 laser has become the main therapeutic procedure for the treatment of internal laryngoceles during the past 20 years.", {"entities": []}], ["An external approach still remains the main therapeutic approach for the treatment of combined laryngoceles.", {"entities": []}], ["Gliadins are the major components of storage proteins in wheat grains, and they play an essential role in the dough extensibility and nutritional quality of flour.", {"entities": []}], ["Because of the large number of the gliadin family members, the high level of sequence identity, and the lack of abundant genomic data for Triticum species, identifying the full complement of gliadin family genes in hexaploid wheat remains challenging.", {"entities": []}], ["Triticum urartu is a wild diploid wheat species and considered the A-genome donor of polyploid wheat species.", {"entities": []}], ["The accession PI428198 (G1812) was chosen to determine the complete composition of the gliadin gene families in the wheat A-genome using the available draft genome.", {"entities": []}], ["Using a PCR-based cloning strategy for genomic DNA and mRNA as well as a bioinformatics analysis of genomic sequence data, 28 gliadin genes were characterized.", {"entities": []}], ["Of these genes, 23 were \u03b1-gliadin genes, three were \u03b3-gliadin genes and two were \u03c9-gliadin genes.", {"entities": []}], ["An RNA sequencing (RNA-Seq) survey of the dynamic expression patterns of gliadin genes revealed that their synthesis in immature grains began prior to 10 days post-anthesis (DPA), peaked at 15 DPA and gradually decreased at 20 DPA.", {"entities": []}], ["The accumulation of proteins encoded by 16 of the expressed gliadin genes was further verified and quantified using proteomic methods.", {"entities": []}], ["The phylogenetic analysis demonstrated that the homologs of these \u03b1-gliadin genes were present in tetraploid and hexaploid wheat, which was consistent with T .", {"entities": []}], ["urartu being the A-genome progenitor species.", {"entities": []}], ["This study presents a systematic investigation of the gliadin gene families in T .", {"entities": []}], ["urartu that spans the genome, transcriptome and proteome, and it provides new information to better understand the molecular structure, expression profiles and evolution of the gliadin genes in T .", {"entities": []}], ["urartu and common wheat.", {"entities": []}], ["Adenosine deaminase (ADA) is a purine catabolic enzyme that manages levels of the biologically active purines adenosine and 2\u2032-deoxyadenosine in tissues and cells.", {"entities": [[21, 24, "GENE"]]}], ["ADA-deficient mice die at 3 wk of age from severe respiratory distress.", {"entities": []}], ["This phenotype is progressive and is linked to perturbations in pulmonary purine metabolism.", {"entities": []}], ["The inflammatory changes found in the lungs of ADA-deficient mice included an accumulation of activated alveolar macrophages and eosinophils.", {"entities": []}], ["These changes were accompanied by a pronounced enlargement of alveolar spaces and increases in mucus production in the bronchial airways.", {"entities": []}], ["The alveolar enlargement was found to be due in part to abnormal alveogenesis.", {"entities": []}], ["Lowering adenosine and 2\u2032-deoxyadenosine levels using ADA enzyme therapy decreased the pulmonary eosinophilia and resolved many of the lung histopathologies.", {"entities": [[97, 109, "DISEASE"], [87, 109, "DISEASE"], [54, 57, "GENE"]]}], ["In addition, genetically restoring ADA to the forestomach of otherwise ADA-deficient mice prevented adenine metabolic disturbances as well as lung inflammation and damage.", {"entities": [[35, 38, "GENE"], [71, 74, "GENE"]]}], ["These data suggest that disturbances in purinergic signaling mediate the lung inflammation and damage seen in ADA-deficient mice.", {"entities": []}], ["Radon therapy using radon (", {"entities": []}], ["The use of swine in biomedical research has increased dramatically in the last decade.", {"entities": []}], ["Diverse genomic- and proteomic databases have been developed to facilitate research using human and rodent models.", {"entities": []}], ["Current porcine gene databases, however, lack the robust annotation to study pig models that are relevant to human studies and for comparative evaluation with rodent models.", {"entities": []}], ["Furthermore, they contain a significant number of errors due to their primary reliance on machine-based annotation.", {"entities": []}], ["To address these deficiencies, a comprehensive literature-based survey was conducted to identify certain selected genes that have demonstrated function in humans, mice or pigs.", {"entities": []}], ["The process identified 13,054 candidate human, bovine, mouse or rat genes/proteins used to select potential porcine homologs by searching multiple online sources of porcine gene information.", {"entities": []}], ["The data in the Porcine Translational Research Database (( http://www.ars.usda.gov/Services/docs.htm?docid=6065 ) is supported by >5800 references, and contains 65 data fields for each entry, including >9700 full length (5\u2032 and 3\u2032) unambiguous pig sequences, >2400 real time PCR assays and reactivity information on >1700 antibodies.", {"entities": []}], ["It also contains gene and/or protein expression data for >2200 genes and identifies and corrects 8187 errors (gene duplications artifacts, mis-assemblies, mis-annotations, and incorrect species assignments) for 5337 porcine genes.", {"entities": []}], ["This database is the largest manually curated database for any single veterinary species and is unique among porcine gene databases in regard to linking gene expression to gene function, identifying related gene pathways, and connecting data with other porcine gene databases.", {"entities": []}], ["This database provides the first comprehensive description of three major Super-families or functionally related groups of proteins (Cluster of Differentiation (CD) Marker genes, Solute Carrier Superfamily, ATP binding Cassette Superfamily), and a comparative description of porcine microRNAs.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-017-4009-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To explore evidence on the links between patient experience and clinical safety and effectiveness outcomes.", {"entities": []}], ["Systematic review.", {"entities": []}], ["A wide range of settings within primary and secondary care including hospitals and primary care centres.", {"entities": []}], ["A wide range of demographic groups and age groups.", {"entities": []}], ["A broad range of patient safety and clinical effectiveness outcomes including mortality, physical symptoms, length of stay and adherence to treatment.", {"entities": []}], ["This study, summarising evidence from 55 studies, indicates consistent positive associations between patient experience, patient safety and clinical effectiveness for a wide range of disease areas, settings, outcome measures and study designs.", {"entities": []}], ["It demonstrates positive associations between patient experience and self-rated and objectively measured health outcomes; adherence to recommended clinical practice and medication; preventive care (such as health-promoting behaviour, use of screening services and immunisation); and resource use (such as hospitalisation, length of stay and primary-care visits).", {"entities": []}], ["There is some evidence of positive associations between patient experience and measures of the technical quality of care and adverse events.", {"entities": []}], ["Overall, it was more common to find positive associations between patient experience and patient safety and clinical effectiveness than no associations.", {"entities": []}], ["The data presented display that patient experience is positively associated with clinical effectiveness and patient safety, and support the case for the inclusion of patient experience as one of the central pillars of quality in healthcare.", {"entities": []}], ["It supports the argument that the three dimensions of quality should be looked at as a group and not in isolation.", {"entities": []}], ["Clinicians should resist sidelining patient experience as too subjective or mood-oriented, divorced from the \u2018real\u2019 clinical work of measuring safety and effectiveness.", {"entities": []}], ["To characterize the 90-day risk of hospitalization with pneumonia among patients treated with different anti-hypertensive drug classes.", {"entities": [[56, 65, "DISEASE"]]}], ["Population based cohort study using five linked databases.", {"entities": []}], ["Individuals over the age of 65 who filled a new outpatient prescription for one of four anti-hypertensive medications: ACE inhibitors (n\u200a=\u200a86 775), ARBs (n\u200a=\u200a33 953), calcium channel blockers (CCB, n\u200a=\u200a34 240), beta blockers (BB, n\u200a=\u200a35 331) and thiazide diuretics (n\u200a=\u200a64 186).", {"entities": []}], ["Hospitalization with pneumonia within 90 days of a qualifying prescription.", {"entities": [[21, 30, "DISEASE"]]}], ["We adjusted for ten a priori selected covariates, including age, sex, diabetes and number of visits to a family doctor.", {"entities": []}], ["Baseline characteristics of the groups were relatively well matched, except for age, sex, diabetes and frequency of family doctor visits.", {"entities": []}], ["128 of the 86 775 patients (0.15%) initiated on an ACE inhibitor and 43 of the 33953 patients (0.13%) of patients initiated on an ARB were hospitalized with pneumonia in the subsequent 90 days.", {"entities": [[157, 166, "DISEASE"]]}], ["135 of 64 186 patients (0.21%) initiated on a thiazide, 112 of 35 331 patients (.32%) initiated on a BB, and 89 of 34 240 (0.26%) patients initiated on a CCB achieved the primary outcome.", {"entities": []}], ["Compared to calcium channel blockers, ACE inhibitors (adjusted OR 0.61, 95% CI 0.46 to 0.81) and ARBs (adjusted OR 0.52, 95% CI 0.36 to 0.76) were associated with a lower risk of pneumonia.", {"entities": [[179, 188, "DISEASE"]]}], ["No benefit was seen with thiazides (adjusted OR 0.87, 95% CI 0.66 to 1.14) or beta blockers (adjusted OR 1.21, 95% CI 0.91 to 1.60).", {"entities": []}], ["Initiating medications that block the renin angiotensin system, compared to other anti-hypertensive medications, is associated with a small absolute reduction in the 90 day risk of hospitalization with pneumonia.", {"entities": [[202, 211, "DISEASE"]]}], ["This paper reports a study undertaken in three remote communities (Mahaboboka, Amboronabo, Mikoboka), located in Sakaraha, Southwestern Madagascar.", {"entities": []}], ["Not only villages are far away from sanitary infrastructures and doctors but drugs and consulting fees are unaffordable to villagers.", {"entities": []}], ["They rely essentially on natural resources for health care as for most of rural areas in Madagascar.", {"entities": []}], ["This paper aims to document medicinal plants used by communities in Sakaraha and to present the most important plant species used in traditional medicine.", {"entities": []}], ["Semi \u2013 structured interview was conducted within 214 informants in 34 villages of the study area.", {"entities": []}], ["Different ailments encountered in the site study were classified in various categories.", {"entities": []}], ["For data analysis, frequency of citation (Fq), Informant Consensus Factor (Fic), Fidelity Level (FL) and Use Value (UV) were assessed to find agreement among informants about the use of plants as remedies.", {"entities": []}], ["Mann-Whitney, Kruskall-Wallis and Spearman correlation tests were performed to determine use of medicinal plants following social status of informants.", {"entities": []}], ["A total of 235 medicinal plant species belonging to 198 genera and 75 families were inventoried.", {"entities": []}], ["The richest families in species used for medicinal purposes were: Fabaceae, Apocynaceae, Rubiaceae, Euphorbiaceae, Asteraceae, and Poaceae.", {"entities": []}], ["Plant species cited by informants were used to treat 76 various ailments classified in 13 categories.", {"entities": []}], ["Leaves and leafy twigs were the most used plant parts and decoction was the mostly cited way of preparation of these medicinal plants species.", {"entities": []}], ["In average, local people cited 6.7\u2009\u00b1\u20096.03 medicinal taxa among them, Cedrelopsis grevei is the most cited medicinal plants (Fq.", {"entities": []}], ["With Cedrelopsis grevei (UV\u2009=\u20090.48), Henonia scoparia (UV\u2009=\u20090.43) are mostly used species.", {"entities": []}], ["Leonotis nepetifolia (FL\u2009=\u200996%) and Strychnos henningsii (FL\u2009=\u200992%) are plant species claimed by high percentage of informants to treat the Digestive System Disorder.", {"entities": []}], ["This study highlighted that medicinal plants used by people from three communities in the Southwestern Madagascar are diverse.", {"entities": []}], ["These plants species ensure care to all family members including babies, children, mothers and adult people.", {"entities": []}], ["Through this study, newly reported medicinal plants were identified for further work.", {"entities": []}], ["The online version of this article (doi:10.1186/s13002-017-0147-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To estimate the prevalences of tobacco use, tobacco experimentation, and frequent smoking among Brazilian adolescents.", {"entities": []}], ["We evaluated participants of the cross-sectional, nation-wide, school-based Study of Cardiovascular Risks in Adolescents (ERICA), which included 12- to 17-year-old adolescents from municipalities of over 100 thousand inhabitants.", {"entities": []}], ["The study sample had a clustered, stratified design and was representative of the whole country, its geographical regions, and all 27 state capitals.", {"entities": []}], ["The information was obtained with self-administered questionnaires.", {"entities": []}], ["Tobacco experimentation was defined as having tried cigarettes at least once in life.", {"entities": []}], ["Adolescents who had smoked on at least one day over the previous 30 days were considered current cigarette smokers.", {"entities": []}], ["Having smoked cigarettes for at least seven consecutive days was an indicator for regular consumption of tobacco.", {"entities": []}], ["Considering the complex sampling design, prevalences and 95% confidence intervals were estimated according to sociodemographic and socio-environmental characteristics.", {"entities": []}], ["We evaluated 74,589 adolescents.", {"entities": []}], ["Among these, 18.5% (95%CI 17.7-19.4) had smoked at least once in life, 5.7% (95%CI 5.3-6.2) smoked at the time of the research, and 2.5% (95%CI 2.2-2.8) smoked often.", {"entities": []}], ["Adolescents aged 15 to 17 years had higher prevalences for all indicators than those aged 12 to 14 years.", {"entities": []}], ["The prevalences did not differ significantly between sexes.", {"entities": []}], ["The highest prevalences were found in the South region and the lowest ones, in the Northeast region.", {"entities": []}], ["Regardless of sex, the prevalences were found to be higher for adolescents who had had paid jobs, who lived with only one parent, and who reported having been in contact with smokers either inside or outside their homes.", {"entities": []}], ["Female public school adolescents were found to smoke more than the ones from private schools.", {"entities": []}], ["Tobacco use among adolescents is still a challenge.", {"entities": []}], ["Intending to reduce the prevalence of tobacco use among young people, especially the ones under socioeconomic vulnerability conditions, Brazil must consolidate and increase effective public health care measures.", {"entities": []}], ["Estimar as preval\u00eancias de tabagismo, experimenta\u00e7\u00e3o e fumo frequente em adolescentes brasileiros.", {"entities": []}], ["Foram avaliados os participantes do Estudo de Riscos Cardiovasculares em Adolescentes (ERICA), estudo transversal de base escolar e abrang\u00eancia nacional.", {"entities": []}], ["Participaram adolescentes de 12 a 17 anos de munic\u00edpios com mais de 100 mil habitantes.", {"entities": []}], ["A amostra foi estratificada e conglomerada e tem representatividade nacional, regional e para as 27 capitais.", {"entities": []}], ["As informa\u00e7\u00f5es foram obtidas usando-se question\u00e1rio autopreench\u00edvel.", {"entities": []}], ["Experimenta\u00e7\u00e3o foi definida como: ter experimentado cigarros alguma vez na vida.", {"entities": []}], ["Foram considerados fumantes atuais de cigarros aqueles que fumaram pelo menos um dia nos \u00faltimos 30 dias.", {"entities": [[67, 71, "GENE"]]}], ["Utilizou-se como indicador de uso frequente de tabaco ter fumado cigarros por pelo menos sete dias seguidos.", {"entities": [[74, 77, "GENE"], [78, 82, "GENE"]]}], ["Considerando-se o desenho complexo da amostra, preval\u00eancias e intervalos de confian\u00e7a de 95% foram estimados segundo caracter\u00edsticas sociodemogr\u00e1ficas e socioambientais.", {"entities": []}], ["Foram avaliados 74.589 adolescentes; dentre esses, 18,5% (IC95% 17,7-19,4) fumaram pelo menos uma vez na vida, 5,7% (IC95% 5,3-6,2) fumavam no momento da pesquisa e 2,5% (IC95% 2,2-2,8) fumavam com frequ\u00eancia.", {"entities": [[83, 87, "GENE"]]}], ["Adolescentes de 15 a 17 anos tiveram preval\u00eancias mais elevadas de todos os indicadores comparados aos de 12 a 14 anos.", {"entities": []}], ["As preval\u00eancias n\u00e3o apresentaram diferen\u00e7as significativas entre sexos.", {"entities": []}], ["Maiores preval\u00eancias foram observadas na regi\u00e3o Sul e menores na regi\u00e3o Nordeste.", {"entities": []}], ["Independentemente de sexo, as preval\u00eancias foram maiores para adolescentes que tinham tido trabalho remunerado, nos que n\u00e3o moravam com os dois pais e que referiram ter tido contato com fumante em casa ou fora.", {"entities": []}], ["Adolescentes do sexo feminino de escolas p\u00fablicas fumavam mais do que as de escolas privadas.", {"entities": []}], ["O tabagismo entre adolescentes ainda \u00e9 um desafio.", {"entities": []}], ["Visando a redu\u00e7\u00e3o da preval\u00eancia de tabagismo entre jovens, em especial os que se encontram em situa\u00e7\u00e3o de vulnerabilidade socioecon\u00f4mica, o Brasil deve consolidar e ampliar medidas de sa\u00fade p\u00fablica efetivas.", {"entities": []}], ["The disease burden due to heat-stress illness (HSI), which can result in significant morbidity and mortality, is expected to increase as the climate continues to warm.", {"entities": []}], ["In the United States (U.S.) much of what is known about HSI epidemiology is from analyses of urban heat waves.", {"entities": []}], ["There is limited research addressing whether HSI hospitalization risk varies between urban and rural areas, nor is much known about additional diagnoses of patients hospitalized for HSI.", {"entities": []}], ["Hospitalizations in Illinois for HSI (ICD-9-CM codes 992.x or E900) in the months of May through September from 1987 to 2014 ( n \u2009=\u20098667) were examined.", {"entities": []}], ["Age-adjusted mean monthly hospitalization rates were calculated for each county using U.S. Census population data.", {"entities": []}], ["Counties were categorized into five urban-rural strata using Rural Urban Continuum Codes (RUCC) (RUCC1, most urbanized to RUCC5, thinly populated).", {"entities": []}], ["Average maximum monthly temperature (\u00b0C) was calculated for each county using daily data.", {"entities": []}], ["Multi-level linear regression models were used, with county as the fixed effect and temperature as random effect, to model monthly hospitalization rates, adjusting for the percent of county population below the poverty line, percent of population that is Non-Hispanic Black, and percent of the population that is Hispanic.", {"entities": []}], ["All analyses were stratified by county RUCC.", {"entities": []}], ["Additional diagnoses of patients hospitalized for HSI and charges for hospitalization were summarized.", {"entities": []}], ["Highest rates of HSI hospitalizations were seen in the most rural, thinly populated stratum (mean annual summer hospitalization rate of 1.16 hospitalizations per 100,000 population in the thinly populated strata vs. 0.45 per 100,000 in the metropolitan urban strata).", {"entities": []}], ["A one-degree Celsius increase in maximum monthly average temperature was associated with a 0.34 increase in HSI hospitalization rate per 100,000 population in the thinly populated counties compared with 0.02 per 100,000 in highly urbanized counties.", {"entities": []}], ["The most common additional diagnoses of patients hospitalized with HSI were dehydration, electrolyte abnormalities, and acute renal disorders.", {"entities": []}], ["Total and mean hospital charges for HSI cases were $167.7 million and $20,500 (in 2014 US dollars).", {"entities": []}], ["Elevated temperatures appear to have different impacts on HSI hospitalization rates as function of urbanization.", {"entities": []}], ["The most rural and the most urbanized counties of Illinois had the largest increases in monthly hospitalization rates for HSI per unit increase in the average monthly maximum temperature.", {"entities": []}], ["This suggests that vulnerability of communities to heat is complex and strategies to reduce HSI may need to be tailored to the degree of urbanization of a county.", {"entities": []}], ["The association between disease markers and health status (HS) overtime is unclear.", {"entities": []}], ["The aim of this study was to verify the predictors of HS at baseline and after three years in Chronic Obstructive Pulmonary Disease (COPD) patients.", {"entities": []}], ["Ninety-five consecutive COPD patients (66% male, age = 67 \u00b1 9 y, FEV 1 = 58 \u00b1 23%) underwent the following evaluations at baseline and after three years: body composition, pulse oximetry (SpO 2 ), six-minute walk distance (6MWD), Modified edical Research Council dyspnea scale (MMRC) and Saint George's Respiratory Questionnaire (SGRQ).", {"entities": [[65, 68, "GENE"]]}], ["The Charlson comorbidity index and BODE index were calculated.", {"entities": []}], ["COPD exacerbations during the follow-up were evaluated.", {"entities": []}], ["At baseline, age, gender, smoking, SpO 2 , BODE index or its components (BMI, MMRC, FEV 1 and 6MWD), and Charlson index were included in a multiple linear regression analysis with the baseline SGRQ total score as the dependent variable.", {"entities": [[84, 87, "GENE"]]}], ["After three years, we included the final values of the variables plus the number of exacerbations and the final SGRQ total score as the dependent variable.", {"entities": []}], ["SGRQ total score (42 \u00b1 19% vs 44 \u00b1 19%; p = 0.041) and activity domain (52 \u00b1 21% vs 60 \u00b1 22%; p < 0.001) deteriorated during follow-up.", {"entities": []}], ["At baseline, BODE index was selected as a predictor of SGRQ total score (R 1 and number of exacerbations were selected as predictors of SGRQ total score (R HS deteriorated significantly over the three-year period and the predictors of HS do not change over time.", {"entities": []}], ["BODE index and dyspnea were predictors at baseline and after three years.", {"entities": []}], ["Exacerbation was also a predictor of HS after three years.", {"entities": []}], ["ClinicalTrials.gov: NCT00605540", {"entities": []}], ["Immunoglobulin G (IgG) Fc N-glycosylation affects antibody-mediated effector functions and varies with inflammation rooted in both communicable and non-communicable diseases.", {"entities": []}], ["Worldwide, communicable and non-communicable diseases tend to segregate geographically.", {"entities": []}], ["Therefore, we studied whether IgG Fc N-glycosylation varies in populations with different environmental exposures in different parts of the world.", {"entities": []}], ["IgG Fc N-glycosylation was analysed in serum/plasma of 700 school-age children from different communities of Gabon, Ghana, Ecuador, the Netherlands and Germany.", {"entities": []}], ["IgG1 galactosylation levels were generally higher in more affluent countries and in more urban communities.", {"entities": []}], ["High IgG1 galactosylation levels correlated with low total IgE levels, low C-reactive protein levels and low prevalence of parasitic infections.", {"entities": []}], ["Linear mixed modelling showed that only positivity for parasitic infections was a significant predictor of reduced IgG1 galactosylation levels.", {"entities": []}], ["That IgG1 galactosylation is a predictor of immune activation is supported by the observation that asthmatic children seemed to have reduced IgG1 galactosylation levels as well.", {"entities": []}], ["This indicates that IgG1 galactosylation levels could be used as a biomarker for immune activation of populations, providing a valuable tool for studies examining the epidemiological transition from communicable to non-communicable diseases.", {"entities": []}], ["There is an increasing concern about sick building syndrome (SBS), especially in Asia.", {"entities": [[51, 59, "DISEASE"], [37, 59, "DISEASE"]]}], ["The aim of this study is to investigate associations between SBS and the home, school environment and personal factors among Japanese junior high school students.", {"entities": []}], ["We investigated students in four junior high schools in Hyogo in Kansai area, Japan.", {"entities": []}], ["A questionnaire study was performed among students (n=1056), 12-15 years old.", {"entities": []}], ["Temperature and relative air humidity was measured in the classrooms and dust was collected from the classroom floors and air and was analysed for cat and dog allergens.", {"entities": []}], ["Associations were analysed by multi-level logistic regression.", {"entities": []}], ["Mucosal symptoms (45.4%), general symptoms (38.9%) and skin symptoms (22.6%) were common.", {"entities": []}], ["Totally 8.8% reported cat allergy, 6.1% dog allergy, 6.0% mold allergy and 25.7% pollen allergy.", {"entities": []}], ["Atopy, window pane condensation, floor dampness and odor at home and high relative air humidity in the classrooms were associated with SBS.", {"entities": []}], ["The prevalence of SBS symptoms was high and associated with both home and school environment.", {"entities": []}], ["Window pane condensation and floor dampness at home can increase the risk for SBS symptoms in students.", {"entities": []}], ["Moreover high relative air humidity at school may increase the risk for SBS.", {"entities": []}], ["Ethnomedicinal knowledge of the Indian Himalayas is very interesting because of the wide range of medicinal plants used in traditional medical practice.", {"entities": []}], ["However, there is a danger of knowledge being lost because the knowledge sharing is very limited and passed on orally.", {"entities": []}], ["The present study is the first ethnomedicinal study in Jakholi area of Rudraprayag district of Northwestern India.", {"entities": []}], ["The aim of present study was to identify traditional medicinal plants used by the inhabitants to treat different ailments and document the associated knowledge of these medicinal plants.", {"entities": []}], ["An ethnomedicinal survey was carried out in 72 of 133 villages and alpine pastures of Jakholi block (800\u20134000\u00a0m asl).", {"entities": [[112, 115, "GENE"]]}], ["Door to door surveys and group discussions, applying semi-structured questionnaires were conducted with traditional healers and villagers in local language (Garhwali).", {"entities": []}], ["Informant Consensus Factor (ICF) was computed to analyse collected ethnomedicinal data.", {"entities": []}], ["A total of 78 species (Gymnosperms 3 species, Monocotyledons 12 and 63 Dicotyledons) belonging to 73 genera in 46 families were identified to treat 14 different ailments categories.", {"entities": []}], ["Most dominant family is Asteraceae (5 species).", {"entities": []}], ["In disease treated categories, Diseases of the skin (DE) have the highest proportion (29.55%) followed by Gastro- intestinal disorder (GA) (25.89%).", {"entities": []}], ["The most life form of plants used was herb (56%) followed by tree (23%) while root was the most frequently used part of the plants and the traditional preparation was mainly applied in the form of paste (37%).", {"entities": []}], ["The highest ICF value (0.99) was found for hair ailments (HA) followed ophthalmologic complaints (OP) and mental afflictions (MA) (0.98).", {"entities": []}], ["The present study provides valuable information about traditional knowledge of medicinal plants of Jakholi Block in the Northwestern Himalaya, India.", {"entities": []}], ["Local communities still possess large traditional knowledge of plants and their therapeutic uses and that the link of that traditional knowledge to modern research could be of importance for the isolation of new phytotherapeutic compounds leading to the development of novel therapeutic active agents.", {"entities": []}], ["Some of the ethnomedicinal plants are facing high threats and are becoming rare, and conservation initiatives are needed to conserve them for sustainable management in the region.", {"entities": []}], ["The diagnosis of smear-negative or sputum-scarce tuberculosis (TB) is problematic as culture takes several weeks and representative biological samples are difficult to obtain.", {"entities": [[49, 61, "DISEASE"]]}], ["RD-1 antigen-specific interferon-\u03b3 release assays (IGRAs) are sensitive and specific blood-based tests for the diagnosis of M. tuberculosis infection.", {"entities": [[127, 139, "DISEASE"]]}], ["The feasibility and diagnostic utility of this rapid immunodiagnostic assay, using cells from induced sputum, is unknown.", {"entities": []}], ["Cells isolated from induced sputum were co-cultured with ESAT-6 and CFP-10 antigens using a standardized enzyme-linked immunospot (ELISPOT) assay (T-SPOT\u00ae.", {"entities": []}], ["TB ) in 101 consecutively recruited TB suspects or non-TB controls.", {"entities": []}], ["An optimization phase using 28 samples was followed by a validation phase using samples from 73 participants (20 with definite or probable TB, and 48 with non-TB).", {"entities": []}], ["Despite optimization of sputum processing 65/73 (89%) of the IGRAs in the validation phase were inconclusive.", {"entities": []}], ["44/73 (60%) tests failed due to sputum induction-related factors [sputum induction-related adverse events (n\u200a=\u200a5), inadequate sputum volume (n\u200a=\u200a8), non-homogenisable sputum (n\u200a=\u200a7), and insufficient numbers of cells to perform the assay (n\u200a=\u200a24)], whilst 20/73 (27%) tests failed due T-SPOT\u00ae.", {"entities": []}], ["TB assay-related factors [excessive debris precluding reading of spots in the ELISPOT well (n\u200a=\u200a6), failure of the positive control (n\u200a=\u200a11), or high spot count in the negative control (n\u200a=\u200a3)].", {"entities": []}], ["Only 8/73 (11%) of the available samples could therefore be correctly categorized (7 definite or probable TB, and 1 non-TB patient).", {"entities": []}], ["Thus, 13/20 (65%) of the definite or probable TB cases remained undiagnosed.", {"entities": []}], ["Rapid immunodiagnosis of pulmonary TB by antigen-specific IFN-\u03b3 ELISPOT responses, using cells from induced sputum, is possible.", {"entities": []}], ["However, the test, in its current ELISPOT format, is not clinically useful because the majority of the assays are inconclusive.", {"entities": []}], ["Objective To investigate whether there is an increased risk of cardiovascular events in people who exhibit iatrogenic Cushing\u2019s syndrome during treatment with glucocorticoids.", {"entities": [[128, 136, "DISEASE"]]}], ["Design Cohort study.", {"entities": []}], ["Setting 424 UK general practices contributing to The Health Improvement Network database.", {"entities": []}], ["Participants People prescribed systemic glucocorticoids and with a diagnosis of iatrogenic Cushing\u2019s syndrome (n=547) and two comparison groups: those prescribed glucocorticoids and with no diagnosis of iatrogenic Cushing\u2019s syndrome (n=3231) and those not prescribed systemic glucocorticoids (n=3282).", {"entities": [[101, 109, "DISEASE"], [224, 232, "DISEASE"]]}], ["Main outcome measures Incidence of cardiovascular events within a year after diagnosis of iatrogenic Cushing\u2019s syndrome or after a randomly selected date, and association between iatrogenic Cushing\u2019s syndrome and risk of cardiovascular events.", {"entities": [[111, 119, "DISEASE"], [200, 208, "DISEASE"]]}], ["Results 417 cardiovascular events occurred in 341 patients.", {"entities": []}], ["Taking into account only the first event by patient (coronary heart disease n=177, heart failure n=101, ischaemic stroke n=63), the incidence rates of cardiovascular events per 100 person years at risk were 15.1 (95% confidence interval 11.8 to 18.4) in those prescribed glucocorticoids and with a diagnosis of iatrogenic Cushing\u2019s syndrome, 6.4 (5.5 to 7.3) in those prescribed glucocorticoids without a diagnosis of iatrogenic Cushing\u2019s syndrome, and 4.1 (3.4 to 4.8) in those not prescribed glucocorticoids.", {"entities": [[62, 75, "DISEASE"], [53, 75, "DISEASE"], [332, 340, "DISEASE"], [439, 447, "DISEASE"]]}], ["In multivariate analyses adjusted for sex, age, intensity of glucocorticoid use, underlying disease, smoking status, and use of aspirin, diabetes drugs, antihypertensive drugs, lipid lowering drugs, or oral anticoagulant drugs, the relation between iatrogenic Cushing\u2019s syndrome and cardiovascular events was strong (adjusted hazard ratios 2.27 (95% confidence interval 1.48 to 3.47) for coronary heart disease, 3.77 (2.41 to 5.90) for heart failure, and 2.23 (0.96 to 5.17) for ischaemic cerebrovascular events).", {"entities": [[397, 410, "DISEASE"], [388, 410, "DISEASE"], [270, 278, "DISEASE"]]}], ["The adjusted hazard ratio for any cardiovascular event was 4.16 (2.98 to 5.82) when the group prescribed glucocorticoids and with iatrogenic Cushing\u2019s syndrome was compared with the group not prescribed glucocorticoids.", {"entities": [[151, 159, "DISEASE"]]}], ["Conclusion People who use glucocorticoids and exhibit iatrogenic Cushing\u2019s syndrome should be aggressively targeted for early screening and management of cardiovascular risk factors.", {"entities": [[75, 83, "DISEASE"]]}], ["We summarize all original research in the field of respirology and critical care published in 2003 and 2004 in Critical Care .", {"entities": []}], ["Articles were grouped into the following categories to facilitate a rapid overview: pathophysiology, therapeutic approaches, and outcome in acute lung injury and acute respiratory distress syndrome; hypoxic pulmonary arterial hypertension; mechanical ventilation; liberation from mechanical ventilation and tracheostomy; ventilator-associated pneumonia; multidrug-resistant infections; pleural effusion; sedation and analgesia; asthma; and techniques and monitoring.", {"entities": [[226, 238, "DISEASE"], [343, 352, "DISEASE"], [189, 197, "DISEASE"], [428, 434, "DISEASE"]]}], ["Beta-blockers are commonly prescribed for patients with cardiovascular disease.", {"entities": []}], ["Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective studies have shown that cardio-selective beta-blockers are safe in COPD and possibly beneficial.", {"entities": [[37, 74, "DISEASE"]]}], ["However, these benefits may reflect symptom improvements due to the cardiac effects of the medication.", {"entities": []}], ["The purpose of this study is to evaluate associations between beta-blocker use and both exacerbation rates and longitudinal measures of lung function in two well-characterized COPD cohorts.", {"entities": []}], ["We retrospectively analyzed 1219 participants with over 180\u00a0days of follow up from the STATCOPE trial, which excluded most cardiac comorbidities, and from the placebo arm of the MACRO trial.", {"entities": []}], ["Primary endpoints were exacerbation rates per person-year and change in spirometry over time in association with beta blocker use.", {"entities": []}], ["Overall 13.9% (170/1219) of participants reported taking beta-blockers at enrollment.", {"entities": []}], ["We found no statistically significant differences in exacerbation rates with respect to beta-blocker use regardless of the prevalence of cardiac comorbidities.", {"entities": []}], ["In the MACRO cohort, patients taking beta-blockers had an exacerbation rate of 1.72/person-year versus a rate of 1.71/person-year in patients not taking beta-blockers.", {"entities": []}], ["In the STATCOPE cohort, patients taking beta-blockers had an exacerbation rate of 1.14/person-year.", {"entities": []}], ["Patients without beta-blockers had an exacerbation rate of 1.34/person-year.", {"entities": []}], ["We found no detrimental effect of beta blockers with respect to change in lung function over time.", {"entities": []}], ["We found no evidence that beta-blocker use was unsafe or associated with worse pulmonary outcomes in study participants with moderate to severe COPD.", {"entities": []}], ["Inflammatory responses induced by peripheral administration of lipopolysaccharide (LPS) triggers depressive-like behavioral syndrome in rodents.", {"entities": [[124, 132, "DISEASE"]]}], ["Inhibition of phosphodiesterase 4 (PDE4) produces a robust anti-inflammatory effect in inflammatory cells.", {"entities": []}], ["Unfortunately, archetypal PDE4 inhibitors cause intolerable gastrointestinal side-effects, such as vomiting and nausea.", {"entities": []}], ["N -isopropyl-3-(cyclopropylmethoxy)-4-difluoromethoxy benzamide (FCPR03) is a novel, selective PDE4 inhibitor with little, or no, emetic potency.", {"entities": []}], ["Our previous studies show that FCPR03 is effective in attenuating neuroinflammation in mice treated with LPS.", {"entities": []}], ["However, whether FCPR03 could exert antidepressant-like effect induced by LPS is largely unknown.", {"entities": []}], ["In the present study, mice injected intraperitoneally (i.p.)", {"entities": []}], ["with LPS was established as an in vivo animal model of depression.", {"entities": []}], ["The antidepressant-like activities of FCPR03 were evaluated using a tail suspension test, forced swimming test, and sucrose preference test.", {"entities": []}], ["We demonstrated that administration of FCPR03 (1 mg/kg) produced antidepressant-like effects in mice challenged by LPS, as evidenced by decreases in the duration of immobility in the forced swim and tail suspension tests, while no significant changes in locomotor activity were observed.", {"entities": []}], ["FCPR03 also increased sucrose preference in mice treated with LPS.", {"entities": []}], ["In addition, treatment with FCPR03 abolished the downregulation of brain-derived neurotrophic factor induced by LPS and decreased the level of corticosterone in plasma.", {"entities": []}], ["Meanwhile, periphery immune challenge by LPS induced enhanced phosphorylation of p38-mitogen activated protein kinase (p38) and c-Jun N-terminal kinase (JNK) in both the cerebral cortex and hippocampus in mice.", {"entities": []}], ["Interestingly, treatment with FCPR03 significantly blocked the role of LPS and reduced the levels of phosphorylated p38 and JNK.", {"entities": []}], ["Collectively, these results indicate that FCPR03 shows antidepressant-like effects in mice challenged by LPS, and the p38/JNK signaling pathway is possibly involved in this process.", {"entities": []}], ["Our findings suggest that FCPR03 is a potential compound for the prevention or treatment of depression.", {"entities": []}], ["Particulate pollution has important consequences for human health, and is an issue of global concern.", {"entities": []}], ["Outdoor air pollution has become a cause for alarm in India in particular because recent data suggest that ambient pollution levels in Indian cities are some of the highest in the world.", {"entities": []}], ["We study the number of particles between 0.5\u03bcm and 2.5\u03bcm indoors while using affordable air purifiers in the highly polluted city of Delhi.", {"entities": []}], ["Though substantial reductions in indoor number concentrations are observed during air purifier use, indoor air quality while using an air purifier is frequently worse than in cities with moderate pollution, and often worse than levels observed even in polluted cities.", {"entities": []}], ["When outdoor pollution levels are higher, on average, indoor pollution levels while using an air purifier are also higher.", {"entities": []}], ["Moreover, the ratio of indoor air quality during air purifier use to two comparison measures of air quality without an air purifier are also positively correlated with outdoor pollution levels, suggesting that as ambient air quality worsens there are diminishing returns to improvements in indoor air quality during air purifier use.", {"entities": []}], ["The findings of this study indicate that although the most affordable air purifiers currently available are associated with significant improvements in the indoor environment, they are not a replacement for public action in regions like Delhi.", {"entities": []}], ["Although private solutions may serve as a stopgap, reducing ambient air pollution must be a public health and policy priority in any region where air pollution is as high as Delhi\u2019s during the winter.", {"entities": []}], ["Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a serious event that is responsible for the progress of the disease, increases in medical costs and high mortality.", {"entities": [[22, 59, "DISEASE"]]}], ["The aim of the present study was to identify AECOPD-specific biomarkers by evaluating the dynamic gene expression profiling of peripheral blood mononuclear cells (PBMCs) from patients with AECOPD on days 1, 3 and 10 after hospital admission and to compare the derived data with data from healthy controls or patients with stable COPD.", {"entities": []}], ["We found that 14 genes were co\u2013differentially upregulated and 2 downregulated greater than 10-fold in patients with COPD or AECOPD compared with the healthy individuals.", {"entities": []}], ["Eight co\u2013differentially upregulated genes and six downregulated genes were identified as a panel of AECOPD-specific genes.", {"entities": []}], ["Downregulation of TCF7 in PBMCs was found to be associated with the severity of COPD.", {"entities": [[18, 22, "GENE"]]}], ["Dynamic changes of Aminolevulinate-delta-synthase 2 and carbonic anhydrase I had similar patterns of Digital Evaluation Score System scores and may serve as potential genes of interest during the course of AECOPD.", {"entities": []}], ["Thus, our findings indicate a panel of altered gene expression patterns in PBMCs that can be used as AECOPD-specific dynamic biomarkers to monitor the course of AECOPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-014-0508-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To assess the cost-effectiveness of a structured education pulmonary rehabilitation programme (SEPRP) for chronic obstructive pulmonary disease (COPD) relative to usual practice in primary care.", {"entities": [[106, 143, "DISEASE"]]}], ["The programme consisted of group-based sessions delivered jointly by practice nurses and physiotherapists over 8\u2005weeks.", {"entities": []}], ["Cost-effectiveness and cost-utility analysis alongside a cluster randomised controlled trial.", {"entities": []}], ["32 general practices in Ireland.", {"entities": []}], ["350 adults with COPD, 69% of whom were moderately affected.", {"entities": []}], ["Intervention arm (n=178) received a 2\u2005h group-based SEPRP session per week over 8\u2005weeks delivered jointly by a practice nurse and physiotherapist at the practice surgery or nearby venue.", {"entities": []}], ["The control arm (n=172) received the usual practice in primary care.", {"entities": []}], ["Incremental costs, Chronic Respiratory Questionnaire (CRQ) scores, quality-adjusted life years (QALYs) gained estimated using the generic EQ5D instrument, and expected cost-effectiveness at 22\u2005weeks trial follow-up.", {"entities": []}], ["The intervention was associated with an increase of \u20ac944 (95% CIs 489 to 1400) in mean healthcare cost and \u20ac261 (95% CIs 226 to 296) in mean patient cost.", {"entities": []}], ["The intervention was associated with a mean improvement of 1.11 (95% CIs 0.35 to 1.87) in CRQ Total score and 0.002 (95% CIs \u22120.006 to 0.011) in QALYs gained.", {"entities": []}], ["These translated into incremental cost-effectiveness ratios of \u20ac850 per unit increase in CRQ Total score and \u20ac472\u2005000 per additional QALY gained.", {"entities": []}], ["The probability of the intervention being cost-effective at respective threshold values of \u20ac5000, \u20ac15\u2005000, \u20ac25\u2005000, \u20ac35\u2005000 and \u20ac45\u2005000 was 0.980, 0.992, 0.994, 0.994 and 0.994 in the CRQ Total score analysis compared to 0.000, 0.001, 0.001, 0.003 and 0.007 in the QALYs gained analysis.", {"entities": []}], ["While analysis suggests that SEPRP was cost-effective if society is willing to pay at least \u20ac850 per one-point increase in disease-specific CRQ, no evidence exists when effectiveness was measured in QALYS gained.", {"entities": []}], ["Current Controlled Trials ISRCTN52\u2005403\u2005063.", {"entities": []}], ["Worksite health promotion and interventions have gained popularity among state agencies.", {"entities": []}], ["We studied the health behaviors and health characteristics of adults employed in state agencies in Oregon and compared those state employees with the statewide population of employed, insured adults.", {"entities": []}], ["We used data from the Oregon Behavioral Risk Factor Surveillance System (BRFSS) and a modified BRFSS survey administered to state employees.", {"entities": []}], ["State employees were compared with employed, insured BRFSS respondents in total and then separately for men and women.", {"entities": []}], ["The prevalence of healthy weight was lower among state employees compared with the statewide population of employed, insured adults (29% vs 35%), and the prevalence of obesity was higher (35% vs 26%).", {"entities": [[168, 175, "DISEASE"]]}], ["State employees were also less likely to meet physical activity recommendations (44% vs 56%).", {"entities": []}], ["Diabetes prevalence was higher among state employees (7% vs 5%), and self-reported excellent or very good health status was lower (54% vs 64%).", {"entities": []}], ["State employees differ from the statewide population of employed, insured adults on a number of health behaviors and conditions.", {"entities": []}], ["These differences suggest obesity prevention and diabetes control as priority areas for state agency worksite interventions.", {"entities": [[26, 33, "DISEASE"]]}], ["In recent years, environmental health science has broadened the scope of its inquiries, expanding its investigations beyond the effects of single pollutants on individuals to incorporate the entire panorama of external factors that may affect people\u2019s health.", {"entities": []}], ["Consideration of the health impacts of the built environment\u2014the human-modified places where we live, work, play, shop, and more\u2014has been a key element in the ongoing evolution of the field of environmental health.", {"entities": []}], ["We compared the conformation of empty and peptide-loaded class I major histocompatibility complex (MHC) molecules at the cell surface.", {"entities": []}], ["Molecular conformations were analyzed by fluorescence resonance energy transfer (FRET) between fluorescent-labeled Fab fragments bound to the alpha 2 domain of the MHC heavy chain and fluorescent-labeled Fab fragments bound to beta 2-microglobulin.", {"entities": []}], ["No FRET was found between Fab fragments bound to empty H-2Kb, but FRET was detected when empty H-2Kb molecules were loaded with peptide.", {"entities": []}], ["The magnitude of FRET depended on the sequence of the peptide used.", {"entities": []}], ["The results imply that empty H-2Kb molecules are in a relatively extended conformation, and that this conformation becomes more compact when peptide is bound.", {"entities": []}], ["These changes, which are reflected in peptide-dependent binding of monoclonal antibodies, affect the surfaces of MHC molecules available for contact with T cell receptors and hence may influence T cell-receptor recognition of MHC molecules.", {"entities": []}], ["Tumstatin is a segment of the collagen-IV protein that is markedly reduced in the airways of asthmatics.", {"entities": []}], ["Tumstatin can play an important role in the development of airway remodelling associated with asthma due to its anti-angiogenic properties.", {"entities": [[94, 100, "DISEASE"]]}], ["This study assessed the anti-angiogenic properties of smaller peptides derived from tumstatin, which contain the interface tumstatin uses to interact with the \u03b1V\u03b23 integrin.", {"entities": []}], ["Primary human lung endothelial cells were exposed to the LF-15, T3 and T7 tumstatin-derived peptides and assessed for cell viability and tube formation in vitro .", {"entities": []}], ["The impact of the anti-angiogenic properties on airways hyperresponsiveness (AHR) was then examined using a murine model of chronic OVA-induced allergic airways disease.", {"entities": [[77, 80, "GENE"]]}], ["The LF-15 and T7 peptides significantly reduced endothelial cell viability and attenuated tube formation in vitro .", {"entities": []}], ["Mice exposed to OVA+ LF-15 or OVA+T7 also had reduced total lung vascularity and AHR was attenuated compared to mice exposed to OVA alone.", {"entities": [[81, 84, "GENE"]]}], ["T3 peptides reduced cell viability but had no effect on any other parameters.", {"entities": []}], ["The LF-15 and T7 peptides may be appropriate candidates for use as novel pharmacotherapies due to their small size and anti-angiogenic properties observed in vitro and in vivo .", {"entities": []}], ["Timely resolution of inflammation is critical for the restoration of homeostasis in injured or infected tissue.", {"entities": []}], ["Chronic inflammation is often characterized by a persistent increase in the concentrations of inflammatory cells and molecular mediators, whose distinct amount and timing characteristics offer an opportunity to identify effective therapeutic regulatory targets.", {"entities": []}], ["Here, we used our recently developed computational model of local inflammation to identify potential targets for molecular interventions and to investigate the effects of individual and combined inhibition of such targets.", {"entities": []}], ["This was accomplished via the development and application of computational strategies involving the simulation and analysis of thousands of inflammatory scenarios.", {"entities": []}], ["We found that modulation of macrophage influx and efflux is an effective potential strategy to regulate the amount of inflammatory cells and molecular mediators in both normal and chronic inflammatory scenarios.", {"entities": []}], ["We identified three molecular mediators \u2212 tumor necrosis factor-\u03b1 (TNF-\u03b1), transforming growth factor-\u03b2 (TGF-\u03b2), and the chemokine CXCL8 \u2212 as potential molecular targets whose individual or combined inhibition may robustly regulate both the amount and timing properties of the kinetic trajectories for neutrophils and macrophages in chronic inflammation.", {"entities": []}], ["Modulation of macrophage flux, as well as of the abundance of TNF-\u03b1, TGF-\u03b2, and CXCL8, may improve the resolution of chronic inflammation.", {"entities": []}], ["A recent approach to quantitatively characterize the timing and intensity of the inflammatory response relies on the use of four quantities termed inflammation indices.", {"entities": []}], ["The values of the inflammation indices may reflect the differences between normal and pathological inflammation, and may be used to gauge the effects of therapeutic interventions aimed to control inflammation.", {"entities": []}], ["Yet, the specific inflammatory mechanisms that can be targeted to selectively control these indices remain unknown.", {"entities": []}], ["Here, we developed and applied a computational strategy to identify potential target mechanisms to regulate such indices.", {"entities": []}], ["We used our recently developed model of local inflammation to simulate thousands of inflammatory scenarios.", {"entities": []}], ["We then subjected the corresponding inflammation index values to sensitivity and correlation analysis.", {"entities": []}], ["We found that the inflammation indices may be significantly influenced by the macrophage influx and efflux rates, as well as by the degradation rates of three specific molecular mediators.", {"entities": []}], ["These results suggested that the indices can be effectively regulated by individual or combined inhibition of those molecular mediators, which we confirmed by computational experiments.", {"entities": []}], ["Taken together, our results highlight possible targets of therapeutic intervention that can be used to control both the timing and the intensity of the inflammatory response.", {"entities": []}], ["Pediatric asthma has gained increasing concerns with poorly understood pathogenesis.", {"entities": [[10, 16, "DISEASE"]]}], ["The purpose of this study was to explore the associations of interleukin-4 (IL-4), IL-6, and IL-12 levels in peripheral blood (PB) with lung function, cellular immune function, and children's quality of life (QOL) with moderate-to-severe asthma.", {"entities": [[238, 244, "DISEASE"]]}], ["A total of 1158 children with moderate-to-severe asthma (the experimental group) and 1075 healthy children (the control group) were recruited for our study.", {"entities": [[49, 55, "DISEASE"]]}], ["Enzyme-linked immunosorbent assay was used to detect IL-4, IL-6, and IL-12 levels.", {"entities": []}], ["T lymphocytes were detected by alkaline phosphatase antialkaline phosphatase, and erythrocyte immune was measured by red blood cell C 3b receptor (RBC-C3bR) rosette-forming test.", {"entities": []}], ["The forced expiratory volume in 1 second (FEV1) and peak expiratory flow (PEF) were detected, after which FEV1/forced vital capacity (FVC) was calculated before and after treatment.", {"entities": []}], ["PedsQL3.0 was used to measure the effect of asthma on QOL of children, and the correlation between IL-4, IL-6, and IL-12 levels and the lung function and QOL was measured.", {"entities": [[44, 50, "DISEASE"]]}], ["Logistic regression analysis was applied to detect related factors of moderate-to-severe asthma of children.", {"entities": [[89, 95, "DISEASE"]]}], ["After treatment, the decreased IL-4 and IL-6 levels and increased IL-12 level were revealed in the experimental group.", {"entities": []}], ["The cellular immune function's disorder was significantly decreased, and an elevated CD 3 , CD 4 , CD 8 , and declined CD 4 /CD 8 level was performed in T lymphocytes.", {"entities": []}], ["RBC-C3bR was increased, and red blood cell immune complex (RBC-IC) was reduced in erythrocyte immune in comparison with those before treatment.", {"entities": []}], ["Lung function parameters all increased.", {"entities": []}], ["After treatment, the symptoms of asthma in children reduced with scores of increased QOL.", {"entities": [[33, 39, "DISEASE"]]}], ["IL-4 was positively related to RBC-IC, but negatively associated with the QOL score.", {"entities": []}], ["IL-6 showed negative connection with CD 4 /CD 8 , RBC-C3bR, FEV1/FVC, and QOL score, and had positive connection with PEF.", {"entities": []}], ["In addition, IL-12 was negatively correlated with PEF.", {"entities": []}], ["The levels of IL-4, RBC-C3bR, FEV1/FVC, and PEF were independent risk factors for the prognosis of treatment for children with moderate-to-severe asthma.", {"entities": [[146, 152, "DISEASE"]]}], ["This study demonstrated that IL-4, IL-6, and IL-12 levels in PB were associated with lung function, cellular immune function, and QOL in children with moderate-to-severe asthma.", {"entities": [[170, 176, "DISEASE"]]}], ["I1 Proceedings of the Fifteenth Annual UT- KBRIN Bioinformatics Summit 2016 Eric C. Rouchka, Julia H. Chariker, Benjamin J. Harrison, Juw Won Park P1 CC-PROMISE: Projection onto the Most Interesting Statistical Evidence (PROMISE) with Canonical Correlation to integrate gene expression and methylation data with multiple pharmacologic and clinical endpoints Xueyuan Cao, Stanley Pounds, Susana Raimondi, James Downing, Raul Ribeiro, Jeffery Rubnitz, Jatinder Lamba P2 Integration of microRNA-mRNA interaction networks with gene expression data to increase experimental power Bernie J Daigle, Jr. P3 Designing and writing software for in silico subtractive hybridization of large eukaryotic genomes Deborah Burgess, Stephanie Gehrlich, John C Carmen P4 Tracking the molecular evolution of Pax gene Nicholas Johnson; Chandrakanth Emani P5 Identifying genetic differences in thermally dimorphic and state specific fungi using in silico genomic comparison Stephanie Gehrlich, Deborah Burgess, John C Carmen P6 Identification of conserved genomic regions and variation therein amongst Cetartiodactyla species using next generation sequencing Kalpani De Silva, Michael P Heaton, Theodore S Kalbfleisch P7 Mining physiological data to identify patients with similar medical events and phenotypes Teeradache Viangteeravat, Rahul Mudunuri, Oluwaseun Ajayi, Fatih \u015een, Eunice Y Huang P8 Smart brief for home health monitoring Mohammad Mohebbi, Luaire Florian, Douglas J Jackson, John F Naber P9 Side-effect term matching for computational adverse drug reaction predictions AKM Sabbir, Sally R Ellingson P10 Enrichment vs robustness: A comparison of transcriptomic data clustering metrics Yuping Lu, Charles A Phillips, Michael A Langston P11 Deep neural networks for transcriptome-based cancer classification Rahul K Sevakula, Raghuveer Thirukovalluru, Nishchal K. Verma, Yan Cui P12 Motif discovery using K-means clustering Mohammed Sayed, Juw Won Park P13 Large scale discovery of active enhancers from nascent RNA sequencing Jing Wang, Qi Liu, Yu Shyr P14 Computationally characterizing genomic pipelines and benchmarking results using GATK best practices on the high performance computing cluster at the University of Kentucky Xiaofei Zhang, Sally R Ellingson P15 Development of approaches enabling the identification of abnormal gene expression from RNA-Seq in personalized oncology Naresh Prodduturi, Gavin R Oliver, Diane Grill, Jie Na, Jeanette Eckel-Passow, Eric W Klee P16 Processing RNA-Seq data of plants infected with coffee ringspot virus Michael M Goodin, Mark Farman, Harrison Inocencio, Chanyong Jang, Jerzy W Jaromczyk, Neil Moore, Kelly Sovacool P17 Comparative transcriptomics of three Acinetobacter baumanii clinical isolates with different antibiotic resistance patterns Leon Dent, Mike Izban, Sammed Mandape, Shruti Sakhare, Siddharth Pratap, Dana Marshall P18 Metagenomic assessment of possible microbial contamination in the equine reference genome assembly M Scotty DePriest, James N MacLeod, Theodore S Kalbfleisch P19 Molecular evolution of cancer driver genes Chandrakanth Emani, Hanady Adam, Ethan Blandford, Joel Campbell, Joshua Castlen, Brittany Dixon, Ginger Gilbert, Aaron Hall, Philip Kreisle, Jessica Lasher, Bethany Oakes, Allison Speer, Maximilian Valentine P20 Biorepository Laboratory Information Management System Naga Satya V Rao Nagisetty, Rony Jose, Teeradache Viangteeravat, Robert Rooney, David Hains", {"entities": [[1777, 1783, "DISEASE"], [3059, 3065, "DISEASE"], [2045, 2048, "GENE"]]}], ["Supplemental Digital Content is available in the text Preeclampsia is a complex genetic disease of pregnancy with a heterogenous presentation, unknown cause and potential severe outcomes for both mother and child.", {"entities": [[80, 95, "DISEASE"]]}], ["Preeclamptic women have increased risk for atherothrombotic cardiovascular disease.", {"entities": []}], ["We aimed to identify heritabilities and phenotypic correlations of preeclampsia and related conditions in the Norwegian Preeclampsia Family Biobank.", {"entities": []}], ["By applying a variance components model, a total of 493 individuals (from 138 families with increased occurrence of preeclampsia) were classified according to 30 disease-related phenotypes.", {"entities": []}], ["Of parous women, 75.7% (263/338) had experienced preeclampsia and 35.7% of women with and 22.4% without preeclampsia delivered children small for gestational age (SGA).", {"entities": []}], ["We identified 11 phenotypes as heritable.", {"entities": []}], ["The increased occurrence of preeclampsia was reflected by the presence [heritability (H2r)\u200a=\u200a0.60)] and severity (H2r\u200a=\u200a0.15) of preeclampsia and being born in a preeclamptic pregnancy (H2r\u200a=\u200a0.25).", {"entities": []}], ["Other heritable phenotypes identified included SGA (H2r\u200a=\u200a0.40), chronic hypertension (H2r\u200a=\u200a0.57), severity of atherothrombotic cardiovascular disease (H2r\u200a=\u200a0.31), BMI (H2r\u200a=\u200a0.60) and pulmonary disease (H2r\u200a=\u200a0.91).", {"entities": [[73, 85, "DISEASE"]]}], ["The heritable phenotype preeclampsia overlapped with SGA ( P \u200a=\u200a0.03), whereas pulmonary disease was phenotypically correlated with atherothrombotic cardiovascular disease ( P \u200a<\u200a0.01), SGA ( P \u200a=\u200a0.02) and BMI ( P \u200a=\u200a0.02).", {"entities": []}], ["This is the first study identifying the H2r of a range of health-related conditions in preeclamptic families.", {"entities": []}], ["Our study demonstrates how refinement of phenotypes leads to better H2r estimation and the identification of a biological relationship between preeclampsia and related traits.", {"entities": []}], ["Exposure to noxious gases and particles contained in both tobacco smoking (TS) and biomass smoke (BS) are well recognized environmental risk factors for chronic obstructive pulmonary disease (COPD).", {"entities": [[153, 190, "DISEASE"]]}], ["COPD is characterized by an abnormal inflammatory response, both in the pulmonary and systemic compartments.", {"entities": []}], ["The differential effects of TS, BS or their combined exposure have not been well characterized yet.", {"entities": []}], ["This study sought to compare the lung function characteristics and systemic inflammatory response in COPD patients exposed to TS, BS or their combination.", {"entities": []}], ["Sociodemographic, clinical and lung functional parameters were compared across 49 COPD patients with a history of smoking and no BS exposure (TS COPD), 31 never-smoker COPD patients with BS exposure (BS COPD), 46 COPD patients with a combined exposure (TS\u2009+\u2009BS COPD) and 52 healthy controls (HC) who have never been exposed neither to TS or BS.", {"entities": []}], ["Blood cell counts, C-reactive protein (CRP), fibrinogen and immunoglobulin E (IgE) levels were quantified in all four groups.", {"entities": [[39, 42, "GENE"]]}], ["TS\u2009+\u2009BS COPD patients exhibited significantly lower oxygen saturation than the rest of groups ( p \u2009<\u20090.01).", {"entities": []}], ["Spirometry and diffusing capacity were significantly higher in BS than in TS or TS\u2009+\u2009BS patients.", {"entities": []}], ["CRP levels were significantly higher in TS COPD patients than in BS COPD group ( p \u2009<\u20090.05), whereas fibrinogen was raised in COPD patients with a history of smoking (TS and TS\u2009+\u2009BS) when compared to control subjects ( p \u2009<\u20090.01).", {"entities": [[0, 3, "GENE"]]}], ["Finally, COPD patients with BS exposure (BS and BS\u2009+\u2009TS groups) showed higher IgE levels than TS and HC ( p \u2009<\u20090.05).", {"entities": []}], ["There are significant physiological and inflammatory differences between COPD patients with TS, BS and TS\u2009+\u2009BS exposures.", {"entities": []}], ["The latter had worse blood oxygenation, whereas the raised levels of IgE in BS exposed patients suggests a differential Th2 systemic inflammatory pattern triggered by this pollutant.", {"entities": []}], ["Severe refractory asthma is a heterogeneous disease.", {"entities": [[18, 24, "DISEASE"]]}], ["We sought to determine statistical clusters from the British Thoracic Society Severe refractory Asthma Registry and to examine cluster-specific outcomes and stability.", {"entities": [[96, 102, "DISEASE"]]}], ["Factor analysis and statistical cluster modelling was undertaken to determine the number of clusters and their membership (N\u200a=\u200a349).", {"entities": []}], ["Cluster-specific outcomes were assessed after a median follow-up of 3 years.", {"entities": []}], ["A classifier was programmed to determine cluster stability and was validated in an independent cohort of new patients recruited to the registry (n\u200a=\u200a245).", {"entities": []}], ["Five clusters were identified.", {"entities": []}], ["Cluster 1 (34%) were atopic with early onset disease, cluster 2 (21%) were obese with late onset disease, cluster 3 (15%) had the least severe disease, cluster 4 (15%) were the eosinophilic with late onset disease and cluster 5 (15%) had significant fixed airflow obstruction.", {"entities": []}], ["At follow-up, the proportion of subjects treated with oral corticosteroids increased in all groups with an increase in body mass index.", {"entities": []}], ["Exacerbation frequency decreased significantly in clusters 1, 2 and 4 and was associated with a significant fall in the peripheral blood eosinophil count in clusters 2 and 4.", {"entities": []}], ["Stability of cluster membership at follow-up was 52% for the whole group with stability being best in cluster 2 (71%) and worst in cluster 4 (25%).", {"entities": []}], ["In an independent validation cohort, the classifier identified the same 5 clusters with similar patient distribution and characteristics.", {"entities": []}], ["Statistical cluster analysis can identify distinct phenotypes with specific outcomes.", {"entities": []}], ["Cluster membership can be determined using a classifier, but when treatment is optimised, cluster stability is poor.", {"entities": []}], ["Whooping cough is a highly contagious respiratory disease caused by Bordetella pertussis .", {"entities": [[79, 88, "DISEASE"]]}], ["Despite widespread vaccination, its incidence has been rising alarmingly, and yet, the physiology of B. pertussis remains poorly understood.", {"entities": [[104, 113, "DISEASE"]]}], ["We combined genome-scale metabolic reconstruction, a novel optimization algorithm, and experimental data to probe the full metabolic potential of this pathogen, using B. pertussis strain Tohama I as a reference.", {"entities": [[170, 179, "DISEASE"]]}], ["Experimental validation showed that B. pertussis secretes a significant proportion of nitrogen as arginine and purine nucleosides, which may contribute to modulation of the host response.", {"entities": [[39, 48, "DISEASE"]]}], ["We also found that B. pertussis can be unexpectedly versatile, being able to metabolize many compounds while displaying minimal nutrient requirements.", {"entities": [[22, 31, "DISEASE"]]}], ["It can grow without cysteine, using inorganic sulfur sources, such as thiosulfate, and it can grow on organic acids, such as citrate or lactate, as sole carbon sources, providing in vivo demonstration that its tricarboxylic acid (TCA) cycle is functional.", {"entities": []}], ["Although the metabolic reconstruction of eight additional strains indicates that the structural genes underlying this metabolic flexibility are widespread, experimental validation suggests a role of strain-specific regulatory mechanisms in shaping metabolic capabilities.", {"entities": []}], ["Among five alternative strains tested, three strains were shown to grow on substrate combinations requiring a functional TCA cycle, but only one strain could use thiosulfate.", {"entities": []}], ["Finally, the metabolic model was used to rationally design growth media with >2-fold improvements in pertussis toxin production.", {"entities": [[101, 110, "DISEASE"]]}], ["This study thus provides novel insights into B. pertussis physiology and highlights the potential, but also the limitations, of models based solely on metabolic gene content.", {"entities": [[48, 57, "DISEASE"]]}], ["IMPORTANCE The metabolic capabilities of Bordetella pertussis , the causative agent of whooping cough, were investigated from a systems-level perspective.", {"entities": [[52, 61, "DISEASE"]]}], ["We constructed a comprehensive genome-scale metabolic model for B. pertussis and challenged its predictions experimentally.", {"entities": [[67, 76, "DISEASE"]]}], ["This systems approach shed light on new potential host-microbe interactions and allowed us to rationally design novel growth media with >2-fold improvements in pertussis toxin production.", {"entities": [[160, 169, "DISEASE"]]}], ["Most importantly, we also uncovered the potential for metabolic flexibility of B. pertussis (significantly larger range of substrates than previously alleged; novel active pathways allowing growth in minimal, nearly mineral nutrient combinations where only the carbon source must be organic), although our results also highlight the importance of strain-specific regulatory determinants in shaping metabolic capabilities.", {"entities": [[82, 91, "DISEASE"]]}], ["Deciphering the underlying regulatory mechanisms appears to be crucial for a comprehensive understanding of B. pertussis 's lifestyle and the epidemiology of whooping cough.", {"entities": [[111, 120, "DISEASE"]]}], ["The contribution of metabolic models in this context will require the extension of the genome-scale metabolic model to integrate this regulatory dimension.", {"entities": []}], ["The objective of this study was to ascertain the scoring and assess the psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), a 43-item Patient-Reported Outcome instrument developed to assess patients' satisfaction and compliance with glaucoma treatment.", {"entities": [[256, 264, "DISEASE"]]}], ["The EDSQ was administered during an observational, retrospective study to 184 French patients treated for glaucoma.", {"entities": [[106, 114, "DISEASE"]]}], ["The hypothesized structure, including six dimensions (patient-clinician relationship; patient experience; patient-treatment interaction; apprehension; patient knowledge; travel), was tested by assessing the internal consistency reliability (Cronbach's alpha) and construct-related validity (item convergent and discriminant validity).", {"entities": []}], ["As unsatisfactory results were demonstrated, another structure was defined using a principal component analysis (PCA) combined with content of items.", {"entities": []}], ["Psychometric properties of this new structure were assessed.", {"entities": []}], ["Scores were compared between low, moderate and high compliance profile groups defined using data collected with the Travalert electronic device.", {"entities": []}], ["Analyses were performed with the 169 patients who completed at least half of the EDSQ items.", {"entities": []}], ["The hypothesized structure showed a Cronbach's alpha lower than 0.70 for four dimensions out of six and an overall poor construct-related validity (range of item-scale correlations: 0.00-0.68).", {"entities": []}], ["The new structure obtained with the PCA included six dimensions: concern about treatment (five items); concern about disease (two items); satisfaction with patient-clinician relationship (five items); positive beliefs (three items); treatment convenience (three items); and self-declared compliance (three items).", {"entities": []}], ["A score ranging from 0 to 100 was calculated for each dimension, with higher scores indicating more of the attribute referred to in the dimension.", {"entities": []}], ["Internal consistency reliability was good (Cronbach's alpha greater than 0.70 for five dimensions).", {"entities": []}], ["The structure offered good construct-related validity (range of item-scale correlations: 0.36-0.82).", {"entities": []}], ["Ceiling effects of 21% and 49%, were observed for the satisfaction with patient-clinician relationship and self-declared compliance scores.", {"entities": []}], ["Patients in low compliance profile group reported the lowest score for the satisfaction with patient-clinician relationship, positive beliefs, treatment convenience and self-declared compliance dimensions, and the highest score for the concern about treatment dimension.", {"entities": []}], ["The scoring of the EDSQ was developed and the questionnaire proved to have satisfactory psychometric properties.", {"entities": []}], ["EDSQ scores showed a promising relationship to compliance profiles.", {"entities": []}], ["The EDSQ could be used in future studies.", {"entities": []}], ["To evaluate associations between binge\u2010eating disorder (BED) and somatic illnesses and determine whether medical comorbidities are more common in individuals who present with BED and comorbid obesity.", {"entities": [[192, 199, "DISEASE"], [39, 54, "DISEASE"]]}], ["Cases ( n \u2009=\u2009850) were individuals with a BED diagnosis in the Swedish eating disorders quality registers.", {"entities": []}], ["Ten community controls were matched to each case on sex, and year, month, and county of birth.", {"entities": []}], ["Associations of BED status with neurologic, immune, respiratory, gastrointestinal, skin, musculoskeletal, genitourinary, circulatory, and endocrine system diseases were evaluated using conditional logistic regression models.", {"entities": []}], ["We further examined these associations by adjusting for lifetime psychiatric comorbidity.", {"entities": []}], ["Amongst individuals with BED, we explored whether comorbid obesity was associated with risk of somatic disorders.", {"entities": [[59, 66, "DISEASE"]]}], ["BED was associated with most classes of diseases evaluated; strongest associations were with diabetes [odds ratio (95% confidence interval)\u2009=\u20095.7 (3.8; 8.7)] and circulatory systems [1.9 (1.3; 2.7)], likely indexing components of metabolic syndrome.", {"entities": [[240, 248, "DISEASE"]]}], ["Amongst individuals with BED, those with comorbid obesity were more likely to have a lifetime history of respiratory [1.5 (1.1; 2.1)] and gastrointestinal [2.6 (1.7; 4.1)] diseases than those without comorbid obesity.", {"entities": [[50, 57, "DISEASE"], [209, 216, "DISEASE"]]}], ["Increased risk of some somatic disease classes in individuals with BED was not simply due to obesity or other lifetime psychiatric comorbidity.", {"entities": [[93, 100, "DISEASE"]]}], ["The association of BED with many somatic illnesses highlights the morbidity experienced by individuals with BED.", {"entities": []}], ["Clinicians treating patients with BED should be vigilant for medical comorbidities.", {"entities": []}], ["Nonpsychiatric providers may be the first clinical contact for those with BED underscoring the importance of screening in primary care.", {"entities": []}], ["\u00a9 2016 The Authors International Journal of Eating Disorders Published by Wiley Periodicals, Inc. (Int J Eat Disord 2017; 50:58\u201365)", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by airway remodeling with an accumulation of inflammatory cells.", {"entities": []}], ["There is also increasing evidence that metalloproteinases (MMPs) may contribute to the pathogenesis of COPD, but the influence of agents that used for the treatment of COPD is not well understood.", {"entities": []}], ["We evaluated whether tiotropium bromide hydrate (TBH), a M 3 muscarinic receptor antagonist, could inhibit MMP production from lung fibroblasts (LFs) in response to tumor necrosis factor (TNF)-\u03b1 stimulation.", {"entities": [[188, 191, "GENE"]]}], ["LFs were established from normal lung tissues taken from patients with lung tumors.", {"entities": []}], ["LFs (5 \u00d7 10 TBH at more than 15 pg/ml inhibited the production of MMP-2 from LFs after TNF-\u03b1 stimulation, whereas TIMP-1 and TIMP-2 production was scarcely affected by TBH through the suppression of both mRNA expression and transcription factor, NF-\u03baB, activation in LFs induced by TNF-\u03b1 stimulation.", {"entities": []}], ["These results suggest that the attenuating effect of TBH on MMP-2 production from LFs induced by inflammatory stimulation may be additional beneficial therapeutic effects not directly relating to its bronchodilatory effects.", {"entities": []}], ["Supplemental Digital Content is available in the text The association of latent tuberculosis infection (LTBI) with subsequent cancer remains unclear.", {"entities": [[80, 92, "DISEASE"], [126, 132, "DISEASE"]]}], ["We investigated the risk of future cancer among tuberculosis (TB) contacts with or without subsequent TB activation.", {"entities": [[48, 60, "DISEASE"], [35, 41, "DISEASE"]]}], ["Using the Taiwan National Health Insurance Research Database, we conducted a nationwide population-based study.", {"entities": []}], ["TB contacts during 1997 to 2012 were included as the study cohort.", {"entities": []}], ["Patients with antecedent cancer and TB were excluded.", {"entities": [[25, 31, "DISEASE"]]}], ["Data from 11,522 TB contacts and 46,088 age-, sex-, and enrollment date\u2013matched subjects during 1997 to 2012 were analyzed.", {"entities": []}], ["The 2 cohorts were monitored until December 31, 2012 for incidence of cancer and TB infection.", {"entities": [[70, 76, "DISEASE"]]}], ["LTBI was defined as a TB contact with subsequent TB activation.", {"entities": []}], ["The primary endpoint was occurrence of newly diagnosed cancer.", {"entities": [[55, 61, "DISEASE"]]}], ["There was no difference in cancer development between the TB contact cohort and comparison cohort (log-rank test, P \u200a=\u200a0.714).", {"entities": [[27, 33, "DISEASE"]]}], ["After multivariate adjustment, the hazard ratio (HR) for cancer among the LTBI patients was 2.29 [95% confidence interval (CI), 1.26\u20134.17; P \u200a=\u200a0.007].", {"entities": [[57, 63, "DISEASE"], [49, 51, "GENE"]]}], ["There was increase in cancer incidences for several specific cancer types, including multiple myeloma (HR 340.28), lung (HR 2.69), kidney and bladder (HR 6.16), hepatobiliary (HR 2.36), and gastrointestinal (HR 2.99) cancers.", {"entities": [[94, 101, "DISEASE"], [85, 101, "DISEASE"], [22, 28, "DISEASE"], [61, 67, "DISEASE"], [103, 105, "GENE"], [121, 123, "GENE"], [151, 153, "GENE"], [176, 178, "GENE"], [208, 210, "GENE"], [103, 105, "GENE"], [121, 123, "GENE"], [151, 153, "GENE"], [176, 178, "GENE"], [208, 210, "GENE"], [103, 105, "GENE"], [121, 123, "GENE"], [151, 153, "GENE"], [176, 178, "GENE"], [208, 210, "GENE"], [103, 105, "GENE"], [121, 123, "GENE"], [151, 153, "GENE"], [176, 178, "GENE"], [208, 210, "GENE"], [103, 105, "GENE"], [121, 123, "GENE"], [151, 153, "GENE"], [176, 178, "GENE"], [208, 210, "GENE"]]}], ["None of the 136 TB contacts who received isoniazid prophylaxis developed cancer.", {"entities": [[73, 79, "DISEASE"]]}], ["LTBI patients had a higher risk of future cancer.", {"entities": [[42, 48, "DISEASE"]]}], ["Acetylcholine (ACh), a classical transmitter of parasympathetic nerve fibres in the airways, is also synthesized by a large number of non-neuronal cells, including airway surface epithelial cells.", {"entities": []}], ["Strongest expression of cholinergic traits is observed in neuroendocrine and brush cells but other epithelial cell types\u2014ciliated, basal and secretory\u2014are cholinergic as well.", {"entities": []}], ["There is cell type-specific expression of the molecular pathways of ACh release, including both the vesicular storage and exocytotic release known from neurons, and transmembrane release from the cytosol via organic cation transporters.", {"entities": []}], ["The subcellular distribution of the ACh release machineries suggests luminal release from ciliated and secretory cells, and basolateral release from neuroendocrine cells.", {"entities": []}], ["The scenario as known so far strongly suggests a local auto-/paracrine role of epithelial ACh in regulating various aspects on the innate mucosal defence mechanisms, including mucociliary clearance, regulation of macrophage function and modulation of sensory nerve fibre activity.", {"entities": []}], ["The proliferative effects of ACh gain importance in recently identified ACh receptor disorders conferring susceptibility to lung cancer.", {"entities": [[124, 135, "DISEASE"], [129, 135, "DISEASE"]]}], ["The cell type-specific molecular diversity of the epithelial ACh synthesis and release machinery implies that it is differently regulated than neuronal ACh release and can be specifically targeted by appropriate drugs.", {"entities": []}], ["Rheumatic disease can loosely be described as any painful condition affecting the loco-motor system, including joints, muscles, connective tissues, and soft tissues around the joints and bones.", {"entities": [[0, 17, "DISEASE"]]}], ["There is a wide spectrum of rheumatic diseases, many of which involve autoimmunity, including systemic lupus erythematosus and rheumatoid arthritis.", {"entities": [[127, 147, "DISEASE"], [103, 122, "DISEASE"], [138, 147, "DISEASE"], [94, 122, "DISEASE"]]}], ["A significant body of evidence now links aberrant epigenetic regulation of gene expression with rheumatic disease and points toward the use of epigenetic targeting agents as potential new treatment options, particularly for those conditions associated with an autoimmune element.", {"entities": [[96, 113, "DISEASE"]]}], ["In this perspective, I will briefly cover the current knowledge surrounding this area in the field of rheumatology.", {"entities": []}], ["Numerous studies have associated air pollutant exposures with adverse birth outcomes, but there is still relatively little information to attribute effects to specific emission sources or air toxics.", {"entities": []}], ["We used three exposure data sources to examine risks of preterm birth in Los Angeles women when exposed to high levels of traffic-related air pollutants - including specific toxics - during pregnancy.", {"entities": []}], ["We identified births during 6/1/04-3/31/06 to women residing within five miles of a Southern California Air Quality Management District (SCAQMD) Multiple Air Toxics Exposure Study (MATES III) monitoring station.", {"entities": []}], ["We identified preterm cases and, using a risk set approach, matched cases to controls based on gestational age at birth.", {"entities": []}], ["Pregnancy period exposure averages were estimated for a number of air toxics including polycyclic aromatic hydrocarbons (PAHs), source-specific PM 2.5 (fine particulates with aerodynamic diameter less than 2.5 \u03bcm) based on a Chemical Mass Balance model, criteria air pollutants based on government monitoring data, and land use regression (LUR) estimates of nitric oxide (NO), nitrogen dioxide (NO 2 ) and nitrogen oxides (NO x ).", {"entities": []}], ["Associations between these metrics and odds of preterm birth were estimated using conditional logistic regression.", {"entities": []}], ["Odds of preterm birth increased 6-21% per inter-quartile range increase in entire pregnancy exposures to organic carbon (OC), elemental carbon (EC), benzene, and diesel, biomass burning and ammonium nitrate PM 2.5 , and 30% per inter-quartile increase in PAHs; these pollutants were positively correlated and clustered together in a factor analysis.", {"entities": []}], ["Associations with LUR exposure metrics were weaker (3-4% per inter-quartile range increase).", {"entities": []}], ["These latest analyses provide additional evidence of traffic-related air pollution's impact on preterm birth for women living in Southern California and indicate PAHs as a pollutant of concern that should be a focus of future studies.", {"entities": []}], ["Other PAH sources besides traffic were also associated with higher odds of preterm birth, as was ammonium nitrate PM 2.5 , the latter suggesting potential importance of secondary pollutants.", {"entities": []}], ["Future studies should focus on accurate modeling of both local and regional spatial and temporal distributions, and incorporation of source information.", {"entities": []}], ["Both outdoor air pollution and extreme temperature have been associated with daily mortality; however, the effect of their interaction is not known.", {"entities": []}], ["This time-series analysis examined the effect of the interaction between outdoor air pollutants and extreme temperature on daily mortality in Shanghai, China.", {"entities": []}], ["A generalized additive model (GAM) with penalized splines was used to analyze mortality, air pollution, temperature, and covariate data.", {"entities": []}], ["The effects of air pollutants were stratified by temperature stratum to examine the interaction effect of air pollutants and extreme temperature.", {"entities": []}], ["We found a statistically significant interaction between PM 10 /O 3 and extreme low temperatures for both total nonaccidental and cause-specific mortality.", {"entities": []}], ["On days with \u201cnormal\u201d temperatures (15th\u201385th percentile), a 10-\u00b5g/m 10 corresponded to a 0.17% (95% CI: 0.03%, 0.32%) increase in total mortality, a 0.23% (0.02%, 0.44%) increase in cardiovascular mortality, and a 0.26% (\u22120.07%, 0.60%) increase in respiratory mortality.", {"entities": []}], ["On low-temperature days (<15th percentile), the estimates changed to 0.40% (0.21%, 0.58%) for total mortality, 0.49% (0.13%, 0.86%) for cardiovascular mortality, and 0.24% (\u22120.33%, 0.82%) for respiratory mortality.", {"entities": []}], ["The interaction pattern of O 3 with lower temperature was similar.", {"entities": []}], ["The interaction between PM 10 /O 3 and lower temperature remained robust when alternative cut-points were used for temperature strata.", {"entities": []}], ["The acute health effects of air pollution might vary by temperature level.", {"entities": []}], ["What we eat simultaneously impacts our exposure to pathogens, allergens, and contaminants, our nutritional status and body composition, our risks for and the progression of chronic diseases, and other outcomes.", {"entities": []}], ["Furthermore, what we eat is influenced by a complex web of drivers, including culture, politics, economics, and our built and natural environments.", {"entities": []}], ["To date, public health initiatives aimed at improving food-related population health outcomes have primarily been developed within \u2018practice silos\u2019, and the potential for complex interactions among such initiatives is not well understood.", {"entities": []}], ["Therefore, our objective was to develop a conceptual model depicting how infectious foodborne illness, food insecurity, dietary contaminants, obesity, and food allergy can be linked via shared drivers, to illustrate potential complex interactions and support future collaboration across public health practice silos.", {"entities": [[142, 149, "DISEASE"], [155, 167, "DISEASE"]]}], ["We developed the conceptual model by first conducting a systematic literature search to identify review articles containing schematics that depicted relationships between drivers and the issues of interest.", {"entities": []}], ["Next, we synthesized drivers into a common model using a modified thematic synthesis approach that combined an inductive thematic analysis and mapping to synthesize findings.", {"entities": []}], ["The literature search yielded 83 relevant references containing 101 schematics.", {"entities": []}], ["The conceptual model contained 49 shared drivers and 227 interconnections.", {"entities": []}], ["Each of the five issues was connected to all others.", {"entities": []}], ["Obesity and food insecurity shared the most drivers ( n \u2009=\u200928).", {"entities": [[0, 7, "DISEASE"]]}], ["Obesity shared several drivers with food allergy ( n \u2009=\u200911), infectious foodborne illness ( n \u2009=\u20097), and dietary contamination ( n \u2009=\u20096).", {"entities": [[0, 7, "DISEASE"], [36, 48, "DISEASE"]]}], ["Food insecurity shared several drivers with infectious foodborne illness ( n \u2009=\u20099) and dietary contamination ( n \u2009=\u20099).", {"entities": []}], ["Infectious foodborne illness shared drivers with dietary contamination ( n \u2009=\u20098).", {"entities": []}], ["Fewer drivers were shared between food allergy and: food insecurity ( n \u2009=\u20094); infectious foodborne illness ( n \u2009=\u20092); and dietary contamination ( n \u2009=\u20091).", {"entities": [[34, 46, "DISEASE"]]}], ["Our model explicates potential interrelationships between five population health issues for which public health interventions have historically been siloed, suggesting that interventions targeted towards these issues have the potential to interact and produce unexpected consequences.", {"entities": []}], ["Public health practitioners working in infectious foodborne illness, food insecurity, dietary contaminants, obesity, and food allergy should actively consider how their seemingly targeted public health actions may produce unintended positive or negative population health impacts.", {"entities": [[108, 115, "DISEASE"], [121, 133, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12889-016-3142-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although the prevalence of pulmonary hypertension (PH) in individuals with chronic obstructive pulmonary disease (COPD) is not known precisely, approximately 10%\u201330% of patients with moderate to severe COPD have elevated pulmonary pressures.", {"entities": [[37, 49, "DISEASE"], [75, 112, "DISEASE"], [27, 49, "DISEASE"]]}], ["The vast majority of PH associated with COPD is mild to moderate and severe PH occurs in <5% of patients.", {"entities": []}], ["When COPD is associated with PH, both mortality and morbidity are increased.", {"entities": []}], ["There are no clinical or physical examination findings that accurately identify patients with underlying PH.", {"entities": []}], ["Radiographic imaging findings are specific but not sensitive indicators of PH.", {"entities": []}], ["Echocardiography is the principle noninvasive diagnostic test but may be technically limited in a significant proportion of patients with COPD.", {"entities": []}], ["Right heart catheterization is required for accurate measurement of pulmonary pressures.", {"entities": []}], ["The combined effects of inflammation, endothelial cell dysfunction, and angiogenesis appear to contribute to the development of PH associated with COPD.", {"entities": []}], ["Systemic vasodilators have not been found to be effective therapy.", {"entities": []}], ["Selective pulmonary vasodilators including inhaled nitric oxide and phosphodiesterase inhibitors are promising treatments for patients with COPD associated PH but further evaluation of these medications is needed prior to their routine use.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a major cause of viral bronchiolitis in infants worldwide, and environmental, viral and host factors are all of importance for disease susceptibility and severity.", {"entities": [[60, 73, "DISEASE"]]}], ["To study the systemic host response to this disease we used the microarray technology to measure mRNA gene expression levels in whole blood of five male infants hospitalised with acute RSV, subtype B, bronchiolitis versus five one year old male controls exposed to RSV during infancy without bronchiolitis.", {"entities": [[201, 214, "DISEASE"], [292, 305, "DISEASE"]]}], ["The gene expression levels were further evaluated in a new experiment using quantitative real-time polymerase chain reaction (QRT-PCR) both in the five infants selected for microarray and in 13 other infants hospitalised with the same disease.", {"entities": []}], ["Among the 30 genes most differentially expressed by microarray nearly 50% were involved in immunological processes.", {"entities": []}], ["We found the highly upregulated interferon, alpha-inducible protein 27 (IFI27) and the highly downregulated gene Charcot-Leyden crystal protein (CLC) to be the two most differentially expressed genes in the microarray study.", {"entities": [[72, 77, "GENE"], [145, 148, "GENE"]]}], ["When performing QRT-PCR on these genes IFI27 was upregulated in all but one infant, and CLC was downregulated in all 18 infants, and similar to that given by microarray.", {"entities": [[39, 44, "GENE"], [88, 91, "GENE"]]}], ["The gene IFI27 is upregulated and the gene CLC is downregulated in whole blood of infants hospitalised with RSV, subtype B, bronchiolitis and is not reported before.", {"entities": [[124, 137, "DISEASE"], [9, 14, "GENE"], [43, 46, "GENE"]]}], ["More studies are needed to elucidate the specificity of these gene expressions in association with host response to this virus in bronchiolitis of moderate severity.", {"entities": [[130, 143, "DISEASE"]]}], ["Chronic diseases that result in end-stage organ damage cause inflammation, which can reveal sequestered self-antigens (SAgs) in that organ and trigger autoimmunity.", {"entities": []}], ["The thymus gland deletes self-reactive T-cells against ubiquitously expressed SAgs, while regulatory mechanisms in the periphery control immune responses to tissue-restricted SAgs.", {"entities": []}], ["It is now established that T-cells reactive to SAgs present in certain organs (e.g., lungs, pancreas, and intestine) are incompletely eliminated, and the dysregulation of peripheral immuneregulation can generate immune responses to SAgs.", {"entities": []}], ["Therefore, chronic diseases can activate self-reactive lymphocytes, inducing tissue-restricted autoimmunity.", {"entities": []}], ["During organ transplantation, donor lymphocytes are tested against recipient serum (i.e., cross-matching) to detect antibodies (Abs) against donor human leukocyte antigens, which has been shown to reduce Ab-mediated hyperacute rejection.", {"entities": []}], ["However, primary allograft dysfunction and rejection still occur frequently.", {"entities": []}], ["Because donor lymphocytes do not express tissue-restricted SAgs, preexisting Abs against SAgs are undetectable during conventional cross-matching.", {"entities": []}], ["Preexisting and de novo immune responses to tissue-restricted SAgs (i.e., autoimmunity) play a major role in rejection.", {"entities": []}], ["In this review, we discuss the evidence that supports autoimmunity as a contributor to rejection.", {"entities": []}], ["Testing for preexisting and de novo immune responses to tissue-restricted SAgs and treatment based on immune responses after organ transplantation may improve short- and long-term outcomes after transplantation.", {"entities": []}], ["There is a growing concern about child mortality especially in developing countries.", {"entities": []}], ["The Government of Tanzania and non-governmental organizations are fighting against diseases like malaria, anaemia, diarrhoea and pneumonia that contribute extensively to child mortality.", {"entities": [[129, 138, "DISEASE"], [97, 104, "DISEASE"]]}], ["This was a hospital-based, retrospective cohort study involving 1130 under-fives (excluding neonates) being either discharged from or died in public hospitals of the Lake Zone in Tanzania.", {"entities": []}], ["We extracted information on symptoms and signs at admission, major diagnoses and causes of death from the medical records.", {"entities": []}], ["We applied binary logistic regression models to assess risk factors associated with in-patient under-five death.", {"entities": []}], ["The major leading morbidities include malaria (49%), anemia (37%), diarrhea (27%), pneumonia (22%) and severe acute malnutrition (21%).", {"entities": [[83, 92, "DISEASE"], [38, 45, "DISEASE"], [67, 75, "DISEASE"], [53, 59, "DISEASE"]]}], ["We found the case fatality of 74 deaths per 1000 under-five admissions.", {"entities": []}], ["Major underlying causes of deaths were severe anaemia, severe malaria and severe pneumonia.", {"entities": [[81, 90, "DISEASE"], [62, 69, "DISEASE"]]}], ["Factors associated with in-patient death were female sex (AOR 1.7; 95% CI 1.0, 2.8) and the odds significantly decreased with increasing level of maternal education.", {"entities": []}], ["Malaria remains a leading cause of admissions in hospitals among under-fives.", {"entities": [[0, 7, "DISEASE"]]}], ["Although the case fatality among children aged between 2 and 59\u00a0months admitted in hospitals in Lake Zone is decreasing, efforts are needed to address major causes of deaths (severe anaemia, severe malaria and severe pneumonia).", {"entities": [[217, 226, "DISEASE"], [198, 205, "DISEASE"]]}], ["An imbalance in Matrix MetalloProteases (MMPs) and Tissue Inhibitors of MMPs (TIMPs) contributes to Chronic Obstructive Pulmonary Disease (COPD) development.", {"entities": []}], ["Longitudinal studies investigating Single Nucleotide Polymorphisms (SNPs) in MMPs and TIMPs with respect to COPD development and lung function decline in the general population are lacking.", {"entities": []}], ["We genotyped SNPs in MMP1 (G-1607GG), MMP2 (-1306 C/T), MMP9 (3 tagging SNPs), MMP12 (A-82G and Asn357Ser) and TIMP1 (Phe124Phe and Ile158Ile) in 1390 Caucasians with multiple FEV 1 measurements from a prospective cohort study in the general population.", {"entities": [[21, 25, "GENE"], [38, 42, "GENE"], [56, 60, "GENE"], [79, 84, "GENE"], [111, 116, "GENE"], [176, 179, "GENE"]]}], ["FEV 1 decline was analyzed using linear mixed effect models adjusted for confounders.", {"entities": [[0, 3, "GENE"]]}], ["Analyses of the X-chromosomal TIMP1 gene were stratified according to sex.", {"entities": [[30, 35, "GENE"]]}], ["All significant associations were repeated in an independent general population cohort (n = 1152).", {"entities": []}], ["MMP2 -1306 TT genotype carriers had excess FEV 1 decline (-4.0 ml/yr, p = 0.03) compared to wild type carriers.", {"entities": [[0, 4, "GENE"], [43, 46, "GENE"]]}], ["TIMP1 Ile158Ile predicted significant excess FEV 1 decline in both males and females.", {"entities": [[0, 5, "GENE"], [45, 48, "GENE"]]}], ["TIMP1 Phe124Phe predicted significant excess FEV 1 decline in males only, which was replicated (p = 0.10) in the second cohort.", {"entities": [[0, 5, "GENE"], [45, 48, "GENE"]]}], ["The MMP2 and TIMP1 Ile158Ile associations were not replicated.", {"entities": [[4, 8, "GENE"], [13, 18, "GENE"]]}], ["Although power was limited, we did not find associations with COPD development.", {"entities": []}], ["We for the first time show that TIMP1 Phe124Phe contributes to excess FEV 1 decline in two independent prospective cohorts, albeit not quite reaching conventional statistical significance in the replication cohort.", {"entities": [[32, 37, "GENE"], [70, 73, "GENE"]]}], ["SNPs in MMPs evidently do not contribute to FEV 1 decline in the general population.", {"entities": [[44, 47, "GENE"]]}], ["Identification of mechanisms promoting neutrophil trafficking to the lungs of patients with cystic fibrosis (CF) is a challenge for next generation therapeutics.", {"entities": [[92, 107, "DISEASE"]]}], ["Cholesterol, a structural component of neutrophil plasma membranes influences cell adhesion, a key step in transmigration.", {"entities": []}], ["The effect of chronic inflammation on neutrophil membrane cholesterol content in patients with CF (PWCF) remains unclear.", {"entities": []}], ["To address this we examined neutrophils of PWCF to evaluate the cause and consequence of altered membrane cholesterol and identified the effects of lung transplantation and ion channel potentiator therapy on the cellular mechanisms responsible for perturbed membrane cholesterol and increased cell adhesion.", {"entities": []}], ["PWCF homozygous for the \u0394F508 mutation or heterozygous for the G551D mutation were recruited (n\u00a0=\u00a048).", {"entities": []}], ["Membrane protein expression was investigated by mass spectrometry.", {"entities": []}], ["The effect of lung transplantation or ivacaftor therapy was assessed by ELISAs, and calcium fluorometric and \u03bc-calpain assays.", {"entities": []}], ["Membranes of CF neutrophils contain less cholesterol, yet increased integrin CD11b expression, and respond to inflammatory induced endoplasmic reticulum (ER) stress by activating \u03bc-calpain.", {"entities": []}], ["In vivo and in vitro, increased \u03bc-calpain activity resulted in proteolysis of the membrane cholesterol trafficking protein caveolin-1.", {"entities": []}], ["The critical role of caveolin-1 for adequate membrane cholesterol content was confirmed in caveolin-1 knock-out mice.", {"entities": []}], ["Lung transplant therapy or treatment of PWCF with ivacaftor, reduced levels of circulating inflammatory mediators and actuated increased caveolin-1 and membrane cholesterol, with concurrent normalized neutrophil adhesion.", {"entities": []}], ["Results demonstrate an auxiliary benefit of lung transplant and potentiator therapy, evident by a reduction in circulating inflammation and controlled neutrophil adhesion.", {"entities": []}], ["\u2022 This study explored neutrophil adhesion in cystic fibrosis.", {"entities": [[45, 60, "DISEASE"]]}], ["\u2022 Altered membrane cholesterol lead to increased adhesion.", {"entities": []}], ["\u2022 Circulating inflammatory mediators caused increased calpain activity and reduced membrane cholesterol content.", {"entities": []}], ["This study explored neutrophil adhesion in cystic fibrosis.", {"entities": [[43, 58, "DISEASE"]]}], ["Altered membrane cholesterol lead to increased adhesion.", {"entities": []}], ["Circulating inflammatory mediators caused increased calpain activity and reduced membrane cholesterol content.", {"entities": []}], ["In patients with cystic fibrosis (CF), chronic inflammation in the circulation, in part originating from the pulmonary compartment, leads to decreased membrane cholesterol in circulating neutrophils, resulting in increased cell adhesion.", {"entities": [[17, 32, "DISEASE"]]}], ["The mechanism of action involves proteolytic down-regulation of the cholesterol trafficking protein caveolin-1.", {"entities": []}], ["The overall effect of lung transplant therapy, or CFTR potentiator treatment, was to significantly diminish the circulating inflammatory burden thereby permitting caveolin-1 expression, with concomitant decreased CF cell adhesion and significant clinical improvement.", {"entities": [[50, 54, "GENE"]]}], ["Cryptogenic organizing pneumonia (COP) is a clinicopathological syndrome of unknown origin.", {"entities": [[23, 32, "DISEASE"], [64, 72, "DISEASE"]]}], ["Corticosteroids are the standard treatment, but clarithromycin (CAM) is also effective.", {"entities": []}], ["The aim of this observational retrospective study was to compare the results of CAM versus prednisone (PRE) treatment in patients with biopsy-proven OP without respiratory insufficiency.", {"entities": []}], ["In a 15-year period, 40 patients were treated with CAM (500 mg twice daily orally for 3 months) and 22 with PRE (mean initial dose of 0.67 \u00b1 0.24 mg/kg/d for a mean of 8.59 \u00b1 3.05 months).", {"entities": []}], ["The clinical presentation, laboratory, and radiological findings did not differ markedly between patients treated with CAM and PRE, with the exception of a higher frequency of sweats (55% vs. 23%; p < 0.015), ground glass opacities (95% vs. 50%; p <0.0001) and nodular lesions (45% vs. 18%; p = 0.036) in the CAM group.", {"entities": []}], ["A complete response was achieved in 35(88%) patients treated with CAM and in all treated with PRE.", {"entities": []}], ["Patients treated with PRE relapsed more frequently than those treated with CAM (54.5% vs. 10%; p < 0.0001).", {"entities": []}], ["Corticosteroid-related adverse events were noticed in 8(6.5%) patients (with one death), but CAM caused only one (2.5%) allergic reaction.", {"entities": []}], ["A FVC >80% identified patients who might be successfully treated with CAM with a sensitivity of 60% and a specificity of 88.57% (AUC 0.869; 95% CI 0.684\u20131; p = 0.008); the figures for the FEV1 were >70%, a sensitivity of 60%, and a specificity of 91.43% (AUC 0.809; 95%CI 0.609\u20131; p = 0.027).", {"entities": []}], ["CAM can be used to treat COP patients in whom the pulmonary function parameters are within normal limits.", {"entities": []}], ["Such therapy is shorter, better tolerated, and associated with fewer adverse events and relapses than is PRE.", {"entities": []}], ["However, the therapy is ineffective in some patients.", {"entities": []}], ["The implementation of guidelines and training initiatives to support communication in cross-cultural primary care consultations is ad hoc across a range of international settings with negative consequences particularly for migrants.", {"entities": []}], ["This situation reflects a well-documented translational gap between evidence and practice and is part of the wider problem of implementing guidelines and the broader range of professional educational and quality interventions in routine practice.", {"entities": []}], ["In this paper, we describe our use of a contemporary social theory, Normalization Process Theory and participatory research methodology\u2014Participatory Learning and Action\u2014to investigate and support implementation of such guidelines and training initiatives in routine practice.", {"entities": []}], ["This is a qualitative case study, using multiple primary care sites across Europe.", {"entities": []}], ["Purposive and maximum variation sampling approaches will be used to identify and recruit stakeholders\u2014migrant service users, general practitioners, primary care nurses, practice managers and administrative staff, interpreters, cultural mediators, service planners, and policy makers.", {"entities": []}], ["We are conducting a mapping exercise to identify relevant guidelines and training initiatives.", {"entities": []}], ["We will then initiate a PLA-brokered dialogue with stakeholders around Normalization Process Theory\u2019s four constructs\u2014coherence, cognitive participation, collective action, and reflexive monitoring.", {"entities": []}], ["Through this, we will enable stakeholders in each setting to select a single guideline or training initiative for implementation in their local setting.", {"entities": []}], ["We will prospectively investigate and support the implementation journeys for the five selected interventions.", {"entities": []}], ["Data will be generated using a Participatory Learning and Action approach to interviews and focus groups.", {"entities": []}], ["Data analysis will follow the principles of thematic analysis, will occur in iterative cycles throughout the project and will involve participatory co-analysis with key stakeholders to enhance the authenticity and veracity of findings.", {"entities": []}], ["This research employs a unique combination of Normalization Process Theory and Participatory Learning and Action, which will provide a novel approach to the analysis of implementation journeys.", {"entities": []}], ["The findings will advance knowledge in the field of implementation science because we are using and testing theoretical and methodological approaches so that we can critically appraise their scope to mediate barriers and improve the implementation processes.", {"entities": []}], ["B and T lymphocyte attenuator (BTLA) is an inhibitory receptor, whose primary role in CD4 336 consecutive patients were included in this study.", {"entities": [[31, 35, "GENE"], [86, 89, "GENE"]]}], ["BTLA expression on CD4 Our results showed that the percentage of BTLA Our study shows that the percentage of BTLA", {"entities": [[0, 4, "GENE"], [65, 69, "GENE"], [109, 113, "GENE"], [19, 22, "GENE"], [0, 4, "GENE"], [65, 69, "GENE"], [109, 113, "GENE"], [0, 4, "GENE"], [65, 69, "GENE"], [109, 113, "GENE"]]}], ["Enzymatic metabolism of polyunsaturated fatty acids (PUFAs) leads to formation of bioactive lipid metabolites (LMs).", {"entities": []}], ["Previous studies have shown that obesity leads to deregulation of LMs in adipose tissues.", {"entities": [[33, 40, "DISEASE"]]}], ["However, most previous studies have focused on single or limited number of LMs, few systematical analyses have been carried out.", {"entities": []}], ["We used a LC-MS/MS-based lipidomics approach, which can analyze >100 LMs produced by cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) enzymes, to analyze profile of LMs in high-fat diet-induced obesity in mice.", {"entities": [[213, 220, "DISEASE"]]}], ["LC-MS/MS showed that dietary feeding of high-fat diet significantly modulated profiles of LMs in adipose tissues.", {"entities": []}], ["Among the three major PUFA metabolizing pathways (COX, LOX, and CYP), CYP-derived fatty acid epoxides were the most dramatically altered LMs.", {"entities": []}], ["Almost all types of fatty acid epoxides were reduced by 70\u201390% in adipose tissues of high-fat diet-fed mice.", {"entities": []}], ["Consistent with the reduced levels of fatty acid epoxides, the gene expressions of several CYP epoxygenases, including Cyp2j5, Cyp2j6 , and Cyp2c44 , were significantly reduced in adipose tissues of high-fat diet-fed mice.", {"entities": []}], ["Our results showed that CYP-derived fatty acid epoxides are the most responsive LMs in high-fat diet-induced obesity, suggesting that these LMs could play critical roles in obesity.", {"entities": [[109, 116, "DISEASE"], [173, 180, "DISEASE"]]}], ["Tuberculosis (TB) is a notifiable disease and health care providers are required to notify every TB case to local authorities.", {"entities": []}], ["We conducted a pilot study to determine the usefulness and feasibility of mobile interface in TB notification (MITUN) voice based system for notification of TB cases by private medical practitioners.", {"entities": []}], ["The study was conducted during September 2013 to October 2014 in three zones of Chennai, an urban setting in South India.", {"entities": []}], ["Private clinics wherein services are provided by single private medical practitioners were approached.", {"entities": []}], ["The steps involved in MITUN included: Registration of the practitioners and notification of TB cases by them through voice interactions.", {"entities": []}], ["Pre and post-intervention questionnaires were administered to collect information on TB notification practices and feasibility of MITUN after an implementation period of 6 months.", {"entities": []}], ["A total of 266 private medical practitioners were approached for the study.", {"entities": []}], ["Of them, 184 (69%) participated in the study; of whom 11 (6%) practitioners used MITUN for TB notification.", {"entities": []}], ["Reasons for not using MITUN include lack of time, referral of patients to government facility, issues related to patient confidentiality and technical problems.", {"entities": []}], ["Suggestions for making mobile phone based TB notification process user-friendly included reducing call duration, including only crucial questions and using missed call or SMS options.", {"entities": [[171, 174, "GENE"]]}], ["The performance (feasibility and usefulness) of MITUN voice based system for TB notification in the present format was sub-optimal.", {"entities": []}], ["Perceived problems, logistical and practical issues preclude scale\u2013up of notification of TB by private practitioners.", {"entities": []}], ["Manual acupuncture has commonly been used in China, either alone or in combination with conventional medicine, to treat diabetic peripheral neuropathy (DPN).", {"entities": [[140, 150, "DISEASE"], [129, 150, "DISEASE"]]}], ["The objective of this study was to perform a systematic review to evaluate the potential benefits and harms of manual acupuncture for DPN to justify its clinical use.", {"entities": []}], ["We searched for published and unpublished randomized controlled trials of manual acupuncture for DPN till 31 March 2013.", {"entities": []}], ["Revman 5.2 software was used for data analysis with effect estimate presented as relative risk (RR) and mean difference (MD) with a 95% confidence interval (CI).", {"entities": []}], ["A total of 25 trials involving 1649 participants were included.", {"entities": []}], ["The methodological quality of included trials was generally poor.", {"entities": []}], ["Meta-analysis showed that manual acupuncture had better effect on global symptom improvement compared with mecobalamin (RR 1.31, 95%CI 1.21 to 1.42), vitamin B1 and B12 (RR 1.55, 95%CI 1.33 to 1.80), and no treatment (RR 1.56, 95%CI 1.31 to 1.85), and that the combination of manual acupuncture and mecobalamin had better effect compared with mecobalamin alone on global symptom improvement (RR 1.56, 95%CI 1.28 to 1.90).", {"entities": []}], ["Adverse events were not reported in any trials.", {"entities": []}], ["The asymmetric funnel plot suggested publication bias.", {"entities": []}], ["Despite the number of trials of manual acupuncture for DPN and their uniformly positive results, no clinically relevant conclusions can be drawn from this review due to the trials\u2019 high risks of bias and the possibility of publication bias.", {"entities": []}], ["Clearly defined and internationally acknowledged outcome measures are required for future study.", {"entities": []}], ["There remains an urgent need for training Chinese researchers in conducting unbiased trials as well as prospectively registering all initiated Chinese trials to avoid publication bias.", {"entities": []}], ["Chronic rhinosinusitis with nasal polyps (CRSwNP) is a highly heterogeneous disease with different host defence responses.", {"entities": []}], ["However, whether periostin and vascular endothelial growth factor (VEGF) are similarly impaired in patients with eosinophilic CRSwNP (ENP) and those with non-eosinophilic CRSwNP (nENP) remains unclear.", {"entities": []}], ["We sought to evaluate the expression and possible modulation of periostin and VEGF, regulated on activation normal T expressed and secreted (RANTES) and eotaxin-2 in the polyp tissues from 30 patients with ENP and from 36 patients with nENP and in middle turbinate tissues from 12 control subjects.", {"entities": []}], ["We found that ENP tissues exhibited a significantly increased expression of periostin and VEGF compared with tissues from patients with nENP and control subjects ( P \u2009<\u20090.05, respectively).", {"entities": []}], ["Accordingly, the expression of VEGF, RANTES, and eotaxin-2 in ENP fibroblasts was significantly up-regulated after stimulation with up-regulated periostin in vitro , but the expression of VEGF and RANTES was significantly inhibited by stimulation with down-regulated periostin.", {"entities": []}], ["Our findings suggest that periostin might play an important role in the occurrence and progression of ENP and might be a potential therapeutic target.", {"entities": []}], ["Perinatal audit and the three-delays model are increasingly being employed to analyse barriers to perinatal health, at both community and facility level.", {"entities": []}], ["Using these approaches, our aim was to assess factors that could contribute to perinatal mortality and potentially avoidable deaths at Rwandan hospitals.", {"entities": []}], ["Perinatal audits were carried out at two main urban hospitals, one at district level and the other at tertiary level, in Kigali, Rwanda, from July 2012 to May 2013.", {"entities": []}], ["Stillbirths and early neonatal deaths occurring after 22 completed weeks of gestation or more, or weighing at least 500\u00a0g, were included in the study.", {"entities": []}], ["Factors contributing to mortality and potentially avoidable deaths, considering the local resources and feasibility, were identified using a three-delays model.", {"entities": []}], ["Out of 8424 births, there were 269 perinatal deaths (106 macerated stillbirths, 63 fresh stillbirths, 100 early neonatal deaths) corresponding to a stillbirth rate of 20/1000 births and a perinatal mortality rate of 32/1000 births.", {"entities": []}], ["In total, 250 perinatal deaths were available for audit.", {"entities": []}], ["Factors contributing to mortality were ascertained for 79% of deaths.", {"entities": []}], ["Delay in care-seeking was identified in 39% of deaths, delay in arriving at the health facility in 10%, and provision of suboptimal care at the health facility in 37%.", {"entities": []}], ["Delay in seeking adequate care was commonly characterized by difficulties in recognising or reporting pregnancy-related danger signs.", {"entities": []}], ["Lack of money was the major cause of delay in reaching a health facility.", {"entities": []}], ["Delay in referrals, diagnosis and management of emergency obstetric cases were the most prominent contributors affecting the provision of appropriate and timely care by healthcare providers.", {"entities": []}], ["Half of the perinatal deaths were judged to be potentially avoidable and 70% of these were fresh stillbirths and early neonatal deaths.", {"entities": []}], ["Factors contributing to delays underlying perinatal mortality were identified in more than three-quarters of deaths.", {"entities": []}], ["Half of the perinatal deaths were considered likely to be preventable and mainly related to modifiable maternal inadequate health-seeking behaviours and intrapartum suboptimal care.", {"entities": []}], ["Strengthening the current roadmap strategy for accelerating the reduction of maternal and neonatal morbidity and mortality is needed for improved perinatal survival.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-017-1269-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There is a lack of evidence regarding the effectiveness of graphic health warning labels (GHWL) in different individuals, including patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[146, 183, "DISEASE"]]}], ["Investigating knowledge and attitudes may allow better implementation of future public health policies.", {"entities": []}], ["We hypothesised that differences in the impact of GHWL exist between non-smokers, smokers and patients with COPD, with decreased efficacy in those groups who are longer and more frequently exposed to them.", {"entities": []}], ["163 participants (54% male, aged 21\u201380) including 60 non-smokers, 53 smokers and 50 patients with COPD (Gold stage II\u2013IV), attending London respiratory outpatient clinics, participated in case-controlled surveys (50 items).", {"entities": []}], ["Ten different GHWL were shown and demographics, smoking history, plans to quit, smoking-risk awareness, emotional response, processing and impact of GHWL on behaviour were recorded.", {"entities": []}], ["Patients were further asked to prioritise the hypothetical treatment or prevention of five specific smoking-related diseases.", {"entities": []}], ["Smokers, in particular those with COPD, were less susceptible to GHWL than non-smokers; 53.4% of all participants expressed fear when looking at GHWL, non-smokers (71.9%) more so than smokers (39.8%, p<0.001).", {"entities": []}], ["COPD participants were less aware of the consequences than non-COPD participants (p<0.001), including an awareness of lung cancer (p=0.001).", {"entities": [[118, 129, "DISEASE"], [123, 129, "DISEASE"]]}], ["Lung cancer (95%), oral cancer (90.2%), heart disease (84.7%) and stroke (71.2%) were correctly associated with smoking, whereas blindness was least associated (23.9%).", {"entities": [[129, 138, "DISEASE"], [0, 11, "DISEASE"], [40, 53, "DISEASE"], [5, 11, "DISEASE"], [24, 30, "DISEASE"]]}], ["However, blindness was prioritised over oral cancer, stroke and in patients with COPD also over heart disease when participants were asked about hypothetical treatment or prevention.", {"entities": [[9, 18, "DISEASE"], [96, 109, "DISEASE"], [45, 51, "DISEASE"]]}], ["GHWL are most effective in non-smokers and a desensitisation effect was observed in smokers and patients with COPD.", {"entities": []}], ["As a consequence, a tailored and concerted public health approach to use such messages is required and \u2018blindness\u2019 deserves to be mentioned in this context because of an unexpectedly high-deterring impact.", {"entities": [[104, 113, "DISEASE"]]}], ["Objective: The objective of this study was to investigate if a breathing technique could counteract the effects of hyperventilation due to a sustained attention task on shoulder muscle activity.", {"entities": []}], ["Background: The trend towards higher levels of automation in industry is increasing.", {"entities": []}], ["Consequently, manufacturing operators often monitor automated process for long periods of their work shift.", {"entities": []}], ["Prolonged monitoring work requires sustained attention, which is a cognitive process that humans are typically poor at and find stressful.", {"entities": []}], ["As sustained attention becomes an increasing requirement of manufacturing operators\u2019 job content, the resulting stress experienced could contribute to the onset of many health problems, including work related musculoskeletal disorders (WRMSDs).", {"entities": []}], ["Methods: The SART attention test was completed by a group of participants before and after a breathing intervention exercise.", {"entities": []}], ["The effects of the abdominal breathing intervention on breathing rate, upper trapezius muscle activity and end-tidal CO 2 were evaluated.", {"entities": []}], ["Results: The breathing intervention reduced the moderation effect of end-tidal CO 2 on upper trapezius muscle activity.", {"entities": []}], ["Conclusions: Abdominal breathing could be a useful technique in reducing the effects of sustained attention work on muscular activity.", {"entities": []}], ["Application: This research can be applied to highly-automated manufacturing industries, where prolonged monitoring of work is widespread and could, in its role as a stressor, be a potential contributor to WRMSDs.", {"entities": []}], ["Anti-inflammatory transcriptional effects of nineteen compounds ( 1 \u2013 19 ) from the soft coral Sinularia maxima were evaluated using NF-\u03baB luciferase and reverse transcriptase polymerase chain reaction.", {"entities": []}], ["Compounds 1 , 2 , 4 , 8 , 15 , 17 , and 18 significantly inhibited TNF\u03b1-induced NF-\u03baB transcriptional activity in HepG2 cells in a dose-dependent manner, with IC 50 values ranging from 15.81\u00a0\u00b1\u00a02.29 to 29.10\u00a0\u00b1\u00a01.54\u00a0\u03bcM.", {"entities": []}], ["Furthermore, the transcriptional inhibitory function of these compounds was confirmed by a decrease in intercellular adhesion molecule-1 and inducible nitric oxide synthase gene expression levels in HepG2 cells.", {"entities": []}], ["These results provide a scientific rationale for the use of the soft coral S. maxima warrant further studies to develop new agents for the prevention and treatment of inflammatory.", {"entities": []}], ["This study is part of a cross-sectional evaluation of complementary medicine providers in primary care in Switzerland.", {"entities": []}], ["It compares patient satisfaction with anthroposophic medicine (AM) and conventional medicine (CON).", {"entities": []}], ["We collected baseline data on structural characteristics of the physicians and their practices and health status and demographics of the patients.", {"entities": []}], ["Four weeks later patients assessed their satisfaction with the received treatment (five items, four point rating scale) and evaluated the praxis care (validated 23-item questionnaire, five point rating scale).", {"entities": []}], ["1946 adult patients of 71 CON and 32 AM primary care physicians participated.", {"entities": []}], ["Baseline characteristics: AM patients were more likely female (75.6% vs. 59.0%, p < 0.001) and had higher education (38.6% vs. 24.7%, p < 0.001).", {"entities": []}], ["They suffered more often from chronic illnesses (52.8% vs. 46.2%, p = 0.015) and cancer (7.4% vs. 1.1%).", {"entities": [[81, 87, "DISEASE"]]}], ["AM consultations lasted on average 23,3 minutes (CON: 16,8 minutes, p < 0.001).", {"entities": []}], ["Satisfaction: More AM patients expressed a general treatment satisfaction (56.1% vs. 43.4%, p < 0.001) and saw their expectations completely fulfilled at follow-up (38.7% vs. 32.6%, p < 0.001).", {"entities": []}], ["AM patients reported significantly fewer adverse side effects (9.3% vs. 15.4%, p = 0.003), and more other positive effects from treatment (31.7% vs. 17.1%, p < 0.001).", {"entities": []}], ["Europep: AM patients appreciated that their physicians listened to them (80.0% vs. 67.1%, p < 0.001), spent more time (76.5% vs. 61.7%, p < 0.001), had more interest in their personal situation (74.6% vs. 60.3%, p < 0.001), involved them more in decisions about their medical care (67.8% vs. 58.4%, p = 0.022), and made it easy to tell the physician about their problems (71.6% vs. 62.9%, p = 0.023).", {"entities": []}], ["AM patients gave significantly better rating as to information and support (in 3 of 4 items p [less than or equal to] 0.044) and for thoroughness (70.4% vs. 56.5%, p < 0.001).", {"entities": []}], ["AM patients were significantly more satisfied and rated their physicians as valuable partners in the treatment.", {"entities": []}], ["This suggests that subject to certain limitations, AM therapy may be beneficial in primary care.", {"entities": []}], ["To confirm this, more detailed qualitative studies would be necessary.", {"entities": []}], ["The mammalian heme peroxidases (MHPs) are a medically important group of enzymes.", {"entities": []}], ["Included in this group are myeloperoxidase, eosinophil peroxidase, lactoperoxidase, and thyroid peroxidase.", {"entities": []}], ["These enzymes are associated with such diverse diseases as asthma, Alzheimer's disease and inflammatory vascular disease.", {"entities": [[104, 120, "DISEASE"], [59, 65, "DISEASE"]]}], ["Despite much effort to elucidate a clearer understanding of the function of the 4 major groups of this multigene family, we still do not have a clear understanding of their relationships to each other.", {"entities": []}], ["Sufficient signal exists for the resolution of the evolutionary relationships of this family of enzymes.", {"entities": []}], ["We demonstrate, using a root mean squared deviation statistic, how the removal of the fastest evolving sites aids in the minimisation of the effect of long branch attraction and the generation of a highly supported phylogeny.", {"entities": []}], ["Based on this phylogeny we have pinpointed the amino acid positions that have most likely contributed to the diverse functions of these enzymes.", {"entities": []}], ["Many of these residues are in close proximity to sites implicated in protein misfolding, loss of function or disease.", {"entities": []}], ["Our analysis of all available genomic sequence data for the MHPs from all available completed mammalian genomes, involved sophisticated methods of phylogeny reconstruction and data treatment.", {"entities": []}], ["Our study has (i) fully resolved the phylogeny of the MHPs and the subsequent pattern of gene duplication, and (ii), we have detected amino acids under positive selection that have most likely contributed to the observed functional shifts in each type of MHP.", {"entities": []}], ["Studies exploring the effect of television viewing on obesity throughout childhood are conflicting.", {"entities": [[54, 61, "DISEASE"]]}], ["Most studies have been confined to single high-income countries.", {"entities": []}], ["Our aim was to examine the association between television viewing habits and Body Mass Index (BMI) in adolescents and children in a multicentre worldwide sample.", {"entities": []}], ["In the International Study of Asthma and Allergies in Children Phase Three, adolescents aged between 12 and 15 years completed questionnaires which included questions on television viewing habits, height and weight.", {"entities": []}], ["Parents/guardians of children aged between 5 and 8 years completed the same questionnaire on behalf of their children.", {"entities": []}], ["The questionnaire asked \u201cDuring a normal week, how many hours a day (24 hours) do you (does your child) watch television?\u201d Responses were categorised as; \u201cshort\u201d (<1 hour), \u201cmoderate\u201d (1 to \u22643 hours), \u201clong\u201d (3 to \u22645 hours) and \u201cprolonged\u201d (>5 hours).", {"entities": []}], ["207,672 adolescents from 37 countries and 77,003 children from 18 countries provided data.", {"entities": []}], ["Daily television viewing in excess of one hour was reported in 89% of adolescents and 79% of children.", {"entities": []}], ["Compared with adolescents in the short viewing group, those in the moderate, long and prolonged groups had BMIs that were 0.14 kg/m Increased television viewing hours were positively associated with BMI in both adolescents and children with an apparent dose response effect.", {"entities": []}], ["These findings extend the evidence that television viewing contributes to increased BMI in childhood.", {"entities": []}], ["Environmental factors are thought to contribute significantly to the increase of asthma prevalence in the last two decades.", {"entities": [[81, 87, "DISEASE"]]}], ["Bisphenol A (BPA) is a xenoestrogen commonly used in consumer products and the plastic industry.", {"entities": []}], ["There is evidence and an ongoing discussion that endocrine disruptors like BPA may affect human health and also exert alterations on in the immune system.", {"entities": []}], ["The aim of this study was to investigate age-dependent effects of BPA on the asthma risk using a murine model to explain the controversial results reported till date.", {"entities": [[77, 83, "DISEASE"]]}], ["BALB/c mice were exposed to BPA via the drinking water for different time periods including pregnancy and breastfeeding.", {"entities": []}], ["To induce an asthma phenotype, mice were sensitized to ovalbumin (OVA), followed by an intrapulmonary allergen challenge.", {"entities": [[13, 19, "DISEASE"]]}], ["BPA exposure during pregnancy and breastfeeding had no significant effect on asthma development in the offspring.", {"entities": [[77, 83, "DISEASE"]]}], ["In contrast, lifelong exposure from birth until the last antigen challenge clearly increased eosinophilic inflammation in the lung, airway hyperreactivity and antigen-specific serum IgE levels in OVA-sensitized adult mice compared to mice without BPA exposure.", {"entities": []}], ["Surprisingly, BPA intake during the sensitization period significantly reduced the development of allergic asthma.", {"entities": [[98, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["This effect was reversed in the presence of a glucocorticoid receptor antagonist.", {"entities": []}], ["Our results demonstrate that the impact of BPA on asthma risk is strongly age-dependent and ranges from asthma-promoting to asthma-reducing effects.", {"entities": [[50, 56, "DISEASE"], [104, 110, "DISEASE"], [124, 130, "DISEASE"]]}], ["This could explain the diversity of results from previous studies regarding the observed health impact of BPA.", {"entities": []}], ["Acute respiratory infections (ARIs) are a major cause of morbidity and mortality in children in Africa.", {"entities": []}], ["The circulation of viruses classically implicated in ARIs is poorly known in Burkina Faso.", {"entities": []}], ["The aim of this study was to identify the respiratory viruses present in children admitted to or consulting at the pediatric hospital in Ouagadougou.", {"entities": []}], ["From July 2010 to July 2011, we tested nasal aspirates of 209 children with upper or lower respiratory infection for main respiratory viruses (respiratory syncytial virus (RSV), metapneumovirus, adenovirus, parainfluenza viruses 1, 2 and 3, influenza A, B and C, rhinovirus/enterovirus), by immunofluorescence locally in Ouagadougou, and by PCR in France.", {"entities": [[241, 250, "DISEASE"]]}], ["Bacteria have also been investigated in 97 samples.", {"entities": []}], ["153 children (73.2%) carried at least one virus and 175 viruses were detected.", {"entities": []}], ["Rhinoviruses/enteroviruses were most frequently detected (rhinovirus n\u200a=\u200a88; enterovirus n\u200a=\u200a38) and were found to circulate throughout the year.", {"entities": []}], ["An epidemic of RSV infections (n\u200a=\u200a25) was identified in September/October, followed by an epidemic of influenza virus (n\u200a=\u200a13), mostly H1N1pdm09.", {"entities": [[103, 112, "DISEASE"]]}], ["This epidemic occurred during the period of the year in which nighttime temperatures and humidity were at their lowest.", {"entities": []}], ["Other viruses tested were detected only sporadically.", {"entities": []}], ["Twenty-two viral co-infections were observed.", {"entities": []}], ["Bacteria were detected in 29/97 samples with 22 viral/bacterial co-infections.", {"entities": []}], ["This study, the first of its type in Burkina Faso, warrants further investigation to confirm the seasonality of RSV infection and to improve local diagnosis of influenza.", {"entities": [[160, 169, "DISEASE"]]}], ["The long-term objective is to optimize therapeutic management of infected children.", {"entities": []}], ["Patient: Male, 48 Final Diagnosis: Low dose cyclophosphamide-induced acute hepatotoxicity Symptoms: Epigastric pain Medication: Withdrawal of cyclophosphamide Clinical Procedure: \u2014 Specialty: Nephrology \u2022 Hepatology \u2022 Gastroenterology \u2022 Toxicology Unexpected drug reaction Cyclophosphamide is commonly used to treat cancers, systemic vasculitides, and kidney diseases (e.g., lupus nephritis and focal segmental glomerulosclerosis).", {"entities": [[395, 429, "DISEASE"], [381, 390, "DISEASE"]]}], ["Acute adverse effects include bone marrow suppression, hemorrhagic cystitis, nausea, vomiting, and hair loss.", {"entities": [[67, 75, "DISEASE"]]}], ["Hepatotoxicity with high dose cyclophosphamide is well recognized but hepatitis due to low dose cyclophosphamide has rarely been described.", {"entities": [[70, 79, "DISEASE"]]}], ["We report the case of a 48-year-old Chinese man with a rapidly progressive glomerulonephritis secondary to granulomatosis with polyangiitis who developed severe acute hepatic failure within 24 hours of receiving low-dose intravenous cyclophosphamide.", {"entities": [[75, 93, "DISEASE"], [55, 93, "DISEASE"]]}], ["The diagnosis of granulomatosis with polyangiitis was supported with a positive c-ANCA serology.", {"entities": []}], ["The patient was treated with high dose methylprednisolone, plasmapheresis, intermittent hemodialysis, and low-dose intravenous cyclophosphamide.", {"entities": []}], ["Hepatotoxicity may occur even after low-dose intravenous cyclophosphamide treatment.", {"entities": []}], ["To the best of our knowledge, this is the first report of severe, non-viral, liver inflammation developing within 24 hours of administration of low-dose intravenous cyclophosphamide (200 mg).", {"entities": []}], ["Physicians should be aware of this serious adverse reaction and should not repeat the cyclophosphamide dose when there is hepatotoxicity caused by the first dose.", {"entities": []}], ["Initial and follow-up liver function tests should be monitored in all patients receiving cyclophosphamide treatment.", {"entities": []}], ["Although \u03b2-blockers are an established therapy in heart failure (HF) guidelines, including for patients with chronic obstructive pulmonary disease (COPD), there remain concerns regarding bronchoconstriction even with cardioselective \u03b2-blockers.", {"entities": [[109, 146, "DISEASE"]]}], ["We wished to assess the real-life use of \u03b2-blockers for patients with HF and comorbid COPD.", {"entities": []}], ["We evaluated data from the Optimum Patient Care Research Database over a period of 1\u2005year for co-prescribing of \u03b2-blockers with either an ACE inhibitor (ACEI) or angiotensin-2 receptor blocker (ARB) in patients with HF alone versus HF+COPD.", {"entities": []}], ["Association with inhaler therapy was also evaluated.", {"entities": []}], ["We identified 89\u2005861 patients with COPD, 24\u2005237 with HF and 10\u2005853 with both conditions.", {"entities": []}], ["In patients with HF+COPD, the mean age was 79\u2005years; 60% were male, and 27% had prior myocardial infarction.", {"entities": [[86, 107, "DISEASE"]]}], ["Of patients with HF+COPD, 22% were taking a \u03b2-blocker in conjunction with either ACEI/ARB (n=2416) compared with 41% of patients with HF only (n=10\u2005002) (adjusted OR 0.54, 95% CI 0.51 to 0.58, p<0.001).", {"entities": []}], ["Among HF+COPD patients taking inhaled corticosteroid (ICS) with long-acting \u03b2-agonist (LABA) and long-acting muscarinic antagonist, 27% of patients were taking an ACEI/ARB with \u03b2-blockers (n=778) versus 46% taking an ACEI/ARB without \u03b2-blockers (n=1316).", {"entities": []}], ["Corresponding figures for those patients taking ICS/LABA were 20% (n=583) versus 48% (n=1367), respectively.", {"entities": []}], ["These data indicate a substantial unmet need for patients with COPD who should be prescribed \u03b2-blockers more often for concomitant HF.", {"entities": []}], ["Hypoxia-inducible factor 1 (HIF-1) is a critical regulator for cellular oxygen balance.", {"entities": []}], ["Myocardial hypoxia can induce the increased expression of HIF-1\u03b1.", {"entities": []}], ["Our goals were to evaluate the value of HIF-1\u03b1 in predicting death of patients with acute decompensated heart failure (ADHF) and describe the in vivo relationship between serum HIF-1\u03b1 and N-terminal\u2013pro-brain natriuretic peptide (NT-proBNP) levels.", {"entities": []}], ["We included 296 patients who were consecutively admitted to the emergency department for ADHF.", {"entities": []}], ["The primary end point was in-hospital death.", {"entities": []}], ["The patients were categorized as HF r EF (patients with reduced systolic function) and HF p EF (patients with preserved systolic function) groups.", {"entities": []}], ["In our patients, the median admission HIF-1\u03b1 level was 2.95\u2009\u00b1\u20090.85\u00a0ng/ml.", {"entities": []}], ["The HIF-1\u03b1 level was elevated significantly in HF r EF patients and deceased patients compared with HF p EF patients and patients who survived.", {"entities": []}], ["The HIF-1\u03b1 level was positively correlated with NT-proBNP and cardiac troponin T levels, and negatively correlated with left ventricular ejection fraction and systolic blood pressure.", {"entities": []}], ["Kaplan\u2013Meier curves revealed a significant increase in in-hospital mortality in ADHF patients with higher HIF-1\u03b1 levels.", {"entities": []}], ["Multivariable Cox regression analysis showed that HIF-1\u03b1 levels were not correlated with the short-term prognosis of ADHF patients.", {"entities": []}], ["This is the first study to evaluate the circulating levels of HIF-1\u03b1 in ADHF patients.", {"entities": []}], ["Serum HIF-1\u03b1 levels may reflect a serious state in patients with ADHF.", {"entities": []}], ["Due to the limitations of the study, serum HIF-1\u03b1 levels were not correlated with the in-hospital mortality based on regression analysis.", {"entities": []}], ["Further studies are needed to demonstrate the diagnostic and/or prognostic role of HIF-1\u03b1 as a risk biomarker in patients with ADHF.", {"entities": []}], ["There is growing evidence that genetic risk factors for common disease are caused by hereditary changes of gene regulation acting in complex pathways.", {"entities": []}], ["Clearly understanding the molecular genetic relationships between genetic control of gene expression and its effect on complex diseases is essential.", {"entities": []}], ["Here we describe the Brisbane Systems Genetics Study (BSGS), a family-based study that will be used to elucidate the genetic factors affecting gene expression and the role of gene regulation in mediating endophenotypes and complex diseases.", {"entities": []}], ["BSGS comprises of a total of 962 individuals from 314 families, for which we have high-density genotype, gene expression and phenotypic data.", {"entities": []}], ["Families consist of combinations of both monozygotic and dizygotic twin pairs, their siblings, and, for 72 families, both parents.", {"entities": []}], ["A significant advantage of the inclusion of parents is improved power to disentangle environmental, additive genetic and non-additive genetic effects of gene expression and measured phenotypes.", {"entities": []}], ["Furthermore, it allows for the estimation of parent-of-origin effects, something that has not previously been systematically investigated in human genetical genomics studies.", {"entities": []}], ["Measured phenotypes available within the BSGS include blood phenotypes and biochemical traits measured from components of the tissue sample in which transcription levels are determined, providing an ideal test case for systems genetics approaches.", {"entities": []}], ["We report results from an expression quantitative trait loci (eQTL) analysis using 862 individuals from BSGS to test for associations between expression levels of 17,926 probes and 528,509 SNP genotypes.", {"entities": []}], ["At a study wide significance level approximately 15,000 associations were observed between expression levels and SNP genotypes.", {"entities": []}], ["These associations corresponded to a total of 2,081 expression quantitative trait loci (eQTL) involving 1,503 probes.", {"entities": []}], ["The majority of identified eQTL (87%) were located within cis -regions.", {"entities": []}], ["The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumatoid arthritis synovial tissue and involved in the progress of inflammatory arthritis.", {"entities": [[92, 112, "DISEASE"], [103, 112, "DISEASE"], [174, 183, "DISEASE"]]}], ["However, the detailed mechanism of how 5-lipoxygenase regulates the inflammatory response in arthritis synovial tissue is still unclear.", {"entities": [[93, 102, "DISEASE"]]}], ["The aim of this study was to investigate the involvement of lipoxygenase pathways in TNF-\u03b1-induced production of cytokines and chemokines.", {"entities": []}], ["Human synovial fibroblasts from rheumatoid patients were used in this study.", {"entities": []}], ["5-LOX inhibitors and shRNA were used to examine the involvement of 5-LOX in TNF-\u03b1-induced cytokines and chemokines expression.", {"entities": []}], ["The signaling pathways were examined by Western Blotting or immunofluorescence staining.", {"entities": []}], ["The effect of 5-LOX inhibitor on TNF-\u03b1-induced chemokine expression and paw edema was also explored in vivo in C57BL/6 mice.", {"entities": []}], ["Treatment with 5-LOX inhibitors significantly decreased TNF-\u03b1-induced pro-inflammatory mediators including interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) in human synovial fibroblasts.", {"entities": []}], ["Knockdown of 5-LOX using shRNA exerted similar inhibitory effects.", {"entities": []}], ["The abrogation of NF-\u03baB activation was involved in the antagonizing effects of these inhibitors.", {"entities": []}], ["Furthermore, 5-LOX inhibitor decreased TNF-\u03b1-induced up-regulation of serum MCP-1 level and paw edema in mouse model.", {"entities": []}], ["Our results provide the evidence that the administration of 5-LOX inhibitors is able to ameliorate TNF-\u03b1-induced cytokine/chemokine release and paw edema, indicating that 5-LOX inhibitors may be developed for therapeutic treatment of inflammatory arthritis.", {"entities": [[247, 256, "DISEASE"]]}], ["As recorded in Traditional Chinese Medicine (TCM) theory, Gancao (Glycyrrhizae Radix et Rhizoma) could weaken the pharmacological effect or increase the toxicity of Yuanhua (Genkwa Flos).", {"entities": []}], ["However, the theory has been suspected due to lack of evidence.", {"entities": []}], ["Here, we investigate whether Gancao could weaken Yuanhua\u2019s diuretic effect, if so, which chemicals and which targets may be involved.", {"entities": []}], ["Results showed that Yuanhua exerted diuretic effect through down-regulating renal AQP 2, without electrolyte disturbances such as K", {"entities": []}], ["It is widely held that the occupational well-being of physicians may affect the quality of their patient care.", {"entities": []}], ["Yet, there is still no comprehensive synthesis of the evidence on this connection.", {"entities": []}], ["This systematic review studied the effect of physicians\u2019 occupational well-being on the quality of patient care.", {"entities": []}], ["We systematically searched PubMed, Embase, and PsychINFO from inception until August 2014.", {"entities": []}], ["Two authors independently reviewed the studies.", {"entities": []}], ["Empirical studies that explored the association between physicians\u2019 occupational well-being and patient care quality were considered eligible.", {"entities": []}], ["Data were systematically extracted on study design, participants, measurements, and findings.", {"entities": []}], ["The Medical Education Research Study Quality Instrument (MERSQI) was used to assess study quality.", {"entities": []}], ["Ultimately, 18 studies were included.", {"entities": []}], ["Most studies employed an observational design and were of average quality.", {"entities": []}], ["Most studies reported positive associations of occupational well-being with patient satisfaction, patient adherence to treatment, and interpersonal aspects of patient care.", {"entities": []}], ["Studies reported conflicting findings for occupational well-being in relation to technical aspects of patient care.", {"entities": []}], ["One study found no association between occupational well-being and patient health outcomes.", {"entities": []}], ["The association between physicians\u2019 occupational well-being and health care\u2019s ultimate goal\u2014improved patient health\u2014remains understudied.", {"entities": []}], ["Nonetheless, research up till date indicated that physicians\u2019 occupational well-being can contribute to better patient satisfaction and interpersonal aspects of care.", {"entities": []}], ["These insights may help in shaping the policies on physicians\u2019 well-being and quality of care.", {"entities": []}], ["The online version of this article (doi:10.1007/s12529-015-9473-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The first adverse reactions to cow\u2019s milk were already described 2000\u00a0years ago.", {"entities": []}], ["However, it was only 50\u00a0years ago that several groups started with the analysis of cow\u2019s milk allergens.", {"entities": []}], ["Meanwhile the spectrum of allergy eliciting proteins within cow\u2019s milk is identified and several cow\u2019s milk allergens have been characterized regarding their biochemical properties, fold and IgE binding epitopes.", {"entities": []}], ["The diagnosis of cow\u2019s milk allergy is diverse ranging from fast and cheap in vitro assays to elaborate in vivo assays.", {"entities": []}], ["Considerable effort was spent to improve the diagnosis from an extract-based into a component resolved concept.", {"entities": []}], ["There is still no suitable therapy available against cow\u2019s milk allergy except avoidance.", {"entities": []}], ["Therefore research needs to focus on the development of suitable and safe immunotherapies that do not elicit severe side effect.", {"entities": []}], ["There is uncertainty about the influence of diet during pregnancy and infancy on a child\u2019s immune development.", {"entities": []}], ["We assessed whether variations in maternal or infant diet can influence risk of allergic or autoimmune disease.", {"entities": []}], ["Two authors selected studies, extracted data, and assessed risk of bias.", {"entities": []}], ["Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to assess certainty of findings.", {"entities": []}], ["We searched Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica dataBASE (EMBASE), Web of Science, Central Register of Controlled Trials (CENTRAL), and Literatura Latino Americana em Ci\u00eancias da Sa\u00fade (LILACS) between January 1946 and July 2013 for observational studies and until December 2017 for intervention studies that evaluated the relationship between diet during pregnancy, lactation, or the first year of life and future risk of allergic or autoimmune disease.", {"entities": []}], ["We identified 260 original studies (964,143 participants) of milk feeding, including 1 intervention trial of breastfeeding promotion, and 173 original studies (542,672 participants) of other maternal or infant dietary exposures, including 80 trials of maternal ( n = 26), infant ( n = 32), or combined ( n = 22) interventions.", {"entities": []}], ["Risk of bias was high in 125 (48%) milk feeding studies and 44 (25%) studies of other dietary exposures.", {"entities": []}], ["Evidence from 19 intervention trials suggests that oral supplementation with nonpathogenic micro-organisms (probiotics) during late pregnancy and lactation may reduce risk of eczema (Risk Ratio [RR] 0.78; 95% CI 0.68\u20130.90; I Our findings support a relationship between maternal diet and risk of immune-mediated diseases in the child.", {"entities": []}], ["Maternal probiotic and fish oil supplementation may reduce risk of eczema and allergic sensitisation to food, respectively.", {"entities": []}], ["Robert Boyle and colleagues reveal the importance of a pregnant woman's diet.", {"entities": []}], ["Diets supplemented with probiotics and fish oils may reduce the likelihood of eczema and other autoimmune conditions in children.", {"entities": []}], ["There is uncertainty about the effects of specific dietary variations in early life on risk of immune-mediated disease.", {"entities": []}], ["We undertook a systematic review of observational and intervention studies of maternal diet during pregnancy and lactation and infant diet during the first year of life to evaluate whether dietary exposures in early life influence risk of allergic or autoimmune disease.", {"entities": []}], ["We found that supplementation with micro-organisms (probiotics) during late pregnancy and breastfeeding may reduce risk of eczema, and fish oil supplementation during pregnancy and breastfeeding may reduce risk of sensitisation to food allergens.", {"entities": []}], ["We found more limited data that longer duration of breastfeeding may reduce risk of eczema and type 1 diabetes mellitus.", {"entities": [[95, 119, "DISEASE"], [102, 119, "DISEASE"]]}], ["A mother\u2019s diet during pregnancy and lactation may influence her child\u2019s risk of developing allergic disease.", {"entities": []}], ["The purpose of this study was to evaluate the antibacterial activity against polymicrobial (PM) biofilms of a condensed tannin extracted from astringent persimmon (PS-M), which is contained in refreshing beverages commercially available in Japan.", {"entities": []}], ["Salivary PM biofilms were formed anaerobically on glass coverslips for 24 and 72\u2009h and were treated for 5\u2009min with sterilized deionized water (DW), 0.05 and 0.2\u2009wt% chlorhexidine digluconate (CHX), and 0.5\u20134.0\u2009wt% PS-M solution.", {"entities": []}], ["The colony forming units (CFU/mL) were determined and morphological changes of the biofilms were observed by scanning electron microscopy (SEM).", {"entities": []}], ["The CFUs were lower in all PS-M and CHX groups compared to the DW group.", {"entities": []}], ["PS-M exerted a dose-dependent effect.", {"entities": []}], ["PS-M (1.53 \u00d7 10", {"entities": []}], ["Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and the Americas, whereas type 2 (HTLV-2) is widely distributed among the indigenous peoples of the Americas, where it appears to be more prevalent than HTLV-1, and in some tribes of Central Africa.", {"entities": []}], ["HTLV-2 is considered ancestral in the Americas and is transmitted to the general population and injection drug users from the indigenous population.", {"entities": []}], ["In the Americas, HTLV-1 has more than one origin, being brought by immigrants in the Paleolithic period through the Bering Strait, through slave trade during the colonial period, and through Japanese immigration from the early 20", {"entities": []}], ["The objective was to delineate the current knowledge of fractional flow reserve (FFR) in terms of definition, features, clinical applications, and pitfalls of measurement of FFR.", {"entities": []}], ["We searched database for primary studies published in English.", {"entities": []}], ["The database of National Library of Medicine (NLM), MEDLINE, and PubMed up to July 2014 was used to conduct a search using the keyword term \u201cFFR\u201d.", {"entities": []}], ["The articles about the definition, features, clinical application, and pitfalls of measurement of FFR were identified, retrieved, and reviewed.", {"entities": []}], ["Coronary pressure-derived FFR rapidly assesses the hemodynamic significance of individual coronary artery lesions and can readily be performed in the catheterization laboratory.", {"entities": []}], ["The use of FFR has been shown to effectively guide coronary revascularization procedures leading to improved patient outcomes.", {"entities": []}], ["FFR is a valuable tool to determine the functional significance of coronary stenosis.", {"entities": [[67, 84, "DISEASE"]]}], ["It combines physiological and anatomical information, and can be followed immediately by percutaneous coronary intervention (PCI) if necessary.", {"entities": []}], ["The technique of FFR measurement can be performed easily, rapidly, and safely in the catheterization laboratory.", {"entities": []}], ["By systematic use of FFR in dubious stenosis and multi-vessel disease, PCI can be made an even more effective and better treatment than it is currently.", {"entities": []}], ["The current clinical evidence for FFR should encourage cardiologists to use this tool in the catheterization laboratory.", {"entities": []}], ["Care pathways have become a popular tool to enhance the quality of care by improving patient outcomes, promoting patient safety, increasing patient satisfaction, and optimizing the use of resources.", {"entities": []}], ["We performed a disease specific systematic review to determine how care pathways in the hospital treatment of heart failure affect in-hospital mortality, length of in-hospital stay, readmission rate and hospitalisation cost when compared with standard care.", {"entities": []}], ["Medline, Cinahl, Embase and the Cochrane Central Register of Controlled Trials were searched from 1985 to 2010.", {"entities": []}], ["Each study was assessed independently by two reviewers.", {"entities": []}], ["Methodological quality of the included studies was assed using the Jadad methodological approach for randomised controlled trials, controlled clinical trials and the New Castle Ottawa Scale for case\u2013control studies, cohort studies and time interrupted series.", {"entities": []}], ["Seven studies met the study inclusion criteria and were included in the systematic review with a total sample of 3,690 patients.", {"entities": []}], ["The combined overall results showed that care pathways have a significant positive effect on mortality and readmission rate.", {"entities": []}], ["A shorter length of hospital stay was also observed compared with the standard care group.", {"entities": []}], ["No significant difference was found in the hospitalisation costs.", {"entities": []}], ["More positive results were observed in controlled trials compared to randomized controlled trials.", {"entities": []}], ["By combining all possible results, it can be concluded that care pathways for treatment of heart failure decrease mortality rates and length of hospital stay, but no statistically significant difference was observed in the readmission rates and hospitalisation costs.", {"entities": []}], ["However, one should be cautious with overall conclusions: what works for one organization may not work for another because of the subtle differences in processes and bottlenecks.", {"entities": []}], ["Oxidative stress, which occurs after ultraviolet (UV) radiation, usually results in Glucocorticoid (GC) resistance and the subsequent development of skin inflammation.", {"entities": [[100, 102, "GENE"]]}], ["One approach to protecting the skin against UV radiation is the use of antioxidants.", {"entities": []}], ["The ginsenoside Rg1 is a novel natural antioxidant isolated from the medicinal plant Panax ginseng C.A.", {"entities": []}], ["We demonstrated that UVB exposure exacerbated inflammation and reduced both the level of the glucocorticoid receptor (GR) and the efficacy of dexamethasone (Dex) in human keratinocytes (HaCaT cells).", {"entities": []}], ["Pretreatment with Rg1 increased the expression of GR and restored Dex responsiveness to inflammation in UVB-irradiated HaCaT cells.", {"entities": []}], ["Mechanistically, Rg1 rescued UVB-induced HDAC2 degradation.", {"entities": [[41, 46, "GENE"]]}], ["HDAC2 knockdown partially abolished the Rg1-induced up-regulation of GR and the enhancement of GC sensitivity.", {"entities": [[0, 5, "GENE"], [95, 97, "GENE"]]}], ["In addition, Rg1 reduced the production of reactive oxygen species (ROS), which preceded the up-regulation of HDAC2, and consequent sensitization of cells to Dex.", {"entities": [[110, 115, "GENE"]]}], ["Moreover, Rg1 treatment promoted the translocation and activation of Nrf2.", {"entities": []}], ["Nrf2 knockdown partially abolished the Rg1-induced decrease of ROS production and increase of HDAC2.", {"entities": [[94, 99, "GENE"]]}], ["Rg1 also potentiated the anti-inflammatory effects of Dex in UVB-irradiated mouse skin.", {"entities": []}], ["In conclusion, we demonstrated that Rg1 attenuated UVB-induced GC insensitivity.", {"entities": [[63, 65, "GENE"]]}], ["Notably, these effects were partially mediated by the Nrf2/HDAC2 pathway.", {"entities": []}], ["Autoimmune thyroid disease (AITD) shows the highest incidence among organ-specific autoimmune diseases and is the most common thyroid disease in humans, including Graves' disease (GD) and Hashimoto's thyroiditis (HT).", {"entities": [[200, 211, "DISEASE"]]}], ["The susceptibility to autoimmune diseases is affected by increased autoantibody levels, susceptibility gene polymorphisms, environmental factors, and psychological factors, but the pathogenesis remains unclear.", {"entities": []}], ["Various cytokines and related genes encoding them play important roles in the development and progression of AITD.", {"entities": []}], ["CD152, an expression product of the CTLA-4 gene, downregulates T cell activation.", {"entities": []}], ["The A/A genotype polymorphism in the CT60 locus may reduce the production of thyroid autoantibodies.", {"entities": []}], ["The C1858T polymorphism of the PTNP22 gene reduces the expression of its encoded LYP, which increases the risk of GD and HT.", {"entities": []}], ["GD is an organ-specific autoimmune disease involving increased secretion of thyroid hormone, whereas HT may be associated with the destruction of thyroid gland tissue and hypothyroidism.", {"entities": [[171, 185, "DISEASE"]]}], ["These two diseases exhibit similar pathogenesis but opposite trends in the clinical manifestations.", {"entities": []}], ["In this review, we focus on the structure and function of these cytokines and related genes in AITD, as well as the association of polymorphisms with susceptibility to GD and HT, and attempt to describe their differences in pathogenesis and clinical manifestations.", {"entities": []}], ["Background: Children of mothers who smoked during pregnancy have a lower birth weight but have a higher chance to become overweight during childhood.", {"entities": []}], ["Objectives: We followed children longitudinally to assess the age when higher body mass index (BMI) z -scores became evident in the children of mothers who smoked during pregnancy, and to evaluate the trajectory of changes until adolescence.", {"entities": []}], ["Methods: We pooled data from two German cohort studies that included repeated anthropometric measurements until 14 years of age and information on smoking during pregnancy and other risk factors for overweight.", {"entities": []}], ["We used longitudinal quantile regression to estimate age- and sex-specific associations between maternal smoking and the 10th, 25th, 50th, 75th, and 90th quantiles of the BMI z -score distribution in study participants from birth through 14 years of age, adjusted for potential confounders.", {"entities": []}], ["We used additive mixed models to estimate associations with mean BMI z -scores.", {"entities": []}], ["Results: Mean and median (50th quantile) BMI z -scores at birth were smaller in the children of mothers who smoked during pregnancy compared with children of nonsmoking mothers, but BMI z -scores were significantly associated with maternal smoking beginning at the age of 4\u20135 years, and differences increased over time.", {"entities": []}], ["For example, the difference in the median BMI z -score between the daughters of smokers versus nonsmokers was 0.12 (95% CI: 0.01, 0.21) at 5 years, and 0.30 (95% CI: 0.08, 0.39) at 14 years of age.", {"entities": []}], ["For lower BMI z -score quantiles, the association with smoking was more pronounced in girls, whereas in boys the association was more pronounced for higher BMI z -score quantiles.", {"entities": []}], ["Conclusions: A clear difference in BMI z -score (mean and median) between children of smoking and nonsmoking mothers emerged at 4\u20135 years of age.", {"entities": []}], ["The shape and size of age-specific effect estimates for maternal smoking during pregnancy varied by age and sex across the BMI z -score distribution.", {"entities": []}], ["Citation: Riedel C, Fenske N, M\u00fcller MJ, Plachta-Danielzik S, Keil T, Grabenhenrich L, von Kries R. 2014.", {"entities": []}], ["Differences in BMI z -scores between offspring of smoking and nonsmoking mothers: a longitudinal study of German children from birth through 14 years of age.", {"entities": []}], ["Environ Health Perspect 122:761\u2013767;\u2002 http://dx.doi.org/10.1289/ehp.1307139", {"entities": []}], ["Cognitive skills are one component of school readiness that reflect a child\u2019s neurodevelopment and are influenced by environmental and social factors.", {"entities": []}], ["Most studies assess the impact of these factors individually, without taking into consideration the complex interactions of multiple factors.", {"entities": []}], ["The objective of this study was to examine the joint association of markers of environmental pollution and of social factors on early cognitive skills in an urban cohort of children.", {"entities": []}], ["For this, we chose isophorone in ambient air as a marker of industrial air pollution.", {"entities": []}], ["Low quality home learning environments was chosen as a marker of the social factors contributing to cognitive development.", {"entities": []}], ["Using a subpopulation from the Early Childhood Longitudinal Study, Birth Cohort (N = 4050), isophorone exposure was assigned using the 2002 National Air Toxics Assessment.", {"entities": []}], ["Home learning environment was assessed with a modified version of the Home Observation for Measurement of the Environment (HOME) Inventory, and standardized math assessment scores were used as a measure of early cognitive skills.", {"entities": []}], ["Multiple linear regression was used to estimate the effect of both exposures on math scores.", {"entities": []}], ["After adjustment for confounders, children living in areas with ambient isophorone in the upper quintile of exposure (>0.49 ng/m", {"entities": []}], ["There is increasing concern about potential long-term effects of antibiotics on children's health.", {"entities": []}], ["Epidemiological studies have revealed that early-life antibiotic exposure can increase the risk of developing immune and metabolic diseases, and rodent studies have shown that administration of high doses of antibiotics has long-term effects on brain neurochemistry and behaviour.", {"entities": []}], ["Here we investigate whether low-dose penicillin in late pregnancy and early postnatal life induces long-term effects in the offspring of mice.", {"entities": []}], ["We find that penicillin has lasting effects in both sexes on gut microbiota, increases cytokine expression in frontal cortex, modifies blood\u2013brain barrier integrity and alters behaviour.", {"entities": []}], ["The antibiotic-treated mice exhibit impaired anxiety-like and social behaviours, and display aggression.", {"entities": []}], ["Concurrent supplementation with Lactobacillus rhamnosus JB-1 prevents some of these alterations.", {"entities": []}], ["These results warrant further studies on the potential role of early-life antibiotic use in the development of neuropsychiatric disorders, and the possible attenuation of these by beneficial bacteria.", {"entities": []}], ["There is concern about potential long-term effects of antibiotics on children's health.", {"entities": []}], ["Here Leclercq et al .", {"entities": []}], ["show, in mice, that low doses of penicillin during late pregnancy and early life induce lasting effects on the offspring, including alterations in gut microbiota, brain cytokine levels and behaviour.", {"entities": []}], ["5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls).", {"entities": []}], ["The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE].", {"entities": []}], ["Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards.", {"entities": []}], ["In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls.", {"entities": []}], ["The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated.", {"entities": []}], ["Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively.", {"entities": []}], ["The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.", {"entities": []}], ["Management of eosinophilic esophagitis (EoE) requires repeated endoscopic mucosal sampling to assess disease activity.", {"entities": [[27, 38, "DISEASE"], [14, 38, "DISEASE"]]}], ["A less invasive and expensive means of monitoring of EoE is required.", {"entities": []}], ["The objective of this study was to assess the accuracy, safety, and tolerability of the cytosponge compared to endoscopy and biopsy for histologic assessment of EoE.", {"entities": []}], ["In this prospective two-center cross-sectional study, patients with known EoE underwent cytosponge sampling followed by endoscopy and biopsy.", {"entities": []}], ["Sample adequacy and eosinophil counts (eos/HPF) were determined for both cytosponge and endoscopic samples.", {"entities": []}], ["The cytosponge was assessed for diagnostic accuracy, safety, and patient preference as compared to endoscopy.", {"entities": []}], ["Six patients (7%) failed to swallow the sponge.", {"entities": []}], ["One hundred and five procedures were successfully performed in 80 patients (66% male, 100% white, 19% stricture).", {"entities": []}], ["The cytosponge sample was adequate in 102 and the biopsy in 104; 101 procedures had adequate samples by both techniques.", {"entities": []}], ["Fifty-seven biopsies were graded as active EoE with \u226515 eos/HPF as the gold standard.", {"entities": []}], ["Eosinophil counts highly correlated between the biopsy and cytosponge ( r =0.78, P <0.0001).", {"entities": []}], ["Using a cutoff of \u226415 eos/HPF for inactive disease, the sensitivity and specificity of the cytosponge was 75% and 86%, respectively.", {"entities": []}], ["Six patients had active EoE on cytosponge not found on biopsy.", {"entities": []}], ["For biopsies with inactive EoE, the cytosponge identified 38/44.", {"entities": []}], ["No complications occurred, and cytosponge endoscopic abrasion scores were low (0.34/4).", {"entities": []}], ["Patients preferred cytosponge to endoscopy with higher rating scores (7.27 vs. 6.11, P =0.002).", {"entities": []}], ["Compared to endoscopy with biopsy, cytosponge provided a minimally invasive, safe, well tolerated, and accurate method to assess EoE histologic activity.", {"entities": []}], ["(ClinicalTrial.gov number NCT01585103).", {"entities": []}], ["Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening disorders that have substantial adverse effects on outcomes in critically ill patients.", {"entities": [[55, 63, "DISEASE"]]}], ["ALI/ARDS develops in response to pulmonary or extrapulmonary injury and is characterized by increased leakage from the pulmonary microvasculature and excessive infiltration of polymorphonuclear cells into the lung.", {"entities": []}], ["Currently, no therapeutic strategies are available to control these fundamental pathophysiological processes in human ALI/ARDS.", {"entities": []}], ["In a variety of animal models and experimental settings, the purine nucleoside adenosine has been demonstrated to regulate both endothelial barrier integrity and polymorphonuclear cell trafficking in the lung.", {"entities": []}], ["Adenosine exerts its effects through four G-protein-coupled receptors (A 1 , A 2A , A 2B , and A 3 ) that are expressed on leukocytes and nonhematopoietic cells, including endothelial and epithelial cells.", {"entities": []}], ["Each type of adenosine receptor (AR) is characterized by a unique pharmacological and physiological profile.", {"entities": []}], ["The development of selective AR agonists and antagonists, as well as the generation of gene-deficient mice, has contributed to a growing understanding of the cellular and molecular processes that are critically involved in the development of ALI/ARDS.", {"entities": []}], ["Adenosine-dependent pathways are involved in both protective and proinflammatory effects, highlighting the need for a detailed characterization of the distinct pathways.", {"entities": []}], ["This review summarizes current experimental observations on the role of adenosine signaling in the development of acute lung injury and illustrates that adenosine and ARs are promising targets that may be exploited in the development of innovative therapeutic strategies.", {"entities": []}], ["Understanding the genetic basis of airflow obstruction and smoking behaviour is key to determining the pathophysiology of chronic obstructive pulmonary disease (COPD).", {"entities": [[122, 159, "DISEASE"]]}], ["We used UK Biobank data to study the genetic causes of smoking behaviour and lung health.", {"entities": []}], ["We sampled individuals of European ancestry from UK Biobank, from the middle and extremes of the forced expiratory volume in 1 s (FEV 1 ) distribution among heavy smokers (mean 35 pack-years) and never smokers.", {"entities": [[130, 133, "GENE"]]}], ["We developed a custom array for UK Biobank to provide optimum genome-wide coverage of common and low-frequency variants, dense coverage of genomic regions already implicated in lung health and disease, and to assay rare coding variants relevant to the UK population.", {"entities": []}], ["We investigated whether there were shared genetic causes between different phenotypes defined by extremes of FEV 1 .", {"entities": [[109, 112, "GENE"]]}], ["We also looked for novel variants associated with extremes of FEV 1 and smoking behaviour and assessed regions of the genome that had already shown evidence for a role in lung health and disease.", {"entities": [[62, 65, "GENE"]]}], ["We set genome-wide significance at p<5\u2008\u00d7\u200810 UK Biobank participants were recruited from March 15, 2006, to July 7, 2010.", {"entities": []}], ["Sample selection for the UK BiLEVE study started on Nov 22, 2012, and was completed on Dec 20, 2012.", {"entities": [[52, 55, "GENE"]]}], ["We selected 50\u2008008 unique samples: 10\u2008002 individuals with low FEV 1 , 10\u2008000 with average FEV 1 , and 5002 with high FEV 1 from each of the heavy smoker and never smoker groups.", {"entities": [[63, 66, "GENE"], [91, 94, "GENE"], [118, 121, "GENE"], [63, 66, "GENE"], [91, 94, "GENE"], [118, 121, "GENE"], [63, 66, "GENE"], [91, 94, "GENE"], [118, 121, "GENE"]]}], ["We noted a substantial sharing of genetic causes of low FEV 1 between heavy smokers and never smokers (p=2\u00b729\u2008\u00d7\u200810 1 , including signals at four novel loci (KANSL1, TSEN54, TET2, and RBM19/TBX5) and independent signals at two previously reported loci (NPNT and HLA-DQB1/HLA-DQA2).", {"entities": [[56, 59, "GENE"], [165, 171, "GENE"], [173, 177, "GENE"], [252, 256, "GENE"]]}], ["These variants also showed association with COPD, including in individuals with no history of smoking.", {"entities": []}], ["The number of copies of a 150 kb region containing the 5\u2032 end of KANSL1, a gene that is important for epigenetic gene regulation, was associated with extremes of FEV 1 .", {"entities": [[162, 165, "GENE"]]}], ["We also discovered five new genome-wide significant signals for smoking behaviour, including a variant in NCAM1 (chromosome 11) and a variant on chromosome 2 (between TEX41 and PABPC1P2 ) that has a trans effect on expression of NCAM1 in brain tissue.", {"entities": [[106, 111, "GENE"], [229, 234, "GENE"], [106, 111, "GENE"], [229, 234, "GENE"]]}], ["By sampling from the extremes of the lung function distribution in UK Biobank, we identified novel genetic causes of lung function and smoking behaviour.", {"entities": []}], ["These results provide new insight into the specific mechanisms underlying airflow obstruction, COPD, and tobacco addiction, and show substantial shared genetic architecture underlying airflow obstruction across individuals, irrespective of smoking behaviour and other airway disease.", {"entities": []}], ["Medical Research Council.", {"entities": []}], ["Patients with syndromic features frequently suffer from recurrent respiratory infections, but little is known about the spectrum of immunological abnormalities associated with their underlying chromosomal aberrations outside the well-known examples of Down and DiGeorge syndromes.", {"entities": []}], ["Therefore, we performed this retrospective, observational survey study.", {"entities": []}], ["All members of the European Society for Immunodeficiencies (ESID) were invited to participate by reporting their patients with chromosomal aberration (excluding Down and DiGeorge syndromes) in combination with one or more identified immunological abnormalities potentially relating to primary immunodeficiency.", {"entities": []}], ["An online questionnaire was used to collect the patient data.", {"entities": []}], ["Forty-six patients were included from 16 centers (24 males, 22 females; median age 10.4\u00a0years [range 1.0\u201369.2\u00a0years]; 36 pediatric, 10 adult patients).", {"entities": []}], ["A variety of chromosomal aberrations associated with immunological abnormalities potentially relating to primary immune deficiency was reported.", {"entities": []}], ["The most important clinical presentation prompting the immunological evaluation was \u2018recurrent ear-nose-throat (ENT) and airway infections\u2019.", {"entities": []}], ["Immunoglobulin isotype and/or IgG-subclass deficiencies were the most prevalent immunological abnormalities reported.", {"entities": []}], ["Our survey yielded a wide variety of chromosomal aberrations associated with immunological abnormalities potentially relating to primary immunodeficiency.", {"entities": []}], ["Although respiratory tract infections can often also be ascribed to other causes (e.g.", {"entities": []}], ["aspiration or structural abnormalities), we show that a significant proportion of patients also have an antibody deficiency requiring specific treatment (e.g.", {"entities": []}], ["immunoglobulin replacement, antibiotic prophylaxis).", {"entities": []}], ["Therefore, it is important to perform immunological investigations in patients with chromosomal aberrations and recurrent ENT or airway infections, to identify potential immunodeficiency that can be specifically treated.", {"entities": []}], ["The online version of this article (doi:10.1186/s13023-016-0492-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Aim : The Helping Evaluate Exenatide in overweight patients with diabetes compared with Long-Acting insulin (HEELA) study was designed to examine whether the glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, could improve HbA1c (\u22647.4%) with minimal weight gain (\u22641 kg) compared with insulin glargine.", {"entities": []}], ["Methods : Patients [body mass index (BMI) >27 kg/m Results : The study population had baseline mean (s.d.)", {"entities": []}], ["age of 56.5 (9.1) years and BMI of 34.1 (5.3) kg/m Conclusions : Additional treatment with exenatide resulted in significantly more overweight and obese patients with an elevated cardiovascular risk and type 2 diabetes achieving better glycaemic control with minimal weight gain compared with insulin glargine.", {"entities": []}], ["P. falciparum malaria is one of the most widespread and deadliest infectious diseases in children under five years in endemic areas.", {"entities": [[14, 21, "DISEASE"]]}], ["The disease has been a strong force for evolutionary selection in the human genome, and uncovering the critical human genetic factors that confer resistance to the disease would provide clues to the molecular basis of protective immunity that would be invaluable for vaccine development.", {"entities": []}], ["We investigated the effect of single nucleotide polymorphisms (SNPs) on malaria pathology in a case- control study of 1862 individuals from two major ethnic groups in three regions with intense perennial P. falciparum transmission in Cameroon.", {"entities": [[72, 79, "DISEASE"]]}], ["Twenty nine polymorphisms in cytokine and toll-like receptor (TLR) genes as well as the sickle cell trait (HbS) were assayed on the Sequenom iPLEX platform.", {"entities": []}], ["Our results confirm the known protective effect of HbS against severe malaria and also reveal a protective effect of SNPs in interleukin-10 (IL10) cerebral malaria and hyperpyrexia.", {"entities": [[147, 163, "DISEASE"], [70, 77, "DISEASE"], [156, 163, "DISEASE"], [141, 145, "GENE"]]}], ["Furthermore, IL17RE rs708567 GA and hHbS rs334 AT individuals were associated with protection from uncomplicated malaria and anaemia respectively in this study.", {"entities": [[113, 120, "DISEASE"], [13, 19, "GENE"]]}], ["Meanwhile, individuals with the hHbS rs334 TT, IL10 rs3024500 AA, and IL17RD rs6780995 GA genotypes were more susceptible to severe malarial anaemia, cerebral malaria, and hyperpyrexia respectively.", {"entities": [[150, 166, "DISEASE"], [159, 166, "DISEASE"], [47, 51, "GENE"], [70, 76, "GENE"]]}], ["Taken together, our results suggest that polymorphisms in some immune response genes may have important implications for the susceptibility to severe malaria in Cameroonians.", {"entities": [[150, 157, "DISEASE"]]}], ["Moreover using uncomplicated malaria may allow us to identify novel pathways in the early development of the disease.", {"entities": [[29, 36, "DISEASE"]]}], ["Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected with diffuse panbronchiolitis and cystic fibrosis.", {"entities": [[133, 148, "DISEASE"]]}], ["Consensus is building that the therapeutic effects are due to anti-inflammatory, rather than anti-microbial activities, but the mode of action is likely complex.", {"entities": []}], ["To gain insights into how the macrolide azithromycin (AZT) modulates inflammatory responses in airways, well-differentiated primary cultures of human airway epithelia were exposed to AZT alone, an inflammatory stimulus consisting of soluble factors from cystic fibrosis airways, or AZT followed by the inflammatory stimulus.", {"entities": [[254, 269, "DISEASE"]]}], ["RNA microarrays were conducted to identify global and specific gene expression changes.", {"entities": []}], ["Analysis of gene expression changes revealed that the AZT treatment alone altered the gene profile of the cells, primarily by significantly increasing the expression of lipid/cholesterol genes and decreasing the expression of cell cycle/mitosis genes.", {"entities": []}], ["The increase in cholesterol biosynthetic genes was confirmed by increased filipin staining, an index of free cholesterol, after AZT treatment.", {"entities": []}], ["AZT also affected genes with inflammatory annotations, but the effect was variable (both up- and down-regulation) and gene specific.", {"entities": []}], ["AZT pretreatment prevented the up-regulation of some genes, such as MUC5AC and MMP9, triggered by the inflammatory stimulus, but the up-regulation of other inflammatory genes, e.g., cytokines and chemokines, such as interleukin-8, was not affected.", {"entities": [[79, 83, "GENE"]]}], ["On the other hand, HLA genes were increased by AZT.", {"entities": [[19, 22, "GENE"]]}], ["Notably, secreted IL-8 protein levels did not reflect mRNA levels, and were, in fact, higher after AZT pretreatment in cultures exposed to the inflammatory stimulus, suggesting that AZT can affect inflammatory pathways other than by altering gene expression.", {"entities": []}], ["These findings suggest that the specific effects of AZT on inflamed and non-inflamed airway epithelia are likely relevant to its clinical activity, and their apparent complexity may help explain the diverse immunomodulatory roles of macrolides.", {"entities": []}], ["Reducing preventable harm from repeat medication prescriptions is a patient safety priority worldwide.", {"entities": []}], ["In the United Kingdom, repeat prescriptions items issued has doubled in the last 20\u00a0years from 5.8 to 13.3 items per patient per annum.", {"entities": []}], ["This has significant resource implications and consequences for avoidable patient harms.", {"entities": []}], ["Consequently, we aimed to test a risk management model to identify, measure, and reduce repeat prescribing system risks in primary care.", {"entities": []}], ["All 48 general medical practices in National Health Service (NHS) Lambeth Clinical Commissioning Group (an inner city area of south London in England) were recruited.", {"entities": [[61, 64, "GENE"]]}], ["Multiple interventions were implemented, including educational workshops, a web\u2010based risk monitoring system, and external reviews of repeat prescribing system risks by clinicians.", {"entities": []}], ["Data were collected via documentation reviews and interviews and subject to basic thematic and descriptive statistical analyses.", {"entities": []}], ["Across the 48 participating general practices, 62 unique repeat prescribing risks were identified on 505 occasions (eg, practices frequently experiencing difficulty interpreting medication changes on hospital discharge summaries), equating to a mean of 8.1 risks per practice (range: 1\u201033; SD\u00a0=\u00a07.13).", {"entities": []}], ["Seven hundred sixty\u2010seven system improvement actions were recommended across 96 categories (eg, alerting hospitals to illegible writing and delays with discharge summaries) with a mean of 15.6 actions per practice (range: 0\u201034; SD\u00a0=\u00a08.0).", {"entities": []}], ["The risk management model tested uncovered important safety concerns and facilitated the development and communication of related improvement recommendations.", {"entities": []}], ["System\u2010wide information on hazardous repeat prescribing and how this could be mitigated is very limited.", {"entities": []}], ["The approach reported may have potential to close this gap and improve the reliability of general practice systems and patient safety, which should be of high interest to primary care organisations internationally.", {"entities": []}], ["As differences in gas exchange between pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) have been demonstrated, we asked if cardiac output measurements determined by acetylene (C 2 H 2 ) uptake significantly differed in these diseases when compared to the thermodilution technique.", {"entities": [[58, 70, "DISEASE"], [114, 126, "DISEASE"], [104, 126, "DISEASE"]]}], ["Single-breath open-circuit C 2 H 2 uptake, thermodilution, and cardiopulmonary exercise testing were performed in 72 PAH and 32 CTEPH patients.", {"entities": []}], ["In PAH patients the results for cardiac output obtained by the two methods showed an acceptable agreement with a mean difference of -0.16 L/min (95% CI -2.64 to 2.32 L/min).", {"entities": []}], ["In contrast, the agreement was poorer in the CTEPH group with the difference being -0.56 L/min (95% CI -4.96 to 3.84 L/min).", {"entities": []}], ["Functional dead space ventilation (44.5 \u00b1 1.6 vs. 32.2 \u00b1 1.4%, p < 0.001) and the mean arterial to end-tidal CO 2 gradient (9.9 \u00b1 0.8 vs. 4.1 \u00b1 0.5 mmHg, p < 0.001) were significantly elevated among CTEPH patients.", {"entities": []}], ["Cardiac output evaluation by the C 2 H 2 technique should be interpreted with caution in CTEPH, as ventilation to perfusion mismatching might be more relevant than in PAH.", {"entities": []}], ["Primary health care (PHC) physicians manage most patients with irritable bowel syndrome (IBS).", {"entities": [[63, 87, "DISEASE"], [79, 87, "DISEASE"]]}], ["In Saudi Arabia, there are limited data on their knowledge, attitudes, and practices about this disorder.", {"entities": []}], ["This study aimed to assess knowledge, attitudes, and practices of primary care physicians about IBS.", {"entities": []}], ["A cross-sectional survey of 70 practitioners aged 36 \u00b1 10.25 years was carried out in primary care centers in AlJouf Province of Saudi Arabia.", {"entities": []}], ["The physicians were asked to fill a valid questionnaire containing their sociodemographic data, and well-modified questions regarding their knowledge, attitudes, and practices about IBS.", {"entities": []}], ["Data was processed and analyzed using SPSS (version 15) program, and the level of significance was set at P <0.05.", {"entities": []}], ["A response rate of 92.9% yielded 65 questionnaires for analysis.", {"entities": []}], ["Majority of physicians surveyed (83.1%) considered IBS as a common health problem in Saudi Arabia, and (55.4%) believed it is underestimated.", {"entities": []}], ["There was a significant association between physicians\u2019 qualifications and using diagnostic tools to facilitate IBS diagnosis (14.3% vs 35.5%; P <0.05), while utilization of \u201cRome or Manning criteria\u201d was more frequent by physicians with master's degree (35.5%) compared to residents (14.3%).", {"entities": []}], ["Also, 35.4% of physicians (15 males and 8 females) were not sure how to diagnose IBS.", {"entities": []}], ["This study suggested that PHC physicians had a suitable attitude toward IBS, but they lacked knowledge, and their practices toward this condition were inappropriate.", {"entities": []}], ["The aim of this study was to investigate the feasibility of main pulmonary artery diameter quantification by thoracic computerized tomography (CT) in the diagnosis of pulmonary hypertension seconder to biomass smoke exposure.", {"entities": [[177, 189, "DISEASE"], [167, 189, "DISEASE"]]}], ["One hundred and four women subjects with biomass smoke exposure and 20 healthy women subjects were enrolled in the prospective study.", {"entities": []}], ["The correlation between echocardiographic estimation of systolic pulmonary artery pressure and the main pulmonary artery diameter of the cases were studied.", {"entities": []}], ["The main pulmonary artery diameter was 26.9\u00b15.1 in the control subjects and 37.1\u00b16.4 in subjects with biomass smoke exposure.", {"entities": []}], ["This difference was statistically significant (p<0.001).", {"entities": []}], ["The systolic pulmonary artery pressure was 22.7\u00b112.4 in the control subjects and 57.3\u00b122 in subjects with biomass smoke exposure.", {"entities": []}], ["This difference was statistically significant (p<0.001).", {"entities": []}], ["Systolic pulmonary artery pressure was significantly correlated with the main pulmonary artery diameter (r=0.614, p<0.01).", {"entities": []}], ["A receiver operating characteristic (ROC) curve analysis showed that a value of 29 mm of the main pulmonary artery diameter differentiated between pulmonary hypertension and non-pulmonary hypertension patients.", {"entities": [[157, 169, "DISEASE"], [188, 200, "DISEASE"], [147, 169, "DISEASE"], [178, 200, "DISEASE"]]}], ["The sensitivity of the measurement to diagnose pulmonary hypertension was 91% and specificity was 80%.", {"entities": [[57, 69, "DISEASE"], [47, 69, "DISEASE"]]}], ["Our results indicate that main pulmonary artery diameter measurements by SCT may suggest presence of pulmonary hypertension in biomass smoke exposed women.", {"entities": [[111, 123, "DISEASE"], [101, 123, "DISEASE"]]}], ["Impact of non-communicable diseases is not well-documented in Ethiopia.", {"entities": []}], ["We aimed to document the prevalence and mortality associated with four major non-communicable diseases in Ethiopia: cardiovascular disease, cancer, diabetes, and chronic obstructive pulmonary disease.", {"entities": [[162, 199, "DISEASE"], [140, 146, "DISEASE"]]}], ["Associated risk factors: hypertension, tobacco-use, harmful use of alcohol, overweight/obesity, and khat -chewing were also studied.", {"entities": [[25, 37, "DISEASE"], [87, 94, "DISEASE"]]}], ["Systematic review of peer-reviewed and grey literature between 1960 and 2011 was done using PubMed search engines and local libraries to identify prevalence studies on the four diseases.", {"entities": []}], ["In total, 32 studies were found, and half of these studies were from Addis Ababa.", {"entities": []}], ["Two hospital-based studies reviewed the prevalence of cardiovascular disease and found a prevalence of 7.2% and 24%; a hospital-based study reviewed cancer prevalence and found a prevalence of 0.3%; two hospital-based studies reviewed diabetes prevalence and found a prevalence of 0.5% and 1.2%; and two hospital-based studies reviewed prevalence of asthma and found a prevalence of 1% and 3.5%.", {"entities": [[350, 356, "DISEASE"], [149, 155, "DISEASE"]]}], ["Few community-based studies were done on the prevalence of diabetes and chronic pulmonary obstructive disease among the population.", {"entities": []}], ["Several studies reviewed the impact of these diseases on mortality: cardiovascular disease accounts for 24% of deaths in Addis Ababa, cancer causes 10% of deaths in the urban settings and 2% deaths in rural setting, and diabetes causes 5% and chronic obstructive pulmonary disease causes 3% of deaths.", {"entities": [[243, 280, "DISEASE"], [134, 140, "DISEASE"]]}], ["Several studies reviewed the impact of these diseases on hospital admissions: cardiovascular disease accounts for 3%-12.6% and found to have increased between 1970s and 2000s; cancer accounts for 1.1%-2.8%, diabetes accounts for 0.5%-1.2%, and chronic obstructive diseases account for 2.7%-4.3% of morbidity.", {"entities": [[176, 182, "DISEASE"]]}], ["Overall, the major non-communicable diseases and related risk factors are highly prevalent, and evidence-based interventions should be designed.", {"entities": []}], ["IgE synthesis requires interleukin 4 (IL-4) and a T-B cell interaction that involves the B cell antigen CD40 and its ligand expressed on activated T cells.", {"entities": [[104, 108, "GENE"]]}], ["IL-4 induces epsilon germline transcription whereas ligation of CD40 results in deletional S mu-->S epsilon switch recombination, expression of mature epsilon transcripts, and IgE synthesis and secretion.", {"entities": [[64, 68, "GENE"]]}], ["We demonstrate that disodium cromoglycate (DSCG), a drug commonly used for the prophylactic treatment of allergic disease, inhibits T cell-driven IgE synthesis by human B cells at concentrations readily achievable in the course of inhaled therapy for asthma.", {"entities": [[251, 257, "DISEASE"]]}], ["Inhibition of IgE synthesis by DSCG was not the result of drug toxicity because DSCG did not affect the viability of T and B cells or their proliferation to mitogens.", {"entities": []}], ["DSCG did not interfere with CD40 ligand expression by T cells but clearly targeted the B cells because it inhibited IgE synthesis induced by anti-CD40 and IL-4 in populations of highly purified B cells.", {"entities": [[28, 32, "GENE"], [146, 150, "GENE"]]}], ["DSCG had no effect on the induction of epsilon germline transcripts by IL-4 but strongly inhibited CD40 mediated S mu-->S epsilon deletional switch recombination in IL-4- treated B cells as assayed by nested primer PCR.", {"entities": [[99, 103, "GENE"]]}], ["The effect of DSCG was not specific for CD40-mediated induction of IgE isotype switching because DSCG inhibited IgE synthesis as well as S mu-->S epsilon deletional switch recombination induced by hydrocortisone and IL-4 in B cells.", {"entities": []}], ["Moreover, the effect of DSCG was not specific for IgE isotype switching because DSCG inhibited the synthesis of IgG4 by B cells sorted for lack of surface expression of IgG4 and stimulated with anti- CD40 and IL-4.", {"entities": [[200, 204, "GENE"]]}], ["DSCG caused only minimal inhibition (< 15%) of spontaneous IgE synthesis by lymphocytes from patients with the hyper- IgE syndrome and did not affect pokeweed mitogen-induced IgG and IgA synthesis by lymphocytes suggesting that it has little effect on B cells that have already undergone isotype switching.", {"entities": [[122, 130, "DISEASE"]]}], ["These results indicate that DSCG inhibits switching to IgE in B cells and suggest a novel potential mechanism for the prevention of allergic disease by DSCG.", {"entities": []}], ["The matrix-specific protein periostin (POSTN) is up-regulated in human cancers and associated with cancer growth, metastasis and angiogenesis.", {"entities": [[99, 105, "DISEASE"], [39, 44, "GENE"]]}], ["Although the stroma of cancer tissues is the main source of POSTN, it is still unclear how POSTN plays a role to facilitate the interplay between cancer cells and cancer-associated fibroblasts (CAFs) in head and neck cancer (HNC), thereby promoting tumorigenesis via modifying the tumor microenvironment.", {"entities": [[23, 29, "DISEASE"], [146, 152, "DISEASE"], [163, 169, "DISEASE"], [217, 223, "DISEASE"], [60, 65, "GENE"], [91, 96, "GENE"], [60, 65, "GENE"], [91, 96, "GENE"]]}], ["Herein, we have performed studies to investigate POSTN and its role in HNC microenvironment.", {"entities": [[49, 54, "GENE"]]}], ["Our results indicated that POSTN was significantly up-regulated in HNCs, especially in the tissues with lymph node metastasis.", {"entities": [[27, 32, "GENE"]]}], ["Moreover, POSTN was highly enriched in the stroma of cancer tissues and produced mainly by CAFs.", {"entities": [[53, 59, "DISEASE"], [10, 15, "GENE"]]}], ["More importantly, we have pinpointed TGF-\u03b23 as the major upstream molecular that triggers the induction of POSTN in CAFs.", {"entities": [[107, 112, "GENE"]]}], ["As such, during the interaction between fibroblasts and cancer cells, the increased stromal POSTN induced by TGF-\u03b23 directly accelerated the growth, migration and invasion of cancer cells.", {"entities": [[56, 62, "DISEASE"], [175, 181, "DISEASE"], [92, 97, "GENE"]]}], ["Hence, our study has provided a novel modulative role for POSTN on HNC progression and further reveals POSTN as an effective biomarker to predict metastasis as well as a potential cancer therapeutic target.", {"entities": [[180, 186, "DISEASE"], [58, 63, "GENE"], [103, 108, "GENE"], [58, 63, "GENE"], [103, 108, "GENE"]]}], ["Teaching emergency management should educate medical students not only for facts and treatment algorithms but also for time effective physical examination, technical skills, and team interaction.", {"entities": []}], ["We tested the hypothesis, that using standardized emergency patients would be more effective in transmitting knowledge and skills compared with a more traditional teaching approach.", {"entities": []}], ["Medical students (n\u200a=\u200a242) in their fourth (second clinical) year were randomized to receive either training on standardized patients simulating 3 emergency settings (\u201cacute chest pain,\u201d \u201cstroke,\u201d and \u201cacute dyspnea/asthma\u201d) or traditional small group seminars.", {"entities": [[216, 222, "DISEASE"]]}], ["Before and after the respective training pathways, the students\u2019 knowledge base (multiple-choice examination) and practical performance (objective structured clinical examination using 3 different emergency scenarios) were assessed.", {"entities": []}], ["Teaching using standardized patients resulted in a significant albeit small improvement in objective structured clinical examination scores (61.2\u200a\u00b1\u200a3 for the standardized patient trained group vs 60.3\u200a\u00b1\u200a3.5 for the traditional seminar group; P \u200a=\u200a0.017, maximum achievable score: 66), but no difference in the written examination scores (27.4\u200a\u00b1\u200a2.4 vs 27.0\u200a\u00b1\u200a4.4; P \u200a=\u200a0.341; maximum achievable score: 30).", {"entities": []}], ["Teaching management of emergencies using standardized patients can improve medical students\u2019 performance in clinical tests, and a change from traditional seminars in favor of practice sessions with standardized patients does not compromise the learning of medical facts.", {"entities": []}], ["Obesity affects 25% of the UK adult population but modest weight loss can reduce the incidence of obesity-related chronic disease.", {"entities": [[0, 7, "DISEASE"], [98, 105, "DISEASE"]]}], ["Some effective weight loss treatments exist but there is no nationally available National Health Service (NHS) treatment service, and general practitioners (GPs) rarely discuss weight management with patients or support behavior change.", {"entities": [[106, 109, "GENE"]]}], ["Evidence shows that commercial weight management services, that most primary care trusts have 'on prescription', are more effective than primary care treatment.", {"entities": []}], ["We propose a controlled trial where patients will be randomized to receive either the offer of help by referral to a weight management service and follow-up to assess progress, or advice to lose weight on medical grounds.", {"entities": []}], ["The primary outcome will be weight change at 12-months.", {"entities": []}], ["Other questions are: what actions do people take to manage their weight in response to the two GP intervention types?", {"entities": []}], ["How do obese patients feel about GPs opportunistically discussing weight management and how does this vary by intervention type?", {"entities": []}], ["How do GPs feel about raising the issue opportunistically and giving the two types of brief intervention?", {"entities": []}], ["What is the cost per kg/m Trial results could make the case for brief interventions for obese people consulting their GP and introduce widespread simple treatments akin to the NHS Stop Smoking Service.", {"entities": [[176, 179, "GENE"]]}], ["Likewise, the intervention could be introduced in the Quality and Outcomes Framework and influence practice worldwide.", {"entities": []}], ["Current Controlled Trials ISRCTN26563137 .", {"entities": []}], ["Many dichotomous traits for complex diseases are often involved more than one locus and/or associated with quantitative biomarkers or environmental factors.", {"entities": []}], ["Incorporating these quantitative variables into linkage analysis as well as localizing two linked disease loci simultaneously could therefore improve the efficiency in mapping genes.", {"entities": []}], ["We extended the robust multipoint Identity-by-Descent (IBD) approach with incorporation of covariates developed previously to simultaneously estimate two linked loci using different types of affected relative pairs (ARPs).", {"entities": []}], ["We showed that the efficiency was enhanced by incorporating a quantitative covariate parametrically or non-parametrically while localizing two disease loci using ARPs.", {"entities": []}], ["In addition to its help in identifying factors associated with the disease and in improving the efficiency in estimating disease loci, this extension also allows investigators to account for heterogeneity in risk-ratios for different ARPs.", {"entities": []}], ["Data released from the collaborative study on the genetics of alcoholism (COGA) for Genetic Analysis Workshop 14 (GAW 14) were used to illustrate the application of this extended method.", {"entities": []}], ["The simulation studies and example illustrated that the efficiency in estimating disease loci was demonstratively enhanced by incorporating a quantitative covariate and by using all relative pairs while mapping two linked loci simultaneously.", {"entities": []}], ["Inflammatory airway diseases are a significant health problems requiring new approaches to the existing therapies and addressing fundamental issues.", {"entities": []}], ["Difficulties in developing effective therapeutic strategies might be caused by lack of understanding of their exact molecular mechanism.", {"entities": []}], ["MicroRNAs (miRNAs) are a class of regulators that already revolutionized the view of gene expression regulation.", {"entities": []}], ["A cumulating number of investigations show a pivotal role of miRNAs in the pathogenesis of asthma, chronic obstructive pulmonary disease (COPD), or airway remodeling through the regulation of many pathways involved in their pathogenesis.", {"entities": [[99, 136, "DISEASE"], [91, 97, "DISEASE"]]}], ["Expression changes of several miRNAs have also been found to play a role in the development and/or improvement in asthma or COPD.", {"entities": [[114, 120, "DISEASE"]]}], ["Still, relatively little is known about the role of miRNAs in inflammatory disorders.", {"entities": []}], ["The microRNA profiles may differ depending on the cell type or antigen-presenting cell.", {"entities": []}], ["Based on the newest literature, this review discusses the current knowledge concerning miRNA contribution and influence on lung inflammation and chosen inflammatory airway diseases: asthma and COPD.", {"entities": [[182, 188, "DISEASE"]]}], ["To evaluate the effect of airborne particulate matter 2.5 (PM 2.5 ) in winter on airway inflammation, water-soluble supernatant (Sup) and water-insoluble precipitate (Pre) in PM 2.5 were inoculated in NC/Nga mice with high sensitivity to mite allergens.", {"entities": []}], ["Sup with aluminum oxide was injected intraperitoneally for sensitization.", {"entities": []}], ["Five days later, Sup, Pre or both Sup and Pre were inoculated via the nasal route five times for more sensitization and a challenge inoculation on the 11th day in NC/Nga mice.", {"entities": []}], ["On the 12th day, mice were examined for airway hyperresponsiveness (AHR), BALF cell count and IL-1\u03b2 concentration, mRNA expression of Th 1 and Th 2 cytokines, chemokines such as eotaxin 1 and eotaxin 2, inflammasomal complex molecules such as IL-1\u03b2, caspase 1 and the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) in lung tissue as well as histopathology.", {"entities": [[68, 71, "GENE"], [329, 334, "GENE"]]}], ["The synergistic effect of Sup and Pre was observed in terms of increases in AHR, BALF cells, the mRNA expression of IL-13, eotaxin1 and IL-1\u03b2, and the IL-1\u03b2 concentration in BALF.", {"entities": [[76, 79, "GENE"]]}], ["Intracellular deposits of insoluble particulates were observed in macrophages around inflammatory granulation of the mouse group treated with Sup and Pre.", {"entities": []}], ["These results suggest that PM 2.5 can induce airway hyperresponsiveness in mice with genetically high sensitivity to mite allergens by an inflammasome-associated mechanism and synergistic action of insoluble particulates and soluble components.", {"entities": []}], ["PDE3s belong to the phosphodiesterases family, where the PDE3A isoform is the major subtype in platelets involved in the cAMP regulation pathway of platelet aggregation.", {"entities": [[57, 62, "GENE"]]}], ["PDE3A inhibitors have been designed as potential antiplatelet agents.", {"entities": [[0, 5, "GENE"]]}], ["In this work, a homology model of PDE3A was developed and used to obtain the binding modes of bicyclic heteroaromatic pyridazinones and pyrazolones.", {"entities": [[34, 39, "GENE"]]}], ["Most of the studied compounds adopted similar orientations within the PDE3A active site, establishing hydrogen bonds with catalytic amino acids.", {"entities": [[70, 75, "GENE"]]}], ["Besides, the structure-activity relationship of the studied inhibitors was described by using a field-based 3D-QSAR method.", {"entities": []}], ["Different structure alignment strategies were employed, including template-based and docking-based alignments.", {"entities": []}], ["Adequate correlation models were obtained according to internal and external validations.", {"entities": []}], ["In general, QSAR models revealed that steric and hydrophobic fields describe the different inhibitory activities of the compounds, where the hydrogen bond donor and acceptor fields have minor contributions.", {"entities": []}], ["It should be stressed that structural elements of PDE3A inhibitors are reported here, through descriptions of their binding interactions and their differential affinities.", {"entities": [[50, 55, "GENE"]]}], ["In this sense, the present results could be useful in the future design of more specific and potent PDE3A inhibitors that may be used for the treatment of cardiovascular diseases.", {"entities": [[100, 105, "GENE"]]}], ["The mammalian carbohydrate galactose-\u03b11,3-galactose (\u03b1-Gal) causes a novel form of food allergy, red meat allergy, where patients experience severe allergic reactions several hours after red meat consumption.", {"entities": [[83, 95, "DISEASE"]]}], ["Here we explored gastric digestion of \u03b1-Gal glycoproteins using an in vitro model.", {"entities": []}], ["Bovine thyroglobulin (BTG), a typical \u03b1-Gal carrying glycoprotein, was digested with pepsin.", {"entities": []}], ["The resulting peptides were characterised by SDS PAGE, immunoblot and ImmunoCAP using sera from 20 red meat allergic patients.", {"entities": [[45, 48, "GENE"]]}], ["During pepsinolysis of BTG, a wide range of peptide bands was observed of which 14 to 17\u2009kDa peptides remained stable throughout the gastric phase.", {"entities": []}], ["The presence of the \u03b1-Gal epitope on the obtained peptides was demonstrated by an anti-\u03b1-Gal antibody and IgE from red meat allergic patients.", {"entities": []}], ["The \u03b1-Gal digests were able to inhibit up to 86% of IgE reactivity to BTG.", {"entities": []}], ["Importantly, basophil activation test demonstrated that the allergenic activity of BTG was retained after digestion in all four tested patients.", {"entities": []}], ["Mass spectrometry-based peptidomics revealed that these peptides represent mostly internal and C-terminal parts of the protein, where the most potent IgE-binding \u03b1-Gal residues were identified at Asn 1756 , Asn 1850 and Asn 2231 .", {"entities": []}], ["Thus allergenic \u03b1-Gal epitopes are stable to pepsinolysis, reinforcing their role as clinically relevant food allergens.", {"entities": []}], ["To analyze whether socioeconomic and health conditions during childhood are associated with mortality during old age.", {"entities": []}], ["Data were extracted from the SABE Study ( Sa\u00fade, Bem-estar e Envelhecimento \u2013 Health, Welfare and Aging), which were performed in 2000 and 2006.", {"entities": []}], ["The sample consisted of 2004 (1,355 living and 649 dead) older adults.", {"entities": []}], ["The statistical analysis was performed based on Poisson regression models, taking into account the time variation of risk observed.", {"entities": []}], ["Older adults\u2019 demographic characteristics and life conditions were evaluated, as were the socioeconomic and lifestyle conditions they acquired during their adult life.", {"entities": []}], ["Only the area of residence during childhood (rural or urban) remained as a factor associated with mortality at advanced ages.", {"entities": []}], ["However, this association lost significance when the variables acquired during adulthood were added to the model.", {"entities": []}], ["Despite the information regarding the conditions during childhood being limited and perhaps not accurately measure the socioeconomic status and health in the first years of life, the findings of this study suggest that improving the environmental conditions of children and creating opportunities during early adulthood may contribute to greater survival rates for those of more advanced years.", {"entities": []}], [": Analisar se as condi\u00e7\u00f5es socioecon\u00f4micas e de sa\u00fade na inf\u00e2ncia est\u00e3o associadas \u00e0 mortalidade em idosos.", {"entities": []}], [": Utilizaram-se os dados do Estudo SABE (Sa\u00fade, Bem-estar e Envelhecimento) realizado em 2000 e 2006.", {"entities": []}], ["A amostra foi composta por 2004 idosos, sendo 1.355 idosos sobreviventes e 649 \u00f3bitos.", {"entities": [[23, 26, "GENE"]]}], ["Modelos de Regress\u00e3o de Poisson foram estimados, levando-se em considera\u00e7\u00e3o a varia\u00e7\u00e3o do tempo de risco.", {"entities": []}], ["Foram avaliadas caracter\u00edsticas demogr\u00e1ficas, condi\u00e7\u00f5es no in\u00edcio da vida do idoso e condi\u00e7\u00f5es socioecon\u00f4micas e de estilo de vida adquiridos na fase adulta.", {"entities": []}], [": Situa\u00e7\u00e3o de resid\u00eancia (rural ou urbano) quando crian\u00e7a associou-se \u00e0 mortalidade nas idades avan\u00e7adas.", {"entities": []}], ["No entanto, essa vari\u00e1vel perdeu signific\u00e2ncia quando vari\u00e1veis que representam caracter\u00edsticas adquiridas na fase adulta foram adicionadas ao modelo.", {"entities": []}], [": Mesmo que as informa\u00e7\u00f5es dispon\u00edveis sobre condi\u00e7\u00f5es na inf\u00e2ncia sejam limitadas e possam n\u00e3o medir com precis\u00e3o o status socioecon\u00f4mico e de sa\u00fade nos primeiros anos de vida, os achados sugerem que melhorias nas condi\u00e7\u00f5es ambientais das crian\u00e7as e a cria\u00e7\u00e3o de oportunidades no in\u00edcio da vida adulta podem contribuir para maior sobreviv\u00eancia nas idades mais avan\u00e7adas.", {"entities": []}], ["Self-management is crucial for effective COPD management.", {"entities": []}], ["This study aimed at identifying associations between self-management and sociodemographic characteristics, clinical characteristics, and symptom burden in people with COPD.", {"entities": []}], ["In this cross-sectional study with 225 participants diagnosed with COPD grades II\u2013IV, multiple linear regression analysis was conducted, using sociodemographic and clinical characteristics and symptom burden (COPD Assessment Test) as the independent variables and the eight self-management domains of the Health Education Impact Questionnaire (heiQ) as the outcome variables.", {"entities": []}], ["Higher symptom burden was significantly associated with worse scores in all self-management domains ( p <0.003), except for self-monitoring and insight ( p =0.012).", {"entities": []}], ["Higher disease severity ( p =0.004) and numbers of comorbidities ( p <0.001) were associated with more emotional distress, and women scored higher than men on positive and active engagement in life ( p =0.001).", {"entities": []}], ["Higher score in pack-years smoking was associated with lower score in health-directed activities ( p =0.006) and self-monitoring and insight ( p <0.001), and participation in organized physical training was associated with higher score in health-directed activities ( p <0.001).", {"entities": []}], ["The final models explained 3.7%\u201331.7% of variance (adjusted R A notable finding of this study was that higher symptom burden was associated with worse scores in all self-management domains, except for self-monitoring and insight.", {"entities": []}], ["In addition, sex, disease severity, comorbidity, pack-years smoking, and participation in organized physical training were associated with one or two self-management domains.", {"entities": []}], ["The study contributes to improved understanding of self-management in COPD.", {"entities": []}], ["However, the explained variance levels indicate that more research needs to be done to uncover what else explains self-management domains in COPD.", {"entities": []}], ["Punica granatum (pomegranate), an edible fruit originating in the Middle East, has been used as a traditional medicine for treatment of pain and inflammatory conditions such as peptic ulcer.", {"entities": [[177, 189, "DISEASE"]]}], ["The numerous risks associated with nonsteroidal anti-inflammatory drugs (NSAIDs) for treatment of pain and inflammation give rise to using medicinal herbs as alternative therapies.", {"entities": []}], ["This study aimed to evaluate the anti-inflammatory effect of isolated compounds from the ethyl acetate (EtOAc) fraction of P. granatum by determination of their inhibitory effects on lipopolysaccharide (LPS), stimulated nitric oxide (NO), prostaglandin E2 (PGE-2), interleukin-6 (IL-6) and cyclooxxgenase-2 (COX-2) release from RAW264.7 cells.", {"entities": []}], ["The compounds ellagic acid, gallic acid and punicalagin A&B were isolated from EtOAc by high performance liquid chromatography (HPLC) and further identified by mass spectrometry (MS).", {"entities": []}], ["The inhibitory effect of ellagic acid, gallic acid and punicalagin A&B were evaluated on the production of LPS-induced NO by Griess reagent, PGE-2 and IL-6 by immunoassay kit and prostaglandin E2 competitive ELISA kit, and COX-2 by Western blotting.", {"entities": []}], ["Ellagic acid, gallic acid and punicalagin A&B potentially inhibited LPS-induced NO, PGE-2 and IL-6 production.", {"entities": []}], ["The results indicate that ellagic acid, gallic acid and punicalagin may be the compounds responsible for the anti-inflammatory potential of P. granatum .", {"entities": []}], ["Although indoleamine 2,3-dioxygenase (IDO)-mediated immune suppression of mesenchymal stem cells (MSCs) has been revealed in septic and tumor microenvironments, the role of IDO in suppressing allergic airway inflammation by MSCs is not well documented.", {"entities": []}], ["We evaluated the effects of adipose-derived stem cells (ASCs) on allergic inflammation in IDO-knockout (KO) asthmatic mice or asthmatic mice treated with ASCs derived from IDO-KO mice.", {"entities": []}], ["ASCs were injected intravenously in wild-type (WT) and IDO-KO asthmatic mice.", {"entities": []}], ["Furthermore, asthmatic mice were injected with ASCs derived from IDO-KO mice.", {"entities": []}], ["We investigated the immunomodulatory effects of ASCs between WT and IDO-KO mice or IDO-KO ASCs in asthmatic mice.", {"entities": []}], ["In asthmatic mice, ASCs significantly reduced airway hyperresponsiveness, the number of total inflammatory cells and eosinophils in bronchoalveolar lavage fluid (BALF), eosinophilic inflammation, goblet hyperplasia, and serum concentrations of total and allergen-specific IgE and IgG1.", {"entities": []}], ["ASCs significantly inhibited Th2 cytokines, such as interleukin (IL)-4, IL-5, and IL-13, and enhanced Th1 cytokine (interferon-\u03b3) and regulatory cytokines (IL-10, TGF-\u03b2) in BALF and lung draining lymph nodes (LLNs).", {"entities": []}], ["ASCs led to significant increases in regulatory T-cells (Tregs) and IL-10 IDO did not play a pivotal role in the suppression of allergic airway inflammation through ASCs, suggesting that it is not the major regulator responsible for suppressing allergic airway inflammation.", {"entities": []}], ["Asthma is a chronic inflammatory airways disease that usually begins in early life and involves gene-environment interactions.", {"entities": [[0, 6, "DISEASE"]]}], ["Although most asthma exhibits allergic inflammation, many allergic individuals do not have asthma.", {"entities": [[14, 20, "DISEASE"], [91, 97, "DISEASE"]]}], ["Here, we report how the asthma gene a disintegrin and metalloprotease 33 ( ADAM33 ) acts as local tissue susceptibility gene that promotes allergic asthma.", {"entities": [[139, 154, "DISEASE"], [24, 30, "DISEASE"], [148, 154, "DISEASE"], [75, 81, "GENE"]]}], ["We show that enzymatically active soluble ADAM33 (sADAM33) is increased in asthmatic airways and plays a role in airway remodeling, independent of inflammation.", {"entities": [[42, 48, "GENE"]]}], ["Furthermore, remodeling and inflammation are both suppressed in Adam33 -null mice after allergen challenge.", {"entities": [[64, 70, "GENE"]]}], ["When induced in utero or added ex vivo, sADAM33 causes structural remodeling of the airways, which enhances postnatal airway eosinophilia and bronchial hyperresponsiveness following subthreshold challenge with an aeroallergen.", {"entities": [[125, 137, "DISEASE"]]}], ["This substantial gene-environment interaction helps to explain the end-organ expression of allergic asthma in genetically susceptible individuals.", {"entities": [[91, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["Finally, we show that sADAM33-induced airway remodeling is reversible, highlighting the therapeutic potential of targeting ADAM33 in asthma.", {"entities": [[133, 139, "DISEASE"], [123, 129, "GENE"]]}], ["Loss of ADAM33 suppresses airway remodeling and allergic inflammation in mice, suggesting the therapeutic potential of targeting ADAM33 in asthma.", {"entities": [[139, 145, "DISEASE"], [8, 14, "GENE"], [129, 135, "GENE"], [8, 14, "GENE"], [129, 135, "GENE"]]}], ["We aimed to investigate the effects of age and gender on the profile of exhaled volatile organic compounds.", {"entities": []}], ["We evaluated 68 healthy adult never-smokers, comparing them by age and by gender.", {"entities": []}], ["Exhaled breath samples were analyzed by an electronic nose (e-nose), resulting in \"breathprints\".", {"entities": []}], ["Principal component analysis and canonical discriminant analysis showed that older subjects (\u2265 50 years of age) could not be distinguished from younger subjects on the basis of their breathprints, as well as that the breathprints of males could not distinguished from those of females (cross-validated accuracy, 60.3% and 57.4%, respectively).Therefore, age and gender do not seem to affect the overall profile of exhaled volatile organic compounds measured by an e-nose.", {"entities": []}], ["Car enzyme inhibition prevents mast cell responses and inflammation following Trichinella spiralis infection or the induction of food allergy\u2013like disease.", {"entities": [[129, 141, "DISEASE"]]}], ["Type 2 cytokine responses are necessary for the development of protective immunity to helminth parasites but also cause the inflammation associated with allergies and asthma.", {"entities": [[167, 173, "DISEASE"]]}], ["Recent studies have found that peripheral hematopoietic progenitor cells contribute to type 2 cytokine\u2013mediated inflammation through their enhanced ability to develop into mast cells.", {"entities": []}], ["In this study, we show that carbonic anhydrase ( Car ) enzymes are up-regulated in type 2\u2013associated progenitor cells and demonstrate that Car enzyme inhibition is sufficient to prevent mouse mast cell responses and inflammation after Trichinella spiralis infection or the induction of food allergy\u2013like disease.", {"entities": [[286, 298, "DISEASE"]]}], ["Further, we used CRISPR/Cas9 technology and illustrate that genetically editing Car1 is sufficient to selectively reduce mast cell development.", {"entities": []}], ["Finally, we demonstrate that Car enzymes can be targeted to prevent human mast cell development.", {"entities": []}], ["Collectively, these experiments identify a previously unrecognized role for Car enzymes in regulating mast cell lineage commitment and suggest that Car enzyme inhibitors may possess therapeutic potential that can be used to treat mast cell\u2013mediated inflammation.", {"entities": []}], ["The role of anxiety and depression in the physical activity (PA) of patients with COPD is controversial.", {"entities": []}], ["We prospectively assessed the effect of symptoms of anxiety and depression on PA in COPD patients.", {"entities": []}], ["We evaluated anxiety and depression (Hospital Anxiety and Depression Scale [HADS]), PA (Dynaport t (baseline and 6 months) and PA at t +1 (6 and 12 months) using regression models with a repeated measures approach.", {"entities": []}], ["Patients had a mean (standard deviation) age of 67 (8) years, forced expiratory volume in 1 second 57 (20)% predicted.", {"entities": []}], ["At baseline, the prevalence of probable anxiety and depression was 10% and 5%, respectively.", {"entities": []}], ["In multivariable models adjusted by confounders and previous PA, patients performed 81 fewer steps/day (95% confidence interval, \u2212149 to \u221212, P =0.02) per extra point in HADS-depression score.", {"entities": []}], ["HADS-anxiety symptoms were not associated with PA.", {"entities": []}], ["In COPD patients, symptoms of depression are prospectively associated with a measurable reduction in PA 6 months later.", {"entities": []}], ["Objective \u00a0To investigate whether symptomatic treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is non-inferior to antibiotics in the treatment of uncomplicated lower urinary tract infection (UTI) in women, thus offering an opportunity to reduce antibiotic use in ambulatory care.", {"entities": []}], ["Design \u00a0Randomised, double blind, non-inferiority trial.", {"entities": []}], ["Setting \u00a017 general practices in Switzerland.", {"entities": []}], ["Participants \u00a0253 women with uncomplicated lower UTI were randomly assigned 1:1 to symptomatic treatment with the NSAID diclofenac (n=133) or antibiotic treatment with norfloxacin (n=120).", {"entities": []}], ["The randomisation sequence was computer generated, stratified by practice, blocked, and concealed using sealed, sequentially numbered drug containers.", {"entities": []}], ["Main outcome measures \u00a0The primary outcome was resolution of symptoms at day 3 (72 hours after randomisation and 12 hours after intake of the last study drug).", {"entities": []}], ["The prespecified principal secondary outcome was the use of any antibiotic (including norfloxacin and fosfomycin as trial drugs) up to day 30.", {"entities": []}], ["Analysis was by intention to treat.", {"entities": []}], ["Results \u00a072/133 (54%) women assigned to diclofenac and 96/120 (80%) assigned to norfloxacin experienced symptom resolution at day 3 (risk difference 27%, 95% confidence interval 15% to 38%, P=0.98 for non-inferiority, P<0.001 for superiority).", {"entities": []}], ["The median time until resolution of symptoms was four days in the diclofenac group and two days in the norfloxacin group.", {"entities": []}], ["A total of 82 (62%) women in the diclofenac group and 118 (98%) in the norfloxacin group used antibiotics up to day 30 (risk difference 37%, 28% to 46%, P<0.001 for superiority).", {"entities": []}], ["Six women in the diclofenac group (5%) but none in the norfloxacin group received a clinical diagnosis of pyelonephritis (P=0.03).", {"entities": [[106, 120, "DISEASE"]]}], ["Conclusion \u00a0Diclofenac is inferior to norfloxacin for symptom relief of UTI and is likely to be associated with an increased risk of pyelonephritis, even though it reduces antibiotic use in women with uncomplicated lower UTI.", {"entities": [[133, 147, "DISEASE"]]}], ["Trial registration \u00a0ClinicalTrials.gov NCT01039545.", {"entities": []}], ["COPD is the third leading cause of death in the world and its global burden is predicted to increase further.", {"entities": []}], ["Even though the prevalence of COPD is well studied, only few studies examined the incidence of COPD in a prospective and standardized manner.", {"entities": []}], ["In a prospective population-based cohort study (Rotterdam Study) enrolling subjects aged \u226545, COPD was diagnosed based on a pre-bronchodilator obstructive spirometry (FEV 1 /FVC\u00a0<\u00a00.70).", {"entities": [[167, 170, "GENE"]]}], ["In absence of an interpretable spirometry within the Rotterdam Study, cases were defined as having COPD diagnosed by a physician on the basis of clinical presentation and obstructive lung function measured by the general practitioner or respiratory physician.", {"entities": []}], ["Incidence rates were calculated by dividing the number of incident cases by the total number of person years of subjects at risk.", {"entities": []}], ["In this cohort of 14,619 participants, 1993 subjects with COPD were identified of whom 689 as prevalent ones and 1304 cases as incident ones.", {"entities": []}], ["The overall incidence rate (IR) of COPD was 8.9/1000 person-years (PY); 95\u00a0% Confidence Interval (CI) 8.4\u20139.4.", {"entities": []}], ["The IR was higher in males and in smokers.", {"entities": []}], ["The proportion of female COPD participants without a history of smoking was 27.2\u00a0%, while this proportion was 7.3\u00a0% in males.", {"entities": []}], ["The prevalence of COPD in the Rotterdam Study is 4.7\u00a0% and the overall incidence is approximately 9/1000 PY, with a higher incidence in males and in smokers.", {"entities": []}], ["The proportion of never-smokers among female COPD cases is substantial.", {"entities": []}], ["The online version of this article (doi:10.1007/s10654-016-0132-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dendritic cells (DCs) direct CD4 How anti-helminth and allergic immune responses are initiated is poorly understood.", {"entities": [[29, 32, "GENE"]]}], ["Here the authors show that to trigger these responses, dendritic cells specifically require methyl-CpG-binding domain-2, a protein promoting repressed chromatin state.", {"entities": []}], ["This article reviews the present indicators, trends, and recent solutions and strategies to tackle major global and country problems in safety and health at work.", {"entities": []}], ["The article is based on the Yant Award Lecture of the American Industrial Hygiene Association (AIHA) at its 2013 Congress.", {"entities": []}], ["We reviewed employment figures, mortality rates, occupational burden of disease and injuries, reported accidents, surveys on self-reported occupational illnesses and injuries, attributable fractions, national economic cost estimates of work-related injuries and ill health, and the most recent information on the problems from published papers, documents, and electronic data sources of international and regional organizations, in particular the International Labor Organization (ILO), World Health Organization (WHO), and European Union (EU), institutions, agencies, and public websites.", {"entities": []}], ["We identified and analyzed successful solutions, programs, and strategies to reduce the work-related negative outcomes at various levels.", {"entities": []}], ["Work-related illnesses that have a long latency period and are linked to ageing are clearly on the increase, while the number of occupational injuries has gone down in industrialized countries thanks to both better prevention and structural changes.", {"entities": []}], ["We have estimated that globally there are 2.3 million deaths annually for reasons attributed to work.", {"entities": []}], ["The biggest component is linked to work-related diseases, 2.0 million, and 0.3 million linked to occupational injuries.", {"entities": []}], ["However, the division of these two factors varies depending on the level of development.", {"entities": []}], ["In industrialized countries the share of deaths caused by occupational injuries and work-related communicable diseases is very low while non-communicable diseases are the overwhelming causes in those countries.", {"entities": []}], ["Economic costs of work-related injury and illness vary between 1.8 and 6.0% of GDP in country estimates, the average being 4% according to the ILO.", {"entities": []}], ["Singapore's economic costs were estimated to be equivalent to 3.2% of GDP based on a preliminary study.", {"entities": []}], ["If economic losses would take into account involuntary early retirement then costs may be considerably higher, for example, in Finland up to 15% of GDP, while this estimate covers various disorders where work and working conditions may be just one factor of many or where work may aggravate the disease, injury, or disorders, such as traffic injuries, mental disorders, alcoholism, and genetically induced problems.", {"entities": []}], ["Workplace health promotion, services, and safety and health management, however, may have a major preventive impact on those as well.", {"entities": []}], ["Leadership and management at all levels, and engagement of workers are key issues in changing the workplace culture.", {"entities": []}], ["Vision Zero is a useful concept and philosophy in gradually eliminating any harm at work.", {"entities": []}], ["Legal and enforcement measures that themselves support companies and organizations need to be supplemented with economic justification and convincing arguments to reduce corner-cutting in risk management, and to avoid short- and long-term disabilities, premature retirement, and corporate closures due to mismanagement and poor and unsustainable work life.", {"entities": []}], ["We consider that a new paradigm is needed where good work is not just considered a daily activity.", {"entities": []}], ["We need to foster stable conditions and circumstances and sustainable work life where the objective is to maintain your health and work ability beyond the legal retirement age.", {"entities": []}], ["We need safe and healthy work, for life.", {"entities": []}], ["Due to easy access and low cost, Internet-delivered therapies offer an attractive alternative to improving health.", {"entities": []}], ["Although numerous websites contain health-related information, finding evidence-based programs (as demonstrated through randomized controlled trials, RCTs) can be challenging.", {"entities": []}], ["We sought to bridge the divide between the knowledge gained from RCTs and communication of the results by conducting a global systematic review and analyzing the availability of evidence-based Internet health programs.", {"entities": []}], ["The study aimed to (1) discover the range of health-related topics that are addressed through Internet-delivered interventions, (2) generate a list of current websites used in the trials which demonstrate a health benefit, and (3) identify gaps in the research that may have hindered dissemination.", {"entities": []}], ["Our focus was on Internet-delivered self-guided health interventions that did not require real-time clinical support.", {"entities": []}], ["A systematic review of meta-analyses was conducted using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (PROSPERO Registration Number CRD42016041258).", {"entities": []}], ["MEDLINE via Ovid, PsycINFO, Embase, Cochrane Database of Systematic Reviews, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched.", {"entities": []}], ["Inclusion criteria included (1) meta-analyses of RCTs, (2) at least one Internet-delivered intervention that measured a health-related outcome, and (3) use of at least one self-guided intervention.", {"entities": []}], ["We excluded group-based therapies.", {"entities": []}], ["There were no language restrictions.", {"entities": []}], ["Of the 363 records identified through the search, 71 meta-analyses met inclusion criteria.", {"entities": []}], ["Within the 71 meta-analyses, there were 1733 studies that contained 268 unique RCTs which tested self-help interventions.", {"entities": []}], ["On review of the 268 studies, 21.3% (57/268) had functional websites.", {"entities": []}], ["These included evidence-based Web programs on substance abuse (alcohol, tobacco, cannabis), mental health (depression, anxiety, post-traumatic stress disorder [PTSD], phobias, panic disorders, obsessive compulsive disorder [OCD]), and on diet and physical activity.", {"entities": [[46, 61, "DISEASE"], [128, 158, "DISEASE"]]}], ["There were also evidence-based programs on insomnia, chronic pain, cardiovascular risk, and childhood health problems.", {"entities": []}], ["These programs tended to be intensive, requiring weeks to months of engagement by the user, often including interaction, personalized and normative feedback, and self-monitoring.", {"entities": []}], ["English was the most common language, although some were available in Spanish, French, Portuguese, Dutch, German, Norwegian, Finnish, Swedish, and Mandarin.", {"entities": []}], ["There were several interventions with numbers needed to treat of <5; these included painACTION, Mental Health Online for panic disorders, Deprexis, Triple P Online (TPOL), and U Can POOP Too.", {"entities": []}], ["Hyperlinks of the sites have been listed.", {"entities": []}], ["A wide range of evidence-based Internet programs are currently available for health-related behaviors, as well as disease prevention and treatment.", {"entities": []}], ["However, the majority of Internet-delivered health interventions found to be efficacious in RCTs do not have websites for general use.", {"entities": []}], ["Increased efforts to provide mechanisms to host \u201cinterventions that work\u201d on the Web and to assist the public in locating these sites are necessary.", {"entities": []}], ["Recent meta-analyses of genome-wide association studies have identified single nucleotide polymorphisms (SNPs) within/near 54 genes associated with lung function measures.", {"entities": []}], ["Current understanding of the contribution of these genes to human lung development is limited.", {"entities": []}], ["We set out to further define i) the expression profile of these genes during human lung development using a unique set of resources to examine both mRNA and protein expression and ii) the link between key polymorphisms and genes using expression quantitative trait loci\u00a0(eQTL) approaches.", {"entities": []}], ["The mRNA expression profile of lung function associated genes across pseudoglandular and canalicular stages of lung development were determined using expression array data of 38 human fetal lungs.", {"entities": []}], ["eQTLs were investigated for selected genes using blood cell and lung tissue data.", {"entities": []}], ["Immunohistochemistry of the top 5 candidates was performed in a panel of 24 fetal lung samples.", {"entities": []}], ["Twenty-nine lung function associated genes were differentially expressed during lung development at the mRNA level.", {"entities": []}], ["The greatest magnitude of effect was observed for 5 genes; TMEM163, FAM13A and HHIP which had increasing expression and CDC123 and PTCH1 with decreased expression across developmental stages.", {"entities": [[59, 66, "GENE"], [68, 74, "GENE"], [79, 83, "GENE"], [120, 126, "GENE"], [131, 136, "GENE"]]}], ["Focussed eQTL analyses investigating SNPs in these five loci identified several cis-eQTL\u2019s.", {"entities": []}], ["Protein expression of TMEM163 increased and CDC123 decreased with fetal lung age in agreement with mRNA data.", {"entities": [[22, 29, "GENE"], [44, 50, "GENE"]]}], ["Protein expression in FAM13A, HHIP and PTCH1 remained relatively constant throughout lung development.", {"entities": [[22, 28, "GENE"], [30, 34, "GENE"], [39, 44, "GENE"]]}], ["We have identified that\u2009>\u200950\u00a0% of lung function associated genes show evidence of differential expression during lung development and we show that in particular TMEM163 and CDC123 are differentially expressed at both the mRNA and protein levels.", {"entities": [[161, 168, "GENE"], [173, 179, "GENE"]]}], ["Our data provides a systematic evaluation of lung function associated genes in this context and offers some insight into the potential role of several of these genes in contributing to human lung development.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0410-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Childhood obesity and asthma are on the rise in the U.S. Clinical and epidemiological data suggest a link between the two, in which overweight and obese children are at higher risk for asthma.", {"entities": [[10, 17, "DISEASE"], [22, 28, "DISEASE"], [185, 191, "DISEASE"]]}], ["Prevention of childhood obesity is preferred over treatment, however, in order to be receptive to messages, parents must perceive that their child is overweight.", {"entities": [[24, 31, "DISEASE"]]}], ["Many parents do not accurately assess their child\u2019s weight status.", {"entities": []}], ["Herein, the relation between parental perceptions of child weight status, observed body mass index (BMI) percentiles, and a measure of child feeding practices were explored in the context of asthma, food allergy, or both.", {"entities": [[199, 211, "DISEASE"], [191, 197, "DISEASE"]]}], ["Out of the children with asthma or food allergy that were classified as overweight/obese by BMI percentiles, 93% were not perceived as overweight/obese by the parent.", {"entities": [[35, 47, "DISEASE"], [25, 31, "DISEASE"]]}], ["Mean scores for concern about child weight were higher in children with both asthma and food allergy than either condition alone, yet there were no significant differences among the groups in terms of pressure to eat and restrictive feeding practices.", {"entities": [[88, 100, "DISEASE"], [77, 83, "DISEASE"]]}], ["In summary, parents of children with asthma or food allergy were less likely to recognize their child\u2019s overweight/obese status and their feeding practices did not differ from those without asthma and food allergy.", {"entities": [[47, 59, "DISEASE"], [201, 213, "DISEASE"], [37, 43, "DISEASE"], [190, 196, "DISEASE"]]}], ["Investigating the health status of agricultural workers is a challenging goal.", {"entities": []}], ["Contradictory outcomes concerning farmers\u2019 health are reported in the literature.", {"entities": []}], ["In this cross-sectional study, certain clinical and neurobehavioral health outcomes were compared between farmers and non-farmers living in the same rural area.", {"entities": []}], ["Farmers (328) and non-farmers (347), matched per age and sex, were selected randomly in an agricultural area in West Greece.", {"entities": []}], ["Both groups underwent haematological and biochemical examinations and were administered two neurobehavioral tests, namely the Mini-Mental State Examination (MMSE) and the Montgomery-\u00c5sberg Depression Rating Scale (MADRS).", {"entities": []}], ["Sociodemographic, personal medical, nutritional and lifestyle data were recorded.", {"entities": []}], ["According to personal statements, farmers suffered from hypertension, cardiovascular, orthopaedic and ENT problems in higher frequency.", {"entities": [[56, 68, "DISEASE"]]}], ["Haematocrit, haemoglobin and serum cholinesterase\u2019s activity were found to be lower among farmers.", {"entities": []}], ["Lower prevalence of hypertension and better performances on MMSE and MADRS tests were recorded in young farmers in relation to young non-farmers, while these findings were reversed in older ages.", {"entities": [[20, 32, "DISEASE"]]}], ["Odds Ratios were calculated through multivariate logistic regression models.", {"entities": []}], ["Factors affecting these impairments remain to be clarified.", {"entities": []}], ["Accounting for the patients\u2019 perspective on quality of care has become increasingly important in the development of Evidence Based Medicine as well as in governmental policies.", {"entities": []}], ["In the Netherlands the Consumer Quality (CQ) Index has been developed to measure the quality of care from the patients\u2019 perspective in different healthcare sectors in a standardized manner.", {"entities": []}], ["Although the scientific accountability of anthroposophic healthcare as a form of integrative medicine is growing, patient experiences with anthroposophic healthcare have not been measured systematically.", {"entities": []}], ["In addition, the specific anthroposophic aspects are not measured by means of existing CQ Indexes.", {"entities": []}], ["To enable accountability of quality of the anthroposophic healthcare from the patients\u2019 perspective the aim of this study is the construction and validation of a CQ Index for anthroposophic healthcare.", {"entities": []}], ["Construction in three phases: Phase 1.", {"entities": []}], ["Determining anthroposophic quality aspects: literature study and focus groups.", {"entities": []}], ["Adding new questions and validating the new questionnaire.", {"entities": []}], ["Research population: random sample from 7910 patients of 22 anthroposophic GPs.", {"entities": []}], ["Data collection: survey, mixed mode by means of the Dillman method.", {"entities": []}], ["Measuring instrument: experience questionnaire: CQ Index General Practice (56 items), added with 27 new anthroposophic items added and an item-importance questionnaire (anthroposophic items only).", {"entities": []}], ["Statistical analyses: Factor analysis, scale construction, internal consistency (Chronbach\u2019s Alpha), inter-item-correlation, discriminative ability (Intra Class Correlation) and inter-factor-correlations.", {"entities": []}], ["Modulation and selection of new questions based on results.", {"entities": []}], ["Criteria of retaining items: general: a limited amount of items, statistical: part of a reliable scale and inter-item-correlation <0,7, and theoretical.", {"entities": []}], ["27 anthroposophic items.", {"entities": []}], ["Two new anthroposophic scales: Scale AntroposophicTreatmentGP: seven items, Alpha=0,832, ICC=4,2 Inter-factor-correlation with existing GP-scales range from r=0,24 (Accessibility) to r=0,56 (TailoredCare).", {"entities": []}], ["Scale InteractionalStyleGP: five items, Alpha=0,810, ICC=5,8, Inter-factor-correlation with existing GP-scales range from r=0,32 (Accessibility) to r=0,76 (TailoredCare).", {"entities": []}], ["Inter-factor-correlation between new scales: r=0,50.", {"entities": []}], ["Phase 3: Adding both scales and four single items.", {"entities": []}], ["Removing eleven items and reformulating two items.", {"entities": []}], ["The CQ Index Anthroposophic Healthcare measures patient experiences with anthroposophic GP\u2019s validly and reliably.", {"entities": []}], ["Regarding the inter-factor-correlations anthroposophic quality aspects from the patients\u2019 perspective are mostly associated with individually tailored care and patient centeredness.", {"entities": []}], ["Despite the downward trend in the absolute number of tuberculosis (TB) cases since 2006 and the fall in the incidence rates since 2001, the burden of disease caused by TB remains a global health challenge.", {"entities": [[53, 65, "DISEASE"]]}], ["The co-infection between TB and HIV adds to this disease burden.", {"entities": []}], ["TB is completely curable through the intake of a strict anti-TB drug treatment regimen which requires an extremely high and consistent level of adherence.The aim of this study was to investigate factors associated with adherence to anti-TB and HIV treatment drugs.", {"entities": []}], ["A cross-sectional survey method was used.", {"entities": []}], ["Three study districts (14 primary health care facilities in each) were selected on the basis of the highest TB caseload per clinic.", {"entities": []}], ["All new TB and new TB retreatment patients were consecutively screened within one month of anti-tuberculosis treatment.", {"entities": [[96, 108, "DISEASE"]]}], ["The sample comprised of 3107 TB patients who had been on treatment for at least three weeks and a sub-sample of the total sample were on both anti-TB treatment and anti-retro-viral therapy(ART) (N\u2009=\u2009757).", {"entities": []}], ["Data collection tools included: a Socio-Demographic Questionnaire; a Post-Traumatic-Stress-Disorder (PTSD) Screen; a Psychological Distress Scale; the Alcohol Use Disorder Identification Test (AUDIT); and self-report measures of tobacco use, perceived health status and adherence to anti-TB drugs and ART.", {"entities": []}], ["The majority of the participants (N\u2009=\u20093107) were new TB cases with a 55.9% HIV co-infection rate in this adult male and female sample 18\u2009years and older.", {"entities": []}], ["Significant predictors of non-adherence common to both anti-TB drugs and to dual therapy (ART and anti-TB drugs) included poverty, having one or more co-morbid health condition, being a high risk for alcohol mis-use and a partner who is HIV positive.", {"entities": []}], ["An additional predictor for non-adherence to anti-TB drugs was tobacco use.", {"entities": []}], ["A comprehensive treatment programme addressing poverty, alcohol mis-use, tobacco use and psycho-social counseling is indicated for TB patients (with and without HIV).", {"entities": []}], ["The treatment care package needs to involve not only the health sector but other relevant government sectors, such as social development.", {"entities": []}], ["Telehealthcare involves the use of information and communication technologies to deliver healthcare at a distance and to support patient self-management through remote monitoring and personalised feedback.", {"entities": []}], ["It is timely to scrutinise the evidence regarding the benefits, risks and costs of telehealthcare.", {"entities": []}], ["Two reviewers searched for relevant systematic reviews published from January 1997 to November 2011 in: The Cochrane Library, MEDLINE, EMBASE, LILACS, IndMed and PakMed.", {"entities": []}], ["Reviewers undertook independent quality assessment of studies using the Critical Appraisal Skills Programme (CASP) tool for systematic reviews.", {"entities": []}], ["1,782 review articles were identified, from which 80 systematic reviews were selected for inclusion.", {"entities": []}], ["These covered a range of telehealthcare models involving both synchronous (live) and asynchronous (store-and-forward) interactions between provider and patients.", {"entities": []}], ["Many studies showed no differences in outcomes between telehealthcare and usual care.", {"entities": []}], ["Several reviews highlighted the large number of short-term (<12 months) feasibility studies with under 20 participants.", {"entities": []}], ["Effects of telehealthcare on health service indicators were reported in several reviews, particularly reduced hospitalisations.", {"entities": []}], ["The reported clinical effectiveness of telehealthcare interventions for patients with long-term conditions appeared to be greatest in those with more severe disease at high-risk of hospitalisation and death.", {"entities": []}], ["The failure of many studies to adequately describe the intervention makes it difficult to disentangle the contributions of technological and human/organisational factors on the outcomes reported.", {"entities": []}], ["Evidence on the cost-effectiveness of telehealthcare remains sparse.", {"entities": []}], ["Patient safety considerations were absent from the evaluative telehealthcare literature.", {"entities": []}], ["Policymakers and planners need to be aware that investment in telehealthcare will not inevitably yield clinical or economic benefits.", {"entities": []}], ["It is likely that the greatest gains will be achieved for patients at highest risk of serious outcomes.", {"entities": []}], ["There is a need for longer-term studies in order to determine whether the benefits demonstrated in time limited trials are sustained.", {"entities": []}], ["Intestinal ischemia has a high mortality and often causes acute lung injury (ALI), which is a serious complication, and is accompanied by high mortality up to 40%.", {"entities": [[11, 19, "DISEASE"]]}], ["An intense local and systemic inflammation occurs during intestinal ischemia/reperfusion (IR)-induced lung injury resulting from activation of immune responses.", {"entities": [[68, 76, "DISEASE"]]}], ["It has been reported that one component of complement, C5a, is indispensable for the full development of IR-induced lung injury, whereas the detailed molecular mechanism remains to be elucidated.", {"entities": []}], ["In this study, we found that intestinal IR induced ALI-like symptoms, and C5a receptor (C5aR) expression was upregulated in alveolar macrophages, which are resident macrophages in lung tissue and are important in pulmonary homeostasis.", {"entities": []}], ["C5a produced during lung injury binds to C5aR in alveolar macrophages, initiates downstream signaling that promotes autophagy, leading to apoptosis of alveolar macrophages.", {"entities": []}], ["Using M\u03c6-ATG5 in vivo C5a interacting with C5aR induced autophagy in alveolar macrophages, which promoted alveolar macrophage apoptosis.", {"entities": []}], ["Further study indicated that autophagy was induced through C5aR-mediated degradation of bcl-2.", {"entities": []}], ["Taken together, our results demonstrated that C5aR-mediated autophagy induced apoptosis in alveolar macrophages, disrupting pulmonary homeostasis and contributing to the development of ALI.", {"entities": []}], ["This novel mechanism suggests new therapeutic potential of autophagy regulation in ALI.", {"entities": []}], ["Extreme constitution \u201c Prakriti \u201d types of Ayurveda exhibit systemic physiological attributes.", {"entities": []}], ["Our earlier genetic study has revealed differences in EGLN1 , key modulator of hypoxia axis between Prakriti types.", {"entities": [[54, 59, "GENE"]]}], ["This was associated with differences in high altitude adaptation and susceptibility to\u00a0high altitude pulmonary edema (HAPE).", {"entities": [[101, 116, "DISEASE"]]}], ["In this study we investigate other molecular differences that contribute to systemic attributes of Prakriti that would be relevant in predictive marker discovery.", {"entities": []}], ["Genotyping of 96 individuals of the earlier cohort was carried out in a panel of 2,800 common genic SNPs represented in Indian Genomic Variation Consortium (IGVC) panel from 24 diverse populations.", {"entities": []}], ["Frequency distribution patterns of Prakriti differentiating variations (FDR correction P\u00a0<\u00a00.05) was studied in IGVC and 55 global populations (HGDP\u2013CEPH) panels.", {"entities": []}], ["Genotypic interactions between VWF , identified from the present analysis, and EGLN1 was analyzed using multinomial logistic regression in Prakriti and Indian populations from contrasting altitudes.", {"entities": [[31, 34, "GENE"], [79, 84, "GENE"]]}], ["Spearman\u2019s Rank correlation was used to study this genotypic interaction with respect to altitude in HGDP\u2013CEPH panel.", {"entities": []}], ["Validation of functional link between EGLN1 and VWF was carried out in a mouse model using chemical inhibition and siRNA studies.", {"entities": [[38, 43, "GENE"], [48, 51, "GENE"]]}], ["Significant differences in allele frequencies were observed in seven genes ( SPTA1, VWF, OLR1, UCP2, OR6K3, LEPR, and OR10Z1 ) after FDR correction (P\u00a0<\u00a00.05).", {"entities": [[77, 82, "GENE"], [84, 87, "GENE"], [89, 93, "GENE"], [95, 99, "GENE"], [108, 112, "GENE"], [118, 124, "GENE"]]}], ["A non synonymous variation (C/T, rs1063856) associated with thrombosis/bleeding susceptibility\u00a0respectively, differed significantly between Kapha\u00a0(C-allele) and Pitta (T-allele) constitution types.", {"entities": []}], ["A combination of derived EGLN1 allele (HAPE associated) and ancestral VWF allele (thrombosis associated) was significantly high in Kapha group compared to Pitta (p\u00a0<\u00a010 EGLN1 specific siRNA in a mouse model lead to a marked increase in vWF levels as well as pro-thrombotic phenotype viz.", {"entities": [[25, 30, "GENE"], [169, 174, "GENE"], [70, 73, "GENE"], [236, 239, "GENE"], [25, 30, "GENE"], [169, 174, "GENE"], [70, 73, "GENE"], [236, 239, "GENE"]]}], ["reduced bleeding time and enhanced platelet count and activation.", {"entities": []}], ["We demonstrate for the first time a genetic link between EGLN1 and VWF in a constitution specific manner which could modulate thrombosis/bleeding susceptibility and outcomes of hypoxia.", {"entities": [[57, 62, "GENE"], [67, 70, "GENE"]]}], ["Integration of Prakriti in population stratification may help assemble common variations in key physiological axes that confers differences in disease occurrence and patho-phenotypic outcomes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12967-015-0542-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Many interventions shown to be effective through clinical trials are not readily implemented in clinical practice.", {"entities": []}], ["Unfortunately, little is known regarding how clinicians construct their perceptions of the effectiveness of medical interventions.", {"entities": []}], ["This study aims to explore general practitioners' perceptions of the nature of 'effectiveness'.", {"entities": []}], ["The design was qualitative in nature using the repertory grid technique to elicit the constructs underlying the perceived effectiveness of a range of medical interventions.", {"entities": []}], ["Eight medical interventions were used as stimuli (diclophenac to reduce acute pain, cognitive behaviour therapy to treat depression, weight loss surgery to achieve weight loss, diet and exercise to prevent type 2 diabetes, statins to prevent heart disease, stopping smoking to prevent heart disease, nicotine replacement therapy to stop smoking, and stop smoking groups to stop smoking).", {"entities": [[242, 255, "DISEASE"], [285, 298, "DISEASE"]]}], ["The setting involved face-to-face interviews followed by questionnaires in London Primary Care Trusts.", {"entities": []}], ["Participants included a random sample of 13 general practitioners.", {"entities": []}], ["Analysis of the ratings showed that the constructs clustered around two dimensions: low patient effort versus high patient effort (dimension one), and small impact versus large impact (dimension two).", {"entities": []}], ["Dimension one represented constructs such as 'success requires little motivation', 'not a lifestyle intervention', and 'health-care professional led intervention'.", {"entities": []}], ["Dimension two represented constructs such as 'weak and/or minimal evidence of effectiveness', 'small treatment effect for users', 'a small proportion of users will benefit' and 'not cost-effective'.", {"entities": []}], ["Constructs within each dimension were closely related.", {"entities": []}], ["General practitioners judged the effectiveness of medical interventions by considering two broad dimensions: the extent to which interventions involve patient effort, and the size of their impact.", {"entities": []}], ["The latter is informed by trial evidence, but the patient effort required to achieve effectiveness seems to be based on clinical judgement.", {"entities": []}], ["Some of the failure of evidence-based medicine to be implemented may be more explicable if both dimensions were attended to.", {"entities": []}], ["Incidence is high, but the predominant strain does not seem to cause greater illness or death than do other strains.", {"entities": []}], ["British Columbia, Canada, has the largest reported population of Cryptococcus gattii \u2013infected persons worldwide.", {"entities": []}], ["To assess the impact of illness, we retrospectively analyzed demographic and clinical features of reported cases, hospitalizations, and deaths during 1999\u20132007.", {"entities": []}], ["A total of 218 cases were reported (average annual incidence 5.8 per million persons).", {"entities": []}], ["Most persons who sought treatment had respiratory illness (76.6%) or lung cryptococcoma (75.4%).", {"entities": []}], ["Persons without HIV/AIDS hospitalized with cryptococcosis were more likely than those with HIV/AIDS to be older and admitted for pulmonary cryptococcosis.", {"entities": [[43, 57, "DISEASE"], [139, 153, "DISEASE"]]}], ["The 19 (8.7%) persons who died were more likely to be older and to have central nervous system disease and infection from the VGIIb strain.", {"entities": [[72, 102, "DISEASE"], [80, 102, "DISEASE"]]}], ["Although incidence in British Columbia is high, the predominant strain (VGIIa) does not seem to cause greater illness or death than do other strains.", {"entities": []}], ["Further studies are needed to explain host and strain characteristics for regional differences in populations affected and disease outcomes.", {"entities": []}], ["Dietary lipids are key for infants to not only meet their high energy needs but also fulfill numerous metabolic and physiological functions critical to their growth, development, and health.", {"entities": []}], ["The lipid composition of breast milk varies during lactation and according to the mother's diet, whereas the lipid composition of infant formulae varies according to the blend of different fat sources.", {"entities": []}], ["This report compares the compositions of lipids in breast milk and infant formulae, and highlights the roles of dietary lipids in term and preterm infants and their potential biological and health effects.", {"entities": []}], ["The major differences between breast milk and formulae lie in a variety of saturated fatty acids (such as palmitic acid, including its structural position) and unsaturated fatty acids (including arachidonic acid and docosahexaenoic acid), cholesterol, and complex lipids.", {"entities": []}], ["The functional outcomes of these differences during infancy and for later child and adult life are still largely unknown, and some of them are discussed, but there is consensus that opportunities exist for improvements in the qualitative lipid supply to infants through the mother's diet or infant formulae.", {"entities": []}], ["Furthermore, research is required in several areas, including the needs of term and preterm infants for long-chain polyunsaturated fatty acids, the sites of action and clinical effects of lipid mediators on immunity and inflammation, the role of lipids on metabolic, neurological, and immunological outcomes, and the mechanisms by which lipids act on short- and long-term health.", {"entities": []}], ["There is an increase of serum levels of IgE during Plasmodium falciparum infections in individuals living in endemic areas.", {"entities": []}], ["These IgEs either protect against malaria or increase malaria pathogenesis.", {"entities": [[34, 41, "DISEASE"], [54, 61, "DISEASE"]]}], ["To get an insight into the exact role played by IgE in the outcome of P. falciparum infection, total IgE levels and functional anti-parasite IgE response were studied in children and adults, from two different endemic areas Gabon and India, exhibiting either uncomplicated malaria, severe non cerebral malaria or cerebral malaria, in comparison with control individuals.", {"entities": [[293, 309, "DISEASE"], [313, 329, "DISEASE"], [273, 280, "DISEASE"], [302, 309, "DISEASE"], [322, 329, "DISEASE"]]}], ["Blood samples were collected from controls and P. falciparum -infected patients before treatment on the day of hospitalization (day 0) in India and, in addition, on days 7 and 30 after treatment in Gabon.", {"entities": []}], ["Total IgE levels were determined by ELISA and functional P. falciparum -specific IgE were estimated using a mast cell line RBL-2H3 transfected with a human Fc\u03b5 RI \u03b1-chain that triggers degranulation upon human IgE cross-linking.", {"entities": []}], ["Mann Whitney and Kruskall Wallis tests were used to compare groups and the Spearman test was used for correlations.", {"entities": []}], ["Total IgE levels were confirmed to increase upon infection and differ with level of transmission and age but were not directly related to the disease phenotype.", {"entities": []}], ["All studied groups exhibited functional parasite-specific IgEs able to induce mast cell degranulation in vitro in the presence of P. falciparum antigens.", {"entities": []}], ["Plasma IgE levels correlated with those of IL-10 in uncomplicated malaria patients from Gabon.", {"entities": [[66, 73, "DISEASE"]]}], ["In Indian patients, plasma IFN-\u03b3 , TNF and IL-10 levels were significantly correlated with IgE concentrations in all groups.", {"entities": [[35, 38, "GENE"]]}], ["Circulating levels of total IgE do not appear to correlate with protection or pathology, or with anti-inflammatory cytokine pattern bias during malaria.", {"entities": [[144, 151, "DISEASE"]]}], ["On the contrary, the P. falciparum -specific IgE response seems to contribute to the control of parasites, since functional activity was higher in asymptomatic and uncomplicated malaria patients than in severe or cerebral malaria groups.", {"entities": [[213, 229, "DISEASE"], [178, 185, "DISEASE"], [222, 229, "DISEASE"]]}], ["The objectives of this study were to explore the relation between body mass index (BMI) and prevalence of diabetes mellitus, hypertension and dyslipidaemia; examine BMI distributions among patients with these conditions; and compare results from two national surveys.", {"entities": [[125, 137, "DISEASE"], [106, 123, "DISEASE"]]}], ["The Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) 2004 screening questionnaire (mailed survey) and the National Health and Nutrition Examination Surveys (NHANES) 1999\u20132002 (interview, clinical and laboratory data) were conducted in nationally representative samples \u2265 18 years old.", {"entities": []}], ["Responses were received from 127,420 of 200,000 households (64%, representing 211,097 adults) for SHIELD, and 4257 participants for NHANES.", {"entities": []}], ["Prevalence of diabetes mellitus, hypertension and dyslipidaemia was estimated within BMI categories, as was distribution of BMI levels among individuals with these diseases.", {"entities": [[33, 45, "DISEASE"], [14, 31, "DISEASE"]]}], ["Mean BMI was 27.8 kg/m", {"entities": []}], ["Majid Ezzati and colleagues examine US data on risk factor exposures and disease-specific mortality and find that smoking and hypertension, which both have effective interventions, are responsible for the largest number of deaths.", {"entities": [[126, 138, "DISEASE"]]}], ["Knowledge of the number of deaths caused by risk factors is needed for health policy and priority setting.", {"entities": []}], ["Our aim was to estimate the mortality effects of the following 12 modifiable dietary, lifestyle, and metabolic risk factors in the United States (US) using consistent and comparable methods: high blood glucose, low-density lipoprotein (LDL) cholesterol, and blood pressure; overweight\u2013obesity; high dietary trans fatty acids and salt; low dietary polyunsaturated fatty acids, omega-3 fatty acids (seafood), and fruits and vegetables; physical inactivity; alcohol use; and tobacco smoking.", {"entities": [[285, 292, "DISEASE"]]}], ["We used data on risk factor exposures in the US population from nationally representative health surveys and disease-specific mortality statistics from the National Center for Health Statistics.", {"entities": []}], ["We obtained the etiological effects of risk factors on disease-specific mortality, by age, from systematic reviews and meta-analyses of epidemiological studies that had adjusted (i) for major potential confounders, and (ii) where possible for regression dilution bias.", {"entities": []}], ["We estimated the number of disease-specific deaths attributable to all non-optimal levels of each risk factor exposure, by age and sex.", {"entities": []}], ["In 2005, tobacco smoking and high blood pressure were responsible for an estimated 467,000 (95% confidence interval [CI] 436,000\u2013500,000) and 395,000 (372,000\u2013414,000) deaths, accounting for about one in five or six deaths in US adults.", {"entities": []}], ["Overweight\u2013obesity (216,000; 188,000\u2013237,000) and physical inactivity (191,000; 164,000\u2013222,000) were each responsible for nearly 1 in 10 deaths.", {"entities": [[11, 18, "DISEASE"]]}], ["High dietary salt (102,000; 97,000\u2013107,000), low dietary omega-3 fatty acids (84,000; 72,000\u201396,000), and high dietary trans fatty acids (82,000; 63,000\u201397,000) were the dietary risks with the largest mortality effects.", {"entities": []}], ["Although 26,000 (23,000\u201340,000) deaths from ischemic heart disease, ischemic stroke, and diabetes were averted by current alcohol use, they were outweighed by 90,000 (88,000\u201394,000) deaths from other cardiovascular diseases, cancers, liver cirrhosis, pancreatitis, alcohol use disorders, road traffic and other injuries, and violence.", {"entities": [[44, 66, "DISEASE"], [53, 66, "DISEASE"], [234, 249, "DISEASE"], [251, 263, "DISEASE"]]}], ["Smoking and high blood pressure, which both have effective interventions, are responsible for the largest number of deaths in the US.", {"entities": []}], ["Other dietary, lifestyle, and metabolic risk factors for chronic diseases also cause a substantial number of deaths in the US.", {"entities": []}], ["Please see later in the article for Editors' Summary A number of modifiable factors are responsible for many premature or preventable deaths.", {"entities": []}], ["For example, being overweight or obese shortens life expectancy, while half of all long-term tobacco smokers in Western populations will die prematurely from a disease directly related to smoking.", {"entities": []}], ["Modifiable risk factors fall into three main groups.", {"entities": []}], ["First, there are lifestyle risk factors.", {"entities": []}], ["These include tobacco smoking, physical inactivity, and excessive alcohol use (small amounts of alcohol may actually prevent diabetes and some types of heart disease and stroke).", {"entities": [[152, 165, "DISEASE"]]}], ["Second, there are dietary risk factors such as a high salt intake and a low intake of fruits and vegetables.", {"entities": []}], ["Finally, there are \u201cmetabolic risk factors,\u201d which shorten life expectancy by increasing a person's chances of developing cardiovascular disease (in particular, heart problems and strokes) and diabetes.", {"entities": []}], ["Metabolic risk factors include having high blood pressure or blood cholesterol and being overweight or obese.", {"entities": []}], ["It should be possible to reduce preventable deaths by changing modifiable risk factors through introducing public health policies, programs and regulations that reduce exposures to these risk factors.", {"entities": []}], ["However, it is important to know how many deaths are caused by each risk factor before developing policies and programs that aim to improve a nation's health.", {"entities": []}], ["Although previous studies have provided some information on the numbers of premature deaths caused by modifiable risk factors, there are two problems with these studies.", {"entities": []}], ["First, they have not used consistent and comparable methods to estimate the number of deaths attributable to different risk factors.", {"entities": []}], ["Second, they have rarely considered the effects of dietary and metabolic risk factors.", {"entities": []}], ["In this new study, the researchers estimate the number of deaths due to 12 different modifiable dietary, lifestyle, and metabolic risk factors for the United States population.", {"entities": []}], ["They use a method called \u201ccomparative risk assessment.\u201d This approach estimates the number of deaths that would be prevented if current distributions of risk factor exposures were changed to hypothetical optimal distributions.", {"entities": []}], ["The researchers extracted data on exposures to these 12 selected risk factors from US national health surveys, and they obtained information on deaths from difference diseases for 2005 from the US National Center for Health Statistics.", {"entities": []}], ["They used previously published studies to estimate how much each risk factor increases the risk of death from each disease.", {"entities": []}], ["The researchers then used a mathematical formula to estimate the numbers of deaths caused by each risk factor.", {"entities": []}], ["Of the 2.5 million US deaths in 2005, they estimate that nearly half a million were associated with tobacco smoking and about 400,000 were associated with high blood pressure.", {"entities": []}], ["These two risk factors therefore each accounted for about 1 in 5 deaths in US adults.", {"entities": []}], ["Overweight\u2013obesity and physical inactivity were each responsible for nearly 1 in 10 deaths.", {"entities": [[11, 18, "DISEASE"]]}], ["Among the dietary factors examined, high dietary salt intake had the largest effect, being responsible for 4% of deaths in adults.", {"entities": []}], ["Finally, while alcohol use prevented 26,000 deaths from ischemic heart disease, ischemic stroke, and diabetes, the researchers estimate that it caused 90,000 deaths from other types of cardiovascular diseases, other medical conditions, and road traffic accidents and violence.", {"entities": [[56, 78, "DISEASE"], [65, 78, "DISEASE"]]}], ["These findings indicate that smoking and high blood pressure are responsible for the largest number of preventable deaths in the US, but that several other modifiable risk factors also cause many deaths.", {"entities": []}], ["Although the accuracy of some of the estimates obtained in this study will be affected by the quality of the data used, these findings suggest that targeting a handful of risk factors could greatly reduce premature mortality in the US.", {"entities": []}], ["The findings might also apply to other countries, although the risk factors responsible for most preventable deaths may vary between countries.", {"entities": []}], ["Importantly, effective individual-level and population-wide interventions are already available to reduce people's exposure to the two risk factors responsible for most preventable deaths in the US.", {"entities": []}], ["The researchers also suggest that combinations of regulation, pricing, and education have the potential to reduce the exposure of US residents to other risk factors that are likely to shorten their lives.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000058 .", {"entities": []}], ["The MedlinePlus encyclopedia contains a page on healthy living (in English and Spanish) The US Centers for Disease Control and Prevention provides information on all aspects of healthy living Healthy People 2010 is a national framework designed to improve the health of people living in the US.", {"entities": []}], ["The Healthy People 2020 Framework is due to be launched in January 2010 The World Health Report 2002Reducing Risks, Promoting Healthy Life provides a global analysis of how healthy life expectancy could be increased The National Health and Nutrition Examination Survey (NHANES) is \u201ca program of studies designed to assess the health and nutritional status of adults and children in the United States\u201d The US Centers for Disease Control and Prevention's site Smoking and Tobacco Use offers a large number of informational and data resources on this important risk factor The American Heart Association and American Cancer Society provide a rich resource for patients and caregivers on many important risk factors including diet, sodium intake, and smoking", {"entities": [[614, 620, "DISEASE"]]}], ["Objectives: we used a quantitative method to systematically synthesize the emerging literature and critically evaluate the effects of Baduanjin on depression and anxiety in people with physical or mental illnesses.", {"entities": []}], ["Additionally, we determined if the number of total Baduanjin training sessions is associated with decreased anxiety and depression levels.", {"entities": []}], ["Methods: both English and Chinese databases were searched for potential studies published between January 1982 and October 2017.", {"entities": []}], ["The eligible randomized controlled trials were considered for meta-analysis.", {"entities": []}], ["Effect size (Hedge\u2019s g) was computed for the pooled effects while the random-effect model was set.", {"entities": []}], ["For moderator analysis; Subgroup meta-analysis for categorical variables and meta-regression for continuous variables were performed.", {"entities": []}], ["Results: the aggregated result has shown a significant benefit in favour of Baduanjin on anxiety (Hedge\u2019s g = \u22120.99; CI \u22121.63 to \u22120.74) and depression (Hedge\u2019s g = \u22121.07; CI \u22121.3 to \u22120.83).", {"entities": []}], ["For continuous potential moderators; meta-regression indicated a significant effect for total hours in Baduanjin practice ( \u03b2 = \u22120.0053; 95% CI \u22120.009 to \u22120.0014; p = 0.008).", {"entities": []}], ["With regard to depression; meta-regression indicated a significant effect for total sessions of Baduanjin practice ( \u03b2 = \u22120.0023; 95% CI \u22120.006 to \u22120.0004; p = 0.028).", {"entities": []}], ["Conclusions: the encouraging findings indicate the efficacy of Baduanjin exercise in reducing depression and anxiety symptoms in people with physical or mental illnesses.", {"entities": []}], ["However; the results should be interpreted with caution because of existing methodological limitations (e.g., high risk of bias; Baduanjin combined with other behavioral interventions; and heterogeneity of control groups).", {"entities": []}], ["In this review, we focus on two attributes of P2X receptor channel function, one essential and one novel.", {"entities": []}], ["First, we propose that P2X receptors are extracellular sensors as well as receptors and ion channels.", {"entities": []}], ["In particular, the large extracellular domain (that comprises 70% of the molecular mass of the receptor channel protein) lends itself to be a cellular sensor.", {"entities": []}], ["Moreover, its exquisite sensitivity to extracellular pH, ionic strength, and multiple ligands evokes the function of a sensor.", {"entities": []}], ["Second, we propose that P2X receptors are extracellular zinc receptors as well as receptors for nucleotides.", {"entities": []}], ["We provide novel data in multiple publications and illustrative data in this invited review to suggest that zinc triggers ATP-independent activation of P2X receptor channel function.", {"entities": []}], ["In this light, P2X receptors are the cellular site of integration between autocrine and paracrine zinc signaling and autocrine and paracrine purinergic signaling.", {"entities": []}], ["P2X receptors may sense changes in these ligands as well as in extracellular pH and ionic strength and transduce these sensations via calcium and/or sodium entry and changes in membrane potential.", {"entities": []}], ["Diabetes mellitus (DM) is one of the most frequently detected conditions in multimorbid disease clusters.", {"entities": []}], ["Platelet activation is one of the key mechanisms underlying atherothrombosis in acute myocardial infarction.", {"entities": [[86, 107, "DISEASE"], [80, 107, "DISEASE"]]}], ["Available data link mean platelet volume (MPV) to poor prognosis not only in cardiovascular and non-cardiovascular disease.", {"entities": []}], ["Given the lack of research data on the association between disease clusters and MPV, we have set out to investigate the link between multimorbidity and MPV in diabetic patients with acute myocardial infarction.", {"entities": [[188, 209, "DISEASE"], [182, 209, "DISEASE"]]}], ["A total of 277 patients with DM and STEMI undergoing primary percutaneous coronary intervention were enrolled.", {"entities": []}], ["Based on the number of comorbidities the study population was divided into two groups: group 1 ( N \u00a0 = \u00a058) with \u2264\u00a01 comorbidity and group 2 ( N \u00a0 = \u00a0219) with \u2265\u00a02 comorbidities.", {"entities": []}], ["A subanalysis was performed within the multimorbidity group: group 2A with two or three comorbidities ( N \u00a0 = \u00a0156) and group 2B with at least four comorbidities ( N \u00a0 = \u00a063).", {"entities": []}], ["In the study population, 15.9% of patients had one comorbidity, and 22.0, 34.3, and 22.7% of patients had two, three, or at least four comorbid conditions, respectively.", {"entities": []}], ["Both MPV and PDW were elevated in multimorbid patients (9.3 vs 10.8\u00a0fl and 9.5 vs 10.3\u00a0fl, respectively).", {"entities": []}], ["The highest platelet volume indices were observed in patients with at least four comorbid conditions.", {"entities": []}], ["There was a moderate positive correlation between MPV and the total number of comorbidities, the number of CVD comorbidities, and the number of non-CVD comorbidities.", {"entities": []}], ["These findings indicate that multimorbidity is associated with an increase in platelet volume indices.", {"entities": []}], ["MPV values increased with the increasing number of comorbid conditions.", {"entities": []}], ["Importantly, MPV values were elevated in some, but not all CVD and non-CVD conditions.", {"entities": []}], ["Self-monitoring is increasingly recommended as a method of managing cardiovascular disease.", {"entities": []}], ["However, the design, implementation and reproducibility of the self-monitoring interventions appear to vary considerably.", {"entities": []}], ["We examined the interventions included in systematic reviews of self-monitoring for four clinical problems that increase cardiovascular disease risk.", {"entities": []}], ["We searched Medline and Cochrane databases for systematic reviews of self-monitoring for: heart failure, oral anticoagulation therapy, hypertension and type 2 diabetes.", {"entities": [[135, 147, "DISEASE"]]}], ["We extracted data using a pre-specified template for the identifiable components of the interventions for each disease.", {"entities": []}], ["Data was also extracted on the theoretical basis of the education provided, the rationale given for the self-monitoring regime adopted and the compliance with the self-monitoring regime by the patients.", {"entities": []}], ["From 52 randomized controlled trials (10,388 patients) we identified four main components in self-monitoring interventions: education, self-measurement, adjustment/adherence and contact with health professionals.", {"entities": []}], ["Considerable variation in these components occurred across trials and conditions, and often components were poorly described.", {"entities": []}], ["Few trials gave evidence-based rationales for the components included and self-measurement regimes adopted.", {"entities": []}], ["The components of self-monitoring interventions are not well defined despite current guidelines for self-monitoring in cardiovascular disease management.", {"entities": []}], ["Few trials gave evidence-based rationales for the components included and self-measurement regimes adopted.", {"entities": []}], ["We propose a checklist of factors to be considered in the design of self-monitoring interventions which may aid in the provision of an evidence-based rationale for each component as well as increase the reproducibility of effective interventions for clinicians and researchers.", {"entities": []}], ["Although interprofessional practice (IPP) offers the potential to enhance rural health services and provide support to rural clinicians, IPP may itself be problematic due to workforce limitations and service fragmentation.", {"entities": [[37, 40, "GENE"], [137, 140, "GENE"], [37, 40, "GENE"], [137, 140, "GENE"]]}], ["Differing socioeconomic and geographic characteristics of rural communities means that the way that IPP occurs in rural contexts will necessarily differ from that occurring in metropolitan contexts.", {"entities": [[100, 103, "GENE"]]}], ["The aim of this study was to investigate the factors contributing to effective IPP in rural contexts, to examine how IPP happens and to identify barriers and enablers.", {"entities": [[79, 82, "GENE"], [117, 120, "GENE"], [79, 82, "GENE"], [117, 120, "GENE"]]}], ["Using Realistic Evaluation as a framework, semi-structured interviews were conducted with health professionals in a range of rural healthcare contexts in NSW, Australia.", {"entities": []}], ["Independent thematic analysis was undertaken by individual research team members, which was then integrated through consensus to achieve a qualitative description of rural IPP practice.", {"entities": [[172, 175, "GENE"]]}], ["There was clear evidence of diversity and complexity associated with IPP in the rural settings that was supported by descriptions of collaborative integrated practice.", {"entities": [[69, 72, "GENE"]]}], ["There were instances where IPP doesn\u2019t and could happen.", {"entities": [[27, 30, "GENE"]]}], ["There were a number of characteristics identified that significantly impacted on IPP including the presence of a shared philosophical position and valuing of IPP and recognition of the benefits, funding to support IPP, pivotal roles, proximity and workforce resources.", {"entities": [[81, 84, "GENE"], [158, 161, "GENE"], [214, 217, "GENE"], [81, 84, "GENE"], [158, 161, "GENE"], [214, 217, "GENE"], [81, 84, "GENE"], [158, 161, "GENE"], [214, 217, "GENE"]]}], ["The nature of IPP in rural contexts is diverse and determined by a number of critical factors.", {"entities": [[14, 17, "GENE"]]}], ["This study goes some of the way towards unravelling the complexity of IPP in rural contexts, highlighting the strong motivating factors that drive IPP.", {"entities": [[70, 73, "GENE"], [147, 150, "GENE"], [70, 73, "GENE"], [147, 150, "GENE"]]}], ["However, it has also identified significant structural and relational barriers related to workload, workforce, entrenched hierarchies and ways of working and service fragmentation.", {"entities": []}], ["Further research is required to explicate the mechanisms that drive successful IPP across a range of diverse rural contexts in order to inform the implementation of robust flexible strategies that will support sustainable models of rural IPP.", {"entities": [[79, 82, "GENE"], [238, 241, "GENE"], [79, 82, "GENE"], [238, 241, "GENE"]]}], ["It has been well-established that some adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for cigarette smoking.", {"entities": []}], ["Current research on the genetic basis of this association could ultimately translate into genetic tests capable of identifying smoking-prone adolescents with ADHD.", {"entities": []}], ["In this study we examined 81 ADHD affected adolescents\u2019 (age 13\u201321) interest in genetic testing for nicotine addiction susceptibility.", {"entities": []}], ["Fifty-seven percent of adolescents indicated a fair amount of interest or more in testing.", {"entities": []}], ["Most adolescents indicated that the personal information revealed from testing would be either useful (29%) or interesting (37%).", {"entities": []}], ["Implications for genetically-informed smoking prevention and cessation interventions in high risk adolescents with ADHD are discussed.", {"entities": []}], ["Innate immune signaling is critical for the development of protective immunity.", {"entities": []}], ["Such signaling is, perforce, tightly controlled.", {"entities": []}], ["Lipoxins (LXs) are eicosanoid mediators that play key counterregulatory roles during infection.", {"entities": []}], ["The molecular mechanisms underlying LX-mediated control of innate immune signaling are of interest.", {"entities": []}], ["In this study, we show that LX and aspirin (ASA)-triggered LX (ATL) inhibit innate immune signaling by inducing suppressor of cytokine signaling (SOCS) 2\u2013dependent ubiquitinylation and proteasome-mediated degradation of TNF receptor\u2013associated factor (TRAF) 2 and TRAF6, which are adaptor molecules that couple TNF and interleukin-1 receptor/Toll-like receptor family members to intracellular signaling events.", {"entities": [[220, 223, "GENE"], [311, 314, "GENE"], [264, 269, "GENE"], [220, 223, "GENE"], [311, 314, "GENE"]]}], ["LX-mediated degradation of TRAF6 inhibits proinflammatory cytokine production by dendritic cells.", {"entities": [[27, 32, "GENE"]]}], ["This restraint of innate immune signaling can be ablated by inhibition of proteasome function.", {"entities": []}], ["In vivo, this leads to dysregulated immune responses, accompanied by increased mortality during infection.", {"entities": []}], ["Proteasomal degradation of TRAF6 is a central mechanism underlying LX-driven immune counterregulation, and a hitherto unappreciated mechanism of action of ASA.", {"entities": [[27, 32, "GENE"]]}], ["These findings suggest a new molecular target for drug development for diseases marked by dysregulated inflammatory responses.", {"entities": []}], ["Stable analogs of vasoactive intestinal peptide (VIP) have been proposed as novel line of therapy in chronic obstructive pulmonary disease (COPD) based on their bronchodilatory and anti-inflammatory effects.", {"entities": [[101, 138, "DISEASE"], [49, 52, "GENE"]]}], ["We speculated that VIP analogs may provide additional benefits in that they exert vasodilatory properties in the lung, and tested this hypothesis in both ex vivo and in vivo models.", {"entities": [[19, 22, "GENE"]]}], ["In isolated perfused mouse lungs and in an in vivo rat model, pulmonary blood vessels were preconstricted by hypoxia and hemodynamic changes in response to systemic ( ex vivo ) or inhaled ( in vivo ) administration of the cyclic VIP analog RO 25-1553 were determined.", {"entities": [[229, 232, "GENE"]]}], ["In mouse lungs, RO 25-1553 reduced intrinsic vascular resistance at normoxia, and attenuated the increase in pulmonary artery pressure in response to acute hypoxia.", {"entities": []}], ["Consistently, inhalation of RO 25-1553 (1 mg\u00b7mL in vivo that was comparable to the effects of inhaled sildenafil.", {"entities": []}], ["This effect was not attributable to systemic cardiovascular effects of RO 25-1553, but to a lung specific reduction in pulmonary vascular resistance, while cardiac output and systemic arterial hemodynamics remained unaffected.", {"entities": []}], ["No adverse effects of RO 25-1553 inhalation on pulmonary gas exchange, ventilation-perfusion matching, or lung fluid content were detected.", {"entities": []}], ["Our findings demonstrate that inhaled delivery of the stable VIP analog RO 25-1553 induces a potent and sustained vasodilatory effect in the pulmonary circulation with no detectable adverse effects.", {"entities": [[61, 64, "GENE"]]}], ["Therapeutic inhalation of RO 25-1553 may provide vascular benefits in addition to its reported anti-inflammatory and bronchodilatory effects in COPD, yet caution is warranted given the overall poor results of vasodilator therapies for pulmonary hypertension secondary to COPD in a series of recent clinical trials.", {"entities": [[245, 257, "DISEASE"], [235, 257, "DISEASE"]]}], ["This paper addresses key biological problems and statistical issues in the analysis of large gene expression data sets that describe systemic temporal response cascades to therapeutic doses in multiple tissues such as liver, skeletal muscle, and kidney from the same animals.", {"entities": []}], ["Affymetrix time course gene expression data U34A are obtained from three different tissues including kidney, liver and muscle.", {"entities": []}], ["Our goal is not only to find the concordance of gene in different tissues, identify the common differentially expressed genes over time and also examine the reproducibility of the findings by integrating the results through meta analysis from multiple tissues in order to gain a significant increase in the power of detecting differentially expressed genes over time and to find the differential differences of three tissues responding to the drug.", {"entities": []}], ["Bayesian categorical model for estimating the proportion of the 'call' are used for pre-screening genes.", {"entities": []}], ["Hierarchical Bayesian Mixture Model is further developed for the identifications of differentially expressed genes across time and dynamic clusters.", {"entities": []}], ["Deviance information criterion is applied to determine the number of components for model comparisons and selections.", {"entities": []}], ["Bayesian mixture model produces the gene-specific posterior probability of differential/non-differential expression and the 95% credible interval, which is the basis for our further Bayesian meta-inference.", {"entities": []}], ["Meta-analysis is performed in order to identify commonly expressed genes from multiple tissues that may serve as ideal targets for novel treatment strategies and to integrate the results across separate studies.", {"entities": []}], ["We have found the common expressed genes in the three tissues.", {"entities": []}], ["However, the up/down/no regulations of these common genes are different at different time points.", {"entities": []}], ["Moreover, the most differentially expressed genes were found in the liver, then in kidney, and then in muscle.", {"entities": []}], ["The technique of molecular imprinting produces artificial receptor sites in a polymer that can be used in a biomimetic sensor.", {"entities": []}], ["This research extends previous studies of a molecularly imprinted polymer (MIP) biomimetic sensor for the small drug theophylline.", {"entities": [[75, 78, "GENE"]]}], ["The presence of theophylline in the biomimetic sensor was monitored by analyzing the peak currents from cyclic voltammetry experiments.", {"entities": []}], ["The functional working range of the MIP modified electrode was 2 - 4 mM theophylline.", {"entities": [[36, 39, "GENE"]]}], ["The concentration of theophylline that resulted in the best signal was 3 mM.", {"entities": []}], ["The MIP sensor showed no response to the structurally related molecule caffeine, and therefore was selective to the target analyte theophylline.", {"entities": [[4, 7, "GENE"]]}], ["This research will provide the foundation for future studies that will result in durable biomimetic sensors that can offer a viable alternative to current sensors.", {"entities": []}], ["Angina bullosa hemorrhagica (ABH) is a disorder of unclear aetiology characterized by abrupt and unprovoked presentation of blood-filled blister over the oral mucosa.", {"entities": []}], ["Histopathology reveals sub epithelial blister containing erythrocytes with superficial perivascular lymphocytic infiltrate.", {"entities": []}], ["We report two cases of ABH of which one was idiopathic and other was associated with chronic renal failure on hemodialysis.", {"entities": []}], ["To compare disability prevalence rates in the major ethnic groups in the UK and understand the risk factors contributing to differences identified.", {"entities": []}], ["It was hypothesised that Indian Asian and African Caribbean people would experience higher rates of disability compared with Europeans.", {"entities": []}], ["Data was collected from 888 European, 636 Indian Asian and 265 African Caribbean men and women, aged 58\u201388 years at 20-year follow-up of community-based cohort study, based in West London.", {"entities": []}], ["Disability was measured using a performance-based locomotor function test and self-reported questionnaires on functional limitation, and instrumental (IADL) and basic activities of daily living (ADL).", {"entities": []}], ["The mean (SD) age of participants at follow-up was 69.6 (6.2) years.", {"entities": []}], ["Compared with Europeans, Indian Asian people were significantly more likely to experience all of the disability outcomes than Europeans; this persisted after adjustment for socioeconomic, behavioural, adiposity and chronic disease risk factors measured at baseline (locomotor dysfunction: adjusted odds ratio (OR) 2.20, 95% CI 1.56\u20133.11; functional limitation: OR 2.77, 2.01\u20133.81; IADL impairment: OR 3.12, 2.20\u20134.41; ADL impairment: OR 1.58, 1.11\u20132.24).", {"entities": []}], ["In contrast, a modest excess risk of disability was observed in African Caribbeans, which was abolished after adjustment (e.g.", {"entities": []}], ["locomotor dysfunction: OR 1.37, 0.90\u20131.91); indeed a reduced risk of ADL impairment appeared after multivariable adjustment (OR from 0.99, 0.68\u20131.45 to 0.59, 0.38\u20130.93), compared with Europeans.", {"entities": []}], ["Substantially elevated risk of disability was observed among Indian Asian participants, unexplained by known factors.", {"entities": []}], ["A greater understanding of determinants of disability and normative functional beliefs of healthy aging is required in this population to inform intervention efforts to prevent disability.", {"entities": []}], ["IgE-mediated hypersensitivity refers to immune reactions that can be rapidly progressing and, in the case of anaphylaxis, are occasionally fatal.", {"entities": []}], ["To that end, identification of the associated allergen is important for facilitating both education and allergen avoidance that are essential to long-term risk reduction.", {"entities": []}], ["As the number of known exposures associated with anaphylaxis is limited, discovery of novel causative agents is crucial to evaluation and management of patients with idiopathic anaphylaxis.", {"entities": []}], ["Within the last 10 years several apparently separate observations were recognized to be related, all of which resulted from the development of antibodies to a carbohydrate moiety on proteins.", {"entities": []}], ["Interestingly, the exposure differed from airborne allergens but was nevertheless capable of producing anaphylactic and hypersensitivity reactions.", {"entities": []}], ["Our recent work has identified these responses as being due to a novel IgE antibody directed against a mammalian oligosaccharide epitope, galactose-alpha-1,3-galactose (\u201calpha-gal\u201d).", {"entities": []}], ["This review will present the historical summary of the identification of cetuximab hypersensitivity due to alpha-gal IgE and discuss the non-primate mammalian meat food allergy as well as current goals and directions of our research programs.", {"entities": [[164, 176, "DISEASE"]]}], ["The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis.", {"entities": [[16, 28, "DISEASE"], [32, 38, "DISEASE"]]}], ["The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls.", {"entities": [[59, 66, "DISEASE"], [140, 152, "DISEASE"], [129, 135, "DISEASE"], [171, 177, "DISEASE"]]}], ["A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study.", {"entities": [[28, 34, "DISEASE"]]}], ["Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer.", {"entities": []}], ["Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 \u00b1 0.29 and 0.88 \u00b1 0.14 g/cm There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status.", {"entities": [[213, 225, "DISEASE"], [229, 235, "DISEASE"]]}], ["Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant.", {"entities": [[36, 43, "DISEASE"], [52, 64, "DISEASE"], [68, 74, "DISEASE"]]}], ["Cyanobacteria are common inhabitants of freshwater lakes and reservoirs throughout the world.", {"entities": []}], ["Under favourable conditions, certain cyanobacteria can dominate the phytoplankton within a waterbody and form nuisance blooms.", {"entities": []}], ["Case reports and anecdotal references dating from 1949 describe a range of illnesses associated with recreational exposure to cyanobacteria: hay fever-like symptoms, pruritic skin rashes and gastro-intestinal symptoms are most frequently reported.", {"entities": []}], ["Some papers give convincing descriptions of allergic reactions while others describe more serious acute illnesses, with symptoms such as severe headache, pneumonia, fever, myalgia, vertigo and blistering in the mouth.", {"entities": [[154, 163, "DISEASE"]]}], ["A coroner in the United States found that a teenage boy died as a result of accidentally ingesting a neurotoxic cyanotoxin from a golf course pond.", {"entities": []}], ["This death is the first recorded human fatality attributed to recreational exposure to cyanobacteria, although uncertainties surround the forensic identification of the suspected cyanotoxin in this case.", {"entities": []}], ["We systematically reviewed the literature on recreational exposure to freshwater cyanobacteria.", {"entities": []}], ["Epidemiological data are limited, with six studies conducted since 1990.", {"entities": []}], ["Statistically significant increases in symptoms were reported in individuals exposed to cyanobacteria compared to unexposed counterparts in two Australian cohort studies, though minor morbidity appeared to be the main finding.", {"entities": []}], ["The four other small studies (three from the UK, one Australian) did not report any significant association.", {"entities": []}], ["However, the potential for serious injury or death remains, as freshwater cyanobacteria under bloom conditions are capable of producing potent toxins that cause specific and severe dysfunction to hepatic or central nervous systems.", {"entities": []}], ["The exposure route for these toxins is oral, from ingestion of recreational water, and possibly by inhalation.", {"entities": []}], ["A range of freshwater microbial agents may cause acute conditions that present with features that resemble illnesses attributed to contact with cyanobacteria and, conversely, acute illness resulting from exposure to cyanobacteria or cyanotoxins in recreational waters could be misdiagnosed.", {"entities": []}], ["Accurately assessing exposure to cyanobacteria in recreational waters is difficult and unreliable at present, as specific biomarkers are unavailable.", {"entities": []}], ["However, diagnosis of cyanobacteria-related illness should be considered for individuals presenting with acute illness following freshwater contact if a description is given of a waterbody visibly affected by planktonic mass development.", {"entities": []}], ["The reduced number of hospital beds and an ageing population have resulted in growing demands for home nursing.", {"entities": []}], ["We know very little about the comprehensive care of these patients.", {"entities": []}], ["The objectives were to identify the care, in addition to primary health care, of patients with primary-care home nursing to give a comprehensive view of their care and to investigate how personal, social and functional factors influence the use of specialised medical care.", {"entities": []}], ["One-third (158) of all patients receiving primary-care home nursing in an area were sampled, and 73 % (116) were included.", {"entities": []}], ["Their care from October 1995 until October 1996 was investigated by sending questionnaires to district nurses and home-help providers and by collecting retrospective data from primary-care records and official statistics.", {"entities": []}], ["We used non-parametric statistical methods, i.e.", {"entities": []}], ["medians and minimum \u2013 maximum, \u03c72, and the Mann-Whitney test, since the data were not normally distributed.", {"entities": []}], ["Conditional logistic regression was used to study whether personal, social or functional factors influenced the chance (expressed as odds ratio) that study patients had made visits to or had received inpatient care from specialised medical care during the study year.", {"entities": []}], ["56 % of the patients had been hospitalised.", {"entities": []}], ["73 % had made outpatient visits to specialised medical care.", {"entities": []}], ["The care took place at 14 different hospitals, and more than 22 specialities were involved, but local care predominated.", {"entities": []}], ["Almost all patients visited doctors, usually in both primary and specialised medical care.", {"entities": []}], ["Patients who saw doctors in specialised care had more help from all other categories of care.", {"entities": []}], ["Patients who received help from their families made more visits to specialised medical care and patients with severe ADL dependence made fewer visits.", {"entities": []}], ["The care of patients with primary-care home nursing is complex.", {"entities": []}], ["Apart from home nursing, all patients also made outpatient visits to doctors, usually in both primary and specialised medical care.", {"entities": []}], ["Many different caregivers and professions were involved.", {"entities": []}], ["Reduced functional capacity decreased and help from family members increased the chance of having received outpatient specialised medical care.", {"entities": []}], ["This raises questions concerning the medical care for patients with both medical and functional problems.", {"entities": []}], ["The effect of antigen specific immunotherapy (SIT) on asthma is supposed to be improved.", {"entities": [[54, 60, "DISEASE"]]}], ["Published data indicate that administration of probiotics alleviates allergic diseases.", {"entities": []}], ["B cells play important roles in the pathogenesis of allergic diseases.", {"entities": []}], ["This study aims to modulate antigen specific B cell property by the administration of Clostridium butyrate ( CB ) in combination with SIT.", {"entities": []}], ["The results showed that after a 3-month treatment, the total asthma clinical score and serum specific IgE were improved in the patients treated with SIT, which was further improved in those treated with both SIT and CB , but not in those treated with CB alone.", {"entities": [[61, 67, "DISEASE"]]}], ["Treatment with SIT and CB increased p300 and STAT3 activation, up regulated the IL-10 gene transcription and increased the frequency of peripheral antigen specific B cells.", {"entities": [[45, 50, "GENE"]]}], ["In conclusion, administration with SIT in combination with CB converts Der p 1 specific B cells to regulatory B cells in asthma patients allergic to Der p 1.", {"entities": [[121, 127, "DISEASE"]]}], ["The data suggest a potential therapeutic remedy in the treatment of allergic diseases.", {"entities": []}], ["Phenotyping asthma according to airway inflammation allows identification of responders to targeted therapy.", {"entities": [[12, 18, "DISEASE"]]}], ["Induced sputum is technically demanding.", {"entities": []}], ["We aimed to identify predictors of sputum inflammatory phenotypes according to easily available clinical characteristics.", {"entities": []}], ["This retrospective study was conducted in 508 asthmatics with successful sputum induction recruited from the University Asthma Clinic of Liege.", {"entities": [[120, 126, "DISEASE"]]}], ["Receiver-operating characteristic (ROC) curve and multiple logistic regression analysis were used to assess the relationship between sputum eosinophil or neutrophil count and a set of covariates.", {"entities": []}], ["Equations predicting sputum eosinophils and neutrophils were then validated in an independent group of asthmatics.", {"entities": []}], ["Eosinophilic (\u22653%) and neutrophilic (\u226576%) airway inflammation were observed in 46% and 18% of patients respectively.", {"entities": []}], ["Predictors of sputum eosinophilia \u22653% were high blood eosinophils, FE NO and IgE level and low FEV 1 /FVC.", {"entities": [[21, 33, "DISEASE"], [95, 98, "GENE"]]}], ["The derived equation was validated with a Cohen\u2019s kappa coefficient of 0.59 (p\u2009<\u20090.0001).", {"entities": []}], ["ROC curves showed a cut-off value of 220/mm Eosinophilic and paucigranulocytic asthma are the dominant inflammatory phenotypes.", {"entities": [[79, 85, "DISEASE"]]}], ["Blood eosinophils provide a practical alternative to predict sputum eosinophilia but sputum neutrophil count is poorly related to blood neutrophils.", {"entities": [[68, 80, "DISEASE"]]}], ["The establishment of the infant gut microbiota is a highly dynamic process dependent on extrinsic and intrinsic factors.", {"entities": []}], ["We characterized the faecal microbiota of 4 breastfed infants and 4 formula-fed infants at 17 consecutive time points during the first 12 weeks of life.", {"entities": []}], ["Microbiota composition was analysed by a combination of 16S rRNA gene sequencing and quantitative PCR (qPCR).", {"entities": []}], ["In this dataset, individuality was a major driver of microbiota composition (P\u2009=\u20090.002) and was more pronounced in breastfed infants.", {"entities": []}], ["A developmental signature could be distinguished, characterized by sequential colonisation of i) intrauterine/vaginal birth associated taxa, ii) skin derived taxa and other typical early colonisers such as Streptococcus and Enterobacteriaceae , iii) domination of Bifidobacteriaceae , and iv) the appearance of adultlike taxa, particularly species associated with Blautia , Eggerthella , and the potential pathobiont Clostridium difficile .", {"entities": []}], ["Low abundance of potential pathogens was detected by 16S profiling and confirmed by qPCR.", {"entities": []}], ["Incidence and dominance of skin and breast milk associated microbes were increased in the gut microbiome of breastfed infants compared to formula-fed infants.", {"entities": []}], ["The approaches in this study indicate that microbiota development of breastfed and formula-fed infants proceeds according to similar developmental stages with microbiota signatures that include stage-specific species.", {"entities": []}], ["Central airway obstruction (CAO) may be caused by various etiologies.", {"entities": []}], ["However, conventional chest X-rays are rarely diagnostic for patients with CAO.", {"entities": []}], ["We here described a 64-year-old asymptomatic female with tracheal mucosa-associated lymphoid tissue lymphoma discovered on spirometric findings during a complete physical examination.", {"entities": [[100, 108, "DISEASE"]]}], ["The plateau of forced expiratory flow was consistent with CAO.", {"entities": []}], ["A decreased peak expiratory flow rate was noted at least 3\u00a0years before the diagnosis, and was attributed to an insufficient effort by the patient.", {"entities": []}], ["Impulse oscillometric measurements, which were taken during quiet breathing and were effort-independent, suggested elevated respiratory resistance.", {"entities": []}], ["These abnormalities completely disappeared after radiation therapy.", {"entities": []}], ["The addition of impulse oscillometry to spirometry may be useful for screening CAO in routine health examinations.", {"entities": []}], ["Four metrics were used to assess exposure to environmental tobacco smoke (ETS) for a probability sample (n = 152) of elementary school-age children in two economically disadvantaged neighborhoods: a) caregiver responses to a baseline questionnaire (BQ) about smoking status and behavior; b) 48-hr time-activity (T-A) data on location and time spent by children in the presence of tobacco smoke; c) total urinary cotinine as a marker for nicotine uptake; and d) urinary NNAL [4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol] + NNAL-Gluc [4-(methylnitrosamino)-1- (3-pyridyl)-1-(O-beta-D-glucopyranuronosyl)butane] as a marker for uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).", {"entities": []}], ["Consistent differences in ETS exposure by ethnicity and race were observed.", {"entities": []}], ["Although data were insufficient to determine differences for NNAL + NNAL-Gluc, BQ responses, T-A data, and cotinine levels all indicated that average ETS exposure was highest for African-American children, moderately high for those designated \"other\" (white, Southeast Asian, Native American), moderately low for Hispanic children, and lowest for Somali immigrant children.", {"entities": []}], ["For example, in February 2000, mean cotinine levels were 14.1 ng/mL for African Americans, 12.2 ng/mL for other, 4.8 ng/mL for Hispanics, and 4.4 ng/mL for Somalis.", {"entities": []}], ["The BQ and T-A data together were reasonably good predictors of total cotinine levels (adjusted r2 = 0.69), and based on limited data, measured total cotinine values were a relatively good predictor of NNAL + NNAL-Gluc (adjusted r2 = 0.73).", {"entities": []}], ["The results suggest that when children are exposed to ETS primarily in their homes, questionnaires and T-A logs might be effective screening tools for identifying those likely to experience higher uptake of nicotine.", {"entities": []}], ["The aim of this study is to develop a locally acting nasal delivery system of triamcinolone acetonide (TA) for the maintenance therapy of allergic rhinitis.", {"entities": [[138, 155, "DISEASE"], [147, 155, "DISEASE"]]}], ["The effect of encapsulating TA in different nanocarriers on its mucosal permeation and retention as well as in vivo nasal deposition has been studied.", {"entities": []}], ["A comparative study was established between polymeric oil core nanocapsules (NCs), lipid nanocarriers such as nanoemulsion (NE), and nanostructured lipid carriers (NLCs).", {"entities": []}], ["The elaborated nanocarriers were compared with TA suspension and the commercially available suspension \u201cNasacort", {"entities": []}], ["Asthma is a heterogeneous disease with variable symptoms especially in children.", {"entities": [[0, 6, "DISEASE"]]}], ["Exhaled nitric oxide (FeNO) has proved to be a marker of inflammation in the airways and has become a substantial part of clinical management of asthmatic children due to its potential to predict possible exacerbation and adjust the dose of inhalant corticosteroids.", {"entities": []}], ["We analyzed potential factors that contribute to the variability of nitric oxide in various clinical and laboratory conditions.", {"entities": []}], ["Study population consisted of 222 asthmatic children and 27 healthy control subjects.", {"entities": []}], ["All children underwent a panel of tests: fractioned exhaled nitric oxide, exhaled carbon monoxide, asthma control test scoring, blood sampling, skin prick tests, and basic spirometry.", {"entities": [[99, 105, "DISEASE"]]}], ["FeNO and other investigated parameters widely changed according to clinical or laboratory characteristics of the tested children.", {"entities": []}], ["Asthmatics showed increased levels of FeNO, exhaled carbon monoxide, total serum IgE, and higher eosinophilia.", {"entities": [[97, 109, "DISEASE"]]}], ["Boys had higher FeNO levels than girls.", {"entities": []}], ["We found a significant positive correlation between FeNO levels and the percentage of blood eosinophils, %predicted of forced vital capacity, total serum IgE levels, and increasing age.", {"entities": []}], ["Various phenotypes of children's asthma are characterized by specific pattern of the results of clinical and laboratory tests.", {"entities": [[33, 39, "DISEASE"]]}], ["FeNO correlates with total serum IgE, blood eosinophilia, age, and some spirometric parameters with different strength.", {"entities": [[44, 56, "DISEASE"]]}], ["Therefore, the coexistence of atopy, concomitant allergic rhinitis/rhinoconjunctivitis, and some other parameters should be considered in critical evaluation of FeNO in the management of asthmatic children.", {"entities": [[49, 66, "DISEASE"], [58, 66, "DISEASE"]]}], ["Patient: Female, 45 Final Diagnosis: Urinary bladder paraganglioma Symptoms: Angina pectoris \u2022 dyspnea \u2022 palpitations Medication: Phenoxybenzamine \u2022 Propanolol Clinical Procedure: Open partial cystectomy Specialty: Endocrinology and Metabolic Rare disease Sympathetic urinary bladder paragangliomas are rare catecholamine-secreting neuroendocrine tumors arising from neural crest cells.", {"entities": [[53, 66, "DISEASE"]]}], ["They are uncommon urinary bladder neoplasms.", {"entities": []}], ["Symptoms classically include micturition-related or unrelated palpitations and syncope with hypertension, headaches, diaphoresis, and hematuria.", {"entities": [[92, 104, "DISEASE"]]}], ["Other than being attributable to vasovagal reactions, micturition-induced cardiovascular symptoms should prompt a search for catecholamine-secreting tumors such as a urinary bladder paraganglioma, as in this case.", {"entities": [[182, 195, "DISEASE"]]}], ["A 45-year-old asthmatic African-American female presented with episodic hematuria that began 4 years ago and episodes of micturition-induced palpitations, dyspnea, substernal tightness, sweating, and throbbing headaches.", {"entities": []}], ["Computed tomography with contrast revealed an enhancing mass along the anterior urinary bladder wall, measuring 2.4\u00d73.5 cm.", {"entities": []}], ["On Positron emission Tomography with [18F] fluorodeoxyglucose integrated with computed tomography (18F-FDG PET/CT), the urinary bladder mass was 18F-FDG avid.", {"entities": []}], ["Serum normetanephrine and supine plasma norepinephrine were significantly elevated and there was mild elevation of supine plasma epinephrine.", {"entities": []}], ["Transurethral resection of the bladder mass revealed a neoplasm with microscopic features and immunohistochemical profile positive for synaptophysin and chromogranin, with negative screening cytokeratin AE1/AE3, suggesting a paraganglioma.", {"entities": [[225, 238, "DISEASE"]]}], ["Following resection of the paraganglioma, there was complete resolution of micturition-induced cardiovascular symptoms on long-term follow-up.", {"entities": [[27, 40, "DISEASE"]]}], ["Micturition-related cardiovascular symptoms are commonly attributed to vasovagal reactions.", {"entities": []}], ["However, urinary bladder pathologies must be ruled out as a cause, as in this rare case of a urinary bladder paraganglioma exhibiting catecholaminergic symptoms.", {"entities": [[109, 122, "DISEASE"]]}], ["Recurrent acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are common, debilitating, costly and often difficult to prevent.", {"entities": [[33, 70, "DISEASE"]]}], ["We reviewed records of patients who had COPD and immunoglobulin (Ig) treatment as adjunctive preventative treatment for AECOPD, and documented all AECOPD episodes for one year before and after initiation of Ig treatment.", {"entities": []}], ["We graded AECOPD episodes as moderate for prescription of antibiotics and/or corticosteroids or for visit to the Emergency Department, and as severe for hospital admission.", {"entities": []}], ["We conducted a retrospective within-subject self-controlled risk interval analysis to compare the outcome of annual AECOPD rate before and after treatment.", {"entities": []}], ["We identified 22 cases of certain COPD, of which three had early discontinuation of Ig treatment due to rash and local swelling to subcutaneous Ig, and five had incomplete records leaving 14 cases for analyses.", {"entities": []}], ["The median baseline IgG level was 5.9 g/L (interquartile range 4.1\u20137.4).", {"entities": []}], ["Eight had CT radiographic bronchiectasis.", {"entities": [[26, 40, "DISEASE"]]}], ["Overall, the incidence of AECOPD was consistently and significantly reduced in frequency from mean 4.7 (\u00b1 3.1) per patient-year before, to 0.6 (\u00b1 1.0) after the Ig treatment ( p = 0.0001).", {"entities": []}], ["There were twelve episodes of severe AECOPD (in seven cases) in the year prior, and one in the year after Ig treatment initiation ( p = 0.016).", {"entities": []}], ["Ig treatment appears to decrease the frequency of moderate and severe recurrent AECOPD.", {"entities": []}], ["A prospective, controlled evaluation of adjunctive Ig treatment to standard therapy of recurrent AECOPD is warranted.", {"entities": []}], ["Bronchopulmonary dysplasia (BPD) is characterized by the aberrant remodeling of the lung parenchyma, resulting from accumulation of fibroblasts or myofibroblasts.", {"entities": []}], ["Circulating fibrocytes are implied in pulmonary fibrosis, but whether these cells are associated with the development of BPD or the progressive fibrosis is unknown.", {"entities": [[38, 56, "DISEASE"]]}], ["The aim of the present study was to investigate the occurrence of fibrocytes in peripheral venous blood and explore whether these cells might be associated with severity of BPD.", {"entities": []}], ["We investigated circulating fibrocytes in 66 patients with BPD, 23 patients with acute respiratory distress syndrome(ARDS) and 11 normal subjects.", {"entities": [[108, 116, "DISEASE"]]}], ["Circulating fibrocytes were defined and quantified as cells positive for CD45 andcollagen-1 by flow cytometry.", {"entities": []}], ["Furthermore, serum SDF-1/CXCL12 and TGF-\u03b21 were evaluated using ELISA methods.", {"entities": []}], ["We also investigated the clinical value of fibrocyte counts by comparison with standard clinical parameters.", {"entities": []}], ["The patients with BPD had significantly increased numbers of fibrocytes compared to the controls (p < 0.01).", {"entities": []}], ["Patients with ARDS were not different from healthy control subjects.", {"entities": []}], ["There was a correlation between the number of fibrocytes and pulmonary hypertension or oxygen saturation (p < 0.05).", {"entities": [[71, 83, "DISEASE"], [61, 83, "DISEASE"]]}], ["Fibrocyte numbers were not correlated with other clinical or functional variables or radiologic severity scores.", {"entities": []}], ["The fibrocyte attractant chemokine CXCL12 increased in plasma (p < 0.05) and was detectable in the bronchoalveolar lavage fluid of 40% of the patients but not in controls.", {"entities": [[35, 41, "GENE"]]}], ["These findings indicate that circulating fibrocytes are increased in patients with BPD and may contribute to pulmonary fibrosis in BPD.", {"entities": [[109, 127, "DISEASE"]]}], ["Circulating fibrocytes, likely recruited through the CXCR4/CXCL12 axis, might contribute to the production of TGF-\u03b21 for the expansion of fibroblast/myofibroblast population in BPD.", {"entities": []}], ["In industrialized countries atopic diseases have been reported to be less likely in children and adolescents with a migrant background compared to non-migrants.", {"entities": []}], ["This paper aimed at both examining and comparing prevalence of asthma, allergic rhinoconjunctivitis and atopic dermatitis and allergic sensitization to specific IgE antibodies in children and adolescents with and without a migrant background.", {"entities": [[104, 121, "DISEASE"], [63, 69, "DISEASE"], [111, 121, "DISEASE"]]}], ["Using data of the population-based German Health Interview and Examination Survey for children and adolescents (KiGGS; n = 17,450; 0\u201317 years), lifetime and 12-month prevalence of atopic diseases and point prevalence of 20 common allergic sensitizations were investigated among migrants compared to non-migrants.", {"entities": []}], ["Multiple regression models were used to estimate the association of atopic disease and allergic sensitization with migrant background.", {"entities": []}], ["In multivariate analyses with substantial adjustment we found atopic dermatitis about one-third less often (OR 0.73, 0.57\u20130.93) in participants with a two-sided migrant background.", {"entities": [[62, 79, "DISEASE"], [69, 79, "DISEASE"]]}], ["Statistically significant associations between allergic sensitizations and a two-sided migrant background remained for birch (OR 0.73, 0.58\u20130.90), soybean (OR 0.72, 0.54\u20130.96), peanut (OR 0.69, 0.53\u20130.90), rice (OR 0.64, 0.48\u20130.87), potato (OR 0.64, 0.48\u20130.85), and horse dander (OR 0.58, 0.40\u20130.85).", {"entities": []}], ["Environmental factors and living conditions might be responsible for the observed differences.", {"entities": []}], ["Evolutionary pressure drives gut microbiota\u2013host coevolution and results in complex interactions between gut microbiota and neural development; however, the molecular mechanisms by which the microbiota governs host behavior remain obscure.", {"entities": []}], ["Here, we report that colonization early in life is crucial for the microbiota to modulate brain development and behavior; later colonization or deletion of microbiota cannot completely reverse the behaviors.", {"entities": []}], ["Microarray analysis revealed an association between absence of gut microbiota and expression in cAMP responding element-binding protein (CREB) regulated genes in the hippocampus.", {"entities": []}], ["The absence of gut microbiota from birth was shown to be associated with decreased CREB expression, followed by decreases of protein kinase C beta (PRKCB) and AMPA receptors expression, and an increase of phosphorylation CREB (pCREB) expression.", {"entities": [[148, 153, "GENE"]]}], ["Microbiota colonization in adolescence restored CREB and pCREB expression, but did not alter PRKCB and AMPARs expression.", {"entities": [[93, 98, "GENE"]]}], ["The removal of the gut microbiota from SPF mice using antibiotics only reduced pCREB expression.", {"entities": []}], ["These findings suggest that (i) colonization of the gut microbiota early in life might facilitate neurodevelopment via PKC\u2013CREB signaling and (ii) although GF mice and ABX mice display reduced anxiety-related behaviors, the molecular mechanisms behind this might differ.", {"entities": []}], ["Despite substantial morbidity associated with respiratory syncytial virus (RSV) infection, there is no licensed vaccine.", {"entities": []}], ["MEDI-559 is a live attenuated intranasal vaccine candidate being developed for prevention of lower respiratory illness due to RSV in young children.", {"entities": []}], ["This randomized, placebo-controlled study evaluated safety of MEDI-559 in healthy, RSV-seronegative children.", {"entities": []}], ["MEDI-559 or placebo was administered on 3 occasions, 2 months apart.", {"entities": []}], ["Primary safety was based on solicited symptoms (SSs) and adverse events (AEs) collected for 28 days after each dose.", {"entities": []}], ["Nasal wash samples were collected 3 times after each dose (days 7-10, 12-18, 28-34) and at sick visits.", {"entities": []}], ["Serum was collected for measuring antibody immune responses to RSV prior to first vaccination and 28 days post final dose.", {"entities": []}], ["Long-term safety was monitored for 365 days from first dose.", {"entities": []}], ["SSs were mild and frequent (MEDI-559 84%; placebo 91%); most common SSs were runny/stuffy nose, cough, and irritability/fussiness.", {"entities": []}], ["AEs occurred in 67% MEDI-559 and 57% placebo recipients: most common AE was upper respiratory tract infection (MEDI-559 35%; placebo 23%).", {"entities": []}], ["Higher incidence of medically attended lower respiratory illness within 28 days after dosing occurred in the MEDI-559 arm compared to placebo (none associated with vaccine virus shedding).", {"entities": []}], ["There was no evidence of enhanced RSV disease.", {"entities": []}], ["Vaccine virus was detected only in MEDI-559 recipients; shedding occurred in 56%subjects, primarily post dose 1.", {"entities": []}], ["A functional immune response was observed in 59% and 9% MEDI-559 and placebo recipients, respectively, by an RSV microneutralization assay.", {"entities": []}], ["Vaccine take, assessed by proportion that shed vaccine-type virus or had a seroresponse against RSV, was seen in 95% MEDI-559 subjects.", {"entities": []}], ["MEDI-559 is therefore biologically active and immunogenic in this seronegative pediatric population.", {"entities": []}], ["Although the frequency of SSs and AEs was not considered clinically significant, the increase in medically attended lower respiratory illnesses in the vaccine group warrants expanded safety studies.", {"entities": []}], ["ClinicalTrials.gov NCT00767416", {"entities": []}], ["People with rheumatoid arthritis (RA) suffer increased risk of disability andpremature mortality.", {"entities": [[12, 32, "DISEASE"], [23, 32, "DISEASE"]]}], ["Health-enhancing physical activity (HEPA) could be one importantfactor to reduce this risk.", {"entities": []}], ["Rising health care costs call for the development and evaluation ofnew modes of rehabilitation, including physical activity in settings outside the health caresystem.", {"entities": []}], ["This cohort study targets 450 patients with RA that do not currently meet HEPA recommendations, recruited from six hospitals reporting to the Swedish Rheumatology Quality Registers (SRQ).", {"entities": []}], ["We have developed a two-year real-life intervention program including a minimum of twice-weekly circuit training, moderately intense physical activity the remaining days of the week and group meetings to support behavior change every other week.", {"entities": []}], ["Our hypothesis is that increased physical activity and exercise will improve perceived health, reduce pain and fatigue, increase muscle function and aerobic capacity, impact psychosocial factors and prevent future cardiovascular events.", {"entities": []}], ["Research questions regard outcomes, retention rates, dose\u2013response matters and the exploration of responder characteristics.", {"entities": []}], ["This protocol outlines recruitment procedure, design, assessment methods and the intervention program of the study.", {"entities": []}], ["The PARA 2010 project is designed to expand the knowledge on HEPA in RA by a progressive approach regarding population, setting, intervention, time frames and outcome measures.", {"entities": []}], ["To our knowledge this is the first long-term HEPA program based on Social Cognitive Theory, and performed in a real life environment to demonstrate if this new setting can promote increased and maintained physical activity in people with RA.", {"entities": []}], ["ISRCTN25539102", {"entities": []}], ["To investigate the association between bed-sharing with the mother at 3\u2005months of age and incidence of hospitalisation due to pneumonia and diarrhoea between 3 and 12\u2005months.", {"entities": [[126, 135, "DISEASE"]]}], ["The 2004 Pelotas Birth Cohort included all live births to mothers living in Pelotas, Brazil, in 2004.", {"entities": []}], ["Information on bed-sharing was obtained at the 3-month follow-up visit, and on hospitalisations at the 12-month visit, both based on mothers\u2019 reports.", {"entities": []}], ["Only singleton infants with complete information on hospitalisation were analysed.", {"entities": []}], ["3906 infants were included.", {"entities": []}], ["The bed-sharing prevalence at 3\u2005months was 46.4% (95% CI 44.9 to 48.0%).", {"entities": []}], ["The incidence of pneumonia admissions between 3 and 12\u2005months was 3.6% (95% CI 3.3 to 4.2%) and diarrhoea, 0.9% (95% CI 0.6 to 1.2%).", {"entities": [[17, 26, "DISEASE"]]}], ["In crude analyses, bed-sharing with the mother was associated with higher incidence of hospitalisation due to both pneumonia and diarrhoea.", {"entities": [[115, 124, "DISEASE"]]}], ["There was interaction between bed-sharing and duration of breastfeeding regarding the chance of admission due to pneumonia.", {"entities": [[113, 122, "DISEASE"]]}], ["Among infants breastfed for 3\u2005months or less, the chance of hospitalisation due to pneumonia among bed-sharers was almost twice as high as among non-bed-sharers (adjusted OR 1.96; 95% CI 1.08 to 3.55).", {"entities": [[83, 92, "DISEASE"]]}], ["There was no association between bed-sharing and hospitalisation due to pneumonia among infants breastfed for longer than 3\u2005months in crude or adjusted analyses.", {"entities": [[72, 81, "DISEASE"]]}], ["The association between bed-sharing and admissions due to diarrhoea lost statistical significance after allowing for confounders.", {"entities": []}], ["The effect of bed-sharing in infancy on the risk of hospitalisation due to pneumonia depends on breastfeeding, such that weaned children present higher risk.", {"entities": [[75, 84, "DISEASE"]]}], ["The giant earthworm, Rhinodrilus alatus (Righi 1971), has been captured in the southeastern Brazilian Cerrado biome for approximately 80 years and used as bait for amateur fishing throughout Brazil.", {"entities": []}], ["Local knowledge and traditional extraction practices are crucial for the establishment of management strategies for the species because, although its extraction involves conflicts and social and environmental impacts, the species is one of the major sources of income for approximately 3,000 people, especially for members of an Afro-descendant community that has approximately 2,000 inhabitants.", {"entities": []}], ["Participatory tools, such as seasonal calendar, transect walks and participatory maps, were individually or collectively used with extractors and traders (former extractors), and 129 semi-structured and unstructured interviews were conducted with the same individuals between 2005 and 2012.", {"entities": []}], ["The capture of Rhinodrilus alatus was observed in different seasons and areas of occurrence of the species in 17 municipalities, where this giant earthworm is the only species extracted for trade.", {"entities": []}], ["All information obtained was verified by community members in 17 meetings.", {"entities": []}], ["The extractors have an extensive knowledge of the life history, behavior, distribution, and possible impacts of climate change on the species.", {"entities": []}], ["Different capture techniques, which have different impacts, are used during the dry and rainy seasons and are passed by the extractors through the generations.", {"entities": []}], ["Local knowledge contributed to the establishment of agreements for the use of capture techniques that have less impact, to the expansion of scientific knowledge and the reassessment of the conservation status of Rhinodrilus alatus .", {"entities": []}], ["The present study may serve as an example for management projects for other giant earthworm species in other regions of Brazil and in other countries.", {"entities": []}], ["Currently, tumor necrosis factor alpha (TNF-alpha) inhibitors are widely used for many autoimmune disorders.", {"entities": []}], ["However, they cause an immunocompromised status that sometimes leads to many cutaneous side effects including atypical infections.", {"entities": []}], ["Herein, we report the first case of adalimumab-related Majocchi's granuloma.", {"entities": []}], ["A 43-year-old Taiwanese male patient with chronic plaque-type psoriasis developed numerous tender nodules 1 month after adalimumab injection.", {"entities": [[62, 71, "DISEASE"]]}], ["The nodules responded poorly to bacterial folliculitis treatment.", {"entities": [[42, 54, "DISEASE"]]}], ["After repeated skin biopsies for pathology and tissue fungal culture, Majocchi's granuloma was confirmed.", {"entities": []}], ["Adalimumab was withheld, and 12 weeks of terbinafine treatment was given.", {"entities": []}], ["On completion of treatment, the nodular skin lesions and dystrophic nail lesions improved dramatically.", {"entities": []}], ["The information, including time span, clinical features, histological findings, and improvement following withdrawal of adalimumab and treatment with an oral antifungal agent, indicates that Majocchi's granuloma was adalimumab-related.", {"entities": []}], ["Psoriasis patients are more susceptible to dermatophyte infection due to local and systemic immunosuppressant therapy.", {"entities": [[0, 9, "DISEASE"]]}], ["It is important to perform a thorough examination for latent dermatophyte infection, including skin and nail lesions, before treatment with TNF-alpha inhibitors and during traditional psoriasis treatment.", {"entities": [[184, 193, "DISEASE"]]}], ["When atypical presentation together with treatment failure is noted in psoriasis patients prescribed biologics, clinicians should investigate evidence of dermatophyte infection and provide proper treatment.", {"entities": [[71, 80, "DISEASE"]]}], ["Sometimes, multiple skin biopsies and tissue fungal cultures are required to establish a correct diagnosis.", {"entities": []}], ["The morbidity and mortality of patients with ischemic cardiomyopathy resulted from ischemia/reperfusion injury are very high.", {"entities": [[54, 68, "DISEASE"], [83, 91, "DISEASE"]]}], ["The present study investigates whether our previously synthesized water-soluble phosphate prodrug of acacetin was cardioprotective against ischemia/reperfusion injury in an in vivo rat model.", {"entities": [[139, 147, "DISEASE"]]}], ["We found that intravenous administration of acacetin prodrug (10\u2009mg/kg) decreased the ventricular arrhythmia score and duration, reduced ventricular fibrillation and infarct size, and improved the impaired heart function induced by myocardial ischemia/reperfusion injury in anesthetized rats.", {"entities": [[243, 251, "DISEASE"]]}], ["The cardioprotective effects were further confirmed with the parent compound acacetin in an ex vivo rat regional ischemia/reperfusion heart model.", {"entities": [[113, 121, "DISEASE"]]}], ["Molecular mechanism analysis revealed that acacetin prevented the ischemia/reperfusion-induced reduction of the anti-oxidative proteins SOD-2 and thioredoxin, suppressed the release of inflammation cytokines TLR4, IL-6 and TNF\u03b1, and decreased myocyte apoptosis induced by ischemia/reperfusion.", {"entities": [[66, 74, "DISEASE"], [272, 280, "DISEASE"], [208, 212, "GENE"]]}], ["Our results demonstrate the novel evidence that acacetin prodrug confer significant in vivo cardioprotective effect against ischemia/reperfusion injury by preventing the reduction of endogenous anti-oxidants and the release of inflammatory cytokines, thereby inhibiting cardiomyocytes apoptosis, which suggests that the water-soluble acacetin prodrug is likely useful in the future as a new drug candidate for treating patients with acute coronary syndrome.", {"entities": [[448, 456, "DISEASE"], [124, 132, "DISEASE"]]}], ["IL-18 is an important mediator involved in chronic inflammatory conditions such as cutaneous lupus erythematosus, psoriasis and chronic eczema.", {"entities": [[114, 123, "DISEASE"], [93, 112, "DISEASE"], [83, 112, "DISEASE"]]}], ["An imbalance between IL-18 and its endogenous antagonist IL-18 binding protein (BP) may account for increased IL-18 activity.", {"entities": []}], ["IL-27 is a cytokine with dual function displaying pro- and anti-inflammatory properties.", {"entities": []}], ["Here we provide evidence for a yet not described anti-inflammatory mode of action on skin resident cells.", {"entities": []}], ["Human keratinocytes and surprisingly also fibroblasts (which do not produce any IL-18) show a robust, dose-dependent and highly inducible mRNA expression and secretion of IL-18BP upon IL-27 stimulation.", {"entities": []}], ["Other IL-12 family members failed to induce IL-18BP.", {"entities": []}], ["The production of IL-18BP peaked between 48\u201372 h after stimulation and was sustained for up to 96 h. Investigation of the signalling pathway showed that IL-27 activates STAT1 in human keratinocytes and that a proximal GAS site at the IL-18BP promoter is of importance for the functional activity of IL-27.", {"entities": [[169, 174, "GENE"]]}], ["The data are in support of a significant anti-inflammatory effect of IL-27 on skin resident cells.", {"entities": []}], ["An important novel property of IL-27 in skin pathobiology may be to counter-regulate IL-18 activities by acting on keratinocytes and importantly also on dermal fibroblasts.", {"entities": []}], ["Alzheimer's disease (AD) and osteoporosis are two closely related multifactorial progressively degenerative diseases that predominantly affect aged people.", {"entities": [[29, 41, "DISEASE"]]}], ["These two diseases share many common risk factors, including old age, being female, smoking, excessive drinking, low estrogen, and vitamin D3 levels.", {"entities": []}], ["Additionally, oxidative damage and the dysfunction of the antioxidant system play important roles in the pathogenesis of osteoporosis and AD.", {"entities": [[121, 133, "DISEASE"]]}], ["A\u03b2 not only leads to impaired memory but also plays a crucial role in the demineralization process of bone tissues of older people and women with menopause.", {"entities": []}], ["Curculigoside can promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character.", {"entities": [[80, 85, "GENE"]]}], ["Therefore, we investigated the effects of CUR on the spatial learning and memory by the Morris water maze and brain immunohistochemistry, and bone microstructure and material properties of femurs by micro-computed tomography and mechanical testing in APP/PS1 mutated transgenic mice.", {"entities": []}], ["Oral administration of CUR can significantly enhance learning performance and ameliorate bone loss in APP/PS1 mutated transgenic mice, and the mechanism may be related to its antioxidant effect.", {"entities": []}], ["Based on these results, CUR has real potential as a new natural resource for developing medicines or dietary supplements for the prevention and treatment of the two closely linked multifactorial progressive degenerative disorders, AD and osteoporosis.", {"entities": [[238, 250, "DISEASE"]]}], ["Age-related incidence and effects of these infections are highest among children <2 years of age.", {"entities": []}], ["Human metapneumovirus (hMPV) is an important cause of lower respiratory tract infections in hospitalized children, but the age-related incidence and effect of hMPV in unselected children in the community have not been evaluated.", {"entities": []}], ["We studied a cohort of 1,338 children <13 years of age throughout 1 respiratory season in Finland during 2000\u20132001.", {"entities": []}], ["We examined children and obtained a nasal swab for viral detection at any sign of respiratory infection.", {"entities": []}], ["hMPV was detected in 47 (3.5%) of the 1,338 children.", {"entities": []}], ["The age-related incidence of hMPV infection was highest (7.6%) in children <2 years of age, in whom hMPV accounted for 1.7% of all infections during the season.", {"entities": []}], ["During the epidemic peak, hMPV caused 7.1% of all respiratory infections in the cohort.", {"entities": []}], ["Acute otitis media developed in 61% of hMPV-infected children <3 years of age.", {"entities": [[6, 18, "DISEASE"]]}], ["Our findings demonstrate that the effect of hMPV in the community is greatest in children <2 years of age.", {"entities": []}], ["Moringa oleifera seeds are a promising resource for food and non-food applications, due to their content of monounsaturated fatty acids with a high monounsaturated/saturated fatty acids (MUFA/SFA) ratio, sterols and tocopherols, as well as proteins rich in sulfated amino acids.", {"entities": []}], ["The rapid growth of Moringa trees in subtropical and tropical areas, even under conditions of prolonged drought, makes this plant a reliable resource to enhance the nutritional status of local populations and, if rationalized cultivation practices are exploited, their economy, given that a biodiesel fuel could be produced from a source not in competition with human food crops.", {"entities": []}], ["Despite the relatively diffuse use of Moringa seeds and their oil in traditional medicine, no pharmacological activity study has been conducted on humans.", {"entities": []}], ["Some encouraging evidence, however, justifies new efforts to obtain clear and definitive information on the benefits to human health arising from seed consumption.", {"entities": []}], ["A critical review of literature data concerning the composition of Moringa oil has set in motion a plan for future investigations.", {"entities": []}], ["Such investigations, using the seeds and oil, will focus on cultivation conditions to improve plant production, and will study the health effects on human consumers of Moringa seeds and their oil.", {"entities": []}], ["An increased risk of total death owing to human T-lymphotropic virus type-I (HTLV-I) infection has been reported.", {"entities": []}], ["However, its etiology and protective factors are unclear.", {"entities": []}], ["Various studies reported fluctuations in immune-inflammatory status among HTLV-I carriers.", {"entities": []}], ["We conducted a matched cohort study among the general population in an HTLV-I-endemic region of Japan to investigate the interaction between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases.", {"entities": [[236, 251, "DISEASE"], [224, 230, "DISEASE"]]}], ["We selected 2180 sub-cohort subjects aged 35\u201369 years from the cohort population, after matching for age, sex, and region with HTLV-I seropositives.", {"entities": []}], ["They were followed up for a maximum of 10 years.", {"entities": []}], ["Inflammatory gene polymorphisms were selected from TNF- \u03b1, IL-10, and NF- \u03ba B1 .", {"entities": []}], ["A Cox proportional hazard model was used to estimate the hazard ratio (HR) and the interaction between gene polymorphisms and HTLV-I for risk of total death and incidence of cancer and atherosclerosis-related diseases.", {"entities": [[185, 200, "DISEASE"], [174, 180, "DISEASE"], [71, 73, "GENE"]]}], ["HTLV-I seropositivity rate was 6.4% in the cohort population.", {"entities": []}], ["The interaction between TNF -\u03b1 1031T/C and HTLV-I for atherosclerosis-related disease incidence was statistically significant ( p \u00a0=\u00a00.020).", {"entities": [[54, 69, "DISEASE"], [24, 27, "GENE"]]}], ["No significant interaction was observed between IL-10 819T/C or NF- \u03ba B1 94ATTG ins/del and HTLV-I.", {"entities": []}], ["An increased HR for total death was observed in the Amami island region, after adjustment of various factors with gene polymorphisms (HR 3.03; 95% confidence interval, 1.18\u20137.77).", {"entities": [[13, 15, "GENE"], [134, 136, "GENE"], [13, 15, "GENE"], [134, 136, "GENE"]]}], ["The present study found the interaction between TNF -\u03b1 1031T/C and HTLV-I to be a risk factor for atherosclerosis-related disease.", {"entities": [[98, 113, "DISEASE"], [48, 51, "GENE"]]}], ["Further follow-up is warranted to investigate protective factors against developing diseases among susceptible HTLV-I carriers.", {"entities": []}], ["\u2022 We observed death and incidence risk with HTLV-I and SNPs in a matched cohort study.", {"entities": []}], ["\u2022 An increased risk for total death with HTLV-I was observed in the island region.", {"entities": []}], ["\u2022 Inflammatory SNP interacted with HTLV-I for atherosclerosis-related disease risk.", {"entities": [[46, 61, "DISEASE"]]}], ["We observed death and incidence risk with HTLV-I and SNPs in a matched cohort study.", {"entities": []}], ["An increased risk for total death with HTLV-I was observed in the island region.", {"entities": []}], ["Inflammatory SNP interacted with HTLV-I for atherosclerosis-related disease risk.", {"entities": [[44, 59, "DISEASE"]]}], ["SENTIERI project (Epidemiological Study of Residents in Italian Contaminated Sites) studied mortality in the sites of national interest for environmental remediation (National Priority Contaminated Sites\u2014NPCSs).", {"entities": []}], ["SENTIERI described mortality of residents in NPCSSs, and it specifically focused on causes of death for which environmental exposure is suspected or ascertained to play an etiologic role.", {"entities": []}], ["The epidemiological evidence of the causal association was classified a priori into one of these three categories: Sufficient (S), Limited (L), and Inadequate (I).", {"entities": []}], ["Mortality in the period 1995\u22122002 was studied for 63 single or grouped causes at the municipal level by computing: crude rate, standardized rate, standardized mortality ratios (SMR), and SMR adjusted for an ad hoc deprivation index.", {"entities": []}], ["Regional populations were used as references for SMR calculations and 90% CI accompanied SMR values.", {"entities": []}], ["The deprivation index was constructed using 2001 national census variables for the following socioeconomic domains: education, unemployment, dwelling ownership, and overcrowding.", {"entities": []}], ["SENTIERI results will allow the priorities setting in remediation intervention so as to prevent adverse health effects from environmental exposure.", {"entities": []}], ["This paper's objective is to present the rationale, methods, advantages, and limitations underlying SENTIERI project and to describe data and resources required to apply a similar approach in other countries.", {"entities": []}], ["The development of a serological marker for early diagnosis of isocyanate-induced occupational asthma (isocyanate-OA) may improve clinical outcome.", {"entities": [[95, 101, "DISEASE"]]}], ["Our previous proteomic study found that expression of vitamin D-binding protein (VDBP) was upregulated in the patients with isocyanate-OA.", {"entities": []}], ["In the present study, we evaluated the clinical relevance of VDBP as a serological marker in screening for isocyanate-OA among exposed workers and its role in the pathogenesis of isocyanate-OA.", {"entities": []}], ["Three study groups including 61 patients with isocyanate-OA (group I), 180 asymptomatic exposed controls (AECs, group II), 58 unexposed healthy controls (NCs, group III) were enrolled in this study.", {"entities": []}], ["The baseline serum VDBP level was significantly higher in group I compared with groups II and III.", {"entities": []}], ["The sensitivity and specificity for predicting the phenotype of isocyanate-OA with VDBP were 69% and 81%, respectively.", {"entities": []}], ["The group I subjects with high VDBP (\u2265 311 \u00b5g/ml) had significantly lower PC 20 methacholine levels than did subjects with low VDBP.", {"entities": [[74, 76, "GENE"]]}], ["The in vitro studies showed that TDI suppressed the uptake of VDBP into RLE-6TN cells, which was mediated by the downregulation of megalin, an endocytic receptor of the 25-hydroxycholecalciferol-VDBP complex.", {"entities": []}], ["Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH) 2 D 3 ] production.", {"entities": []}], ["The findings of this study suggest that the serum VDBP level may be used as a serological marker for the detection of isocyanate-OA among workers exposed to isocyanate.", {"entities": []}], ["The TDI-induced VEGF production/secretion was reversed by 1,25(OH) 2 D 3 treatment, which may provide a potential therapeutic strategy for patients with isocyanate-OA.", {"entities": []}], ["The eosinophilic response to clozapine is well described in the literature, causing a variety of responses, from serositis to colitis.", {"entities": []}], ["However, there are not case reports describing a clozapine-induced marked eosinophilia resulting in multiorgan dysfunction.", {"entities": [[74, 86, "DISEASE"]]}], ["In this case report, we describe a 24\u00a0year old Caucasian male who presented with severe systemic eosinophilia resulting in eosinophilic GI tract infiltration, myocarditis, pericardial and pleural effusions with dramatic improvement following drug withdrawal.", {"entities": [[159, 170, "DISEASE"], [97, 109, "DISEASE"]]}], ["Clozapine associated eosinophilia should be suspected in the setting of eosinophilic infiltration of multiple organs.", {"entities": [[21, 33, "DISEASE"]]}], ["Multiple factors are involved in the variability of host's response to P. falciparum infection, like the intensity and seasonality of malaria transmission, the virulence of parasite and host characteristics like age or genetic make-up.", {"entities": [[134, 141, "DISEASE"]]}], ["Although admitted nowadays, the involvement of host genetic factors remains unclear.", {"entities": []}], ["Discordant results exist, even concerning the best-known malaria resistance genes that determine the structure or function of red blood cells.", {"entities": [[57, 64, "DISEASE"]]}], ["Here we report on a genome-wide linkage and association study for P. falciparum infection intensity and mild malaria attack among a Senegalese population of children and young adults from 2 to 18 years old.", {"entities": [[109, 116, "DISEASE"]]}], ["A high density single nucleotide polymorphisms (SNP) genome scan (Affimetrix GeneChip Human Mapping 250K-nsp) was performed for 626 individuals: i.e.", {"entities": []}], ["249 parents and 377 children out of the 504 ones included in the follow-up.", {"entities": []}], ["The population belongs to a unique ethnic group and was closely followed-up during 3 years.", {"entities": []}], ["Genome-wide linkage analyses were performed on four clinical and parasitological phenotypes and association analyses using the family based association tests (FBAT) method were carried out in regions previously linked to malaria phenotypes in literature and in the regions for which we identified a linkage peak.", {"entities": [[221, 228, "DISEASE"]]}], ["Analyses revealed three strongly suggestive evidences for linkage: between mild malaria attack and both the 6p25.1 and the 12q22 regions (empirical p-value\u200a=\u200a5\u00d710 ARHGAP26 gene in the 5q31\u2013q33 region (p-value\u200a=\u200a3.7\u00d710", {"entities": [[80, 87, "DISEASE"], [163, 171, "GENE"]]}], ["Infection is a common cause of acute lung injury (ALI).", {"entities": []}], ["This study was aimed to explore whether Toll-like receptors 4 (TLR 4 ) of airway smooth muscle cells (ASMCs) play a role in lipopolysaccharide (LPS)-induced airway hyperresponsiveness and potential mechanisms.", {"entities": []}], ["In vivo : A sensitizing dose of LPS (50 \u00b5g) was administered i.p.", {"entities": []}], ["to female mice before anesthesia with either 3% sevoflurane or phenobarbital i.p.", {"entities": []}], ["After stabilization, the mice were challenged with 5 \u00b5g of intratracheal LPS to mimic inflammatory attack.", {"entities": []}], ["The effects of sevoflurane were assessed by measurement of airway responsiveness to methacholine, histological examination, and IL-1, IL-6, TNF-\u03b1 levels in bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["Protein and gene expression of TLR 4 and NF-\u03baB were also assessed.", {"entities": []}], ["In vitro : After pre-sensitization of ASMCs and ASM segments for 24h, levels of TLR 4 and NF-\u03baB proteins in cultured ASMCs were measured after continuous LPS exposure for 1, 3, 5, 12 and 24h in presence or absence of sevoflurane.", {"entities": []}], ["Constrictor and relaxant responsiveness of ASM was measured 24 h afterwards.", {"entities": []}], ["The mRNA and protein levels of NF-\u03baB and TLR 4 in ASM were increased and maintained at high level after LPS challenge throughout 24h observation period, both in vivo and in vitro .", {"entities": []}], ["Sevoflurane reduced LPS-induced airway hyperresponsiveness, lung inflammatory cell infiltration and proinflammatory cytokines release in BALF as well as maximal isometric contractile force of ASM segments to acetylcholine, but it increased maximal relaxation response to isoproterenol.", {"entities": []}], ["Treatment with specific NF-\u03baB inhibitor produced similar protections as sevoflurane, including decreased expressions of TLR 4 and NF-\u03baB in cultured ASMCs and improved pharmacodynamic responsiveness of ASM to ACh and isoproterenol.", {"entities": []}], ["This study demonstrates the crucial role of TLR 4 activation in ASMCs during ALI in response to LPS.", {"entities": []}], ["Sevoflurane exerts direct relaxant and anti-inflammatory effects in vivo and in vitro via inhibition of TLR 4 /NF-\u03baB pathway.", {"entities": []}], ["A comprehensive smoke-free air law was enacted on June 1, 2012 in most of Marion County, Indiana, including all of the City of Indianapolis.", {"entities": []}], ["We evaluated changes in acute myocardial infarction (AMI) admission rates in Indianapolis and Marion County before compared to after the law.", {"entities": [[30, 51, "DISEASE"], [24, 51, "DISEASE"]]}], ["We collected AMI admissions from five Marion County hospitals between May 2007 and December 2014.", {"entities": []}], ["We used Poisson regression to evaluate the overall effects of the law on monthly AMI hospitalizations, adjusting for month, seasonality, meteorology, air pollution, and hospital utilization.", {"entities": []}], ["We tested the interactions between the law and AMI risk factors on monthly AMI admission rates to identify subpopulations for which the effects might be stronger.", {"entities": []}], ["Monthly AMI admissions declined 20% (95% CI 14\u201325%) in Marion County and 25% (95% CI 20\u201329%) in Indianapolis after the law was implemented.", {"entities": []}], ["We observed decreases among never (21%, 95% CI 13\u201329%), former (28%, 95% CI 21\u201334%), and current smokers (26%, 95% CI 11\u201338%); Medicaid beneficiaries (19%, 95% CI 9\u201329%) and non-beneficiaries (26%, 95% CI 20\u201331%).", {"entities": []}], ["We observed decreases among those with a history of diabetes (Yes: 22%, 95% CI 14\u201329%; No: 25%, 95% CI 18\u201331%), congestive heart failure (Yes: 23%, 95% CI 16\u201330%; No: 24%, 95% CI 17\u201331%), and hypertension (Yes: 23%, 95% CI 17\u201328%: No: 26%, 95% CI 15\u201336%).", {"entities": [[112, 136, "DISEASE"], [192, 204, "DISEASE"]]}], ["We observed decreases in AMI admissions comparable with previous studies.", {"entities": []}], ["We identified subpopulations who benefitted from the law, such as former and current smokers, and those without comorbidities such as congestive heart failure and hypertension.", {"entities": [[134, 158, "DISEASE"], [163, 175, "DISEASE"]]}], ["The online version of this article (10.1186/s12889-018-5153-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hypobaric hypoxia, physical and psychosocial stress may influence key cardiovascular parameters including blood pressure (BP) and pulse pressure (PP).", {"entities": []}], ["We investigated the effects of mild hypobaric hypoxia exposure on BP and PP reactivity to mental and physical stress and to passive elevation by cable car.", {"entities": []}], ["36 healthy volunteers participated in a defined test procedure consisting of a period of rest 1, mental stress task (KLT-R), period of rest 2, combined mental (KLT-R) and physical task (bicycle ergometry) and a last period of rest both at Graz, Austria (353 m asl) and at the top station Dachstein (2700 m asl).", {"entities": [[260, 263, "GENE"], [306, 309, "GENE"], [260, 263, "GENE"], [306, 309, "GENE"]]}], ["Beat-to-beat heart rate and BP were analysed both during the test procedures at Graz and at Dachstein and during passive 1000 m elevation by cable car (from 1702 m to 2700 m).", {"entities": []}], ["A significant interaction of kind of stress (mental vs. combined mental and physical) and study location (Graz vs. Dachstein) was found in the systolic BP (p\u200a=\u200a.007) and PP (p\u200a=\u200a.002) changes indicating that during the combined mental and physical stress task sBP was significantly higher under hypoxic conditions whereas sBP and PP were similar during mental stress both under normobaric normoxia (Graz) and under hypobaric hypoxia (Dachstein).", {"entities": []}], ["During the passive ascent in cable car less trivialization (psychological coping strategy) was associated with an increase in PP (p\u200a=\u200a.004).", {"entities": []}], ["Our data show that combined mental and physical stress causes a significant higher raise in sBP and PP under hypoxic conditions whereas isolated mental stress did not affect sBP and PP under hypoxic conditions.", {"entities": []}], ["PP-reaction to ascent in healthy subjects is not uniform.", {"entities": []}], ["BP reactions to ascent that represents an accumulation of physical (mild hypobaric hypoxia) and psychological stressors depend on predetermined psychological traits (stress coping strategies).", {"entities": []}], ["Thus divergent cardiovascular reactions can be explained by applying the multidimensional aspects of the biopsychosocial concept.", {"entities": []}], ["The current approach to, cardiopulmonary resuscitation of pregnant women in the third trimester has been to adhere to the \u201cfour-minute rule\u201d: If pulses have not returned within 4\u00a0min of the start of resuscitation, perform a cesarean birth so that birth occurs in the next minute.", {"entities": []}], ["This investigation sought to re-examine the evidence for the four-minute rule.", {"entities": []}], ["A literature review focused on perimortem cesarean birth was performed using the same key words that were used in formulating the \u201cfour-minute rule.\u201d Maternal and neonatal injury free survival rates as a function of arrest to birth intervals were determined, as well as actual incision to birth intervals.", {"entities": []}], ["Both maternal and neonatal injury free survival rates diminished steadily as the time interval from maternal arrest to birth increased.", {"entities": []}], ["There was no evidence for any specific survival threshold at 4\u00a0min.", {"entities": []}], ["Skin incision to birth intervals of 1\u00a0min occurred in only 10% of women.", {"entities": []}], ["Once a decision to deliver is made, care providers should proceed directly to Cesarean birth during maternal cardiac arrest in the third trimester rather than waiting for 4\u00a0min for restoration of the maternal pulse.", {"entities": []}], ["Birth within 1\u00a0min from the start of the incision is uncommon in these circumstances.", {"entities": []}], ["Image 1 \u2022 Half of maternal/fetal pairs who are delivered by Cesarean birth within 25\u00a0min survive without injury.", {"entities": []}], ["\u2022 The injury free survival rate for both has a roughly linear decrease as the time interval from arrest to birth increases.", {"entities": []}], ["\u2022 Very few babies could be delivered within 1\u00a0min of the Cesarean section incision.", {"entities": []}], ["Half of maternal/fetal pairs who are delivered by Cesarean birth within 25\u00a0min survive without injury.", {"entities": []}], ["The injury free survival rate for both has a roughly linear decrease as the time interval from arrest to birth increases.", {"entities": []}], ["Very few babies could be delivered within 1\u00a0min of the Cesarean section incision.", {"entities": []}], ["This information suggests that the current cardio-pulmonary resuscitation guideline in pregnancy, known as the four-minute rule, needs to be changed.", {"entities": []}], ["Injury free survival for both mother and baby decreases steadily from the moment of cardiac arrest until cesarean birth.", {"entities": []}], ["Furthermore, in actual practice, the baby usually cannot be delivered within 1\u00a0min of the start of surgery.", {"entities": []}], ["Once a decision for delivery has been made, Cesarean birth should be initiated promptly without waiting for 4\u00a0min.", {"entities": []}], ["In practice, the recommendation to proceed to cesarean birth without delay is also likely to result in less confusion than the current \u201cFour-Minute rule.\u201d", {"entities": []}], ["IL-4R\u03b1 expression on airway smooth muscle cells is sufficient for the development of airway hyperresponsiveness.", {"entities": []}], ["Production of the cytokines IL-4 and IL-13 is increased in both human asthma and mouse asthma models, and Stat6 activation by the common IL-4/IL-13R drives most mouse model pathophysiology, including airway hyperresponsiveness (AHR).", {"entities": [[70, 76, "DISEASE"], [87, 93, "DISEASE"], [106, 111, "GENE"], [228, 231, "GENE"]]}], ["However, the precise cellular mechanisms through which IL-4R\u03b1 induces AHR remain unclear.", {"entities": [[70, 73, "GENE"]]}], ["Overzealous bronchial smooth muscle constriction is thought to underlie AHR in human asthma, but the smooth muscle contribution to AHR has never been directly assessed.", {"entities": [[85, 91, "DISEASE"], [72, 75, "GENE"], [131, 134, "GENE"], [72, 75, "GENE"], [131, 134, "GENE"]]}], ["Furthermore, differences in mouse versus human airway anatomy and observations that selective IL-13 stimulation of Stat6 in airway epithelium induces murine AHR raise questions about the importance of direct IL-4R effects on smooth muscle in murine asthma models and the relevance of these models to human asthma.", {"entities": [[249, 255, "DISEASE"], [306, 312, "DISEASE"], [115, 120, "GENE"], [157, 160, "GENE"]]}], ["Using transgenic mice in which smooth muscle is the only cell type that expresses or fails to express IL-4R\u03b1, we demonstrate that direct smooth muscle activation by IL-4, IL-13, or allergen is sufficient but not necessary to induce AHR.", {"entities": [[232, 235, "GENE"]]}], ["Five genes known to promote smooth muscle migration, proliferation, and contractility are activated by IL-13 in smooth muscle in vivo.", {"entities": []}], ["These observations demonstrate that IL-4R\u03b1 promotes AHR through multiple mechanisms and provide a model for testing smooth muscle\u2013directed asthma therapeutics.", {"entities": [[139, 145, "DISEASE"], [52, 55, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular morbidity and mortality.", {"entities": []}], ["The aim of this study was to determine the prevalence of asymptomatic peripheral arterial disease (PAD) and the associated risk factors for patients with COPD.", {"entities": []}], ["This prospective cross-sectional study enrolled 427 COPD patients (mean age: 70.0 years) without PAD symptoms consecutively.", {"entities": []}], ["Demographic data, lung function and cardiovascular risk factors were recorded.", {"entities": []}], ["The ankle-brachial index (ABI) was used to detect PAD (ABI<0.90).", {"entities": []}], ["The overall prevalence of asymptomatic PAD in the COPD patients was 8% (2.5% in the younger participants (<65 years of age, n\u200a=\u200a118) and 10% in the elderly participants (\u226565 years of age, n\u200a=\u200a309).", {"entities": []}], ["The COPD patients with asymptomatic PAD had a significantly higher rate of hyperlipidemia (47.1% vs. 10.4%) and hypertension (79.4% vs. 45.8%) than those without asymptomatic PAD (p<0.05).", {"entities": [[112, 124, "DISEASE"]]}], ["There was no significant difference in lung function (forced vital capacity and forced expiratory volume in one second) between the two groups.", {"entities": []}], ["In multivariate logistic regression, hyperlipidemia was the strongest independent factor for PAD (odds ratio (OR): 6.89, p<0.005), followed by old age (OR: 4.80), hypertension (OR: 3.39) and smoking burden (pack-years, OR: 1.02).", {"entities": [[163, 175, "DISEASE"]]}], ["The prevalence of asymptomatic PAD among COPD patients in Taiwan is lower than in Western countries.", {"entities": []}], ["Hyperlipidemia, old age, hypertension, and smoking burden were the associated cardiovascular risk factors.", {"entities": [[25, 37, "DISEASE"]]}], ["However, there was no association between lung function and PAD in the COPD patients.", {"entities": []}], ["Borrowing money is a common strategy to cope with health care costs.", {"entities": []}], ["The impact of borrowing on households can be severe, leading to indebtedness and further impoverishment.", {"entities": []}], ["However, the available literature on borrowing practices for health is limited.", {"entities": []}], ["We explore borrowing practices for paying for health care by the poor in Cambodia and provide a typology, associated conditions, and the extent of the phenomenon.", {"entities": []}], ["In addition to a semi-structured literature review, in-depth interviews were conducted with representatives of 47 households with health-related debt and 19 managers of formal or informal credit schemes.", {"entities": []}], ["A large proportion of Cambodians, especially the poor, resort to borrowing to meet the cost of health care.", {"entities": []}], ["Because of limited cash flow and access to formal creditors, the majority take out loans with high interest rates from informal money lenders.", {"entities": []}], ["The most common type of informal credit is locally known as Changkar and consists of five kinds of loans: short-term loans, medium-term loans, seasonal loans, loans for an unspecified period, and loans with repayment in labour, each with different lending and repayment conditions and interest rates.", {"entities": []}], ["This study suggests the importance of informal credit for coping with the cost of treatment and its potentially negative impact on the livelihood of Cambodian people.", {"entities": []}], ["We provide directions for further studies on financial protection interventions to mitigate harmful borrowing practices to pay for health care in Cambodia.", {"entities": []}], ["Salamanca, Mexico occupied fourth place nationally in contaminating emissions.", {"entities": []}], ["The aim of the study was to determine the impact of air pollution on the frequency of pulmonary function alterations and respiratory symptoms in school-age children in a longitudinal repeated-measures study.", {"entities": []}], ["We recruited a cohort of 464 children from 6 to 14 years of age, from two schools differing in distance from the major stationary air pollution sources.", {"entities": []}], ["Spirometry, respiratory symptoms and air pollutants (O 3, SO 2 , NO, NO 2 , NOx, PM 10 ,) were obtained for each season.", {"entities": []}], ["Mixed models for continuous variables and multilevel logistic regression for respiratory symptoms were fitted taking into account seasonal variations in health effects according to air pollution levels.", {"entities": []}], ["Abnormalities in lung function and frequency of respiratory symptoms were higher in the school closer to major stationary air pollution sources than in the distant school.", {"entities": []}], ["However, in winter differences on health disappeared.", {"entities": []}], ["The principal alteration in lung function was the obstructive type, which frequency was greater in those students with greater exposure (10.4% vs. 5.3%; OR = 1.95, 95% CI 1.0-3.7), followed by the mixed pattern also more frequent in the same students (4.1% vs. 0.9%; OR = 4.69, 95% CI, 1.0-21.1).", {"entities": []}], ["PM 10 levels were the most consistent factor with a negative relationship with FVC, FEV 1 and PEF but with a positive relationship with FEV 1 /FVC coefficient according to its change per 3-month period.", {"entities": [[84, 87, "GENE"], [136, 139, "GENE"], [84, 87, "GENE"], [136, 139, "GENE"]]}], ["Students from the school closer to major stationary air pollution sources had in general more respiratory symptoms than those from the distant school.", {"entities": []}], ["However, in winter air pollution was generalized in this city and differences in health disappeared.", {"entities": []}], ["PM 10 levels were the most consistent factor related to pulmonary function according, to its change per 3-month period.", {"entities": []}], ["Cysteinyl leukotrienes (cys-LTs) are very important factors in the pathophysiology of bronchial asthma.", {"entities": [[96, 102, "DISEASE"]]}], ["Cys-LT receptor antagonists (LTRAs) decrease allergic airway inflammation.", {"entities": []}], ["The aim of the present study was to determine the differential effects of LTRAs and corticosteroids on allergic airway inflammation and allergen-specific cytokine production from lymphoid tissues using a murine model of asthma.", {"entities": [[220, 226, "DISEASE"]]}], ["Four groups of female BALB/c mice [control (Cont); Dermatophagoides farinae allergen-sensitized (AS); pranlukast (Prl), an LTRA-treated AS; and dexamethasone (Dex)-treated AS] were examined.", {"entities": [[114, 117, "GENE"]]}], ["Lung pathology and cytokine production by prepared mononuclear cells isolated from mediastinal lymph nodes (MLNs) and spleen were compared among these groups.", {"entities": []}], ["AS mice exhibited allergic airway inflammation and significant increases in allergen-specific Th1 and Th2 cytokines in MLNs and spleen.", {"entities": []}], ["Prl-treated mice showed significant attenuation of allergic airway inflammation concomitant with reduction of Th2 cytokines and IFN-\u03b3 in MLNs but not in spleen.", {"entities": []}], ["In contrast, Dex significantly decreased Th1 and Th2 cytokines in MLNs and also decreased them (except IL-13 and IL-2) in spleen.", {"entities": []}], ["The inflammatory effects of cys-LTs could differ in lymphoid organs.", {"entities": []}], ["LTRAs potentially regulate allergic airway inflammation in an organ- and cytokine-specific manner, while systemic corticosteroid shows nonspecific effects.", {"entities": []}], ["Fibroblast to myofibroblast transition is believed to contribute to airway remodelling in lung diseases such as asthma and chronic obstructive pulmonary disease.", {"entities": [[123, 160, "DISEASE"], [112, 118, "DISEASE"]]}], ["This study examines the role of aclidinium, a new long-acting muscarinic antagonist, on human fibroblast to myofibroblast transition.", {"entities": []}], ["Human bronchial fibroblasts were stimulated with carbachol (10 Collagen type I and \u03b1-SMA mRNA and protein expression, as well as percentage \u03b1-SMA microfilament-positive cells, were upregulated in a similar way by carbachol and TGF-\u03b21, and aclidinium reversed these effects.", {"entities": []}], ["Carbachol-induced myofibroblast transition was mediated by an increase in ERK1/2 phosphorylation, RhoA-GTP activation and cyclic monophosphate downregulation as well as by the autocrine TGF-\u03b21 release, which were effectively reduced by aclidinium.", {"entities": []}], ["TGF-\u03b21 activated the non-neuronal cholinergic system.", {"entities": []}], ["Suppression of M1, M2 or M3 partially prevented carbachol- and TGF-\u03b21-induced myofibroblast transition.", {"entities": []}], ["Aclidinium dose-dependently reduced fibroblast proliferation and migration.", {"entities": []}], ["Aclidinium inhibits human lung fibroblast to myofibrobast transition.", {"entities": []}], ["Experimental animal studies indicate that environmental contaminants can have adverse effects on several organs and tissues of the immune system.", {"entities": []}], ["Such effects are known to lead to increased host susceptibility to microbial infections and to compromised immunosurveillance mechanisms normally instrumental in the elimination of neoplastic cells and the prevention of autoimmune diseases.", {"entities": []}], ["Evaluation of the potential risk environmental contaminants pose to the human immune system is currently accomplished via extrapolation of experimentally derived animal data to humans.", {"entities": []}], ["Presently, this process requires that uncertainty factors such as interspecies differences and genetic variability be considered.", {"entities": []}], ["Naturally, the process of risk assessment would be greatly facilitated if it were based on clinically relevant data derived from studying humans known to be exposed to environmental contaminants.", {"entities": []}], ["However, the existing human data are scarce and often described as very limited in scope.", {"entities": []}], ["To generate the much-needed human data we need to identify a set of clinically relevant immunologic end points that, when adequately standardized, can be incorporated easily into the design of prospective epidemiologic studies.", {"entities": []}], ["Bangladesh suffers from a lack of healthcare providers.", {"entities": []}], ["The growing chronic disease epidemic's demand for healthcare resources will further strain Bangladesh's limited healthcare workforce.", {"entities": []}], ["Little is known about how Bangladeshis with chronic disease seek care.", {"entities": []}], ["This study describes chronic disease patients' care seeking behavior by analyzing which providers diagnose these diseases.", {"entities": []}], ["During 2 month periods in 2009, a cross-sectional survey collected descriptive data on chronic disease diagnoses among 3 surveillance populations within the International Center for Diarrheal Disease Research, Bangladesh (ICDDR, B) network.", {"entities": []}], ["The maximum number of respondents (over age 25) who reported having ever been diagnosed with a chronic disease determined the sample size.", {"entities": []}], ["Using SAS software (version 8.0) multivariate regression analyses were preformed on related sociodemographic factors.", {"entities": []}], ["Of the 32,665 survey respondents, 8,591 self reported having a chronic disease.", {"entities": []}], ["Chronically ill respondents were 63.4% rural residents.", {"entities": []}], ["Hypertension was the most prevalent disease in rural (12.4%) and urban (16.1%) areas.", {"entities": []}], ["In rural areas chronic disease diagnoses were made by MBBS doctors (59.7%) and Informal Allopathic Providers (IAPs) (34.9%).", {"entities": []}], ["In urban areas chronic disease diagnoses were made by MBBS doctors (88.0%) and IAP (7.9%).", {"entities": []}], ["Our analysis identified several groups that depended heavily on IAP for coverage, particularly rural, poor and women.", {"entities": []}], ["IAPs play important roles in chronic disease care, particularly in rural areas.", {"entities": []}], ["Input and cooperation from IAPs are needed to minimize rural health disparities.", {"entities": []}], ["More research on IAP knowledge and practices regarding chronic disease is needed to properly utilize this potential healthcare resource.", {"entities": []}], ["Environmental risk assessments characterizing potential environmental impacts of exotic weeds are more abundant and comprehensive for potential or new invaders than for widespread and well-established species such as Dalmatian ( Linaria dalmatica [L.] Mill.)", {"entities": []}], ["and yellow ( L. vulgaris Mill.)", {"entities": []}], ["Specific effects evaluated in our assessment of environmental risks posed by yellow and Dalmatian toadflax included competitive displacement of other plant species, reservoirs of plant disease, animal and insect use, animal toxicity, human toxicity and allergenicity, erosion, and wildfire.", {"entities": []}], ["Effect and exposure uncertainties for potential impacts of toadflax on human and ecological receptors were rated.", {"entities": []}], ["Using publicly available information we were able to characterize ecological and human health impacts associated with toadflax, and to identify specific data gaps contributing to a high uncertainty of risk.", {"entities": []}], ["Evidence supporting perceived negative environmental impacts of invasive toadflax was scarce.", {"entities": []}], ["Background: Smoking rates for people with severe mental illness have remained high despite significant declines in smoking rates in the general population, particularly for residents of community supported residential facilities (SRFs) where smoking has been largely neglected and institutionalized.", {"entities": []}], ["Methods: Two studies undertaken 10 years apart (2000 and 2010) with SRFs in Adelaide, Australia looked at historical trends to determine whether any progress has been made to address smoking for this population.", {"entities": []}], ["The first study was ethnographic and involved narrative description and analysis of the social milieu of smoking following multiple observations of smoking behaviours in two SRFs.", {"entities": []}], ["The second study involved an eight-week smoking cessation group program providing tailored support and free nicotine replacement therapy to residents across six SRFs.", {"entities": []}], ["Changes in smoking behaviours were measured using pre and post surveys with residents, with outcomes verified by also seeking SRF staff and smoking cessation group facilitator qualitative feedback and reflection on their observations of residents and the setting.", {"entities": [[126, 129, "GENE"]]}], ["Results: The culture of smoking in mental health SRFs is a complex part of the social milieu of these settings.", {"entities": []}], ["There appears to have been little change in smoking behaviours of residents and attitudes and support responses by staff of SRFs since 2000 despite smoking rates declining in the general community.", {"entities": []}], ["Tailored smoking cessation group programs for this population were well received and did help SRF residents to quit or cut down their smoking.", {"entities": [[94, 97, "GENE"]]}], ["They did challenge staff negative attitudes to residents\u2019 capacity to smoke less or quit.", {"entities": []}], ["Conclusions: A more systematic approach that addresses SRF regulations, smoke-free policies, staff attitudes and training, and consistent smoking cessation support to residents is needed.", {"entities": [[55, 58, "GENE"]]}], ["Dihydromyricetin (DHM) is a plant flavonoid and is the primary active ingredient isolated from the medicinal herb, Ampelopsis grossedentata .", {"entities": []}], ["DHM has been shown to possess various pharmacological activities, including anti-inflammatory effects.", {"entities": []}], ["However, the possible role of DHM in asthma treatment remains to be elucidated.", {"entities": [[37, 43, "DISEASE"]]}], ["The present study aimed to investigate its anti-inflammatory properties in mice with symptoms of allergic asthma.", {"entities": [[97, 112, "DISEASE"], [106, 112, "DISEASE"]]}], ["The C57BL/6 mice were sensitized and challenged with ovalbumin (OVA) to induce asthma.", {"entities": [[79, 85, "DISEASE"]]}], ["DHM or phosphate-buffered saline treatment was administered 1 h prior to the OVA challenge.", {"entities": []}], ["The levels of interleukin (IL)-4, IL-5 and IL-13 in the bronchoalveolar lavage (BAL) fluid were measured by enzyme-linked immunosorbent assay (ELISA), and OVA-specific serum IgE and IgG1 levels were also determined by ELISA.", {"entities": []}], ["Histopathological staining was performed to evaluate the infiltration of inflammatory cells into the BAL fluid, lung tissues and goblet cell hyperplasia.", {"entities": []}], ["DHM treatment significantly reduced the total number of inflammatory cells, including eosinophils, neutrophils, lymphocytes and macrophages, in the BAL fluid.", {"entities": []}], ["DHM also reduced the levels of IL-4, IL-5 and IL-13 in the BAL fluid, and reduced the secretion of OVA-specific IgE and IgG1 in the serum.", {"entities": []}], ["The histological staining demonstrated that DHM treatment effectively suppressed the OVA-induced inflammatory cells in the lung tissues and in the mucus hypersecreted by goblet cells in the airway.", {"entities": []}], ["These results showed that DHM had a potent anti-inflammatory effect in an OVA-induced mouse model of asthma, offering potential as an anti-inflammatory agent for the treatment of asthma.", {"entities": [[101, 107, "DISEASE"], [179, 185, "DISEASE"]]}], ["The link between eosinophils and the development of airway hyperresponsiveness (AHR) in asthma is still controversial.", {"entities": [[88, 94, "DISEASE"], [80, 83, "GENE"]]}], ["This question was assessed in a murine model of asthma in which we performed a dose ranging study to establish whether the dose of steroid needed to inhibit the eosinophil infiltration correlated with that needed to block AHR.", {"entities": [[48, 54, "DISEASE"], [222, 225, "GENE"]]}], ["The sensitised BALB/c mice were dosed with vehicle or dexamethasone (0.01\u20133 mg/kg) 2 hours before and 6 hours after each challenge (once daily for 6 days) and 2 hours before AHR determination by whole-body plethysmography.", {"entities": [[174, 177, "GENE"]]}], ["At 30 minutes after the AHR to aerosolised methacholine the mice were lavaged and differential white cell counts were determined.", {"entities": [[24, 27, "GENE"]]}], ["Challenging with antigen caused a significant increase in eosinophils in the bronchoalveolar lavage (BAL) fluid and lung tissue, and increased AHR.", {"entities": [[143, 146, "GENE"]]}], ["Dexamethasone reduced BAL and lung tissue eosinophilia (ED 50 values of 0.06 and 0.08 mg/kg, respectively), whereas a higher dose was needed to block AHR (ED 50 of 0.32 mg/kg at 3 mg/ml methacholine.", {"entities": [[42, 54, "DISEASE"], [150, 153, "GENE"]]}], ["Dissociation was observed between the dose of steroid needed to affect AHR in comparison with eosinophilia and suggests that AHR is not a direct consequence of eosinophilia.", {"entities": [[94, 106, "DISEASE"], [160, 172, "DISEASE"], [71, 74, "GENE"], [125, 128, "GENE"], [71, 74, "GENE"], [125, 128, "GENE"]]}], ["This novel pharmacological approach has revealed a clear dissociation between eosinophilia and AHR by using steroids that are the mainstay of asthma therapy.", {"entities": [[78, 90, "DISEASE"], [142, 148, "DISEASE"], [95, 98, "GENE"]]}], ["These data suggest that eosinophilia is not associated with AHR and questions the rationale that many pharmaceutical companies are adopting in developing low-molecular-mass compounds that target eosinophil activation/recruitment for the treatment of asthma.", {"entities": [[24, 36, "DISEASE"], [250, 256, "DISEASE"], [60, 63, "GENE"]]}], ["The cell cycle must be tightly coordinated for proper control of embryonic development and for the long-term maintenance of organs such as the lung.", {"entities": []}], ["There is emerging evidence that Kinesin family member 7 ( Kif7 ) promotes Hedgehog ( Hh ) signaling during embryonic development, and its misregulation contributes to diseases such as ciliopathies and cancer.", {"entities": [[201, 207, "DISEASE"], [58, 62, "GENE"]]}], ["Kif7 encodes a microtubule interacting protein that controls Hh signaling through regulation of microtubule dynamics within the primary cilium.", {"entities": [[0, 4, "GENE"]]}], ["However, whether Kif7 has a function in nonciliated cells remains largely unknown.", {"entities": [[17, 21, "GENE"]]}], ["The role Kif7 plays in basic cell biological processes like cell proliferation or cell cycle progression also remains to be elucidated.", {"entities": [[9, 13, "GENE"]]}], ["Here, we show that Kif7 is required for coordination of the cell cycle, and inactivation of this gene leads to increased cell proliferation in vivo and in vitro .", {"entities": [[19, 23, "GENE"]]}], ["Immunostaining and transmission electron microscopy experiments show that Kif7 Kif7 Kif7 may function as a general regulator of cellular proliferation.", {"entities": [[74, 78, "GENE"], [79, 83, "GENE"], [84, 88, "GENE"], [74, 78, "GENE"], [79, 83, "GENE"], [84, 88, "GENE"], [74, 78, "GENE"], [79, 83, "GENE"], [84, 88, "GENE"]]}], ["We ascertained that in G1, Kif7 and microtubule dynamics regulate the expression and activity of several components of the cell cycle machinery known to control entry into S phase.", {"entities": [[27, 31, "GENE"]]}], ["Our data suggest that Kif7 may function to regulate the maintenance of the respiratory airway architecture by controlling cellular density, cell proliferation, and cycle exit through its role as a microtubule associated protein.", {"entities": [[22, 26, "GENE"]]}], ["Respiratory diseases such as lung cancer, COPD, and asthma are the second leading cause of death in the United States.", {"entities": [[29, 40, "DISEASE"], [52, 58, "DISEASE"], [34, 40, "DISEASE"]]}], ["These diseases are heterogeneous and arise from genetic factors, environmental hazards, or developmental abnormalities that persist throughout life.", {"entities": []}], ["An increased understanding of the genes and cellular mechanisms regulating respiratory system homeostasis and regeneration should provide information for the development of future therapeutics.", {"entities": []}], ["We show that the gene Kif7 regulates cell proliferation, cellular density, and intracellular signaling within the epithelial and mesenchymal cells of the respiratory airway.", {"entities": [[22, 26, "GENE"]]}], ["We expand on the known role for Kif7 in regulating microtubule architecture within ciliated cells by showing that this protein regulates cell signaling in non-ciliated secretory cells.", {"entities": [[32, 36, "GENE"]]}], ["Furthermore, we show that microtubules function to regulate the abundance and activity of several factors known to be required for proper cell cycle timing.", {"entities": []}], ["We propose that Kif7 and microtubule dynamics hone cellular signaling necessary for control of the balance between cell proliferation and cell cycle exit, and we provide evidence that Kif7 has a critical role in the maintenance of the respiratory system in postnatal life.", {"entities": [[16, 20, "GENE"], [184, 188, "GENE"], [16, 20, "GENE"], [184, 188, "GENE"]]}], ["Mechanical strain alters protein expression.", {"entities": []}], ["It results in phosphorylation of MAP kinases and up-regulation of extracellular matrix proteins.", {"entities": []}], ["We investigated whether phosphorylation of MAP kinase family members was increased in response to mechanical strain in fibroblasts from asthmatic patients (AF) and normal controls (NF), and whether phosphorylation of these signaling molecules would be different in the two cell populations.", {"entities": []}], ["Fibroblasts were obtained from mild, atopic asthmatics and non-atopic volunteers using endobronchial biopsy.", {"entities": []}], ["Cells were grown on flexible, collagen I-coated membranes, and subjected to mechanical strain (Flexercell).", {"entities": []}], ["MAP kinase phosphorylation was measured at baseline, and during one hour of strain.", {"entities": []}], ["We also examined the effect of strain on proteoglycan production.", {"entities": []}], ["At baseline, there was increased phosphorylation of ERK1/2 and p38, and decreased phosphorylation of JNK in AF vs NF.", {"entities": []}], ["During strain in NF, p38 phosphorylation was increased.", {"entities": []}], ["Conversely in AF, strain resulted in an increase in JNK phosphorylation, had no effect on phosphorylation of p38, and resulted in a decrease in ERK1/2 phosphorylation.", {"entities": []}], ["There was a significant increase in versican protein production after 24 h strain in both AF and NF.", {"entities": []}], ["JNK inhibition reversed the strain-induced increase in versican in NF, but had no effect in AF.", {"entities": []}], ["These results show that there are phenotypic differences in MAP kinase phosphorylation in AF vs NF, and that different signaling pathways are involved in transducing mechanical stimuli in these two populations of cells.", {"entities": []}], ["Eosinophils have been implicated as playing a major role in allergic airway responses.", {"entities": []}], ["However, the importance of these cells to the development of this disease has remained ambiguous despite many studies, partly because of lack of appropriate model systems.", {"entities": []}], ["In this study, using transgenic murine models, we more clearly delineate a role for eosinophils in asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["We report that, in contrast to results obtained on a BALB/c background, eosinophil-deficient C57BL/6 \u0394dblGATA mice (eosinophil-null mice via the \u0394DblGATA1 mutation) have reduced airway hyperresponsiveness, and cytokine production of interleukin (IL)-4, -5, and -13 in ovalbumin-induced allergic airway inflammation.", {"entities": []}], ["This was caused by reduced T cell recruitment into the lung, as these mouse lungs had reduced expression of CCL7/MCP-3, CC11/eotaxin-1, and CCL24/eotaxin-2.", {"entities": []}], ["Transferring eosinophils into these eosinophil-deficient mice and, more importantly, delivery of CCL11/eotaxin-1 into the lung during the development of this disease rescued lung T cell infiltration and airway inflammation when delivered together with allergen.", {"entities": []}], ["These studies indicate that on the C57BL/6 background, eosinophils are integral to the development of airway allergic responses by modulating chemokine and/or cytokine production in the lung, leading to T cell recruitment.", {"entities": []}], ["Although studies have examined the association between nonsteroidal anti-inflammatory drugs (NSAIDs) use and central nervous system (CNS) tumors risk, the results are inconclusive.", {"entities": []}], ["Here, we conducted a dose-response meta-analysis in order to investigate the correlation between NSAIDs use and CNS tumors risk.", {"entities": []}], ["Up to July 2017, 12 studies were included in current meta-analysis.", {"entities": []}], ["NSAIDs use was significantly associated with a lower risk of CNS tumors.", {"entities": []}], ["Furthermore, non-aspirin NSAIDs or aspirin use are significantly associated with a lower risk of CNS tumors.", {"entities": []}], ["Additionally, NSAIDs use was associated with significantly a lower risk of glioma, glioblastoma but not meningioma.", {"entities": [[83, 95, "DISEASE"], [104, 114, "DISEASE"]]}], ["Subgroup analysis showed consistent findings.", {"entities": []}], ["Furthermore, a significant dose-response relationship was observed between NSAIDs use and CNS tumors risk.", {"entities": []}], ["Increasing cumulative 100 defined daily dose of NSAIDs use was associated with a 5% decrement of CNS tumors risk, increasing NSAIDs or non-aspirin NSAIDs or aspirin use (per 3 prescriptions increment) was associated with a 7%, 7%, 10% decrement of CNS tumors risk, increasing per 2 year of duration of NSAIDs or non-aspirin NSAIDs or aspirin use was associated with a 6%, 8%, 6% decrement of CNS tumors risk.", {"entities": []}], ["Considering these promising results, NSAIDs use might provide helpful for reducing CNS tumors risk.", {"entities": []}], ["Large sample size and different ethnic population are warranted to validate this association.", {"entities": []}], ["The dendritic cell (DC) possesses the ability to stimulate both T helper 1 (Th1) and Th2 responses depending on activation stimuli.", {"entities": []}], ["Although it is known that chemically or genetically modified DC can be used therapeutically to steer immune responses towards either Th1 or Th2, cellular therapy with ex vivo manipulated DC is clinically difficult.", {"entities": []}], ["Here we demonstrate a novel method of switching immune responses from Th1 to Th2 through in vivo immune modulation by administration of siRNA.", {"entities": []}], ["We demonstrate that siRNA targeting of the IL-12p35 gene leads to a Th2 bias in vitro through an IL-10 dependent mechanism.", {"entities": []}], ["In vivo administration of siRNA admixed with the oil-based contrast agent lipiodol in the presence of antigen and adjuvant induced a deviation in recall response to reduced production of IFN-\u03b3 and augmented IL-4 response using either KLH or ovalbumin.", {"entities": []}], ["This simple method of in vivo modification of immune response possesses therapeutic potential in Th1-mediated diseases such as multiple sclerosis and autoimmune diabetes.", {"entities": [[127, 145, "DISEASE"]]}], ["B cells, key cells in allergic inflammation, differentiate in the bone marrow and their precursors include pro-B, pre-B and immature B cells.", {"entities": []}], ["Eosinophil progenitor cells increase in the lung after allergen exposure.", {"entities": []}], ["However, the existence and possible role of B cell precursors in the lung during allergic inflammation remains elusive.", {"entities": []}], ["A BALB/c mouse model of allergic airway inflammation was utilized to perform phenotypic and quantification analyses of pro-B and pre-B cells in the lung by flow cytometry.", {"entities": []}], ["B cell maturation factors IL-7 and B cell-activating factor (BAFF) and their receptors (CD127 and BAFFR, BCMA, TACI, respectively) were also evaluated in the lung and serum.", {"entities": []}], ["The effect of anti-BAFF treatment was investigated both in vivo ( i .", {"entities": []}], ["administration of BAFF-R-Ig fusion protein) and in vitro (colony forming cell assay).", {"entities": []}], ["Finally, BAFF levels were examined in the bronchoalveolar lavage (BAL) of asthmatic patients and healthy controls.", {"entities": []}], ["Precursor pro and pre-B cells increase in the lung after allergen exposure, proliferate in the lung tissue in vivo , express markers of chemotaxis (CCR10 and CXCR4) and co-stimulation (CD40, CD86) and are resistant to apoptosis (Bax).", {"entities": [[148, 153, "GENE"], [158, 163, "GENE"], [185, 189, "GENE"], [191, 195, "GENE"], [229, 232, "GENE"]]}], ["Precursor B cells express receptors for BAFF at baseline, while after allergen challenge both their ligand BAFF and the BCMA receptor expression increases in B cell precursors.", {"entities": []}], ["Blocking BAFFR in the lung in vivo decreases eosinophils and proliferating precursor B cells.", {"entities": []}], ["Blocking BAFFR in bone marrow cultures in vitro reduces pre-B colony formation units.", {"entities": []}], ["BAFF is increased in the BAL of severe asthmatics.", {"entities": []}], ["Our data support the concept of a BAFF-mediated role for B cell precursors in allergic airway inflammation.", {"entities": []}], ["Research on the origins and development of human IgE\u2010expressing (IgE in\u00a0vivo and the low frequency of class switch recombination ( CSR ) to IgE ex\u00a0vivo .", {"entities": []}], ["To determine the main source of IgE CSR to IgE ex\u00a0vivo .", {"entities": []}], ["Human tonsil B cells were analyzed by flow cytometry ( FACS ) and cultured with IL \u20104 and anti\u2010 CD 40 to induce CSR to IgE.", {"entities": []}], ["Na\u00efve, germinal center (GC), early GC (eGC), and memory tonsil B cells were isolated by FACS , and their capacities for IL \u20104 and anti\u2010 CD 40 signaling, cell proliferation, and de novo class switching to IgE were analyzed by RT \u2010 PCR and FACS .", {"entities": [[24, 26, "GENE"], [35, 37, "GENE"], [24, 26, "GENE"], [35, 37, "GENE"]]}], ["B cells from different tonsils exhibited varying capacities for CSR to IgE ex\u00a0vivo .", {"entities": []}], ["This was correlated with the percentage of eGC B cells in the tonsil at the outset of the culture.", {"entities": []}], ["Despite relatively poor cell viability, eGC and GC B\u2010cell cultures produced the highest yields of IgE IL \u20104R and CD 40 signaling and relative rates of cell proliferation.", {"entities": [[48, 50, "GENE"]]}], ["This study shows that the maturation state of tonsil B cells determines their capacity to undergo class switching to IgE ex\u00a0vivo , with the GC \u2010derived B cells yielding the highest percentage of IgE", {"entities": [[140, 142, "GENE"]]}], ["Gene expression changes in the structural cells of the airways are thought to play a role in the development of asthma and airway hyperresponsiveness.", {"entities": [[112, 118, "DISEASE"]]}], ["This includes changes to smooth muscle contractile machinery and epithelial barrier integrity genes.", {"entities": []}], ["We used a targeted gene expression arrays to identify changes in the expression and co-expression of genes important in asthma pathology.", {"entities": [[120, 126, "DISEASE"]]}], ["RNA was isolated from the airways of donor lungs from 12 patients with asthma (8 fatal) and 12 non-asthmatics controls and analyzed using a multiplexed, hypothesis-directed platform to detect differences in gene expression.", {"entities": [[71, 77, "DISEASE"]]}], ["Genes were grouped according to their role in airway dysfunction: airway smooth muscle contraction, cytoskeleton structure and regulation, epithelial barrier function, innate and adaptive immunity, fibrosis and remodeling, and epigenetics.", {"entities": []}], ["Differential gene expression and gene co-expression analyses were used to identify disease associated changes in the airways of asthmatics.", {"entities": []}], ["There was significantly decreased abundance of integrin beta 6 and Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1) in the airways of asthmatics, genes which are known to play an important role in barrier function.", {"entities": [[79, 81, "GENE"], [111, 115, "GENE"]]}], ["Significantly elevated levels of Collagen Type 1 Alpha 1 (COL1A1) and COL3A1 which have been shown to modulate cell proliferation and inflammation, were found in asthmatic airways.", {"entities": [[58, 64, "GENE"], [70, 76, "GENE"]]}], ["Additionally, we identified patterns of differentially co-expressed genes related to pathways involved in virus recognition and regulation of interferon production.", {"entities": []}], ["7 of 8 pairs of differentially co-expressed genes were found to contain CCCTC-binding factor (CTCF) motifs in their upstream promoters.", {"entities": [[94, 98, "GENE"]]}], ["Changes in the abundance of genes involved in cell-cell and cell-matrix interactions could play an important role in regulating inflammation and remodeling in asthma.", {"entities": [[159, 165, "DISEASE"]]}], ["Additionally, our results suggest that alterations to the binding site of the transcriptional regulator CTCF could drive changes in gene expression in asthmatic airways.", {"entities": [[104, 108, "GENE"]]}], ["Several asthma susceptibility loci are known to contain CTCF motifs and so understanding the role of this transcription factor may expand our understanding of asthma pathophysiology and therapeutic options.", {"entities": [[8, 14, "DISEASE"], [159, 165, "DISEASE"], [56, 60, "GENE"]]}], ["The online version of this article (10.1186/s12890-017-0545-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The GPCR DP1 promotes the activity of L-PGDS, the enzyme that produces the DP1 agonist PGD 2 , while at the same time L-PGDS promotes the export and activity of DP1 in response to PGD 2 .", {"entities": [[87, 90, "GENE"], [180, 183, "GENE"], [87, 90, "GENE"], [180, 183, "GENE"]]}], ["Export of newly synthesized G protein\u2013coupled receptors (GPCRs) remains poorly characterized.", {"entities": []}], ["We show in this paper that lipocalin-type prostaglandin D 2 (PGD 2 ) synthase (L-PGDS) interacts intracellularly with the GPCR DP1 in an agonist-independent manner.", {"entities": [[61, 64, "GENE"]]}], ["L-PGDS promotes cell surface expression of DP1, but not of other GPCRs, in HEK293 and HeLa cells, independent of L-PGDS enzyme activity.", {"entities": []}], ["In addition, formation of a DP1\u2013Hsp90 complex necessary for DP1 export to the cell surface is dependent on the interaction between L-PGDS and the C-terminal MEEVD residues of Hsp90.", {"entities": []}], ["Surprisingly, PGD 2 synthesis by L-PGDS is promoted by coexpression of DP1, suggesting a possible intracrine/autocrine signaling mechanism.", {"entities": [[14, 17, "GENE"]]}], ["In this regard, L-PGDS increases the formation of a DP1\u2013ERK1/2 complex and increases DP1-mediated ERK1/2 signaling.", {"entities": []}], ["Our findings define a novel cooperative mechanism in which a GPCR (DP1) promotes the activity of the enzyme (L-PGDS) that produces its agonist (PGD 2 ) and in which this enzyme in turn acts as a cofactor (of Hsp90) to promote export and agonist-dependent activity of the receptor.", {"entities": [[144, 147, "GENE"]]}], ["The aetiology of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis has not been well defined.", {"entities": [[81, 91, "DISEASE"]]}], ["Here we review two factors which may play a role in the pathogenesis of the disease: genetics and infection.", {"entities": []}], ["In particular, we discuss the role of autoantibodies to LAMP-2, which may arise following infection with Gram-negative bacteria, and may contribute to the development of ANCA-associated systemic vasculitis in genetically susceptible individuals.", {"entities": [[195, 205, "DISEASE"]]}], ["To clarify the effects of lung function following exposure to diesel engine exhaust (DEE), we recruited 137 diesel engine testing workers exposed to DEE and 127 non-DEE-exposed workers as study subjects.", {"entities": []}], ["We performed lung function tests and measured cytokinesis-block micronucleus (CBMN) cytome index and levels of urinary polycyclic aromatic hydrocarbons (PAHs) metabolites.", {"entities": []}], ["There was a significant decrease of forced expiratory volume in 1 second (FEV 1 ), ratio of forced expiratory volume in 1 second to forced vital capacity (FEV 1 / FVC), maximal mid expiratory flow curve (MMF), forced expiratory flow at 50% of FVC (FEF 50% ), and forced expiratory flow at 75% of FVC (FEF 75% ) in the DEE-exposed workers than non-DEE-exposed workers (all p <0.05).", {"entities": [[74, 77, "GENE"], [155, 158, "GENE"], [74, 77, "GENE"], [155, 158, "GENE"]]}], ["Among all study subjects, the decreases of FEF 75% were associated with the increasing levels of PAHs metabolites ( p <0.05), and there were negative correlations between FEV 1 , FEV 1 /FVC, MMF, FEF 50% , and FEF 75% with CBMN cytome index (all p <0.05).", {"entities": [[171, 174, "GENE"], [179, 182, "GENE"], [171, 174, "GENE"], [179, 182, "GENE"]]}], ["Our results show that long-term exposure to DEE can induce lung function decline which shows mainly obstructive changes and influence of small airways function.", {"entities": []}], ["The decreased lung function is associated with internal dosage of DEE exposure, and accompany with the increasing CBMN cytome index.", {"entities": []}], ["The incidence and severity of allergic asthma is rising, and novel strategies to prevent or treat this disease are needed.", {"entities": [[30, 45, "DISEASE"], [39, 45, "DISEASE"]]}], ["This study investigated the effects of different mixtures of non-digestible oligosaccharides combined with Bifidobacterium breve M-16V ( BB ) on the development of allergic airway inflammation in an animal model for house dust mite (HDM)-induced allergic asthma.", {"entities": [[246, 261, "DISEASE"], [255, 261, "DISEASE"]]}], ["BALB/c mice were sensitized intranasally (i.n.)", {"entities": []}], ["with HDM and subsequently challenged (i.n.)", {"entities": []}], ["with PBS or HDM while being fed diets containing different oligosaccharide mixtures in combination with BB or an isocaloric identical control diet.", {"entities": []}], ["Bronchoalveolar lavage fluid (BALF) inflammatory cell influx, chemokine and cytokine concentrations in lung homogenates and supernatants of ex vivo HDM-restimulated lung cells were analyzed.", {"entities": []}], ["The HDM-induced influx of eosinophils and lymphocytes was reduced by the diet containing the short-chain and long-chain fructo-oligosaccharides and BB (FF BB ).", {"entities": []}], ["In addition to the HDM-induced cell influx, concentrations of IL-33, CCL17, CCL22, IL-6, IL-13 and IL-5 were increased in supernatants of lung homogenates or BALF and IL-4, IFN-\u03b3 and IL-10 were increased in restimulated lung cell suspensions of HDM-allergic mice.", {"entities": [[69, 74, "GENE"], [76, 81, "GENE"]]}], ["The diet containing FF BB reduced IL-6, IFN-\u03b3, IL-4 and IL-10 concentrations, whereas the combination of galacto-oligosaccharides and long-chain fructo-oligosaccharides with BB was less potent in this model.", {"entities": []}], ["These findings show that synbiotic dietary supplementation can affect respiratory allergic inflammation induced by HDM.", {"entities": []}], ["The combination of FF BB was most effective in the prevention of HDM-induced airway inflammation in mice.", {"entities": []}], ["In coming decades the proportion of very elderly people living in the Western world will dramatically increase.", {"entities": []}], ["This forthcoming \"grey epidemic\" will lead to an explosion of chronic diseases.", {"entities": []}], ["In order to anticipate booming health care expenditures and to assure that social security is funded in the future, research focusing on the relationship between chronic diseases, frailty and disability is needed.", {"entities": []}], ["The general aim of the BELFRAIL cohort study (BF C80+) is to study the dynamic interaction between health, frailty and disability in a multi-system approach focusing on cardiac dysfunction and chronic heart failure, lung function, sarcopenia, renal insufficiency and immunosenescence.", {"entities": []}], ["The BF C80+ is a prospective, observational, population-based cohort study of subjects aged 80 years and older in three well-circumscribed areas of Belgium.", {"entities": []}], ["In total, 29 general practitioner (GP) centres were asked to include patients aged 80 and older.", {"entities": []}], ["Only three exclusion criteria were used: severe dementia, in palliative care and medical emergency.", {"entities": [[48, 56, "DISEASE"]]}], ["Two sampling methods for the recruitment of patients were used.", {"entities": []}], ["Between November 2, 2008 and September 15, 2009, 567 subjects were included in the BF C80+ study.", {"entities": []}], ["Every study participant was invited to undergo four study visits.", {"entities": []}], ["The GP recorded background variables and medical history and performed a detailed anamnesis and clinical examination.", {"entities": []}], ["The clinical research assistant performed an extensive examination including performance testing, questionnaires and technical examinations.", {"entities": []}], ["Echocardiography was performed at home by a cardiologist.", {"entities": []}], ["A blood sample was collected in the morning.", {"entities": []}], ["Follow-up reporting of hard outcome measures including mortality, hospitalization and morbidity was organized.", {"entities": []}], ["A second data collection is planned after 18 months.", {"entities": []}], ["The BF C80+ was designed to acquire a better understanding of the epidemiology and pathophysiology of chronic diseases in the very elderly and to study the dynamic interaction between health, frailty and disability in a multi-system approach.", {"entities": []}], ["The wide variety of dimensions investigated in the BF C80+ will enable us not only to investigate in depth the relationship between the different physiological systems but also to initiate new research questions based on this unique database of community-dwelling elderly.", {"entities": []}], ["Anti-viral prophylaxis is used to prevent the transmission of influenza.", {"entities": [[62, 71, "DISEASE"]]}], ["We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.", {"entities": [[44, 53, "DISEASE"]]}], ["Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered.", {"entities": [[11, 14, "GENE"]]}], ["The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week.", {"entities": []}], ["Three blood samples were taken for haemagglutination inhibition testing - at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore.", {"entities": []}], ["Questionnaires were also administered to collect clinical symptoms.", {"entities": []}], ["237 personnel were included for analysis.", {"entities": []}], ["The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237).", {"entities": [[35, 44, "DISEASE"]]}], ["This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis.", {"entities": []}], ["Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR.", {"entities": []}], ["Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted.", {"entities": []}], ["There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888).", {"entities": []}], ["No allergic, neuropsychiatric or other severe side-effects were noted.", {"entities": []}], ["Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation.", {"entities": []}], ["Asymptomatic infections occur during prophylaxis, which may confer protection against future infection.", {"entities": []}], ["Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks.", {"entities": [[75, 84, "DISEASE"]]}], ["Epidemiological studies indicate associations between childhood exposure with phthalates and bisphenol A (BPA) and the pubertal development.", {"entities": []}], ["We examined associations between the pre-pubertal phthalate and BPA body burden and the longitudinally assessed sexual maturation of eight- to thirteen-year-old children.", {"entities": []}], ["We started with eight- to ten-year-old children in the baseline study and quantified phthalate metabolites and BPA in 472 urine samples (250 boys; 222 girls; mean age: 8.8 years).", {"entities": []}], ["Associations between the pubertal development, assessed in three annual follow-up studies by Puberty Development scale questionnaires (PD scales), and the chemical exposure from the baseline visit were longitudinally analyzed with generalized estimation equations.", {"entities": []}], ["The number of children with both chemical measures and PD scores (calculated from the PD scales) was 408.", {"entities": []}], ["In the third follow-up, 49% of the girls and 18% of the boys had reached mid-puberty.", {"entities": []}], ["For girls, we observed a delayed pubertal development with the di-hexyl-ethyl phthalate (DEHP) metabolites (\u03b2: -0.16 to -0.23; p \u2264 0.05 or p \u2264 0.1), mono-n-butyl phthalate (\u03b2: -0.15; 95% CI: -0.31; 0.01), mono-benzyl phthalate (\u03b2: -0.11; 95% CI: -0,24; -0,01), and mono-ethyl phthalate (MEP) (\u03b2: -0.15; 95% CI: -0.28; -0.01).", {"entities": []}], ["In addition, significant non-linear associations of the DEHP metabolites and BPA with the PD scores were found, when their quadratic effects were included in the GEE models.", {"entities": []}], ["In boys, no consistent relationships between the PD scores and the chemicals were detected except of an accelerated development with the \u2211DEHP metabolites (\u03b2: 0.16; 95% CI: -0.02; -0.34).", {"entities": []}], ["We found indications that pre-pubertal exposures with phthalates and BPA were associated with pubertal timing in children, particularly in girls.", {"entities": []}], ["For boys, associations were inconsistent, and not necessarily in line with the known anti-androgenicity of some phthalates during prenatal exposure.", {"entities": []}], ["Obesity is one of Mississippi's pressing public health problems.", {"entities": [[0, 7, "DISEASE"]]}], ["Since 2005, the state has ranked first in the nation in adult obesity prevalence.", {"entities": [[62, 69, "DISEASE"]]}], ["For authorities to take targeted action against the obesity epidemic, counties, regions, and subpopulations that are most affected by obesity need to be identified.", {"entities": [[52, 59, "DISEASE"], [134, 141, "DISEASE"]]}], ["The objective of this study was to assess the scope, socioeconomic and geographic characteristics, and temporal trends of the obesity epidemic in Mississippi.", {"entities": [[126, 133, "DISEASE"]]}], ["Using 2007-2009 Mississippi Behavioral Risk Factor Surveillance System data and auxiliary data, we applied a small-area estimation method to estimate county-level obesity prevalence in 2007 through 2009, to assess the association between obesity and socioeconomic factors and to evaluate temporal trends.", {"entities": [[163, 170, "DISEASE"], [238, 245, "DISEASE"]]}], ["We determined geographic patterns by mapping obesity prevalence.", {"entities": [[45, 52, "DISEASE"]]}], ["We appraised the precision of estimates by the width of 95% confidence intervals, and we validated our small-area estimates by comparing them with direct estimates.", {"entities": []}], ["In 2009, the county prevalence of obesity ranged from 30.5% to 44.2%.", {"entities": [[34, 41, "DISEASE"]]}], ["Counties with the highest prevalence of obesity were in the Delta region and along the Mississippi River.", {"entities": [[40, 47, "DISEASE"]]}], ["The obesity prevalence increased from 2007 through 2009.", {"entities": [[4, 11, "DISEASE"]]}], ["Age, sex, race, education, and employment status were associated with obesity.", {"entities": [[70, 77, "DISEASE"]]}], ["The 2009 obesity prevalence in all Mississippi counties was substantially higher than the national average and differed by geography and race.", {"entities": [[9, 16, "DISEASE"]]}], ["Although urgent intervention measures are needed in the entire state, policies and programs giving higher priority to higher-risk areas and subpopulations identified by this study may be better strategies.", {"entities": []}], ["We evaluated the pharmacokinetics (PK), safety, and tolerability of a novel oral CRTh2 antagonist, fevipiprant (QAW039), in healthy subjects.", {"entities": []}], ["Peak concentrations of fevipiprant in plasma were observed 1\u20123 hours postdosing.", {"entities": []}], ["Concentrations declined in a multiexponential manner, followed by an apparent terminal phase (t 1/2 , \u223c20 hours).", {"entities": []}], ["Steady state was achieved in 4 days with <2\u2010fold accumulation.", {"entities": []}], ["Elimination was partly by renal excretion (\u226430% of the dose) and glucuronidation.", {"entities": []}], ["Food had minimal impact on the PK of fevipiprant, and it was well tolerated at single and multiple oral doses up to 500 mg/day.", {"entities": []}], ["No dose\u2010dependent adverse events were observed, and all the events were mild or moderate in severity.", {"entities": []}], ["Systemic concentrations were sufficiently high to achieve relevant target occupancy, considering in vitro pharmacology data.", {"entities": []}], ["In summary, the data support further development as a once\u2010daily oral therapy for allergic diseases.", {"entities": []}], ["Mycoplasmas cause chronic respiratory diseases in animals and humans, and to date, development of vaccines have been problematic.", {"entities": []}], ["Using a murine model of mycoplasma pneumonia, lymphocyte responses, specifically T cells, were shown to confer protection as well as promote immunopathology in mycoplasma disease.", {"entities": [[35, 44, "DISEASE"]]}], ["Because T cells play such a critical role, it is important to define the role of antigen presenting cells (APC) as these cells may influence either exacerbation of mycoplasma disease pathogenesis or enhancement of protective immunity.", {"entities": [[107, 110, "GENE"]]}], ["The roles of APC, such as dendritic cells and/or macrophages, and their ability to modulate adaptive immunity in mycoplasma disease are currently unknown.", {"entities": [[13, 16, "GENE"]]}], ["Therefore, the purpose of this study was to identify individual pulmonary APC populations that may contribute to the activation of T cell responses during mycoplasma disease pathogenesis.", {"entities": [[74, 77, "GENE"]]}], ["The present study indeed demonstrates increasing numbers of CD11c in vitro .", {"entities": []}], ["In vivo , these CD11c", {"entities": []}], ["Youth health-related fitness positively affects academic outcomes, although limited research has focused on the relationship between fitness and school absenteeism.", {"entities": []}], ["We examined the longitudinal association between individual children\u2019s fitness and lagged school absenteeism over 4 years in urban middle schools.", {"entities": []}], ["Six cohorts of New York City public school students were followed from grades 5 through 8 (school years 2006\u20132007 through 2012\u20132013; n = 349,381).", {"entities": []}], ["A 3-level longitudinal generalized linear mixed model was used to test the association of change in fitness composite percentile scores and 1-year lagged child-specific days absent.", {"entities": []}], ["Adjusted 3-level negative binomial models showed that students with a more than 20% increase, 10% to 20% increase, less than 10% increase or decrease, and 10% to 20% decrease in fitness from the year prior had 11.9% (95% confidence interval [CI], 7.2\u201316.8), 6.1% (95% CI, 1.0\u201311.4), 2.6% (95% CI, \u22121.1 to 6.5), and 0.4% (95% CI, \u22124.3 to 5.4) lower absenteeism compared with students with a more than 20% fitness decrease.", {"entities": []}], ["Cumulative effects of fitness improvement could have a significant impact on child absenteeism over time, particularly in high-need subgroups.", {"entities": []}], ["Future research should examine the potential for school-based fitness interventions to reduce absenteeism rates, particularly for youths who have fitness drop-offs in adolescence.", {"entities": []}], ["This guidance describes how the FDA evaluates patient-reported outcome (PRO) instruments used as effectiveness endpoints in clinical trials.", {"entities": []}], ["It also describes our current thinking on how sponsors can develop and use study results measured by PRO instruments to support claims in approved product labeling (see appendix point 1).", {"entities": []}], ["It does not address the use of PRO instruments for purposes beyond evaluation of claims made about a drug or medical product in its labeling.", {"entities": []}], ["By explicitly addressing the review issues identified in this guidance, sponsors can increase the efficiency of their endpoint discussions with the FDA during the product development process, streamline the FDA's review of PRO endpoint adequacy, and provide optimal information about the patient's perspective of treatment benefit at the time of product approval.", {"entities": []}], ["A PRO is a measurement of any aspect of a patient's health status that comes directly from the patient (i.e., without the interpretation of the patient's responses by a physician or anyone else).", {"entities": []}], ["In clinical trials, a PRO instrument can be used to measure the impact of an intervention on one or more aspects of patients' health status, hereafter referred to as PRO concepts, ranging from the purely symptomatic (response of a headache) to more complex concepts (e.g., ability to carry out activities of daily living), to extremely complex concepts such as quality of life , which is widely understood to be a multidomain concept with physical, psychological, and social components.", {"entities": []}], ["Data generated by a PRO instrument can provide evidence of a treatment benefit from the patient perspective.", {"entities": []}], ["For this data to be meaningful, however, there should be evidence that the PRO instrument effectively measures the particular concept that is studied.", {"entities": []}], ["Generally, findings measured by PRO instruments may be used to support claims in approved product labeling if the claims are derived from adequate and well-controlled investigations that use PRO instruments that reliably and validly measure the specific concepts at issue.", {"entities": []}], ["The glossary defines many of the terms used in this guidance.", {"entities": []}], ["In particular, the term instrument refers to the actual questions or items contained in a questionnaire or interview schedule along with all the additional information and documentation that supports the use of these items in producing a PRO measure (e.g., interviewer training and instructions, scoring and interpretation manual).", {"entities": []}], ["The term conceptual framework refers to how items are grouped according to subconcepts or domains (e.g., the item walking without help may be grouped with another item, walking with difficulty , within the domain of ambulation , and ambulation may be further grouped into the concept of physical ability ).", {"entities": []}], ["FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities.", {"entities": []}], ["Instead, guidance documents describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.", {"entities": []}], ["The use of the word should in Agency guidance documents means that something is suggested or recommended but not required.", {"entities": []}], ["First publication of the Draft Guidance by the Food and Drug Administration- February 2006.", {"entities": []}], ["To understand the relationships between brain structures and function (behavior and cognition) in healthy aging.", {"entities": []}], ["The study group was composed of 56 healthy elderly subjects who underwent neuropsychological assessment and quantitative magnetic resonance imaging.", {"entities": []}], ["Cluster analysis classified the cohort into two groups, one (cluster 1) in which the magnetic resonance imaging metrics were more preserved (mean age: 66.4 years) and another (cluster 2) with less preserved markers of healthy brain tissue (mean age: 75.4 years).", {"entities": []}], ["The subjects in cluster 2 (older group) had worse indices of interference in the Stroop test compared with the subjects in cluster 1 (younger group).", {"entities": []}], ["Therefore, a simple test such as the Stroop test could differentiate groups of younger and older subjects based on magnetic resonance imaging metrics.", {"entities": []}], ["These results are in agreement with the inhibitory control hypotheses regarding cognitive aging and may also be important in the interpretation of studies with other clinical groups, such as patients with dementia and mild cognitive impairment.", {"entities": [[205, 213, "DISEASE"]]}], ["The aim of this study is to quantify the burden of chronic obstructive pulmonary disease (COPD) \u2013 incidence, prevalence, and mortality \u2013 and identify trends in Australia, Canada, France, Germany, Italy, Japan, The Netherlands, Spain, Sweden, the United Kingdom, and the United States of America.", {"entities": [[51, 88, "DISEASE"]]}], ["A structured literature search was performed (January 2000 to September 2010) of PubMed and EMBASE, identifying English-language articles reporting COPD prevalence, incidence, or mortality.", {"entities": []}], ["Of 2838 articles identified, 299 full-text articles were reviewed, and data were extracted from 133 publications.", {"entities": []}], ["Prevalence data were extracted from 80 articles, incidence data from 15 articles, and mortality data from 58 articles.", {"entities": []}], ["Prevalence ranged from 0.2%\u201337%, but varied widely across countries and populations, and by COPD diagnosis and classification methods.", {"entities": []}], ["Prevalence and incidence were greatest in men and those aged 75 years and older.", {"entities": []}], ["Mortality ranged from 3\u2013111 deaths per 100,000 population.", {"entities": []}], ["Mortality increased in the last 30\u201340 years; more recently, mortality decreased in men in several countries, while increasing or stabilizing in women.", {"entities": []}], ["Although COPD mortality increased over time, rates declined more recently, likely indicating improvements in COPD management.", {"entities": []}], ["In many countries, COPD mortality has increased in women but decreased in men.", {"entities": []}], ["This may be explained by differences in smoking patterns and a greater vulnerability in women to the adverse effects of smoking.", {"entities": []}], ["Point your SmartPhone at the code above.", {"entities": []}], ["If you have a QR code reader the video abstract will appear.", {"entities": []}], ["Or use: http://dvpr.es/Nl3LKT", {"entities": []}], ["Nerve growth factor (NGF) is overexpressed in patients with inflammatory lung diseases, including virus infections.", {"entities": [[21, 24, "GENE"]]}], ["Airway surface liquid (ASL), which is regulated by epithelial cell ion transport, is essential for normal lung function.", {"entities": [[23, 26, "GENE"]]}], ["No information is available regarding the effect of NGF on ion transport of airway epithelium.", {"entities": [[52, 55, "GENE"]]}], ["To investigate whether NGF can affect ion transport, human primary air\u2010interface cultured epithelial cells were placed in Ussing chambers to obtain transepithelial voltage (\u22127.1 \u00b1 3.4 mV), short\u2010circuit current ( I sc , 5.9 \u00b1 1.0 \u03bc A), and transepithelial resistance (750 \u2126 \u00b7cm I sc by 55.3%.", {"entities": [[23, 26, "GENE"]]}], ["Apically applied NGF (1 ng/mL) reduced I sc by 5.3% in 5 min; basolaterally applied NGF had no effect.", {"entities": [[17, 20, "GENE"], [84, 87, "GENE"], [17, 20, "GENE"], [84, 87, "GENE"]]}], ["The response to amiloride was reduced (41.6%) in the presence of NGF.", {"entities": [[65, 68, "GENE"]]}], ["K\u2010252a (10 nmol/L, apical) did not itself affect Na \u03bc mol/L, apical and basolateral) did not itself affect Na I sc in the presence of apical nystatin (50 \u03bc mol/L).", {"entities": []}], ["These results indicate that NGF inhibits Na Nerve growth factor (apical, 1 ng/mL) reduced amiloride\u2010sensitive Na", {"entities": [[28, 31, "GENE"]]}], ["Current data on anaphylaxis is based on retrospective and register based studies.", {"entities": []}], ["The objective of this study was to describe the epidemiology of anaphylaxis in a 1 year prospective study at the emergency care setting, Odense University Hospital, Denmark (2013\u20132014).", {"entities": []}], ["Prospective study at the emergency care setting, Odense University Hospital, Denmark (2013\u20132014).", {"entities": []}], ["To identify anaphylaxis cases, records from all patients with clinical suspicion on anaphylaxis or a related diagnosis according to the International Classification of Diseases 10 and from patients treated at the emergency care setting or at prehospital level with adrenaline, antihistamines or glucocorticoids were reviewed daily.", {"entities": []}], ["The identified cases were referred to the Allergy Center, where a standardized interview regarding the anaphylactic reaction was conducted.", {"entities": []}], ["International guidelines were applied for the assessment of anaphylaxis and its pharmacological treatment.", {"entities": []}], ["Severity of the anaphylactic reaction was evaluated according to Sampson\u2019s severity score.", {"entities": []}], ["We identified 180 anaphylactic patients.", {"entities": []}], ["Anaphylaxis represented 0.3%\u20130.4% of all contacts in the emergency care setting with an incidence rate of 26.8 cases per 100,000 person years (95% CI: 14.3\u201345.8) in children and 40.4 cases per 100,000 person years (95% CI: 32.8\u201349.3) in adults.", {"entities": []}], ["Moderate to severe anaphylaxis was registered in 96% of the cases.", {"entities": []}], ["Skin (96%) and respiratory (79%) symptoms were the most frequent registered, but 7% of cases in adults occurred without skin manifestations.", {"entities": []}], ["The most common elicitor in children was food (61%), while drugs (48%) and venom (24%) were the main suspected elicitors in adults.", {"entities": []}], ["Adrenaline was administered in 25% of the cases and it was significantly less administered than glucocorticoids (83%) and antihistamines (91%).", {"entities": []}], ["The mortality rate during our study period was 0.3 cases per 100,000 person years.", {"entities": []}], ["This is one of the first prospective studies on the epidemiology of anaphylaxis in children and adults, where the patients are identified not only based on diagnosis codes but also on history, symptoms and treatment and thereafter classified according to international diagnosis criteria for anaphylaxis.", {"entities": []}], ["A limitation of this study is that only patients who gave consent to participate in the study were included.", {"entities": []}], ["Furthermore, patients may have attended other hospitals during the study period.", {"entities": []}], ["Therefore, the estimates are minimum figures.", {"entities": []}], ["The prospective study design with a broad search profile yield a higher incidence than previously reported.", {"entities": []}], ["Adrenaline was administered in a low proportion of the patients with moderate to severe anaphylaxis.", {"entities": []}], ["Standardized diagnosis criteria among physicians treating anaphylaxis are needed.", {"entities": []}], ["More than any other organ, the heart is particularly sensitive to gene expression deregulation, often leading in the long run to impaired contractile performances and excessive fibrosis deposition progressing to heart failure.", {"entities": []}], ["Recent investigations provide evidences that the protein phosphatases (PPs), as their counterpart protein kinases, are important regulators of cardiac physiology and development.", {"entities": []}], ["Two main groups, the protein serine/threonine phosphatases and the protein tyrosine phosphatases (PTPs), constitute the PPs family.", {"entities": []}], ["Here, we provide an overview of the role of PTP subfamily in the development of the heart and in cardiac pathophysiology.", {"entities": []}], ["Based on recent in silico studies, we highlight the importance of PTPs as therapeutic targets for the development of new drugs to restore PTPs signaling in the early and late events of heart failure.", {"entities": []}], ["Cannabidiol (CBD) and \u2206 in vitro , but not following oral administration in humans.", {"entities": []}], ["Here we show that oral co-administration of cannabinoids with lipids can substantially increase their intestinal lymphatic transport in rats.", {"entities": []}], ["CBD concentrations in the lymph were 250-fold higher than in plasma, while THC concentrations in the lymph were 100-fold higher than in plasma.", {"entities": []}], ["Since cannabinoids are currently in clinical use for the treatment of spasticity in multiple sclerosis (MS) patients and to alleviate nausea and vomiting associated with chemotherapy in cancer patients, lymphocytes from those patients were used to assess the immunomodulatory effects of cannabinoids.", {"entities": [[84, 102, "DISEASE"], [186, 192, "DISEASE"]]}], ["The levels of cannabinoids recovered in the intestinal lymphatic system, but not in plasma, were substantially above the immunomodulatory threshold in murine and human lymphocytes.", {"entities": []}], ["CBD showed higher immunosuppressive effects than THC.", {"entities": []}], ["Moreover, immune cells from MS patients were more susceptible to the immunosuppressive effects of cannabinoids than those from healthy volunteers or cancer patients.", {"entities": [[149, 155, "DISEASE"]]}], ["Therefore, administering cannabinoids with a high-fat meal or in lipid-based formulations has the potential to be a therapeutic approach to improve the treatment of MS, or indeed other autoimmune disorders.", {"entities": []}], ["However, intestinal lymphatic transport of cannabinoids in immunocompromised patients requires caution.", {"entities": []}], ["Particulate matter (PM) exposure is related to pulmonary and cardiovascular diseases, with increased inflammatory status.", {"entities": []}], ["The release of the proinflammatory interleukin- (IL-) 1 \u03b2 , is controlled by a dual pathway, the formation of inactive pro-IL-1 \u03b2 , through Toll-like receptors (TLRs) activation, and its cleavage by NLRP3 inflammasome.", {"entities": [[199, 204, "GENE"]]}], ["THP-1-derived macrophages were exposed for 6\u2009h to 2.5\u2009 \u03bc g/cm 10 , and the potential to promote IL-1 \u03b2 release by binding TLRs and activating NLRP3 has been examined.", {"entities": [[142, 147, "GENE"]]}], ["Summer PM 10 , induced a marked IL-1 \u03b2 response in the absence of LPS priming (50-fold increase compared to unexposed cells), which was reduced by caspase-1 inhibition (91% of inhibition respect summer PM 10 -treated cells) and by TLR-2 and TLR-4 inhibitors (66% and 53% of inhibition, resp.).", {"entities": []}], ["Furthermore, summer PM 10 increased the number of early endosomes, and oxidative stress inhibition nearly abolished PM 10 -induced IL-1 \u03b2 response (90% of inhibition).", {"entities": []}], ["These findings suggest that summer PM 10 contains constituents both related to the activation of membrane TLRs and activation of the inflammasome NLPR3 and that TLRs activation is of pivotal importance for the magnitude of the response.", {"entities": []}], ["ROS formation seems important for PM 10 -induced IL-1 \u03b2 response, but further investigations are needed to elucidate the molecular pathway by which this effect is mediated.", {"entities": []}], ["Monocyte chemotactic protein-1 (MCP-1) is a member of the CC family of cytokines.", {"entities": []}], ["It has monocyte and lymphocyte chemotactic activity and stimulates histamine release from basophils.", {"entities": []}], ["MCP-1 is implicated in the pathogenesis of inflammatory diseases, including asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["The airway smooth muscle (ASM) layer is thickened in asthma, and the growth factors and cytokines secreted by ASM cells play a role in the inflammatory response of the bronchial wall.", {"entities": [[53, 59, "DISEASE"]]}], ["Glucocorticoids and \u03b2 2 -agonists are first-line drug treatments for asthma.", {"entities": [[69, 75, "DISEASE"]]}], ["Little is known about the effect of asthma treatments on MCP-1 production from human ASM cells.", {"entities": [[36, 42, "DISEASE"]]}], ["Here, we determined the effect of ciclesonide (a glucocorticoid) and formoterol (a \u03b2 2 -agonist) on MCP-1 production from human ASM cells.", {"entities": []}], ["TNF\u03b1 and IL-1\u03b2 induced MCP-1 secretion from human ASM cells.", {"entities": []}], ["Formoterol had no effect on MCP-1 expression, while ciclesonide significantly inhibited IL-1\u03b2- and TNF\u03b1-induced MCP-1.", {"entities": []}], ["Furthermore, ciclesonide inhibited IL-1\u03b2- and TNF\u03b1-induced MCP-1 mRNA and IL-1\u03b2- and TNF\u03b1-induced MCP-1 promoter and enhancer luciferase reporters.", {"entities": []}], ["Western blots showed that ciclesonide had no effect on I\u03baB degradation.", {"entities": []}], ["Finally, ciclesonide inhibited an NF-\u03baB luciferase reporter.", {"entities": []}], ["Our data show that ciclesonide inhibits IL-1\u03b2- and TNF\u03b1-induced MCP-1 production from human ASM cells via a transcriptional mechanism involving inhibition of NF-\u03baB binding.", {"entities": []}], ["Evidence-based medicine promotes and relies on the use of evidence in developing clinical practice guidelines (CPGs).", {"entities": []}], ["The Chinese healthcare system includes both traditional Chinese medicine (TCM) and Western medicine, which are expected to be equally reflected in Chinese CPGs.", {"entities": []}], ["To evaluate the inclusion of TCM-related information in Western medicine CPGs developed in China and the adoption of high level evidence.", {"entities": []}], ["All CPGs were identified from the China Guideline Clearinghouse (CGC), which is the main Chinese organisation maintaining the guidelines issued by the Ministry of Health of China, the Chinese Medical Association and the Chinese Medical Doctors\u2019 Association.", {"entities": []}], ["TCM-related contents were extracted from all the CPGs identified.", {"entities": []}], ["Extracted information comprised the institution issuing the guideline, date of issue, disease, recommendations relating to TCM, evidence level of the recommended content and references supporting the recommendations.", {"entities": []}], ["A total of 604 CPGs were identified, only a small number of which (74/604; 12%) recommended TCM therapy and only five guidelines (7%) had applied evidence grading.", {"entities": []}], ["The 74 CPGs involved 13 disease systems according to the International Classification of Diseases 10th edition.", {"entities": []}], ["TCM was mainly recommended in the treatment part of the guidelines (73/74, 99%), and more than half of the recommendations (43/74, 58%) were related to Chinese herbal medicine (single herbs or herbal treatment based on syndrome differentiation).", {"entities": [[219, 227, "DISEASE"]]}], ["Few Chinese Western medicine CPGs recommend TCM therapies and very few provide evidence grading for the TCM recommendation.", {"entities": []}], ["We suggest that future guideline development should be based on systematic searches for evidence to support CPG recommendations and involve a multidisciplinary approach including TCM expertise.", {"entities": []}], ["Recently, mRNA vaccines have been introduced as a safety-optimized alternative to plasmid DNA-based vaccines for protection against allergy.", {"entities": []}], ["However, it remained unclear whether the short persistence of this vaccine type would limit memory responses and whether the protective immune response type would be maintained during recurrent exposure to allergen.", {"entities": []}], ["We tested the duration of protective memory responses in mice vaccinated with mRNA encoding the grass pollen allergen Phl p 5 by challenging them with recombinant allergen, 3.5, 6, and 9 months after vaccination.", {"entities": []}], ["In a second experiment, vaccinated mice were repeatedly challenged monthly with aerosolized allergen over a period of 7 months.", {"entities": []}], ["Antibody and cytokine responses as well as lung inflammation and airway hyperresponsiveness were assessed.", {"entities": []}], ["mRNA vaccination induced robust TH1 memory responses for at least 9 months.", {"entities": []}], ["Vaccination efficiently suppressed TH2 cytokines, IgE responses, and lung eosinophilia.", {"entities": [[74, 86, "DISEASE"]]}], ["Protection was maintained after repeated exposure to aerosolized allergen and no TH1 associated pathology was observed.", {"entities": []}], ["Lung function remained improved compared to nonvaccinated controls.", {"entities": []}], ["Our data clearly indicate that mRNA vaccination against Phl p 5 induces robust, long-lived memory responses, which can be recalled by allergen exposure without side effects.", {"entities": []}], ["mRNA vaccines fulfill the requirements for safe prophylactic vaccination without the need for booster immunizations.", {"entities": []}], ["Previous studies have revealed that Triptolide damages female reproductive capacity, but the mechanism is unclear.", {"entities": []}], ["In this study, we used Caenorhabditis elegans to investigate the effects of Triptolide on the germline and explore its possible mechanisms.", {"entities": []}], ["Our data show that exposure for 4 h to 50 and 100 mg/L Triptolide reduced C. elegans fertility, led to depletion and inactivation of spermatids with the changes in the expression levels of related genes, and increased the number of unfertilized oocytes through damaging chromosomes and DNA damage repair mechanisms.", {"entities": []}], ["After 24 and 48 h of the 4 h exposure to 50 and 100 mg/L Triptolide, we observed shrink in distal tip cells, an increase in the number of apoptotic cells, a decrease in the number of mitotic germ cells and oocytes in diakinesis stage, and chromatin aggregates in \u22121 oocytes.", {"entities": []}], ["Moreover, expression patterns of the genes associated with mitotic germ cell proliferation, apoptosis, and oocyte quality were altered after Triptolide exposure.", {"entities": []}], ["Therefore, Triptolide may damage fertility of nematodes by hampering the development of oocytes at different developmental stages.", {"entities": []}], ["Alterations in the expression patterns of genes involved in oocyte development may explain the corresponding changes in oocyte development in nematodes exposed to Triptolide.", {"entities": []}], ["Beyond their critical role in humoral immunity, B lymphocytes can employ a variety of immunomodulatory mechanisms including expression of the apoptosis-inducing molecule Fas ligand (FasL; CD178).", {"entities": [[170, 173, "GENE"]]}], ["Here, we extensively characterized the surface phenotype of FasL", {"entities": []}], ["Cats ( Felis domesticus ) are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy.", {"entities": []}], ["In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic efficacy of a novel intranasal liposome-entrapped vaccines made of native Fel d 1 (major cat allergen) in comparison with the vaccine made of crude cat hair extract (cCE).", {"entities": [[32, 49, "DISEASE"], [41, 49, "DISEASE"]]}], ["BALB/c mice were sensitized with cCE mixed with alum intraperitoneally and intranasally.", {"entities": []}], ["The allergic mice were treated with eight doses of either liposome (L)-entrapped native Fel d 1 (L-nFD1), L-cCE), or placebo on every alternate day.", {"entities": []}], ["Vaccine efficacy evaluation was performed one day after provoking the treated mice with aerosolic cCE.", {"entities": []}], ["All allergenized mice developed histological features of allergic rhinitis with rises of serum specific-IgE and Th2 cytokine gene expression.", {"entities": [[57, 74, "DISEASE"], [66, 74, "DISEASE"]]}], ["Serum IgE and intranasal mucus production of allergic mice reduced significantly after vaccination in comparison with the placebo mice.", {"entities": []}], ["The vaccines also caused a shift of the Th2 response (reduction of Th2 cytokine expressions) towards the non-pathogenic responses: Th1 (down-regulation of the Th1 suppressive cytokine gene, IL-35 ) and Treg (up-regulation of IL-10 and TGF-\u03b2 ).", {"entities": []}], ["In conclusions, a mouse model of allergic rhinitis to cat allergens was successfully developed.", {"entities": [[33, 50, "DISEASE"], [42, 50, "DISEASE"]]}], ["The intranasal, liposome-adjuvanted vaccines, especially the refined single allergen formulation, assuaged the allergic manifestations in the modeled mice.", {"entities": []}], ["The prototype vaccine is worthwhile testing further for clinical use in the pet allergic patients.", {"entities": []}], ["This research aimed to explore the effects of interferon-\u03b3 ( IFN- \u03b3) polymorphisms and expression profile on susceptibility to ankylosing spondylitis (AS) in a Chinese population.", {"entities": [[138, 149, "DISEASE"], [127, 149, "DISEASE"]]}], ["Blood samples were collected from 89 AS patients and 106 healthy controls.", {"entities": []}], ["IFN- \u03b3 polymorphisms were genotyped by polymerase chain reaction (PCR) and sequencing methods.", {"entities": []}], ["The genotype distribution of polymorphism in the control group was detected by Hardy-Weinberg equilibrium (HWE).", {"entities": []}], ["Odds ratios (OR) with 95% confidence intervals (95%CI) were calculated using the \u03c7 IFN- \u03b3 polymorphisms.", {"entities": []}], ["Moreover, serum IFN-\u03b3 level was measured by ELISA.", {"entities": []}], ["rs1861493 and rs2430561 polymorphisms were conformed to be in HWE in genotypes distribution of the control group ( P >0.05 for both).", {"entities": []}], ["However, only TT genotype and T allele of rs2430561 presented significantly higher frequencies in AS patients than in healthy controls ( P =0.04 and 0.03, respectively), indicating that they obviously increased the risk of AS in a Chinese population (OR=2.54, 95%CI=1.01\u20136.40; OR=1.60, 95%CI=1.04\u20132.46).", {"entities": []}], ["In AS patients, serum IFN-\u03b3 level was higher than in controls, and its expression patterns showed significant association with genotypes of rs2430561.", {"entities": []}], ["IFN- \u03b3 rs2430561 polymorphism may contribute to the risk of AS through influencing IFN-\u03b3 expression.", {"entities": []}], ["Pd-catalyzed cross-coupling reactions that form C\u2013N bonds have become useful methods to synthesize anilines and aniline derivatives, an important class of compounds throughout chemical research.", {"entities": []}], ["A key factor in the widespread adoption of these methods has been the continued development of reliable and versatile catalysts that function under operationally simple, user-friendly conditions.", {"entities": []}], ["This review provides an overview of Pd-catalyzed N-arylation reactions found in both basic and applied chemical research from 2008 to the present.", {"entities": []}], ["Selected examples of C\u2013N cross-coupling reactions between nine classes of nitrogen-based coupling partners and (pseudo)aryl halides are described for the synthesis of heterocycles, medicinally relevant compounds, natural products, organic materials, and catalysts.", {"entities": []}], ["Glucocorticoids (Gc) are potent anti-inflammatory agents with wide clinical application.", {"entities": [[17, 19, "GENE"]]}], ["We have previously shown that increased serum concentration significantly attenuates regulation of a simple Gc-responsive reporter.", {"entities": []}], ["We now find that glucocorticoid receptor (GR) regulation of some endogenous transactivated but not transrepressed genes is impaired, suggesting template specificity.", {"entities": []}], ["Serum did not directly affect GR expression, activity or trafficking, implicating GR crosstalk with other signalling pathways.", {"entities": []}], ["Indeed, a JNK inhibitor completely abolished the serum effect.", {"entities": []}], ["We identified the Gc modulating serum component as cholesterol.", {"entities": [[18, 20, "GENE"]]}], ["Cholesterol loading mimicked the serum effect, which was readily reversed by JNK inhibition.", {"entities": []}], ["Chelation of serum cholesterol with methyl-\u03b2-cyclodextrin or inhibition of cellular cholesterol synthesis with simvastatin potentiated the Gc response.", {"entities": [[139, 141, "GENE"]]}], ["To explore the effect in vivo we used ApoE in vitro studies, we find no impact of elevated cholesterol on the expression of GR, or on the hypothalamic\u2013pituitary\u2013adrenal axis, measured by dexamethasone suppression test.", {"entities": [[38, 42, "GENE"]]}], ["Instead we find selective Gc resistance on some hepatic target genes in ApoE in vivo .", {"entities": [[26, 28, "GENE"], [72, 76, "GENE"]]}], ["Taken together these findings reveal a new environmental constraint on Gc action with relevance to both inflammation and cancer.", {"entities": [[121, 127, "DISEASE"], [71, 73, "GENE"]]}], ["The various sphingosine kinase (SphK) isoenzymes (isozymes) and isoforms, key players in normal cellular physiology, are strongly implicated in cancer and other diseases.", {"entities": [[144, 150, "DISEASE"]]}], ["Mutations in SphKs, that may justify abnormal physiological function, have not been recorded.", {"entities": []}], ["Nonetheless, there is a large and growing body of evidence demonstrating the contribution of gain or loss of function and the imbalance in the SphK/S1P rheostat to a plethora of pathological conditions including cancer, diabetes and inflammatory diseases.", {"entities": [[212, 218, "DISEASE"]]}], ["SphK is expressed as two isozymes SphK1 and SphK2, transcribed from genes located on different chromosomes and both isozymes catalyze the phosphorylation of sphingosine to S1P.", {"entities": [[34, 39, "GENE"], [44, 49, "GENE"]]}], ["Expression of each SphK isozyme produces alternately spliced isoforms.", {"entities": []}], ["In recent years the importance of the contribution of SpK1 expression to treatment resistance in cancer has been highlighted and, additionally, differences in treatment outcome appear to also be dependent upon SphK isoform expression.", {"entities": [[97, 103, "DISEASE"]]}], ["This review focuses on an exciting emerging area of research involving SphKs functions, expression and subcellular localization, highlighting the complexity of targeting SphK in cancer and also comorbid diseases.", {"entities": [[178, 184, "DISEASE"]]}], ["This review also covers the SphK isoenzymes and isoforms from a historical perspective, from their first discovery in murine species and then in humans, their role(s) in normal cellular function and in disease processes, to advancement of SphK as an oncotarget.", {"entities": []}], ["In settler societies such as Australia, Canada, New Zealand and the United States, health inequities drive lower health status and poorer health outcomes in Indigenous populations.", {"entities": []}], ["This research unravels the dense complexity of how historical policy decisions in Canada can influence inequities in health care access in the 21 This qualitative study was based in Saskatchewan, a Western Canadian province which has proportionately one of the largest provincial populations of an Indigenous subpopulation (status Indians) which is the focus of this study.", {"entities": []}], ["The study began with determining approaches to OSA care provision based on Canadian Thoracic Society guidelines for referral, diagnosis and treatment of sleep disordered breathing.", {"entities": []}], ["Thereafter, health policy determining health benefits coverage and program differences between status Indians and other Canadians were ascertained.", {"entities": []}], ["Finally, respirologists who specialized in sleep medicine were interviewed.", {"entities": []}], ["All interviews were audio-recorded and the transcripts were thematically analyzed using NVIVO.", {"entities": []}], ["In terms of access and provision of OSA care, different patient pathways emerged for status Indians in comparison with other Canadians.", {"entities": []}], ["Using Saskatchewan as a case study, the preliminary evidence suggests that status Indians face significant barriers in accessing diagnostic and treatment services for OSA in a timely manner.", {"entities": []}], ["In order to confirm initial findings, further investigations are required in other Canadian jurisdictions.", {"entities": []}], ["Moreover, as other clinical conditions could share similar features of health care access and provision of health benefits coverage, this policy analysis could be replicated in other provincial and territorial health care systems across Canada, and other settler nations where there are differential health coverage arrangements for Indigenous peoples.", {"entities": []}], ["Exome sequencing using next-generation sequencing technologies is a cost efficient approach to selectively sequencing coding regions of human genome for detection of disease variants.", {"entities": []}], ["A significant amount of DNA fragments from the capture process fall outside target regions, and sequence data for positions outside target regions have been mostly ignored after alignment.", {"entities": []}], ["We performed whole exome sequencing on 22 subjects using Agilent SureSelect capture reagent and 6 subjects using Illumina TrueSeq capture reagent.", {"entities": []}], ["We also downloaded sequencing data for 6 subjects from the 1000 Genomes Project Pilot 3 study.", {"entities": []}], ["Using these data, we examined the quality of SNPs detected outside target regions by computing consistency rate with genotypes obtained from SNP chips or the Hapmap database, transition-transversion (Ti/Tv) ratio, and percentage of SNPs inside dbSNP.", {"entities": []}], ["For all three platforms, we obtained high-quality SNPs outside target regions, and some far from target regions.", {"entities": []}], ["In our Agilent SureSelect data, we obtained 84,049 high-quality SNPs outside target regions compared to 65,231 SNPs inside target regions (a 129% increase).", {"entities": []}], ["For our Illumina TrueSeq data, we obtained 222,171 high-quality SNPs outside target regions compared to 95,818 SNPs inside target regions (a 232% increase).", {"entities": []}], ["For the data from the 1000 Genomes Project, we obtained 7,139 high-quality SNPs outside target regions compared to 1,548 SNPs inside target regions (a 461% increase).", {"entities": []}], ["These results demonstrate that a significant amount of high quality genotypes outside target regions can be obtained from exome sequencing data.", {"entities": []}], ["These data should not be ignored in genetic epidemiology studies.", {"entities": []}], ["Leonotis nepetifolia Linn (Lamiaceae) is used in traditional medicine for its calming (tranquilizing) effects.", {"entities": []}], ["The aim of this study was to determine whether there is any scientific justification for this use.", {"entities": []}], ["To achieve this purpose, we investigated the behavioural effects of the methanol extract of Leonotis nepetifolia stem (37.5, 75 and 150 mg/kg) in mice.", {"entities": []}], ["Acute toxicity studies were carried out on the methanol stem extract of Leonotis nepetifolia to determine the LD50.", {"entities": []}], ["The behavioural tests employed were diazepam-induced sleep onset and duration, hole board assay for exploratory activity, mouse beam walk assay for motor coordination, and the staircase test for the detection of anxiolytic compounds.", {"entities": []}], ["Preliminary phytochemical screening was also carried out on the extract.", {"entities": []}], ["The intraperitoneal LD50 value was found to be 3.8 g/kg.", {"entities": []}], ["The results showed that the extract significantly prolonged the duration of diazepam-induced sleep at the highest dose (150 mg/kg).", {"entities": []}], ["There was no observable effect on exploratory activity and motor coordination at the doses tested (37.5, 75 and 150 mg/kg).", {"entities": []}], ["The extract, however, at 150 mg/kg elicited a significant decrease in the number of rearings in the staircase test, an effect also observed in the group of mice injected with an anxiolytic dose of diazepam.", {"entities": []}], ["The preliminary phytochemical screening revealed the presence of alkaloids, saponins, glycosides and triterpenoids.", {"entities": []}], ["The results obtained suggest that the crude methanol extract of Leonotis nepetifolia stem possesses some biologically active constituents with potential anxiolytic activity and thus may justify its traditional use as a tranquilizer.", {"entities": []}], ["Glutaredoxins (Grx) are redox enzymes that remove glutathione bound to protein thiols, know as S-glutathionylation (PSSG).", {"entities": []}], ["PSSG is a reservoir of GSH and can affect the function of proteins.", {"entities": []}], ["It inhibits the NF-\u03baB pathway and LPS aspiration in Grx1 KO mice with decreased inflammatory cytokine levels.", {"entities": []}], ["In this study we investigated whether absence of Grx1 similarly repressed cigarette smoke-induced inflammation in an exposure model in mice.", {"entities": []}], ["Cigarette smoke exposure for four weeks decreased lung PSSG levels, but increased PSSG in lavaged cells and lavage fluid (BALF).", {"entities": []}], ["Grx1 KO mice had increased levels of PSSG in lung tissue, BALF and BAL cells in response to smoke compared to wt mice.", {"entities": []}], ["Importantly, levels of multiple inflammatory mediators in the BALF were decreased in Grx1 KO animals following cigarette smoke exposure compared to wt mice, as were levels of neutrophils, dendritic cells and lymphocytes.", {"entities": []}], ["On the other hand, macrophage numbers were higher in Grx1 KO mice in response to smoke.", {"entities": []}], ["Although cigarette smoke in vivo caused inverse effects in inflammatory and resident cells with respect to PSSG, primary macrophages and epithelial cells cultured from Grx1 KO mice both produced less KC compared to cells isolated from WT mice after smoke extract exposure.", {"entities": []}], ["In this manuscript, we provide evidence that Grx1 has an important role in regulating cigarette smoke-induced lung inflammation which seems to diverge from its effects on total PSSG.", {"entities": []}], ["Secondly, these data expose the differential effect of cigarette smoke on PSSG in inflammatory versus resident lung cells.", {"entities": []}], ["About 25% of 1990-1991 Persian Gulf War veterans experience disabling fatigue, widespread pain, and cognitive dysfunction termed Gulf War illness (GWI) or Chronic Multisymptom Illness (CMI).", {"entities": []}], ["A leading theory proposes that wartime exposures initiated prolonged production of reactive oxygen species (ROS) and central nervous system injury.", {"entities": []}], ["The endogenous antioxidant L-carnosine (\u03b2-alanyl-L-histidine) is a potential treatment since it is a free radical scavenger in nervous tissue.", {"entities": []}], ["To determine if nutritional supplementation with L-carnosine would significantly improve pain, cognition and fatigue in GWI, a randomized double blind placebo controlled 12 week dose escalation study involving 25 GWI subjects was employed.", {"entities": []}], ["L-carnosine was given as 500, 1000, and 1500 mg increasing at 4 week intervals.", {"entities": []}], ["Outcomes included subjective fatigue, pain and psychosocial questionnaires, and instantaneous fatigue and activity levels recorded by ActiWatch Score devices.", {"entities": []}], ["Cognitive function was evaluated by WAIS-R digit symbol substitution test.", {"entities": []}], ["Carnosine had 2 potentially beneficial effects: WAIS-R scores increased significantly, and there was a decrease in diarrhea associated with irritable bowel syndrome.", {"entities": [[140, 164, "DISEASE"], [156, 164, "DISEASE"], [115, 123, "DISEASE"]]}], ["No other significant incremental changes were found.", {"entities": []}], ["Therefore, 12 weeks of carnosine (1500 mg) may have beneficial cognitive effects in GWI.", {"entities": []}], ["Fatigue, pain, hyperalgesia, activity and other outcomes were resistant to treatment.", {"entities": []}], ["Human lung tissue, directly exposed to the environmental oxidants and toxicants, is apt to be harmed to bring about acute or chronic oxidative insults.", {"entities": []}], ["The nuclear factor erythroid 2-related factor 2 (Nrf2) represents a central cellular defense mechanism, and is a target for developing agents against oxidative insult-induced human lung diseases.", {"entities": []}], ["Our previous study found that the EtOH extract of Cinnamomum chartophyllum protected human bronchial epithelial cells against oxidative insults via Nrf2 activation.", {"entities": []}], ["In this study, a systemic phytochemical investigation of the aerial parts of C. chartophyllum led to the isolation of thirty chemical constituents, which were further evaluated for their Nrf2 inducing potential using NAD(P)H: quinone reductase (QR) assay.", {"entities": []}], ["Among these purified constituents, a sesquiterpenoid bearing \u03b1, \u03b2-unsaturated ketone group, 3 S -(+)-9-oxonerolidol (NLD), and a diphenyl sharing phenolic groups, 3, 3\u2032, 4, 4\u2032-tetrahydroxydiphenyl (THD) significantly activated Nrf2 and its downstream genes, NAD(P)H quinone oxidoreductase 1 (NQO-1), and \u03b3-glutamyl cysteine synthetase (\u03b3-GCS), and enhanced the nuclear translocation and stabilization of Nrf2 in human lung epithelial cells.", {"entities": []}], ["Importantly, NLD and THD had no toxicities under the Nrf2 inducing doses.", {"entities": []}], ["THD also demonstrated a potential of interrupting Nrf2-Keap1 protein\u2013protein interaction (PPI).", {"entities": []}], ["Furthermore, NLD and THD protected human lung epithelial cells against sodium arsenite [As(III)]-induced cytotoxicity.", {"entities": []}], ["Taken together, we conclude that NLD and THD are two novel Nrf2 activators with potential application of preventing acute and chronic oxidative insults in human lung tissue.", {"entities": []}], ["fx1 \u2022 The chemical compositions of Cinnamomum chartophyllum are firstly identified.", {"entities": []}], ["\u2022 The active ingredients supporting the biological functions of C. chartophyllum are verified.", {"entities": []}], ["\u2022 NLD and THD are identified to be Nrf2 activators for the first time.", {"entities": []}], ["\u2022 NLD and THD protect human lung epithelial cells against As(III)-induced cytotoxicity.", {"entities": []}], ["The chemical compositions of Cinnamomum chartophyllum are firstly identified.", {"entities": []}], ["The active ingredients supporting the biological functions of C. chartophyllum are verified.", {"entities": []}], ["NLD and THD are identified to be Nrf2 activators for the first time.", {"entities": []}], ["NLD and THD protect human lung epithelial cells against As(III)-induced cytotoxicity.", {"entities": []}], ["Protease activated receptors (PARs) have been recognized as a distinctive four-member family of seven transmembrane G protein-coupled receptors (GPCRs) that can be cleaved by certain serine proteases.", {"entities": []}], ["In recent years, there has been considerable interest in the role of PARs in allergic inflammation, the fundamental pathologic changes of allergy, but the potential roles of PARs in allergy remain obscure.", {"entities": []}], ["Since many of these proteases are produced and actively involved in the pathologic process of inflammation including exudation of plasma components, inflammatory cell infiltration, and tissue damage and repair, PARs appear to make important contribution to allergy.", {"entities": []}], ["The aim of the present review is to summarize the expression of PARs in inflammatory and structural cells, the influence of agonists or antagonists of PARs on cell behavior, and the involvement of PARs in allergic disorders, which will help us to better understand the roles of serine proteases and PARs in allergy.", {"entities": []}], ["During respiratory-virus infection, excessive lymphocyte activation can cause pathology both in acute infection and in exacerbations of chronic respiratory diseases.", {"entities": []}], ["The costimulatory molecule CD161 is expressed on lymphocyte subsets implicated in promoting respiratory inflammation, including Th2, Th17, mucosally associated invariant T (MAIT) cells, and type 2 innate lymphoid cells.", {"entities": []}], ["We asked whether the CD161 ligand LLT1 could be expressed on respiratory epithelial cells following respiratory-virus infection as a mechanism by which respiratory-virus infection could promote activation of proinflammatory lymphocytes.", {"entities": []}], ["In response to respiratory syncytial virus (RSV) infection, expression of LLT1 was upregulated in the BEAS-2B respiratory epithelial cell line and primary human bronchial epithelial cells.", {"entities": []}], ["Imaging studies revealed that LLT1 expression increased in both RSV-infected and cocultured uninfected cells, suggesting that soluble factors produced during infection stimulate LLT1 expression.", {"entities": []}], ["TLR3 and TLR2/6 ligands led to a rapid increase in LLT1 mRNA in respiratory epithelial cells, as did the proinflammatory cytokines type I interferons, interleukin 1\u03b2 (IL-1\u03b2), and tumor necrosis factor alpha (TNF-\u03b1), which are produced early in respiratory-virus infection.", {"entities": [[0, 4, "GENE"]]}], ["Immunohistochemistry confirmed the increase in LLT1 protein on the epithelial cell surface, and live-cell confocal microscopy demonstrated accumulation of epithelial LLT1 at synapses formed with CD161 IMPORTANCE The immune response to respiratory-virus infection is essential for clearing the pathogen but, if excessive, can lead to tissue damage and obstruction of the airways.", {"entities": []}], ["How viral infection activates immune cells in the lungs is not fully understood.", {"entities": []}], ["Here, we show that LLT1 can be expressed in lung cells in response to infection.", {"entities": []}], ["LLT1 triggers CD161, a receptor on inflammatory immune cells.", {"entities": []}], ["This mechanism may promote activation of immune cells in the lungs in viral infection and could be a novel target for therapies aimed at reducing lung inflammation.", {"entities": []}], ["Background .", {"entities": []}], ["The aim of this study is to compare the effects of sevoflurane and propofol on one lung ventilation (OLV) induced ischemia-reperfusion injury (IRI) by determining the blood gas, ischemia-modified albumin (IMA), and malonyldialdehyde (MDA).", {"entities": [[114, 122, "DISEASE"], [178, 186, "DISEASE"]]}], ["Material and Methods .", {"entities": []}], ["Forty-four patients undergoing thoracic surgery with OLV were randomized in two groups (sevoflurane Group S, propofol Group P).", {"entities": []}], ["Anesthesia was inducted with thiopental and was maintained with 1\u20132.5% of sevoflurane within the 40/60% of O 2 /N 2 O mixture in Group S. In Group P anesthesia was inducted with propofol and was maintained with infusion of propofol and remifentanil.", {"entities": []}], ["Hemodynamic records and blood samples were obtained before anesthesia induction ( t 1 ), 1\u2009min before two lung ventilation ( t 2 ), 30\u2009min after two lung ventilation ( t 3 ), and postoperative sixth hours ( t 4 ).", {"entities": []}], ["Heart rate at t 2 and t 3 in Group P was significantly lower than that in Group S. While there were no significant differences in terms of pH and pCO 2 , pO 2 at t 2 and t 3 in Group S was significantly lower than that in Group P. IMA levels at t 4 in Group S were significantly lower than those in Group P. Conclusion .", {"entities": []}], ["Sevoflurane may offer protection against IRI after OLV in thoracic surgery.", {"entities": []}], ["Recurrent respiratory papillomatosis (RRP) is a relatively rare, chronic disease caused by Human Papilloma Virus (HPV) 6 and 11, and characterized by wart\u2010like lesions in the airway affecting voice and respiratory function.", {"entities": [[97, 106, "DISEASE"]]}], ["The majority of HPV infections are asymptomatic and resolve spontaneously, however, some individuals are afflicted with persistent HPV infections.", {"entities": []}], ["Failure to eliminate HPV 6 and 11 due to a defect immune responsiveness to these specific genotypes is proposed to play a major role in the development of RRP.", {"entities": []}], ["We performed a phenotypic characterization of peripheral blood mononuclear cells (PBMC) collected from 16 RRP patients and 12 age\u2010matched healthy controls, using immunoflow cytometry, and monoclonal antibodies against differentiation and activation markers.", {"entities": []}], ["The cytokine mRNA profile of monocytes, T helper\u2010, T cytotoxic\u2010, and NK cells was assessed using RT\u2010qPCR cytokine analysis, differentiating between Th1\u2010, Th2\u2010, Th3/regulatory\u2010, and inflammatory immune responses.", {"entities": []}], ["We found a dominance of cytotoxic T cells, activated NK cells, and high numbers of stressed MIC A/B expressing lymphocytes.", {"entities": []}], ["There was an overall suppression of cytokine mRNA production and an aberrant cytokine mRNA profile in the activated NK cells.", {"entities": []}], ["These findings demonstrate an immune dysregulation with inverted CD4", {"entities": [[65, 68, "GENE"]]}], ["Mycobacterium tuberculosis is an intracellular pathogen that parasitizes the host macrophage.", {"entities": [[14, 26, "DISEASE"]]}], ["While approximately two billion people are infected worldwide, only 5 to 10% become diseased with pulmonary tuberculosis, at least in the absence of comorbidities.", {"entities": [[108, 120, "DISEASE"], [98, 120, "DISEASE"]]}], ["Tuberculosis control requires development of noninvasive methods probing the host immune status to help distinguish latent infection from active tuberculosis.", {"entities": [[0, 12, "DISEASE"], [145, 157, "DISEASE"]]}], ["With such methods, high-risk individuals could be targeted for treatment before disease manifestation.", {"entities": []}], ["Previous investigations have been based on examination of peripheral blood cells or, more rarely, lung macrophages obtained with invasive procedures, such as bronchoalveolar lavages.", {"entities": []}], ["Here we show that differences exist in the expression of a surface protein (Toll-like receptor 2) between macrophages recovered from the sputum of individuals in different diagnostic groups: i.e., infection free, latent tuberculosis infection, and active pulmonary tuberculosis.", {"entities": [[220, 232, "DISEASE"], [265, 277, "DISEASE"], [255, 277, "DISEASE"]]}], ["Thus, phenotypic analysis of local macrophages obtained with noninvasive procedures can help distinguish among tuberculosis infection stages.", {"entities": [[111, 123, "DISEASE"]]}], ["During tuberculosis, macrophages are critical for both pathogen survival and host immune activation.", {"entities": [[7, 19, "DISEASE"]]}], ["Since expression of particular cell surface markers reflects cell function, we used flow cytometry to measure the abundance of surface markers associated with polarity, lipid uptake, or pattern recognition on macrophages found in induced sputum.", {"entities": []}], ["Nine macrophage surface markers were examined from three groups of donors: infection-free, latent tuberculosis infection, and active pulmonary tuberculosis.", {"entities": [[98, 110, "DISEASE"], [143, 155, "DISEASE"], [133, 155, "DISEASE"]]}], ["Using a trend test, we found that expression of Toll-like receptor 2 was greater from absence of infection to latent infection and from latent infection to active tuberculosis.", {"entities": [[163, 175, "DISEASE"]]}], ["The results point to the possibility that innate immune cell phenotypes be used to distinguish among tuberculosis infection stages.", {"entities": [[101, 113, "DISEASE"]]}], ["Moreover, this study shows that readily accessible sputum macrophages have potential for tuberculosis diagnosis and prognosis.", {"entities": [[89, 101, "DISEASE"]]}], ["IMPORTANCE Mycobacterium tuberculosis is an intracellular pathogen that parasitizes the host macrophage.", {"entities": [[25, 37, "DISEASE"]]}], ["While approximately two billion people are infected worldwide, only 5 to 10% become diseased with pulmonary tuberculosis, at least in the absence of comorbidities.", {"entities": [[108, 120, "DISEASE"], [98, 120, "DISEASE"]]}], ["Tuberculosis control requires development of noninvasive methods probing the host immune status to help distinguish latent infection from active tuberculosis.", {"entities": [[0, 12, "DISEASE"], [145, 157, "DISEASE"]]}], ["With such methods, high-risk individuals could be targeted for treatment before disease manifestation.", {"entities": []}], ["Previous investigations have been based on examination of peripheral blood cells or, more rarely, lung macrophages obtained with invasive procedures, such as bronchoalveolar lavages.", {"entities": []}], ["Here we show that differences exist in the expression of a surface protein (Toll-like receptor 2) between macrophages recovered from the sputum of individuals in different diagnostic groups: i.e., infection free, latent tuberculosis infection, and active pulmonary tuberculosis.", {"entities": [[220, 232, "DISEASE"], [265, 277, "DISEASE"], [255, 277, "DISEASE"]]}], ["Thus, phenotypic analysis of local macrophages obtained with noninvasive procedures can help distinguish among tuberculosis infection stages.", {"entities": [[111, 123, "DISEASE"]]}], ["Oxidative stress occurs when free radicals and other reactive species overwhelm the availability of antioxidants.", {"entities": []}], ["Reactive oxygen species (ROS), reactive nitrogen species, and their counterpart antioxidant agents are essential for physiological signaling and host defense, as well as for the evolution and persistence of inflammation.", {"entities": []}], ["When their normal steady state is disturbed, imbalances between oxidants and antioxidants may provoke pathological reactions causing a range of nonrespiratory and respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).", {"entities": [[198, 235, "DISEASE"]]}], ["In the respiratory system, ROS may be either exogenous from more or less inhalative gaseous or particulate agents such as air pollutants, cigarette smoke, ambient high-altitude hypoxia, and some occupational dusts, or endogenously generated in the context of defense mechanisms against such infectious pathogens as bacteria, viruses, or fungi.", {"entities": []}], ["ROS may also damage body tissues depending on the amount and duration of exposure and may further act as triggers for enzymatically generated ROS released from respiratory, immune, and inflammatory cells.", {"entities": []}], ["This paper focuses on the general relevance of free radicals for the development and progression of both COPD and pulmonary emphysema as well as novel perspectives on therapeutic options.", {"entities": [[114, 133, "DISEASE"]]}], ["Unfortunately, current treatment options do not suffice to prevent chronic airway inflammation and are not yet able to substantially alter the course of COPD.", {"entities": []}], ["Effective therapeutic antioxidant measures are urgently needed to control and mitigate local as well as systemic oxygen bursts in COPD and other respiratory diseases.", {"entities": []}], ["In addition to current therapeutic prospects and aspects of genomic medicine, trending research topics in COPD are presented.", {"entities": []}], ["Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma frequently coexist and are always present in patients with aspirin exacerbated respiratory disease (AERD).", {"entities": [[54, 60, "DISEASE"]]}], ["Although the pathogenic mechanisms of this condition are still unknown, AERD may be due, at least in part, to an imbalance in eicosanoid metabolism (increased production of cysteinyl leukotrienes (CysLTs) and reduced biosynthesis of prostaglandin (PG) E 2 ), possibly increasing and perpetuating the process of inflammation.", {"entities": []}], ["PGE 2 results from the metabolism of arachidonic acid (AA) by cyclooxygenase (COX) enzymes, and seems to play a central role in homeostasis maintenance and inflammatory response modulation in airways.", {"entities": []}], ["Therefore, the abnormal regulation of PGE 2 could contribute to the exacerbated processes observed in AERD.", {"entities": []}], ["PGE 2 exerts its actions through four G-protein-coupled receptors designated E-prostanoid (EP) receptors EP1, EP2, EP3, and EP4.", {"entities": []}], ["Altered PGE 2 production as well as differential EP receptor expression has been reported in both upper and lower airways of patients with AERD.", {"entities": []}], ["Since the heterogeneity of these receptors is the key for the multiple biological effects of PGE 2 this review focuses on the studies available to elucidate the importance of these receptors in inflammatory airway diseases.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-014-0100-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although laboratory stressor tests have been applied as a preliminary protocol in some cardiovascular studies, there is a lack of data comparing the pressor and chronotropic responses among the main stressor tests.", {"entities": []}], ["Therefore, the aim of this study was to evaluate the variability in hemodynamic responsiveness to the main stressor tests, establish a hyperresponsiveness cutoff criterion and analyze the influence of gender and family history of cardiovascular diseases (CVDs) in healthy subjects.", {"entities": []}], ["We examined hemodynamic responses to physical (cold pressor and handgrip tests) and mental (Stroop color-word test) stressors in 98 subjects (48 males and 50 females) without CVDs.", {"entities": []}], ["All stressor tests resulted in increased blood pressure (BP) levels, which were lower and less dispersed in the handgrip test compared to the cold pressor test.", {"entities": []}], ["Adopting the 75", {"entities": []}], ["Interventions targeting multiple risk factors for cardiovascular disease (CVD), including poor diet and physical inactivity, are more effective than interventions targeting a single risk factor.", {"entities": []}], ["A motivational interviewing (MI) intervention can provide modest dietary improvements and physical activity increases, while adding cognitive behaviour therapy (CBT) skills may enhance the effects of MI.", {"entities": []}], ["We designed a randomised controlled trial (RCT) to examine whether specific behaviour change techniques integrating MI and CBT result in favourable changes in weight and physical activity in those at high risk of CVD.", {"entities": []}], ["A group and individual intervention will be compared to usual care.", {"entities": []}], ["A group intervention offers potential benefits from social support and may be more cost effective.", {"entities": []}], ["Individuals aged between 40 and 74 years in 11 South London Clinical Commissioning Groups who are at high risk of developing CVD (\u226520%) in the next 10 years will be recruited.", {"entities": []}], ["A sample of 1,704 participants will be randomised to receive the enhanced MI intervention, delivered by trained healthy lifestyle facilitators (HLFs), in group or individual formats, in 10 sessions (plus an introductory session) over one year, or usual care.", {"entities": []}], ["Randomisation will be conducted by King\u2019s College London Clinical Trials Unit and researchers collecting outcome data will be blinded to treatment allocation.", {"entities": []}], ["At 12-month and 24-month follow-up assessments, primary outcomes will be change in weight and physical activity (average steps per day).", {"entities": []}], ["Secondary outcomes include changes in low-density lipoprotein cholesterol and CVD risk score.", {"entities": []}], ["Incidence of CVD events since baseline will be recorded.", {"entities": []}], ["A process evaluation will be conducted to evaluate factors which impact on delivery, adherence and outcome.", {"entities": []}], ["An economic evaluation will estimate relative cost-effectiveness of each type of intervention delivery.", {"entities": []}], ["This RCT assesses the effectiveness of a healthy lifestyle intervention for people at high risk of CVD.", {"entities": []}], ["Benefits of the study include the ethnic and socioeconomic diversity of the study population and that, via social support within the group setting and long-term follow-up period, the intervention offers the potential to support maintenance of a healthy lifestyle.", {"entities": []}], ["This trial is registered with the ISRCTN registry (identifier: ISRCTN84864870, registered 15 May 2012).", {"entities": []}], ["Airway remodeling is a pathophysiologic process at the clinical, cellular, and molecular level relating to chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD), asthma and mustard lung.", {"entities": [[151, 188, "DISEASE"], [197, 203, "DISEASE"]]}], ["These diseases are associated with the dysregulation of multiple molecular pathways in the airway cells.", {"entities": []}], ["Little progress has so far been made in discovering the molecular causes of complex disease in a holistic systems manner.", {"entities": []}], ["Therefore, pathway and network reconstruction is an essential part of a systems biology approach to solve this challenging problem.", {"entities": []}], ["In this paper, multiple data sources were used to construct the molecular process of airway remodeling pathway in mustard lung as a model of airway disease.", {"entities": []}], ["We first compiled a master list of genes that change with airway remodeling in the mustard lung disease and then reconstructed the pathway by generating and merging the protein-protein interaction and the gene regulatory networks.", {"entities": [[91, 103, "DISEASE"]]}], ["Experimental observations and literature mining were used to identify and validate the master list.", {"entities": []}], ["The outcome of this paper can provide valuable information about closely related chronic obstructive airway diseases which are of great importance for biologists and their future research.", {"entities": []}], ["Reconstructing the airway remodeling interactome provides a starting point and reference for the future experimental study of mustard lung, and further analysis and development of these maps will be critical to understanding airway diseases in patients.", {"entities": []}], ["Type 1 diabetes incidence presents a decreasing gradient in Europe from the Nordic countries to the Mediterranean ones.", {"entities": []}], ["Exception to this gradient is represented by Sardinia, the second largest Mediterranean island whose population shows the highest incidence in Europe, after Finland.", {"entities": []}], ["The genetic features of this population have created a fertile ground for the epidemic of the disease, however, as well as being strikingly high, the incidence rate has suddenly presented a continuous increase from the \u201850s, not explainable by accumulation of new genetic variants.", {"entities": []}], ["Several environmental factors have been taken into account, possibly interacting with the genetic/epigenetic scenario, but there are no strong evidences to date.", {"entities": []}], ["The present study investigated the hypothesis that geochemical elements could create permissive environmental conditions for autoimmune diabetes.", {"entities": []}], ["An ecological analysis was performed to test possible correlations between the values of eight elements in stream sediments and type 1 diabetes incidence rate in Sardinia.", {"entities": []}], ["Analyses revealed negative associations between elements, such as Co, Cr, Cu, Mn, Ni, Zn, and type 1 diabetes incidence.", {"entities": []}], ["The results suggest a possible protective role of some elements against the onset of the disease.", {"entities": []}], ["To assess the safety and efficacy of omarigliptin in J apanese patients with type 2 diabetes ( T2D ).", {"entities": []}], ["In a 24\u2010week double\u2010blind trial, 414 patients with T2D were randomized to omarigliptin 25\u2009mg once weekly, sitagliptin 50\u2009mg once daily or placebo.", {"entities": []}], ["The double\u2010blind period was followed by a 28\u2010week open\u2010label extension during which all patients received omarigliptin 25\u2009mg once weekly.", {"entities": []}], ["Efficacy endpoints were glycated haemoglobin ( HbA1c ), 2\u2010hour postprandial glucose ( PPG ) and fasting plasma glucose ( FPG ) levels.", {"entities": []}], ["After 24\u2009weeks, the least squares ( LS ) mean change from baseline in HbA1c was \u22120.66% for omarigliptin, \u22120.65% for sitagliptin and 0.13% for placebo.", {"entities": []}], ["The difference in LS mean for omarigliptin vs placebo was \u22120.80% ( P \u2009<\u2009.001).", {"entities": []}], ["The difference in LS mean for omarigliptin vs sitagliptin was \u22120.02% (95% confidence interval \u22120.15, 0.12), which met the criterion for non\u2010inferiority to sitagliptin.", {"entities": []}], ["Both active treatments provided significant reductions in FPG and 2\u2010hour PPG compared with placebo ( P \u2009<\u2009.001).", {"entities": []}], ["Over the 24\u2010week double\u2010blind period, there were no clinically meaningful differences in the incidence rates of adverse events among the treatment groups.", {"entities": []}], ["There was 1 episode of symptomatic hypoglycaemia in the sitagliptin group and none in the omarigliptin or placebo groups.", {"entities": []}], ["In the 28\u2010week open\u2010label period, omarigliptin provided persistent improvements in glycaemic control without notable change in safety profile compared with the double\u2010blind period.", {"entities": []}], ["Omarigliptin had no meaningful effect on body weight.", {"entities": []}], ["In J apanese patients with T2D , omarigliptin 25\u2009mg once weekly provided significant glucose\u2010lowering compared with placebo and was non\u2010inferior to sitagliptin 50\u2009mg once daily.", {"entities": []}], ["Omarigliptin was generally well tolerated for up to 52\u2009weeks.", {"entities": []}], ["Acute exacerbations of chronic bronchitis (AECB), including chronic obstructive pulmonary disease (AECOPD), represent a substantial patient burden.", {"entities": [[60, 97, "DISEASE"], [31, 41, "DISEASE"]]}], ["Few data exist on outpatient antibiotic management for AECB/AECOPD in Eastern/South Eastern Europe, in particular on the use of moxifloxacin (Avelox\u00ae), although moxifloxacin is widely approved in this region based on evidence from international clinical studies.", {"entities": []}], ["AVANTI (AVelox\u00ae in Acute Exacerbations of chroNic bronchiTIs) was a prospective, observational study conducted in eight Eastern European countries in patients\u2009>\u200935 years with AECB/AECOPD to whom moxifloxacin was prescribed.", {"entities": [[50, 60, "DISEASE"]]}], ["In addition to safety and efficacy outcomes, data on risk factors and the impact of exacerbation on daily life were collected.", {"entities": []}], ["In the efficacy population (N\u2009=\u20092536), chronic bronchitis had been prevalent for\u2009>\u200910 years in 31.4% of patients and 66.0% of patients had concomitant COPD.", {"entities": [[47, 57, "DISEASE"]]}], ["Almost half the patients had never smoked, in contrast to data from Western Europe and the USA, where only one-quarter of COPD patients are non-smokers.", {"entities": []}], ["The mean number of exacerbations in the last 12 months was 2.7 and 26.3% of patients had been hospitalized at least once for exacerbation.", {"entities": []}], ["Physician compliance with the recommended moxifloxacin dose (400 mg once daily) was 99.6%.", {"entities": []}], ["The mean duration of moxifloxacin therapy for the current exacerbation (Anthonisen type I or II in 83.1%; predominantly type I) was 6.4\u2009\u00b1\u20091.9 days.", {"entities": []}], ["Symptom improvement was reported after a mean of 3.4\u2009\u00b1\u20091.4 days.", {"entities": []}], ["After 5 days, 93.2% of patients reported improvement and, in total, 93.5% of patients were symptom-free after 10 days.", {"entities": []}], ["In the safety population (N\u2009=\u20092672), 57 (2.3%) patients had treatment-emergent adverse events (TEAEs) and 4 (0.15%) had serious TEAEs; no deaths occurred.", {"entities": []}], ["These results are in line with the known safety profile of moxifloxacin.", {"entities": []}], ["A significant number of patients in this observational study had risk factors for poor outcome, justifying use of moxifloxacin.", {"entities": []}], ["The safety profile of moxifloxacin and its value as an antibiotic treatment were confirmed.", {"entities": []}], ["Physicians complied with the recommended 400 mg once-daily dose in a large proportion of patients, confirming the advantages of this simple dosing regimen.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT00846911", {"entities": []}], ["Kanglaite\u00ae injection (KLT), with a main ingredient of Coix seed oil (a traditional Chinese medicine), has been widely used for cancer treatment in China.", {"entities": [[127, 133, "DISEASE"]]}], ["KLT has an inhibitory effect on many kinds of tumors and PI3K/Akt/mTOR signaling promotes cell survival, proliferation, and progression in cancer cells.", {"entities": [[139, 145, "DISEASE"]]}], ["Therefore, targeting this pathway may lead to the development of novel therapeutic approaches for human cancers.", {"entities": []}], ["Here, we examined the effects of KLT on the PI3K/Akt/mTOR pathway in pancreatic cancer xenografts in mice, and assessed its therapeutic potential.", {"entities": [[69, 86, "DISEASE"], [80, 86, "DISEASE"]]}], ["Growth and apoptosis of tumor xenografts were examined, and the expression levels of genes and proteins involved in the PI3K/Akt/mTOR pathway were measured by RT-PCR and western blotting, respectively.", {"entities": []}], ["Our results revealed that KLT dramatically inhibited the growth of pancreatic cancer xenografts and induced apoptosis simultaneously.", {"entities": [[67, 84, "DISEASE"], [78, 84, "DISEASE"]]}], ["Furthermore, it downregulated the expression of phospho-Akt and phospho-mTOR.", {"entities": []}], ["These results suggest that KLT can suppress growth and induce apoptosis of pancreatic cancer xenografts.", {"entities": [[75, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["Moreover, KLT can downregulate the expression of phospho-Akt and phospho-mTOR to modulate the PI3K/Akt/mTOR signaling pathway.", {"entities": []}], ["Globally, house dust mites (HDM) are one of the main sources of allergens causing Type I allergy, which has a high risk of progressing into a severe disabling disease manifestation such as allergic asthma.", {"entities": [[189, 204, "DISEASE"], [198, 204, "DISEASE"]]}], ["The strong protease activities of a number of these allergens are thought to be involved in several steps of the pathophysiology of this allergic disease.", {"entities": []}], ["It has been a common notion that protease activity may be one of the properties that confers allergenicity to proteins.", {"entities": []}], ["In this review we summarize and discuss the roles of the different HDM proteases in the development of Type I allergy.", {"entities": []}], ["The prevalence of nontuberculous mycobacterial (NTM) disease is rising.", {"entities": [[48, 51, "GENE"]]}], ["An understanding of known risk factors for disease sheds light on the immunological and physical barriers to infection, and how and why they may be overcome.", {"entities": []}], ["This review focuses on human NTM infection, supported by experimental and in vitro data of relevance to the practising clinician who seeks to understand why their patient has NTM infection and how to further investigate.", {"entities": [[29, 32, "GENE"], [175, 178, "GENE"], [29, 32, "GENE"], [175, 178, "GENE"]]}], ["First, the underlying immune response to NTM disease is examined.", {"entities": [[41, 44, "GENE"]]}], ["Important insights regarding NTM disease susceptibility come from nature's own knockouts, the primary immune deficiency disorders.", {"entities": [[29, 32, "GENE"]]}], ["We summarise the current knowledge surrounding interferon-gamma (IFN\u03b3)-interleukin-12 (IL-12) axis abnormalities, followed by a review of phagocytic defects, T cell lymphopenia and rarer genetic conditions known to predispose to NTM disease.", {"entities": [[165, 176, "DISEASE"], [229, 232, "GENE"]]}], ["We discuss how these define key immune pathways involved in the host response to NTM.", {"entities": [[81, 84, "GENE"]]}], ["Iatrogenic immunosuppression is also important, and we evaluate the impact of novel biological therapies, as well as bone marrow transplant and chemotherapy for solid organ malignancy, on the epidemiology and presentation of NTM disease, and discuss the host defence dynamics thus revealed.", {"entities": [[225, 228, "GENE"]]}], ["NTM infection and disease in the context of other chronic illnesses including HIV and malnutrition is reviewed.", {"entities": [[0, 3, "GENE"]]}], ["The role of physical barriers to infection is explored.", {"entities": []}], ["We describe how their compromise through different mechanisms including cystic fibrosis, bronchiectasis and smoking-related lung disease can result in pulmonary NTM colonisation or infection.", {"entities": [[89, 103, "DISEASE"], [72, 87, "DISEASE"], [124, 136, "DISEASE"], [161, 164, "GENE"]]}], ["We also summarise further associations with host factors including body habitus and age.", {"entities": []}], ["We use the presented data to develop an over-arching model that describes human host defences against NTM infection, where they may fail, and how this framework can be applied to investigation in routine clinical practice.", {"entities": [[102, 105, "GENE"]]}], ["In those with symptoms indicative of obstructive sleep apnea (OSA), respiratory-specific health-related quality of life (HRQL) may be an important patient-centered outcome.", {"entities": []}], ["The aim of this study was to assess the associations between sleepiness, fatigue, and impaired general and respiratory-specific HRQL among persons with suspected OSA.", {"entities": []}], ["We evaluated military veterans consecutively referred for suspected OSA with sleep studies yielding apnea-hypopnea index (AHI) values.", {"entities": []}], ["They also completed the sleepiness (Epworth Sleepiness Scale [ESS]), and fatigue (Fatigue Severity Scale [FSS]) questionnaires, as well as two HRQL instruments (the generic Short-Form SF-12v2 yielding the Physical Component Scale [PCS] and the respiratory-specific Airways Questionnaire [AQ]-20R).", {"entities": []}], ["Multiple linear regression tested the associations between ESS and FSS (standardized as Z scores for scaling comparability) with AQ-20R, accounting for AHI, SF-12v2-PCS and comorbid respiratory conditions other than OSA.", {"entities": []}], ["We studied 1578 veterans (median age 61.1 [IQR 16.8] years; 93.9% males).", {"entities": []}], ["Of these, 823 (52%) met AHI criteria for moderate to severe OSA (AHI \u226515/h).", {"entities": []}], ["The majority reported excessive daytime sleepiness (53%; median ESS 11 [IQR 9]) or fatigue (61%; median FSS 42 [IQR 23]).", {"entities": []}], ["The median AQ-20R was 4 [IQR 1\u20138].", {"entities": []}], ["Controlling for AHI, SF-12v2-PCS, respiratory co-morbid conditions, body mass index, and demographics, both ESS and FSS were significantly associated with poorer AQ-20R: for each; ESS, 1.6 points (95% CI 1.4\u20131.9), and for FSS, 2.5 points (95% CI, 2.3\u20132.7).", {"entities": []}], ["Greater daytime sleepiness and fatigue are associated with poorer respiratory-specific HRQL, over and above the effects of OSA, respiratory comorbidity, and generic physical HRQL.", {"entities": []}], ["Background .", {"entities": []}], ["A magnitude 7.1 earthquake hit Canterbury in September 2010.", {"entities": []}], ["This earthquake and associated aftershocks took the lives of 185 people and drastically changed residents' living, working, and social conditions.", {"entities": []}], ["To explore the impact of the earthquakes on smoking status and levels of tobacco consumption in the residents of Christchurch.", {"entities": []}], ["Semistructured interviews were carried out in two city malls and the central bus exchange 15 months after the first earthquake.", {"entities": []}], ["A total of 1001 people were interviewed.", {"entities": []}], ["In August 2010, prior to any earthquake, 409 (41%) participants had never smoked, 273 (27%) were currently smoking, and 316 (32%) were ex-smokers.", {"entities": []}], ["Since the September 2010 earthquake, 76 (24%) of the 316 ex-smokers had smoked at least one cigarette and 29 (38.2%) had smoked more than 100 cigarettes.", {"entities": []}], ["Of the 273 participants who were current smokers in August 2010, 93 (34.1%) had increased consumption following the earthquake, 94 (34.4%) had not changed, and 86 (31.5%) had decreased their consumption.", {"entities": []}], ["53 (57%) of the 93 people whose consumption increased reported that the earthquake and subsequent lifestyle changes as a reason to increase smoking.", {"entities": []}], ["Conclusion .", {"entities": []}], ["24% of ex-smokers resumed smoking following the earthquake, resulting in increased smoking prevalence.", {"entities": []}], ["Tobacco consumption levels increased in around one-third of current smokers.", {"entities": []}], ["We report data from the first Utstein-style study of physician-provided pre-hospital advanced airway management.", {"entities": []}], ["Anaesthesiologists from eight pre-hospital critical care teams in the Central Denmark Region (a mixed rural and urban region with 1.27 million inhabitants) prospectively registered data according to the template for reporting data from pre-hospital advanced airway management.", {"entities": []}], ["Data collection took place from February 1 The overall incidence of successful pre-hospital endotracheal intubation among 636 intubation attempts was 99.7%, even though 22.4% of pre-hospital endotracheal intubations required more than one intubation attempt.", {"entities": []}], ["The overall incidence of complications related to pre-hospital advanced airway management was 7.9%.", {"entities": []}], ["Following rapid sequence intubation, the incidence of first pass success was 85.8%, the overall incidence of complications was 22.0%, the incidence of hypotension 7.3% and that of hypoxia 5.3%.", {"entities": []}], ["Multiple endotracheal intubation attempts were associated with an increased overall incidence of complications.", {"entities": []}], ["No airway management related deaths occurred.", {"entities": []}], ["The overall incidence of successful pre-hospital endotracheal intubations compares to those found in other physician-staffed pre-hospital systems.", {"entities": []}], ["The incidence of pre-hospital endotracheal intubations requiring more than one attempt is higher than suspected.", {"entities": []}], ["The incidence of hypotension or hypoxia after pre-hospital rapid sequence intubation compares to those found in UK emergency departments.", {"entities": []}], ["Pre-hospital advanced airway management including pre-hospital endotracheal intubation performed by experienced anaesthesiologists is associated with high success rates and relatively low incidences of complications.", {"entities": []}], ["An increased first pass success rate following pre-hospital endotracheal intubation may further reduce the incidence of complications and enhance patient safety in our system.", {"entities": []}], ["Current guidelines for the management of chronic obstructive pulmonary disease (COPD) recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe disease and/or increased exacerbation risk.", {"entities": [[41, 78, "DISEASE"]]}], ["However, there are discrepancies between guidelines and real-life practice, as ICS are being overprescribed.", {"entities": []}], ["In light of the increasing concerns about the clinical benefit and long-term risks associated with ICS use, therapy needs to be carefully weighed on a case-by-case basis, including in patients already on ICS.", {"entities": []}], ["Several studies sought out to determine the effects of withdrawing ICS in patients with COPD.", {"entities": []}], ["Early studies have deterred clinicians from reducing ICS in patients with COPD as they reported that an abrupt withdrawal of ICS precipitates exacerbations, and results in a deterioration in lung function and symptoms.", {"entities": []}], ["However, these studies were fraught with numerous methodological limitations.", {"entities": []}], ["Recently, two randomized controlled trials and a real-life prospective study revealed that ICS can be safely withdrawn in certain patients.", {"entities": []}], ["Of these, the WISDOM (Withdrawal of Inhaled Steroids During Optimized Bronchodilator Management) trial was the largest and first to examine stepwise withdrawal of ICS in patients with COPD receiving maintenance therapy of long-acting bronchodilators (ie, tiotropium and salmeterol).", {"entities": []}], ["Even with therapy being in line with the current guidelines, the findings of the WISDOM trial indicate that not all patients benefit from including ICS in their treatment regimen.", {"entities": []}], ["Indeed, only certain COPD phenotypes seem to benefit from ICS therapy, and validated markers that predict ICS response are urgently warranted in clinical practice.", {"entities": []}], ["Furthermore, we are now better equipped with a larger armamentarium of novel and more effective long-acting \u03b2 2 -agonist/long-acting muscarinic antagonist combinations that can be considered by clinicians to optimize bronchodilation and allow for safer ICS withdrawal.", {"entities": []}], ["In addition to providing a review of the aforementioned, this perspective article proposes an algorithm for the stepwise withdrawal of ICS in real-life clinical practice.", {"entities": []}], ["Bisphenol S (BPS) is an industrial alternative to the endocrine disruptor bisphenol A (BPA), and can be found in many products labeled \u201cBPA-free\u201d.", {"entities": []}], ["Its use has grown in recent years, and presently it is considered a ubiquitous emerging pollutant.", {"entities": []}], ["To date there is a lack of information on the effects of BPS on invertebrates, although they represent more than 95% of known species in the animal kingdom and are crucial for the structure and proper function of ecosystems.", {"entities": []}], ["In this study, real-time RT-PCR was used to determine the early detrimental effects of BPS on the transcriptional rate of genes in the model species Chironomus riparius , specifically those related to the ecdysone pathway ( EcR , ERR , E74 , Vtg , cyp18a1 ) crucial for insect development and metamorphosis, stress and biotransformation mechanisms ( hsp70 , hsp40 , cyp4g , GPx , GSTd3 ) that regulate adaptive responses and determine survival, and ribosome biogenesis ( its2 , rpL4 , rpL13 ) which is essential for protein synthesis and homeostasis.", {"entities": [[478, 482, "GENE"], [485, 490, "GENE"]]}], ["While 24-hour exposure to 0.5, 5, 50, and 500 \u03bcg/L BPS had no effect on larval survival, almost all the studied genes were upregulated following a non-monotonic dose-response curve.", {"entities": []}], ["Genes with the greatest increases in transcriptional activity (fold change relative to control) were EcR (3.8), ERR (2), E74 (2.4), cyp18a1 (2.5), hsp70 (1.7), hsp40 (2.5), cyp4g (6.4), GPx (1.8), and GST (2.1), while others including Vtg , GAPDH , and selected ribosomal genes remained stable.", {"entities": [[241, 246, "GENE"]]}], ["We also measured the transcriptional activity of these genes 24 hours after BPS withdrawal and a general downregulation compared to controls was observed, though not significant in most cases.", {"entities": []}], ["Our findings showed that BPS exposure altered the transcriptional profile of these genes, which may have consequences for the hormone system and several metabolic pathways.", {"entities": []}], ["Although further research is needed to elucidate its mode of action, these results raise new concerns about the safety of BPA alternatives.", {"entities": []}], ["To estimate trends in leisure time physical activity and physical fitness between 1987-2006 in older Spanish people.", {"entities": []}], ["We analyzed data collected from the Spanish National Health Surveys conducted in 1987 (n = 29,647), 1993 (n = 20,707), 1995-1997 (n = 12,800), 2001 (n = 21,058), 2003 (n = 21,650), and 2006 (n = 29,478).", {"entities": []}], ["The number of subjects aged \u2265 65 years included in the current study was 29,263 (1987: n = 4,958-16.7%; 1993: n = 3,751-17.8%; 1995-97: n = 2,229-17.4%; 2001: n = 4,356-20.7%; 2003: 6,134-28.3%; 2006: 7,835-26.5%).", {"entities": []}], ["Main variables included leisure-time physical activity and physical fitness.", {"entities": []}], ["We analyzed socio-demographic characteristics, self-rated health status, lifestyle habit and co-morbid conditions using multivariate logistic regression models.", {"entities": []}], ["Women exhibited lower prevalence of leisure time physical activity and physical fitness compared to men (P < 0.05).", {"entities": []}], ["The multivariate analysis for time trends found that practising leisure time physical activity increased from 1987 to 2006 (P < 0.001).", {"entities": []}], ["Variables associated with a lower likelihood of practicing leisure time physical activity were: age \u2265 80 years old, \u2265 2 co-morbid chronic conditions, and obesity.", {"entities": [[154, 161, "DISEASE"]]}], ["Variables associated with lower physical fitness included: age \u2265 80 years, worse self rated health; \u2265 2 medications (only for walking), and obesity.", {"entities": [[140, 147, "DISEASE"]]}], ["We found an increase in leisure time physical activity in the older Spanish population.", {"entities": []}], ["Older age, married status, co-morbid conditions, obesity, and worse self-perceived health status were associated with lower activity.", {"entities": [[49, 56, "DISEASE"]]}], ["Identification of these factors can help to identify individuals at risk for physical inactivity.", {"entities": []}], ["Vagus nerve stimulation ( VNS ) is effective in refractory epilepsy and depression and is being investigated in heart failure, headache, gastric motility disorders and asthma.", {"entities": [[168, 174, "DISEASE"]]}], ["The first VNS device required surgical implantation of electrodes and a stimulator.", {"entities": []}], ["Adverse events ( AE s) are generally associated with implantation or continuous on\u2212off stimulation.", {"entities": []}], ["Infection is the most serious implantation\u2010associated AE .", {"entities": []}], ["Bradycardia and asystole have also been described during implantation, as has vocal cord paresis, which can last up to 6\u00a0months and depends on surgical skill and experience.", {"entities": []}], ["The most frequent stimulation\u2010associated AE s include voice alteration, paresthesia, cough, headache, dyspnea, pharyngitis and pain, which may require a decrease in stimulation strength or intermittent or permanent device deactivation.", {"entities": [[111, 122, "DISEASE"]]}], ["Newer non\u2010invasive VNS delivery systems do not require surgery and permit patient\u2010administered stimulation on demand.", {"entities": []}], ["These non\u2010invasive VNS systems improve the safety and tolerability of VNS , making it more accessible and facilitating further investigations across a wider range of uses.", {"entities": []}], ["Low testosterone level may be a reversible risk factor for functional disability and deterioration in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[116, 153, "DISEASE"]]}], ["We sought to systematically assess the endogenous testosterone levels and effect of testosterone therapy on exercise capacity and health-related quality of life (HRQoL) outcomes in COPD patients, as well as to inform guidelines and practice.", {"entities": []}], ["Systematic review and meta-analysis.", {"entities": []}], ["We searched PubMed, Scopus, Cochrane Library, CINAHL, Health Source Nursing and PsychINFO and the reference lists of retrieved articles published before May 2012.", {"entities": []}], ["Observational studies on endogenous testosterone levels in people with chronic lung disease compared with controls, or randomised controlled trials (RCTs) on testosterone therapy for exercise capacity and/or HRQoL outcomes in COPD patients were eligible.", {"entities": [[79, 91, "DISEASE"]]}], ["Data on the mean difference in endogenous total testosterone (TT) values, and the mean difference in exercise capacity and HRQoL values were extracted and pooled using random effects meta-analysis.", {"entities": []}], ["Nine observational studies in 2918 men with COPD reported consistently lower levels of TT compared with controls (weighted mean difference was \u20133.21\u2005nmol/L (95% CI \u22125.18\u00a0to \u22121.23)).", {"entities": []}], ["Six RCTs in 287 participants yielded five studies on peak muscle strength and peak cardiorespiratory fitness outcomes (peak oxygen uptake (VO 2 ) and workload) and three studies on HRQoL outcomes.", {"entities": []}], ["Testosterone therapies significantly improved peak muscle strength (standardised mean difference (SMD) was 0.31 (95% CI 0.05 to 0.56)) and peak workload (SMD was 0.27 (95% CI 0.01 to 0.52)) compared with control conditions (all but one used placebo), but not peak VO 2 (SMD was 0.21 (95% CI \u22120.15 to 0.56)) or HRQoL (SMD was \u20130.03 (95% CI \u22120.32 to 0.25)).", {"entities": []}], ["Men with COPD have clinically relevant lower than normal TT levels.", {"entities": []}], ["Insufficient evidence from short-term studies in predominately male COPD patients suggests that testosterone therapy improves exercise capacity outcomes, namely peak muscle strength and peak workload.", {"entities": []}], ["The dominant paradigm in understanding drug action focuses on the intended therapeutic effects and frequent adverse reactions.", {"entities": []}], ["However, this approach may limit opportunities to grasp unintended drug actions, which can open up channels to repurpose existing drugs and identify rare adverse drug reactions.", {"entities": []}], ["Advances in systems biology can be exploited to comprehensively understand pharmacodynamic actions, although proper frameworks to represent drug actions are still lacking.", {"entities": []}], ["We suggest a novel platform to construct a drug-specific pathway in which a molecular-level mechanism of action is formulated based on pharmacologic, pharmacogenomic, transcriptomic, and phenotypic data related to drug response ( http://databio.gachon.ac.kr/tools/ ).", {"entities": []}], ["In this platform, an adoption of three conceptual levels imitating drug perturbation allows these pathways to be realistically rendered in comparison to those of other models.", {"entities": []}], ["Furthermore, we propose a new method that exploits functional features of the drug-specific pathways to predict new indications as well as adverse reactions.", {"entities": []}], ["For therapeutic uses, our predictions significantly overlapped with clinical trials and an up-to-date drug-disease association database.", {"entities": []}], ["Also, our method outperforms existing methods with regard to classification of active compounds for cancers.", {"entities": []}], ["For adverse reactions, our predictions were significantly enriched in an independent database derived from the Food and Drug Administration (FDA) Adverse Event Reporting System and meaningfully cover an Adverse Reaction Database provided by Health Canada.", {"entities": []}], ["Lastly, we discuss several predictions for both therapeutic indications and side-effects through the published literature.", {"entities": []}], ["Our study addresses how we can computationally represent drug-signaling pathways to understand unintended drug actions and to facilitate drug discovery and screening.", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-017-1558-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Heart failure patients with implantable defibrillators place a significant burden on health care systems.", {"entities": []}], ["Remote monitoring allows assessment of device function and heart failure parameters, and may represent a safe, effective, and cost-saving method compared to conventional in-office follow-up.", {"entities": []}], ["We hypothesized that remote device monitoring represents a cost-effective approach.", {"entities": []}], ["This paper summarizes the economic evaluation of the Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) study, a multicenter clinical trial aimed at measuring the benefits of remote monitoring for heart failure patients with implantable defibrillators.", {"entities": []}], ["Two hundred patients implanted with a wireless transmission\u2013enabled implantable defibrillator were randomized to receive either remote monitoring or the conventional method of in-person evaluations.", {"entities": []}], ["Patients were followed for 16 months with a protocol of scheduled in-office and remote follow-ups.", {"entities": []}], ["The economic evaluation of the intervention was conducted from the perspectives of the health care system and the patient.", {"entities": []}], ["A cost-utility analysis was performed to measure whether the intervention was cost-effective in terms of cost per quality-adjusted life year (QALY) gained.", {"entities": []}], ["Overall, remote monitoring did not show significant annual cost savings for the health care system (\u20ac1962.78 versus \u20ac2130.01; P =.80).", {"entities": []}], ["There was a significant reduction of the annual cost for the patients in the remote arm in comparison to the standard arm (\u20ac291.36 versus \u20ac381.34; P =.01).", {"entities": []}], ["Cost-utility analysis was performed for 180 patients for whom QALYs were available.", {"entities": []}], ["The patients in the remote arm gained 0.065 QALYs more than those in the standard arm over 16 months, with a cost savings of \u20ac888.10 per patient.", {"entities": []}], ["Results from the cost-utility analysis of the EVOLVO study show that remote monitoring is a cost-effective and dominant solution.", {"entities": []}], ["Remote management of heart failure patients with implantable defibrillators appears to be cost-effective compared to the conventional method of in-person evaluations.", {"entities": []}], ["ClinicalTrials.gov NCT00873899; http://clinicaltrials.gov/show/NCT00873899 (Archived by WebCite at http://www.webcitation.org/6H0BOA29f).", {"entities": []}], ["Networks are employed to represent many nonlinear complex systems in the real world.", {"entities": []}], ["The topological aspects and relationships between the structure and function of biological networks have been widely studied in the past few decades.", {"entities": []}], ["However dynamic and control features of complex networks have not been widely researched, in comparison to topological network features.", {"entities": []}], ["In this study, we explore the relationship between network controllability, topological parameters, and network medicine (metabolic drug targets).", {"entities": []}], ["Considering the assumption that targets of approved anticancer metabolic drugs are driver nodes (which control cancer metabolic networks), we have applied topological analysis to genome-scale metabolic models of 15 normal and corresponding cancer cell types.", {"entities": [[111, 117, "DISEASE"], [240, 246, "DISEASE"]]}], ["The results show that besides primary network parameters, more complex network metrics such as motifs and clusters may also be appropriate for controlling the systems providing the controllability relationship between topological parameters and drug targets.", {"entities": []}], ["Consequently, this study reveals the possibilities of following a set of driver nodes in network clusters instead of considering them individually according to their centralities.", {"entities": []}], ["This outcome suggests considering distributed control systems instead of nodal control for cancer metabolic networks, leading to a new strategy in the field of network medicine.", {"entities": [[91, 97, "DISEASE"]]}], ["There are several publications reported that obstructive sleep apnea (OSA) was associated with asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["However, large-scaled, population-based cohort study has been limited.", {"entities": []}], ["We aimed to examine the risk of OSA among adult patients with asthma in an Asian population.", {"entities": [[62, 68, "DISEASE"]]}], ["We conducted a retrospective cohort study using data from the National Health Insurance (NHI) of Taiwan.", {"entities": []}], ["The asthma cohort included 38,840 newly diagnosed patients between 2000 and 2010.", {"entities": [[4, 10, "DISEASE"]]}], ["The date of diagnosis was defined as the index date.", {"entities": []}], ["Each patient was randomly matched with four people without asthma according to gender, age, and the index year as the comparison cohort.", {"entities": [[59, 65, "DISEASE"]]}], ["The occurrence of OSA was followed up until the end of 2011.", {"entities": []}], ["The risk of OSA was estimated using the Cox proportional hazard model after adjusting for gender, age, and comorbidities.", {"entities": []}], ["The overall incidence of OSA was 2.51-fold greater in the asthma cohort than in the comparison cohort (12.1 versus 4.84 per 1000 person-years).", {"entities": [[58, 64, "DISEASE"]]}], ["Compared to non-asthma subjects, the adjusted hazard ratio (aHR) of OSA increased to 1.78 for asthma patients with one or less annual emergency room (ER) visit, and 23.8 for those who visited ER more than once per year.", {"entities": [[16, 22, "DISEASE"], [94, 100, "DISEASE"], [60, 63, "GENE"]]}], ["In addition, aHR in patients with inhaled steroid treatment compared to those without steroid treatment was 1.33 (95% CI = 1.01\u20131.76).", {"entities": [[13, 16, "GENE"]]}], ["Patients with asthma have a significantly higher risk of developing OSA than the general population.", {"entities": [[14, 20, "DISEASE"]]}], ["The results suggest that the risk of OSA is proportional to asthma control and patients with inhaled steroid treatment have a higher risk for OSA than those without steroid treatment.", {"entities": [[60, 66, "DISEASE"]]}], ["Adult cholesterol concentrations might be influenced by early-life factors, such as breastfeeding and birth weight, referred to as \u201cearly programming\u201d.", {"entities": []}], ["How such early factors exert their influence over the life course is still poorly understood.", {"entities": []}], ["Evidence from studies in children and adolescents is scarce and conflicting.", {"entities": []}], ["We investigated the influence of 6 different perinatal risk factors on childhood total and HDL cholesterol concentrations and total-to-HDL cholesterol ratio measured at 8 years of age, and additionally we studied the role of the child's current Body Mass Index (BMI).", {"entities": []}], ["Anthropometric measures and blood plasma samples were collected during a medical examination in 751 8-year-old children participating in the prospective Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study.", {"entities": []}], ["Linear and logistic regression were performed to estimate associations of total and HDL cholesterol concentrations with breastfeeding, birth weight, infant weight gain, maternal overweight before pregnancy, gestational diabetes and maternal smoking during pregnancy, taking into account the child's current BMI.", {"entities": [[207, 227, "DISEASE"]]}], ["Linear regressions showed an association between total-to-HDL cholesterol ratio and maternal pre-pregnancy overweight (\u03b2\u200a=\u200a0.15, Confidence Interval 95% (CI): 0.02, 0.28), rapid infant weight gain (\u03b2\u200a=\u200a0.13, 95%CI: 0.01, 0.26), and maternal smoking during pregnancy (\u03b2\u200a=\u200a0.14, 95%CI: 0.00, 0.29).", {"entities": []}], ["These associations were partly mediated by the child's BMI.", {"entities": []}], ["Total-to-HDL cholesterol ratio in 8-year-old children was positively associated with maternal pre-pregnancy overweight, maternal smoking during pregnancy and rapid infant weight gain.", {"entities": []}], ["Scientific and technological advances in our understanding of the nature and consequences of human genetic variation are now allowing genetic determinants of susceptibility to common multifactorial diseases to be defined, as well as our individual response to therapy.", {"entities": []}], ["I review how genome-wide association studies are robustly identifying new disease susceptibility loci, providing insights into disease pathogenesis and potential targets for drug therapy.", {"entities": []}], ["Some of the remarkable advances being made using current genetic approaches in Crohn's disease, coronary artery disease and atrial fibrillation are described, together with examples from malaria, HIV/AIDS, asthma, prostate cancer and venous thrombosis which illustrate important principles underpinning this field of research.", {"entities": [[187, 194, "DISEASE"], [206, 212, "DISEASE"], [223, 229, "DISEASE"], [214, 229, "DISEASE"]]}], ["The limitations of current approaches are also noted, highlighting how much of the genetic risk remains unexplained and resolving specific functional variants difficult.", {"entities": []}], ["There is a need to more clearly understand the significance of rare variants and structural genomic variation in common disease, as well as epigenetic mechanisms.", {"entities": []}], ["Specific examples from pharmacogenomics are described including warfarin dosage and prediction of abacavir hypersensitivity that illustrate how in some cases such knowledge is already impacting on clinical practice, while in others prospective evaluation of clinical utility and cost-effectiveness is required to define opportunities for personalized medicine.", {"entities": []}], ["There is also a need for a broader debate about the ethical implications of current advances in genetics for medicine and society.", {"entities": []}], ["To determine the appropriateness of medical imaging examinations involving radiation and to estimate the effective radiation dose and costs associated.", {"entities": []}], ["Cross-sectional retrospective study.", {"entities": []}], ["Two Spanish public tertiary hospitals.", {"entities": []}], ["2022 medical imaging tests were extracted from the radiology information system in February and March of 2014.", {"entities": []}], ["MRI and ultrasound examinations were excluded.", {"entities": []}], ["Five outcomes were set independently by at least two researchers according to four guidelines: (1) appropriate; (2) inappropriate; (3) inappropriate due to repetition, if the timing to carry out next diagnostic tests was incorrect according to guidelines; (4) not adequately justified, if the referral form did not include enough clinical information to allow us to understand the patient\u2019s clinical condition; and (5) not included in the guidelines, if the referral could not be matched to a clinical scenario described in the guidelines.", {"entities": []}], ["We estimated the prevalence of the five categories according to relevant clinical and sociodemographic variables and the effective radiation dose and costs for each category.", {"entities": []}], ["Approximately half of the imaging tests were deemed as appropriate (967, 47.8%) while one-third (634, 31.4%) were considered inappropriate.", {"entities": []}], ["19.6% of the effective dose and 25.2% of the cost were associated with inappropriate tests.", {"entities": []}], ["Women were less likely than men to have an imaging test classified as appropriate (adjusted OR 0.70,95%\u2009CI 0.57 to 0.86).", {"entities": []}], ["Imaging tests requested by general practitioners were less likely to be considered appropriate than those requested by central services (adjusted OR 0.60, 95%\u2009CI 0.38 to 0.93).", {"entities": []}], ["Mammography and CT were more likely to be appropriate than conventional X-rays.", {"entities": []}], ["There was a significant frequency of inappropriateness, which resulted in a high percentage of associated effective radiation dose.", {"entities": []}], ["Percentage of inappropriateness depends on sociodemographic and clinical characteristics such as sex, age, referral physician and medical imaging test.", {"entities": []}], ["The T allele of rs7927894 (at 11q13.5) was associated with atopic dermatitis and other allergic diseases.", {"entities": [[59, 76, "DISEASE"], [66, 76, "DISEASE"]]}], ["Our purpose was to replicate the association with allergic phenotypes and explore the role of rs7927894 in predisposing to persistent allergic rhinitis and atopic asthma.", {"entities": [[134, 151, "DISEASE"], [143, 151, "DISEASE"], [163, 169, "DISEASE"]]}], ["We also wanted to explore if other SNPs at 11q13.5 contributed to effect of rs7927894.", {"entities": []}], ["We studied patients with atopic dermatitis (N = 270), atopic asthma (N = 486), persistent allergic rhinitis (N = 589) and controls matched for age, sex and region (N = 540, N = 372 and N = 1178, respectively).", {"entities": [[90, 107, "DISEASE"], [25, 42, "DISEASE"], [99, 107, "DISEASE"], [61, 67, "DISEASE"], [32, 42, "DISEASE"]]}], ["We found that rs7927894 T was associated with atopic dermatitis (OR = 1.39, CI: 1.12\u20131.73, P = 0.003) and independently with persistent allergic rhinitis (OR = 1.24, CI:1.07\u20131.43, P = 0.0043, P corrected = 0.013) but not atopic asthma.", {"entities": [[136, 153, "DISEASE"], [46, 63, "DISEASE"], [145, 153, "DISEASE"], [228, 234, "DISEASE"], [53, 63, "DISEASE"]]}], ["Analysis of additional tagging SNPs (rs7930763, rs2513517, rs7125552) showed that effect of rs7927894 T was limited to haplotypes encoding G at rs7125552.", {"entities": []}], ["In conclusion, rs7927894 T is associated not only with atopic dermatitis but also persistent allergic rhinitis.", {"entities": [[93, 110, "DISEASE"], [55, 72, "DISEASE"], [102, 110, "DISEASE"], [62, 72, "DISEASE"]]}], ["Since these effects are haplotype dependent rs7927894 alone does not account for the association between 11q13.5 and atopic dermatitis/persistent allergic rhinitis.", {"entities": [[146, 163, "DISEASE"], [117, 134, "DISEASE"], [155, 163, "DISEASE"], [124, 134, "DISEASE"]]}], ["Mammalian Peptidoglycan Recognition Proteins (PGRPs) are a family of evolutionary conserved bactericidal innate immunity proteins, but the mechanism through which they kill bacteria is unclear.", {"entities": []}], ["We previously proposed that PGRPs are bactericidal due to induction of reactive oxygen species (ROS), a mechanism of killing that was also postulated, and later refuted, for several bactericidal antibiotics.", {"entities": []}], ["Here, using whole genome expression arrays, qRT-PCR, and biochemical tests we show that in both Escherichia coli and Bacillus subtilis PGRPs induce a transcriptomic signature characteristic of oxidative stress, as well as correlated biochemical changes.", {"entities": []}], ["However, induction of ROS was required, but not sufficient for PGRP killing.", {"entities": []}], ["PGRPs also induced depletion of intracellular thiols and increased cytosolic concentrations of zinc and copper, as evidenced by transcriptome changes and supported by direct measurements.", {"entities": []}], ["Depletion of thiols and elevated concentrations of metals were also required, but by themselves not sufficient, for bacterial killing.", {"entities": []}], ["Chemical treatment studies demonstrated that efficient bacterial killing can be recapitulated only by the simultaneous addition of agents leading to production of ROS, depletion of thiols, and elevation of intracellular metal concentrations.", {"entities": []}], ["These results identify a novel mechanism of bacterial killing by innate immunity proteins, which depends on synergistic effect of oxidative, thiol, and metal stress and differs from bacterial killing by antibiotics.", {"entities": []}], ["These results offer potential targets for developing new antibacterial agents that would kill antibiotic-resistant bacteria.", {"entities": []}], ["Bacterial infections are still a major cause of morbidity and mortality because of increasing antibiotic resistance.", {"entities": []}], ["New targets for developing new approaches to antibacterial therapy are needed, because discovering new or improving current antibiotics have become increasingly difficult.", {"entities": []}], ["One such approach is developing new antibacterial agents based on the antibacterial mechanisms of bactericidal innate immunity proteins, such as human peptidoglycan recognition proteins (PGRPs).", {"entities": []}], ["Thus, our aim was to determine how PGRPs kill bacteria.", {"entities": []}], ["We previously proposed that PGRPs kill bacteria by inducing toxic oxygen by-products (\u201creactive oxygen species\u201d, ROS) in bacteria.", {"entities": []}], ["It was also previously proposed, but recently refuted, that bactericidal antibiotics kill bacteria by inducing ROS production in bacteria.", {"entities": []}], ["These findings prompted us to evaluate in greater detail the mechanism of PGRP-induced bacterial killing, including the role of ROS in PGRP killing.", {"entities": []}], ["We show here that PGRPs kill bacteria through synergistic induction of ROS, depletion of thiols, and increasing intracellular concentration of metals, which are all required, but individually not sufficient for bacterial killing.", {"entities": []}], ["Our results reveal a novel bactericidal mechanism of innate immunity proteins, which differs from killing by antibiotics and offers alternative targets for developing new antibacterial therapies for antibiotic-resistant bacteria.", {"entities": []}], ["mRNA translation into proteins is highly regulated, but the role of mRNA isoforms, noncoding RNAs (ncRNAs), and genetic variants remains poorly understood.", {"entities": []}], ["mRNA levels on polysomes have been shown to correlate well with expressed protein levels, pointing to polysomal loading as a critical factor.", {"entities": []}], ["To study regulation and genetic factors of protein translation we measured levels and allelic ratios of mRNAs and ncRNAs (including microRNAs) in lymphoblast cell lines (LCL) and in polysomal fractions.", {"entities": []}], ["We first used targeted assays to measure polysomal loading of mRNA alleles, confirming reported genetic effects on translation of OPRM1 and NAT1 , and detecting no effect of rs1045642 ( 3435C>T ) in ABCB1 (MDR1) on polysomal loading while supporting previous results showing increased mRNA turnover of the 3435T allele.", {"entities": [[130, 135, "GENE"], [140, 144, "GENE"], [199, 204, "GENE"]]}], ["Use of high-throughput sequencing of complete transcript profiles (RNA-Seq) in three LCLs revealed significant differences in polysomal loading of individual RNA classes and isoforms.", {"entities": []}], ["Correlated polysomal distribution between protein-coding and non-coding RNAs suggests interactions between them.", {"entities": []}], ["Allele-selective polysome recruitment revealed strong genetic influence for multiple RNAs, attributable either to differential expression of RNA isoforms or to differential loading onto polysomes, the latter defining a direct genetic effect on translation.", {"entities": []}], ["Genes identified by different allelic RNA ratios between cytosol and polysomes were enriched with published expression quantitative trait loci (eQTLs) affecting RNA functions, and associations with clinical phenotypes.", {"entities": []}], ["Polysomal RNA-Seq combined with allelic ratio analysis provides a powerful approach to study polysomal RNA recruitment and regulatory variants affecting protein translation.", {"entities": []}], ["\u2022 Explains the design rationale for a novel electronic audit and feedback system.", {"entities": []}], ["\u2022 Identifies usability issues through a multi-method laboratory user evaluation.", {"entities": []}], ["\u2022 Uses findings to inform the evidence-based user-centred design of computerised audit and feedback.", {"entities": []}], ["\u2022 Determines their implications for patient safety.", {"entities": []}], ["Explains the design rationale for a novel electronic audit and feedback system.", {"entities": []}], ["Identifies usability issues through a multi-method laboratory user evaluation.", {"entities": []}], ["Uses findings to inform the evidence-based user-centred design of computerised audit and feedback.", {"entities": []}], ["Determines their implications for patient safety.", {"entities": []}], ["Electronic audit and feedback (e-A&F) systems are used worldwide for care quality improvement.", {"entities": []}], ["They measure health professionals\u2019 performance against clinical guidelines, and some systems suggest improvement actions.", {"entities": []}], ["However, little is known about optimal interface designs for e-A&F, in particular how to present suggested actions for improvement.", {"entities": []}], ["We developed a novel theory-informed system for primary care (the Performance Improvement plaN GeneratoR; PINGR) that covers the four principal interface components: clinical performance summaries; patient lists; detailed patient-level information; and suggested actions.", {"entities": []}], ["As far as we are aware, this is the first report of an e-A&F system with all four interface components.", {"entities": []}], ["(1) Use a combination of quantitative and qualitative methods to evaluate the usability of PINGR with target end-users; (2) refine existing design recommendations for e-A&F systems; (3) determine the implications of these recommendations for patient safety.", {"entities": []}], ["We recruited seven primary care physicians to perform seven tasks with PINGR, during which we measured on-screen behaviour and eye movements.", {"entities": []}], ["Participants subsequently completed usability questionnaires, and were interviewed in-depth.", {"entities": []}], ["Data were integrated to: gain a more complete understanding of usability issues; enhance and explain each other\u2019s findings; and triangulate results to increase validity.", {"entities": []}], ["Participants committed a median of 10 errors (range 8\u201321) when using PINGR\u2019s interface, and completed a median of five out of seven tasks (range 4\u20137).", {"entities": []}], ["Errors violated six usability heuristics: clear response options; perceptual grouping and data relationships; representational formats; unambiguous description; visually distinct screens for confusable items; and workflow integration.", {"entities": []}], ["Eye movement analysis revealed the integration of components largely supported effective user workflow, although the modular design of clinical performance summaries unnecessarily increased cognitive load.", {"entities": []}], ["Interviews and questionnaires revealed PINGR is user-friendly, and that improved information prioritisation could further promote useful user action.", {"entities": []}], ["Comparing our results with the wider usability literature we refine a previously published set of interface design recommendations for e-A&F.", {"entities": []}], ["The implications for patient safety are significant regarding: user engagement; actionability; and information prioritisation.", {"entities": []}], ["Our results also support adopting multi-method approaches in usability studies to maximise issue discovery and the credibility of findings.", {"entities": []}], ["Amauroderma rugosum , commonly known as \u201cJi\u01cez\u012b\u201d in China, is a wild mushroom traditionally used by the Chinese to reduce inflammation, to treat diuretic and upset stomach, and to prevent cancer.", {"entities": [[187, 193, "DISEASE"]]}], ["It is also used by the indigenous communities in Malaysia to prevent epileptic episodes and incessant crying by babies.", {"entities": []}], ["The aim of this study was to compare the wild and domesticated basidiocarps of A .", {"entities": []}], ["rugosum for antioxidant and in vitro anti-inflammatory effects in LPS-stimulated RAW264.7 cells.", {"entities": []}], ["The wild basidiocarps of A .", {"entities": []}], ["rugosum were collected from the Belum Forest, Perak, Malaysia and the domesticated basidiocarps of A .", {"entities": []}], ["rugosum were cultivated in the mushroom house located in the University of Malaya, Kuala Lumpur, Malaysia.", {"entities": []}], ["Both the wild and domesticated basidiocarps were subjected to ethanolic extraction and the extracts were tested for antioxidant and anti-inflammatory activities.", {"entities": []}], ["In this study, the crude ethanolic extract of wild (WB) and domesticated (DB) basidiocarps of A .", {"entities": []}], ["rugosum had comparable total phenolic content and DPPH scavenging activity.", {"entities": []}], ["However, WB (EC 50 = 222.90 \u03bcg/mL) displayed a better ABTS cation radical scavenging activity than DB (EC 50 = 469.60 \u03bcg/mL).", {"entities": []}], ["Both WB and DB were able to scavenge nitric oxide (NO) radical and suppress the NO production in LPS-stimulated RAW264.7 cells and this effect was mediated through the down-regulation of inducible nitric oxide synthase (iNOS) gene.", {"entities": []}], ["In addition, both WB and DB caused down-regulation of the inflammatory gene TNF-\u03b1 and the up-regulation of the anti-inflammatory gene IL-10.", {"entities": []}], ["There was no inhibitory effect of WB and DB on nuclear translocation of NF-\u03baB p65.", {"entities": []}], ["In conclusion, the wild and domesticated basidiocarps of A .", {"entities": []}], ["rugosum possessed antioxidant and in vitro anti-inflammatory properties.", {"entities": []}], ["WB and DB inhibited downstream inflammatory mediators (TNF-\u03b1 and NO) and induced anti-inflammatory cytokine IL-10 production.", {"entities": []}], ["No inhibitory effects shown on upstream nuclear translocation of NF-\u03baB p65.", {"entities": []}], ["WB and DB exhibited antioxidant activity and attenuation of proinflammatory mediators and therefore, A .", {"entities": []}], ["rugosum may serve as a potential therapeutic agent in the management of inflammation.", {"entities": []}], ["Venous blood was drawn from 35 pregnant Hispanic women living in Brownsville, Texas, and matched cord blood was collected at birth.", {"entities": []}], ["Gas chromatography/mass spectrometry was used to measure concentrations of 55 individual PAHs or groups of PAHs.", {"entities": []}], ["Results indicate that these women and their fetuses were regularly exposed to multiple PAHs at comparatively low concentrations, with levels in cord blood generally exceeding levels in paired maternal blood.", {"entities": []}], ["While the possibility of related adverse effects on the fetus is uncertain, these exposures in combination with socioeconomically-disadvantaged and environmentally-challenging living conditions raise legitimate public health concerns.", {"entities": []}], ["The protective effects of the tuberculosis vaccine Bacillus Calmette-Guerin (BCG) on unrelated infections are thought to be mediated by long-term metabolic changes and chromatin remodeling through histone modifications in innate immune cells such as monocytes, a process termed trained immunity.", {"entities": [[30, 42, "DISEASE"]]}], ["Here, we show that BCG induction of trained immunity in monocytes is accompanied by a strong increase in glycolysis and, to a lesser extent, glutamine metabolism, both in an in-vitro model and after vaccination of mice and humans.", {"entities": []}], ["Pharmacological and genetic modulation of rate-limiting glycolysis enzymes inhibits trained immunity, changes that are reflected by the effects on the histone marks (H3K4me3 and H3K9me3) underlying BCG-induced trained immunity.", {"entities": []}], ["These data demonstrate that a shift of the glucose metabolism toward glycolysis is crucial for the induction of the histone modifications and functional changes underlying BCG-induced trained immunity.", {"entities": []}], ["The identification of these pathways may be a first step toward vaccines that combine immunological and metabolic stimulation.", {"entities": []}], ["\u2022 Cellular metabolism undergoes major shifts in BCG-trained monocytes \u2022 The Akt-mTOR signaling pathway is essential for these shifts in metabolism \u2022 Induction of glucose and glutamine metabolism are crucial in trained immunity \u2022 The metabolic changes are the result of rewiring of chromatin modifications Cellular metabolism undergoes major shifts in BCG-trained monocytes The Akt-mTOR signaling pathway is essential for these shifts in metabolism Induction of glucose and glutamine metabolism are crucial in trained immunity The metabolic changes are the result of rewiring of chromatin modifications Arts et\u00a0al.", {"entities": []}], ["found that glycolysis and glutamine metabolism, regulated by the Akt-mTOR pathway, are central mediators for the induction of trained immunity by BCG in monocytes.", {"entities": []}], ["They show that metabolic changes are dependent on changes in histone modifications, which are influenced by metabolic changes.", {"entities": []}], ["To develop a model of care coordination for patients living with advanced progressive illness and their unpaid caregivers, and to understand their perspective regarding care coordination.", {"entities": []}], ["A prospective longitudinal, multi-perspective qualitative study involving a case-study approach.", {"entities": []}], ["Serial in-depth interviews were conducted, transcribed verbatim and then analyzed through open and axial coding in order to construct categories for three cases (sites).", {"entities": []}], ["This was followed by continued thematic analysis to identify underlying conceptual coherence across all cases in order to produce one coherent care coordination model.", {"entities": []}], ["Fifty-six purposively sampled patients and 27 case-linked unpaid caregivers.", {"entities": []}], ["Three cases from contrasting primary, secondary and tertiary settings within Britain.", {"entities": []}], ["Coordination is a deliberate cross-cutting action that involves high-quality, caring and well-informed staff, patients and unpaid caregivers who must work in partnership together across health and social care settings.", {"entities": []}], ["For coordination to occur, it must be adequately resourced with efficient systems and services that communicate.", {"entities": []}], ["Patients and unpaid caregivers contribute substantially to the coordination of their care, which is sometimes volunteered at a personal cost to them.", {"entities": []}], ["Coordination is facilitated through flexible and patient-centered care, characterized by accurate and timely information communicated in a way that considers patients\u2019 and caregivers\u2019 needs, preferences, circumstances and abilities.", {"entities": []}], ["Within the midst of advanced progressive illness, coordination is a shared and complex intervention involving relational, structural and information components.", {"entities": []}], ["Our study is one of the first to extensively examine patients\u2019 and caregivers\u2019 views about coordination, thus aiding conceptual fidelity.", {"entities": []}], ["These findings can be used to help avoid oversimplifying a real-world problem, such as care coordination.", {"entities": []}], ["Avoiding oversimplification can help with the development, evaluation and implementation of real-world coordination interventions for patients and their unpaid caregivers in the future.", {"entities": []}], ["Despite the accelerating pace of scientific discovery, the current clinical research enterprise does not sufficiently address pressing clinical questions.", {"entities": []}], ["Given the constraints on clinical trials, for a majority of clinical questions, the only relevant data available to aid in decision making are based on observation and experience.", {"entities": []}], ["Our purpose here is 3-fold.", {"entities": []}], ["First, we describe the classic context of medical research guided by Poppers\u2019 scientific epistemology of \u201cfalsificationism.\u201d Second, we discuss challenges and shortcomings of randomized controlled trials and present the potential of observational studies based on big data.", {"entities": []}], ["Third, we cover several obstacles related to the use of observational (retrospective) data in clinical studies.", {"entities": []}], ["We conclude that randomized controlled trials are not at risk for extinction, but innovations in statistics, machine learning, and big data analytics may generate a completely new ecosystem for exploration and validation.", {"entities": []}], ["Airway stabilization for severe, symptomatic tracheobronchomalacia (TBM) may be accomplished by silicone Y-stent placement.", {"entities": []}], ["Common complications of the Y-stent include mucus plugging and granulation tissue formation.", {"entities": []}], ["We describe a rare case of massive hemoptysis originating from a silicone Y-stent placed for TBM.", {"entities": []}], ["An emergent bronchoscopy showed an actively bleeding, pulsatile vessel at the distal end of the left bronchial limb of the Y-stent.", {"entities": []}], ["It was felt that the bleeding was caused by, or at least impacted by, the distal left bronchial limb of the Y-stent eroding into the airway wall.", {"entities": []}], ["We hypothesized that placement of oxidized regenerated cellulose (ORC) would provide initial hemostasis, and the subsequent placement of a biocompatible surgical sealant would lead to definitive resolution.", {"entities": []}], ["ORC provided sufficient hemostasis and the subsequent synthetic polymer reinforced the tissue for complete cessation of the bleed.", {"entities": []}], ["The combined use of ORC and a biocompatible surgical sealant provided long-term management for life-threatening hemoptysis, and potentially morbid procedures such as embolization or surgery were avoided by advanced endobronchial therapy.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, is constitutively expressed in urothelial cells that also express protease-activated receptors (PAR).", {"entities": [[40, 43, "GENE"]]}], ["Urothelial PAR1 receptors were shown to mediate bladder inflammation.", {"entities": []}], ["We showed that PAR1 and PAR4 activator, thrombin, also mediates urothelial MIF release.", {"entities": [[75, 78, "GENE"]]}], ["We hypothesized that stimulation of urothelial PAR1 or PAR4 receptors elicits release of urothelial MIF that acts on MIF receptors in the urothelium to mediate bladder inflammation and pain.", {"entities": [[100, 103, "GENE"], [117, 120, "GENE"], [100, 103, "GENE"], [117, 120, "GENE"]]}], ["Thus, we examined the effect of activation of specific bladder PAR receptors on MIF release, bladder pain, micturition and histological changes.", {"entities": [[80, 83, "GENE"]]}], ["MIF release was measured in vitro after exposing immortalized human urothelial cells (UROtsa) to PAR1 or PAR4 activating peptides (AP).", {"entities": [[0, 3, "GENE"]]}], ["Female C57BL/6 mice received intravesical PAR1- or PAR4-AP for one hour to determine: 1) bladder MIF release in vivo within one hour; 2) abdominal hypersensitivity (allodynia) to von Frey filament stimulation 24 hours after treatment; 3) micturition parameters 24 hours after treatment; 4) histological changes in the bladder as a result of treatment; 5) changes in expression of bladder MIF and MIF receptors using real-time RT-PCR; 6) changes in urothelial MIF and MIF receptor, CXCR4, protein levels using quantitative immunofluorescence; 7) effect of MIF or CXCR4 antagonism.", {"entities": [[97, 100, "GENE"], [388, 391, "GENE"], [396, 399, "GENE"], [459, 462, "GENE"], [467, 470, "GENE"], [555, 558, "GENE"], [97, 100, "GENE"], [388, 391, "GENE"], [396, 399, "GENE"], [459, 462, "GENE"], [467, 470, "GENE"], [555, 558, "GENE"], [97, 100, "GENE"], [388, 391, "GENE"], [396, 399, "GENE"], [459, 462, "GENE"], [467, 470, "GENE"], [555, 558, "GENE"], [97, 100, "GENE"], [388, 391, "GENE"], [396, 399, "GENE"], [459, 462, "GENE"], [467, 470, "GENE"], [555, 558, "GENE"], [97, 100, "GENE"], [388, 391, "GENE"], [396, 399, "GENE"], [459, 462, "GENE"], [467, 470, "GENE"], [555, 558, "GENE"], [481, 486, "GENE"], [562, 567, "GENE"], [97, 100, "GENE"], [388, 391, "GENE"], [396, 399, "GENE"], [459, 462, "GENE"], [467, 470, "GENE"], [555, 558, "GENE"], [481, 486, "GENE"], [562, 567, "GENE"]]}], ["PAR1- or PAR4-AP triggered MIF release from both human urothelial cells in vitro and mouse urothelium in vivo .", {"entities": [[27, 30, "GENE"]]}], ["Twenty-four hours after intravesical PAR1- or PAR4-AP, we observed abdominal hypersensitivity in mice without changes in micturition or bladder histology.", {"entities": []}], ["PAR4-AP was more effective and also increased expression of bladder MIF and urothelium MIF receptor, CXCR4.", {"entities": [[68, 71, "GENE"], [87, 90, "GENE"], [68, 71, "GENE"], [87, 90, "GENE"], [101, 106, "GENE"]]}], ["Bladder CXCR4 localized to the urothelium.", {"entities": [[8, 13, "GENE"]]}], ["Antagonizing MIF with ISO-1 eliminated PAR4- and reduced PAR1-induced hypersensitivity, while antagonizing CXCR4 with AMD3100 only partially prevented PAR4-induced hypersensitivity.", {"entities": [[13, 16, "GENE"], [107, 112, "GENE"]]}], ["Bladder PAR activation elicits urothelial MIF release and urothelial MIF receptor signaling at least partly through CXCR4 to result in abdominal hypersensitivity without overt bladder inflammation.", {"entities": [[42, 45, "GENE"], [69, 72, "GENE"], [42, 45, "GENE"], [69, 72, "GENE"], [116, 121, "GENE"]]}], ["PAR-induced bladder pain may represent an interesting pre-clinical model of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) where pain occurs without apparent bladder injury or pathology.", {"entities": []}], ["MIF is potentially a novel therapeutic target for bladder pain in IC/PBS patients.", {"entities": [[0, 3, "GENE"]]}], ["Deficient suppression of T cell responses to allergen by CD4", {"entities": [[57, 60, "GENE"]]}], ["There has been tremendous interest in constructing in vitro cardiac tissue for a range of fundamental studies of cardiac development and disease and as a commercial system to evaluate therapeutic drug discovery prioritization and toxicity.", {"entities": []}], ["Although there has been progress towards studying 2-dimensional cardiac function in vitro , there remain challenging obstacles to generate rapid and efficient scaffold-free 3-dimensional multiple cell type co-culture cardiac tissue models.", {"entities": []}], ["Herein, we develop a programmed rapid self-assembly strategy to induce specific and stable cell-cell contacts among multiple cell types found in heart tissue to generate 3D tissues through cell-surface engineering based on liposome delivery and fusion to display bio-orthogonal functional groups from cell membranes.", {"entities": []}], ["We generate, for the first time, a scaffold free and stable self assembled 3 cell line co-culture 3D cardiac tissue model by assembling cardiomyocytes, endothelial cells and cardiac fibroblast cells via a rapid inter-cell click ligation process.", {"entities": []}], ["We compare and analyze the function of the 3D cardiac tissue chips with 2D co-culture monolayers by assessing cardiac specific markers, electromechanical cell coupling, beating rates and evaluating drug toxicity.", {"entities": []}], ["A long-term existing schistosome infection can aid in maintaining immuno-homeostasis, thus providing protection against various types of autoimmune diseases to the infected host.", {"entities": []}], ["Such benefits have often been associated with acute or egg stage infection and with the egg-induced Th2 response.", {"entities": []}], ["However, since schistosome infection undergoes different stages, each associated with a specific induction of Th responses, the requirements for the ability of the different stages of schistosome infection to protect against autoimmune disease has not been elucidated.", {"entities": []}], ["The present study was designed to study whether different stages of schistosome infection offer unique protection in collagen-induced arthritis and its mechanisms.", {"entities": [[134, 143, "DISEASE"]]}], ["Arthritis susceptible strain DBA/1 male mice were infected with Schistosoma japonicum for either 2 weeks resulting in early stage infection or for 7 weeks resulting in acute or egg stage infection.", {"entities": [[0, 9, "DISEASE"]]}], ["Following Schistosoma japonicum infection, collagen II was administered to induce collagen-induced arthritis, an animal model for human rheumatoid arthritis.", {"entities": [[136, 156, "DISEASE"], [99, 108, "DISEASE"], [147, 156, "DISEASE"]]}], ["Infection by Schistosoma japonicum significantly reduced the severity and the incidence of experimental autoimmune collagen-induced arthritis.", {"entities": [[132, 141, "DISEASE"]]}], ["However, this beneficial effect can only be provided by a pre-established acute stage of infection but not by a pre-established early stage of the infection.", {"entities": []}], ["The protection against collagen-induced arthritis correlated with reduced levels of anti-collagen II IgG, especially the subclass of IgG2a.", {"entities": [[40, 49, "DISEASE"]]}], ["Moreover, in protected mice increased levels of IL-4 were present at the time of collagen II injection together with sustained higher IL-4 levels during the course of arthritis development.", {"entities": [[167, 176, "DISEASE"]]}], ["In contrast, in unprotected mice minimal levels of IL-4 were present at the initial stage of collagen II challenge together with lack of IL-4 induction following Schistosoma japonicum infection.", {"entities": []}], ["The protective effect against collagen-induced arthritis provided by Schistosoma japonicum infection is infection stage-dependent.", {"entities": [[47, 56, "DISEASE"]]}], ["Furthermore, the ability of schistosomiasis to negatively regulate the onset of collagen-induced arthritis is associated with a dominant as well as long-lasting Th2 response at the initiation and development of autoimmune joint and systemic inflammation.", {"entities": [[97, 106, "DISEASE"], [28, 43, "DISEASE"]]}], ["G2D (genes to diseases) is a web resource for prioritizing genes as candidates for inherited diseases.", {"entities": []}], ["It uses three algorithms based on different prioritization strategies.", {"entities": []}], ["The input to the server is the genomic region where the user is looking for the disease-causing mutation, plus an additional piece of information depending on the algorithm used.", {"entities": []}], ["This information can either be the disease phenotype (described as an online Mendelian inheritance in man (OMIM) identifier), one or several genes known or suspected to be associated with the disease (defined by their Entrez Gene identifiers), or a second genomic region that has been linked as well to the disease.", {"entities": []}], ["In the latter case, the tool uses known or predicted interactions between genes in the two regions extracted from the STRING database.", {"entities": []}], ["The output in every case is an ordered list of candidate genes in the region of interest.", {"entities": []}], ["For the first two of the three methods, the candidate genes are first retrieved through sequence homology search, then scored accordingly to the corresponding method.", {"entities": []}], ["This means that some of them will correspond to well-known characterized genes, and others will overlap with predicted genes, thus providing a wider analysis.", {"entities": []}], ["G2D is publicly available at http://www.ogic.ca/projects/g2d_2/", {"entities": []}], ["To study the prevalence of, and discuss factors contributing to, household second-hand smoke exposure in six counties in China, providing scientific support for the need to establish tobacco control measures in these areas.", {"entities": []}], ["A cross-sectional survey was performed.", {"entities": []}], ["Investigators conducted face-to-face interviews using a standardised questionnaire to collect information on demographics, passive smoking behaviours and knowledge, and attitudes towards tobacco control.", {"entities": []}], ["The setting was six counties from the three provinces: Mianzhu and Xichong counties in Sichuan Province; Anyi and Hukou counties in Jiangxi Province; and Xinan and Yanshi counties in Henan Province.", {"entities": []}], ["A total of 8142 non-smokers (aged 18\u201369) in 2004 were included in the data analysis.", {"entities": []}], ["Household second-hand smoke exposure rate as defined as the proportion of household passive smokers in the non-smoker population was used as the measure of household second-hand smoke exposure.", {"entities": []}], ["The analysis of 8142 non-smokers revealed that, in these selected counties, the household second-hand smoke exposure rate was 48.3%.", {"entities": []}], ["Respondents had positive attitudes towards tobacco control.", {"entities": []}], ["Of 6972 respondents, 84.4% supported all the three tobacco control policies (banning smoking in public places, banning the selling of cigarettes to minors, banning all cigarette advertisements).", {"entities": []}], ["In 3165 families with smokers, 87.2% of respondents reported that smokers would smoke in front of them.", {"entities": []}], ["In 2124 families with smokers and children, 76.5% of respondents reported that smokers would smoke in front of children.", {"entities": []}], ["As many as 42.1% of non-smokers would offer cigarettes to their guests, and only 46.8% of respondents would ask smokers to smoke outdoors.", {"entities": []}], ["Only 6.3% of families completely forbade smoking at home.", {"entities": []}], ["Multivariate logistic regression analysis revealed high second-hand smoke exposure for the following demographic groups: Jiangxi Province inhabitants, females, those with low education level, farmers and married respondents.", {"entities": []}], ["Household second-hand smoke exposure rates in the selected counties were high.", {"entities": []}], ["A high percentage of respondents reported that smokers would smoke in front of them and children.", {"entities": []}], ["The pressure from non-smokers against smoking was relatively low, although offering cigarette was prevalent.", {"entities": []}], ["Households that were completely smoking-free were rare, Further studies on these correlated factors could help us establish effective measures to reduce household second-hand smoke exposure.", {"entities": []}], ["In May 2009, the New Zealand government announced a new policy aimed at improving the quality of Emergency Department care and whole hospital performance.", {"entities": []}], ["Governments have increasingly looked to time targets as a mechanism for improving hospital performance and from a whole system perspective, using the Emergency Department waiting time as a performance measure has the potential to see improvements in the wider health system.", {"entities": []}], ["However, the imposition of targets may have significant adverse consequences.", {"entities": []}], ["There is little empirical work examining how the performance of the wider hospital system is affected by such a target.", {"entities": []}], ["This project aims to answer the following questions: How has the introduction of the target affected broader hospital performance over time, and what accounts for these changes?", {"entities": []}], ["Which initiatives and strategies have been successful in moving hospitals towards the target without compromising the quality of other care processes and patient outcomes?", {"entities": []}], ["Is there a difference in outcomes between different ethnic and age groups?", {"entities": []}], ["Which initiatives and strategies have the greatest potential to be transferred across organisational contexts?", {"entities": []}], ["The study design is mixed methods; combining qualitative research into the behaviour and practices of specific case study hospitals with quantitative data on clinical outcomes and process measures of performance over the period 2006-2012.", {"entities": []}], ["All research activity is guided by a Kaupapa M\u0101ori Research methodological approach.", {"entities": []}], ["A dynamic systems model of acute patient flows was created to frame the study.", {"entities": []}], ["Consequences of the target (positive and negative) will be explored by integrating analyses and insights gained from the quantitative and qualitative streams of the study.", {"entities": []}], ["At the time of submission of this protocol, the project has been underway for 12 months.", {"entities": []}], ["This time was necessary to finalise both the case study sites and the secondary outcomes through key stakeholder consultation.", {"entities": []}], ["We believe that this is an appropriate juncture to publish the protocol, now that the sites and final outcomes to be measured have been determined.", {"entities": []}], ["To date, diagnosing food allergies in children still presents a diagnostic dilemma, leading to uncertainty concerning the definite diagnosis of peanut allergy, as well as to the need for strict diets and the potential need for adrenalin auto-injectors.", {"entities": []}], ["This uncertainty in particular is thought to contribute to a lower quality of life.", {"entities": []}], ["In the diagnostic process double-blind food challenges are considered the gold standard, but they are time-consuming as well as potentially hazardous.", {"entities": []}], ["Other diagnostic tests have been extensively studied and among these component-resolved diagnostics appeared to present a promising alternative: Ara h2, a peanut storage protein in previous studies showed to have a significant predictive value.", {"entities": []}], ["Sixty-two out of 72 children, with suspected peanut allergy were analyzed using serum specific IgE and/or skin prick tests and specific IgE to several components of peanut (Ara h 1, 2, 3, 6, 8, 9).", {"entities": []}], ["Subsequently, double-blind food challenges were performed.", {"entities": []}], ["The correlation between the various diagnostic tests and the overall outcome of the double-blind food challenges were studied, in particular the severity of the reaction and the eliciting dose.", {"entities": []}], ["The double-blind provocation with peanut was positive in 33 children (53\u00a0%).", {"entities": []}], ["There was no relationship between the eliciting dose and the severity of the reaction.", {"entities": []}], ["A statistically significant relationship was found between the skin prick test, specific IgE directed to peanut, Ara h 1, Ara h 2 or Ara h 6, and the outcome of the food challenge test, in terms of positive or negative ( P \u2009<\u2009.001).", {"entities": []}], ["However, we did not find any relationship between sensitisation to peanut extract or the different allergen components and the severity of the reaction or the eliciting dose.", {"entities": []}], ["There was no correlation between IgE directed to Ara h 3, Ara h 8, Ara h 9 and the clinical outcome of the food challenge.", {"entities": []}], ["This study shows that component-resolved diagnostics is not superior to specific IgE to peanut extract or to skin prick testing.", {"entities": []}], ["At present, it cannot replace double-blind placebo-controlled food challenges for determination of the eliciting dose or the severity of the peanut allergy in our patient group.", {"entities": []}], ["The online version of this article (doi:10.1186/s12887-016-0609-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We developed a new statistical framework to find genetic variants associated with extreme longevity.", {"entities": []}], ["The method, informed GWAS (iGWAS), takes advantage of knowledge from large studies of age-related disease in order to narrow the search for SNPs associated with longevity.", {"entities": []}], ["To gain support for our approach, we first show there is an overlap between loci involved in disease and loci associated with extreme longevity.", {"entities": []}], ["These results indicate that several disease variants may be depleted in centenarians versus the general population.", {"entities": []}], ["Next, we used iGWAS to harness information from 14 meta-analyses of disease and trait GWAS to identify longevity loci in two studies of long-lived humans.", {"entities": []}], ["In a standard GWAS analysis, only one locus in these studies is significant ( APOE/TOMM40 ) when controlling the false discovery rate (FDR) at 10%.", {"entities": []}], ["With iGWAS, we identify eight genetic loci to associate significantly with exceptional human longevity at FDR < 10%.", {"entities": []}], ["We followed up the eight lead SNPs in independent cohorts, and found replication evidence of four loci and suggestive evidence for one more with exceptional longevity.", {"entities": []}], ["The loci that replicated (FDR < 5%) included APOE/TOMM40 (associated with Alzheimer\u2019s disease), CDKN2B/ANRIL (implicated in the regulation of cellular senescence), ABO (tags the O blood group), and SH2B3/ATXN2 (a signaling gene that extends lifespan in Drosophila and a gene involved in neurological disease).", {"entities": [[164, 167, "GENE"]]}], ["Our results implicate new loci in longevity and reveal a genetic overlap between longevity and age-related diseases and traits, including coronary artery disease and Alzheimer\u2019s disease.", {"entities": []}], ["iGWAS provides a new analytical strategy for uncovering SNPs that influence extreme longevity, and can be applied more broadly to boost power in other studies of complex phenotypes.", {"entities": []}], ["Longevity is a complex phenotype, and few genetic variants that affect lifespan have been identified.", {"entities": []}], ["However, aging and disease are closely related, and a great deal is known about the genetic basis of disease risk.", {"entities": []}], ["Here, we show using genome-wide association studies (GWAS) of longevity and disease that there is an overlap between loci involved in longevity and loci involved in several diseases, such as Alzheimer\u2019s disease and coronary artery disease.", {"entities": []}], ["We then develop a new statistical framework to find genetic variants associated with extreme longevity.", {"entities": []}], ["The method, informed GWAS (iGWAS), takes advantage of knowledge from 14 large studies of disease and disease-related traits in order to narrow the search for SNPs associated with longevity.", {"entities": []}], ["Using iGWAS, we found eight SNPs that are significant in our discovery cohorts, and we were able to validate four of these in replication studies of long-lived subjects.", {"entities": []}], ["Our results implicate new loci in longevity and reveal a genetic overlap between longevity and age-related diseases and traits.", {"entities": []}], ["Beyond the study of human longevity, iGWAS can be applied to boost statistical power in any GWAS of a target phenotype by using larger GWAS of genetically-related conditions.", {"entities": []}], ["We present a general approach to perform association analyses in pedigrees of arbitrary size and structure, which also allows for a mixture of pedigree members and independent individuals to be analyzed together, to test genetic markers and qualitative or quantitative traits.", {"entities": []}], ["Our software, PedGenie, uses Monte Carlo significance testing to provide a valid test for related individuals that can be applied to any test statistic, including transmission disequilibrium statistics.", {"entities": []}], ["Single locus at a time, composite genotype tests, and haplotype analyses may all be performed.", {"entities": []}], ["We illustrate the validity and functionality of PedGenie using simulated and real data sets.", {"entities": []}], ["For the real data set, we evaluated the role of two tagging-single nucleotide polymorphisms (tSNPs) in the DNA repair gene, NBS1 , and their association with female breast cancer in 462 cases and 572 controls selected to be BRCA1/2 mutation negative from 139 high-risk Utah breast cancer families.", {"entities": [[158, 178, "DISEASE"], [165, 178, "DISEASE"], [274, 287, "DISEASE"], [172, 178, "DISEASE"], [281, 287, "DISEASE"]]}], ["The results from PedGenie were shown to be valid both for accurate p -value calculations and consideration of pedigree structure in the simulated data set.", {"entities": []}], ["A nominally significant association with breast cancer was observed with the NBS1 tSNP rs709816 for carriage of the rare allele (OR = 1.61, 95% CI = 1.10\u20132.35, p = 0.019).", {"entities": [[41, 54, "DISEASE"], [48, 54, "DISEASE"]]}], ["PedGenie is a flexible and valid statistical tool that is intuitively simple to understand, makes efficient use of all the data available from pedigrees without requiring trimming, and is flexible to the types of tests to which it can be applied.", {"entities": []}], ["Further, our analyses of real data indicate NBS1 may play a role in the genetic etiology of heritable breast cancer.", {"entities": [[102, 115, "DISEASE"], [109, 115, "DISEASE"]]}], ["Tobacco smoke exposure harms children and adults.", {"entities": []}], ["Yet, 40% of children worldwide are exposed to tobacco smoke in their homes.", {"entities": []}], ["Such widespread parental failure to protect children is puzzling, and may be related to risk perceptions.", {"entities": []}], ["No consensus exists about how to measure parental risk perceptions of tobacco smoke exposure.", {"entities": []}], ["The objective of this research was to study P arental R isk Perceptions of child E xposure to T obacco S moke (PRETS) using various dimensions of risk perceptions: likelihood of harm, susceptibility to harm, and severity of harm.", {"entities": []}], ["We aimed to estimate PRETS and identify correlates of PRETS, and assess the association between PRETS, parental smoking status, and home smoking behaviors.", {"entities": []}], ["We conducted 132 face-to-face interviews with parents of infants.", {"entities": []}], ["Parents who smoked regularly believed that infant tobacco smoke exposure was less dangerous than did other parents (p = .0158).", {"entities": []}], ["Birthplace of parent was significantly associated with risk perception (p = .0019); parents of Russian origin believed the overall risk to be less than did those born elsewhere.", {"entities": []}], ["Smoking status, ethnicity, and employment status were associated with smoking in the home.", {"entities": []}], ["The relationship between smoking behavior in the home and risk perceptions was complex, and may have been modified by ethnicity.", {"entities": []}], ["Parental risk perceptions concerning child exposure to tobacco smoke are associated with smoking behavior and ethnicity.", {"entities": []}], ["Understanding how to measure risk perceptions, and identifying risk perception dimensions which differ between families with and without home smoking bans, may contribute to the development of effective interventions to protect children from the harmful effects of tobacco smoke exposure.", {"entities": []}], ["Occipital nerve block (ONB) has been used in several primary headache syndromes with good results.", {"entities": []}], ["Information on its effects in facial pain is sparse.", {"entities": []}], ["In this chart review, the efficacy of ONB using lidocaine and dexamethasone was evaluated in 20 patients with craniofacial pain syndromes comprising 8 patients with trigeminal neuralgia, 6 with trigeminal neuropathic pain, 5 with persistent idiopathic facial pain and 1 with occipital neuralgia.", {"entities": [[165, 185, "DISEASE"]]}], ["Response was defined as an at least 50% reduction of original pain.", {"entities": []}], ["Mean response rate was 55% with greatest efficacy in trigeminal (75%) and occipital neuralgia (100%) and less efficacy in trigeminal neuropathic pain (50%) and persistent idiopathic facial pain (20%).", {"entities": []}], ["The effects lasted for an average of 27\u00a0days with sustained benefits for 69, 77 and 107\u00a0days in three patients.", {"entities": []}], ["Side effects were reported in 50%, albeit transient and mild in nature.", {"entities": []}], ["ONBs are effective in trigeminal pain involving the second and third branch and seem to be most effective in craniofacial neuralgias.", {"entities": []}], ["They should be considered in facial pain before more invasive approaches, such as thermocoagulation or vascular decompression, are performed, given that side effects are mild and the procedure is minimally invasive.", {"entities": []}], ["Patients with stable COPD show improvements in exercise capacity and muscular function after the application of whole body vibration.", {"entities": []}], ["We aimed to evaluate whether this modality added to conventional physiotherapy in exacerbated hospitalised COPD patients would be safe and would improve exercise capacity and quality of life.", {"entities": []}], ["49 hospitalised exacerbated COPD patients were randomized (1:1) to undergo physiotherapy alone or physiotherapy with the addition of whole body vibration.", {"entities": []}], ["The primary endpoint was the between-group difference of the 6-minute walking test (day of discharge \u2013 day of admission).", {"entities": []}], ["Secondary assessments included chair rising test, quality of life, and serum marker analysis.", {"entities": []}], ["Whole body vibration did not cause procedure-related adverse events.", {"entities": []}], ["Compared to physiotherapy alone, it led to significantly stronger improvements in 6-minute walking test (95.55\u2009\u00b1\u200976.29 m vs. 6.13\u2009\u00b1\u200981.65 m; p\u2009=\u20090.007) and St. Georges Respiratory Questionnaire (-6.43\u2009\u00b1\u200914.25 vs. 5.59\u2009\u00b1\u200919.15, p\u2009=\u20090.049).", {"entities": []}], ["Whole body vibration increased the expression of the transcription factor peroxisome proliferator receptor gamma coactivator-1-\u03b1 and serum levels of irisin, while it decreased serum interleukin-8.", {"entities": []}], ["Whole body vibration during hospitalised exacerbations did not cause procedure-related adverse events and induced clinically significant benefits regarding exercise capacity and health-related quality of life that were associated with increased serum levels of irisin, a marker of muscle activity.", {"entities": []}], ["German Clinical Trials Register DRKS00005979 .", {"entities": []}], ["Registered 17 March 2014.", {"entities": []}], ["To evaluate the prevalence and microbiological characterization of community-acquired (CA) methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in a kindergarten.", {"entities": []}], ["Point prevalence study.", {"entities": []}], ["Nasal swabs were collected from healthy children younger than 7 years of age who were attending a kindergarten in Taipei, Taiwan.", {"entities": []}], ["A parent questionnaire regarding MRSA risk factors was administered simultaneously.", {"entities": []}], ["All CA-MRSA colonization isolates were archived for subsequent antimicrobial susceptibility and molecular typing.", {"entities": []}], ["Of the 68 children who participated in the study, 17 (25%) had S. aureus isolated from nasal swabs.", {"entities": []}], ["Nine (13.2%) of the 68 children had CA-MRSA carriage, and none of them had any identified risk factors.", {"entities": []}], ["Antimicrobial susceptibility testing revealed all of the 9 CA-MRSA colonization isolates had uniformly high resistance (100%) to both clindamycin and erythromycin, the macrolide-lincosamide-streptogramin-constitutive phenotype and the ermB gene.", {"entities": []}], ["Pulsed-field gel electrophoresis revealed 8 (88.9%) of 9 CA-MRSA colonization isolates were genetically related and multilocus sequence typing revealed all isolates had sequence type 59.", {"entities": []}], ["All of the colonization isolates carried the staphylococcal cassette chromosome mec type IV, but none were positive for the Panton-Valentine leukocidin genes.", {"entities": []}], ["The results of this study suggest that a single predominant CA-MRSA colonization strain featuring high clindamycin resistance circulated in this kindergarten.", {"entities": []}], ["Additionally, due to the established transmissibility of colonization isolates, the high prevalence of nasal carriage of CA-MRSA among healthy attendees in kindergartens may indicate the accelerated spread of CA-MRSA in the community.", {"entities": []}], ["Obesity and asthma are two chronic conditions that affect millions of people.", {"entities": [[0, 7, "DISEASE"], [12, 18, "DISEASE"]]}], ["Genetic and lifestyle factors such as diet, physical activity, and early exposure to micro-organisms are important factors that may contribute to the escalating prevalence of both conditions.", {"entities": []}], ["The prevalence of asthma is higher in obese individuals.", {"entities": [[18, 24, "DISEASE"]]}], ["Recently, two major phenotypes of asthma with obesity have been described: one phenotype of early-onset asthma that is aggravated by obesity, and a second phenotype of later-onset asthma that predominantly affects women.", {"entities": [[46, 53, "DISEASE"], [133, 140, "DISEASE"], [34, 40, "DISEASE"], [104, 110, "DISEASE"], [180, 186, "DISEASE"]]}], ["Systemic inflammation and mechanical effect, both due to the expansion of the adipose tissue, have been proposed as the main reasons for the association between obesity and asthma.", {"entities": [[161, 168, "DISEASE"], [173, 179, "DISEASE"]]}], ["However, the mechanisms involved are not yet fully understood.", {"entities": []}], ["Moreover, it has also been suggested that insulin resistance syndrome can have a role in the association between these conditions.", {"entities": [[61, 69, "DISEASE"]]}], ["The intestinal microbiota is an important factor in the development of the immune system, and can be considered a link between obesity and asthma.", {"entities": [[127, 134, "DISEASE"], [139, 145, "DISEASE"]]}], ["In the obese state, higher lipopolysaccharide (LPS) serum levels as a consequence of a microbiota dysbiosis have been found.", {"entities": []}], ["In addition, changes in microbiota composition result in a modification of carbohydrate fermentation capacity, therefore modifying short chain fatty acid (SCFA) levels.", {"entities": []}], ["The main objective of this review is to summarize the principal findings that link obesity and asthma.", {"entities": [[83, 90, "DISEASE"], [95, 101, "DISEASE"]]}], ["The white button mushroom, Agaricus bisporus , is the most commonly grown mushroom in Iran; however, there is a significant shortage of research on its antioxidant activity and other medicinal properties.", {"entities": []}], ["The aim of this study was to evaluate antioxidant capacity of the methanolic extracts from four cultivated strains and four Internal Transcribed Spacer (ITS)-identified, Iranian wild isolates of A .", {"entities": []}], ["Evaluations were made for total phenols, flavonoids and anthocyanins, and 2, 2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity.", {"entities": []}], ["Overall, results showed that all the wild isolates exhibited significantly lower DPPH-derived EC 50 , compared to the cultivated strains (p < 0.05).", {"entities": []}], ["A relatively high relationship was observed between total phenols and flavonoids or anthocyanins (r 50 s (r", {"entities": []}], ["Nonviral gene delivery is now considered a promising alternative to viral vectors.", {"entities": []}], ["Among nonviral gene delivery agents, polyethylenimine (PEI) has emerged as a potent candidate for gene delivery to the lung.", {"entities": []}], ["PEI has some advantages over other polycations in that it combines strong DNA compaction capacity with an intrinsic endosomolytic activity.", {"entities": []}], ["However, intracellular (mainly the nuclear membrane) and extracellular obstacles still hamper its efficiency in vitro and in vivo, depending on the route of administration and the type of PEI.", {"entities": []}], ["Nuclear delivery has been increased by adding nuclear localization signals.", {"entities": []}], ["To overcome nonspecific interactions with biological fluids, extracellular matrix components and nontarget cells, strategies have been developed to protect polyplexes from these interactions and to increase target specificity and gene expression.", {"entities": []}], ["When gene delivery into airway epithelial cells of the conducting airways is necessary, aerosolization of complexes seems to be better suited to guarantee higher transgene expression in the airway epithelial cells with lower toxicity than observed with either intratracheal or intravenous administration.", {"entities": []}], ["Aerosolization, indeed, is useful to target the alveolar epithelium and pulmonary endothelium.", {"entities": []}], ["Proof-of-principle that PEI-mediated gene delivery has therapeutic application to some genetic and acquired lung disease is presented, using as genetic material either plasmidic DNA or small-interfering RNA, although optimization of formulation and delivery protocols and limitation of toxicity need further studies.", {"entities": [[108, 120, "DISEASE"]]}], ["The present paper brings to the medical specialists\u2019 attention a possibility of multivalent imagistic investigation \u2013 the palmar electrographic method submitted to a totally new analysis by the fractal method.", {"entities": []}], ["Its support for information recording is the radiosensitive film.", {"entities": []}], ["This makes it resemble the radiological investigation, which opened the way of correlating the shape of certain structures of the organism with their function.", {"entities": []}], ["By the specific electromagnetic impressing of the ultra photosensitive film, palmar electrography has the advantage of catching the shape of certain radiative phenomena , generated by certain structures in their functional dynamics \u2013 at the level of the human palmar tegument.", {"entities": []}], ["This makes it resemble the EEG, EKG and EMG investigations.", {"entities": []}], ["The purpose of this presentation is to highlight a new modality of studying the states of the human organism in its permanent adaptation to the living environment, using a new anthropological, informational vision \u2013 by fractal processing and by the couple of concepts system / interface \u2013 much closer to reality than the present systemic thinking.", {"entities": []}], ["The human palm, which has a special medical-anthropological relevance, is analysed as a complex adaptive biological and socio-cultural interface between the internal and external environment.", {"entities": []}], ["The fractal phenomena recorded on the image are ubicuitary in nature and especially in the living world [ , , , ] and their shapes may be described mathematically and used for decoding their informational laws.", {"entities": []}], ["They may have very usefulimplications in the medical act.", {"entities": []}], ["The paper presents a few introductory elements to the fractal theory, and, in the final part, the pursued objectives are concretely shown by grouping the EG images according to certain more important medical-anthropological themes .", {"entities": []}], ["Despite advances in immunosuppressive drugs, long-term success of liver transplantation is still limited by the development of chronic liver allograft dysfunction.", {"entities": []}], ["Although the exact pathogenesis of chronic liver allograft dysfunction remains to be established, there is strong evidence that chemokines are involved in organ damage induced by inflammatory and immune responses after liver surgery.", {"entities": []}], ["Chemokines are a group of low-molecular-weight molecules whose function includes angiogenesis, haematopoiesis, mitogenesis, organ fibrogenesis, tumour growth and metastasis, and participating in the development of the immune system and in inflammatory and immune responses.", {"entities": []}], ["The purpose of this review is to collect all the research that has been done so far concerning chemokines and the pathogenesis of chronic liver allograft dysfunction and helpfully, to pave the way for designing therapeutic strategies and pharmaceutical agents to ameliorate chronic allograft dysfunction after liver transplantation.", {"entities": []}], ["The aims of this study were to assess the prevalence of diagnosed atrial fibrillation (AF), the drug use in patients with AF in terms of antithrombotic (AT) strategies used and the compliance with treatment, and to describe the characteristics of patients affected by AF in relation to treatment.", {"entities": []}], ["The data collected were provided from databases of general practitioners (GPs) of the Local Health Unit of Bologna in Italy.", {"entities": []}], ["From January 1, 2009, to December 31, 2012, all subjects aged \u226518 years followed by the 44 GPs enrolled in the study were evaluated, and the subjects with a diagnosis of AF were included in the analysis.", {"entities": []}], ["From 2009 to 2012, we identified 1,413 patients with a diagnosis of AF (2.09% of 67,517 patients of the 44 GPs).", {"entities": []}], ["A total of 1,413 patients with a diagnosis of AF (2.09% of 67,517 patients of the 44 GPs) were enrolled in the study.", {"entities": []}], ["During the study, 14% of the enrolled patients did not receive any prescription of ATs, 30% and 39.56% were treated only with antiplatelet (AP) agents and oral anticoagulants (OACs), respectively, and 16.28% of the patients received prescriptions for both an OAC and an AP agent; of the patients receiving prescriptions for both, only 4.17% received these therapies at the same time.", {"entities": []}], ["Among the OAC users, the percentage of patients still on treatment with the index drug during the last 3 months of observation was 76.9%.", {"entities": []}], ["Our findings emphasize that in an Italian real-world setting, the burden of AF in general population from a public health point of view underscores the need for improvement in utilization of appropriate ATs in patients with known AF.", {"entities": []}], ["Large-scale prospective cohort studies are invaluable in epidemiology, but they are increasingly difficult and costly to establish and follow-up.", {"entities": []}], ["More efficient methods for recruitment, data collection and follow-up are essential if such studies are to remain feasible with limited public and research funds.", {"entities": []}], ["Here, we discuss how these challenges were addressed in the UK COSMOS cohort study where fixed budget and limited time frame necessitated new approaches to consent and recruitment between 2009-2012.", {"entities": []}], ["Web-based e-consent and data collection should be considered in large scale observational studies, as they offer a streamlined experience which benefits both participants and researchers and save costs.", {"entities": []}], ["Commercial providers of register and marketing data, smartphones, apps, email, social media, and the internet offer innovative possibilities for identifying, recruiting and following up cohorts.", {"entities": []}], ["Using examples from UK COSMOS, this article sets out the dos and don\u2019ts for today's cohort studies and provides a guide on how best to take advantage of new technologies and innovative methods to simplify logistics and minimise costs.", {"entities": []}], ["Thus a more streamlined experience to the benefit of both research participants and researchers becomes achievable.", {"entities": []}], ["Despite access to various pharmacotherapies and counseling support to aid cessation, smokers typically demonstrate quit rates below 50%.", {"entities": []}], ["This report describes the results of a Phase 2a study exploring the efficacy of a liquid nicotine delivery system as an aid to smoking cessation assessed after 12 weeks of therapy.", {"entities": []}], ["A single-arm Phase 2a study was conducted.", {"entities": []}], ["Community-based smokers (ages 18+ years, smoking at least 10 cigarettes daily for the past year and interested in making a quit attempt) were recruited and completed clinic visits at 2 week intervals over the 12 week study period where carbon monoxide levels were assessed and the Smoke-Break product was rated on taste and overall satisfaction.", {"entities": []}], ["Participants were provided with a supply of liquid nicotine cigarettes (e.g., Smoke-Break) at each clinic visit.", {"entities": []}], ["A total of 69 smokers were enrolled and received the intervention product (intention to treat group, ITT) and 52 smokers verified participation (according to protocol group, ATP).", {"entities": []}], ["The cessation rate at 12 weeks after the baseline visit, assessed as the bioverified point prevalence of abstinence, was 71.1% (95% confidence interval [CI] 58.8%-83.5%) in the ATP group and 53.6% (41.8%-65.4%) in the ITT group.", {"entities": []}], ["Participants rated the liquid nicotine delivery system highly and also expressed general satisfaction.", {"entities": []}], ["Few adverse events were identified with no serious adverse events.", {"entities": []}], ["These results support the efficacy of the liquid nicotine delivery system in smoking cessation.", {"entities": []}], ["If this nicotine delivery product proves to be effective in larger trials, it could represent an inexpensive, readily accessible and well-tolerated agent to promote smoking cessation.", {"entities": []}], ["This trial is registered at clinicaltrials.gov as study NCT00715871.", {"entities": []}], ["Tetramethylpyrazine (TMP) is one of the active ingredients extracted from the Chinese herb Chuanxiong, which has been used to treat cerebrovascular and cardiovascular diseases, pulmonary diseases and cancer.", {"entities": [[200, 206, "DISEASE"]]}], ["However, the molecular mechanisms underlying the actions of TMP have not been fully elucidated.", {"entities": []}], ["In a previous study we showed that TMP-mediated glioma suppression and neural protection involves the inhibition of CXCR4 expression.", {"entities": [[116, 121, "GENE"]]}], ["The SDF-1/CXCR4 axis plays a fundamental role in many physiological and pathological processes.", {"entities": []}], ["In this study, we further investigated whether the regulation of the SDF-1/CXCR4 pathway is also involved in the TMP-mediated inhibition of neovascularization or fibrosis and improvement of microcirculation.", {"entities": []}], ["Using a scratch-wound assay, we demonstrated that TMP significantly suppressed the migration and tubule formation of the human umbilical vein endothelial cell line ECV304 in vitro.", {"entities": []}], ["The expression of CXCR4 in ECV304 cells is notably down-regulated after TMP treatment.", {"entities": [[18, 23, "GENE"]]}], ["In addition, TMP significantly suppresses corneal neovascularization in a rat model of corneal alkali burn injury.", {"entities": [[42, 68, "DISEASE"]]}], ["The expression of CXCR4 on days 1, 3 and 7 post-injury was determined through RT-PCR analysis.", {"entities": [[18, 23, "GENE"]]}], ["Consistent with our hypotheses, the expression of CXCR4 in the rat cornea is significantly increased with alkali burn and dramatically down-regulated with TMP treatment.", {"entities": [[50, 55, "GENE"]]}], ["Moreover, TMP treatment significantly attenuates bleomycin-induced rat pulmonary fibrosis, while immunofluorescence shows a notably decreased amount of CXCR4-positive cells in the TMP-treated group.", {"entities": [[71, 89, "DISEASE"]]}], ["Furthermore, TMP significantly down-regulates the expression of CXCR4 in platelets, lymphocytes and red blood cells.", {"entities": [[64, 69, "GENE"]]}], ["Whole-blood viscosity and platelet aggregation in rats are significantly decreased by TMP treatment.", {"entities": []}], ["These results show that TMP exerts potent effects in inhibiting neovascularization, fibrosis and thrombosis under pathological conditions; thus, the underlying mechanism of TMP might partially contribute to the down-regulation of CXCR4.", {"entities": [[230, 235, "GENE"]]}], ["Combination treatment of inhaled corticosteroid (ICS) plus long-acting \u03b22-agonist (LABA) is widely used as a maintenance regimen for the management of asthma.", {"entities": [[151, 157, "DISEASE"]]}], ["This study evaluated the effect of the \u03b22-adrenergic receptor (ADRB2) polymorphism on lung function and asthma control with regular use of combination treatment of an inhaled ICS plus LABA.", {"entities": [[104, 110, "DISEASE"], [63, 68, "GENE"]]}], ["43 Korean asthmatics who were symptomatic despite regular ICS use for at least 3 months were enrolled.", {"entities": []}], ["For a 2-week run-in period, they received ICS (budesonide 800 \u00b5g/day) plus terbutaline (5 \u00b5g prn).", {"entities": []}], ["During the 24-week active treatment period, they received budesonide 160 \u00b5g and formoterol 4.5 \u00b5g b.i.d.", {"entities": []}], ["as maintenance and rescue medication.", {"entities": []}], ["Pulmonary function and quality of life scores were monitored every 8 weeks; morning/evening peak expiratory flow meter (PEFR) was recorded daily.", {"entities": []}], ["Patients were genotyped for ADRB2 Arg16Gly using single base extension methodology.", {"entities": [[28, 33, "GENE"]]}], ["During the run-in period, there were no significant between-group differences in lung function; after 8 weeks of active treatment, Arg/Arg patients had significantly higher forced expiratory volume in 1 secord (FEV 1 ) and maximal mid-expiratory flow (MMEF) ( p = 0.023 and p = 0.021, respectively), and better asthma control and quality of life after 24 weeks ( p = 0.016 and p = 0.028, respectively).", {"entities": [[311, 317, "DISEASE"], [211, 214, "GENE"]]}], ["During treatment, there was a greater improvement in morning/evening PEFR in Arg/Arg patients.", {"entities": []}], ["Asthmatic patients with the Arg/Arg genotype at codon 16 of ADRB2 achieve better asthma control with long-term regular use of combined budesonide and formoterol treatment, suggesting that the ADRB2 genotype may dictate choice of treatment strategy.", {"entities": [[81, 87, "DISEASE"], [60, 65, "GENE"], [192, 197, "GENE"], [60, 65, "GENE"], [192, 197, "GENE"]]}], ["Haber-Bosch nitrogen (N) has been increasingly used in industrial products, e.g., nylon, besides fertilizer.", {"entities": []}], ["Massive numbers of species of industrial reactive N (Nr) have emerged and produced definite consequences but receive little notice.", {"entities": []}], ["Based on a comprehensive inventory, we show that (1) the industrial N flux has increased globally from 2.5 to 25.4\u2005Tg N yr x emissions from fossil fuel combustion; (2) more than 25% of industrial products (primarily structural forms, e.g., nylon) tend to accumulate in human settlements due to their long service lives; (3) emerging Nr species define new N-assimilation and decomposition pathways and change the way that Nr is released to the environment; and (4) the loss of these Nr species to the environment has significant negative human and ecosystem impacts.", {"entities": [[115, 117, "GENE"]]}], ["Incorporating industrial Nr into urban environmental and biogeochemical models could help to advance urban ecology and environmental sciences.", {"entities": []}], ["Objective .", {"entities": []}], ["Vernal keratoconjunctivitis (VKC) is a chronic recurrent bilateral inflammation of the conjunctiva associated with atopy.", {"entities": [[7, 27, "DISEASE"]]}], ["Several inflammatory and tissue remodeling factors contribute to VKC disease.", {"entities": []}], ["The aim is to provide a chip-based protein analysis in tears from patients suffering from quiescent or active VKC.", {"entities": []}], ["This study cohort included 16 consecutive patients with VKC and 10 controls.", {"entities": []}], ["Participants were subjected to clinical assessment of ocular surface and tear sampling.", {"entities": []}], ["Total protein quantification, total protein sketch, and protein array (sixty protein candidates) were evaluated.", {"entities": []}], ["An overall increased Fluorescent Intensity expression was observed in VKC arrays.", {"entities": []}], ["Particularly, IL1 \u03b2 , IL15, IL21, Eotaxin2, TACE, MIP1 \u03b1 , MIP3 \u03b1 , NCAM1, ICAM2, \u03b2 NGF, NT4, BDNF, \u03b2 FGF, SCF, MMP1, and MMP2 were increased in quiescent VKC.", {"entities": [[22, 26, "GENE"], [28, 32, "GENE"], [68, 73, "GENE"], [75, 80, "GENE"], [84, 87, "GENE"], [94, 98, "GENE"], [112, 116, "GENE"], [122, 126, "GENE"]]}], ["Of those candidates, only IL1 \u03b2 , IL15, IL21, \u03b2 NGF, SCF, MMP2, Eotaxin2, TACE, MIP1 \u03b1 , MIP3 \u03b1 , NCAM1, and ICAM2 were increased in both active and quiescent VKC.", {"entities": [[34, 38, "GENE"], [40, 44, "GENE"], [48, 51, "GENE"], [58, 62, "GENE"], [98, 103, "GENE"], [109, 114, "GENE"]]}], ["Finally, NT4, \u03b2 FGF, and MMP1 were highly increased in active VKC.", {"entities": [[25, 29, "GENE"]]}], ["Conclusion .", {"entities": []}], ["A distinct \u201cprotein tear-print\u201d characterizes VKC activity, confirming some previously reported factors and highlighting some new candidates common to quiescent and active states.", {"entities": []}], ["Those candidates expressed in quiescent VKC might be considered as predictive indicators of VKC reactivation and/or exacerbation out-of-season.", {"entities": []}], ["Self-management is recognised as an essential criteria for the provision of high quality care for chronic obstructive pulmonary disease (COPD).", {"entities": [[98, 135, "DISEASE"]]}], ["The management of COPD is usually delivered by a wide range of healthcare practitioners.", {"entities": []}], ["This study aimed to understand the factors affecting self-management of COPD from the perspectives of the different multidisciplinary healthcare teams involved in COPD care.", {"entities": []}], ["Semi-structured interviews were conducted with participants from primary care, specialist respiratory and pulmonary rehabilitation (PR) teams.", {"entities": []}], ["Purposive sampling and snowballing were employed in participant recruitment.", {"entities": []}], ["All interviews were audio-recorded and transcribed verbatim and data were analysed thematically.", {"entities": []}], ["A total of 20 participants (eight primary care practitioners, seven respiratory specialists and five PR practitioners) were interviewed until data saturation was reached.", {"entities": []}], ["Participants identified a range of complex and interrelated factors affecting COPD self-management that were grouped into three broad categories\u2014patient, practitioner and organisational/system-level factors.", {"entities": []}], ["Patient-level factors were predominantly considered as barriers, with COPD knowledge and understanding, and the individual patients\u2019 life circumstances/context being the most prominent issues.", {"entities": []}], ["Practitioner-level factors identified were practitioners\u2019 speciality, interest and experience in respiratory conditions as the overarching factor that influenced how self-management was understood and practiced.", {"entities": []}], ["A number of organisational/system-level factors were identified by all practitioners, including inconsistency of referral pathways and the wide variations of different self-management planning tools.", {"entities": []}], ["Factors affecting self-management of COPD across these three levels need to be tackled equally in order to improve the effectiveness of interventions and to embed and integrate self-management support approaches into routine practice.", {"entities": []}], ["Better co-ordination between healthcare services, practitioners and patients may help improve self-management for chronic lung disease.", {"entities": [[122, 134, "DISEASE"]]}], ["Self-management is crucial for patients with chronic obstructive pulmonary disease (COPD), but it can be difficult for healthcare workers to monitor and support patient progress.", {"entities": [[45, 82, "DISEASE"]]}], ["Oladapo Ogunbayo at Newcastle University, UK, and co-workers conducted interviews with healthcare practitioners to explore perceived barriers to successful self-management of COPD.", {"entities": []}], ["Three distinct categories emerged; those at patient level, practitioner level and organisational level, the needs of which should be carefully balanced to improved self-management.", {"entities": []}], ["Patient knowledge and understanding of COPD, alongside individual life circumstances, were often barriers to effective self-care.", {"entities": []}], ["Those practitioners with specialist respiratory knowledge took a more holistic approach to self-management than their primary care counterparts.", {"entities": []}], ["A lack of continuity between services and across self-management planning tools presented further barriers.", {"entities": []}], ["Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovitis leading to destruction of cartilage and bone.", {"entities": [[11, 20, "DISEASE"], [76, 85, "DISEASE"]]}], ["PLA2 enzymes are key players in inflammation regulating the release of unsaturated fatty acids such as arachidonic acid (AA), a precursor of pro-inflammatory eicosanoids.", {"entities": []}], ["Several lines of evidence point to toll-like receptors (TLRs) as drivers of synovitis and joint destruction in RA.", {"entities": [[76, 85, "DISEASE"]]}], ["However, few studies have addressed the implication of PLA2 activity downstream TLR activation in the synovium.", {"entities": []}], ["Here, we aimed to characterize PLA2 enzyme involvement in TLR2-induced signaling in synovial fibroblast-like cells.", {"entities": []}], ["TLRs1-7 and a range of sPLA2, iPLA2 and cPLA2 enzymes were found to be transcriptionally expressed in cultured synoviocytes.", {"entities": []}], ["Activation of TLR2/1 and TLR2/6 led to phosphorylation of cPLA2\u03b1 at Ser 2 production; effects that were attenuated by cPLA2\u03b1 inhibitors.", {"entities": []}], ["In contrast, sPLA2 inhibitors did not affect AA or PGE 2 release.", {"entities": []}], ["cPLA2\u03b1 inhibitors furthermore attenuated TLR-induced expression of IL-6, IL-8 and COX2.", {"entities": []}], ["COX1/2 inhibitors attenuated TLR2/6-induced IL-6 transcription and protein production comparable to cPLA2\u03b1 inhibition.", {"entities": []}], ["Moreover, exogenously PGE 2 added alone induced IL-6 production and completely rescued IL-6 transcription when added simultaneously with FSL-1 in the presence of a cPLA2\u03b1 inhibitor.", {"entities": []}], ["Our results demonstrate for the first time that cPLA2\u03b1 is involved in TLR2/1- and TLR2/6-induced AA release, PGE 2 production and pro-inflammatory cytokine expression in synoviocytes, possibly through COX/PGE 2 -dependent pathways.", {"entities": []}], ["These findings expand our understanding of cPLA2\u03b1 as a modulator of inflammatory molecular mechanisms in chronic diseases such as RA.", {"entities": []}], ["Cystic fibrosis airways are deficient for L-arginine, a substrate for nitric oxide synthases (NOSs) and arginases.", {"entities": []}], ["The rationale for this study was to quantify NOS and arginase activity in the mouse lung.", {"entities": []}], ["Anesthetized unventilated mice received a primed constant stable isotope intravenous infusion containing labeled L-arginine, ornithine, and citrulline.", {"entities": []}], ["The isotopic enrichment of each of the infused isotopomers and its product amino acids were measured in plasma and organ homogenates using liquid chromatography-tandem mass spectrometry.", {"entities": []}], ["The effect of infection was studied three days after direct tracheal instillation of Pseudomonas-coated agar beads.", {"entities": []}], ["In the infusion model, lung infection resulted in a significant (28-fold) increase in NOS activity in lung but not in trachea, kidney, liver, or plasma.", {"entities": []}], ["Absolute rates of arginase activity in solid tissues could not be calculated in this model.", {"entities": []}], ["In an isolated lung perfusion model used for comparison increased NOS activity in infected lungs was confirmed (28.5-fold) and lung arginase activity was increased 9.7-fold.", {"entities": []}], ["The activity of L-arginine metabolizing enzymes can be measured using stable isotope conversion in the mouse.", {"entities": []}], ["Accumulation of L-ornithine in the whole mouse model hindered the exact quantification of arginase activity in the lung, a problem that was overcome utilizing an isolated lung perfusion model.", {"entities": []}], ["Asthma exacerbations remain a major unmet clinical need.", {"entities": [[0, 6, "DISEASE"]]}], ["The difficulty in obtaining airway tissue and bronchoalveolar lavage samples during exacerbations has greatly hampered study of naturally occurring exacerbations.", {"entities": []}], ["This study was conducted to determine if mRNA profiling of peripheral blood mononuclear cells (PBMCs) could provide information on the systemic molecular pathways involved during asthma exacerbations.", {"entities": [[179, 185, "DISEASE"]]}], ["Over the course of one year, gene expression levels during stable asthma, exacerbation, and two weeks after an exacerbation were compared using oligonucleotide arrays.", {"entities": [[66, 72, "DISEASE"]]}], ["For each of 118 subjects who experienced at least one asthma exacerbation, the gene expression patterns in a sample of peripheral blood mononuclear cells collected during an exacerbation episode were compared to patterns observed in multiple samples from the same subject collected during quiescent asthma.", {"entities": [[54, 60, "DISEASE"], [299, 305, "DISEASE"]]}], ["Analysis of covariance identified genes whose levels of expression changed during exacerbations and returned to quiescent levels by two weeks.", {"entities": []}], ["Heterogeneity among visits in expression profiles was examined using K-means clustering.", {"entities": []}], ["Three distinct exacerbation-associated gene expression signatures were identified.", {"entities": []}], ["One signature indicated that, even among patients without symptoms of respiratory infection, genes of innate immunity were activated.", {"entities": []}], ["Antigen-independent T cell activation mediated by IL15 was also indicated by this signature.", {"entities": [[50, 54, "GENE"]]}], ["A second signature revealed strong evidence of lymphocyte activation through antigen receptors and subsequent downstream events of adaptive immunity.", {"entities": []}], ["The number of genes identified in the third signature was too few to draw conclusions on the mechanisms driving those exacerbations.", {"entities": []}], ["This study has shown that analysis of PBMCs reveals systemic changes accompanying asthma exacerbation and has laid the foundation for future comparative studies using PBMCs.", {"entities": [[82, 88, "DISEASE"]]}], ["Migraine constitutes 16% of primary headaches affecting 10-20% of general population according to International Headache Society.", {"entities": [[0, 8, "DISEASE"]]}], ["Till now nonsteroidalanti-inflammatory drugs (NSAIDS), opioids and triptans are the drugs being used for acute attack of migraine.", {"entities": [[121, 129, "DISEASE"]]}], ["Substances with proven efficacy for prevention include \u03b2-blockers, calcium channel blockers, antiepileptic drugs and antidepressants.", {"entities": []}], ["All the already available drugs have certain limitations.", {"entities": []}], ["Either they are unable to produce complete relief or 30-40% patients are no responders or drugs produce adverse effects.", {"entities": []}], ["This necessitates the search for more efficacious and well-tolerated drugs.", {"entities": []}], ["A new class of drugs like angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor antagonists have recently been studied for their off label use in prophylaxis of migraine.", {"entities": [[193, 201, "DISEASE"]]}], ["Studies, done so far, have shown results in favour of their clinical use because of the ability to reduce number of days with headache, number of days with migraine, hours with migraine, headache severity index, level of disability, improved Quality of life and decrease in consumption of specific or nonspecific analgesics.", {"entities": [[156, 164, "DISEASE"], [177, 185, "DISEASE"]]}], ["This article reviews the available evidence on the efficacy and safety of these drugs in prophylaxis of migraine and can give physician a direction to use these drugs for chronic migraineurs.", {"entities": [[104, 112, "DISEASE"]]}], ["Searches of pubmed, Cochrane database, Medscape, Google and clinicaltrial.org were made using terms like ACE inhibitors, angiotensin II receptor antagonists and migraine.", {"entities": [[161, 169, "DISEASE"]]}], ["Relevant journal articles were chosen to provide necessary information.", {"entities": []}], ["Clinical teachers often observe interactions that may contribute to health care disparities, yet may hesitate to teach about them.", {"entities": []}], ["A pedagogical model could help faculty structure teaching about health care disparities in the clinical setting, but to our knowledge, none have been adapted for this purpose.", {"entities": []}], ["In this paper, we adapt an established model, Time-Effective Strategies for Teaching (TEST), to the teaching of health care disparities.", {"entities": []}], ["We use several case scenarios to illustrate the core components of the model: diagnose the learner, teach rapidly to the learner\u2019s need, and provide feedback.", {"entities": []}], ["The TEST model is straightforward, easy to use, and enables the incorporation of teaching about health care disparities into routine clinical teaching.", {"entities": []}], ["Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have been shown to be vitamin D3 (VD3) deficient, which is associated with more severe disease and increased polyp size.", {"entities": []}], ["To gain mechanistic insights into these observational studies, we examined the impact of VD3 deficiency on inflammation and VD3 metabolism in an Aspergillus fumigatus (Af) mouse model of chronic rhinosinusitis (Af-CRS).", {"entities": []}], ["Balb/c mice were fed control or VD3 deficient diet for 4 weeks.", {"entities": []}], ["Mice were then sensitized with intraperitoneal Af, and one week later given Af intranasally every three days for four weeks while being maintained on control or VD3 deficient diet.", {"entities": []}], ["Airway function, sinonasal immune cell infiltrate and sinonasal VD3 metabolism profiles were then examined.", {"entities": []}], ["Mice with VD3 deficiency had increased Penh and sRaw values as compared to controls as well as exacerbated changes in sRaw when coupled with Af-CRS.", {"entities": []}], ["As compared to controls, VD3 deficient and Af-CRS mice had reduced sinonasal 1\u03b1-hydroxylase and the active VD3 metabolite, 1,25(OH) 2 D 3 .", {"entities": []}], ["Differential analysis of nasal lavage samples showed that VD3 deficiency alone and in combination with Af-CRS profoundly upregulated eosinophil, neutrophil and lymphocyte numbers.", {"entities": []}], ["VD3 deficiency exacerbated increases in monocyte-derived dendritic cell (DC) associated with Af-CRS.", {"entities": []}], ["Conversely, T-regulatory cells were decreased in both Af-CRS mice and VD3 deficient mice, though coupling VD3 deficiency with Af-CRS did not exacerbate CD4 or T-regulatory cells numbers.", {"entities": [[152, 155, "GENE"]]}], ["Lastly, VD3 deficiency had a modifying or exacerbating impact on nasal lavage levels of IFN-\u03b3, IL-6, IL-10 and TNF-\u03b1, but had no impact on IL-17A.", {"entities": []}], ["VD3 deficiency causes changes in sinonasal immunity, which in many ways mirrors the changes observed in Af-CRS mice, while selectively exacerbating inflammation.", {"entities": []}], ["Furthermore, both VD3 deficiency and Af-CRS were associated with altered sinonasal VD3 metabolism causing reductions in local levels of the active VD3 metabolite, 1,25(OH) 2 D 3 , even with adequate circulating levels.", {"entities": []}], ["Literature shows the effects of type of cancer and/or anticancer treatment on live birth percentages and/or pregnancy and neonatal complications in female cancer survivors.", {"entities": [[40, 46, "DISEASE"], [155, 161, "DISEASE"]]}], ["However, studies analyzing the obstetric and offspring risks of the morbid conditions associated with previous anti-cancer treatments are missing.", {"entities": [[116, 122, "DISEASE"]]}], ["The present review aims to uncover these risks.", {"entities": []}], ["A literature search based on publications up to March 2016 identified by PubMed and references cited in relevant articles.", {"entities": []}], ["The morbid conditions associated with prior anticancer treatments including chemotherapy, radiotherapy, surgery, and/or hematopoietic stem-cell transplant may induce not only obstetric and neonatal complications but also long-term effects on offspring.", {"entities": []}], ["Whereas some risks are predominantly evidenced in untreated women others are observed in both treated and untreated women.", {"entities": []}], ["These risks may be superimposed on those induced by the current women\u2019s trend in Western societies to postpone maternity.", {"entities": []}], ["Medical professionals should be aware and inform female cancer survivors wishing to have a child not only of the short- and long-term risks to themselves and their prospective offspring of previous anticancer treatments, fertility-preservation technologies, and pregnancy itself, but also of those risks linked to the morbid conditions induced by prior anticancer treatments.", {"entities": [[56, 62, "DISEASE"]]}], ["Once female cancer survivors wishing to have a child have been properly informed about the risks of reproduction, they will be best placed to make decisions of whether or not to have a biological or donor-conceived child.", {"entities": [[12, 18, "DISEASE"]]}], ["In addition, when medical professionals be aware of these risks, they will be also best placed to provide appropriate treatments before/during pregnancy in order to prevent or alleviate the impact of these morbid conditions on maternal and offspring health.", {"entities": []}], ["Pollen is a clinically important airborne allergen and one of the major causes of allergic conjunctivitis.", {"entities": [[82, 105, "DISEASE"], [91, 105, "DISEASE"]]}], ["A subpopulation of patients with atopic dermatitis (AD) are also known to have exacerbated skin eruptions on the face, especially around the eyelids, after contact with pollen.", {"entities": [[33, 50, "DISEASE"], [40, 50, "DISEASE"]]}], ["This pollen-induced skin reaction is now known as pollen dermatitis.", {"entities": [[57, 67, "DISEASE"]]}], ["Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that plays an essential role in allergic inflammation.", {"entities": [[40, 43, "GENE"]]}], ["Recent findings suggest that MIF is involved in several allergic disorders, including AD.", {"entities": [[29, 32, "GENE"]]}], ["In this study, MIF knockout (KO), MIF transgenic (Tg) and WT littermate mice were immunized with ragweed (RW) pollen or Japanese cedar (JC) pollen and challenged via eye drops.", {"entities": [[15, 18, "GENE"], [34, 37, "GENE"], [15, 18, "GENE"], [34, 37, "GENE"], [50, 52, "GENE"]]}], ["We observed that the numbers of conjunctiva- and eyelid-infiltrating eosinophils were significantly increased in RW and JC pollen-sensitized MIF Tg compared with WT mice or MIF KO mice.", {"entities": [[141, 144, "GENE"], [173, 176, "GENE"], [145, 147, "GENE"], [141, 144, "GENE"], [173, 176, "GENE"]]}], ["The mRNA expression levels of eotaxin, interleukin (IL)-5 and IL-13 were increased in pollen-sensitized eyelid skin sites of MIF Tg mice.", {"entities": [[125, 128, "GENE"], [129, 131, "GENE"]]}], ["An in vitro analysis revealed that high eotaxin expression was induced in dermal fibroblasts by MIF combined with stimulation of IL-4 or IL-13.", {"entities": [[96, 99, "GENE"]]}], ["This eotaxin expression was inhibited by the treatment with CD74 siRNA in fibroblasts.", {"entities": [[60, 64, "GENE"]]}], ["These findings indicate that MIF can induce eosinophil accumulation in the conjunctiva and eyelid dermis exposed to pollen.", {"entities": [[29, 32, "GENE"]]}], ["Therefore, targeted inhibition of MIF might result as a new option to control pollen-induced allergic conjunctivitis and pollen dermatitis.", {"entities": [[93, 116, "DISEASE"], [102, 116, "DISEASE"], [128, 138, "DISEASE"], [34, 37, "GENE"]]}], ["This paper describes the background, aim, and design of a prospective birth-cohort study in Korea called the COhort for Childhood Origin of Asthma and allergic diseases (COCOA).", {"entities": []}], ["COCOA objectives are to investigate the individual and interactive effects of genetics, perinatal environment, maternal lifestyle, and psychosocial stress of mother and child on pediatric susceptibility to allergic diseases.", {"entities": []}], ["The participants in COCOA represents a Korean inner-city population.", {"entities": []}], ["Recruitment started on 19 November, 2007 and will continue until 31 December, 2015.", {"entities": []}], ["Recruitment is performed at five medical centers and eight public-health centers for antenatal care located in Seoul.", {"entities": []}], ["Participating mother-baby pairs are followed from before birth to adolescents.", {"entities": []}], ["COCOA investigates whether the following five environmental variables contribute causally to the development and natural course of allergic diseases: (1) perinatal indoor factors ( i.e.", {"entities": []}], ["house-dust mite, bacterial endotoxin, tobacco smoking, and particulate matters 2.5 and 10), (2) perinatal outdoor pollutants, (3) maternal prenatal psychosocial stress and the child\u2019s neurodevelopment, (4) perinatal nutrition, and (5) perinatal microbiome.", {"entities": []}], ["Cord blood and blood samples from the child are used to assess whether the child\u2019s genes and epigenetic changes influence allergic-disease susceptibility.", {"entities": []}], ["Thus, COCOA aims to investigate the contributions of genetics, epigenetics, and various environmental factors in early life to allergic-disease susceptibility in later life.", {"entities": []}], ["How these variables interact to shape allergic-disease susceptibility is also a key aim.", {"entities": []}], ["The COCOA data collection schedule includes 11 routine standardized follow-up assessments of all children at 6\u00a0months and every year until 10\u00a0years of age, regardless of allergic-disease development.", {"entities": []}], ["The mothers will complete multiple questionnaires to assess the baseline characteristics, the child\u2019s exposure to environmental factors, maternal pre- and post-natal psychological stress, and the child\u2019s neurodevelopment, nutritional status, and development of allergic and respiratory illnesses.", {"entities": []}], ["The child\u2019s microbiome, genes, epigenetics, plasma cytokine levels, and neuropsychological status, the microbiome of the residence, and the levels of indoor and outdoor pollutants are measured by standard procedures.", {"entities": []}], ["The COCOA study will improve our understanding of how individual genetic or environmental risk factors influence susceptibility to allergic disease and how these variables interact to shape the phenotype of allergic diseases.", {"entities": []}], ["Self-management support is a key component of effective chronic care management, yet in practice appears to be the least implemented and most challenging.", {"entities": []}], ["This study explores whether and how self-management support is integrated into chronic care approaches in 13 European countries.", {"entities": []}], ["In addition, it investigates the level of and barriers to implementation of support strategies in health care practice.", {"entities": []}], ["We conducted a review among the 13 participating countries, based on a common data template informed by the Chronic Care Model.", {"entities": []}], ["Key informants presented a sample of representative chronic care approaches and related self-management support strategies.", {"entities": []}], ["The cross-country review was complemented by a Dutch case study of health professionals\u2019 views on the implementation of self-management support in practice.", {"entities": []}], ["Self-management support for chronically ill patients remains relatively underdeveloped in Europe.", {"entities": []}], ["Similarities between countries exist mostly in involved providers (nurses) and settings (primary care).", {"entities": []}], ["Differences prevail in mode and format of support, and materials used.", {"entities": []}], ["Support activities focus primarily on patients\u2019 medical and behavioral management, and less on emotional management.", {"entities": []}], ["According to Dutch providers, self-management support is not (yet) an integral part of daily practice; implementation is hampered by barriers related to, among others, funding, IT and medical culture.", {"entities": []}], ["Although collaborative care for chronic conditions is becoming more important in European health systems, adequate self-management support for patients with chronic disease is far from accomplished in most countries.", {"entities": []}], ["There is a need for better understanding of how we can encourage both patients and health care providers to engage in productive interactions in daily chronic care practice, which can improve health and social outcomes.", {"entities": []}], ["Chronic cough is associated with airway inflammation and remodelling.", {"entities": []}], ["Abnormal airway smooth muscle cell (ASMC) function may underlie mechanisms of chronic cough.", {"entities": []}], ["Our objective was to examine the transcriptome and focused secretome of ASMCs from chronic cough patients and healthy non-cough volunteers.", {"entities": []}], ["ASMC gene expression profiling was performed at baseline and/or after stimulation with polyinosinic:polycytidylic acid (poly(I:C)) to mimic viral infection.", {"entities": []}], ["Supernatants were collected for multiplex analysis.", {"entities": []}], ["Our results showed no significant differentially expressed genes (DEGs, false discovery rate (FDR) <0.05) between chronic cough and healthy non-cough ASMCs at baseline.", {"entities": []}], ["Poly(I:C) stimulation resulted in 212 DEGs (>1.5 fold-change, FDR <0.05) in ASMCs from chronic cough patients compared with 1674 DEGs in healthy non-cough volunteers.", {"entities": []}], ["The top up-regulated genes included chemokine (C\u2013X\u2013C motif) ligand (CXCL) 11 ( CXCL11 ), CXCL10 , chemokine (C\u2013C motif) ligand (CCL) 5 ( CCL5 ) and interferon-induced protein 44 like ( IFI44L ) corresponding with inflammation and innate immune response pathways.", {"entities": [[79, 85, "GENE"], [89, 95, "GENE"], [137, 141, "GENE"], [185, 191, "GENE"]]}], ["ASMCs from cough subjects had enhanced activation of viral response pathways in response to poly(I:C) compared with healthy non-cough subjects, reduced activation of pathways involved in chronic inflammation and equivalent activation of neuroregulatory genes.", {"entities": []}], ["The poly(I:C)-induced release of inflammatory mediators, including CXCL8, interleukin (IL)-6 and CXCL1, from ASMCs from cough patients was significantly impaired compared with healthy non-cough subjects.", {"entities": [[97, 102, "GENE"]]}], ["Addition of fluticasone propionate (FP) to poly(I:C)-treated ASMCs resulted in greater gene expression changes in healthy non-cough ASMCs.", {"entities": []}], ["FP had a differential effect on poly(I:C)-induced mediator release between chronic cough and healthy non-cough volunteers.", {"entities": []}], ["In conclusion, altered innate immune and inflammatory gene profiles within ASMCs, rather than infiltrating cells or nerves, may drive the cough response following respiratory viral infection.", {"entities": []}], ["Guidelines for assessing methodological and reporting quality of systematic reviews (SRs) were developed to contribute to implementing evidence-based health care and the reduction of research waste.", {"entities": []}], ["As SRs assessing a cohort of SRs is becoming more prevalent in the literature and with the increased uptake of SR evidence for decision-making, methodological quality and standard of reporting of SRs is of interest.", {"entities": []}], ["The objective of this study is to evaluate SR adherence to the Quality of Reporting of Meta-analyses (QUOROM) and PRISMA reporting guidelines and the A Measurement Tool to Assess Systematic Reviews (AMSTAR) and Overview Quality Assessment Questionnaire (OQAQ) quality assessment tools as evaluated in methodological overviews.", {"entities": []}], ["The Cochrane Library, MEDLINE\u00ae, and EMBASE\u00ae databases were searched from January 1990 to October 2014.", {"entities": []}], ["Title and abstract screening and full-text screening were conducted independently by two reviewers.", {"entities": []}], ["Reports assessing the quality or reporting of a cohort of SRs of interventions using PRISMA, QUOROM, OQAQ, or AMSTAR were included.", {"entities": []}], ["All results are reported as frequencies and percentages of reports and SRs respectively.", {"entities": []}], ["Of the 20,765 independent records retrieved from electronic searching, 1189 reports were reviewed for eligibility at full text, of which 56 reports (5371 SRs in total) evaluating the PRISMA, QUOROM, AMSTAR, and/or OQAQ tools were included.", {"entities": []}], ["Notable items include the following: of the SRs using PRISMA, over 85% (1532/1741) provided a rationale for the review and less than 6% (102/1741) provided protocol information.", {"entities": []}], ["For reports using QUOROM, only 9% (40/449) of SRs provided a trial flow diagram.", {"entities": []}], ["However, 90% (402/449) described the explicit clinical problem and review rationale in the introduction section.", {"entities": []}], ["Of reports using AMSTAR, 30% (534/1794) used duplicate study selection and data extraction.", {"entities": []}], ["Conversely, 80% (1439/1794) of SRs provided study characteristics of included studies.", {"entities": []}], ["In terms of OQAQ, 37% (499/1367) of the SRs assessed risk of bias (validity) in the included studies, while 80% (1112/1387) reported the criteria for study selection.", {"entities": []}], ["Although reporting guidelines and quality assessment tools exist, reporting and methodological quality of SRs are inconsistent.", {"entities": []}], ["Mechanisms to improve adherence to established reporting guidelines and methodological assessment tools are needed to improve the quality of SRs.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-017-0527-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Supplemental Digital Content is Available in the Text.", {"entities": []}], ["Article first published online 10 June 2016.", {"entities": []}], ["Orofacial granulomatosis (OFG) is a rare, inflammatory disorder of the mouth, in which some patients also have intestinal Crohn's disease (CD).", {"entities": []}], ["The etiology remains largely unknown, although there is a high prevalence of atopy, and oral granulomas are also seen in other immune disorders particularly CD and sarcoidosis.", {"entities": [[164, 175, "DISEASE"]]}], ["We investigated whether genetic variants associated with an increased risk of CD, sarcoidosis, or atopy were also associated with susceptibility to OFG.", {"entities": [[82, 93, "DISEASE"]]}], ["Patients were stratified clinically as isolated oral manifestations (OFG only) or concurrent intestinal CD (OFG+CD).", {"entities": []}], ["We genotyped 201 patients and 1023 healthy controls for risk variants in NOD2, IRGM, IL23R, ATG16L1 (CD), BTNL2 (sarcoidosis), and FLG (atopy).", {"entities": [[113, 124, "DISEASE"], [73, 77, "GENE"], [79, 83, "GENE"], [85, 90, "GENE"], [92, 99, "GENE"], [106, 111, "GENE"], [131, 134, "GENE"]]}], ["The coding regions of the NOD2 gene were screened for rare, potentially pathogenic variants in OFG.", {"entities": [[26, 30, "GENE"]]}], ["A combined analysis of 3 CD-risk variants in NOD2 showed no association with any OFG subgroup.", {"entities": [[45, 49, "GENE"]]}], ["NOD2 p.L1007insC was associated with OFG+CD ( P = 0.023) and IL23R p.R381Q with all OFG ( P = 0.031).", {"entities": [[0, 4, "GENE"], [61, 66, "GENE"]]}], ["The sarcoidosis risk variant rs2076530 in BTNL2 was associated with all OFG ( P = 0.013).", {"entities": [[4, 15, "DISEASE"], [42, 47, "GENE"]]}], ["We identified 7 rare missense NOD2 alleles in 8 individuals with OFG, 4 OFG-only patients and 4 patients with OFG+CD.", {"entities": [[30, 34, "GENE"]]}], ["There was a significant enrichment of NOD2 variants in the OFG+CD group compared to the OFG-only group ( P = 0.008, common variants; P = 0.04, all common and rare variants).", {"entities": [[38, 42, "GENE"]]}], ["Our findings suggest that genetic variants in NOD2 are only associated with OFG in patients with concurrent intestinal disease.", {"entities": [[108, 126, "DISEASE"], [46, 50, "GENE"]]}], ["A genome-wide association scan is needed to fully define the genetic architecture of OFG.", {"entities": []}], ["To explore changes in healthcare professionals\u2019 views about the diagnosis and management of heart failure since a study in 2003.", {"entities": []}], ["Focus groups and a national online cross-sectional survey.", {"entities": []}], ["Focus groups (n=8 with a total of 56 participants) were conducted in the North East of England using a phenomenological framework and purposive sampling, informing a UK online survey (n=514).", {"entities": []}], ["4 categories were identified as contributing to variations in the diagnosis and management of heart failure.", {"entities": []}], ["Three previously known categories included: uncertainty about clinical practice, the value of clinical guidelines and tensions between individual and organisational practice.", {"entities": []}], ["A new category concerned uncertainty about end-of-life care.", {"entities": []}], ["Survey responses found that confidence varied among professional groups in diagnosing left ventricular systolic dysfunction (LVSD): 95% of cardiologists, 93% of general physicians, 66% of general practitioners (GPs) and 32% of heart failure nurses.", {"entities": []}], ["For heart failure with preserved ejection fraction (HFpEF), confidence levels were much lower: 58% of cardiologists, 43% of general physicians, 7% of GPs and 6% of heart failure nurses.", {"entities": []}], ["Only 5\u201335% of respondents used natriuretic peptides for LVSD or HFpEF.", {"entities": []}], ["Confidence in interpreting test findings was fundamental to the use of all diagnostic tests.", {"entities": []}], ["Clinical guidelines were reported to be helpful when diagnosing LVSD by 33% of nurses and 50\u201356% of other groups, but fell to 5\u201328% for HFpEF.", {"entities": []}], ["Some GPs did not routinely initiate diuretics (23%), ACE-inhibitors (22%) or \u03b2-blockers (38%) for LVSD for reasons including historical teaching, perceived side effects and burden of monitoring.", {"entities": []}], ["For end-of-life care, there was no consensus about responsibility for heart failure management.", {"entities": []}], ["Reported differences in the way heart failure is diagnosed and managed have changed little in the past decade.", {"entities": []}], ["Variable access to diagnostic tests, modes of care delivery and non-uniform management approaches persist.", {"entities": []}], ["The current National Health Service (NHS) context may not be conducive to addressing these issues.", {"entities": [[37, 40, "GENE"]]}], ["Clinical targeting of TNFR family of receptors (CD40, CD134 and CD137) with immunostimulatory monoclonal antibodies has been successful in cancer immunotherapy.", {"entities": [[139, 145, "DISEASE"], [48, 52, "GENE"]]}], ["However, targeting of CD27 with a mAb is a relatively new approach to provide costimulation of immune cells undergoing activation.", {"entities": [[22, 26, "GENE"]]}], ["Thus, activation of human CD27 (TNFRSF7) with a monoclonal antibody (varlilumab) has previously been demonstrated to result in T cell activation and anti-tumor activity in preclinical models, and is currently in early phase clinical trials in patients with advanced malignancies.", {"entities": [[26, 30, "GENE"]]}], ["In this study we used an in vitro system using human peripheral blood T cells to characterize the varlilumab-mediated costimulatory effects in combination with TCR stimulation in terms of phenotypic, transcriptional and functionality changes.", {"entities": []}], ["T cells were isolated from normal volunteer PBMCs using magnetic bead isolation kits and stimulated in vitro with plate bound anti-CD3 Ab (OKT3) and varlilumab or control Ab for 72\u00a0h. Activation profiles were monitored by ELISA or Luminex-based testing cytokine/chemokine releases, cell surface phenotyping for costimulatory and coinhibitory markers and CFSE dye dilution by proliferating T cells and Tregs.", {"entities": []}], ["Changes in gene expression and transcriptome analysis of varlilumab-stimulated T cells was carried on Agilent Human whole genome microarray datasets using a suite of statistical and bioinformatic software tools.", {"entities": []}], ["Costimulation of T cells with varlilumab required continuous TCR signaling as pre-activated T cells were unable to produce cytokines with CD27 signaling alone.", {"entities": [[138, 142, "GENE"]]}], ["Analysis of T cell subsets further revealed that memory CD4+ and CD8+ T cells were specifically activated with a bias toward CD8+ T lymphocyte proliferation.", {"entities": []}], ["Activation was accompanied by upregulated cell surface expression of costimulatory [4-1BB, OX40, GITR and ICOS] and coinhibitory [PD-1] molecules.", {"entities": [[106, 110, "GENE"]]}], ["Importantly, varlilumab costimulation did not activate purified Tregs as measured by cytokine production, proliferation and suppression of dividing non-Treg T cells.", {"entities": []}], ["Analysis of changes in gene expression during varlilumab stimulation of T cells revealed modulation of pro-inflammatory signatures consistent with cellular activation and proliferation, with the IL-2 pathway showing the highest frequency of gene modulation.", {"entities": []}], ["Altogether, the data reveal the requirements and T cell subtype-specific effects of CD27 costimulation, and helps select relevant biomarkers for studying the effects of varlilumab in patients.", {"entities": [[84, 88, "GENE"]]}], ["The online version of this article (doi:10.1186/s40425-015-0080-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The X chromosome plays an important role in human diseases and traits.", {"entities": []}], ["However, few X-linked associations have been reported in genome-wide association studies, partly due to analytical complications and low statistical power.", {"entities": []}], ["In this study, we propose tests of X-linked association that capitalize on variance heterogeneity caused by various factors, predominantly the process of X-inactivation.", {"entities": []}], ["In the presence of X-inactivation, the expression of one copy of the chromosome is randomly silenced.", {"entities": []}], ["Due to the consequent elevated randomness of expressed variants, females that are heterozygotes for a quantitative trait locus might exhibit higher phenotypic variance for that trait.", {"entities": []}], ["We propose three tests that build on this phenomenon: 1) A test for inflated variance in heterozygous females; 2) A weighted association test; and 3) A combined test.", {"entities": []}], ["Test 1 captures the novel signal proposed herein by directly testing for higher phenotypic variance of heterozygous than homozygous females.", {"entities": []}], ["As a test of variance it is generally less powerful than standard tests of association that consider means, which is supported by extensive simulations.", {"entities": []}], ["Test 2 is similar to a standard association test in considering the phenotypic mean, but differs by accounting for (rather than testing) the variance heterogeneity.", {"entities": []}], ["As expected in light of X-inactivation, this test is slightly more powerful than a standard association test.", {"entities": []}], ["Finally, test 3 further improves power by combining the results of the first two tests.", {"entities": []}], ["We applied the these tests to the ARIC cohort data and identified a novel X-linked association near gene AFF2 with blood pressure, which was not significant based on standard association testing of mean blood pressure.", {"entities": [[105, 109, "GENE"]]}], ["Variance-based tests examine overdispersion, thereby providing a complementary type of signal to a standard association test.", {"entities": []}], ["Our results point to the potential to improve power of detecting X-linked associations in the presence of variance heterogeneity.", {"entities": []}], ["Structured association mapping is proving to be a powerful strategy to find genetic polymorphisms associated with disease.", {"entities": []}], ["However, these algorithms are often distributed as command line implementations that require expertise and effort to customize and put into practice.", {"entities": []}], ["Because of the difficulty required to use these cutting-edge techniques, geneticists often revert to simpler, less powerful methods.", {"entities": []}], ["To make structured association mapping more accessible to geneticists, we have developed an automatic processing system called Auto-SAM.", {"entities": []}], ["Auto-SAM enables geneticists to run structured association mapping algorithms automatically, using parallelization.", {"entities": []}], ["Auto-SAM includes algorithms to discover gene-networks and find population structure.", {"entities": []}], ["Auto-SAM can also run popular association mapping algorithms, in addition to five structured association mapping algorithms.", {"entities": []}], ["Auto-SAM is available through GenAMap, a front-end desktop visualization tool.", {"entities": []}], ["GenAMap and Auto-SAM are implemented in JAVA; binaries for GenAMap can be downloaded from http://sailing.cs.cmu.edu/genamap .", {"entities": []}], ["Oncolytic virotherapy is an emerging and promising treatment modality that uses replicating viruses as selective antitumor agents.", {"entities": []}], ["Here, we report that a classical protein kinase A (PKA) inhibitor, H89, synergizes with oncolytic virus M1 in various cancer cells through activation of Epac1 (exchange protein directly activated by cAMP 1).", {"entities": [[118, 124, "DISEASE"]]}], ["H89 substantially increases viral replication in refractory cancer cells, leading to unresolvable Endoplasmic Reticulum stress, and cell apoptosis.", {"entities": [[60, 66, "DISEASE"]]}], ["Microarray analysis indicates that H89 blunts antiviral response in refractory cancer cells through retarding the nuclear translocation of NF-\u03baB.", {"entities": [[79, 85, "DISEASE"]]}], ["Importantly, in vivo studies show significant antitumor effects during M1/H89 combination treatment.", {"entities": []}], ["Overall, this study reveals a previously unappreciated role for H89 and demonstrates that activation of the Epac1 activity can improve the responsiveness of biotherapeutic agents for cancer.", {"entities": [[183, 189, "DISEASE"]]}], ["A genome-wide association study among Europeans related polymorphisms of the TLR locus at 4p14 and the FCGR2A locus at 1q23.3 to Helicobacter pylori serologic status.", {"entities": [[103, 109, "GENE"]]}], ["We replicated associations of 4p14 but not 1q23.3 with anti- H. pylori antibodies in 1,402 Finnish males.", {"entities": []}], ["Importantly, our analysis clarified that the phenotype affected by 4p14 is quantitative level of these antibodies rather than association with seropositivity per se .", {"entities": []}], ["Additionally, we annotated variants at 4p14 as expression quantitative trait loci associated with TLR6/10 and FAM114A1.", {"entities": []}], ["Our findings suggest that 4p14 polymorphisms are linked to host immune response to H. pylori infection but not to its acquisition.", {"entities": []}], ["Public health programs can only deliver benefits if they are able to sustain activities over time.", {"entities": []}], ["There is a broad literature on program sustainability in public health, but it is fragmented and there is a lack of consensus on core constructs.", {"entities": []}], ["The purpose of this paper is to present a new conceptual framework for program sustainability in public health.", {"entities": []}], ["This developmental study uses a comprehensive literature review, input from an expert panel, and the results of concept-mapping to identify the core domains of a conceptual framework for public health program capacity for sustainability.", {"entities": []}], ["The concept-mapping process included three types of participants (scientists, funders, and practitioners) from several public health areas ( e .", {"entities": []}], ["g ., tobacco control, heart disease and stroke, physical activity and nutrition, and injury prevention).", {"entities": [[22, 35, "DISEASE"]]}], ["The literature review identified 85 relevant studies focusing on program sustainability in public health.", {"entities": []}], ["Most of the papers described empirical studies of prevention-oriented programs aimed at the community level.", {"entities": []}], ["The concept-mapping process identified nine core domains that affect a program\u2019s capacity for sustainability: Political Support, Funding Stability, Partnerships, Organizational Capacity, Program Evaluation, Program Adaptation, Communications, Public Health Impacts, and Strategic Planning.", {"entities": []}], ["Concept-mapping participants further identified 93 items across these domains that have strong face validity\u201489% of the individual items composing the framework had specific support in the sustainability literature.", {"entities": []}], ["The sustainability framework presented here suggests that a number of selected factors may be related to a program\u2019s ability to sustain its activities and benefits over time.", {"entities": []}], ["These factors have been discussed in the literature, but this framework synthesizes and combines the factors and suggests how they may be interrelated with one another.", {"entities": []}], ["The framework presents domains for public health decision makers to consider when developing and implementing prevention and intervention programs.", {"entities": []}], ["The sustainability framework will be useful for public health decision makers, program managers, program evaluators, and dissemination and implementation researchers.", {"entities": []}], ["The skin microbiome exists in dynamic equilibrium with the host, but when the skin is compromised, bacteria can colonize the wound and impair wound healing.", {"entities": []}], ["Thus, the interplay between normal skin microbial interactions versus pathogenic microbial interactions in wound repair is important.", {"entities": []}], ["Bacteria are recognized by innate host pattern recognition receptors, and we previously showed an important role for the pattern recognition receptor NOD2 in skin wound repair.", {"entities": [[150, 154, "GENE"]]}], ["NOD2 is implicated in changes in the composition of the intestinal microbiota in Crohn\u2019s disease, but its role on skin microbiota is unknown.", {"entities": [[0, 4, "GENE"]]}], ["Nod2 -deficient ( Nod2 Nod2 Nod2 Pseudomonas in Nod2 Pseudomonas species directly impair wound healing, wild-type mice were infected with Pseudomonas aeruginosa biofilms and, akin to Nod2", {"entities": [[0, 4, "GENE"], [18, 22, "GENE"], [23, 27, "GENE"], [28, 32, "GENE"], [48, 52, "GENE"], [183, 187, "GENE"], [0, 4, "GENE"], [18, 22, "GENE"], [23, 27, "GENE"], [28, 32, "GENE"], [48, 52, "GENE"], [183, 187, "GENE"], [0, 4, "GENE"], [18, 22, "GENE"], [23, 27, "GENE"], [28, 32, "GENE"], [48, 52, "GENE"], [183, 187, "GENE"], [0, 4, "GENE"], [18, 22, "GENE"], [23, 27, "GENE"], [28, 32, "GENE"], [48, 52, "GENE"], [183, 187, "GENE"], [0, 4, "GENE"], [18, 22, "GENE"], [23, 27, "GENE"], [28, 32, "GENE"], [48, 52, "GENE"], [183, 187, "GENE"], [0, 4, "GENE"], [18, 22, "GENE"], [23, 27, "GENE"], [28, 32, "GENE"], [48, 52, "GENE"], [183, 187, "GENE"]]}], ["To study the association between impaired glucose regulation (IGR), screen-detected type 2 diabetes, and previously known diabetes and depressive symptoms.", {"entities": []}], ["Altogether, 2,712 participants from three hospital districts in Finland attended a health examination.", {"entities": []}], ["Cutoff scores \u226510 and \u226516 in the 21-item Beck Depression Inventory (BDI-21) were used for depressive symptoms.", {"entities": []}], ["The participants were defined as having known diabetes if they reported diabetes.", {"entities": []}], ["An oral glucose tolerance test was used to detect normal glucose regulation (NGR), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and screen-detected diabetes.", {"entities": []}], ["The participants were defined as having IGR if they had IFG or IGT.", {"entities": []}], ["Prevalence of depressive symptoms, defined as a BDI-21 cutoff score \u226510, was 14.4% for those with NGR, 13.7% for those with IGR, 14.8% for those with screen-detected diabetes, and 26.4% for those with previously known diabetes.", {"entities": []}], ["The corresponding prevalences for a cutoff score \u226516 were 3.4, 3.4, 4.2, and 7.5%, respectively.", {"entities": []}], ["Compared with NGR and adjusted for demographic, lifestyle, and biological factors, the odds ratios for IGR, screen-detected diabetes, and previously known diabetes were 0.91 (95% CI 0.69\u20131.20), 0.70 (0.45\u20131.08), and 1.35 (0.84\u20132.15), respectively, for a cutoff score \u226510.", {"entities": []}], ["For a cutoff score \u226516, the corresponding odds ratios were 1.05 (0.62\u20131.76), 0.87 (0.40\u20131.90), and 1.56 (0.69\u20133.50), respectively.", {"entities": []}], ["Participants with diagnosed diabetes had a higher prevalence of depressive symptoms than participants with NGR, IGR, and previously unknown diabetes.", {"entities": []}], ["When potential confounding factors were included in the analysis, previously known diabetes was not significantly associated with depressive symptoms.", {"entities": []}], ["High altitude polycythemia (HAPC) is a common chronic disease at high altitude, which is characterized by excessive erythrocytosis (females, hemoglobin \u2265 190 g/L; males, hemoglobin \u2265 210 g/L).", {"entities": [[14, 26, "DISEASE"]]}], ["It is the most common disease in chronic mountain sickness casued primarily by persistent arterial hypoxia and ventilatory impairment.", {"entities": []}], ["However, the disease is still unmanageable and related molecular mechanisms remain largely unclear.", {"entities": []}], ["This study aims to explore the genetic basis of HAPC in the Chinese Han and Tibetan populations.", {"entities": []}], ["Subjects were screened for HAPC using the latest approved diagnostic criteria.", {"entities": []}], ["To explore the hereditary basis of HAPC and investigate the association between three genes ( EPAS1, ITGA6, ERBB4 ) and HAPC in Chinese Han and Tibetan populations.", {"entities": [[94, 99, "GENE"], [101, 106, "GENE"], [108, 113, "GENE"]]}], ["We enrolled 100 patients (70 Han, 30 Tibetan) with HAPC and 100 healthy control subjects (30 Han, 70 Tibetan).", {"entities": []}], ["Subjects were screened for HAPC using the latest approved diagnostic criteria combined with excessive erythrocytosis and clinical symptoms.", {"entities": []}], ["Analysis of variance was used to evaluate the impact of polymorphism on HAPC based on genetic variation.", {"entities": []}], ["The Chi-squared test and analyses of genetic models, rs75591953 and rs75984373 in EPAS1 , rs6744873 in ITGA6 , rs17335043 in ERBB4 showed associations with reduced HAPC susceptibility in Han populations.", {"entities": [[82, 87, "GENE"], [103, 108, "GENE"], [125, 130, "GENE"]]}], ["Additionally, in Tibetan populations, rs3749148 in ITGA6 , rs934607 and rs141267844 in ERBB4 showed a reduced risk of HAPC, whereas rs6710946 in ERBB4 increased the risk of HAPC.", {"entities": [[51, 56, "GENE"], [87, 92, "GENE"], [145, 150, "GENE"], [87, 92, "GENE"], [145, 150, "GENE"]]}], ["Our study suggest that the polymorphisms in the EPAS1, ITGA6 and ERBB4 correlate with susceptibility to HAPC.", {"entities": [[48, 53, "GENE"], [55, 60, "GENE"], [65, 70, "GENE"]]}], ["The aim of the present cross-sectional study was to assess possible associations between osteopontin (OPN), and thrombin-cleaved (N-half) OPN, and nephropathy and coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).", {"entities": [[217, 234, "DISEASE"], [210, 234, "DISEASE"]]}], ["Plasma levels of OPN, N-half OPN, and high-sensitivity C-reactive protein (hsCRP) were determined in 301 diabetic patients with (n = 226) or without (n = 75) angiographically documented CAD (luminal diameter narrowing >50%), as well as in 75 non-diabetic controls with normal angiography.", {"entities": []}], ["The estimated glomerular filtration rate (eGFR) was calculated in all patients.", {"entities": [[42, 46, "GENE"]]}], ["Plasma levels of OPN and hsCRP were significantly higher in patients with T2DM compared with controls.", {"entities": []}], ["In addition, there was a higher occurrence of moderate renal insufficiency and lower eGFR in patients with T2DM (all P < 0.01).", {"entities": [[85, 89, "GENE"]]}], ["T2DM patients in whom OPN levels were greater than the median value had higher serum creatinine levels, a greater prevalence of mild or moderate renal insufficiency, a higher incidence of CAD, and lower eGFR (all P < 0.05) than T2DM patients in whom OPN levels were the same as or lower than the median value.", {"entities": [[203, 207, "GENE"]]}], ["However, there were no differences in these parameters when patients were stratified according to plasma N-half OPN levels.", {"entities": []}], ["Furthermore, there was a significant correlation between OPN, but not N-half OPN, and the severity of nephropathy and CAD in diabetes.", {"entities": []}], ["After adjustment for potential confounders and treatments, multiple linear regression analysis demonstrated an independent association between OPN, but not N-half OPN, and eGFR.", {"entities": [[172, 176, "GENE"]]}], ["Multivariate logistic regression revealed that higher OPN levels conferred a fourfold greater risk of renal insufficiency and CAD in patients with T2DM.", {"entities": []}], ["The results of the present study demonstrate that there is an independent association between plasma levels of OPN, but not N-half OPN, and the presence and severity of nephropathy and CAD in diabetes.", {"entities": []}], ["More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life.", {"entities": []}], ["Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality.", {"entities": []}], ["With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death.", {"entities": []}], ["This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.", {"entities": []}], ["The prevalence of chronic hypertension is increasing in pregnant women.", {"entities": [[26, 38, "DISEASE"]]}], ["Beta-blockers are among the most prevalent anti-hypertensive agents used in early pregnancy.", {"entities": []}], ["The objective of this study was to investigate whether first-trimester use of beta-blockers increases the risk of specific congenital anomalies in offspring.", {"entities": []}], ["A population-based case-malformed control study was conducted in 117,122 registrations of congenital anomalies from 17 European Concerted Action on Congenital Anomalies and Twins (EUROCAT) registries participating in EUROmediCAT with data for all or part of the period between 1995 and 2013.", {"entities": []}], ["Associations previously reported in the literature (signals) were tested and an exploratory analysis was performed to identify new signals.", {"entities": []}], ["Odds ratios of exposure to any beta-blocker or to a beta-blocker subgroup were calculated for each signal anomaly compared with two control groups (non-chromosomal, non-signal anomalies and chromosomal anomalies).", {"entities": []}], ["The exploratory analyses were performed for each non-signal anomaly compared with all the other non-signal anomalies.", {"entities": []}], ["The signals from the literature (congenital heart defects, oral clefts, neural tube defects and hypospadias) were not confirmed.", {"entities": [[96, 107, "DISEASE"]]}], ["Our exploratory analysis revealed that multi-cystic renal dysplasia had significantly increased odds of occurring after maternal exposure to combined alpha- and beta-blockers (adjusted odds ratio 3.8; 95% confidence interval 1.3\u201311.0).", {"entities": []}], ["Beta-blocker use in the first trimester of pregnancy was not found to be associated with a higher risk of specific congenital anomalies in the offspring, but a new signal between alpha- and beta-blockers and multi-cystic renal dysplasia was found.", {"entities": []}], ["Future large epidemiological studies are needed to confirm or refute our findings.", {"entities": []}], ["The online version of this article (10.1007/s40264-017-0627-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report provides a framework for classifying COPD reflecting the impacts of disease on patients and for targeting treatment recommendations.", {"entities": []}], ["The GOLD 2017 introduced a new classification with 16 subgroups based on a composite of spirometry and symptoms/exacerbations.", {"entities": []}], ["Data from the population-based PLATINO study, collected at baseline and at follow-up, in three sites in Latin America were analyzed to compare the following: 1) the distribution of COPD patients according to GOLD 2007, 2013, and 2017; 2) the stability of the 2007 and 2013 classifications; and 3) the mortality rate over time stratified by GOLD 2007, 2013, and 2017.", {"entities": []}], ["Of the 524 COPD patients evaluated, most of them were classified as Grade I or II (GOLD 2007) and Group A or B (GOLD 2013), with \u224870% of those classified as Group A in GOLD 2013 also classified as Grade I in GOLD 2007 and the highest percentage (41%) in Group D (2013) classified as Grade III (2007).", {"entities": []}], ["According to GOLD 2017, among patients with Grade I airflow limitation, 69% of them were categorized into Group A, whereas Grade IV patients were more evenly distributed among Groups A\u2013D.", {"entities": []}], ["Most of the patients classified by GOLD 2007 remained in the same airflow limitation group at the follow-up; a greater temporal variability was observed with GOLD 2013 classification.", {"entities": []}], ["Incidence-mortality rate in patients classified by GOLD 2007 was positively associated with increasing severity of airflow obstruction; for GOLD 2013 and GOLD 2017 (Groups A\u2013D), highest mortality rates were observed in Groups C and D. No clear pattern was observed for mortality across the GOLD 2017 subgroups.", {"entities": []}], ["The PLATINO study data suggest that GOLD 2007 classification shows more stability over time compared with GOLD 2013.", {"entities": []}], ["No clear patterns with respect to the distribution of patients or incidence-mortality rates were observed according to GOLD 2013/2017 classification.", {"entities": []}], ["Prenatally stressed offspring exhibit increased susceptibility to inflammatory disorders due to in utero programming.", {"entities": []}], ["Research into the effects of n-3 PUFAs shows promising results for the treatment and prevention of these disorders.", {"entities": []}], ["The purpose of this study was to investigate whether maternal fishmeal supplementation during pregnancy and lactation protects against programming of the offspring\u2019s immune response following simulated maternal infection.", {"entities": []}], ["In order to accomplish this, 53 ewes were fed a diet supplemented with fishmeal (FM; rich in n-3 PUFA) or soybean meal (SM; rich in n-6 PUFAs) from day 100 of gestation (gd 100) through lactation.", {"entities": []}], ["On gd135, half the ewes from each dietary group were challenged with either 1.2\u00a0\u03bcg/kg Escherichia coli lipopolysaccharide (LPS) endotoxin to simulate a bacterial infection, or saline as the control.", {"entities": []}], ["At 4.5\u00a0months of age the offspring\u2019s dermal immune response was assessed by cutaneous hypersensitivity testing with ovalbumin (OVA) and candida albicans (CAA) 21 days after sensitization.", {"entities": []}], ["Skinfold measurements were taken and serum blood samples were also collected to assess the primary and secondary antibody immune response.", {"entities": []}], ["Offspring born to SM\u2009+\u2009LPS mothers had a significantly greater change in skinfold thickness in response to both antigens as well as a greater secondary antibody response to OVA compared to all treatments.", {"entities": []}], ["Supplementation during pregnancy with FM appears to protect against adverse fetal programming that may occur during maternal infection and this may reduce the risk of atopic disease later in life.", {"entities": []}], ["The idea of chiropractors treating children is controversial, yet many parents seek chiropractic care for their children.", {"entities": []}], ["The reasons for this are not well documented.", {"entities": []}], ["Part one of this study aimed to document the profile of all paediatric patients consulting Norwegian chiropractors in 2013 using National Health Insurance data (NHI) with regards to age, gender and primary complaints.", {"entities": []}], ["Part two aimed to provide a more detailed description of these patients in the form of a descriptive, paper-based survey.", {"entities": []}], ["Part one involved Norwegian NHI data from 2013.", {"entities": []}], ["Part two consisted of a year-long, paper-based survey.", {"entities": []}], ["Chiropractors registered with the Norwegian chiropractic association (NKF) were invited to participate via email.", {"entities": []}], ["Participating chiropractors were assigned one random month to collect data.", {"entities": []}], ["All paediatric patients (or their parents) during that were asked to complete questionnaires containing information on presenting complaint, consequences of this complaint, age, and mode of referral.", {"entities": []}], ["In general, there was good concordance between part one and two of the study in terms of age, gender and presenting complaint.", {"entities": []}], ["The youngest children constituted the largest paediatric group in Norwegian chiropractic practice.", {"entities": []}], ["Musculoskeletal problems were the most common reason for children visiting a chiropractor in all of the age categories, according to NHI data.", {"entities": []}], ["Part two of the study found that one-third of young school children and adolescents reported pain lasting longer than 1-year.", {"entities": []}], ["Eleven percent of children found that their complaint had severely affected their mood and 22\u00a0% felt their activities were very limited by their condition.", {"entities": []}], ["Referrals from healthcare professionals were uncommon.", {"entities": []}], ["The survey\u2019s results were based on 161 completed questionnaires, received from 15\u00a0% of the Norwegian chiropractors.", {"entities": []}], ["Musculoskeletal problems constituted the most common presenting complaint for children and adolescents presenting to Norwegian chiropractors.", {"entities": []}], ["A sizable proportion of children seemed to be adversely affected by their complaints in terms of low mood and limitations of daily activities.", {"entities": []}], ["Chronic presentations were not uncommon.", {"entities": []}], ["The small sample size of the survey demands that the results be interpreted with caution.", {"entities": []}], ["Effective interventions to improve immunosuppressive medication adherence among adolescent and young adult kidney transplant recipients are desperately needed.", {"entities": []}], ["This paper describes the aims, design, and methods of the Teen Adherence in Kidney transplant, Effectiveness of Intervention Trial (TAKE-IT) study.", {"entities": []}], ["TAKE-IT is a multicentre, prospective, open-label, parallel arm randomized controlled trial that aims to determine the effectiveness of a clinic-based intervention, including educational, organizational, and behavioural components, in improving immunosuppressive medication adherence among adolescent and young adult kidney transplant recipients.", {"entities": []}], ["Individuals between 11 and 24\u00a0years of age who are at least 3\u00a0months post-transplant and followed in one of the eight participating pediatric kidney transplant programs, or their affiliated adult transplant programs are eligible to participate.", {"entities": []}], ["All participating centers are tertiary care pediatric hospitals in Canada or the United States.", {"entities": []}], ["Adherence is monitored using an electronic multi-dose pillbox for all participants during a 3-month run-in period, followed by a 12-month intervention interval.", {"entities": []}], ["The primary outcome is \u2018taking adherence\u2019, defined as the proportion of prescribed doses of immunosuppressive medications that were taken, as measured using electronic monitoring.", {"entities": []}], ["All participants meet with the study \u2018Coach\u2019 at 3\u00a0month intervals.", {"entities": []}], ["The intervention, administered by trained lay personnel, targets common adherence barriers.", {"entities": []}], ["In addition to forming an Adherence Support Team, intervention participants identify personal barriers to adherence and use Action-focused problem-solving to address them, have their electronic adherence data fed back to them, and have the option to receive email, text message, or visual cue dose reminders.", {"entities": []}], ["Participants in the control group meet with the coach but do not receive the other components of the intervention.", {"entities": []}], ["The study aims to have 75 participants in each group complete the study.", {"entities": []}], ["Since recruitment began in Feb. 2012, 198 adolescents have been approached to participate, of whom 130 have completed a baseline visit.", {"entities": []}], ["As of March 31, 2014, 125 had been randomized, and 86, 68, 61, and 50 participants had completed 6-month, 9-month, 12-month, and 15-month visits respectively.", {"entities": []}], ["Clinicaltrials.gov registration NCT01356277 (May 17, 2011).", {"entities": []}], ["Objective: This study examines the International Classification of Functioning, Disability, and Health model (ICF) using a data set of 2,563 community-dwelling elderly with disease-independent measures of mobility, physical activity, and social networking, to represent ICF constructs.", {"entities": []}], ["Method: The relationship between chronic disease and disability (independent and dependent variables) was examined using logistic regression.", {"entities": []}], ["To demonstrate variability in activity performance with functional impairment, graphing was used.", {"entities": []}], ["The relationship between functional impairment, activity performance, and social participation was examined graphically and using ANOVA.", {"entities": []}], ["The impact of cognitive deficits was quantified through stratifying by dementia.", {"entities": [[71, 79, "DISEASE"]]}], ["Results: Disability is strongly related to chronic disease (Wald 25.5, p < .001), functional impairment with activity performance ( F = 34.2, p < .001), and social participation ( F = 43.6, p < .001).", {"entities": []}], ["With good function, there is considerable variability in activity performance (inter-quartile range [IQR] = 2.00), but diminishes with high impairment (IQR = 0.00) especially with cognitive deficits.", {"entities": []}], ["Discussion: Environment modification benefits those with moderate functional impairment, but not with higher grades of functional loss.", {"entities": []}], ["Cortisol was reported to downregulate body-fluid Ca epithelial calcium channel ( ecac ), 11\u03b2-hydroxylase and the glucocorticoid receptor ( gr ).", {"entities": []}], ["Exogenous cortisol increased Ca ecac and hydroxysteroid 11-beta dehydrogenase 2 (hsd11b2) , but downregulated 11\u03b2-hydroxylase and the gr with no effects on other Ca mineralocorticoid receptor ( mr ).", {"entities": [[81, 88, "GENE"]]}], ["Morpholino knockdown of the GR, but not the MR, was found to impair zebrafish Ca ecac expression.", {"entities": []}], ["To further explore the regulatory mechanism of cortisol in Ca 3 was analyzed.", {"entities": []}], ["Cortisol stimulated expressions of vitamin D-25hydroxylase ( cyp27a1 ), cyp27a1 like ( cyp27a1l ), 1\u03b1-OHase ( cyp27b1 ) at 3 dpf through GR, the first time to demonstrate the relationship between cortisol and vitamin D 3 in fish.", {"entities": [[61, 68, "GENE"], [72, 79, "GENE"], [61, 68, "GENE"], [72, 79, "GENE"], [110, 117, "GENE"]]}], ["In conclusion, cortisol stimulates ecac expression to enhance Ca 3 signaling to stimulate Ca", {"entities": []}], ["Limb girdle muscular dystrophy type 2 (LGMD2) is a genetically heterogeneous autosomal recessive disorder caused by mutations in 15 known genes.", {"entities": [[12, 30, "DISEASE"]]}], ["DNA sequencing of all candidate genes can be expensive and laborious, whereas a selective sequencing approach often fails to provide a molecular diagnosis.", {"entities": []}], ["We aimed to efficiently identify pathogenic mutations via homozygosity mapping in a population in which the genetics of LGMD2 has not been well characterized.", {"entities": []}], ["Thirteen consanguineous families containing a proband with LGMD2 were recruited from Saudi Arabia, and for 11 of these families, selected individuals were genotyped at 10,204 single nucleotide polymorphisms.", {"entities": []}], ["Linkage analysis excluded all but one or two known genes in ten of 11 genotyped families, and haplotype comparisons between families allowed further reduction in the number of candidate genes that were screened.", {"entities": []}], ["Mutations were identified by DNA sequencing in all 13 families, including five novel mutations in four genes, by sequencing at most two genes per family.", {"entities": []}], ["One family was reclassified as having a different myopathy based on genetic and clinical data after linkage analysis excluded all known LGMD2 genes.", {"entities": [[50, 58, "DISEASE"]]}], ["LGMD2 subtypes A and B were notably absent from our sample of patients, indicating that the distribution of LGMD2 mutations in Saudi Arabian families may be different than in other populations.", {"entities": []}], ["Our data demonstrate that homozygosity mapping in consanguineous pedigrees offers a more efficient means of discovering mutations that cause heterogeneous disorders than comprehensive sequencing of known candidate genes.", {"entities": []}], ["The online version of this article (doi:10.1007/s10048-010-0250-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Since Mexico's joining the North American Free Trade Agreement (NAFTA) and the Organization for Economic Cooperation and Development (OECD) in 1994, it has witnessed rapid industrialization.", {"entities": []}], ["A byproduct of this industrialization is increasing population exposure to environmental pollutants, of which some have been associated with childhood disease.", {"entities": []}], ["We therefore identified and assessed the adequacy of existing international and Mexican governance instruments and policy tools to protect children from environmental hazards.", {"entities": []}], ["We first systematically reviewed PubMed, the Mexican legal code and the websites of the United Nations, World Health Organization, NAFTA and OECD as of July 2007 to identify the relevant governance instruments, and analyzed the approach these instruments took to preventing childhood diseases of environmental origin.", {"entities": []}], ["Secondly, we interviewed a purposive sample of high-level government officials, researchers and non-governmental organization representatives, to identify their opinions and attitudes towards children's environmental health and potential barriers to child-specific protective legislation and implementation.", {"entities": []}], ["We identified only one policy tool describing specific measures to reduce developmental neurotoxicity and other children's health effects from lead.", {"entities": []}], ["Other governance instruments mention children's unique vulnerability to ozone, particulate matter and carbon monoxide, but do not provide further details.", {"entities": []}], ["Most interviewees were aware of Mexican environmental policy tools addressing children's health needs, but agreed that, with few exceptions, environmental policies do not address the specific health needs of children and pregnant women.", {"entities": []}], ["Interviewees also cited state centralization of power, communication barriers and political resistance as reasons for the absence of a strong regulatory platform.", {"entities": []}], ["The Mexican government has not sufficiently accounted for children's unique vulnerability to environmental contaminants.", {"entities": []}], ["If regulation and legislation are not updated and implemented to protect children, increases in preventable exposures to toxic chemicals in the environment may ensue.", {"entities": []}], ["MicroRNAs (miRNAs) are a class of short non-coding RNAs with posttranscriptional regulatory functions.", {"entities": []}], ["To date, more than 600 human miRNAs have been experimentally identified, and estimated to regulate more than one third of cellular messenger RNAs.", {"entities": []}], ["Accumulating evidence has linked the dysregulated expression patterns of miRNAs to a variety of diseases, such as cancer, neurodegenerative diseases, cardiovascular diseases and viral infections.", {"entities": [[114, 120, "DISEASE"]]}], ["MiRNAs provide its particular layer of network for gene regulation, thus possessing the great potential both as a novel class of therapeutic targets and as a powerful intervention tool.", {"entities": []}], ["In this regard, synthetic RNAs that contain the binding sites of miRNA have been shown to work as a \u201cdecoy\u201d or \u201cmiRNA sponge\u201d to inhibit the function of specific miRNAs.", {"entities": []}], ["On the other hand, miRNA expression vectors have been used to restore or overexpress specific miRNAs to achieve a long-term effect.", {"entities": []}], ["Further, double-stranded miRNA mimetics for transient replacement have been experimentally validated.", {"entities": []}], ["Endogenous precursor miRNAs have also been used as scaffolds for the induction of RNA interference.", {"entities": []}], ["This article reviews the recent progress on this emerging technology as a powerful tool for gene regulation studies and particularly as a rationale strategy for design of therapeutics.", {"entities": []}], ["To determine the association of human papillomavirus infection (HPV) and transitional cell carcinoma (TCC).", {"entities": [[73, 100, "DISEASE"], [91, 100, "DISEASE"]]}], ["Using polymerase chain reaction, fifty-nine bladder tissue specimens of patients with transitional cell carcinoma of bladder compared with 20 bladder samples of cases with non-neoplastic disorders.", {"entities": [[86, 113, "DISEASE"], [104, 113, "DISEASE"]]}], ["Male to female ratio was similar in the two groups (50/9 vs. 16/4, P = 0.62).", {"entities": []}], ["Mean age was 67 \u00b1 10.8 years and 52 \u00b1 20.3 years in the case and control groups, respectively ( P = 0.6).", {"entities": []}], ["Of the 59 tissue specimens with diagnosis of transitional cell carcinoma, HPV DNA was detected in 21 (35.6%) samples, while it was present in only one sample (5%) in the control group ( P = 0.008).", {"entities": [[45, 72, "DISEASE"], [63, 72, "DISEASE"]]}], ["HPV18 was the most common type of virus with the incidence rate of 17/21(81%).", {"entities": []}], ["HPV might play a causative role in transitional cell carcinoma of bladder in our geographic area.", {"entities": [[35, 62, "DISEASE"], [53, 62, "DISEASE"]]}], ["Co-morbidity of bladder, bowel, and non-specific pelvic pain symptoms is highly prevalent in women.", {"entities": []}], ["Little evidence is present on modulation of pelvic pain syndromes by sex hormones, therefore, the objective of this study was to clarify the effects of hormonal fluctuations within the estrous cycle on regulatory neuropeptides in female rats using a model of neurogenic bladder dysfunction.", {"entities": [[259, 277, "DISEASE"]]}], ["The estrous cycle in female rats (Sprague-Dawley, 230\u2013250 g) was assessed by vaginal smears and weight of uterine horns.", {"entities": []}], ["Neurogenic bladder dysfunction was induced by a single inflammatory insult to the distal colon.", {"entities": [[0, 18, "DISEASE"]]}], ["Protein expression of calcitonin gene related peptide (CGRP), substance P (SP), nerve growth factor (NGF), and brain derived neurotrophic factor (BDNF) in the pelvic organs, sensory ganglia and lumbosacral spinal cord was compared in rats in proestrus (high estrogen) vs diestrus (low estrogen).", {"entities": [[101, 104, "GENE"], [146, 150, "GENE"]]}], ["Under normal physiological conditions, concentration of SP and CGRP was similar in the distal colon and urinary bladder during all phases of the estrous cycle, however, acute colitis induced a significant up-regulation of CGRP content in the colon (by 63%) and urinary bladder (by 54%, p\u22640.05 to control) of rats in proestrus.", {"entities": []}], ["These changes were accompanied by a significant diminution of CGRP content in L6-S2 DRG after colonic treatment, likely associated with its release in the periphery.", {"entities": []}], ["In rats with high estrogen at the time of testing (proestrus), experimental colitis caused a significant up-regulation of BDNF colonic content from 26.1\u00b18.5 pg/ml to 83.4\u00b132.5 pg/ml (N\u200a=\u200a7, p\u22640.05 to control) and also induced similar effects on BDNF in the urinary bladder which was also up-regulated by 5-fold in rats in proestrus (p\u22640.05 to respective control).", {"entities": [[122, 126, "GENE"], [245, 249, "GENE"], [122, 126, "GENE"], [245, 249, "GENE"]]}], ["Our results demonstrate estrous cycle dependent fluctuations of regulatory neuropeptides in the lower urinary tract upon colon-bladder cross-sensitization, which may contribute to pain fluctuations in female patients with neurogenic bladder pain.", {"entities": [[222, 240, "DISEASE"]]}], ["Incomplete reporting is a frequent waste in research.", {"entities": []}], ["Our aim was to evaluate the impact of a writing aid tool (WAT) based on the CONSORT statement and its extension for non-pharmacologic treatments on the completeness of reporting of randomized controlled trials (RCTs).", {"entities": []}], ["We performed a \u2018split-manuscript\u2019 RCT with blinded outcome assessment.", {"entities": []}], ["Participants were masters and doctoral students in public health.", {"entities": []}], ["They were asked to write, over a 4-hour period, the methods section of a manuscript based on a real RCT protocol, with a different protocol provided to each participant.", {"entities": []}], ["Methods sections were divided into six different domains: \u2018trial design\u2019, \u2018randomization\u2019, \u2018blinding\u2019, \u2018participants\u2019, \u2018interventions\u2019, and \u2018outcomes\u2019.", {"entities": []}], ["Participants had to draft all six domains with access to the WAT for a random three of six domains.", {"entities": []}], ["The random sequence was computer-generated and concealed.", {"entities": []}], ["For each domain, the WAT comprised reminders of the corresponding CONSORT item(s), bullet points detailing all the key elements to be reported, and examples of good reporting.", {"entities": []}], ["The control intervention consisted of no reminders.", {"entities": []}], ["The primary outcome was the mean global score for completeness of reporting (scale 0\u201310) for all domains written with or without the WAT.", {"entities": []}], ["Forty-one participants wrote 41 different manuscripts of RCT methods sections, corresponding to 246 domains (six for each of the 41 protocols).", {"entities": []}], ["All domains were analyzed.", {"entities": []}], ["For the primary outcome, the mean (SD) global score for completeness of reporting was higher with than without use of the WAT: 7.1 (1.2) versus 5.0 (1.6), with a mean (95 % CI) difference 2.1 (1.5\u20132.7; P <0.01).", {"entities": []}], ["Completeness of reporting was significantly higher with the WAT for all domains except for blinding and outcomes.", {"entities": []}], ["Use of the WAT could improve the completeness of manuscripts reporting the results of RCTs.", {"entities": []}], ["Clinicaltrials.gov ( http://clinicaltrials.gov NCT02127567 , registration date first received April 29, 2014) The online version of this article (doi:10.1186/s12916-015-0460-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["T-cell immunoglobulin mucin-3 (TIM3) is a T H 1-specific type 1 membrane protein that regulates T H 1 proliferation and the development of immunological tolerance.", {"entities": []}], ["TIM3 and its genetic variants have been suggested to play a role in regulating allergic diseases.", {"entities": []}], ["Polymorphisms in the TIM3 promoter region have been reported to be associated with allergic phenotypes in several populations.", {"entities": []}], ["The aims of this study were to examine whether genetic variation in the promoter region of TIM3 influenced transcription of the gene and risk for allergic phenotypes.", {"entities": []}], ["We performed 5' rapid amplification of cDNA ends and reverse transcription-polymerase chain reaction.", {"entities": []}], ["We screened for polymorphisms in the promoter region.", {"entities": []}], ["Deletion analysis was used to localize the promoter region of TIM3 .", {"entities": []}], ["Genotyping was performed by TaqMan assays in three asthma/allergy population samples.", {"entities": [[51, 57, "DISEASE"]]}], ["We found two regions with promoter activity in TIM3 .", {"entities": []}], ["One region was from -214 bp to +58 bp and the other from -1.6 kb to -914 bp relative to the transcription start site.", {"entities": []}], ["None of the single nucleotide polymorphisms (SNPs) or haplotypes affected the transcriptional activity in reporter gene assays.", {"entities": []}], ["No association between the SNPs and any phenotype was observed in the study cohorts.", {"entities": []}], ["Our findings indicate that SNPs and haplotypes in the TIM3 promoter region do not have a functional effect in vitro and are not associated with allergic diseases.", {"entities": []}], ["These data suggest that polymorphisms in the TIM3 promoter region are unlikely to play an important role in susceptibility to allergic diseases.", {"entities": []}], ["Background: Salivary secretory disorders can be the result of a wide range of factors.", {"entities": []}], ["Their prevalence and negative effects on the patient's quality of life oblige the clinician to confront the issue.", {"entities": []}], ["Aim: To review the salivary secretory disorders, inducing drugs and their clinical management.", {"entities": []}], ["Methods: In this article, a literature search of these dysfunctions was conducted with the assistance of a research librarian in the MEDLINE/PubMed Database.", {"entities": []}], ["Results: Xerostomia, or dry mouth syndrome, can be caused by medication, systemic diseases such as Sj\u00f6gren's Syndrome, glandular pathologies, and radiotherapy of the head and neck.", {"entities": [[34, 42, "DISEASE"], [109, 117, "DISEASE"]]}], ["Treatment of dry mouth is aimed at both minimizing its symptoms and preventing oral complications with the employment of sialogogues and topical acting substances.", {"entities": []}], ["Sialorrhea and drooling, are mainly due to medication or neurological systemic disease.", {"entities": []}], ["There are various therapeutic, pharmacologic, and surgical alternatives for its management.", {"entities": []}], ["The pharmacology of most of the substances employed for the treatment of salivary disorders is well-known.", {"entities": []}], ["Nevertheless, in some cases a significant improvement in salivary function has not been observed after their administration.", {"entities": []}], ["Conclusion: At present, there are numerous frequently prescribed drugs whose unwanted effects include some kind of salivary disorder.", {"entities": []}], ["In addition, the differing pathologic mechanisms, and the great variety of existing treatments hinder the clinical management of these patients.", {"entities": []}], ["The authors have designed an algorithm to facilitate the decision making process when physicians, oral surgeons, or dentists face these salivary dysfunctions.", {"entities": []}], ["Imatinib mesylate is a small-molecule tyrosine kinase inhibitor (TKi) designed to target c-ABL and BCR-ABL, approved for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.", {"entities": [[138, 162, "DISEASE"], [146, 162, "DISEASE"], [154, 162, "DISEASE"]]}], ["Adverse cutaneous reactions induced by imatinib are frequent, generally moderate, and dose-dependent.", {"entities": []}], ["The aim of this work was to investigate the possible contribution of interleukin (IL)-33 and IL-31, cytokines involved in disorders associated with itching, in the pathogenesis of pruritus in a patient undergoing imatinib mesylate treatment.", {"entities": []}], ["His IL-31 and IL-33 serum levels were significantly higher than in the control group (respectively 96.6 pg/mL vs. 7.623\u00b17.681 pg/mL and 27.566 pg/mL vs. 6.170\u00b17.060 pg/mL).", {"entities": []}], ["In light of these findings, imatinib mesylate-related symptoms of dermatologic toxicities might be related to the release of IL-31 and IL-33.", {"entities": []}], ["In particular, it is supposable that TKi usage could cause keratinocyte injury, the release of IL-33, and the consequent interaction with its receptor on mast cells that induces the secretion of several factors capable of causing skin manifestations, including IL-31, a known pruritus-inducing cytokine.", {"entities": []}], ["This report, to the best of our knowledge, is the first work describing the possible involvement of the IL-31/IL-33 axis in the pathogenesis of skin side effects related to imatinib mesylate treatment.", {"entities": []}], ["The risk factors for radiation pneumonitis (RP) in patients with chronic obstructive pulmonary disease (COPD) are unclear.", {"entities": [[65, 102, "DISEASE"]]}], ["Mean lung dose (MLD) and percentage of irradiated lung volume are common predictors of RP, but the most accurate dosimetric parameter has not been established.", {"entities": []}], ["We hypothesized that the total lung volume irradiated without emphysema would influence the onset of RP.", {"entities": []}], ["We retrospectively evaluated 100 patients who received radiotherapy for lung cancer.", {"entities": [[72, 83, "DISEASE"], [77, 83, "DISEASE"]]}], ["RP was graded according to the Common Terminology Criteria for Adverse Events (version 4.03).", {"entities": []}], ["We quantified low attenuation volume (LAV) using quantitative computed tomography analysis.", {"entities": []}], ["The association between RP and traditional dosimetric parameters including MLD, volume of the lung receiving a dose of \u22652\u00a0Gy, \u2265 5\u00a0Gy, \u2265 10\u00a0Gy, \u2265 20\u00a0Gy, and \u226530\u00a0Gy, and counterpart measurements of the lung without LAV, were analyzed by logistic regression.", {"entities": []}], ["We compared each dosimetric parameter for RP using multiple predictive performance measures including area under the receiver operating characteristic curve (AUC) and integrated discrimination improvement (IDI).", {"entities": []}], ["Of 100 patients, RP of Grades 1, 2, 3, 4, and 5 was diagnosed in 24, 12, 13, 1, and 1 patients, respectively.", {"entities": []}], ["Compared with traditional dosimetric parameters, counterpart measurements without LAV improved risk prediction of symptomatic RP.", {"entities": []}], ["The ratio of the lung without LAV receiving \u226530\u00a0Gy to the total lung volume without LAV most accurately predicted symptomatic RP (AUC, 0.894; IDI, 0.064).", {"entities": []}], ["Irradiated lung volume without LAV predicted RP more accurately than traditional dosimetric parameters.", {"entities": []}], ["The online version of this article (10.1186/s13014-017-0891-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Tobacco smoke exposure (TSE) is a worldwide health problem and it is considered a risk factor for pregnant women\u2019s and children\u2019s health, particularly for respiratory morbidity during the first year of life.", {"entities": []}], ["Few significant birth cohort studies on the effect of prenatal TSE via passive and active maternal smoking on the development of severe bronchiolitis in early childhood have been carried out worldwide.", {"entities": [[136, 149, "DISEASE"]]}], ["From November 2009 to December 2012, newborns born at \u226533\u00a0weeks of gestational age (wGA) were recruited in a longitudinal multi-center cohort study in Italy to investigate the effects of prenatal and postnatal TSE, among other risk factors, on bronchiolitis hospitalization and/or death during the first year of life.", {"entities": [[244, 257, "DISEASE"]]}], ["Two thousand two hundred ten newborns enrolled at birth were followed-up during their first year of life.", {"entities": []}], ["Of these, 120 (5.4\u00a0%) were hospitalized for bronchiolitis.", {"entities": [[44, 57, "DISEASE"]]}], ["No enrolled infants died during the study period.", {"entities": []}], ["Prenatal passive TSE and maternal active smoking of more than 15 cigarettes/daily are associated to a significant increase of the risk of offspring children hospitalization for bronchiolitis, with an adjHR of 3.5 (CI 1.5\u20138.1) and of 1.7 (CI 1.1\u20132.6) respectively.", {"entities": [[177, 190, "DISEASE"]]}], ["These results confirm the detrimental effects of passive TSE and active heavy smoke during pregnancy for infants\u2019 respiratory health, since the exposure significantly increases the risk of hospitalization for bronchiolitis in the first year of life.", {"entities": [[209, 222, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12931-015-0312-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We investigated the prevalence of pertussis in Korean adolescents and adults with persistent cough.", {"entities": [[34, 43, "DISEASE"]]}], ["Study population was adolescents (aged 11-20 yr) and adults (\u2265 21 yr old) who showed persistent cough of 1-8 weeks' duration.", {"entities": []}], ["Pertussis was diagnosed by culture, polymerase chain reaction (PCR), and serology.", {"entities": [[0, 9, "DISEASE"]]}], ["A total of 310 subjects participated in this study, and 76 cases (24.5%) met the criteria for laboratory-confirmed pertussis.", {"entities": [[115, 124, "DISEASE"]]}], ["The majority of the pertussis cases (66/76) were confirmed by serology, while 3 cases (1.0%) were diagnosed with culture, and 10 cases (3.2%) were detected with PCR.", {"entities": [[20, 29, "DISEASE"]]}], ["Of the 76 subjects diagnosed with pertussis, 20/86 cases were adolescents and 56/224 cases were adults.", {"entities": [[34, 43, "DISEASE"]]}], ["Neither adolescents nor adults received adolescent-adult booster against pertussis within the previous 5 yr. Pertussis can be a primary cause of persistent cough in Korean adolescents and adults.", {"entities": [[73, 82, "DISEASE"], [109, 118, "DISEASE"]]}], ["Genome-wide association studies (GWAS) have successfully identified genetic loci associated with glycemic traits.", {"entities": []}], ["However, characterizing the functional significance of these loci has proven challenging.", {"entities": []}], ["We sought to gain insights into the regulation of fasting insulin and fasting glucose through the use of gene expression microarray data from peripheral blood samples of participants without diabetes in the Framingham Heart Study (FHS) ( n = 5,056), the Rotterdam Study (RS) ( n = 723), and the InCHIANTI Study (Invecchiare in Chianti) ( n = 595).", {"entities": []}], ["Using a false discovery rate q <0.05, we identified three transcripts associated with fasting glucose and 433 transcripts associated with fasting insulin levels after adjusting for age, sex, technical covariates, and complete blood cell counts.", {"entities": []}], ["Among the findings, circulating IGF2BP2 transcript levels were positively associated with fasting insulin in both the FHS and RS.", {"entities": [[32, 39, "GENE"]]}], ["Using 1000 Genomes\u2013imputed genotype data, we identified 47,587 cis -expression quantitative trait loci (eQTL) and 6,695 trans -eQTL associated with the 433 significant insulin-associated transcripts.", {"entities": []}], ["Of note, we identified a trans -eQTL (rs592423), where the A allele was associated with higher IGF2BP2 levels and with fasting insulin in an independent genetic meta-analysis comprised of 50,823 individuals.", {"entities": [[95, 102, "GENE"]]}], ["We conclude that integration of genomic and transcriptomic data implicate circulating IGF2BP2 mRNA levels associated with glucose and insulin homeostasis.", {"entities": [[86, 93, "GENE"]]}], ["Distressed individuals in Korea may benefit from the practice of mind\u2013body exercises such as Qigong.", {"entities": []}], ["However, the effectiveness of such techniques needs to be investigated.", {"entities": []}], ["Fifty participants who were eligible to this study were randomized into a group receiving a 4-week intervention of a brief Qigong-based stress reduction program (BQSRP) or a wait-list control group.", {"entities": []}], ["Before and after the intervention period, saliva samples were collected and questionnaires were completed on perceived stress, anxiety, \u201c Hwa-Byung \u201d (anger syndrome), and quality of life.", {"entities": [[157, 165, "DISEASE"]]}], ["Salivary cortisol has emerged in mind-body therapy research as an easy-to-collect, relatively inexpensive, biologic marker of stress.", {"entities": []}], ["Salivary corisol were collected to evaluate physiological effect of BQSRP.", {"entities": []}], ["Between-group comparisons of change from baseline to study completion were analyzed by analysis of covariance for the Perceived Stress Scale and independent two sample t- tests for other measures.", {"entities": []}], ["Compared with the control group, the BQSRP intervention group displayed significantly larger decreases in Perceived Stress Scale scores ( p = 0.0006), State Anxiety scores ( p = 0.0028), Trait Anxiety scores ( p < 0.0001), personality subscale scores of the Hwa-Byung Scale ( p = 0.0321), symptoms scores of the Hwa-Byung Scale ( p = 0.0196), and a significantly larger increase in World Health Organization Quality of Life Abbreviated version scores ( p s < .05).", {"entities": []}], ["Salivary cortisol levels were not changed.", {"entities": []}], ["The BQSRP appears to be effective in reducing stress perception, anxiety, anger, and improving quality of life (KCT0000056).", {"entities": []}], ["The ideal cell type to regenerate an acutely injured or chronically diseased lung would be a stem cell population from the patient's own lung.", {"entities": []}], ["Consequently, extensive research efforts have focused on identifying and characterizing endogenous lung stem cells.", {"entities": []}], ["Advances in techniques to facilitate cell isolation, labelling and tracking in vivo to determine their fate have led to the identification of several putative stem cell niches.", {"entities": []}], ["Recently, convincing evidence has emerged for a novel stem/progenitor cell population in the submucous glands of the cartilaginous airways.", {"entities": []}], ["These findings support the concept that there is no classical stem cell 'hierarchy' but that different progenitor populations within spatially distinct lung regions regenerate the lung epithelium adjacent to its niche.", {"entities": []}], ["Intriguingly, recent findings challenge this concept; it was reported that the human lung may contain a primitive stem cell capable of differentiating into multiple cells of both endodermal and mesodermal lineage and of regenerating the injured lung.", {"entities": []}], ["This suggests that a classical stem cell hierarchy may, in fact, exist in the lung.", {"entities": []}], ["Although caution is needed in interpreting these emerging findings, the implications for our current concepts regarding lung stem cells, the insights into lung repair and regeneration, and the potential therapeutic implications are considerable.", {"entities": []}], ["Evidence from randomized controlled trials (RCTs) is required to guide treatment of critically ill children, but the number of RCTs available is limited and the publications are often difficult to find.", {"entities": []}], ["The objectives of this review were to systematically identify RCTs in pediatric critical care and describe their methods and reporting.", {"entities": []}], ["We searched MEDLINE, EMBASE, LILACS and CENTRAL (from inception to April 16, 2013) and reference lists of included RCTs and relevant systematic reviews.", {"entities": []}], ["We included published RCTs administering any intervention to children in a pediatric ICU.", {"entities": []}], ["We excluded trials conducted in neonatal ICUs, those enrolling exclusively preterm infants, and individual patient crossover trials.", {"entities": []}], ["Pairs of reviewers independently screened studies for eligibility, assessed risk of bias, and abstracted data.", {"entities": []}], ["Discrepancies were resolved by consensus.", {"entities": []}], ["We included 248 RCTs: 45 (18%) were multicentered and 14 (6%) were multinational.", {"entities": []}], ["Trials most frequently enrolled both medical and surgical patients (43%) but postoperative cardiac surgery was the single largest population studied (19%).", {"entities": []}], ["The most frequently evaluated types of intervention were medications (63%), devices (11%) and nutrition (8%).", {"entities": []}], ["Laboratory or physiological measurements were the most frequent type of primary outcomes (18%).", {"entities": []}], ["Half of these trials (50%) reported blinding.", {"entities": []}], ["Of the 107 (43%) trials that reported an a priori sample size, 34 (32%) were stopped early.", {"entities": []}], ["The median number of children randomized per trial was 49 and ranged from 6 to 4,947.", {"entities": []}], ["The frequency of RCT publications increased at a mean rate of 0.7 RCTs per year ( P <0.001) from 1 to 20 trials per year.", {"entities": []}], ["This scoping review identified the available RCTs in pediatric critical care and made them accessible to clinicians and researchers ( http://epicc.mcmaster.ca ).", {"entities": []}], ["Most focused on medications and intermediate or surrogate outcomes, were single-centered and were conducted in North America and Western Europe.", {"entities": []}], ["The results of this review underscore the need for trials with rigorous methodology, appropriate outcome measures, and improved quality of reporting to ensure that high quality evidence exists to support clinical decision-making in this vulnerable population.", {"entities": []}], ["BCG, a potent inducer of Th1 immune response, has been suggested to suppress Th2 response which is known to mediate IgE-mediated allergic disorders, in particular allergic asthma.", {"entities": [[163, 178, "DISEASE"], [172, 178, "DISEASE"]]}], ["Schultz-Dale reaction is known to be a model of IgE-mediated hypersensitivity.", {"entities": []}], ["This study was done to investigate whether BCG infection suppresses the Schultz-Dale reaction by inhibiting Th2 response and allergen-specific IgE production.", {"entities": []}], ["Twenty-four Sprague-Dawley rats were sensitized and provoked with ovalbumin (OVA).", {"entities": []}], ["A pretreatment of 6\u00d710 The Schultz-Dale reaction and serum OVA-specific IgE levels were significantly decreased in BCG infected and OVA sensitized rats compared with only sensitized rats (p<0.0l and p<0.05, respectively).", {"entities": []}], ["As compared with only sensitized rats, IL-4 concentration and a ratio of IFN-\u03b3 : IL-4 in BCG infected and OVA sensitized rats were significantly decreased (p<0.001) and increased (p<0.05), respectively.", {"entities": []}], ["The Schultz-Dale reaction was correlated with OVA-specific IgE levels (r=0.50, p<0.05), IL-4 concentration (r=0.69, p<0.001), and ratio of IFN- : IL-4 (r=\u22120.44, p<0.05).", {"entities": []}], ["OVA-specific IgE levels were correlated with IL-4 concentration (r=0.61, p<0.01) and ratio of IFN-\u03b3 : IL-4 (r=\u22120.48, p<0.05).", {"entities": []}], ["These findings suggest that BCG infection prior to allergen sensitization may inhibit Schultz-Dale reaction developed in the sensitized rat tracheal smooth muscle via the suppressive effects of Th2 immune response and allergen-specific IgE production.", {"entities": []}], ["There is global concern over significant threats from a wide variety of environmental hazards to which children face.", {"entities": []}], ["Large-scale and long-term birth cohort studies are needed for better environmental management based on sound science.", {"entities": []}], ["The primary objective of the Japan Environment and Children\u2019s Study (JECS), a nation-wide birth cohort study that started its recruitment in January 2011, is to elucidate environmental factors that affect children\u2019s health and development.", {"entities": []}], ["Approximately 100,000 expecting mothers who live in designated study areas will be recruited over a 3-year period from January 2011.", {"entities": []}], ["Participating children will be followed until they reach 13 years of age.", {"entities": []}], ["Exposure to environmental factors will be assessed by chemical analyses of bio-specimens (blood, cord blood, urine, breast milk, and hair), household environment measurements, and computational simulations using monitoring data (e.g.", {"entities": []}], ["ambient air quality monitoring) as well as questionnaires.", {"entities": []}], ["JECS\u2019 priority outcomes include reproduction/pregnancy complications, congenital anomalies, neuropsychiatric disorders, immune system disorders, and metabolic/endocrine system disorders.", {"entities": []}], ["Genetic factors, socioeconomic status, and lifestyle factors will also be examined as covariates and potential confounders.", {"entities": []}], ["To maximize representativeness, we adopted provider-mediated community-based recruitment.", {"entities": []}], ["Through JECS, chemical substances to which children are exposed during the fetal stage or early childhood will be identified.", {"entities": []}], ["The JECS results will be translated to better risk assessment and management to provide healthy environment for next generations.", {"entities": []}], ["To describe the incidence of acute community-acquired infections (lower respiratory tract infections, urinary tract infections and sepsis) among the UK population aged \u226565\u00a0years with diabetes mellitus, and all-cause 28-day hospital admission rates and mortality.", {"entities": [[183, 200, "DISEASE"]]}], ["We used electronic primary care records from the Clinical Practice Research Datalink, linked to death certificates and Hospital Episode Statistics admission data, to conduct a retrospective cohort study from 1997 to 2011.", {"entities": []}], ["Among the 218 805 older people with diabetes there was a high burden of community-acquired infection, lower respiratory tract infections having the highest incidence (crude rate: 152.7/1000\u00a0person-years) followed by urinary tract infections (crude rates 51.4 and 147.9/1000 person-years for men and women, respectively).", {"entities": []}], ["The incidence of all infections increased over time, which appeared to be driven by the population\u2019s changing age structure.", {"entities": []}], ["Most patients diagnosed with pneumonia and sepsis were hospitalized on the same day (77.8 and 75.1%, respectively).", {"entities": [[29, 38, "DISEASE"]]}], ["For lower respiratory tract infections and urinary tract infections, a large proportion of 28-day hospitalizations were after the day of diagnosis (39.1 and 44.3%, respectively), and a notable proportion of patients (7.1 and 5.1%, respectively) were admitted for a cardiovascular condition.", {"entities": []}], ["In the 4\u00a0weeks after onset, all-cause mortality was 32.1% for pneumonia (3115/9697), 31.7% for sepsis (780/2461), 4.1% for lower respiratory tract infections (5685/139 301) and 1.6% for urinary tract infections (1472/91 574).", {"entities": [[62, 71, "DISEASE"]]}], ["The present large cohort study provides up-to-date detailed infection incidence estimates among older people with diabetes in the community, with variation by age, sex and region and over time.", {"entities": []}], ["This should be of use for patient communication of risk and future healthcare planning.", {"entities": []}], ["Our objective was to assess the prevalence of chronic bronchitis and chronic obstructive pulmonary disease (COPD) and their correlates among a Lebanese nonsmoker group.", {"entities": [[69, 106, "DISEASE"], [54, 64, "DISEASE"]]}], ["A cross-sectional study was conducted between October 2009 and September 2010, using a multistage cluster sample throughout Lebanon including Lebanese residents aged 40 years and above with no exclusion criteria.", {"entities": []}], ["Pre- and postbronchodilator spirometry measurements were performed and carbon monoxide level was measured in exhaled air.", {"entities": []}], ["COPD was defined and classified according to the Global Initiative for Chronic Obstructive Lung Disease guidelines or according to the lower limit of normal (forced expiratory volume in 1 second/forced vital capacity postbronchodilator < 5th percentile of the healthy population having the same age and sex).", {"entities": []}], ["Chronic bronchitis was defined by the declaration of morning cough and expectorations for more than 3 months a year over more than 2 years in individuals with normal spirometry.", {"entities": [[8, 18, "DISEASE"]]}], ["Out of 2201 individuals, 732 were never-smokers: 25 (3.4%) of them had COPD, and 86 (11.75%) fulfilled the definition of chronic bronchitis.", {"entities": [[129, 139, "DISEASE"]]}], ["Correlates of COPD included a childhood respiratory disease, house heated by diesel, and older age.", {"entities": []}], ["On the other hand, correlates of chronic bronchitis included childhood respiratory diseases, living in southern Lebanon versus other regions, heating home by gas, older age, number of smokers at work, and lower height.", {"entities": [[41, 51, "DISEASE"]]}], ["A substantial percentage of the nonsmoking population may exhibit chronic bronchitis or COPD.", {"entities": [[74, 84, "DISEASE"]]}], ["The significant correlates mentioned above should be taken into consideration in order to reduce the risk of developing such chronic and debilitating respiratory diseases.", {"entities": []}], ["Long acting bronchodilators are the standard of care in the management of chronic obstructive pulmonary disease (COPD).", {"entities": [[74, 111, "DISEASE"]]}], ["The aim of this study was to investigate the efficacy and safety of V0162, a novel anticholinergic agent with bronchodilator properties, in preclinical models and in patients with COPD.", {"entities": []}], ["Guinea pigs were used to evaluate the impact of V0162 on the acetylcholine or histamine-induced bronchoconstriction.", {"entities": []}], ["V0162 was also investigated in an allergic asthma model on ovalbumin-sensitized guinea pig.", {"entities": [[34, 49, "DISEASE"], [43, 49, "DISEASE"]]}], ["For clinical investigations, healthy volunteers were included in a dose-escalation, randomized, placebo-controlled phase I study to determine the maximal tolerated dose, followed by a randomized, placebo-controlled, cross-over phase II study in patients with COPD.", {"entities": []}], ["V0162 was given via inhalation route.", {"entities": []}], ["The objectives of the phase I/II study were to assess the safety and efficacy of V0162, in terms of bronchodilation and reduction in hyperinflation.", {"entities": []}], ["Preclinical results showed that V0162 was able to prevent bronchoconstriction induced either by acetylcholine or histamine.", {"entities": []}], ["V0162 reversed the bronchoconstriction and airway inflammation caused by ovalbumin challenge in sensitized guinea pigs.", {"entities": []}], ["In the healthy volunteers study, 88 subjects were enrolled: 66 received V0162 and 22 received placebo.", {"entities": []}], ["No particular safety concerns were raised.", {"entities": []}], ["The maximal tolerated dose was not reached and the dose escalation was stopped at 2400\u00a0\u03bcg.", {"entities": []}], ["A total of 20 patients with COPD were then enrolled.", {"entities": []}], ["All patients received a single-dose of V0162 1600\u00a0\u03bcg and of placebo in two alternating periods.", {"entities": []}], ["In COPD patients, V0162 demonstrated a significant increase in FEV 1 compared with placebo (148\u2009\u00b1\u2009137\u00a0ml vs. 36\u2009\u00b1\u2009151\u00a0ml, p \u2009=\u20090.003).", {"entities": [[63, 66, "GENE"]]}], ["This bronchodilatory effect was corroborated by a reduction in hyperinflation.", {"entities": []}], ["There was a trend toward dyspnea relief (change in visual analog scale at 22\u00a0h, \u221215.1\u2009\u00b1\u200926.0\u00a0mm vs.- 5.3\u2009\u00b1\u200928.8\u00a0mm with placebo, p \u2009=\u20090.054).", {"entities": []}], ["No serious adverse events (AEs) were reported.", {"entities": []}], ["Most common AEs were productive and non-productive cough, dyspnea and pruritus.", {"entities": []}], ["V0162 improved pulmonary function and tended to improve dyspnea in patients with COPD over more than 24\u00a0h. The slight plasmatic exposure observed might support the good safety profile.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT01348555", {"entities": []}], ["Commercial investment is bringing space tourism closer to reality.", {"entities": []}], ["Marlene Grenon and colleagues outline what doctors will need to know", {"entities": []}], ["Self-management of asthma may improve asthma outcomes.", {"entities": [[19, 25, "DISEASE"], [38, 44, "DISEASE"]]}], ["The Internet has been suggested as a tool for the monitoring and self-management of asthma.", {"entities": [[84, 90, "DISEASE"]]}], ["However, in a recent study we found that a Web interface had some disadvantages and that users stopped using the application after a short while.", {"entities": []}], ["The primary objective of this study was to evaluate, from a user perspective, the feasibility of using short message service (SMS) for asthma diary data collection through mobile phones.", {"entities": [[135, 141, "DISEASE"], [126, 129, "GENE"]]}], ["The secondary objective was to investigate patient compliance with an SMS diary, as measured by response rates over time.", {"entities": [[70, 73, "GENE"]]}], ["The study included quantitative response rate data, based on SMS collection, and qualitative data from a traditional focus group setting.", {"entities": [[61, 64, "GENE"]]}], ["In a period of 2 months, the participants received 4 SMS messages each day, including a medication reminder, a request to enter peak flow, data on sleep loss, and medication dosage.", {"entities": [[53, 56, "GENE"]]}], ["Participants were asked to reply to a minimum of 3 of the messages per day.", {"entities": []}], ["Diary inputs were collected in a database and the response rate per patient was expressed as the number of diary inputs (SMS replies) divided by diary requests (product of number of days in the study and the number of diary questions per day) for each participant.", {"entities": [[121, 124, "GENE"]]}], ["After the study period, the participants were invited to a focus group interview addressing the participants' attitudes to their disease, their experience with the SMS asthma diary, and their future expectations from the SMS asthma diary.", {"entities": [[168, 174, "DISEASE"], [225, 231, "DISEASE"], [164, 167, "GENE"], [221, 224, "GENE"], [164, 167, "GENE"], [221, 224, "GENE"]]}], ["Twelve patients with asthma (6 males, 6 females) participated in the data collection study.", {"entities": [[21, 27, "DISEASE"]]}], ["The median age was 38.5 (range: 13 \u2013 57) years.", {"entities": []}], ["The median response rate per patient was 0.69 (range: 0.03 \u2013 0.98), ie, half the participants reported more than about two thirds of the requested diary data.", {"entities": []}], ["Furthermore, response rates were relatively steady during the study period with no signs of decreasing usage over time.", {"entities": []}], ["From the subsequent focus group interview with 9 users we learned that, in general, the participants were enthusiastic about the SMS diary \u2013 it became an integrated part of their everyday life.", {"entities": [[129, 132, "GENE"]]}], ["However, the participants wished for a simpler diary with only one SMS message to respond to and a system with a Web interface for system customization and graphical display of diary data history.", {"entities": [[67, 70, "GENE"]]}], ["This study suggests that SMS collection of asthma diary data is feasible, and that SMS may be a tool for supporting the self-management of asthma (and possibly other chronic diseases) in motivated and self-efficacious patients because mobile phones are a part of people's everyday lives and enable active requests for data wherever the patient is.", {"entities": [[43, 49, "DISEASE"], [139, 145, "DISEASE"], [25, 28, "GENE"], [83, 86, "GENE"], [25, 28, "GENE"], [83, 86, "GENE"]]}], ["The combination of SMS data collection and a traditional Web page for data display and system customization may be a better and more usable tool for patients than the use of Web-based asthma diaries which suffer from high attrition rates.", {"entities": [[184, 190, "DISEASE"], [19, 22, "GENE"]]}], ["Coronary guidewire-based diagnostic assessments with hyperemia may cause iatrogenic complications.", {"entities": []}], ["We assessed the safety of guidewire-based measurement of coronary physiology, using intravenous adenosine, in patients with an acute coronary syndrome.", {"entities": [[142, 150, "DISEASE"]]}], ["We prospectively enrolled invasively managed STEMI and NSTEMI patients in two simultaneously conducted studies in 6 centers (NCT01764334; NCT02072850).", {"entities": []}], ["All of the participants underwent a diagnostic coronary guidewire study using intravenous adenosine (140\u00a0\u03bcg/kg/min) infusion for 1\u20132\u00a0min.", {"entities": []}], ["The patients were prospectively assessed for the occurrence of serious adverse events (SAEs) and symptoms and invasively measured hemodynamics were also recorded.", {"entities": []}], ["648 patients (n\u00a0=\u00a0298 STEMI patients in 1 hospital; mean time to reperfusion 253\u00a0min; n\u00a0=\u00a0350 NSTEMI in 6 hospitals; median time to angiography from index chest pain episode 3 (2, 5) days) were included between March 2011 and May 2013.", {"entities": []}], ["Two NSTEMI patients (0.3% overall) experienced a coronary dissection related to the guidewire.", {"entities": []}], ["No guidewire dissections occurred in the STEMI patients.", {"entities": []}], ["Chest symptoms were reported in the majority (86%) of patient's symptoms during the adenosine infusion.", {"entities": []}], ["No serious adverse events occurred during infusion of adenosine and all of the symptoms resolved after the infusion ceased.", {"entities": []}], ["In this multicenter analysis, guidewire-based measurement of FFR and IMR using intravenous adenosine was safe in patients following STEMI or NSTEMI.", {"entities": []}], ["Self-limiting symptoms were common but not associated with serious adverse events.", {"entities": []}], ["Finally, coronary dissection in STEMI and NSTEMI patients was noted to be a rare phenomenon.", {"entities": []}], ["Environmental pollutants as non-heritable factors are now recognized as triggers for multiple human inflammatory diseases involving T cells.", {"entities": []}], ["We postulated that lipid antigen presentation mediated by cluster of differentiation 1 (CD1) proteins for T cell activation is susceptible to lipophilic environmental pollutants.", {"entities": []}], ["To test this notion, we determined whether the common lipophilic pollutants benzo[a]pyrene and diesel exhaust particles impact on the activation of lipid-specific T cells.", {"entities": []}], ["Our results demonstrated that the expression of CD1a and CD1d proteins, and the activation of CD1a- and CD1d-restricted T cells were sensitively inhibited by benzo[a]pyrene even at the low concentrations detectable in exposed human populations.", {"entities": [[48, 52, "GENE"], [94, 98, "GENE"], [57, 61, "GENE"], [104, 108, "GENE"]]}], ["Similarly, diesel exhaust particles showed a marginal inhibitory effect.", {"entities": []}], ["Using transcriptomic profiling, we discovered that the gene expression for regulating endocytic and lipid metabolic pathways was perturbed by benzo[a]pyrene.", {"entities": []}], ["Imaging flow cytometry also showed that CD1a and CD1d proteins were retained in early and late endosomal compartments, respectively, supporting an impaired endocytic lipid antigen presentation for T cell activation upon benzo[a]pyrene exposure.", {"entities": [[40, 44, "GENE"], [49, 53, "GENE"]]}], ["This work conceptually demonstrates that lipid antigen presentation for T cell activation is inhibited by lipophilic pollutants through profound interference with gene expression and endocytic function, likely further disrupting regulatory cytokine secretion and ultimately exacerbating inflammatory diseases.", {"entities": []}], ["ADAM33 has been identified as an asthma-associated gene in an out-bred population.", {"entities": [[33, 39, "DISEASE"], [0, 6, "GENE"]]}], ["Genetic studies suggested that the functional role of this metalloprotease was in airway remodeling.", {"entities": []}], ["However, the mechanistic roles of the disease-associated SNPs have yet to be elucidated especially in the context of the pathophysiology of asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["One disease-associated SNP, BC+1, which resides in intron BC toward the 5' end of ADAM33, is highly associated with the disease.", {"entities": [[82, 88, "GENE"]]}], ["The region surrounding this genetic variant was cloned into a model system to determine if there is a regulatory element within this intron that influences transcription.", {"entities": []}], ["The BC+1 protective allele did not impose any affect on the transcription of the reporter gene.", {"entities": []}], ["However, the at-risk allele enforced such a repressive affect on the promoter that no protein product from the reporter gene was detected.", {"entities": []}], ["These results indicated that there exists within intron BC a regulatory element that acts as a repressor for gene expression.", {"entities": []}], ["Moreover, since SNP BC+1 is a common genetic variant, this region may interact with other undefined regulatory elements within ADAM33 to provide a rheostat effect, which modulates pre-mRNA processing.", {"entities": [[127, 133, "GENE"]]}], ["Thus, SNP BC+1 may have an important role in the modulation of ADAM33 gene expression.", {"entities": [[63, 69, "GENE"]]}], ["These data provide for the first time a functional role for a disease-associated SNP in ADAM33 and begin to shed light on the deregulation of this gene in the pathophysiology of asthma.", {"entities": [[178, 184, "DISEASE"], [88, 94, "GENE"]]}], ["Moderate cooling of smooth muscle can modulate force production and may contribute to pathophysiological conditions, but the mechanisms underlying its effects are poorly understood.", {"entities": []}], ["Interestingly, cooling increases force in rat ureter, but decreases it in guinea pigs.", {"entities": []}], ["Therefore, this study used ureteric smooth muscle as a model system to elucidate the mechanisms of the effects of cooling on excitation-contraction coupling.", {"entities": []}], ["Simultaneous recordings of force, intracellular [Ca", {"entities": []}], ["Sedation is an essential part of paediatric critical care.", {"entities": []}], ["Midazolam, often in combination with opioids, is the current gold standard drug.", {"entities": []}], ["However, as it is a far-from-ideal agent, clonidine is increasingly being used in children.", {"entities": []}], ["This drug is prescribed off-label for this indication, as many drugs in paediatrics are.", {"entities": []}], ["Therefore, the CLOSED trial aims to provide data on the pharmacokinetics, safety and efficacy of clonidine for the sedation of mechanically ventilated patients in order to obtain a paediatric-use marketing authorisation.", {"entities": []}], ["The CLOSED study is a multicentre, double-blind, randomised, active-controlled non-inferiority trial with a 1:1 randomisation between clonidine and midazolam.", {"entities": []}], ["Both treatment groups are stratified according to age in three groups with the same size: <28 days (n=100), 28 days to <2 years (n=100) and 2\u201318 years (n=100).", {"entities": []}], ["The primary end point is defined as the occurrence of sedation failure within the study period.", {"entities": []}], ["Secondary end points include a pharmacokinetic/pharmacodynamic relationship, pharmacogenetics, occurrence of delirium and withdrawal syndrome, opioid consumption and neurodevelopment in the neonatal age group.", {"entities": [[133, 141, "DISEASE"]]}], ["Logistic regression will be used for the primary end point, appropriate statistics will be used for the secondary end points.", {"entities": []}], ["Written informed consent will be obtained from the parents/caregivers.", {"entities": []}], ["Verbal or deferred consent will be used in the sites where national legislation allows.", {"entities": []}], ["The study has institutional review board approval at recruiting sites.", {"entities": []}], ["The results will be published in a peer-reviewed journal and shared with the worldwide medical community.", {"entities": []}], ["EudraCT: 2014-003582-24; Clinicaltrials.gov: NCT02509273; pre-results.", {"entities": []}], ["In each influenza season, a distinct group of young, otherwise healthy individuals with no risk factors succumbs to life-threatening infection.", {"entities": [[8, 17, "DISEASE"]]}], ["To better understand the cause for this, we analyzed a broad range of immune responses in blood from a unique cohort of patients, comprising previously healthy individuals hospitalized with and without respiratory failure during one influenza season, and infected with one specific influenza A strain.", {"entities": [[202, 221, "DISEASE"], [233, 242, "DISEASE"], [282, 291, "DISEASE"]]}], ["This analysis was compared with similarly hospitalized influenza patients with known risk factors (total of n = 60 patients recruited).", {"entities": [[55, 64, "DISEASE"]]}], ["We found a sustained increase in a specific subset of proinflammatory monocytes, with high TNF-\u03b1 expression and an M1-like phenotype (independent of viral titers), in these previously healthy patients with severe disease.", {"entities": []}], ["The relationship between M1-like monocytes and immunopathology was strengthened using murine models of influenza, in which severe infection generated using different models (including the high-pathogenicity H5N1 strain) was also accompanied by high levels of circulating M1-like monocytes.", {"entities": [[103, 112, "DISEASE"]]}], ["Additionally, a raised M1/M2 macrophage ratio in the lungs was observed.", {"entities": []}], ["These studies identify a specific subtype of monocytes as a modifiable immunological determinant of disease severity in this subgroup of severely ill, previously healthy patients, offering potential novel therapeutic avenues.", {"entities": []}], ["In a cohort of influenza patients, previously healthy and young patients who succumbed to life-threatening disease were defined by high levels of circulating M1-like, TNF-\u03b1", {"entities": [[15, 24, "DISEASE"]]}], ["Functional mimetics of the sialyl Lewis trans -sialidase of Trypanosoma cruzi .", {"entities": []}], ["These compounds inhibited the binding of E-, L-, and P-selectin-coated nanoparticles to polyacrylamide-bound sialyl-Lewis", {"entities": []}], ["Indirect evidence suggests that cancer anorexia is associated with specific aversions to macronutrients.", {"entities": [[32, 38, "DISEASE"]]}], ["To investigate this, patients with cancer anorexia and hospitalized control subjects devised 3-day menus comprising foods that they wished to eat.", {"entities": [[35, 41, "DISEASE"]]}], ["These foods were then provided for 3 days and the intakes of each food carefully measured.", {"entities": []}], ["As expected, patients with cancer anorexia consumed substantially less energy than hospitalized control subjects (6.0 +/- 0.9 MJ vs 9.5 +/- 0.5 MJ, P < 0.001).", {"entities": [[27, 33, "DISEASE"]]}], ["However, macronutrient composition was consistently maintained in the patients with cancer anorexia.", {"entities": [[84, 90, "DISEASE"]]}], ["These data argue against cancer anorexia representing a state of macronutrient aversion.", {"entities": [[25, 31, "DISEASE"]]}], ["Health disparities occur when adverse health conditions are unequal across populations due in part to gaps in wealth.", {"entities": []}], ["These disparities continue to plague global health.", {"entities": [[30, 36, "DISEASE"]]}], ["Decades of research suggests that the natural environment can play a key role in sustaining the health of the public.", {"entities": []}], ["However, the influence of the natural environment on health disparities is not well-articulated.", {"entities": []}], ["Green spaces provide ecosystem services that are vital to public health.", {"entities": []}], ["This paper discusses the link between green spaces and some of the nation\u2019s leading health issues such as obesity, cardiovascular health, heat-related illness, and psychological health.", {"entities": [[106, 113, "DISEASE"]]}], ["These associations are discussed in terms of key demographic variables\u2014race, ethnicity, and income.", {"entities": []}], ["The authors also identify research gaps and recommendations for future research.", {"entities": []}], ["We have investigated the cytotoxicity and reactive oxygen species (ROS) generation for indoor and outdoor soots: candle, wood, diesel, tire, and natural gas burner soots \u2013 along with surrogate black carbon, various multiwall carbon nanotube aggregate materials, TiO 2 (anatase) and chrysotile asbestos as reference materials.", {"entities": []}], ["All soots were observed utilizing TEM and FESEM to be composed of aggregated, primary spherules (20\u201380 nm diameter) forming complex, branched fractal structures.", {"entities": []}], ["These spherules were composed of intercalated, turbostratic arrangements of curved graphene fragments with varying concentrations of polycyclic aromatic hydrocarbon (PAH) isomers.", {"entities": []}], ["In vitro cultures with an immortalized human lung epithelial carcinoma cell line (A549) treated with these materials showed decreased cell viability and variations in ROS production, with no correlations to PAH content.", {"entities": [[61, 70, "DISEASE"]]}], ["The data demonstrate that soots are cytotoxic and that cytotoxicity is not related to PAH content but is related to ROS generation, suggesting that soot induces cellular oxidative stress and that cell viability assays can be indicators of ROS production.", {"entities": []}], ["Multimorbidity is becoming more prevalent.", {"entities": []}], ["Previously-used methods of assessing multimorbidity relied on counting the number of health conditions, often in relation to an index condition (comorbidity), or grouping conditions based on body or organ systems.", {"entities": []}], ["Recent refinements in statistical approaches have resulted in improved methods to capture patterns of multimorbidity, allowing for the identification of nonrandomly occurring clusters of multimorbid health conditions.", {"entities": []}], ["This paper aims to identify nonrandom clusters of multimorbidity.", {"entities": []}], ["The Australian Work Outcomes Research Cost-benefit (WORC) study cross-sectional screening dataset (approximately 78,000 working Australians) was used to explore patterns of multimorbidity.", {"entities": []}], ["Exploratory factor analysis was used to identify nonrandomly occurring clusters of multimorbid health conditions.", {"entities": []}], ["Six clinically-meaningful groups of multimorbid health conditions were identified.", {"entities": []}], ["These were: factor 1: arthritis, osteoporosis, other chronic pain, bladder problems, and irritable bowel; factor 2: asthma, chronic obstructive pulmonary disease, and allergies; factor 3: back/neck pain, migraine, other chronic pain, and arthritis; factor 4: high blood pressure, high cholesterol, obesity, diabetes, and fatigue; factor 5: cardiovascular disease, diabetes, fatigue, high blood pressure, high cholesterol, and arthritis; and factor 6: irritable bowel, ulcer, heartburn, and other chronic pain.", {"entities": [[204, 212, "DISEASE"], [124, 161, "DISEASE"], [298, 305, "DISEASE"], [33, 45, "DISEASE"], [22, 31, "DISEASE"], [238, 247, "DISEASE"], [426, 435, "DISEASE"], [116, 122, "DISEASE"]]}], ["These clusters do not fall neatly into organ or body systems, and some conditions appear in more than one cluster.", {"entities": []}], ["Considerably more research is needed with large population-based datasets and a comprehensive set of reliable health diagnoses to better understand the complex nature and composition of multimorbid health conditions.", {"entities": []}], ["There is a need for new, noninvasive risk assessment tools for use in lung cancer population screening and prevention programs.", {"entities": [[70, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["To investigate the technical feasibility of determining DNA methylation in exhaled breath condensate, we applied our previously-developed method for tag-adapted bisulfite genomic DNA sequencing (tBGS) for mapping of DNA methylation, and adapted it to exhaled breath condensate (EBC) from lung cancer cases and non-cancer controls.", {"entities": [[288, 299, "DISEASE"], [293, 299, "DISEASE"], [314, 320, "DISEASE"]]}], ["Promoter methylation patterns were analyzed in DAPK, RASSF1A and PAX5\u03b2 promoters in EBC samples from 54 individuals, comprised of 37 controls [current- (n = 19), former- (n = 10), and never-smokers (n = 8)] and 17 lung cancer cases [current- (n = 5), former- (n = 11), and never-smokers (n = 1)].", {"entities": [[214, 225, "DISEASE"], [219, 225, "DISEASE"]]}], ["We found: (1) Wide inter-individual variability in methylation density and spatial distribution for DAPK, PAX5\u03b2 and RASSF1A .", {"entities": []}], ["(2) Methylation patterns from paired exhaled breath condensate and mouth rinse specimens were completely divergent.", {"entities": []}], ["(3) For smoking status, the methylation density of RASSF1A was statistically different (p = 0.0285); pair-wise comparisons showed that the former smokers had higher methylation density versus never smokers and current smokers (p = 0.019 and p = 0.031).", {"entities": []}], ["For DAPK and PAX5\u03b2 , there was no such significant smoking-related difference.", {"entities": []}], ["Underlying lung disease did not impact on methylation density for this geneset.", {"entities": [[11, 23, "DISEASE"]]}], ["(4) In case-control comparisons, CpG at -63 of DAPK promoter and +52 of PAX5\u03b2 promoter were significantly associated with lung cancer status (p = 0.0042 and 0.0093, respectively).", {"entities": [[122, 133, "DISEASE"], [127, 133, "DISEASE"]]}], ["After adjusting for multiple testing, both loci were of borderline significance (p adj = 0.054 and 0.031).", {"entities": []}], ["(5) The DAPK gene had a regional methylation pattern with two blocks (1)~-215~-113 and (2) -84 ~+26); while similar in block 1, there was a significant case-control difference in methylation density in block 2 (p = 0.045); (6)Tumor stage and histology did not impact on the methylation density among the cases.", {"entities": []}], ["(7) The results of qMSP applied to EBC correlated with the corresponding tBGS sequencing map loci.", {"entities": []}], ["Our results show that DNA methylation in exhaled breath condensate is detectable and is likely of lung origin.", {"entities": []}], ["Suggestive correlations with smoking and lung cancer case-control status depend on individual gene and CpG site examined.", {"entities": [[41, 52, "DISEASE"], [46, 52, "DISEASE"]]}], ["The discovery of the interferon-lambda (IFN- \u03bb ) family has considerably contributed to our understanding of the role of interferon not only in viral infections but also in cancer.", {"entities": [[173, 179, "DISEASE"]]}], ["IFN- \u03bb proteins belong to the new type III IFN group.", {"entities": []}], ["Type III IFN is structurally similar to type II IFN (IFN- \u03b3 ) but functionally identical to type I IFN (IFN- \u03b1 / \u03b2 ).", {"entities": []}], ["However, in contrast to type I or type II IFNs, the response to type III IFN is highly cell-type specific.", {"entities": []}], ["Only epithelial-like cells and to a lesser extent some immune cells respond to IFN- \u03bb .", {"entities": []}], ["This particular pattern of response is controlled by the differential expression of the IFN- \u03bb receptor, which, in contrast to IFN- \u03b1 , should result in limited side effects in patients.", {"entities": []}], ["Recently, we and other groups have shown in several animal models a potent antitumor role of IFN- \u03bb that will open a new challenging era for the current IFN therapy.", {"entities": []}], ["Drugs against multiple targets may overcome the many limitations of single targets and achieve a more effective and safer control of the disease.", {"entities": []}], ["Numerous high-throughput experiments have been performed in this emerging field.", {"entities": []}], ["However, systematic identification of multiple drug targets and their best intervention requires knowledge of the underlying disease network and calls for innovative computational methods that exploit the network structure and dynamics.", {"entities": []}], ["Here, we develop a robust computational algorithm for finding multiple target optimal intervention (MTOI) solutions in a disease network.", {"entities": []}], ["MTOI identifies potential drug targets and suggests optimal combinations of the target intervention that best restore the network to a normal state, which can be customer designed.", {"entities": []}], ["We applied MTOI to an inflammation-related network.", {"entities": []}], ["The well-known side effects of the traditional non-steriodal anti-inflammatory drugs and the recently recalled Vioxx were correctly accounted for in our network model.", {"entities": []}], ["A number of promising MTOI solutions were found to be both effective and safer.", {"entities": []}], ["The aim of this study was to determine the correlation between glucocorticoids (GCs) and insulin resistance (IR) in healthy individuals by conducting a systematic meta-analysis.", {"entities": []}], ["A systematic literature review was conducted using 9 electronic databases.", {"entities": []}], ["Only case-control studies investigating fasting plasma glucose (FPG) and IR were enrolled based on strictly established selection criteria.", {"entities": []}], ["Statistical analyses were performed by Stata software, version 12.0 (Stata Corporation, College Station, Texas, USA).", {"entities": []}], ["Among 496 initially retrieved articles, only 6 papers published in English were eventually included in this meta-analysis.", {"entities": []}], ["A total of 201 healthy individuals (105 in GC group and 96 in control group) were included in the 6 studies.", {"entities": [[43, 45, "GENE"]]}], ["In 4 of these 6 studies, dexamethasone was used, and in the other 2 studies prednisolone was given.", {"entities": []}], ["This meta-analysis revealed that the FPG, fasting insulin (FINS), and homeostasis model assessment of insulin resistance (HOMA-IR) levels in the GC group were all significantly higher than that in the control group (FPG: SMD=2.65, 95%CI=1.42~3.88, P <0.001; FINS: SMD=2.48, 95%CI=1.01~3.95, P =0.001; HOMA-IR: SMD=38.30, 95%CI=24.38~52.22, P <0.001).", {"entities": [[145, 147, "GENE"]]}], ["In conclusion, our present study revealed that therapies using GCs might result in elevated FPG, FINS, and HOMA-IR, and thereby contribute to IR in healthy individuals.", {"entities": []}], ["The nucleotide-binding oligomerization domain containing 1 ( NOD1 ) gene encodes a pattern recognition receptor that senses pathogens, leading to downstream responses characteristic of innate immunity.", {"entities": [[61, 65, "GENE"]]}], ["We investigated the role of NOD1 single nucleotide polymorphisms (SNPs) on IBD risk in a New Zealand Caucasian population, and studied Nod1 expression in response to bacterial invasion in the Caco2 cell line.", {"entities": [[28, 32, "GENE"], [135, 139, "GENE"], [28, 32, "GENE"], [135, 139, "GENE"]]}], ["DNA samples from 388 Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis patients and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common SNPs in NOD1 , using the MassARRAY NOD1 (Nod1) was studied after infection of Caco2 cells with Escherichia coli LF82.", {"entities": [[47, 65, "DISEASE"], [206, 210, "GENE"], [233, 237, "GENE"], [239, 243, "GENE"], [206, 210, "GENE"], [233, 237, "GENE"], [239, 243, "GENE"], [206, 210, "GENE"], [233, 237, "GENE"], [239, 243, "GENE"]]}], ["Carrying the rs2075818 G allele decreased the risk of CD (OR = 0.66, 95% CI = 0.50\u20130.88, p < 0.002) but not UC.", {"entities": []}], ["There was an increased frequency of the three SNP (rs2075818, rs2075822, rs2907748) haplotype, CTG (p = 0.004) and a decreased frequency of the GTG haplotype (p = 0.02).in CD.", {"entities": []}], ["The rs2075822 CT or TT genotypes were at an increased frequency (genotype p value = 0.02), while the rs2907748 AA or AG genotypes showed decreased frequencies in UC (p = 0.04), but not in CD.", {"entities": []}], ["Functional assays showed that Nod1 is produced 6 hours after bacterial invasion of the Caco2 cell line.", {"entities": [[30, 34, "GENE"]]}], ["The NOD1 gene is important in signalling invasion of colonic cells by pathogenic bacteria, indicative of its' key role in innate immunity.", {"entities": [[4, 8, "GENE"]]}], ["Carrying specific SNPs in this gene significantly modifies the risk of CD and/or UC in a New Zealand Caucasian population.", {"entities": []}], ["To describe the characteristics of new users of cilostazol in Europe with the aim to support the evaluation of its benefit/risk as used in regular clinical practice before the implementation of labeling changes recommended by the European Medicines Agency.", {"entities": []}], ["New users of cilostazol were identified in populations enrolled in five European health automated databases in the UK (The Health Improvement Network [THIN]), Spain (EpiChron cohort and Information System for the Improvement of Research in Primary Care [SIDIAP]), Sweden (National Registers), and Germany (German Pharmacoepidemiological Research Database [GePaRD]) between 2002 and 2012.", {"entities": []}], ["New users were characterized according to the prevalence of cardiovascular disease and other comorbidities, concurrent use of interacting medications, new contraindications, duration of use, and potential off\u2010label prescribing.", {"entities": []}], ["We identified 22\u00a0593 new users of cilostazol.", {"entities": []}], ["The median age was between 68.0 (THIN) and 73.7 (Sweden) years.", {"entities": []}], ["More than 78% of users had concomitant cardiovascular disease, and between 78.8% (GePaRD) and 91.6% (THIN) were treated with interacting medications.", {"entities": []}], ["Prevalence of new cardiovascular contraindications ranged from 1.5% (THIN) to 11.6% (GePaRD), and concurrent use of two or more antiplatelet drugs ranged from 6.3% (SIDIAP) to 13.5% (EpiChron cohort).", {"entities": []}], ["Between 39.4% (Sweden) and 52.9% (THIN) of users discontinued cilostazol in the first 3\u00a0months.", {"entities": []}], ["Between 41.0% (SIDIAP) and 93.4% (THIN) were considered to have received cilostazol according to the European Medicines Agency labeling.", {"entities": []}], ["In this collaborative European study, most cilostazol users were elderly patients with a high prevalence of cardiovascular diseases and other comorbidity and concurrent use of interacting drugs, indicating that this is a vulnerable population at high risk of complications, especially cardiovascular events.", {"entities": []}], ["\u00a9 2017 The Authors.", {"entities": []}], ["Pharmacoepidemiology and Drug Safety Published by John Wiley & Sons Ltd.", {"entities": []}], ["In the Netherlands, 1.4% of tuberculosis (TB) cases are caused by Mycobacterium bovis .", {"entities": [[28, 40, "DISEASE"]]}], ["After we admitted 3 patients with M. bovis infections to our reference hospital, we conducted a retrospective analysis of all M. bovis disease in the Netherlands during 1993\u20132007.", {"entities": []}], ["We analyzed data from 231 patients for clinical, demographic, treatment, and outcome characteristics and for risk factors.", {"entities": []}], ["Most patients were native Dutch (n = 138; 59.7%) or Moroccan (n = 54; 23.4%).", {"entities": []}], ["Disease was mainly extrapulmonary (n = 136; 58.9%).", {"entities": []}], ["Although 95 patients had pulmonary disease, person-to-person transmission did not occur, as shown by structural DNA fingerprinting analysis.", {"entities": []}], ["Lymph node TB was more likely to develop in women (p<0.0001), whereas pulmonary M. bovis disease developed more frequently in men (p<0.0001).", {"entities": []}], ["Diagnosis was accurate but delayed and led to inadequate treatment in 26% of the cases.", {"entities": []}], ["Proportion of deaths from M. bovis disease was higher than that for M. tuberculosis disease.", {"entities": [[71, 83, "DISEASE"]]}], ["Patient problem solving and decision making are recognized as essential to effective self-management across multiple chronic diseases.", {"entities": []}], ["However, a health-related problem-solving instrument that demonstrates sensitivity to disease control parameters in multiple diseases has not been established.", {"entities": []}], ["To determine, in two disease samples, internal consistency and associations with disease control of the Health Problem-Solving Scale (HPSS), a 50-item measure with 7 subscales assessing effective and ineffective problem-solving approaches, learning from past experiences, and motivation/orientation.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["Outpatients from university-affiliated medical center HIV ( N \u2009=\u2009111) and diabetes mellitus (DM, N \u2009=\u200978) clinics.", {"entities": [[74, 91, "DISEASE"]]}], ["HPSS, CD4, hemoglobin A1c (HbA1c), and number of hospitalizations in the previous year and Emergency Department (ED) visits in the previous 6\u00a0months.", {"entities": [[6, 9, "GENE"]]}], ["Administration time for the HPSS ranged from 5 to 10\u00a0minutes.", {"entities": []}], ["Cronbach\u2019s alpha for the total HPSS was 0.86 and 0.89 for HIV and DM, respectively.", {"entities": []}], ["Higher total scores (better problem solving) were associated with higher CD4 and fewer hospitalizations in HIV and lower HbA1c and fewer ED visits in DM.", {"entities": [[73, 76, "GENE"]]}], ["Health Problem-Solving Scale subscales representing negative problem-solving approaches were consistently associated with more hospitalizations (HIV, DM) and ED visits (DM).", {"entities": []}], ["The HPSS may identify problem-solving difficulties with disease self-management and assess effectiveness of interventions targeting patient decision making in self-care.", {"entities": []}], ["This study\u2019s aim was to assess the perceptions of welding apprentices concerning welding fumes being associated with respiratory and cardiovascular disorders and assess the implementation of risk communication as a primary prevention tool in the welding training process.", {"entities": []}], ["This quasi-experimental, non-randomized study with before-and-after design was conducted with 84 welding apprentices in Southern Brazil.", {"entities": []}], ["Poisson Regression analysis was used.", {"entities": []}], ["Relative Risk was the measure used with a 95% confidence interval and 5% ( p \u2264 0.05) significance level.", {"entities": []}], ["Significant association was found between perceptions of worsened symptoms of respiratory disorders caused by welding fumes and educational level ( p = 0.049), the use of goggles to protect against ultraviolet rays ( p = 0.023), and access to services in private health facilities without insurance coverage ( p = 0.001).", {"entities": []}], ["Apprentices younger than 25 years old were 4.9 times more likely to perceive worsened cardiovascular symptoms caused by welding fumes after risk communication (RR = 4.91; CI 95%: 1.09 to 22.2).", {"entities": []}], ["The conclusion is that risk communication as a primary preventive measure in continuing education processes implemented among apprentices, who are future welders, was efficacious.", {"entities": []}], ["Thus, this study confirms that risk communication can be implemented as a primary prevention tool in welding apprenticeships.", {"entities": []}], ["Prunella vulgaris var.", {"entities": []}], ["lilacina , a herbal medicine, has long been used in Korea for the treatment of sore throat, and to alleviate fever and accelerate wound healing.", {"entities": []}], ["Although the therapeutic effect of P. vulgaris var.", {"entities": []}], ["lilacina is likely associated with anti-inflammatory activity, the precise underlying mechanisms are largely unknown.", {"entities": []}], ["Here, we sought to elucidate the possible mechanisms of the anti-inflammatory activity.", {"entities": []}], ["We have investigated the anti-inflammatory activity of the various solvent fractions (hexane, butanol, chloroform and water) from the ethanol extract of P. vulgaris var.", {"entities": []}], ["lilacina in activated macrophages.", {"entities": []}], ["The hexane fraction exhibited higher anti-inflammatory activities, inducing inhibition of nitric oxide and prostaglandin E2 production as well as inducible nitric oxide synthase, cyclooxygenase-2, and tumor necrosis factor-\u03b1 mRNA expression in response to lipopolysaccharide stimulation.", {"entities": []}], ["Moreover, the hexane fraction from P. vulgaris var.", {"entities": []}], ["lilacina significantly inhibited the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) and the nuclear translocation of the NF-\u03baB p50 and p65 subunits.", {"entities": []}], ["These results indicate that P. vulgaris var.", {"entities": []}], ["lilacina has an anti-inflammatory capacity in vitro , suggesting that it could be a potential source of natural anti-inflammatory agents.", {"entities": []}], ["A higher slow vital capacity (VC) compared with forced vital capacity (FVC) indicates small airway collapse and air trapping.", {"entities": []}], ["We hypothesized that a larger difference between VC and FVC (VC-FVC) would predict impaired exercise capacity in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[127, 164, "DISEASE"]]}], ["Pulmonary function and incremental cardiopulmonary exercise responses were assessed in 97 COPD patients.", {"entities": []}], ["Patients were then divided into two groups: one in which VC\u2009>\u2009FVC (n\u2009=\u200977) and the other in which VC\u2009\u2264\u2009FVC (n\u2009=\u200920).", {"entities": []}], ["Patients with VC\u2009>\u2009FVC had lower FEV 1 and peak oxygen uptake (VO 2 /kg) compared with patients with VC\u2009\u2264\u2009FVC.", {"entities": [[33, 36, "GENE"]]}], ["There was a significant inverse correlation for the entire group between VC-FVC and peak VO 2 /kg (r\u2009=\u2009-0.404; p\u2009<\u20090.001).", {"entities": []}], ["There was also a direct correlation between FEV 1 % pred and peak VO 2 /kg (r\u2009=\u20090.418; p\u2009<\u20090.001).", {"entities": [[44, 47, "GENE"]]}], ["The results of the multivariate regression analysis with peak VO 2 /kg as the dependent variable showed that VC-FVC, FEV 1 (% pred) and age were all significant independent predictors of peak VO 2 /kg.", {"entities": [[117, 120, "GENE"]]}], ["The model explained 35.9% of the peak VO 2 /kg variance.", {"entities": []}], ["The difference between VC and FVC, easily measured by spirometry, can be used not only as an index of severity of airflow limitation, but also to predict exercise performance in COPD patients.", {"entities": []}], ["Influenza vaccinations are recommended for health professionals by the WHO and the CDC.", {"entities": [[0, 9, "DISEASE"]]}], ["Medical students are important health professionals not only as future physicians, but also due to their frequent contact with patients during their education.", {"entities": []}], ["The aim of this study was to compare the knowledge, attitudes, motivations and influenza vaccinations of medicine students in three different countries: Poland, France, and Iran.", {"entities": [[79, 88, "DISEASE"]]}], ["1045 self-reported questionnaires were given to medical students of Warsaw Medical University (n = 502), the Faculty of Medicine of Strasbourg University (n = 371) and Teheran University of Medical Sciences (n = 172).", {"entities": []}], ["In France, students working in a hospital can be vaccinated free of charge.", {"entities": []}], ["In Poland and Iran students are required to pay for the vaccine and have to arrange the administration of the vaccine on their own.", {"entities": []}], ["Vaccination of students during the year of the study time was generally infrequent: the highest was in Strasbourg 29.7%; it was lower in Warsaw 15.2%, and lowest in Teheran at 4.7%.", {"entities": []}], ["Similarly, 60% of medical students in Strasbourg, 65% of students in Warsaw and 86% of students in Teheran have never been vaccinated.", {"entities": []}], ["The percentage of students knowing that they belong to the group of people that have strong indications for being vaccinated was 78% in Strasbourg, 48% in Warsaw and 40% in Teheran.", {"entities": []}], ["The main reasons for obtaining a shot, cited by students, were to protect from influenza and the fear of disease sequelae.", {"entities": [[79, 88, "DISEASE"]]}], ["The most important reasons for not being vaccinated were laziness, lack of time, and also lack of knowledge of the indications in favor of being vaccinated.", {"entities": []}], ["Being vaccinated at least once in the past is the most important predictor of the vaccination in the current season.", {"entities": []}], ["Few medical students in all of the examined countries are immunized against influenza.", {"entities": [[76, 85, "DISEASE"]]}], ["Data indicate that providing access to free vaccinations, although very important, cannot alone solve the problem.", {"entities": []}], ["Strengthening educational efforts seems crucial, although no immediate effects should be expected due to remarkable inertia.", {"entities": []}], ["Influencing attitudes at an earlier stage can be more advantageous.", {"entities": []}], ["Dmd ( mdx ) mice are used as a genetic and biochemical model of dystrophin deficiency.", {"entities": [[0, 3, "GENE"]]}], ["The long-term consequences of glucocorticoid (GC) treatment on dystrophin-deficient skeletal and heart muscle are not yet known.", {"entities": [[46, 48, "GENE"]]}], ["Here we used systematic phenotyping to assess the long-term consequences of GC treatment in mdx mice.", {"entities": [[76, 78, "GENE"]]}], ["Our investigation addressed not only the effects of GC on the disease phenotype but also the question of whether GCs can be used as a positive control for preclinical drug evaluations.", {"entities": [[52, 54, "GENE"]]}], ["We performed nine pre-clinical efficacy trials (treated N\u200a=\u200a129, untreated N\u200a=\u200a106) of different durations in 9-to-50-week-old dystrophic mdx mice over a 3-year time period using standardized methods.", {"entities": []}], ["In all these trials, we used either 1 mg/kg body weight of prednisone or 5 mg/kg body weight of prednisolone as positive controls to compare the efficacy of various test drugs.", {"entities": []}], ["Data from untreated controls and GC-treated mice in the various trials have been pooled and analyzed to assess the effects of GCs on dystrophin-deficient skeletal and cardiac muscles of mdx mice.", {"entities": []}], ["Our results indicate that continuous GC treatment results in early (e.g., at 50 days) improvements in normalized parameters such as grip strength, motor coordination and maximal in vitro force contractions on isolated EDL muscle, but these initial benefits are followed by a progressive loss of muscle strength after 100 days.", {"entities": [[37, 39, "GENE"]]}], ["We also found a significant increase in heart fibrosis that is reflected in a significant deterioration in cardiac systolic function after 100 days of treatment.", {"entities": []}], ["Continuous administration of prednisone to mdx mice initially improves skeletal muscle strength, but further therapy result in deterioration of muscle strength and cardiac function associated with enhanced cardiac fibrosis.", {"entities": []}], ["These results suggest that GCs may not serve as an appropriate positive control for long-term mdx mouse preclinical trials.", {"entities": []}], ["Results of the Global Adult Tobacco Survey in Kerala, India found that 42\u00a0% of adults were exposed to second hand smoke (SHS) inside the home.", {"entities": []}], ["Formative research carried out in rural Kerala suggests that exposure may be much higher.", {"entities": []}], ["Numerous studies have called for research and intervention on SHS exposure among women and children as an important component of maternal and child health activities.", {"entities": []}], ["Community-based participatory research was carried out in Kerala.", {"entities": []}], ["First, a survey was conducted to assess prevalence of SHS exposure in households.", {"entities": []}], ["Next, a proof of concept study was conducted to develop and test the feasibility of a community-wide smoke free homes initiative.", {"entities": []}], ["Educational materials were developed and pretested in focus groups.", {"entities": []}], ["After feasibility was established, pilot studies were implemented in two other communities.", {"entities": []}], ["Post intervention, surveys were conducted as a means of assessing changes in community support.", {"entities": []}], ["At baseline, between 70 and 80\u00a0% of male smokers regularly smoked inside the home.", {"entities": []}], ["Over 80\u00a0% of women had asked their husband not to do so.", {"entities": []}], ["Most women felt powerless to change their husband\u2019s behavior.", {"entities": []}], ["When women were asked about supporting a smoke free homes intervention, 88\u00a0% expressed support for the idea, but many expressed doubt that their husbands would comply.", {"entities": []}], ["Educational meetings were held to discuss the harms of second hand smoke.", {"entities": []}], ["Community leaders signed a declaration that their community was part of the smoke free homes initiative.", {"entities": []}], ["Six months post intervention a survey was conducted in these communities; between 34 and 59\u00a0% of men who smoked no longer smoked in their home.", {"entities": []}], ["The smoke free homes initiative is based on the principle of collective efficacy.", {"entities": []}], ["Recognizing the difficulty for individual women to effect change in their household, the movement establishes a smoke free community mandate.", {"entities": []}], ["Based on evaluation data from two pilot studies, we can project that between a 30 and 60\u00a0% reduction of smoking in the home may be achieved, the effect size determined by how well the smoke free home steps are implemented, the characteristics of the community, and the motivation of community level facilitators.", {"entities": []}], ["Despite consistent evidence of a higher short-term risk of cardiovascular mortality associated with ambient temperature, there have been discrepant findings on the association between temperature and ischemic stroke.", {"entities": []}], ["Moreover, few studies have considered potential confounding by ambient fine particulate matter air pollution <2.5 \u03bcm in diameter (PM 2.5 ) and none have examined the impact of temperature changes on stroke in the subsequent hours rather than days.", {"entities": []}], ["The aim of this study was to evaluate whether changes in temperature trigger an ischemic stroke in the following hours and days and whether humid days are particularly harmful.", {"entities": []}], ["We reviewed the medical records of 1,705 patients residing in the metropolitan region of Boston, Mass., USA, who were hospitalized with neurologist-confirmed ischemic stroke, and we abstracted data on the time of symptom onset and clinical characteristics.", {"entities": []}], ["We obtained hourly meteorological data from the National Weather Service station and hourly PM 2.5 data from the Harvard ambient monitoring station.", {"entities": []}], ["We used the time-stratified case-crossover design to assess the association between ischemic stroke and apparent temperature averaged over 1-7 days prior to stroke onset adjusting for PM 2.5 .", {"entities": []}], ["We assessed whether differences in apparent temperature trigger a stroke within shorter time periods by examining the association between stroke onset and apparent temperature levels averaged in 2-hour increments prior to stroke onset (0-2 h through 36-38 h).", {"entities": []}], ["We tested whether the association varied by health characteristics or by PM 2.5 , ozone or relative humidity.", {"entities": []}], ["The incidence rate ratio of ischemic stroke was 1.09 (95% confidence interval 1.01-1.18) following a 5\u00b0C decrement in average apparent temperature over the 2 days preceding symptom onset.", {"entities": []}], ["The higher risk associated with cooler temperatures peaked in the first 14-34 h. There was no statistically significant difference in the association between temperature and ischemic stroke across seasons.", {"entities": []}], ["The risk of ischemic stroke was not meaningfully different across subgroups of patients defined by health characteristics.", {"entities": []}], ["The association between ischemic stroke and ambient temperature was stronger on days with higher levels of relative humidity.", {"entities": []}], ["Lower temperatures are associated with a higher risk of ischemic stroke onset in both warm and cool seasons, and the risk is higher on days with higher levels of relative humidity.", {"entities": []}], ["Based on this study and the body of literature on ambient temperature and cardiovascular events, identifying methods for mitigating cardiovascular risk may be warranted.", {"entities": []}], ["The Swedish Family-Cancer Database was used to analyse site-specific risk of second primary malignancies following 53\u2008159 haematolymphoproliferative disorders (HLPD) diagnosed between 1958 and 1996.", {"entities": [[19, 25, "DISEASE"]]}], ["Standardized incidence ratio (SIR) of a second malignancy was calculated as the ratio of observed to expected numbers of second malignancies by applying site-, sex-, age-, period-, residence- and occupation-specific rates in the corresponding population in the Database to the appropriate person-years at risk.", {"entities": []}], ["Among 18\u2008960 patients with non-Hodgkin's lymphoma (NHL), there was over a 3-fold significant increase in cancer of the tongue, small intestine, nose, kidney and nervous system, squamous cell carcinoma (SCC) of the skin, NHL, Hodgkin's disease (HD) and lymphoid and myeloid leukaemia.", {"entities": [[191, 200, "DISEASE"], [177, 200, "DISEASE"], [41, 49, "DISEASE"], [105, 111, "DISEASE"]]}], ["Among 5353 patients with HD, there was over a 4-fold significant increase in cancer of the salivary glands, nasopharynx and thyroid, NHL and myeloid leukaemia, and over a 1.6-fold increase in cancer of the stomach, colon, lung, breast, skin (melanoma and SCC), nervous system and soft tissues and lymphoid leukaemia.", {"entities": [[242, 250, "DISEASE"], [77, 83, "DISEASE"], [192, 198, "DISEASE"]]}], ["Among 28\u2008846 patients with myeloma and leukaemia, there was a significant increase in cancer of the skin, nervous system and non-thyroid endocrine glands and all HLPD except for myeloma.", {"entities": [[27, 34, "DISEASE"], [178, 185, "DISEASE"], [86, 92, "DISEASE"]]}], ["Our findings showed some clustering between first and second primaries among Epstein\u2013Barr virus-, ultraviolet radiation- and immunosuppression-related cancers.", {"entities": []}], ["\u00a9 2001 Cancer Research Campaign http://www.bjcancer.com", {"entities": [[7, 13, "DISEASE"]]}], ["Self-efficacy for coping with cancer is a specific construct that refers to behaviors that occur in the course of dealing with a cancer diagnosis, cancer treatments, and transitioning to survivorship.", {"entities": [[30, 36, "DISEASE"], [129, 135, "DISEASE"], [147, 153, "DISEASE"]]}], ["One of the more widely used measures of self-efficacy for coping strategies with cancer is the Cancer Behavior Inventory.", {"entities": [[81, 87, "DISEASE"], [95, 101, "DISEASE"]]}], ["The following general questions provide a framework for this research: 1.", {"entities": []}], ["Is self-efficacy for coping with cancer related to distress and quality of life of a cancer patient?.", {"entities": [[33, 39, "DISEASE"], [85, 91, "DISEASE"]]}], ["Do self-efficacy for coping with cancer and the target psychological outcomes (i.e., distress and quality of life) change in longitudinal studies, with or without intervention?", {"entities": [[33, 39, "DISEASE"]]}], ["One-hundred eighty studies cited the different versions of the Cancer Behavior Inventory and 47 used the scale.", {"entities": [[63, 69, "DISEASE"]]}], ["Result showed an inverse relationship between self-efficacy for coping with cancer and distress, and a positive relationship between self-efficacy for coping with cancer and Quality of Life, both with a large effect size.", {"entities": [[76, 82, "DISEASE"], [163, 169, "DISEASE"]]}], ["The strong relationship of self-efficacy and outcomes, resulted of the specificity of the instrument, which targets specific coping strategies that are closely aligned with positive outcomes in adjusting to cancer.", {"entities": [[207, 213, "DISEASE"]]}], ["However, the results are consistent with the theory, which states that compared to those with low efficacy, highly efficacious people demonstrate less anxiety and better adjustment in stressful situations and consistent with prior results in which self-efficacy is positively related to quality of life.", {"entities": []}], ["Many toxic substances in the workplace can modify human health and quality of life and there is still insufficient data on respiratory outcomes in adults exposed to phthalates.", {"entities": []}], ["The aim of this work was to assess in waste management workers from the Nitra region of Slovakia ( n = 30) the extent of exposure to phthalates and health-related outcomes.", {"entities": []}], ["Four urinary phthalate metabolites mono(2-ethylhexyl) phthalate (MEHP), monobutyl phthalate (MnBP), monoethyl phthalate (MEP) and monoisononyl phthalate (MiNP) were determined by high-performance liquid chromatography with mass spectrometry (HPLC-MS/MS).", {"entities": []}], ["Urinary concentration of MEHP was positively associated with ratio of forced expiratory volume in 1 s to forced vital capacity % (FEV 1 /FVC) ( r = 0.431; p = 0.018) and MiNP with fat free mass index (FFMI) ( r = 0.439; p = 0.015).", {"entities": [[130, 133, "GENE"]]}], ["The strongest predictor of pulmonary function was the pack/year index as smoking history that predicted a decrease of pulmonary parameters, the FEV 1 /FVC, % of predicted values of peak expiratory flow (PEF % of PV) and FEV 1 % of PV.", {"entities": [[144, 147, "GENE"], [220, 223, "GENE"], [144, 147, "GENE"], [220, 223, "GENE"]]}], ["Unexpectedly, urinary MEHP and MINP were positively associated with pulmonary function expressed as PEF % of PV and FEV 1 /FVC.", {"entities": [[116, 119, "GENE"]]}], ["We hypothesize that occupational exposure to phthalates estimated from urinary metabolites (MEHP, MiNP) can modify pulmonary function on top of lifestyle factors.", {"entities": []}], ["The nasopharynx is a reservoir for pathogens associated with respiratory illnesses such as asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["Next-generation sequencing (NGS) has been used to characterize the nasopharyngeal microbiome of infants and adults during health and disease; less is known, however, about the composition and temporal dynamics (i.e., longitudinal variation) of microbiotas from children and adolescents.", {"entities": []}], ["Here we use NGS technology to characterize the nasopharyngeal microbiomes of asthmatic children and adolescents (6 to 18 years) and determine their stability over time.", {"entities": []}], ["Two nasopharyngeal washes collected 5.5 to 6.5 months apart were taken from 40 children and adolescents with asthma living in the Washington D.C. area.", {"entities": [[109, 115, "DISEASE"]]}], ["Sequence data from the 16S-V4 rRNA gene region (~250 bp) were collected from the samples using the MiSeq platform.", {"entities": []}], ["Raw data were processed in mothur (SILVA123 reference database) and Operational Taxonomic Units (OTU)-based alpha- and beta-diversity metrics were estimated.", {"entities": []}], ["Relatedness among samples was assessed using PCoA ordination and Procrustes analyses.", {"entities": []}], ["Differences in microbial diversity and taxon mean relative proportions were assessed using linear mixed effects models.", {"entities": []}], ["Core microbiome analyses were also performed to identify stable and consistent microbes of the nasopharynx.", {"entities": []}], ["A total of 2,096,584 clean 16S sequences corresponding to an average of 167 OTUs per sample were generated.", {"entities": []}], ["Representatives of Moraxella* , Staphylococcus* , Dolosigranulum , Corynebacterium , Prevotella , Streptococcus* , Haemophilus* , Fusobacterium* and a Neisseriaceae genus accounted for 86% of the total reads.", {"entities": []}], ["These nine genera have been previously found in the nasopharynxes of both infants and adults, but in different proportions.", {"entities": []}], ["OTUs from the five genera highlighted ( * ) above defined the nasopharyngeal core microbiome at the 95% level.", {"entities": []}], ["No significant differences in alpha- and beta-diversity were observed between seasons, but bacterial mean relative proportions of Haemophilus , Moraxella , Staphylococcus and Corynebacterium varied significantly between summer-fall and age groups (inter-patient variation).", {"entities": []}], ["Additionally, OTUs varied significantly within patients between time points in 35 of the 40 patients analyzed.", {"entities": []}], ["Future cross-sectional studies should be mindful of the temporal dynamics of the nasopharyngeal microbiota.", {"entities": []}], ["In autoimmune disorders, the underlying pathogenic mechanism is the formation of antigen-antibody complexes which trigger an inflammatory response by inducing the infiltration of neutrophils.", {"entities": []}], ["Epithelial cell-derived neutrophil-activating peptide-78 (ENA-78) is a chemokine that recruits and activates neutrophils, thus it could play a pathogenic role in inflammation and autoimmune disorders.", {"entities": []}], ["Some autistic children have elevated levels of brain specific auto-antibodies.", {"entities": []}], ["We are the first to evaluate serum expression of ENA-78 and its relation to antineuronal auto-antibodies in autistic children.", {"entities": []}], ["Serum ENA-78 and antineuronal auto-antibodies were measured by ELISA test in 62 autistic children aged between 4\u201311 years and 62 health-matched controls.", {"entities": []}], ["Serum levels of ENA-78 were significantly higher in autistic children than healthy controls (P\u2009<\u20090.001).", {"entities": []}], ["Increased serum levels of ENA-78 have been found in 69.35% of autistic patients.", {"entities": []}], ["In addition, autistic children had significantly higher percent positivity of serum antineuronal auto-antibodies (64.5%) than healthy controls (6.45%), P\u2009<\u20090.001.", {"entities": []}], ["There was a significant positive association between the positivity of serum antineuronal auto-antibodies and the elevated levels of serum ENA-78 (P\u2009<\u20090.001) in autistic children.", {"entities": []}], ["Serum levels of ENA-78 were elevated in autistic children and they were significantly associated with the increased levels of serum antineuronal auto-antibodies.", {"entities": []}], ["However, these data should be treated with caution until further research is conducted to determine the pathogenic role of ENA-78 in autism and its relation to brain specific auto-antibodies that have been found in some autistic children.", {"entities": []}], ["The possible therapeutic role of ENA-78 antagonist in autistic children should be also studied.", {"entities": []}], ["Ursolic acid (UA) is a promising molecule with anti-inflammatory, analgesic and potential anti-arthritic activity.", {"entities": []}], ["This study was undertaken to make formulation and evaluation of Ocimum sanctum L. leaf extract (OLE) loaded nano-structured lipid carriers (OLE-NLCs) for improved transdermal delivery of UA.", {"entities": []}], ["Different surfactants, solid lipids and liquid lipids were used for the preparation of NLCs.", {"entities": []}], ["The NLCs were developed using emulsion solvent diffusion and evaporation method.", {"entities": []}], ["Different physicochemical properties, entrapment efficacy, in vitro release evaluation, and ex vivo permeation studies of the prepared NLCs were carried out.", {"entities": []}], ["The in vivo anti-arthritic activity of OLE-loaded NLC gel and control gel formulation (OLE free NLC gel) against Complete Freund's Adjuvant (CFA) induced arthritis in wister albino rats was also carried out.", {"entities": [[154, 163, "DISEASE"]]}], ["OLE-NLCs were composed of spherical particles having a mean particle size of ~120 nm, polydispersity index of ~0.162 and zeta potential of ~ -27 mV.", {"entities": []}], ["The high entrapment efficiency (EE) of UA ~89.56% was attained.", {"entities": []}], ["The in vitro release study demonstrated a prolonged release of UA from the NLCs up to 12 h. The developed formulation was found to be significantly better with respect to the drug permeation amount with an enhancement ratio of 2.69 as compared with marketed formulation.", {"entities": []}], ["The in vivo biological activity investigations, studies showed that the newly prepared NLCs formulation of OLE showed excellent anti-arthritic activity and the results were found at par with standard marketed diclofenac gel for its analgesic and anti-arthritic activities.", {"entities": []}], ["These results were also supported by radiological analysis and molecular docking studies.", {"entities": []}], ["The overall results proved that the prepared OLE-NLCs were very effective for the treatment of arthritis and the results were found at par with standard marketed the standard formulation of diclofenac gel.", {"entities": [[95, 104, "DISEASE"]]}], ["Maintenance of therapeutic International Normalized Ratio (INR) in the community is generally poor.", {"entities": []}], ["The supervised environment in long-term care facilities may represent a more ideal setting for warfarin therapy since laboratory monitoring, compliance, dose adjustment, and interacting medications can all be monitored and controlled.", {"entities": []}], ["The objectives of this study were to determine how effectively warfarin was administered to a cohort of residents in long-term care facilities, to identify the proportion of residents prescribed warfarin-interacting drugs and to ascertain factors associated with poor INR control.", {"entities": []}], ["A chart review of 105 residents receiving warfarin therapy in five long-term care facilities in Hamilton, Ontario was performed.", {"entities": []}], ["Data were collected on INR levels, warfarin prescribing and monitoring practices, and use of interacting medications.", {"entities": []}], ["Over a 12 month period (28,555 resident-days, 78.2 resident years) 3065 INR values were available.", {"entities": []}], ["Residents were within, below and above the therapeutic range 54%, 35% and 11% of the time, respectively.", {"entities": []}], ["Seventy-nine percent of residents were prescribed at least one warfarin-interacting medication during the period in review.", {"entities": []}], ["Residents receiving interacting medications spent less time in the therapeutic range (53.0% vs. 58.2%, OR = 0.93, 95% confidence interval 0.88 to 0.97, P = 0.002).", {"entities": []}], ["Adequacy of anticoagulation varied significantly between physicians (time in therapeutic range 45.9 to 63.9%).", {"entities": []}], ["In this group of long-term care residents, warfarin control was suboptimal.", {"entities": []}], ["Both prescriber and co-prescription of interacting medications were associated with poorer INR control.", {"entities": []}], ["Future studies should seek strategies to improve prescriber skill and decrease use of interacting medications.", {"entities": []}], ["Ocular surface inflammation associated with Sj\u00f6gren's syndrome is characterized by a loss of secretory function and alteration in numbers of mucin secreting goblet cells.", {"entities": [[54, 62, "DISEASE"]]}], ["Such changes are a prominent feature of ocular surface inflammatory diseases and are attributed to inflammation; however, the exact effect of the inflammatory cytokines on conjunctival goblet cell function remains largely unknown.", {"entities": []}], ["In this study, we developed a primary culture of mouse goblet cells from conjunctival tissue and evaluated the effects on their function by inflammatory cytokines detected in the conjunctiva of mouse model of Sj\u00f6gren's syndrome (Thrombospondin-1 deficient mice).", {"entities": [[219, 227, "DISEASE"]]}], ["We found that apoptosis of goblet cells was primarily induced by TNF- \u03b1 and IFN- \u03b3 .", {"entities": []}], ["These two cytokines also inhibited mucin secretion by goblet cells in response to cholinergic stimulation, whereas IL-6 enhanced such secretion.", {"entities": []}], ["No changes in secretory response were detected in the presence of IL-13 or IL-17.", {"entities": []}], ["Goblet cells proliferated to varying degrees in response to all the tested cytokines with the greatest response to IL-13 followed by IL-6.", {"entities": []}], ["Our results therefore reveal that inflammatory cytokines expressed in the conjunctiva during an ocular surface disease directly disrupt conjunctival goblet cell functions, compromising the protective function of tears, thereby contributing to ocular surface damage.", {"entities": []}], ["Natural killer T (NKT) cells are a subset of T cells that recognize glycolipid antigens presented by the CD1d protein.", {"entities": [[105, 109, "GENE"]]}], ["The initial discovery of immunostimulatory glycolipids from a marine sponge and the T cells that respond to the compounds has led to extensive research by chemists and immunologists to understand how glycolipids are recognized, possible responses by NKT cells, and the structural features of glycolipids necessary for stimulatory activity.", {"entities": []}], ["The presence of this cell type in humans and most mammals suggests that it plays critical roles in antigen recognition and the interface between innate and adaptive immunity.", {"entities": []}], ["Both endogenous and exogenous natural antigens for NKT cells have been identified, and it is likely that glycolipid antigens remain to be discovered.", {"entities": []}], ["Multiple series of structurally varied glycolipids have been synthesized and tested for stimulatory activity.", {"entities": []}], ["The structural features of glycolipids necessary for NKT cell stimulation are moderately well understood, and designed compounds have proven to be much more potent antigens than their natural counterparts.", {"entities": []}], ["Nevertheless, control over NKT cell responses by designed glycolipids has not been optimized, and further research will be required to fully reveal the therapeutic potential of this cell type.", {"entities": []}], ["\"Alternatively-activated\" macrophages are found in Th2-mediated inflammatory settings such as nematode infection and allergic pulmonary inflammation.", {"entities": []}], ["Due in part to a lack of markers, these cells have not been well characterized in vivo and their function remains unknown.", {"entities": []}], ["We have used murine macrophages elicited by nematode infection (NeM\u03c6) as a source of in vivo derived alternatively activated macrophages.", {"entities": []}], ["Using three distinct yet complementary molecular approaches we have established a gene expression profile of alternatively activated macrophages and identified macrophage genes that are regulated in vivo by IL-4.", {"entities": []}], ["First, genes abundantly expressed were identified by an expressed sequence tag strategy.", {"entities": []}], ["Second, an array of 1176 known mouse genes was screened for differential expression between NeM\u03c6 from wild type or IL-4 deficient mice.", {"entities": []}], ["Third, a subtractive library was screened to identify novel IL-4 dependent macrophage genes.", {"entities": []}], ["Differential expression was confirmed by real time RT-PCR analysis.", {"entities": []}], ["Our data demonstrate that alternatively activated macrophages generated in vivo have a gene expression profile distinct from any macrophage population described to date.", {"entities": []}], ["Several of the genes we identified, including those most abundantly expressed, have not previously been associated with macrophages and thus this study provides unique new information regarding the phenotype of macrophages found in Th2-mediated, chronic inflammatory settings.", {"entities": []}], ["Our data also provide additional in vivo evidence for parallels between the inflammatory processes involved in nematode infection and allergy.", {"entities": []}], ["Receptor occupancy (RO) assays are designed to quantify the binding of therapeutics to their targets on the cell surface and are frequently used to generate pharmacodynamic (PD) biomarker data in nonclinical and clinical studies of biopharmaceuticals.", {"entities": []}], ["When combined with the pharmacokinetic (PK) profile, RO data can establish PKPD relationships, which are crucial for informing dose decisions.", {"entities": []}], ["RO is commonly measured by flow cytometry on fresh blood specimens and is subject to numerous technical and logistical challenges.", {"entities": []}], ["To ensure that reliable and high quality results are generated from RO assays, careful assay design, key reagent characterization, data normalization/reporting, and thorough planning for implementation are of critical importance during development.", {"entities": []}], ["In this article, the authors share their experiences and perspectives in these areas and discuss challenges and potential solutions when developing and implementing a flow cytometry\u2010based RO method in support of biopharmaceutical drug development.", {"entities": []}], ["\u00a9 2015 The Authors Cytometry Part B: Clinical Cytometry Published by Wiley Periodicals, Inc.", {"entities": []}], ["Grass pollen, in particular from Lolium multiflorum is a major allergen source in temperate climate zones of Southern Brazil.", {"entities": []}], ["The IgE sensitization profile of Brazilian grass pollen allergic patients to individual allergen molecules has not been analyzed yet.", {"entities": []}], ["To analyze the IgE sensitization profile of a Brazilian grass pollen allergic population using individual allergen molecules.", {"entities": []}], ["We analyzed sera from 78 grass pollen allergic patients for the presence of IgE antibodies specific for 103 purified micro-arrayed natural and recombinant allergens by chip technology.", {"entities": []}], ["IgE-ELISA inhibition experiments with Lolium multiflorum , Phleum pratense extracts and a recombinant fusion protein consisting of Phl p 1, Phl p 2, Phl p 5 and Phl p 6 were performed to investigate cross-reactivities.", {"entities": []}], ["Within the Brazilian grass pollen allergic patients, the most frequently recognized allergens were Phl p 1 (95%), Phl p 5 (82%), Phl p 2 (76%) followed by Phl p 4 (64%), Phl p 6 (45%), Phl p 11 (18%) and Phl p 12 (18%).", {"entities": []}], ["Most patients were sensitized only to grass pollen allergens but not to allergens from other sources.", {"entities": []}], ["A high degree of IgE cross-reactivity between Phleum pratense , Lolium multiflorum and the recombinant timothy grass fusion protein was found.", {"entities": []}], ["Component-resolved analysis of sera from Brazilian grass pollen allergic patients reveals an IgE recognition profile compatible with a typical Pooideae sensitization.", {"entities": []}], ["The high degree of cross-reactivity between Phleum pratense and Lolium multiflorum allergens suggests that diagnosis and immunotherapy can be achieved with timothy grass pollen allergens in the studied population.", {"entities": []}], ["Air pollution data in Bangkok, Thailand, indicate that levels of particulate matter with aerodynamic diameter \u226410 \u03bcm (PM 10 ) are significantly higher than in most cities in North America and Western Europe, where the health effects of PM 10 are well documented.", {"entities": []}], ["However, the pollution mix, seasonality, and demographics are different from those in developed Western countries.", {"entities": []}], ["It is important, therefore, to determine whether the large metropolitan area of Bangkok is subject to similar effects of PM 10 .", {"entities": []}], ["This study was designed to investigate the mortality risk from air pollution in Bangkok, Thailand.", {"entities": []}], ["The study period extended from 1999 to 2003, for which the Ministry of Public Health provided the mortality data.", {"entities": []}], ["Measures of air pollution were derived from air monitoring stations, and information on temperature and relative humidity was obtained from the weather station in central Bangkok.", {"entities": []}], ["The statistical analysis followed the common protocol for the multicity PAPA (Public Health and Air Pollution Project in Asia) project in using a natural cubic spline model with smooths of time and weather.", {"entities": []}], ["The excess risk for non-accidental mortality was 1.3% [95% confidence interval (CI), 0.8\u20131.7] per 10 \u03bcg/m 10 , with higher excess risks for cardiovascular and above age 65 mortality of 1.9% (95% CI, 0.8\u20133.0) and 1.5% (95% CI, 0.9\u20132.1), respectively.", {"entities": []}], ["In addition, the effects from PM 10 appear to be consistent in multipollutant models.", {"entities": []}], ["The results suggest strong associations between several different mortality outcomes and PM 10 .", {"entities": []}], ["In many cases, the effect estimates were higher than those typically reported in Western industrialized nations.", {"entities": []}], ["Objectives .", {"entities": []}], ["To determine whether obesity correction equations for the Canadian general population, which are dependent on the prevalence of obesity, are appropriate for use in Atlantic Canada, which has the highest obesity rates in the country.", {"entities": [[21, 28, "DISEASE"], [128, 135, "DISEASE"], [203, 210, "DISEASE"]]}], ["Also, to compare the accuracy of the national equations to equations developed specifically for the Atlantic Canadian population.", {"entities": []}], ["The dataset consisted of Canadian Community Health Survey (CCHS) 2007-2008 data collected on 17,126 Atlantic Canadians and a subsample of adults, who provided measured height and weight (MHW) data.", {"entities": []}], ["Atlantic correction equations were developed in the MHW subsample.", {"entities": []}], ["Using separate multiple regression models for men and women, self-reported body mass index (BMI) was corrected by multiplying the self-reported estimate by its corresponding model coefficient and adding the model intercept.", {"entities": []}], ["Paired t -tests were used to determine whether corrected mean BMI values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", {"entities": []}], ["The analyses were repeated using the national equations.", {"entities": []}], ["Both the Atlantic and the national equations yielded corrected obesity estimates that were significantly more accurate than those based on self-report.", {"entities": [[63, 70, "DISEASE"]]}], ["Conclusion .", {"entities": []}], ["The results provide some evidence of the generalizability of the national equations to atypical regions of Canada.", {"entities": []}], ["Viruses use a limited set of host pathways for infection.", {"entities": []}], ["These pathways represent bona fide antiviral targets with low likelihood of viral resistance.", {"entities": []}], ["We identified the salicylanilide niclosamide as a broad range antiviral agent targeting acidified endosomes.", {"entities": []}], ["Niclosamide is approved for human use against helminthic infections, and has anti-neoplastic and antiviral effects.", {"entities": []}], ["Its mode of action is unknown.", {"entities": []}], ["Here, we show that niclosamide, which is a weak lipophilic acid inhibited infection with pH-dependent human rhinoviruses (HRV) and influenza virus.", {"entities": [[131, 140, "DISEASE"]]}], ["Structure-activity studies showed that antiviral efficacy and endolysosomal pH neutralization co-tracked, and acidification of the extracellular medium bypassed the virus entry block.", {"entities": []}], ["Niclosamide did not affect the vacuolar H Current antiviral approaches are directed against specific viral targets but are limited in their broad-spectrum potential.", {"entities": []}], ["Targeting host pathways, on the other hand can have broad antiviral effects, albeit with possible side effects.", {"entities": []}], ["Here, we report the mode of antiviral action of a small chemical compound, niclosamide.", {"entities": []}], ["Niclosamide belongs to the salicylanilides, and has been FDA approved to treat parasitic helminthic infestations in humans since decades.", {"entities": []}], ["In recent years, niclosamide was shown to have anti-neoplastic and antiviral effects.", {"entities": []}], ["We screened a library of FDA-approved chemicals, and found that niclosamide is an entry inhibitor for a number of pH-dependent respiratory viruses, including influenza virus and human rhinoviruses.", {"entities": [[158, 167, "DISEASE"]]}], ["Cell biological and biochemical analyses and intracellular pH measurements showed that niclosamide neutralizes acidic membrane-bounded compartments.", {"entities": []}], ["Niclosamide did not affect the vacuolar ATPase but acted as a protonophore, both in vesicles isolated from cells, and protein-free liposome assays.", {"entities": []}], ["It blocked rhinovirus infections synergistically with the proton ATPase inhibitor bafilomycin A1.", {"entities": []}], ["Niclosamide targets endosomes by a mode of action distinct from that of endosomal pH neutralizing agents, such as chloroquine, which accumulates in acidic endosomes.", {"entities": []}], ["IL-17 is a pro-inflammatory cytokine implicated in the pathogenesis of glomerulonephritis and IL-17 deficient mice are protected from nephrotoxic nephritis.", {"entities": [[71, 89, "DISEASE"], [146, 155, "DISEASE"]]}], ["However, a regulatory role for IL-17 has recently emerged.", {"entities": []}], ["We describe a novel protective function for IL-17 in the kidney.", {"entities": []}], ["Bone marrow chimeras were created using wild-type and IL-17 deficient mice and nephrotoxic nephritis was induced.", {"entities": [[91, 100, "DISEASE"]]}], ["IL-17 deficient hosts transplanted with wild-type bone marrow had worse disease by all indices compared to wild-type to wild-type bone marrow transplants (serum urea p<0.05; glomerular thrombosis p<0.05; tubular damage p<0.01), suggesting that in wild-type mice, IL-17 production by renal cells resistant to radiation is protective.", {"entities": []}], ["IL-17 deficient mice transplanted with wild-type bone marrow also had a comparatively altered renal phenotype, with significant differences in renal cytokines (IL-10 p<0.01; IL-1\u03b2 p<0.001; IL-23 p<0.01), and macrophage phenotype (expression of mannose receptor p<0.05; inducible nitric oxide synthase p<0.001).", {"entities": []}], ["Finally we show that renal mast cells are resistant to radiation and produce IL-17, suggesting they are potential local mediators of disease protection.", {"entities": []}], ["This is a novel role for intrinsic cells in the kidney that are radio-resistant and produce IL-17 to mediate protection in nephrotoxic nephritis.", {"entities": [[135, 144, "DISEASE"]]}], ["This has clinical significance as IL-17 blockade is being trialled as a therapeutic strategy in some autoimmune diseases.", {"entities": []}], ["High altitude pulmonary edema (HAPE) is a form of high altitude illness characterized by cough, dyspnea upon exertion progressing to dyspnea at rest and eventual death, seen in patients who ascend over 2,500 meters, particularly if that ascent is rapid.", {"entities": [[14, 29, "DISEASE"]]}], ["This case describes a patient with no prior history of HAPE and extensive experience hiking above 2,500 meters who developed progressive dyspnea and cough while ascending to 3,200 meters.", {"entities": []}], ["His risk factors included rapid ascent, high altitude, male sex, and a possible genetic predisposition for HAPE.", {"entities": []}], ["Previous studies indicate multiple influences on the overall health of HIV-infected persons; however, few assess and rank longitudinal changes in social and structural barriers that are disproportionately found in impoverished populations.", {"entities": []}], ["We empirically ranked factors that longitudinally impact the overall health status of HIV-infected homeless and unstably housed men.", {"entities": []}], ["Between 2002 and 2008, a cohort of 288 HIV+ homeless and unstably housed men was recruited and followed over time.", {"entities": []}], ["The population was 60% non-Caucasian and the median age was 41 years; 67% of study participants reported recent drug use and 20% reported recent homelessness.", {"entities": []}], ["At baseline, the median CD4 cell count was 349 cells/\u00b5l and 18% of eligible persons (CD4<350) took antiretroviral therapy (ART).", {"entities": [[24, 27, "GENE"], [85, 88, "GENE"], [24, 27, "GENE"], [85, 88, "GENE"]]}], ["Marginal structural models were used to estimate the population-level effects of behavioral, social, and structural factors on overall physical and mental health status (measured by the SF-36), and targeted variable importance (tVIM) was used to empirically rank factors by their influence.", {"entities": []}], ["After adjusting for confounding, and in order of their influence, the three factors with the strongest negative effects on physical health were unmet subsistence needs, Caucasian race, and no reported source of instrumental support.", {"entities": []}], ["The three factors with the strongest negative effects on mental health were unmet subsistence needs, not having a close friend/confidant, and drug use.", {"entities": []}], ["ART adherence >90% ranked 5th for its positive influence on mental health, and viral load ranked 4th for its negative influence on physical health.", {"entities": []}], ["The inability to meet food, hygiene, and housing needs was the most powerful predictor of poor physical and mental health among homeless and unstably housed HIV-infected men in an urban setting.", {"entities": []}], ["Impoverished persons will not fully benefit from progress in HIV medicine until these barriers are overcome, a situation that is likely to continue fueling the US HIV epidemic.", {"entities": []}], ["As part of a Berlin-based research consortium on health in old age, the OMAHA (Operationalizing Multimorbidity and Autonomy for Health Services Research in Aging Populations) study aims to develop a conceptual framework and a set of standardized instruments and indicators for continuous monitoring of multimorbidity and associated health care needs in the population 65 years and older.", {"entities": []}], ["OMAHA is a longitudinal epidemiological study including a comprehensive assessment at baseline and at 12-month follow-up as well as brief intermediate telephone interviews at 6 and 18 months.", {"entities": []}], ["In order to evaluate different sampling procedures and modes of data collection, the study is conducted in two different population-based samples of men and women aged 65 years and older.", {"entities": []}], ["A geographically defined sample was recruited from an age and sex stratified random sample from the register of residents in Berlin-Mitte (Berlin OMAHA study cohort, n = 299) for assessment by face-to-face interview and examination.", {"entities": []}], ["A larger nationwide sample (German OMAHA study cohort, n = 730) was recruited for assessment by telephone interview among participants in previous German Telephone Health Surveys.", {"entities": []}], ["In both cohorts, we successfully applied a multi-dimensional set of instruments to assess multimorbidity, functional disability in daily life, autonomy, quality of life (QoL), health care services utilization, personal and social resources as well as socio-demographic and biographical context variables.", {"entities": []}], ["Response rates considerably varied between the Berlin and German OMAHA study cohorts (22.8% vs. 59.7%), whereas completeness of follow-up at month 12 was comparably high in both cohorts (82.9% vs. 81.2%).", {"entities": []}], ["The OMAHA study offers a wide spectrum of data concerning health, functioning, social involvement, psychological well-being, and cognitive capacity in community-dwelling older people in Germany.", {"entities": []}], ["Results from the study will add to methodological and content-specific discourses on human resources for maintaining quality of life and autonomy throughout old age, even in the face of multiple health complaints.", {"entities": []}], ["To investigate the expressions of IL-17A in different phases of radiation-induced lung injury and the effect of dexamethasone.", {"entities": []}], ["The thorax of C57BL/6 mice was irradiated with 15\u2009Gy rays.", {"entities": []}], ["Mice from dexamethasone-treated group were injected intraperitoneally with dexamethasone (0.42\u2009mg/kg/day) every day for the first month after irradiation.", {"entities": []}], ["IL-17A in lung tissues was detected by immunohistochemistry.", {"entities": []}], ["IL-17A, TGF- \u03b2 1, and IL-6 in bronchoalveolar lavage fluid were detected by ELISA.", {"entities": []}], ["Lung inflammation and collagen deposition were observed by H&E and Masson methods.", {"entities": []}], ["The degree of alveolitis and fibrosis was judged according to scoring.", {"entities": []}], ["IL-17A expression was appreciable at 1 week, peaked at 4 weeks, and subsequently declined at 8 weeks after irradiation.", {"entities": []}], ["IL-17A was reduced after dexamethasone application at all the observation periods.", {"entities": []}], ["Dexamethasone also inhibited expressions of TGF- \u03b2 , IL-6, and TNF- \u03b1 in bronchoalveolar lavage fluid.", {"entities": []}], ["Moreover, dexamethasone attenuated the severity of lung injury by reducing the infiltration of inflammatory cells and collagen deposition.", {"entities": []}], ["Terms of survival and the time of death in mice of treatment group were postponed and survival rate was improved.", {"entities": []}], ["Conclusions.", {"entities": []}], ["IL-17A plays an important role in the process of radiation-induced lung injury.", {"entities": []}], ["And dexamethasone may provide a protective role in lung injury induced by radiation.", {"entities": []}], ["Infectious Bovine Keratoconjunctivitis (IBK) in beef cattle, commonly known as pinkeye, is a bacterial disease caused by M o r a x e l l a bovis .", {"entities": []}], ["IBK is characterized by excessive tearing and ulceration of the cornea.", {"entities": [[24, 41, "DISEASE"]]}], ["Perforation of the cornea may also occur in severe cases.", {"entities": []}], ["IBK is considered the most important ocular disease in cattle production, due to the decreased growth performance of infected individuals and its subsequent economic effects.", {"entities": []}], ["IBK is an economically important, lowly heritable categorical disease trait.", {"entities": []}], ["Mass selection of unaffected animals has not been successful at reducing disease incidence.", {"entities": []}], ["Genome-wide studies can determine chromosomal regions associated with IBK susceptibility.", {"entities": []}], ["The objective of the study was to detect single-nucleotide polymorphism (SNP) markers in linkage disequilibrium (LD) with genetic variants associated with IBK in American Angus cattle.", {"entities": []}], ["The proportion of phenotypic variance explained by markers was 0.06 in the whole genome analysis of IBK incidence classified as two, three or nine categories.", {"entities": []}], ["Whole-genome analysis using any categorisation of (two, three or nine) IBK scores showed that locations on chromosomes 2, 12, 13 and 21 were associated with IBK disease.", {"entities": []}], ["The genomic locations on chromosomes 13 and 21 overlap with QTLs associated with Bovine spongiform encephalopathy, clinical mastitis or somatic cell count.", {"entities": [[124, 132, "DISEASE"]]}], ["Results of these genome-wide analyses indicated that if the underlying genetic factors confer not only IBK susceptibility but also IBK severity, treating IBK phenotypes as a two-categorical trait can cause information loss in the genome-wide analysis.", {"entities": []}], ["These results help our overall understanding of the genetics of IBK and have the potential to provide information for future use in breeding schemes.", {"entities": []}], ["Obesity has grown worldwide over the last few decades.", {"entities": [[0, 7, "DISEASE"]]}], ["In its different degrees, obesity is accompanied by many clinical and biochemical alterations reflecting the pathological condition of various body tissues.", {"entities": [[26, 33, "DISEASE"]]}], ["Among the mechanisms underlying the pathogenesis of obesity and associated complications, oxidative stress (OS) may be playing an important role.", {"entities": [[52, 59, "DISEASE"]]}], ["In the present study, we have characterized at systemic level the degree of OS status in a group of morbid obese patients (BMI>40\u00a0kg/m fx1 \u2022 A study on the clinical and oxidative stress status in morbid obesity is shown.", {"entities": [[203, 210, "DISEASE"], [196, 210, "DISEASE"]]}], ["\u2022 Morbid obese patients present an important reduction of antioxidant enzymes.", {"entities": []}], ["\u2022 This deficiency is accompanied by the increase of lipid peroxidation and DNA damage.", {"entities": []}], ["\u2022 Bariatric surgery normalizes the metabolic profile and oxidative stress status.", {"entities": []}], ["\u2022 8-oxo-dG can be use as a clinical marker for the monitoring of morbid obesity.", {"entities": [[72, 79, "DISEASE"], [65, 79, "DISEASE"]]}], ["A study on the clinical and oxidative stress status in morbid obesity is shown.", {"entities": [[62, 69, "DISEASE"], [55, 69, "DISEASE"]]}], ["Morbid obese patients present an important reduction of antioxidant enzymes.", {"entities": []}], ["This deficiency is accompanied by the increase of lipid peroxidation and DNA damage.", {"entities": []}], ["Bariatric surgery normalizes the metabolic profile and oxidative stress status.", {"entities": []}], ["8-oxo-dG can be use as a clinical marker for the monitoring of morbid obesity.", {"entities": [[70, 77, "DISEASE"], [63, 77, "DISEASE"]]}], ["The C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me), one of the synthetic triterpenoids, has been found to have potent anti-inflammatory and anticancer properties in vitro and in vivo.", {"entities": []}], ["However, its usefulness in mitigating radiation-induced lung injury (RILI), including radiation-induced lung inflammation and fibrosis, has not been tested.", {"entities": []}], ["The aim of this study was to explore the therapeutic effect of CDDO-Me on RILI in mice and the underlying mechanisms.", {"entities": []}], ["Herein, we found that administration of CDDO-Me improved the histopathological score, reduced the number of inflammatory cells and concentrations of total protein in bronchoalveolar lavage fluid, suppressed secretion and expression of proinflammatory cytokines, including transforming growth factor-\u03b2 and interleukin-6, elevated expression of the anti-inflammatory cytokine interleukin-10, and downregulated the mRNA level of profibrotic genes, including for fibronectin, \u03b1-smooth muscle actin, and collagen I. CDDO-Me attenuated radiation-induced lung inflammation.", {"entities": []}], ["CDDO-Me also decreased the Masson\u2019s trichrome stain score, hydroxyproline content, and mRNA level of profibrotic genes, and blocked radiation-induced collagen accumulation and fibrosis.", {"entities": []}], ["Collectively, these findings suggest that CDDO-Me ameliorates radiation-induced lung inflammation and fibrosis, and this synthetic triterpenoid is a promising novel therapeutic agent for RILI.", {"entities": []}], ["Further mechanistic, efficacy, and safety studies are warranted to elucidate the role of CDDO-Me in the management of RILI.", {"entities": []}], ["To investigate the effect of antioxidants and immunosuppresants on mixed peripheral blood mononuclear cells (PBMC) - chemically injured keratocytes reaction (MLKR).", {"entities": []}], ["The PBMC stimulation assay was performed using chemically injured keratocytes treated with 0.05 N NaOH for 90 s (MLKR).", {"entities": []}], ["MLKR were treated with various drugs including rapamycin, dexamethasone, mycophenoleic acid (MPA), alpha lipoic acid (ALA), and N-acetyl cysteine (NAC).", {"entities": []}], ["Matrix metalloprotease-9 (MMP-9), transforming growth factor\u2013beta 1 (TGF-\u03b21), interleukin-6 (IL-6), and macrophage migration inhibitory factor (MIF) secretion profiles of activated PBMCs stimulated by NaOH-treated keratocytes were determined by ELISA.", {"entities": [[144, 147, "GENE"]]}], ["Anti-oxidants as well as immunosuppressants suppressed PBMC proliferation.", {"entities": []}], ["MMP-9 levels were lower in antioxidants group.", {"entities": []}], ["IL-6 levels decreased in dexamethasone group and anti-oxidants group.", {"entities": []}], ["Combination of immunosuppressants and antioxidants suppressed more PBMC proliferation except for rapamycin + ALA group, suppressed MMP-9 production except for MPA + ALA group, decreased IL-6 levels and increased MIF levels except for rapamycin + ALA group.", {"entities": [[212, 215, "GENE"]]}], ["TGF-\u03b21 levels were elevated in rapamycin group and rapamycin + ALA group.", {"entities": []}], ["Cytokine production was different depending on combination of drugs.Our results suggest that the different drugs should be selected for treatment according to the phases of corneal chemical burn.", {"entities": []}], ["Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patients.", {"entities": [[44, 62, "DISEASE"], [0, 15, "DISEASE"]]}], ["It is recognized as a potential complication of metformin use, particularly in patients with risk factors such as renal dysfunction, liver disease, and heavy alcohol ingestion.", {"entities": [[133, 146, "DISEASE"]]}], ["These conditions are associated with systemic hypoxemia, which may be caused by cardiorespiratory disease, major surgery, sepsis, dehydration, old age, and overdose.", {"entities": []}], ["The reported frequency of lactic acidosis is 0.06 per 1000 patient-years, mostly in patients with predisposing factors.", {"entities": [[26, 41, "DISEASE"]]}], ["This case is important because it details the seriousness of metformin-associated lactic acidosis in a critically ill patient and because, to the best of our knowledge, our patient survived with minimal residual defect despite experiencing a cardiac arrest.", {"entities": [[82, 97, "DISEASE"]]}], ["A 66-year-old Caucasian woman presented to our hospital with profound lactic acidosis, which was initially thought to be ischemic gut.", {"entities": [[70, 85, "DISEASE"]]}], ["She then survived an in-hospital pulseless electrical activity arrest.", {"entities": []}], ["Metformin-associated lactic acidosis is a diagnosis by exclusion; however, a high degree of clinical suspicion supplemented by prompt multisystem organ support can significantly influence the outcome in critically ill patients.", {"entities": [[21, 36, "DISEASE"]]}], ["The nature of the immune response to infection is dependent on the type of infecting organism.", {"entities": []}], ["Intracellular organisms such as Toxoplasma gondii stimulate a Th1-driven response associated with production of IL-12, IFN-\u03b3, nitric oxide and IgG2a antibodies and classical activation of macrophages.", {"entities": []}], ["In contrast, extracellular helminths such as Fasciola hepatica induce Th2 responses characterised by the production of IL-4, IL-5, IL-10 and IgG1 antibodies and alternative activation of macrophages.", {"entities": []}], ["As co-infections with these types of parasites commonly exist in the field it is relevant to examine how the various facets of the immune responses induced by each may influence or counter-regulate that of the other.", {"entities": []}], ["Regardless, of whether F. hepatica infection preceded or succeeded T. gondii infection, there was little impact on the production of the Th1 cytokines IL-12, IFN-\u03b3 or on the development of classically-activated macrophages induced by T. gondii .", {"entities": []}], ["By contrast, the production of helminth-specific Th2 cytokines, such as IL-4 and IL-5, was suppressed by infection with T. gondii .", {"entities": []}], ["Additionally, the recruitment and alternative activation of macrophages by F. hepatica was blocked or reversed by subsequent infection with T. gondii .", {"entities": []}], ["The clinical symptoms of toxoplasmosis and the survival rate of infected mice were not significantly altered by the helminth.", {"entities": [[25, 38, "DISEASE"]]}], ["Despite previous studies showing that F. hepatica suppressed the classical activation of macrophages and the Th1-driven responses of mice to bystander microbial infection, as well as reduced their ability to reject these, here we found that the potent immune responses to T. gondii were capable of suppressing the responses to helminth infection.", {"entities": []}], ["Clearly, the outcome of particular infections in polyparasitoses depends on the means and potency by which each pathogen controls the immune response.", {"entities": []}], ["To develop public health adaptation strategies and to project the impacts of climate change on human health, indicators of vulnerability and preparedness along with accurate surveillance data on climate-sensitive health outcomes are needed.", {"entities": []}], ["We researched and developed environmental health indicators for inputs into human health vulnerability assessments for climate change and to propose public health preventative actions.", {"entities": []}], ["We conducted a review of the scientific literature to identify outcomes and actions that were related to climate change.", {"entities": []}], ["Data sources included governmental and nongovernmental agencies and the published literature.", {"entities": []}], ["Sources were identified and assessed for completeness, usability, and accuracy.", {"entities": []}], ["Priority was then given to identifying longitudinal data sets that were applicable at the state and community level.", {"entities": []}], ["We present a list of surveillance indicators for practitioners and policy makers that include climate-sensitive health outcomes and environmental and vulnerability indicators, as well as mitigation, adaptation, and policy indicators of climate change.", {"entities": []}], ["A review of environmental health indicators for climate change shows that data exist for many of these measures, but more evaluation of their sensitivity and usefulness is needed.", {"entities": []}], ["Further attention is necessary to increase data quality and availability and to develop new surveillance databases, especially for climate-sensitive morbidity.", {"entities": []}], ["Alveolar resident memory T cells (T RM ) comprise a currently uncharacterized mixture of cell subpopulations.", {"entities": []}], ["The CD3 RM could contribute to compartment-specific immune responses in the lung.", {"entities": []}], ["Encouraging prompt help-seeking for cancer symptoms can help shorten the patient interval and improve timely diagnosis.", {"entities": [[36, 42, "DISEASE"]]}], ["We explored factors associated with help-seeking in a primary care sample reporting \u2018alarm' symptoms.", {"entities": []}], ["A questionnaire was mailed to 9771 adults (\u2a7e50 years of age and no cancer diagnosis) and 3766 (39%) returned it.", {"entities": [[67, 73, "DISEASE"]]}], ["Our sample included 1732 adults reporting at least one cancer \u2018alarm' symptom; with a total of 2726 symptoms.", {"entities": [[55, 61, "DISEASE"]]}], ["Respondents completed questions relating to help-seeking, demographic and symptom characteristics (e.g., type, knowledge, concern, interference and attribution).", {"entities": []}], ["Over a third of people who reported a cancer \u2018alarm' symptom in the past 3 months had not sought help from a doctor.", {"entities": [[38, 44, "DISEASE"]]}], ["An unexplained lump (odds ratio (OR) 2.46, 1.42\u20134.26) and persistent unexplained pain (OR 1.79, 1.19\u20132.69) were associated with increased likelihood of help-seeking.", {"entities": []}], ["Symptom concern (OR 3.10, 2.19\u20134.39) and interference (OR 3.06, 2.15\u20134.36) were associated with an increased likelihood of seeking help independently of symptom type.", {"entities": []}], ["People who were not working (OR 1.41, 1.09\u20131.83), were married/cohabiting rather than single (OR 1.38, 1.10\u20131.74) and were older (60\u201369 years) rather than younger (50\u201359 years; OR 1.33, 1.02\u20131.75) were more likely to have sought help.", {"entities": []}], ["Our findings highlighted symptom type and symptom characteristics as key drivers of help-seeking.", {"entities": []}], ["We also found that there may be specific demographic groups where encouraging help-seeking might be warranted.", {"entities": []}], ["Intestinal manipulation (IM) during abdominal surgery results in intestinal inflammation leading to hypomotility or ileus.", {"entities": [[116, 121, "DISEASE"]]}], ["Mast cell activation is thought to play a crucial role in the pathophysiology of postoperative ileus (POI).", {"entities": [[95, 100, "DISEASE"]]}], ["However, this conclusion was mainly drawn using mast cell-deficient mouse models with abnormal Kit signaling.", {"entities": []}], ["These mice also lack interstitial cells of Cajal (ICC) resulting in aberrant gastrointestinal motility even prior to surgery, compromising their use as model to study POI.", {"entities": []}], ["To avoid these experimental weaknesses we took advantage of a newly developed knock-in mouse model, Cpa3 , devoid of mast cells but with intact Kit signaling.", {"entities": [[100, 104, "GENE"]]}], ["The role of mast cells in the development of POI and intestinal inflammation was evaluated assessing gastrointestinal transit and muscularis externa inflammation after IM in two strains of mice lacking mast cells, i.e.", {"entities": []}], ["Kit and Cpa3 mice, and by use of the mast cell stabilizer cromolyn.", {"entities": [[8, 12, "GENE"]]}], ["Kit mice lack ICC networks and already revealed significantly delayed gastrointestinal transit even before surgery.", {"entities": []}], ["IM did not further delay intestinal transit, but induced infiltration of myeloperoxidase positive cells, expression of inflammatory cytokines and recruitment of monocytes and neutrophils into the muscularis externa.", {"entities": []}], ["On the contrary, Cpa3 mice have a normal network of ICC and normal gastrointestinal.", {"entities": [[17, 21, "GENE"]]}], ["Surprisingly, IM in Cpa3 mice caused delay in gut motility and intestinal inflammation as in wild type littermates mice ( Cpa3 ).", {"entities": [[20, 24, "GENE"], [122, 126, "GENE"], [20, 24, "GENE"], [122, 126, "GENE"]]}], ["Furthermore, treatment with the mast cell inhibitor cromolyn resulted in an inhibition of mast cells without preventing POI.", {"entities": []}], ["Here, we confirm that IM induced mast cell degranulation.", {"entities": []}], ["However, our data demonstrate that mast cells are not required for the pathogenesis of POI in mice.", {"entities": []}], ["Although there might be species differences between mouse and human, our results argue against mast cell inhibitors as a therapeutic approach to shorten POI.", {"entities": []}], ["Stroke remains a significant unmet condition in the USA and throughout the world.", {"entities": []}], ["To date, only approximately 3% of the population suffering an ischemic stroke benefit from the thrombolytic drug tissue plasminogen activator, largely due to the drug\u2019s narrow therapeutic window.", {"entities": []}], ["The last decade has witnessed extensive laboratory studies suggesting the therapeutic potential of cell-based therapy for stroke.", {"entities": []}], ["Limited clinical trials of cell therapy in stroke patients are currently being pursued.", {"entities": []}], ["Bone marrow-derived stem cells are an attractive, novel transplantable cell source for stroke.", {"entities": []}], ["There remain many unanswered questions in the laboratory before cell therapy can be optimized for transplantation in the clinical setting.", {"entities": []}], ["Here, we discuss the various translational hurdles encountered in bringing cell therapy from the laboratory to the clinic, using stem cell therapeutics as an emerging paradigm for stroke as a guiding principle.", {"entities": []}], ["In particular, we focus on the preclinical studies of cell transplantation in experimental stroke with emphasis on a better understanding of mechanisms of action in an effort to optimize efficacy and to build a safety profile for advancing cell therapy to the clinic.", {"entities": []}], ["A forward looking strategy of combination therapy involving stem cell transplantation and pharmacologic treatment is also discussed.", {"entities": []}], ["We present prediction and variable importance (VIM) methods for longitudinal data sets containing continuous and binary exposures subject to missingness.", {"entities": []}], ["We demonstrate the use of these methods for prognosis of medical outcomes of severe trauma patients, a field in which current medical practice involves rules of thumb and scoring methods that only use a few variables and ignore the dynamic and high-dimensional nature of trauma recovery.", {"entities": []}], ["Well-principled prediction and VIM methods can provide a tool to make care decisions informed by the high-dimensional patient\u2019s physiological and clinical history.", {"entities": []}], ["Our VIM parameters are analogous to slope coefficients in adjusted regressions, but are not dependent on a specific statistical model, nor require a certain functional form of the prediction regression to be estimated.", {"entities": []}], ["In addition, they can be causally interpreted under causal and statistical assumptions as the expected outcome under time-specific clinical interventions, related to changes in the mean of the outcome if each individual experiences a specified change in the variable (keeping other variables in the model fixed).", {"entities": []}], ["Better yet, the targeted MLE used is doubly robust and locally efficient.", {"entities": []}], ["Because the proposed VIM does not constrain the prediction model fit, we use a very flexible ensemble learner (the SuperLearner), which returns a linear combination of a list of user-given algorithms.", {"entities": []}], ["Not only is such a prediction algorithm intuitive appealing, it has theoretical justification as being asymptotically equivalent to the oracle selector.", {"entities": []}], ["The results of the analysis show effects whose size and significance would have been not been found using a parametric approach (such as stepwise regression or LASSO).", {"entities": []}], ["In addition, the procedure is even more compelling as the predictor on which it is based showed significant improvements in cross-validated fit, for instance area under the curve (AUC) for a receiver-operator curve (ROC).", {"entities": []}], ["Thus, given that 1) our VIM applies to any model fitting procedure, 2) under assumptions has meaningful clinical (causal) interpretations and 3) has asymptotic (influence-curve) based robust inference, it provides a compelling alternative to existing methods for estimating variable importance in high-dimensional clinical (or other) data.", {"entities": []}], ["The raised-volume rapid thoracoabdominal compression (RVRTC) manoeuvre has been applied to obtain full forced expiratory flow-volume curves in infants.", {"entities": []}], ["No reference data are available for Asian populations.", {"entities": []}], ["This study was conducted to establish predictive reference equations for Taiwanese infants.", {"entities": []}], ["Full-term infants without any chronic disease or major anomaly were enrolled from this cohort study.", {"entities": []}], ["Full forced expiratory flow-volume curves were acquired using RVRTC manoeuvres through Jaeger\u2019s system.", {"entities": []}], ["Tidal breath analysis, passive respiratory mechanics, and tidal forced expiratory flow-volume curves were performed and collected at the same measurement.", {"entities": []}], ["Multiple linear analyses were used to model the variables.", {"entities": []}], ["We performed 117 tests of RVRTC flow-volume curves in 97 infants.", {"entities": []}], ["The results revealed that all parameters, except for FEV 0.5 /FVC, correlated highly and positively with body length.", {"entities": [[53, 56, "GENE"]]}], ["These parameters correlated significantly with other parameters of passive respiratory mechanics and tidal forced expiratory flow-volume curves.", {"entities": []}], ["This is the first study to establish equipment-specific reference data of full forced expiration using RVRTC manoeuvres in Asian infants.", {"entities": []}], ["The results revealed that parameters of RVRTC manoeuvres are moderately related to other parameters of infant lung function.", {"entities": []}], ["These race-specific reference data can be used to more precisely and efficiently diagnose respiratory diseases in infants of Chinese ethnicity.", {"entities": []}], ["Genetic diversity across different human populations can enhance understanding of the genetic basis of disease.", {"entities": []}], ["We calculated the genetic risk of 102 diseases in 1,043 unrelated individuals across 51 populations of the Human Genome Diversity Panel.", {"entities": []}], ["We found that genetic risk for type 2 diabetes and pancreatic cancer decreased as humans migrated toward East Asia.", {"entities": [[51, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["In addition, biliary liver cirrhosis, alopecia areata, bladder cancer, inflammatory bowel disease, membranous nephropathy, systemic lupus erythematosus, systemic sclerosis, ulcerative colitis, and vitiligo have undergone genetic risk differentiation.", {"entities": [[71, 97, "DISEASE"], [197, 205, "DISEASE"], [132, 151, "DISEASE"], [38, 53, "DISEASE"], [21, 36, "DISEASE"], [38, 46, "DISEASE"], [123, 151, "DISEASE"], [63, 69, "DISEASE"], [173, 191, "DISEASE"]]}], ["This analysis represents a large-scale attempt to characterize genetic risk differentiation in the context of migration.", {"entities": []}], ["We anticipate that our findings will enable detailed analysis pertaining to the driving forces behind genetic risk differentiation.", {"entities": []}], ["The environment humans inhabit has changed many times in the last 100,000 years.", {"entities": []}], ["Migration and dynamic local environments can lead to genetic adaptations favoring beneficial traits.", {"entities": []}], ["Many genes responsible for these adaptations can alter disease susceptibility.", {"entities": []}], ["Genes can also affect disease susceptibility by varying randomly across different populations.", {"entities": []}], ["We have studied genetic variants that are known to modify disease susceptibility in the context of worldwide migration.", {"entities": []}], ["We found that variants associated with 11 diseases have been affected to an extent that is not explained by random variation.", {"entities": []}], ["We also found that the genetic risk of type 2 diabetes has steadily decreased along the worldwide human migration trajectory from Africa to America.", {"entities": []}], ["This paper presents key conclusions and future research needs from a Workshop on the Risk Assessment of Urban Air, Emissions, Exposure, Risk Identification, and Quantification, which was held in Stockholm during June 1992 by 41 participants from 13 countries.", {"entities": []}], ["Research is recommended in the areas of identification and quantification of toxics in source emissions and ambient air, atmospheric transport and chemistry, exposure level assessment, the development of improved in vitro bioassays, biomarker development, the development of more accurate epidemiological methodologies, and risk quantification techniques.", {"entities": []}], ["Studies are described that will be necessary to assess and reduce the level of uncertainties associated with each step of the risk assessment process.", {"entities": []}], ["International collaborative research efforts between industry and government organizations are recommended as the most effective way to carry out this research.", {"entities": []}], ["The incidence of Sj\u00f6gren syndrome (SS) in primary biliary cirrhosis (PBC) patients is high.", {"entities": [[42, 67, "DISEASE"], [25, 33, "DISEASE"]]}], ["The influence of SS on the clinical outcomes of PBC patients, however, remains unclear.", {"entities": []}], ["Our study retrospectively collected data on PBC-only patients and PBC patients with concomitant SS (PBC-SS) to compare the clinical differences of long-term outcomes between them.", {"entities": []}], ["A total of 183 patients were diagnosed with PBC from January 1999 to December 2014 at our hospital.", {"entities": []}], ["Of these, the authors excluded patients with diabetes, hypertension, advanced liver cirrhosis at initial diagnosis of PBC (Child\u2013Turcotte\u2013Pugh classification score of \u22657) and other liver diseases (ie, alcoholic liver disease, alpha-antitrypsin deficiency, viral hepatitis, and primary sclerosing cholangitis), and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.", {"entities": [[55, 67, "DISEASE"], [285, 307, "DISEASE"], [211, 224, "DISEASE"], [375, 395, "DISEASE"], [351, 370, "DISEASE"], [78, 93, "DISEASE"], [262, 271, "DISEASE"], [296, 307, "DISEASE"], [386, 395, "DISEASE"], [256, 271, "DISEASE"], [342, 370, "DISEASE"]]}], ["Of the remaining 125 patients, 77 (61.6%) were PBC-only and 48 (38.4%) were PBC-SS patients.", {"entities": []}], ["The mean follow-up duration was 8.76 years.", {"entities": []}], ["During the observation period, the incidence of interstitial lung disease was higher in the PBC-SS group than in the PBC-only group ( P \u200a=\u200a0.005).", {"entities": [[48, 73, "DISEASE"], [61, 73, "DISEASE"]]}], ["The occurrence of spontaneous bacterial peritonitis was significantly different in PBC-SS patients than in PBC-only patients ( P \u200a=\u200a0.002).", {"entities": [[40, 51, "DISEASE"]]}], ["The overall survival was lower in PBC-SS patients than in PBC-only patients ( P \u200a=\u200a0.033).", {"entities": []}], ["Although the incidence of hepatocellular carcinoma, end-stage renal disease, variceal bleeding, and hypothyroidism were all higher in the PBC-SS group than in the PBC-only group, the differences were not significant.", {"entities": [[26, 50, "DISEASE"], [41, 50, "DISEASE"], [100, 114, "DISEASE"]]}], ["Our study suggests that PBC-SS patients have a higher risk of developing interstitial lung disease and spontaneous bacterial peritonitis and have a poor prognosis.", {"entities": [[73, 98, "DISEASE"], [125, 136, "DISEASE"], [86, 98, "DISEASE"]]}], ["Aggressive surveillance of thyroid and pulmonary functions should therefore be performed in these patients.", {"entities": []}], ["To assess the inequalities in access, utilization, and quality of health care services according to the socioeconomic status.", {"entities": []}], ["This population-based cross-sectional study evaluated 2,927 individuals aged \u2265 20 years living in Pelotas, RS, Southern Brazil, in 2012.", {"entities": []}], ["The associations between socioeconomic indicators and the following outcomes were evaluated: lack of access to health services, utilization of services, waiting period (in days) for assistance, and waiting time (in hours) in lines.", {"entities": []}], ["We used Poisson regression for the crude and adjusted analyses.", {"entities": []}], ["The lack of access to health services was reported by 6.5% of the individuals who sought health care.", {"entities": []}], ["The prevalence of use of health care services in the 30 days prior to the interview was 29.3%.", {"entities": []}], ["Of these, 26.4% waited five days or more to receive care and 32.1% waited at least an hour in lines.", {"entities": []}], ["Approximately 50.0% of the health care services were funded through the Unified Health System.", {"entities": []}], ["The use of health care services was similar across socioeconomic groups.", {"entities": []}], ["The lack of access to health care services and waiting time in lines were higher among individuals of lower economic status, even after adjusting for health care needs.", {"entities": []}], ["The waiting period to receive care was higher among those with higher socioeconomic status.", {"entities": []}], ["Although no differences were observed in the use of health care services across socioeconomic groups, inequalities were evident in the access to and quality of these services.", {"entities": []}], ["The authors report the case of 46-year-old man with recurrent hemoptysis.", {"entities": []}], ["Bronchoscopy revealed a submucosal tumor protruding into the tracheal lumen.", {"entities": []}], ["Transbronchial biopsy failed to obtain a conclusive diagnosis; only surgery allowed complete resection of the tumor and confirmed the diagnosis of tracheal mucoepidermoid carcinoma.", {"entities": [[171, 180, "DISEASE"], [156, 180, "DISEASE"]]}], ["We discuss the unusual submucosal presentation of this tumor, and the contribution of surgery for diagnosis and therapy.", {"entities": []}], ["Emergency department (ED) visits for asthma exacerbation reflect a failure of longitudinal asthma management.", {"entities": [[37, 43, "DISEASE"], [91, 97, "DISEASE"]]}], ["However, little is known about the characteristics of patients with frequent ED visits (\u22652 visits in a 1-year period).", {"entities": []}], ["We aimed to characterise the adult patients who frequently presented to the ED for asthma exacerbation in Japan.", {"entities": [[83, 89, "DISEASE"]]}], ["A multicentre chart review study of 23 EDs across Japan.", {"entities": []}], ["Adults aged 18\u201354\u2005years who presented to the ED with asthma exacerbation from 2009 to 2011.", {"entities": [[53, 59, "DISEASE"]]}], ["Frequency of ED visits for asthma exacerbation in a 1-year period, including the index ED visit.", {"entities": [[27, 33, "DISEASE"]]}], ["Of the 1002 eligible patients, 218 (22%) had frequent ED visits, accounting for 48% of total ED visits for asthma exacerbation in the 1-year period.", {"entities": [[107, 113, "DISEASE"]]}], ["Specifically, 12% had 2 ED visits and 10% had \u22653 visits.", {"entities": []}], ["In these patients, guideline-recommended chronic management was suboptimal.", {"entities": []}], ["For example, among patients with \u22653 ED visits, only 63% were treated with inhaled corticosteroids and 49% were current smokers.", {"entities": []}], ["In a multinomial logistic regression model, markers of chronic asthma severity (history of hospitalisation for asthma and use of inhaled corticosteroids) were significantly associated with a higher frequency of ED visits (both p<0.05).", {"entities": [[63, 69, "DISEASE"], [111, 117, "DISEASE"]]}], ["This multicentre study in Japan demonstrated that many patients are frequent ED users for asthma exacerbation.", {"entities": [[90, 96, "DISEASE"]]}], ["We also found that their asthma control management is suboptimal, most likely contributing to worse chronic severity and more frequent ED visits.", {"entities": [[25, 31, "DISEASE"]]}], ["Further dissemination and adoption of evidence-based guidelines are required to reduce asthma morbidity in this high-risk population.", {"entities": [[87, 93, "DISEASE"]]}], ["Transthoracic echocardiography is the primary imaging modality for the diagnosis of right ventricular (RV) involvement in congenital and acquired heart diseases.", {"entities": []}], ["There is increasing recognition of the contribution of RV dysfunction in heart diseases affecting children and adolescents, but there is insufficient information on reference intervals for the echocardiographic measurements of the right heart in children and adolescents that represent all the continental populations of the world.", {"entities": []}], ["The aim of this systematic review was to collate, from published studies, normative data for echocardiographic evaluation of the right heart in children and adolescents, and to identify gaps in knowledge in this field especially with respect to sub-Saharan Africans.", {"entities": []}], ["We performed a systematic literature search to identify studies of reference intervals for right heart measurements as determined by transthoracic echocardiography in healthy children and adolescents of school-going age.", {"entities": []}], ["Articles were retrieved from electronic databases with a combination of search terms from the earliest date available until May 2013.", {"entities": []}], ["Reference data were available for a broad range of variables.", {"entities": []}], ["Fifty one studies out of 3096 publications were included.", {"entities": []}], ["The sample sizes of the reference populations ranged from 13 to 2036 with ages varying from 5 to 21 years.", {"entities": []}], ["We identified areas lacking sufficient reference data.", {"entities": []}], ["These included reference data for determining right atrial size, tricuspid valve area, RV dimensions and areas, the RV % fractional area change, pulmonary artery pressure gradients and the right-sided haemodynamics, including the inferior vena cava dimensions and collapsibility.", {"entities": []}], ["There were no data for sub-Saharan African children and adolescents.", {"entities": []}], ["Reliable reference data are lacking for important echocardiographic measurements of the RV in children and adolescents, especially for sub-Saharan Africans.", {"entities": []}], ["An important outcome of any clinical intervention is the change in the subject's own perceived state of health.", {"entities": []}], ["This can be categorized as health-related quality of life (HRQL), utility (preference-based health state), and daily life performance.", {"entities": []}], ["174 Swedish subjects with chronic obstructive pulmonary disease (COPD) (mean age 64.3 \u00b1 12 years) completed five self-administered questionnaires: Short Form 36 (SF-36), St George's Respiratory Questionnaire (SGRQ), EuroQol-5D (EQ-5D), Health States-COPD (HS-COPD), and Work Productivity and Activity Impairment Questionnaire for COPD (WPAI-COPD).", {"entities": [[26, 63, "DISEASE"]]}], ["The subjects scored these outcomes instruments for ease of completion using a 5-point scale.", {"entities": []}], ["The time taken to complete them was noted and the administrators' opinion of the subjects' comprehension of the questionnaires recorded using a 4-point scale.", {"entities": []}], ["A score of 1\u20133 (\"very easy\" to \"acceptable\") was recorded by 92% of subjects for the SF-36, 90% for SGRQ, 80% for EQ-5D, 83% for WPAI-COPD, and 53% for HS-COPD.", {"entities": []}], ["The HS-COPD was graded \"very difficult\" to complete by 21% of subjects compared with 3\u20135% of subjects for the other questionnaires.", {"entities": []}], ["The mean time taken to complete all questionnaires was 39 minutes, and the large majority of subjects scored \"good\" for understanding by the administrator.", {"entities": []}], ["Age correlated significantly with the degree of the subject's opinion of the ease of completion of five outcomes instruments, while the influence of gender, socio-economic status and disease severity was not statistically significant.", {"entities": []}], ["Particulate air pollution is associated with increased incidence of respiratory symptoms and decreased pulmonary, function but the relative impact of pollution from different domestic energy sources is not well-known or studied.", {"entities": []}], ["The study was aimed at assessing the association between particulate concentrations, respiratory symptoms and lung function.", {"entities": []}], ["It was a cross-sectional study comprised of randomly selected residents of three communities.", {"entities": []}], ["These communities were selected according to the predominant type of fuel used for household cooking which were: firewood, kerosene and liquefied petroleum gas (LPG).", {"entities": []}], ["Assessment of the indoor PM 10 levels was done by filtration using the Gent stacked filter unit sampler for collection of atmospheric aerosol in two size fractions (PM 2.5 and PM 10 ).", {"entities": []}], ["The Medical Research Council (MRC) questionnaire was administered followed by spirometry test.", {"entities": []}], ["The mean PM 10 concentration in participants using LPG, kerosene and firewood was 80.8 \u00b1 9.52 \u03bcg/m P < 0.05).", {"entities": []}], ["The participants using firewood had the highest prevalence of pulmonary and non-pulmonary symptoms (57.1%), whereas subjects using LPG had the lowest (23.8%).", {"entities": []}], ["There are high levels of particulate matter pollutions with respiratory effects in residential indoor environments in Ile-Ife, Nigeria", {"entities": []}], ["The seasonal influenza vaccine coverage rate in China is only 1.9\u00a0%.", {"entities": [[13, 22, "DISEASE"]]}], ["There is no information available on the economic burden of influenza-associated outpatient visits and hospitalizations at the national level, even though this kind of information is important for informing national-level immunization policy decision-making.", {"entities": [[60, 69, "DISEASE"]]}], ["A retrospective telephone survey was conducted in 2013/14 to estimate the direct and indirect costs of seasonal influenza-associated outpatient visits and hospitalizations from a societal perspective.", {"entities": [[112, 121, "DISEASE"]]}], ["Study participants were laboratory-confirmed cases registered in the National Influenza-like Illness Surveillance Network and Severe Acute Respiratory Infections Sentinel Surveillance Network in China in 2013.", {"entities": [[78, 87, "DISEASE"]]}], ["Patient-reported costs from the survey were validated by a review of hospital accounts for a small sample of the inpatients.", {"entities": []}], ["The study enrolled 529 outpatients (median age: eight years; interquartile range [IQR]: five to 20\u00a0years) and 254 inpatients (median age: four years; IQR: two to seven years).", {"entities": []}], ["Among the outpatients, 22.1\u00a0% (117/529) had underlying diseases and among the inpatients, 52.8\u00a0% (134/254) had underlying diseases.", {"entities": []}], ["The average total costs related to influenza-associated outpatient visits and inpatient visits were US$ 155 (standard deviation, SD US$ 122) and US$ 1,511 (SD US$ 1,465), respectively.", {"entities": [[35, 44, "DISEASE"]]}], ["Direct medical costs accounted for 45 and 69\u00a0% of the total costs related to influenza-associated outpatient and inpatient visits, respectively.", {"entities": [[77, 86, "DISEASE"]]}], ["For influenza outpatients, the mean cost per episode in children aged below five years (US$ 196) was higher than that in other age groups (US$ 129\u2013153).", {"entities": [[4, 13, "DISEASE"]]}], ["For influenza inpatients, the mean cost per episode in adults aged over 60\u00a0years (US$ 2,735) was much higher than that in those aged below 60\u00a0years (US$ 1,417\u20131,621).", {"entities": [[4, 13, "DISEASE"]]}], ["Patients with underlying medical conditions had higher costs per episode than patients without underlying medical conditions (outpatients: US$ 186 vs. US$ 146; inpatients: US$ 1,800 vs. US$ 1,189).", {"entities": []}], ["In the baseline analysis, inpatients reported costs were 18\u00a0% higher than those found in the accounts review ( n \u2009=\u200938).", {"entities": []}], ["The economic burden of influenza-associated outpatient and inpatient visits in China is substantial, particularly for young children, the elderly, and patients with underlying medical conditions.", {"entities": [[23, 32, "DISEASE"]]}], ["More widespread influenza vaccination would likely alleviate the economic burden of patients.", {"entities": [[16, 25, "DISEASE"]]}], ["The actual impact and cost-effectiveness analysis of the influenza immunization program in China merits further investigation.", {"entities": [[57, 66, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s40249-015-0077-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To study the type and frequency of adverse events associated with anti-tumor necrosis factor (TNF) therapy and evaluate for any serologic and genetic associations.", {"entities": [[94, 97, "GENE"]]}], ["This study was a retrospective review of patients attending the inflammatory bowel disease (IBD) centers at Cedars-Sinai IBD Center from 2005-2016.", {"entities": [[64, 90, "DISEASE"]]}], ["Adverse events were identified via chart review.", {"entities": []}], ["IBD serologies were measured by ELISA.", {"entities": []}], ["DNA samples were genotyped at Cedars-Sinai using Illumina Infinium Immunochipv1 array per manufacturer\u2019s protocol.", {"entities": []}], ["SNPs underwent methodological review and were evaluated using several SNP statistic parameters to ensure optimal allele-calling.", {"entities": []}], ["Standard and rigorous QC criteria were applied to the genetic data, which was generated using immunochip.", {"entities": []}], ["Genetic association was assessed by logistic regression after correcting for population structure.", {"entities": []}], ["Altogether we identified 1258 IBD subjects exposed to anti-TNF agents in whom Immunochip data were available.", {"entities": []}], ["269/1258 patients (21%) were found to have adverse events to an anti-TNF-\u03b1 agent that required the therapy to be discontinued.", {"entities": []}], ["25% of women compared to 17% of men experienced an adverse event.", {"entities": []}], ["All adverse events resolved after discontinuing the anti-TNF agent.", {"entities": []}], ["In total: n = 66 (5%) infusion reactions; n = 49 (4%) allergic/serum sickness reactions; n = 19 (1.5%) lupus-like reactions, n = 52 (4%) rash, n = 18 (1.4%) infections.", {"entities": []}], ["In Crohn\u2019s disease, IgA ASCA ( P = 0.04) and IgG-ASCA ( P = 0.02) levels were also lower in patients with any adverse events, and anti-I2 level in ulcerative colitis was significantly associated with infusion reactions ( P = 0.008).", {"entities": [[147, 165, "DISEASE"]]}], ["The logistic regression/human annotation and network analyses performed on the Immunochip data implicated the following five signaling pathways: JAK-STAT (Janus Kinase-signal transducer and activator of transcription), measles, IBD, cytokine-cytokine receptor interaction, and toxoplasmosis for any adverse event.", {"entities": [[219, 226, "DISEASE"], [277, 290, "DISEASE"]]}], ["Our study shows 1 in 5 IBD patients experience an adverse event to anti-TNF therapy with novel serologic, genetic , and pathways associations.", {"entities": []}], ["There is a vast amount of information published regarding the impact of 2009 pandemic Influenza A (pH1N1) virus infection.", {"entities": []}], ["However, a comparison of risk factors and outcome during the 2010-2011 post-pandemic period has not been described.", {"entities": []}], ["A prospective, observational, multi-center study was carried out to evaluate the clinical characteristics and demographics of patients with positive RT-PCR for H1N1 admitted to 148 Spanish intensive care units (ICUs).", {"entities": []}], ["Data were obtained from the 2009 pandemic and compared to the 2010-2011 post-pandemic period.", {"entities": []}], ["Nine hundred and ninety-seven patients with confirmed An/H1N1 infection were included.", {"entities": []}], ["Six hundred and forty-eight patients affected by 2009 (pH1N1) virus infection and 349 patients affected by the post-pandemic Influenza (H1N1)v infection period were analyzed.", {"entities": []}], ["Patients during the post-pandemic period were older, had more chronic comorbid conditions and presented with higher severity scores (Acute Physiology And Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA)) on ICU admission.", {"entities": []}], ["Patients from the post-pandemic Influenza (H1N1)v infection period received empiric antiviral treatment less frequently and with delayed administration.", {"entities": []}], ["Mortality was significantly higher in the post-pandemic period.", {"entities": []}], ["Multivariate analysis confirmed that haematological disease, invasive mechanical ventilation and continuous renal replacement therapy were factors independently associated with worse outcome in the two periods.", {"entities": []}], ["HIV was the only new variable independently associated with higher ICU mortality during the post-pandemic Influenza (H1N1)v infection period.", {"entities": []}], ["Patients from the post-pandemic Influenza (H1N1)v infection period had an unexpectedly higher mortality rate and showed a trend towards affecting a more vulnerable population, in keeping with more typical seasonal viral infection.", {"entities": []}], ["IL-18 polymorphisms influence the transcriptional activity of the IL-18 gene and associated with various diseases.", {"entities": []}], ["However, their relationships with hepatitis B virus-related liver diseases had not reached a consensus.", {"entities": [[34, 43, "DISEASE"]]}], ["So we conducted this case-control study with a view to clarifying the association.", {"entities": []}], ["We included four groups: healthy controls, chronic hepatitis B virus (CHB) carriers, liver cirrhosis (LC) and hepatocellular carcinoma (HCC) groups with each group of 250 persons.", {"entities": [[110, 134, "DISEASE"], [125, 134, "DISEASE"], [85, 100, "DISEASE"], [51, 60, "DISEASE"]]}], ["Odd ratios (ORs) and 95% confidence intervals (95%CIs) with or without adjustment were calculated.", {"entities": []}], ["Haplotype analysis was also performed.", {"entities": []}], ["The results showed people carrying rs187238 CG genotype had a lower risk of LC (CG vs. CC: OR = 0.59, 95%CI = 0.38\u20130.91, P = 0.02), while GG genotype carriers had a higher risk of HCC (GG vs. CC+CG: OR = 4.73, 95%CI = 1.01\u201322.1, P = 0.03) than those with CC and CG genotypes in healthy group.", {"entities": []}], ["Rs187238 GG genotype increased the risk from CHB to LC status (GG vs. CC: OR = 4.81, 95%CI = 1.03\u201322.6; GG vs. CC+CG: OR = 4.73, 95%CI = 1.01\u201322.1), meanwhile the trend also existed by controlling confounding factors (GG vs. CC: OR = 6.25, 95%CI = 1.09\u201335.8; GG vs. CC+CG: OR = 5.91, 95%CI = 1.04\u201333.7).", {"entities": []}], ["Haplotype Crs187238Trs1946518 moderately decreased the risk of CHB carriers developing into HCC (OR = 0.69, 95%CI = 0.50\u20130.96, P = 0.03) after adjustment.", {"entities": []}], ["In conclusion, IL-18 rs187238 GG genotype may increase the risk of HCC in healthy population and the risk of LC in CHB carriers.", {"entities": []}], ["The incidence of pediatric-onset inflammatory bowel disease (IBD) is increasing worldwide.", {"entities": [[33, 59, "DISEASE"]]}], ["We used population-based health administrative data to determine national Canadian IBD incidence, prevalence, and trends over time of childhood-onset IBD.", {"entities": []}], ["We identified children <16 years (y) diagnosed with IBD 1999\u20132010 from health administrative data in five provinces (Alberta, Manitoba, Nova Scotia, Ontario, Quebec), comprising 79.2% of the Canadian population.", {"entities": []}], ["Standardized incidence and prevalence were calculated per 100,000 children.", {"entities": []}], ["Annual percentage change (APC) in incidence and prevalence were determined using Poisson regression analysis.", {"entities": [[26, 29, "GENE"]]}], ["Provincial estimates were meta-analyzed using random-effects models to produce national estimates.", {"entities": []}], ["5,214 incident cases were diagnosed during the study period (3,462 Crohn\u2019s disease, 1,382 ulcerative colitis, 279 type unclassifiable).", {"entities": [[90, 108, "DISEASE"]]}], ["The incidence in Canada was 9.68 (95% CI 9.11 to 10.25) per 100,000 children.", {"entities": []}], ["Incidence was similar amongst most provinces, but higher in Nova Scotia.", {"entities": []}], ["APC in incidence did not significantly change over the study period in the overall cohort (+2.06%, 95% CI \u22120.64% to +4.76%).", {"entities": [[0, 3, "GENE"]]}], ["However, incidence significantly increased in children aged 0\u20135y (+7.19%, 95% +2.82% to +11.56%).", {"entities": []}], ["Prevalence at the end of the study period in Canada was 38.25 (95% CI 35.78 to 40.73) per 100,000 children.", {"entities": []}], ["Prevalence increased significantly over time, APC +4.56% (95% CI +3.71% to +5.42%).", {"entities": [[46, 49, "GENE"]]}], ["Canada has amongst the highest incidence of childhood-onset IBD in the world.", {"entities": []}], ["Prevalence significantly increased over time.", {"entities": []}], ["Incidence was not statistically changed with the exception of a rapid increase in incidence in the youngest group of children.", {"entities": []}], ["GTPase of the immune associated nucleotide binding protein (GIMAP) family of proteins are expressed essentially in cells of the hematopoietic system.", {"entities": []}], ["Mutation in the founding member of this gene family, Gimap5 , results in the lymphopenic phenotype in Bio-Breeding diabetes prone rats.", {"entities": [[53, 59, "GENE"]]}], ["In mice, deletion of functional Gimap5 gene affects the survival and renewal of hematopoietic stem cells in addition to the defects observed in T cells.", {"entities": [[32, 38, "GENE"]]}], ["Here we show that T cells from OTII TCR-transgenic Gimap5 Gimap5 mutant rats and mice show decreased phosphorylation of STAT5 following stimulation with IL-7.", {"entities": [[51, 57, "GENE"], [58, 64, "GENE"], [51, 57, "GENE"], [58, 64, "GENE"]]}], ["Our results suggest that functional Gimap5 is required for optimal signaling through TCR and IL-7R in T cells.", {"entities": [[36, 42, "GENE"]]}], ["We investigated the association between single-nucleotide polymorphisms in regulation of telomere elongation helicase 1 ( RTEL1 ), which has been associated with telomere length in several brain cancers and age-related diseases, and the risk of chronic obstructive pulmonary disease (COPD) in a Chinese Han population.", {"entities": [[245, 282, "DISEASE"], [122, 127, "GENE"]]}], ["In a case\u2013control study that included 279 COPD cases and 290 healthy controls, five single-nucleotide polymorphisms in RTEL1 were selected and genotyped using the Sequenom MassARRAY platform.", {"entities": [[119, 124, "GENE"]]}], ["Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using unconditional logistic regression after adjusting for age and gender.", {"entities": []}], ["In the genotype model analysis, we determined that rs4809324 polymorphism had a decreased effect on the risk of COPD (CC versus TT: OR =0.28; 95% CI =0.10\u20130.82; P =0.02).", {"entities": []}], ["In the genetic model analysis, we found that the \u201cC/C\u201d genotype of rs4809324 was associated with a decreased risk of COPD based on the codominant model (OR =0.33; 95% CI =0.13\u20130.86; P =0.022) and recessive model (OR =0.32; 95% CI =0.12\u20130.80; P =0.009).", {"entities": []}], ["Our data shed new light on the association between genetic polymorphisms of RTEL1 and COPD susceptibility in the Chinese Han population.", {"entities": [[76, 81, "GENE"]]}], ["There have been few reports on the role of Fc receptors (FcRs) and immunoglobulin G (IgG) in asthma.", {"entities": [[93, 99, "DISEASE"]]}], ["The purpose of this study is to clarify the role of inhibitory FcRs and antigen presenting cells (APCs) in pathogenesis of asthma and to evaluate antigen-transporting and presenting capacity by APCs in the tracheobronchial mucosa.", {"entities": [[123, 129, "DISEASE"], [98, 102, "GENE"], [194, 198, "GENE"], [98, 102, "GENE"], [194, 198, "GENE"]]}], ["In Fc\u03b3RIIB deficient (KO) and C57BL/6 (WT) mice, the effects of intratracheal instillation of antigen-specific IgG were analysed using the model with sensitization and airborne challenge with ovalbumin (OVA).", {"entities": []}], ["Thoracic lymph nodes instilled with fluorescein-conjugated OVA were analysed by fluorescence microscopy.", {"entities": []}], ["Moreover, we analysed the CD11c in vitro were also analysed.", {"entities": []}], ["Moreover, in Fc\u03b3RIIB KO mice intravenously transplanted dendritic cells (DCs) differentiated from BMDCs of WT mice, the effects of intratracheal instillation of anti-OVA IgG were evaluated by bronchoalveolar lavage (BAL).", {"entities": []}], ["In WT mice, total cells and eosinophils in BAL fluid reduced after instillation with anti-OVA IgG1.", {"entities": []}], ["Anti-OVA IgG1 suppressed airway inflammation in hyperresponsiveness and histology.", {"entities": []}], ["In addition, the number of the fluorescein-conjugated OVA in CD11c Antigen-specific IgG ameliorates allergic airway inflammation via Fc\u03b3RIIB on DCs.", {"entities": []}], ["Fulminant hepatic failure (FHF) is a clinically severe type of liver injury with an extremely high mortality rate.", {"entities": []}], ["Although the pathological mechanisms of FHF are not well understood, evidence suggests that the complement system is involved in the pathogenesis of a variety of liver disorders.", {"entities": []}], ["In the present study, to investigate the role of complement in FHF, we examined groups of mice following intraperitoneal injection of LPS/D-GalN: wild-type C57BL/6 mice, wild-type mice treated with a C3aR antagonist, C5aR monoclonal antibody (C5aRmAb) or CR2-Factor H (CR2-fH, an inhibitor of the alternative pathway), and C3 deficient mice (C3", {"entities": [[323, 325, "GENE"], [342, 344, "GENE"], [323, 325, "GENE"], [342, 344, "GENE"]]}], ["Inhaled endotoxin induces airways\u2019neutrophilia, in human.", {"entities": []}], ["TNF-a being a key cytokine in the response to endotoxin, the effect of anti-TNF on the endotoxin-induced neutrophilic response was evaluated among healthy volunteers.", {"entities": []}], ["Among a population of 30 healthy subjects, an induced-sputum was collected 2\u00a0weeks before, and 24\u00a0hours after an inhalation of 20 mcg endotoxin (E coli 026:B6).", {"entities": []}], ["Then, the subjects were randomized into 3 parallel groups treated with control, oral methylprednisolone 20\u00a0mg/day during 7\u00a0days or anti-TNF (adalimumab, Humira\u00ae, Abbott) 40\u00a0mg SC.", {"entities": []}], ["One week later, an induced-sputum was sampled, 24\u00a0hours after an inhalation of endotoxin.", {"entities": []}], ["After endotoxin inhalation, the number of total cells, neutrophils and macrophages was significantly increased (p <0.001).", {"entities": []}], ["Compared to the response to endotoxin among the control group, anti-TNF inhibited the endotoxin-induced neutrophil influx, both in relative (51.3 (\u00b16.4)% versus 26.2 (\u00b15.3)%, p <0.002) and in absolute values (1321 (443\u20133935) cells/mcL versus 247 (68\u2013906) cells/mcL, p <0.02).", {"entities": []}], ["The endotoxin-induced neutrophilic response was not significantly modified among the control group and oral corticosteroid group.", {"entities": []}], ["While oral corticosteroid had no effect, anti-TNF inhibited the neutrophil influx in sputum, induced by inhalation of endotoxin, in human subject.", {"entities": []}], ["The endotoxin model could be an early predictor of clinical efficacy of novel therapeutics.", {"entities": []}], ["ClinicalTrials.gov NCT02252809 (EudraCT2008-005526-37)", {"entities": []}], ["Filamentous fungi in drinking water distribution systems are known to (a) block water pipes; (b) cause organoleptic biodeterioration; (c) act as pathogens or allergens and (d) cause mycotoxin contamination.", {"entities": []}], ["Yeasts might also cause problems.", {"entities": []}], ["This study describes the occurrence of several fungal species in a water distribution system supplied by groundwater in Recife\u2014Pernambuco, Brazil.", {"entities": []}], ["Water samples were collected from four sampling sites from which fungi were recovered by membrane filtration.", {"entities": []}], ["The numbers in all sampling sites ranged from 5 to 207 colony forming units (CFU)/100 mL with a mean value of 53 CFU/100 mL.", {"entities": []}], ["In total, 859 isolates were identified morphologically, with Aspergillus and Penicillium the most representative genera (37% and 25% respectively), followed by Trichoderma and Fusarium (9% each), Curvularia (5%) and finally the species Pestalotiopsis karstenii (2%).", {"entities": []}], ["Ramichloridium and Leptodontium were isolated and are black yeasts, a group that include emergent pathogens.", {"entities": []}], ["The drinking water system in Recife may play a role in fungal dissemination, including opportunistic pathogens.", {"entities": []}], ["Background : Outside the USA, Agency for Healthcare Research and Quality (AHRQ) prevention quality indicators (PQIs) have been used to compare the quality of primary care services only at a national or regional level.", {"entities": []}], ["However, in several national health systems, primary care is not directly managed by the regions but is in charge of smaller territorial entities.", {"entities": []}], ["We evaluated whether PQIs might be used to compare the performance of local providers such as Italian local health authorities (LHAs) and health districts.", {"entities": []}], ["Methods : We analysed the hospital discharge abstracts of 44 LHAs (and 11 health districts) of five Italian regions (including \u224818 million residents) in 2008\u201310.", {"entities": []}], ["Age-standardized PQI rates were computed following AHRQ specifications.", {"entities": []}], ["Potential predictors were investigated using multilevel modelling.", {"entities": []}], ["Results : We analysed 11 470 722 hospitalizations.", {"entities": []}], ["The overall rates of preventable hospitalizations (composite PQI 90) were 1012, 889 and 988 (\u00d7100 000 inhabitants) in 2008, 2009 and 2010, respectively.", {"entities": []}], ["Composite PQIs were able to differentiate LHAs and health districts and showed small variation in the performance ranking over years.", {"entities": []}], ["Conclusion : Although further research is required, our findings support the use of composite PQIs to evaluate the performance of relatively small primary health care providers (50 000\u201360 000 enrollees) in countries with universal health care coverage.", {"entities": []}], ["Achieving high precision may be crucial for a structured quality assessment system to align hospitalization rate indicators with measures of other contexts of care (cost, clinical management, satisfaction/experience) that are typically computed at a local level.", {"entities": []}], ["Soybean allergy is one of the most common food allergies especially among children.", {"entities": []}], ["The Food Allergen Labeling and Consumer Protection Act (FALCPA) in the US requires the labeling of soy lecithin because it is derived from soybeans and may contain a number of IgE-binding proteins, possibly representing a source of hidden allergens.", {"entities": []}], ["Here we describe a pediatric case of soy allergy misunderstood as drug allergy.", {"entities": []}], ["An 11-year-old Caucasian girl was referred to our Allergy Unit because of the delayed appearance of an itching papular rash at the site of an injection of benzathine benzylpenicillin delivered by prefilled syringe.", {"entities": []}], ["A skin test with benzathine benzylpenicillin and detection of serum-specific IgE to penicilloyl V, penicilloyl G, ampicillin and amoxicillin were negative.", {"entities": []}], ["From her past medical history we know that, at the age of three years, she presented with edema of the lips and difficulty in breathing after eating a soy ice-cream.", {"entities": []}], ["For that reason, she underwent a skin prick test with soybean that was negative and a serum-specific IgE to soybean test that was weakly positive (0.21KU/L).", {"entities": []}], ["She underwent an oral provocation test with soy milk that yielded a positive result.", {"entities": []}], ["We describe a case of a patient with a delayed reaction to soy as a hidden allergen in a benzathine benzylpenicillin prefilled syringe.", {"entities": []}], ["This case shows that lecithin contaminated by soy proteins and used as an excipient in drugs can cause reactions in patients with soy allergy.", {"entities": []}], ["For that reason, the source of lecithin should always be specified among the constituents of drugs to avoid a source of hidden allergens and difficulties in the allergy work-up.", {"entities": []}], ["Several efforts have been deployed to cure osteosarcoma, a high-grade malignant bone tumour in children and adolescents.", {"entities": [[43, 55, "DISEASE"]]}], ["However, some challenges such as drug resistance, relapse, and tumour metastasis remain owing to the existence of cancer stem cells (CSC).", {"entities": [[114, 120, "DISEASE"]]}], ["There is an urgent need to develop cost-effective and safe therapies.", {"entities": []}], ["Wogonin, an extract from the root of Scutellaria baicalensis , has long been considered as a promising natural and safe compound for anti-tumourigenesis, particularly to inhibit tumour invasion and metastasis.", {"entities": []}], ["Hoechst 33,342 staining, wound healing assay, sphere formation assay, western blotting, and gelatin zymography assays were performed in CD133 positive osteosarcoma cell.", {"entities": [[151, 163, "DISEASE"]]}], ["In this study, we examined the effect of Wogonin on the mobility of human osteosarcoma CSC.", {"entities": [[74, 86, "DISEASE"]]}], ["Wogonin induces apoptosis of human osteosarcoma CSC, inhibits its mobility in vitro via downregulation of MMP-9 expression, and represses its renewal ability.", {"entities": [[35, 47, "DISEASE"]]}], ["We demonstrated that Wogonin decreases the renewal capacity of CSC.", {"entities": []}], ["By inhibiting the formation of and reducing the size of spheres, Wogonin at a concentration of 40\u201380\u00a0\u03bcM effectively minimizes potential risk from CSC.", {"entities": []}], ["Taken together, we have demonstrated a new approach for developing a potential therapy for osteosarcoma.", {"entities": [[91, 103, "DISEASE"]]}], ["(A) To measure the extent to which different candidate outcome measures identified high-risk prescribing that is potentially changeable by the data-driven quality improvement in primary care (DQIP) intervention.", {"entities": []}], ["(B) To explore the value of reviewing identified high-risk prescribing to clinicians.", {"entities": []}], ["(C) To optimise the components of the DQIP intervention.", {"entities": []}], ["Mixed method study.", {"entities": []}], ["General practices in two Scottish Health boards.", {"entities": []}], ["4 purposively sampled general practices of varying size and socioeconomic deprivation.", {"entities": []}], ["Prescribing measures targeting (1) high-risk use of the non-steroidal anti-inflammatory drugs (NSAIDs) and antiplatelets; (2) \u2018Asthma control\u2019 and (3) \u2018Antithrombotics in atrial fibrillation (AF)\u2019.", {"entities": []}], ["The prescribing measures were used to identify patients for review by general practices.", {"entities": []}], ["The ability of the measures to identify potentially changeable high-risk prescribing was measured as the proportion of patients reviewed where practices identified a need for action.", {"entities": []}], ["Field notes were recorded from meetings between researchers and staff and key staff participated in semistructured interviews exploring their experience of the piloted intervention processes.", {"entities": []}], ["Practices identified a need for action in 68%, 25% and 18% of patients reviewed for prescribing measures (1), (2) and (3), respectively.", {"entities": []}], ["General practitioners valued being prompted to review patients, and perceived that (1) \u2018NSAID and antiplatelet\u2019 and (2) \u2018antithrombotics in AF\u2019 were the most important to act on.", {"entities": []}], ["Barriers to initial and ongoing engagement and to sustaining improvements in prescribing were identified.", {"entities": []}], ["\u2018NSAIDs and antiplatelets\u2019 measures were selected as the most suitable outcome measures for the DQIP trial, based on evidence of this prescribing being more easily changeable.", {"entities": []}], ["In response to the barriers identified, the intervention was designed to include a financial incentive, additional ongoing feedback on progress and reprompting review of patients, whose high-risk prescribing was restarted after a decision to stop.", {"entities": []}], ["Clinicaltrials.gov NCT01425502.", {"entities": []}], ["Immunoglobulin E (IgE) is crucial for the development of airway inflammation in atopic asthma, and inhibition of IgE using monoclonal antibodies is now part of asthma therapy.", {"entities": [[87, 93, "DISEASE"], [160, 166, "DISEASE"]]}], ["However, the impact of ordinary anti\u2010inflammatory treatment on IgE is unclear.", {"entities": []}], ["The aim of this study was to investigate if optimization of treatment with inhaled corticosteroid (ICS) and leukotriene\u2010receptor antagonist (LTRA) according to symptoms or exhaled nitric oxide (F E NO) levels over a one\u2010year period affects IgE concentrations.", {"entities": []}], ["Altogether, 158 relatively well\u2010controlled but multi\u2010sensitized asthmatics (age 18\u201365 years), with ongoing ICS treatment at baseline, were included in this post hoc analysis of data from a randomized, controlled trial on F E NO\u2010guided asthma therapy.", {"entities": [[235, 241, "DISEASE"]]}], ["Asthma control and quality of life (Juniper ACQ and mAQLQ), F E NO, and serum IgE were measured at baseline and after one year.", {"entities": [[0, 6, "DISEASE"]]}], ["Concentrations of IgE antibodies to six common perennial aeroallergens were summed up (perennial IgE).", {"entities": []}], ["We found that perennial and total IgE decreased by 10.2% and 16.0% ( P \u2009<\u2009.001 both comparisons).", {"entities": []}], ["This was not related to allergen exposure, whereas the total use of ICS and LTRA during the year correlated with the reduction in perennial IgE ( P \u2009=\u2009.030 and P \u2009=\u2009.013).", {"entities": []}], ["The decrease in perennial and total IgE correlated significantly with the reduction in F E NO ( P \u2009<\u2009.003 and P \u2009<\u2009.001), and with improvements in ACQ and mAQLQ scores ( P \u2009<\u20090.05, all comparisons).", {"entities": []}], ["We conclude that one year of optimization of treatment with ICS and LTRA in patients with persistent atopic asthma resulted in significant decreases in total IgE and IgE antibodies; these decreases correlated with a reduction in F E NO and improvements in asthma control and quality of life.", {"entities": [[108, 114, "DISEASE"], [256, 262, "DISEASE"]]}], ["Thus, IgE is reduced by ordinary asthma controller medications and the effect on IgE seems to be clinically important.", {"entities": [[33, 39, "DISEASE"]]}], ["Alternaria is considered one of the most common saprophytic fungal genera on the planet.", {"entities": []}], ["It is comprised of many species that exhibit a necrotrophic phytopathogenic lifestyle.", {"entities": []}], ["Several species are clinically associated with allergic respiratory disorders although rarely found to cause invasive infections in humans.", {"entities": []}], ["Finally, Alternaria spp.", {"entities": []}], ["are among the most well known producers of diverse fungal secondary metabolites, especially toxins.", {"entities": []}], ["We have recently sequenced and annotated the genomes of 25 Alternaria spp.", {"entities": []}], ["including but not limited to many necrotrophic plant pathogens such as A. brassicicola (a pathogen of Brassicaceous crops like cabbage and canola) and A. solani (a major pathogen of Solanaceous plants like potato and tomato), and several saprophytes that cause allergy in human such as A. alternata isolates.", {"entities": []}], ["These genomes were annotated and compared.", {"entities": []}], ["Multiple genetic differences were found in the context of plant and human pathogenicity, notably the pro-inflammatory potential of A. alternata .", {"entities": []}], ["The Alternaria genomes database was built to provide a public platform to access the whole genome sequences, genome annotations, and comparative genomics data of these species.", {"entities": []}], ["Genome annotation and comparison were performed using a pipeline that integrated multiple computational and comparative genomics tools.", {"entities": []}], ["Alternaria genome sequences together with their annotation and comparison data were ported to Ensembl database schemas using a self-developed tool (EnsImport).", {"entities": []}], ["Collectively, data are currently hosted using a customized installation of the Ensembl genome browser platform.", {"entities": []}], ["Recent efforts in fungal genome sequencing have facilitated the studies of the molecular basis of fungal pathogenicity as a whole system.", {"entities": []}], ["The Alternaria genomes database provides a comprehensive resource of genomics and comparative data of an important saprophytic and plant/human pathogenic fungal genus .", {"entities": []}], ["The database will be updated regularly with new genomes when they become available.", {"entities": []}], ["The Alternaria genomes database is freely available for non-profit use at http://alternaria.vbi.vt.edu .", {"entities": []}], ["Interaction between the inhibitory molecule PD-L2 on dendritic cells and repulsive guidance molecule b (RGMb) on lung macrophages is required to establish respiratory tolerance.", {"entities": [[104, 108, "GENE"]]}], ["We report that programmed death ligand 2 (PD-L2), a known ligand of PD-1, also binds to repulsive guidance molecule b (RGMb), which was originally identified in the nervous system as a co-receptor for bone morphogenetic proteins (BMPs).", {"entities": [[119, 123, "GENE"]]}], ["PD-L2 and BMP-2/4 bind to distinct sites on RGMb.", {"entities": [[44, 48, "GENE"]]}], ["Normal resting lung interstitial macrophages and alveolar epithelial cells express high levels of RGMb mRNA, whereas lung dendritic cells express PD-L2.", {"entities": [[98, 102, "GENE"]]}], ["Blockade of the RGMb\u2013PD-L2 interaction markedly impaired the development of respiratory tolerance by interfering with the initial T cell expansion required for respiratory tolerance.", {"entities": []}], ["Experiments with PD-L2\u2013deficient mice showed that PD-L2 expression on non\u2013T cells was critical for respiratory tolerance, but expression on T cells was not required.", {"entities": []}], ["Because PD-L2 binds to both PD-1, which inhibits antitumor immunity, and to RGMb, which regulates respiratory immunity, targeting the PD-L2 pathway has therapeutic potential for asthma, cancer, and other immune-mediated disorders.", {"entities": [[178, 184, "DISEASE"], [186, 192, "DISEASE"], [76, 80, "GENE"]]}], ["Understanding this pathway may provide insights into how to optimally modulate the PD-1 pathway in cancer immunotherapy while minimizing adverse events.", {"entities": [[99, 105, "DISEASE"]]}], ["Living near vegetation, often called \u201cgreen space\u201d or \u201cgreenness\u201d, has been associated with numerous health benefits.", {"entities": []}], ["We hypothesized that the two key components of urban vegetation, trees and grass, may differentially affect health.", {"entities": []}], ["We estimated the association between near-residence trees, grass, and total vegetation (from the 2010 High Resolution Land Cover dataset for New York City (NYC)) with self-reported health from a survey of NYC adults (n = 1281).", {"entities": []}], ["We found higher reporting of \u201cvery good\u201d or \u201cexcellent\u201d health for respondents with the highest, compared to the lowest, quartiles of tree (RR = 1.23, 95% CI = 1.06\u20131.44) but not grass density (relative risk (RR) = 1.00, 95% CI = 0.86\u20131.17) within 1000 m buffers, adjusting for pertinent confounders.", {"entities": []}], ["Significant positive associations between trees and self-reported health remained after adjustment for grass, whereas associations with grass remained non-significant.", {"entities": []}], ["Adjustment for air pollutants increased beneficial associations between trees and self-reported health; adjustment for parks only partially attenuated these effects.", {"entities": []}], ["Results were null or negative using a 300 m buffer.", {"entities": []}], ["Findings imply that higher exposure to vegetation, particularly trees outside of parks, may be associated with better health.", {"entities": []}], ["If replicated, this may suggest that urban street tree planting may improve population health.", {"entities": []}], ["Disease-associated loci identified through genome-wide association studies (GWAS) frequently localize to non-coding sequence.", {"entities": []}], ["We and others have demonstrated strong enrichment of such single nucleotide polymorphisms (SNPs) for expression quantitative trait loci (eQTLs), supporting an important role for regulatory genetic variation in complex disease pathogenesis.", {"entities": []}], ["Herein we describe our initial efforts to develop a predictive model of disease-associated variants leveraging eQTL information.", {"entities": []}], ["We first catalogued cis -acting eQTLs (SNPs within 100kb of target gene transcripts) by meta-analyzing four studies of three blood-derived tissues ( n = 586).", {"entities": []}], ["At a false discovery rate < 5%, we mapped eQTLs for 6,535 genes; these were enriched for disease-associated genes ( P < 10 P < 10 P < 10", {"entities": []}], ["We investigated the association between monovalent influenza A (H1N1) pdm09 (H1N1pdm) vaccine and pneumonia in elderly people.", {"entities": [[51, 60, "DISEASE"], [98, 107, "DISEASE"]]}], ["Study design was a hospital-based, matched case-control study.", {"entities": []}], ["Cases comprised patients \u226565\u00a0years old who had been newly diagnosed with pneumonia.", {"entities": [[73, 82, "DISEASE"]]}], ["For each case, 2 controls were defined as individuals with other diseases (not pneumonia) who were matched by sex, age, entry date, and the visited hospital.", {"entities": [[79, 88, "DISEASE"]]}], ["Study period was the interval from 1 September 2009 until 30 September 2010.", {"entities": []}], ["Because a pandemic of influenza A (H1N1) occurred during study period, we analyzed selected subjects who had enrolled during the influenza A (H1N1) pandemic.", {"entities": [[22, 31, "DISEASE"], [129, 138, "DISEASE"]]}], ["We calculated the odds ratios (ORs) and 95% confidence intervals (CIs) for pneumonia in H1N1pdm-vaccinated subjects compared with unvaccinated subjects using a conditional logistic regression model to assess the association between H1N1pdm vaccine and pneumonia.", {"entities": [[75, 84, "DISEASE"], [252, 261, "DISEASE"]]}], ["The subjects during the period of the influenza A (H1N1) pandemic were 20 cases and 40 controls.", {"entities": [[38, 47, "DISEASE"]]}], ["Subjects who had received H1N1pdm vaccine showed a significantly decreased OR for pneumonia (OR = 0.10, 95% CI = 0.01\u20130.98) compared with unvaccinated subjects.", {"entities": [[82, 91, "DISEASE"]]}], ["In conclusion, H1N1pdm vaccination may have prevented pneumonia among the elderly during the 2009\u20132010 influenza A (H1N1) pandemic in Japan.", {"entities": [[103, 112, "DISEASE"], [54, 63, "DISEASE"]]}], ["The spectrum of dermatological manifestations during neonatal period varies from transient self-limiting conditions to serious dermatoses; the latter, fortunately few, are disproportionately stressful to the parents, who due to lack of specialized pediatric dermatology clinics frequently get tossed between a dermatologist and a pediatrician.", {"entities": []}], ["This study was formulated to record cutaneous changes over the first five postnatal days of life and to statistically correlate those changes occurring in \u2265 11 neonates with three (parity, associated illnesses, and mode of delivery) maternal and three (sex, birth weight, and gestational age) neonatal factors.", {"entities": []}], ["This descriptive, cross-sectional study at a tertiary care hospital entailed recording detailed dermatological examination of 300 neonates having some (physiological and/or pathological) cutaneous changes and their statistical evaluation using the Chi-square test and significance ( P < 0.05) as above.", {"entities": []}], ["Superficial cutaneous desquamation (SCD), Mongolian spots (MS), and erythema toxicum neonatorum (ETN) were the first three common changes among a total of 15 conditions observed overall; these three, as also milia and icterus, revealed statistical significance with both maternal as well as neonatal factors.", {"entities": [[36, 39, "GENE"]]}], ["Lanugo and napkin dermatitis (ND) were statistically significant with respect to two neonatal factors and cradle cap (CC), a single maternal factor.", {"entities": [[18, 28, "DISEASE"]]}], ["Gestational age was of statistical significance regarding five cutaneous changes, associated maternal illness during pregnancy regarding four, birth weight as well as parity regarding three each, and sex of the neonate as well as mode of delivery regarding two each.", {"entities": []}], ["Despite observing a statistically significant correlation of eight cutaneous changes with three maternal and/or three neonatal factors, more extensive studies in neonatal dermatology are required for validation of these unique statistical correlations.", {"entities": []}], ["Over 45 million Americans are uninsured or underinsured.", {"entities": []}], ["Those living in poverty exhibit the worst health status.", {"entities": []}], ["Employment, education, income, and race are important factors in a person's ability to acquire healthcare access.", {"entities": []}], ["Having established that there are people lacking healthcare access due to multi-factorial etiologies, the question arises as to whether the intervention necessary to assist them in obtaining such access should be considered a privilege, or a right.", {"entities": []}], ["The right to healthcare access is examined from the perspective of Western thought.", {"entities": []}], ["Specifically through the works of Aristotle, Immanuel Kant, Thomas Hobbes, Thomas Paine, Hannah Arendt, James Rawls, and Norman Daniels, which are accompanied by a contemporary example of intervention on behalf of the medically needy by the The Johns Hopkins Urban Health Institute.", {"entities": []}], ["As human beings we are all valuable social entities whereby, through the force of morality, through implicitly forged covenants among us as individuals and between us and our governments, and through the natural rights we maintain as individuals and those we collectively surrender to the common good, it has been determined by nature, natural laws, and natural rights that human beings have the right, not the privilege, to healthcare access.", {"entities": []}], ["Individuals from families recruited for the Long Life Family Study (LLFS) (n= 4559) were examined and compared to individuals from other cohorts to determine whether the recruitment targeting longevity resulted in a cohort of individuals with better health and function.", {"entities": []}], ["Other cohorts with similar data included the Cardiovascular Health Study, the Framingham Heart Study, and the New England Centenarian Study.", {"entities": []}], ["Diabetes, chronic pulmonary disease and peripheral artery disease tended to be less common in LLFS probands and offspring compared to similar aged persons in the other cohorts.", {"entities": []}], ["Pulse pressure and triglycerides were lower, high density lipids were higher, and a perceptual speed task and gait speed were better in LLFS.", {"entities": []}], ["Age-specific comparisons showed differences that would be consistent with a higher peak, later onset of decline or slower rate of change across age in LLFS participants.", {"entities": []}], ["These findings suggest several priority phenotypes for inclusion in future genetic analysis to identify loci contributing to exceptional survival.", {"entities": []}], ["Vitamin D is under scrutiny as a potential regulator of the development of respiratory diseases characterised by chronic lung inflammation, including asthma and chronic obstructive pulmonary disease.", {"entities": [[161, 198, "DISEASE"], [150, 156, "DISEASE"]]}], ["It has anti-inflammatory effects; however, knowledge around the relationship between dietary vitamin D, inflammation and the microbiome in the lungs is limited.", {"entities": []}], ["In our previous studies, we observed more inflammatory cells in the bronchoalveolar lavage fluid and increased bacterial load in the lungs of vitamin D-deficient male mice with allergic airway disease, suggesting that vitamin D might modulate the lung microbiome.", {"entities": []}], ["In the current study, we examined in more depth the effects of vitamin D deficiency initiated early in life, and subsequent supplementation with dietary vitamin D on the composition of the lung microbiome and the extent of respiratory inflammation.", {"entities": []}], ["BALB/c dams were fed a vitamin D-supplemented or -deficient diet throughout gestation and lactation, with offspring continued on this diet post-natally.", {"entities": []}], ["Some initially deficient offspring were fed a supplemented diet from 8\u00a0weeks of age.", {"entities": []}], ["The lungs of na\u00efve adult male and female offspring were compared prior to the induction of allergic airway disease.", {"entities": []}], ["In further experiments, offspring were sensitised and boosted with the experimental allergen, ovalbumin (OVA), and T helper type 2-skewing adjuvant, aluminium hydroxide, followed by a single respiratory challenge with OVA.", {"entities": []}], ["In mice fed a vitamin D-containing diet throughout life, a sex difference in the lung microbial community was observed, with increased levels of an Acinetobacter operational taxonomic unit (OTU) in female lungs compared to male lungs.", {"entities": []}], ["This effect was not observed in vitamin D-deficient mice or initially deficient mice supplemented with vitamin D from early adulthood.", {"entities": []}], ["In addition, serum 25-hydroxyvitamin D levels inversely correlated with total bacterial OTUs, and Pseudomonas OTUs in the lungs.", {"entities": []}], ["Increased levels of the antimicrobial murine \u00df-defensin-2 were detected in the bronchoalveolar lavage fluid of male and female mice fed a vitamin D-containing diet.", {"entities": []}], ["The induction of OVA-induced allergic airway disease itself had a profound affect on the OTUs identified in the lung microbiome, which was accompanied by substantially more respiratory inflammation than that induced by vitamin D deficiency alone.", {"entities": []}], ["These data support the notion that maintaining sufficient vitamin D is necessary for optimal lung health, and that vitamin D may modulate the lung microbiome in a sex-specific fashion.", {"entities": []}], ["Furthermore, our data suggest that the magnitude of the pro-inflammatory and microbiome-modifying effects of vitamin D deficiency were substantially less than that of allergic airway disease, and that there is an important interplay between respiratory inflammation and the lung microbiome.", {"entities": []}], ["Dengue virus is an emerging infectious agent that infects an estimated 50\u2013100 million people annually worldwide, yet current diagnostic practices cannot detect an etiologic pathogen in \u223c40% of dengue-like illnesses.", {"entities": []}], ["Metagenomic approaches to pathogen detection, such as viral microarrays and deep sequencing, are promising tools to address emerging and non-diagnosable disease challenges.", {"entities": []}], ["In this study, we used the Virochip microarray and deep sequencing to characterize the spectrum of viruses present in human sera from 123 Nicaraguan patients presenting with dengue-like symptoms but testing negative for dengue virus.", {"entities": []}], ["We utilized a barcoding strategy to simultaneously deep sequence multiple serum specimens, generating on average over 1 million reads per sample.", {"entities": []}], ["We then implemented a stepwise bioinformatic filtering pipeline to remove the majority of human and low-quality sequences to improve the speed and accuracy of subsequent unbiased database searches.", {"entities": []}], ["By deep sequencing, we were able to detect virus sequence in 37% (45/123) of previously negative cases.", {"entities": []}], ["These included 13 cases with Human Herpesvirus 6 sequences.", {"entities": []}], ["Other samples contained sequences with similarity to sequences from viruses in the Herpesviridae , Flaviviridae , Circoviridae , Anelloviridae , Asfarviridae , and Parvoviridae families.", {"entities": []}], ["In some cases, the putative viral sequences were virtually identical to known viruses, and in others they diverged, suggesting that they may derive from novel viruses.", {"entities": []}], ["These results demonstrate the utility of unbiased metagenomic approaches in the detection of known and divergent viruses in the study of tropical febrile illness.", {"entities": []}], ["Dengue virus infection is a global health concern, affecting as many as 100 million people annually worldwide.", {"entities": []}], ["A critical first step to proper treatment and control of any virus infection is a correct diagnosis.", {"entities": []}], ["Traditional diagnostic tests for viruses depend on amplification of conserved portions of the viral genome, detection of the binding of antibodies to viral proteins, or replication of the virus in cell cultures.", {"entities": []}], ["These methods have a major shortcoming: they are unable to detect divergent or novel viruses for which a priori sequence, serological, or cellular tropism information is not known.", {"entities": []}], ["In our study, we use two approaches, microarrays and deep sequencing, to virus identification that are less susceptible to such shortcomings.", {"entities": []}], ["We used these unbiased tools to search for viruses in blood collected from Nicaraguan children with clinical symptoms indicating dengue virus infection, but for whom current dengue virus detection assays yielded negative results.", {"entities": []}], ["We were able to identify both known and divergent viruses in about one third of previously negative samples, demonstrating the utility of these approaches to detect viruses in cases of unknown dengue-like illness.", {"entities": []}], ["The perception of respiratory sensations can be of significant importance to individuals for survival and greatly impact quality of life.", {"entities": []}], ["Respiratory sensory gating, similar to somatosensory gating with exteroceptive stimuli, is indicative of brain cortices filtering out repetitive respiratory stimuli and has been investigated in adults with and without diseases.", {"entities": []}], ["Respiratory gating can be tested with the respiratory-related evoked potential (RREP) method in the electroencephalogram with a paired inspiratory occlusion paradigm.", {"entities": []}], ["Here, the RREP N1 component elicited by the second stimulus (S2) shows reduced amplitudes compared to the RREP N1 component elicited by the first stimulus (S1).", {"entities": []}], ["However, little is known regarding the effect of development on respiratory sensory gating.", {"entities": []}], ["The present study examined respiratory sensory gating in 22 typically developed school-aged children and 22 healthy adults.", {"entities": []}], ["Paired inspiratory occlusions of 150-ms each with an inter-stimulus-interval of 500-ms were delivered randomly every 2\u20134 breaths during recording.", {"entities": []}], ["The main results showed a significantly larger RREP N1 S2/S1 ratio in the children group than in the adult group.", {"entities": []}], ["In addition, children compared to adults demonstrated significantly smaller N1 peak amplitudes in response to S1.", {"entities": []}], ["Our results suggest that school-aged children, compared to adults, display reduced respiratory sensory gating.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by irreversible progressive airflow limitation related to tobacco smoking.", {"entities": []}], ["This limitation is caused by chronic inflammation of the airways and lung parenchyma and is associated with increased activity of parasympathetic system.", {"entities": []}], ["The most effective bronchodilators in COPD are muscarinic receptor antagonists (MRA), which reverse, at least in part, compromised respiratory function.", {"entities": []}], ["MRA also contribute to control inflammatory processes via interactions with inflammatory signaling molecules.", {"entities": []}], ["The use of the long-acting cholinolytic bronchodilatator - tiotropium, with high affinity to M3 receptors, is suggested as a first line maintenance treatment in COPD patients.", {"entities": []}], ["In this study we assessed M3 receptor protein expression in induced sputum of 27 stable COPD patients before and after therapy consisting of 18 \u03bcg once daily tiotropium for 12 weeks.", {"entities": []}], ["Lung function tests including spirometry, lung volumes, and DLCO were performed before and after therapy in all COPD patients.", {"entities": []}], ["The patients were subjected to the sputum induction procedures before and after therapy.", {"entities": []}], ["Sputum cells were isolated, sample-specific cell profiles were characterized, and the cells were processed to isolate pure cytosolic fractions.", {"entities": []}], ["Cytosolic M3 protein and HDAC2 levels and nuclear acetylated histone H3 (AcH3) expression was quantified using specific antibodies against human proteins and Western blot with enhanced luminescence detection.", {"entities": [[25, 30, "GENE"]]}], ["Therapy significantly increased the mean forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) volume (P < 0.05).", {"entities": []}], ["The mean expression of M3 protein was higher by 37% after therapy (P < 0.05), HDAC2 expression was not altered, while AcH3 level was increased by about 90% (P < 0.01), compared with the corresponding data before therapy.", {"entities": [[78, 83, "GENE"]]}], ["HDAC2 expression before therapy was positively correlated with AcH3 expression (r = 0.74), while after therapy no correlation was detected.", {"entities": [[0, 5, "GENE"]]}], ["FEV1, FCV, and cytosolic M3 protein expression did not correlate with other biochemical parameters tested.", {"entities": []}], ["Twelve weeks of tiotropium therapy in COPD patients improves clinical indices of lung function and involves alterations in sputum cell chromatin acetylation and also increased cholinergic M3 receptor internalization.", {"entities": []}], ["The aim of this clinical trial was to assess the efficacy and safety of curcuminoid complex extract from turmeric rhizome with turmeric volatile oil (CuraMed\u00ae) and its combination with boswellic acid extract from Indian frankincense root (Curamin\u00ae) vs placebo for the treatment of 40- to 70-year-old patients with osteoarthritis (OA).", {"entities": [[314, 328, "DISEASE"]]}], ["The effects of CuraMed\u00ae 500-mg capsules (333\u00a0mg curcuminoids) and Curamin\u00ae 500-mg capsules (350\u00a0mg curcuminoids and 150\u00a0mg boswellic acid) taken orally three times a day for 12\u00a0weeks in 201 patients was investigated in a three-arm, parallel-group, randomized, double-blinded, placebo-controlled trial.", {"entities": []}], ["Primary outcome efficacy measures included OA physical function performance-based tests, the WOMAC recommended index of joint pain, morning stiffness, limitations of physical function, and the patients\u2019 global assessment of disease severity.", {"entities": []}], ["Favorable effects of both preparations compared to placebo were observed after only 3\u00a0months of continuous treatment.", {"entities": []}], ["A significant effect of Curamin\u00ae compared to placebo was observed both in physical performance tests and the WOMAC joint pain index, while superior efficacy of CuraMed vs placebo was observed only in physical performance tests.", {"entities": []}], ["The effect size compared to placebo was comparable for both treatment groups but was superior in the Curamin\u00ae group.", {"entities": []}], ["The treatments were well tolerated.", {"entities": []}], ["Twelve-week use of curcumin complex or its combination with boswellic acid reduces pain-related symptoms in patients with OA.", {"entities": []}], ["Curcumin in combination with boswellic acid is more effective.", {"entities": []}], ["Combining Curcuma longa and Boswellia serrata extracts in Curamin\u00ae increases the efficacy of OA treatment presumably due to synergistic effects of curcumin and boswellic acid.", {"entities": []}], ["This trial is registered at the database www.clinicaltrials.gov .", {"entities": []}], ["https://clinicaltrials.gov/ct2/show/NCT02390349?term=EuroPharma&rank=1 .", {"entities": []}], ["Study registration number: NCT02390349 .", {"entities": []}], ["Clinicians often encounter information about drug-drug interactions (DDIs) during clinical practice.", {"entities": []}], ["This information is found within product information (hardcopy and electronic) and various electronic systems.", {"entities": []}], ["Prescribers may receive medication-related communications in practice that are distributed by facsimile (fax), mail, or telephone from pharmacies and pharmacy benefit managers (PBMs).", {"entities": []}], ["The purpose of this study was to determine if near-real time fax alerts for potential drug-drug interactions (PDDIs) would influence prescribing.", {"entities": []}], ["A prospective study, in cooperation with a pharmacy benefit manager (PBM), was conducted targeting 18 clinically important PDDIs.", {"entities": []}], ["Fax alerts included an individualized letter to the prescriber with a list of the interacting drugs, PDDI evidence summaries with citations, and recommended clinical management strategies.", {"entities": []}], ["Among the 18 PDDIs, 13 PDDIs could be assessed for prescription therapy changes using pharmacy claims data.", {"entities": []}], ["A prospective cohort design was used to evaluate changes in prescription dispensing 90-days following a PDDI fax alert.", {"entities": []}], ["A total of 8,075 fax alerts were sent to prescribers and there were 4,712 alerts for the 13 PDDIs that could be assessed for change using pharmacy claims data.", {"entities": []}], ["There were 2,019 patients (interventions) for which fax alerts were sent to their prescribers who were matched with a control group consisting of patients with the same PDDIs but for whom no fax alert was sent.", {"entities": []}], ["Overall, this study found 154 (7.6%) of patients in the fax alert group compared to 132 (6.5%) in the control group had changes in therapy (p\u2009=\u20090.177).", {"entities": []}], ["This fax alert intervention program observed no statistically significant differences in prescribing with a fax alert compared to the control group.", {"entities": []}], ["If PBMs chose to send individualized, evidence-based information to clinicians regarding drug-drug interactions, this study suggests it may not be an effective intervention to mitigate harm.", {"entities": []}], ["In this study, LPS-induced inflammatory responses in BEAS-2B human bronchial epithelial cells and human umbilical vein endothelial cell (HUVEC)s were found to be prevented by Dickkopf-1 (DKK-1), a secreted Wnt antagonist, and LGK974, a small molecular inhibitor of the Wnt secretion.", {"entities": []}], ["LPS-induced I\u03baB degradation and NF-\u03baB nuclear translocation as well as the expressions of pro-inflammatory genes including IL-6, IL-8, TNF- \u03b1, IL-1\u03b2, MCP-1, MMP-9, COX-2 and iNOS, were all suppressed by DKK-1 and LGK974 in a dose-dependent manner.", {"entities": []}], ["The suppressive effects of LGK974 on NF-\u03baB, I\u03baB, and pro-inflammatory gene expression were rescued by ectopic expression of \u03b2-catenin, suggesting that the anti-inflammatory activity of LGK974 is mediated by modulation of the Wnt/\u03b2-catenin pathway and not by unrelated side effects.", {"entities": []}], ["When Wnt recombinant proteins were treated to cells, Wnt3a and Wnt5a significantly induced pro-inflammatory gene expressions, while Wnt7a and Wnt10b showed little effects.", {"entities": [[53, 58, "GENE"], [63, 68, "GENE"], [132, 137, "GENE"], [142, 148, "GENE"]]}], ["It was also found that Wnt3a and Wnt5a expressions were significantly induced by LPS treatment.", {"entities": [[23, 28, "GENE"], [33, 38, "GENE"]]}], ["Consistently, knockdown of Wnt3a and Wnt5a blocked LPS-induced inflammatory responses, while treatment of recombinant Wnt3a and Wnt5a proteins rescued the inhibition of inflammatory responses by LGK974.", {"entities": [[27, 32, "GENE"], [118, 123, "GENE"], [37, 42, "GENE"], [128, 133, "GENE"], [27, 32, "GENE"], [118, 123, "GENE"], [37, 42, "GENE"], [128, 133, "GENE"]]}], ["Findings of this study showed that DKK-1 and LGK974 suppress LPS-induced inflammatory response by modulating Wnt/\u03b2-catenin pathway.", {"entities": []}], ["Respiratory syncytial virus ( RSV ) is the most frequent cause of hospitalization in infants worldwide.", {"entities": []}], ["It is recognized by Toll\u2010like receptor 4 ( TLR 4) and cluster of differentiation 14 ( CD 14) in the innate immune response.", {"entities": []}], ["Previous case\u2013control studies reported the influence of TLR 4 Asp299Gly, TLR 4 Thr399Ile, and CD 14 C\u2010159T polymorphisms on the risk of severe RSV infection.", {"entities": []}], ["However, a decisive conclusion has not been achieved.", {"entities": []}], ["Therefore, we performed this meta\u2010analysis to examine the association between these three polymorphisms and the development of RSV bronchiolitis.", {"entities": [[131, 144, "DISEASE"]]}], ["A systematic literature search was performed using the PubMed, EM base, Google Scholar Search, China National Knowledge Infrastructure, China Biological Medicine, and Wanfang Databases.", {"entities": []}], ["The data were extracted and pooled odds ratios with 95% confidence intervals were calculated under six genetic models.", {"entities": []}], ["A total of six studies with 1009 cases and 1348 controls, three studies with 473 cases and 481 controls, or four studies with 325 cases and 650 controls relating to each of the three polymorphisms were included in this meta\u2010analysis.", {"entities": []}], ["The analyzed data indicated that all of these polymorphisms were not associated with the risk of severe RSV infection.", {"entities": []}], ["This is the first meta\u2010analysis to investigate the relationship of TLR 4 Asp299Gly, TLR 4 Thr399Ile, and CD 14 C\u2010159T polymorphisms with the risk of severe RSV infection.", {"entities": []}], ["Although the results of this retrospective analysis indicated a lack of the association, more extensive multicentric studies with large sample sizes are necessary to provide a more reliable estimation of the association between these three polymorphisms and RSV bronchiolitis susceptibility.", {"entities": [[262, 275, "DISEASE"]]}], ["Early diagnosis of influenza infection maximizes the effectiveness of antiviral medicines.", {"entities": [[19, 28, "DISEASE"]]}], ["Here, we assess the ability for clinical characteristics and rapid influenza tests to predict PCR-confirmed influenza infection in a sentinel, cross-sectional study for influenza-like illness (ILI) in Thailand.", {"entities": [[67, 76, "DISEASE"], [108, 117, "DISEASE"], [169, 178, "DISEASE"]]}], ["Participants meeting criteria for acute ILI (fever > 38\u00b0C and cough or sore throat) were recruited from inpatient and outpatient departments in Bangkok, Thailand, from 2009\u20132014.", {"entities": []}], ["The primary endpoint for the study was the occurrence of virologically-confirmed influenza infection (based upon detection of viral RNA by RT-PCR) among individuals presenting for care with ILI.", {"entities": [[81, 90, "DISEASE"]]}], ["Nasal and throat swabs were tested by rapid influenza test (QuickVue) and by RT-PCR.", {"entities": [[44, 53, "DISEASE"]]}], ["Vaccine effectiveness (VE) was calculated using the case test-negative method.", {"entities": []}], ["Classification and Regression Tree (CART) analysis was used to predict influenza RT-PCR positivity based upon symptoms reported.", {"entities": [[71, 80, "DISEASE"]]}], ["We enrolled 4572 individuals with ILI; 32.7% had detectable influenza RNA by RT-PCR.", {"entities": [[60, 69, "DISEASE"]]}], ["Influenza cases were attributable to influenza B (38.6%), A(H1N1)pdm09 (35.1%), and A(H3N2) (26.3%) viruses.", {"entities": [[0, 9, "DISEASE"], [37, 46, "DISEASE"]]}], ["VE was highest against influenza A(H1N1)pdm09 virus and among adults.", {"entities": [[23, 32, "DISEASE"]]}], ["The most important symptoms for predicting influenza PCR-positivity among patients with ILI were cough, runny nose, chills, and body aches.", {"entities": [[43, 52, "DISEASE"]]}], ["The accuracy of the CART predictive model was 72.8%, with an NPV of 78.1% and a PPV of 59.7%.", {"entities": []}], ["During epidemic periods, PPV improved to 68.5%.", {"entities": []}], ["The PPV of the QuickVue assay relative to RT-PCR was 93.0% overall, with peak performance during epidemic periods and in the absence of oseltamivir treatment.", {"entities": []}], ["Clinical criteria demonstrated poor predictive capability outside of epidemic periods while rapid tests were reasonably accurate and may provide an acceptable alternative to RT-PCR testing in resource-limited areas.", {"entities": []}], ["We investigated the association of living alone with mortality among older persons, independently of marital, health and other factors, and explored its effect modification by age group, sex, marital status and physical functional disability.", {"entities": []}], ["Using data from 8\u00a0years of mortality follow up (1 September 2003 to 31 December 2011) of 2553 participants in the Singapore Longitudinal Ageing Studies (SLAS) cohort, we estimated hazard ratio (HR) of mortality associated with living alone using Cox proportional hazard models.", {"entities": [[194, 196, "GENE"]]}], ["At baseline, 7.4\u00a0% ( N \u2009=\u2009189) of the participants were living alone, and 227 (8.9\u00a0%) died during the follow up period.", {"entities": []}], ["Living alone was significantly associated with mortality 1.66 (95 % CI, 1.05\u20132.63), controlling for health status (hypertension, diabetes, chronic lung disease, stroke, heart disease, kidney failure, IADL\u2013ADL disability and depressive symptoms), marital status and other variables (age, sex, housing type).", {"entities": [[115, 127, "DISEASE"], [169, 182, "DISEASE"], [184, 198, "DISEASE"], [147, 159, "DISEASE"]]}], ["Possible substantive effect modification by sex (p for interaction\u2009=\u20090.106) and marital status (p for interaction <0.115) were observed: higher among men (HR\u2009=\u20092.36, 95\u00a0% CI, 1.24\u20134.49) than women (HR\u2009=\u20091.14, 95 % CI, 0.58\u20132.22), and among single, divorce or widowed (HR\u2009=\u20092.26, 95\u00a0% CI, 1.24\u20134.10) than married individuals (HR\u2009=\u20090.83, 95\u00a0% CI, 0.30\u20132.31).", {"entities": [[155, 157, "GENE"], [198, 200, "GENE"], [268, 270, "GENE"], [325, 327, "GENE"], [155, 157, "GENE"], [198, 200, "GENE"], [268, 270, "GENE"], [325, 327, "GENE"], [155, 157, "GENE"], [198, 200, "GENE"], [268, 270, "GENE"], [325, 327, "GENE"], [155, 157, "GENE"], [198, 200, "GENE"], [268, 270, "GENE"], [325, 327, "GENE"]]}], ["Living alone was associated with increased mortality, independently of marital, health and other variables.", {"entities": []}], ["The impact of living alone on mortality appeared to be stronger among men and those who were single, divorced or married.", {"entities": []}], ["Recent studies have shown ethnic differences concerning cardio-vascular disease, diabetes and mental health.", {"entities": [[63, 79, "DISEASE"]]}], ["Little is known about ethnic differences in skin morbidity.", {"entities": []}], ["The purpose of this study was to describe possible ethnic differences in self-reported skin morbidity in a Western urban community.", {"entities": []}], ["The design was cross sectional.", {"entities": []}], ["40 888 adults in Oslo, Norway, received a postal questionnaire providing information on socio-demographic factors and self-reported health, including items on skin complaints.", {"entities": []}], ["18770 individuals answered the questionnaire.", {"entities": []}], ["In the sample 84% were from Norway.", {"entities": []}], ["The largest immigrant group was from Western countries (5%) and the Indian Subcontinent (3%).", {"entities": []}], ["Itch was the most prevalent reported skin symptom (7%), and was significantly more reported by men from East Asia (18%) and Middle East/North Africa (13%).", {"entities": []}], ["The same observations were seen for reported dry and sore skin.", {"entities": []}], ["Hair loss was a dominating complaint for men from the Indian Subcontinent and the Middle East/North Africa (23% and 25%) and for women from the same ethnic groups.", {"entities": []}], ["Women from Sub-Saharan Africa reported significantly more pimples than in the other groups (17%).", {"entities": []}], ["The study showed that there were significant differences in self-reported skin complaints among ethnic groups.", {"entities": []}], ["Issues concerning the cultural value of some skin symptoms should be examined further.", {"entities": []}], ["This study aimed to determine the prevalence of musculoskeletal (MSK) pain and rheumatic diseases in the Raramuri population (also known as Tarahumaras) who are an indigenous group in the northern state of Chihuahua in Mexico.", {"entities": []}], ["We used the Community-Oriented Program for Control of Rheumatic Diseases (COPCORD) methodology.", {"entities": []}], ["An analytical cross-sectional study was conducted including indigenous Raramuri aged \u226518\u00a0years from communities settled in Chihuahua City.", {"entities": []}], ["Subjects with positive MSK pain were evaluated by primary care physicians and rheumatologists.", {"entities": []}], ["Demographic and occupational factors such as gender and job type associated with rheumatic disease were investigated.", {"entities": [[81, 98, "DISEASE"]]}], ["A total of 380 indigenous Raramuri (mean age 33.6\u2009\u00b1\u200913.1\u00a0years; 37.9\u00a0% male) were interviewed.", {"entities": []}], ["Seventy-six individuals (20\u00a0%) reported MSK pain in the last 7\u00a0days.", {"entities": []}], ["Pain intensity was reported as \u201csevere\u201d and \u201cthe most severe\u201d in 30\u00a0% of the cases.", {"entities": []}], ["Fifty-six individuals (14.7\u00a0%) reported pain in the past and 86 (22.6\u00a0%) had either past or current pain.", {"entities": []}], ["The prevalence of rheumatic diseases was 10.5\u00a0%.", {"entities": []}], ["Diagnosed diseases were osteoarthritis (6.6\u00a0%), low back pain (1.6\u00a0%), spondyloarthritis (0.8\u00a0%), rheumatoid arthritis (0.5\u00a0%), non-specific arthritis (0.5\u00a0%), rheumatic regional pain syndromes (0.3\u00a0%), and fibromyalgia (0.3\u00a0%).", {"entities": [[98, 118, "DISEASE"], [109, 118, "DISEASE"], [141, 150, "DISEASE"], [24, 38, "DISEASE"], [207, 219, "DISEASE"]]}], ["Rheumatic disease was associated with the following variables: age (odds ratio (OR) 1.04, 95\u00a0% confidence interval (CI) 1.02\u20131.08; p \u2009=\u20090.006), family history of rheumatic symptoms (OR 6.9; 95\u00a0% CI 2.6\u201318.7; p \u2009<\u20090.001), and Health Assessment Questionnaire-Disability Index (OR 28.9; 95\u00a0% CI 2.8\u2013289.7; p \u2009<\u20090.001).", {"entities": [[0, 17, "DISEASE"]]}], ["A high prevalence of non-traumatic MSK pain suggests the need for a rheumatic disease prevention program in the Raramuri people in Chihuahua, Mexico.", {"entities": [[68, 85, "DISEASE"]]}], ["A systematic literature review was conducted to summarize the existing evidence on presumed determinants of heart failure (HF) medication adherence.", {"entities": []}], ["The aim was to assess the evidence and provide directions for future medication adherence interventions for HF patients.", {"entities": []}], ["Based on a search in relevant databases and a quality assessment, eleven articles were included in the review.", {"entities": []}], ["A best evidence synthesis was used to combine the results of presumed determinants that were found more than once in the literature.", {"entities": []}], ["Results were classified according the World Health Organization\u2019s (WHO) multidimensional adherence model.", {"entities": []}], ["Results demonstrated a relationship between having been institutionalized in the past (including hospitalizations and nursing home visits) and higher adherence levels.", {"entities": []}], ["This finding is related to the healthcare system dimension of the WHO model.", {"entities": []}], ["The presumed determinants related to the other dimensions, such as social and economic factors, condition-related, therapy-related, and patient-related factors of the multidimensional adherence model all had inconsistent evidence.", {"entities": []}], ["However, there was also an indication that patients\u2019 educational level and the number of healthcare professionals they have visited are not related to higher adherence levels.", {"entities": []}], ["Based on the current review, HF patients who have been institutionalized in the past are more adherent to HF medication.", {"entities": []}], ["Many other presumed determinants were investigated, but displayed inconsistent evidence.", {"entities": []}], ["Due to the lack of evidence, it was not possible to make recommendations for future interventions.", {"entities": []}], ["Wireless body area networks (WBANs) are severely energy constrained, and how to improve the energy efficiency so as to prolong the network lifetime as long as possible is one of the most important goals of WBAN research.", {"entities": []}], ["Low data-rate WBANs are promising to cut down the energy consumption and extend the network lifetime.", {"entities": []}], ["Considering the characteristics and demands of low data-rate WBANs, a low duty-cycling medium access control (MAC) protocol is specially designed for this kind of WBAN in this paper.", {"entities": []}], ["Longer superframes are exploited to cut down the energy consumed on the transmissions and receptions of redundant beacon frames.", {"entities": []}], ["Insertion time slots are embedded into the inactive part of a superframe to deliver the frames and satisfy the quality of service (QoS) requirements.", {"entities": []}], ["The number of the data subsections in an insertion time slot can be adaptively adjusted so as to accommodate low data-rate WBANs with different traffic.", {"entities": []}], ["Simulation results show that the proposed MAC protocol performs well under the condition of low data-rate monitoring traffic.", {"entities": []}], ["The present work is intended to demonstrate that most of the paradoxes, controversies, and contradictions accumulated in molecular and cell biology over many years of research can be readily resolved if the cell and living systems in general are re-interpreted within an alternative paradigm of biological organization that is based on the concepts and empirical laws of nonequilibrium thermodynamics.", {"entities": []}], ["In addition to resolving paradoxes and controversies, the proposed re-conceptualization of the cell and biological organization reveals hitherto unappreciated connections among many seemingly disparate phenomena and observations, and provides new and powerful insights into the universal principles governing the emergence and organizational dynamics of living systems on each and every scale of biological organizational hierarchy, from proteins and cells to economies and ecologies.", {"entities": []}], ["Sepsis in critically ill patients is almost associated with bad prognosis and its early detection may improve the prognosis.", {"entities": []}], ["However, it is difficult to monitor the immunological state of these patients depending on the traditional markers of infection or inflammatory mediators.", {"entities": []}], ["Accelerated lymphocyte death may reflect good idea about the prognosis especially when combined with 20S proteasome determinations, a recently discovered marker for muscle degradation in patients with sepsis.", {"entities": []}], ["The hypothesis of the present study is to evaluate the role of serum 20S proteasome at early diagnosis of sepsis and its correlation with lymphocyte apoptosis to predict prognosis and consequently the early interference in critically ill patients suffering from a broad range of diseases in the intensive care unit.", {"entities": []}], ["Sixty-seven critically ill adult intensive care patients were divided into two groups, 32 septic critically ill patients (sepsis group) and 35 non-septic critically ill patients (non-sepsis group), in addition to 33 apparently healthy subjects from the out patient clinic (control group).", {"entities": []}], ["Patients were tested for serum values of 20S proteasome using ELISA and for percentage of lymphocyte death using annexin V and 7-aminoactinomycin D dye by flow cytometry.", {"entities": []}], ["Measured median value of serum 20S proteasome was significantly higher in septic patients compared with both the non-septic and control groups.", {"entities": []}], ["A significant increase in the percentage of apoptotic lymphocytes was detected in septic patients when compared with the non-sepsis and control groups.", {"entities": []}], ["The correlation of both 20S proteasome and percentage of apoptotic lymphocytes was found to be significantly positive in both septic and non-septic patients.", {"entities": []}], ["The correlation of median values of 20S proteasome and the percentage of apoptotic lymphocyte median values could be a good indicator of patient prognosis and survival in critically ill patients.", {"entities": []}], ["Measurement of health inequities is fundamental to all health equity initiatives.", {"entities": []}], ["It is complex because it requires considerations of ethics, methods, and policy.", {"entities": []}], ["Drawing upon the recent developments in related specialized fields, in this paper we incorporate alternative definitions of health inequity explicitly and transparently in its measurement.", {"entities": []}], ["We propose a three-stage approach to measuring health inequities that assembles univariate health inequality, univariate health inequity, and bivariate health inequities in a systematic and comparative manner.", {"entities": []}], ["We illustrate the application of the three-stage approach using the Joint Canada/United States Survey of Health, measuring health by the Health Utilities Index (HUI).", {"entities": []}], ["Univariate health inequality is the distribution of the observed HUI across individuals.", {"entities": []}], ["Univariate health inequity is the distribution of unfair HUI \u2013 components of HUI associated with ethically unacceptable factors \u2013 across individuals.", {"entities": []}], ["To estimate the unfair HUI, we apply two popular definitions of inequity: \u201cequal opportunity for health\u201d (health outcomes due to factors beyond individual control are unfair), and \u201cpolicy amenability\u201d (health outcomes due to factors amenable to policy interventions are unfair).", {"entities": []}], ["We quantify univariate health inequality and inequity using the Gini coefficient.", {"entities": []}], ["We assess bivariate inequities using a regression-based decomposition method.", {"entities": []}], ["Our analysis reveals that, empirically, different definitions of health inequity do not yield statistically significant differences in the estimated amount of univariate inequity.", {"entities": []}], ["This derives from the relatively small explanatory power common in regression models describing variations in health.", {"entities": []}], ["As is typical, our model explains about 20% of the variation in the observed HUI.", {"entities": []}], ["With regard to bivariate inequities, income and health care show strong associations with the unfair HUI.", {"entities": []}], ["The measurement of health inequities is an excitingly multidisciplinary endeavour.", {"entities": []}], ["Its development requires interdisciplinary integration of advances from relevant disciplines.", {"entities": []}], ["The proposed three-stage approach is one such effort and stimulates cross-disciplinary dialogues, specifically, about conceptual and empirical significance of definitions of health inequities.", {"entities": []}], ["The online version of this article (doi:10.1186/s12939-014-0098-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There is biological evidence that the brain opioidergic system plays a critical role in the addictive properties of nicotine.", {"entities": []}], ["The purpose of the present study was to examine the associations of single nucleotide polymorphisms (SNPs) in the genes encoding mu-opioid receptor (MOR) and the MOR-interacting proteins (including OPRM1 , ARRB2 , and HINT1 ) with smoking behaviors in Chinese men.", {"entities": [[198, 203, "GENE"], [206, 211, "GENE"], [218, 223, "GENE"]]}], ["A total of 284 subjects (including current and ex-smokers) were recruited.", {"entities": []}], ["Special questionnaires were used to assess smoking behaviors including age of smoking initiation, daily cigarette consumption, and Fagerstr\u00f6m test for nicotine dependence (FTND) score.", {"entities": [[151, 170, "DISEASE"]]}], ["Participant samples were genotyped for six SNPs in the opioid pathway genes: rs1799971 in OPRM1 , rs1045280, rs2036657 and rs3786047 in ARRB2 , rs3852209 and rs2278060 in HINT1 .", {"entities": [[90, 95, "GENE"], [136, 141, "GENE"], [171, 176, "GENE"]]}], ["Linear and logistic regression models were used to determine single-locus and haplotype-based association analyses.", {"entities": []}], ["There was no significant association between any of SNPs analyzed and smoking behaviors.", {"entities": []}], ["Logistic regression analyses under dominant, recessive, and additive models showed no significant associations of the six SNPs with smoking status (current vs. ex-smokers).", {"entities": []}], ["After adjustment for age at enrollment and smoking initiation age, HINT1 rs3852209 was significantly associated with smoking status with an OR of 0.54 (95% CI, 0.31-0.95; P \u2009=\u20090.03) under dominant inheritance model.", {"entities": [[67, 72, "GENE"]]}], ["No haplotypes in ARRB2 or HINT1 were related to smoking status.", {"entities": [[17, 22, "GENE"], [26, 31, "GENE"]]}], ["The present study indicates no significant association between common genetic variations in MOR and MOR-interacting proteins and smoking behaviors in Chinese men, and gives suggestive evidence that HINT1 rs3852209 may be related to smoking status.", {"entities": [[198, 203, "GENE"]]}], ["The findings require confirmation from further studies in additional larger samples.", {"entities": []}], ["T helper 2 (Th2) cells are defined by their ability to produce the hallmark cytokine IL-4.", {"entities": []}], ["However, to mediate allergic inflammation in tissues, Th2 cells must secrete additional cytokines including IL-13 and IL-5.", {"entities": []}], ["We used IL-4 and IL-13 dual-reporter mice to show that naive CD4 Gata3 , Il5 , and Il3 transcripts.", {"entities": [[61, 64, "GENE"], [65, 70, "GENE"], [73, 76, "GENE"], [83, 86, "GENE"]]}], ["Thus, TSLP drives the early differentiation of a distinct population of effector Th2 cells with pro-inflammatory properties.", {"entities": [[6, 10, "GENE"]]}], ["T helper 2 (Th2) cells are pivotal in the development of allergy.", {"entities": []}], ["Allergen exposure primes IL-4 Bcl6 and Il21 transcripts and high levels of Gata3 , Il3 , and Il5 .", {"entities": [[30, 34, "GENE"], [39, 43, "GENE"], [75, 80, "GENE"], [83, 86, "GENE"], [93, 96, "GENE"]]}], ["Our findings suggest a role of TSLP in directly promoting Th2 cell effector function and support the notion of TSLP as a key driver of Th2 inflammation.", {"entities": [[31, 35, "GENE"], [111, 115, "GENE"], [31, 35, "GENE"], [111, 115, "GENE"]]}], ["To assess the yield of screening for atrial fibrillation (AF) with a hand-held single-lead electrocardiogram (ECG) device during influenza vaccination in primary care in the Netherlands.", {"entities": [[129, 138, "DISEASE"]]}], ["We used the MyDiagnostick to screen for AF in persons who participated in influenza vaccination sessions of ten Dutch primary care practices.", {"entities": [[74, 83, "DISEASE"]]}], ["In case of suspected AF detection by the stick, the recorded 1-min ECG registrations were analysed by a cardiologist.", {"entities": []}], ["We scrutinized electronic medical files of the general practitioners to obtain information about the cases screened.", {"entities": []}], ["Multivariable logistic regression analysis was performed to predict the relation between patient characteristics and a new screen-detected diagnosis of AF.", {"entities": []}], ["In total, 3269 persons were screened for AF during the influenza vaccination sessions of 10 general practitioner practices.", {"entities": [[55, 64, "DISEASE"]]}], ["As a result, 37 (1.1%) new cases of AF were detected.", {"entities": []}], ["Prior transient ischeamic attack or stroke (OR 6.05; 95%CI 1.93\u201319.0), and age (OR 1.09 per year; 95% CI 1.05\u20131.14) were independent predictors for such newly screen-detected AF.", {"entities": []}], ["Of the 37 screen-detected AF cases, 2.7% had a CHA 2 DS 2 -VASc of 0, 18.9% a score of 1, and 78.4% a score of 2 or more.", {"entities": []}], ["The majority needed oral anticoagulant therapy.", {"entities": []}], ["Screening seems feasible with an easy to use single-lead, hand-held ECG device with automatic AF detection during influenza vaccination in primary care and results in a \u20181-day\u2019 yield of 1.1% new cases of AF.", {"entities": [[114, 123, "DISEASE"]]}], ["NCT02006524.", {"entities": []}], ["Adenocarcinoma originating from the digestive system is a major contributor to cancer-related deaths worldwide.", {"entities": [[0, 14, "DISEASE"], [79, 85, "DISEASE"]]}], ["Tumor recurrence, advanced local growth and metastasis are key factors that frequently prevent these tumors from curative surgical treatment.", {"entities": []}], ["Preclinical research has demonstrated that the dependency of these tumors on supporting mesenchymal stroma results in susceptibility to cell-based therapies targeting this stroma.", {"entities": []}], ["TREAT-ME1 is a prospective, uncontrolled, single-arm phase I/II study assessing the safety and efficacy of genetically modified autologous mesenchymal stromal cells (MSC) as delivery vehicles for a cell-based gene therapy for advanced, recurrent or metastatic gastrointestinal or hepatopancreatobiliary adenocarcinoma.", {"entities": [[303, 317, "DISEASE"], [166, 169, "GENE"]]}], ["Autologous bone marrow will be drawn from each eligible patient after consent for bone marrow donation has been obtained (under a separate EC-approved protocol).", {"entities": []}], ["In the following ~10\u00a0weeks the investigational medicinal product (IMP) is developed for each patient.", {"entities": []}], ["To this end, the patient\u2019s MSCs are stably transfected with a gamma-retroviral, replication-incompetent and self-inactivating (SIN) vector system containing a therapeutic promoter - gene construct that allows for tumor-specific expression of the therapeutic gene.", {"entities": []}], ["After release of the IMP the patients are enrolled after given informed consent for participation in the TREAT-ME 1 trial.", {"entities": []}], ["In the phase I part of the study, the safety of the IMP is tested in six patients by three treatment cycles consisting of re-transfusion of MSCs at different concentrations followed by administration of the prodrug Ganciclovir.", {"entities": []}], ["In the phase II part of the study, sixteen patients will be enrolled receiving IMP treatment.", {"entities": []}], ["A subgroup of patients that qualifies for surgery will be treated preoperatively with the IMP to verify homing of the MSCs to tumors as to be confirmed in the surgical specimen.", {"entities": []}], ["The TREAT-ME1 clinical study involves a highly innovative therapeutic strategy combining cell and gene therapy and is conducted at a high level of pharmaceutical quality ensuring patient safety.", {"entities": []}], ["This patient-tailored approach represents the first clinical study worldwide utilizing genetically engineered MSCs in humans.", {"entities": []}], ["EU Clinical Trials Register/European Union Drug Regulating Authorities Clinical Trials Database number: 2012-003741-15", {"entities": []}], ["The indoor biome is a novel habitat which recent studies have shown exhibit not only high microbial diversity, but also high arthropod diversity.", {"entities": []}], ["Here, we analyze findings from a survey of 50 houses (southeastern USA) within the context of additional survey data concerning house and room features, along with resident behavior, to explore how arthropod diversity and community composition are influenced by physical aspects of rooms and their usage, as well as the lifestyles of human residents.", {"entities": []}], ["We found that indoor arthropod diversity is strongly influenced by access to the outdoors and carpeted rooms hosted more types of arthropods than non-carpeted rooms.", {"entities": []}], ["Arthropod communities were similar across most room types, but basements exhibited more unique community compositions.", {"entities": []}], ["Resident behavior such as house tidiness, pesticide usage, and pet ownership showed no significant influence on arthropod community composition.", {"entities": []}], ["Arthropod communities across all rooms in houses exhibit trophic structure\u2014with both generalized predators and scavengers included in the most frequently found groups.", {"entities": []}], ["These findings suggest that indoor arthropods serve as a connection to the outdoors, and that there is still much yet to be discovered about their impact on indoor health and the unique ecological dynamics within our homes.", {"entities": []}], ["While Th17 cells can protect against colonization by pathogenic organisms, they also have the potential to become pathogenic and promote autoimmune and inflammatory diseases.", {"entities": []}], ["Mechanisms that control their pathogenic potential remain poorly understood.", {"entities": []}], ["Here we show that Ndfip1, a co-activator of the E3 ubiquitin ligase Itch, restricts the frequency and pathogenicity of Th17 cells.", {"entities": [[18, 24, "GENE"]]}], ["Mice lacking Ndfip1 have increased numbers of Th17 cells, and this increase is cell intrinsic.", {"entities": [[13, 19, "GENE"]]}], ["We found that Ndfip1 restricts production of the proinflammatory cytokines in Th17 cells.", {"entities": [[14, 20, "GENE"]]}], ["Increased cytokine production correlated with reduced degradation and accumulation of ROR\u03b3T.", {"entities": []}], ["When transferred in vivo , Th17 cells lacking Ndfip1 were more likely to maintain their ability to make IL-17, were more potent proinflammatory cytokine producers, and were powerful inducers of colitis.", {"entities": [[46, 52, "GENE"]]}], ["Together our data support an essential role for Ndfip1 in degrading ROR\u03b3T and suppressing Th17 lineage stability, proinflammatory cytokine production, and pathogenicity.", {"entities": [[48, 54, "GENE"]]}], ["Evidence suggests that interaction between key genes mediating signaling and transcriptional networks involving effector T-cell responses may influence an individual\u2019s susceptibility to develop allergic rhinitis(AR).", {"entities": [[194, 211, "DISEASE"], [203, 211, "DISEASE"]]}], ["The aim of this study was todetermine whether specific interactions between key genes involved in effector T-cell pathways are associated with an individual\u2019s susceptibility to develop AR in Han Chinese subjects.", {"entities": []}], ["A cohort of 489 patients with AR and 421 healthy controls was enrolled from the Han Chinese population in Beijing, China.", {"entities": []}], ["AR was established by questionnaire and clinical examination, and peripheral blood was drawn from all subjects for DNA extraction.", {"entities": []}], ["A total of 96 single nucleotide polymorphisms (SNPs) in 26 reprehensive candidate genes involved in T helper 1 (Th1), Th2, Th17, Th9 and T regulatory cell pathways were selected from the International Haplotype Mappingdatabase for Han Chinese in Beijing (CHB) population, and IlluminaGoldenGate assay was conducted for SNP genotyping.", {"entities": []}], ["The PLINK software package was used to perform statistical analyses.", {"entities": []}], ["Simple SNP-phenotype association analysis using logistic regression showed SNP rs8193036 in IL17A gene, rs2569254 in IL-12 and rs1898413 in ROR\u03b1 weresignificantlyassociatedwith AR.Simple SNP-phenotype association analysis with genetic models demonstrated thatrs2569254 in IL-12, rs1031508 in STAT4, and rs3741809 in IL-26 were likely to be recessive, rs8193036 in IL17A allelic, rs897200in STAT4 genotypic, and rs1898413 in ROR\u03b1 dominant.", {"entities": [[92, 97, "GENE"], [364, 369, "GENE"], [292, 297, "GENE"], [390, 395, "GENE"], [92, 97, "GENE"], [364, 369, "GENE"], [292, 297, "GENE"], [390, 395, "GENE"]]}], ["Epistasis analyses exhibited that 83 SNPs in 23 genes were significantly interactive; of which 59 interactions/SNP pairs demonstrated OR values higher than 2 or lower than 0.5, and 12 interactions/SNP pairs OR values higher than 4 or lower than 0.25.", {"entities": []}], ["STAT3, ROR\u03b1 and IL-26, involved in Th17 pathway,were the mostfrequentlyinteractive genes.", {"entities": [[0, 5, "GENE"]]}], ["This study suggests that interactions between several SNPs in key genes involved in effector T-cell pathways are likely to influence an individual\u2019s susceptibility to develop AR.", {"entities": []}], ["The aim was to study the glycaemic control of type 2 diabetic patients, and to identify factors associated with unacceptable glycaemic control (defined as HbA 1c >8.0%).", {"entities": []}], ["Analysis of data collected in a cross-sectional survey of type 2 diabetic patients in eight SingHealth Polyclinics in January 2009.", {"entities": []}], ["HbA 1c value was measured on the day of the survey, while information on patient and diabetic characteristics was obtained through a questionnaire.", {"entities": []}], ["Odds ratio of having unacceptable glycaemic control was estimated for selected variables using multiple logistic regression models.", {"entities": []}], ["A total of 688 patients were included in the analysis.", {"entities": []}], ["The mean (\u00b1 standard deviation) and median (range) HbA 1c levels were 7.6% (\u00b1 1.35) and 7.3% (5.0% to 14.0%), respectively.", {"entities": []}], ["25.4% of the patients had an unacceptable HbA 1c level of >8.0% and the odds of this were higher (p\u2009<\u20090.05) in patients with the following characteristics: younger age, longer diabetes duration, presence of insulin treatment, and poorer compliance to medication.", {"entities": []}], ["Younger adult patients were found to have poorer glycaemic control, and hence targeted educational and behaviour modification programmes would be required to effectively manage this group of patients.", {"entities": []}], ["Because they are a closed founder population, the Old Order Amish (OOA) of Lancaster County have been the subject of many medical genetics studies.", {"entities": []}], ["We constructed four versions of Anabaptist Genealogy Database (AGDB) using three sources of genealogies and multiple updates.", {"entities": []}], ["In addition, we developed PedHunter, a suite of query software that can solve pedigree-related problems automatically and systematically.", {"entities": []}], ["We report on how we have used new features in PedHunter to quantify the number and expected genetic contribution of founders to the OOA.", {"entities": []}], ["The queries and utility of PedHunter programs are illustrated by examples using AGDB in this paper.", {"entities": []}], ["For example, we calculated the number of founders expected to be contributing genetic material to the present-day living OOA and estimated the mean relative founder representation for each founder.", {"entities": []}], ["New features in PedHunter also include pedigree trimming and pedigree renumbering, which should prove useful for studying large pedigrees.", {"entities": []}], ["With PedHunter version 2.0 querying AGDB version 4.0, we identified 34,160 presumed living OOA individuals and connected them into a 14-generation pedigree descending from 554 founders (332 females and 222 males) after trimming.", {"entities": []}], ["From the analysis of cumulative mean relative founder representation, 128 founders (78 females and 50 males) accounted for over 95% of the mean relative founder contribution among living OOA descendants.", {"entities": []}], ["The OOA are a closed founder population in which a modest number of founders account for the genetic variation present in the current OOA population.", {"entities": []}], ["Improvements to the PedHunter software will be useful in future studies of both the OOA and other populations with large and computerized genealogies.", {"entities": []}], ["Cigarette smoke (CS) exerts protective effect against ulcerative colitis.", {"entities": [[54, 72, "DISEASE"], [17, 19, "GENE"]]}], ["The mechanism of this phenomenon remains unknown.", {"entities": []}], ["One of the possible explanation by which CS exerts its anti-inflammatory action is modulation of immune system.", {"entities": [[41, 43, "GENE"]]}], ["Therefore, the aim of the study was to evaluate the effect of CS on the course of inflammation and subpopulations of lymphocytes in the blood and colon in mice with dextran sulfate sodium (DSS)-induced colitis.", {"entities": [[62, 64, "GENE"]]}], ["C57BL6/cmdb mice were exposed to CS for 4\u00a0weeks.", {"entities": [[33, 35, "GENE"]]}], ["Colitis was induced with 3.5% DSS given for 10\u00a0days.", {"entities": []}], ["Severity of colitis was determined by disease activity index (DAI), body weight changes, and macro- and microscopic characteristics of inflammation.", {"entities": []}], ["Peripheral subpopulations of lymphocytes were assessed by flow cytometry (blood) or immunohistochemistry (colonic tissue).", {"entities": []}], ["Mice treated with 3.5% DSS developed severe colitis with significantly decreased body weight, increased DAI, and macroscopic and histological features of colonic inflammation.", {"entities": []}], ["These findings were diminished after concomitant exposure to CS.", {"entities": [[61, 63, "GENE"]]}], ["Mice exposed to DSS alone demonstrated significantly decreased percentage of total CD4 p \u00a0=\u00a00.0007), accompanied by increase of CD8 p \u00a0=\u00a00.0001).", {"entities": [[83, 86, "GENE"]]}], ["Concomitant CS exposure reversed inappropriate CD4 Our study has demonstrated that CS exposure decreases severity of DSS-induced colitis.", {"entities": [[12, 14, "GENE"], [83, 85, "GENE"], [47, 50, "GENE"], [12, 14, "GENE"], [83, 85, "GENE"]]}], ["This phenomenon was accompanied by changes in CD4/CD8 ratio and B cell level in the peripheral blood and colon.", {"entities": []}], ["These mechanisms may be responsible for protective effect of smoking in ulcerative colitis.", {"entities": [[72, 90, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s00384-017-2882-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The prescription of physical activity for hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can be complicated by the presence of comorbidities.", {"entities": [[91, 128, "DISEASE"]]}], ["The current research aimed to synthesize the relevant literature on the benefits of exercise for people with multimorbidities who experience an AECOPD, and ask: What are the parameters and outcomes of exercise in AECOPD and in conditions that are common comorbidities as reported by systematic reviews (SRs)?", {"entities": []}], ["An SR was performed using the Cochrane Collaboration protocol.", {"entities": []}], ["Nine electronic databases were searched up to July 2011.", {"entities": []}], ["Articles were included if they (1) described participants with AECOPD, chronic obstructive pulmonary disease (COPD), or one of eleven common comorbidities, (2) were an SR, (3) examined aerobic training (AT), resistance training (RT), balance training (BT), or a combination thereof, (4) included at least one outcome of fitness, and (5) compared exercise training versus control/sham.", {"entities": [[71, 108, "DISEASE"]]}], ["This synthesis examined 58 SRs of exercise training in people with AECOPD, COPD, or eleven chronic conditions commonly associated with COPD.", {"entities": []}], ["Meta-analyses of endurance (aerobic or exercise capacity, 6-minute walk distance \u2013 6MWD) were shown to significantly improve in most conditions (except osteoarthritis, osteoporosis, and depression), whereas strength was shown to improve in five of the 13 conditions searched: COPD, older adults, heart failure, ischemic heart disease, and diabetes.", {"entities": [[311, 333, "DISEASE"], [320, 333, "DISEASE"], [168, 180, "DISEASE"], [152, 166, "DISEASE"]]}], ["Several studies of different conditions also reported improvements in quality of life, function, and control or prevention outcomes.", {"entities": []}], ["Meta-analyses also demonstrate that exercise training decreases the risk of mortality in older adults, and those with COPD or ischemic heart disease.", {"entities": [[126, 148, "DISEASE"], [135, 148, "DISEASE"]]}], ["The most common types of training were AT and RT.", {"entities": []}], ["BT and functional training were commonly applied in older adults.", {"entities": []}], ["The quality of the SRs for most conditions was moderate to excellent (>65%) as evaluated by AMSTAR scores.", {"entities": []}], ["In summary, this synthesis showed evidence of significant benefits from exercise training in AECOPD, COPD, and conditions that are common comorbidities.", {"entities": []}], ["A broader approach to exercise and activity prescription in pulmonary rehabilitation may induce therapeutic benefits to ameliorate clinical sequelae associated with AECOPD and comorbidities such as the inclusion of BT and functional training.", {"entities": []}], ["Objective : The aim of this study was to compare the moisturising efficacy and acceptability of physical characteristics of two commonly prescribed emollients licenced in the UK, Doublebase Dayleve gel (DELP) and Diprobase cream (DIPC).", {"entities": []}], ["Methods: The study was a double-blind, concurrent bi-lateral comparison in female eczema subjects with dry skin.", {"entities": []}], ["Results : In Part 1, comparing the area under the curve (AUC) change from baseline corneometer readings over 24 h following single applications of the emollients to the volar forearms of 34 subjects, the AUC for DELP was more than three times that seen for DIPC ( p \u2009<\u20090.0001).", {"entities": []}], ["In Part 2, comparing the same outcome measured over 5 days of twice daily applications to the lower legs in 36 subjects, the AUC for DELP was approximately five times that for DIPC ( p \u2009<\u20090.0001).", {"entities": []}], ["69% of subjects \u201cLike Slightly\u201d or \u201cLike Strongly\u201d DELP compared to 33% for DIPC ( p \u2009=\u20090.025).", {"entities": []}], ["72% indicated they would use DELP again compared to 33% for DIPC ( p \u2009=\u20090.033).", {"entities": []}], ["75% of subjects preferred DELP, 17% preferred DIPC and 8% expressed no preference ( p \u2009=\u20090.0004).", {"entities": []}], ["Influenza disease burden and economic impact data are needed to assess the potential value of interventions.", {"entities": [[0, 9, "DISEASE"]]}], ["Such information is limited from resource\u2010limited settings.", {"entities": []}], ["We therefore studied the cost of influenza in Peru.", {"entities": [[33, 42, "DISEASE"]]}], ["We used data collected during June 2009\u2013December 2010 from laboratory\u2010confirmed influenza cases identified through a household cohort in Peru.", {"entities": [[80, 89, "DISEASE"]]}], ["We determined the self\u2010reported direct and indirect costs of self\u2010treatment, outpatient care, emergency ward care, and hospitalizations through standardized questionnaires.", {"entities": []}], ["We recorded costs accrued 15\u2010day from illness onset.", {"entities": []}], ["Direct costs represented medication, consultation, diagnostic fees, and health\u2010related expenses such as transportation and phone calls.", {"entities": []}], ["Indirect costs represented lost productivity during days of illness by both cases and caregivers.", {"entities": []}], ["We estimated the annual economic cost and the impact of a case of influenza on a household.", {"entities": [[66, 75, "DISEASE"]]}], ["There were 1321 confirmed influenza cases, of which 47% sought health care.", {"entities": [[26, 35, "DISEASE"]]}], ["Participants with confirmed influenza illness paid a median of $13 [interquartile range ( IQR ) 5\u201326] for self\u2010treatment, $19 ( IQR 9\u201334) for ambulatory non\u2010medical attended illness, $29 ( IQR 14\u201351) for ambulatory medical attended illness, and $171 ( IQR 113\u2013258) for hospitalizations.", {"entities": [[28, 37, "DISEASE"]]}], ["Overall, the projected national cost of an influenza illness was $83\u2013$85\u00a0millions.", {"entities": [[43, 52, "DISEASE"]]}], ["Costs per influenza illness represented 14% of the monthly household income of the lowest income quartile (compared to 3% of the highest quartile).", {"entities": [[10, 19, "DISEASE"]]}], ["Influenza virus infection causes an important economic burden, particularly among the poorest families and those hospitalized.", {"entities": [[0, 9, "DISEASE"]]}], ["Prevention strategies such as annual influenza vaccination program targeting SAGE population at risk could reduce the overall economic impact of seasonal influenza.", {"entities": [[37, 46, "DISEASE"], [154, 163, "DISEASE"]]}], ["Abnormal inflammations are central therapeutic targets in numerous infectious and autoimmune diseases.", {"entities": []}], ["Dendritic cells (DCs) are involved in these inflammations, serving as both antigen presenters and proinflammatory cytokine providers.", {"entities": []}], ["As an immuno-suppressor applied to the therapies of multiple sclerosis and allograft transplantation, fingolimod (FTY720) was shown to affect DC migration and its crosstalk with T cells.", {"entities": [[52, 70, "DISEASE"]]}], ["We posit FTY720 can induce an anergy-polarized phenotype switch on DCs in vitro , especially upon endotoxic activation.", {"entities": []}], ["A lipopolysaccharide (LPS)-induced mouse bone marrow-derived dendritic cell (BMDC) activation model was employed to test FTY720-induced phenotypic changes on immature and mature DCs.", {"entities": []}], ["Specifically, methods for morphology, nanostructure, cytokine production, phagocytosis, endocytosis and specific antigen presentation studies were used.", {"entities": []}], ["FTY720 induced significant alterations of surface markers, as well as decline of shape indices, cell volume, surface roughness in LPS-activated mature BMDCs.", {"entities": []}], ["These phenotypic, morphological and topographical changes were accompanied by FTY720-mediated down-regulation of proinflammatory cytokines, including IL-6, TNF-\u03b1, IL-12 and MCP-1.", {"entities": []}], ["Together with suppressed nitric oxide (NO) production and CCR7 transcription in FTY720-treated BMDCs with or without LPS activation, an inhibitory mechanism of NO and cytokine reciprocal activation was suggested.", {"entities": [[58, 62, "GENE"]]}], ["This implication was supported by the impaired phagocytotic, endocytotic and specific antigen presentation abilities observed in the FTY720-treated BMDCs.", {"entities": []}], ["In conclusion, we demonstrated FTY720 can induce anergy-polarization in both immature and LPS-activated mature BMDCs.", {"entities": []}], ["A possible mechanism is FTY720-mediated reciprocal suppression on the intrinsic activation pathway and cytokine production with endpoint exhibitions on phagocytosis, endocytosis, antigen presentation as well as cellular morphology and topography.", {"entities": []}], ["The European Community Respiratory Health Survey is a major international study designed to assess lung health in adults.", {"entities": []}], ["This Australian follow-up investigated changes in symptoms between sexes and the roles of asthma, smoking, age, sex, height, and change in body mass index (\u0394BMI) on lung function decline (LFD), which is a major risk factor for chronic obstructive pulmonary disease (COPD).", {"entities": [[227, 264, "DISEASE"], [90, 96, "DISEASE"]]}], ["LFD was measured as the rate of decline over time in FEV 1 (mL/year) (\u0394FEV 1 ) and FVC (\u0394FVC) between 1993 and 2013.", {"entities": [[53, 56, "GENE"]]}], ["Multiple linear regression was used to estimate associations between risk factors and LFD, separately for males and females.", {"entities": []}], ["Multiple logistic regression was used to assess sex differences and changes in respiratory symptoms over time.", {"entities": []}], ["In Melbourne, 318 subjects (53.8% females) participated.", {"entities": []}], ["The prevalence of most respiratory symptoms had either remained relatively stable over 20 years or decreased (significantly so for wheeze).", {"entities": []}], ["The exception was shortness of breath after activity, which had increased.", {"entities": []}], ["Among the 262 subjects who completed spirometry, current smoking declined from 20.2% to 7.3%.", {"entities": []}], ["Overall mean (\u00b1 standard deviation) FEV 1 declined by 23.1 (\u00b117.1) and FVC by 22.9 (\u00b120.2) mL/year.", {"entities": [[36, 39, "GENE"]]}], ["Predictors of \u0394FEV 1 in males were age, maternal smoking, and baseline FEV 1 ; and in females they were age, \u0394BMI, baseline FEV 1 , and pack-years in current smokers.", {"entities": [[71, 74, "GENE"], [124, 127, "GENE"], [71, 74, "GENE"], [124, 127, "GENE"]]}], ["Decline in FVC was predicted by baseline FVC, age, and \u0394BMI in both sexes; however, baseline FVC predicted steeper decline in females than males.", {"entities": []}], ["Most respiratory symptoms remained stable or decreased over time in both sexes.", {"entities": []}], ["Age, baseline lung function, and change in BMI were associated with the rate of decline in both sexes.", {"entities": []}], ["However, obesity and personal smoking appear to put females at higher risk of LFD than males.", {"entities": [[9, 16, "DISEASE"]]}], ["Health promotion campaigns should particularly target females to prevent COPD.", {"entities": []}], ["Lipopolysaccharide (LPS) contributes to asthma exacerbations and development of inhaled corticosteroid insensitivity.", {"entities": [[40, 46, "DISEASE"]]}], ["Complete resistance to systemic corticosteroids is rare, and most patients lie on a continuum of steroid responsiveness.", {"entities": []}], ["This study aimed to examine the sensitivity of combined ovalbumin- (Ova) and LPS-induced functional and inflammatory responses to inhaled and systemic corticosteroid in conscious guinea pigs to test the hypothesis that the route of administration affects sensitivity.", {"entities": []}], ["Guinea pigs were sensitized to Ova and challenged with inhaled Ova alone or combined with LPS.", {"entities": []}], ["Airway function was determined by measuring specific airway conductance via whole-body plethysmography.", {"entities": []}], ["Airway hyper-responsiveness to histamine was determined before and 24 hours post-Ova challenge.", {"entities": []}], ["Airway inflammation and underlying mechanisms were determined from bronchoalveolar lavage cell counts and lung tissue cytokines.", {"entities": []}], ["Vehicle or dexamethasone was administered by once-daily i.p.", {"entities": []}], ["injection (5, 10, or 20 mg/kg) or twice-daily inhalation (4 or 20 mg/ml) for 6 days before Ova challenge or Ova with LPS.", {"entities": []}], ["LPS exacerbated Ova-induced responses, elongating early asthmatic responses (EAR), prolonging histamine bronchoconstriction, and further elevating airway inflammation.", {"entities": []}], ["Intraperitoneal dexamethasone (20 mg/kg) significantly reduced the elongated EAR and airway inflammation but not the increased bronchoconstriction to histamine.", {"entities": []}], ["In contrast, inhaled dexamethasone (20 mg/ml), which inhibited responses to Ova alone, did not significantly reduce functional and inflammatory responses to combined Ova and LPS.", {"entities": []}], ["Combined Ova and LPS\u2013induced functional and inflammatory responses are insensitive to inhaled, but they are only partially sensitive to systemic, dexamethasone.", {"entities": []}], ["This finding suggests that the route of corticosteroid administration may be important in determining corticosteroid sensitivity of asthmatic responses.", {"entities": []}], ["Animal studies and clinical trials have examined the potential benefits of statins in asthma management with contradictory results.", {"entities": [[86, 92, "DISEASE"]]}], ["The objective of this study was to determine if asthma patients on concurrent statins are less likely to have asthma-related hospitalisations.", {"entities": [[48, 54, "DISEASE"], [110, 116, "DISEASE"]]}], ["A retrospective cohort study using Mississippi Medicaid data for 2002\u20132004.", {"entities": []}], ["Asthma patients \u226518\u2005years were identified using the ICD9 code 493.xx from 1 July 2002 through 31 December 2003.", {"entities": [[0, 6, "DISEASE"]]}], ["The index date for an exposed subject was any date within the identification period, 180\u2005days prior to which the subject had at least one inhaled corticosteroid prescription and at least an 80% adherence rate to statins.", {"entities": []}], ["Asthma patients on inhaled corticosteroids, but not on statins, were selected as the unexposed population.", {"entities": [[0, 6, "DISEASE"]]}], ["The two groups were matched and followed for 1 year beginning the index date.", {"entities": []}], ["Patient outcomes in terms of hospitalisations and ER visits were compared using conditional logistic regression.", {"entities": []}], ["After matching, there were 479 exposed subjects and 958 corresponding unexposed subjects.", {"entities": []}], ["The odds of asthma-related hospitalisation and/or emergency room (ER) visits for asthma patients on concurrent statins were almost half the odds for patients not on statins (OR=0.55; 95% CI (0.37 to 0.84); p=0.0059).", {"entities": [[12, 18, "DISEASE"], [81, 87, "DISEASE"]]}], ["Similarly, the odds of asthma-related ER visits were significantly lower for patients on statins (OR=0.48; 95% CI (0.28 to 0.82); p=0.0069).", {"entities": [[23, 29, "DISEASE"]]}], ["The findings suggest beneficial effects of statins in asthma management.", {"entities": [[54, 60, "DISEASE"]]}], ["Further prospective investigations are required to provide more conclusive evidence.", {"entities": []}], ["Statins have been shown to have promising therapeutic potential in mediating anti-inflammatory processes in animal model studies as well as clinical trials of rheumatoid arthritis, autoimmune encephalomyelitis, inflammatory colitis and psoriasis.", {"entities": [[159, 179, "DISEASE"], [236, 245, "DISEASE"], [170, 179, "DISEASE"], [192, 209, "DISEASE"]]}], ["Along the same line of reasoning, recently there has been some discussion regarding the use of statins in asthma management in addition to inhaled corticosteroid therapy.", {"entities": [[106, 112, "DISEASE"]]}], ["The purpose of this study was to investigate the beneficial effects of statins on asthma outcomes using the Mississippi Medicaid claims database.", {"entities": [[82, 88, "DISEASE"]]}], ["The findings suggest that statins may be beneficial in asthma management.", {"entities": [[55, 61, "DISEASE"]]}], ["The study accounts for several additional potential confounders not previously explored in the other observational studies.", {"entities": []}], ["The study uses a propensity score-matched cohort study design, which in itself should take into account potential confounding effects.", {"entities": []}], ["The study was conducted using Medicaid claims data, and therefore, there is a possibility of misclassification due to coding errors during claims processing.", {"entities": []}], ["It has been hypothesized that cellular damage caused by oxidative stress is associated with late-life depression but epidemiological evidence is limited.", {"entities": []}], ["In the present study we evaluated the association between urinary 8-iso-prostaglandin F 2\u03b1 (8-iso-PGF 2\u03b1 ), a biomarker of lipid peroxidation, and depressed mood in a large sample of community-dwelling older adults.", {"entities": []}], ["Participants were selected from the Health, Aging and Body Composition study, a community-based longitudinal study of older persons (aged 70\u201379 years).", {"entities": []}], ["The present analyses was based on a subsample of 1027 men and 948 women free of mobility disability.", {"entities": []}], ["Urinary concentration of 8-iso-PGF 2\u03b1 was measured by radioimmunoassay methods and adjusted for urinary creatinine.", {"entities": []}], ["Depressed mood was defined as a score greater than 5 on the 15-item Geriatric Depression Scale and/or use of antidepressant medications.", {"entities": []}], ["Depressed mood was present in 3.0% of men and 5.5% of women.", {"entities": []}], ["Depressed men presented higher urinary concentrations of 8-iso-PGF 2\u03b1 than non-depressed men even after adjustment for multiple sociodemographic, lifestyle and health factors ( p\u200a=\u200a 0.03, Cohen\u2019s d\u200a=\u200a0.30).", {"entities": []}], ["This association was not present in women (depressed status-by-sex interaction p \u200a=\u200a0.04).", {"entities": []}], ["Our study showed that oxidative damage may be linked to depression in older men from a large sample of the general population.", {"entities": []}], ["Further studies are needed to explore whether the modulation of oxidative stress may break down the link between late-life depression and its deleterious health consequences.", {"entities": []}], ["Medicinal flora plays a vital role in treating various types of ailments in living beings.", {"entities": []}], ["The present study was planned to investigate and document systematically the indigenous knowledge in a scientifically little explored area of Ladha sub-division, South Waziristan agency, Pakistan.", {"entities": []}], ["Hence, this study would contribute positively to the field of ethnopharmacology.", {"entities": []}], ["Prior to ethnomedicinal data collection, regular field visits were conducted during the month of May and June 2015 to locate the sites and respondents from where the traditional knowledge was to be recorded.", {"entities": []}], ["Ethno-medicinal data was collected during the month July and August 2015 through rapid appraisal approach (RAA) based on direct interaction with the indigenous communities by making group discussions, corner meetings and semi-structured interviews.", {"entities": []}], ["Data was evaluated statistically by using the index of Use value (UV) and Frequency of citations (FC).", {"entities": []}], ["A total of 82 medicinal plants belonging to 42 families were reported in the study.", {"entities": []}], ["Leaves were the most frequently used plant parts.", {"entities": []}], ["Highest use values were recorded for Peganum harmala (0.93), Punica granatum (0.91), Thymus mongolicus (0.90), Chenopodium album (0.89), Coriandrum sativum (0.87), Mentha longifolia (0.87), Lactuca serriola (0.87) and Portulaca oleracea (0.87).", {"entities": []}], ["Medicinal plants used for the gastro intestinal complexities and respiratory diseases were more than 9% followed by skin and diarrhea (7% each), liver disorders (5%) cough and cold fever (5%).", {"entities": [[125, 133, "DISEASE"]]}], ["People of the area mostly still rely on traditional herbal therapies.", {"entities": []}], ["Keeping in mind the dependence of the indigenous community for their primary health care on such herbal remedies, pharmacological and critical toxicological investigation of certain flora is necessary.", {"entities": []}], ["Moreover, projects should be designed to analyze the existing issues and problems related with medicinal plants conservation.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a life-limiting lung disease with considerable impact on patients and carers as the disease progresses.", {"entities": [[11, 29, "DISEASE"], [55, 67, "DISEASE"]]}], ["Currently few treatments are available.", {"entities": []}], ["We aimed to evaluate the clinical and cost-effectiveness of available treatments for IPF.", {"entities": []}], ["Systematic reviews of clinical effectiveness, quality of life and cost effectiveness were undertaken.", {"entities": []}], ["Eleven bibliographic databases were searched from inception to July 2013 and studies were assessed for eligibility against a set of pre-defined criteria.", {"entities": []}], ["Two reviewers screened references, extracted data from included studies and appraised their quality.", {"entities": []}], ["An advisory group was consulted about the choice of interventions.", {"entities": []}], ["A narrative review was undertaken and where feasible fixed effect and random effects meta-analysis were undertaken including a network meta-analysis (NMA).", {"entities": []}], ["A decision-analytic Markov model was developed to estimate cost-effectiveness of pharmacological treatments for IPF.", {"entities": []}], ["Following best practice recommendations, the model perspective was of the national health service and personal social services, a discount rate of 3.5% for costs and health benefits was applied and outcomes were expressed as cost per quality adjusted life-year gained.", {"entities": []}], ["Parameter values were obtained from the NMA and systematic reviews.", {"entities": []}], ["Sensitivity analyses were undertaken.", {"entities": []}], ["Fourteen studies were included in the review of clinical effectiveness, of which one evaluated azathioprine, three N-acetylcysteine [NAC] (alone or in combination), four pirfenidone, one nintedanib, one sildenafil, one thalidomide, two pulmonary rehabilitation, and one a disease management programme.", {"entities": []}], ["Study quality was generally good.", {"entities": []}], ["Evidence suggests that some effective treatments are available.", {"entities": []}], ["In NMA only nintedanib and pirfenidone show statistically significant improvements.", {"entities": []}], ["The model results show increased survival for five pharmacological treatments (NAC triple therapy, inhaled NAC, nintedanib, pirfenidone, and sildenafil) compared with best supportive care, at increased cost.", {"entities": []}], ["Only inhaled NAC was cost-effective at current willingness to pay thresholds but it may not be clinically effective.", {"entities": []}], ["Few interventions have any statistically significant effect and the cost-effectiveness of treatments is uncertain.", {"entities": []}], ["A lack of studies on palliative care approaches was identified and there is a need for further research into pulmonary rehabilitation and thalidomide in particular.", {"entities": []}], ["A well conducted RCT on inhaled NAC therapy should also be considered.", {"entities": []}], ["The online version of this article (doi:10.1186/2050-6511-15-63) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pulmonary arterial hypertension (PAH) is a life-threatening disease which, if untreated, leads to right ventricular failure and often death.", {"entities": [[19, 31, "DISEASE"]]}], ["Several effective therapies are now available for PAH, including endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs.", {"entities": []}], ["The prostacyclin analog treprostinil has proven efficacious when delivered by subcutaneous or intravenous infusion, and most recently by inhalation.", {"entities": []}], ["Inhaled treprostinil has been shown to be 64%\u201372% bioavailable in healthy volunteers.", {"entities": []}], ["Pilot clinical studies have elucidated the acute hemodynamic effects and relative pulmonary selectivity of this agent, as well as established target dosing in PAH and nonoperable chronic thromboembolic PAH.", {"entities": []}], ["Likewise, chronically administered inhaled treprostinil resulted in clinical and hemodynamic improvement.", {"entities": []}], ["Both pilot studies confirmed a satisfactory safety profile in patients with PAH.", {"entities": []}], ["The pivotal Phase III trial, TRIUMPH-I, demonstrated the efficacy and safety of inhaled treprostinil (target dose of 54 \u03bcg four times daily) in PAH patients added to background therapies of bosentan or sildenafil, as assessed by improvements in the primary endpoint, peak six-minute walk distance (median placebo-corrected treatment effect of 20 m), as well as select secondary endpoints.", {"entities": []}], ["Inhaled treprostinil is approved by the US Food and Drug Administration for patients with World Health Organization Group I PAH to improve exercise ability.", {"entities": []}], ["Studies establishing effectiveness included predominately patients with New York Heart Association functional class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%).", {"entities": []}], ["In recent years the greatest progress in our understanding of pneumoconioses, other than those produced by asbestos, silica, and coal, has been in the arena of metal-induced parenchymal lung disorders.", {"entities": []}], ["Inhalation of metal dusts and fumes can induce a wide range of lung pathology, including airways disorders, cancer, and parenchymal diseases.", {"entities": [[108, 114, "DISEASE"]]}], ["The emphasis of this update is on parenchymal diseases caused by metal inhalation, including granulomatous disease, giant cell interstitial pneumonitis, chemical pneumonitis, and interstitial fibrosis, among others.", {"entities": []}], ["The clinical characteristics, epidemiology, and pathogenesis of disorders arising from exposure to aluminum, beryllium, cadmium, cobalt, copper, iron, mercury, and nickel are presented in detail.", {"entities": []}], ["Metal fume fever, an inhalation fever syndrome attributed to exposure to a number of metals, is also discussed.", {"entities": [[38, 46, "DISEASE"]]}], ["Advances in our knowledge of antigen-specific immunologic reactions in the lung are particularly evident in disorders secondary to beryllium and nickel exposure, where immunologic mechanisms have been well characterized.", {"entities": []}], ["For example, current evidence suggests that beryllium acts as an antigen, or hapten, and is presented by antigen-presenting cells to CD4+ T cells, which possess specific surface antigen receptors.", {"entities": []}], ["Other metals such as cadmium and mercury induce nonspecific damage, probably by initiating production of reactive oxygen species.", {"entities": []}], ["Additionally, genetic susceptibility markers associated with increased risk have been identified in some metal-related diseases such as chronic beryllium disease and hard metal disease.", {"entities": []}], ["Future research needs include development of biologic markers of metal-induced immunologic disease, detailed characterization of human exposure, examination of gene alleles that might confer risk, and association of exposure data with that of genetic susceptibility.", {"entities": []}], ["The Necessity-Concerns Framework (NCF) posits that non-adherence to inhaled corticosteroids (ICS) in asthma is influenced by doubts about the necessity for ICS and concerns about their potential adverse effects.", {"entities": [[101, 107, "DISEASE"]]}], ["This feasibility study examined whether these beliefs could be changed by briefing asthma nurse specialists on ways of addressing necessity beliefs and concerns within consultations.", {"entities": [[83, 89, "DISEASE"]]}], ["Pre-post intervention study.", {"entities": []}], ["Secondary care.", {"entities": []}], ["Patients with a diagnosis of moderate to severe asthma who were prescribed daily ICS were recruited to either a hospital care group (n=79; 71.0% female) or intervention group (n=57; 66.7% female).", {"entities": [[48, 54, "DISEASE"]]}], ["Asthma nurse specialists attended a 1.5-day NCF briefing.", {"entities": [[0, 6, "DISEASE"]]}], ["Beliefs about ICS (primary outcome) and self-reported adherence were measured preconsultation and 1\u2005month postconsultation.", {"entities": []}], ["Participants also rated their satisfaction with their consultations immediately after the consultation.", {"entities": []}], ["Consultation recordings were coded to assess intervention delivery.", {"entities": []}], ["After the NCF briefing, nurse specialists elicited and addressed beliefs about medicine more frequently.", {"entities": []}], ["The frequency of using the NCF remained low, for example, open questions eliciting adherence were used in 0/59 hospital care versus 14/49 (28.6%) intervention consultations.", {"entities": []}], ["Doubts about personal necessity for, and concerns about, ICS were reduced at 1 month postbriefing (p<0.05), but the intervention was not applied extensively enough to improve adherence.", {"entities": []}], ["The intervention changed nurse consultations, but not sufficiently enough to fully address non-adherence or adherence-related ICS beliefs (necessity and concerns).", {"entities": []}], ["More effective techniques are needed to support nurse specialists and other practitioners to apply the intervention in hospital asthma review consultations.", {"entities": [[128, 134, "DISEASE"]]}], ["Recalcitrant chronic rhinosinusitis without polyposis (CRSsP) is a challenging condition to manage as traditional medical therapies and surgery fail to provide satisfactory clinical improvements.", {"entities": []}], ["Colloidal silver (CS), a widely used naturopathic agent, has recently shown anti-biofilm properties both in vitro and within a rhinosinusitis animal model.", {"entities": [[18, 20, "GENE"]]}], ["To date, no trials involving humans have been published in world literature.", {"entities": []}], ["The purpose of this study was to assess the efficacy of CS as a topical nasal spray in patients with refractory CRSsP.", {"entities": [[56, 58, "GENE"]]}], ["A prospective cohort study was conducted using a convenience sample of 20 randomized patients with crossover methodology, comparing nasal sprays with CS versus saline.", {"entities": [[150, 152, "GENE"]]}], ["Patients sprayed twice daily for six weeks with the first intervention and then switched to the second for the next six weeks, with measurements made at baseline and each time point.", {"entities": []}], ["Primary outcomes were changes in SNOT-22 and Lund-Kennedy (LK) endoscopic scores.", {"entities": []}], ["All analysis was non-parametric and was conducted using STATA 14.", {"entities": []}], ["Twenty-two patients were enrolled in the study with 20 completing the entire protocol.", {"entities": []}], ["Mean 6-week change in SNOT-22 scores were \u22122.8 and 1.0 for saline and CS, respectively ( p \u2009=\u20090.373).", {"entities": [[70, 72, "GENE"]]}], ["Similarly, mean 6-week change in LK scores were \u22121.4 and \u22121.1 for saline and CS, respectively ( p \u2009=\u20090.794).", {"entities": [[77, 79, "GENE"]]}], ["Significant period effects were observed with the SNOT-22 score between the randomized groups.", {"entities": []}], ["No participants experienced negative health effects directly attributable to the administration of intranasal CS.", {"entities": [[110, 112, "GENE"]]}], ["Commercially available CS nasal spray did not demonstrate any meaningful subjective or objective improvements in patients with recalcitrant CRSsP.", {"entities": [[23, 25, "GENE"]]}], ["NCT02403479 .", {"entities": []}], ["Registered on March 1, 2015.", {"entities": []}], ["Muscle co-activation plays an important role in enhancing joint stability for movement regulation during motor learning activities.", {"entities": []}], ["In normal aging, greater muscle co-activation is induced during gait in elderly adults.", {"entities": []}], ["This study investigated age-related changes in muscle co-activation and spatio-temporal parameters during gait and identified the relationship between muscle co-activation and gait speed.", {"entities": []}], ["A total of 46 adult volunteers participated in this study in three age groups (15 young adults [8 males, 7 females; age, 24.27\u2009\u00b1\u20092.71], 15 middle-aged adults [8 males, 7 females; age, 53.71\u2009\u00b1\u20092.52], and 16 elderly adults [7 males, 9 females; age, 76.88\u2009\u00b1\u20093.48]).", {"entities": []}], ["All participants underwent locomotion analysis using a Three-dimensional motion analysis system and 12-channel dynamic electromyography.", {"entities": []}], ["The elderly adults showed significantly higher co-activation than the young and middle-aged adults during gait ( p \u2009<\u20090.05).", {"entities": []}], ["In contrast, elderly adults showed significantly lower trunk co-activation than the young and middle-aged adults ( p \u2009<\u20090.05).", {"entities": []}], ["Muscle co-activation was significantly correlated with gait speed by aging.", {"entities": []}], ["Muscle co-activation of the trunk showed a significant positive correlation with gait speed based on age.", {"entities": []}], ["However, muscle co-activation of the lower extremity showed a significant negative correlation with gait speed based on age.", {"entities": []}], ["This finding demonstrated that less muscle co-activation of the trunk was related to locomotive instability in elderly adults.", {"entities": []}], ["Therefore, clarification of the relationship between trunk co-activation and locomotor instability will be helpful for developing optimal rehabilitation of elderly people to prevent fall.", {"entities": []}], ["Exposure to particulate matter (PM) air pollution has been shown to exacerbate children's asthma, but the exposure sources and temporal characteristics are still under study.", {"entities": [[90, 96, "DISEASE"]]}], ["Children's exposure to PM is likely to involve both combustion-related ambient PM and PM related to a child's activity in various indoor and outdoor microenvironments.", {"entities": []}], ["Among 19 children with asthma, 9-17 years of age, we examined the relationship of temporal changes in percent predicted forced expiratory volume in 1 sec (FEV1) to personal continuous PM exposure and to 24-hr average gravimetric PM mass measured at home and central sites.", {"entities": [[23, 29, "DISEASE"]]}], ["Subjects were followed for 2 weeks during either the fall of 1999 or the spring of 2000, in a southern California region affected by transported air pollution.", {"entities": []}], ["FEV(subscript)1(/subscript) was measured by subjects in the morning, afternoon, and evening.", {"entities": [[0, 3, "GENE"]]}], ["Exposure measurements included continuous PM using a passive nephelometer carried by subjects; indoor, outdoor home, and central-site 24-hr gravimetric PM2.5 (PM of aerodynamic diameter < 2.5 microm) and PM10; and central-site hourly PM10, nitrogen dioxide, and ozone.", {"entities": []}], ["Data were analyzed with linear mixed models controlling for within-subject autocorrelation, FEV1 maneuver time, and exposure period.", {"entities": []}], ["We found inverse associations of FEV1 with increasing PM exposure during the 24 hr before the FEV1 maneuver and with increasing multiday PM averages.", {"entities": [[80, 82, "GENE"]]}], ["Deficits in percent predicted FEV1 (95% confidence interval) for given PM interquartile ranges measured during the preceding 24-hr were as follows: 128 microg/m3 1-hr maximum personal PM, -6.0% (-10.5 to -1.4); 30 microg/m3 24-hr average personal PM, -5.9% (-10.8 to -1.0); 6.7 microg/m3 indoor home PM2.5, -1.6% (-2.8 to -0.4); 16 microg/m3 indoor home PM10, -2.1% (-3.7 to -0.4); 7.1 microg/m3 outdoor home PM2.5, -1.1% (-2.4 to 0.1); and 7.5 microg/m3 central-site PM2.5, -0.7% (-1.9 to 0.4).", {"entities": []}], ["Stronger associations were found for multiday moving averages of PM for both personal and stationary-site PM.", {"entities": []}], ["Stronger associations with personal PM were found in boys allergic to indoor allergens.", {"entities": []}], ["FEV1 was weakly associated with NO2 but not with O3.", {"entities": []}], ["Results suggest mixed respiratory effects of PM in asthmatic children from both ambient background exposures and personal exposures in various microenvironments.", {"entities": []}], ["The authors assessed sex and age differences in secondhand smoke (SHS) exposure among vulnerable adolescent populations.", {"entities": []}], ["Data from the 2013 Korea Youth Risk Behavior Web-based Survey of 64,499 non-smokers aged 13\u201318 years were analyzed using multiple logistic regression.", {"entities": []}], ["Girls were exposed 1.26 times (95% confidence interval, 1.21\u20131.32) more to home SHS than boys, and the younger adolescents were more likely to be exposed to home SHS than were the older, regardless of sex ( p < 0.001).", {"entities": []}], ["Younger girls living with or without current smokers and the younger boys living with current smokers were more likely to be exposed to SHS at home, when the data were stratified according to current household member smoking, which was one of the main risk factors for SHS exposure at home.", {"entities": []}], ["Girls living with current smokers were more likely to be exposed to SHS at home than boys regardless age.", {"entities": []}], ["Girls and younger adolescents, populations vulnerable to smoke exposure, were more likely to be exposed to SHS at home, even though they should be more protected.", {"entities": []}], ["It is necessary to improve home SHS awareness, especially among these vulnerable populations.", {"entities": []}], ["Oncolytic adenoviruses are modified based on adenovirus serotype 5 (Ad5), which belongs to subgroup C and depends on Coxsackie-adenovirus receptor (CAR) to recognize target cells.", {"entities": []}], ["However, expression of CAR is generally low or lost in certain tumors including hepatocellular carcinoma (HCC).", {"entities": [[80, 104, "DISEASE"], [95, 104, "DISEASE"]]}], ["By contrast, CD46 is highly expressed in various types of malignant tumor cells.", {"entities": [[13, 17, "GENE"]]}], ["Therefore, we constructed an adenovirus vector expressing the human RANTES/CCL5 gene regulated by oxygen-dependent degradation domain (ODD) and analyzed its antitumor effects in vitro and in vivo .", {"entities": []}], ["The human RANTES/CCL5 gene was fused with ODD by PCR and the recombinant oncolytic adenovirus containing RANTES-ODD, SG511-CCL5-ODD, was constructed by the Gateway system, which infected cells by binding CD46.", {"entities": [[204, 208, "GENE"]]}], ["Viral replication experiments were performed to evaluate the selective replication ability of SG511-CCL5-ODD.", {"entities": []}], ["RANTES expression was determined by ELISA.", {"entities": []}], ["The chemotactic test was used to analyze the ability of the expressed RANTES to recruit NK92 cells.", {"entities": []}], ["The antitumor effects of SG511-CCL5-ODD were examined in HCC xenografts in nude mice.", {"entities": []}], ["A chimeric oncolytic adenovirus, SG511-CCL5-ODD, was constructed successfully.", {"entities": []}], ["Cells infected with the recombinant virus were able to express RANTES selectively in different environments controlled by ODD and the expressed RANTES was able to recruit NK92 cells by its chemotactic effect in vitro and improve the anticancer immune response in HCC xenografts in nude mice.", {"entities": []}], ["The chimeric adenovirus SG511-CCL5-ODD highly expressed the RANTES-ODD fusion gene in the hypoxia of HCC under the control of the ODD and effectively attracted NK92 cells and a high number of immunocytes.", {"entities": []}], ["These factors had complementary advantages and, in combination, exerted enhanced antitumor efficacy.", {"entities": []}], ["Although many studies have demonstrated the benefits of reminder/recall (RR) measures to address patient under-immunization and improve immunization coverage, they are not widely implemented by healthcare providers.", {"entities": []}], ["We identified providers\u2019 perceived barriers to their use from existing literature.", {"entities": []}], ["We conducted a systematic review of relevant articles published in English between January 1990 and July 2011 that examined the perceptions of healthcare providers regarding barriers to tracking patient immunization history and implementing RR interventions.", {"entities": []}], ["We searched MEDLINE, PubMed, EMBASE, Cumulative Index to Nursing and Allied Health Literature, Academic Search Premier, and PsychINFO.", {"entities": []}], ["Additional strategies included hand-searching the references of pertinent articles and related reviews, and searching keywords in Google Scholar and Google.", {"entities": []}], ["Ten articles were included; all described populations in the United States, and examined perceptions of family physicians, pediatricians, and other immunization staff.", {"entities": []}], ["All articles were of moderate-high methodological quality; the majority (n=7) employed survey methodology.", {"entities": []}], ["The most frequently described barriers involved the perceived human and financial resources associated with implementing an RR intervention, as well as low confidence in the accuracy of patient immunization records, given the lack of data sharing between multiple immunization providers.", {"entities": []}], ["Changes to staff workflow, lack of appropriate electronic patient-tracking functionalities, and uncertainty regarding the success of RR interventions were also viewed as barriers to their adoption.", {"entities": []}], ["Although transitioning to electronic immunization records and registries should facilitate the implementation of RR interventions, numerous perceived barriers must still be overcome before the full benefits of these methods can be realized.", {"entities": []}], ["Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common chronic mental health condition in children and adolescents.", {"entities": []}], ["The application of health-related quality of life (HRQOL) as a pediatric population health measure may facilitate risk assessment and resource allocation, the identification of health disparities, and the determination of health outcomes from interventions and policy decisions for children and adolescents with ADHD at the local community, state, and national health level.", {"entities": []}], ["An analysis from an existing statewide database to determine the feasibility, reliability, and validity of the 23-item PedsQL\u2122 4.0 (Pediatric Quality of Life Inventory\u2122) Generic Core Scales as a patient-reported outcome (PRO) measure of pediatric population health for children and adolescents with ADHD.", {"entities": []}], ["The PedsQL\u2122 4.0 Generic Core Scales (Physical, Emotional, Social, School Functioning) were completed by families through a statewide mail survey to evaluate the HRQOL of new enrollees in the State of California State's Children's Health Insurance Program (SCHIP).", {"entities": []}], ["Seventy-two children ages 5\u201316 self-reported their HRQOL.", {"entities": []}], ["The PedsQL\u2122 4.0 evidenced minimal missing responses, achieved excellent reliability for the Total Scale Score (\u03b1 = 0.92 child self-report, 0.92 parent proxy-report), and distinguished between healthy children and children with ADHD.", {"entities": []}], ["Children with ADHD self-reported severely impaired psychosocial functioning, comparable to children with newly-diagnosed cancer and children with cerebral palsy.", {"entities": [[146, 160, "DISEASE"], [121, 127, "DISEASE"]]}], ["The results suggest that population health monitoring may identify children with ADHD at risk for adverse HRQOL.", {"entities": []}], ["The implications of measuring pediatric HRQOL for evaluating the population health outcomes of children with ADHD internationally are discussed.", {"entities": []}], ["Public health interventions have received increased attention from policy makers, and there has been a corresponding increase in the number of economic evaluations within the domain of public health.", {"entities": []}], ["However, methods to evaluate public health interventions are less well established than those for medical interventions.", {"entities": []}], ["Focusing on health as an outcome measure is likely to underestimate the impact of many public health interventions.", {"entities": []}], ["This paper provides a review of outcome measures in public health; and describes the benefits of using the capability approach as a means to developing an all encompassing outcome measure.", {"entities": []}], ["Background .", {"entities": []}], ["Inflammation and remodeling are integral parts of asthma pathophysiology.", {"entities": [[50, 56, "DISEASE"]]}], ["We sought to describe the clinical and pathologic features of near fatal asthma exacerbation (NFE).", {"entities": [[73, 79, "DISEASE"]]}], ["Bronchial biopsies were collected prospectively from NFE I subjects.", {"entities": []}], ["Another NFE II group and a moderate severity exacerbation control group (ME II) were retrospectively identified\u2014no biopsies obtained.", {"entities": []}], ["All NFE II ( n = 9) subjects exhibited remodeling and significant inflammation (eosinophilic, neutrophilic).", {"entities": []}], ["NFE II group ( n = 37) had a significant history of prior intubation and inhaled corticosteroids usage compared to ME II group ( n = 41).", {"entities": []}], ["They also exhibited leukocytosis, eosinophilia, and longer hospitalization days.", {"entities": [[34, 46, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Remodeling, eosinophilic, and neutrophilic inflammation were observed in NFE.", {"entities": []}], ["NFE is associated with prior intubation and inhaled corticosteroids usage.", {"entities": []}], ["Overuse of short-acting bronchodilators is internationally recognised as a marker of poor asthma control, high healthcare use and increased risk of asthma death.", {"entities": [[90, 96, "DISEASE"], [148, 154, "DISEASE"]]}], ["Young adults with asthma commonly overuse short-acting bronchodilators.", {"entities": [[18, 24, "DISEASE"]]}], ["We sought to determine the reasons for overuse of bronchodilator inhalers in a sample of young adults with asthma.", {"entities": [[107, 113, "DISEASE"]]}], ["Qualitative study using a purposive extreme case sample.", {"entities": []}], ["A large urban UK general practice.", {"entities": []}], ["Twenty-one adults with moderate asthma, aged 20\u201332\u2005years.", {"entities": [[32, 38, "DISEASE"]]}], ["Twelve were high users of short-acting bronchodilators, nine were low users.", {"entities": []}], ["Asthma had a major impact on respondents\u2019 lives, disrupting their childhood, family life and career opportunities.", {"entities": [[0, 6, "DISEASE"]]}], ["High users of short-acting bronchodilators had adapted poorly to having asthma and expressed anger at the restrictions they experienced.", {"entities": [[72, 78, "DISEASE"]]}], ["Overuse made sense to them: short-acting bronchodilators were a rapid, effective, cheap \u2018quick-fix\u2019 for asthma symptoms.", {"entities": [[104, 110, "DISEASE"]]}], ["High users had poorer control of asthma and held explanatory models of asthma which emphasised short-term relief via bronchodilation over prevention.", {"entities": [[33, 39, "DISEASE"], [71, 77, "DISEASE"]]}], ["Both high and low users held strong views about having to pay for asthma medication, with costs cited as a reason for not purchasing anti-inflammatory inhalers.", {"entities": [[66, 72, "DISEASE"]]}], ["Young adults who were high users of short-acting bronchodilators had adapted poorly to having asthma and had poor asthma control.", {"entities": [[94, 100, "DISEASE"], [114, 120, "DISEASE"]]}], ["They gave coherent reasons for overuse.", {"entities": []}], ["Strategies that might address high bronchodilator use in young adults include improving education to help young people accept and adapt to their illness, reducing stigmatisation and providing free asthma medication to encourage the use of anti-inflammatory inhalers.", {"entities": [[197, 203, "DISEASE"]]}], ["Population aging is closely related to high prevalence of chronic conditions in developed countries.", {"entities": []}], ["In this context, health care policies aim to increase life span cost-effectively while maintaining quality of life and functional ability.", {"entities": []}], ["There is still, however, a need for further understanding of how chronic conditions affect these health aspects.", {"entities": []}], ["The aim of this paper is to assess the individual and combined impact of chronic physical and mental conditions on quality of life and disability in Spain, and secondly to show gender trends.", {"entities": []}], ["Cross-sectional data were collected from the COURAGE study.", {"entities": []}], ["A total of 3,625 participants over 50 years old from Spain were included.", {"entities": []}], ["Crude and adjusted multiple linear regressions were conducted to detect associations between individual chronic conditions and disability, and between chronic conditions and quality of life.", {"entities": []}], ["Separate models were used to assess the influence of the number of diseases on the same variables.", {"entities": []}], ["Additional analogous regressions were performed for males and females.", {"entities": []}], ["All chronic conditions except hypertension were statistically associated with poor results in quality of life and disability.", {"entities": [[30, 42, "DISEASE"]]}], ["Depression, anxiety and stroke were found to have the greatest impact on outcomes.", {"entities": []}], ["The number of chronic conditions was associated with substantially lower quality of life [\u03b2 for 4+ diseases: \u221218.10 (\u221220.95,\u221215.25)] and greater disability [\u03b2 for 4+ diseases: 27.64 (24.99,30.29].", {"entities": []}], ["In general, women suffered from higher rates of multimorbidity and poorer results in quality of life and disability.", {"entities": []}], ["Chronic conditions impact greatly on quality of life and disability in the older Spanish population, especially when co-occurring diseases are added.", {"entities": []}], ["Multimorbidity considerations should be a priority in the development of future health policies focused on quality of life and disability.", {"entities": []}], ["Further studies would benefit from an expanded selection of diseases.", {"entities": []}], ["Policies should also deal with gender idiosyncrasy in certain cases.", {"entities": []}], ["Acute lung injury (ALI) is a serious respiratory disorder for which therapy is primarily supportive once infection is excluded.", {"entities": []}], ["Surgical lung biopsy may rule out other diagnoses, but has not been generally useful for therapy decisions or prognosis in this setting.", {"entities": []}], ["Importantly, tissue and peripheral blood eosinophilia, the hallmarks of steroid-responsive acute eosinophilic pneumonia, are not commonly linked with ALI.", {"entities": [[110, 119, "DISEASE"], [97, 119, "DISEASE"], [41, 53, "DISEASE"]]}], ["We hypothesized that occult eosinophilic pneumonia may explain better outcomes for some patients with ALI.", {"entities": [[41, 50, "DISEASE"], [28, 50, "DISEASE"]]}], ["Immunohistochemistry using a novel monoclonal antibody recognizing eosinophil peroxidase ( EPX-mAb ) was used to assess intrapulmonary eosinophil accumulation/degranulation.", {"entities": []}], ["Lung biopsies from ALI patients ( n = 20) were identified following review of a pathology database; 45% of which (i.e., 9/20) displayed classical diffuse alveolar damage (ALI-DAD).", {"entities": []}], ["Controls were obtained from uninvolved tissue in patients undergoing lobectomy for lung cancer ( n = 10).", {"entities": [[83, 94, "DISEASE"], [88, 94, "DISEASE"]]}], ["Serial biopsy sections were stained with hematoxylin and eosin ( H&E ) and subjected to EPX-mAb immunohistochemistry.", {"entities": []}], ["EPX-mAb immunohistochemistry provided a >40-fold increased sensitivity to detect eosinophils in the lung relative to H&E stained sections.", {"entities": []}], ["This increased sensitivity led to the identification of higher numbers of eosinophils in ALI patients compared with controls; differences using H&E staining alone were not significant.", {"entities": []}], ["Clinical assessments showed that lung infiltrating eosinophil numbers were higher in ALI patients that survived hospitalization compared with non-survivors.", {"entities": []}], ["A similar conclusion was reached quantifying eosinophil degranulation in each biopsy.", {"entities": []}], ["The enhanced sensitivity of EPX-mAb immunohistochemistry uniquely identified eosinophil accumulation/degranulation in patients with ALI relative to controls.", {"entities": []}], ["More importantly, this method was a prognostic indicator of patient survival.", {"entities": []}], ["These observations suggest that EPX-mAb immunohistochemistry may represent a diagnostic biomarker identifying a subset of ALI patients with improved clinical outcomes.", {"entities": []}], ["Elastin gene mutations have been associated with a variety of phenotypes.", {"entities": []}], ["Autosomal dominant cutis laxa (ADCL) is a rare disorder that presents with lax skin, typical facial characteristics, inguinal hernias, aortic root dilatation and pulmonary emphysema.", {"entities": [[19, 29, "DISEASE"], [162, 181, "DISEASE"]]}], ["In most patients, frameshift mutations are found in the 3\u2019 region of the elastin gene (exons 30-34) which result in a C-terminally extended protein, though exceptions have been reported.", {"entities": []}], ["We clinically and molecularly characterized the thus far largest cohort of ADCL patients, consisting of 19 patients from six families and one sporadic patient.", {"entities": []}], ["Molecular analysis showed C-terminal frameshift mutations in exon 30, 32, and 34 of the elastin gene and identified a mutational hotspot in exon 32 (c.2262delA).", {"entities": []}], ["This cohort confirms the previously reported clinical constellation of skin laxity (100%), inguinal hernias (51%), aortic root dilatation (55%) and emphysema (37%).", {"entities": []}], ["ADCL is a clinically and molecularly homogeneous disorder, but intra- and interfamilial variability in the severity of organ involvement needs to be taken into account.", {"entities": []}], ["Regular cardiovascular and pulmonary evaluations are imperative in the clinical follow-up of these patients.", {"entities": []}], ["Gene expression patterns can provide vital clues to the pathogenesis of neoplastic diseases.", {"entities": []}], ["We investigated the expression of 950 genes in Hodgkin's disease (HD) by analyzing differential mRNA expression using microarrays.", {"entities": []}], ["In two independent microarray experiments, the HD-derived cell lines L428 and KMH2 were compared with an Epstein-Barr virus (EBV)-immortalized lymphoblastoid B cell line, LCL-GK.", {"entities": []}], ["Interleukin (IL)-13 and IL-5 were found to be highly expressed in the HD-derived cell lines.", {"entities": []}], ["Examination of IL-13 and IL-5 expression by Northern blot analysis and enzyme-linked immunosorbent assay confirmed these results and revealed the expression of IL-13 in a third HD-derived cell line, HDLM2.", {"entities": []}], ["Control LCL and EBV-negative non-Hodgkin lymphoma\u2013derived cell lines did not express IL-13.", {"entities": [[41, 49, "DISEASE"]]}], ["In situ hybridization of lymph node tissue from HD patients showed that elevated levels of IL-13 were specifically expressed by Hodgkin/Reed-Sternberg (H/RS) tumor cells.", {"entities": []}], ["Treatment of a HD-derived cell line with a neutralizing antibody to IL-13 resulted in a dose-dependent inhibition of H/RS cell proliferation.", {"entities": []}], ["These data suggest that H/RS cells produce IL-13 and that IL-13 plays an important role in the stimulation of H/RS cell growth, possibly by an autocrine mechanism.", {"entities": []}], ["Modulation of the IL-13 signaling pathway may be a logical objective for future therapeutic strategies.", {"entities": []}], ["Reactive oxygen species (ROS) play an important pathogenic role in the development of many diseases, including kidney disease.", {"entities": [[111, 125, "DISEASE"]]}], ["Major ROS generators in the glomerulus of the kidney are the p47phox-containing NAPDH oxidases NOX1 and NOX2.", {"entities": [[95, 99, "GENE"]]}], ["The cytosolic p47phox subunit is a key regulator of the assembly and function of NOX1 and NOX2 and its expression and phosphorylation are up-regulated in the course of renal injury, and have been shown to exacerbate diabetic nephropathy.", {"entities": [[81, 85, "GENE"]]}], ["However, its role in non-diabetic-mediated glomerular injury is unclear.", {"entities": []}], ["To address this, we subjected p47phox-null mice to either adriamycin-mediated or partial renal ablation-mediated glomerular injury.", {"entities": []}], ["Deletion of p47phox protected the mice from albuminuria and glomerulosclerosis in both injury models.", {"entities": []}], ["Integrin \u03b11-null mice develop more severe glomerulosclerosis than wild type mice in response to glomerular injury mainly due to increased production of ROS.", {"entities": []}], ["Interestingly, the protective effects of p47phox knockout were more profound in p47phox/integrin \u03b11 double knockout mice.", {"entities": []}], ["I n vitro analysis of primary mesangial cells showed that deletion of p47phox led to reduced basal levels of superoxide and collagen IV production.", {"entities": []}], ["Thus, p47phox-dependent NADPH oxidases are a major glomerular source of ROS, contribute to kidney injury, and are potential targets for antioxidant therapy in fibrotic disease.", {"entities": []}], ["There is considerable variability in the susceptibility of smokers to develop chronic obstructive pulmonary disease (COPD).", {"entities": [[78, 115, "DISEASE"]]}], ["The only known genetic risk factor is severe deficiency of \u03b1 1 -antitrypsin, which is present in 1\u20132% of individuals with COPD.", {"entities": []}], ["We conducted a genome-wide association study (GWAS) in a homogenous case-control cohort from Bergen, Norway (823 COPD cases and 810 smoking controls) and evaluated the top 100 single nucleotide polymorphisms (SNPs) in the family-based International COPD Genetics Network (ICGN; 1891 Caucasian individuals from 606 pedigrees) study.", {"entities": []}], ["The polymorphisms that showed replication were further evaluated in 389 subjects from the US National Emphysema Treatment Trial (NETT) and 472 controls from the Normative Aging Study (NAS) and then in a fourth cohort of 949 individuals from 127 extended pedigrees from the Boston Early-Onset COPD population.", {"entities": []}], ["Logistic regression models with adjustments of covariates were used to analyze the case-control populations.", {"entities": []}], ["Family-based association analyses were conducted for a diagnosis of COPD and lung function in the family populations.", {"entities": []}], ["Two SNPs at the \u03b1-nicotinic acetylcholine receptor (CHRNA 3/5) locus were identified in the genome-wide association study.", {"entities": []}], ["They showed unambiguous replication in the ICGN family-based analysis and in the NETT case-control analysis with combined p -values of 1.48\u00d710 PLoS Genetics ; doi:10.1371/journal.pgen.1000429).", {"entities": []}], ["The CHRNA 3/5 and the HHIP loci make a significant contribution to the risk of COPD.", {"entities": [[22, 26, "GENE"]]}], ["CHRNA3/5 is the same locus that has been implicated in the risk of lung cancer.", {"entities": [[67, 78, "DISEASE"], [72, 78, "DISEASE"]]}], ["There is considerable variability in the susceptibility of smokers to develop chronic obstructive pulmonary disease (COPD), which is a heritable multi-factorial trait.", {"entities": [[78, 115, "DISEASE"]]}], ["Identifying the genetic determinants of COPD risk will have tremendous public health importance.", {"entities": []}], ["This study describes the first genome-wide association study (GWAS) in COPD.", {"entities": []}], ["We conducted a GWAS in a homogenous case-control cohort from Norway and evaluated the top 100 single nucleotide polymorphisms in the family-based International COPD Genetics Network.", {"entities": []}], ["The polymorphisms that showed replication were further evaluated in subjects from the US National Emphysema Treatment Trial and controls from the Normative Aging Study and then in a fourth cohort of extended pedigrees from the Boston Early-Onset COPD population.", {"entities": []}], ["Two polymorphisms in the \u03b1-nicotinic acetylcholine receptor 3/5 locus on chromosome 15 showed unambiguous evidence of association with COPD.", {"entities": []}], ["This locus has previously been implicated in both smoking behavior and risk of lung cancer, suggesting the possibility of multiple functional polymorphisms in the region or a single polymorphism with wide phenotypic consequences.", {"entities": [[79, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["The hedgehog interacting protein (HHIP) locus on chromosome 4, which is associated with COPD, is also a significant risk locus for COPD.", {"entities": [[34, 38, "GENE"]]}], ["Indoor air pollution from biomass fuel use has been found to be responsible for more than 1.6 million annual deaths and 2.7% of the global burden of disease.", {"entities": []}], ["This makes it the second biggest environmental contributor to ill health, behind unsafe water and sanitation.", {"entities": []}], ["The main objective of this study was to investigate if there was any association between use of bio-fuels in food catering enterprises and respiratory health of the workers.", {"entities": []}], ["A cross-sectional design was employed, and data collected using Qualitative and quantitative techniques.", {"entities": []}], ["The study found significantly higher prevalence of respiratory health outcomes among respondents in enterprises using biomass fuels compared to those using processed fuels.", {"entities": []}], ["Biomass fuels are thus a major public health threat to workers in this sub-sector, and urgent intervention is required.", {"entities": []}], ["The study recommends a switch from biomass fuels to processed fuels to protect the health of the workers.", {"entities": []}], ["The California Health Interview Survey, the largest state health survey in the United States, uses community-based participatory research principles to develop each cycle.", {"entities": []}], ["Other large-scale health surveys rarely include participatory research approaches.", {"entities": []}], ["Every 2 years, the California Health Interview Survey generates state and local population-based data on health insurance coverage, access to health care, chronic disease prevalence and management, health behaviors and disease prevention, and other health issues in California.", {"entities": []}], ["The survey is used for policy and program development, advocacy, and research.", {"entities": []}], ["The development of the California Health Interview Survey involves more than 145 people from more than 60 state and local policymaking bodies, public health agencies, advocacy groups, research organizations, and health care organizations.", {"entities": []}], ["They participate as volunteers in an advisory board, on technical advisory committees, and in work groups that interact with California Health Interview Survey research staff in an accountable advisory process that shapes survey topics, measures, and sample design and determines languages selected for translation.", {"entities": []}], ["Survey results and data are provided to the communities involved in the survey.", {"entities": []}], ["California Health Interview Survey data have been widely used by local, state, and national public health leaders, policymakers, advocates, and researchers to improve access to health insurance and health care services and to develop and target prevention programs for obesity and chronic illnesses.", {"entities": [[269, 276, "DISEASE"]]}], ["The California Health Interview Survey participatory research model has been an effective approach to planning and implementing a health survey and should be considered by developers of other large health surveys.", {"entities": []}], ["Hyaluronan (HA), a long-chain polysaccharide, is currently being evaluated as a potential therapeutic agent for a number of inflammatory disorders.", {"entities": []}], ["The effect of HA on inflammation appears to be related to its molecular size, with larger polysaccharide chains having anti-inflammatory activity and smaller ones having proinflammatory properties.", {"entities": []}], ["This dichotomous behavior is particularly relevant to the work of our laboratory on an aerosolized preparation of HA to treat pulmonary emphysema.", {"entities": [[126, 145, "DISEASE"]]}], ["The breakdown of inhaled HA into smaller fragments could possibly induce an inflammatory reaction in the lung that counteracts any beneficial effect.", {"entities": []}], ["Consequently, the proposed therapeutic use of HA will require development of treatment strategies aimed at minimizing its proinflammatory activity.", {"entities": []}], ["Inflammation is a series of complex biological responses to protect the host from pathogen invasion.", {"entities": []}], ["Chronic inflammation is considered a major cause of diseases, such as various types of inflammatory/autoimmune diseases and cancers.", {"entities": []}], ["Spleen tyrosine kinase (Syk) was initially found to be highly expressed in hematopoietic cells and has been known to play crucial roles in adaptive immune responses.", {"entities": [[24, 27, "GENE"]]}], ["However, recent studies have reported that Syk is also involved in other biological functions, especially in innate immune responses.", {"entities": [[43, 46, "GENE"]]}], ["Although Syk has been extensively studied in adaptive immune responses, numerous studies have recently presented evidence that Syk has critical functions in macrophage-mediated inflammatory responses and is closely related to innate immune response.", {"entities": [[9, 12, "GENE"], [127, 130, "GENE"], [9, 12, "GENE"], [127, 130, "GENE"]]}], ["This review describes the characteristics of Syk-mediated signaling pathways, summarizes the recent findings supporting the crucial roles of Syk in macrophage-mediated inflammatory responses and diseases, and discusses Syk-targeted drug development for the therapy of inflammatory diseases.", {"entities": [[45, 48, "GENE"], [141, 144, "GENE"], [219, 222, "GENE"]]}], ["For allergic disorders, the increasing prevalence over the past decade has been attributed in part to the lack of microbial burden in developed countries ('hygiene hypothesis').", {"entities": []}], ["Variation in genes encoding toll-like receptors (TLRs) as the receptor system for the first innate immune response to microbial stimuli has been implicated in various inflammatory diseases.", {"entities": []}], ["We evaluated here the role of a coding variation, Ser249Pro, in the TLR6 gene in the pathogenesis of asthma, atopic dermatitis (AD) and chronic obstructive pulmonary disease (COPD).", {"entities": [[109, 126, "DISEASE"], [136, 173, "DISEASE"], [101, 107, "DISEASE"], [116, 126, "DISEASE"], [68, 72, "GENE"]]}], ["Genotyping of the Ser249Pro polymorphism in 68 unrelated adult patients and 132 unrelated children with asthma, 185 unrelated patients with COPD, 295 unrelated individuals with AD and 212 healthy control subjects was performed by restriction enzyme digestion.", {"entities": [[104, 110, "DISEASE"]]}], ["We found a weak association of the 249Ser allele with childhood asthma (p = 0.03).", {"entities": [[64, 70, "DISEASE"]]}], ["Yet, significance was lost after Bonferroni correction.", {"entities": []}], ["No association was evident for AD or COPD.", {"entities": []}], ["Variation in TLR6 might play a role in the pathogenesis of childhood asthma.", {"entities": [[69, 75, "DISEASE"], [13, 17, "GENE"]]}], ["Chronic Obstructive Pulmonary Disease (COPD) is a systemic disease; morbidity and mortality due to COPD are on the increase, and it has great impact on patients' lives.", {"entities": []}], ["Most COPD patients are managed by general practitioners (GP).", {"entities": []}], ["Too often, GPs base their initial assessment of patient's disease severity mainly on lung function.", {"entities": []}], ["However, lung function correlates poorly with COPD-specific health-related quality of life and exacerbation frequency.", {"entities": []}], ["A validated COPD disease risk index that better represents the clinical manifestations of COPD and is feasible in primary care seems to be useful.", {"entities": []}], ["The objective of this study is to develop and validate a practical COPD disease risk index that predicts the clinical course of COPD in primary care patients with GOLD stages 2\u20134.", {"entities": []}], ["We will conduct 2 linked prospective cohort studies with COPD patients from GPs in Switzerland and the Netherlands.", {"entities": []}], ["We will perform a baseline assessment including detailed patient history, questionnaires, lung function, history of exacerbations, measurement of exercise capacity and blood sampling.", {"entities": []}], ["During the follow-up of at least 2 years, we will update the patients' profile by registering exacerbations, health-related quality of life and any changes in the use of medication.", {"entities": []}], ["The primary outcome will be health-related quality of life.", {"entities": []}], ["Secondary outcomes will be exacerbation frequency and mortality.", {"entities": []}], ["Using multivariable regression analysis, we will identify the best combination of variables predicting these outcomes over one and two years and, depending on funding, even more years.", {"entities": []}], ["Despite the diversity of clinical manifestations and available treatments, assessment and management today do not reflect the multifaceted character of the disease.", {"entities": []}], ["This is in contrast to preventive cardiology where, nowadays, the treatment in primary care is based on patient-specific and fairly refined cardiovascular risk profile corresponding to differences in prognosis.", {"entities": []}], ["After completion of this study, we will have a practical COPD-disease risk index that predicts the clinical course of COPD in primary care patients with GOLD stages 2\u20134.", {"entities": []}], ["In a second step we will incorporate evidence-based treatment effects into this model, such that the instrument may guide physicians in selecting treatment based on the individual patients' prognosis.", {"entities": []}], ["ClinicalTrials.gov Archive NCT00706602", {"entities": []}], ["Intensive care-acquired weakness is a common problem, leads to significant impairment in physical functioning and muscle strength, and is prevalent in individuals with sepsis.", {"entities": []}], ["Early rehabilitation has been shown to be safe and feasible; however, commencement is often delayed due to a patient's inability to co-operate.", {"entities": []}], ["An intervention that begins early in an intensive care unit (ICU) admission without the need for patient volition may be beneficial in attenuating muscle wasting.", {"entities": []}], ["The eRiCC (early rehabilitation in critical care) trial will investigate the effectiveness of functional electrical stimulation-assisted cycling and cycling alone, compared to standard care, in individuals with sepsis.", {"entities": []}], ["This is a single centre randomised controlled trial.", {"entities": []}], ["Participants (n=80) aged \u226518\u2005years, with a diagnosis of sepsis or severe sepsis, who are expected to be mechanically ventilated for \u226548\u2005h and remain in the intensive care \u22654\u2005days will be randomised within 72\u2005h of admission to (1) standard care or (2) intervention where participants will receive functional electrical muscle stimulation-assisted supine cycling on one leg while the other leg undergoes cycling alone.", {"entities": []}], ["Primary outcome measures include: muscle mass (quadriceps ultrasonography; bioelectrical impedance spectroscopy); muscle strength (Medical Research Council Scale; hand-held dynamometry) and physical function (Physical Function in Intensive Care Test; Functional Status Score in intensive care; 6\u2005min walk test).", {"entities": []}], ["Blinded outcome assessors will assess measures at baseline, weekly, at ICU discharge and acute hospital discharge.", {"entities": []}], ["Secondary measures will be evaluated in a nested subgroup (n=20) and will consist of biochemical/histological analyses of collected muscle, urine and blood samples at baseline and at ICU discharge.", {"entities": []}], ["Ethics approval has been obtained from the relevant institution, and results will be published to inform clinical practice in the care of patients with sepsis to optimise rehabilitation and physical function outcomes.", {"entities": []}], ["Australian and New Zealand Clinical Trials Registry ACTRN12612000528853.", {"entities": []}], ["Pulmonary fibrosis is a progressive disease with only few treatment options available at the moment.", {"entities": []}], ["Recently, the nucleoside uridine has been shown to exert anti-inflammatory effects in different animal models, e.g.", {"entities": []}], ["in acute lung injury or bronchial asthma.", {"entities": [[34, 40, "DISEASE"]]}], ["Therefore, we investigated the influence of uridine supplementation on inflammation and fibrosis in the classical bleomycin model.", {"entities": []}], ["Male C57BL/6 mice received an intratracheal injection of bleomycin on day 0 and were treated intraperitoneally with uridine or vehicle.", {"entities": []}], ["The degree of inflammation and fibrosis was assessed at different time points.", {"entities": []}], ["Uridine administration resulted in attenuated inflammation, as demonstrated by reduced leukocytes and pro-inflammatory cytokines in the broncho-alveolar lavage (BAL) fluid.", {"entities": []}], ["Furthermore, collagen deposition in the lung interstitium was also reduced by uridine supplementation.", {"entities": []}], ["Similar results were obtained in a model in which animals received repeated intraperitoneal bleomycin injections.", {"entities": []}], ["In addition uridine inhibited collagen and TGF-\u00df synthesis by primary lung fibroblasts, the release of pro-inflammatory cytokines by human lung epithelial cells, as well as the production of reactive oxygen species by human neutrophils.", {"entities": []}], ["In summary, we were able to show that uridine has potent anti-inflammatory and anti-fibrotic properties.", {"entities": []}], ["As uridine supplementation has been shown to be well tolerated and safe in humans, this might be a new therapeutic approach for the treatment of fibrotic lung diseases.", {"entities": []}], ["The ATP-binding cassette subfamily C member 4 gene encodes a transmembrane protein involved in the export of proinflammatory molecules, including leukotriene, prostaglandin, and sphingosine-1-phosphate across the plasma membrane.", {"entities": []}], ["Those metabolites play important roles in asthma.", {"entities": [[42, 48, "DISEASE"]]}], ["We investigated the potential associations between ABCC4 gene polymorphisms and asthma phenotype.", {"entities": [[80, 86, "DISEASE"], [51, 56, "GENE"]]}], ["In total, 270 asthma patients and 120 normal healthy controls were enrolled for a genetic association study.", {"entities": [[14, 20, "DISEASE"]]}], ["Two polymorphisms (\u22121508A>G and \u2212642C>G) in the ABCC4 promoter were genotyped.", {"entities": [[48, 53, "GENE"]]}], ["The functional variability of the promoter polymorphisms was analyzed by luciferase reporter assay.", {"entities": []}], ["Inflammatory cytokine levels were measured by enzyme-linked immunosorbent assay.", {"entities": []}], ["Serum and urinary eicosanoid metabolites, sphingosine-1-phosphate, were evaluated by quadrupole time-of-flight mass spectrometry.", {"entities": []}], ["Asthma patients carrying the G allele at \u22121508A>G had significantly higher serum levels of periostin, myeloperoxidase, and urinary levels of 15-hydroxyeicosatetraenoic acid and sphingosine-1-phosphate ( P = 0.016, P = 0.027, P = 0.032, and P = 0.010, resp.)", {"entities": [[0, 6, "DISEASE"]]}], ["compared with noncarrier asthma patients.", {"entities": [[25, 31, "DISEASE"]]}], ["Luciferase activity was significantly enhanced in human epithelial A549 cells harboring a construct containing the \u22121508G allele ( P < 0.01 for each) compared with a construct containing the \u22121508A allele.", {"entities": []}], ["A functional polymorphism in the ABCC4 promoter, \u22121508A>G, may increase extracellular 15-hydroxyeicosatetraenoic acid, sphingosine-1-phosphate, and periostin levels, contributing to airway inflammation in asthmatics.", {"entities": [[33, 38, "GENE"]]}], ["Severe asthma is characterised by persistent inflammation, hyperreactivity and remodeling of the airways.", {"entities": [[7, 13, "DISEASE"]]}], ["No efficient treatment is available, this is particularly the case for steroid resistant phenotypes.", {"entities": []}], ["Our aim therefore was to develop a preclinical model showing characteristics of severe human asthma including steroid insensitivity.", {"entities": [[93, 99, "DISEASE"]]}], ["Mice were first sensitized with ovalbumin, extracts of cockroach or house dust mite followed by a challenge period of seven weeks.", {"entities": []}], ["Further to this, an additional group of mice was sensitized with all three allergens and then challenged with allergen alternating weekly between allergens.", {"entities": []}], ["All three allergens applied separately to the mice induced comparably strong Th2-type airway inflammation, airway hyperreactivity and airway remodeling, which was characterised by fibrosis and increased smooth muscle thickness.", {"entities": []}], ["In contrast, application of all three allergens together resulted in a greater Th2 response and increased airway hyperreactivity and a stronger albeit not significant remodeling phenotype compared to using HDM or CRA.", {"entities": []}], ["In this triple allergen model dexamethasone application, during the last 4 weeks of challenge, showed no suppressive effects on any of these parameters in this model.", {"entities": []}], ["In contrast, both TLR7 agonist resiquimod and TLR9 agonist CpG-ODN reduced allergen-specific IgE, eosinophils, and collagen I in the lungs.", {"entities": [[18, 22, "GENE"], [46, 50, "GENE"]]}], ["The TLR9 agonist also reduced IL-4 and IL-5 whilst increasing IFN-\u03b3 and strongly IL-10 levels in the lungs, effects not seen with the TLR7 agonist.", {"entities": [[4, 8, "GENE"], [134, 138, "GENE"]]}], ["However, neither TLR agonist had any effect on airway hyperreactivity and airway smooth muscle mass.", {"entities": []}], ["In conclusion we have developed a severe asthma model, which is steroid resistant and only partially sensitive to TLR7 and TLR9 agonist treatment.", {"entities": [[41, 47, "DISEASE"], [114, 118, "GENE"], [123, 127, "GENE"]]}], ["This model may be particular useful to test new potential therapeutics aiming at treating steroid resistant asthma in humans and investigating the underlying mechanisms responsible for steroid insensitivity.", {"entities": [[108, 114, "DISEASE"]]}], ["Nasal strips are used by athletes, people who snore, and asthmatics to ease the burden of breathing.", {"entities": []}], ["Although there are some published studies that demonstrate higher flow with nasal strips, none had directly measured the effect of the strips on nasal resistance using the airflow perturbation device (APD).", {"entities": []}], ["The APD is an inexpensive instrument that can measure respiratory resistance based on changes in mouth pressure and rate of airflow.", {"entities": []}], ["This study tested forty-seven volunteers (14 men and 33 women), ranging in age from 17 to 51.", {"entities": []}], ["Each volunteer was instructed to breathe normally into the APD using an oronasal mask with and without nasal strips.", {"entities": []}], ["The APD measured respiratory resistance during inhalation, exhalation, and an average of the two.", {"entities": []}], ["Results of a paired mean t-test comparing nasal strip against no nasal strip were statistically significant at the p = 0.05 level.", {"entities": []}], ["The Breathe Right\u2122 nasal dilator strips lowered nasal resistance by an average of 0.5 cm H 2 0/Lps from an average nasal resistance of 5.5 cm H 2 0/Lps.", {"entities": []}], ["Nasal strips reduce nasal resistance when measured with the APD.", {"entities": []}], ["The effect is equal during exhalation and during inhalation.", {"entities": []}], ["Reciprocal interactions between lung mesenchymal and epithelial cells play essential roles in lung organogenesis and homeostasis.", {"entities": []}], ["Although the molecular markers and related animal models that target lung epithelial cells are relatively well studied, molecular markers of lung mesenchymal cells and the genetic tools to target and/or manipulate gene expression in a lung mesenchyme-specific manner are not available, which becomes a critical barrier to the study of lung mesenchymal biology and the related pulmonary diseases.", {"entities": []}], ["We have identified a mouse Tbx4 gene enhancer that contains conserved DNA sequences across many vertebrate species with lung or lung-like gas exchange organ.", {"entities": [[27, 31, "GENE"]]}], ["We then generate a mouse line to express rtTA/LacZ under the control of the Tbx4 lung enhancer, and therefore a Tet-On inducible transgenic system to target lung mesenchymal cells at different developmental stages.", {"entities": [[76, 80, "GENE"]]}], ["By combining a Tbx4-rtTA driven Tet-On inducible Cre expression mouse line with a Cre reporter mouse line, the spatial-temporal patterns of Tbx4 lung enhancer targeted lung mesenchymal cells were defined.", {"entities": [[15, 19, "GENE"], [140, 144, "GENE"]]}], ["Pulmonary endothelial cells and vascular smooth muscle cells were targeted by the Tbx4-rtTA driver line prior to E11.5 and E15.5, respectively, while other subtypes of lung mesenchymal cells including airway smooth muscle cells, fibroblasts, pericytes could be targeted during the entire developmental stage.", {"entities": []}], ["Developmental lung mesenchymal cells can be specifically marked by Tbx4 lung enhancer activity.", {"entities": [[67, 71, "GENE"]]}], ["With our newly created Tbx4 lung enhancer-driven Tet-On inducible system, lung mesenchymal cells can be specifically and differentially targeted in vivo for the first time by controlling the doxycycline induction time window.", {"entities": [[23, 27, "GENE"]]}], ["This novel system provides a unique tool to study lung mesenchymal cell lineages and gene functions in lung mesenchymal development, injury repair, and regeneration in mice.", {"entities": []}], ["We report that like other T cells cultured in the presence of transforming growth factor (TGF) \u03b2, Th17 cells also produce interleukin (IL) 9.", {"entities": []}], ["Th17 cells generated in vitro with IL-6 and TGF-\u03b2 as well as purified ex vivo Th17 cells both produced IL-9.", {"entities": []}], ["To determine if IL-9 has functional consequences in Th17-mediated inflammatory disease, we evaluated the role of IL-9 in the development and progression of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.", {"entities": [[216, 234, "DISEASE"], [180, 197, "DISEASE"]]}], ["The data show that IL-9 neutralization and IL-9 receptor deficiency attenuates disease, and this correlates with decreases in Th17 cells and IL-6\u2013producing macrophages in the central nervous system, as well as mast cell numbers in the regional lymph nodes.", {"entities": []}], ["Collectively, these data implicate IL-9 as a Th17-derived cytokine that can contribute to inflammatory disease.", {"entities": []}], ["This article analyzes why adulteration became a key trope of the Indian drug market.", {"entities": []}], ["Adulteration had a pervasive presence, being present in medical discourses, public opinion and debate, and the nationalist claim for government intervention.", {"entities": []}], ["The article first situates the roots of adulteration in the composite nature of this market, which involved the availability of drugs of different potencies as well as the presence of multiple layers of manufacturers, agents, and distributors.", {"entities": []}], ["It then shows that such a market witnessed the availability of drugs of diverse potency and strengths, which were understood as elements of adulteration in contemporary medical and official discourse.", {"entities": []}], ["Although contemporary critics argued that the lack of government legislation and control allowed adulteration to sustain itself, this article establishes that the culture of the dispensation of drugs in India necessarily involved a multitude of manufacturer\u2013retailers, bazaar traders, and medical professionals practicing a range of therapies.", {"entities": []}], ["Whether the inflammatory biomarker procalcitonin provides prognostic information across clinical settings and different acute respiratory tract infections (ARIs) is poorly understood.", {"entities": []}], ["In the present study, we investigated the prognostic value of admission procalcitonin levels to predict adverse clinical outcome in a large ARI population.", {"entities": []}], ["We analysed data from 14 trials and 4,211 ARI patients to study associations of admission procalcitonin levels and setting specific treatment failure and mortality alone at 30\u00a0days.", {"entities": []}], ["We used multivariable hierarchical logistic regression and conducted sensitivity analyses stratified by clinical settings and ARI diagnoses to assess the results\u2019 consistency.", {"entities": []}], ["Overall, 864 patients (20.5%) experienced treatment failure and 252 (6.0%) died.", {"entities": []}], ["The ability of procalcitonin to differentiate patients with from those without treatment failure was highest in the emergency department setting (treatment failure area under the curve (AUC): 0.64 (95% confidence interval (CI): 0.61, 0.67), adjusted odds ratio (OR): 1.85 (95% CI: 1.61, 2.12), P <0.001; and mortality AUC: 0.67 (95% CI: 0.63, 0.71), adjusted OR: 1.82 (95% CI: 1.45, 2.29), P <0.001).", {"entities": []}], ["In lower respiratory tract infections, procalcitonin was a good predictor of identifying patients at risk for mortality (AUC: 0.71 (95% CI: 0.68, 0.74), adjusted OR: 2.13 (95% CI: 1.82, 2.49), P <0.001).", {"entities": []}], ["In primary care and intensive care unit patients, no significant association of initial procalcitonin levels and outcome was found.", {"entities": []}], ["Admission procalcitonin levels are associated with setting specific treatment failure and provide the most prognostic information regarding ARI in the emergency department setting.", {"entities": []}], ["Many cockroach species have adapted to urban environments, and some have been serious pests of public health in the tropics and subtropics.", {"entities": []}], ["Here, we present the 3.38-Gb genome and a consensus gene set of the American cockroach, Periplaneta americana .", {"entities": []}], ["We report insights from both genomic and functional investigations into the underlying basis of its adaptation to urban environments and developmental plasticity.", {"entities": []}], ["In comparison with other insects, expansions of gene families in P. americana exist for most core gene families likely associated with environmental adaptation, such as chemoreception and detoxification.", {"entities": []}], ["Multiple pathways regulating metamorphic development are well conserved, and RNAi experiments inform on key roles of 20-hydroxyecdysone, juvenile hormone, insulin, and decapentaplegic signals in regulating plasticity.", {"entities": []}], ["Our analyses reveal a high level of sequence identity in genes between the American cockroach and two termite species, advancing it as a valuable model to study the evolutionary relationships between cockroaches and termites.", {"entities": []}], ["The American cockroach ( Periplaneta americana ) is an hemimetabolous insect with rapid growth, high fecundity, and remarkable tissue-regeneration capability.", {"entities": []}], ["Here Li et al sequence its 3.38-Gb genome and perform the functional studies, yielding insights into its environmental adaptation and developmental plasticity.", {"entities": []}], ["An individual's perceived need to improve their physical health ( PNIPH ) is an essential precursor to adopting healthy behaviors.", {"entities": []}], ["Nine potentially modifiable risk factors ( PMRF s) for myocardial infarction collectively account for \u226590% of the population attributable risk.", {"entities": [[55, 76, "DISEASE"]]}], ["Though widely recognized, their impact on individuals\u2019 health perceptions is unclear.", {"entities": []}], ["Residents from 6 provinces were administered a module on changes to improve health as part of the 2011\u20132012 Canadian Community Health Survey, yielding relevant data for 8 of the 9 PMRF s sought.", {"entities": []}], ["The potential effects of PMRF s individually and cumulatively on PNIPH were examined using modified Poisson regression.", {"entities": []}], ["In total, 45\u00a0443 respondents were included, representing 11\u00a0006\u00a0123 individuals and corresponding to 96.8% of the adult population of the sampled provinces.", {"entities": []}], ["The sum of PMRF s was positively associated with PNIPH (adjusted prevalence ratio, 1.08; 95% CI, 1.07\u20131.09 per additional PMRF ) with 82.3% of individuals with \u22655 PMRF s reporting this perception.", {"entities": []}], ["Smoking, obesity, and low physical activity were most strongly associated with PNIPH, whereas hypertension and diabetes mellitus exhibited no association with this outcome after adjusting for potential confounders.", {"entities": [[94, 106, "DISEASE"], [9, 16, "DISEASE"], [111, 128, "DISEASE"]]}], ["Barriers to adopting healthy behaviors were reported by 55.9% of individuals endorsing PNIPH .", {"entities": []}], ["The cumulative burden of PMRF s is positively associated with PNIPH ; however, individual PMRF s differentially contribute to this perception.", {"entities": []}], ["Among those at highest cardiac risk, \u22481 in 5 denied PNIPH .", {"entities": []}], ["A better understanding of factors underlying health perceptions and behaviors is needed to capitalize on cardiovascular preventive efforts.", {"entities": []}], ["Being discovered long ago basophils have been neglected for more than a century.", {"entities": []}], ["During the past decade evidence emerged that basophils share features of innate and adaptive immunity.", {"entities": []}], ["Nowadays, basophils are best known for their striking effector role in the allergic reaction.", {"entities": []}], ["They hence have been used for establishing new diagnostic tests and therapeutic approaches and for characterizing natural and recombinant allergens as well as hypoallergens, which display lower or diminished IgE-binding activity.", {"entities": []}], ["However, it was a long way from discovery in 1879 until identification of their function in hypersensitivity reactions, including adverse drug reactions.", {"entities": []}], ["Starting with a historical background, this review highlights the modern view on basophil biology.", {"entities": []}], ["Prenatal growth restriction and low birth weight have been linked to long-term alterations of health, presumably via adaptive modifications of the epigenome.", {"entities": []}], ["Recent studies indicate a plasticity of the 11p15 epigenotype in response to environmental changes during early stages of human development.", {"entities": []}], ["We analyzed methylation levels at different 11p15 loci in 20 growth-discordant monozygotic twin pairs.", {"entities": []}], ["Intrauterine development was discordant due to severe twin-to-twin transfusion syndrome (TTTS), which was treated by fetoscopic laser coagulation of communicating vessels before 25\u00a0weeks of gestation.", {"entities": [[54, 87, "DISEASE"], [79, 87, "DISEASE"]]}], ["Methylation levels at age 4 were determined in blood and buccal cell-derived DNA by the single nucleotide primer extension reaction ion pair reverse-phase high performance liquid chromatography (SNuPE IP RP HPLC) assay.", {"entities": []}], ["Methylation at LINE-1 repeats was analyzed as an estimate of global methylation.", {"entities": []}], ["In general, variance of locus-specific methylation levels appeared to be higher in buccal cell- as compared to blood cell-derived DNA samples.", {"entities": []}], ["Paired analyses within the twin pairs revealed significant differences at only one CpG site (IGF2 dmr0 SN3 ( blood ), +1.9% in donors; P \u2009=\u20090.013).", {"entities": [[93, 97, "GENE"]]}], ["When plotting the twin pair-discordance in birth weight against the degree of discordance in site-specific methylation at age 4, only a few CpGs were found to interact (one CpG site each at IGF2dmr0 in blood/saliva DNA, one CpG at LINE-1 repeats in saliva DNA), with 26 to 36% of the intra-twin pair divergence at these sites explained by prenatal growth discordance.", {"entities": []}], ["However, across the entire cohort of 40 children, site-specific methylation did not correlate with SD-scores for weight or length at birth.", {"entities": []}], ["Insulin-like growth factor-II serum concentrations showed significant within-twin pair correlations at birth (R\u2009=\u20090.57) and at age 4 (R\u2009=\u20090.79), but did not differ between donors and recipients.", {"entities": []}], ["They also did not correlate with the analyzed 11p15 methylation parameters.", {"entities": []}], ["In a cohort of 20 growth-discordant monozygotic twin pairs, severe alteration in placental blood supply due to TTTS appears to leave only weak, if any, epigenetic marks at the analyzed CpG sites at 11p15.", {"entities": []}], ["Air pollution is an important contributor to respiratory disease in children.", {"entities": []}], ["To examine associations between household reporting of childhood respiratory conditions and household characteristics related to air pollution in Alaska Native communities.", {"entities": []}], ["In-home surveys were administered in 2 rural regions of Alaska.", {"entities": []}], ["The 12-month prevalence of respiratory conditions was summarized by region and age.", {"entities": []}], ["Odds ratios (ORs) were calculated to describe associations between respiratory health and household and air quality characteristics.", {"entities": []}], ["Household-reported respiratory health data were collected for 561 children in 328 households.", {"entities": []}], ["In 1 region, 33.6% of children aged <5 years had a recent history of pneumonia and/or bronchitis.", {"entities": [[69, 78, "DISEASE"], [86, 96, "DISEASE"]]}], ["Children with these conditions were 2 times more likely to live in a wood-heated home, but these findings were imprecise.", {"entities": []}], ["Resident concern with mould was associated with elevated prevalence of respiratory infections in children (ORs 1.6\u20132.5), while reported wheezing was associated with 1 or more smokers living in the household.", {"entities": []}], ["Reported asthma in 1 region (7.6%) was lower than national prevalence estimates.", {"entities": [[9, 15, "DISEASE"]]}], ["Findings suggest that there may be preventable exposures, including wood smoke and mould that affect childhood respiratory disease in these rural areas.", {"entities": []}], ["Additional research is needed to quantify particulate matter 2.5 microns in aerodynamic diameter or less and mould exposures in these communities, and to objectively evaluate childhood respiratory health.", {"entities": []}], ["Growing interest on the effects of home telemonitoring on patients with chronic heart failure (HF) has led to a rise in the number of systematic reviews addressing the same or very similar research questions with a concomitant increase in discordant findings.", {"entities": []}], ["Differences in the scope, methods of analysis, and methodological quality of systematic reviews can cause great confusion and make it difficult for policy makers and clinicians to access and interpret the available evidence and for researchers to know where knowledge gaps in the extant literature exist.", {"entities": []}], ["This overview aims to collect, appraise, and synthesize existing evidence from multiple systematic reviews on the effectiveness of home telemonitoring interventions for patients with chronic heart failure (HF) to inform policy makers, practitioners, and researchers.", {"entities": []}], ["A comprehensive literature search was performed on MEDLINE, EMBASE, CINAHL, and the Cochrane Library to identify all relevant, peer-reviewed systematic reviews published between January 1996 and December 2013.", {"entities": []}], ["Reviews were searched and screened using explicit keywords and inclusion criteria.", {"entities": []}], ["Standardized forms were used to extract data and the methodological quality of included reviews was appraised using the AMSTAR (assessing methodological quality of systematic reviews) instrument.", {"entities": []}], ["Summary of findings tables were constructed for all primary outcomes of interest, and quality of evidence was graded by outcome using the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) system.", {"entities": []}], ["Post-hoc analysis and subgroup meta-analyses were conducted to gain further insights into the various types of home telemonitoring technologies included in the systematic reviews and the impact of these technologies on clinical outcomes.", {"entities": []}], ["A total of 15 reviews published between 2003 and 2013 were selected for meta-level synthesis.", {"entities": []}], ["Evidence from high-quality reviews with meta-analysis indicated that taken collectively, home telemonitoring interventions reduce the relative risk of all-cause mortality (0.60 to 0.85) and heart failure-related hospitalizations (0.64 to 0.86) compared with usual care.", {"entities": []}], ["Absolute risk reductions ranged from 1.4%-6.5% and 3.7%-8.2%, respectively.", {"entities": []}], ["Improvements in HF-related hospitalizations appeared to be more pronounced in patients with stable HF: hazard ratio (HR) 0.70 (95% credible interval [Crl] 0.34-1.5]).", {"entities": [[117, 119, "GENE"]]}], ["Risk reductions in mortality and all-cause hospitalizations appeared to be greater in patients who had been recently discharged (\u226428 days) from an acute care setting after a recent HF exacerbation: HR 0.62 (95% CrI 0.42-0.89) and HR 0.67 (95% CrI 0.42-0.97), respectively.", {"entities": [[198, 200, "GENE"], [230, 232, "GENE"], [198, 200, "GENE"], [230, 232, "GENE"]]}], ["However, quality of evidence for these outcomes ranged from moderate to low suggesting that further research is very likely to have an important impact on our confidence in the observed estimates of effect and may change these estimates.", {"entities": []}], ["The post-hoc analysis identified five main types of non-invasive telemonitoring technologies included in the systematic reviews: (1) video-consultation, with or without transmission of vital signs, (2) mobile telemonitoring, (3) automated device-based telemonitoring, (4) interactive voice response, and (5) Web-based telemonitoring.", {"entities": []}], ["Of these, only automated device-based telemonitoring and mobile telemonitoring were effective in reducing the risk of all-cause mortality and HF-related hospitalizations.", {"entities": []}], ["More research data are required for interactive voice response systems, video-consultation, and Web-based telemonitoring to provide robust conclusions about their effectiveness.", {"entities": []}], ["Future research should focus on understanding the process by which home telemonitoring works in terms of improving outcomes, identify optimal strategies and the duration of follow-up for which it confers benefits, and further investigate whether there is differential effectiveness between chronic HF patient groups and types of home telemonitoring technologies.", {"entities": []}], ["Extensively hydrolyzed (EH) formula with Lactobacillus rhamnosus GG (LGG) was demonstrated to alleviate cow\u2019s milk allergy (CMA) symptoms and promote faster acquisition of tolerance to cow\u2019s milk protein.", {"entities": []}], ["We previously demonstrated that partially hydrolyzed (PH) and EH formulas with LGG supported normal growth in healthy-term infants through 120\u00a0days of age.", {"entities": []}], ["The objective of the current study was to evaluate growth, development, and specific adverse events through 5\u00a0years of age in participants from that cohort who continued receiving study formula.", {"entities": []}], ["Infants who completed a double-blind, randomized growth and tolerance study were eligible to continue receiving the assigned study formula through 1\u00a0year of age (control: EH casein formula, EHF, or one of two investigational formulas: EH casein formula with LGG (EHF-LGG) or a PH formula with LGG (PHF-LGG)) and participate in follow-up through 5\u00a0years of age.", {"entities": [[190, 193, "GENE"], [263, 266, "GENE"]]}], ["Anthropometric measures, behavior development, and specific adverse events were recorded.", {"entities": []}], ["No significant differences in achieved weight and height or behavioral development outcomes at 3 or 5\u00a0years of age were observed among study groups.", {"entities": []}], ["Few statistically significant differences in the incidence of specific infection-related events through years 3 or 5 were observed among study groups, none of which were considered clinically relevant.", {"entities": []}], ["Conclusion : Extensively and partially hydrolyzed formulas with LGG were associated with normal growth and development and long-term safety through 5\u00a0years of age.", {"entities": []}], ["The National Children\u2019s Study is considering a wide spectrum of airborne pollutants that are hypothesized to potentially influence pregnancy outcomes, neurodevelopment, asthma, atopy, immune development, obesity, and pubertal development.", {"entities": [[204, 211, "DISEASE"], [169, 175, "DISEASE"]]}], ["In this article we summarize six applicable exposure assessment lessons learned from the Centers for Children\u2019s Environmental Health and Disease Prevention Research that may enhance the National Children\u2019s Study: a ) Selecting individual study subjects with a wide range of pollution exposure profiles maximizes spatial-scale exposure contrasts for key pollutants of study interest.", {"entities": []}], ["b ) In studies with large sample sizes, long duration, and diverse outcomes and exposures, exposure assessment efforts should rely on modeling to provide estimates for the entire cohort, supported by subject-derived questionnaire data.", {"entities": []}], ["c ) Assessment of some exposures of interest requires individual measurements of exposures using snapshots of personal and microenvironmental exposures over short periods and/or in selected microenvironments.", {"entities": []}], ["d ) Understanding issues of spatial\u2013temporal correlations of air pollutants, the surrogacy of specific pollutants for components of the complex mixture, and the exposure misclassification inherent in exposure estimates is critical in analysis and interpretation.", {"entities": []}], ["e ) \u201cUsual\u201d temporal, spatial, and physical patterns of activity can be used as modifiers of the exposure/outcome relationships.", {"entities": []}], ["f ) Biomarkers of exposure are useful for evaluation of specific exposures that have multiple routes of exposure.", {"entities": []}], ["If these lessons are applied, the National Children\u2019s Study offers a unique opportunity to assess the adverse effects of air pollution on interrelated health outcomes during the critical early life period.", {"entities": []}], ["Mast cells are primary effector cells of allergy, and recruitment of mast cells in involved tissue is one of the key events in allergic inflammation.", {"entities": []}], ["Tryptase is the most abundant secretory product of mast cells, but little is known of its influence on mast cell accumulation.", {"entities": []}], ["Using mouse peritoneal model, cell migration assay, and flow cytometry analysis, we investigated role of tryptase in recruiting mast cells.", {"entities": []}], ["The results showed that tryptase induced up to 6.7-fold increase in mast cell numbers in mouse peritoneum following injection.", {"entities": []}], ["Inhibitors of tryptase, an antagonist of PAR-2 FSLLRY-NH 2 , and pretreatment of mice with anti-ICAM-1, anti-CD11a, and anti-CD18 antibodies dramatically diminished tryptase induced mast cell accumulation.", {"entities": []}], ["On the other hand, PAR-2 agonist peptides SLIGRL-NH 2 and tc-LIGRLO-NH 2 provoked mast cell accumulation following injection.", {"entities": []}], ["These implicate that tryptase induced mast cell accumulation is dependent on its enzymatic activity, activation of PAR-2, and interaction between ICAM-1 and LFA-1.", {"entities": []}], ["Moreover, induction of trans-endothelium migration of mast cells in vitro indicates that tryptase acts as a chemoattractant.", {"entities": []}], ["In conclusion, provocation of mast cell accumulation by mast cell tryptase suggests a novel self-amplification mechanism of mast cell accumulation.", {"entities": []}], ["Mast cell stabilizers as well as PAR-2 antagonist agents may be useful for treatment of allergic reactions.", {"entities": []}], ["\u03b2-Adrenoceptor antagonists boast a 50-year use for symptomatic control in numerous cardiovascular diseases.", {"entities": []}], ["One might expect highly selective antagonists are available for the human \u03b2-adrenoceptor subtype involved in these diseases, yet few truly \u03b2 1 -selective molecules exist.", {"entities": []}], ["To address this clinical need, we re-evaluated LK 204-545 ( 1 ),1 a selective \u03b2 1 -adrenoceptor antagonist, and discovered it possessed significant partial agonism.", {"entities": []}], ["Removal of 1 \u2019s aromatic nitrile afforded 19 , a ligand with similar \u03b2 1 -adrenoceptor selectivity and partial agonism (log K D of \u22127.75 and \u22125.15 as an antagonist of functional \u03b2 1 - and \u03b2 2 -mediated responses, respectively, and 34% of the maximal response of isoprenaline (\u03b2 1 )).", {"entities": []}], ["In vitro \u03b2-adrenoceptor selectivity and partial agonism of 19 were mirrored in vivo.", {"entities": []}], ["We designed analogues of 19 to improve affinity, selectivity, and partial agonism.", {"entities": []}], ["Although partial agonism could not be fully attenuated, SAR suggests that an extended alkoxyalkoxy side chain, alongside substituents at the meta - or para -positions of the phenylurea, increases ligand affinity and \u03b2 1 -selectivity.", {"entities": []}], ["Environmental teratogenic factors (e.g.", {"entities": []}], ["alcohol) are preventable.", {"entities": []}], ["We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy.", {"entities": []}], ["The previous human teratogenic studies had serious methodological problems, e.g.", {"entities": []}], ["the first trimester concept is outdated because environmental teratogens cannot induce congenital abnormalities in the first month of gestation.", {"entities": []}], ["In addition, teratogens usually cause specific congenital abnormalities or syndromes.", {"entities": []}], ["Finally, the importance of chemical structures, administrative routes and reasons for treatment at the evaluation of medicinal products was not considered.", {"entities": []}], ["On the other hand, in the so-called case-control epidemiological studies in general recall bias was not limited.", {"entities": []}], ["These biases explain that the teratogenic risk of drugs is exaggerated, while the benefit of medicine use during pregnancy is underestimated.", {"entities": []}], ["Thus, a better balance is needed between the risk and benefit of drug treatments during pregnancy.", {"entities": []}], ["Of course, we have to do our best to reduce the risk of teratogenic drugs as much as possible, however, it is worth stressing the preventive effect of drugs for maternal diseases (e.g.", {"entities": []}], ["diabetes mellitus and hyperthermia) related congenital abnormalities.", {"entities": [[0, 17, "DISEASE"]]}], ["Proanthocyanidins belong to a class of polyphenolic compounds called flavonoids and have been reported to exhibit important biological activities.", {"entities": []}], ["The immature inflorescence of Cocos nucifera L. is used by Ayurvedic and traditional medical practitioners for the treatment of menorrhagia in Sri Lanka.", {"entities": []}], ["Our studies have shown that the inflorescence of Cocos nucifera L. predominantly contains proanthocyanidins.", {"entities": []}], ["To determine the antioxidant, anti-inflammatory and anticancer activities of ethyl acetate soluble proanthocyanidins (EASPA) of immature inflorescence of Cocos nucifera L. EASPA fraction of an acetone/water (7:3) extract of Cocos nucifera L. inflorescence was purified on Sephadex LH-20 and was used for the study.", {"entities": []}], ["Antioxidant activity of EASPA was determined using DPPH and SOR scavenging assays.", {"entities": []}], ["Anti-inflammatory activity of EASPA was determined by oxidative burst assay using chemiluminescence technique.", {"entities": []}], ["MTT colorimetric assay was used to evaluate the cytotoxicity of EASPA to both PC3 and HeLa cells.", {"entities": []}], ["EASPA showed radical scavenging activity against both DPPH and superoxide radicals with IC50 values of 11.02\u2009\u00b1\u20090.60\u00a0\u03bcg/mL and 26.11\u2009\u00b1\u20090.72\u00a0\u03bcg/mL.", {"entities": []}], ["In both assays, EASPA showed less antioxidant activity than the standards used.", {"entities": []}], ["It exhibited similar anti-inflammatory activity (IC50\u2009=\u200910.31\u2009\u00b1\u20091.11\u00a0\u03bcg/mL) to ibuprofen (IC50\u2009=\u200911.20\u2009\u00b1\u20091.90\u00a0\u03bcg/mL) (P\u2009\u2265\u20090.05).", {"entities": []}], ["EASPA also showed stronger cytotoxic activity towards Hela cells (IC50\u2009=\u200918.78\u2009\u00b1\u20090.90\u00a0\u03bcg/mL) than tamoxifen (IC50\u2009=\u200928.80\u2009\u00b1\u20091.94\u00a0\u03bcg/mL) ( P \u2009\u2264\u20090.05), while low cytotoxicity was observed against PC3 cells (IC50\u2009=\u200944.21\u2009\u00b1\u20090.73\u00a0\u03bcg/mL) compared to doxorubicin (IC50\u2009=\u20091.38\u2009\u00b1\u20090.16\u00a0\u03bcg/mL).", {"entities": []}], ["EASPA showed antioxidant, anti-inflammatory and anticancer activities.", {"entities": []}], ["Health is a result of influences operating at multiple levels.", {"entities": []}], ["For example, inadequate housing, poor educational attainment, and reduced access to health care are clustered together, and are all associated with reduced health.", {"entities": []}], ["Policies which try to change individual people's behaviour have limited effect when people have little control over their environment.", {"entities": []}], ["However, structural environmental change and an understanding of the way that influences interact with each other, has the potential to facilitate healthy choices irrespective of personal resources.", {"entities": []}], ["The aim of Environments for Healthy Living (EHL) is to investigate the impact of gestational and postnatal environments on health, and to examine where structural change can be brought about to optimise health outcomes.", {"entities": []}], ["The baseline assessment will focus on birth outcomes and maternal and infant health.", {"entities": []}], ["EHL is a longitudinal birth cohort study.", {"entities": []}], ["We aim to recruit 1000 pregnant women in the period April 2010 to March 2013.", {"entities": []}], ["We will examine the impact of the gestational environment (maternal health) and the postnatal environment (housing and neighbourhood conditions) on subsequent health outcomes for the infants born to these women.", {"entities": []}], ["Data collection will commence during the participants' pregnancy, from approximately 20 weeks gestation.", {"entities": []}], ["Participants will complete a questionnaire, undergo anthropometric measurements, wear an accelerometer, compile a food diary, and have environmental measures taken within their home.", {"entities": []}], ["They will also be asked to consent to having a sample of umbilical cord blood taken following delivery of their baby.", {"entities": []}], ["These data will be complemented by routinely collected electronic data such as health records from GP surgeries, hospital admissions, and child health and development records.", {"entities": []}], ["Thereafter, participants will be visited annually for follow-up of subsequent exposures and child health outcomes.", {"entities": []}], ["The baseline assessment of EHL will provide information concerning the impact of gestational and postnatal environments on birth outcomes and maternal and infant health.", {"entities": []}], ["The findings can be used to inform the development of complex interventions targeted at structural, environmental factors, intended to reduce ill-health.", {"entities": []}], ["Long-term follow-up of the cohort will focus on relationships between environmental exposures and the later development of adverse health outcomes, including obesity and diabetes.", {"entities": [[158, 165, "DISEASE"]]}], ["We examined the health effects of exposure to acidic air pollution among children living in 24 communities in the United States and Canada.", {"entities": []}], ["Parents of children between the ages of 8 and 12 completed a self-administered questionnaire and provided consent for their child to perform a standardized forced expiratory maneuver at school in 22 of these communities.", {"entities": []}], ["Air quality and meteorology were measured in each community for the year preceding the pulmonary function tests.", {"entities": []}], ["Forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1.0) measurements of 10,251 white children were examined in a two-stage regression analysis that adjusted for age, sex, height, weight, and sex-height interaction.", {"entities": []}], ["In this study, a 52 nmol/m3 difference in annual mean particle strong acidity was associated with a 3.5% (95% CI, 2.0-4.9) decrement in adjusted FVC and a 3.1% (95% CI, 1.6-4.6) decrement in adjusted FEV1.0.", {"entities": []}], ["The FVC decrement was larger, although not significantly different, for children who were lifelong residents of their communities (4.1%, 95% CI, 2.5-5.8).", {"entities": []}], ["The relative odds for low lung function (that is, measured FVC less than or equal to 85% of predicted), was 2.5 (95% CI, 1.8-3.6) across the range of particle strong acidity exposures.", {"entities": []}], ["These data suggest that long-term exposure to ambient particle strong acidity may have a deleterious effect on lung growth, development, and function.", {"entities": []}], ["The purpose of this study was to describe the prevalence of respiratory diseases in older adults and compare the demographic, health and smoking characteristics of those with and without these diseases.", {"entities": []}], ["Furthermore, we evaluate the association between smoking status and patterns in health care and how concordant this care is with guidelines.", {"entities": []}], ["Using a nationally representative sample of 29,902 older adults who participated in the Medicare Current Beneficiary Survey (1992\u20132002), we compared guideline recommendations on the treatment and prevention of chronic obstructive pulmonary disease and asthma with survey utilization data, including the use of bronchodilators, spirometry and influenza vaccine.", {"entities": [[342, 351, "DISEASE"], [210, 247, "DISEASE"], [252, 258, "DISEASE"]]}], ["26% to 30% of older adults were diagnosed with or self-reported chronic respiratory diseases; however 69% received no pharmacological treatment and 30% of patients reporting use of pharmacological treatments did not receive short-acting bronchodilator inhalers.", {"entities": []}], ["Current smokers appeared to receive significantly less care for respiratory diseases than non-smokers or former smokers.", {"entities": []}], ["Disparities between recommended and actual care for older adults with chronic lung disease require further research.", {"entities": [[78, 90, "DISEASE"]]}], ["The needs of older adults with co-morbidities and nicotine addiction deserve special attention in care as well as guideline development and implementation.", {"entities": []}], ["Accessibility of travel may be better understood if psychological factors underlying change in travel behavior are known.", {"entities": []}], ["This paper examines older (65+) travelers\u2019 motives for changing their travel behavior.", {"entities": []}], ["These changes are grounded in critical incidents earlier encountered in public-transport travel.", {"entities": []}], ["A scientific framework is developed based on cognitive and behavioral theory.", {"entities": []}], ["In 29 individual interviews, travelers\u2019 critical reactions ( i.e.", {"entities": []}], [", cognitive, emotional, and/or behavioral) to 77 critical incidents were examined.", {"entities": []}], ["By applying critical incident technique (CIT), five reaction themes were identified that had generated travel-behavior change: firm restrictions, unpredictability, unfair treatment, complicated trips, and earlier adverse experiences.", {"entities": []}], ["To improve older travelers\u2019 access to public transport, key findings were: (a) service must be designed so as to strengthen the feeling of being in control throughout the journey; (b) extended personal service would increase predictability in the travel chain and decrease travel complexity; consequently, (c) when designing new services and making effective accessibility interventions, policy makers should consider and utilize underlying psychological factors that could direct traveler behavior.", {"entities": []}], ["Arginine is a crucial amino acid that serves to modulate the cellular immune response during infection.", {"entities": []}], ["Arginine is also a common substrate for both inducible nitric oxide synthase (iNOS) and arginase.", {"entities": []}], ["The generation of nitric oxide from arginine is responsible for efficient immune response and cytotoxicity of host cells to kill the invading pathogens.", {"entities": []}], ["On the other hand, the conversion of arginine to ornithine and urea via the arginase pathway can support the growth of bacterial and parasitic pathogens.", {"entities": []}], ["The competition between iNOS and arginase for arginine can thus contribute to the outcome of several parasitic and bacterial infections.", {"entities": []}], ["There are two isoforms of vertebrate arginase, both of which catalyze the conversion of arginine to ornithine and urea, but they differ with regard to tissue distribution and subcellular localization.", {"entities": []}], ["In the case of infection with Mycobacterium, Leishmania , Trypanosoma , Helicobacter , Schistosoma , and Salmonella spp ., arginase isoforms have been shown to modulate the pathology of infection by various means.", {"entities": []}], ["Despite the existence of a considerable body of evidence about mammalian arginine metabolism and its role in immunology, the critical choice to divert the host arginine pool by pathogenic organisms as a survival strategy is still a mystery in infection biology.", {"entities": []}], ["In the immediate postoperative period, obese patients are more likely to exhibit hypoxaemia due to atelectasis and impaired respiratory mechanics, changes which can be attenuated by non-invasive ventilation (NIV).", {"entities": []}], ["The aim of the study was to evaluate the duration of any effects of early initiation of short term pressure support NIV vs. traditional oxygen delivery via venturi mask in obese patients during their stay in the PACU.", {"entities": []}], ["After ethics committee approval and informed consent, we prospectively studied 60 obese patients (BMI 30-45) undergoing minor peripheral surgery.", {"entities": []}], ["Half were randomly assigned to receive short term NIV during their PACU stay, while the others received routine treatment (supplemental oxygen via venturi mask).", {"entities": []}], ["Premedication, general anaesthesia and respiratory settings were standardized.", {"entities": []}], ["We measured arterial oxygen saturation by pulse oximetry and blood gas analysis on air breathing.", {"entities": []}], ["Inspiratory and expiratory lung function was measured preoperatively (baseline) and at 10 min, 1 h, 2 h, 6 h and 24 h after extubation, with the patient supine, in a 30 degrees head-up position.", {"entities": []}], ["The two groups were compared using repeated-measure analysis of variance (ANOVA) and t-test analysis.", {"entities": []}], ["Statistical significance was considered to be P < 0.05.", {"entities": []}], ["There were no differences at the first assessment.", {"entities": []}], ["During the PACU stay, pulmonary function in the NIV group was significantly better than in the controls (p < 0.0001).", {"entities": []}], ["Blood gases and the alveolar to arterial oxygen partial pressure difference were also better (p < 0.03), but with the addition that overall improvements are of questionable clinical relevance.", {"entities": []}], ["These effects persisted for at least 24 hours after surgery (p < 0.05).", {"entities": []}], ["Early initiation of short term NIV during in the PACU promotes more rapid recovery of postoperative lung function and oxygenation in the obese.", {"entities": []}], ["The effect lasted 24 hours after discontinuation of NIV.", {"entities": []}], ["Patient selection is necessary in order to establish clinically relevant improvements.", {"entities": []}], ["DRKS00000751; http://www.germanctr.de", {"entities": []}], ["Limited data are available regarding differences in presentation and management of pediatric emergency department (PED) patients based on insurance status.", {"entities": []}], ["The objective of the study was to assess the difference in management of pediatric facial lacerations based on medical insurance status.", {"entities": []}], ["We conducted a retrospective cohort study with universal sampling of patients with facial lacerations who were treated in an urban PED (45K visits/year) over a one-year period.", {"entities": []}], ["Demographic features and injury characteristics for patients with commercial (private) insurance and those with Medicaid or Medicare (public) insurance were compared.", {"entities": []}], ["Of 1235 children included in the study, 667 (54%) had private insurance and 485 (39%) had public insurance.", {"entities": []}], ["The two groups did not differ in age or gender, arrival by ambulance, location of injury occurrence, mechanism of injury, part of face involved, length or depth of laceration, use of local anesthetic, or method of repair but differed in acuity assigned at triage.", {"entities": []}], ["Patients with public insurance were found less likely to have subspecialty consultation in bivariable (OR=0.41, 95% CI [0.24\u20130.68]) and multivariable logistic regression analyses (OR=0.45, 95% CI [0.25\u20130.78]).", {"entities": []}], ["Patients with public insurance received procedural sedation significantly less often than those with private insurance (OR=0.48, 95% CI [0.29\u20130.76]).", {"entities": []}], ["This difference was not substantiated in multivariable models (OR=0.74, 95% CI [0.40\u20131.31]).", {"entities": []}], ["Patients with public insurance received less subspecialty consultation compared to privately insured patients despite a similarity in the presentation and characteristics of their facial lacerations.", {"entities": []}], ["The reasons for these disparities require further investigation.", {"entities": []}], ["Data about burden of influenza in pregnancy in India are scant.", {"entities": [[21, 30, "DISEASE"]]}], ["In order to assess the contribution of influenza to acute respiratory illness (ARI) in pregnancy, 266 north Indian pregnant females with febrile ARI were studied from December 2014 to May 2015.", {"entities": [[39, 48, "DISEASE"]]}], ["Twin nasopharyngeal/oropharyngeal swabs were obtained and tested for influenza viruses by RT-PCR.", {"entities": [[69, 78, "DISEASE"]]}], ["Fifty (18.8%) patients tested positive for influenza (A/H1N1pdm09 in 41, A/H3N2 in 8, and influenza B Yamagata in 1).", {"entities": [[43, 52, "DISEASE"], [90, 99, "DISEASE"]]}], ["Rigors, headache, and a family history of ARI were significantly more frequent in influenza positive patients.", {"entities": [[82, 91, "DISEASE"]]}], ["Oseltamivir and supportive therapy were administered to all confirmed cases.", {"entities": []}], ["Nine influenza positive cases needed hospitalization for their respiratory illness, and 5 developed respiratory failure.", {"entities": [[100, 119, "DISEASE"], [5, 14, "DISEASE"]]}], ["Of these, 4 (3 in third trimester) succumbed to their illness.", {"entities": []}], ["We conclude that influenza viruses are a cause of significant morbidity and mortality among pregnant females with ARI in north India.", {"entities": [[17, 26, "DISEASE"]]}], ["As such, appropriate preventive strategies of influenza vaccination and early initiation of antiviral therapy during illness are stressed.", {"entities": [[46, 55, "DISEASE"]]}], ["Objective .", {"entities": []}], ["To evaluate the usefulness of carboxyhemoglobin (CO-Hb) levels as a biomarker to predict the development and severity of bronchopulmonary dysplasia (BPD).", {"entities": []}], ["Twenty-five infants born at <33\u2009wk of gestational age or with a birth weight of <1,500\u2009g were enrolled.", {"entities": []}], ["CO-Hb levels were measured between postnatal days 5 and 8, 12 and 15, 19 and 22, and 26 and 29.", {"entities": []}], ["Urinary levels of 8-hydroxydeoxyguanosine (8-OHdG), advanced oxidation protein products, and N \u03b5 -(hexanoyl) lysine were measured between postnatal days 5 and 8 and 26 and 29.", {"entities": []}], ["Receiver operating characteristic (ROC) analysis was used to compare the biomarkers' predictive values.", {"entities": []}], ["Compared with infants in the no-or-mild BPD group, infants with moderate-to-severe BPD exhibited higher CO-Hb levels during the early postnatal period and higher 8-OHdG levels between postnatal days 5 and 8.", {"entities": []}], ["Using ROC analysis to predict the development of moderate-to-severe BPD, the area under the curve (AUC) for CO-Hb levels between postnatal days 5 and 8 was higher than AUCs for the urinary markers.", {"entities": []}], ["Conclusions .", {"entities": []}], ["CO-Hb levels during the early postnatal period may serve as a practical marker for evaluating oxidative stress and the severity of subsequently developing BPD.", {"entities": []}], ["The aims of this systematic review and meta-analysis of randomized controlled trials are to evaluate the effects of active heated humidifiers (HHs) and moisture exchangers (HMEs) in preventing artificial airway occlusion and pneumonia, and on mortality in adult critically ill patients.", {"entities": [[225, 234, "DISEASE"]]}], ["In addition, we planned to perform a meta-regression analysis to evaluate the relationship between the incidence of artificial airway occlusion, pneumonia and mortality and clinical features of adult critically ill patients.", {"entities": [[145, 154, "DISEASE"]]}], ["Computerized databases were searched for randomized controlled trials (RCTs) comparing HHs and HMEs and reporting artificial airway occlusion, pneumonia and mortality as predefined outcomes.", {"entities": [[143, 152, "DISEASE"]]}], ["Relative risk (RR), 95% confidence interval for each outcome and I Eighteen RCTs and 2442 adult critically ill patients were included in the analysis.", {"entities": []}], ["The incidence of artificial airway occlusion (RR\u2009=\u20091.853; 95% CI 0.792\u20134.338), pneumonia (RR\u2009=\u2009932; 95% CI 0.730\u20131.190) and mortality (RR\u2009=\u20091.023; 95% CI 0.878\u20131.192) were not different in patients treated with HMEs and HHs.", {"entities": [[79, 88, "DISEASE"]]}], ["However, in the subgroup analyses the incidence of airway occlusion was higher in HMEs compared with HHs with non-heated wire (RR\u2009=\u20093.776; 95% CI 1.560\u20139.143).", {"entities": []}], ["According to the meta-regression, the effect size in the treatment group on artificial airway occlusion was influenced by the percentage of patients with pneumonia (\u03b2\u2009=\u2009-0.058; p \u2009=\u20090.027; favors HMEs in studies with high prevalence of pneumonia), and a trend was observed for an effect of the duration of mechanical ventilation (MV) (\u03b2\u2009=\u2009-0.108; p \u2009=\u20090.054; favors HMEs in studies with longer MV time).", {"entities": [[154, 163, "DISEASE"], [236, 245, "DISEASE"]]}], ["In this meta-analysis we found no superiority of HMEs and HHs, in terms of artificial airway occlusion, pneumonia and mortality.", {"entities": [[104, 113, "DISEASE"]]}], ["A trend favoring HMEs was observed in studies including a high percentage of patients with pneumonia diagnosis at admission and those with prolonged MV.", {"entities": [[91, 100, "DISEASE"]]}], ["However, the choice of humidifiers should be made according to the clinical context, trying to avoid possible complications and reaching the appropriate performance at lower costs.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-017-1710-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Endometriosis is an enigmatic disease.", {"entities": [[0, 13, "DISEASE"]]}], ["Gene expression profiling of endometriosis has been used in several studies, but few studies went further to classify subtypes of endometriosis based on expression patterns and to identify possible pathways involved in endometriosis.", {"entities": [[29, 42, "DISEASE"], [130, 143, "DISEASE"], [219, 232, "DISEASE"]]}], ["Some of the observed pathways are more inconsistent between the studies, and these candidate pathways presumably only represent a fraction of the pathways involved in endometriosis.", {"entities": [[167, 180, "DISEASE"]]}], ["We applied a standardised microarray preprocessing and gene set enrichment analysis to six independent studies, and demonstrated increased concordance between these gene datasets.", {"entities": []}], ["We find 16 up-regulated and 19 down-regulated pathways common in ovarian endometriosis data sets, 22 up-regulated and one down-regulated pathway common in peritoneal endometriosis data sets.", {"entities": [[73, 86, "DISEASE"], [166, 179, "DISEASE"], [65, 86, "DISEASE"]]}], ["Among them, 12 up-regulated and 1 down-regulated were found consistent between ovarian and peritoneal endometriosis.", {"entities": [[102, 115, "DISEASE"]]}], ["The main canonical pathways identified are related to immunological and inflammatory disease.", {"entities": []}], ["Early secretory phase has the most over-represented pathways in the three uterine cycle phases.", {"entities": []}], ["There are no overlapping significant pathways between the dataset from human endometrial endothelial cells and the datasets from ovarian endometriosis which used whole tissues.", {"entities": [[137, 150, "DISEASE"], [129, 150, "DISEASE"]]}], ["The study of complex diseases through pathway analysis is able to highlight genes weakly connected to the phenotype which may be difficult to detect by using classical univariate statistics.", {"entities": []}], ["By standardised microarray preprocessing and GSEA, we have increased the concordance in identifying many biological mechanisms involved in endometriosis.", {"entities": [[139, 152, "DISEASE"]]}], ["The identified gene pathways will shed light on the understanding of endometriosis and promote the development of novel therapies.", {"entities": [[69, 82, "DISEASE"]]}], ["Spirometrically-defined chronic obstructive pulmonary disease (COPD) is considered progressive but its natural history is inadequately studied.", {"entities": [[24, 61, "DISEASE"]]}], ["We hypothesized that spirometrically-defined COPD states could undergo beneficial transitions.", {"entities": []}], ["Participants in the Lovelace Smokers\u2019 Cohort ( n \u2009=\u20091553), primarily women, were longitudinally studied over 5\u00a0years.", {"entities": []}], ["Spirometric states included normal postbronchodilator spirometry, COPD Stage I, Unclassified state, and COPD Stage II+, as defined by GOLD guidelines.", {"entities": []}], ["Beneficial transitions included either a decrease in disease severity, including resolution of spirometric abnormality, or maintenance of non-diseased state.", {"entities": []}], ["\u2018All smokers\u2019 ( n \u2009=\u20091553) and subgroups with normal and abnormal spirometry at baseline ( n \u2009=\u2009956 and 597 respectively) were separately analyzed.", {"entities": []}], ["Markov-like model of transition probabilities over an average follow-up period of 5\u00a0years were calculated.", {"entities": []}], ["Among \u2018all smokers\u2019, COPD Stage I, Unclassified, and COPD Stage II+ states were associated with probabilities of 16, 39, and 22\u00a0% respectively for beneficial transitions, and of 16, 35, and 4\u00a0% respectively for resolution.", {"entities": []}], ["Beneficial transitions were more common for new-onset disease than for pre-existing disease ( p \u2009<\u20090.001).", {"entities": []}], ["Beneficial transitions were less common among older smokers, men, or those with bronchial hyperresponsiveness but more common among Hispanics and smokers with excess weight.", {"entities": []}], ["This observational study of ever smokers, shows that spirometrically-defined COPD states, may not be uniformly progressive and can improve or resolve over time.", {"entities": []}], ["The implication of these findings is that the spirometric diagnosis of COPD can be unstable.", {"entities": []}], ["Furthermore, COPD may have a pre-disease state when interventions might help reverse or change its natural history.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0468-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["X-radiation and nitrogen mustard administration inhibit the formation of precipitins for whole bovine serum and bovine serum gamma globulin in the rabbit.", {"entities": []}], ["When specific antibody formation is inhibited by these agents, intravenous injection of a single large dose of bovine serum gamma globulin is not usually followed by the development of tissue lesions 9 to 11 days later, as occurs fairly regularly in control animals.", {"entities": []}], ["A fall in titre of serum complement to very low levels for 3 to 5 days is closely correlated in time with the disappearance of antigen from the circulation following the intravenous injection of single large doses of bovine serum albumin and bovine serum gamma globulin.", {"entities": []}], ["A rise in complement titre to normal levels occurs as antibodies appear in the serum.", {"entities": []}], ["This sudden fall in complement titre is correlated with the development of characteristic lesions, and does not occur when antibody formation is inhibited.", {"entities": []}], ["The data presented are interpreted as evidence in favor of the concept that the lesions are due to a reaction between antigen fixed in or on tissue cells and circulating antibody.", {"entities": []}], ["The possible significance of serum complement in the pathogenesis of anaphylactic tissue lesions is discussed.", {"entities": []}], ["Oxytocin is recommended by the World Health Organisation as the most effective uterotonic for the prevention and treatment of postpartum haemorrhage.", {"entities": []}], ["The requirement for parenteral administration by trained healthcare providers and the need for the drug solution to be maintained under cold-chain storage limit the use of oxytocin in the developing world.", {"entities": []}], ["In this study, a spray-dried ultrafine formulation of oxytocin was developed with an optimal particle size diameter (1-5 \u00b5m) to facilitate aerosolised delivery via the lungs.", {"entities": []}], ["A powder formulation of oxytocin, using mannitol, glycine and leucine as carriers, was prepared with a volume-based median particle diameter of 1.9 \u00b5m.", {"entities": []}], ["Oxytocin content in the formulation was assayed using high-performance liquid chromatography-mass spectroscopy and was found to be unchanged after spray-drying.", {"entities": []}], ["Ex vivo contractility studies utilising human and ovine uterine tissue indicated no difference in the bioactivity of oxytocin before and after spray-drying.", {"entities": []}], ["Uterine electromyographic (EMG) activity in postpartum ewes following pulmonary ( in vivo ) administration of oxytocin closely mimicked that observed immediately postpartum (0-12 h following normal vaginal delivery of the lamb).", {"entities": []}], ["In comparison to the intramuscular injection, pulmonary administration of an oxytocin dry powder formulation to postpartum ewes resulted in generally similar EMG responses, however a more rapid onset of uterine EMG activity was observed following pulmonary administration (129 \u00b1 18 s) than intramuscular injection (275 \u00b1 22 s).", {"entities": []}], ["This is the first study to demonstrate the potential for oxytocin to elicit uterine activity after systemic absorption as an aerosolised powder from the lungs.", {"entities": []}], ["Aerosolised oxytocin has the potential to provide a stable and easy to administer delivery system for effective prevention and treatment of postpartum haemorrhage in resource-poor settings in the developing world.", {"entities": []}], ["In-stent neoatherosclerosis (NA), characterized by a relatively thin fibrous cap and large volume of yellow-lipid accumulation after drug-eluting stents (DES) implantation, has attracted much attention owing to its close relationship with late complications, such as revascularization and late stent thrombosis (ST).", {"entities": [[154, 157, "GENE"]]}], ["Accumulating evidence has demonstrated that more than one-third of patients with first-generation DES present with NA.", {"entities": [[98, 101, "GENE"]]}], ["Even in the advent of second-generation DES, NA still occurs.", {"entities": [[40, 43, "GENE"]]}], ["It is indicated that endothelial dysfunction induced by DES plays a critical role in neoatherosclerotic development.", {"entities": [[56, 59, "GENE"]]}], ["Upregulation of reactive oxygen species (ROS) induced by DES implantation significantly affects endothelial cells healing and functioning, therefore rendering NA formation.", {"entities": [[57, 60, "GENE"]]}], ["In light of the role of ROS in suppression of endothelial healing, combining antioxidant therapies with stenting technology may facilitate reestablishing a functioning endothelium to improve clinical outcome for patients with stenting.", {"entities": []}], ["One third of Bahraini adult (20\u201364\u00a0years) males and 7.0% of females use some form of tobacco.", {"entities": []}], ["The corresponding rates for cigarette and waterpipe tobacco smoking (WTS) are 11.0% and 6.0%, respectively.", {"entities": []}], ["The objective of the study was to determine the knowledge on tobacco smoking and past smoking related behavior of male patients attending the Quit Tobacco Clinics (QTC) in Bahrain.", {"entities": []}], ["A sample of 339 male clinic attendees was taken proportional to the population distribution in the three QTC at Al Hoora Health Center, Hamad Kanoo Health Center, and Bank of Bahrain and Kuwait Health Center.", {"entities": []}], ["Data collection was performed until the sample size was completed (September 2015 to December 2016).", {"entities": []}], ["Knowledge on the health effects of cigarette and WTS was examined based on 10 statements on cigarette and similar ones on WTS.", {"entities": []}], ["Respondents \u201cagreeing\u201d with the statements were considered knowledgeable and those \u201cdisagreeing\u201d or responding \u201cdon\u2019t know\u201d, not knowledgeable.", {"entities": []}], ["All the \u201cagree\u201d responses for cigarette/WTS were summed across the 10 health effects and average health knowledge scores for cigarette/WTS were computed.", {"entities": []}], ["Most of the study participants were Bahraini nationals, ever married and educated with at least secondary level.", {"entities": []}], ["The majority (65.8%) of participants smoked a single type of tobacco product, and the rest, two (28.0%) or three or more (6.2%).", {"entities": []}], ["Age of starting cigarette and WTS was 16.2\u2009\u00b1\u20094.0 and 19.3\u2009\u00b1\u20096.7\u00a0years, respectively.", {"entities": []}], ["The majority (81%) smoked in the presence of other family members and 26.3% in the presence of a child.", {"entities": []}], ["76.2% smoked in the presence of others in their cars.", {"entities": [[48, 52, "GENE"]]}], ["18.9% of the attendees had quit smoking at the time of interview.", {"entities": []}], ["81% of the participants knew about the hazards of both cigarette and WTS with a significantly higher ( p \u00a0=\u20090.0001) mean knowledge score for cigarette (93.3\u2009\u00b1\u20093.0%) than WTS (85.2\u2009\u00b1\u20092.1%).", {"entities": []}], ["The relative lack of knowledge on the hazards of WTS in a sample of Arab country population with an increasing trend of WTS warrants the attention of health policy makers in the country and region.", {"entities": []}], ["There is mounting evidence to suggest that environmental factors play a major role in the development of neurodegenerative diseases like ALS (Amyotrophic Lateral Sclerosis).", {"entities": []}], ["The non-protein amino acid beta-N-methylamino-L-alanine (BMAA) was first associated with the high incidence of Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex (ALS/PDC) in Guam, and has been implicated as a potential environmental factor in ALS, Alzheimer\u2019s disease, and other neurodegenerative diseases.", {"entities": []}], ["BMAA has a number of toxic effects on motor neurons including direct agonist action on NMDA and AMPA receptors, induction of oxidative stress, and depletion of glutathione.", {"entities": []}], ["As a non-protein amino acid, there is also the strong possibility that BMAA could cause intraneuronal protein misfolding, the hallmark of neurodegeneration.", {"entities": []}], ["While an animal model for BMAA-induced ALS is lacking, there is substantial evidence to support a link between this toxin and ALS.", {"entities": []}], ["The ramifications of discovering an environmental trigger for ALS are enormous.", {"entities": []}], ["In this article, we discuss the history, ecology, pharmacology and clinical ramifications of this ubiquitous, cyanobacteria-derived toxin.", {"entities": []}], ["Immunoglobulin E (IgE) is the antibody that plays a central role in the mechanisms of allergic diseases such as asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["Interactions with its receptors, Fc\u03b5RI on mast cells and CD23 on B cells, are mediated by the Fc region, a dimer of the C\u03b52, C\u03b53 and C\u03b54 domains.", {"entities": []}], ["A sub-fragment lacking the C\u03b52 domains, Fc\u03b53\u20134, also binds to both receptors, although receptor binding almost exclusively involves the C\u03b53 domains.", {"entities": []}], ["This domain also contains the N-linked glycosylation site conserved in other isotypes.", {"entities": []}], ["We report here the crystal structures of IgE-Fc and Fc\u03b53\u20134 at the highest resolutions yet determined, 1.75\u00a0\u00c5 and 2.0\u00a0\u00c5 respectively, revealing unprecedented detail regarding the carbohydrate and its interactions with protein domains.", {"entities": []}], ["Analysis of the crystallographic B-factors of these, together with all earlier IgE-Fc and Fc\u03b53\u20134 structures, shows that the C\u03b53 domains exhibit the greatest intrinsic flexibility and quaternary structural variation within IgE-Fc.", {"entities": []}], ["Intriguingly, both well-ordered carbohydrate and disordered polypeptide can be seen within the same C\u03b53 domain.", {"entities": []}], ["A simplified method for comparing the quaternary structures of the C\u03b53 domains in free and receptor-bound IgE-Fc structures is presented, which clearly delineates the Fc\u03b5RI and CD23 bound states.", {"entities": []}], ["Importantly, differential scanning fluorimetric analysis of IgE-Fc and Fc\u03b53\u20134 identifies C\u03b53 as the domain most susceptible to thermally-induced unfolding, and responsible for the characteristically low melting temperature of IgE.", {"entities": []}], ["\u2022 The C\u03b53 domains of IgE are most susceptible to thermally induced unfolding determined by differential scanning fluorimetry.", {"entities": []}], ["\u2022 The C\u03b53 domains are responsible for the characteristically low melting temperature of IgE.", {"entities": []}], ["\u2022 The C\u03b53 domains exhibit the greatest intrinsic flexibility.", {"entities": []}], ["\u2022 Quaternary structural diversity of C\u03b53 domains is compared across all known structures using a simplified single parameter.", {"entities": []}], ["\u2022 Human IgE-Fc and Fc\u03b53\u20134 domain structures are determined at the highest resolutions yet reported (1.75\u00a0\u00c5 and 2.0\u00a0\u00c5).", {"entities": []}], ["The C\u03b53 domains of IgE are most susceptible to thermally induced unfolding determined by differential scanning fluorimetry.", {"entities": []}], ["The C\u03b53 domains are responsible for the characteristically low melting temperature of IgE.", {"entities": []}], ["The C\u03b53 domains exhibit the greatest intrinsic flexibility.", {"entities": []}], ["Quaternary structural diversity of C\u03b53 domains is compared across all known structures using a simplified single parameter.", {"entities": []}], ["Human IgE-Fc and Fc\u03b53\u20134 domain structures are determined at the highest resolutions yet reported (1.75\u00a0\u00c5 and 2.0\u00a0\u00c5).", {"entities": []}], ["The use of complementary and alternative medicine (CAM) is growing.", {"entities": []}], ["However the factors contributing to changes over time and to birth cohort differences in CAM use are not well understood.", {"entities": []}], ["We used data from 10186 participants, who were aged 20\u201369 years at the first cycle of data collection in the longitudinal component of the Canadian National Population Health Survey (1994/95-2010/11).", {"entities": []}], ["We examined chiropractic and other practitioner-based CAM use with a focus on five birth cohorts: pre-World War II (born 1925\u20131934); World War II (born 1935\u20131944); older baby boomers (born 1945\u20131954); younger baby boomers (born 1955\u20131964); and Gen Xers (born 1965\u20131974).", {"entities": []}], ["The survey collected data every two years on predisposing (e.g., sex, education), enabling (e.g., income), behavior-related factors (e.g., obesity), need (e.g., chronic conditions), and use of conventional care (primary care and specialists).", {"entities": [[139, 146, "DISEASE"]]}], ["The findings suggest that, at corresponding ages, more recent cohorts reported greater CAM (OR = 25.9, 95% CI: 20.0; 33.6 for Gen Xers vs. pre-World War) and chiropractic use than their predecessors (OR = 2.2, 95% CI: 1.7; 2.8 for Gen Xers vs. pre-World War).", {"entities": []}], ["There was also a secular trend of increasing CAM use, but not chiropractic use, over time (period effect) across all ages.", {"entities": []}], ["Factors associated with cohort differences were different for CAM and chiropractic use.", {"entities": []}], ["Cohort differences in CAM use were partially related to a period effect of increasing CAM use over time across all ages while cohort differences in chiropractic use were related to the higher prevalence of chronic conditions among recent cohorts.", {"entities": []}], ["The use of conventional care was positively related to greater CAM use (OR = 1.8, 95% CI: 1.6; 2.0) and chiropractic use (OR = 1.2, 95% CI: 1.1; 1.4) but did not contribute to changes over time or to cohort differences in CAM and chiropractic use.", {"entities": []}], ["The higher CAM use over time and in recent cohorts could reflect how recent generations are approaching their healthcare needs by expanding conventional care to include CAM therapies and practice for treatment and health promotion.", {"entities": []}], ["The findings also underscore the importance of doctors discussing CAM use with their patients.", {"entities": []}], ["In asthma, mechanisms contributing to chronicity remain to be determined.", {"entities": [[3, 9, "DISEASE"]]}], ["Recent models of sensitisation with prolonged airway allergen challenges reproduce typical features of chronic asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["However, the interplay between inflammation, structural changes and lung function is poorly understood.", {"entities": []}], ["This study was performed to delineate functional, structural and immunological airway changes after cessation of long term challenges to elucidate factors contributing to the development of prolonged lung function changes.", {"entities": []}], ["Mice sensitised systemically were consecutively challenged intranasally with ovalbumin for two or eight weeks.", {"entities": []}], ["After the end of challenges, lung function, airway inflammation, features of airway remodelling, local T-cell cytokines and systemic ovalbumin-specific antibodies were monitored.", {"entities": []}], ["Long term challenges resulted in airway hyperresponsiveness lasting 2 weeks and reduced baseline lung function for 6 weeks after their cessation.", {"entities": []}], ["In contrast, these changes resolved within one week after short term challenges.", {"entities": []}], ["Prolonged transforming growth factor beta (TGF-\u03b2)1 production and marked peribronchial fibrosis were only induced by long term challenges.", {"entities": []}], ["Importantly, fibrosis became apparent only after the onset of lung function changes and outlasted them.", {"entities": []}], ["Further, long term challenges led to prolonged and intense airway inflammation with marked lymphocytosis, but moderate eosinophilia, sustained IL-5 production and ovalbumin-specific IgG2a antibodies, the latter suggesting a Th1 component to the immune response.", {"entities": [[119, 131, "DISEASE"]]}], ["In contrast, following short term challenges airway inflammation was dominated by eosinophils and associated with a strong, but transient IL-13 response.", {"entities": []}], ["Prolonged lung function changes after long term allergen challenges seem to develop and resolve independently of the persistent peribronchial fibrosis.", {"entities": []}], ["They are more closely associated with intense airway inflammation, marked lymphocytosis, prolonged IL-5 and TGF-\u03b21 production in the airways and a Th1 immune response.", {"entities": []}], ["Ibuprofen is the most widely used non-steroidal anti-inflammatory drug (NSAID) for the treatment of inflammation, mild-to-moderate pain and fever in children, and is the only NSAID approved for use in children aged \u22653\u00a0months.", {"entities": []}], ["Its efficacy and safety profile have led to its increasing use in paediatric care, even without medical prescription.", {"entities": []}], ["However, an increase of suspected adverse reactions to ibuprofen has been noted in concomitance with the raised, often medically unsupervised, consumption of the drug.", {"entities": []}], ["The purpose of this work was a critical review of the paediatric literature over the last 15\u00a0years on side effects and adverse events associated with ibuprofen, in order to highlight circumstances associated with higher risks and to promote safe and appropriate use of this drug.", {"entities": []}], ["The literature from 2000 to date demonstrates that gastrointestinal events are rare, but (when they occur) include both upper and lower digestive tract lesions.", {"entities": []}], ["Dehydration plays an important role in triggering renal damage, so ibuprofen should not be given to patients with diarrhoea and vomiting, with or without fever.", {"entities": []}], ["Likewise, ibuprofen should never be administered to patients who are sensitive to it or to other NSAIDs.", {"entities": []}], ["It is contraindicated in neonates and in children with wheezing and persistent asthma and/or during varicella.", {"entities": [[79, 85, "DISEASE"]]}], ["Most of the analysed studies reported adverse events when ibuprofen was being used for fever symptoms or flu-like syndrome.", {"entities": [[114, 122, "DISEASE"]]}], ["Ibuprofen should not be used as an antipyretic, except in rare cases.", {"entities": []}], ["Ibuprofen remains the drug of first choice in the treatment of inflammatory pain in children.", {"entities": []}], ["Trafficking in women and children is a gross violation of human rights.", {"entities": []}], ["However, this does not prevent an estimated 800 000 women and children to be trafficked each year across international borders.", {"entities": []}], ["Eighty per cent of trafficked persons end in forced sex work.", {"entities": []}], ["India has been identified as one of the Asian countries where trafficking for commercial sexual exploitation has reached alarming levels.", {"entities": []}], ["While there is a considerable amount of internal trafficking from one state to another or within states, India has also emerged as a international supplier of trafficked women and children to the Gulf States and South East Asia, as well as a destination country for women and girls trafficked for commercial sexual exploitation from Nepal and Bangladesh.", {"entities": []}], ["Trafficking for commercial sexual exploitation is a highly profitable and low risk business that preys on particularly vulnerable populations.", {"entities": []}], ["This paper presents an overview of the trafficking of women and girls for sexual exploitation (CSE) in India; identifies the health impacts of CSE; and suggest strategies to respond to trafficking and related issues.", {"entities": []}], ["Conjunctival biopsies constitute a fairly large number of cases in a typical busy ophthalmic pathology practice.", {"entities": []}], ["They range from a single biopsy through multiple mapping biopsies to assess the extent of a particular pathological process.", {"entities": []}], ["Like most anatomical sites, the conjunctiva is subject to a very wide range of pathological processes.", {"entities": []}], ["This article will cover key, commonly encountered nonneoplastic and neoplastic entities.", {"entities": []}], ["Where relevant, sections will include recommendations on how best to submit specimens to the ophthalmic pathology laboratory and the relevance of up-to-date molecular techniques.", {"entities": []}], ["Hypersecretion of mucin due to goblet cell hyperplasia is frequently encountered in many chronic airway diseases, such as chronic bronchitis, bronchiectasis, bronchial asthma and cystic fibrosis.", {"entities": [[142, 156, "DISEASE"], [179, 194, "DISEASE"], [168, 174, "DISEASE"], [130, 140, "DISEASE"]]}], ["Even in normal individuals, viral infection or bacterial pneumonia frequently provoke huge amounts of bronchial secretions which may cause airway obstruction.", {"entities": [[57, 66, "DISEASE"], [47, 66, "DISEASE"]]}], ["The production of mucin was regulated by epidermal growth factor (EGF) in vitro Rat tracheal epithelial cells were obtained by pronase dissociation from the male Fisher 344 rats.", {"entities": [[66, 69, "GENE"]]}], ["When cells became confluent, they were divided into 6 groups and stimulated with either EGF for 24 hours or Pseudomonas extracts for 12 hours with or without selective EGF-R tyrosine kinase inhibitor tyrphostin AG 1478.", {"entities": [[88, 91, "GENE"], [168, 171, "GENE"]]}], ["We found that both EGF and Pseudomonas extracts phosphorylated the tyrosine residue in the EGF receptor from the rat tracheal epithelial cells and this tyrosine phosphorylation was nearly completely blocked by selective EGF-R tyrosine kinase inhibitor tyrphostin AG 1478.", {"entities": [[19, 22, "GENE"], [91, 94, "GENE"], [220, 223, "GENE"], [19, 22, "GENE"], [91, 94, "GENE"], [220, 223, "GENE"]]}], ["The mucin secretion was also stimulated by either EGF or Pseudomonas extracts but more strong secretion of mucin and MUC5AC gene expression in the rat tracheal epithelial cell was done by Pseudomonas extracts.", {"entities": [[50, 53, "GENE"]]}], ["These data suggest that Pseudomonas secretes the mucin by way of the EGF receptor and MUC5AC gene expression and the inhibitors of EGF receptor tyrosine phosphorylation would be useful to prevent the huge production of mucin due to Pseudomonas aeruginosa lung infection.", {"entities": [[69, 72, "GENE"], [131, 134, "GENE"], [69, 72, "GENE"], [131, 134, "GENE"]]}], ["Anthroposophic medicine offers a variety of treatments, among others the oil-dispersion bath, developed in the 1930s by Werner Junge.", {"entities": []}], ["Based on the phenomenon that oil and water do not mix and on recommendations of Rudolf Steiner, Junge developed a vortex mechanism which churns water and essential oils into a fine mist.", {"entities": []}], ["The oil-covered droplets empty into a tub, where the patient immerses for 15\u201330 minutes.", {"entities": []}], ["We review the current literature on oil-dispersion baths.", {"entities": []}], ["The following databases were searched: Medline, Pubmed, Embase, AMED and CAMbase.", {"entities": []}], ["The search terms were 'oil-dispersion bath' and 'oil bath', and their translations in German and French.", {"entities": []}], ["An Internet search was also performed using Google Scholar, adding the search terms 'study' and 'case report' to the search terms above.", {"entities": []}], ["Finally, we asked several experts for gray literature not listed in the above-mentioned databases.", {"entities": []}], ["We included only articles which met the criterion of a clinical study or case report, and excluded theoretical contributions.", {"entities": []}], ["Among several articles found in books, journals and other publications, we identified 1 prospective clinical study, 3 experimental studies (enrolling healthy individuals), 5 case reports, and 3 field-reports.", {"entities": []}], ["In almost all cases, the studies described beneficial effects \u2013 although the methodological quality of most studies was weak.", {"entities": []}], ["Main indications were internal/metabolic diseases and psychiatric/neurological disorders.", {"entities": []}], ["Beyond the obvious beneficial effects of warm bathes on the subjective well-being, it remains to be clarified what the unique contribution of the distinct essential oils dispersed in the water can be.", {"entities": []}], ["There is a lack of clinical studies exploring the efficacy of oil-dispersion baths.", {"entities": []}], ["Such studies are recommended for the future.", {"entities": []}], ["In sarcoidosis, increased Th17 cell fractions have been reported in bronchoalveolar lavage fluid, and elevated numbers of Th17 cells producing IFN- \u03b3 have been observed in peripheral blood.", {"entities": [[3, 14, "DISEASE"]]}], ["The balance between Th1, Th17, and FoxP3 \u03b3 was investigated.", {"entities": [[35, 40, "GENE"]]}], ["The fractions of FoxP3 P = 0.017 and P = 0.011, resp.).", {"entities": [[17, 22, "GENE"]]}], ["The proportion of Th17 cells positive for IFN- \u03b3 was greater in sarcoidosis than controls (median 72.4% versus 31%, P = 0.0005) and increased with radiologic stage ( N = 23, rho = 0.45, and P = 0.03).", {"entities": [[64, 75, "DISEASE"]]}], ["IFN- \u03b3 N = 23, rho = 0.64, and P = 0.001), and the ratio of IFN- \u03b3 \u03b3 \u03b3 could be a consequence of a Th1-polarized cytokine milieu.", {"entities": []}], ["Our results indicate a possible immune cell imbalance in sarcoidosis.", {"entities": [[57, 68, "DISEASE"]]}], ["Effectiveness of Internet-based self-management in patients with asthma has been shown, but its cost-effectiveness is unknown.", {"entities": [[65, 71, "DISEASE"]]}], ["We conducted a cost-effectiveness analysis of Internet-based asthma self-management compared with usual care.", {"entities": [[61, 67, "DISEASE"]]}], ["Cost-effectiveness analysis alongside a randomized controlled trial, with 12 months follow-up.", {"entities": []}], ["Patients were aged 18 to 50 year and had physician diagnosed asthma.", {"entities": [[61, 67, "DISEASE"]]}], ["The Internet-based self-management program involved weekly on-line monitoring of asthma control with self-treatment advice, remote Web communications, and Internet-based information.", {"entities": [[81, 87, "DISEASE"]]}], ["We determined quality adjusted life years (QALYs) as measured by the EuroQol-5D and costs for health care use and absenteeism.", {"entities": []}], ["We performed a detailed cost price analysis for the primary intervention.", {"entities": []}], ["QALYs did not statistically significantly differ between the Internet group and usual care: difference 0.024 (95% CI, \u22120.016 to 0.065).", {"entities": []}], ["Costs of the Internet-based intervention were $254 (95% CI, $243 to $265) during the period of 1 year.", {"entities": []}], ["From a societal perspective, the cost difference was $641 (95% CI, $\u22121957 to $3240).", {"entities": []}], ["From a health care perspective, the cost difference was $37 (95% CI, $\u2212874 to $950).", {"entities": []}], ["At a willingness-to-pay of $50000 per QALY, the probability that Internet-based self-management was cost-effective compared to usual care was 62% and 82% from a societal and health care perspective, respectively.", {"entities": []}], ["Internet-based self-management of asthma can be as effective as current asthma care and costs are similar.", {"entities": [[34, 40, "DISEASE"], [72, 78, "DISEASE"]]}], ["Current Controlled Trials ISRCTN79864465", {"entities": []}], ["Anti-PD-1 therapy yields objective clinical responses in 30\u201340% of advanced melanoma patients.", {"entities": [[76, 84, "DISEASE"]]}], ["Since most patients do not respond, predictive biomarkers to guide treatment selection are needed.", {"entities": []}], ["We hypothesize that MHC-I/II expression is required for tumour antigen presentation and may predict anti-PD-1 therapy response.", {"entities": []}], ["In this study, across 60 melanoma cell lines, we find bimodal expression patterns of MHC-II, while MHC-I expression was ubiquitous.", {"entities": [[25, 33, "DISEASE"]]}], ["A unique subset of melanomas are capable of expressing MHC-II under basal or IFN\u03b3-stimulated conditions.", {"entities": []}], ["Using pathway analysis, we show that MHC-II(+) cell lines demonstrate signatures of \u2018PD-1 signalling', \u2018allograft rejection' and \u2018T-cell receptor signalling', among others.", {"entities": []}], ["In two independent cohorts of anti-PD-1-treated melanoma patients, MHC-II positivity on tumour cells is associated with therapeutic response, progression-free and overall survival, as well as CD4 Immunotherapy is used to treat melanoma, however patient responses vary widely highlighting the need for factors that can predict therapeutic success.", {"entities": [[48, 56, "DISEASE"], [227, 235, "DISEASE"], [192, 195, "GENE"]]}], ["Here, the authors show that MHC-II molecules expressed by tumour cells are positively correlated with a good response to therapy and overall patient survival.", {"entities": []}], ["Online information retrieval systems have the potential to improve patient care but there are few comparative studies of the impact of online evidence on clinicians' decision-making behaviour in routine clinical work.", {"entities": []}], ["A randomized controlled parallel design is employed to assess the effectiveness of an online evidence retrieval system, Quick Clinical (QC) in improving clinical decision-making processes in general practice.", {"entities": []}], ["Eligible clinicians are randomised either to receive access or not to receive access to QC in their consulting rooms for 12 months.", {"entities": []}], ["Participants complete pre- and post trial surveys.", {"entities": []}], ["Two-hundred general practitioners are recruited.", {"entities": []}], ["Participants must be registered to practice in Australia, have a computer with Internet access in their consulting room and use electronic prescribing.", {"entities": []}], ["Clinicians planning to retire or move to another practice within 12 months or participating in any other clinical trial involving electronic extraction of prescriptions data are excluded from the study.", {"entities": []}], ["The primary end-points for the study is clinician acceptance and use of QC and the resulting change in decision-making behaviour.", {"entities": []}], ["The study will examine prescribing patterns related to frequently prescribed medications where there has been a recent significant shift in recommendations regarding their use based upon new evidence.", {"entities": []}], ["Secondary outcome measures include self-reported changes in diagnosis, patient education, prescriptions written, investigations and referrals.", {"entities": []}], ["A trial under experimental conditions is an effective way of examining the impact of using QC in routine general practice consultations.", {"entities": []}], ["Aspirin-induced asthma (AIA) and aspirin-induced urticaria/angioedema (AIU) are two major aspirin-related allergies.", {"entities": [[49, 58, "DISEASE"], [16, 22, "DISEASE"], [59, 69, "DISEASE"]]}], ["We summarize recent findings related to their molecular genetic mechanisms in order to identify genetic susceptibility markers for differentiating AIU and AIA.", {"entities": []}], ["The overproduction of cysteinyl leukotriene has been suggested as a mechanism in both AIU and AIA.", {"entities": []}], ["Increased expression of CYSLTR1 with CYLSTR1 and CYSLTR2 polymorphisms are new findings in AIA, while the ALOX5 promoter polymorphism has been noted in AIU.", {"entities": [[24, 31, "GENE"], [49, 56, "GENE"], [106, 111, "GENE"]]}], ["An HLA study suggested that DPB1*0301 is a strong genetic marker for AIA, and that HLA DRB1*1302 and DQB1*0609 are markers for AIU susceptibility.", {"entities": [[3, 6, "GENE"], [83, 86, "GENE"], [3, 6, "GENE"], [83, 86, "GENE"]]}], ["Several single nucleotide polymorphisms (SNPs) in the promoters of EP2 , TBX21 , COX-2 , Fc\u03b5RI\u03b2 , and TBXA2R were associated with AIA, while an Fc\u03b5RI\u03b1 promoter polymorphism was associated with AIU.", {"entities": [[73, 78, "GENE"], [102, 108, "GENE"]]}], ["The functional studies of the key genes involved in AIA and AIU are summarized.", {"entities": []}], ["The identification and functional study of genetic markers for AIA and AIU susceptibility would further elucidate the pathogenic mechanisms and facilitate the development of early diagnostic markers to establish therapeutic targets.", {"entities": []}], ["Pneumococcal disease causes substantial morbidity and mortality, including among adults.", {"entities": []}], ["Adult pneumococcal vaccines help to prevent these burdens, but they are underused.", {"entities": []}], ["Accounting for the full benefits of adult pneumococcal vaccination may promote more rational resource allocation decisions with respect to adult pneumococcal vaccines.", {"entities": []}], ["Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a systematic review to assess the extent to which the literature has empirically captured (e.g., through measurement or modeling) the full benefits of adult pneumococcal vaccination.", {"entities": []}], ["We systematically searched PubMed and Embase to identify studies published between January 1, 2010 and April 10, 2016 that examine adult pneumococcal vaccination.", {"entities": []}], ["We included articles if they captured any health or economic benefit of an adult pneumococcal vaccine administered to adults age \u2265 50 or \u2265 18 in risk groups.", {"entities": []}], ["Finally, we summarized the literature by categorizing the types of benefits captured, the perspective taken, and the strength of the evidence presented.", {"entities": []}], ["Our protocol is number 42016038335 in the PROSPERO International prospective register of systematic reviews.", {"entities": []}], ["We identified 5,857 papers and included 150 studies for analysis.", {"entities": []}], ["While most capture health gains and healthcare cost savings, far fewer studies consider additional benefit categories, such as productivity gains.", {"entities": []}], ["However, the studies with a broader approach still exhibit significant limitations; for example, many present only abstracts, while others offer no new measurements.", {"entities": []}], ["Studies that examine the 13-valent pneumococcal conjugate vaccine focus more on broad economic benefits, but still have limitations.", {"entities": []}], ["This review highlights the need for more robust empirical accounting of the full benefits of adult pneumococcal vaccination.", {"entities": []}], ["Literature outside this realm indicates that these broad benefits may be substantial.", {"entities": []}], ["Failing to investigate the full benefits may lead society to undervalue vaccines' contributions and therefore underinvest in their development and adoption.", {"entities": []}], ["Physicians associate empathy with benevolent emotions and with developing a shared understanding with patients.", {"entities": []}], ["While there have been many articles on managing \u201cdifficult\u201d patients, little attention has been paid to the challenges physicians face during conflicts with patients, especially when both parties are angry and yet empathy is still needed.", {"entities": []}], ["This topic is especially important in light of recent studies showing that practicing medicine increasingly requires physicians to manage their own feelings of anger and frustration.", {"entities": []}], ["This article seeks to describe how physicians can learn to empathize with patients even when they are both subject to emotions that lead to interpersonal distancing.", {"entities": []}], ["Empathy is defined as engaged curiosity about another\u2019s particular emotional perspective.", {"entities": []}], ["Five specific ways for physicians to foster empathy during conflict are described: recognizing one\u2019s own emotions, attending to negative emotions over time, attuning to patients\u2019 verbal and nonverbal emotional messages, and becoming receptive to negative feedback.", {"entities": []}], ["Importantly, physicians who learn to empathize with patients during emotionally charged interactions can reduce anger and frustration and also increase their therapeutic impact.", {"entities": []}], ["Reactive oxygen and nitrogen species (e.g.", {"entities": []}], ["H 2 O 2 , nitric oxide) confer redox regulation of essential cellular signaling pathways such as cell differentiation, proliferation, migration and apoptosis.", {"entities": []}], ["In addition, classical regulation of gene expression or activity, including gene transcription to RNA followed by translation to the protein level, by transcription factors (e.g.", {"entities": []}], ["NF-\u03baB, HIF-1\u03b1) and mRNA binding proteins (e.g.", {"entities": []}], ["GAPDH, HuR) is subject to redox regulation.", {"entities": [[0, 5, "GENE"]]}], ["This review will give an update of recent discoveries in this field, and specifically highlight the impact of reactive oxygen and nitrogen species on DNA repair systems that contribute to genomic stability.", {"entities": []}], ["Emphasis will be placed on the emerging role of redox mechanisms regulating epigenetic pathways (e.g.", {"entities": []}], ["miRNA, DNA methylation and histone modifications).", {"entities": []}], ["By providing clinical correlations we discuss how oxidative stress can impact on gene regulation/activity and vise versa, how epigenetic processes, other gene regulatory mechanisms and DNA repair can influence the cellular redox state and contribute or prevent development or progression of disease.", {"entities": []}], ["\u2022 Classical and epigenetic pathways of gene regulation are summarized.", {"entities": []}], ["\u2022 Pathways of DNA repair are summarized.", {"entities": []}], ["\u2022 The impact of redox signaling and oxidative stress on these pathways is discussed.", {"entities": []}], ["\u2022 Redox regulation of mRNA stability is discussed.", {"entities": []}], ["\u2022 New therapeutic strategies related to genome stability are presented.", {"entities": []}], ["Classical and epigenetic pathways of gene regulation are summarized.", {"entities": []}], ["Pathways of DNA repair are summarized.", {"entities": []}], ["The impact of redox signaling and oxidative stress on these pathways is discussed.", {"entities": []}], ["Redox regulation of mRNA stability is discussed.", {"entities": []}], ["New therapeutic strategies related to genome stability are presented.", {"entities": []}], ["Lower physical and social functioning in pregnancy has been linked to an increased risk of preterm delivery and low birth weight infants, butt few studies have examined racial differences in pregnant women\u2019s perception of their functioning.", {"entities": []}], ["Even fewer studies have elucidated the demographic and clinical factors contributing to racial differences in functioning.", {"entities": []}], ["Our objective was to determine whether there are racial differences in health-related quality of life (HRQoL) in early pregnancy; and if so, to identify the contributions of socio-demographic characteristics, depression symptoms, social support and clinical factors to these differences.", {"entities": []}], ["Cross-sectional study of 175 women in early pregnancy attending prenatal clinics in urban setting.", {"entities": []}], ["In multivariate analysis, we assessed the independent relation of black race (compared to white) to HRQoL scores from the eight domains of the Medical Outcomes (SF-36) Survey: Physical Functioning, Role-Physical, Bodily Pain, Vitality, General Health, Social Functioning, Role-Emotional, and Mental Health.", {"entities": []}], ["We compared socio-demographic and clinical factors and depression symptoms between black and white women and assessed the relative importance of these factors in explaining racial differences in physical and social functioning.", {"entities": []}], ["Black women comprised 59% of the sample; white women comprised 41%.", {"entities": []}], ["Before adjustment, black women had scores that were 14 points lower in Physical Function and Bodily Pain, 8 points lower in General Health, 4 points lower in Vitality and 7 points lower in Social Functioning.", {"entities": []}], ["After adjustment for depression symptoms, social support and clinical factors, black women still had HRQoL scores that were 4 to 10 points lower than white women, but the differences were no longer statistically significant.", {"entities": []}], ["Level of social support and payment source accounted for most of the variation in Physical Functioning, Bodily Pain and General Health.", {"entities": []}], ["Social support accounted for most of the differences in Vitality and Social Functioning.", {"entities": []}], ["Payment source and social support accounted for much of the racial differences in physical and social function scores.", {"entities": []}], ["Efforts to reduce racial differences might focus on improving social support networks and Socio-economic barriers.", {"entities": []}], ["Several studies have reported an association between chronic obstructive pulmonary disease (COPD) and periodontal diseases.", {"entities": [[53, 90, "DISEASE"]]}], ["However, a large-scale population-based cohort study was previously absent from the literature.", {"entities": []}], ["Therefore, we evaluated the risk of periodontal diseases in patients with COPD in a nationwide population.", {"entities": []}], ["From the National Health Insurance claims data of Taiwan, we identified 22,332 patients with COPD who were newly diagnosed during 2000 to 2010.", {"entities": []}], ["For each case, two individuals without COPD were randomly selected and frequency matched by age, sex, and diagnosis year.", {"entities": []}], ["Both groups were followed up till the end of 2011.", {"entities": []}], ["The overall incidence of periodontal diseases was 1.19-fold greater in the COPD group than in the comparison group (32.2 vs 26.4 per 1000 person-years; 95% confidence interval [CI] 1.15\u20131.24).", {"entities": []}], ["Compared with non-COPD patients, the adjusted hazard ratios of patients with COPD increased with the number of emergency room visits (from 1.14 [95% CI 1.10\u20131.19] to 5.09 [95% CI 4.53\u20135.72]) and admissions (from 1.15 [95% CI 1.10\u20131.20] to 3.17 [95% CI 2.81\u20133.57]).", {"entities": []}], ["In addition, the adjusted hazard ratios of patients with COPD treated with inhaled corticosteroids (1.22, 95% CI 1.11\u20131.34) and systemic corticosteroids (1.15, 95% CI 1.07\u20131.23) were significantly higher than those of patients not treated with corticosteroids.", {"entities": []}], ["Patient with COPD are at a higher risk of developing periodontal diseases than the general population.", {"entities": []}], ["Our results also support that the risk of periodontal diseases is proportional to COPD control.", {"entities": []}], ["In addition, patients who receive corticosteroid treatment are at a higher risk of developing periodontal diseases.", {"entities": []}], ["Advances in perinatal care have markedly increased the prospects of survival for infants born extremely preterm (EP).", {"entities": []}], ["The aim of this study was to investigate hospitalisation rates and respiratory morbidity from five to 11\u00a0years of age in a prospective national cohort of EP children born in the surfactant era.", {"entities": []}], ["This was a national prospective cohort study of all children born in Norway during 1999 and 2000 with gestational age (GA) <\u200928\u00a0weeks or birth weight\u2009<\u20091000\u00a0grams, and of individually matched term-born controls recruited for a regional subsample.", {"entities": []}], ["Data on hospital admissions, respiratory symptoms, and use of asthma medication was obtained by parental questionnaires at 11\u00a0years of age.", {"entities": [[62, 68, "DISEASE"]]}], ["Questionnaires were returned for 232/372 (62%) EP-born and 57/61 (93%) regional term-born controls.", {"entities": []}], ["Throughout the study period, 67 (29%) EP-born and seven (13%) term-born\u00a0controls were admitted to hospital (odds ratio (OR) 2.90, 95% confidence interval (CI): 1.25, 6.72).", {"entities": []}], ["Admissions were mainly due to surgical procedures, with only 12% due to respiratory causes, and were not influenced by neonatal bronchopulmonary dysplasia (BPD) or low GA(\u2264 25\u00a0weeks).", {"entities": []}], ["Respiratory symptoms, asthma and use of asthma medication tended to be more common for EP-born, significantly so for medication use and wheeze on exercise.", {"entities": [[22, 28, "DISEASE"], [40, 46, "DISEASE"]]}], ["Neonatal BPD was a risk factor for medication use, but not for current wheeze.", {"entities": []}], ["In multivariate regression models, home oxygen after discharge (OR 4.84, 95%\u00a0CI: 1.38, 17.06) and parental asthma (OR 4.38, 95%\u00a0CI: 1.69, 11.38) predicted current asthma, but neither BPD nor low GA were associated with respiratory symptoms at 11\u00a0years of age.", {"entities": [[107, 113, "DISEASE"], [163, 169, "DISEASE"]]}], ["Hospitalisation rates five to 11\u00a0years after EP birth were low, but twice those of term-born\u00a0controls, and unrelated to neonatal BPD and low GA. Respiratory causes were rare.", {"entities": []}], ["Respiratory complaints were more common in children born EP, but the burden of symptoms had declined since early childhood.", {"entities": []}], ["Resistance to anti-malarial drugs is a widespread problem for control programmes for this devastating disease.", {"entities": []}], ["Molecular tests are available for many anti-malarial drugs and are useful tools for the surveillance of drug resistance.", {"entities": []}], ["However, the correlation of treatment outcome and molecular tests with particular parasite markers is not perfect, due in part to individuals who are able to clear genotypically drug-resistant parasites.", {"entities": []}], ["This study aimed to identify molecular markers in the human genome that correlate with the clearance of malaria parasites after drug treatment, despite the drug resistance profile of the protozoan as predicted by molecular approaches.", {"entities": [[104, 111, "DISEASE"]]}], ["3721 samples from five African countries, which were known to contain genotypically drug resistant parasites, were analysed.", {"entities": []}], ["These parasites were collected from patients who subsequently failed to clear their infection following drug treatment, as expected, but also from patients who successfully cleared their infections with drug-resistant parasites.", {"entities": []}], ["67 human polymorphisms (SNPs) on 17 chromosomes were analysed using Sequenom's mass spectrometry iPLEX gold platform, to identify regions of the human genome, which contribute to enhanced clearance of drug resistant parasites.", {"entities": []}], ["An analysis of all data from the five countries revealed significant associations between the phenotype of ability to clear drug-resistant Plasmodium falciparum infection and human immune response loci common to all populations.", {"entities": []}], ["Overall, three SNPs showed a significant association with clearance of drug-resistant parasites with odds ratios of 0.76 for SNP rs2706384 (95% CI 0.71-0.92, P = 0.005), 0.66 for SNP rs1805015 (95% CI 0.45-0.97, P = 0.03), and 0.67 for SNP rs1128127 (95% CI 0.45-0.99, P = 0.05), after adjustment for possible confounding factors.", {"entities": []}], ["The first two SNPs (rs2706384 and rs1805015) are within loci involved in pro-inflammatory (interferon-gamma) and anti-inflammatory (IL-4) cytokine responses.", {"entities": []}], ["The third locus encodes a protein involved in the degradation of misfolded proteins within the endoplasmic reticulum, and its role, if any, in the clearance phenotype is unclear.", {"entities": []}], ["The study showed significant association of three loci in the human genome with the ability of parasite to clear drug-resistant P. falciparum in samples taken from five countries distributed across sub-Saharan Africa.", {"entities": []}], ["Both SNP rs2706384 and SNP1805015 have previously been reported to be associated with risk of malaria infection in African populations.", {"entities": [[94, 101, "DISEASE"]]}], ["The loci are involved in the Th1/Th2 balance, and the association of SNPs within these genes suggests a key role for antibody in the clearance of drug-resistant parasites.", {"entities": []}], ["It is possible that patients able to clear drug-resistant infections have an enhanced ability to control parasite growth.", {"entities": []}], ["Non-typeable Haemophilus influenza (NTHi) infection is common in COPD.", {"entities": [[25, 34, "DISEASE"]]}], ["Corticosteroids can have limited therapeutic effects in COPD patients.", {"entities": []}], ["NTHi causes corticosteroid insensitive cytokine production from COPD alveolar macrophages.", {"entities": []}], ["We investigated the mechanisms by which NTHi causes corticosteroid insensitive inflammatory responses, and the effects of NTHi exposure on COPD macrophage polarisation.", {"entities": []}], ["Alveolar macrophages from COPD patients and controls were exposed to NTHi in conjunction with the corticosteroid dexamethasone and/or the p38 MAPK inhibitor BIRB-796.", {"entities": []}], ["Cytokine release, GR phosphorylation and modulation and macrophage phenotype were analysed.", {"entities": []}], ["Dexamethasone significantly inhibited NTHi induced TNF-\u03b1, IL-6 and IL-10 from COPD macrophages but, CXCL8 was not suppressed.", {"entities": []}], ["BIRB-796 combined with dexamethasone caused significantly greater inhibition of all cytokines than either drug alone ( p \u2009<\u20090.05 all comparisons).", {"entities": []}], ["NTHi caused phosphorylation of GR S226 reducing GR nuclear localisation, an effect regulated by p38 MAPK.", {"entities": []}], ["NTHi altered macrophage polarisation by increasing IL-10 and decreasing CD36, CD206, CD163 and HLA-DR. NTHi exposure causes p38 MAPK dependent GR phosphorylation associated with decreased GR function in COPD alveolar macrophages.", {"entities": [[72, 76, "GENE"], [85, 90, "GENE"]]}], ["Combining a p38 MAPK inhibitor with corticosteroids can enhance anti-inflammatory effects during NTHi exposure of COPD alveolar macrophages.", {"entities": []}], ["NTHi causes macrophage polarisation that favours bacterial persistence.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0539-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Human Microbiome Project will establish a reference data set for analysis of the microbiome of healthy adults by surveying multiple body sites from 300 people and generating data from over 12,000 samples.", {"entities": []}], ["To characterize these samples, the participating sequencing centers evaluated and adopted 16S rDNA community profiling protocols for ABI 3730 and 454 FLX Titanium sequencing.", {"entities": []}], ["In the course of establishing protocols, we examined the performance and error characteristics of each technology, and the relationship of sequence error to the utility of 16S rDNA regions for classification- and OTU-based analysis of community structure.", {"entities": []}], ["The data production protocols used for this work are those used by the participating centers to produce 16S rDNA sequence for the Human Microbiome Project.", {"entities": []}], ["Thus, these results can be informative for interpreting the large body of clinical 16S rDNA data produced for this project.", {"entities": []}], ["ShK, from the sea anemone Stichodactyla helianthus , is a 35-residue disulfide-rich peptide that blocks the voltage-gated potassium channel Kv1.3 at ca.", {"entities": []}], ["10 pM and the related channel Kv1.1 at ca.", {"entities": []}], ["We developed an analog of this peptide, ShK-186, which is currently in Phase 1b-2a clinical trials for the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.", {"entities": [[148, 166, "DISEASE"], [171, 191, "DISEASE"], [182, 191, "DISEASE"]]}], ["While ShK-186 displays a >100-fold improvement in selectivity for Kv1.3 over Kv1.1 compared with ShK, there is considerable interest in developing peptides with an even greater selectivity ratio.", {"entities": []}], ["In this report, we describe several variants of ShK that incorporate p -phophono-phenylalanine at the N -terminus coupled with internal substitutions at Gln16 and Met21.", {"entities": []}], ["In addition, we also explored the combinatorial effects of these internal substitutions with an alanine extension at the C- terminus.", {"entities": []}], ["Their selectivity was determined by patch-clamp electrophysiology on Kv1.3 and Kv1.1 channels stably expressed in mouse fibroblasts.", {"entities": []}], ["The peptides with an alanine extension blocked Kv1.3 at low pM concentrations and exhibited up to 2250-fold selectivity for Kv1.3 over Kv1.1.", {"entities": []}], ["Analogs that incorporates p-phosphono-phenylalanine at the N -terminus blocked Kv1.3 with IC 50 s in the low pM range and did not affect Kv1.1 at concentrations up to 100 nM, displaying a selectivity enhancement of >10,000-fold for Kv1.3 over Kv1.1.", {"entities": []}], ["Other potentially important Kv channels such as Kv1.4 and Kv1.6 were only partially blocked at 100 nM concentrations of each of the ShK analogs.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is common but largely underdiagnosed.", {"entities": []}], ["Case-finding initiatives have been evaluated in primary care, but few studies have explored the views of service providers on implementing them in practice.", {"entities": []}], ["To explore the views of primary health care providers on case finding for COPD.", {"entities": []}], ["A total of 20 semi-structured interviews were conducted from March 2014 to September 2014 among general practitioners, nurses, and managers from practices participating in a large COPD case-finding trial based in primary care in the West Midlands, UK.", {"entities": []}], ["Participants\u2019 views were sought to explore perceived benefits, harms, barriers, and facilitators to implementing COPD case finding in practice.", {"entities": []}], ["Interviews were transcribed and analyzed using the framework method.", {"entities": []}], ["Participants felt that case finding improves patient care but also acknowledged potential harms to providers (increase in workload) and to patients (overdiagnosis).", {"entities": []}], ["Insufficient resources, poor knowledge of COPD, and limited access to diagnostic services were viewed as barriers to diagnosis, while provision of community respiratory services, including COPD specialist nurses, and support from secondary care were thought to be facilitators.", {"entities": []}], ["Participants also expressed a need for more education on COPD for both patients and clinicians.", {"entities": []}], ["Care providers believe that early detection of COPD improves patient care but also has accompanying harms.", {"entities": []}], ["Barriers to diagnosing COPD, such as insufficient expertise in primary care and limited access to diagnostic services in the community, should be explored and addressed.", {"entities": []}], ["The knowledge and attitudes of the public about COPD and its symptoms should also be investigated to inform future education and awareness-raising strategies.", {"entities": []}], ["The epidemiology and disease burden of annual influenza in children in mainland People's Republic of China have not been reported in detail.", {"entities": [[46, 55, "DISEASE"]]}], ["To understand the incidence and epidemiology of laboratory-proven influenza hospitalization in children in China, a review of available laboratory and hospital admission data was undertaken.", {"entities": [[66, 75, "DISEASE"]]}], ["We conducted a retrospective population-based study in Suzhou and the surrounding area of Jiangsu province, China for hospitalized cases of respiratory illness at Suzhou Children's Hospital.", {"entities": []}], ["Cases of pneumonia or respiratory illness were identified from hospital computer data bases.", {"entities": [[9, 18, "DISEASE"]]}], ["Routine virological testing by fluorescent monoclonal antibody assay of all hospitalized children identified influenza and other viruses.", {"entities": [[109, 118, "DISEASE"]]}], ["We calculated incidence rates using census population denominators.", {"entities": []}], ["Of 7,789 specimens obtained during 2007 and 2008, 85 were positive for influenza A and 25 for influenza B.", {"entities": [[71, 80, "DISEASE"], [94, 103, "DISEASE"]]}], ["There were 282 specimens with parainfluenza virus and 1392 with RSV.", {"entities": []}], ["Influenza occurred throughout the year, with peaks in the winter, and in August/September.", {"entities": [[0, 9, "DISEASE"]]}], ["Overall estimated annual incidence of laboratory-proven influenza hospitalization was 23-27/100,000 children 0-4 years old, and 60/100,000 in infants 0-6 months, with an average hospitalization of 9 days.", {"entities": [[56, 65, "DISEASE"]]}], ["Influenza disease in young children in this part of China is a relatively common cause of hospitalization, and occurs throughout the year.", {"entities": [[0, 9, "DISEASE"]]}], ["The use of influenza vaccine in Chinese children has the potential to reduce the effect of influenza in the children, as well as in their communities.", {"entities": [[11, 20, "DISEASE"], [91, 100, "DISEASE"]]}], ["Studies are needed to further assess the burden of influenza, and to develop and refine effective strategies of immunization of young children in China.", {"entities": [[51, 60, "DISEASE"]]}], ["Maternal obesity may influence neonatal and childhood morbidities through increased inflammation and/or altered immune response.", {"entities": [[9, 16, "DISEASE"]]}], ["Less is known about paternal obesity.", {"entities": [[29, 36, "DISEASE"]]}], ["We hypothesized that excessive parental weight contributes to elevated inflammation and altered immunoglobulin (Ig) profiles in neonates.", {"entities": []}], ["In the Upstate KIDS Study maternal pre-pregnancy body mass index (BMI) was obtained from vital records and paternal BMI from maternal report.", {"entities": []}], ["Biomarkers were measured from newborn dried blood spots (DBS) among neonates whose parents provided consent.", {"entities": []}], ["Inflammatory scores were calculated by assigning one point for each of 5 pro-inflammatory biomarkers above the median and one point for an anti-inflammatory cytokine below the median.", {"entities": []}], ["Linear regression models and generalized estimating equations were used to estimate mean differences (\u03b2) and 95% confidence intervals (CI) in the inflammatory score and Ig levels by parental overweight/obesity status compared to normal weight.", {"entities": [[202, 209, "DISEASE"]]}], ["Among 2974 pregnancies, 51% were complicated by excessive maternal weight (BMI>25), 73% by excessive paternal weight, and 28% by excessive gestational weight gain.", {"entities": []}], ["Maternal BMI categories of overweight (BMI 25.0-29.9) and obese class II/III (BMI\u226535) were associated with increased neonatal inflammation scores (\u03b2=0.12, 95% CI: 0.02, 0.21; p=0.02, and \u03b2=0.13, CI: \u22120.002, 0.26; p=0.05, respectively) but no increase was observed in the obese class I group (BMI 30-34.9).", {"entities": []}], ["Mothers with class I and class II/III obesity had newborns with increased IgM levels (\u03b2=0.11, CI: 0.04, 0.17; p=0.001 and \u03b2=0.12, CI: 0.05, 0.19); p<0.001, respectively).", {"entities": [[38, 45, "DISEASE"]]}], ["Paternal groups of overweight, obese class I and obese class II/III had decreased neonatal IgM levels (\u03b2=\u22120.08, CI: \u22120.13,-0.03, p=0.001; \u03b2=\u22120.07, CI: \u22120.13, \u22120.01, p=0.029 and \u03b2=\u22120.11, CI:\u22120.19,-0.04, p=0.003, respectively).", {"entities": []}], ["Excessive maternal weight was generally associated with increased inflammation and IgM supporting previous observations of maternal obesity and immune dysregulation in offspring.", {"entities": [[132, 139, "DISEASE"]]}], ["The role of paternal obesity requires further study.", {"entities": [[21, 28, "DISEASE"]]}], ["Psychosocial stress has been identified as a risk factor in association with cardiovascular disease but less attention has been paid to heterogeneity in vulnerability to stress.", {"entities": []}], ["The serial Color Word Test (CWT) measures adaptation to a stressful situation and it can be used to identify individuals that are vulnerable to stress.", {"entities": []}], ["Prospective studies have shown that individuals with a maladaptive behavior in this test are exposed to an increased risk of future cardiovascular events.", {"entities": []}], ["The aim of the present study was to investigate whether maladaptive behavior in the serial CWT alone or in combination with any specific personality dimension was associated with severity of myocardial infarction (MI).", {"entities": [[191, 212, "DISEASE"]]}], ["MI-patients (n = 147) completed the test and filled in a personality questionnaire in close proximity to the acute event.", {"entities": []}], ["The results were analyzed in association with four indicators of severity: maximum levels above median of the cardiac biomarkers troponin I and creatine kinase-MB (CKMB), Q-wave infarctions, and a left ventricular ejection fraction (LVEF) \u2264 50%.", {"entities": []}], ["Maladaptive behavior in the serial CWT together with low scores on extraversion were associated with maximum levels above median of cardiac troponin I (OR 2.97, CI 1.08-8.20, p = 0.04) and CKMB (OR 3.33, CI 1.12-9.93, p = 0.03).", {"entities": []}], ["No associations were found between the combination maladaptive behavior and low scores on extraversion and Q-wave infarctions or a decreased LVEF.", {"entities": []}], ["Maladaptive behavior in combination with low scores on extraversion is associated with higher cardiac biomarker levels following an MI.", {"entities": []}], ["The serial CWT and personality questionnaires could be used to identify individuals vulnerable to the hazardous effects of stress and thereby are exposed to an increased risk of a more severe infarction.", {"entities": []}], ["Propofol anesthesia is often associated with decreased incidence of gagging, coughing or laryngospasm, and provides intense suppression on airway reflex during tracheal intubation and laryngeal mask airway insertion.", {"entities": []}], ["Propofol pretreatment is also effective in reducing the occurrence of opioid-induced coughing.", {"entities": []}], ["These benefits are often attributed to bronchodilator and sedative effects of propofol.", {"entities": []}], ["However, severe coughing following sedative doses of 1% propofol has not been reported so far.", {"entities": []}], ["We report a rare case of violent coughing following low-dose propofol infusion in a patient with Becker's muscular dystrophy.", {"entities": [[106, 124, "DISEASE"]]}], ["Diabetes mortality at the United States\u2013Mexico border is twice the national average.", {"entities": []}], ["Type 2 diabetes mellitus is increasingly diagnosed among children and adolescents.", {"entities": [[7, 24, "DISEASE"]]}], ["Fragmented services and scarce resources further restrict access to health care.", {"entities": []}], ["Increased awareness of the incidence of disease and poor health outcomes became a catalyst for creating community-based coalitions and partnerships with the University of Arizona that focused on diabetes.", {"entities": []}], ["Five partnerships between the communities and the University of Arizona were formed to address these health issues.", {"entities": []}], ["They began with health promotion as their goal and were challenged to add policy and environmental change to their objectives.", {"entities": []}], ["Understanding the meaning of policy in the community context is the first step in the transition from program to policy.", {"entities": []}], ["Policy participation brings different groups together, strengthening ties and building trust among community members and community organizations.", {"entities": []}], ["Data on progress and outcomes were collected from multiple sources.", {"entities": []}], ["We used the Centers for Disease Control and Prevention's Racial and Ethnic Approaches to Community Health (REACH) 2010 Community Change Model as the capacity-building and analytic framework for supporting and documenting the transition of coalitions from program to policy.", {"entities": []}], ["Over 5 years, the coalitions made the transition, in varying degrees, from a programmatic focus to a policy planning and advocacy focus.", {"entities": []}], ["The coalitions raised community awareness, built community capacity, encouraged a process of \"change in change agents,\" and advocated for community environmental and policy shifts to improve health behaviors.", {"entities": []}], ["The five coalitions made environmental and policy impacts by engaging in policy advocacy.", {"entities": []}], ["These outcomes indicate the successful, if not consistently sustained, transition from program to policy.", {"entities": []}], ["Whether and how these \"changes in change agents\" are transferable to the larger community over the long term remains to be seen.", {"entities": []}], ["This study estimated the association between particulate air pollution and daily mortality in Utah Valley using the synoptic climatological approach to control for potential weather effects.", {"entities": []}], ["This approach was compared with alternative weather modeling approaches.", {"entities": []}], ["Although seasonality explained a significant amount of variability in mortality, other weather variables explained only a very small amount of additional variability in mortality.", {"entities": []}], ["The synoptic climatological approach performed as well or slightly better than alternative approaches to controlling for weather.", {"entities": []}], ["However, the estimated effect of particulate pollution on mortality was mostly unchanged or slightly larger when synoptic categories were used to control for weather.", {"entities": []}], ["Furthermore, the shape of the estimated dose-response relationship was similar when alternative approaches to controlling for weather were used.", {"entities": []}], ["The associations between particulate pollution and daily mortality were not significantly different from a linear exposure-response relationship that extends throughout the full observed range of pollution.", {"entities": []}], ["Alzheimer's disease (AD), characterized by progressive dementia and deterioration of cognitive function, is an unsolved social and medical problem.", {"entities": [[55, 63, "DISEASE"]]}], ["Age, nutrition, and toxins are the most common causes of AD.", {"entities": []}], ["However, currently no credible treatment is available for AD.", {"entities": []}], ["Traditional herbs and phytochemicals may delay its onset and slow its progression and also allow recovery by targeting multiple pathological causes by antioxidative, anti-inflammatory, and antiamyloidogenic properties.", {"entities": []}], ["They also regulate mitochondrial stress, apoptotic factors, free radical scavenging system, and neurotrophic factors.", {"entities": []}], ["Neurotrophins such as BDNF, NGF, NT3, and NT4/5 play a vital role in neuronal and nonneuronal responses to AD.", {"entities": [[22, 26, "GENE"], [28, 31, "GENE"]]}], ["Neurotrophins depletion accelerates the progression of AD and therefore, replacing such neurotrophins may be a potential treatment for neurodegenerative disease.", {"entities": [[135, 160, "DISEASE"]]}], ["Here, we review the phytochemicals that mediate the signaling pathways involved in neuroprotection specifically neurotrophin-mediated activation of Trk receptors and members of p75 in vitro neurotrophin potentiating activity, their in vivo and clinical efficacy trials has yet to be established.", {"entities": []}], ["Therefore, further research is necessary to prove the neuroprotective effects in preclinical models and in humans.", {"entities": []}], ["DNA-based gene therapy has considerable therapeutic potential, but the challenges associated with delivery continue to limit progress.", {"entities": []}], ["Messenger RNA (mRNA) has the potential to provide for transient production of therapeutic proteins, without the need for nuclear delivery and without the risk of insertional mutagenesis.", {"entities": []}], ["Here we describe the sustained delivery of therapeutic proteins in vivo in both rodents and non-human primates via nanoparticle-formulated mRNA.", {"entities": []}], ["Nanoparticles formulated with lipids and lipid-like materials were developed for delivery of two separate mRNA transcripts encoding either human erythropoietin (hEPO) or factor IX (hFIX) protein.", {"entities": []}], ["Dose-dependent protein production was observed for each mRNA construct.", {"entities": []}], ["Upon delivery of hEPO mRNA in mice, serum EPO protein levels reached several orders of magnitude (>125\u2009000-fold) over normal physiological values.", {"entities": [[42, 45, "GENE"]]}], ["Further, an increase in hematocrit (Hct) was established, demonstrating that the exogenous mRNA-derived protein maintained normal activity.", {"entities": []}], ["The capacity of producing EPO in non-human primates via delivery of formulated mRNA was also demonstrated as elevated EPO protein levels were observed over a 72-h time course.", {"entities": [[26, 29, "GENE"], [118, 121, "GENE"], [26, 29, "GENE"], [118, 121, "GENE"]]}], ["Exemplifying the possible broad utility of mRNA drugs, therapeutically relevant amounts of human FIX (hFIX) protein were achieved upon a single intravenous dose of hFIX mRNA-loaded lipid nanoparticles in mice.", {"entities": []}], ["In addition, therapeutic value was established within a hemophilia B (FIX knockout (KO)) mouse model by demonstrating a marked reduction in Hct loss following injury (incision) to FIX KO mice.", {"entities": []}], ["A quantitative measurement of inequality in geographic accessibility to pediatric care as well as that of mean distance or travel time is very important for priority setting to ensure fair access to pediatric facilities.", {"entities": []}], ["However, conventional techniques for measuring inequality is inappropriate in geographic settings.", {"entities": []}], ["Since inequality measures of access distance or travel time is strongly influenced by the background geographic distribution patterns, they cannot be directly used for regional comparisons of geographic accessibility.", {"entities": []}], ["The objective of this study is to resolve this issue by using a standardization approach.", {"entities": []}], ["Travel times to the nearest pediatric care were calculated for all children in Oita Prefecture, Japan.", {"entities": []}], ["Relative mean differences were considered as the inequality measure for secondary medical service areas, and were standardized with an expected value estimated from a Monte Carlo simulation based on complete spatial randomness.", {"entities": []}], ["The observed mean travel times in the area considered averaged 4.50 minutes, ranging from 1.83 to 7.02 minutes.", {"entities": []}], ["The mean of the observed inequality measure was 1.1, ranging from 0.9 to 1.3.", {"entities": []}], ["The expected values of the inequality measure varied according to the background geographic distribution pattern of children, which ranged from 0.3 to 0.7.", {"entities": []}], ["After standardizing the observed inequality measure with the expected one, we found that the ranks of the inequality measure were reversed for the observed areas.", {"entities": []}], ["Using the indicator proposed in this paper, it is possible to compare the inequality in geographic accessibility among regions.", {"entities": []}], ["Such a comparison may facilitate priority setting in health policy and planning.", {"entities": []}], ["The high educated live longer and healthier lives when compared to the low educated.", {"entities": []}], ["Physical fitness as a health indicator reflects the level of physical activity along with other health-influencing factors such as obesity, smoking, chronic diseases and individual training effects.", {"entities": [[131, 138, "DISEASE"]]}], ["Studies support that self-rated physical fitness correlates with objectively measured physical fitness well.", {"entities": []}], ["However, the educational differences in self-rated physical fitness are not known.", {"entities": []}], ["Our aim was to study educational differences in self-rated physical fitness in Finnish population.", {"entities": []}], ["The data were collected in 2007 for a cross-sectional population based National FINRISK Study.", {"entities": []}], ["The analyzed data included 2722 men and 3108 women aged 25 to 74\u00a0years.", {"entities": []}], ["Statistical method was ordinal logistic regression.", {"entities": []}], ["Longer educational career was associated with better self-rated physical fitness.", {"entities": []}], ["The educational differences in self-rated physical fitness were largely explained by health behavior.", {"entities": []}], ["Leisure-time physical activity explained fully and body mass index partly the educational differences in self-rated physical fitness among men.", {"entities": []}], ["The combination of body mass index, history of chronic diseases and smoking explained the differences fully among men and partly among women.", {"entities": []}], ["Leisure-time, occupational and commuting physical activities, body mass index, history of chronic diseases and smoking together explained all educational differences in self-rated physical fitness among both genders.", {"entities": []}], ["Although educational differences in self-rated physical fitness were found, they were explained by health behavior related factors.", {"entities": []}], ["Leisure-time physical activity offered the strongest single explanation for the educational differences in self-rated physical fitness.", {"entities": []}], ["Thus, possibilities for leisure-time physical activity should be increased especially among the low educated.", {"entities": []}], ["Influenza A (H1N1)pdm09 (2009 H1N1) re-circulated as the predominant virus from January through February 2011 in China.", {"entities": []}], ["National surveillance of 2009 H1N1 as a notifiable disease was maintained to monitor potential changes in disease severity from the previous season.", {"entities": []}], ["To describe the characteristics of hospitalized cases with 2009 H1N1 infection and analyze risk factors for severe illness during the 2010\u20132011winter season in China, we obtained surveillance data from hospitalized cases with 2009 H1N1 infection from November 2010 through May 2011, and reviewed medical records from 701 hospitalized cases.", {"entities": []}], ["Age-standardized risk ratios were used to compare the age distribution of patients that were hospitalized and died due to 2009 H1N1 between the 2010\u20132011winter season to those during the 2009\u20132010 pandemic period.", {"entities": []}], ["During the 2010\u20132011 winter season, children less than 5 years of age had the highest relative risk of hospitalization and death, followed by adults aged 65 years or older.", {"entities": []}], ["Additionally, the relative risk of hospitalized cases aged 5\u201314 and 15\u201324 years was lower compared to children less than 5 years of age.", {"entities": []}], ["During the winter season of 2010\u20132011, the proportions of adults aged 25 years or older for hospitalization and death were significantly higher than those during the 2009\u20132010 pandemic period.", {"entities": []}], ["Being male, having a chronic medical condition, delayed hospital admission (\u22653 days from onset) or delayed initiation of antiviral treatment (\u22655 days from onset) were associated with severe illness among non-pregnant patients \u22652 years of age.", {"entities": []}], ["We observed a change in high risk groups for hospitalization for 2009 H1N1 during the winter months immediately following the pandemic period compared to the high risk groups identified during the pandemic period.", {"entities": []}], ["Our nationally notifiable disease surveillance system enabled us to understand the evolving epidemiology of 2009 H1N1 infection after the pandemic period.", {"entities": []}], ["Lower levels of physical activity and cardiorespiratory fitness are key risk factors of chronic adult diseases.", {"entities": []}], ["Physical activity and cardiorespiratory fitness are predicted by birth weight, but the underlying parental and pregnancy-related factors remain largely unknown.", {"entities": []}], ["We examined how prenatal determinants are associated with physical activity and cardiorespiratory fitness in adolescence.", {"entities": []}], ["Of the 16-year-old members of the population-based Northern Finland Birth Cohort 1986 (NFBC 1986), 6682 singletons with no major physical disability reported their amount of physical activity outside school hours, and 4706 completed a submaximal cycle ergometer test assessing cardiorespiratory fitness.", {"entities": []}], ["Physical activity was expressed as metabolic equivalent hours per week (METh/week) and cardiorespiratory fitness as peak oxygen uptake (ml\u00b7kg A higher birth weight and longer length of gestation predicted lower levels of physical activity and cardiorespiratory fitness at 16\u00a0years, although the association between length of gestation and physical activity was inverse U-shaped.", {"entities": []}], ["Mother\u2019s or father\u2019s overweight or obesity before pregnancy were associated with lower levels of their offspring\u2019s physical activity and fitness in adolescence.", {"entities": [[35, 42, "DISEASE"]]}], ["Adjusting for maternal pregnancy disorders and the adolescent\u2019s own BMI attenuated the associations with the mother\u2019s but not the father\u2019s overweight/obesity.", {"entities": [[150, 157, "DISEASE"]]}], ["Furthermore, maternal GDM predicted lower cardiorespiratory fitness.", {"entities": []}], ["A high birth weight and parental overweight/obesity are associated with lower levels of both physical activity and cardiorespiratory fitness in adolescence, while maternal GDM and longer length of gestation are associated with lower cardiorespiratory fitness.", {"entities": [[44, 51, "DISEASE"]]}], ["Both long and short lengths of gestation predict low physical activity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-017-4237-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Occult Hepatitis C virus (HCV) infection is a new pathological entity characterized by presence of liver disease and absence or very low levels of detectable HCV-RNA in serum.", {"entities": [[99, 112, "DISEASE"]]}], ["Abnormal values of liver enzymes and presence of replicative HCV-RNA in peripheral blood mononuclear cells are also observed.", {"entities": []}], ["Aim of the study was to evaluate occult HCV occurrence in a population unselected for hepatic disease.", {"entities": []}], ["We chose from previous epidemiological studies three series of subjects (n\u200a=\u200a276, age range 40\u201365 years) unselected for hepatic disease.", {"entities": []}], ["These subjects were tested for the presence of HCV antibodies and HCV-RNA in plasma and in the peripheral blood mononuclear cells (PBMCs) by using commercial systems.", {"entities": []}], ["All subjects tested negative for HCV antibodies and plasma HCV-RNA and showed normal levels of liver enzymes; 9/276 patients (3.3%) were positive for HCV-RNA in PBMCs, identifying a subset of subjects with potential occult HCV infection.", {"entities": []}], ["We could determine the HCV type for 8 of the 9 patients finding type 1a (3 patients), type 1b (2 patients), and type 2a (3 patients).", {"entities": []}], ["The results of this study show evidence that occult HCV infection may occur in a population unselected for hepatic disease.", {"entities": []}], ["A potential risk of HCV infection spread by subjects harbouring occult HCV infection should be considered.", {"entities": []}], ["Design of prospective studies focusing on the frequency of infection in the general population and on the clinical evolution of occult HCV infection will be needed to verify this unexpected finding.", {"entities": []}], ["High-affinity receptor I (Fc\u03b5RI) on mast cells and basophils plays a key role in the immunoglobulin E (IgE)-mediated type I hypersensitivity mediated by allergen cross-linking of the specific IgE-Fc\u03b5RI complex.", {"entities": []}], ["Thus, prevention of IgE binding to Fc\u03b5RI on these cells is an effective therapy for allergic disease.", {"entities": []}], ["We have developed a strategy to disrupt IgE binding to Fc\u03b5RI using an antibody targeting Fc\u03b5RI\u03b1.", {"entities": []}], ["Fab fragment antibodies, which lack the Fc domain, with high affinity and specificity for Fc\u03b5RI\u03b1 and effective inhibitory activity against IgE-Fc\u03b5RI binding were screened.", {"entities": []}], ["IgE-induced histamine, \u03b2-hexosaminidase and Ca Fcer1a Tg(FCER1A)1Bhk/J mouse model of passive cutaneous anaphylaxis (PCA) was used to examine the inhibitory effect of NPB311 on allergic skin inflammation.", {"entities": [[47, 53, "GENE"], [57, 63, "GENE"], [54, 56, "GENE"], [47, 53, "GENE"], [57, 63, "GENE"]]}], ["NPB311 exhibited high affinity to human Fc\u03b5RI\u03b1 (KD=4 nM) and inhibited histamine, \u03b2-hexosaminidase and Ca Our approach for producing anti-Fc\u03b5RI\u03b1 Fab fragment antibody NPB311 may enable clinical application to a therapeutic pathway in IgE/Fc\u03b5RI-mediated diseases.", {"entities": []}], ["It is unknown whether aggressive medication strategies should be used for early COPD with or without lung hyperinflation.", {"entities": []}], ["We aimed to explore the characteristics and bronchodilator responsiveness of early COPD patients (stages I and II) with/without lung hyperinflation.", {"entities": []}], ["Four hundred and six patients with COPD who performed both lung volume and bronchodilation tests were retrospectively analyzed.", {"entities": []}], ["Residual volume to total lung capacity >120% of predicted values indicated lung hyperinflation.", {"entities": []}], ["The characteristics and bronchodilator responsiveness were compared between the patients with and without lung hyperinflation across all stages of COPD.", {"entities": []}], ["The percentages of patients with lung hyperinflation were 72.7% in the entire cohort, 19.4% in stage I, 68.5% in stage II, 95.3% in stage III, and 100.0% in stage IV.", {"entities": []}], ["The patients with lung hyperinflation exhibited poorer lung function but better bronchodilator responsiveness of both forced expiratory volume in 1 second and forced vital capacity than those without lung hyperinflation during early COPD ( t =2.21\u20135.70, P =0.000\u20130.029), especially in stage I, while age, body mass index, smoking status, smoking history, and disease duration were similar between the two subgroups in the same stages.", {"entities": []}], ["From stages I to IV of subgroups with lung hyperinflation, stage I patients had the best bronchodilator responsiveness.", {"entities": []}], ["Use of bronchodilator responsiveness of forced vital capacity to detect the presence of lung hyperinflation in COPD patients showed relatively high sensitivities (69.5%\u201375.3%) and specificities (70.3%\u201375.7%).", {"entities": []}], ["We demonstrated the novel finding that early COPD patients with lung hyperinflation are associated with poorer lung function but better bronchodilator responsiveness and established a simple method for detecting lung hyperinflation.", {"entities": []}], ["T helper 9 (Th9) cells contribute to lung inflammation and allergy as sources of interleukin-9 (IL-9).", {"entities": []}], ["However, the mechanisms by which IL-9/Th9 mediate immunopathology in the lung are unknown.", {"entities": []}], ["Here we report an IL-9-driven positive feedback loop that reinforces allergic inflammation.", {"entities": []}], ["We show that IL-9 increases IL-2 production by mast cells, which leads to expansion of CD25 In patients with cystic fibrosis, IL-9 signalling is increased.", {"entities": [[109, 124, "DISEASE"]]}], ["The authors describe an inflammatory loop in which IL-9 produced by Th9 cells drives mast cells to produce IL-2, resulting in ILC2 cell activation, and show inhibition of this loop with blocking antibodies to IL-9 in a mouse model of pulmonary infection.", {"entities": []}], ["The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor.", {"entities": []}], ["The murine CHS model was induced by applying oxazolone to the ears of mice.", {"entities": []}], ["Mesenchymal stromal cells were applied via two methods (intravenous or local injection) at three time points: 1 day before sensitization, 1 day before challenge, or 1 h after challenge.", {"entities": []}], ["Prostaglandin E 2 (PGE 2 ) and sulprostone were administered subcutaneously 1 h after challenge.", {"entities": []}], ["The application of GMSCs, bone marrow mesenchymal stem cells, and adipose-derived stem cells all effectively suppressed CHS; however, GMSC treatment exhibited the greatest efficacy.", {"entities": []}], ["Local injection of GMSCs led to a more marked attenuation of CHS compared with intravenous injection, especially during the late phase of CHS, and this manifested as decreased infiltration of inflammatory cells, suppression of the levels of various proinflammatory cytokines, reconstruction of the disrupted Th1/Th2 balance, and upregulation of regulatory T cells in the allergen contact areas.", {"entities": []}], ["Pretreatment with indomethacin significantly abrogated the GMSC-mediated immunosuppressive effects, while PGE 2 application reversed the effects of indomethacin pretreatment of GMSCs.", {"entities": []}], ["Moreover, GMSC administration promoted the expression of EP 3 , a prostaglandin E receptor, and the application of sulprostone, an agonist of EP 3 , significantly attenuated CHS to a similar degree as that of GMSC administration.", {"entities": []}], ["GMSCs have reproducible and powerful immunomodulatory functions.", {"entities": []}], ["Local injection of GMSCs is the superior mode for therapeutic application.", {"entities": []}], ["PGE 2 \u2013EP 3 signaling plays an important role in the immunomodulatory functions of GMSCs in murine CHS.", {"entities": []}], ["The online version of this article (doi:10.1186/s13287-016-0361-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To compare the effect of nebulized racemic epinephrine to nebulized racemic albuterol on successful discharge from the emergency department (ED).", {"entities": []}], ["Children up to their 18th month of life presenting to two teaching hospital EDs with a clinical diagnosis of bronchiolitis who were ill enough to warrant treatment but did not need immediate intubation were eligible for this double-blind randomized controlled trial (RCT).", {"entities": [[109, 122, "DISEASE"]]}], ["Patients received either three doses of racemic albuterol or one dose of racemic epinephrine plus two saline nebulizers.", {"entities": []}], ["Disposition was decided 2 hours after the first nebulizer.", {"entities": []}], ["Successful discharge was defined as not requiring additional bronchodilators in the ED after study drug administration and not subsequently admitted within 72 hours.", {"entities": []}], ["Adjusted relative risks (aRR) were estimated using the modified Poisson regression with successful discharge as the dependent variable and study drug and severity of illness as exposures.", {"entities": []}], ["Secondary analysis was performed for patients aged less than 12 months and first presentation.", {"entities": []}], ["The authors analyzed 703 patients; 352 patients were given albuterol and 351 epinephrine.", {"entities": []}], ["A total of 173 in the albuterol group and 160 in the epinephrine group were successfully discharged (crude RR = 1.08, 95% confidence interval [CI] = 0.92 to 1.26).", {"entities": []}], ["When adjusted for severity of illness, patients who received albuterol were significantly more likely than patients receiving epinephrine to be successfully discharged (aRR = 1.18, 95% CI = 1.02 to 1.36).", {"entities": []}], ["This was also true among those with first presentation and in those less than 12 months of age.", {"entities": []}], ["In children up to the 18th month of life, ED treatment of bronchiolitis with nebulized racemic albuterol led to more successful discharges than nebulized epinephrine.", {"entities": [[58, 71, "DISEASE"]]}], ["ACADEMIC EMERGENCY MEDICINE 2008; 15:305\u2013313 \u00a9 2008 by the Society for Academic Emergency Medicine", {"entities": []}], ["Psychological factors, specific lifestyles and environmental stressors may influence etiopathogenesis and evolution of chronic diseases.", {"entities": []}], ["We investigate the association between Chronic Inflammatory Bowel Diseases (IBD) and psychological dimensions such as personality traits, defence mechanisms, and Alexithymia, i.e.", {"entities": [[162, 173, "DISEASE"]]}], ["deficits of emotional awareness with inability to give a name to emotional states.", {"entities": []}], ["We analyzed a survey of 100 patients with IBD and a control group of 66 healthy individuals.", {"entities": []}], ["The survey involved filling out clinical and anamnestic forms and administering five psychological tests.", {"entities": []}], ["These were then analyzed by using a network representation of the system by considering it as a bipartite network in which elements of one set are the 166 individuals, while the elements of the other set are the outcome of the survey.", {"entities": []}], ["We then run an unsupervised community detection algorithm providing a partition of the 166 participants into clusters.", {"entities": []}], ["That allowed us to determine a statistically significant association between psychological factors and IBD.", {"entities": []}], ["We find clusters of patients characterized by high neuroticism, alexithymia, impulsivity and severe physical conditions and being of female gender.", {"entities": [[64, 75, "DISEASE"]]}], ["We therefore hypothesize that in a population of alexithymic patients, females are inclined to develop psychosomatic diseases like IBD while males might eventually develop behavioral disorders.", {"entities": []}], ["A retrospective investigation of the clinical and radiologic features as well as the bronchoscopic appearance was carried out in patients with endobronchial aspergilloma.", {"entities": []}], ["Ten patients with endobronchial aspergilloma diagnosed by bronchoscopy and histological examination were identified at the Gyeongsang University Hospital of Korea, from May 2003 to May 2009.", {"entities": []}], ["The patients included 9 men and 1 woman, and the age of the patients ranged from 36 to 76 (median, 58 years).", {"entities": []}], ["The associated diseases or conditions were: previous pulmonary tuberculosis in 7 patients, lung cancer in 2 patients, pulmonary resection in 1 patient, and foreign body of the bronchus in 1 patient.", {"entities": [[91, 102, "DISEASE"], [63, 75, "DISEASE"], [53, 75, "DISEASE"], [96, 102, "DISEASE"]]}], ["The chest radiologic finding showed fibrotic changes as a consequence of previous tuberculosis infection in 6 patients and a mass-like lesion in 2 patients.", {"entities": [[82, 94, "DISEASE"]]}], ["Two patients had a co-existing fungus ball, and an endobronchial lesion was suspected in only 2 patients on the CT scan.", {"entities": []}], ["The bronchoscopic appearance was a whitish to yellow necrotic mass causing bronchial obstruction in 7 patients, foreign body with adjacent granulation tissue and whitish necrotic tissue in 1 patient, whitish necrotic tissue at an anastomosis site in 1 patient, and a protruding mass with whitish necrotic tissue in 1 patient.", {"entities": []}], ["An endobronchial aspergilloma is a rare presentation of pulmonary aspergilosis and is usually incidentally found in immunocompetent patients with underlying lung disease.", {"entities": [[157, 169, "DISEASE"]]}], ["It usually appears as a necrotic mass causing bronchial obstruction on bronchoscopy and can be confirmed by biopsy.", {"entities": []}], ["The main proteinaceous component of the keratohyalin granules within the granular layer keratinocytes of the epidermis is the giant, repetitive polyprotein profilaggrin.", {"entities": []}], ["When granular layer cells commit to terminal differentiation to form the flattened squames of the stratum corneum, profilaggrin is rapidly cleaved into multiple copies of the 37\u00a0 kD a filaggrin monomer, which binds to and condenses the keratin cytoskeleton, thereby facilitating cellular compression.", {"entities": []}], ["Within the stratum corneum, filaggrin is broken down to form natural moisturising factor, a pool of amino acids and derivatives thereof that exerts multiple effects.", {"entities": []}], ["Filaggrin is therefore essential for normal stratum corneum biogenesis and physiology.", {"entities": []}], ["In 2006, the McLean group identified the first loss\u2010of\u2010function mutations in the filaggrin gene ( FLG ) as the cause of the common monogenic genodermatosis ichthyosis vulgaris ( IV ).", {"entities": [[156, 175, "DISEASE"], [98, 101, "GENE"]]}], ["In parallel, they showed by multiple methods that these\u00a0mutations, carried by up to 10% of various human populations are the major genetic predisposing factor for atopic dermatitis (eczema) and all of the associated allergic phenotypes that constitute the atopic diathesis.", {"entities": [[163, 180, "DISEASE"], [170, 180, "DISEASE"]]}], ["This paradigm\u2010shifting work showed that skin barrier deficiency is a major early event in the pathophysiology of eczema and allergy.", {"entities": []}], ["What is already known?", {"entities": []}], ["Filaggrin is a critically important, multifunctional protein required for the normal biogenesis and physiology of the stratum corneum.", {"entities": []}], ["Filaggrin is a critically important, multifunctional protein required for the normal biogenesis and physiology of the stratum corneum.", {"entities": []}], ["What does (recent) work tell us?", {"entities": []}], ["Loss\u2010of\u2010function mutations in the filaggrin gene are common in the human population and cause clinically dry skin, ichthyosis vulgaris and importantly, are a major genetic predisposing factor for atopic dermatitis and its associated allergic conditions.", {"entities": [[115, 134, "DISEASE"], [196, 213, "DISEASE"], [203, 213, "DISEASE"]]}], ["This work revealed that skin barrier deficiency is the major pathomechanism underlying atopic disease.", {"entities": []}], ["Loss\u2010of\u2010function mutations in the filaggrin gene are common in the human population and cause clinically dry skin, ichthyosis vulgaris and importantly, are a major genetic predisposing factor for atopic dermatitis and its associated allergic conditions.", {"entities": [[115, 134, "DISEASE"], [196, 213, "DISEASE"], [203, 213, "DISEASE"]]}], ["This work revealed that skin barrier deficiency is the major pathomechanism underlying atopic disease.", {"entities": []}], ["We have previously demonstrated that activation of the cyclic adenosine monophosphate (cAMP) pathway kills multiple myeloma (MM) cells both in vitro and in vivo .", {"entities": [[116, 123, "DISEASE"], [107, 123, "DISEASE"]]}], ["In the present study we have investigated the potential of enhancing the killing of MM cell lines and primary MM cells by combining the cAMP-elevating compound forskolin with the commonly used MM therapeutic drugs melphalan, cyclophosphamide, doxorubicin, bortezomib and dexamethasone.", {"entities": []}], ["We observed that forskolin potentiated the killing induced by all the tested agents as compared to treatment with the single agents alone.", {"entities": []}], ["In particular, forskolin had a synergistic effect on the dexamethasone-responsive cell lines H929 and OM-2.", {"entities": []}], ["By knocking down the proapoptotic BCL-2 family member BIM, we proved this protein to be involved in the synergistic induction of apoptosis by dexamethasone and forskolin.", {"entities": []}], ["The ability of forskolin to maintain the killing of MM cells even at lower concentrations of the conventional agents suggests that forskolin may be used to diminish treatment-associated side effects.", {"entities": []}], ["Our findings support a potential role of forskolin in combination with current conventional agents in the treatment of MM.", {"entities": []}], ["Teaching the steps of evidence-based practice (EBP) has become standard curriculum for health professions at both student and professional levels.", {"entities": [[47, 50, "GENE"]]}], ["Determining the best methods for evaluating EBP learning is hampered by a dearth of valid and practical assessment tools and by the absence of guidelines for classifying the purpose of those that exist.", {"entities": [[44, 47, "GENE"]]}], ["Conceived and developed by delegates of the Fifth International Conference of Evidence-Based Health Care Teachers and Developers, the aim of this statement is to provide guidance for purposeful classification and development of tools to assess EBP learning.", {"entities": [[244, 247, "GENE"]]}], ["This paper identifies key principles for designing EBP learning assessment tools, recommends a common taxonomy for new and existing tools, and presents the Classification Rubric for EBP Assessment Tools in Education (CREATE) framework for classifying such tools.", {"entities": [[51, 54, "GENE"], [182, 185, "GENE"], [51, 54, "GENE"], [182, 185, "GENE"]]}], ["Recommendations are provided for developers of EBP learning assessments and priorities are suggested for the types of assessments that are needed.", {"entities": [[47, 50, "GENE"]]}], ["Examples place existing EBP assessments into the CREATE framework to demonstrate how a common taxonomy might facilitate purposeful development and use of EBP learning assessment tools.", {"entities": [[24, 27, "GENE"], [154, 157, "GENE"], [24, 27, "GENE"], [154, 157, "GENE"]]}], ["The widespread adoption of EBP into professional education requires valid and reliable measures of learning.", {"entities": [[27, 30, "GENE"]]}], ["Limited tools exist with established psychometrics.", {"entities": []}], ["This international consensus statement strives to provide direction for developers of new EBP learning assessment tools and a framework for classifying the purposes of such tools .", {"entities": [[90, 93, "GENE"]]}], ["Mother\u2019s milk is widely accepted as nutritious and protective to the newborn mammals by providing not only macronutrients but also immune-defensive factors.", {"entities": []}], ["However, the mechanisms accounting for these benefits are not fully understood.", {"entities": []}], ["Here we show that maternal very-low-density-lipoprotein receptor (VLDLR) deletion in mice causes the production of defective milk containing diminished level of platelet-activating factor acetylhydrolase (PAFAH).", {"entities": [[66, 71, "GENE"]]}], ["As a consequence, the nursing neonates suffer from alopecia, anemia and growth retardation owing to elevated levels of pro-inflammatory platelet-activating factors (PAFs).", {"entities": [[51, 59, "DISEASE"], [61, 67, "DISEASE"]]}], ["VLDLR deletion significantly impairs the expression of phospholipase A2 group 7 ( Pla2g7 ) in macrophages, which decreases PAFAH secretion.", {"entities": [[0, 5, "GENE"], [82, 88, "GENE"]]}], ["Exogenous oral supplementation of neonates with PAFAH effectively rescues the toxicity.", {"entities": []}], ["These findings not only reveal a novel role of VLDLR in suppressing inflammation by maintaining macrophage PAFAH secretion, but also identify the maternal VLDLR as a key genetic program that ensures milk quality and protects the newborns.", {"entities": [[47, 52, "GENE"], [155, 160, "GENE"], [47, 52, "GENE"], [155, 160, "GENE"]]}], ["Periostin is a biomarker indicating the presence of type 2 inflammation and submucosal fibrosis; serum periostin levels have been associated with asthma severity.", {"entities": [[146, 152, "DISEASE"]]}], ["Macrolides have immunomodulatory effects and are considered a potential therapy for patients with severe asthma.", {"entities": [[105, 111, "DISEASE"]]}], ["Therefore, we investigated whether macrolides can also modulate pulmonary periostin production.", {"entities": []}], ["Using quantitative PCR and ELISA, we measured periostin production in human lung fibroblasts stimulated by interleukin-13 (IL-13) in the presence of two 14-member\u2013ring macrolides\u2014clarithromycin or erythromycin\u2014or a 16-member\u2013ring macrolide, josamycin.", {"entities": []}], ["Phosphorylation of signal transducers and activators of transcription 6 (STAT6), downstream of IL-13 signaling, was evaluated by Western blotting.", {"entities": [[73, 78, "GENE"]]}], ["Changes in global gene expression profile induced by IL-13 and/or clarithromycin were assessed by DNA microarray analysis.", {"entities": []}], ["Clarithromycin and erythromycin, but not josamycin, inhibited IL-13\u2013stimulated periostin production.", {"entities": []}], ["The inhibitory effects of clarithromycin were stronger than those of erythromycin.", {"entities": []}], ["Clarithromycin significantly attenuated STAT6 phosphorylation induced by IL-13.", {"entities": [[40, 45, "GENE"]]}], ["Global gene expression analyses demonstrated that IL-13 increased mRNA expression of 454 genes more than 4-fold, while decreasing its expression in 390 of these genes (85.9%), mainly \u201cextracellular,\u201d \u201cplasma membrane,\u201d or \u201cdefense response\u201d genes.", {"entities": []}], ["On the other hand, clarithromycin suppressed 9.8% of the genes in the absence of IL-13.", {"entities": []}], ["Clarithromycin primarily attenuated the gene expression of extracellular matrix protein, including periostin, especially after IL-13.", {"entities": []}], ["Clarithromycin suppressed IL-13\u2013induced periostin production in human lung fibroblasts, in part by inhibiting STAT6 phosphorylation.", {"entities": [[110, 115, "GENE"]]}], ["This suggests a novel mechanism of the immunomodulatory effect of clarithromycin in asthmatic airway inflammation and fibrosis.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0519-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The degree to which host genetic variation can modulate microbial communities in humans remains an open question.", {"entities": []}], ["Here, we performed a genetic mapping study of the microbiome in two accessible upper airway sites, the nasopharynx and the nasal vestibule, during two seasons in 144 adult members of a founder population of European decent.", {"entities": []}], ["We estimated the relative abundances (RAs) of genus level bacteria from 16S rRNA gene sequences and examined associations with 148,653 genetic variants (linkage disequilibrium [LD] r q \u2009<\u20090.05) and were enriched for genes in mucosal immunity pathways.", {"entities": []}], ["The most significant association was between the RA of Dermacoccus (phylum Actinobacteria) and a variant 8\u00a0kb upstream of TINCR (rs117042385; p \u2009=\u20091.61\u2009\u00d7\u200910 q \u2009=\u20090.002), a long non-coding RNA that binds to peptidoglycan recognition protein 3 ( PGLYRP3 ) mRNA , a gene encoding a known antimicrobial protein.", {"entities": [[244, 251, "GENE"]]}], ["A second association was between a missense variant in PGLYRP4 (rs3006458) and the RA of an unclassified genus of family Micrococcaceae (phylum Actinobacteria) ( p \u2009=\u20095.10\u2009\u00d7\u200910 q\u2009= \u20090.032).", {"entities": [[55, 62, "GENE"]]}], ["Our findings provide evidence of host genetic influences on upper airway microbial composition in humans and implicate mucosal immunity genes in this relationship.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-016-0227-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hyperlipidic diets limit glucose oxidation and favor amino acid preservation, hampering the elimination of excess dietary nitrogen and the catabolic utilization of amino acids.", {"entities": []}], ["We analyzed whether reduced urea excretion was a consequence of higher NO x ; (nitrite, nitrate, and other derivatives) availability caused by increased nitric oxide production in metabolic syndrome.", {"entities": [[190, 198, "DISEASE"]]}], ["Rats fed a cafeteria diet for 30 days had a higher intake and accumulation of amino acid nitrogen and lower urea excretion.", {"entities": []}], ["There were no differences in plasma nitrate or nitrite.", {"entities": []}], ["NO x and creatinine excretion accounted for only a small part of total nitrogen excretion.", {"entities": []}], ["Rats fed a cafeteria diet had higher plasma levels of glutamine, serine, threonine, glycine, and ornithine when compared with controls, whereas arginine was lower.", {"entities": []}], ["Liver carbamoyl-phosphate synthetase I activity was higher in cafeteria diet-fed rats, but arginase I was lower.", {"entities": []}], ["The high carbamoyl-phosphate synthetase activity and ornithine levels suggest activation of the urea cycle in cafeteria diet-fed rats, but low arginine levels point to a block in the urea cycle between ornithine and arginine, thereby preventing the elimination of excess nitrogen as urea.", {"entities": []}], ["The ultimate consequence of this paradoxical block in the urea cycle seems to be the limitation of arginine production and/or availability.", {"entities": []}], ["Immune responses are tightly regulated to ensure efficient pathogen clearance while avoiding tissue damage.", {"entities": []}], ["Here we report that SET domain bifurcated 2 (Setdb2) was the only protein lysine methyltransferase induced during influenza virus infection.", {"entities": [[114, 123, "DISEASE"], [45, 51, "GENE"]]}], ["Setdb2 expression depended on type-I interferon signaling and it repressed the expression of the neutrophil attractant Cxcl1 and other NF-\u03baB target genes.", {"entities": [[0, 6, "GENE"], [119, 124, "GENE"]]}], ["This coincided with Setdb2 occupancy at the Cxcl1 promoter, which in the absence of Setdb2 displayed reduced H3K9 tri-methylation.", {"entities": [[20, 26, "GENE"], [84, 90, "GENE"], [44, 49, "GENE"], [20, 26, "GENE"], [84, 90, "GENE"]]}], ["Setdb2 hypomorphic gene-trap mice exhibited increased neutrophil infiltration in sterile lung inflammation and were less sensitive to bacterial superinfection upon influenza virus infection.", {"entities": [[164, 173, "DISEASE"], [0, 6, "GENE"]]}], ["This suggests that a Setdb2-mediated regulatory crosstalk between the type-I interferon and NF-\u03baB pathways represents an important mechanism for virus-induced susceptibility to bacterial superinfection.", {"entities": []}], ["Elderly persons make greater use of psychotropic drugs, but there are few international studies on social differences in the use of these medications.", {"entities": []}], ["The aim of this study is to examine social differences in the use of psychotropic drugs among persons aged 65\u201374 years in the International Mobility in Aging Study (IMIAS).", {"entities": []}], ["The sample consisted of 1,995 participants in the IMIAS 2012 baseline study in Saint-Hyacinthe (Canada), Kingston (Canada), Tirana (Albania), Manizales (Colombia), and Natal (Brazil).", {"entities": []}], ["During home visits, all medication taken by the participants in the previous 15\u00a0days was recorded.", {"entities": []}], ["We then used the Anatomical Therapeutic Chemical classification system to code psychotropic drugs as anxiolytics, sedatives, hypnotics (ASH); antidepressants (ADP); or analgesics, antiepileptics, or antiparkinsonians (AEP).", {"entities": []}], ["Prevalence ratios for psychotropic drug use according to sex, education, income, and occupation were estimated by fitting a Poisson regression and controlling for demographic and health covariates.", {"entities": []}], ["Psychotropic drug use was higher among Canadian participants than among those living outside Canada.", {"entities": []}], ["Prevalence of AEP drug use was higher for women than men in the Canadian and Latin American sites.", {"entities": []}], ["In Tirana, antidepressant drugs were rarely used.", {"entities": []}], ["Socioeconomic differences varied among sites.", {"entities": []}], ["In the Canadian cities, low socioeconomic standing was associated with higher frequency of psychotropic drug use.", {"entities": []}], ["In the Latin American cities, elderly people with high education and income levels showed a higher level of antidepressant drug use, while people with manual occupations had a higher use of AEP drugs.", {"entities": []}], ["In Tirana, ASH drug use was higher among those with low income.", {"entities": []}], ["An inverse association was observed between socioeconomic standing and psychotropic drug use in Canada, while the opposite was true in Latin America.", {"entities": []}], ["Albania was notable for an absence of antidepressant use and greater use of ASH drugs among low-income groups.", {"entities": []}], ["Access to appropriate, affordable, acceptable and comprehensive primary health care (PHC) is critical for improving the health of Indigenous populations.", {"entities": []}], ["Whilst appropriate infrastructure, sufficient funding and knowledgeable health care professionals are crucial, these elements alone will not lead to the provision of appropriate care for all Indigenous people.", {"entities": []}], ["This systematic literature review synthesised international evidence on the factors that enable or inhibit the implementation of interventions aimed at improving chronic disease care for Indigenous people.", {"entities": []}], ["A systematic review using Medical Literature Analysis and Retrieval System Online (MEDLINE) (PubMed platform), Web of Science, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, Excerpta Medica Database (EMBASE), ATSIHealth, Australian Indigenous HealthInfoNet via Informit Online and Primary Health Care Research and Information Service (PHCRIS) databases was undertaken.", {"entities": []}], ["Studies were included if they described an intervention for one or more of six chronic conditions that was delivered in a primary health care setting in Australia, New Zealand, Canada or the United States.", {"entities": []}], ["Attitudes, beliefs, expectations, understandings and knowledge of patients, their families, Indigenous communities, providers and policy makers were of interest.", {"entities": []}], ["Published and unpublished qualitative and quantitative studies from 1998 to 2013 were considered.", {"entities": []}], ["Qualitative findings were pooled using a meta-aggregative approach, and quantitative data were presented as a narrative summary.", {"entities": []}], ["Twenty three studies were included.", {"entities": []}], ["Meta-aggregation of qualitative data revealed five synthesised findings, related to issues within the design and planning phase of interventions, the chronic disease workforce, partnerships between service providers and patients, clinical care pathways and patient access to services.", {"entities": []}], ["The available quantitative data supported the qualitative findings.", {"entities": []}], ["Three key features of enablers and barriers emerged from the findings: (1) they are not fixed concepts but can be positively or negatively influenced, (2) the degree to which the work of an intervention can influence an enabler or barrier varies depending on their source and (3) they are inter-related whereby a change in one may effect a change in another.", {"entities": []}], ["Future interventions should consider the findings of this review as it provides an evidence-base that contributes to the successful design, implementation and sustainability of chronic disease interventions in primary health care settings intended for Indigenous people.", {"entities": []}], ["The online version of this article (doi:10.1186/s13012-015-0261-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Elders who utilize the emergency department (ED) may have little prospective knowledge of appropriate expectations during an ED encounter.", {"entities": []}], ["Improving elder orientation to ED expectations is important for satisfaction and health education.", {"entities": []}], ["The purpose of this study was to evaluate a multi-media education intervention as a method for informing independently living elders about ED care.", {"entities": []}], ["The program delivered messages categorically as, the number of tests, providers, decisions and disposition decision making.", {"entities": []}], ["Interventional trial of representative elders over 59 years of age comparing pre and post multimedia program exposure.", {"entities": []}], ["A brief (0.3 hour) video that chronicled the key events after a hypothetical 911 call for chest pain was shown.", {"entities": []}], ["The video used a clinical narrator, 15 ED health care providers, and 2 professional actors for the patient and spouse.", {"entities": []}], ["Pre- and post-video tests results were obtained with audience response technology (ART) assessed learning using a 4 point Likert scale.", {"entities": []}], ["Valid data from 142 participants were analyzed pre to post rankings (Wilcoxon signed-rank tests).", {"entities": []}], ["The following four learning objectives showed significant improvements: number of tests expected [median differences on a 4-point Likert scale with 95% confidence intervals: 0.50 (0.00, 1.00)]; number of providers expected 1.0 (1.00, 1.50); communications 1.0 (1.00, 1.50); and pre-hospital medical treatment 0.50 (0.00, 1.00).", {"entities": []}], ["Elders (96%) judged the intervention as improving their ability to cope with an ED encounter.", {"entities": []}], ["A short video with graphic side-bar information is an effective educational strategy to improve elder understanding of expectations during a hypothetical ED encounter following calling 911.", {"entities": []}], ["To investigate the association between iodinated contrast medium (ICM) exposure during computed tomography (CT) and the subsequent development of thyroid disorders in patients without known thyroid disease in Taiwan, an iodine-sufficient area.", {"entities": []}], ["We conducted a population-based cohort study by using data from 1996 to 2012 in the Taiwan National Health Insurance Research Database.", {"entities": []}], ["A total of 33,426 patients who underwent ICM-enhanced CT were included as the study cohort.", {"entities": []}], ["To avoid selection bias, we used propensity score and matched for the index year (defined as the year of first ICM exposure) to retrieve 33,426 patients as the comparison cohort.", {"entities": []}], ["No patients in the 2 cohorts had any known thyroid disease before the index year.", {"entities": []}], ["Patients with a history of amiodarone treatment or coronary angiography and those with <1 year follow-up were excluded.", {"entities": []}], ["Participants were followed until a new diagnosis of thyroid disorder or December 31, 2011.", {"entities": []}], ["Hazard ratios (HRs) with 95% confidence interval (95% CI) were calculated using the Cox proportional hazards regression.", {"entities": []}], ["An association was identified between ICM exposure and the subsequent development of thyroid disorders after adjustment for potential confounders (adjusted HR\u200a=\u200a1.17; 95% CI: 1.07\u20131.29; P \u200a=\u200a0.001).", {"entities": [[156, 158, "GENE"]]}], ["Male patients and patients\u2019 ages \u226540 years in the ICM-exposure cohort had a higher adjusted HR for developing thyroid disorders than did those in the non-ICM-exposure cohort.", {"entities": [[92, 94, "GENE"]]}], ["Hypothyroidism had the highest adjusted HR (HR\u200a=\u200a1.37; 95% CI: 1.06\u20131.78; P \u200a<\u200a0.05) among all thyroid disorders and had a higher risk of development or detection during >0.5-year post-ICM exposure compared with that during \u22640.5-year post-ICM exposure (HR\u200a=\u200a1.26; 95% CI: 1.01\u20131.58; P \u200a<\u200a0.05).", {"entities": [[40, 42, "GENE"], [44, 46, "GENE"], [253, 255, "GENE"], [40, 42, "GENE"], [44, 46, "GENE"], [253, 255, "GENE"], [40, 42, "GENE"], [44, 46, "GENE"], [253, 255, "GENE"]]}], ["Repeated ICM exposure increased the risk of thyroid disorders in patients who accepted >1 time of ICM per year on average compared with those who accepted \u22641 time per year on average (adjusted HR\u200a=\u200a3.04; 95% CI: 2.47\u20133.73; P \u200a<\u200a0.001).", {"entities": [[193, 195, "GENE"]]}], ["This study identified ICM exposure during CT as a risk factor for the subsequent development of thyroid disorders in patients without known thyroid disease, particularly in patients with repeated exposure.", {"entities": []}], ["E\u2010cigarettes are perceived as harmless; however, evidence of their safety is lacking.", {"entities": []}], ["New data suggests E\u2010cigarettes discharge a range of compounds capable of physiological damage to users.", {"entities": []}], ["We previously established that cigarette smoke caused defective alveolar macrophage phagocytosis.", {"entities": []}], ["The present study compared the effect E\u2010cigarette of components; E\u2010liquid flavors, nicotine, vegetable glycerine, and propylene glycol on phagocytosis, proinflammatory cytokine secretion, and phagocytic recognition molecule expression using differentiated THP \u20101 macrophages.", {"entities": []}], ["Similar to CSE , phagocytosis of NTH i bacteria was significantly decreased by E\u2010liquid flavoring (11.65\u201315.75%) versus control (27.01%).", {"entities": []}], ["Nicotine also decreased phagocytosis (15.26%).", {"entities": []}], ["E\u2010liquid, nicotine, and E\u2010liquid+ nicotine reduced phagocytic recognition molecules; SR \u2010A1 and TLR \u20102.", {"entities": []}], ["IL \u20108 secretion increased with flavor and nicotine, while TNF \u03b1 , IL \u20101 \u03b2 , IL \u20106, MIP \u20101 \u03b1 , MIP \u20101 \u03b2 , and MCP \u20101 decreased after exposure to most flavors and nicotine.", {"entities": [[58, 61, "GENE"], [83, 86, "GENE"], [94, 97, "GENE"], [83, 86, "GENE"], [94, 97, "GENE"]]}], ["PG , VG , or PG : VG mix also induced a decrease in MIP \u20101 \u03b1 and MIP \u20101 \u03b2 .", {"entities": [[52, 55, "GENE"], [65, 68, "GENE"], [52, 55, "GENE"], [65, 68, "GENE"]]}], ["We conclude that E\u2010cigarettes can cause macrophage phagocytic dysfunction, expression of phagocytic recognition receptors and cytokine secretion pathways.", {"entities": []}], ["As such, E\u2010cigarettes should be treated with caution by users, especially those who are nonsmokers.", {"entities": []}], ["The association between physical activity, sedentary behavior and health-related quality of life in children and adolescents has been mostly investigated in those young people with chronic disease conditions.", {"entities": []}], ["No systematic review to date has synthesized the relationship between physical activity, sedentary behavior and health-related quality of life in the general healthy population of children and adolescents.", {"entities": []}], ["The purpose of this study was to review systematically the existing literature that evaluated the relations between physical activity, sedentary behavior and health-related quality of life in the general population of children and adolescents.", {"entities": []}], ["We conducted a computer search for English language literature from databases of MEDLINE, EMBASE, PSYCINFO and PubMed-related articles as well as the reference lists of existing literature between 1946 and the second week of January 2017 to retrieve eligible studies.", {"entities": []}], ["We included the studies that assessed associations between physical activity and/or sedentary behavior and health-related quality of life among the general population of children and adolescents aged between 3\u201318 years.", {"entities": []}], ["The study design included cross-sectional, longitudinal and health intervention studies.", {"entities": []}], ["We excluded the studies that examined associations between physical activity, sedentary behavior and health-related quality of life among children and adolescents with specific chronic diseases, and other studies and reports including reviews, meta-analyses, study protocols, comments, letters, case reports and guidelines.", {"entities": []}], ["We followed up the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement in the reporting of this review.", {"entities": []}], ["The risk of bias of the primary studies was assessed by the Newcastle-Ottawa Scale.", {"entities": []}], ["We synthesized the difference in health-related quality of life scores between different levels of physical activity and sedentary time.", {"entities": []}], ["In total, 31 studies met the inclusion criteria and were synthesized in the review.", {"entities": []}], ["Most of the included studies used a cross-sectional design (n = 21).", {"entities": []}], ["There were six longitudinal studies and three school-based physical activity intervention studies.", {"entities": []}], ["One study used both cross-sectional and longitudinal designs.", {"entities": []}], ["We found that higher levels of physical activity were associated with better health-related quality of life and increased time of sedentary behavior was linked to lower health-related quality of life among children and adolescents.", {"entities": []}], ["A dose-response relation between physical activity, sedentary behavior and health-related quality of life was observed in several studies suggesting that the higher frequency of physical activity or the less time being sedentary, the better the health-related quality of life.", {"entities": []}], ["The findings in this study suggest that school health programs promoting active lifestyles among children and adolescents may contribute to the improvement of health-related quality of life.", {"entities": []}], ["Future research is needed to extend studies on longitudinal relationships between physical activity, sedentary behavior and health-related quality of life, and on effects of physical activity interventions on health-related quality of life among children and youth.", {"entities": []}], ["Body weight is negatively associated with adolescent Health-Related Quality of Life (HRQoL).", {"entities": []}], ["Despite this well-established relationship, some adolescents with obesity do not display the expected HRQoL decreases.", {"entities": [[66, 73, "DISEASE"]]}], ["This study hypothesised weight perception as a moderator of the association between weight status and adolescent HRQoL.", {"entities": []}], ["Subjects were secondary school students from an obesity prevention project in the Barwon South-West region of Victoria, Australia, entitled It's Your Move ( N= 3040).", {"entities": [[48, 55, "DISEASE"]]}], ["Measures included standardised body mass index ( BMI-z ; World Health Organization growth standards), weight perception and HRQoL, measured by the Paediatric Quality of Life Inventory.", {"entities": []}], ["Linear regression and average marginal effect analyses were conducted on cross-sectional baseline data to determine the significance of any interaction between weight perception and measured weight status in shaping adolescent HRQoL.", {"entities": []}], ["The BMI-z /perceived weight status interaction was significantly associated with adolescent HRQoL outcomes.", {"entities": []}], ["Adolescents with BMI z -scores in the overweight/obesity range who perceived themselves as overweight had lower HRQoL than those who perceived themselves as \u2018about right.'", {"entities": [[49, 56, "DISEASE"]]}], ["Conversely, adolescents with BMI scores in the lower end of the normal range or in the thinness range who perceived themselves as underweight had lower HRQoL than those with \u2018about right' perceptions.", {"entities": []}], ["This was the first study to report third-variable impacts of a body-perception variable on the relationship between adolescent weight status and HRQoL.", {"entities": []}], ["Adolescents' weight perceptions significantly moderated the relationship between overweight/obesity and reduced HRQoL.", {"entities": [[92, 99, "DISEASE"]]}], ["Adolescents who were outside the normal weight range and misperceived their objectively measured weight status enjoyed a higher HRQoL than adolescents whose weight perception was concordant with their actual weight status.", {"entities": []}], ["These findings suggest that practitioners may need to exercise caution when educating adolescents about their weight status, as such \u2018reality checks' may negatively impact on adolescent HRQoL.", {"entities": []}], ["It is suggested that more research be conducted to examine this potential effect.", {"entities": []}], ["The high specificity of antibodies for their antigen allows a fine discrimination of target conformations and post-translational modifications, making antibodies the first choice tool to interrogate the proteome.", {"entities": []}], ["We describe here an approach based on a large-scale intracellular expression and selection of antibody fragments in eukaryotic cells, so-called intrabodies, and the subsequent identification of their natural target within living cell.", {"entities": []}], ["Starting from a phenotypic trait, this integrated system allows the identification of new therapeutic targets together with their companion inhibitory intrabody.", {"entities": []}], ["We applied this system in a model of allergy and inflammation.", {"entities": []}], ["We first cloned a large and highly diverse intrabody library both in a plasmid and a retroviral eukaryotic expression vector.", {"entities": []}], ["After transfection in the RBL-2H3 rat basophilic leukemia cell line, we performed seven rounds of selection to isolate cells displaying a defect in Fc\u03b5RI-induced degranulation.", {"entities": [[49, 57, "DISEASE"]]}], ["We used high throughput sequencing to identify intrabody sequences enriched during the course of selection.", {"entities": []}], ["Only one intrabody was common to both plasmid and retroviral selections, and was used to capture and identify its target from cell extracts.", {"entities": []}], ["Mass spectrometry analysis identified protein RGD1311164 (C12orf4), with no previously described function.", {"entities": [[58, 65, "GENE"]]}], ["Our data demonstrate that RGD1311164 is a cytoplasmic protein implicated in the early signaling events following Fc\u03b5RI-induced cell activation.", {"entities": []}], ["This work illustrates the strength of the intrabody-based in-cell selection, which allowed the identification of a new player in mast cell activation together with its specific inhibitor intrabody.", {"entities": []}], ["Weaning (or introduction of complementary feeding) is a special and important moment in the growth of a child, both for the family and the infant itself, and it can play a major role in the child\u2019s future health.", {"entities": []}], ["Throughout the years, various weaning modes have come in succession, the latest being baby-led weaning; the timing for introducing foods and the requirements of which sort of nutrient for weaning have also changed over time.", {"entities": []}], ["Furthermore, the role played by nutrition, especially in the early stages of life, for the onset of later non-communicable disorders, such as diabetes, obesity or coeliac disease has also been increasingly highlighted.", {"entities": [[152, 159, "DISEASE"]]}], ["Members of Italian Society of Gastroenterology, Hepathology and Pediatric Nutrition (SIGENP) and the Italian Society of Allergology and Pediatric Immunology (SIAIP) Emilia Romagna here propose a practical approach for pediatricians to deal with daily practice.", {"entities": []}], ["The four main areas for discussion were weaning in relation with the onset of allergic diseases, coeliac disease, diabetes and metabolic syndrome, the nutrition requirements to take into account for assessing the diet of infants under one year of age and about the practice of baby-led weaning focusing on limits and benefits, respectively.", {"entities": [[137, 145, "DISEASE"]]}], ["Lung diseases (resulting from air pollution) require a widely accessible method for risk estimation and early diagnosis to ensure proper and responsive treatment.", {"entities": []}], ["Radiomics-based fractal dimension analysis of X-ray computed tomography attenuation patterns in chest voxels of mice exposed to different air polluting agents was performed to model early stages of disease and establish differential diagnosis.", {"entities": []}], ["To model different types of air pollution, BALBc/ByJ mouse groups were exposed to cigarette smoke combined with ozone, sulphur dioxide gas and a control group was established.", {"entities": []}], ["Two weeks after exposure, the frequency distributions of image voxel attenuation data were evaluated.", {"entities": []}], ["Specific cut-off ranges were defined to group voxels by attenuation.", {"entities": []}], ["Cut-off ranges were binarized and their spatial pattern was associated with calculated fractal dimension, then abstracted by the fractal dimension -- cut-off range mathematical function.", {"entities": []}], ["Nonparametric Kruskal-Wallis (KW) and Mann\u2013Whitney post hoc (MWph) tests were used.", {"entities": []}], ["Each cut-off range versus fractal dimension function plot was found to contain two distinctive Gaussian curves.", {"entities": []}], ["The ratios of the Gaussian curve parameters are considerably significant and are statistically distinguishable within the three exposure groups.", {"entities": []}], ["A new radiomics evaluation method was established based on analysis of the fractal dimension of chest X-ray computed tomography data segments.", {"entities": []}], ["The specific attenuation patterns calculated utilizing our method may diagnose and monitor certain lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis or lung carcinomas.", {"entities": [[122, 159, "DISEASE"], [176, 188, "DISEASE"], [168, 174, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12880-016-0118-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Spontaneous preterm deliveries that occur before the 34th week of gestation, and particularly before the 32nd week of gestation, have been strongly associated to intrauterine infection, ascending from vagina, and represent the largest portion of neonatal deaths and neurological problems.", {"entities": []}], ["Bacterial vaginosis, characterized by a diminished or absent flora of lactobacilli and increased colonization of several anaerobic or facultative microorganisms, increases two times the risk of preterm delivery before the 34th week.", {"entities": [[0, 19, "DISEASE"]]}], ["Trials of antibiotics failed to show efficacy and effectiveness against spontaneous preterm birth related to bacterial vaginosis.", {"entities": [[109, 128, "DISEASE"]]}], ["Some studies indicate benefit from selected probiotics to treat genitourinary infections, including bacterial vaginosis.", {"entities": [[100, 119, "DISEASE"]]}], ["The purpose of this study is to evaluate the effectiveness of the early administration of selected probiotics to pregnant women with asymptomatic bacterial vaginosis/intermediate degree infection to reduce the occurrence of spontaneous preterm delivery and related neonatal mortality and morbidity.", {"entities": [[146, 165, "DISEASE"]]}], ["Women attending public prenatal care services in Rio de Janeiro will be screened to select asymptomatic pregnant women, less than 20 weeks' gestation, with no indication of elective preterm delivery.", {"entities": []}], ["Those with vaginal pH > = 4.5 and a Nugent score between 4 and 10 (intermediate degree infection or bacterial vaginosis) will be randomized to either the placebo or the intervention group, after written informed consent.", {"entities": [[100, 119, "DISEASE"]]}], ["Intervention consists in the use of probiotics, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, 2 capsules a day, each capsule containing more than one million bacilli of each strain, for 6-12 weeks, up to the 24th-25th wk of gestation.", {"entities": []}], ["Ancillary analyses include quantification of selected cervicovaginal cytokines and genotyping of selected polymorphisms.", {"entities": []}], ["The randomization process is stratified for history of preterm delivery and blocked.", {"entities": []}], ["Allocation concealment was designed as well as blinding of women, caregivers and outcome evaluators.", {"entities": []}], ["The study will be supervised by an independent monitoring committee.", {"entities": []}], ["Outcomes under study are preterm delivery (< 34- < 32 weeks of gestation) and associated neonatal complications: early neonatal sepsis, bronchopulmonary dysplasia, periventricular leukomalacia, necrotizing enterocolitis, and prematurity-related retinopathy; definitions were adapted from those recommended by the 2002 version of the Vermont-Oxford Network.", {"entities": [[164, 192, "DISEASE"]]}], ["Trial registration at NIH register: NCT00303082.", {"entities": []}], ["Airway smooth muscle (ASM) cells play a critical role in the pathophysiology of asthma due to their hypercontractility and their ability to proliferate and secrete inflammatory mediators.", {"entities": [[80, 86, "DISEASE"]]}], ["microRNAs (miRNAs) are gene regulators that control many signaling pathways and thus serve as potential therapeutic alternatives for many diseases.", {"entities": []}], ["We have previously shown that miR-708 and miR-140-3p regulate the MAPK and PI3K signaling pathways in human ASM (HASM) cells following TNF-\u03b1 exposure.", {"entities": [[30, 37, "GENE"], [42, 52, "GENE"]]}], ["In this study, we investigated the regulatory effect of these miRNAs on other asthma-related genes.", {"entities": [[78, 84, "DISEASE"]]}], ["Microarray analysis using the Illumina platform was performed with total RNA extracted from miR-708 (or control miR)-transfected HASM cells.", {"entities": [[92, 99, "GENE"]]}], ["Inhibition of candidate inflammation-associated gene expression was further validated by qPCR and ELISA.", {"entities": []}], ["The most significant biologic functions for the differentially expressed gene set included decreased inflammatory response, cytokine expression and signaling.", {"entities": []}], ["qPCR revealed inhibition of expression of CCL11 , CXCL10 , CCL2 and CXCL8 , while the release of CCL11 was inhibited in miR-708-transfected cells.", {"entities": [[42, 47, "GENE"], [97, 102, "GENE"], [50, 56, "GENE"], [59, 63, "GENE"], [42, 47, "GENE"], [97, 102, "GENE"]]}], ["Transfection of cells with miR-140-3p resulted in inhibition of expression of CCL11 , CXCL12 , CXCL10 , CCL5 and CXCL8 and of TNF-\u03b1-induced CXCL12 release.", {"entities": [[27, 37, "GENE"], [78, 83, "GENE"], [86, 92, "GENE"], [140, 146, "GENE"], [95, 101, "GENE"], [104, 108, "GENE"], [86, 92, "GENE"], [140, 146, "GENE"]]}], ["In addition, expression of RARRES2 , CD44 and ADAM33 , genes known to contribute to the pathophysiology of asthma, were found to be inhibited in miR-708-transfected cells.", {"entities": [[107, 113, "DISEASE"], [27, 34, "GENE"], [37, 41, "GENE"], [46, 52, "GENE"]]}], ["These results demonstrate that miR-708 and miR-140-3p exert distinct effects on inflammation-associated gene expression and biological function of ASM cells.", {"entities": [[31, 38, "GENE"], [43, 53, "GENE"]]}], ["Targeting these miRNA networks may provide a novel therapeutic mechanism to down-regulate airway inflammation and ASM proliferation in asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["The high prevalence of childhood asthma in low-income, inner-city populations is not fully understood but has been at least partly attributed to the disproportionate exposures associated with socioeconomic disadvantage.", {"entities": [[33, 39, "DISEASE"]]}], ["The contribution of indoor allergens to asthma is well documented, but links between socioeconomic disadvantage and indoor allergen levels are not clear.", {"entities": [[40, 46, "DISEASE"]]}], ["We investigated levels of cockroach allergens (Bla g 2) in a sample of 132 Dominican or African American low-income households with young children in northern Manhattan in New York City (40% were receiving public assistance) to determine whether the distribution of allergens is a function of housing deterioration.", {"entities": []}], ["Deterioration was measured by the presence and number of physical housing problems (holes in the ceilings and walls, water damage, etc.).", {"entities": []}], ["More than 50% of the sample had two or more types of housing dilapidation, and 67% of the sample reported cockroach sightings in their homes.", {"entities": []}], ["Samples of dust were collected from kitchen and bedroom surfaces.", {"entities": []}], ["We hypothesized that the greater the dilapidation, the higher the allergen levels, independent of income, sociocultural factors, and pest-control methods.", {"entities": []}], ["In addition, we hypothesized that the homes of families characterized by frequent moves (23.5%) would have higher allergen levels than more stable families.", {"entities": []}], ["Results showed significant positive associations between housing deterioration and allergen levels in kitchens, after adjusting for income and ethnicity, with independent effects of residential stability (p< 0.05).", {"entities": []}], ["Bedroom allergen levels were associated with housing instability (p < 0.01) and ethnicity (p< 0.01).", {"entities": []}], ["Findings demonstrated that indoor household allergen levels are related to degree of household disrepair, after adjusting for individual family attributes, suggesting that social-structural aspects of housing may be appropriate targets for public health interventions designed to reduce allergen exposure.", {"entities": []}], ["TSG-6 is an inflammation-induced protein that is produced at pathological sites, including arthritic joints.", {"entities": []}], ["In animal models of arthritis, TSG-6 protects against joint damage; this has been attributed to its inhibitory effects on neutrophil migration and plasmin activity.", {"entities": [[20, 29, "DISEASE"]]}], ["Here we investigated whether TSG-6 can directly influence bone erosion.", {"entities": []}], ["Our data reveal that TSG-6 inhibits RANKL-induced osteoclast differentiation/activation from human and murine precursor cells, where elevated dentine erosion by osteoclasts derived from TSG-6 TSG-6", {"entities": [[142, 157, "DISEASE"]]}], ["The relation between primary hypertension (PH), target organ damage (TOD) and oxidative stress (SOX) is not known.", {"entities": [[29, 41, "DISEASE"]]}], ["We assessed SOX in 86 children with PH before and after 12\u00a0months of standard non-pharmacological and pharmacological therapy based on renin-angiotensin system blockade.", {"entities": []}], ["Patients with left ventricular hypertrophy (LVH) and with carotid intima-media thickness (cIMT) >2SDS had higher thiobarbituric acid reactive substances (TBARS) concentrations in comparison to patients without LVH or with normal cIMT.", {"entities": []}], ["Patients with metabolic syndrome (MS) had lower activity of gluthatione peroxidase, higher asymmetric dimethyloarginine (ADMA) and oxidized LDL cholesterol (oxyLDL) in comparison to patients without MS. TBARS correlated with left ventricular concentric hypertrophy, cIMT, albuminuria and SBP/24\u00a0h. ADMA and oxyLDL correlated with CRP and TG/HDL ratio.", {"entities": [[24, 32, "DISEASE"], [330, 333, "GENE"]]}], ["After 1\u00a0year of antihypertensive treatment blood pressure, TOD and prevalence of MS decreased.", {"entities": []}], ["TBARS decreased and glutathione concentrations increased.", {"entities": []}], ["The decrease of TBARS concentration correlated with the decrease of body mass index (BMI).", {"entities": []}], ["Decrease of oxyLDL and ADMA correlated with increased insulin sensitivity, however markers of SOX did not correlate with BP decrease.", {"entities": []}], ["SOX in children with PH correlates with TOD, metabolic abnormalities, changes in fat amount and improvement of insulin sensitivity, but not with BP decrease.", {"entities": []}], ["Objective .", {"entities": []}], ["To report on changes in sensitivity to mold allergens determined by changes in intradermal skin testing reactivity, after exposure to two severe hurricanes.", {"entities": []}], ["A random, retrospective allergy charts review divided into 2 groups of 100 patients each: Group A, patients tested between 2003 and 2010 prior to hurricanes, and Group B, patients tested in 2014 and 2015 following hurricanes.", {"entities": []}], ["Reactivity to eighteen molds was determined by intradermal skin testing.", {"entities": []}], ["Test results, age, and respiratory symptoms were recorded.", {"entities": []}], ["Chi-square test determined reactivity/sensitivity differences between groups.", {"entities": []}], ["Posthurricane patients had 34.6 times more positive results ( p < 0.0001) at weaker dilutions, all tested molds were found to be more reactive, and 95% had at least one positive test versus only 62% before the hurricanes ( p < 0.0001); average mold reactivity was 55% versus 16% while 17% of patients reacted to the entire panel versus none before the hurricanes ( p < 0.0001).", {"entities": []}], ["The posthurricane population was younger ( p < 0.001) and included more patients with asthma or lower respiratory symptoms ( p < 0.05).", {"entities": [[86, 92, "DISEASE"]]}], ["Conclusion .", {"entities": []}], ["Reactivity and sensitization to mold allergens increased compared to patients before the hurricanes.", {"entities": []}], ["This supports climatologists' hypothesis that environmental changes resulting from hurricanes can be a health risk as reflected in increased allergic sensitivities and symptoms and has significant implications for physicians treating patients from affected areas.", {"entities": []}], ["Most evidence (not all) points in the direction that individuals with a higher level of health literacy will less frequently utilize the health care system than individuals with lower levels of health literacy.", {"entities": []}], ["The underlying reasons of this effect are largely unclear, though people\u2019s ability to seek health information independently at the time of wide availability of such information on the Internet has been cited in this context.", {"entities": []}], ["We propose and test two potential mediators of the negative effect of eHealth literacy on health care utilization: (1) health information seeking and (2) gain in empowerment by information seeking.", {"entities": []}], ["Data were collected in New Zealand, the United Kingdom, and the United States using a Web-based survey administered by a company specialized on providing online panels.", {"entities": []}], ["Combined, the three samples resulted in a total of 996 baby boomers born between 1946 and 1965 who had used the Internet to search for and share health information in the previous 6 months.", {"entities": []}], ["Measured variables include eHealth literacy, Internet health information seeking, the self-perceived gain in empowerment by that information, and the number of consultations with one\u2019s general practitioner (GP).", {"entities": []}], ["Path analysis was employed for data analysis.", {"entities": []}], ["We found a bundle of indirect effect paths showing a positive relationship between health literacy and health care utilization: via health information seeking (Path 1), via gain in empowerment (Path 2), and via both (Path 3).", {"entities": []}], ["In addition to the emergence of these indirect effects, the direct effect of health literacy on health care utilization disappeared.", {"entities": []}], ["The indirect paths from health literacy via information seeking and empowerment to GP consultations can be interpreted as a dynamic process and an expression of the ability to find, process, and understand relevant information when that is necessary.", {"entities": []}], ["Skin protects the body from the environment and is an important component of the innate and adaptive immune systems.", {"entities": []}], ["Atopic dermatitis and contact dermatitis are among the most frequent inflammatory skin diseases and are both determined by multigenic predisposition, environmental factors, and aberrant immune response.", {"entities": [[22, 40, "DISEASE"], [0, 17, "DISEASE"], [7, 17, "DISEASE"], [30, 40, "DISEASE"]]}], ["Peptidoglycan Recognition Proteins (Pglyrps) are expressed in the skin and we report here that they modulate sensitivity to experimentally-induced atopic dermatitis and contact dermatitis.", {"entities": [[169, 187, "DISEASE"], [147, 164, "DISEASE"], [154, 164, "DISEASE"], [177, 187, "DISEASE"]]}], ["Pglyrp3 Pglyrp4 Pglyrp2 Pglyrp3 Pglyrp4 Pglyrp3 Pglyrp4 Pglyrp3 in vivo induction of Treg cells by vitamin D or after neutralization of IL-17.", {"entities": [[0, 7, "GENE"], [24, 31, "GENE"], [40, 47, "GENE"], [56, 63, "GENE"], [8, 15, "GENE"], [32, 39, "GENE"], [48, 55, "GENE"], [16, 23, "GENE"], [0, 7, "GENE"], [24, 31, "GENE"], [40, 47, "GENE"], [56, 63, "GENE"], [8, 15, "GENE"], [32, 39, "GENE"], [48, 55, "GENE"], [0, 7, "GENE"], [24, 31, "GENE"], [40, 47, "GENE"], [56, 63, "GENE"], [8, 15, "GENE"], [32, 39, "GENE"], [48, 55, "GENE"], [0, 7, "GENE"], [24, 31, "GENE"], [40, 47, "GENE"], [56, 63, "GENE"]]}], ["By contrast, Pglyrp1", {"entities": [[13, 20, "GENE"]]}], ["Activated naive CD4 ex vivo isolated naive CD4 Il17a, Zfp362, Ccr6, Acsbg1, Dpp4, Rora and Dclk1 showing pronounced demethylation selectively in ex vivo isolated Th17 cells when compared to other ex vivo isolated Th cell subsets and in vitro generated Th17 cells, suggesting that this unique epigenetic signature allows identifying and functionally characterizing in vivo generated Th17 cells.", {"entities": [[16, 19, "GENE"], [43, 46, "GENE"], [16, 19, "GENE"], [43, 46, "GENE"], [47, 52, "GENE"], [62, 66, "GENE"], [68, 74, "GENE"], [76, 80, "GENE"], [82, 86, "GENE"], [91, 96, "GENE"]]}], ["There is an ongoing debate about equity and equality in health care, and whether immigrants benefit equally from services as the non-immigrant population.", {"entities": []}], ["The study focuses on benefits from and adherence to the diabetes mellitus type 2 (DM 2) disease management program (DMP) among Turkish immigrants in Germany.", {"entities": [[56, 73, "DISEASE"]]}], ["So far, it has not been researched whether this group benefits from enrollment in the DMP as well as diabetics from the non-immigrant population.", {"entities": []}], ["Data on the non-immigrant sample (N = 702) stem from a survey among members of a German health insurance, the Turkish immigrant sample (N = 102) was recruited in the area of Hamburg.", {"entities": []}], ["Identical questions in both surveys enable comparing major components.", {"entities": []}], ["Regarding process quality, Turkish diabetics do not differ from the non-immigrant sample; moreover, they have significantly more often received documentation and diabetes training.", {"entities": []}], ["In terms of outcome quality however, results display a greater benefit on behalf of the non-immigrant sample (e.g., blood parameters and body mass index), and they also met more of the DMP criteria.", {"entities": []}], ["This underlines the need of diabetics with Turkish background for further education and information in order to become the empowered patient as is intended by the DMP as well as to prevent comorbidities.", {"entities": []}], ["Our previous genome-wide linkage scan mapped five loci for caries experience.", {"entities": []}], ["The purpose of this study was to fine map one of these loci, the locus 13q31.1, in order to identify genetic contributors to caries.", {"entities": []}], ["Seventy-two pedigrees from the Philippines were studied.", {"entities": []}], ["Caries experience was recorded and DNA was extracted from blood samples obtained from all subjects.", {"entities": []}], ["Sixty-one single nucleotide polymorphisms (SNPs) in 13q31.1 were genotyped.", {"entities": []}], ["Association between caries experience and alleles was tested.", {"entities": []}], ["We also studied 1,481 DNA samples obtained from saliva of subjects from the USA, 918 children from Brazil, and 275 children from Turkey, in order to follow up the results found in the Filipino families.", {"entities": []}], ["We used the AliBaba2.1 software to determine if the nucleotide changes of the associated SNPs changed the prediction of the presence of transcription-binding site sequences and we also analyzed the gene expression of the genes selected based on binding predictions.", {"entities": []}], ["Mutation analysis was also performed in 33 Filipino individuals of a segment of 13q31.1 that is highly conserved in mammals.", {"entities": []}], ["Statistically significant association with high caries experience was found for 11 markers in 13q31.1 in the Filipino families.", {"entities": []}], ["Haplotype analysis also confirmed these results.", {"entities": []}], ["In the populations used for follow-up purposes, associations were found between high caries experience and a subset of these markers.", {"entities": []}], ["Regarding the prediction of the transcription-binding site, the base change of the SNP rs17074565 was found to change the predicted-binding of genes that could be involved in the pathogenesis of caries.", {"entities": []}], ["When the sequence has the allele C of rs17074565, the potential transcription factors binding the sequence are GR and GATA1 .", {"entities": [[118, 123, "GENE"]]}], ["When the subject carries the G allele of rs17074565, the potential transcription factor predicted to bind to the sequence is GATA3 .", {"entities": [[125, 130, "GENE"]]}], ["The expression of GR in whole saliva was higher in individuals with low caries experience when compared to individuals with high caries experience (p =\u20090.046).", {"entities": []}], ["No mutations were found in the highly conserved sequence.", {"entities": []}], ["Genetic factors contributing to caries experience may exist in 13q31.1.", {"entities": []}], ["The rs17074565 is located in an intergenic region and is predicted to disrupt the binding sites of two different transcription factors that might be involved with caries experience.", {"entities": []}], ["GR expression in saliva may be a biomarker for caries risk and should be further explored.", {"entities": []}], ["Subjective memory is commonly considered to be a unidimensional measure.", {"entities": []}], ["However, theories of performance-based memory suggest that subjective memory could be divided into more than one dimension.", {"entities": []}], ["To divide subjective memory into theoretically related components of memory and explore the relationship to disease.", {"entities": []}], ["In this study, various aspects of self-reported memory were studied with respect to demographics and diseases in the third wave of the HUNT epidemiological study in middle Norway.", {"entities": []}], ["The study included all individuals 55 years of age or older, who responded to a nine-item questionnaire on subjective memory and questionnaires on health (n=18\u2009633).", {"entities": []}], ["A principle component analysis of the memory items resulted in two memory components; the criterion used was an eigenvalue above 1, which accounted for 54% of the total variance.", {"entities": []}], ["The components were interpreted as long-term memory (LTM; the first component; 43% of the total variance) and short-term memory (STM; the second component; 11% of the total variance).", {"entities": []}], ["Memory impairment was significantly related to all diseases (except Bechterew\u2019s disease), most strongly to brain infarction, heart failure, diabetes, cancer, chronic obstructive pulmonary disease and whiplash.", {"entities": [[158, 195, "DISEASE"], [107, 123, "DISEASE"], [150, 156, "DISEASE"]]}], ["For most diseases, the STM component was more affected than the LTM component; however, in cancer, the opposite pattern was seen.", {"entities": [[91, 97, "DISEASE"]]}], ["Subjective memory impairment as measured in HUNT contained two components, which were differentially associated with diseases.", {"entities": []}], ["Airborne particles have been linked to increased mortality and morbidity.", {"entities": []}], ["As most research has focused on fine particles (PM 2.5 ), the health implications of coarse particles (PM 10-2.5 ) are not well understood.", {"entities": []}], ["We conducted a systematic review and meta-analysis of associations for short- and long-term PM 10-2.5 concentrations with mortality and hospital admissions.", {"entities": []}], ["Using 23 mortality and 10 hospital admissions studies, we documented suggestive evidence of increased morbidity and mortality in relation to higher short-term PM 10-2.5 concentrations, with stronger relationships for respiratory than cardiovascular endpoints.", {"entities": []}], ["Reported associations were highly heterogeneous, however, especially by geographic region and average PM 10-2.5 concentrations.", {"entities": []}], ["Adjustment for PM 2.5 and publication bias resulted in weaker and less precise effect estimates, although positive associations remained for short-term PM 10-2.5 concentrations.", {"entities": []}], ["Inconsistent relationships between effect estimates for PM 10-2.5 and correlations between PM 10-2.5 and PM 2.5 concentrations, however, indicate that PM 10-2.5 associations cannot be solely explained by co-exposure to PM 2.5 .", {"entities": []}], ["While suggestive evidence was found of increased mortality with long-term PM 10-2.5 concentrations, these associations were not robust to control for PM 2.5 .", {"entities": []}], ["Additional research is required to better understand sources of heterogeneity of associations between PM 10-2.5 and adverse health outcomes.", {"entities": []}], ["Practitioners who come into contact with the intoxicated, such as those in unscheduled care, often have limited resources to provide structured interventions.", {"entities": []}], ["There is therefore a need for cost-effective alcohol interventions requiring minimal input.", {"entities": []}], ["This study assesses the barriers, acceptability and validity of text messaging to collect daily alcohol consumption data and explores the feasibility of a text-delivered intervention in an exploratory randomised controlled trial.", {"entities": []}], ["Participants (n = 82) completed the initial online screening survey and those eligible were asked each day, for 157 days via text message, to reply with the number of alcohol units consumed the previous day.", {"entities": []}], ["Analyses compared standard measures of hazardous consumption with self-report alcohol use.", {"entities": []}], ["Attrition and sampling biases were examined.", {"entities": []}], ["Study I included secondary exploratory analyses using data from 70 participants to determine associations between events (including Christmas and other celebratory occasions) and consumption.", {"entities": []}], ["Study I further included the thematic analysis of semi-structured interview data and assessed the feasibility of and barriers to surveillance and interventions delivered through text messaging.", {"entities": []}], ["Developing findings from Study I, Study II developed an exploratory randomised control trial that delivered a single message on monthly alcohol expenditure in order to assess effect size and test generalisability.", {"entities": []}], ["Self-report alcohol consumption data was significantly associated with FAST and AUDIT scores.", {"entities": []}], ["Attrition from the study was not associated with greater alcohol use.", {"entities": []}], ["Greater alcohol use was observed on Fridays, Saturdays and Wednesdays as were notable celebratory events.", {"entities": []}], ["Interview data indicated that text messaging was acceptable to participants and preferred over email and web-based methods.", {"entities": []}], ["The exploratory randomised controlled trial suggested that a simple text delivered intervention might be effective in eliciting a reduction in alcohol consumption in a future trial.", {"entities": []}], ["The ubiquity of mobile telephones and the acceptability of text messaging suggests that this approach can be developed as a surveillance tool to collect high frequency consumption data to identify periods of vulnerability and that it can offer a platform through which targeted interventions can be delivered.", {"entities": []}], ["Please cite this paper as: Ambrose CS et\u00a0al.", {"entities": [[35, 37, "GENE"]]}], ["(2011) The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.", {"entities": [[74, 83, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(2), 67\u201375.", {"entities": [[0, 9, "DISEASE"]]}], ["In the United States, two types of vaccines are recommended for the prevention of influenza: an intranasal live attenuated influenza vaccine (LAIV) for eligible individuals aged 2\u201349\u2003years and unadjuvanted injectable trivalent inactivated vaccines (TIV) for eligible individuals aged \u22656\u2003months.", {"entities": [[82, 91, "DISEASE"], [123, 132, "DISEASE"]]}], ["Several recent studies have compared the efficacy of the 2 vaccines in children and adults.", {"entities": []}], ["In children 6\u2003months to 18\u2003years of age, each of the four comparative studies of LAIV and TIV demonstrated that LAIV was more protective.", {"entities": []}], ["In individuals 17\u201349\u2003years of age, most comparative studies have demonstrated that LAIV and TIV were similarly efficacious or that TIV was more efficacious.", {"entities": []}], ["However, LAIV was shown to be more protective than TIV in new military recruits of all ages, and placebo\u2010controlled studies in adults in 1997\u20131998 suggested that LAIV was more protective against the mismatched A/H3N2 strain.", {"entities": []}], ["The relative efficacy of LAIV and TIV among young adults may vary depending on the specific population and the antigenic match between the vaccines and circulating strains.", {"entities": []}], ["In adults 60\u2003years of age and older, limited data suggest that the two vaccines are similarly effective.", {"entities": []}], ["In children and adults, studies also suggest that the relative efficacy of LAIV versus TIV may increase when measured against more severe illness.", {"entities": []}], ["Additional research comparing LAIV and TIV is needed in adults and would also be valuable in older children and adolescents.", {"entities": []}], ["Studies should examine the role of pre\u2010existing immunity as well as vaccine impact on influenza illness of varying severity.", {"entities": [[86, 95, "DISEASE"]]}], ["The objective of this study was to develop a method of classifying comorbid conditions that accounts for both the severity and joint effects of the diseases.", {"entities": []}], ["The Troms\u00f8 Study is a cohort study with a longitudinal design utilizing a survey approach with physical examinations in the Troms\u00f8 municipality from 1974 to 2008, where in total 40051 subjects participated.", {"entities": []}], ["We used Troms\u00f8 4 as reference population and the Norwegian Institute of Public Health (FHI) panel as validation population.", {"entities": []}], ["Ordinal regression was used to assess the effect of comorbid disease on Self-Reported Health (SRH).", {"entities": []}], ["The model is controlled for interaction between diseases, mental health, age, and gender.", {"entities": []}], ["The health impact index estimated levels of SRH.", {"entities": []}], ["The comparison of predicted and observed SRH showed no significant differences.", {"entities": []}], ["Spearman\u2019s correlation showed that increasing levels of comorbidity were related to lower levels of SRH (R S = -0.36, p <.001).", {"entities": []}], ["The Charlson Comorbidity Index(CCI) was also associated with SRH (r = -.25, p <.001).", {"entities": []}], ["When focusing on only individuals with a comorbid disease, the relation between SRH and the Health Impact Index (HII) was strengthened (r = -.42, p <.001), while the association between SRH and CCI was attenuated (r = -.14, p <.001).", {"entities": []}], ["CCI was designed to control for comorbid conditions when survival/mortality is the outcome of interest but is inaccurate when the outcome is SRH.", {"entities": []}], ["We conclude that HII should be used when SRH is not available, and well-being or quality of survival/life is the outcome of interest.", {"entities": []}], ["We describe two cases of large solitary luteinized follicle cyst of pregnancy and puerperium (LSLFCPP) with new clinicopathologic findings.", {"entities": []}], ["The first case occurred in a 40-year old woman who was found to have a left ovarian mass during the third trimester of pregnancy.", {"entities": []}], ["The patient delivered a full term healthy female infant via caesarean section.", {"entities": []}], ["The ovarian mass was removed by oophorectomy.", {"entities": []}], ["The specimen showed a unilocular, thin-walled, clear fluid filled cyst measuring 15 \u00d7 12 \u00d7 5 cm.", {"entities": []}], ["Microscopically, the cyst was lined by single to multiple layers of luteinized cells with mainly small, round and regular nuclei and focally enlarged, bizarre, and hyperchromatic nuclei.", {"entities": []}], ["Occasional mitotic figures were seen.", {"entities": []}], ["The cyst wall showed marked edema and nests of luteinized cells that were morphologically similar to the cyst lining cells.", {"entities": []}], ["Groups of lesional cells were surrounded by reticulin fibers.", {"entities": []}], ["The patient has been healthy without disease after 7 years.", {"entities": []}], ["The second patient was a 29-year old pregnant woman who was found to have a right ovarian cyst by ultrasound at 14-week gestation.", {"entities": [[82, 94, "DISEASE"]]}], ["She then presented with preterm labor at 33-week gestation and delivered a healthy female infant via caesarean section.", {"entities": []}], ["A right salpingo-oophorectomy was performed.", {"entities": []}], ["Gross inspection of the specimen revealed a unilocular, brown mucoid fluid filled cyst measuring 14 \u00d7 11 \u00d7 9 cm.", {"entities": []}], ["The cyst surfaces were smooth, and the cyst wall exhibited marked edema.", {"entities": []}], ["Microscopic examination showed features similar to the first case: cyst lined by luteinized cells with focal large nuclei, scattered nests of luteinized cells in the edematous fibrous wall, and reticulin fibers surrounding large nests of lesional cells.", {"entities": []}], ["No mitoses, however, were identified in the second case.", {"entities": []}], ["The patient has been well without disease 1 year after surgery.", {"entities": []}], ["These two cases contribute to a better understanding of LSLFCPP.", {"entities": []}], ["Our case in the 40-year old patient is the first to show mitotic figures in LSLFCPP and suggests that the presence of occasional mitoses should not exclude a diagnosis of LSLFCPP.", {"entities": []}], ["The lesion in the second patient caused preterm labor.", {"entities": []}], ["Nevertheless, absence of disease recurrence in our patients demonstrates a benign nature of LSLFCPP.", {"entities": []}], ["Children of mothers infected with soil-transmitted helminths (STH) may have an increased susceptibility to STH infection.", {"entities": []}], ["We did a case-control study nested in a birth cohort in Ecuador.", {"entities": []}], ["Data from 1,004 children aged 7 months to 3 years were analyzed.", {"entities": []}], ["Cases were defined as children with Ascaris lumbricoides and/or Trichuris trichiura , controls without.", {"entities": []}], ["Exposure was defined as maternal infection with A. lumbricoides and/or T. trichiura , detected during the third trimester of pregnancy.", {"entities": []}], ["The analysis was restricted to households with a documented infection to control for infection risk.", {"entities": []}], ["Children of mothers with STH infections had a greater risk of infection compared to children of uninfected mothers (adjusted OR 2.61, 95% CI: 1.88\u20133.63, p<0.001).", {"entities": []}], ["This effect was particularly strong in children of mothers with both STH infections (adjusted OR: 5.91, 95% CI: 3.55\u20139.81, p<0.001).", {"entities": []}], ["Newborns of infected mothers had greater levels of plasma IL-10 than those of uninfected mothers (p\u200a=\u200a0.033), and there was evidence that cord blood IL-10 was increased among newborns who became infected later in childhood (p\u200a=\u200a0.060).", {"entities": []}], ["Our data suggest that maternal STH infections increase susceptibility to infection during early childhood, an effect that was associated with elevated IL-10 in cord plasma.", {"entities": []}], ["Soil-transmitted helminths (intestinal worms) are among the most common childhood infections worldwide and are a significant cause of morbidity particularly among poor populations living in developing countries.", {"entities": []}], ["The potent immune modulatory effects of these parasites have been suggested to be a determinant of the epidemiological distributions of other infectious diseases (e.g., HIV and tuberculosis) and allergy.", {"entities": [[177, 189, "DISEASE"]]}], ["There is strong epidemiological evidence that some individuals have an increased susceptibility to re-infection after treatment and the mechanisms underlying this are not well understood.", {"entities": []}], ["A possible explanation is that in utero exposure to maternal STH infections may increase the risk of infection during childhood, but, as far as we are aware, no published study has addressed this hypothesis for STH infections in humans.", {"entities": []}], ["In this study, we evaluated whether children of mothers infected with STH infections have a greater risk of infection when compared to children of uninfected mothers.", {"entities": []}], ["We also examined whether this increased susceptibility to infection might occur through the tolerogenic effects of increased levels in the systemic circulation of the immune regulatory cytokine IL-10, in early life.", {"entities": []}], ["Our data provide evidence that maternal STH infections predispose children to infections with STH parasites, and this effect was associated with elevated levels of IL-10 in newborn blood.", {"entities": []}], ["Neutrophils cast neutrophil extracellular traps (NETs) to ensnare microbial pathogens.", {"entities": []}], ["Nevertheless, the molecular rheostats that regulate NETosis in response to bacteria are not clearly established.", {"entities": []}], ["We hypothesized that stress-activated protein kinase or c-Jun N-terminal Kinase (SAPK/JNK) is a molecular switch that turns on NETosis in response to increasing concentrations of lipopolysaccharide (LPS)- and Gram-negative bacteria.", {"entities": []}], ["Here we show that Escherichia coli LPS (0111:B4; 10\u201325\u2009\u03bcg/ml), but not phorbol myristate acetate (PMA), activates JNK in human neutrophils in a dose-dependent manner.", {"entities": []}], ["JNK inhibitors SP600125 and TCSJNK6o, and a TLR4 inhibitor TAK242 suppress reactive oxygen species production and NETosis in LPS-, but not PMA-treated neutrophils.", {"entities": [[44, 48, "GENE"]]}], ["Diphenyleneiodonium suppresses LPS-induced NETosis, confirming that endotoxin induces NADPH oxidase-dependent NETosis.", {"entities": []}], ["Immunoblots, Sytox Green assays, and confocal microscopy of cleaved caspase-3 and nuclear morphology show that JNK inhibition does not induce apoptosis in LPS-stimulated neutrophils.", {"entities": []}], ["JNK inhibition also suppresses NETosis induced by two typical Gram-negative bacteria, E. coli and Pseudomonas aeruginosa .", {"entities": []}], ["Therefore, we propose that neutrophils use a TLR4-dependent, JNK-mediated molecular sensing mechanism to initiate NADPH oxidase-dependent suicidal NETosis in response to increasing concentrations of LPS, and Gram-negative bacteria.", {"entities": []}], ["The LPS-TLR4-JNK activation axis determines the fate of these cells: to be or not to be NETotic neutrophils.", {"entities": []}], ["Data on the etiologies of pneumonia among children are inadequate, especially in developing countries.", {"entities": [[26, 35, "DISEASE"]]}], ["The principal objective is to undertake a multicenter incident case\u2013control study of <5-year-old children hospitalized with pneumonia in developing and emerging countries, aiming to identify the causative agents involved in pneumonia while assessing individual and microbial factors associated with the risk of severe pneumonia.", {"entities": [[124, 133, "DISEASE"], [224, 233, "DISEASE"], [318, 327, "DISEASE"]]}], ["A multicenter case\u2013control study, based on the GABRIEL network, is ongoing.", {"entities": []}], ["Ten study sites are located in 9 countries over 3 continents: Brazil, Cambodia, China, Haiti, India, Madagascar, Mali, Mongolia, and Paraguay.", {"entities": []}], ["At least 1,000 incident cases and 1,000 controls will be enrolled and matched for age and date.", {"entities": []}], ["Cases are hospitalized children <5\u00a0years with radiologically confirmed pneumonia, and the controls are children without any features suggestive of pneumonia.", {"entities": [[71, 80, "DISEASE"], [147, 156, "DISEASE"]]}], ["Respiratory specimens are collected from all enrolled subjects to identify 19 viruses and 5 bacteria.", {"entities": []}], ["Whole blood from pneumonia cases is being tested for 3 major bacteria.", {"entities": [[17, 26, "DISEASE"]]}], ["S. pneumoniae -positive specimens are serotyped.", {"entities": []}], ["Urine samples from cases only are tested for detection of antimicrobial activity.", {"entities": []}], ["The association between procalcitonin, C-reactive protein and pathogens is being evaluated.", {"entities": []}], ["A discovery platform will enable pathogen identification in undiagnosed samples.", {"entities": []}], ["This multicenter study will provide descriptive results for better understanding of pathogens responsible for pneumonia among children in developing countries.", {"entities": [[110, 119, "DISEASE"]]}], ["The identification of determinants related to microorganisms associated with pneumonia and its severity should facilitate treatment and prevention.", {"entities": [[77, 86, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12879-014-0635-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Large epidemiological studies in DNA biobanks have increasingly used less invasive methods for obtaining DNA samples, such as saliva collection.", {"entities": []}], ["Although lower amounts of DNA are obtained as compared with blood collection, this method has been widely used because of its more simple logistics and increased response rate.", {"entities": []}], ["The present study aimed to verify whether a storage time of 8\u2009months decreases the quality of DNA from collected samples.", {"entities": []}], ["Saliva samples were collected with an OrageneTM DNA Self-Collection Kit from 4,110 subjects aged 14\u201315\u2009years.", {"entities": []}], ["The samples were processed in two aliquots with an 8-month interval between them.", {"entities": []}], ["Quantitative and qualitative evaluations were carried out in 20% of the samples by spectrophotometry and genotyping.", {"entities": []}], ["Descriptive analyses and paired t-tests were performed.", {"entities": []}], ["The mean volume of saliva collected was 2.2\u2009mL per subject, yielding on average 184.8\u2009\u03bcg DNA per kit.", {"entities": []}], ["Most samples showed a Ratio of OD differences (RAT) between 1.6 and 1.8 in the qualitative evaluation.", {"entities": []}], ["The evaluation of DNA quality by TaqMan\u00ae, High Resolution Melting (HRM), and restriction fragment length polymorphism-PCR (RFLP-PCR) showed a rate of success of up to 98% of the samples.", {"entities": []}], ["The sample store time did not reduce either the quantity or quality of DNA extracted with the Oragene kit.", {"entities": []}], ["The study results showed that a storage period of 8\u2009months at room temperature did not reduce the quality of the DNA obtained.", {"entities": []}], ["In addition, the use of the Oragene kit during fieldwork in large population-based studies allows for DNA of high quantity and high quality.", {"entities": []}], ["Identifying etiologies of acute febrile illnesses (AFI) is challenging due to non-specific presentation and limited availability of diagnostics.", {"entities": []}], ["Prospective AFI studies provide a methodology to describe the syndrome by age and etiology, findings that can be used to develop case definitions and multiplexed diagnostics to optimize management.", {"entities": [[62, 70, "DISEASE"]]}], ["We conducted a 3-year prospective AFI study in Puerto Rico.", {"entities": []}], ["Patients with fever \u22647 days were offered enrollment, and clinical data and specimens were collected at enrollment and upon discharge or follow-up.", {"entities": []}], ["Blood and oro-nasopharyngeal specimens were tested by RT-PCR and immunodiagnostic methods for infection with dengue viruses (DENV) 1\u20134, chikungunya virus (CHIKV), influenza A and B viruses (FLU A/B), 12 other respiratory viruses (ORV), enterovirus, Leptospira spp., and Burkholderia pseudomallei .", {"entities": [[163, 172, "DISEASE"], [136, 147, "DISEASE"]]}], ["Clinical presentation and laboratory findings of participants infected with DENV were compared to those infected with CHIKV, FLU A/B, and ORV.", {"entities": []}], ["Clinical predictors of laboratory-positive dengue compared to all other AFI etiologies were determined by age and day post-illness onset (DPO) at presentation.", {"entities": []}], ["Of 8,996 participants enrolled from May 7, 2012 through May 6, 2015, more than half (54.8%, 4,930) had a pathogen detected.", {"entities": []}], ["Pathogens most frequently detected were CHIKV (1,635, 18.2%), FLU A/B (1,074, 11.9%), DENV 1\u20134 (970, 10.8%), and ORV (904, 10.3%).", {"entities": []}], ["Participants with DENV infection presented later and a higher proportion were hospitalized than those with other diagnoses (46.7% versus 27.3% with ORV, 18.8% with FLU A/B, and 11.2% with CHIKV).", {"entities": []}], ["Predictors of dengue in participants presenting <3 DPO included leukopenia, thrombocytopenia, headache, eye pain, nausea, and dizziness, while negative predictors were irritability and rhinorrhea.", {"entities": [[64, 74, "DISEASE"], [76, 92, "DISEASE"]]}], ["Predictors of dengue in participants presenting 3\u20135 DPO were leukopenia, thrombocytopenia, facial/neck erythema, nausea, eye pain, signs of poor circulation, and diarrhea; presence of rhinorrhea, cough, and red conjunctiva predicted non-dengue AFI.", {"entities": [[61, 71, "DISEASE"], [73, 89, "DISEASE"], [162, 170, "DISEASE"]]}], ["By enrolling febrile patients at clinical presentation, we identified unbiased predictors of laboratory-positive dengue as compared to other common causes of AFI.", {"entities": []}], ["These findings can be used to assist in early identification of dengue patients, as well as direct anticipatory guidance and timely initiation of correct clinical management.", {"entities": []}], ["We conducted a prospective study of acute febrile illness (AFI) in Puerto Rico to better understand the etiology of AFI among all age groups in the tropics.", {"entities": []}], ["Such findings could assist clinicians to identify disease-specific characteristics, which can then be used to initiate proper patient management.", {"entities": []}], ["We enrolled 8,996 AFI patients and tested them for dengue viruses 1\u20134 (DENV 1\u20134) and 21 other pathogens.", {"entities": []}], ["A pathogen was detected in 55% of patients, most frequently chikungunya virus (CHIKV, 18%), influenza A or B virus (FLU A/B, 12%), DENV 1\u20134 (11%), or another respiratory virus (ORV, 10%).", {"entities": [[92, 101, "DISEASE"], [60, 71, "DISEASE"]]}], ["Participants with dengue presented later after symptom onset and were hospitalized more often (47%) than patients with another etiology of AFI (27% with ORV, 19% with FLU A/B, and 11% with CHIKV).", {"entities": []}], ["Predictors of patients with dengue differed by timing of presentation but included eye pain, nausea, and low white blood cell or platelet counts; negative predictors included symptoms of respiratory illness.", {"entities": []}], ["By enrolling febrile patients at clinical presentation, we identified unbiased predictors of patients with dengue as compared to other common AFI.", {"entities": []}], ["Findings can be used to diagnose dengue patients to provide early and appropriate clinical management.", {"entities": []}], ["The phosphatidylinositol 3-kinase (PI3K) pathway is activated in chronic obstructive pulmonary disease (COPD), but the regulatory mechanisms for this pathway are yet to be elucidated.", {"entities": [[65, 102, "DISEASE"]]}], ["The aim of this study was to determine the expression and role of phosphatase and tensin homolog deleted from chromosome 10 (PTEN), a negative regulator of the PI3K pathway, in COPD.", {"entities": [[125, 129, "GENE"]]}], ["PTEN protein expression was measured in the peripheral lung of COPD patients compared with smoking and nonsmoking controls.", {"entities": [[0, 4, "GENE"]]}], ["The direct influence of cigarette smoke extract (CSE) on PTEN expression was assessed using primary lung epithelial cells and a cell line (BEAS-2B) in the presence or absence of l -buthionine-sulfoximine (BSO) to deplete intracellular glutathione.", {"entities": [[57, 61, "GENE"]]}], ["The impact of PTEN knockdown by RNA interference on cytokine production was also examined.", {"entities": [[14, 18, "GENE"]]}], ["In peripheral lung, PTEN protein was significantly decreased in patients with COPD compared with the subjects without COPD ( P < 0.001) and positively correlated with the severity of airflow obstruction (forced expiratory volume in 1-s percent predicted; r = 0.50; P = 0.0012).", {"entities": [[20, 24, "GENE"]]}], ["Conversely, phosphorylated Akt, as a marker of PI3K activation, showed a negative correlation with PTEN protein levels ( r = \u22120.41; P = 0.0042).", {"entities": [[99, 103, "GENE"]]}], ["In both primary bronchial epithelial cells and BEAS-2B cells, CSE decreased PTEN protein, which was reversed by N -acetyl cysteine treatment.", {"entities": [[76, 80, "GENE"]]}], ["PTEN knockdown potentiated Akt phosphorylation and enhanced production of proinflammatory cytokines, such as IL-6, CXCL8, CCL2, and CCL5.", {"entities": [[0, 4, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"]]}], ["In conclusion, oxidative stress reduces PTEN protein levels, which may result in increased PI3K signaling and amplification of inflammation in COPD.", {"entities": [[40, 44, "GENE"]]}], ["Several chronic conditions leading to skeletal muscle dysfunction are known to be associated with changes in the expression of myosin heavy chain (MHC) isoforms at both the mRNA and protein level.", {"entities": []}], ["Many of these conditions are modelled, pre-clinically, in the guinea pig due to similar disease onset and progression to the human condition, and their generally well-characterised anatomy.", {"entities": []}], ["MHC composition is amenable to determination by protein and mRNA based methodologies, the latter quantifying the expression of MHC isoform-specific gene transcripts allowing the detection of earlier, and more subtle changes.", {"entities": []}], ["As such, the MHC mRNAs, and specific oligonucleotide primers of all common laboratory species have been available for some time.", {"entities": []}], ["However, due to incomplete genomic annotation, assessment of guinea pig MHC mRNA expression has not been previously possible, precluding the full characterisation of early changes in skeletal muscle in response to disease and disease modulation.", {"entities": []}], ["The purpose of this study was to characterise the multigenic structure of the sarcomeric MHC family in the guinea pig, and to design and validate specific oligonucleotide primers to enable the assessment of the predominant adult-muscle associated MHC mRNAs in relevant disease models.", {"entities": []}], ["Using a combination of ligase-mediated rapid amplification of 5' and 3' cDNA ends (RACE) and bioinformatics, mRNAs to the four main skeletal-muscle isoforms of MHC were determined.", {"entities": []}], ["Specific oligonucleotide primers were designed, and following verification of their specificity, found to successfully determine the expression of each MHC mRNA independently.", {"entities": []}], ["Because of their utilisation in the in vivo modelling of disease, there is a requirement to develop molecular methods that accurately differentiate the different MHC mRNAs in the guinea pig to enable rapid profiling of muscle composition in appropriate disease models.", {"entities": []}], ["The methods developed here are suitable for the characterisation of muscle MHC expression at the molecular level from animal tissue samples and biopsy material.", {"entities": []}], ["The publication of these specific oligonucleotide primers for the guinea pig MHC variants will enable researchers to rapidly and accurately quantify acute changes in MHC mRNA expression in either developmental or in guinea pig disease models where a marker of altered skeletal muscle function is required.", {"entities": []}], ["A novel hierarchical heterostructures based on \u03b1 -Fe 2 O 3 /NiO nanosheet-covered fibers were synthesized using a simple two-step process named the electrospinning and hydrothermal techniques.", {"entities": []}], ["A high density of \u03b1 -Fe 2 O 3 nanosheets were uniformly and epitaxially deposited on a NiO nanofibers.", {"entities": []}], ["The crystallinity, morphological structure and surface composition of nanostructured based on \u03b1 -Fe 2 O 3 /NiO composites were investigated by XRD, SEM, TEM, EDX, XPS and BET analysis.", {"entities": []}], ["The extremely branched \u03b1 -Fe 2 O 3 /NiO nanosheet-covered fibers delivered an extremely porous atmosphere with huge specific surface area essential for superior gas sensors.", {"entities": []}], ["Different nanostructured based on \u03b1 -Fe 2 O 3 /NiO composites were also explored by adjusting the volume ratio of the precursors.", {"entities": []}], ["The as-prepared samples based on \u03b1 -Fe 2 O 3 /NiO nanocomposite sensors display apparently enhanced sensing characteristics, including higher sensing response, quick response with recovery speed and better selectivity towards acetone gas at lower operating temperature as compared to bare NiO nanofibers.", {"entities": []}], ["The sensing response of S-2 based \u03b1-Fe 2 O 3 /NiO nanosheet-covered fibers were 18.24 to 100\u2009ppm acetone gas at 169\u2009\u00b0C, which was about 6.9 times higher than that of bare NiO nanofibers.", {"entities": []}], ["The upgraded gas sensing performance of composites based on \u03b1 -Fe 2 O 3 /NiO nanosheet-covered fibers might be ascribed to the exclusive morphologies with large surface area, p-n heterojunctions and the synergetic performance of \u03b1 -Fe 2 O 3 and NiO.", {"entities": []}], ["Dry cough, dyspenea and diffuse centrilobular nodules in both lungs of radiologic findings similar to hypersensitivity pneumonitis (HP) are rare initial presentation in chronic granulomatous disease (CGD).", {"entities": [[169, 198, "DISEASE"], [132, 134, "GENE"]]}], ["CGD is remarkable for increased susceptibility to bacterial and fungal infections as well as high sensitivity to inciting antigens such as Aspergillus species due to dysregulated inflammation.", {"entities": []}], ["We identified three children who had an initial presentation mimicking HP and were subsequently diagnosed as CGD.", {"entities": [[71, 73, "GENE"]]}], ["All patients developed invasive pulmonary A. fumigatus infection (IPAI) following systemic glucocorticoid therapy.", {"entities": []}], ["Two of the three patients were found to have mutations in NCF1 gene and one patient in NCF2 gene.", {"entities": [[58, 62, "GENE"], [87, 91, "GENE"]]}], ["As HP is uncommon in children, we should consider the possibility of CGD in children with HP, even in mimicking HP patients with suggestive inhalation history and negative fungal cultures.", {"entities": [[3, 5, "GENE"], [90, 92, "GENE"], [112, 114, "GENE"], [3, 5, "GENE"], [90, 92, "GENE"], [112, 114, "GENE"], [3, 5, "GENE"], [90, 92, "GENE"], [112, 114, "GENE"]]}], ["A prompt diagnosis of CGD is essential to enable initiation of prophylactic antibacterial and antifungal therapies.", {"entities": []}], ["In various regions of Brazil, several species of the genus Byrsonima (Malpighiaceae) are widely used to treat gastrointestinal complications.", {"entities": []}], ["This genus has about 150 species of shrubs and trees distributed over the entire Neotropical region.", {"entities": []}], ["Various biological activities have been identified in these plants, especially antioxidant, antimicrobial and topical and systemic anti-inflammatory activities.", {"entities": []}], ["The aim of this study was to investigate the mutagenicity and antimutagenicity of hydroalcoholic leaf extracts of six species of Byrsonima: B. verbascifolia, B. correifolia, B. coccolobifolia, B. ligustrifolia, B. fagifolia and B. intermedia by the Salmonella microsome assay (Ames test).", {"entities": []}], ["Mutagenic and antimutagenic activity was assessed by the Ames test, with the Salmonella typhimurium tester strains TA100, TA98, TA97a and TA102, with (+S9) and without (-S9) metabolization, by the preincubation method.", {"entities": []}], ["Only B. coccolobifolia and B. ligustrifolia showed mutagenic activity.", {"entities": []}], ["However, the extracts of B. verbascifolia, B. correifolia, B. fagifolia and B. intermedia were found to be strongly antimutagenic against at least one of the mutagens tested.", {"entities": []}], ["These results contribute to valuable data on the safe use of medicinal plants and their potential chemopreventive effects.", {"entities": []}], ["Considering the excellent antimutagenic activities extracted from B. verbascifolia , B. correifolia , B. fagifolia and B. intermedia, these extracts are good candidate sources of chemopreventive agents.", {"entities": []}], ["However, B. coccolobifolia and B. ligustrifolia showed mutagenic activity, suggesting caution in their use.", {"entities": []}], ["Nonimmune pregnant women are at risk of developing congenital rubella syndrome and measles complications.", {"entities": [[83, 90, "DISEASE"], [70, 78, "DISEASE"], [62, 69, "DISEASE"]]}], ["We aimed to identify pregnant women susceptible to rubella or measles in order to determine the need for immunity screening and supplemental immunization in women of childbearing age.", {"entities": [[62, 69, "DISEASE"], [51, 58, "DISEASE"]]}], ["This seroprevalence survey was conducted by convenience sampling in obstetric hospitals affiliated with Shiraz University of Medical Sciences (southern Iran).", {"entities": []}], ["Serum IgG levels were measured by ELISA.", {"entities": []}], ["Mean age of the 175 pregnant women was 27.3\u00b15.3 (range 16 to 42) years.", {"entities": []}], ["The geometric mean concentration of anti-rubella IgG was 14.9 IU/mL (CI 95%,14.1\u201315.5), and that of anti-measles IgG was 13.8 IU/mL (CI 95%, 13\u201314.5).", {"entities": [[105, 112, "DISEASE"], [41, 48, "DISEASE"]]}], ["One hundred sixty-eight women (96%) had a protective serologic level (>11 IU/mL) of IgG against rubella, and 143 (81.7%) had a protective level against measles.", {"entities": [[152, 159, "DISEASE"], [96, 103, "DISEASE"]]}], ["Except for a significant inverse correlation that was showed by univariate analysis between anti-rubella IgG and the women\u2019s age (P\u200a=\u200a0.01), immunity did not correlate with demographic or obstetric characteristics or medical history.", {"entities": [[97, 104, "DISEASE"]]}], ["There was no significant correlation between anti-rubella and anti-measles IgG levels (P\u200a=\u200a0.25).", {"entities": [[67, 74, "DISEASE"], [50, 57, "DISEASE"]]}], ["Nearly a decade after Iran\u2019s nationwide measles-rubella vaccination campaign for the population aged 5\u201325 years, most pregnant women up to 34 years of age had humoral immunity against rubella.", {"entities": [[40, 47, "DISEASE"], [48, 55, "DISEASE"], [184, 191, "DISEASE"]]}], ["We recommend rubella immunity screening or catch-up immunization for women older than 35 years who wish to become pregnant, and measles immunity screening and appropriate vaccination for all women of childbearing age.", {"entities": [[128, 135, "DISEASE"], [13, 20, "DISEASE"]]}], ["Nanomaterials can get into the blood circulation after injection or by release from implants but also by permeation of the epithelium after oral, respiratory or dermal exposure.", {"entities": []}], ["Once in the blood, they can affect hemostasis, which is usually not intended.", {"entities": []}], ["This review addresses effects of biological particles and engineered nanomaterials on hemostasis.", {"entities": []}], ["The role of platelets and coagulation in normal clotting and the interaction with the immune system are described.", {"entities": []}], ["Methods to identify effects of nanomaterials on clotting and results from in vitro and in vivo studies are summarized and the role of particle size and surface properties discussed.", {"entities": []}], ["The literature overview showed that mainly pro-coagulative effects of nanomaterials have been described.", {"entities": []}], ["In vitro studies suggested stronger effects of smaller than of larger NPs on coagulation and a greater importance of material than of surface charge.", {"entities": [[70, 73, "GENE"]]}], ["For instance, carbon nanotubes, polystyrene particles, and dendrimers inferred with clotting independent from their surface charge.", {"entities": []}], ["Coating of particles with polyethylene glycol was able to prevent interaction with clotting by some particles, while it had no effect on others and the more recently developed bio-inspired surfaces might help to design coatings for more biocompatible particles.", {"entities": []}], ["The mainly pro-coagulative action of nanoparticles could present a particular risk for individuals affected by common diseases such as diabetes, cancer, and cardiovascular diseases.", {"entities": [[145, 151, "DISEASE"]]}], ["Under standardized conditions, in vitro assays using human blood appear to be a suitable tool to study mechanisms of interference with hemostasis and to optimize hemocompatibility of nanomaterials.", {"entities": []}], ["The aim of this study was to evaluate new and previously hypothesised non-genetic risk factors for serologic subtypes of rheumatoid arthritis (RA) defined by the presence or absence of auto-antibodies to cyclic citrullinated peptides (CCP).", {"entities": [[121, 141, "DISEASE"], [132, 141, "DISEASE"]]}], ["In a national case-control study, we included 515 patients recently diagnosed with RA according to the American College of Rheumatology 1987 classification criteria and 769 gender- and age-matched population controls.", {"entities": []}], ["Telephone interviews provided information about non-genetic exposures, and serum samples for patients were tested for anti-CCP-antibodies.", {"entities": []}], ["Associations between exposure variables and risk of anti-CCP-positive and anti-CCP-negative RA were evaluated using logistic regression.", {"entities": []}], ["A series of RA subtype-specific risk factors were identified.", {"entities": []}], ["Tobacco smoking (odds ratio [OR] = 1.65; 95% confidence interval: 1.03\u20132.64, for >20 versus 0 pack-years) was selectively associated with risk of anti-CCP-positive RA, whereas alcohol consumption exhibited an inverse dose-response association with this RA subtype (OR = 1.98, 1.22\u20133.19, for 0 versus >0\u20135 drinks per week).", {"entities": []}], ["Furthermore, coffee consumption (OR = 2.18; 1.07\u20134.42, for >10 versus 0 cups per day), ever use of oral contraceptives (OR = 1.65; 1.06\u20132.57) and having a first-degree relative with schizophrenia (OR = 4.18; 1.54\u201311.3) appeared more strongly associated with risk of anti-CCP-positive RA.", {"entities": [[182, 195, "DISEASE"]]}], ["Obesity was selectively associated with risk of anti-CCP-negative RA, with obese individuals being at more than 3-fold increased risk of this subtype compared with normal-weight individuals (OR = 3.45; 1.73\u20136.87).", {"entities": []}], ["Age at menarche was the only examined factor that was significantly associated with both serologic subtypes of RA (p-trends = 0.01); women with menarche at age \u2265 15 years had about twice the risk of either RA subtype compared with women with menarche at age \u2264 12 years.", {"entities": []}], ["Major differences in risk factor profiles suggest distinct etiologies for anti-CCP-positive and anti-CCP-negative RA.", {"entities": []}], ["Meniere's disease is an episodic vestibular syndrome associated with sensorineural hearing loss (SNHL) and tinnitus.", {"entities": [[44, 52, "DISEASE"], [69, 95, "DISEASE"]]}], ["Patients with MD have an elevated prevalence of several autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and psoriasis), which suggests a shared autoimmune background.", {"entities": [[140, 151, "DISEASE"], [77, 97, "DISEASE"], [156, 165, "DISEASE"], [108, 127, "DISEASE"], [88, 97, "DISEASE"], [99, 127, "DISEASE"], [129, 151, "DISEASE"]]}], ["Functional variants of several genes involved in the NF-\u03baB pathway, such as REL , TNFAIP3 , NFKB1 and TNIP1 , have been associated with two or more immune-mediated diseases and allelic variations in the TLR10 gene may influence bilateral affectation and clinical course in MD.", {"entities": [[82, 89, "GENE"], [92, 97, "GENE"], [102, 107, "GENE"], [203, 208, "GENE"]]}], ["We have genotyped 716 cases of MD and 1628 controls by using the ImmunoChip, a high-density genotyping array containing 186 autoimmune loci, to explore the association of immune system related-loci with sporadic MD.", {"entities": []}], ["Although no single nucleotide polymorphism (SNP) reached a genome-wide significant association (p<10 NFKB1 gene (rs3774937 and rs4648011) were associated with a faster hearing loss progression in patients with unilateral SNHL.", {"entities": [[101, 106, "GENE"]]}], ["So, individuals with unilateral MD carrying the C allele in rs3774937 or G allele in rs4648011 had a shorter mean time to reach hearing stage 3 (>40 dB HL) (log-rank test, corrected p values were p\u200a=\u200a0.009 for rs3774937 and p\u200a=\u200a0.003 for rs4648011, respectively).", {"entities": []}], ["No variants influenced hearing in bilateral MD.", {"entities": []}], ["Our data support that the allelic variants rs3774937 and rs4648011 can modify hearing outcome in patients with MD and unilateral SNHL.", {"entities": []}], ["One of the major challenges in treating major depressive disorder (MDD) is patients\u2019 non-adherence to medication.", {"entities": [[40, 65, "DISEASE"]]}], ["This study aimed to explore the barriers and facilitators of patients\u2019 adherence to antidepressants among outpatients with MDD.", {"entities": []}], ["Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia.", {"entities": []}], ["Participants were purposively sampled from different genders and ethnicities.", {"entities": []}], ["Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach.", {"entities": []}], ["A total of 30 patients were interviewed.", {"entities": []}], ["Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence.", {"entities": []}], ["The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics.", {"entities": []}], ["The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks.", {"entities": []}], ["Patient-specific barriers and medication side effects were the major challenges for adhering to treatment.", {"entities": []}], ["Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators.", {"entities": []}], ["Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.", {"entities": []}], ["HLA-G is a non-classical HLA class-Ib molecule expressed mainly by the extravillous cytotrophoblasts (EVT) of the placenta.", {"entities": [[0, 5, "GENE"], [0, 3, "GENE"], [25, 28, "GENE"]]}], ["The expression of HLA-G on these fetal cells protects the EVT cells from immune rejection and is therefore important for a healthy pregnancy.", {"entities": [[18, 23, "GENE"]]}], ["The mechanisms controlling HLA-G expression are largely unknown.", {"entities": [[27, 32, "GENE"]]}], ["Here we demonstrate that miR-148a and miR-152 down-regulate HLA-G expression by binding its 3\u2032UTR and that this down-regulation of HLA-G affects LILRB1 recognition and consequently, abolishes the LILRB1-mediated inhibition of NK cell killing.", {"entities": [[25, 33, "GENE"], [38, 45, "GENE"], [60, 65, "GENE"], [131, 136, "GENE"], [60, 65, "GENE"], [131, 136, "GENE"], [145, 151, "GENE"], [196, 202, "GENE"]]}], ["We further demonstrate that the C/G polymorphism at position +3142 of HLA-G 3\u2032UTR has no effect on the miRNA targeting of HLA-G. We show that in the placenta both miR-148a and miR-152 miRNAs are expressed at relatively low levels, compared to other healthy tissues, and that the mRNA levels of HLA-G are particularly high and we therefore suggest that this might enable the tissue specific expression of HLA-G.", {"entities": [[70, 75, "GENE"], [122, 127, "GENE"], [294, 299, "GENE"], [404, 409, "GENE"], [163, 171, "GENE"], [176, 183, "GENE"], [70, 75, "GENE"], [122, 127, "GENE"], [294, 299, "GENE"], [404, 409, "GENE"], [70, 75, "GENE"], [122, 127, "GENE"], [294, 299, "GENE"], [404, 409, "GENE"]]}], ["Many epidemiological studies examining the relationships between adverse health outcomes and exposure to air pollutants use ambient air pollution measurements as a proxy for personal exposure levels.", {"entities": []}], ["When pollution levels vary at neighbourhood levels, using ambient pollution data from sparsely located fixed monitors may inadequately capture the spatial variation in ambient pollution.", {"entities": []}], ["A major constraint to moving toward exposure assessments and epidemiological studies of air pollution at a neighbourhood level is the lack of readily available data at appropriate spatial resolutions.", {"entities": []}], ["Spatial property assessment data are widely available in North America and may provide an opportunity for developing neighbourhood level air pollution exposure assessments.", {"entities": []}], ["This paper provides a detailed description of spatial property assessment data available in the Pacific Northwest of Canada and the United States, and provides examples of potential applications of spatial property assessment data for improving air pollution exposure assessment at the neighbourhood scale, including: (1) creating variables for use in land use regression modelling of neighbourhood levels of ambient air pollution; (2) enhancing wood smoke exposure estimates by mapping fireplace locations; and (3) using data available on individual building characteristics to produce a regional air pollution infiltration model.", {"entities": []}], ["Spatial property assessment data are an extremely detailed data source at a fine spatial resolution, and therefore a source of information that could improve the quality and spatial resolution of current air pollution exposure assessments.", {"entities": []}], ["HMO databases offer an opportunity for community based epidemiologic studies of asthma incidence, etiology and treatment.", {"entities": [[80, 86, "DISEASE"]]}], ["The incidence of asthma in HMO populations and the utility of HMO data, including use of computerized algorithms and manual review of medical charts for determining etiologic factors has not been fully explored.", {"entities": [[17, 23, "DISEASE"]]}], ["We identified adult-onset asthma, using computerized record searches in a New England HMO.", {"entities": [[26, 32, "DISEASE"]]}], ["Monthly, our software applied exclusion and inclusion criteria to identify an \"at-risk\" population and \"potential cases\".", {"entities": []}], ["Electronic and paper medical records from the past year were then reviewed for each potential case.", {"entities": []}], ["Persons with other respiratory diseases or insignificant treatment for asthma were excluded.", {"entities": [[71, 77, "DISEASE"]]}], ["Confirmed adult-onset asthma (AOA) cases were defined as those potential cases with either new-onset asthma or reactivated mild intermittent asthma that had been quiescent for at least one year.", {"entities": [[22, 28, "DISEASE"], [101, 107, "DISEASE"], [141, 147, "DISEASE"]]}], ["We validated the methods by reviewing charts of selected subjects rejected by the algorithm.", {"entities": []}], ["The algorithm was 93 to 99.3% sensitive and 99.6% specific.", {"entities": []}], ["Sixty-three percent (n = 469) of potential cases were confirmed as AOA.", {"entities": []}], ["Two thirds of confirmed cases were women with an average age of 34.8 (SD 11.8), and 45% had no evidence of previous asthma diagnosis.", {"entities": [[116, 122, "DISEASE"]]}], ["The annualized monthly rate of AOA ranged from 4.1 to 11.4 per 1000 at-risk members.", {"entities": []}], ["Physicians most commonly attribute asthma to infection (59%) and allergy (14%).", {"entities": [[35, 41, "DISEASE"]]}], ["New-onset cases were more likely attributed to infection, while reactivated cases were more associated with allergies.", {"entities": []}], ["Medical charts included a discussion of work exposures in relation to asthma in only 32 (7%) cases.", {"entities": [[70, 76, "DISEASE"]]}], ["Twenty-three of these (72%) indicated there was an association between asthma and workplace exposures for an overall rate of work-related asthma of 4.9%.", {"entities": [[71, 77, "DISEASE"], [138, 144, "DISEASE"]]}], ["Computerized HMO records can be successfully used to identify AOA.", {"entities": []}], ["Manual review of these records is important to confirm case status and is useful in evaluation of provider consideration of etiologies.", {"entities": []}], ["We demonstrated that clinicians attribute most AOA to infection and tend to ignore the contribution of environmental and occupational exposures.", {"entities": []}], ["Health policy, guidelines, and standards advocate giving patients comprehensive information and facilitating their involvement in health-related decision-making.", {"entities": []}], ["Routine assessment of patient reports of these processes is needed.", {"entities": []}], ["Our objective was to examine decision-making processes, specifically information provision and consumer involvement in decision-making, for nine pregnancy, labour, and birth procedures, as reported by maternity care consumers in Queensland, Australia.", {"entities": []}], ["Participants were women who had a live birth in Queensland in a specified time period and were not found to have had a baby that died since birth, who completed the extended Having a Baby in Queensland Survey, 2010 about their maternity care experiences, and who reported at least one of the nine procedures of interest.", {"entities": []}], ["For each procedure, women answered two questions that measured perceived (i) receipt of information about the benefits and risks of the procedure and (ii) role in decision-making about the procedure.", {"entities": []}], ["In all, 3,542 eligible women (34.2%) completed the survey.", {"entities": []}], ["Between 4% (for pre-labour caesarean section) and 60% (for vaginal examination) of women reported not being informed of the benefits and risks of the procedure they experienced.", {"entities": []}], ["Between 2% (epidural) and 34% (episiotomy) of women reported being unconsulted in decision-making.", {"entities": []}], ["Over one quarter (26%) of the women who experienced episiotomy reported being neither informed nor consulted.", {"entities": []}], ["There is an urgent need for interventions that facilitate information provision and consumer involvement in decision-making about several perinatal procedures, especially those performed within the time-limited intrapartum care episode.", {"entities": []}], ["Asthma and obesity are important and growing health issues worldwide.", {"entities": [[11, 18, "DISEASE"], [0, 6, "DISEASE"]]}], ["Obesity is considered a risk factor for asthma, due to the induction of changes in airway mechanics and altered airway inflammation.", {"entities": [[0, 7, "DISEASE"], [40, 46, "DISEASE"]]}], ["We cross-sectionally investigated the effect of increased weight on pulmonary function in a large population sample of healthy children, aged 10\u201317 yrs living in Palermo, Italy.", {"entities": []}], ["Explanatory effect of weight on lung function variables were evaluated by multiple linear regression models, taking into account height, gender, and age-class.", {"entities": []}], ["Among the 2,393 subjects, FVC and FEV 1 were positively correlated to weight.", {"entities": [[34, 37, "GENE"]]}], ["Multiple regression models showed that the weight beta coefficient for FEV 1 was significantly lower with respect to that for FVC (0.005 and 0.009 l/kg, respectively), indicating a different magnitude in explanatory effect of weight on FVC and FEV 1 .", {"entities": [[71, 74, "GENE"], [244, 247, "GENE"], [71, 74, "GENE"], [244, 247, "GENE"]]}], ["Both FEV 1 /FVC and FEF 25\u201375% /FVC ratios were negatively correlated to weight, while FEF 25\u201375% was not significantly correlated.", {"entities": [[5, 8, "GENE"]]}], ["Similar results were obtained also when 807 symptomatic subjects were introduced in the model through a sensitivity analysis.", {"entities": []}], ["In healthy children, the disproportionate increase of FEV 1 and FVC with weight produces airflow decrease and consequently apparent poorer lung function independently from respiratory disease status.", {"entities": [[54, 57, "GENE"]]}], ["Multiple chemical sensitivities (MCS) syndrome, also known as idiopathic environmental intolerance, is a controversial diagnosis that encompasses a wide range of waxing and waning, subjective symptoms referable to more than one body system and provoked by exposure to low levels of chemicals, foods, or other agents in the environment.", {"entities": [[38, 46, "DISEASE"]]}], ["Although MCS has been studied extensively, a unifying mechanism explaining the illness remains obscure, and clinicians are divided as to whether such a medical entity exists separately from psychosomatic syndromes.", {"entities": []}], ["MCS is an adult diagnosis; there is little reference to pediatric cases in the scientific literature.", {"entities": []}], ["In this case from the Pediatric Environmental Health Subspecialty Unit at Boston's Children's Hospital, I present the case of a preschool child who had suffered from milk allergy and poor weight gain as an infant, and then later developed asthma, allergic symptoms, sinusitis, headaches, fatigue, and rashes precipitated by an expanding variety of chemicals, foods, and allergens.", {"entities": [[266, 275, "DISEASE"], [239, 245, "DISEASE"]]}], ["I review definitions, mechanisms, diagnostic strategies, and management, and discuss some uniquely pediatric features of MCS as illustrated by this case.", {"entities": []}], ["Thyroid cancer incidence in Korea is the highest in the world and has recently increased steeply.", {"entities": [[0, 14, "DISEASE"], [8, 14, "DISEASE"]]}], ["However, factors contributing to this sudden increase have not been fully elucidated, and few studies have explored the postoperative prognosis.", {"entities": []}], ["The Thyroid Cancer Longitudinal Study (T-CALOS) was initiated with three aims: (1) to identify factors predicting quality of life, recurrence, and incidence of other diseases after thyroid cancer treatments; (2) to investigate environmental exposure to radiation, toxicants and molecular factors in relation to tumour aggressiveness; and (3) to evaluate gene\u2013environment interactions that increase thyroid cancer in comparison with healthy participants from a pool of nationwide population-based healthy examinees.", {"entities": [[4, 18, "DISEASE"], [181, 195, "DISEASE"], [398, 412, "DISEASE"], [12, 18, "DISEASE"], [189, 195, "DISEASE"], [406, 412, "DISEASE"]]}], ["T-CALOS enrols patients with incident thyroid cancer from three general hospitals, Seoul National University Hospital, Seoul National University Bundang Hospital and National Medical Center, Korea.", {"entities": [[38, 52, "DISEASE"], [46, 52, "DISEASE"]]}], ["The study is an ongoing project expecting to investigate 5000 patients with thyroid cancer up until 2017.", {"entities": [[76, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["Healthy examinees with a normal thyroid confirmed by sonography have been enrolled at the Healthy Examination Center at Seoul National University Hospital.", {"entities": []}], ["We are also performing individual matching using two nationwide databases that are open to the public.", {"entities": []}], ["Follow-up information is obtained at patients\u2019 clinical visits and by linkage to the national database.", {"entities": []}], ["For statistical analysis, we will use conditional logistic regression models and a Cox proportional hazard regression model.", {"entities": []}], ["A number of stratifications and sensitivity analyses will be performed to confirm the results.", {"entities": []}], ["Based on a large sample size, a prospective study design, comprehensive data collection and biobank, T-CALOS has been independently peer-reviewed and approved by the three hospitals and two funding sources (National Research Foundation of Korea and Korean Foundation for Cancer Research).", {"entities": [[271, 277, "DISEASE"]]}], ["The results of T-CALOS will be published according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) criteria.", {"entities": []}], ["Worldwide, respiratory syncytial virus (RSV) is considered to be the most important viral cause of respiratory morbidity and mortality among infants and young children.", {"entities": []}], ["Although no active vaccine is available on the market yet, there are several active vaccine development programs in various stages.", {"entities": []}], ["To assess whether one of these vaccines might be a future asset for national immunization programs, modeling the costs and benefits of various vaccination strategies is needed.", {"entities": []}], ["To evaluate the potential cost-effectiveness of RSV vaccination of infants and/or pregnant women in Turkey.", {"entities": []}], ["A multi-cohort static Markov model with cycles of one month was used to compare the cost-effectiveness of vaccinated cohorts versus non-vaccinated cohorts.", {"entities": []}], ["The 2014 Turkish birth cohort was divided by twelve to construct twelve monthly birth cohorts of equal size (111,459 new-borns).", {"entities": []}], ["Model input was based on clinical data from a multicenter prospective study from Bursa, Turkey, combined with figures from the (inter)national literature and publicly available data from the Turkish Statistical Institute (T\u00dc\u00cfK).", {"entities": []}], ["Incremental cost-effectiveness ratios (ICERs) were expressed in Turkish Lira (TL) per quality-adjusted life year (QALY) gained.", {"entities": []}], ["Vaccinating infants at 2 and 4 months of age would prevent 145,802 GP visits, 8,201 hospitalizations and 48 deaths during the first year of life, corresponding to a total gain of 1650 QALYs.", {"entities": []}], ["The discounted ICER was estimated at 51,969 TL (26,220 US $ in 2013) per QALY gained.", {"entities": []}], ["Vaccinating both pregnant women and infants would prevent more cases, but was less attractive from a pure economic point of view with a discounted ICER of 61,653 TL (31,106 US $ in 2013) per QALY.", {"entities": []}], ["Vaccinating only during pregnancy would result in fewer cases prevented than infant vaccination and a less favorable ICER.", {"entities": []}], ["RSV vaccination of infants and/or pregnant women has the potential to be cost-effective in Turkey.", {"entities": []}], ["Although using relatively conservative assumptions, all evaluated strategies remained slightly below the threshold of 3 times the GDP per capita.", {"entities": []}], ["Regulation of respiratory mucosal immunity by microbial-derived metabolites has been a proposed mechanism that may provide airway protection.", {"entities": []}], ["Here we examine the effect of oral Lactobacillus johnsonii -supplementation on metabolic and immune response dynamics during respiratory syncytial virus (RSV) infection.", {"entities": []}], ["L. johnsonii -supplementation reduced airway Th2 cytokines, dendritic cell function, increased T-regulatory cells, and was associated with a reprogrammed circulating metabolic environment, including docosahexanoic acid (DHA) enrichment.", {"entities": []}], ["RSV-infected bone-marrow derived dendritic cells (BMDC) from L. johnsonii -supplemented mice had altered cytokine secretion, reduced expression of co-stimulatory molecules, and modified CD4+ T cell cytokines.", {"entities": []}], ["This was replicated upon co-incubation of wild-type BMDCs with either plasma from L. johnsonii -supplemented mice, or DHA.", {"entities": []}], ["Finally, airway transfer of BMDCs from L. johnsonii -supplemented mice, or with wild-type derived BMDCs pre-treated with plasma from L. johnsonii -supplemented mice, reduced airway pathologic responses to infection in recipient animals.", {"entities": []}], ["Thus, L. johnsonii -supplementation mediates airway mucosal protection via immunomodulatory metabolites and altered immune function.", {"entities": []}], ["Anxiety and depression are common and treatable risk factors for re-hospitalisation and death in patients with COPD.", {"entities": []}], ["The degree of lung function impairment does not sufficiently explain anxiety and depression.", {"entities": []}], ["The BODE index allows a functional classification of COPD beyond FEV 1 .", {"entities": [[65, 68, "GENE"]]}], ["The aim of this cross-sectional study was (1) to test whether the BODE index is superior to the GOLD classification for explaining anxious and depressive symptoms; and (2) to assess which components of the BODE index are associated with these psychological aspects of COPD.", {"entities": []}], ["COPD was classified according to the GOLD stages based on FEV 1%predicted in 122 stable patients with COPD.", {"entities": [[58, 61, "GENE"]]}], ["An additional four stage classification was constructed based on the quartiles of the BODE index.", {"entities": []}], ["The hospital anxiety and depression scale was used to assess anxious and depressive symptoms.", {"entities": []}], ["The overall prevalence of anxious and depressive symptoms was 49% and 52%, respectively.", {"entities": []}], ["The prevalence of anxious symptoms increased with increasing BODE stages but not with increasing GOLD stages.", {"entities": []}], ["The prevalence of depressive symptoms increased with both increasing GOLD and BODE stages.", {"entities": []}], ["The BODE index was superior to FEV 1%predicted for explaining anxious and depressive symptoms.", {"entities": [[31, 34, "GENE"]]}], ["Anxious symptoms were explained by dyspnoea.", {"entities": []}], ["Depressive symptoms were explained by both dyspnoea and reduced exercise capacity.", {"entities": []}], ["The BODE index is superior to the GOLD classification for explaining anxious and depressive symptoms in COPD patients.", {"entities": []}], ["These psychological consequences of the disease may play a role in future classification systems of COPD.", {"entities": []}], ["Foxp3 reg ) cells suppress immune cell activation and establish normal immune homeostasis.", {"entities": [[0, 5, "GENE"]]}], ["How T reg cells maintain their identity is not completely understood.", {"entities": []}], ["Here we show that Ndfip1, a coactivator of Nedd4-family E3 ubiquitin ligases, is required for T reg cell stability and function.", {"entities": [[18, 24, "GENE"]]}], ["Ndfip1 deletion in T reg cells results in autoinflammatory disease.", {"entities": [[0, 6, "GENE"]]}], ["Ndfip1-deficient T reg cells are highly proliferative and are more likely to lose Foxp3 expression to become IL-4-producing T H 2 effector cells.", {"entities": [[82, 87, "GENE"]]}], ["Proteomic analyses indicate altered metabolic signature of Ndfip1-deficient T reg cells and metabolic profiling reveals elevated glycolysis and increased mTORC1 signalling.", {"entities": []}], ["Ndfip1 restricts T reg cell metabolism and IL-4 production via distinct mechanisms, as IL-4 deficiency does not prevent hyperproliferation or elevated mTORC1 signalling in Ndfip1-deficient T reg cells.", {"entities": [[0, 6, "GENE"], [172, 178, "GENE"]]}], ["Thus, Ndfip1 preserves T reg lineage stability and immune homeostasis by preventing the expansion of highly proliferative and metabolically active T reg cells and by preventing pathological secretion of IL-4 from T reg cells.", {"entities": [[6, 12, "GENE"]]}], ["T regulatory (T reg ) cells are essential for maintaining immune homeostasis, but how the stability of their lineage and function is regulated is unclear.", {"entities": []}], ["Here the authors show that Ndfip1 is essential for suppressing T reg cell IL-4 production and metabolic alteration to preserve Treg lineage and function.", {"entities": [[27, 33, "GENE"]]}], ["Fingolimod is a sphingosine\u20101\u2010phosphate receptor modulator for the treatment of relapsing\u2013remitting multiple sclerosis ( RRMS ).", {"entities": [[100, 118, "DISEASE"]]}], ["Despite an established effect on heart rate, the effect of fingolimod on cardiac repolarization is not completely known.", {"entities": []}], ["Twenty\u2010seven patients with RRMS underwent 24\u2010hr ambulatory ECG before fingolimod (baseline), at the day of fingolimod initiation (1D) and after three\u2010month treatment (3M).", {"entities": []}], ["The mean values of RR \u2010interval as well as QT \u2010interval corrected by Bazzet's ( QT cBaz) and Fridericia's ( QT cFri) formula were compared between baseline, 1D, and 3M over 24\u2010hr period as well as at daytime and nighttime.", {"entities": []}], ["QT cBaz over 24\u2010hr was shorter at 1D (414\u00a0\u00b1\u00a020\u00a0ms, p \u00a0<\u00a0.001) and at 3M (414\u00a0\u00b1\u00a020 ms, p \u00a0<\u00a0.001) than at baseline (418\u00a0\u00b1\u00a020 ms).", {"entities": []}], ["In contrast, QT cFri over 24\u2010hr was longer at 1D (410\u00a0\u00b1\u00a019 ms, p \u00a0<\u00a0.001) but similar at 3M (406\u00a0\u00b1\u00a019 ms, p \u00a0=\u00a0.355) compared to baseline (407\u00a0\u00b1\u00a019 ms).", {"entities": []}], ["Daytime QT cBaz was shorter at 1D ( p \u00a0<\u00a0.001) and at 3M ( p \u00a0=\u00a0.007), whereas daytime QT cFri was longer at 1D ( p \u00a0<\u00a0.05) but similar at 3M ( p \u00a0=\u00a0ns) compared to baseline.", {"entities": []}], ["During the night, changes were observed neither in QT cBaz nor in QT cFri between baseline, 1D, and 3M.", {"entities": []}], ["Changes in cardiac repolarization after fingolimod initiation were mild and occurred at daytime.", {"entities": []}], ["Ambiguously, QT cBaz demonstrated shortening, whereas QT cFri showed prolongation in cardiac repolarization after fingolimod initiation.", {"entities": []}], ["The formula applied for QT \u2010interval correction needs to be taken carefully into account as evaluating pharmacovigilance issues related to fingolimod.", {"entities": []}], ["Patient reported outcome measures (PROMs) are self-report measures of health status increasingly promoted for use in healthcare quality improvement.", {"entities": []}], ["However people with low literacy skills or learning disabilities may find PROMs hard to complete.", {"entities": []}], ["Our study investigated stakeholder views on the accessibility and use of PROMs to develop suggestions for more inclusive practice.", {"entities": []}], ["Taking PROMs recommended for chronic obstructive pulmonary disease (COPD) as an example, we conducted 8 interviews with people with low literacy skills and/or learning disabilities, and 4 focus groups with 20 health professionals and people with COPD.", {"entities": [[29, 66, "DISEASE"]]}], ["Discussions covered the format and delivery of PROMs using the EQ-5D and St George Respiratory Questionnaire as prompts.", {"entities": []}], ["Thematic framework analysis focused on three main themes: Accessibility , Ease of Use , and Contextual factors .", {"entities": []}], ["Accessibility included issues concerning the questionnaire format, and suggestions for improvement included larger font sizes and more white space.", {"entities": []}], ["Ease of Use included discussion about PROMs\u2019 administration.", {"entities": []}], ["While health professionals suggested PROMs could be completed in waiting rooms, patients preferred settings with more privacy and where they could access help from people they know.", {"entities": []}], ["Contextual Factors included other challenges and wider issues associated with completing PROMs.", {"entities": []}], ["While health professionals highlighted difficulties created by the system in managing patients with low literacy/learning disabilities, patient participants stressed that understanding the purpose of PROMs was important to reduce intimidation.", {"entities": []}], ["Adjusting PROMs\u2019 format, giving an explicit choice of where patients can complete them, and clearly conveying PROMs\u2019 purpose and benefit to patients may help to prevent inequality when using PROMs in health services.", {"entities": []}], ["Viral-induced asthma exacerbations, which exhibit both Th1-type neutrophilia and Th2-type inflammation, associate with secretion of Interleukin (IL)-1\u03b2.", {"entities": [[14, 20, "DISEASE"]]}], ["IL-1\u03b2 induces neutrophilic inflammation.", {"entities": []}], ["It may also increase Th2-type cytokine expression.", {"entities": []}], ["We hypothesised that IL-1\u03b2 is causally involved in both Th1 and Th2 features of asthma exacerbations.", {"entities": [[80, 86, "DISEASE"]]}], ["This hypothesis is tested in our mouse model of viral stimulus-induced asthma exacerbation.", {"entities": [[71, 77, "DISEASE"]]}], ["Wild-type (WT) and IL-1\u03b2 deficient (IL-1\u03b2 Expression of IL-1\u03b2, neutrophil chemoattractants, CXCL1 and CCL5, the Th2-upstream cytokine IL-33, and Muc5ac were induced at exacerbation in WT mice and were significantly inhibited in IL-1\u03b2 Without being involved in the baseline HDM-induced allergic asthma, IL-1\u03b2 signalling was required to induce neutrophil chemotactic factors, IL-33, and Muc5ac expression at viral stimulus-induced exacerbation.", {"entities": [[285, 300, "DISEASE"], [294, 300, "DISEASE"], [92, 97, "GENE"], [102, 106, "GENE"]]}], ["We suggest that IL-1\u03b2 has a role both in neutrophilic and Th2 inflammation at viral-induced asthma exacerbations.", {"entities": [[92, 98, "DISEASE"]]}], ["The online version of this article (10.1186/s12931-018-0725-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Interest in the health effects of particulate matter (PM) has focused on identifying sources of PM, including biomass burning, power plants, and gasoline and diesel emissions that may be associated with adverse health risks.", {"entities": []}], ["Few epidemiologic studies, however, have included source-apportionment estimates in their examinations of PM health effects.", {"entities": []}], ["We analyzed a time-series of chemically speciated PM measurements in Atlanta, Georgia, and conducted an epidemiologic analysis using data from three distinct source-apportionment methods.", {"entities": []}], ["The key objective of this analysis was to compare epidemiologic findings generated using both factor analysis and mass balance source-apportionment methods.", {"entities": []}], ["We analyzed data collected between November 1998 and December 2002 using positive-matrix factorization (PMF), modified chemical mass balance (CMB-LGO), and a tracer approach.", {"entities": []}], ["Emergency department (ED) visits for a combined cardiovascular (CVD) and respiratory disease (RD) group were assessed as end points.", {"entities": [[94, 96, "GENE"]]}], ["We estimated the risk ratio (RR) associated with same day PM concentrations using Poisson generalized linear models.", {"entities": []}], ["There were significant, positive associations between same-day PM 2.5 (PM with aero-dynamic diameter \u2264 2.5 \u03bcm) concentrations attributed to mobile sources (RR range, 1.018\u20131.025) and biomass combustion, primarily prescribed forest burning and residential wood combustion, (RR range, 1.024\u20131.033) source categories and CVD-related ED visits.", {"entities": []}], ["Associations between the source categories and RD visits were not significant for all models except sulfate-rich secondary PM 2.5 (RR range, 1.012\u20131.020).", {"entities": [[47, 49, "GENE"]]}], ["Generally, the epidemiologic results were robust to the selection of source-apportionment method, with strong agreement between the RR estimates from the PMF and CMB-LGO models, as well as with results from models using single-species tracers as surrogates of the source-apportioned PM 2.5 values.", {"entities": []}], ["Despite differences among the source-apportionment methods, these findings suggest that modeled source-apportioned data can produce robust estimates of acute health risk.", {"entities": []}], ["In Atlanta, there were consistent associations across methods between PM 2.5 from mobile sources and biomass burning with both cardiovascular and respiratory ED visits, and between sulfate-rich secondary PM 2.5 with respiratory visits.", {"entities": []}], ["We implemented a community based interventional health screening for individuals located within one mile of a 54 metric tons release of liquid chlorine following a 16 tanker car train derailment on 6 January, 2005 in Graniteville, South Carolina, USA.", {"entities": []}], ["Public health intervention occurred 8\u201310\u00a0months after the event, and provided pulmonary function and mental health assessment by primary care providers.", {"entities": []}], ["Its purpose was to evaluate those exposed to chlorine for evidence of ongoing impairment for medical referral and treatment.", {"entities": []}], ["We report comparative analysis between self-report of respiratory symptoms via questionnaire and quantitative spirometry results.", {"entities": []}], ["Health assessments were obtained through respiratory symptom and exposure questionnaires, simple spirometry, and physical exam.", {"entities": []}], ["Simple spirometry was used as the standard to identify continued breathing problems.", {"entities": []}], ["Sensitivity, specificity, positive and negative predictive values were applied to evaluate the validity of the respiratory questionnaire.", {"entities": []}], ["We also identified the direction of discrepancy between self-reported respiratory symptoms and spirometry measures.", {"entities": []}], ["Generalized estimation equations determined prevalence ratios for abnormal spirometry based on the presence of participant persistent respiratory symptoms.", {"entities": []}], ["Covariate adjustment was made for participant age, sex, race, smoking and educational status.", {"entities": []}], ["Two hundred fifty-nine people participated in the Graniteville health screening; 53 children (mean age = 11\u00a0years, range: <1-16), and 206 adults (mean age = 50\u00a0years, range: 18\u201389).", {"entities": []}], ["Of these, 220 (85%) performed spirometry maneuvers of acceptable quality.", {"entities": []}], ["Almost 67% (n = 147) displayed abnormal spirometry, while 50% (n = 110) reported persistent new-onset respiratory symptoms.", {"entities": []}], ["Moreover, abnormal spirometry was seen in 65 participants (29%) who did not report any discernible breathing problems.", {"entities": []}], ["This represented a net 16.8% underreporting of symptoms.", {"entities": []}], ["Sensitivity and specificity of questionnaire self-report of symptoms were low at 55.8% and 61.6%, respectively.", {"entities": []}], ["Persistent cough (41%) and shortness of breath (39%) were the most frequently reported respiratory symptoms.", {"entities": []}], ["Eight to ten months after acute chlorine exposure, the Graniteville health screening participants under-reported respiratory symptoms when compared to abnormal spirometry results.", {"entities": []}], ["Sensitivity and specificity were low, and we determined that relying upon the self-report questionnaire was not adequate to objectively assess the lung health of our population following irritant gas exposure.", {"entities": []}], ["Adjusting medication for uncontrolled asthma involves selecting one of several options from the same or a higher treatment step outlined in asthma guidelines.", {"entities": [[38, 44, "DISEASE"], [140, 146, "DISEASE"]]}], ["We examined the relative benefit of introducing budesonide/formoterol (BUD/FORM) maintenance and reliever therapy (Symbicort SMART This is a post hoc analysis of the results of five large clinical trials (>12000 patients) comparing BUD/FORM maintenance and reliever therapy with other treatments categorised by treatment step at study entry.", {"entities": []}], ["Both current clinical asthma control during the last week of treatment and exacerbations during the study were examined.", {"entities": [[22, 28, "DISEASE"]]}], ["At each GINA treatment step, the proportion of patients achieving target levels of current clinical control were similar or higher with BUD/FORM maintenance and reliever therapy compared with the same or a higher fixed maintenance dose of inhaled corticosteroid/long-acting \u03b2 2 -agonist (ICS/LABA) (plus short-acting \u03b2 2 -agonist [SABA] as reliever), and rates of exacerbations were lower at all treatment steps in BUD/FORM maintenance and reliever therapy versus same maintenance dose ICS/LABA (P < 0.01) and at treatment Step 4 versus higher maintenance dose ICS/LABA (P < 0.001).", {"entities": []}], ["BUD/FORM maintenance and reliever therapy also achieved significantly higher rates of current clinical control and significantly lower exacerbation rates at most treatment steps compared with a higher maintenance dose ICS + SABA (Steps 2-4 for control and Steps 3 and 4 for exacerbations).", {"entities": []}], ["With all treatments, the proportion of patients achieving current clinical control was lower with increasing treatment steps.", {"entities": []}], ["BUD/FORM maintenance and reliever therapy may be a preferable option for patients on Steps 2 to 4 of asthma guidelines requiring a more effective treatment and, compared with other fixed dose alternatives, is most effective in the higher treatment steps.", {"entities": [[101, 107, "DISEASE"]]}], ["Interleukin-5 (IL-5) regulates the growth and function of eosinophils.", {"entities": []}], ["It induces rapid tyrosine phosphorylation of Lyn and Jak2 tyrosine kinases.", {"entities": [[45, 48, "GENE"], [53, 57, "GENE"]]}], ["The role of tyrosine phosphatases in IL-5 signal transduction has not been investigated.", {"entities": []}], ["In this study, we provide first evidence that SH2 protein tyrosine phosphatase 2 (SHPTP2) phosphotyrosine phosphatase plays a key role in prevention of eosinophil death by IL-5.", {"entities": []}], ["We found that IL-5 produced a rapid activation and tyrosine phosphorylation of SHPTP2 within 1 min.", {"entities": []}], ["The tyrosine phosphorylated SHPTP2 was complexed with the adapter protein Grb2 in IL-5\u2013stimulated eosinophils.", {"entities": [[74, 78, "GENE"]]}], ["Furthermore, SHPTP2 appeared to physically associate with \u03b2 common (\u03b2 c ) chain of the IL-5 receptor (IL-5\u03b2 c R).", {"entities": []}], ["The association of SHPTP2 with IL-5\u03b2 c R was reconstituted using a synthetic phosphotyrosine-containing peptide, \u03b2 c 605\u2013624, encompassing tyrosine (Y) c receptor and Grb2 and its early activation are required for the coupling of the receptor to the Ras signaling pathway and for prevention of eosinophil death by IL-5.", {"entities": [[167, 171, "GENE"]]}], ["To examine the association of individual income and end of life (EOL) care in older cancer decedents in Taiwan.", {"entities": [[84, 90, "DISEASE"]]}], ["Retrospective cohort study.", {"entities": []}], ["National Health Insurance Research Database (NHIRD) in Taiwan.", {"entities": []}], ["28,978 decedents >65 years were diagnosed with cancer and died during 2009-2011 in Taiwan.", {"entities": [[47, 53, "DISEASE"]]}], ["Of these decedents, 10941, 16535, and 1502 were categorized by individual income as having low, moderate, and high SES, respectively.", {"entities": []}], ["Indicators of aggressiveness of EOL care: chemotherapy use before EOL, more than one emergency department (ER) visit, more than one hospital admission, hospital length of stay >14 days, intensive care unit (ICU) admission, and dying in a hospital.", {"entities": []}], ["Low individual income was associated with more aggressive EOL treatment (estimate -0.30 for moderate income, -0.27 for high income, both p<0.01).", {"entities": []}], ["The major source of aggressiveness was the tendency for older decedents with low income to die in the acute care hospital.", {"entities": []}], ["The indicators had an increasing trend from 2009 to 2011, except for hospital stay >14 days.", {"entities": []}], ["Low individual income is associated with more aggressive EOL treatment in older cancer decedents.", {"entities": [[80, 86, "DISEASE"]]}], ["Public health providers should make available appropriate education and hospice resources to these decedents and their families, to reduce the amount of aggressive terminal care such decedents receive.", {"entities": []}], ["Growth charts and child growth assessment have become prime global instruments in child health practice over the 30 years.", {"entities": []}], ["An updated, continuous growth standard that bridges size at birth values with postnatal growth values can improve child growth screening and monitoring.", {"entities": []}], ["This novel growth chart was constructed from two sources of information.", {"entities": []}], ["Size at birth (weight, length and head circumference) reference values were updated based on information of normal deliveries (i.e.", {"entities": []}], ["singleton live births without severe congenital malformation, with healthy mothers and born vaginally) from the Swedish Medical Birth Registry, 1990\u20131999 (n = 810393).", {"entities": []}], ["Weight was evaluated using logarithmic transformation as for postnatal weight.", {"entities": []}], ["Standard deviations were estimated from data within the empirical mean \u00b1 1.0 SD for each gestational week and gender.", {"entities": []}], ["These values were smoothed by empirical curve-fitting together with values from our recently published postnatal growth reference including 3650 longitudinally followed children from birth to final height [ This study presents the first continuous gender specific growth chart from birth irrespective of gestational age at birth until 2 years of age for weight, length and head circumference.", {"entities": []}], ["Birth weight at 40 weeks of gestation increased approximately 100 gram and length increased only 1 mm compared with earlier Swedish reference from 1977\u201381.", {"entities": []}], ["The curve is now less S-shaped as compared with earlier curves and compared with 4 curves from other countries and with more constant variation over the whole range.", {"entities": []}], ["Our values picture the unrestricted pattern of growth improving the detection of a deviating growth pattern, when the growth of an individual infant is plotted on the charts.", {"entities": []}], ["Especially for very preterm infants age corrected growth can be more easily evaluated although it must be recognized that the early comparison is with what is estimated as normal growth in uterus.", {"entities": []}], ["The reference values are useful in child health care systems for population screening, but also in research or in the clinic for evaluating various growth promoting interventions \u2013 either nutritional, surgical or therapeutic \u2013 that might affect a child in early life.", {"entities": []}], ["Geographic public health surveillance is concerned with describing and disseminating geographic information about disease and other measures of health to policy makers and the public.", {"entities": []}], ["While methodological developments in the geographical analysis of disease are numerous, few have been integrated into a framework that also considers the effects of case ascertainment bias on the effectiveness of chronic disease surveillance.", {"entities": []}], ["We present a framework for the geographic surveillance of chronic disease that integrates methodological developments in the spatial statistical analysis and case ascertainment.", {"entities": []}], ["The framework uses an hierarchical approach to organize and model health information derived from an administrative health data system, and importantly, supports the detection and analysis of case ascertainment bias in geographic data.", {"entities": []}], ["We test the framework on asthmatic data from Alberta, Canada.", {"entities": []}], ["We observe high prevalence in south-western Alberta, particularly among Aboriginal females.", {"entities": []}], ["We also observe that persons likely mistaken for asthmatics tend to be distributed in a pattern similar to asthmatics, suggesting that there may be an underlying social vulnerability to a variety of respiratory illnesses, or the presence of a diagnostic practice style effect.", {"entities": []}], ["Finally, we note that clustering of asthmatics tends to occur at small geographic scales, while clustering of persons mistaken for asthmatics tends to occur at larger geographic scales.", {"entities": []}], ["Routine and ongoing geographic surveillance of chronic diseases is critical to developing an understanding of underlying epidemiology, and is critical to informing policy makers and the public about the health of the population.", {"entities": []}], ["The prevalence of mental health concerns and risky health behaviours among young people is of global concern.", {"entities": []}], ["A large proportion of young people in New Zealand (NZ) are affected by depression, suicidal ideation and other mental health concerns, but the majority do not access help.", {"entities": []}], ["For NZ indigenous M\u0101ori, the burden of morbidity and mortality associated with mental health is considerably higher.", {"entities": []}], ["Targeted screening for risky behaviours and mental health concerns among youth in primary care settings can lead to early detection and intervention for emerging or current mental health and psychosocial issues.", {"entities": []}], ["Opportunistic screening for youth in primary care settings is not routinely undertaken due to competing time demands, lack of context-specific screening tools and insufficient knowledge about suitable interventions.", {"entities": []}], ["Strategies are required to improve screening that are acceptable and appropriate for the primary care environment.", {"entities": []}], ["This article outlines the development, utilisation and ongoing evaluation and implementation strategies for YouthCHAT.", {"entities": []}], ["YouthCHAT is a rapid, electronic, self-report screening tool that assesses risky health-related behaviours and mental health concerns, with a \u2018help question\u2019 that enables youth to prioritise areas they want help with.", {"entities": []}], ["The young person can complete YouthCHAT in the waiting room prior to consultation, and after completion, the clinician can immediately access a summary report which includes algorithms for stepped-care interventions using a strength-based approach.", {"entities": []}], ["A project to scale up the implementation is about to commence, using a co-design participatory research approach to assess acceptability and feasibility with successive roll-out to clinics.", {"entities": []}], ["In addition, a counter-balanced randomised trial of YouthCHAT versus clinician-administered assessment is underway at a NZ high school.", {"entities": []}], ["Opportunistic screening for mental health concerns and other risky health behaviours during adolescence can yield significant health gains and prevent unnecessary morbidity and mortality.", {"entities": []}], ["The systematic approaches to screening and provision of algorithms for stepped-care intervention will assist in delivering time efficient, early, more comprehensive interventions for youth with mental health concerns and other health compromising behaviours.", {"entities": []}], ["The early detection of concerns and facilitation to evidence-based interventions has the potential to lead to improved health outcomes, particularly for under-served indigenous populations.", {"entities": []}], ["A trillion of microorganisms colonize the mammalian intestine.", {"entities": []}], ["Most of them have coevolved with the host in a symbiotic relationship and some of them have developed strategies to promote their replication in the presence of competing microbiota.", {"entities": []}], ["Recent evidence suggests that perturbation of the microbial community favors the emergence of opportunistic pathogens, in particular adherent-invasive Escherichia coli (AIEC) that can increase incidence and severity of gut inflammation in the context of Crohn's disease (CD).", {"entities": []}], ["This review will report the importance of AIEC as triggers of intestinal inflammation, focusing on their impact on epithelial barrier function and stimulation of mucosal inflammation.", {"entities": []}], ["Beyond manipulation of immune response, restoration of gut microbiota as a new treatment option for CD patients will be discussed.", {"entities": []}], ["Few studies have investigated the complex relationship among asthma control, sleep problems, and health-related quality of life (HRQOL) among children with asthma.", {"entities": [[61, 67, "DISEASE"], [156, 162, "DISEASE"]]}], ["This study aimed to test the longitudinal effect of asthma control status on asthma-specific HRQOL through the mechanism of nighttime sleep quality and daytime sleepiness.", {"entities": [[52, 58, "DISEASE"], [77, 83, "DISEASE"]]}], ["229 dyads of asthmatic children and their parents engaged in the Patient-Reported Outcomes Measurement Information System (PROMIS Poorer asthma control status was directly associated with lower asthma-specific HRQOL at within-subject and between-subject levels ( p\u2019s <0.05); however, effects of asthma control on asthma-specific HRQOL were indirectly influenced through daytime sleepiness at within-subject level ( p <0.05), and through nighttime sleep quality and daytime sleepiness at between-subject level ( p <0.05).", {"entities": [[137, 143, "DISEASE"], [194, 200, "DISEASE"], [295, 301, "DISEASE"], [313, 319, "DISEASE"]]}], ["Asthma control status is associated with asthma-specific HRQOL, and this association is mediated by nighttime sleep quality and daytime sleepiness.", {"entities": [[0, 6, "DISEASE"], [41, 47, "DISEASE"]]}], ["Clinicians should address sleep problems related to asthma control to improve HRQOL for asthmatic children.", {"entities": [[52, 58, "DISEASE"]]}], ["Self-rated health taps health holistically and dynamically blends prior health histories with current illness burdens and expectations for future health.", {"entities": []}], ["While consistently found as an independent predictor of functional decline, sentinel health events, physician visits, hospital episodes, and mortality, much less is known about intra-individual changes in self-rated health across the life course, especially for African Americans.", {"entities": []}], ["Data on 998 African American men and women aged 50\u201364 years old were taken from a probability-based community sample that was first assessed in 2000\u20132001 and re-assessed 1, 2, 3, 4, 7, and 9 years later.", {"entities": []}], ["Using an innovative approach for including decedents in the analysis, semi-parametric group-based mixture models were used to identify person-centered group trajectories of self-rated health over time.", {"entities": []}], ["Multivariable multinomial logistic regression analysis was then used to differentiate the characteristics of AAH participants classified into the different group trajectories.", {"entities": []}], ["Four self-rated health group trajectories were identified: persistently good health, good but declining health, persistently fair health, and fair but declining health.", {"entities": []}], ["The main characteristics that differentiated the self-rated health trajectory groups from each other were age, education, smoking, morbidity (angina, congestive heart failure, diabetes, and kidney disease), having been hospitalized in the year prior to baseline, depressive symptoms, mobility limitations, and initial self-rated health.", {"entities": [[150, 174, "DISEASE"], [190, 204, "DISEASE"]]}], ["This is the first study to examine self-rated health trajectories separately among African Americans.", {"entities": []}], ["Four qualitatively distinct self-rated health group trajectories were identified that call into question the accuracy of prior reports that a single, average self-rated health trajectory for African Americans adequately captures their within-group heterogeneity.", {"entities": []}], ["Hand-assisted laparoscopic surgery was found to be a useful modality in managing benign gynecological disease.", {"entities": []}], ["Hand assist laparoscopic surgery (HALS) is a surgical modality rarely used in benign gynecology.", {"entities": []}], ["We analyzed nonmalignant pelvic disorders that utilized HALS to see whether there is any benefit over standard laparotomy.", {"entities": []}], ["A case control chart review identified patients who underwent HALS for a variety of benign gynecological conditions from 2004 through 2007.", {"entities": []}], ["Cases were then compared with a control group of all the patients who underwent similar procedures for the same diagnosis via laparotomy (ELAP) in our center within the same time period.", {"entities": []}], ["The groups were comparable with respect to age, BMI, and surgical indication.", {"entities": []}], ["Twenty-nine patients were analyzed: 12 cases (HALS) and 17 controls (ELAP).", {"entities": []}], ["Each group was broken up into 2 subsets: Group A, older patients who underwent surgery for pelvic organ prolapse or diverticulitis with adnexectomy and Group B, younger patients who underwent surgery for pelvic pain, endometriosis, or both.", {"entities": [[116, 130, "DISEASE"], [217, 230, "DISEASE"]]}], ["Hospital stay in Group B was statistically lower in the HALS cases vs. the ELAP controls, (2.9 vs. 5.4 days, P=0.04).", {"entities": []}], ["All HALS and ELAP patients were then analyzed for overall trends.", {"entities": []}], ["HALS cases had shorter hospitalization than ELAP controls had (3.3 vs 4.5 days, P=0.035).", {"entities": []}], ["Estimated blood loss was also less overall in the HALS cases vs. the ELAP controls (175 vs 355.9 mL, P=0.021).", {"entities": []}], ["There were 2 adverse outcomes reported in Group A of the HALS cases.", {"entities": []}], ["These 2 patients experienced postoperative hernias though the hand-assist port-site incision.", {"entities": []}], ["Compared with laparotomy, overall, HALS offers the advantage of decreased hospitalization and decreased intraoperative blood loss.", {"entities": []}], ["Postoperative hernias through the HA port site may be a potential problem with this technique.", {"entities": []}], ["Mercury is a toxic heavy metal which is widely dispersed in nature.", {"entities": []}], ["Most human exposure results from fish consumption or dental amalgam.", {"entities": []}], ["Mercury occurs in several chemical forms, with complex pharmacokinetics.", {"entities": []}], ["Mercury is capable of inducing a wide range of clinical presentations.", {"entities": []}], ["Diagnosis of mercury toxicity can be challenging but can be obtained with reasonable reliability.", {"entities": []}], ["Effective therapies for clinical toxicity have been described.", {"entities": []}], ["In the United States and elsewhere, recreational water quality is monitored for fecal indicator bacteria to help prevent swimming-associated illnesses.", {"entities": []}], ["Standard methods to measure these bacteria take at least 24 hours to obtain results.", {"entities": []}], ["Molecular approaches such as quantitative polymerase chain reaction (qPCR) can estimate these bacteria faster, in under 3 hours.", {"entities": []}], ["Previously, we demonstrated that measurements of the fecal indicator bacteria Enterococcus using qPCR were associated with gastrointestinal (GI) illness among swimmers at freshwater beaches.", {"entities": []}], ["In this paper, we report on results from three marine beach sites.", {"entities": []}], ["We interviewed beach-goers and collected water samples at marine beaches affected by treated sewage discharges in Mississippi in 2005, and Rhode Island and Alabama in 2007.", {"entities": []}], ["Ten to twelve days later, we obtained information about gastrointestinal, respiratory, eye, ear and skin symptoms by telephone.", {"entities": []}], ["We tested water samples for fecal indicator organisms using qPCR and other methods.", {"entities": []}], ["We enrolled 6,350 beach-goers.", {"entities": []}], ["The occurrence of GI illness among swimmers was associated with a log 10 -increase in exposure to qPCR-determined estimates of fecal indicator organisms in the genus Enterococcus (AOR = 2.6, 95% CI 1.3-5.1) and order Bacteroidales (AOR = 1.9, 95% CI 1.3-2.9).", {"entities": []}], ["Estimates of organisms related to Clostridium perfringens and a subgroup of organisms in the genus Bacteroides were also determined by qPCR in 2007, as was F+ coliphage, but relationships between these indicators and illness were not statistically significant.", {"entities": []}], ["This study provides the first evidence of a relationship between gastrointestinal illness and estimates of fecal indicator organisms determined by qPCR at marine beaches.", {"entities": []}], ["Theterm gluten intolerance may refer to three types of human disorders: autoimmune celiac disease (CD), allergy to wheat and non-celiac gluten sensitivity (NCGS).", {"entities": [[83, 97, "DISEASE"]]}], ["Gluten is a mixture of prolamin proteins present mostly in wheat, but also in barley, rye and oat.", {"entities": []}], ["Gluten can be subdivided into three major groups: S-rich, S-poor and high molecular weight proteins.", {"entities": []}], ["Prolamins within the groups possess similar structures and properties.", {"entities": []}], ["All gluten proteins are evolutionarily connected and share the same ancestral origin.", {"entities": []}], ["Gluten proteins are highly resistant to hydrolysis mediated by proteases of the human gastrointestinal tract.", {"entities": []}], ["It results in emergence of pathogenic peptides, which cause CD and allergy in genetically predisposed people.", {"entities": []}], ["There is a hierarchy of peptide toxicity and peptide recognition by T cells.", {"entities": []}], ["Nowadays, there are several ways to detoxify gluten peptides: the most common is gluten-free diet (GFD), which has proved its effectiveness; prevention programs, enzymatic therapy, correction of gluten pathogenicity pathways and genetically modified grains with reduced immunotoxicity.", {"entities": []}], ["A deep understanding of gluten intolerance underlying mechanisms and detailed knowledge of gluten properties may lead to the emergence of novel effective approaches for treatment of gluten-related disorders.", {"entities": []}], ["This study evaluated the acute effects of ambient ozone (O3), fine particulate matter (PM2.5), and strong aerosol acidity on the pulmonary function of exercising adults.", {"entities": []}], ["During the summers of 1991 and 1992, volunteers (18-64 years of age) were solicited from hikers on Mt.", {"entities": []}], ["Washington, New Hampshire.", {"entities": []}], ["Volunteer nonsmokers with complete covariates (n = 530) had pulmonary function measured before and after their hikes.", {"entities": []}], ["We calculated each hiker's posthike percentage change in forced expiratory volume in 1 sec (FEV1), forced vital capacity (FVC), the ratio of these two (FEV1/FVC), forced expiratory flow between 25 and 75% of FVC(FEF25-75%), and peak expiratory flow rate (PEFR).", {"entities": []}], ["Average O3 exposures ranged from 21 to 74 ppb.", {"entities": []}], ["After adjustment for age,sex, smoking status (former versus never), history of asthma or wheeze, hours hiked, ambient temperature, and other covariates, there was a 2.6% decline in FEV1 [95% confidence interval (CI), 0.4-4.7; p = 0.02] and a 2.2% decline in FVC (CI, 0.8-3.5; p =0.003) for each 50 ppb increment in mean O3.", {"entities": [[79, 85, "DISEASE"]]}], ["There were consistent associations of decrements in both FVC (0.4% decline; CI,0.2-0.6, p = 0.001) and PEFR (0.8% decline; CI, 0.01-1.6; p = 0.05) with PM2.5 and of decrements in PEFR (0.4% decline; CI, 0.1-0.7; p = 0.02) with strong aerosol acidity across the interquartile range of these exposures.", {"entities": []}], ["Hikers with asthma or a history of wheeze (n = 40) had fourfold greater responsiveness to ozone than others.", {"entities": [[12, 18, "DISEASE"]]}], ["With prolonged outdoor exercise, low-level exposures to O3, PM2.5, and strong aerosol acidity were associated with significant effects on pulmonary function among adults.", {"entities": []}], ["Hikers with a history of asthma or wheeze had significantly greater air pollution-related changes in pulmonary function.", {"entities": [[25, 31, "DISEASE"]]}], ["The promise of drug repurposing is that existing drugs may be used for new disease indications in order to curb the high costs and time for approval.", {"entities": []}], ["The goal of computational methods for drug repurposing is to enable solutions for safer, cheaper and faster drug discovery.", {"entities": []}], ["Towards this end, we developed a novel method that integrates genetic and clinical phenotype data from large-scale GWAS and PheWAS studies with detailed drug information on the concept of transitive Drug-Gene-Disease triads.", {"entities": []}], ["We created \"RE:fine Drugs,\" a freely available, interactive dashboard that automates gene, disease and drug-based searches to identify drug repurposing candidates.", {"entities": []}], ["This web-based tool supports a user-friendly interface that includes an array of advanced search and export options.", {"entities": []}], ["Results can be prioritized in a variety of ways, including but not limited to, biomedical literature support, strength and statistical significance of GWAS and/or PheWAS associations, disease indications and molecular drug targets.", {"entities": []}], ["Here we provide a protocol that illustrates the functionalities available in the \"RE:fine Drugs\" system and explores the different advanced options through a case study.", {"entities": []}], ["Transcription factor specificity protein 1 (Sp1) is involved in diverse cellular functions.", {"entities": [[44, 47, "GENE"]]}], ["We recently found that Sp1 was significantly decreased in skin biopsies from patients with atopic dermatitis (AD) and had an even greater reduction in AD patients with a history of eczema herpeticum.", {"entities": [[91, 108, "DISEASE"], [181, 198, "DISEASE"], [98, 108, "DISEASE"], [23, 26, "GENE"]]}], ["In the current study, we sought to better understand the role of Sp1 in skin biological processes by using a small interfering RNA (siRNA) technique to knock down Sp1 gene expression in normal human keratinocytes (NHK) and investigated the genome-wide gene expression profiling of Sp1- silenced NHK.", {"entities": [[65, 68, "GENE"], [163, 166, "GENE"], [281, 284, "GENE"], [65, 68, "GENE"], [163, 166, "GENE"], [281, 284, "GENE"]]}], ["The gene arrays revealed that 53 genes had more than three-fold changes in expression in Sp1-silenced NHK as compared to scrambled siRNA silenced cells.", {"entities": []}], ["Strikingly, six kallikrein-related peptidase genes, KLK5, KLK6, KLK7, KLK8, KLK10, and KLK12 were up-regulated in NHK following Sp1 silencing.", {"entities": [[52, 56, "GENE"], [58, 62, "GENE"], [64, 68, "GENE"], [70, 74, "GENE"], [76, 81, "GENE"], [87, 92, "GENE"], [128, 131, "GENE"]]}], ["Functionally, protease activity was significantly enhanced in Sp1-silenced keratinocytes as compared to scrambled siRNA silenced keratinocytes.", {"entities": []}], ["Moreover, thymic stromal lymphopoietin (TSLP), an epithelial derived T H 2 promoting cytokine, was induced in Sp1-silenced keratinocytes due to elevated kallikrein activity.", {"entities": [[40, 44, "GENE"]]}], ["These results indicate that Sp1 expression deficiency leads to abnormally increased kallikrein protease activity in keratinocytes and may contribute to T H 2 immune responses in the skin by inducing TSLP.", {"entities": [[28, 31, "GENE"], [199, 203, "GENE"]]}], ["The conduct of oral food challenges as the preferred diagnostic standard for food allergy ( FA ) was harmonized over the last years.", {"entities": [[77, 89, "DISEASE"]]}], ["However, documentation and interpretation of challenge results, particularly in research settings, are not sufficiently standardized to allow valid comparisons between studies.", {"entities": []}], ["Our aim was to develop a diagnostic toolbox to capture and report clinical observations in double\u2010blind placebo\u2010controlled food challenges ( DBPCFC ).", {"entities": []}], ["A group of experienced allergists, paediatricians, dieticians, epidemiologists and data managers developed generic case report forms and standard operating procedures for DBPCFC s and piloted them in three clinical centres.", {"entities": []}], ["The follow\u2010up of the EuroPrevall/i FAAM birth cohort and other i FAAM work packages applied these methods.", {"entities": []}], ["A set of newly developed questionnaire or interview items capture the history of FA.", {"entities": []}], ["Together with sensitization status, this forms the basis for the decision to perform a DBPCFC , following a standardized decision algorithm.", {"entities": []}], ["A generic form including details about severity and timing captures signs and symptoms observed during or after the procedures.", {"entities": []}], ["In contrast to the commonly used dichotomous outcome FA vs no FA , the allergy status is interpreted in multiple categories to reflect the complexity of clinical decision\u2010making.", {"entities": []}], ["The proposed toolbox sets a standard for improved documentation and harmonized interpretation of DBPCFC s. By a detailed documentation and common terminology for communicating outcomes, these tools hope to reduce the influence of subjective judgment of supervising physicians.", {"entities": []}], ["All forms are publicly available for further evolution and free use in clinical and research settings.", {"entities": []}], ["A systematic review was performed to evaluate how the maximum recommended starting dose (MRSD) was determined in first-in-human (FIH) studies with monoclonal antibodies (mAbs).", {"entities": []}], ["Factors associated with the choice of each MRSD determination method were also identified.", {"entities": []}], ["PubMed was searched for FIH studies with mAbs published in English between January 1, 1990 and December 31, 2013, and the following information was extracted: MRSD determination method, publication year, therapeutic area, antibody type, safety factor, safety assessment results after the first dose, and number of dose escalation steps.", {"entities": []}], ["Seventy-nine FIH studies with mAbs were identified, 49 of which clearly reported the MRSD determination method.", {"entities": []}], ["The no observed adverse effects level (NOAEL)-based approach was the most frequently used method, whereas the model-based approach was the least commonly used method (34.7% vs 16.3%).", {"entities": []}], ["The minimal anticipated biological effect level (MABEL)- or minimum effective dose (MED)-based approach was used more frequently in 2011\u20132013 than in 1990\u20132007 (31.6% vs 6.3%, P =0.036), reflecting a slow, but steady acceptance of the European Medicines Agency\u2019s guidance on mitigating risks for FIH clinical trials (2007).", {"entities": []}], ["The median safety factor was much lower for the MABEL- or MED-based approach than for the other MRSD determination methods (10 vs 32.2\u201353).", {"entities": []}], ["The number of dose escalation steps was not significantly different among the different MRSD determination methods.", {"entities": []}], ["The MABEL-based approach appears to be safer and as efficient as the other MRSD determination methods for achieving the objectives of FIH studies with mAbs faster.", {"entities": []}], ["The contribution of the metal components of particulate pollutants to acute respiratory effects has not been adequately evaluated.", {"entities": []}], ["Moreover, little is known about the effects of genetic polymorphisms of xenobiotic metabolism on pulmonary function.", {"entities": []}], ["This study was conducted to assess lung function decrement associated with metal components in particulate pollutants and genetic polymorphisms of glutathione S- transferase M1 and T1.", {"entities": []}], ["We studied 43 schoolchildren who were in the 3rd to 6th grades.", {"entities": []}], ["Each student measured peak expiratory flow rate three times a day for 42 days.", {"entities": []}], ["Particulate air concentrations were monitored every day, and the concentrations of iron, manganese, lead, zinc, and aluminum in the particles were measured.", {"entities": []}], ["Glutathione S -transferase M1 and T1 genetic polymorphisms were determined using DNA extracted from participant buccal washings.", {"entities": []}], ["We used a mixed linear regression model to estimate the association between peak expiratory flow rate and particulate air pollutants.", {"entities": []}], ["We found significant reduction in the peak expiratory flow rate after the children\u2019s exposure to particulate pollutants.", {"entities": []}], ["The effect was shown most significantly 1 day after exposure to the ambient particles.", {"entities": []}], ["Manganese and lead in the particles also reduced the peak expiratory flow rate.", {"entities": []}], ["Genetic polymorphisms of glutathione S -transferase M1 and T1 did not significantly affect peak expiratory flow rate.", {"entities": []}], ["This study demonstrated that particulate pollutants and metals such as manganese and lead in the particles are associated with a decrement of peak expiratory flow rate.", {"entities": []}], ["These effects were robust even with consideration of genetic polymorphisms of glutathione S -transferase.", {"entities": []}], ["Globally, asthma is a chronic inflammatory respiratory disease affecting over 300 million people.", {"entities": [[10, 16, "DISEASE"]]}], ["Some asthma patients remain poorly controlled by conventional therapies and experience more life-threatening exacerbations.", {"entities": [[5, 11, "DISEASE"]]}], ["Vitamin D, as an adjunct therapy, may improve disease control in severe asthma patients since vitamin D enhances glucocorticoid responsiveness and mitigates airway smooth muscle (ASM) hyperplasia.", {"entities": [[72, 78, "DISEASE"]]}], ["We sought to characterize differences in transcriptome responsiveness to vitamin D between fatal asthma- and non-asthma-derived ASM by using RNA-Seq to measure ASM transcript expression in five donors with fatal asthma and ten non-asthma-derived donors at baseline and with vitamin D treatment.", {"entities": [[97, 103, "DISEASE"], [113, 119, "DISEASE"], [212, 218, "DISEASE"], [231, 237, "DISEASE"]]}], ["Based on a Benjamini-Hochberg corrected p-value <0.05, 838 genes were differentially expressed in fatal asthma vs. non-asthma-derived ASM at baseline, and vitamin D treatment compared to baseline conditions induced differential expression of 711 and 867 genes in fatal asthma- and non-asthma-derived ASM, respectively.", {"entities": [[104, 110, "DISEASE"], [119, 125, "DISEASE"], [269, 275, "DISEASE"], [285, 291, "DISEASE"]]}], ["Functional gene categories that were highly represented in all groups included extracellular matrix, and responses to steroid hormone stimuli and wounding.", {"entities": []}], ["Genes differentially expressed by vitamin D also included cytokine and chemokine activity categories.", {"entities": []}], ["Follow-up qPCR and individual analyte ELISA experiments were conducted for four cytokines (i.e.", {"entities": []}], ["CCL2, CCL13, CXCL12, IL8) to measure TNF\u03b1-induced changes by asthma status and vitamin D treatment.", {"entities": [[61, 67, "DISEASE"], [0, 4, "GENE"], [6, 11, "GENE"], [13, 19, "GENE"], [21, 24, "GENE"]]}], ["Vitamin D inhibited TNF\u03b1-induced IL8 protein secretion levels to a comparable degree in fatal asthma- and non-asthma-derived ASM even though IL8 had significantly higher baseline levels in fatal asthma-derived ASM.", {"entities": [[94, 100, "DISEASE"], [110, 116, "DISEASE"], [195, 201, "DISEASE"], [33, 36, "GENE"], [141, 144, "GENE"], [33, 36, "GENE"], [141, 144, "GENE"]]}], ["Our findings identify vitamin D-specific gene targets and provide transcriptomic data to explore differences in the ASM of fatal asthma- and non-asthma-derived donors.", {"entities": [[129, 135, "DISEASE"], [145, 151, "DISEASE"]]}], ["Investigation of an extract from the marine cyanobacterium Lyngbya semiplena , collected in Tumon Bay, Guam, led to the identification of three new cyclodepsipeptides, lyngbyastatins 8\u201310 ( 1 \u2013 3 ).", {"entities": []}], ["The structures of 1 \u2013 3 were determined by NMR, MS, ESIMS fragmentation and chemical degradation.", {"entities": []}], ["Compounds 1 \u2013 3 are closely related to lyngbyastatins 4\u20137.", {"entities": []}], ["Like the latter compounds, we found 1 \u2013 3 to inhibit porcine pancreatic elastase, with IC 50 values of 123 nM, 210 nM and 120 nM, respectively.", {"entities": []}], ["Indonesia's hospital\u2010based Severe Acute Respiratory Infection (SARI) surveillance system, Surveilans Infeksi Saluran Pernafasan Akut Berat Indonesia (SIBI), was established in 2013.", {"entities": []}], ["While respiratory illnesses such as SARI pose a significant problem, there are limited incidence\u2010based data on influenza disease burden in Indonesia.", {"entities": [[111, 120, "DISEASE"]]}], ["This study aimed to estimate the incidence of influenza\u2010associated SARI in Indonesia during 2013\u20102016 at three existing SIBI surveillance sites.", {"entities": [[46, 55, "DISEASE"]]}], ["From May 2013 to April 2016, inpatients from sentinel hospitals in three districts of Indonesia (Gunung Kidul, Balikpapan, Deli Serdang) were screened for SARI.", {"entities": []}], ["Respiratory specimens were collected from eligible inpatients and screened for influenza viruses.", {"entities": [[79, 88, "DISEASE"]]}], ["Annual incidence rates were calculated using these SIBI\u2010enrolled influenza\u2010positive SARI cases as a numerator, with a denominator catchment population defined through hospital admission survey (HAS) to identify respiratory\u2010coded admissions by age to hospitals in the sentinel site districts.", {"entities": [[65, 74, "DISEASE"]]}], ["From May 2013 to April 2016, there were 1527 SARI cases enrolled, of whom 1392 (91%) had specimens tested and 199 (14%) were influenza\u2010positive.", {"entities": [[125, 134, "DISEASE"]]}], ["The overall estimated annual incidence of influenza\u2010associated SARI ranged from 13 to 19 per 100\u00a0000 population.", {"entities": [[42, 51, "DISEASE"]]}], ["Incidence was highest in children aged 0\u20104\u00a0years (82\u2010114 per 100\u00a0000 population), followed by children 5\u201014\u00a0years (22\u201036 per 100\u00a0000 population).", {"entities": []}], ["Incidence rates of influenza\u2010associated SARI in these districts indicate a substantial burden of influenza hospitalizations in young children in Indonesia.", {"entities": [[19, 28, "DISEASE"], [97, 106, "DISEASE"]]}], ["Further studies are needed to examine the influenza burden in other potential risk groups such as pregnant women and the elderly.", {"entities": [[42, 51, "DISEASE"]]}], ["Survival implications of nontuberculous mycobacterial pulmonary disease (NTM-PD) and NTM pulmonary isolation without disease (NTM-PI) are unclear.", {"entities": [[73, 76, "GENE"], [85, 88, "GENE"], [126, 129, "GENE"]]}], ["To study deaths associated with NTM-PD and NTM-PI and differences in survival between them, we conducted a population-based cohort study of persons with microbiologically defined NTM-PD or NTM-PI diagnosed during 2001\u20132013 in Ontario, Canada.", {"entities": []}], ["We used propensity score matching and Cox proportional hazards models to compare survival.", {"entities": []}], ["Among 9,681 NTM-PD patients and 10,936 NTM-PI patients, 87% and 91%, respectively, were successfully matched with unexposed controls.", {"entities": []}], ["Both NTM-PD and NTM-PI were associated with higher rates of death for all species combined and for most individual species.", {"entities": []}], ["Compared with NTM-PI, NTM-PD was associated with higher death rates for all species combined, Mycobacterium avium complex, and M. xenopi .", {"entities": []}], ["NTM-PD and NTM-PI were significantly associated with death, NTM-PD more so than NTM-PI.", {"entities": []}], ["Cefaclor is widely prescribed for various infectious diseases.", {"entities": []}], ["As its consumption increases, the number of hypersensitivity reactions to cefaclor has increased.", {"entities": []}], ["This study aimed to evaluate the immunologic findings of immediate hypersensitivity to cefaclor.", {"entities": []}], ["We enrolled 47 patients with immediate hypersensitivity to cefaclor from Ajou University Hospital and Asan Medical Center.", {"entities": []}], ["Serum specific IgE, IgG1, and IgG4 antibodies to cefaclor-human serum albumin (HSA) conjugate were measured by enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["The most common phenotype was anaphylaxis (Group I, 78.7%), followed by urticaria (Group II, 21.3%).", {"entities": [[72, 81, "DISEASE"]]}], ["The detection of specific IgE, IgG1, and IgG4 to cefaclor-HSA conjugate by ELISA tended to be higher in Group I (40.5%, 41.7%, 21.6%) than in Group II (20.0%, 20.0%, 0%) with no statistical significance.", {"entities": []}], ["Significant associations were found between specific IgE and IgG1 or IgG4 ( p <0.001, p =0.019).", {"entities": []}], ["ELISA inhibition tests showed significant inhibitions by both free cefaclor and cefaclor-HSA conjugate.", {"entities": []}], ["For basophil activation tests in patients having no specific IgE antibody, the CD63 expression level on basophils increased with incubations of free cefaclor.", {"entities": [[79, 83, "GENE"]]}], ["The most common manifestation of immediate hypersensitivity to cefaclor was anaphylaxis, most of which was mediated by IgE; however, a non-IgE mediated direct basophil activation mechanism was suggested in a subset of anaphylaxis patients.", {"entities": []}], ["To describe the intra-rater and inter-rater reliability of the Brazilian Portuguese version of the fatigue severity scale (FSS) in patients with COPD and to identify the presence of its association with parameters of pulmonary function, dyspnea, and functional capacity.", {"entities": []}], ["This was an observational cross-sectional study involving 50 patients with COPD, who completed the FSS in interviews with two researchers in two visits.", {"entities": []}], ["The FSS scores were correlated with those of the Medical Research Council (MRC) scale, as well as with FEV 1 , FVC, and six-minute walk distance (6MWD).", {"entities": [[103, 106, "GENE"]]}], ["The mean age of the patients was 69.4 \u00b1 8.23 years, whereas the mean FEV 1 was 46.5 \u00b1 20.4% of the predicted value.", {"entities": [[69, 72, "GENE"]]}], ["The scale was reliable, with an intraclass correlation coefficient of 0.90 (95% CI, 0.81-0.94; p < 0.01).", {"entities": []}], ["The FSS scores showed significant correlations with those of MRC scale (r = 0.70; p < 0.01), as well as with 6MWD (r = \u20130.77; p < 0.01), FEV 1 (r = \u20130.38; p < 0.01), FVC (r = \u20130.35; p < 0.01), and stage of the disease in accordance with the Global Initiative for Chronic Obstructive Lung Disease criteria (r = 0.37; p < 0.01).", {"entities": [[137, 140, "GENE"]]}], ["The Brazilian Portuguese version of the FSS proved reliable for use in COPD patients in Brazil and showed significant correlations with sensation of dyspnea, functional capacity, pulmonary function, and stage of the disease.", {"entities": []}], ["Descrever a reprodutibilidade intra e interobservador da vers\u00e3o brasileira da escala de gravidade da fadiga (EGF) em pacientes com DPOC e verificar a presen\u00e7a de sua associa\u00e7\u00e3o com par\u00e2metros de fun\u00e7\u00e3o pulmonar, dispneia e capacidade funcional.", {"entities": [[109, 112, "GENE"]]}], ["Estudo observacional de corte transversal no qual 50 pacientes com DPOC responderam a EGF em forma de entrevista a dois pesquisadores em duas visitas.", {"entities": [[86, 89, "GENE"]]}], ["Os escores da EGF foram correlacionados aos da escala Medical Research Council (MRC), VEF 1 , CVF e a dist\u00e2ncia percorrida no teste da caminhada de seis minutos (DTC6).", {"entities": [[14, 17, "GENE"]]}], ["A m\u00e9dia de idade dos pacientes foi de 69,4 \u00b1 8,23 anos, enquanto a de VEF 1 foi de 46,5 \u00b1 20,4% do previsto.", {"entities": []}], ["A EGF foi considerada reprodut\u00edvel, com um coeficiente de correla\u00e7\u00e3o intraclasse de 0,90 (IC95%, 0,81-0,94; p < 0,01).", {"entities": [[2, 5, "GENE"]]}], ["Os escores da EGF mostraram correla\u00e7\u00f5es significantes com os da escala MRC (r = 0,70; p < 0,01), DTC6 (r = \u20130,77; p < 0,01), VEF 1 (r = \u20130,38; p < 0,01), CVF (r = \u20130,35; p < 0,01) e a est\u00e1gio da doen\u00e7a pela Global Initiative for Chronic Obstructive Lung Disease (r = 0,37; p < 0,01).", {"entities": [[14, 17, "GENE"]]}], ["A vers\u00e3o brasileira da EGF mostrou-se reprodut\u00edvel para uso em pacientes com DPOC no Brasil e apresentou correla\u00e7\u00f5es significantes com a sensa\u00e7\u00e3o de dispneia, capacidade funcional, fun\u00e7\u00e3o pulmonar e est\u00e1gio da doen\u00e7a.", {"entities": [[23, 26, "GENE"]]}], ["Epidemiologic studies have shown conflicting results regarding the role of traffic pollution in the development of allergic disease.", {"entities": []}], ["This study investigated the relationship between living close to traffic and ever dispense of prescribed oral antihistamines or nasal anti-allergic medication, among young children.", {"entities": []}], ["The underlying aim was to investigate if children growing up close to traffic pollution are at higher risk of developing allergy in early childhood.", {"entities": []}], ["We investigated a birth cohort in southern Sweden, consisting of N \u2009=\u200926 128 children (0\u20136 years) with health outcome and exposure data.", {"entities": []}], ["Of these children, N \u2009=\u20097898, had additional covariate information.", {"entities": []}], ["Traffic intensity and yearly averages of dispersion-modeled concentrations of NO X (100\u2009\u00d7\u2009100\u00a0m grid) at residential addresses, were linked with registry data on dispensed allergy medication (the Swedish Prescribed Drug Register).", {"entities": []}], ["Individual level covariate information was obtained from questionnaires distributed to parents at Child Health Care-center visits, eight months after birth.", {"entities": []}], ["Cox proportional hazards regression was used for the statistical analyses.", {"entities": []}], ["Living in close proximity to a road with equal to or greater than 8640 cars/day (compared to 0\u20138639 cars/day), was not associated with higher incidence of ever dispensed oral antihistamine or nasal anti-allergic medication, with or without adjustment for confounders (sex, breastfeeding, parental allergy, parental origin, season, and year of birth).", {"entities": []}], ["Similar results were found in relation to NO X .", {"entities": []}], ["Traffic-related exposure was not associated with higher incidence of ever dispensed medication against allergy, in children 0\u20136 years in southern Sweden.", {"entities": []}], ["These results indicates that traffic-related exposure may not be a risk factor for early onset allergy in children in southern Sweden.", {"entities": []}], ["However, children with dispense of prescribed allergy medication may be a selected subgroup, and the results for this group may not be generalizable to all children with allergy.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-2356-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Around, 30\u201340% of HER2-positive breast cancers do not show substantial clinical benefit from the targeted therapy and, thus, the mechanisms underlying resistance remain partially unknown.", {"entities": []}], ["Interestingly, ERBB2 is frequently co-amplified and co-expressed with neighbour genes that may play a relevant role in this cancer subtype.", {"entities": [[124, 130, "DISEASE"], [15, 20, "GENE"]]}], ["Here, using an in silico analysis of data from 2,096 breast tumours, we reveal a significant correlation between Gasdermin B ( GSDMB ) gene (located 175 kilo bases distal from ERBB2 ) expression and the pathological and clinical parameters of poor prognosis in HER2-positive breast cancer.", {"entities": [[275, 288, "DISEASE"], [282, 288, "DISEASE"], [127, 132, "GENE"], [176, 181, "GENE"]]}], ["Next, the analysis of three independent cohorts (totalizing 286 tumours) showed that approximately 65% of the HER2-positive cases have GSDMB gene amplification and protein over-expression.", {"entities": [[135, 140, "GENE"]]}], ["Moreover, GSDMB expression was also linked to poor therapeutic responses in terms of lower relapse free survival and pathologic complete response as well as positive lymph node status and the development of distant metastasis under neoadjuvant and adjuvant treatment settings, respectively.", {"entities": [[10, 15, "GENE"]]}], ["Importantly, GSDMB expression promotes survival to trastuzumab in different HER2-positive breast carcinoma cells, and is associated with trastuzumab resistance phenotype in vivo in Patient Derived Xenografts.", {"entities": [[97, 106, "DISEASE"], [90, 106, "DISEASE"], [13, 18, "GENE"]]}], ["In summary, our data identifies the ERBB2 co-amplified and co-expressed gene GSDMB as a critical determinant of poor prognosis and therapeutic response in HER2-positive breast cancer.", {"entities": [[169, 182, "DISEASE"], [176, 182, "DISEASE"], [36, 41, "GENE"], [77, 82, "GENE"]]}], ["Tamoxifen is the most widely used anti-estrogen for the treatment of breast cancer.", {"entities": [[69, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["Studies show that the combination therapy with other substances that helps the activity of tamoxifen.", {"entities": []}], ["The objective of this study was to evaluate the effect of tamoxifen when used in combination with tranilast on human breast cancer cells.", {"entities": [[117, 130, "DISEASE"], [124, 130, "DISEASE"]]}], ["Two MCF-7 and MDA-MB-231 human breast cancer cell lines were treated with tamoxifen and/or tranilast.", {"entities": [[31, 44, "DISEASE"], [38, 44, "DISEASE"]]}], ["The cell viability and cytotoxicity was assessed using MTT and LDH assays; the apoptotic effects were examined by TUNEL assay, acridine orange/ethidium bromide staining and DNA laddering, also the expression levels of bax and bcl-2 genes were detected by real-time RT-PCR.", {"entities": [[218, 221, "GENE"]]}], ["The mRNA expression of TGF-\u03b2 ligands and receptors examined using real-time RT-PCR and TGF-\u03b21 protein secretion levels were also evaluated by ELISA assay.", {"entities": []}], ["Inhibitory effect of these drugs on invasion and metastasis were tested by wound healing and matrigel invasion assay.", {"entities": []}], ["We found that combination of these drugs led to a marked increase in growth and proliferation inhibition compared to either agent alone.", {"entities": []}], ["Furthermore, bax and bcl-2 affected by tamoxifen and/or tranilast and resulted in a significant increase in bax and decrease in bcl-2 mRNA expression.", {"entities": [[13, 16, "GENE"], [108, 111, "GENE"], [13, 16, "GENE"], [108, 111, "GENE"]]}], ["In addition, treatment with tamoxifen and/or tranilast resulted in significant decreased in TGF-\u03b21, 2, 3, TGF-\u03b2RI and II mRNA and TGF-\u03b21 protein levels while TGF-\u03b2RIII mRNA level was increased and invasion was also inhibited.", {"entities": []}], ["These findings indicate that tranilast, by synergistic effect, enhances the activity of tamoxifen and the TGF-\u03b2 pathway is a target for this combination therapy, therefore; we propose that this combined treatment may be suitable selection in prevention of breast cancer.", {"entities": [[256, 269, "DISEASE"], [263, 269, "DISEASE"]]}], ["Microarray profiling of ten head and neck cancer lines revealed novel p53 and NF-\u03baB transcriptional gene expression signatures which distinguished tumor cell subsets in association with their p53 status.", {"entities": [[42, 48, "DISEASE"]]}], ["Differentially expressed gene profiles have previously been observed among pathologically defined cancers by microarray technologies, including head and neck squamous cell carcinomas (HNSCCs).", {"entities": []}], ["However, the molecular expression signatures and transcriptional regulatory controls that underlie the heterogeneity in HNSCCs are not well defined.", {"entities": []}], ["Genome-wide cDNA microarray profiling of ten HNSCC cell lines revealed novel gene expression signatures that distinguished cancer cell subsets associated with p53 status.", {"entities": [[123, 129, "DISEASE"]]}], ["Three major clusters of over-expressed genes (A to C) were defined through hierarchical clustering, Gene Ontology, and statistical modeling.", {"entities": []}], ["The promoters of genes in these clusters exhibited different patterns and prevalence of transcription factor binding sites for p53, nuclear factor-\u03baB (NF-\u03baB), activator protein (AP)-1, signal transducer and activator of transcription (STAT)3 and early growth response (EGR)1, as compared with the frequency in vertebrate promoters.", {"entities": []}], ["Cluster A genes involved in chromatin structure and function exhibited enrichment for p53 and decreased AP-1 binding sites, whereas clusters B and C, containing cytokine and antiapoptotic genes, exhibited a significant increase in prevalence of NF-\u03baB binding sites.", {"entities": []}], ["An increase in STAT3 and EGR1 binding sites was distributed among the over-expressed clusters.", {"entities": [[15, 20, "GENE"], [25, 29, "GENE"]]}], ["Novel regulatory modules containing p53 or NF-\u03baB concomitant with other transcription factor binding motifs were identified, and experimental data supported the predicted transcriptional regulation and binding activity.", {"entities": []}], ["The transcription factors p53, NF-\u03baB, and AP-1 may be important determinants of the heterogeneous pattern of gene expression, whereas STAT3 and EGR1 may broadly enhance gene expression in HNSCCs.", {"entities": [[134, 139, "GENE"], [144, 148, "GENE"]]}], ["Defining these novel gene signatures and regulatory mechanisms will be important for establishing new molecular classifications and subtyping, which in turn will promote development of targeted therapeutics for HNSCC.", {"entities": []}], ["The TAM receptors T yro3, A xl, and M ertk are receptor tyrosine kinases that dampen host innate immune responses following engagement with their ligands, Gas6 and Protein S, which recognize phosphatidylserine on apoptotic cells.", {"entities": [[155, 159, "GENE"]]}], ["In a form of apoptotic mimicry, many enveloped viruses display phosphatidylserine on the outer leaflet of their membranes, enabling TAM receptor activation and down-regulation of antiviral responses.", {"entities": []}], ["Accordingly, we hypothesized that a deficiency of TAM receptors would enhance antiviral responses and protect against viral infection.", {"entities": []}], ["Unexpectedly, mice lacking Mertk and/or Axl but not Tyro3 exhibited greater vulnerability to infection with neuroinvasive West Nile and La Crosse viruses.", {"entities": [[27, 32, "GENE"], [40, 43, "GENE"], [52, 57, "GENE"]]}], ["This phenotype was associated with increased blood-brain barrier permeability, which enhanced virus entry into and infection of the brain.", {"entities": []}], ["Activation of Mertk synergized with IFN-\u03b2 to tighten cell junctions and prevent virus transit across brain microvascular endothelial cells.", {"entities": [[14, 19, "GENE"]]}], ["Because TAM receptors restrict pathogenesis of neuroinvasive viruses, these findings have implications for TAM antagonists that are currently in clinical development.", {"entities": []}], ["Diarrhea is one of the leading causes of morbidity and mortality in humans in developed and developing countries.", {"entities": [[0, 8, "DISEASE"]]}], ["Furthermore, increased resistance to antibiotics has resulted in serious challenges in the treatment of this infectious disease worldwide.", {"entities": []}], ["Therefore, there exists a need to develop alternative natural or combination drug therapies.", {"entities": []}], ["The aim of the present study was to investigate the synergistic effect of curcumin-1 in combination with three antibiotics against five diarrhea causing bacteria.", {"entities": [[136, 144, "DISEASE"]]}], ["The antibacterial activity of curcumin-1 and antibiotics was assessed by the broth microdilution method, checkerboard dilution test, and time-kill assay.", {"entities": []}], ["Antimicrobial activity of curcumin-1 was observed against all tested strains.", {"entities": []}], ["The MICs of curcumin-1 against test bacteria ranged from 125 to 1000\u2009 \u03bc g/mL.", {"entities": []}], ["In the checkerboard test, curcumin-1 markedly reduced the MICs of the antibiotics cefaclor, cefodizime, and cefotaxime.", {"entities": []}], ["Significant synergistic effect was recorded by curcumin-1 in combination with cefotaxime.", {"entities": []}], ["The toxicity of curcumin-1 with and without antibiotics was tested against foreskin (FS) normal fibroblast and no significant cytotoxicity was observed.", {"entities": []}], ["From our result it is evident that curcumin-1 enhances the antibiotic potentials against diarrhea causing bacteria in in vitro condition.", {"entities": [[89, 97, "DISEASE"]]}], ["This study suggested that curcumin-1 in combination with antibiotics could lead to the development of new combination of antibiotics against diarrhea causing bacteria.", {"entities": [[141, 149, "DISEASE"]]}], ["Ethnobotanical studies on the use of plants amongst migrant populations are of great relevance to public health.", {"entities": []}], ["Traditional health strategies, which incorporate plants as medicines, foods, or both \u2013 can play an important role in individual well-being.", {"entities": []}], ["However, at the same time, migrant populations\u2019 traditional knowledge of such practices may be under a state of greater threat of decline due to factors such as limited access to the plant materials and physical isolation from the homeland, which serves as the primary living reservoir for this knowledge.", {"entities": []}], ["In this study, we conducted a medical ethnobotanical survey focusing on a comparison of local medicinal food and health strategies with members of two Asian immigrant populations in metro-Atlanta: Chinese and Taiwanese.", {"entities": []}], ["Snowball sampling techniques were employed to recruit 83 study participants, 57 of which were included in the final analysis.", {"entities": []}], ["Semi-structured interview techniques were used to question participants about their beliefs and usage of the yin yang system, usage of Chinese herbs and medicinal foods, preference and usage of Eastern and Western medicines, and gardening for medicinal foods.", {"entities": []}], ["Comparison of the two groups demonstrated a remarkable difference in health strategies concerning medicinal plant use, including statistically significant differences in beliefs concerning yin and yang, uses of Eastern versus Western medicine, and gardening for medicinal foods.", {"entities": []}], ["Domestic health strategies in the form of medicinal foods play an important role in local health practices, especially among the Taiwanese participants.", {"entities": []}], ["The collective desire for the use of both Eastern and Western medicine by both groups highlights the important role that cultural competency training will play in preparing allopathic health practitioners to serve increasingly diverse patient populations in the US.", {"entities": []}], ["Although several studies have demonstrated the efficacy of probiotics for preventing upper respiratory tract infections (URTIs) in at-risk populations, including children and the elderly, few studies have investigated the efficacy of probiotics in healthy adults living normal, everyday lives.", {"entities": []}], ["Thus, we tried to evaluate the effects of Lactobacillus casei strain Shirota-fermented milk (LcS-FM) on the incidence of URTIs in healthy middle-aged office workers.", {"entities": []}], ["In a randomized controlled trial, 96 eligible male workers aged 30\u201349\u00a0years consumed LcS-FM containing 1.0\u00a0\u00d7\u00a010 The incidence of URTIs during the intervention period was significantly lower in the LcS-FM group than in the CM group (22.4 vs. 53.2\u00a0%, P \u00a0=\u00a00.002).", {"entities": []}], ["The time-to-event analysis showed that the LcS-FM group had a significantly higher URTI-free rate than the CM group over the test period (log-rank test: \u03c7 P \u00a0=\u00a00.0008).", {"entities": []}], ["The cumulative number of URTI episodes and cumulative days with URTI symptoms per person was lower in the LcS-FM group, and the duration per episode was shorter.", {"entities": []}], ["Inhibition of both reductions in NK cell activity in peripheral blood mononuclear cells and increases in salivary cortisol levels was observed in the LcS-FM group.", {"entities": []}], ["The results suggest that the daily intake of fermented milk with LcS may reduce the risk of URTIs in healthy middle-aged office workers, probably through modulation of the immune system.", {"entities": []}], ["The enlargement of the European Union since 2004 has led to an increase in the number of Eastern European migrants living in the UK.", {"entities": []}], ["The health of this group is under-researched though some mixed evidence shows they are at higher risk of certain physical health conditions such as heart attacks, strokes, HIV and alcohol use and have poorer mental health.", {"entities": []}], ["This is compounded by poor or insecure housing, low pay, isolation and prejudice.", {"entities": []}], ["We aimed to understand the health needs and health service experiences of the Eastern European population in a town in Northern England.", {"entities": []}], ["Five semi structured one-to-one and small group interviews and five focus groups were conducted with 42 Eastern European participants between June and September 2014.", {"entities": []}], ["The majority of participants were Polish and other participants were from Belarus, Hungary, Latvia, Russia, Slovakia and Ukraine.", {"entities": []}], ["The data were analysed using thematic framework analysis.", {"entities": []}], ["Key findings included a good understanding the UK health service structure and high registration and use of general practice/primary care services.", {"entities": []}], ["However, overall, there were high levels of dissatisfaction, frustration and distrust in General Practitioners (GP).", {"entities": []}], ["The majority of participants viewed the GP as unhelpful and dismissive; a barrier to secondary/acute care; reluctant to prescribe antibiotics; and that GPs too often advised them to take paracetamol (acetaminophen) and rest.", {"entities": []}], ["Overwhelmingly participants had strong opinions about access to primary care and the role of the general practitioners.", {"entities": []}], ["Although the design of the UK health service was well understood, participants were unhappy with the system of GP as gatekeeper and felt it inferior to the consumer-focused health systems in their country of origin.", {"entities": []}], ["More work is needed to promote the importance of self-care, reduce antibiotic and medication use, and to increase trust in the GP.", {"entities": []}], ["Compelling evidence supports the cost effectiveness and potential impact of physical activity on chronic disease prevention and health promotion.", {"entities": []}], ["Quality of evidence is one piece, but certainly not the sole determinant of whether public health interventions, physical activity focused or otherwise, achieve their full potential for impact.", {"entities": []}], ["Health promotion at both population and community levels must progress beyond health intervention models that isolate individuals from social, environmental, and political systems of influence.", {"entities": []}], ["We offer a critical evaluation of lessons learned from two successful research initiatives to provide insights as to how health promotion research contributes to sustained impact.", {"entities": []}], ["We highlight factors key to success including the theoretical and methodological integration of: i) a social ecological approach; ii) participatory action research (PAR) methods; and iii) an interdisciplinary team.", {"entities": []}], ["To identify and illustrate the key elements of our success we layered an evaluation of steps taken atop a review of relevant literature.", {"entities": []}], ["In the school-based case study (Action Schools!", {"entities": []}], ["BC), the success of our approach included early and sustained engagement with a broad cross-section of stakeholders, establishing partnerships across sectors and at different levels of government, and team members across multiple disciplines.", {"entities": []}], ["In the neighbourhood built environment case study, the three domains guided our approach through study design and team development, and the integration of older adults\u2019 perspectives into greenway design plans.", {"entities": []}], ["In each case study we describe how elements of the domains serve as a guide for our work.", {"entities": []}], ["To sustain and maximize the impact of community-based public health interventions we propose the integration of elements from three domains of research that acknowledge the interplay between social, environmental and poilitical systems of influence.", {"entities": []}], ["We emphasize that a number of key factors determine whether evidence from public health interventions in school and built environment settings is applied in practice and policy sectors.", {"entities": []}], ["These include relationship building at individual, community, and societal levels of the social ecological model, using participatory action research methods, and involving an engaged and committed interdisciplinary team.", {"entities": []}], ["Exosomes participate in intercellular messaging by transporting bioactive lipid-, protein- and RNA-molecules and -complexes.", {"entities": []}], ["The contents of the exosomes reflect the physiological status of an individual making exosomes promising targets for biomarker analyses.", {"entities": []}], ["In the present study we extracted exosome microRNAs (exomiRs) from serum samples of premenopausal women (n\u2009=\u20098) and monozygotic postmenopausal twins (n\u2009=\u200910 female pairs), discordant for the use of estrogenic hormone replacement therapy (HRT), in order to see whether the age or/and the use of HRT associates with exomiR content.", {"entities": []}], ["A total of 241 exomiRs were detected by next generation sequencing, 10 showing age, 14 HRT and 10 age +HRT -related differences.", {"entities": []}], ["When comparing the groups, differentially expressed miRs were predicted to affect cell proliferation processes showing inactivation with younger age and HRT usage.", {"entities": []}], ["MiR-106-5p, -148a-3p, -27-3p, -126-5p, -28-3p and -30a-5p were significantly associated with serum 17\u03b2-estradiol.", {"entities": []}], ["MiRs formed two hierarchical clusters being indicative of positive or negative health outcomes involving associations with body composition, serum 17\u03b2-estradiol, fat-, glucose- and inflammatory markers.", {"entities": []}], ["Circulating exomiR clusters, obtained by NGS, could be used as indicators of metabolic and inflammatory status affected by hormonal changes at menopause.", {"entities": []}], ["Furthermore, the individual effects of HRT-usage could be evaluated based on the serum exomiR signature.", {"entities": []}], ["Antipsychotics are used to treat delirium in the intensive care unit (ICU) despite unproven efficacy.", {"entities": []}], ["We hypothesized that atypical antipsychotic treatment in the ICU is a risk factor for antipsychotic prescription at discharge, a practice that might increase risk since long-term use is associated with increased mortality.", {"entities": []}], ["After excluding patients on antipsychotics prior to admission, we examined antipsychotic use in a prospective cohort of ICU patients with acute respiratory failure and/or shock.", {"entities": [[144, 163, "DISEASE"]]}], ["We collected data on medication use from medical records and assessed patients for delirium using the Confusion Assessment Method for the ICU.", {"entities": []}], ["Using multivariable logistic regression, we analyzed whether age, delirium duration, atypical antipsychotic use, and discharge disposition (each selected a priori) were independent risk factors for discharge on an antipsychotic.", {"entities": []}], ["We also examined admission Acute Physiology and Chronic Health Evaluation (APACHE) II score, haloperidol use, and days of benzodiazepine use in post hoc analyses.", {"entities": []}], ["After excluding 18 patients due to prior antipsychotic use and three who withdrew, we included 500 patients.", {"entities": []}], ["Among 208 (42%) treated with an antipsychotic, median (interquartile range) age was 59 (49\u201369) years and APACHE II score was 26 (22\u201332), characteristics that were similar among antipsychotic nonusers.", {"entities": []}], ["Antipsychotic users were more likely than nonusers to have had delirium (93% vs. 61%, p \u2009<\u20090.001).", {"entities": []}], ["Of the 208 antipsychotic users, 172 survived to hospital discharge, and 42 (24%) of these were prescribed an antipsychotic at discharge.", {"entities": []}], ["Treatment with an atypical antipsychotic was the only independent risk factor for antipsychotic prescription at discharge (odds ratio 17.6, 95% confidence interval 4.9 to 63.3; p \u2009<\u20090.001).", {"entities": []}], ["Neither age, delirium duration, nor discharge disposition were risk factors ( p \u2009=\u20090.11, 0.38, and 0.12, respectively) in the primary regression model, and post hoc analyses found APACHE II ( p \u2009=\u20090.07), haloperidol use ( p \u2009=\u20090.16), and days of benzodiazepine use ( p \u2009=\u20090.31) were also not risk factors for discharge on an antipsychotic.", {"entities": []}], ["In this study, antipsychotics were used to treat nearly half of all antipsychotic-na\u00efve ICU patients and were prescribed at discharge to 24% of antipsychotic-treated patients.", {"entities": []}], ["Treatment with an atypical antipsychotic greatly increased the odds of discharge with an antipsychotic prescription, a practice that should be examined carefully during medication reconciliation since these drugs carry \u201cblack box warnings\u201d regarding long-term use.", {"entities": []}], ["Children suffering from rheumatic disease are faced with multidimensional challenges that affect their quality of life and family dynamics.", {"entities": [[24, 41, "DISEASE"]]}], ["Symptom management and monitoring of the course of the disease over time are important to minimize disability and pain.", {"entities": []}], ["Poor disease control and anticipation of the need for treatment changes may be prompted by specialist medical follow-up and regular nurse-led consultations with the patient and families, in which information and support is provided.", {"entities": []}], ["The purpose of this study was to evaluate the impact of a nurse-led telephone intervention or Telenursing (TN) compared to standard care (SC) on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their parents.", {"entities": []}], ["A multicentered, randomized, longitudinal, crossover trial was conducted with pediatrics outpatients newly diagnosed with inflammatory rheumatic diseases.", {"entities": []}], ["Participants were randomly assigned to two groups TN and SC for 12\u00a0months and crossed-over for the following 12\u00a0months.", {"entities": []}], ["TN consisted of providing individualized affective support, health information and aid to decision making.", {"entities": []}], ["Satisfaction (primary outcome) and health outcomes were assessed with the Client Satisfaction Questionnaire-8 and the Juvenile Arthritis Multidimensional Assessment Report, respectively.", {"entities": []}], ["A mixed effect model, including a group x time interaction, was performed for each outcome.", {"entities": []}], ["Satisfaction was significantly higher when receiving TN (OR\u00a0=\u00a07.7, 95% CI: 1.8\u201333.6).", {"entities": []}], ["Morning stiffness (OR\u00a0=\u00a03.2, 95% CI: 0.97\u20137.15) and pain (OR\u00a0=\u00a02.64, 95% CI: 0.97\u20137.15) were lower in the TN group.", {"entities": []}], ["For both outcomes a carry-over effect was observed with a higher impact of TN during the 12 first months of the study.", {"entities": []}], ["The other outcomes did not show any significant improvements between groups.", {"entities": []}], ["TN had a positive impact on satisfaction and on morning stiffness and pain of children with inflammatory rheumatic diseases and their families.", {"entities": []}], ["This highlights the importance of support by specialist nurses in improving satisfaction and symptom management for children with inflammatory rheumatisms and their families.", {"entities": []}], ["ClinicalTrial.gov identifier: NCT01511341 (December 1st, 2012).", {"entities": []}], ["The UK performs poorly relative to other economically developed countries on numerous indicators of care quality for children.", {"entities": []}], ["The contribution of iatrogenic harm to these outcomes is unclear.", {"entities": []}], ["As primary care is the first point of healthcare contact for most children, we sought to investigate the safety of care provided to children in this setting.", {"entities": []}], ["We undertook a mixed methods investigation of reports of primary care patient safety incidents involving sick children from England and Wales\u2019 National Reporting and Learning System between 1 January 2005 and 1 December 2013.", {"entities": []}], ["Two reviewers independently selected relevant incident reports meeting prespecified criteria, and then descriptively analyzed these reports to identify the most frequent and harmful incident types.", {"entities": []}], ["This was followed by an in-depth thematic analysis of a purposive sample of reports to understand the reasons underpinning incidents.", {"entities": []}], ["Key candidate areas for strengthening primary care provision and reducing the risks of systems failures were then identified through multidisciplinary discussions.", {"entities": []}], ["Of 2,191 safety incidents identified from 2,178 reports, 30% ( n = 658) were harmful, including 12 deaths and 41 cases of severe harm.", {"entities": []}], ["The children involved in these incidents had respiratory conditions ( n = 387; 18%), injuries ( n = 289; 13%), nonspecific signs and symptoms, e.g., fever ( n = 281; 13%), and gastrointestinal or genitourinary conditions ( n = 268; 12%), among others.", {"entities": []}], ["Priority areas for improvement included safer systems for medication provision in community pharmacies; triage processes to enable effective and timely assessment, diagnosis, and referral of acutely sick children attending out-of-hours services; and enhanced communication for robust safety netting between professionals and parents.", {"entities": []}], ["The main limitations of this study result from underreporting of safety incidents and variable data quality.", {"entities": []}], ["Our findings therefore require further exploration in longitudinal studies utilizing case review methods.", {"entities": []}], ["This study highlights opportunities to reduce iatrogenic harm and avoidable child deaths.", {"entities": []}], ["Globally, healthcare systems with primary-care-led models of delivery must now examine their existing practices to determine the prevalence and burden of these priority safety issues, and utilize improvement methods to achieve sustainable improvements in care quality.", {"entities": []}], ["Using a mixed methods approach, Philippa Rees and colleagues describe patient safety incidents involving sick children in primary care in England & Wales.", {"entities": []}], ["Children receive most of their healthcare in the community setting rather than the hospital setting, but very little is known about the safety of this care.", {"entities": []}], ["There are signs from previous research that the UK is providing poorer quality pediatric care than its similarly economically developed counterparts.", {"entities": []}], ["The purpose of this study was to identify what safety concerns there are involving children in primary care, in order to accelerate and inform improvement efforts.", {"entities": []}], ["We analyzed 2,191 reports from a national collection of patient safety incidents that involved sick children in primary care in England and Wales.", {"entities": []}], ["Of the incidents included in this study, 30% were reported as harmful.", {"entities": []}], ["Medication errors, particularly in the community pharmacy setting, were commonly reported.", {"entities": []}], ["Incidents that involved diagnosis, assessment, or referral of sick children were the most harmful of those reported: there were ten deaths, 15 reports of severe harm, and 69 reports of moderate harm.", {"entities": []}], ["Poor communication underpinned many of the safety incidents reported as harming children.", {"entities": []}], ["It is important to note that our findings are limited by the biased nature of incident report data (not all incidents get reported) and require further studies to confirm them.", {"entities": []}], ["However, the frequency with which certain incidents are reported clearly points to areas of care requiring improvement.", {"entities": []}], ["Safer and more reliable medication dispensing systems are needed.", {"entities": []}], ["Out-of-hours telephone triage systems are not fit for pediatric purpose and require improvement.", {"entities": []}], ["Mandatory pediatric training for all general practice trainees is essential.", {"entities": []}], ["We hope that this study acts as an impetus for long-overdue widespread improvement efforts in this area.", {"entities": []}], ["Differences in the composition of the gut microbiota have been associated with a range of diseases using culture-independent methods.", {"entities": []}], ["Reliable extraction of nucleic acid is a key step in identifying the composition of the faecal microbiota.", {"entities": []}], ["Five widely used commercial deoxyribonucleic acid (DNA) extraction kits (QIAsymphony\u00ae Virus/Bacteria Midi Kit (kit QS), ZR Fecal DNA MiniPrep\u2122 (kit Z), QIAamp\u00ae DNA Stool Mini Kit (kit QA), Ultraclean\u00ae Fecal DNA Isolation Kit (kit U) and PowerSoil\u00ae DNA Isolation Kit (kit P)) were evaluated, using human faecal samples.", {"entities": []}], ["Yield, purity and integrity of total genomic DNA were compared spectrophotometrically and using gel electrophoresis.", {"entities": []}], ["Three bacteria, commonly found in human faeces were quantified using real time polymerase chain reaction (qPCR) and total bacterial diversity was studied using denaturing gradient gel electrophoresis (DGGE) as well as terminal restriction fragment length polymorphism (T-RFLP).", {"entities": []}], ["The measurements of DNA yield and purity exhibited variations between the five kits tested in this study.", {"entities": []}], ["Automated kit QS exhibited the best quality and highest quantity of DNA.", {"entities": []}], ["All kits were shown to be reproducible with CV values\u00a0\u2264\u00a00.46 for DNA extraction.", {"entities": []}], ["qPCR results showed that all kits were uniformly efficient for extracting DNA from the selected target bacteria.", {"entities": []}], ["DGGE and T-RFLP produced the highest diversity scores for DNA extracted using kit Z (H\u2032\u00a0=\u00a02.30 and 1.27) and kit QS (H\u2032\u00a0=\u00a02.16 and 0.94), which also extracted the highest DNA yields compared to the other kits assessed.", {"entities": []}], ["\u2022 Five commercial bacterial DNA extraction kits were compared on human faecal samples.", {"entities": []}], ["\u2022 Extraction efficiency and isolated bacterial diversity were evaluated.", {"entities": []}], ["\u2022 Quantitation by qPCR of targeted bacteria commonly found in human faeces \u2022 Automated kit QS provided the highest DNA yield and best quality DNA.", {"entities": []}], ["\u2022 Automated kit QS extracted high bacterial diversity and provides practical advantages.", {"entities": []}], ["Five commercial bacterial DNA extraction kits were compared on human faecal samples.", {"entities": []}], ["Extraction efficiency and isolated bacterial diversity were evaluated.", {"entities": []}], ["Quantitation by qPCR of targeted bacteria commonly found in human faeces Automated kit QS provided the highest DNA yield and best quality DNA.", {"entities": []}], ["Automated kit QS extracted high bacterial diversity and provides practical advantages.", {"entities": []}], ["The novel A/J Min/+ mouse, which is a model for human Familial Adenomatous Polyposis (FAP), develops spontaneously multiple adenocarcinomas in the colon as well as in the small intestine.", {"entities": [[86, 89, "GENE"]]}], ["Agaricus blazei Murill (AbM) is an edible Basidiomycetes mushroom that has been used in traditional medicine against cancer and other diseases.", {"entities": [[117, 123, "DISEASE"]]}], ["The mushroom contains immunomodulating \u03b2-glucans and is shown to have antitumor effects in murine cancer models.", {"entities": [[98, 104, "DISEASE"]]}], ["Andosan Basidiomycetes mushrooms Hericeum erinaceus and Grifola frondosa .", {"entities": []}], ["Tap water with 10% Andosan The results from this mouse model for colorectal cancer shows significant protection of orally administered Andosan", {"entities": [[65, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["Early-life chemical exposure may influence immune system development, subsequently affecting child health.", {"entities": []}], ["We investigated immunomodulatory potentials of polychlorinated biphenyls (PCBs) and p,p' -DDE in infants.", {"entities": []}], ["Prenatal exposure to PCBs and p,p' -DDE was estimated from maternal serum concentrations during pregnancy.", {"entities": []}], ["Postnatal exposure was calculated from concentrations of the compounds in mother's milk, total number of nursing days, and percentage of full nursing each week during the 3 month nursing period.", {"entities": []}], ["Number and types of infections among infants were registered by the mothers (N = 190).", {"entities": []}], ["White blood cell counts (N = 86) and lymphocyte subsets (N = 52) were analyzed in a subgroup of infants at 3 months of age.", {"entities": []}], ["Infants with the highest prenatal exposure to PCB congeners CB-28, CB-52 and CB-101 had an increased risk of respiratory infection during the study period.", {"entities": []}], ["In contrast, the infection odds ratios (ORs) were highest among infants with the lowest prenatal mono- ortho PCB (CB-105, CB-118, CB-156, CB-167) and di- ortho PCB (CB-138, CB-153, CB-180) exposure, and postnatal mono- and di- ortho PCB, and p,p' -DDE exposure.", {"entities": []}], ["Similar results were found for pre- and postnatal CB-153 exposure, a good marker for total PCB exposure.", {"entities": []}], ["Altogether, a negative relationship was indicated between infections and total organochlorine compound exposure during the whole pre- and postnatal period.", {"entities": []}], ["Prenatal exposure to CB-28, CB-52 and CB-101 was positively associated with numbers of lymphocytes and monocytes in infants 3 months after delivery.", {"entities": []}], ["Prenatal exposure to p,p' -DDE was negatively associated with the percentage of eosinophils.", {"entities": []}], ["No significant associations were found between PCB and p,p' -DDE exposure and numbers/percentages of lymphocyte subsets, after adjustment for potential confounders.", {"entities": []}], ["This hypothesis generating study suggests that background exposure to PCBs and p,p' -DDE early in life modulate immune system development.", {"entities": []}], ["Strong correlations between mono- and di- ortho PCBs, and p,p' -DDE exposures make it difficult to identify the most important contributor to the suggested immunomodulation, and to separate effects due to pre- and postnatal exposure.", {"entities": []}], ["The suggested PCB and p,p' -DDE modulation of infection risks may have consequences for the health development during childhood, since respiratory infections early in life may be risk factors for asthma and middle ear infections.", {"entities": [[196, 202, "DISEASE"]]}], ["Genomic instability is a common feature of cancer etiology.", {"entities": [[43, 49, "DISEASE"]]}], ["This provides an avenue for therapeutic intervention, since cancer cells are more susceptible than normal cells to DNA damaging agents.", {"entities": [[60, 66, "DISEASE"]]}], ["However, there is growing evidence that the epigenetic mechanisms that impact DNA methylation and histone status also contribute to genomic instability.", {"entities": []}], ["The DNA damage response, for example, is modulated by the acetylation status of histone and non-histone proteins, and by the opposing activities of histone acetyltransferase and histone deacetylase (HDAC) enzymes.", {"entities": []}], ["Many HDACs overexpressed in cancer cells have been implicated in protecting such cells from genotoxic insults.", {"entities": [[28, 34, "DISEASE"]]}], ["Thus, HDAC inhibitors, in addition to unsilencing tumor suppressor genes, also can silence DNA repair pathways, inactivate non-histone proteins that are required for DNA stability, and induce reactive oxygen species and DNA double-strand breaks.", {"entities": []}], ["This review summarizes how dietary phytochemicals that affect the epigenome also can trigger DNA damage and repair mechanisms.", {"entities": []}], ["Where such data is available, examples are cited from studies in vitro and in vivo of polyphenols, organosulfur/organoselenium compounds, indoles, sesquiterpene lactones, and miscellaneous agents such as anacardic acid.", {"entities": []}], ["Finally, by virtue of their genetic and epigenetic mechanisms, cancer chemopreventive agents are being redefined as chemo- or radio-sensitizers.", {"entities": [[63, 69, "DISEASE"]]}], ["A sustained DNA damage response coupled with insufficient repair may be a pivotal mechanism for apoptosis induction in cancer cells exposed to dietary phytochemicals.", {"entities": [[119, 125, "DISEASE"]]}], ["Future research, including appropriate clinical investigation, should clarify these emerging concepts in the context of both genetic and epigenetic mechanisms dysregulated in cancer, and the pros and cons of specific dietary intervention strategies.", {"entities": [[175, 181, "DISEASE"]]}], ["The aim was to determine if baseline measures can predict response to pulmonary rehabilitation in terms of six-minute walk distance (6MWD) or quality of life.", {"entities": []}], ["Participants with COPD who attended pulmonary rehabilitation between 2010 and 2012 were recruited.", {"entities": []}], ["Baseline measures evaluated included physical activity, quadriceps strength, comorbidities, inflammatory markers, and self-efficacy.", {"entities": []}], ["Participants were classified as a responder with improvement in 6MWD (criteria of \u226525\u2009m or \u22652SD) and Chronic Respiratory Questionnaire (CRQ; \u22650.5 points/question).", {"entities": []}], ["Eighty-five participants with a mean (SD) age of 67(9) years and a mean forced expiratory volume in one second of 55(22)% were studied.", {"entities": []}], ["Forty-nine and 19 participants were responders when using the 6MWD criteria of \u226525\u2009m and \u226561.9\u2009m, respectively, with forty-four participants improving in CRQ.", {"entities": []}], ["In a regression model, responders in 6MWD (\u226525\u2009m criteria) had lower baseline quadriceps strength ( P = 0.028) and higher baseline self-efficacy scores ( P = 0.045).", {"entities": []}], ["Independent predictors of 6MWD response (\u226561.9\u2009m criteria) were participants with metabolic disease ( P = 0.007) and lower baseline quadriceps strength ( P = 0.016).", {"entities": []}], ["Lower baseline CRQ was the only independent predictor of CRQ response.", {"entities": []}], ["A participant with relatively lower baseline quadriceps strength was the strongest independent predictor of 6MWD response.", {"entities": []}], ["Metabolic disease may predict 6MWD response, but predictors of CRQ response remain unclear.", {"entities": []}], ["Severe pneumonia developed in young adults who had no identifiable risk factors.", {"entities": [[7, 16, "DISEASE"]]}], ["We describe the clinical characteristics and outcomes of adults hospitalized with pneumonia during the pandemic (H1N1) 2009 outbreak.", {"entities": [[82, 91, "DISEASE"]]}], ["Patients admitted to a general hospital in San Luis Potos\u00ed, Mexico, from April 10 through May 11, 2009, suspected to have influenza virus\u2013associated pneumonia were evaluated.", {"entities": [[122, 131, "DISEASE"], [149, 158, "DISEASE"]]}], ["We identified 50 patients with suspected influenza pneumonia; the presence of influenza virus was confirmed in 18: 11 with pandemic (H1N1) 2009 virus, 5 with unsubtypeable influenza A virus, 1 with seasonal influenza A virus (H3N2), and 1 in whom assay results for seasonal and pandemic (H1N1) 2009 viruses were positive.", {"entities": [[41, 50, "DISEASE"], [78, 87, "DISEASE"], [172, 181, "DISEASE"], [207, 216, "DISEASE"], [51, 60, "DISEASE"]]}], ["Eighteen patients were treated in the intensive care unit, and 10 died.", {"entities": []}], ["During the pandemic (H1N1) 2009 outbreak, severe pneumonia developed in young adults who had no identifiable risk factors; early diagnosis and treatment of influenza virus infections may have a determinant role in outcome.", {"entities": [[156, 165, "DISEASE"], [49, 58, "DISEASE"]]}], ["The concept of a matricellular protein was first proposed by Paul Bornstein in the mid-1990s to account for the non-lethal phenotypes of mice with inactivated genes encoding thrombospondin-1, tenascin-C, or SPARC.", {"entities": [[207, 212, "GENE"]]}], ["It was also recognized that these extracellular matrix proteins were primarily counter or de-adhesive.", {"entities": []}], ["This review reappraises the matricellular concept after nearly two decades of continuous investigation.", {"entities": []}], ["The expanded matricellular family as well as the diverse and often unexpected functions, cellular location, and interacting partners/receptors of matricellular proteins are considered.", {"entities": []}], ["Development of therapeutic strategies that target matricellular proteins are discussed in the context of pathology and regenerative medicine.", {"entities": []}], ["The present study analyses the ability of the alveolar slope of the single-breath nitrogen washout test (N 2 -slope) to diagnose and predict the development of the bronchiolitis obliterans syndrome (BOS).", {"entities": [[189, 197, "DISEASE"], [164, 188, "DISEASE"], [164, 177, "DISEASE"]]}], ["We present a retrospective analysis of 61 consecutive bilateral lung or heart-lung transplant recipients who were followed at regular control visits during a three year follow-up.", {"entities": []}], ["The operating characteristics of the N 2 -slope to diagnose BOS and potential BOS (BOS 0-p) and to predict BOS were determined based on cut off values of 95% specificity.", {"entities": []}], ["The sensitivity of the N 2 -slope to identify BOS was 96%, and BOS 0-p 100%.", {"entities": []}], ["The predictive ability to predict BOS with a N 2 -slope > 478% of the predicted normal was 56%, and if combined with a coincident FEV 1 < 90% of the basal value, the predictive ability was 75%.", {"entities": [[130, 133, "GENE"]]}], ["The predictive ability of either the N 2 -slope or of FEV 1 to diagnose BOS is limited but the combination of the two appears useful.", {"entities": [[54, 57, "GENE"]]}], ["Follow-up protocols of bilateral lung and heart-lung transplant recipients should consider including tests sensitive to obstruction of the peripheral airways.", {"entities": []}], ["Targeted disruption of death receptor (DR)6 results in enhanced CD4 .", {"entities": [[64, 67, "GENE"]]}], ["In vitro, DR6 l expression were observed in DR6", {"entities": []}], ["In March 2005, Armenia enacted legislation protecting employees from secondhand smoke.", {"entities": []}], ["This research was the first attempt to understand the attitudes, beliefs and practices of managers of public and private enterprises regarding smoke-free worksite policies.", {"entities": []}], ["Mixed methods were used.", {"entities": []}], ["The study team conducted focus group discussions with worksite administrators to explore their beliefs, attitudes and practices related to worksite smoking.", {"entities": []}], ["These findings guided development of a quantitative instrument to collect more representative data on the same issues.", {"entities": []}], ["Using stratified random sampling, 243 worksites were interviewed from June-July 2005, representing state/municipal, health, educational, culture and business institutions in three of Armenia's largest cities.", {"entities": []}], ["Smoking-related practices differed significantly across institutions.", {"entities": []}], ["More than half of the managers (55.6%) reported having smoking restrictions at worksites, including 37.0% who reported smoke-free workplaces; however, smoking or the presence of ashtrays was observed in 27.8% of workplaces reported to be smoke-free.", {"entities": []}], ["A substantial proportion of the administrators favored both banning indoor smoking and allowing smoking in special areas.", {"entities": []}], ["Only 38.0% of managers were aware of employees' existing legal protections from exposure to secondhand smoke.", {"entities": []}], ["Knowledge of these regulations was not related to adherence to smoke-free worksite policies.", {"entities": []}], ["The research also revealed widespread confusion between the concepts of worksite smoking restrictions and smoke-free workplaces.", {"entities": []}], ["Public awareness campaigns that promote promulgation and enforcement of worksite smoking regulations could increase employee demand for smoke-free worksites.", {"entities": []}], ["As one of the first studies to investigate smoking-related worksite practices, attitudes and beliefs in former Soviet countries, these findings provide insight into law enforcement processes in economies in transition.", {"entities": []}], ["Smoking and aberrant epithelial responses are risk factors for lung cancer as well as chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.", {"entities": [[63, 74, "DISEASE"], [86, 123, "DISEASE"], [139, 157, "DISEASE"], [128, 157, "DISEASE"], [68, 74, "DISEASE"]]}], ["In these conditions, disease progression is associated with epithelial damage and fragility, airway remodelling and sub-epithelial fibrosis.", {"entities": []}], ["The aim of this study was to assess the acute effects of cigarette smoke on epithelial cell phenotype and pro-fibrotic responses in vitro and in vivo .", {"entities": []}], ["Apoptosis was significantly greater in unstimulated cells from COPD patients compared to control, but proliferation and CXCL8 release were not different.", {"entities": []}], ["Cigarette smoke dose-dependently induced apoptosis, proliferation and CXCL8 release with normal epithelial cells being more responsive than COPD patient derived cells.", {"entities": []}], ["Cigarette smoke did not induce epithelial-mesenchymal transition.", {"entities": []}], ["In vivo, cigarette smoke exposure promoted epithelial apoptosis and proliferation.", {"entities": []}], ["Moreover, mimicking a virus-induced exacerbation by exposing to mice to poly I:C, exaggerated the inflammatory responses, whereas expression of remodelling genes was similar in both.", {"entities": []}], ["Collectively, these data indicate that cigarette smoke promotes epithelial cell activation and hyperplasia, but a secondary stimulus is required for the remodelling phenotype associated with COPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0565-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Future health systems require the means to assess and track the neural and physiological function of a user over long periods of time, and in the community.", {"entities": []}], ["Human body responses are manifested through multiple, interacting modalities \u2013 the mechanical, electrical and chemical; yet, current physiological monitors (e.g.", {"entities": []}], ["actigraphy, heart rate) largely lack in cross-modal ability, are inconvenient and/or stigmatizing.", {"entities": []}], ["We address these challenges through an inconspicuous earpiece, which benefits from the relatively stable position of the ear canal with respect to vital organs.", {"entities": []}], ["Equipped with miniature multimodal sensors, it robustly measures the brain, cardiac and respiratory functions.", {"entities": []}], ["Comprehensive experiments validate each modality within the proposed earpiece, while its potential in wearable health monitoring is illustrated through case studies spanning these three functions.", {"entities": []}], ["We further demonstrate how combining data from multiple sensors within such an integrated wearable device improves both the accuracy of measurements and the ability to deal with artifacts in real-world scenarios.", {"entities": []}], ["Innovations to be deployed during consultations with patients may influence the clinical performance of the medical practitioner.", {"entities": []}], ["This study examined the impact on General Practitioners' (GPs) consultation performance of novel computer software, designed for use while consulting the patient.", {"entities": []}], ["Six GPs were video recorded consulting six actor-patients in a simulated clinical environment.", {"entities": []}], ["Two sessions were recorded with six consultations per GP.", {"entities": []}], ["Five cases presented cancer symptoms which warranted a referral for specialist investigation.", {"entities": [[21, 27, "DISEASE"]]}], ["Practitioners were invited to use a novel software package to process referrals made during the consultations in the second session.", {"entities": []}], ["Two assessors independently reviewed the consultation performance using the Leicester Assessment Package (LAP).", {"entities": []}], ["Inter-rater agreement was assessed by a Bland-Altman plot of the difference in score against the average score.", {"entities": []}], ["Sixty of the seventy two consultations were successfully recorded.", {"entities": []}], ["Each video consultation was scored twice by two assessors leaving 120 LAP scores available for analysis.", {"entities": []}], ["There was no evidence of a difference in the variance with increasing score (Pitmans test p = 0.09).", {"entities": []}], ["There was also no difference in the mean differences between assessor scores whether using the software or not (T-test, P = 0.49) The actor-patient consultation can be used to test clinical innovations as a prelude to a formal clinical trial.", {"entities": []}], ["However the logistics of the study may impact on the validity of the results and need careful planning.", {"entities": []}], ["Ideally innovations should be tested within the context of a laboratory designed for the purpose, incorporating a pool of practitioners whose competencies have been established and assessors who can be blinded to the aims of the study.", {"entities": []}], ["Although, use of animal species in disease treatment and culture practices is as ancient as that of plant species; however ethnomedicinal uses and cultural values of animal species have rarely been reported.", {"entities": []}], ["Present study is the first report on the medicinal uses of mammals and bird species in Pakistan.", {"entities": []}], ["Questionnaires and semi-structured interviews were applied to collect qualitative and quantitative data from local informants ( N \u00a0=\u00a0109).", {"entities": []}], ["Relative frequency of mention (RFM), fidelity level (FL), relative popularity level (RPL), similarity index (SI) and rank order priority (ROP) indices were used to analyzed the data.", {"entities": []}], ["One hundred and eight species of animals, which include: 83% birds and 17% mammals were documented.", {"entities": []}], ["In total 30 mammalian and 28 birds\u2019 species were used to treat various diseases such as rheumatic disorders, skin infections and sexual weakness among several others.", {"entities": []}], ["Fats, flesh, blood, milk and eggs were the most commonly utilized body parts.", {"entities": []}], ["Bos taurus, Bubalus bubalis, Capra aegagrus hircus, Felis domesticus, Lepus nigricollis dayanus and Ovis aries (mammals) and Anas platyrhynchos domesticus, Columba livia, Coturnix coturnix, Gallus gallus and Passer domesticus (birds) were the highly utilized species.", {"entities": []}], ["Medicinal and cultural uses of 30% mammals and 46% birds were reported for the first time, whereas 33% mammals and 79% birds depicted zero similarity with previous reports.", {"entities": []}], ["Present study exhibits significant ethnozoological knowledge of local inhabitants and their strong association with animal species, which could be helpful in sustainable use of biodiversity of the region.", {"entities": []}], ["Additionally, in vitro and in vivo evaluation of biological activities in the mammalian and birds\u2019 species with maximum fidelity level and frequency of mention could be important to discover animal based novel drugs.", {"entities": []}], ["Some commonly used mammals and birds species of the study area", {"entities": []}], ["To investigate the association between serum 25-hydroxyvitamin D [25(OH)D] level and history of community-acquired pneumonia (CAP).", {"entities": [[115, 124, "DISEASE"]]}], ["We identified 16,975 individuals (\u226517 years) from the third National Health and Nutrition Examination Survey (NHANES III) with documented 25(OH)D levels.", {"entities": []}], ["To investigate the association of 25(OH)D with history of CAP in these participants, we developed a multivariable logistic regression model, adjusting for demographic factors (age, sex, race, poverty-to-income ratio, and geographic location), clinical data (body mass index, smoking status, asthma, chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, stroke, chronic kidney disease, neutropenia, and alcohol consumption), and season.", {"entities": [[338, 362, "DISEASE"], [399, 413, "DISEASE"], [415, 426, "DISEASE"], [299, 336, "DISEASE"], [291, 297, "DISEASE"], [364, 381, "DISEASE"]]}], ["Locally weighted scatterplot smoothing (LOWESS) was used to depict the relationship between increasing 25(OH)D levels and the cumulative frequency of CAP in the study cohort.", {"entities": []}], ["The median [interquartile range (IQR)] serum 25(OH)D level was 24 (IQR 18\u201332) ng/mL.", {"entities": []}], ["2.1% [95% confidence interval (CI): 1.9\u20132.3] of participants reported experiencing a CAP within one year of their participation in the national survey.", {"entities": []}], ["After adjusting for demographic factors, clinical data, and season, 25(OH)D levels <30 ng/mL were associated with 56% higher odds of CAP [odds ratio 1.56; 95% confidence interval: 1.17\u20132.07] compared to levels \u226530 ng/mL.", {"entities": []}], ["LOWESS analysis revealed a near linear relationship between vitamin D status and the cumulative frequency of CAP up to 25(OH)D levels around 30 ng/mL.", {"entities": []}], ["Among 16,975 participants in NHANES III, 25(OH)D levels were inversely associated with history of CAP.", {"entities": []}], ["Randomized controlled trials are warranted to determine the effect of optimizing vitamin D status on the risk of CAP.", {"entities": []}], ["While many of the commonly used conservative treatments for knee osteoarthritis (OA) have been recognized to be effective, there is still insufficient evidence available.", {"entities": [[65, 79, "DISEASE"]]}], ["Among the pharmacological treatments for knee OA, oral non-steroidal anti-inflammatory drugs (NSAIDs) act rapidly and are recommended for the management of OA.", {"entities": []}], ["However, frequent and serious adverse effects of NSAIDs have been recognized.", {"entities": []}], ["Intra-articular injections of hyaluronic acid (IA-HA) for the treatment of knee OA have been shown to reduce pain and improve joint function.", {"entities": []}], ["However, there has been no qualified direct comparison study of the efficacy and safety between IA-HA and NSAIDs for patients with knee OA.", {"entities": []}], ["The aim of this study was to clarify the efficacy and safety of early-phase IA-HA in comparison to those of NSAIDs for patients with knee OA.", {"entities": []}], ["This multicenter, randomized, open-label, parallel-group, non-inferiority comparison study with an oral NSAID involved a total of 200 patients with knee OA.", {"entities": []}], ["An independent, computer-generated randomization sequence was used to randomly assign patients in a 1:1 ratio to NSAIDs three times per day for five weeks (n\u2009=\u2009100) or IA-HA once a week for five weeks (n\u2009=\u2009100).", {"entities": []}], ["The primary endpoint was the percentage change in the patient-oriented outcome measure for knee OA, the Japanese Knee Osteoarthritis Measure (JKOM) score.", {"entities": [[118, 132, "DISEASE"]]}], ["All patients were questioned regarding any adverse events during treatment.", {"entities": []}], ["The full analysis set (FAS) was used for analysis.", {"entities": [[23, 26, "GENE"]]}], ["The margin of non-inferiority was 10%.", {"entities": []}], ["The analyses of primary endpoint included 98 patients in the IA-HA group and 86 patients in the NSAID group.", {"entities": []}], ["The difference in the percentage changes of the JKOM score between the two intervention arms (IA-HA; -34.7% ( P <0.001), NSAID; -32.2% ( P <0.001)) was -2.5% (95% confidence interval (CI): -14.0 to 9.1), indicating IA-HA was not inferior to NSAID.", {"entities": []}], ["The frequency of both withdrawal and adverse events in the IA-HA group were significantly lower than those in the NSAID group ( P \u2009=\u20090.026 and 0.004, respectively).", {"entities": []}], ["The early efficacy of IA-HA is suggested to be not inferior to that of NSAIDs, and that the safety of the early phase of IA-HA is superior to that of NSAIDs for patients with knee OA.", {"entities": []}], ["UMIN Clinical Trials Registry (UMIN - CTR), UMIN000001026 .", {"entities": []}], ["In recent years, studies have sought to understand the mechanisms involved in the alteration of autophagic flux in Alzheimer's disease (AD).", {"entities": []}], ["Alongside the recent description of the impairment of lysosomal acidification, we wanted to study the relationships between inflammation and autophagy, two physiological components deregulated in AD.", {"entities": []}], ["Therefore, a longitudinal study was performed in APPswePS1dE9 transgenic mice at three, six and twelve months of age.", {"entities": []}], ["Autophagic markers (Beclin-1, p62 and LC3) and the activation of mammalian Target of Rapamycin (mTOR) signaling pathway were quantified by western blot.", {"entities": [[96, 100, "GENE"]]}], ["Cytokine levels (IL-1\u03b2, TNF-\u03b1 and IL-6) were measured by ELISA.", {"entities": []}], ["Transmission electron microscopy was performed to detect autophagic vacuoles.", {"entities": []}], ["Mann-Whitney tests were used to compare wild-type (WT) versus APPswePS1dE9 mice.", {"entities": []}], ["Longitudinal changes in parameters were analyzed with a Kruskal-Wallis test followed by a post-hoc Dunn\u2019s test.", {"entities": []}], ["Correlation between two parameters was assessed using a Spearman test.", {"entities": []}], ["Compared to 12-month old WT mice, 12-month old APPswePS1dE9 mice had higher levels of IL-1\u03b2 and TNF-\u03b1, a greater inhibition of the mTOR signaling pathway and lower levels of Beclin-1 expression both in cortex and hippocampus.", {"entities": [[131, 135, "GENE"]]}], ["Regarding the relationship of the various parameters in 12-month old APPswePS1dE9 mice, Beclin-1 rates were positively correlated with IL-1\u03b2 and TNF-\u03b1 levels.", {"entities": []}], ["And, on the contrary, TNF-\u03b1 levels were inversely correlated with the levels of mTOR activation.", {"entities": [[80, 84, "GENE"]]}], ["Altogether, these results suggest that inflammation could induce autophagy in APPswePS1dE9 mice.", {"entities": []}], ["However, these transgenic mice displayed a large accumulation of autophagic vesicles within dystrophic neurons in cortex and hippocampus, indicating a terminal failure in the autophagic process.", {"entities": []}], ["This first demonstration of relationships between inflammation and autophagy in in vivo models of AD should be taken into account in new therapeutic strategies to prevent inflammation and/or stimulate autophagy in advanced neurodegenerative process such as AD.", {"entities": []}], ["The escalating cost of global health care is driving the development of new technologies to identify early indicators of an individual\u2019s risk of disease.", {"entities": []}], ["Traditionally, epidemiologists have identified such risk factors using medical databases and lengthy clinical studies but these are often limited in size and cost and can fail to take full account of diseases where there are social stigmas or to identify transient acute risk factors.", {"entities": []}], ["Here we report that Web search engine queries coupled with information on Wikipedia access patterns can be used to infer health events associated with an individual user and automatically generate Web-based risk markers for some of the common medical conditions worldwide, from cardiovascular disease to sexually transmitted infections and mental health conditions, as well as pregnancy.", {"entities": []}], ["Using anonymized datasets, we present methods to first distinguish individuals likely to have experienced specific health events, and classify them into distinct categories.", {"entities": []}], ["We then use the self-controlled case series method to find the incidence of health events in risk periods directly following a user\u2019s search for a query category, and compare to the incidence during other periods for the same individuals.", {"entities": []}], ["Searches for pet stores were risk markers for allergy.", {"entities": []}], ["We also identified some possible new risk markers; for example: searching for fast food and theme restaurants was associated with a transient increase in risk of myocardial infarction, suggesting this exposure goes beyond a long-term risk factor but may also act as an acute trigger of myocardial infarction.", {"entities": [[162, 183, "DISEASE"], [286, 307, "DISEASE"]]}], ["Dating and adult content websites were risk markers for sexually transmitted infections, such as human immunodeficiency virus (HIV).", {"entities": []}], ["Web-based methods provide a powerful, low-cost approach to automatically identify risk factors, and support more timely and personalized public health efforts to bring human and economic benefits.", {"entities": []}], ["Regulatory T-cells (Tregs), characterized as CD4+CD25 Cord blood mononuclear cells (CBMC) were isolated from 70 healthy neonates, stimulated for 3 days with the microbial stimulus lipid A (LpA), and allergen Dermatophagoides pteronyssinus (Derp1).", {"entities": [[189, 192, "GENE"]]}], ["Tregs (CD4+CD25 Demethylation of FOXP3 in whole blood was specific for isolated CD4+CD25 FOXP3 demethylation reliable quantifies Tregs in cord blood.", {"entities": [[33, 38, "GENE"], [89, 94, "GENE"], [33, 38, "GENE"], [89, 94, "GENE"]]}], ["FOXP3 demethylation corresponds well with the suppressive potential of Tregs.", {"entities": [[0, 5, "GENE"]]}], ["The resulting strict correlation with functionally suppressive Tregs and the relative ease of measurement render it into a valuable novel marker for large field studies assessing Tregs as qualitative marker indicative of functional activity.", {"entities": []}], ["Toll-like Receptor 3 (TLR3) detects viral dsRNA during viral infection.", {"entities": [[22, 26, "GENE"]]}], ["However, most natural viral dsRNAs are poor activators of TLR3 in cell-based systems, leading us to hypothesize that TLR3 needs additional factors to be activated by viral dsRNAs.", {"entities": [[58, 62, "GENE"], [117, 121, "GENE"], [58, 62, "GENE"], [117, 121, "GENE"]]}], ["The anti-microbial peptide LL37 is the only known human member of the cathelicidin family of anti-microbial peptides.", {"entities": []}], ["LL37 complexes with bacterial lipopolysaccharide (LPS) to prevent activation of TLR4, binds to ssDNA to modulate TLR9 and ssRNA to modulate TLR7 and 8.", {"entities": [[80, 84, "GENE"], [113, 117, "GENE"], [140, 144, "GENE"]]}], ["It synergizes with TLR2/1, TLR3 and TLR5 agonists to increase IL8 and IL6 production.", {"entities": [[27, 31, "GENE"], [36, 40, "GENE"], [62, 65, "GENE"], [70, 73, "GENE"]]}], ["This work seeks to determine whether LL37 enhances viral dsRNA recognition by TLR3.", {"entities": [[78, 82, "GENE"]]}], ["Using a human bronchial epithelial cell line (BEAS2B) and human embryonic kidney cells (HEK 293T) transiently transfected with TLR3, we found that LL37 enhanced poly(I:C)-induced TLR3 signaling and enabled the recognition of viral dsRNAs by TLR3.", {"entities": [[127, 131, "GENE"], [179, 183, "GENE"], [241, 245, "GENE"], [127, 131, "GENE"], [179, 183, "GENE"], [241, 245, "GENE"], [127, 131, "GENE"], [179, 183, "GENE"], [241, 245, "GENE"]]}], ["The presence of LL37 also increased the cytokine response to rhinovirus infection in BEAS2B cells and in activated human peripheral blood mononuclear cells.", {"entities": []}], ["Confocal microscopy determined that LL37 could co-localize with TLR3.", {"entities": [[64, 68, "GENE"]]}], ["Electron microscopy showed that LL37 and poly(I:C) individually formed globular structures, but a complex of the two formed filamentous structures.", {"entities": []}], ["To separate the effects of LL37 on TLR3 and TLR4, other peptides that bind RNA and transport the complex into cells were tested and found to activate TLR3 signaling in response to dsRNAs, but had no effect on TLR4 signaling.", {"entities": [[35, 39, "GENE"], [150, 154, "GENE"], [44, 48, "GENE"], [209, 213, "GENE"], [35, 39, "GENE"], [150, 154, "GENE"], [44, 48, "GENE"], [209, 213, "GENE"]]}], ["This is the first demonstration that LL37 and other RNA-binding peptides with cell penetrating motifs can activate TLR3 signaling and facilitate the recognition of viral ligands.", {"entities": [[115, 119, "GENE"]]}], ["LL37 and several cell-penetrating peptides can enhance signaling by TLR3 and enable TLR3 to respond to viral dsRNA.", {"entities": [[68, 72, "GENE"], [84, 88, "GENE"], [68, 72, "GENE"], [84, 88, "GENE"]]}], ["Antiflammin-2 (AF2) is a nonapeptide corresponding to the amino acid residues 246\u2013254 of lipocortin-1 showing anti-inflammatory activity both in vitro and in vivo.", {"entities": []}], ["The effect of AF2 on the thromboxane B 2 (TXB 2 ) and histamine release from isolated and perfused guinea-pig lungs has been studied.", {"entities": []}], ["AF-2 (10\u2013100 nM) inhibited leukotriene C 4 - (LTC 4 ) (3 ng) and antigen-induced (ovalbumin, 1 mg) TXB 2 release in normal and sensitized lungs, respectively.", {"entities": []}], ["In contrast AF-2 (100 nM) did not modify TXB 2 release induced by histamine (5 \u03bcg) or bradykinin (5 \u03bcg) in normal lungs.", {"entities": []}], ["Antigen-induced histamine release was not affected by 100 nM AF-2 infusion.", {"entities": []}], ["When tested in chopped lung fragments AF-2 (0.1\u201325 \u03bcM) did not modify the release of histamine and TXB 2 induced by antigen (ovalbumin, 10 \u03bcg ml 2 release is selective and depends on the stimulus applied.", {"entities": []}], ["In this respect AF-2 mimics, at least in part, the actions of both glucocorticoids and lipocortin-1.", {"entities": []}], ["The purpose of this study was to develop a transdermal ligustrazine patch containing a stable formulation and with good entrapment efficiency, release rate, and transdermal absorption.", {"entities": []}], ["Ligustrazine ethosomes were prepared by ethanol injection-sonication, with entrapment efficiency as an indicator.", {"entities": []}], ["Using acrylic resin as the primary constituent, the ligustrazine ethosome patch was prepared by adding succinic acid as a crosslinking agent and triethyl citrate as a plasticizer.", {"entities": []}], ["In vitro release and transdermal permeation studies were carried out.", {"entities": []}], ["Finally, a pharmacokinetic study was carried out in rats to explore relative bioavailability.", {"entities": []}], ["The formulations of ligustrazine ethosome were 1% (w/v) phospholipid, 0.4% (w/v) cholesterol, and 45% (v/v) ethanol.", {"entities": []}], ["Ligustrazine ethosomes were obtained with an average particle size of 78.71 \u00b1 1.23 nm and an average entrapment efficiency of 86.42% \u00b1 1.50%.", {"entities": []}], ["In vitro transdermal testing of the ligustrazine ethosome patches showed that the cumulative 24-hour amount of ligustrazine was up to 183 \u00b1 18 \u03bcg/cm Compared with conventional ligustrazine administration, ligustrazine ethosome patches could promote better drug absorption and increase bioavailability.", {"entities": []}], ["This study demonstrates that the transdermal action of the ligustrazine ethosome patch was comparatively good.", {"entities": []}], ["The expression level and clinical significance of NR4A1 are presently unknown in the non-small-cell lung carcinoma (NSCLC).", {"entities": [[105, 114, "DISEASE"], [100, 114, "DISEASE"], [50, 55, "GENE"]]}], ["This study aimed to explore the expression, prognostic value, and function of NR4A1 in NSCLC.", {"entities": [[78, 83, "GENE"]]}], ["Methods: Clinicopathological parameters of 167 NSCLC patients who received radical surgery from January 2007 and December 2012 were retrospectively reviewed.", {"entities": []}], ["The NR4A1 expression in NSCLC tumors and the adjacent matched para-carcinoma specimens were examined, and the association between NR4A1 expression and clinical variables was explored.", {"entities": [[67, 76, "DISEASE"], [4, 9, "GENE"], [130, 135, "GENE"], [4, 9, "GENE"], [130, 135, "GENE"]]}], ["Cell viability assay, and transwell migration and invasion assays were used to access the function of NR4A1 in NSCLC.", {"entities": [[102, 107, "GENE"]]}], ["Kaplan-Meier analysis and Cox regression were performed to investigate the prognostic significance of NR4A1 for NSCLC.", {"entities": [[102, 107, "GENE"]]}], ["Results: NR4A1 was overexpressed in NSCLC tissues compared with the para-carcinoma specimens.", {"entities": [[73, 82, "DISEASE"], [9, 14, "GENE"]]}], ["Consistently, Oncomine analysis showed that NR4A1 was overexpressed in NSCLC tissues compared with normal tissues in published datasets (P < 0.001).", {"entities": [[44, 49, "GENE"]]}], ["The elevated NR4A1 expression was associated with carcinoma recurrence (P < 0.05).", {"entities": [[50, 59, "DISEASE"], [13, 18, "GENE"]]}], ["The 5-year median overall survival (OS) and progression free survival (PFS) were significantly poorer in the NR4A1-overexpression group.", {"entities": []}], ["Multivariate Cox analysis showed that NR4A1 overexpression was an independent factor for OS (HR, 95%CI: P < 0.05) and PFS (HR, 95%CI: P < 0.05) in NSCLC.", {"entities": [[38, 43, "GENE"], [93, 95, "GENE"], [123, 125, "GENE"], [93, 95, "GENE"], [123, 125, "GENE"]]}], ["Moreover, knockdown of NR4A1 significantly reduced NSCLC cell proliferation, migration, and invasion.", {"entities": [[23, 28, "GENE"]]}], ["Conclusions: NR4A1 exhibits a tumor-promoting effect on NSCLC, and might serve as a promising prognostic biomarker and a therapeutic target for NSCLC.", {"entities": [[13, 18, "GENE"]]}], ["Parental smoking is the major source of children\u2019s secondhand smoke exposure and is influenced by parents\u2019 perception of children\u2019s exposure.", {"entities": []}], ["However, the factors associated with these perceptions remain unclear.", {"entities": []}], ["The objective of this study was to examine factors associated with parents\u2019 perceptions about parental smoking in the presence of children and its consequences.", {"entities": []}], ["We conducted a cross-sectional study on parents\u2019 perceptions of parental smoking and measured their evaluations of its consequences using a self-report questionnaire.", {"entities": []}], ["Other variables include socio-demographic characteristics and smoking-related experience.", {"entities": []}], ["Results show that parents\u2019 gender, education level, occupational type, smoking status, and agreement on a home smoking ban independently predict parents\u2019 evaluation of the consequences of parental smoking in the presence of children.", {"entities": []}], ["Parents\u2019 gender, education level, annual family income, smoking status, agreement on a home smoking ban, and evaluation of the consequences of parental smoking independently predicted parents\u2019 perceptions.", {"entities": []}], ["Findings indicated that a specific group expressed greater acceptance of parental smoking and was less aware of its risks.", {"entities": []}], ["Motivating parents to create a smoke-free home and increasing awareness of the adverse consequences of parental smoking is beneficial in reinforcing attitudes opposed to parental smoking.", {"entities": []}], ["Both airflow limitation and obstructive sleep apnea-hypopnea syndrome (OSAHS)-related symptoms are most prevalent in the elderly population.", {"entities": [[61, 69, "DISEASE"]]}], ["Previous studies revealed significant associations between OSAHS-related symptoms and obstructive airway diseases in the general population.", {"entities": []}], ["However, other studies showed that the frequency of OSAHS-related symptoms in patients with obstructive airway diseases decreases after the age of 60 and older.", {"entities": []}], ["To investigate the prevalence of OSAHS-related symptoms (snoring, breathing pauses, and excessive daytime sleepiness [EDS]) and their relations to airflow limitation, for people over 65 years old.", {"entities": []}], ["A full screening spirometry program was performed in a total of 490 aging participants (mean age 77.5 years \u2013 range 65\u201398) who were attending 16 home care settings in central Greece.", {"entities": []}], ["Airflow limitation was assessed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric criteria (FEV 1 /FVC <70%).", {"entities": [[133, 136, "GENE"]]}], ["The Berlin Questionnaire and the Epworth Sleepiness Scale were used to screen individuals for OSAHS-related symptoms.", {"entities": []}], ["Bivariate associations were described using odds ratio (OR) with 95% confidence intervals (CI).", {"entities": []}], ["Airflow limitation prevalence was 17.1% (male 24.2% and female 9.9%) and was strongly related to male gender and smoking status.", {"entities": []}], ["The prevalence rates of frequent snoring, breathing pauses, and EDS were 28.1%, 12.9%, and 11.6%, respectively.", {"entities": []}], ["However, participants with airflow limitation were less likely to report breathing pauses, frequent snoring, EDS, and obesity.", {"entities": [[118, 125, "DISEASE"]]}], ["Finally, frequent snoring was significantly more common in males than females.", {"entities": []}], ["This study revealed decreased frequency of OSAHS-related symptoms in participants with airflow limitation suggesting that OSAHS-related symptoms and airflow limitation are not related in our elderly population.", {"entities": []}], ["The Th2 immune response in chronic schistosomiasis is associated with the development of periportal fibrosis.", {"entities": [[35, 50, "DISEASE"]]}], ["However, little is known about the phenotype and activation status of T cells in the process.", {"entities": []}], ["Objective .", {"entities": []}], ["To evaluate the profile of T cells in schistosomiasis patients with periportal fibrosis.", {"entities": [[38, 53, "DISEASE"]]}], ["It was a cross-sectional study, conducted in the village of Agua Preta, Bahia, Brazil, which included 37 subjects with periportal fibrosis determined by ultrasound.", {"entities": []}], ["Peripheral blood mononuclear cells were obtained by the Ficcol-hypaque gradient and the frequency of T cells expressing the surface markers CD28, CD69, CD25, and CTLA-4 was determined by flow cytometry.", {"entities": [[140, 144, "GENE"], [146, 150, "GENE"]]}], ["The frequency of CD4 Conclusion .", {"entities": [[17, 20, "GENE"]]}], ["The high frequency of activated T cells coinciding with a low frequency of putative Treg cells may account for the development of periportal fibrosis in human schistosomiasis.", {"entities": [[159, 174, "DISEASE"]]}], ["Emergency department (ED) visit and hospital admissions (HA) data have been an indispensible resource for assessing acute morbidity impacts of air pollution.", {"entities": []}], ["ED visits and HAs are types of health care visits with similarities, but also potentially important differences.", {"entities": []}], ["Little previous information is available regarding the impact of health care visit type on observed acute air pollution-health associations from studies conducted for the same location, time period, outcome definitions and model specifications.", {"entities": []}], ["As part of a broader study of air pollution and health in St. Louis, individual-level ED and HA data were obtained for a 6.5\u2009year period for acute care hospitals in the eight Missouri counties of the St. Louis metropolitan area.", {"entities": []}], ["Patient demographic characteristics and diagnostic code distributions were compared for four visit types including ED visits, HAs, HAs that came through the ED, and non-elective HAs.", {"entities": []}], ["Time-series analyses of the relationship between daily ambient ozone and PM 2.5 and selected cardiorespiratory outcomes were conducted for each visit type.", {"entities": []}], ["Our results indicate that, compared with ED patients, HA patients tended to be older, had evidence of greater severity for some outcomes, and had a different mix of specific outcomes.", {"entities": []}], ["Consideration of \u2018HA through ED\u2019 appeared to more effectively select acute visits than consideration of \u2018non-elective HA\u2019.", {"entities": []}], ["While outcomes with the strongest observed temporal associations with air pollutants tended to show strong associations for all visit types, we found some differences in observed associations for ED visits and HAs.", {"entities": []}], ["For example, risk ratios for the respiratory disease-ozone association were 1.020 for ED visits and 1.004 for \u2018HA through ED\u2019; risk ratios for the asthma/wheeze-ozone association were 1.069 for ED visits and 1.106 for \u2018HA through ED\u2019.", {"entities": [[147, 153, "DISEASE"]]}], ["Several factors (e.g.", {"entities": []}], ["age) were identified that may be responsible, in part, for the differences in observed associations.", {"entities": []}], ["Demographic and diagnostic differences between visit types may lead to preference for one visit type over another for some questions and populations.", {"entities": []}], ["The strengths of observed associations with air pollutants sometimes varied between different health care visit types, but the relative strengths of association generally were specific to the pollutant-outcome combination.", {"entities": []}], ["Aims: Neuropeptide substance P (SP) is produced and released by a subset of peripheral sensory neurons that respond to tissue damage (nociceptors).", {"entities": []}], ["SP exerts excitatory effects in the central nervous system, but peripheral SP actions are still poorly understood; therefore, here, we aimed at investigating these peripheral mechanisms.", {"entities": []}], ["Results: SP acutely inhibited T-type voltage-gated Ca V 3.2 channel sensitivity to ambient zinc, as it can be prevented or reversed by zinc chelation and mimicked by exogenous zinc.", {"entities": []}], ["Elimination of the zinc-binding site in Ca V 3.2 rendered the channel insensitive to SP-mediated inhibition.", {"entities": []}], ["Importantly, peripherally applied SP significantly reduced bradykinin-induced nociception in rats in vivo ; knock-down of Ca V 3.2 significantly reduced this anti-nociceptive effect.", {"entities": []}], ["This atypical signaling cascade shared the initial steps with the SP-mediated augmentation of M-type K Innovation: Our study established a mechanism underlying the peripheral anti-nociceptive effect of SP whereby this neuropeptide produces ROS-dependent inhibition of pro-algesic T-type Ca Conclusion: SP modulates T-type channel activity in nociceptors by a redox-dependent tuning of channel sensitivity to zinc; this novel modulatory pathway contributes to the peripheral anti-nociceptive effect of SP.", {"entities": []}], ["Redox Signal .", {"entities": []}], ["25, 233\u2013251.", {"entities": []}], ["Siderophore biosynthesis by the highly lethal mould Aspergillus fumigatus is essential for virulence, but non-existent in humans, presenting a rare opportunity to strategize therapeutically against this pathogen.", {"entities": []}], ["We have previously demonstrated that A. fumigatus excretes fusarinine C and triacetylfusarinine C to capture extracellular iron, and uses ferricrocin for hyphal iron storage.", {"entities": []}], ["Here, we delineate pathways of intra- and extracellular siderophore biosynthesis and show that A. fumigatus synthesizes a developmentally regulated fourth siderophore, termed hydroxyferricrocin, employed for conidial iron storage.", {"entities": []}], ["By inactivation of the nonribosomal peptide synthetase SidC, we demonstrate that the intracellular siderophores are required for germ tube formation, asexual sporulation, resistance to oxidative stress, catalase A activity, and virulence.", {"entities": []}], ["Restoration of the conidial hydroxyferricrocin content partially rescues the virulence of the apathogenic siderophore null mutant \u0394sidA , demonstrating an important role for the conidial siderophore during initiation of infection.", {"entities": []}], ["Abrogation of extracellular siderophore biosynthesis following inactivation of the acyl transferase SidF or the nonribosomal peptide synthetase SidD leads to complete dependence upon reductive iron assimilation for growth under iron-limiting conditions, partial sensitivity to oxidative stress, and significantly reduced virulence, despite normal germ tube formation.", {"entities": []}], ["Our findings reveal distinct cellular and disease-related roles for intra- and extracellular siderophores during mammalian Aspergillus infection.", {"entities": []}], ["Patients with suppressed immune systems due to cancer treatments, HIV/AIDS, organ transplantation, or genetic disorders are at high risk of infection with the ubiquitously present fungal pathogen Aspergillus fumigatus .", {"entities": [[47, 53, "DISEASE"]]}], ["Treatments for this disease, collectively termed invasive aspergillosis, are often not successful, and prospects for survival can be slim.", {"entities": [[58, 71, "DISEASE"], [49, 71, "DISEASE"]]}], ["A. fumigatus produces small molecules, termed siderophores, for acquisition and storage of iron, an element essential for growth.", {"entities": []}], ["We found that these siderophores are crucial for virulence of A. fumigatus because their removal (by gene deletion) prevents or lessens disease in a mouse model of invasive aspergillosis.", {"entities": [[173, 186, "DISEASE"], [164, 186, "DISEASE"]]}], ["Siderophores are not produced by humans so they present good prospects for new therapies, as drugs that specifically target siderophore production, rather than activities shared by humans and fungi, are less likely to affect patients adversely.", {"entities": []}], ["Previous studies have found higher circulating levels of tissue inhibitor of matrix metalloproteinase (TIMP)-1 in nonsurviving septic patients than in surviving septic patients, and an association between the 372 T/C genetic polymorphism of TIMP-1 and the risk of developing certain diseases.", {"entities": []}], ["However, the relationship between genetic polymorphisms of TIMP-1, circulating TIMP-1 levels and survival in patients with severe sepsis has not been examined, and this was the objective of the study.", {"entities": []}], ["This multicentre, prospective, observational study was carried out in six Spanish ICUs.", {"entities": []}], ["We determined the 372 T/C genetic polymorphism of TIMP-1 (rs4898), serum levels of TIMP-1, matrix metalloproteinase (MMP)-9, MMP-10, TNF\u03b1, IL-10 and plasma plasminogen activator inhibitor-1 (PAI-1).", {"entities": []}], ["Survival at 30 days from ICU admission was the endpoint assessed.", {"entities": []}], ["The association between continuous variables was carried out using Spearman's rank correlation coefficient or Spearman's rho coefficient.", {"entities": []}], ["Multivariate logistic regression analysis was applied to determine the association between the 372 T/C genetic polymorphism and survival 30 days from ICU admission.", {"entities": []}], ["Of 275 patients with severe sepsis, 80 had genotype CC, 55 had genotype CT and 140 had genotype TT of the 372 T/C genetic polymorphism of TIMP-1.", {"entities": []}], ["Patients with the T allele showed higher serum levels of TIMP-1 than patients without the T allele ( P = 0.004).", {"entities": []}], ["Multiple logistic regression analysis showed that the T allele was associated with higher mortality at 30 days (odds ratio = 2.08; 95% confidence interval = 1.06 to 4.09; P = 0.03).", {"entities": []}], ["Survival analysis showed that patients with the T allele presented lower 30-day survival than patients without the T allele (\u03c7 P = 0.016).", {"entities": []}], ["We found an association between TIMP-1 levels and levels of MMP-9 (\u03c1 = -0.19; P = 0.002), MMP-10 (\u03c1 = 0.55; P <0.001), TNF\u03b1 (\u03c1 = 0.56; P <0.001), IL-10 (\u03c1 = 0.48; P <0.001) and PAI-1 (\u03c1 = 0.49; P <0.001).", {"entities": []}], ["The novel findings of our study are that septic patients with the T allele in the 372 T/C genetic polymorphism of TIMP-1 showed higher serum TIMP-1 levels and lower survival rate.", {"entities": []}], ["The determination of the 372 T/C genetic polymorphism of TIMP-1 thus has prognostic implications and could help in the selection of patients who may benefit from modulation of the MMP/TIMP balance.", {"entities": []}], ["Biomedical knowledge bases (KB\u2019s) have become important assets in life sciences.", {"entities": []}], ["Prior work on KB construction has three major limitations.", {"entities": []}], ["First, most biomedical KBs are manually built and curated, and cannot keep up with the rate at which new findings are published.", {"entities": []}], ["Second, for automatic information extraction (IE), the text genre of choice has been scientific publications, neglecting sources like health portals and online communities.", {"entities": []}], ["Third, most prior work on IE has focused on the molecular level or chemogenomics only, like protein-protein interactions or gene-drug relationships, or solely address highly specific topics such as drug effects.", {"entities": []}], ["We address these three limitations by a versatile and scalable approach to automatic KB construction.", {"entities": []}], ["Using a small number of seed facts for distant supervision of pattern-based extraction, we harvest a huge number of facts in an automated manner without requiring any explicit training.", {"entities": []}], ["We extend previous techniques for pattern-based IE with confidence statistics, and we combine this recall-oriented stage with logical reasoning for consistency constraint checking to achieve high precision.", {"entities": []}], ["To our knowledge, this is the first method that uses consistency checking for biomedical relations.", {"entities": []}], ["Our approach can be easily extended to incorporate additional relations and constraints.", {"entities": []}], ["We ran extensive experiments not only for scientific publications, but also for encyclopedic health portals and online communities, creating different KB\u2019s based on different configurations.", {"entities": []}], ["We assess the size and quality of each KB, in terms of number of facts and precision.", {"entities": []}], ["The best configured KB, KnowLife, contains more than 500,000 facts at a precision of 93% for 13 relations covering genes, organs, diseases, symptoms, treatments, as well as environmental and lifestyle risk factors.", {"entities": []}], ["KnowLife is a large knowledge base for health and life sciences, automatically constructed from different Web sources.", {"entities": []}], ["As a unique feature, KnowLife is harvested from different text genres such as scientific publications, health portals, and online communities.", {"entities": []}], ["Thus, it has the potential to serve as one-stop portal for a wide range of relations and use cases.", {"entities": []}], ["To showcase the breadth and usefulness, we make the KnowLife KB accessible through the health portal ( http://knowlife.mpi-inf.mpg.de ).", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-015-0549-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Bronchodilators are a central therapy for symptom relief in respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, with inhaled \u03b2 2 -adrenoceptor agonists and anticholinergics being the primary treatments available.", {"entities": [[89, 126, "DISEASE"], [138, 144, "DISEASE"]]}], ["The present studies evaluated the in vivo pharmacology of (R)-6-[[3-[[4-[5-[[2-Hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino]pent-1-ynyl]phenyl]carbamoyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methylquinoline-3-carboxamide (GS-5759), a novel bifunctional compound with both phosphodiesterase 4 (PDE4) inhibitor and long-acting \u03b2 2 -adrenoceptor agonist (LABA) activity, which has been optimized for inhalation delivery.", {"entities": []}], ["GS-5759 dose-dependently inhibited pulmonary neutrophilia in a lipopolysaccharide (LPS) aerosol challenge model of inflammation in rats with an ED 50 \u2264 10 \u03bc g/kg.", {"entities": []}], ["GS-5759 was also a potent bronchodilator with an ED 50 of 0.09 \u03bc g/kg in guinea pigs and 3.4 \u03bc g/kg in dogs after methylcholine (MCh) and ragweed challenges respectively.", {"entities": []}], ["In cynomolgus monkeys, GS-5759 was dosed as a fine-particle dry powder and was efficacious in the same dose range in both MCh and LPS challenge models, with an ED 50 = 70 \u03bc g/kg for bronchodilation and ED 50 = 4.9 \u03bc g/kg for inhibition of LPS-induced pulmonary neutrophilia.", {"entities": []}], ["In models to determine therapeutic index (T.I.", {"entities": []}], ["), efficacy for bronchodilation was evaluated against increased heart rate and GS-5759 had a T.I.", {"entities": []}], ["of 700 in guinea pigs and >31 in dogs.", {"entities": []}], ["In a ferret model of emesis, no emesis was seen at doses several orders of magnitude greater than the ED 50 observed in the rat LPS inflammation model.", {"entities": []}], ["GS-5759 is a bifunctional molecule developed for the treatment of COPD, which has both bronchodilator and anti-inflammatory activity and has the potential for combination as a triple therapy with a second compound, within a single inhalation device.", {"entities": []}], ["The widespread use of dental implants and reconstructive procedures for their positioning has led to an increase in sinonasal complications of dental disease and treatment (SCDDT).", {"entities": []}], ["Diagnosis requires accurate dental and rhinological evaluation, including computed tomography (CT).", {"entities": []}], ["The aim of this study is to investigate a multidisciplinary approach for the treatment of SCDDT by combining endoscopic endonasal surgery (EES) and an intraoral approach on the basis of a preliminary classification system already proposed by other authors.", {"entities": []}], ["Moreover, we analysed the percentage of odontogenic maxillary sinusitis extending to the anterior ethmoidal sinuses and bacteria involved in the pathogenesis of SCDDT.", {"entities": [[52, 71, "DISEASE"], [62, 71, "DISEASE"]]}], ["Between January 2012 and August 2015, in our series of 31 patients, 16/31 patients (51.6%) were treated with EES, 3/31 patients (9.7%) with an intraoral approach and 12/31 patients (38.7%) with a combined approach.", {"entities": []}], ["All patients reported improvement in sinusitis symptoms confirmed by clinical examinations and CT scan.", {"entities": [[37, 46, "DISEASE"]]}], ["No significant complications were recorded and revision surgery was not required.", {"entities": []}], ["Finally, the results of this preliminary study suggest that a multidisciplinary approach to SCDDT from diagnosis to therapy allows more precise diagnosis and comprehensive therapy to achieve a rapid recovery and minimise the risk of recurrence.", {"entities": []}], ["To examine dose\u2013response associations between depressive symptoms and suicide and modification effects of sex, age and health status in older Chinese.", {"entities": []}], ["We used the Chinese version of the 15-item Geriatric Depression Scale (GDS) to measure depressive symptoms (GDS score\u00a0\u2265\u00a08) and Cox regression to examine association with suicide mortality in a population-based cohort of 55,946 individuals, aged 65\u00a0years or above, enrolled from July 1998 to December 2000 at one of 18 Elderly Health Centres of Hong Kong Department of Health.", {"entities": []}], ["The cohort was followed up for suicide mortality till 31 March 2009 (mean follow-up 8.7\u00a0years).", {"entities": []}], ["Depressive symptoms were associated with suicide in men [hazard ratio (HR) 2.03, 95% confidence interval (CI) 0.96\u20134.29] and women (HR\u00a0=\u00a02.36, 95% CI 1.31\u20134.24) after adjusting for age, education, monthly expenditure, smoking, alcohol drinking, physical activity, body mass index, health status, and self-rated health.", {"entities": [[71, 73, "GENE"], [132, 134, "GENE"], [71, 73, "GENE"], [132, 134, "GENE"]]}], ["There was no threshold for GDS score and suicide in either sex.", {"entities": []}], ["Age, sex and health status did not modify the association.", {"entities": []}], ["Depressive symptoms predict higher suicide risk in older Chinese in a dose\u2013response pattern.", {"entities": []}], ["These associations were not attenuated by adjustment for health status, suggesting that depressive symptoms in older people are likely to be an independent causal factor for suicide.", {"entities": []}], ["The GDS score showed no threshold in predicting suicide risk, suggesting that older people with low GDS scores deserve further attention and those with very high scores need urgent intervention.", {"entities": []}], ["We aimed to assess the association between allergic conditions and risk/mortality of colorectal cancer (CRC).", {"entities": [[85, 102, "DISEASE"], [96, 102, "DISEASE"]]}], ["A systematic literature search was conducted using Pubmed and Embase to identify relevant studies.", {"entities": []}], ["Prospective studies assessing the association between allergic conditions and risk/mortality of CRC were included.", {"entities": []}], ["Risk ratios (RRs) were pooled with either a fixed- or a random-effects model according to heterogeneity.", {"entities": []}], ["A total of 515379 participants and 10345 CRC cases from 12 studies were included in the analysis of CRC risk, while four studies with 1484741 individuals and 30040 CRC deaths were included in the analysis of CRC mortality.", {"entities": []}], ["The pooled RR for the association between allergic conditions and CRC risk was 0.88 (95% CI 0.83\u20130.92).", {"entities": []}], ["The inverse association was observed both in colon cancer (pooled RR\u2009=\u20090.83, 95% CI 0.72\u20130.97) and rectal cancer (pooled RR\u2009=\u20090.83, 95% CI 0.74\u20130.93).", {"entities": [[45, 57, "DISEASE"], [51, 57, "DISEASE"], [106, 112, "DISEASE"]]}], ["Moreover, no gender difference was observed in the analysis of CRC risk (for males, pooled RR\u2009=\u20090.88, 95% CI 0.81\u20130.96; for females, pooled RR\u2009=\u20090.88, 95% CI 0.82\u20130.95).", {"entities": []}], ["And allergic conditions were also found to be inversely associated with CRC mortality (pooled RR\u2009=\u20090.88, 95% CI 0.83\u20130.92).", {"entities": []}], ["In conclusion, the current meta-analysis provides further evidence that allergic conditions were inversely associated with CRC risk and mortality.", {"entities": []}], ["Influenza and respiratory syncytial viruses ( RSV ) are important viral pathogens in childhood.", {"entities": [[0, 9, "DISEASE"]]}], ["Our aim was to estimate the effect of influenza and RSV on excess hospitalizations for acute lower respiratory tract infections ( ALRTI ) in children aged \u22645.", {"entities": [[38, 47, "DISEASE"]]}], ["Retrospective, population\u2010based study was performed for five seasons (2006\u20132011).", {"entities": []}], ["Slovenian national hospital discharge data and surveillance data were used to estimate the effect of influenza and/or RSV on ALRTI hospitalizations (acute bronchiolitis, pneumonia, and acute bronchitis) using rate difference method.", {"entities": [[101, 110, "DISEASE"], [170, 179, "DISEASE"], [155, 168, "DISEASE"], [191, 201, "DISEASE"]]}], ["An excess was observed in average weekly ALRTI hospitalizations per 100\u00a0000 among children aged \u22645 in all five seasons during influenza and/or RSV active period.", {"entities": [[126, 135, "DISEASE"]]}], ["During three seasons, there was higher excess in ALRTI hospitalizations in the period when influenza/ RSV cocirculated compared with the RSV period.", {"entities": [[91, 100, "DISEASE"]]}], ["In pandemic season (2009/2010), the only one without influenza/ RSV overlap, excess hospitalization was higher in RSV period.", {"entities": [[53, 62, "DISEASE"]]}], ["The highest excess of hospitalizations was found among the youngest children (0\u20105 months old).", {"entities": []}], ["In all five seasons, acute bronchiolitis was the most common ALRTI recorded in hospitalized young children.", {"entities": [[27, 40, "DISEASE"]]}], ["Respiratory syncytial viruses was leading viral pathogen associated with ALRTI hospitalizations in children aged \u22645.", {"entities": []}], ["The cocirculation of influenza virus increased the burden of ALRTI hospitalizations especially in seasons with A(H3) predominance.", {"entities": [[21, 30, "DISEASE"]]}], ["COPD is a progressive disease, which can take different routes, leading to great heterogeneity.", {"entities": []}], ["The aim of the post-hoc analysis reported here was to perform continuous analyses of advanced lung function measurements, using linear and nonlinear regressions.", {"entities": []}], ["Fifty-one COPD patients with mild to very severe disease (Global Initiative for Chronic Obstructive Lung Disease [GOLD] Stages I\u2013IV) and 41 healthy smokers were investigated post-bronchodilation by flow-volume spirometry, body plethysmography, diffusion capacity testing, and impulse oscillometry.", {"entities": []}], ["The relationship between COPD severity, based on forced expiratory volume in 1 second (FEV 1 ), and different lung function parameters was analyzed by flexible nonparametric method, linear regression, and segmented linear regression with break-points.", {"entities": [[87, 90, "GENE"]]}], ["Most lung function parameters were nonlinear in relation to spirometric severity.", {"entities": []}], ["Parameters related to volume (residual volume, functional residual capacity, total lung capacity, diffusion capacity [diffusion capacity of the lung for carbon monoxide], diffusion capacity of the lung for carbon monoxide/alveolar volume) and reactance (reactance area and reactance at 5Hz) were segmented with break-points at 60%\u201370% of FEV 1 .", {"entities": [[338, 341, "GENE"]]}], ["FEV 1 /forced vital capacity (FVC) and resonance frequency had break-points around 80% of FEV 1 , while many resistance parameters had break-points below 40%.", {"entities": [[0, 3, "GENE"], [90, 93, "GENE"], [0, 3, "GENE"], [90, 93, "GENE"]]}], ["The slopes in percent predicted differed; resistance at 5 Hz minus resistance at 20 Hz had a linear slope change of \u22125.3 per unit FEV 1 , while residual volume had no slope change above and \u22123.3 change per unit FEV 1 below its break-point of 61%.", {"entities": [[130, 133, "GENE"], [211, 214, "GENE"], [130, 133, "GENE"], [211, 214, "GENE"]]}], ["Continuous analyses of different lung function parameters over the spirometric COPD severity range gave valuable information additional to categorical analyses.", {"entities": []}], ["Parameters related to volume, diffusion capacity, and reactance showed break-points around 65% of FEV 1 , indicating that air trapping starts to dominate in moderate COPD (FEV 1 =50%\u201380%).", {"entities": [[98, 101, "GENE"], [172, 175, "GENE"], [98, 101, "GENE"], [172, 175, "GENE"]]}], ["This may have an impact on the patient\u2019s management plan and selection of patients and/or outcomes in clinical research.", {"entities": []}], ["With an increase in the population and industrialization, a lot of valuable natural resources are depleted to prepare and manufacture products.", {"entities": []}], ["However industrialization on the other hand has waste disposal issues, causing dust and environmental pollution.", {"entities": []}], ["In this work, Aluminium Metal Matrix Composite is prepared by reinforcing 10\u2009wt% and 20\u2009wt% of wet grinder stone dust particles an industrial waste obtained during processing of quarry rocks which are available in nature.", {"entities": []}], ["In the composite materials design wear is a very important criterion requiring consideration which ensures the materials reliability in applications where they come in contact with the environment and other surfaces.", {"entities": []}], ["Dry sliding wear test was carried out using pin-on-disc apparatus on the prepared composites.", {"entities": []}], ["The results reveal that increasing the reinforcement content from 10\u2009wt% to 20\u2009wt% increases the resistance to wear rate.", {"entities": []}], ["Activation of peroxisome proliferator-activated receptors (PPAR) \u03b1/\u03b3 is known to inhibit the increases in matrix metalloproteinase (MMP) and reactive oxygen species (ROS) induced by ultraviolet light (UV).", {"entities": []}], ["Extracts of natural herbs, such as Kochia scoparia and Rosa multiflora , have a PPAR \u03b1/\u03b3 dual agonistic effect.", {"entities": []}], ["Therefore, we investigated whether and how they have an antiaging effect on photoaging skin.", {"entities": []}], ["Eighteen-week-old hairless mice were irradiated with UVA 14 J/cm Kochia scoparia and Rosa multiflora (KR) was topically applied on the dorsal skin of photoaging mice twice a day for 8 weeks.", {"entities": []}], ["Tesaglitazar, a known PPAR \u03b1/\u03b3 agonist, and vehicle (propylene glycol:ethanol = 7:3, v / v ) were applied as positive and negative controls, respectively.", {"entities": []}], ["Dermal effects (including dermal thickness, collagen density, dermal expression of procollagen 1 and collagenase 13) and epidermal effects (including skin barrier function, epidermal proliferation, epidermal differentiation, and epidermal cytokines) were measured and compared.", {"entities": []}], ["In photoaging murine skin, KR resulted in a significant recovery of dermal thickness as well as dermal fibroblasts, although it did not change dermal collagen density.", {"entities": []}], ["KR increased the expression of dermal transforming growth factor (TGF)-\u03b2.", {"entities": []}], ["The dermal effects of KR were explained by an increase in procollagen 1 expression, induced by TGF-\u03b2, and a decrease in MMP-13 expression.", {"entities": []}], ["KR did not affect basal transepidermal water loss (TEWL) or stratum corneum (SC) integrity, but did decrease SC hydration.", {"entities": []}], ["It also did not affect epidermal proliferation or epidermal differentiation.", {"entities": []}], ["KR decreased the expression of epidermal interleukin (IL)-1\u03b1.", {"entities": []}], ["Collectively, KR showed possible utility as a therapeutic agent for photoaging skin, with few epidermal side effects such as epidermal hyperplasia or poor differentiation.", {"entities": []}], ["Allergic sensitisation has been ascribed to a dysregulated relationship between allergen-specific Th1, Th2 and regulatory T cells.", {"entities": []}], ["We hypothesised that the relationship between these T cell subsets could be better defined using a short-term allergen stimulation system followed by direct analysis of CD154-positive T cells.", {"entities": []}], ["Using peripheral blood samples from birch pollinosis patients and healthy non-atopic controls, we sought to explore the frequencies and phenotype of birch-stimulated CD154-positive T helper cells following ex vivo birch allergen stimulation.", {"entities": []}], ["Activated CD154-positive Th1, Th2 and Tr1-like cells, that co-expressed IFN\u03b3, IL-4 and IL-10 respectively, were identified in both birch-allergic and non-allergic participants.", {"entities": []}], ["We observed a close correlation between Th1, Th2 and Tr1-like cell frequency in non-allergic volunteers, such that the three parameters increased together to maintain a low Th2: Th1 ratio.", {"entities": []}], ["The relationship between Th1, Th2 and Tr1-like responses was dysregulated in birch-allergic patients, with abrogation of the IL-10 response and a higher Th2: Th1 ratio.", {"entities": []}], ["A close correlation was observed between Th2 cell frequency and the absolute concentration of birch-specific IgE within the birch-allergic group, and we confirmed previous reports of a more differentiated T cell phenotype in allergic subjects.", {"entities": []}], ["The findings demonstrate an important balance between IFN\u03b3, IL-4 and IL-10\u2009T cell responses to birch allergen in health, where Th2 responses to allergens were frequently observed, but apparently balanced by Th1 and regulatory responses.", {"entities": []}], ["The detection of CD154 positive T cells after short-term antigen stimulation may be a useful method for the detection of T cell responses to allergens when cost, speed and convenience are priorities.", {"entities": []}], ["Effects of the World Trade Center (WTC) disaster on children\u2019s respiratory health have not been definitively established.", {"entities": []}], ["This report describes respiratory health findings among children who were < 18 years of age on 11 September 2001 (9/11) and examine associations between disaster-related exposures and respiratory health.", {"entities": []}], ["Children recruited for the WTC Health Registry (WTCHR) included child residents and students (kindergarten through 12th grade) in Manhattan south of Canal Street, children who were south of Chambers Street on 9/11, and adolescent disaster-related workers or volunteers.", {"entities": []}], ["We collected data via computer-assisted telephone interviews in 2003\u20132004, with interview by adult proxy for children still < 18 years of age at that time.", {"entities": []}], ["We compared age-specific asthma prevalence with National Health Interview Survey estimates.", {"entities": [[25, 31, "DISEASE"]]}], ["Among 3,184 children enrolled, 28% were < 5 years of age on 9/11; 34%, 5\u201311 years; and 39%, 12\u201317 years.", {"entities": []}], ["Forty-five percent had a report of dust cloud exposure on 9/11.", {"entities": []}], ["Half (53%) reported at least one new or worsened respiratory symptom, and 5.7% reported new asthma diagnoses.", {"entities": [[92, 98, "DISEASE"]]}], ["Before 9/11, age-specific asthma prevalence in enrolled children was similar to national estimates, but prevalence at interview was elevated among enrollees < 5 years of age.", {"entities": [[26, 32, "DISEASE"]]}], ["Dust cloud exposure was associated with new asthma diagnosis (adjusted odds ratio = 2.3; 95% confidence interval, 1.5\u20133.5).", {"entities": [[44, 50, "DISEASE"]]}], ["Asthma prevalence after 9/11 among WTCHR enrollees < 5 years of age was higher than national estimates, and new asthma diagnosis was associated with dust cloud exposure in all age groups.", {"entities": [[0, 6, "DISEASE"], [112, 118, "DISEASE"]]}], ["We will determine severity of asthma and persistence of other respiratory symptoms on follow-up surveys.", {"entities": [[30, 36, "DISEASE"]]}], ["Epoxyeicotrienoic acids (EETs) are cytochrome P450-dependent anti-hypertensive and anti-inflammatory derivatives of arachidonic acid, which are highly abundant in the kidney and considered reno-protective.", {"entities": []}], ["EETs are degraded by the enzyme soluble epoxide hydrolase (sEH) and sEH inhibitors are considered treatment for chronic renal failure (CRF).", {"entities": []}], ["We determined whether sEH inhibition attenuates the progression of CRF in the 5/6-nephrectomy model (5/6-Nx) in mice.", {"entities": []}], ["5/6-Nx mice were treated with a placebo, an ACE-inhibitor (Ramipril, 40 mg/kg), the sEH-inhibitor cAUCB or the CYP-inhibitor fenbendazole for 8 weeks.", {"entities": []}], ["5/6-Nx induced hypertension, albuminuria, glomerulosclerosis and tubulo-interstitial damage and these effects were attenuated by Ramipril.", {"entities": [[15, 27, "DISEASE"]]}], ["In contrast, cAUCB failed to lower the blood pressure and albuminuria was more severe as compared to placebo.", {"entities": []}], ["Plasma EET-levels were doubled in 5/6 Nx-mice as compared to sham mice receiving placebo.", {"entities": []}], ["Renal sEH expression was attenuated in 5/6-Nx mice but cAUCB in these animals still further increased the EET-level.", {"entities": []}], ["cAUCB also increased 5-HETE and 15-HETE, which derive from peroxidation or lipoxygenases.", {"entities": []}], ["Similar to cAUCB, CYP450 inhibition increased HETEs and promoted albuminuria.", {"entities": []}], ["Thus, sEH-inhibition failed to elicit protective effects in the 5/6-Nx model and showed a tendency to aggravate the disease.", {"entities": []}], ["These effects might be consequence of a shift of arachidonic acid metabolism into the lipoxygenase pathway.", {"entities": []}], ["Dendritic cells can prime na\u00efve CD4 H 2 cell-dependent immunity.", {"entities": [[32, 35, "GENE"]]}], ["We identify basophils as a dominant cell population that coexpressed MHC class II and Il4 message following helminth infection.", {"entities": [[86, 89, "GENE"]]}], ["Basophilia was promoted by thymic stromal lymphopoietin (TSLP) and depletion of basophils impaired immunity to helminth infection.", {"entities": [[57, 61, "GENE"]]}], ["In vitro , basophils promoted antigen-specific CD4 in vivo .", {"entities": [[47, 50, "GENE"]]}], ["Collectively, these studies suggest that MHC class II-dependent interactions between basophils and CD4 H 2 cytokine responses and immunity against helminth infection.", {"entities": [[99, 102, "GENE"]]}], ["We evaluated the association between coding region variants of adrenergic receptor genes and therapeutic effect in patients with congestive heart failure (CHF).", {"entities": [[129, 153, "DISEASE"]]}], ["One hundred patients with stable CHF (left ventricular ejection fraction [LVEF] < 45%) were enrolled.", {"entities": []}], ["Enrolled patients started 1.25 mg bisoprolol treatment once daily, then up-titrated to the maximally tolerable dose, at which they were treated for 1 year.", {"entities": []}], ["Genotypic analysis was carried out, but the results were blinded to the investigators throughout the study period.", {"entities": []}], ["At position 389 of the \u03b2-1 adrenergic receptor gene (ADRB1), the observed minor Gly allele frequency (Gly389Arg + Gly389Gly) was 0.21, and no deviation from Hardy-Weinberg equilibrium was observed in the genotypic distribution of Arg389Gly ( p = 0.75).", {"entities": [[53, 58, "GENE"]]}], ["Heart rate was reduced from 80.8 \u00b1 14.3 to 70.0 \u00b1 15.0 beats per minute ( p < 0.0001).", {"entities": []}], ["There was no significant difference in final heart rate across genotypes.", {"entities": []}], ["However, the Arg389Arg genotype group required significantly more bisoprolol compared to the Gly389X (Gly389Arg + Gly389Gly) group (5.26 \u00b1 2.62 mg vs. 3.96 \u00b1 2.05 mg, p = 0.022).", {"entities": []}], ["There were no significant differences in LVEF changes or remodeling between two groups.", {"entities": []}], ["Also, changes in exercise capacity and brain natriuretic peptide level were not significant.", {"entities": []}], ["However, interestingly, there was a two-fold higher rate of readmission (21.2% vs. 10.0%, p = 0.162) and one CHF-related death in the Arg389Arg group.", {"entities": []}], ["The ADRB1 Gly389X genotype showed greater response to bisoprolol than the Arg389Arg genotype, suggesting the potential of individually tailoring \u03b2-blocker therapy according to genotype.", {"entities": [[4, 9, "GENE"]]}], ["The burden of infection in industrialized countries has prompted considerable effort to improve the outcomes of patients with sepsis.", {"entities": []}], ["This has been formalized through the Surviving Sepsis Campaign 'bundles', derived from the recommendations of 11 professional societies, which have promoted global improvement in those practices whose primary goal it is to reduce sepsis-related death.", {"entities": []}], ["However, difficulties remain in implementing all of the procedures recommended by the experts, despite the apparent pragmatism of those procedures.", {"entities": []}], ["We summarize the main proposals made by the Surviving Sepsis Campaign and focus on the difficulties associated with making a proper diagnosis and supplying adequate treatment promptly to septic patients.", {"entities": []}], ["We assessed the literacy level and readability of online communications about H1N1/09 influenza issued by the Centers for Disease Control and Prevention (CDC) during the first month of outbreak.", {"entities": [[86, 95, "DISEASE"]]}], ["Documents were classified as targeting one of six audiences ranging in technical expertise.", {"entities": []}], ["Flesch-Kincaid (FK) measure assessed literacy level for each group of documents.", {"entities": []}], ["ANOVA models tested for differences in FK scores across target audiences and over time.", {"entities": []}], ["Readability was assessed for documents targeting non-technical audiences using the Suitability Assessment of Materials (SAM).", {"entities": []}], ["Overall, there was a main-effect by audience, F (5, 82)\u200a=\u200a29.72, P<.001, but FK scores did not vary over time, F (2, 82)\u200a=\u200a.34, P>.05.", {"entities": []}], ["A time-by-audience interaction was significant, F (10, 82)\u200a=\u200a2.11, P<.05.", {"entities": []}], ["Documents targeting non-technical audiences were found to be text-heavy and densely-formatted.", {"entities": []}], ["The vocabulary and writing style were found to adequately reflect audience needs.", {"entities": []}], ["The reading level of CDC guidance documents about H1N1/09 influenza varied appropriately according to the intended audience; sub-optimal formatting and layout may have rendered some text difficult to comprehend.", {"entities": [[58, 67, "DISEASE"]]}], ["Regulatory T cells are central actors in the maintenance of tolerance of self-antigens or allergens and in the regulation of the intensity of the immune response during infections by pathogens.", {"entities": []}], ["An understanding of the network of the interaction between regulatory T cells, antigen presenting cells and effector T cells is starting to emerge.", {"entities": []}], ["Dynamical systems analysis can help to understand the dynamical properties of an interaction network and can shed light on the different tasks that can be accomplished by a network.", {"entities": []}], ["We used a mathematical model to describe a interaction network of adaptive regulatory T cells, in which mature precursor T cells may differentiate into either adaptive regulatory T cells or effector T cells, depending on the activation state of the cell by which the antigen was presented.", {"entities": []}], ["Using an equilibrium analysis of the mathematical model we show that, for some parameters, the network has two stable equilibrium states: one in which effector T cells are strongly regulated by regulatory T cells and another in which effector T cells are not regulated because the regulatory T cell population is vanishingly small.", {"entities": []}], ["We then simulate different types of perturbations, such as the introduction of an antigen into a virgin system, and look at the state into which the system falls.", {"entities": []}], ["We find that whether or not the interaction network switches from the regulated (tolerant) state to the unregulated state depends on the strength of the antigenic stimulus and the state from which the network has been perturbed.", {"entities": []}], ["Our findings suggest that the interaction network studied in this paper plays an essential part in generating and maintaining tolerance against allergens and self-antigens.", {"entities": []}], ["G-protein-coupled receptors (GPCRs) are integral membrane proteins that initiate stimulus-dependent activation of cognate heterotrimeric G-proteins, triggering ensuing downstream cellular responses.", {"entities": []}], ["Tight regulation of GPCR-evoked pathways is required because prolonged stimulation can be detrimental to an organism.", {"entities": []}], ["Ste2 , a GPCR in Saccharomyces cerevisiae that mediates response of MAT a haploids to the peptide mating pheromone \u03b1-factor, is down-regulated by both constitutive and agonist-induced endocytosis.", {"entities": []}], ["Efficient agonist-stimulated internalization of Ste2 requires its association with an adaptor protein, the \u03b1-arrestin Rod1 / Art4 , which recruits the HECT-domain ubiquitin ligase Rsp5 , allowing for ubiquitinylation of the C-terminal tail of the receptor and its engagement by the clathrin-dependent endocytic machinery.", {"entities": [[118, 122, "GENE"], [125, 129, "GENE"]]}], ["We previously showed that dephosphorylation of Rod1 by calcineurin (phosphoprotein phosphatase 2B) is required for optimal Rod1 function in Ste2 down-regulation.", {"entities": [[47, 51, "GENE"], [123, 127, "GENE"], [47, 51, "GENE"], [123, 127, "GENE"]]}], ["We show here that negative regulation of Rod1 by phosphorylation is mediated by two distinct stress-activated protein kinases, Snf1 /AMPK and Ypk1 /SGK1, and demonstrate both in vitro and in vivo that this phospho-regulation impedes the ability of Rod1 to promote mating pathway desensitization.", {"entities": [[41, 45, "GENE"], [248, 252, "GENE"], [41, 45, "GENE"], [248, 252, "GENE"]]}], ["These studies also revealed that, in the absence of its phosphorylation, Rod1 can promote adaptation independently of Rsp5 -mediated receptor ubiquitinylation, consistent with recent evidence that \u03b1-arrestins can contribute to cargo recognition by both clathrin-dependent and clathrin-independent mechanisms.", {"entities": [[73, 77, "GENE"]]}], ["However, in cells lacking a component (formin Bni1 ) required for clathrin-independent entry, Rod1 derivatives that are largely unphosphorylated and unable to associate with Rsp5 still promote efficient adaptation, indicating a third mechanism by which this \u03b1-arrestin promotes desensitization of the pheromone-response pathway.", {"entities": [[94, 98, "GENE"]]}], ["Symptom distress in patients toward the end of life can change rapidly.", {"entities": []}], ["Family caregivers have the potential to help patients manage those symptoms, as well as their own stress, if they are equipped with the proper resources.", {"entities": []}], ["Electronic health (eHealth) systems may be able to provide those resources.", {"entities": []}], ["Very sick patients may not be able to use such systems themselves to report their symptoms but family caregivers could.", {"entities": []}], ["The aim of this paper was to assess the effects on cancer patient symptom distress of an eHealth system that alerts clinicians to significant changes in the patient\u2019s symptoms, as reported by a family caregiver.", {"entities": [[51, 57, "DISEASE"]]}], ["A pooled analysis from two randomized clinical trials (NCT00214162 and NCT00365963) compared outcomes at 12 months for two unblinded groups: a control group (Comprehensive Health Enhancement Support System [CHESS]-Only) that gave caregivers access to CHESS, an online support system, and an experimental group (CHESS+CR [Clinician Report]), which also had CHESS but with a CR that automatically alerted clinicians if symptoms exceeded a predetermined threshold of severity.", {"entities": []}], ["Participants were dyads (n=235) of patients with advanced lung, breast, or prostate cancer and their respective family caregivers from 5 oncology clinics in the United States of America.", {"entities": [[84, 90, "DISEASE"], [75, 90, "DISEASE"]]}], ["The proportion of improved patient threshold symptoms was compared between groups using area-under-the-curve analysis and binomial proportion tests.", {"entities": []}], ["The proportion of threshold symptoms out of all reported symptoms was also examined.", {"entities": []}], ["When severe caregiver-reported symptoms were shared with clinicians, the symptoms were more likely to be subsequently reported as improved than when the symptoms were not shared with clinicians ( P <.001).", {"entities": []}], ["Fewer symptom reports were completed in the group of caregivers whose reports went to clinicians than in the CHESS-Only group ( P <.001), perhaps because caregivers, knowing their reports might be sent to a doctor, feared they might be bothering the clinician.", {"entities": []}], ["This study suggests that an eHealth system designed for caregivers that alerts clinicians to worrisome changes in patient health status may lead to reduced patient distress.", {"entities": []}], ["Clinicaltrials.gov NCT00214162; https://clinicaltrials.gov/ct2/show/NCT00214162 (Archived by WebCite at http://www.webcitation.org/6nmgdGfuD) and Clinicaltrials.gov NCT00365963; https://clinicaltrials.gov/ct2/show/NCT00365963 (Archived by WebCite at http://www.webcitation.org/6nmh0U8VP)", {"entities": []}], ["This study aimed to investigate the pulmonary function in patients with inflammatory bowel disease (IBD) and its clinical feature and risk factors.", {"entities": [[72, 98, "DISEASE"]]}], ["One hundred fourteen patients with IBD and 120 healthy subjects were recruited.", {"entities": []}], ["The medical information including general situation, biochemical examinations, lung function, and the treatment was recorded and analyzed.", {"entities": []}], ["In 107 patients (107/114, 93.86%), lung function testing showed the pulmonary ventilation, residual volume, and pulmonary diffusion in IBD patients significantly increased as compared to controls ( P \u200a<\u200a.05).", {"entities": []}], ["No significant differences were observed between ulcerative colitis (UC) patients and Crohn disease (CD) patients ( P \u200a>\u200a.05).", {"entities": [[49, 67, "DISEASE"]]}], ["However, the vital capacity, forced vital capacity, MVV, forced expiratory volume in first second, peak expiratory flow rate, and maximum mid-expiratory flow in IBD patients significantly decreased when compared with controls ( P \u200a<\u200a.01).", {"entities": []}], ["There was no significant correlation between pulmonary function and severity and extent of IBD.", {"entities": []}], ["The chronicity of inflammation might probably reduce the possibility of developing pulmonary dysfunction, while the erythrocyte sedimentation rate (ESR) was found as a harmful factor for developing pulmonary dysfunction.", {"entities": []}], ["The pulmonary function significantly decreases in IBD patients and is characterized by either simple restrictive/obstructive dysfunction or mixed.", {"entities": []}], ["The pulmonary function of IBD patients has no relationship with the severity and extent of IBD.", {"entities": []}], ["IBD combined with pulmonary dysfunction was imperceptible, and clinicians could consider performing pulmonary function testing for IBD patient as many as possible, especially for those who have high level of ESR or any respiratory symptoms like cough, in order to avoid severe pulmonary damage.", {"entities": []}], ["Power and precision are greater in meta-analyses than individual study analyses.", {"entities": []}], ["However, dichotomisation of continuous outcomes in certain studies poses a problem as estimates from primary studies can only be pooled if they have a common outcome.", {"entities": []}], ["Meta-analyses may include pooled summaries of either or both the continuous and dichotomous forms, and potentially have a different combination of studies for each depending on whether the outcome was dichotomised in the primary studies or not.", {"entities": []}], ["This dual-outcome issue can lead to loss of power and/or selection bias.", {"entities": []}], ["In this study we aimed to illustrate how dichotomisation of a continuous outcome in primary studies may result in biased estimates of pooled risk and odds ratios in meta-analysis using secondary analyses of published meta-analyses with the outcome, birthweight, which is commonly analysed both as continuous, and dichotomous (low birthweight: birthweight\u2009<\u20092,500\u00a0g).", {"entities": []}], ["Meta-analyses published in January 2010 - December 2011 were obtained using searches in PubMed, Embase, Web of Science, and Cochrane Database of Systematic Reviews with the outcome birthweight.", {"entities": []}], ["We used a distributional method to estimate the pooled odds/risk ratio of low birthweight and its standard error as a function of the data reported in the primary studies of the included meta-analyses where accessible.", {"entities": []}], ["Seventy-six meta-analyses were identified.", {"entities": []}], ["Thirty-seven percent (28/76) of the meta-analyses reported only the dichotomous form of the outcome while 26% (20/76) reported only the continuous form.", {"entities": []}], ["In one meta-analysis (1/76), birthweight was analysed as continuous for one intervention and as binary for another and 36% (27/76) presented both dichotomous and continuous birthweight summaries.", {"entities": []}], ["In meta-analyses with a continuous outcome, primary studies data were accessible in 39/48 and secondary analyses using the distributional approach provided consistent inferences for both the continuous and distributional estimates in 38/39.", {"entities": []}], ["The distributional method applied in primary studies allows both a continuous and dichotomous outcome to be estimated providing consistent inferences.", {"entities": []}], ["The use of this method in primary studies may restrict selective outcome bias in meta-analyses.", {"entities": []}], ["The objective of this study was to identify the risk factors for ARI in the Australian community.", {"entities": []}], ["We used a national survey of 7578 randomly selected respondents in 2008\u20132009 to identify the risk factors of ARI.", {"entities": []}], ["A case was defined as a person experiencing cold or flu with one or more symptoms of: fever, chills, sore throat, runny nose, or cough in the previous four weeks.", {"entities": []}], ["There were 19.8% (1505/7578) of respondents who reported ARI in the four weeks prior to the survey.", {"entities": []}], ["Age was an independent risk factor for ARI, with the risk of acquiring ARI decreasing as age increased.", {"entities": []}], ["Respondents reporting asthma (OR 1.4, 95%CI: 1.2\u20131.7) or having someone in their house attending childcare (OR 1.6, 95%CI: 1.2\u20132.1) were more likely to report ARI.", {"entities": [[22, 28, "DISEASE"]]}], ["It is important to identify ways of interrupting transmission of ARI amongst children.", {"entities": []}], ["Improving identification of risk factors will enable targeted interventions for this exceedingly common syndrome.", {"entities": [[104, 112, "DISEASE"]]}], ["This phase 3 trial is the first to evaluate the efficacy and safety of treatment with the systemic TNF \u2010\u03b1 inhibitor, adalimumab, for Chinese patients with moderate\u2010to\u2010severe plaque psoriasis.", {"entities": [[181, 190, "DISEASE"], [99, 102, "GENE"]]}], ["In the 12\u2010week, double\u2010blind, placebo\u2010controlled Period A, patients were randomized 4 : 1 to receive adalimumab 40 mg every\u2010other\u2010week (following a single 80 mg dose), or placebo every\u2010other\u2010week.", {"entities": []}], ["In the subsequent 12\u2010week, open\u2010label, Period B, all patients received adalimumab 40 mg every\u2010other\u2010week starting at week 13, following a single, blinded dose at week 12 of adalimumab 80 mg or matching placebo (for patients receiving placebo or adalimumab in Period A respectively).", {"entities": []}], ["In Period A, efficacy was analysed for all randomized patients and safety for all patients receiving \u22651 dose of the study drug.", {"entities": []}], ["For the 425 patients in this study (87 placebo; 338 adalimumab), a higher percentage randomized to adalimumab achieved the primary endpoint of \u226575% improvement from baseline in PASI score ( PASI 75) at week 12: placebo 11.5% (10/87); adalimumab 77.8% (263/338; P < 0.001).", {"entities": []}], ["Physician's Global Assessment of clear to minimal was achieved at week 12 by 14.9% placebo (13/87) and 80.5% adalimumab (272/338; P < 0.001).", {"entities": []}], ["For patients who received adalimumab at any time during the study (All\u2010adalimumab Population), treatment\u2010emergent adverse events ( AE s) were reported by 63.4%; the most common was upper respiratory infection (16.1%).", {"entities": []}], ["Serious AE s were reported by 3.5% of the All\u2010adalimumab Population, and serious infectious AE s by 1.2%, which include lung infection, pneumonia and tuberculosis [2 (0.5%) patients each].", {"entities": [[136, 145, "DISEASE"], [150, 162, "DISEASE"]]}], ["There was one death (chronic heart failure).", {"entities": []}], ["In these Chinese patients with moderate\u2010to\u2010severe psoriasis, a significantly greater percentage treated with adalimumab compared with placebo achieved efficacy endpoints at week 12 and efficacy was sustained to week 24.", {"entities": [[50, 59, "DISEASE"]]}], ["Safety results were consistent with the known adalimumab safety profile; no new safety signals were identified in the 24 weeks of treatment.", {"entities": []}], ["Multiple genes have been implicated by association studies in altering inflammatory bowel disease (IBD) predisposition.", {"entities": [[71, 97, "DISEASE"]]}], ["Paediatric patients often manifest more extensive disease and a particularly severe disease course.", {"entities": []}], ["It is likely that genetic predisposition plays a more substantial role in this group.", {"entities": []}], ["To identify the spectrum of rare and novel variation in known IBD susceptibility genes using exome sequencing analysis in eight individual cases of childhood onset severe disease.", {"entities": []}], ["DNA samples from the eight patients underwent targeted exome capture and sequencing.", {"entities": []}], ["Data were processed through an analytical pipeline to align sequence reads, conduct quality checks, and identify and annotate variants where patient sequence differed from the reference sequence.", {"entities": []}], ["For each patient, the entire complement of rare variation within strongly associated candidate genes was catalogued.", {"entities": []}], ["Across the panel of 169 known IBD susceptibility genes, approximately 300 variants in 104 genes were found.", {"entities": []}], ["Excluding splicing and HLA -class variants, 58 variants across 39 of these genes were classified as rare, with an alternative allele frequency of <5%, of which 17 were novel.", {"entities": [[23, 26, "GENE"]]}], ["Only two patients with early onset Crohn's disease exhibited rare deleterious variations within NOD2 : the previously described R702W variant was the sole NOD2 variant in one patient, while the second patient also carried the L1007 frameshift insertion.", {"entities": [[96, 100, "GENE"], [155, 159, "GENE"], [96, 100, "GENE"], [155, 159, "GENE"]]}], ["Both patients harboured other potentially damaging mutations in the GSDMB , ERAP2 and SEC16A genes.", {"entities": [[68, 73, "GENE"], [76, 81, "GENE"], [86, 92, "GENE"]]}], ["The two patients severely affected with ulcerative colitis exhibited a distinct profile: both carried potentially detrimental variation in the BACH2 and IL10 genes not seen in other patients.", {"entities": [[40, 58, "DISEASE"], [143, 148, "GENE"], [153, 157, "GENE"]]}], ["For each of the eight individuals studied, all non-synonymous, truncating and frameshift mutations across all known IBD genes were identified.", {"entities": []}], ["A unique profile of rare and potentially damaging variants was evident for each patient with this complex disease.", {"entities": []}], ["We aimed at estimating the prevalence and at identifying the frequent comorbidities of diabetes mellitus in a region of northeastern I taly from administrative health data.", {"entities": [[87, 104, "DISEASE"]]}], ["The prevalence was estimated according to two disease definitions, based on administrative health data.", {"entities": []}], ["Association rule mining was used to detect comorbid diagnoses that coexisted with a diagnosis of diabetes among patients admitted to the regional hospitals.", {"entities": []}], ["The prevalence of known diabetes in 2010 was 6.0\u20138.1%, with great variations by age class (from approximately 2% <60\u00a0years to more than 20% in some elderly age groups).", {"entities": []}], ["Of 155,494 patients admitted to the hospital in 2011, 9,358 had a diagnosis of diabetes.", {"entities": []}], ["A total of 12 rules satisfied our criteria for support (>0.5%) and confidence (>5%), and identified nine frequent isolated comorbidities and three pairs of comorbid diagnoses.", {"entities": []}], ["The rule with the highest support (2.4%) and confidence (39.5%) identified the combination of diabetes and essential hypertension.", {"entities": [[117, 129, "DISEASE"], [107, 129, "DISEASE"]]}], ["Association rule mining was useful, because it showed the complexity of diabetic patients.", {"entities": []}], ["Clinical management of those patients cannot neglect comorbidities.", {"entities": []}], ["When a medicine such as rofecoxib (Vioxx) is withdrawn, or a whole class of medicines discredited such as the selective COX-2 inhibitors (COX-2s), follow-up of impacts at consumer level can be difficult and costly.", {"entities": []}], ["The Australian Longitudinal Study on Women's Health provides a rare opportunity to examine individual consumer medicine use following a major discrediting event, the withdrawal of rofecoxib and issuing of safety warnings on the COX-2 class of medicines.", {"entities": []}], ["The overall objective of this paper was to examine the impact of this discrediting event on dispensing of the COX-2 class of medicines, by describing medicine switching behaviours of older Australian women using rofecoxib in September 2004; the uptake of other COX-2s; and the characteristics of women who continued using a COX-2.", {"entities": []}], ["Participants were concessional beneficiary status women from the Older cohort (born 1921-26) of the Australian Longitudinal Study on Women's Health who consented to linkage to Pharmaceutical Benefits Scheme data, with at least one rofecoxib prescription dispensed in the 12 months before rofecoxib withdrawal.", {"entities": []}], ["A prescription was defined as one dispensing occasion.", {"entities": []}], ["Women were grouped by rofecoxib pattern of use: continuous (nine or more prescriptions dispensed in the 12 months prior to rofecoxib withdrawal) or non-continuous (eight or less prescriptions dispensed in the 12 months prior to rofecoxib withdrawal) users.", {"entities": []}], ["Incidence rate per 100,000 person days and incidence risk ratio described uptake of alternate medicines, following rofecoxib withdrawal.", {"entities": []}], ["Kaplan-Meier curves described differences in uptake patterns by medicine and pattern of rofecoxib use.", {"entities": []}], ["Patterns of use of COX-2s in the next 100 days after first COX-2 uptake were described.", {"entities": []}], ["Medicine switches and pattern of medicines uptake differed significantly depending upon whether a woman was a continuous or non-continuous rofecoxib user prior to rofecoxib discrediting.", {"entities": []}], ["Continuous rofecoxib users overwhelmingly switched to another COX-2 and remained continuing COX-2 users for at least 100 days post-switch.", {"entities": []}], ["The typical switching behaviour of this group of women suggests that the issues leading to the discrediting of rofecoxib were not seen as a COX-2 class effect by prescribers to this high use group of consumers.", {"entities": []}], ["The current review article is an attempt to explain the therapeutic potential of mangiferin, a bioactive compound of the mango, against lifestyle-related disorders.", {"entities": []}], ["Mangiferin (2-\u03b2-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one) can be isolated from higher plants as well as the mango fruit and their byproducts (i.e.", {"entities": []}], ["peel, seed, and kernel).", {"entities": []}], ["It possesses several health endorsing properties such as antioxidant, antimicrobial, antidiabetic, antiallergic, anticancer, hypocholesterolemic, and immunomodulatory.", {"entities": []}], ["It suppresses the activation of peroxisome proliferator activated receptor isoforms by changing the transcription process.", {"entities": []}], ["Mangiferin protects against different human cancers, including lung, colon, breast, and neuronal cancers, through the suppression of tumor necrosis factor \u03b1 expression, inducible nitric oxide synthase potential, and proliferation and induction of apoptosis.", {"entities": []}], ["It also protects against neural and breast cancers by suppressing the expression of matrix metalloproteinase (MMP)-9 and MMP-7 and inhibiting enzymatic activity, metastatic potential, and activation of the \u03b2-catenin pathway.", {"entities": []}], ["It has the capacity to block lipid peroxidation, in order to provide a shielding effect against physiological threats.", {"entities": []}], ["Additionally, mangiferin enhances the capacity of the monocyte-macrophage system and possesses antibacterial activity against gram-positive and gram-negative bacteria.", {"entities": []}], ["This review summarizes the literature pertaining to mangiferin and its associated health claims.", {"entities": []}], ["Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects multiple organs, including the lungs, pancreas, liver and intestine.", {"entities": [[0, 15, "DISEASE"], [47, 63, "DISEASE"]]}], ["Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) locus lead to defective proteins and reduced Cl In this study, our aims were to detect and quantitate Resolvin D1 (RvD1) in sputum and plasma from patients with CF and compare levels of RvD1 with biomarkers of inflammation and lung function.", {"entities": [[17, 32, "DISEASE"], [70, 74, "GENE"]]}], ["We studied 27 CF patients aged 6 to 55 years (median 16 years) in a prospective approach.", {"entities": []}], ["DHA can be found in the plasma of our CF patients in the milligram range and is decreased in comparison to a healthy control group.", {"entities": []}], ["The DHA-derived pro-resolving mediator Resolvin D1 (RvD1) was also present in the plasma (286.4 \u00b1 50 pg/ mL, mean \u00b1 SEM) and sputum (30.0 \u00b1 2.6 pg/ mL, mean \u00b1 SEM) samples from our patients with CF and showed a positive correlation with sputum inflammatory markers.", {"entities": []}], ["The plasma concentrations of RvD1 were ten times higher than sputum concentrations.", {"entities": []}], ["Interestingly, sputum RvD1/ IL-8 levels showed a positive correlation with FEV 1 (r s = 0.3962, p< 0.05).", {"entities": [[75, 78, "GENE"]]}], ["SPMs, like RvD1, are well known to down-regulate inflammatory pathways.", {"entities": []}], ["Our study shows that the bioactive lipid mediator RvD1, derived from DHA, was present in sputum and plasma of CF patients and may serve as a representative peripheral biomarker of the lung resolution program for CF patients.", {"entities": []}], ["Forecasting bifurcations such as critical transitions is an active research area of relevance to the management and preservation of ecological systems.", {"entities": []}], ["In particular, anticipating the distance to critical transitions remains a challenge, together with predicting the state of the system after these transitions are breached.", {"entities": []}], ["In this work, a new model-less method is presented that addresses both these issues based on monitoring recoveries from large perturbations.", {"entities": []}], ["The approach uses data from recoveries of the system from at least two separate parameter values before the critical point, to predict both the bifurcation and the post-bifurcation dynamics.", {"entities": []}], ["The proposed method is demonstrated, and its performance evaluated under different levels of measurement noise, with two ecological models that have been used extensively in previous studies of tipping points and alternative steady states.", {"entities": []}], ["The first one considers the dynamics of vegetation under grazing; the second, those of macrophyte and phytoplankton in shallow lakes.", {"entities": []}], ["Applications of the method to more complex situations are discussed together with the kinds of empirical data needed for its implementation.", {"entities": []}], ["Asthma is a common chronic disease with several variant phenotypes and endotypes.", {"entities": [[0, 6, "DISEASE"]]}], ["NSAID-exacerbated respiratory disease (NERD) is one such endotype characterized by asthma, chronic rhinosinusitis (CRS) with nasal polyps, and hypersensitivity to aspirin/cyclooxygenase-1 inhibitors.", {"entities": [[83, 89, "DISEASE"]]}], ["NERD is more associated with severe asthma than other asthma phenotypes.", {"entities": [[36, 42, "DISEASE"], [54, 60, "DISEASE"]]}], ["Regarding diagnosis, aspirin challenge tests via the oral or bronchial route are a standard diagnostic method; reliable in vitro diagnostic tests are not available.", {"entities": []}], ["Recent studies have reported various biomarkers of phenotype, diagnosis, and prognosis.", {"entities": []}], ["In this review, we summarized the known potential biomarkers of NERD that are distinct from those of aspirin-tolerant asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["We also provided an overview of the different NERD subgroups.", {"entities": []}], ["The IL-1 family cytokine IL-33 is involved in the induction of airway inflammation in allergic patients and after viral infection.", {"entities": []}], ["Several cell types, including CD4 H 2 cells and the recently described type 2 innate lymphoid cells (ILCs), are targets for IL-33, yet the mechanisms by which this cytokine modulates their activation are not clear.", {"entities": [[30, 33, "GENE"]]}], ["Our goal was to investigate a role for mammalian target of rapamycin (mTOR) signaling in the activation of T H 2 and ILC responses and the induction of airway inflammation by IL-33.", {"entities": [[70, 74, "GENE"]]}], ["We biochemically determined the effect of IL-33 on mTOR activation in T H 2 cells and ILCs and examined the effect\u00a0of this signaling pathway in\u00a0vivo using a murine model of IL-33\u2013induced lung inflammation.", {"entities": [[51, 55, "GENE"]]}], ["We found that IL-33 induces mTOR activation through p110\u03b4 phosphoinositide 3-kinase and that blockade of the mTOR pathway inhibited IL-33\u2013induced IL-5 and IL-13 production by T H 2 cells and ILCs.", {"entities": [[28, 32, "GENE"], [109, 113, "GENE"], [28, 32, "GENE"], [109, 113, "GENE"]]}], ["Furthermore, use of a ribosomal protein S6 kinase 1 inhibitor implicated a role for ribosomal protein S6 kinase 1 in IL-33\u2013induced mTOR-dependent cytokine production.", {"entities": []}], ["Intranasal administration of IL-33 to wild-type mice induced airway inflammation, whereas adoptive transfer of wild-type ILCs to IL-33 receptor\u2013deficient (St2 ) mice recapitulated this response.", {"entities": []}], ["Importantly, coadministration of the mTOR inhibitor rapamycin reduced IL-33\u2013dependent ILC, macrophage, and eosinophil accumulation; cytokine secretion; and mucus deposition in the airways.", {"entities": [[37, 41, "GENE"]]}], ["These data reveal a hitherto unrecognized role of mTOR signaling in IL-33\u2013driven, ILC-dependent inflammation in\u00a0vivo and suggest that manipulation of this pathway might represent a target for therapeutic intervention for airway inflammation.", {"entities": [[50, 54, "GENE"]]}], ["The aim of this study was to review original scientific articles describing the relationship between atmospheric pollution and damage to human health.", {"entities": []}], ["We also aimed to determine which of these studies mentioned public policy issues.", {"entities": []}], ["Original articles relating to atmospheric pollution and human health published between 1995 and 2009 were retrieved from the PubMed database and analyzed.", {"entities": []}], ["This study included only articles dealing with atmospheric pollutants resulting primarily from vehicle emissions.", {"entities": []}], ["Three researchers were involved in the final selection of the studies, and the chosen articles were approved by at least two of the three researchers.", {"entities": []}], ["Of the 84 non-Brazilian studies analyzed, 80 showed an association between atmospheric pollution and adverse effects on human health.", {"entities": []}], ["Moreover, 66 showed evidence of adverse effects on human health, even at levels below the permitted emission standards.", {"entities": []}], ["Three studies mentioned public policies aimed at changing emission standards.", {"entities": []}], ["Similarly, the 29 selected Brazilian studies reported adverse associations with human health, and 27 showed evidence of adverse effects even at levels below the legally permitted emission standards.", {"entities": []}], ["Of these studies, 16 mentioned public policies aimed at changing emission standards.", {"entities": []}], ["Based on the Brazilian and non-Brazilian scientific studies that have been conducted, it can be concluded that, even under conditions that are compliant with Brazilian air quality standards, the concentration of atmospheric pollutants in Brazil can negatively affect human health.", {"entities": []}], ["However, as little discussion of this topic has been generated, this finding demonstrates the need to incorporate epidemiological evidence into decisions regarding legal regulations and to discuss the public policy implications in epidemiological studies.", {"entities": []}], ["Cytokine expression was assessed during antigen-induced arthritis (AIA) in synovial membrane (SM), inguinal lymph node (LN), and spleen using competitive RT-PCR and sandwich ELISA.", {"entities": [[56, 65, "DISEASE"]]}], ["In the SM, early elevations of IL-1\u03b2 and IL-6 mRNA (by 6 hours; 450- and 200-fold, respectively) correlated with the joint swelling; a 6-fold increase in tumor necrosis factor \u03b1 (TNF\u03b1) was not significant.", {"entities": []}], ["Not only IL-2 and IFN-\u03b3 (which increased 10,000-fold and 200-fold, respectively), but also IL-5 and IL-10, increased acutely (6 hours \u2013 day 1; 3-fold and 35-fold, respectively) in the SM.", {"entities": []}], ["In general, the protein levels in the SM for IL-1\u03b2, IL-6, TNF\u03b1, IFN-\u03b3, IL-4, and IL-10 (increase from 4-fold to 15-fold) matched the course of mRNA expression.", {"entities": []}], ["In the inguinal LN, there were early mRNA elevations of IL-6 (a 2.5-fold increase by 6 hours, which correlated positively with the joint swelling) and IL-2 (4-fold by 6 hours), as well as later rises of IL-4 and IL-5 (2.5- and 4-fold, respectively, by day 3).", {"entities": []}], ["No significant elevations of the corresponding proteins in this tissue were observed, except for IL-1\u03b2 (by day 6) and IL-10 (by day 1).", {"entities": []}], ["In the spleen, there were significant mRNA elevations at 6 hours of IL-1\u03b2 (1.5-fold), IL-6 (4-fold; positively correlated with the joint swelling), IFN-\u03b3 (3-fold), and IL-2 (7- to 10-fold).", {"entities": []}], ["IL-5 and IL-10 (2- and 3-fold, respectively) peaked from 6 hours to day 3 in the spleen.", {"entities": []}], ["Increases of the corresponding proteins were significant in comparison with day 0 only in the case of IL-2 (day 6).", {"entities": []}], ["By day 6 (transition to the chronic phase), the mRNA for cytokines declined to or below prearthritis levels in all the tissues studied except for IL-1\u03b2 in the SM and IL-6 in the spleen.", {"entities": []}], ["AIA is thus characterized by four phenomena: early synovial activation of macrophages, T helper (Th)1-like, and Th2-like cells; late, well-segregated Th2-like responses in the inguinal LN; late, overlapping Th1-like/Th2-like peaks in the spleen; and chronic elevation of synovial IL-1\u03b2 mRNA and spleen IL-6 mRNA.", {"entities": []}], ["The objective of this article is to illustrate the usefulness of Medical Expenditure Panel Survey (MEPS) data for examining variations in medical expenditures for people with multiple chronic conditions (MCC).", {"entities": [[204, 207, "GENE"]]}], ["We analyzed 2009 MEPS data to produce estimates of treated prevalence for MCC and associated medical expenditures for adults in the US civilian noninstitutionalized population (sample = 24,870).", {"entities": [[74, 77, "GENE"]]}], ["We also identified the most common dyad and triad combinations of treated conditions.", {"entities": []}], ["Approximately one-quarter of civilian US adults were treated for MCCs in 2009; 18.3% were treated for 2 to 3 conditions and 7% were treated for 4 or more conditions.", {"entities": []}], ["The proportion of adults treated for MCC increased with age.", {"entities": [[37, 40, "GENE"]]}], ["White non-Hispanic adults were most likely and Hispanic and Asian adults were least likely to be treated for MCC.", {"entities": [[109, 112, "GENE"]]}], ["Health care expenditures increased as the number of chronic conditions treated increased.", {"entities": []}], ["Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated for MCC; diabetes in conjunction with these 2 conditions was a common triad.", {"entities": [[26, 38, "DISEASE"], [108, 111, "GENE"]]}], ["MEPS has the capacity to produce national estimates of health care expenditures associated with MCC.", {"entities": [[96, 99, "GENE"]]}], ["MEPS data in conjunction with data from other US Department of Health and Human Services sources provide information that can inform policies addressing the complex issue of MCC.", {"entities": [[174, 177, "GENE"]]}], ["Atopic dermatitis (AD) is a common, chronic childhood skin disorder caused by complex genetic, immunological, and environmental interactions.", {"entities": [[7, 17, "DISEASE"]]}], ["It significantly impairs quality of life for both child and family.", {"entities": []}], ["Treatment is complex and must be tailored to the individual taking into account personal, social, and emotional factors, as well as disease severity.", {"entities": []}], ["This review covers the management of AD in children with topical treatments, focusing on: education and empowerment of patients and caregivers, avoidance of trigger factors, repair and maintenance of the skin barrier by correct use of emollients, control of inflammation with topical corticosteroids and calcineurin inhibitors, minimizing infection, and the use of bandages and body suits.", {"entities": []}], ["Allergic conjunctivitis (AC) may follow seasonal or perennial pattern.", {"entities": [[9, 23, "DISEASE"]]}], ["There are climatic and racial risk factors involved in some types of AC.", {"entities": []}], ["It is more prevalent in warm climatic conditions and among Afro-Caribbeans, Arabs and Asians and less among the White populations.", {"entities": []}], ["Clinical presentations also seem to follow climatic and genetic predisposition.", {"entities": []}], ["The purpose of this study is to determine the prevalence of AC and its clinical presentations in a hospital setting in this region in people of all ages.", {"entities": []}], ["This is a hospital-based retrospective study of new patients seen at Adoose Specialist Hospital, Jos the capital city of Plateau State in North Central Nigeria with clinical diagnosis of AC from 2000 to 2009.", {"entities": []}], ["There were 972 subjects, 474 (48.8%) males and 498 (51.2%) females with M:F ratio of 1:1.05.", {"entities": []}], ["The most common symptom was itching followed by redness, pains, watery/mucoid discharge, sticky eyes, puffy eyes and photophobia.", {"entities": []}], ["The presence of papillae in the upper tarsal or lower conjunctiva, a discrete or confluent gelatinous hypertrophy of the limbal conjunctiva (Trantas dots), hyperpigmentation, hyperemia/chemosis of the conjunctiva were the common signs.", {"entities": []}], ["AC was more prevalent in those aged 1\u221216 years 38.4% decreasing to 4.9% in the age group above 50 years.", {"entities": []}], ["The presentation followed perennial pattern, with a peak around July.", {"entities": []}], ["The most prevalent ocular comorbid condition was refractive error (distant RE and presbyopia) in 15.4%, followed by pterygium/pinguecula 3.6%, bacterial conjunctivitis in 2.2%, glaucoma 2.1% and eyelid disorders 1.7%.", {"entities": [[82, 92, "DISEASE"], [177, 185, "DISEASE"], [126, 136, "DISEASE"], [143, 167, "DISEASE"], [49, 65, "DISEASE"], [153, 167, "DISEASE"], [116, 125, "DISEASE"]]}], ["Cataract was present in 1.3%, and keratopathy 1.1%.", {"entities": [[34, 45, "DISEASE"]]}], ["Other conditions such as episcleritis, dry eye, vitamin A deficiency and posterior segment disease were also present in decreasing order.", {"entities": []}], ["Systemic association were few with generalised body atopy in 0.3%.", {"entities": []}], ["The prevalence of AC was 32% and is similar to what pertains in some of the African hospital studies, but differs in presentation from the Caucasians.", {"entities": []}], ["Athletes in Malaysia need to perform in a hot and humid environment due to the climatic nature of the country.", {"entities": []}], ["c0 hronic supplementation of Panax ginseng (PG) (a deciduous perennial plant belonging to the Araliaceae family) enhances physical performance.", {"entities": []}], ["As the ergogenic effect of acute supplementation of PG on endurance performance has not been explored in the Malaysian population especially in a hot and humid condition this study was taken up.", {"entities": []}], ["Nine heat adapted recreational runners (age : 25.4 \u00b1 6.9 yr, body mass : 57.6 \u00b1 8.4 kg; body height : 168.3 \u00b1 7.6 cm) were recruited in this placebo-controlled double-blind randomized study.", {"entities": []}], ["Subjects ingested 200 mg of PG one hour before the exercise test on treadmill at 70 per cent of their VO 2max in a laboratory environment of 31 \u00b0C and 70 per cent relative humidity.", {"entities": []}], ["They drank 3 ml/kg body weight of cool water every 20 min during the exercise to prevent adverse effects of dehydration.", {"entities": []}], ["Blood samples were drawn every 20 min for the analysis of glucose, lactate, insulin and free fatty acids.", {"entities": []}], ["Oxygen uptake was determined every 20 min while heart rate, body and skin temperatures, and ratings of perceived exertion (RPE) were recorded every 10 min during the trials.", {"entities": [[123, 126, "GENE"]]}], ["Endurance running time to exhaustion did not differ between PG and placebo trials.", {"entities": []}], ["Heart rate, skin temperature, core body temperature, oxygen uptake, RPE, plasma insulin, glucose, free fatty acid and lactate levels during the endurance exercise did not show any significant differences between the trials.", {"entities": [[68, 71, "GENE"]]}], ["We conclude that acute supplementation of 200 mg of PG did not affect the endurance running performance of the heat-adapted male recreational runners in the heat.", {"entities": []}], ["Traditional Ecological Knowledge (TEK) is a term, relatively new to Western science, that encompasses a subset of traditional knowledge maintained by Indigenous nations about the relationships between people and the natural environment.", {"entities": [[34, 37, "GENE"]]}], ["The term was first shared by tribal elders in the 1980s to help raise awareness of the importance of TEK.", {"entities": [[101, 104, "GENE"]]}], ["TEK has become a construct that Western scientists have increasingly considered for conducting culturally relevant research with Tribal nations.", {"entities": [[0, 3, "GENE"]]}], ["The authors aim to position TEK in relation to other emerging schools of thought, that is, concepts such as the exposome, social determinants of health (SDoH), and citizen science, and to explore TEK\u2019s relevance to environmental health research.", {"entities": [[28, 31, "GENE"], [196, 199, "GENE"], [28, 31, "GENE"], [196, 199, "GENE"]]}], ["This article provides examples of successful application of TEK principles in federally funded research when implemented with respect for the underlying cultural context and in partnership with Indigenous communities.", {"entities": [[60, 63, "GENE"]]}], ["Rather than treating TEK as an adjunct or element to be quantified or incorporated into Western scientific studies, TEK can instead ground our understanding of the environmental, social, and biomedical determinants of health and improve our understanding of health and disease.", {"entities": [[21, 24, "GENE"], [116, 119, "GENE"], [21, 24, "GENE"], [116, 119, "GENE"]]}], ["This article provides historical and recent examples of how TEK has informed Western scientific research.", {"entities": [[60, 63, "GENE"]]}], ["This article provides recommendations for researchers and federal funders to ensure respect for the contributions of TEK to research and to ensure equity and self-determination for Tribal nations who participate in research.", {"entities": [[117, 120, "GENE"]]}], ["https://doi.org/10.1289/EHP858", {"entities": []}], ["Public health research involving social or kin groups (such as sexual partners or family members), rather than samples of unrelated individuals, has become more widespread in response to social ecological approaches to disease treatment and prevention.", {"entities": []}], ["This approach requires the development of innovative sampling, recruitment and screening methodologies tailored to the study of related individuals.", {"entities": []}], ["In this paper, we describe a set of sampling, recruitment and screening protocols developed to enlist urban, drug-using, heterosexual couples into a public health research study.", {"entities": []}], ["This population is especially hard to reach because they are engaged in illegal and/or stigmatized behaviors.", {"entities": []}], ["The protocols were designed to integrate adaptive sampling, street- and referral-based recruitment, and screening procedures to verify study eligibility and relationship status.", {"entities": []}], ["Recruitment of heterosexual couples through one partner, preferably the female, can be an effective enlistment technique.", {"entities": []}], ["Verification of relationship status is an important component of dyadic research.", {"entities": []}], ["Comparison of parallel questionnaires administered to each member of a dyad can aid in the assessment of relationship status.", {"entities": []}], ["However, multiple independent sources of information should be used to verify relationship status when available.", {"entities": []}], ["Adaptive sampling techniques were effective in reaching drug-using heterosexual couples in an urban setting, and the application of these methods to other groups of related individuals in clinical and public health research may prove to be useful.", {"entities": []}], ["However, care must be taken to consider potential sources of sampling bias when interpreting and generalizing study results.", {"entities": []}], ["Studies have indicated that altered maternal micronutrients and vitamins influence the development of newborns and altered nutrient exposure throughout the lifetime may have potential health effects and increased susceptibility to chronic diseases.", {"entities": []}], ["In recent years, folic acid (FA) exposure has significantly increased as a result of mandatory FA fortification and supplementation during pregnancy.", {"entities": []}], ["Since FA modulates DNA methylation and affects gene expression, we investigated whether the amount of FA ingested during gestation alters gene expression in the newborn cerebral hemisphere, and if the increased exposure to FA during gestation and throughout the lifetime alters behavior in C57BL/6J mice.", {"entities": []}], ["Dams were fed FA either at 0.4 mg or 4 mg/kg diet throughout the pregnancy and the resulting pups were maintained on the diet throughout experimentation.", {"entities": []}], ["Newborn pups brain cerebral hemispheres were used for microarray analysis.", {"entities": []}], ["To confirm alteration of several genes, quantitative RT-PCR (qRT-PCR) and Western blot analyses were performed.", {"entities": []}], ["In addition, various behavior assessments were conducted on neonatal and adult offspring.", {"entities": []}], ["Results from microarray analysis suggest that the higher dose of FA supplementation during gestation alters the expression of a number of genes in the newborns\u2019 cerebral hemispheres, including many involved in development.", {"entities": []}], ["QRT-PCR confirmed alterations of nine genes including down-regulation of Cpn2 , Htr4 , Zfp353 , Vgll2 and up-regulation of Xist , Nkx6-3 , Leprel1 , Nfix, Slc17a7 .", {"entities": [[80, 84, "GENE"], [139, 146, "GENE"], [149, 153, "GENE"], [155, 162, "GENE"]]}], ["The alterations in the expression of Slc17a7 and Vgll2 were confirmed at the protein level.", {"entities": [[37, 44, "GENE"]]}], ["Pups exposed to the higher dose of FA exhibited increased ultrasonic vocalizations, greater anxiety-like behavior and hyperactivity.", {"entities": []}], ["These findings suggest that although FA plays a significant role in mammalian cellular machinery, there may be a loss of benefit from higher amounts of FA.", {"entities": []}], ["Unregulated high FA supplementation during pregnancy and throughout the life course may have lasting effects, with alterations in brain development resulting in changes in behavior.", {"entities": []}], ["We report a case of phenytoin-associated Hodgkin's disease of lymphocyte predominance subtype, which developed after two years of phenytoin (Epanutin) treatment.", {"entities": []}], ["Four other English cases of phenytoin-associated lmphoid malignancy are also reviewed.", {"entities": []}], ["Abnormal expression of thymic stromal lymphopoietin (TSLP) and its receptor (TSLPR) was found in patients with acute coronary syndrome.", {"entities": [[126, 134, "DISEASE"], [53, 57, "GENE"]]}], ["Ticagrelor, an oral platelet ADP P2Y12 receptor antagonist, is widely used in these patients.", {"entities": []}], ["The aim of this study was to verify whether different doses of ticagrelor regulated plaque progression and platelet activity by modulating TSLP/TSLPR.", {"entities": []}], ["Seventy-five ApoE-/- mice were randomly divided into five groups: (1) high-cholesterol diet (HCD, n = 15); (2) HCD plus ticagrelor 25 mg/kg/d (T1, n = 15); (3) HCD plus ticagrelor 50 mg/kg/d (T2, n = 15); (4) HCD plus ticagrelor 100 mg/kg/d (T3, n = 15); and (5) a normal diet group (ND, n = 15).", {"entities": []}], ["At day 0 and at week 16, blood lipids and serum TSLP levels, expression of TSLPR, CD62, and CD63, platelet aggregation, platelet ATP release, PI3K/Akt signaling pathway, and plaque morphology were assessed.", {"entities": [[48, 52, "GENE"], [92, 96, "GENE"]]}], ["HCD increased TSLPR expression and atherosclerosis progression but high-dose ticagrelor (100 mg/kg) moderated this trend.", {"entities": [[35, 50, "DISEASE"]]}], ["TSLPR was positively correlated with Akt1, platelet aggregation, corrected plaque area, and vulnerability index in the T3 group (P<0.01).", {"entities": [[37, 41, "GENE"]]}], ["In conclusion, low-dose ticagrelor only inhibited platelet activity.", {"entities": []}], ["Besides this inhibition, high-dose ticagrelor modulated platelet activity and atherosclerosis mediated by TSLPR, potentially through the PI3K/Akt signal pathway.", {"entities": [[78, 93, "DISEASE"]]}], ["Patterns of skin and bronchial reactions to the allergen were examined in thirty perennial asthmatics who showed a positive early cutaneous reaction (ECR) to the skin prick test with Dermatophagoides farinael.", {"entities": []}], ["A dualcutaneous reaction (DCR) was elicited in nine subjects by the skin prick test and in twenty-four by the intradermal test.", {"entities": []}], ["The size of the late cutaneous reaction (LCR) to the intradermal test was found to correlate with that of the preceding ECR.", {"entities": []}], ["A bronchial provocation test resulted in no reaction in six, and isloated early asthmatic reaction (EAR) in three, and a dual asthmatic reaction (DAR) in twenty-one.", {"entities": []}], ["A large LCR was associated with the occurrence of DAR and the patients with a large LCR required a lower allergen concentration to elicit an EAR.", {"entities": []}], ["Retinol is one of the most biologically active forms of vitamin A and is hypothesized to influence a wide range of human diseases including asthma, cardiovascular disease, infectious diseases and cancer.", {"entities": [[140, 146, "DISEASE"], [196, 202, "DISEASE"]]}], ["We conducted a genome-wide association study of 5006 Caucasian individuals drawn from two cohorts of men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study and the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.", {"entities": [[142, 148, "DISEASE"], [228, 234, "DISEASE"]]}], ["We identified two independent single-nucleotide polymorphisms associated with circulating retinol levels, which are located near the transthyretin ( TTR ) and retinol binding protein 4 ( RBP4 ) genes which encode major carrier proteins of retinol: rs1667255 ( P = 2.30\u00d7 10 P = 6.04\u00d7 10 RBP4 in independent samples from the Nurses\u2019 Health Study and the Invecchiare in Chianti Study (InCHIANTI) that included 3792 women and 504 men ( P = 9.49\u00d7 10 ), but found no association for retinol with rs1667255 in TTR among women, thus suggesting evidence for gender dimorphism ( P -interaction = 1.31\u00d7 10", {"entities": [[149, 152, "GENE"], [503, 506, "GENE"], [187, 191, "GENE"], [286, 290, "GENE"], [187, 191, "GENE"], [286, 290, "GENE"], [149, 152, "GENE"], [503, 506, "GENE"]]}], ["Cancer chemoprevention is considered one of the most promising areas in current cancer research, and asiaticoside, which is derived from the plant Centella asiatica , has a relative lack of systemic toxicity.", {"entities": [[0, 6, "DISEASE"], [80, 86, "DISEASE"]]}], ["The purpose of this study was to investigate whether asiaticoside is effective against 7,12-dimethylbenz(a)anthracene (DMBA)-induced carcinogenicity in vitro (MCF-7 and other cells) and in vivo (DMBA-induced rat cancer).", {"entities": [[212, 218, "DISEASE"]]}], ["An MTT assay was performed involving the treatment of MCF-7 cells for 48\u00a0h with H 2 O 2 alone and H 2 O 2 \u2009+\u2009different asiaticoside concentrations.", {"entities": []}], ["Flow cytometry was performed, and the level of caspase 3, tumour necrosis factor-alpha (TNF-\u03b1) and interleukin-1 (IL-1) were quantified.", {"entities": []}], ["Adult female Sprague\u2013Dawley (SD) rats were divided into five groups designated I (control), II (DMBA-induced cancer), III (pre- and post-treatment with asiaticoside (200\u00a0\u03bcg/animal) in DMBA-induced cancer), IV (post-treatment with asiaticoside in DMBA-induced cancer), and V (treated with asiaticoside alone, drug control).", {"entities": [[109, 115, "DISEASE"], [197, 203, "DISEASE"], [259, 265, "DISEASE"]]}], ["Twelve weeks post-DMBA, rats developed mammary tumours.", {"entities": []}], ["Rats either were sacrificed or imaged with MIBI.", {"entities": []}], ["Histological examination of tumour tissues was performed.", {"entities": []}], ["Tumour MIBI uptake ratios were determined.", {"entities": []}], ["The data are expressed as the means\u2009\u00b1\u2009standard deviation.", {"entities": []}], ["Appropriate t -test and ANOVA statistical methods were used to compare data.", {"entities": []}], ["The IC50 of asiaticoside for MCF-7 cells was determined to be 40\u00a0\u03bcM.", {"entities": []}], ["Asiaticoside has potential for hydrogen peroxide cytotoxicity, and the caspase-3 activity increased with increasing asiaticoside dose in MCF-7 cells treated for 48\u00a0h. The expression of the cytokines TNF-\u03b1 and IL-1\u03b2 was significantly decreased and correlated with MIBI uptake ratios in vitro and in vivo after asiaticoside administration.", {"entities": []}], ["This study demonstrates that asiaticoside is effective in vitro and in vivo in inducing apoptosis and enhancing anti-tumour activity.", {"entities": []}], ["Inflammation originating from the adipose tissue is considered to be one of the main driving forces for the development of insulin resistance and type 2 diabetes in obese individuals.", {"entities": []}], ["Although a plethora of different immune cells shapes adipose tissue inflammation, this review is specifically focused on the contribution of macrophages that reside in adipose tissue in lean and obese conditions.", {"entities": []}], ["Both conventional and tissue-specific functions of adipose tissue macrophages (ATMs) in lean and obese adipose tissue are discussed and linked with metabolic and inflammatory changes that occur during the development of obesity.", {"entities": [[220, 227, "DISEASE"]]}], ["Furthermore, we will address various circulating and adipose tissue-derived triggers that may be involved in shaping the ATM phenotype and underlie ATM function in lean and obese conditions.", {"entities": [[121, 124, "GENE"], [148, 151, "GENE"], [121, 124, "GENE"], [148, 151, "GENE"]]}], ["Finally, we will highlight how these changes affect adipose tissue inflammation and may be targeted for therapeutic interventions to improve insulin sensitivity in obese individuals.", {"entities": []}], ["Translating research findings into clinical practice is a major challenge to improve the quality of healthcare delivery.", {"entities": []}], ["Shared decision making (SDM) has been shown to be effective and has not yet been widely adopted by health providers.", {"entities": []}], ["This paper describes the participatory approach used to adapt and implement an evidence-based asthma SDM intervention into primary care practices.", {"entities": [[94, 100, "DISEASE"]]}], ["A participatory research approach was initiated through partnership development between practice staff and researchers.", {"entities": []}], ["The collaborative team worked together to adapt and implement a SDM toolkit.", {"entities": []}], ["Using the RE-AIM framework and qualitative analysis, we evaluated both the implementation of the intervention into clinical practice, and the level of partnership that was established.", {"entities": []}], ["Analysis included the number of adopting clinics and providers, the patients\u2019 perception of the SDM approach, and the number of clinics willing to sustain the intervention delivery after 1 year.", {"entities": []}], ["All six clinics and physician champions implemented the intervention using half-day dedicated asthma clinics while 16% of all providers within the practices have participated in the intervention.", {"entities": [[94, 100, "DISEASE"]]}], ["Themes from the focus groups included the importance of being part the development process, belief that the intervention would benefit patients, and concerns around sustainability and productivity.", {"entities": []}], ["One year after initiation, 100% of clinics have sustained the intervention, and 90% of participating patients reported a shared decision experience.", {"entities": []}], ["Use of a participatory research process was central to the successful implementation of a SDM intervention in multiple practices with diverse patient populations.", {"entities": []}], ["Despite epidemiological evidences of relationship between poor lung function and atherosclerosis, the relationship between poor lung function and microalbuminuria (MAU), an early surrogate marker of both kidney damage and atherosclerosis, is not well understood.", {"entities": [[81, 96, "DISEASE"], [222, 237, "DISEASE"]]}], ["Hence, we plan to investigate the relationship between poor lung function and MAU using multivariate models to adjust for other atherogenic risk factors.", {"entities": []}], ["We used data from the 5 1 /FVC ratio (<0.7) are defined as restrictive and obstructive patterns, respectively.", {"entities": []}], ["Urine albumin to urine creatinine levels ratio (UACR) were measured in spot urine samples.", {"entities": []}], ["MAU was defined as UACR >30 mg/g.", {"entities": []}], ["Inverse relationship was observed between lung function and UACR.", {"entities": []}], ["In an age-adjusted regression model, the regression coefficient (B) of 10% lower FVC was 11.09 in men ( P \u200a=\u200a0.002), which remained significant after adjustment for SBP, FBG, triglyceride level, BMI, smoking history, and heavy alcohol consumption (B\u200a=\u200a7.52, P \u200a=\u200a0.043).", {"entities": []}], ["When the restrictive pattern was compared to the normal pattern, the odds ratios (OR) (95% confidence interval, 95%CI) for MAU were 1.90 (1.32\u20132.72) in men, after adjustment for age, hypertension, diabetes mellitus, triglyceride level, obesity, smoking history, physical activity, and heavy alcohol consumption.", {"entities": [[183, 195, "DISEASE"], [236, 243, "DISEASE"], [197, 214, "DISEASE"]]}], ["Our study, the first investigation in Asia, demonstrated that the restrictive pattern is related to MAU in men.", {"entities": []}], ["Furthermore, there was linear relationship between lower FVC and UACR.", {"entities": []}], ["Thus, our current study suggests that poor lung function, particularly the restrictive pattern, is related to kidney damage as well as atherosclerosis.", {"entities": [[135, 150, "DISEASE"]]}], ["To evaluate temporal differences in the documentation of neurological findings by the same physicians in patients with ischaemic stroke while in hospital.", {"entities": []}], ["We also investigated differences in the rate of documentation of neurological findings in patients with stroke between internists and neurosurgeons.", {"entities": []}], ["A retrospective medical chart review.", {"entities": []}], ["Hospitalised adult patients with acute ischaemic stroke who stayed 7 or more days in our hospital.", {"entities": []}], ["Neurosurgeons (n=8) and internists (n=19) caring for these patients (including up to 10 patients per physician).", {"entities": []}], ["The documentation rate of any neurological finding in the patients on each day (from day 1 to 7 and on discharge).", {"entities": []}], ["The documentation rates of eight neurological finding components (consciousness, mental status, cranial nerves, motor function, sensory function, coordination, reflexes and gait).", {"entities": []}], ["We included only documentation by the same physician.", {"entities": []}], ["Fisher\u2019s exact test was used to evaluate differences in outcomes between neurosurgeons and internists.", {"entities": []}], ["During the study period, we identified 172 patients with stroke who were cared for by 27 physicians.", {"entities": []}], ["The documentation rates of any neurological findings were 94% (day 1), 58% (day 2), 35% (day 3), 40% (day 4), 32% (day 5), 30% (day 6) and 23% (day 7).", {"entities": []}], ["On discharge, all eight neurological finding components were documented in less than 10% of all cases.", {"entities": []}], ["The documentation rate was significantly higher by internists than that by neurosurgeons on each day but not on discharge.", {"entities": []}], ["The documentation rate of neurological findings by physicians during usual stroke care decreased to less than 50% after the third hospital day.", {"entities": []}], ["Given the importance of temporal changes in the neurological symptoms of patients with stroke, further study is needed to determine whether this low documentation rate after the third hospital day was due to a lack of physician interest in neurological findings or other factors.", {"entities": []}], ["This is the first report of a case-control epidemiological study on lymphomas and leukaemias occurring in Yorkshire during 1979-84.", {"entities": []}], ["This paper deals with the results of the Hodgkin's disease analysis comprising 248 cases and 489 controls.", {"entities": []}], ["The results indicate support for previous work with respect to small family size and past history of infectious mononucleosis.", {"entities": [[101, 125, "DISEASE"]]}], ["Positive observations made in a previous pilot study are also confirmed and extended with respect to associations with certain chronic skin lesions, dental anaesthesia and familial factors.", {"entities": []}], ["Negative associations are described with respect to X-ray exposures and cigarette smoking.", {"entities": []}], ["It is proposed that these results fit into a general hypothesis that these conditions are the result of interaction between infectious agents and altered immunity in those persons genetically predisposed.", {"entities": []}], ["Bronchial thermoplasty (BT) is a recently developed treatment for patients with moderate-to-severe asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["A few studies have suggested the clinical efficacy of this intervention.", {"entities": []}], ["However, no study has evaluated the cost-effectiveness of BT compared to other alternative treatments for moderate-to-severe allergic asthma, which currently include omalizumab and standard therapy.", {"entities": [[125, 140, "DISEASE"], [134, 140, "DISEASE"]]}], ["To evaluate the cost-effectiveness of standard therapy, BT, and omalizumab for moderate-to-severe allergic asthma in the USA.", {"entities": [[98, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["A probabilistic Markov model with weekly cycles was developed to reflect the course of asthma progression over a 5-year time horizon.", {"entities": [[87, 93, "DISEASE"]]}], ["The study population was adults with moderate-to-severe allergic asthma whose asthma remained uncontrolled despite using high-dose inhaled corticosteroids (ICS, with or without long-acting beta-agonists [LABA]).", {"entities": [[56, 71, "DISEASE"], [65, 71, "DISEASE"], [78, 84, "DISEASE"]]}], ["A perspective of the health-care system was adopted with asthma-related costs as well as quality-adjusted life years (QALYs) and exacerbations as the outcomes.", {"entities": [[57, 63, "DISEASE"]]}], ["For standard therapy, BT, and omalizumab, the discounted 5-year costs and QALYs were $15,400 and 3.08, $28,100 and 3.24, and $117,000 and 3.26, respectively.", {"entities": []}], ["The incremental cost-effectiveness ratio (ICER) of BT versus standard therapy and omalizumab versus BT was $78,700/QALY and $3.86 million/QALY, respectively.", {"entities": []}], ["At the willingness-to-pay (WTP) of $50,000/QALY and $100,000/QALY, the probability of BT being cost-effective was 9%, and 67%, respectively.", {"entities": []}], ["The corresponding expected value of perfect information (EVPI) was $155 and $1,530 per individual at these thresholds.", {"entities": []}], ["In sensitivity analyses, increasing the costs of BT from $14,900 to $30,000 increased its ICER relative to standard therapy to $178,000/QALY, and decreased the ICER of omalizumab relative to BT to $3.06 million/QALY.", {"entities": []}], ["Reducing the costs of omalizumab by 25% decreased its ICER relative to BT by 29%.", {"entities": []}], ["Based on the available evidence, our study suggests that there is more than 60% chance that BT becomes cost-effective relative to omalizumab and standard therapy at the WTP of $100,000/QALY in patients with moderate-to-severe allergic asthma.", {"entities": [[226, 241, "DISEASE"], [235, 241, "DISEASE"]]}], ["However, there is a substantial uncertainty in the underlying evidence, indicating the need for future research towards reducing such uncertainty.", {"entities": []}], ["Aims: \u03b2-blockers are underused in Chinese patients with coronary heart disease.", {"entities": [[65, 78, "DISEASE"], [56, 78, "DISEASE"]]}], ["The prescribed dose is often low.", {"entities": []}], ["The aim of this study was to investigate the effect of metoprolol succinate doses of 95 mg and 190 mg on heart rate (HR) control, as well as drug tolerance, in Chinese patients with stable angina, low-dose \u03b2-blocker use and unsatisfactory HR control.", {"entities": [[117, 119, "GENE"], [239, 241, "GENE"], [117, 119, "GENE"], [239, 241, "GENE"]]}], ["Methods: This was a multicenter, randomized, open-label, parallel-group trial in 15 clinical sites.", {"entities": []}], ["Patients with stable angina, taking low-dose \u03b2-blockers (equivalent to metoprolol succinate 23.75-47.5 mg/day), and having a resting HR of \u2265 65 bpm were enrolled and randomized to either the metoprolol 95-mg group or the 190-mg group.", {"entities": [[133, 135, "GENE"]]}], ["The change in 24-h average HR from baseline recorded by Holter monitoring and the percentages of patients with resting HR controlled to \u2264 60 bpm were compared between the two groups.", {"entities": [[27, 29, "GENE"], [119, 121, "GENE"], [27, 29, "GENE"], [119, 121, "GENE"]]}], ["Results: Two hundred thirty-one patients entered the intent-to-treat population for the main analysis.", {"entities": []}], ["The change in 24-h average HR from baseline was -0.62 \u00b1 0.66 bpm in the 95 mg group and -2.99 \u00b1 0.62 bpm in the 190 mg group (p = 0.0077) after 8 weeks of treatment.", {"entities": [[27, 29, "GENE"]]}], ["The percentages of patients with resting HR controlled to \u2264 60 bpm were 24.1% (95% CI: 16.35%, 31.93%) and 40.0% (95% CI: 31.05%, 48.95%), respectively (p = 0.0019).", {"entities": [[41, 43, "GENE"]]}], ["Only 4 and 2 of the patients, respectively, discontinued the study drugs because of hypotension or bradycardia.", {"entities": []}], ["Conclusions: The metoprolol succinate dose of 190 mg is superior to the 95 mg dose in terms of HR control, in Chinese patients with stable angina, low-dose \u03b2-blocker use and unsatisfactory HR control.", {"entities": [[95, 97, "GENE"], [189, 191, "GENE"], [95, 97, "GENE"], [189, 191, "GENE"]]}], ["Both doses were well tolerated.", {"entities": []}], ["To identify if there is a dose-dependent risk of diabetes complications in patients treated with corticosteroids who have both diabetes and chronic obstructive pulmonary disorder (COPD).", {"entities": []}], ["A retrospective study of administrative claims data from the Australian Government Department of Veterans\u2019 Affairs, from 1 July 2001 to 30 June 2008, of diabetes patients newly initiated on metformin or sulfonylurea.", {"entities": []}], ["COPD was identified by dispensings of tiotropium or ipratropium in the 6 months preceding study entry.", {"entities": []}], ["Total corticosteroid use (inhaled and systemic) in the 12 months after study entry was determined.", {"entities": []}], ["The outcome was time to hospitalization for a diabetes-related complication.", {"entities": []}], ["Competing risks and Cox proportional hazard regression analyses were conducted with adjustment for a number of covariates.", {"entities": []}], ["A total of 18,226 subjects with diabetes were identified, of which 5.9% had COPD.", {"entities": []}], ["Of those with COPD, 67.2% were dispensed corticosteroids in the 12 months from study entry.", {"entities": []}], ["Stratification by dose of corticosteroids demonstrated a 94% increased likelihood of hospitalization for a diabetes complication for those who received a total defined daily dose (DDD) of corticosteroids \u22650.83/day (subhazard ratio 1.94 [95% CI 1.14\u20133.28], P = 0.014), by comparison with those who did not receive a corticosteroid.", {"entities": []}], ["Lower doses of corticosteroid (<0.83 DDD/day) were not associated with an increased risk of diabetes-related hospitalization.", {"entities": []}], ["In patients with diabetes and COPD, an increased risk of diabetes-related hospitalizations was only evident with use of high doses of corticosteroids.", {"entities": []}], ["This highlights the need for constant revision of corticosteroid dose in those with diabetes and COPD, to ensure that the minimally effective dose is used, together with review of appropriate response to therapy.", {"entities": []}], ["BACKGROUND: Data on spirometrically defined chronic airflow limitation (CAL) are scarce in developing countries.", {"entities": []}], ["OBJECTIVE: To estimate the prevalence of spirometrically defined CAL in Kashmir, North India.", {"entities": []}], ["METHODS: Using Burden of Obstructive Lung Disease survey methods, we administered questionnaires to randomly selected adults aged \u2a7e40 years.", {"entities": []}], ["Post-bronchodilator spirometry was performed to estimate the prevalence of CAL and its relation to potential risk factors.", {"entities": []}], ["RESULTS: Of 1100 participants initially recruited, 953 (86.9%) responded and 757 completed acceptable spirometry and questionnaires.", {"entities": []}], ["The prevalence of a forced expiratory volume in 1 s/forced vital capacity (FEV 1 /FVC) ratio less than the lower limit of normal was 17.3% (4.5) in males and 14.8% (2.1) in females.", {"entities": [[75, 78, "GENE"]]}], ["Risk factors for CAL included higher age, cooking with wood and lower educational status.", {"entities": []}], ["The prevalence of current smoking was 61% in males and 22% in females; most smoked hookahs .", {"entities": []}], ["CAL was found equally in non-smoking males and females, and was independently associated with the use of the hookah, family history of respiratory disease and poor education.", {"entities": []}], ["A self-reported doctor's diagnosis of chronic obstructive pulmonary disease was reported in 8.4/1000 (0.9% of females and 0.8% of males).", {"entities": [[38, 75, "DISEASE"]]}], ["CONCLUSION:Spirometrically confirmed CAL is highly prevalent in Indian Kashmir, and seems to be related to the high prevalence of smoking, predominantly in the form of hookah smoking.", {"entities": []}], ["To investigate the obstetric and psychological characteristics of women who opt to use epidural analgesia (EDA) during labour and the impact of participating in labour preparation courses on women\u2019s decisions to use EDA.", {"entities": [[107, 110, "GENE"], [216, 219, "GENE"], [107, 110, "GENE"], [216, 219, "GENE"]]}], ["Longitudinal cohort study.", {"entities": []}], ["Akershus University Hospital, Norway.", {"entities": []}], ["2596 women with singleton pregnancies and intended vaginal delivery.", {"entities": []}], ["Data were collected using two self-completed questionnaires at pregnancy weeks 17 and 32.", {"entities": []}], ["Fear of childbirth was assessed by the Wijma Delivery Expectancy Questionnaire (W-DEQ).", {"entities": []}], ["Symptoms of anxiety were measured by the Hopkins Symptom Check List (SCL-25) and depression by the Edinburgh Postnatal Depression Scale (EPDS).", {"entities": []}], ["Obstetric and socio-demographic information was retrieved from birth records at the maternity ward.", {"entities": []}], ["Preference for EDA was indicated by the questionnaire item \u201cI would prefer an epidural regardless\u201d on a 4-point scale (1 = highly agree, 4 = highly disagree) at pregnancy week 32.", {"entities": [[15, 18, "GENE"]]}], ["Twenty-one percent of the women (540/2596) answered that they would choose EDA as the only alternative method of analgesia during labour.", {"entities": [[75, 78, "GENE"]]}], ["Counselling for fear of childbirth [OR 3.23 (95%CI 2.12; 4.92)] and W-DEQ sum score \u2265 85 [OR 2.95 (95%CI 2.06; 4.23)] were significantly (p<0.001) associated with choice of EDA.", {"entities": [[173, 176, "GENE"]]}], ["Participation in labour preparation courses was significantly (p = 0.008) associated with a reduction of intended use of EDA during labour [OR 0.67 (95%CI 0.49; 0.90)].", {"entities": [[121, 124, "GENE"]]}], ["Fear of childbirth is significantly associated with women\u2019s choice of EDA during labour.", {"entities": [[70, 73, "GENE"]]}], ["On the other hand, women that participate in labour preparation courses would rather consider other methods of analgesia during labour.", {"entities": []}], ["Chronic nonhealing wounds have been heralded as a silent epidemic, causing significant morbidity and mortality especially in elderly, diabetic, and obese populations.", {"entities": []}], ["Polymicrobial biofilms in the wound bed are hypothesized to disrupt the highly coordinated and sequential events of cutaneous healing.", {"entities": []}], ["Both culture-dependent and -independent studies of the chronic-wound microbiome have almost exclusively focused on bacteria, omitting what we hypothesize are important fungal contributions to impaired healing and the development of complications.", {"entities": []}], ["Here we show for the first time that fungal communities (the mycobiome) in chronic wounds are predictive of healing time, associated with poor outcomes, and form mixed fungal-bacterial biofilms.", {"entities": []}], ["We longitudinally profiled 100, nonhealing diabetic-foot ulcers with high-throughput sequencing of the pan-fungal internal transcribed spacer 1 (ITS1) locus, estimating that up to 80% of wounds contain fungi, whereas cultures performed in parallel captured only 5% of colonized wounds.", {"entities": []}], ["The \u201cmycobiome\u201d was highly heterogeneous over time and between subjects.", {"entities": []}], ["Fungal diversity increased with antibiotic administration and onset of a clinical complication.", {"entities": []}], ["The proportions of the phylum Ascomycota were significantly greater ( P = 0.015) at the beginning of the study in wounds that took >8\u00a0weeks to heal.", {"entities": []}], ["Wound necrosis was distinctly associated with pathogenic fungal species, while taxa identified as allergenic filamentous fungi were associated with low levels of systemic inflammation.", {"entities": []}], ["Directed culturing of wounds stably colonized by pathogens revealed that interkingdom biofilms formed between yeasts and coisolated bacteria.", {"entities": []}], ["Combined, our analyses provide enhanced resolution of the mycobiome during impaired wound healing, its role in chronic disease, and impact on clinical outcomes.", {"entities": []}], ["Wounds are an underappreciated but serious complication for a diverse spectrum of diseases.", {"entities": []}], ["High-risk groups, such as persons with diabetes, have a 25% lifetime risk of developing a wound that can become chronic.", {"entities": []}], ["The majority of microbiome research related to chronic wounds is focused on bacteria, but the association of fungi with clinical outcomes remains to be elucidated.", {"entities": []}], ["Here we describe the dynamic fungal communities in 100 diabetic patients with foot ulcers.", {"entities": []}], ["We found that communities are unstable over time, but at the first clinical presentation, the relative proportions of different phyla predict healing times.", {"entities": []}], ["Pathogenic fungi not identified by culture reside in necrotic wounds and are associated with a poor prognosis.", {"entities": []}], ["In wounds stably colonized by fungi, we identified yeasts capable of forming biofilms in concert with bacteria.", {"entities": []}], ["Our findings illuminate the associations of the fungal mycobiome with wound prognosis and healing.", {"entities": []}], ["The global trend of increased life expectancy and increased prevalence of chronic and degenerative diseases will impact on health systems.", {"entities": []}], ["To identify effective intervention and prevention strategies, greater understanding of the risk factors for and cumulative effects of chronic disease processes and their effects on function and quality of life is needed.", {"entities": []}], ["The Busselton Healthy Ageing Study aims to enhance understanding of ageing by relating the clustering and interactions of common chronic conditions in adults to function.", {"entities": []}], ["Longitudinal (3\u20135 yearly) follow-up is planned.", {"entities": []}], ["Phase I (recruitment) is a cross-sectional community-based prospective cohort study involving up to 4,000 'Baby Boomers\u2019 (born from 1946 to 1964) living in the Busselton Shire, Western Australia.", {"entities": []}], ["The study protocol involves a detailed, self-administered health and risk factor questionnaire and a range of physical assessments including body composition and bone density measurements, cardiovascular profiling (blood pressure, ECG and brachial pulse wave velocity), retinal photography, tonometry, auto-refraction, spirometry and bronchodilator responsiveness, skin allergy prick tests, sleep apnoea screening, tympanometry and audiometry, grip strength, mobility, balance and leg extensor strength.", {"entities": []}], ["Cognitive function and reserve, semantic memory, and pre-morbid intelligence are assessed.", {"entities": []}], ["Participants provide a fasting blood sample for assessment of lipids, blood glucose, C-reactive protein and renal and liver function, and RNA, DNA and serum are stored.", {"entities": []}], ["Clinically relevant results are provided to all participants.", {"entities": []}], ["The prevalence of risk factors, symptoms and diagnosed illness will be calculated and the burden of illness will be estimated based on the observed relationships and clustering of symptoms and illness within individuals.", {"entities": []}], ["Risk factors for combinations of illness will be compared with those for single illnesses and the relation of combinations of illness and symptoms to cognitive and physical function will be estimated.", {"entities": []}], ["This study will enable a thorough characterization of multiple disease processes and their risk factors within a community-based sample of individuals to determine their singular, interactive and cumulative effects on ageing.", {"entities": []}], ["The project will provide novel cross-sectional data and establish a cohort that will be used for longitudinal analyses of the genetic, lifestyle and environmental factors that determine whether an individual ages well or with impairment.", {"entities": []}], ["The diagnosis of COPD is not always consistent with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy in daily clinical practice, especially in primary care.", {"entities": []}], ["This study aimed to estimate the overall COPD prevalence and severity, to identify differences between newly and previously diagnosed patients, and to evaluate the potential COPD overtreatment in a smoking population attending a primary care spirometry surveillance program.", {"entities": []}], ["A study was conducted in 10 primary health care centers of Central Greece during a 7-month period.", {"entities": []}], ["Eligible participants were aged \u226540 years and were either current smokers or exsmokers.", {"entities": []}], ["A total of 186 subjects were included (68% males, mean age 62.3\u00b112.6 years, mean life-time tobacco exposure 50 pack-years).", {"entities": []}], ["COPD prevalence was 17.8%, identified to be higher in elderly males.", {"entities": []}], ["Forty-two percent of the COPD group were newly diagnosed patients, who were of younger age, current smokers, presented with less dyspnea and better health status, and mainly appeared with mild-to-moderate disease.", {"entities": []}], ["Interestingly, 61.4% of non-COPD and 85.7% of newly diagnosed COPD individuals had been using inhaled medication under primary care provider\u2019s prescription without ever undergoing spirometry or further evaluation by a pulmonologist; thus, the phenomena of COPD overdiagnosis and missed diagnosis came into the spotlight.", {"entities": []}], ["Moreover, only 26.3% of known COPD patients were properly medicated according to GOLD guidelines, while half of them were inappropriately treated with triple inhaled therapy.", {"entities": []}], ["We reported a significant prevalence of COPD in smoking population attending this spirometry program.", {"entities": []}], ["A remarkable proportion of COPD patients were undiagnosed and made case finding worthwhile.", {"entities": []}], ["Underutilization of spirometry in the diagnosis and management of COPD as well as general practitioners\u2019 nonadherence to the GOLD treatment guidelines was confirmed by our data.", {"entities": []}], ["These findings highlight the need for a major overhaul and culture change in primary care settings of Central Greece.", {"entities": []}], ["Exhaled breath temperature has been suggested as a new method to detect and monitor pathological processes in the respiratory system.", {"entities": []}], ["The putative mechanism of this approach is based upon changes in the blood flow.", {"entities": []}], ["So far potential factors that influence breath temperature have not been studied in the general population.", {"entities": []}], ["The exhaled breath temperature was measured in 151 healthy non-smoking elderly (aged: 60\u201380\u00a0years) at room temperature with the X-halo device with an accuracy of 0.03\u00b0C.", {"entities": []}], ["We related exhaled breath temperature by use of regression models with potential predictors including: host factors (sex, age) and environmental factors (BMI, physical activity, and traffic indicators).", {"entities": []}], ["Exhaled breath temperature was lower in women than in men and was inversely associated with age, physical activity.", {"entities": []}], ["BMI and daily average ambient temperature were positively associated with exhaled breath temperature.", {"entities": []}], ["Independent of the aforementioned covariates, exhaled breath temperature was significantly associated with several traffic indicators.", {"entities": []}], ["Residential proximity to major road was inversely associated with exhaled breath temperature: doubling the distance to the nearest major intense road was observed a decrease of 0.17\u00b0C (95% CI: -0.33 to -0.01; p\u2009=\u20090.036).", {"entities": []}], ["Exhaled breath temperature has been suggested as a noninvasive method for the evaluation of airway inflammation.", {"entities": []}], ["We provide evidence that several factors known to be involved in proinflammatory conditions including BMI, physical activity and residential proximity to traffic affect exhaled breath temperature.", {"entities": []}], ["In addition, we identified potential confounders that should be taken into account in clinical and epidemiological studies on exhaled breath temperature including sex, age, and ambient temperature.", {"entities": []}], ["Adenosine receptors (ARs) are potential therapeutic targets for Parkinson\u2019s disease, diabetes, pain, stroke and cancers.", {"entities": []}], ["Prediction of subtype selectivity is therefore important from both therapeutic and mechanistic perspectives.", {"entities": []}], ["In this paper, we introduced a shape similarity profile as molecular descriptor, namely three-dimensional biologically relevant spectrum (BRS-3D), for AR selectivity prediction.", {"entities": []}], ["Pairwise regression and discrimination models were built with the support vector machine methods.", {"entities": []}], ["The average determination coefficient ( r 2B vs A 3 ) model performed best with q r RMSE \u2009=\u20090.828 for test sets.", {"entities": []}], ["The models\u2019 robustness and stability were validated with 100 times resampling and 500 times Y-randomization.", {"entities": []}], ["We compared the performance of BRS-3D with 3D descriptors calculated by MOE.", {"entities": []}], ["BRS-3D performed as good as, or better than, MOE 3D descriptors.", {"entities": []}], ["The performances of the discrimination models were also encouraging, with average accuracy (ACC) 0.912 and MCC 0.792 (test set).", {"entities": [[107, 110, "GENE"]]}], ["The 2A-3 (A 2A vs A 3 ) selectivity discrimination model ( ACC \u2009=\u20090.882 and MCC \u2009=\u20090.715 for test set) outperformed an earlier reported one ( ACC \u2009=\u20090.784).", {"entities": [[76, 79, "GENE"]]}], ["These results demonstrated that, through multiple conformation encoding, BRS-3D can be used as an effective molecular descriptor for AR subtype selectivity prediction.", {"entities": []}], ["Mast cells (MC) and myeloid dendritic cells (DC) act proximally in detecting and processing antigens and immune insults.", {"entities": []}], ["We sought to understand their comparative dynamic behavior with respect to the airway epithelium in the steady state and in response to an allergic stimulus in mouse trachea.", {"entities": []}], ["We devised methods to label MC in living trachea and to demonstrate that MC and DC occupy distinct layers of the tracheal mucosa, with DC being closer to the lumen.", {"entities": []}], ["DC numbers doubled after allergen challenge, but MC numbers remained stable.", {"entities": []}], ["MC and DC migrated minimally in either steady state or allergen-challenge conditions, and their interactions with one another appeared to be stochastic and relatively infrequent.", {"entities": []}], ["While DC, unlike MC, exhibited probing behaviors involving dendrites, these projections did not cross the epithelium into the airway lumen.", {"entities": []}], ["MC typically were located too far from the epithelial surface to contact the tracheal lumen.", {"entities": []}], ["However, MC had protrusions toward and into blood vessels, likely to load with IgE.", {"entities": []}], ["Thus, DC and MC occupy distinct niches and engage in sessile surveillance in the mouse trachea.", {"entities": []}], ["Little or no access of these cell types to the airway lumen suggests that trans-epithelial transport of proteins in the steady state would be required for them to access luminal antigens.", {"entities": []}], ["WeChat is a convenient and popular social medium, and it seems to be an appropriate platform for education and management of patients.", {"entities": []}], ["This study sought to identify usefulness in clinical control of cough-variant asthma (CVA).", {"entities": [[78, 84, "DISEASE"]]}], ["A randomized controlled trial was conducted among 80 CVA patients.", {"entities": []}], ["After being assigned to either the traditional group (TG) or the WeChat group (WG), they received the same inhalation therapy, but patients in WG received additional education and instruction via our public account on the WeChat application.", {"entities": [[54, 56, "GENE"]]}], ["Questionnaires on asthma and chronic cough, data on pulmonary function, blood-related items, follow-up adherence, and Emergency Department (ED) visits were collected at the initial visit and at 3 months.", {"entities": [[18, 24, "DISEASE"]]}], ["A total of 67 participants completed the trial for analysis.", {"entities": []}], ["FEV 1 /predicted and FEV 1 /FVC were significantly increased in WG ( p <0.001; p =0.012) after 3 months.", {"entities": [[0, 3, "GENE"], [21, 24, "GENE"], [0, 3, "GENE"], [21, 24, "GENE"]]}], ["PD 20 -FEV 1 was increased in both groups compared with baseline, but more pronounced in WG ( p =0.004).", {"entities": []}], ["ACQ-7 scores were improved in both groups ( p =0.024; p <0.001).", {"entities": []}], ["Participants allocated to WG experienced a greater improvement in AQLQ and LCQ scores, and between-group differences were significant at 3 months ( p =0.040; p =0.001).", {"entities": []}], ["Furthermore, we observed decreases in blood eosinophil count and FeNO in WG ( p =0.048; p =0.014), and WG presented better follow-up compliance ( p =0.034).", {"entities": []}], ["Using WeChat as part of treatment and management of CVA can help patients learn about their disease and medications, as well as improve disease control and therapy outcomes.", {"entities": []}], ["Atopic dermatitis is a chronic, relapsing inflammatory skin disease characterized by intense pruritus, excoriations and limited therapies.", {"entities": [[0, 17, "DISEASE"], [55, 67, "DISEASE"], [7, 17, "DISEASE"]]}], ["Dupilumab, a monoclonal antibody against interleukin-4 receptor alpha, is a promising new treatment option for atopic dermatitis.", {"entities": [[111, 128, "DISEASE"], [118, 128, "DISEASE"]]}], ["We sought to systematically summarize the efficacy, safety, and influence on quality of life of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults.", {"entities": [[146, 163, "DISEASE"], [153, 163, "DISEASE"]]}], ["A total of 7 RCTs containing 2705 subjects were identified.", {"entities": []}], ["Significantly more patients receiving dupilumab (611/1789) achieved Investigator\u2019s Global Assessment response compared with the control (89/916; RR, 3.95; P < 0.001).", {"entities": []}], ["Dupilumab was significantly more effective in reducing Eczema Area and Severity Index, peak pruritus numerical rating scale score, and body surface area.", {"entities": []}], ["Treatment duration rather than administration frequency slightly influenced the efficacy.", {"entities": []}], ["Dupilumab treatment also contributed to marked improvement in patients\u2019 quality of life and psychological symptoms.", {"entities": []}], ["Incidence of adverse events was similar in dupilumab group and control group.", {"entities": []}], ["Dupilumab is effective and safe for the treatment of moderate-to-severe atopic dermatitis in adults.", {"entities": [[72, 89, "DISEASE"], [79, 89, "DISEASE"]]}], ["This meta-analysis supports the role of dupilumab as a primary targeted biologic therapy in adult patients with moderate-to-severe atopic dermatitis.", {"entities": [[131, 148, "DISEASE"], [138, 148, "DISEASE"]]}], ["We searched Pubmed, Embase, and the Cochrane Library for eligible trials.", {"entities": []}], ["Only double-blinded randomized controlled trials (RCTs) investigating the efficacy and safety of dupilumab in treating moderate-to-severe atopic dermatitis were included in this analysis.", {"entities": [[138, 155, "DISEASE"], [145, 155, "DISEASE"]]}], ["We made a comparison of dupilumab with control based on the pooled relative risk (RR), weighted mean difference, and their corresponding 95% confidence intervals of different measurements.", {"entities": []}], ["Although cigarette smoke is known to be a complex mixture of over 4000 substances that can lead to damage through active or passive smoking, its mechanisms and biochemical consequences in pregnancy and neonates are not yet fully understood.", {"entities": []}], ["Therefore, in the present study, we propose to study the impact of smoking during gestation on the viability of blood mononuclear cells (MNC) from umbilical cords of newborns to assess the degree of oxidative stress and cell viability.", {"entities": []}], ["After childbirth, the cord blood and the umbilical cord were immediately collected in public hospitals in Greater Vitoria, ES, Brazil.", {"entities": []}], ["Flow cytometry was used to analyze the cord blood followed by biochemical and histological tests to analyze possible changes in the umbilical cord.", {"entities": []}], ["Pregnant smokers had a reduction of MNC viability from the umbilical cord (10%), an increase in the production of reactive oxygen species (ROS) and an increase in cell apoptosis (~2-fold) compared to pregnant non-smokers.", {"entities": []}], ["In the umbilical cord, it was observed an increase of advanced oxidation protein products - AOPP (~2.5-fold) and a loss of the typical architecture and disposition of endothelial cells from the umbilical artery.", {"entities": []}], ["These data suggest that maternal cigarette smoking during pregnancy (even in small amounts) may compromise the viability of MNC cells and damage the umbilical cord structure, possibly by excessive ROS bioavailability.", {"entities": []}], ["The health effects of suspended particulate matter (PM) may depend on its chemical composition.", {"entities": []}], ["Associations between maternal exposure to chemical constituents of PM and newborn\u2019s size have been little examined.", {"entities": []}], ["We aimed to investigate the associations of exposure to elemental constituents of PM with term low birth weight (LBW; weight < 2,500 g among births after 37 weeks of gestation), mean birth weight, and head circumference, relying on standardized fine-scale exposure assessment and with extensive control for potential confounders.", {"entities": []}], ["We pooled data from eight European cohorts comprising 34,923 singleton births in 1994\u20132008.", {"entities": []}], ["Annual average concentrations of elemental constituents of PM \u2264 2.5 and \u2264 10 \u03bcm (PM 2.5 and PM 10 ) at maternal home addresses during pregnancy were estimated using land-use regression models.", {"entities": []}], ["Adjusted associations between each birth measurement and concentrations of eight elements (copper, iron, potassium, nickel, sulfur, silicon, vanadium, and zinc) were calculated using random-effects regression on pooled data.", {"entities": []}], ["A 200-ng/m 2.5 was associated with an increased risk of LBW (adjusted odds ratio = 1.36; 95% confidence interval: 1.17, 1.58).", {"entities": []}], ["Increased nickel and zinc in PM 2.5 concentrations were also associated with an increased risk of LBW.", {"entities": []}], ["Head circumference was reduced at higher exposure to all elements except potassium.", {"entities": []}], ["All associations with sulfur were most robust to adjustment for PM 2.5 mass concentration.", {"entities": []}], ["All results were similar for PM 10 .", {"entities": []}], ["Sulfur, reflecting secondary combustion particles in this study, may adversely affect LBW and head circumference, independently of particle mass.", {"entities": []}], ["Pedersen M, Gehring U, Beelen R, Wang M, Giorgis-Allemand L, Andersen AM, Basaga\u00f1a X, Bernard C, Cirach M, Forastiere F, de Hoogh K, Gra\u017eulevi\u010dien\u0117 R, Gruzieva O, Hoek G, Jedynska A, Kl\u00fcmper C, Kooter IM, Kr\u00e4mer U, Kukkonen J, Porta D, Postma DS, Raaschou-Nielsen O, van Rossem L, Sunyer J, S\u00f8rensen M, Tsai MY, Vrijkotte TG, Wilhelm M, Nieuwenhuijsen MJ, Pershagen G, Brunekreef B, Kogevinas M, Slama R. 2016.", {"entities": [[322, 324, "GENE"]]}], ["Elemental constituents of particulate matter and newborn\u2019s size in eight European cohorts.", {"entities": []}], ["Environ Health Perspect 124:141\u2013150;\u2002 http://dx.doi.org/10.1289/ehp.1409546", {"entities": []}], ["Airway irritants such as ozone are known to impair lung function and induce airway inflammation.", {"entities": []}], ["Clara cell protein (CC16) is a small anti-inflammatory protein secreted by the nonciliated bronchiolar Clara cells.", {"entities": []}], ["CC16 in serum has been proposed as a noninvasive and sensitive marker of lung epithelial injury.", {"entities": []}], ["In this study, we used lung function and serum CC16 concentration to examine the pulmonary responses to ambient O 3 exposure and swimming pool attendance.", {"entities": []}], ["The measurements were made on 57 children 10\u201311 years of age before and after outdoor exercise for 2 hr.", {"entities": [[101, 103, "GENE"]]}], ["Individual O 3 exposure was estimated as the total exposure dose between 0700 hr until the second blood sample was obtained (mean O 3 concentration/m 3 levels did not cause any significant changes in mean serum CC16 concentrations before or after outdoor exercise, nor was any decrease in lung function detected.", {"entities": [[78, 80, "GENE"]]}], ["However, children who regularly visited chlorinated indoor swimming pools had significantly lower CC16 levels in serum than did nonswimming children both before and after exercise (respectively, 57 \u00b1 2.4 and 53 \u00b1 1.7 \u03bcg/L vs. 8.2 \u00b1 2.8 and 8.0 \u00b1 2.6 \u03bcg/L; p < 0.002).", {"entities": []}], ["These results indicate that repeated exposure to chlorination by-products in the air of indoor swimming pools has adverse effects on the Clara cell function in children.", {"entities": []}], ["A possible relation between such damage to Clara cells and pulmonary morbidity (e.g., asthma) should be further investigated.", {"entities": [[86, 92, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) is the most common cause of infant hospitalizations and severe RSV infections are a significant risk factor for childhood asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["The pathogenic mechanisms responsible for RSV induced immunopathophysiology remain elusive.", {"entities": []}], ["Using an age-appropriate mouse model of RSV, we show that IL-33 plays a critical role in the immunopathogenesis of severe RSV, which is associated with higher group 2 innate lymphoid cells (ILC2s) specifically in neonates.", {"entities": []}], ["Infection with RSV induced rapid IL-33 expression and an increase in ILC2 numbers in the lungs of neonatal mice; this was not observed in adult mice.", {"entities": []}], ["Blocking IL-33 with antibodies or using an IL-33 receptor knockout mouse during infection was sufficient to inhibit RSV immunopathogenesis (i.e., airway hyperresponsiveness, Th2 inflammation, eosinophilia, and mucus hyperproduction); whereas administration of IL-33 to adult mice during RSV infection was sufficient to induce RSV disease.", {"entities": [[192, 204, "DISEASE"]]}], ["Additionally, elevated IL-33 and IL-13 were observed in nasal aspirates from infants hospitalized with RSV; these cytokines declined during convalescence.", {"entities": []}], ["In summary, IL-33 is necessary, either directly or indirectly, to induce ILC2s and the Th2 biased immunopathophysiology observed following neonatal RSV infection.", {"entities": []}], ["This study provides a mechanism involving IL-33 and ILC2s in RSV mediated human asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["IL-33 is responsible for the immunopathophysiological response observed following neonatal RSV infection in mice.", {"entities": []}], ["Its presence in nasal aspirates of human infants with severe RSV and suggests its role in disease severity and asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["Studies on social capital and health outcomes have become common, but the relationship between neighborhood social capital and sleep duration by gender is still unclear.", {"entities": []}], ["We examined the relationship between neighborhood social capital and sleep duration by gender in adults living in a rural community in Japan.", {"entities": []}], ["We conducted a cross-sectional survey of 12,321 residents aged \u226520\u00a0years in a town in Mie Prefecture in January\u2013March 2013.", {"entities": []}], ["Self-completed questionnaires were collected from the residents ( n \u2009=\u20097782; valid participation rate, 63.2%).", {"entities": []}], ["We used five items to assess the neighborhood social capital (Cronbach\u2019s \u03b1\u2009=\u20090.86).", {"entities": []}], ["We summed up the scores of each item, and then divided the participants into four groups by quartile of total scores of neighborhood social capital (lowest, low, high, and highest).", {"entities": []}], ["Sleep duration of <\u20097\u00a0h/day was defined as insufficient sleep duration according to previous studies.", {"entities": []}], ["To adjust for potential confounders, we performed a multiple log-binominal regression analysis and estimated the prevalence ratios (PRs) and 95% confidence intervals (CIs) for insufficient sleep.", {"entities": []}], ["Overall 42% of the men and 45% of the women had insufficient sleep.", {"entities": []}], ["In the men, the lowest group of neighborhood social capital presented a 22% higher prevalence of insufficient sleep (PR 1.22; 95% CIs 1.08\u20131.38) compared to the highest group of neighborhood social capital.", {"entities": []}], ["Similarly the low group of neighborhood social capital and the high group of neighborhood social capital had 20 and 19% higher prevalence of insufficient sleep (PR 1.20; 95% CIs 1.06\u20131.36; PR 1.19; 95% CIs 1.06\u20131.34, respectively) compared to the highest group of neighborhood social capital.", {"entities": []}], ["For women there was no significant association between neighborhood social capital and insufficient sleep after controlling for all potential confounders.", {"entities": []}], ["Having lower neighborhood social capital was associated with insufficient sleep among Japanese adults, particularly in the men.", {"entities": []}], ["This suggests that the context of neighborhood social capital by gender should be considered to promote healthier behaviors with regard to getting enough sleep.", {"entities": []}], ["The online version of this article (10.1186/s12889-018-5204-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Medical applications (apps) for smart phones and tablet computers are growing in number and are commonly used in healthcare.", {"entities": []}], ["In this context, there is a need for a diverse community of app users, medical researchers, and app developers to better understand the app landscape.", {"entities": [[60, 63, "GENE"], [96, 99, "GENE"], [136, 139, "GENE"], [60, 63, "GENE"], [96, 99, "GENE"], [136, 139, "GENE"], [60, 63, "GENE"], [96, 99, "GENE"], [136, 139, "GENE"]]}], ["In mid-2012, we undertook an environmental scan and classification of the medical app landscape in the two dominant platforms by searching the medical category of the Apple iTunes and Google Play app download sites.", {"entities": [[82, 85, "GENE"], [196, 199, "GENE"], [82, 85, "GENE"], [196, 199, "GENE"]]}], ["We identified target audiences, functions, costs and content themes using app descriptions and captured these data in a database.", {"entities": [[74, 77, "GENE"]]}], ["We only included apps released or updated between October 1, 2011 and May 31, 2012, with a primary \u201cmedical\u201d app store categorization, in English, that contained health or medical content.", {"entities": [[109, 112, "GENE"]]}], ["Our sample of Android apps was limited to the most popular apps in the medical category.", {"entities": []}], ["Our final sample of Apple iOS (n\u2009=\u20094561) and Android (n\u2009=\u2009293) apps illustrate a diverse medical app landscape.", {"entities": [[97, 100, "GENE"]]}], ["The proportion of Apple iOS apps for the public (35%) and for physicians (36%) is similar.", {"entities": []}], ["Few Apple iOS apps specifically target nurses (3%).", {"entities": []}], ["Within the Android apps, those targeting the public dominated in our sample (51%).", {"entities": []}], ["The distribution of app functions is similar in both platforms with reference being the most common function.", {"entities": [[20, 23, "GENE"]]}], ["Most app functions and content themes vary considerably by target audience.", {"entities": [[5, 8, "GENE"]]}], ["Social media apps are more common for patients and the public, while conference apps target physicians.", {"entities": []}], ["We characterized existing medical apps and illustrated their diversity in terms of target audience, main functions, cost and healthcare topic.", {"entities": []}], ["The resulting app database is a resource for app users, app developers and health informatics researchers.", {"entities": [[14, 17, "GENE"], [45, 48, "GENE"], [56, 59, "GENE"], [14, 17, "GENE"], [45, 48, "GENE"], [56, 59, "GENE"], [14, 17, "GENE"], [45, 48, "GENE"], [56, 59, "GENE"]]}], ["The online version of this article (doi:10.1186/1756-0500-7-573) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Quantitative assessments of the health status of a population are essential to make decisions and set priorities in the field of public health.", {"entities": []}], ["Changing epidemiologic patterns increase the demand for comprehensive estimates of population health across the full health spectrum, including non-communicable diseases and injuries.", {"entities": []}], ["Burden of disease (BoD) analysis has helped meet this need.", {"entities": []}], ["With the success of the Global Burden of Disease (GBD) Study, the BoD technique has become predominantly associated with the GBD approach and its methodology using disability-adjusted life year (DALY) has been rapidly disseminated and generally accepted over the last several years.", {"entities": []}], ["The first Korean BoD study using the DALY metric was presented in 2002.", {"entities": []}], ["Various BoD studies have since been conducted, but the DALY concept has remained primarily academic and has not yet been actively utilized in the health policy arena.", {"entities": []}], ["Here, we review the DALY metric and population-based Korean BoD studies using national health data, with the intent of increasing the understanding of their value and their potential role in strengthening future assessments of the Korean population\u2019s health status.", {"entities": []}], ["Various in\u00a0vitro tests assess different aspects of the underlying immune mechanism of IgE-mediated food allergy.", {"entities": [[99, 111, "DISEASE"]]}], ["Some can be used for diagnostic purposes; specific IgE to allergen extracts is widely available; specific IgE to allergen components is used in most specialist centers, and the basophil activation test is becoming increasingly used clinically.", {"entities": []}], ["IgE to allergen peptides, T-cell assays, allergen-specific/total IgE ratios, and allergen-specific IgG4/IgE ratios are currently reserved for research.", {"entities": []}], ["Different factors can modulate the likelihood of IgE-mediated food allergy of a given allergy test result, namely, the patients' age, ethnicity, previous allergic reaction to the identified food, concomitant atopic conditions, and geographical location, and need to be taken into account when interpreting the allergy test results in the clinic.", {"entities": [[62, 74, "DISEASE"]]}], ["The importance of the specific food, the clinical resources available, and patient preferences are additional aspects that need to be considered when deciding whether an oral food challenge is required to reach an accurate diagnosis of IgE-mediated food allergy.", {"entities": [[249, 261, "DISEASE"]]}], ["Low birthweight is associated with a decreased risk of childhood leukemia and an increased risk of both cardiovascular disease and all\u2010cause mortality in adult life.", {"entities": [[65, 73, "DISEASE"], [55, 73, "DISEASE"]]}], ["Possible biological mediators include systemic innate immunity and inflammation.", {"entities": []}], ["We tested the hypothesis that birthweight was inversely associated with serum high sensitivity C reactive protein assay (hsCRP), a measure of both innate immunity and systemic inflammation.", {"entities": []}], ["Data on birthweight and current anthropometric measures along with a range of exposures were collected at 1 and 3 years of age in a population\u2010based cohort study of young children living in Havana, Cuba.", {"entities": []}], ["A total of 986 children aged 3\u2010years\u2010old provided blood samples that were analyzed for serum hsCRP levels.", {"entities": []}], ["Nearly 49% of children had detectable hsCRP levels in their serum.", {"entities": []}], ["Lower birthweight was linearly associated with the natural log of hsCRP levels (beta coefficient \u22120.70 mg\u00a0L Birthweight was inversely associated with serum hsCRP levels in children aged 3 years living in Cuba.", {"entities": []}], ["These observations provide a potential mechanism that is present at the age of 3 years to explain the association between low birthweight and both decreased childhood leukemia and increased cardiovascular disease in adults.", {"entities": [[167, 175, "DISEASE"], [157, 175, "DISEASE"]]}], ["Ankle fractures are one of the more commonly occurring forms of trauma managed by orthopaedic teams worldwide.", {"entities": []}], ["The impacts of these injuries are not restricted to pain and disability caused at the time of the incident, but may also result in long term physical, psychological, and social consequences.", {"entities": []}], ["There are currently no ankle fracture specific patient-reported outcome measures with a robust content foundation.", {"entities": []}], ["This investigation aimed to develop a thematic conceptual framework of life impacts following ankle fracture from the experiences of people who have suffered ankle fractures as well as the health professionals who treat them.", {"entities": []}], ["A qualitative investigation was undertaken using in-depth semi-structured interviews with people (n=12) who had previously sustained an ankle fracture (patients) and health professionals (n=6) that treat people with ankle fractures.", {"entities": []}], ["Interviews were audio-recorded and transcribed.", {"entities": []}], ["Each phrase was individually coded and grouped in categories and aligned under emerging themes by two independent researchers.", {"entities": []}], ["Saturation occurred after 10 in-depth patient interviews.", {"entities": []}], ["Time since injury for patients ranged from 6 weeks to more than 2 years.", {"entities": []}], ["Experience of health professionals ranged from 1 year to 16 years working with people with ankle fractures.", {"entities": []}], ["Health professionals included an Orthopaedic surgeon (1), physiotherapists (3), a podiatrist (1) and an occupational therapist (1).", {"entities": []}], ["The emerging framework derived from patient data included eight themes (Physical, Psychological, Daily Living, Social, Occupational and Domestic, Financial, Aesthetic and Medication Taking).", {"entities": []}], ["Health professional responses did not reveal any additional themes, but tended to focus on physical and occupational themes.", {"entities": []}], ["The nature of life impact following ankle fractures can extend beyond short term pain and discomfort into many areas of life.", {"entities": []}], ["The findings from this research have provided an empirically derived framework from which a condition-specific patient-reported outcome measure can be developed.", {"entities": []}], ["COPD exerts a substantial burden on health and health care systems globally and will continue to do so for the foreseeable future.", {"entities": []}], ["Treatment however can be costly and health care providers are interested in both whether treatments can offer improvements in disease burden and whether they represent value for money.", {"entities": []}], ["Economic evaluations seek to resolve this issue by producing results that can be used to inform and assist the decision maker in allocating scarce health care resources.", {"entities": []}], ["In this paper we introduce economic evaluation and then use these themes to review and critically appraise the existing COPD economic evaluations, in order to assess quality in light of today\u2019s standards.", {"entities": []}], ["The use of existing economic evaluations in informing the decision maker is then discussed.", {"entities": []}], ["Ten out of the fifteen studies were clinical trial or observational study based, and the remaining five on a decision analytic model.", {"entities": []}], ["Study design, interventions, outcome measures and the use of uncertainty varied considerably; consequentially the results are difficult to compare in any consistent manner.", {"entities": []}], ["Efforts for future studies to harmonize study design and methodology, particularly towards adopting a modeling framework, using current treatment as comparator and adopting a common effectiveness measure, such as the QALY, should be made in order to produce results that are comparable and useful to a decision maker.", {"entities": []}], ["Mapping hundreds of genetic variants through genome wide association studies provided an opportunity to gain insights into the pathobiology of immune\u2010mediated diseases.", {"entities": []}], ["However, as most of the disease variants fall outside the gene coding sequences the functional interpretation of the exact role of the associated variants remains to be determined.", {"entities": []}], ["The integration of disease\u2010associated variants with large scale genomic maps of cell\u2010type\u2010specific gene regulation at both chromatin and transcript levels deliver examples of functionally prioritized causal variants and genes.", {"entities": []}], ["In particular, the enrichment of disease variants with histone marks can point towards the cell types most relevant to disease development.", {"entities": []}], ["Furthermore, chromatin contact maps that link enhancers to promoter regions in a direct way allow the identification of genes that can be regulated by the disease variants.", {"entities": []}], ["Candidate genes implicated with such approaches can be further examined through the correlation of gene expression with genotypes.", {"entities": []}], ["Additionally, in the context of immune\u2010mediated diseases it is important to combine genomics with immunology approaches.", {"entities": []}], ["Genotype correlations with the immune system as a whole, as well as with cellular responses to different stimuli, provide a valuable platform for understanding the functional impact of disease\u2010associated variants.", {"entities": []}], ["The intersection of immunogenomic resources with disease\u2010associated variants paints a detailed picture of disease causal mechanisms.", {"entities": []}], ["Here, we provide an overview of recent studies that combine these approaches to identify disease vulnerable pathways.", {"entities": []}], ["Clinicians search PubMed for answers to clinical questions although it is time consuming and not always successful.", {"entities": []}], ["To determine if PubMed used with its Clinical Queries feature to filter results based on study quality would improve search success (more correct answers to clinical questions related to therapy).", {"entities": []}], ["We invited 528 primary care physicians to participate, 143 (27.1%) consented, and 111 (21.0% of the total and 77.6% of those who consented) completed the study.", {"entities": []}], ["Participants answered 14 yes/no therapy questions and were given 4 of these (2 originally answered correctly and 2 originally answered incorrectly) to search using either the PubMed main screen or PubMed Clinical Queries narrow therapy filter via a purpose-built system with identical search screens.", {"entities": []}], ["Participants also picked 3 of the first 20 retrieved citations that best addressed each question.", {"entities": []}], ["They were then asked to re-answer the original 14 questions.", {"entities": []}], ["We found no statistically significant differences in the rates of correct or incorrect answers using the PubMed main screen or PubMed Clinical Queries.", {"entities": []}], ["The rate of correct answers increased from 50.0% to 61.4% (95% CI 55.0%-67.8%) for the PubMed main screen searches and from 50.0% to 59.1% (95% CI 52.6%-65.6%) for Clinical Queries searches.", {"entities": []}], ["These net absolute increases of 11.4% and 9.1%, respectively, included previously correct answers changing to incorrect at a rate of 9.5% (95% CI 5.6%-13.4%) for PubMed main screen searches and 9.1% (95% CI 5.3%-12.9%) for Clinical Queries searches, combined with increases in the rate of being correct of 20.5% (95% CI 15.2%-25.8%) for PubMed main screen searches and 17.7% (95% CI 12.7%-22.7%) for Clinical Queries searches.", {"entities": []}], ["PubMed can assist clinicians answering clinical questions with an approximately 10% absolute rate of improvement in correct answers.", {"entities": []}], ["This small increase includes more correct answers partially offset by a decrease in previously correct answers.", {"entities": []}], ["Reliable data on causes of death form the basis for building evidence on health policy, planning, monitoring, and evaluation.", {"entities": []}], ["In Ethiopia, the majority of deaths occur at home and civil registration systems are not yet functional.", {"entities": []}], ["The main objective of verbal autopsy (VA) is to describe the causes of death at the community or population level where civil registration and death certification systems are weak and where most people die at home without having had contact with the health system.", {"entities": []}], ["Causes of death were classified and prepared based on the International Classification of Diseases (ICD-10).", {"entities": []}], ["The cause of a death was ascertained based on an interview with next of kin or other caregivers using a standardized questionnaire that draws information on signs, symptoms, medical history, and circumstances preceding death.", {"entities": []}], ["The cause of death, or the sequence of causes that led to death, is assigned based on the data collected by the questionnaire.", {"entities": []}], ["The complete VA questionnaires were given to two blinded physicians and reviewed independently.", {"entities": []}], ["A third physician was assigned to review the case when disagreements in diagnosis arose.", {"entities": []}], ["Communicable diseases (519 deaths [48.0%]), non-communicable diseases (377 deaths [34.8%]), and external causes (113 deaths [10.4%]) were the main causes of death between 2007 and 2013.", {"entities": []}], ["Of communicable diseases, tuberculosis (207 deaths [19.7%]), HIV/AIDS (96 deaths [8.9%]) and meningitis (76 deaths [7.0%]) were the most common causes of death.", {"entities": [[26, 38, "DISEASE"], [93, 103, "DISEASE"]]}], ["Tuberculosis, HIV/AIDS, and meningitis were the most common causes of deaths among adults.", {"entities": [[0, 12, "DISEASE"], [28, 38, "DISEASE"]]}], ["Death due to non-communicable diseases showed an increasing trend.", {"entities": []}], ["Increasing community awareness of infections and their interrelationships, tuberculosis case finding, effective local TB programs, successful treatment, and interventions for HIV are supremely important.", {"entities": [[75, 87, "DISEASE"]]}], ["Soluble guanylate cyclase (sGC) has been suggested as a therapeutic target for cardiac ischemia-reperfusion (IR) injury.", {"entities": [[87, 95, "DISEASE"]]}], ["Until now, the molecular mechanism of BAY 60\u20132770, a sGC activator, in cardiac IR injury has not been assessed.", {"entities": []}], ["To identify the cardioprotective effects of BAY 60\u20132770 in IR-injured rat hearts, IR injury was established by occlusion of LAD for 40 min and reperfusion for 7 days, and the effects of BAY 60\u20132770 on myocardial protection were assessed by echocardiography and TTC staining.", {"entities": []}], ["5 nM and 5 \u03bcM of BAY 60\u20132770 were perfused into isolated rat hearts in a Langendorff system.", {"entities": []}], ["After 10- or 30-min reperfusion with BAY 60\u20132770, cGMP and cAMP concentrations and PKG activation status were examined.", {"entities": []}], ["Hearts were also perfused with 1 \u03bcM KT5823 or 100 \u03bcM 5-HD in conjunction with 5 nM Bay 60\u20132770 to evaluate the protective role of PKG.", {"entities": []}], ["Mitochondrial oxidative stress was investigated under hypoxia-reoxygenation in H9c2 cells.", {"entities": []}], ["In IR-injured rat hearts, BAY 60\u20132770 oral administration reduced infarct size by TTC staining and improved left ventricular function by echocardiography.", {"entities": []}], ["Tissue samples from BAY 60-2770-perfused hearts had approximately two-fold higher cGMP levels.", {"entities": []}], ["BAY 60\u20132770 increased PKG activity in the myocardium, and the reduced infarct area by BAY 60\u20132770 was abrogated by KT-5823 in isolated myocardium.", {"entities": []}], ["In H9c2 cardiac myoblasts, hypoxia-reoxygenation-mediated mitochondrial ROS generation was diminished with BAY 60\u20132770 treatment, but was recovered by pretreatment with KT-5823.", {"entities": []}], ["BAY 60\u20132770 demonstrated a protective effect against cardiac IR injury via mitoKATP opening and decreased mitoROS by PKG activation.", {"entities": []}], ["BAY 60\u20132770 has a protective effect against cardiac IR injury via mitoKATP opening and decreased mitoROS by PKG activation.", {"entities": []}], ["These results demonstrated that BAY 60\u20132770 may be used as a therapeutic agent for cardiac IR injury.", {"entities": []}], ["Deep inspirations (DIs) have a dilatory effect on airway smooth muscle (ASM) that helps to prevent or reduce more severe bronchoconstriction in healthy individuals.", {"entities": []}], ["However, this bronchodilation appears to fail in some asthmatic patients or under certain conditions, and the reason is unclear.", {"entities": []}], ["Additionally, quantitative effects of the frequency and magnitude of DIs on bronchodilation are not well understood.", {"entities": []}], ["In the present study, we used a computational model of bronchoconstriction to study the effects of DI volumes, time intervals between intermittent DIs, relative speed of ASM constriction, and ASM activation on bronchoconstriction and the emergence of ventilation defects (VDefs).", {"entities": []}], ["Our results showed a synergistic effect between the volume of DIs and the time intervals between them on bronchoconstriction and VDefs.", {"entities": []}], ["There was a domain of conditions with sufficiently large volumes of DIs and short time intervals between them to prevent VDefs.", {"entities": []}], ["Among conditions without VDefs, larger volumes of DIs resulted in greater airway dilation.", {"entities": []}], ["Similarly, the time interval between DIs, during which the activated ASM re-constricts, affected the amplitude of periodic changes in airway radii.", {"entities": []}], ["Both the relative speed of ASM constriction and ASM activation affected what volume of DIs and what time interval between them could prevent the emergence of VDefs.", {"entities": []}], ["In conclusion, quantitative characteristics of DIs, such as their volume and time interval between them, affect bronchoconstriction and may contribute to difficulties in asthma.", {"entities": [[170, 176, "DISEASE"]]}], ["Better understanding of the quantitative aspects of DIs may result in novel or improved therapeutic approaches.", {"entities": []}], ["This study aims to identify factors associated with poor adherence to COPD treatment in patients receiving a fixed-dose combination (FDC) of inhaled corticosteroids and long-acting \u03b2 2 -agonist (ICS/LABA), focusing on the importance of inhaler devices.", {"entities": []}], ["We conducted a retrospective and multicenter study based on a review of medical registries between 2007 and 2012 of COPD patients (n=1,263) treated with ICS/LABA FDC, whose medical devices were either dry powder inhalers (DPIs) or pressurized metered-dose inhalers (pMDI).", {"entities": []}], ["Medication adherence included persistence outcomes through 18 months and medication possession ratios.", {"entities": []}], ["Data on exacerbations, comorbidities, demographic characteristics, and health care resource utilization were also included as confounders of adherence.", {"entities": []}], ["The analyses revealed that COPD patients whose medication was delivered through a DPI were less likely to have medication adherence compared to patients with pMDI, after adjusting for confounding factors, especially active ingredients.", {"entities": []}], ["Younger groups of patients were less likely to be adherent compared to the oldest group.", {"entities": []}], ["Smoker men were less likely to be adherent compared to women and non-smokers.", {"entities": []}], ["Comorbidities decreased the probability of treatment adherence.", {"entities": []}], ["Those patients that visited their doctor once a month were more likely to adhere to their medication regimen; however, suboptimal adherence was more likely to occur among those patients who visited more than three times per month their doctor.", {"entities": []}], ["We also found that worsening of COPD is negatively associated with adherence.", {"entities": []}], ["According to this study, inhaler devices influence patients\u2019 adherence to long-term COPD medication.", {"entities": []}], ["We also found that DPIs delivering ICS/LABA FDC had a negative impact on adherence.", {"entities": []}], ["Patients\u2019 clinic and socioeconomic characteristics were associated with adherence.", {"entities": []}], ["S100A9 was originally discovered as a factor secreted by inflammatory cells.", {"entities": [[0, 6, "GENE"]]}], ["Recently, S100A9 was found to be associated with several human malignancies.", {"entities": [[10, 16, "GENE"]]}], ["The purpose of this study is to investigate S100A9 expression in gastric cancer and explore its role in cancer progression.", {"entities": [[73, 79, "DISEASE"], [104, 110, "DISEASE"], [44, 50, "GENE"]]}], ["S100A9 expression in gastric tissue samples from 177 gastric cancer patients was assessed by immunohistochemistry.", {"entities": [[61, 67, "DISEASE"], [0, 6, "GENE"]]}], ["The expression of its dimerization partner S100A8 and the S100A8/A9 heterodimer were also assessed by the same method.", {"entities": [[43, 49, "GENE"], [58, 64, "GENE"]]}], ["The effect of exogenous S100A9 on motility of gastric cancer cells AGS and BGC-823 was then investigated.", {"entities": [[54, 60, "DISEASE"], [24, 30, "GENE"]]}], ["S100A9 was specifically expressed by inflammatory cells such as macrophages and neutrophils in human gastric cancer and gastritis tissues.", {"entities": [[120, 129, "DISEASE"], [109, 115, "DISEASE"], [0, 6, "GENE"]]}], ["Statistical analysis showed that a high S100A9 cell count (>\u2009=\u2009200) per 200x magnification microscopic field in cancer tissues was predictive of early stage gastric cancer.", {"entities": [[112, 118, "DISEASE"], [165, 171, "DISEASE"], [40, 46, "GENE"]]}], ["High S100A9-positive cell count was negatively correlated with lymph node metastasis ( P \u2009=\u20090.009) and tumor invasion ( P \u2009=\u20090.011).", {"entities": []}], ["S100A9 was identified as an independent prognostic predictor of overall survival of patients with gastric cancer ( P \u2009=\u20090.04).", {"entities": [[106, 112, "DISEASE"], [0, 6, "GENE"]]}], ["Patients with high S100A9 cell count were with favorable prognosis ( P \u2009=\u20090.021).", {"entities": [[19, 25, "GENE"]]}], ["Further investigation found that S100A8 distribution in human gastric cancer tissues was similar to S100A9.", {"entities": [[70, 76, "DISEASE"], [33, 39, "GENE"], [100, 106, "GENE"]]}], ["However, the number of S100A8-positive cells did not positively correlate with patient survival.", {"entities": []}], ["The inflammatory cells infiltrating cancer were S100A8/A9 negative, while those in gastritis were positive.", {"entities": [[83, 92, "DISEASE"], [36, 42, "DISEASE"]]}], ["Furthermore, exogenous S100A9 protein inhibited migration and invasion of gastric cancer cells.", {"entities": [[82, 88, "DISEASE"], [23, 29, "GENE"]]}], ["Our results suggested S100A9-positive inflammatory cells in gastric cancer tissues are associated with early stage of gastric cancer and good prognosis.", {"entities": [[68, 74, "DISEASE"], [126, 132, "DISEASE"]]}], ["Industry-sponsored clinical trials, in the past performed almost exclusively in more developed countries, now often recruit participants globally.", {"entities": []}], ["However, recruitment from outside high-income countries may not represent the ultimate target population for the intervention.", {"entities": []}], ["Clinical trial registries provide an opportunity to quantify and examine the type of clinical research performed in various geographic regions.", {"entities": []}], ["We sought to characterize industry-sponsored randomized controlled trials conducted in high-income countries and to compare these trials to those performed outside high-income countries.", {"entities": []}], ["Clinical trial data on all industry-funded randomized controlled trials conducted between 2006 and 2014 were obtained from the registry ClinicalTrials.gov.", {"entities": []}], ["Trials were classified according to their study sites as conducted in high or non-high income countries, and data on trial characteristics were collected.", {"entities": []}], ["Of 22,511 relevant trials, a total of 6,085 (27.0\u00a0%) trials included study sites outside a high-income country, and 2,045 (9.1\u00a0%) were conducted exclusively outside high-income countries.", {"entities": []}], ["Of country groups, Central Europe had the greatest number of trials (3,127), followed by Eastern Europe (2,075).", {"entities": []}], ["The percentage of trials with study sites outside high-income countries remained relatively constant over the study period.", {"entities": []}], ["Studies with sites outside high-income countries tended to recruit more participants (median enrolled participants 265 vs. 71, P <0.001), to be longer (median study duration 20 vs. 13\u00a0months, P <0.05), and to study more advanced phase interventions (Phase 3 or 4 trial 58\u00a0% vs. 33\u00a0%, P <0.001).", {"entities": []}], ["More than a quarter of industry-sponsored trials include participants from outside high-income countries and this rate remained stable over the 7-year study period.", {"entities": []}], ["Trials conducted outside high-income countries tend to be larger, have a longer duration, and study later phase interventions compared to studies performed exclusively in high-income countries.", {"entities": []}], ["The online version of this article (doi:10.1186/s12961-015-0019-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity TNFAIP3 mutant truncated proteins are likely to act by haploinsufficiency since they do not exert a dominant-negative effect in overexpression experiments.", {"entities": [[88, 95, "GENE"]]}], ["Patients\u2019 cells show increased degradation of I\u03baB\u03b1 and nuclear translocation of NF\u03baB p65, and increased expression of NF\u03baB-mediated proinflammatory cytokines.", {"entities": []}], ["A20 restricts NF\u03baB signals via deubiquitinating (DUB) activity.", {"entities": []}], ["In cells expressing the mutant A20 protein, there is defective removal of K63-linked ubiquitin from TRAF6, NEMO, and RIP1 after TNF stimulation.", {"entities": [[100, 105, "GENE"], [128, 131, "GENE"]]}], ["NF\u03baB-dependent pro-inflammatory cytokines are potential therapeutic targets for these patients.", {"entities": []}], ["There is a need for new molecular-guided contrast agents to enhance surgical procedures such as tumor resection that require a high degree of precision.", {"entities": []}], ["Cysteine cathepsins are highly up-regulated in a wide variety of cancers, both in tumor cells and in the tumor-supporting cells of the surrounding stroma.", {"entities": []}], ["Therefore, tools that can be used to dynamically monitor their activity in vivo could be used as imaging contrast agents for intraoperative fluorescence image guided surgery (FGS).", {"entities": []}], ["Although multiple classes of cathepsin-targeted substrate probes have been reported, most suffer from overall fast clearance from sites of protease activation, leading to reduced signal intensity and duration in vivo .", {"entities": []}], ["Here we describe the design and synthesis of a series of near-infrared fluorogenic probes that exploit a latent cationic lysosomotropic effect (LLE) to promote cellular retention upon protease activation.", {"entities": []}], ["These probes show tumor-specific retention, fast activation kinetics, and rapid systemic distribution.", {"entities": []}], ["We demonstrate that they are suitable for detection of diverse cancer types including breast, colon and lung tumors.", {"entities": [[63, 69, "DISEASE"]]}], ["Most importantly, the agents are compatible with the existing, FDA approved, da Vinci surgical system for fluorescence guided tumor resection.", {"entities": []}], ["Therefore, our data suggest that the probes reported here can be used with existing clinical instrumentation to detect tumors and potentially other types of inflammatory lesions to guide surgical decision making in real time.", {"entities": []}], ["Allergic reactions towards the birch major pollen allergen Bet v 1 are among the most common causes of spring pollinosis in the temperate climate zone of the Northern hemisphere.", {"entities": []}], ["Natural Bet v 1 is composed of a complex mixture of different isoforms.", {"entities": []}], ["Detailed analysis of recombinant Bet v 1 isoforms revealed striking differences in immunologic as well as allergenic properties of the molecules, leading to a classification of Bet v 1 isoforms into high, medium, and low IgE binding proteins.", {"entities": []}], ["Especially low IgE binding Bet v 1 isoforms have been described as ideal candidates for desensitizing allergic patients with allergen specific immunotherapy (SIT).", {"entities": []}], ["Since diagnosis and therapy of allergic diseases are highly dependent on recombinant proteins, continuous improvement of protein production is an absolute necessity.", {"entities": []}], ["Therefore, two different methods for recombinant production of a low IgE binding Bet v 1 isoform were applied; one based on published protocols, the other by implementing latest innovations in protein production.", {"entities": []}], ["Both batches of Bet v 1.0401 were extensively characterized by an array of physicochemical as well as immunological methods to compare protein primary structure, purity, quantity, folding, aggregation state, thermal stability, and antibody binding capacity.", {"entities": []}], ["The experiments demonstrated that IgE antibody binding properties of recombinant isoallergens can be significantly influenced by the production method directly affecting possible clinical applications of the molecules.", {"entities": []}], ["The emergency department (ED) has a pivotal influence on the management of acute heart failure (AHF), but data concerning current ED management are scarce.", {"entities": []}], ["This Beijing AHF Registry Study investigated the characteristics, ED management, and short- and long-term clinical outcomes of AHF.", {"entities": []}], ["This prospective, multicenter, observational study consecutively enrolled 3335 AHF patients who visited 14 EDs in Beijing from January 1, 2011, to September 23, 2012.", {"entities": []}], ["Baseline data on characteristics and management were collected in the EDs.", {"entities": []}], ["Follow-up data on death and readmissions were collected until November 31, 2013, with a response rate of 92.80%.", {"entities": []}], ["The data were reported as median (interquartile range) for the continuous variables, or as number (percentage) for the categorical variables.", {"entities": []}], ["The median age of the enrolled patients was 71 (58\u201379) years, and 46.84% were women.", {"entities": []}], ["In patients with AHF, coronary heart disease (43.27%) was the most common etiology, and myocardium ischemia (30.22%) was the main precipitant.", {"entities": [[31, 44, "DISEASE"], [22, 44, "DISEASE"], [99, 107, "DISEASE"]]}], ["Most of the patients in the ED received intravenous treatments, including diuretics (79.28%) and vasodilators (74.90%).", {"entities": []}], ["Fewer patients in the ED received neurohormonal antagonists, and 25.94%, 31.12%, and 33.73% of patients received angiotensin converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and spironolactone, respectively.", {"entities": []}], ["The proportions of patients who were admitted, discharged, left against medical advice, and died were 55.53%, 33.58%, 7.08%, and 3.81%, respectively.", {"entities": []}], ["All-cause mortalities at 30 days and 1 year were 15.30% and 32.27%, respectively.", {"entities": []}], ["Substantial details on characteristics and ED management of AHF were investigated.", {"entities": []}], ["The clinical outcomes of AHF patients were dismal.", {"entities": []}], ["Thus, further investigations of ED-based therapeutic approaches for AHF are needed.", {"entities": []}], ["Use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of gastric or oesophageal adenocarcinomas.", {"entities": []}], ["We examined the association between self-reported use of aspirin or non-aspirin NSAIDs in the earlier 12 months and gastric non-cardia ( N =182), gastric cardia ( N =178), and oesophageal adenocarcinomas ( N =228) in a prospective cohort ( N =311\u2009115) followed for 7 years.", {"entities": []}], ["Hazard ratios (HRs) and 95% confidence intervals (CIs) come from Cox models adjusted for potential confounders.", {"entities": []}], ["Use of any aspirin (HR, 95% CI: 0.64, 0.47\u20130.86) or other NSAIDs (0.68, 0.51\u20130.92) was associated with a significantly lower risk of gastric non-cardia adenocarcinoma.", {"entities": [[152, 166, "DISEASE"], [20, 22, "GENE"]]}], ["Neither aspirin (0.86, 0.61\u20131.20) nor other NSAIDs (0.91, 0.67\u20131.22) had a significant association with gastric cardia cancer.", {"entities": [[112, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["We found no significant association between using aspirin (1.00, 0.73\u20131.37) or other NSAIDs (0.90, 69\u20131.17) and oesophageal adenocarcinoma.", {"entities": [[124, 138, "DISEASE"]]}], ["We also performed a meta-analysis of the association between the use of NSAIDs and risk of gastric and oesophageal adenocarcinoma.", {"entities": [[115, 129, "DISEASE"]]}], ["In this analysis, aspirin use was inversely associated with both gastric and oesophageal adenocarcinomas, with summary odds ratios (95% CI) for non-cardia, cardia, and oesophageal adenocarcinomas of 0.64 (0.52\u20130.80), 0.82 (0.65\u20131.04), and 0.64 (0.52\u20130.79), respectively.", {"entities": []}], ["The corresponding numbers for other NSAIDs were 0.68 (0.57\u20130.81), 0.80 (0.67\u20130.95), and 0.65 (0.50\u20130.85), respectively.", {"entities": []}], ["Health-related quality of life (HRQOL) measurement has emerged as an important health outcome in clinical trials, clinical practice improvement strategies, and healthcare services research and evaluation.", {"entities": []}], ["HRQOL measures are also increasingly proposed for use in clinical practice settings to inform treatment decisions.", {"entities": []}], ["In settings where HRQOL measures have been utilized with adults, physicians report such measures as useful, some physicians alter their treatment based on patient reports on such instruments, and patients themselves generally feel the instruments to be helpful.", {"entities": []}], ["However, there is a dearth of studies evaluating the clinical utility of HRQOL measurement in pediatric clinical practice.", {"entities": []}], ["This paper provides an updated review of the literature and proposes a precept governing the application of pediatric HRQOL measurement in pediatric clinical practice.", {"entities": []}], ["Utilizing HRQOL measurement in pediatric healthcare settings can facilitate patient-physician communication, improve patient/parent satisfaction, identify hidden morbidities, and assist in clinical decision-making.", {"entities": []}], ["Demonstrating the utility of pediatric HRQOL measurement in identifying children with the greatest needs, while simultaneously demonstrating the cost advantages of providing timely, targeted interventions to address those needs, may ultimately provide the driving force for incorporating HRQOL measurement in pediatric clinical practice.", {"entities": []}], ["In 2004, a practice charge for physician visits ('Praxisgebuehr') was implemented in the German health care system, mainly in order to reduce expenditures of sickness funds by reducing outpatient physician visits.", {"entities": []}], ["In the statutory sickness funds, all adults now have to pay \u20ac 10 at their first physician visit in each 3 month period, except for vaccinations and preventive services.", {"entities": []}], ["This study looks at the effect of this new patient fee on delaying or avoiding physician visits, with a special emphasis on different income groups.", {"entities": []}], ["Six representative surveys (conducted between 2004 and 2006) of the Bertelsmann Healthcare Monitor were analysed, comprising 7,769 women and men aged 18 to 79 years.", {"entities": []}], ["The analyses are based on stratified analyses and logistic regression models, including a focus on the subgroup having a chronic disease.", {"entities": []}], ["Two results can be highlighted.", {"entities": []}], ["First, avoiding or delaying a physician visit due to this fee is seen most often among younger and healthier adults.", {"entities": []}], ["Second, those in the lowest income group are much more affected in this way than the better of.", {"entities": []}], ["The multivariate analysis in the subgroup of respondents having a chronic disease shows, for example, that this reaction is reported 2.45 times more often in the lowest income group than in the highest income group (95% CI: 1.90\u20133.15).", {"entities": []}], ["The analyses indicate that the effects of the practice charge differ by socio-economic group.", {"entities": []}], ["It would be important to assess these effects in more detail, especially the effects on health care quality and health outcomes.", {"entities": []}], ["It can be assumed, however, that avoiding or delaying physician visits jeopardizes both, and that health inequalities are increasing due to the practice charge.", {"entities": []}], ["Traumatic brain injury (TBI) is a leading cause of death and disability worldwide.", {"entities": []}], ["After the initial primary mechanical injury, a complex secondary injury cascade involving oxidative stress and neuroinflammation follows, which may exacerbate the injury and complicate the healing process.", {"entities": []}], ["NADPH oxidase 2 (NOX2) is a major contributor to oxidative stress in TBI pathology, and inhibition of NOX2 is neuroprotective.", {"entities": []}], ["The NLRP3 inflammasome can become activated in response to oxidative stress, but little is known about the role of NOX2 in regulating NLRP3 inflammasome activation following TBI.", {"entities": [[4, 9, "GENE"], [134, 139, "GENE"], [4, 9, "GENE"], [134, 139, "GENE"]]}], ["In this study, we utilized NOX2 knockout mice to study the role of NOX2 in mediating NLRP3 inflammasome expression and activation following a controlled cortical impact.", {"entities": [[85, 90, "GENE"]]}], ["Expression of NLRP3 inflammasome components NLRP3 and apoptosis-associated speck-like protein containing a CARD (ASC), as well as its downstream products cleaved caspase-1 and interleukin-1 \u03b2 (IL-1 \u03b2 ), was robustly increased in the injured cerebral cortex following TBI.", {"entities": [[14, 19, "GENE"], [44, 49, "GENE"], [14, 19, "GENE"], [44, 49, "GENE"]]}], ["Deletion of NOX2 attenuated the expression, assembly, and activity of the NLRP3 inflammasome via a mechanism that was associated with TXNIP, a sensor of oxidative stress.", {"entities": [[74, 79, "GENE"], [134, 139, "GENE"]]}], ["The results support the notion that NOX2-dependent inflammasome activation contributes to TBI pathology.", {"entities": []}], ["In Mexico, inappropriate prescription of drugs with potential interactions causing serious risks to patient health has been little studied.", {"entities": []}], ["Work in this area has focused mainly on hospitalized patients, with only specific drug combinations analyzed; moreover, the studies have not produced conclusive results.", {"entities": []}], ["In the present study, we determined the frequency of potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age, who used Mexican Institute of Social Security (IMSS) family medicine clinics.", {"entities": []}], ["In addition, we aimed to identify the associated factors for these interactions.", {"entities": []}], ["We collected information on general patient characteristics, medical histories, and medication (complete data).", {"entities": []}], ["The study included 624 ambulatory patients over 50 years of age, with non-malignant pain syndrome, who made ambulatory visits to two IMSS family medicine clinics in Mexico City.", {"entities": [[89, 97, "DISEASE"]]}], ["The patients received 7-day prescriptions for non-opioid analgesics.", {"entities": []}], ["The potential interactions were identified by using the Thompson Micromedex program.", {"entities": []}], ["Data were analyzed using descriptive, bivariate and multiple logistic regression analyses.", {"entities": []}], ["The average number of prescribed drugs was 5.9 \u00b1 2.5.", {"entities": []}], ["About 80.0% of patients had prescriptions implying one or more potential drug-drug interactions and 3.8% of patients were prescribed drug combinations with interactions that should be avoided.", {"entities": []}], ["Also, 64.0% of patients had prescriptions implying one or more potential drug disease interactions.", {"entities": []}], ["The factors significantly associated with having one or more potential interactions included: taking 5 or more medicines (adjusted Odds Ratio (OR): 4.34, 95%CI: 2.76\u20136.83), patient age 60 years or older (adjusted OR: 1.66, 95% CI: 1.01\u20132.74) and suffering from cardiovascular diseases (adjusted OR: 7.26, 95% CI: 4.61\u201311.44).", {"entities": []}], ["The high frequency of prescription of drugs with potential drug interactions showed in this study suggests that it is common practice in primary care level.", {"entities": []}], ["To lower the frequency of potential interactions it could be necessary to make a careful selection of therapeutic alternatives, and in cases without other options, patients should be continuously monitored to identify adverse events.", {"entities": []}], ["A proper balance between different T helper (Th) cell subsets is necessary for normal functioning of the adaptive immune system.", {"entities": []}], ["Revealing key genes and pathways driving the differentiation to distinct Th cell lineages provides important insight into underlying molecular mechanisms and new opportunities for modulating the immune response.", {"entities": []}], ["Previous computational methods to quantify and visualize kinetic differential expression data of three or more lineages to identify reciprocally regulated genes have relied on clustering approaches and regression methods which have time as a factor, but have lacked methods which explicitly model temporal behavior.", {"entities": []}], ["We studied transcriptional dynamics of human umbilical cord blood T helper cells cultured in absence and presence of cytokines promoting Th1 or Th2 differentiation.", {"entities": []}], ["To identify genes that exhibit distinct lineage commitment dynamics and are specific for initiating differentiation to different Th cell subsets, we developed a novel computational methodology (LIGAP) allowing integrative analysis and visualization of multiple lineages over whole time-course profiles.", {"entities": []}], ["Applying LIGAP to time-course data from multiple Th cell lineages, we identified and experimentally validated several differentially regulated Th cell subset specific genes as well as reciprocally regulated genes.", {"entities": []}], ["Combining differentially regulated transcriptional profiles with transcription factor binding site and pathway information, we identified previously known and new putative transcriptional mechanisms involved in Th cell subset differentiation.", {"entities": []}], ["All differentially regulated genes among the lineages together with an implementation of LIGAP are provided as an open-source resource.", {"entities": []}], ["The LIGAP method is widely applicable to quantify differential time-course dynamics of many types of datasets and generalizes to any number of conditions.", {"entities": []}], ["It summarizes all the time-course measurements together with the associated uncertainty for visualization and manual assessment purposes.", {"entities": []}], ["Here we identified novel human Th subset specific transcripts as well as regulatory mechanisms important for the initiation of the Th cell subset differentiation.", {"entities": []}], ["To assess the efficacy and effectiveness of seasonal influenza vaccines in healthy children up to the age of 18 years.", {"entities": [[53, 62, "DISEASE"]]}], ["MedLine, EMBASE, CENTRAL, CINAHL, WHOLIS, LILACS, and Global Health were searched for randomized controlled trials and cohort and case-control studies investigating the efficacy or effectiveness of influenza vaccines in healthy children up to the age of 18 years.", {"entities": [[198, 207, "DISEASE"]]}], ["The studies were assessed for their quality and data on the outcomes of influenza-like illness, laboratory-confirmed influenza, and hospitalizations were extracted.", {"entities": [[72, 81, "DISEASE"], [117, 126, "DISEASE"]]}], ["Seven meta-analyses were performed for different vaccines and different study outcomes.", {"entities": []}], ["Vaccine efficacy for live vaccines, using random effects model, was as follows: (i) for similar antigen, using per-protocol analysis: 83.4% (78.3%-88.8%); (ii) for similar antigen, using intention to treat analysis: 82.5 (76.7%-88.6%); (iii) for any antigen, using per protocol analysis: 76.4% (68.7%-85.0%); (iv) for any antigen, using intention to treat analysis: 76.7% (68.8%-85.6%).", {"entities": []}], ["Vaccine efficacy for inactivated vaccines, for similar antigen, using random effects model, was 67.3% (58.2%-77.9%).", {"entities": []}], ["Vaccine effectiveness against influenza-like illness for live vaccines, using random effects model, was 31.4% (24.8%-39.6%) and using fixed-effect model 44.3% (42.6%-45.9%).", {"entities": [[30, 39, "DISEASE"]]}], ["Vaccine effectiveness against influenza-like illness for inactivated vaccines, using random effects model, was 32.5% (20.0%-52.9%) and using fixed-effect model 42.6% (38.3%-47.5%).", {"entities": [[30, 39, "DISEASE"]]}], ["Influenza vaccines showed high efficacy in children, particularly live vaccines.", {"entities": [[0, 9, "DISEASE"]]}], ["Effectiveness was lower and the data on hospitalizations were very limited.", {"entities": []}], ["Millions of people who need treatment for substance use disorders (SUD) do not receive it.", {"entities": []}], ["Evidence-based practices for treating SUD exist, and some are appropriate for delivery outside of specialty care settings.", {"entities": []}], ["Primary care is an opportune setting in which to deliver SUD treatment because many individuals see their primary care providers at least once a year.", {"entities": []}], ["Further, the Patient Protection and Affordable Care Act (PPACA) increases coverage for SUD treatment and is increasing the number of individuals seeking primary care services.", {"entities": []}], ["In this article, we present the protocol for a study testing the effects of an organizational readiness and service delivery intervention on increasing the uptake of SUD treatment in primary care and on patient outcomes.", {"entities": []}], ["In a randomized controlled trial, we test the combined effects of an organizational readiness intervention consisting of implementation tools and activities and an integrated collaborative care service delivery intervention based on the Chronic Care Model on service system (patient-centered care, utilization of substance use disorder treatment, utilization of health care services and adoption and sustainability of evidence-based practices) and patient (substance use, consequences of use, health and mental health, and satisfaction with care) outcomes.", {"entities": []}], ["We also use a repeated measures design to test organizational changes throughout the study, such as acceptability, appropriateness and feasibility of the practices to providers, and provider intention to adopt the practices.", {"entities": []}], ["We use provider focus groups, provider and patient surveys, and administrative data to measure outcomes.", {"entities": []}], ["The present study responds to critical gaps in health care services for people with substance use disorders, including the need for greater access to SUD treatment and greater uptake of evidence-based practices in primary care.", {"entities": []}], ["We designed a multi-level study that combines implementation tools to increase organizational readiness to adopt and sustain evidence-based practices (EBPs) and tests the effectiveness of a service delivery intervention on service system and patient outcomes related to SUD services.", {"entities": []}], ["Current controlled trials: NCT01810159 The online version of this article (doi:10.1186/s13012-015-0256-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Egyptian government introduced the first directly acting antivirals (DAAs) into Egypt through the government funded National Treatment Program.", {"entities": []}], ["As yet, there has been no investigation into the effects of these new DAAs therapies on patient reported outcomes (PROs).", {"entities": []}], ["This study aimed to (1) assess the PROs (health-related quality of life (HRQoL), mental health and perceived social support) of HCV patients receiving DAAs therapy prior, during and at the end of therapy; (2) evaluate PROs of Interferon-free (dual) users versus Interferon-containing (triple) users cross the three different time periods; and (3) identify the predictors of HRQoL of DAAs therapy users cross the three different time periods.", {"entities": []}], ["A prospective observational design was used.", {"entities": []}], ["Patients with chronic HCV undergoing treatment following the Egyptian National Guidelines at one of the national treatment centers were approached.", {"entities": []}], ["Data collection occurred in the period from February to October 2015.", {"entities": []}], ["Data was collected at three time points: (1) baseline (time 0: T0), before initiating therapy); (2) 5/6\u00a0weeks after initiation of therapy (time 1 of therapy: T1) and at the end of the therapy (Time 2: T2).", {"entities": []}], ["Four PROs questionnaires were utilized for data collection: (1) Multidimensional Scale of Perceived Social Support (MSPSS), (2) The Depression Anxiety Stress Scales (DASS-21), (3) the Liver Disease Symptom Index-2.0 (LDSI-2.0) for testing disease specific HRQoL and (4) the Center for Adherence Support Evaluation (CASE) Index, alongside the background data sheet.", {"entities": []}], ["Sixty-two patients participated.", {"entities": []}], ["There was a change in HRQoL, symptom experience and mental health across the three different time periods.", {"entities": []}], ["HRQoL was impaired more after starting the course of therapy (T1) than at baseline (T0) and end of therapy (T2), z\u2009\u2265\u2009-2.04, p \u2009\u2264\u2009.04.", {"entities": []}], ["Also, symptom experience deteriorated more during the treatment period than at the baseline, Z\u2009\u2265\u2009-1.97, p \u2009\u2264\u2009.04.", {"entities": []}], ["Anxiety and stress were significantly higher during the treatment period than at the end of treatment.", {"entities": []}], ["Perceived social support was significantly higher during the treatment period than at baseline and end of therapy, Z\u2009\u2265\u2009-2.27, p \u2009\u2264\u2009.023.", {"entities": []}], ["During the course of therapy, triple users were more likely to report poorer HRQoL and anxiety than dual users ( p \u2009\u2264\u2009.04).", {"entities": []}], ["By the end of therapy, the two arms of therapy had no significant differences in any of the PROs.", {"entities": []}], ["At baseline, the predictor model significantly ( p \u2009=\u2009.000) explained 37.5% of the variation in the HRQoL prior to therapy.", {"entities": []}], ["Depression was the main variable that contributed to (41.3%) predicting change in HRQoL prior to therapy.", {"entities": []}], ["During therapy, the model significantly ( p \u2009=\u2009.000) explained 76% of the variation in the HRQoL-T1.", {"entities": []}], ["Stress-T1, body mass index (BMI)-T1 and HRQoL-T0 significantly and respectively predicted 44.4, 46.5 and 31.1% of the variation in HRQoL-T1.", {"entities": []}], ["At the end of therapy, the model significantly ( p \u2009=\u2009.000) predicted 80.5% of the variation in the HRQoL-T2.", {"entities": []}], ["HRQoL-T1 and anxiety-T2 significantly predicted 72.3 and 61.6% of the variation in HRQoL-T2.", {"entities": []}], ["Baseline HRQoL, depression and BMI should be systematically assessed before starting the antiviral therapy for early detection and the improvement of the impairment before the initiation of therapy.", {"entities": []}], ["Anxiety should be frequently assessed and followed up through the course of antiviral therapy.", {"entities": []}], ["The triple group required more nursing and practitioner attention due to increased anxiety levels and impaired HRQoL during the treatment therapy.", {"entities": []}], ["Understanding the link between vaccine immunogenicity and efficacy is currently a major focus in HIV research.", {"entities": []}], ["Consequently, recent developments in the HIV-1 vaccine field have led to a closer look at immune responses to known efficacious vaccines.", {"entities": []}], ["We undertook a study to explore clinical predictors of vaccine efficacy following recombinant hepatitis B (rHBV) vaccination in a cohort of HIV-uninfected, hepatitis B virus na\u00efve women living in a peri-urban setting in Cape Town.", {"entities": [[94, 103, "DISEASE"], [156, 165, "DISEASE"]]}], ["Our aim was to define host biological risk factors associated with lack of vaccine uptake.", {"entities": []}], ["We found a significant association (p=0.009) between body mass index (BMI) and lack of vaccine-specific IgG titre (<10mIU/mL).", {"entities": []}], ["Obese individuals (BMI \u2265 30kg/m", {"entities": []}], ["Macrophages are an integral part of the innate immune system and key players in pathogen clearance and tissue remodelling.", {"entities": []}], ["Both functions are accomplished by a pivotal network of different macrophage subtypes, including proinflammatory M1 and anti-inflammatory M2 macrophages.", {"entities": []}], ["Previously, our laboratory identified the transcription factor interferon regulatory factor 5 (IRF5) as the master regulator of the M1 macrophage polarisation.", {"entities": [[95, 99, "GENE"]]}], ["IRF5 was found to be highly expressed in human M1 compared to M2 macrophages.", {"entities": [[0, 4, "GENE"]]}], ["Furthermore, IRF5 dictates the expression of proinflammatory genes such as IL12b and IL23a whilst repressing anti-inflammatory genes like IL10 .", {"entities": [[13, 17, "GENE"], [75, 80, "GENE"], [85, 90, "GENE"], [138, 142, "GENE"]]}], ["Here we show that murine bone marrow derived macrophages differentiated in vitro with GM-CSF are also characterised by high levels of IRF5 mRNA and protein and express proinflammatory cytokines upon LPS stimulation.", {"entities": [[134, 138, "GENE"]]}], ["These macrophages display characteristic expression of M1-marker MHC II but lack the M2-marker CD206.", {"entities": []}], ["Significantly, we develop intracellular staining of IRF5- expressing macrophages and utilise it to recapitulate the in vitro results in an in vivo model of antigen-induced arthritis, emphasising their physiological relevance.", {"entities": [[172, 181, "DISEASE"]]}], ["Thus, we establish the species-invariant role of IRF5 in controlling the inflammatory macrophage phenotype both in vitro and in in vivo .", {"entities": [[49, 53, "GENE"]]}], ["Asthma is a chronic respiratory disease known for its high susceptibility to environmental exposure.", {"entities": [[0, 6, "DISEASE"]]}], ["Inadvertent inhalation of engineered or incidental nanomaterials is a concern for human health, particularly for those with underlying disease susceptibility.", {"entities": []}], ["In this review we provide a comprehensive analysis of those studies focussed on safety assessment of different nanomaterials and their unique characteristics on asthma and allergic airway disease.", {"entities": [[161, 167, "DISEASE"]]}], ["These include in vivo and in vitro approaches as well as human and population studies.", {"entities": []}], ["The weight of evidence presented supports a modifying role for nanomaterial exposure on established asthma as well as the development of the condition.", {"entities": [[100, 106, "DISEASE"]]}], ["Due to the variability in modelling approaches, nanomaterial characterisation and endpoints used for assessment in these studies, there is insufficient information for how one may assign relative hazard potential to individual nanoscale properties.", {"entities": []}], ["New developments including the adoption of standardised models and focussed in vitro and in silico approaches have the potential to more reliably identify properties of concern through comparative analysis across robust and select testing systems.", {"entities": []}], ["Importantly, key to refinement and choice of the most appropriate testing systems is a more complete understanding of how these materials may influence disease at the cellular and molecular level.", {"entities": []}], ["Detailed mechanistic insight also brings with it opportunities to build important population and exposure susceptibilities into models.", {"entities": []}], ["Ultimately, such approaches have the potential to more clearly extrapolate relevant toxicological information, which can be used to improve nanomaterial safety assessment for human disease susceptibility.", {"entities": []}], ["The online version of this article (10.1186/s12989-017-0228-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Welfare dependence and low work participation among young people have raised concern in many European countries.", {"entities": []}], ["Reading and writing difficulties (RWD) might make young people vulnerable to work integration problems and welfare dependence through negative influences on education and health.", {"entities": []}], ["Our main objective of this study was to examine if RWD in adolescence affected the risk of welfare dependence in young adulthood.", {"entities": []}], ["Baseline information on self-reported RWD, health and family was obtained for 8950 school-attending adolescents in Nord-Tr\u00f8ndelag County, Norway, participating in the Young-HUNT1 survey, 1995-97.", {"entities": []}], ["All individuals were linked to biological parents to identify siblings and parental education from national registers.", {"entities": []}], ["Welfare dependence was assessed by the reception of social benefits (medical and economic) from the national social insurance database (1998-2007).", {"entities": []}], ["Only long-term benefits (> 180 days) were included.", {"entities": []}], ["The adolescents who reported RWD at baseline were more likely to receive medical or social benefits during follow-up compared with those who did not report RWD.", {"entities": []}], ["In girls with RWD, the adjusted 5-year risk (at age 24 to 28) for receiving medical benefits was 0.20 (95% confidence interval 0.14-0.26), compared with 0.11 (0.09-0.12) in girls without RWD.", {"entities": []}], ["In boys the corresponding risks were 0.13 (0.09-0.17) and 0.08 (0.07-0.09).", {"entities": []}], ["The associations between RWD in adolescence and welfare dependence later in life suggest that increased attention should be paid to these problems when discussing the public health aspects of work integration, since there might be a potential for prevention.", {"entities": []}], ["To study the protecting effects of dexamethasone on thymus of rats with severe acute pancreatitis (SAP).", {"entities": [[85, 97, "DISEASE"], [79, 97, "DISEASE"]]}], ["The SAP rats were randomly assigned to the model group and dexamethasone-treated group, the other normal healthy rats were assigned to the sham operation group.", {"entities": []}], ["The rat survival, thymus pathological changes, apoptotic index, as well as expression levels of NF- \u03ba B, P-selectin, Bax, Bcl-2, and Caspase-3 protein of all groups were observed, respectively, at 3 hours, 6 hours, and 12 hours.", {"entities": [[117, 120, "GENE"]]}], ["The contents of amylase and endotoxin in plasma as well as the contents of TNF- \u03b1 , PLA 2 , and NO in serum were determined.", {"entities": []}], ["There was no marked difference between the model group and treated group in survival.", {"entities": []}], ["The contents of different indexes in blood of treated group were lower than those of the model group to various degrees at different time points.", {"entities": []}], ["The thymus pathological score was lower in treated group than in model group at 12 hours.The treated group in Caspase-3 protein expression of thymus significantly exceeded the model group at 12 hours.", {"entities": []}], ["The apoptotic index was significantly higher in treated group than in model group.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Dexamethasone has protecting effects on thymus of SAP rats.", {"entities": []}], ["While antismoking media campaigns have demonstrated effectiveness, less is known about the country-level effects of increased media dosing.", {"entities": []}], ["The 2012 US Tips From Former Smokers (Tips) campaign generated approximately 1.6 million quit attempts overall; however, the specific dose\u2013response from the campaign was only assessed by self-report.", {"entities": []}], ["Assess the impact of higher ad exposure during the 2013 Tips campaign on quit-related behaviours and intentions, campaign awareness, communication about campaign, and disease knowledge.", {"entities": []}], ["A 3-month national media buy was supplemented within 67 (of 190) randomly selected local media markets.", {"entities": []}], ["Higher-dose markets received media buys 3 times that of standard-dose markets.", {"entities": []}], ["We compared outcomes of interest using data collected via web-based surveys from nationally representative, address-based probability samples of 5733 cigarette smokers and 2843 non-smokers.", {"entities": []}], ["In higher-dose markets, 87.2% of smokers and 83.9% of non-smokers recalled television campaign exposure versus 75.0% of smokers and 73.9% of non-smokers in standard-dose markets.", {"entities": []}], ["Among smokers overall, the relative quit attempt rate was 11% higher in higher-dose markets (38.8% vs 34.9%; p<0.04).", {"entities": []}], ["The higher-dose increase was larger in African-Americans (50.9% vs 31.8%; p<0.01).", {"entities": []}], ["Smokers in higher-dose markets without a mental health condition, with a chronic health condition, or with only some college education made quit attempts at a higher rate than those in standard-dose markets.", {"entities": []}], ["Non-smokers in higher-dose markets were more likely to talk with family or friends about smoking dangers (43.1% vs 35.7%; p<0.01) and had greater knowledge of smoking-related diseases.", {"entities": []}], ["The US 2013 Tips antismoking media campaign compared standard and higher doses by randomisation of local media markets.", {"entities": []}], ["Results demonstrate the effectiveness of a higher dose for engaging non-smokers and further increasing quit attempts among smokers, especially African-Americans.", {"entities": []}], ["Air pollution is one of the leading global public health risks but its magnitude in many developing countries\u2019 cities is not known.", {"entities": []}], ["We aimed to measure the concentration of particulate matter with aerodynamic diameter <2.5 \u00b5m (PM 2.5 ), nitrogen dioxide (NO 2 ), sulfur dioxide (SO 2 ), and ozone (O 3 ) pollutants in two Ugandan cities (Kampala and Jinja).", {"entities": []}], ["PM 2.5 , O 3 , temperature and humidity were measured with real-time monitors, while NO 2 and SO 2 were measured with diffusion tubes.", {"entities": []}], ["We found that the mean concentrations of the air pollutants PM 2.5 , NO 2 , SO 2 and O 3 were 132.1 \u03bcg/m 2.5 concentration is 5.3 times the World Health Organization (WHO) cut-off limits while the NO 2 , SO 2 and O 3 concentrations are below WHO cut-off limits.", {"entities": []}], ["PM 2.5 levels were higher in Kampala than in Jinja (138.6 \u03bcg/m vs. 99.3 \u03bcg/m vs. 120.5 \u03bcg/m 2.5 concentrations (152.6 \u03bcg/m", {"entities": []}], ["Expression of the platelet-activating factor receptor is upregulated in the respiratory epithelium of smokers and chronic obstructive pulmonary disease patients.", {"entities": [[114, 151, "DISEASE"]]}], ["We have recently determined that increased expression of PAFr correlates with higher levels of adhesion to human bronchial epithelial cells by non-typable Haemophilus influenzae and Streptococcus pneumoniae which are major bacterial pathogens in acute exacerbations of COPD.", {"entities": []}], ["In addition, we found that a PAFr antagonist decreased the adhesion of both respiratory bacterial pathogens to non-cigarette exposure control levels.", {"entities": []}], ["This highlights the possibility that epithelial receptors, that are upregulated in response to cigarette smoke, could be targeted to specifically block chronic bacterial infections of the lower respiratory tract.", {"entities": []}], ["In this commentary, we explore the question of whether adhesion to a temporally-upregulated host receptor is a common event in chronic bacterial disease, and as such, could represent a putative therapeutic target for blocking infection by respiratory and other pathogens.", {"entities": []}], ["The Chinese herbal Bufei Jianpi formula (BJF) provides an effective treatment option for chronic obstructive pulmonary disease (COPD).", {"entities": [[89, 126, "DISEASE"]]}], ["However, the systems-level mechanism underlying the clinical effects of BJF on COPD remains unknown.", {"entities": []}], ["In this study, a systems pharmacology model based on absorption filtering, network targeting, and systems analyses was applied specifically to clarify the active compounds and therapeutic mechanisms of BJF.", {"entities": []}], ["Then, a rat model of cigarette smoke- and bacterial infection-induced COPD was used to investigate the therapeutic mechanisms of BJF on COPD and its comorbidity.", {"entities": []}], ["The pharmacological system successfully identified 145 bioactive ingredients from BJF and revealed 175 potential targets.", {"entities": []}], ["There was a significant target overlap between the herbal constituents of BJF.", {"entities": []}], ["These results suggested that each herb of BJF connected with similar multitargets, indicating potential synergistic effects among them.", {"entities": []}], ["The integrated target\u2013disease network showed that BJF probably was efficient for the treatment of not only respiratory tract diseases but also other diseases, such as nervous system and cardiovascular diseases.", {"entities": []}], ["The possible mechanisms of action of BJF were related to activation of inflammatory response, immune responses, and matrix metalloproteinases, among others.", {"entities": []}], ["Furthermore, we demonstrated that BJF treatment could effectively prevent COPD and its comorbidities, such as ventricular hypertrophy, by inhibition of inflammatory cytokine production, matrix metalloproteinases expression, and other cytokine production in vivo.", {"entities": []}], ["This study using the systems pharmacology method, in combination with in vivo experiments, helped us successfully dissect the molecular mechanism of BJF for the treatment of COPD and predict the potential targets of the multicomponent BJF, which provides a new approach to illustrate the synergetic mechanism of the complex prescription and discover more effective drugs against COPD.", {"entities": []}], ["BrdU is a commonly used reagent in cell proliferation assays, and WST-1 measurement is widely used to detect cell viability.", {"entities": []}], ["However, no previous study has formally reported the combination of the two assays, which may be used to detect the proliferation and viability simultaneously.", {"entities": []}], ["In this study, we examined the effect of adding BrdU 2\u00a0h prior to the WST-1 assay and tried to test the possibility of the combined detection using rat airway smooth muscle cells.", {"entities": []}], ["The WST-1 measurements obtained from the combined detection were consistent with those obtained from the separate detection, which suggested that the addition of BrdU 2\u00a0h prior to the WST-1 analysis did not affect the WST-1 results.", {"entities": []}], ["The BrdU measurements obtained from the combined detection also demonstrated the same trend as that obtained from the separate detection, and dosages of 200, 400 and 800\u00a0ng/ml testing reagent significantly inhibited the proliferation of rat airway smooth muscle cells.", {"entities": []}], ["Our study suggests that the BrdU and WST-1 measurements can be applied simultaneously without mutual interference, which may increase the efficacy and consistency of these measurements to a certain extent.", {"entities": []}], ["Chronic systemic inflammation triggers alterations in the central nervous system that may relate to the underlying inflammatory component reported in neurodegenerative disorders such as multiple sclerosis and Alzheimer's disease.", {"entities": [[186, 204, "DISEASE"]]}], ["However, it is far from being understood whether and how peripheral inflammation contributes to induce brain inflammatory response in such illnesses.", {"entities": []}], ["As part of the barriers that separate the blood from the brain, the choroid plexus conveys inflammatory immune signals into the brain, largely through alterations in the composition of the cerebrospinal fluid.", {"entities": []}], ["In the present study we investigated the mouse choroid plexus gene expression profile, using microarray analyses, in response to a repeated inflammatory stimulus induced by the intraperitoneal administration of lipopolysaccharide every two weeks for a period of three months; mice were sacrificed 3 and 15 days after the last lipopolysaccharide injection.", {"entities": []}], ["The data show that the choroid plexus displays a sustained response to the repeated inflammatory stimuli by altering the expression profile of several genes.", {"entities": []}], ["From a total of 24,000 probes, 369 are up-regulated and 167 are down-regulated 3 days after the last lipopolysaccharide injection, while at 15 days the number decreases to 98 and 128, respectively.", {"entities": []}], ["The pathways displaying the most significant changes include those facilitating entry of cells into the cerebrospinal fluid, and those participating in the innate immune response to infection.", {"entities": []}], ["These observations contribute to a better understanding of the brain response to peripheral inflammation and pave the way to study their impact on the progression of several disorders of the central nervous system in which inflammation is known to be implicated.", {"entities": []}], ["A case-control study of the aetiology of testicular cancer was conducted using information obtained by interview and from case-notes of 259 cases with testicular cancer and two sets of control patients -238 men with diagnoses other than testicular cancer attending the same radiotherapy centres as those attended by the cases, and 251 hospital in-patients not attending radiotherapy departments.", {"entities": [[41, 58, "DISEASE"], [151, 168, "DISEASE"], [237, 254, "DISEASE"], [52, 58, "DISEASE"], [162, 168, "DISEASE"], [248, 254, "DISEASE"]]}], ["Logistic regression analyses were performed, after stratifying by age and region of residence, to estimate the relative risks (RRs) associated with various aspects of prior medical history.", {"entities": []}], ["The risk of testicular cancer was found to be raised for men with a history of cryptorchidism (RR based on comparison with all controls = 6.3; P less than 0.001), inguinal hernia (RR = 1.6; P = 0.14), mumps orchitis (RR = 12.7; P = 0.006), atopy (RR = 1.8; P = 0.03), and meningitis (RR = 3.0; P = 0.21).", {"entities": [[207, 215, "DISEASE"], [79, 93, "DISEASE"], [272, 282, "DISEASE"], [12, 29, "DISEASE"], [23, 29, "DISEASE"], [201, 206, "DISEASE"]]}], ["Inguinal herniorrhaphy before the age of 15 years was particularly a risk factor for seminoma, whereas the relative risks were similar for seminoma and teratoma for the other factors.", {"entities": [[152, 160, "DISEASE"], [85, 93, "DISEASE"], [139, 147, "DISEASE"]]}], ["The results add to the growing evidence that congenital abnormalities involving the process of testicular descent and closure of the processus vaginalis are risk factors for testicular cancer, and that some types of testicular damage later in life may also be important.", {"entities": [[174, 191, "DISEASE"], [185, 191, "DISEASE"]]}], ["The findings of associations with previous atopy and certain infections suggest a possible second aetiological mechanism - that immunological abnormalities may be associated with an increased risk of testis cancer.", {"entities": [[207, 213, "DISEASE"]]}], ["Clinical characteristics of human bocavirus (HBoV) infection have been studied worldwide, but their importance of those characteristics remains unknown.", {"entities": []}], ["We investigated distinctive clinical features of HBoV-positive children with lower respiratory tract infection (LRTI).", {"entities": []}], ["During April 2007\u2013July 2009, for 402 hospitalized children younger than 2\u00a0years with LRTI, we prospectively examined virus genomes in nasopharyngeal swabs for HBoV, respiratory syncytial virus (RSV), rhinovirus, metapneumovirus, parainfluenzavirus, and adenovirus.", {"entities": []}], ["The HBoV genomes were identified in 34 patients (8.5%).", {"entities": []}], ["Clinical and laboratory data of HBoV-positive and other virus/bacteria-negative patients ( n \u2009=\u200918) were analyzed and compared with data of RSV-single positive patients ( n \u2009=\u200999).", {"entities": []}], ["The seasonal distribution of HBoV exhibits a concentration of cases during March\u2013September, with most RSV cases occurring during winter in Japan.", {"entities": []}], ["The minimum age of HBoV-positive patients was 5\u00a0months, although 44 patients (44%) with RSV were younger than 6\u00a0months.", {"entities": []}], ["The main clinical features were respiratory distress and hypoxia.", {"entities": []}], ["Hypoxia advances within 3\u00a0days after onset.", {"entities": []}], ["The mean oxygen saturation on arrival was 92.8%, which was significantly lower than that in patients with RSV ( p \u2009<\u20090.001).", {"entities": []}], ["White blood cell counts were similar among groups.", {"entities": []}], ["However, the percentage of neutrophils in white blood cells were significantly higher in HBoV-positive patients (62 vs. 45%, p \u2009<\u20090.001).", {"entities": []}], ["Their prognoses were good.", {"entities": []}], ["Their hospital stays were 6.6\u00a0days.", {"entities": []}], ["HBoV-single positive patients show several clinical characteristics, such as seasonality, age, hypoxia, and neutrophilia, which differ from those with RSV infection.", {"entities": []}], ["Identification of sensitive and specific biomarkers with clinical and translational utility will require smart experimental strategies that would augment expanding the breadth and depth of molecular measurements within the constraints of currently available technologies.", {"entities": []}], ["Exosomes represent an information rich matrix to discern novel disease mechanisms that are thought to contribute to pathologies such as dementia and cancer.", {"entities": [[136, 144, "DISEASE"], [149, 155, "DISEASE"]]}], ["Although proteomics and transcriptomic studies have been reported using Exosomes-Like Vesicles (ELVs) from different sources, exosomal metabolome characterization and its modulation in health and disease remains to be elucidated.", {"entities": []}], ["Here we describe methodologies for UPLC-ESI-MS based small molecule profiling of ELVs from human plasma and cell culture media.", {"entities": []}], ["In this study, we present evidence that indeed ELVs carry a rich metabolome that could not only augment the discovery of low abundance biomarkers but may also help explain the molecular basis of disease progression.", {"entities": []}], ["This approach could be easily translated to other studies seeking to develop predictive biomarkers that can subsequently be used with simplified targeted approaches.", {"entities": []}], ["Microwave ablation (MWA) is a new technology developed in recent years, which is widely used in various disciplines.", {"entities": []}], ["Microwave ablation is an alternative to surgery in the management of various tumors, and it has been demonstrated to be effective in the management of primary tumors and metastatic tumors.", {"entities": []}], ["Microwave ablation is widely used in the treatment of hepatocellular carcinoma with an obvious effect and less side effects, and only 2.7% had serious complications.", {"entities": [[54, 78, "DISEASE"], [69, 78, "DISEASE"]]}], ["Many studies have confirmed the complications are thermal damage, hemorrhage, pleural effusion, bile leak, tumor seeding, hepatic abscess, cholangitis, and so forth.", {"entities": [[139, 150, "DISEASE"]]}], ["But diaphragm perforation is rare, and it is probably the first case reported.", {"entities": []}], ["This article describes diaphragmatic perforation secondary to MWA of the liver with subsequent pleural effusion and diaphragmatic hernia.", {"entities": []}], ["We also describe its management via the laparoscopic approach.", {"entities": []}], ["Viral and bacterial infections are the most common causes of chronic obstructive pulmonary disease (COPD) exacerbations.", {"entities": [[61, 98, "DISEASE"]]}], ["Whether serum inflammatory markers can differentiate bacterial from virus infection in patients with COPD exacerbation requiring emergency department (ED) visits remains controversial.", {"entities": []}], ["Viral culture and polymerase chain reaction (PCR) were used to identify the viruses in the oropharynx of patients with COPD exacerbations.", {"entities": []}], ["The bacteria were identified by the semiquantitative culture of the expectorated sputum.", {"entities": []}], ["The peripheral blood white blood cell (WBC) counts, serum C-reactive protein (CRP), procalcitonin (PCT), and clinical symptoms were compared among patients with different types of infections.", {"entities": [[78, 81, "GENE"]]}], ["Viruses were isolated from 16 (22.2%) of the 72 patients enrolled.", {"entities": []}], ["The most commonly identified viruses were parainfluenza type 3, influenza A, and rhinovirus.", {"entities": [[64, 73, "DISEASE"]]}], ["A total of 30 (41.7%) patients had positive bacterial cultures, with the most commonly found bacteria being Haemophilus influenzae and Haemophilus parainfluenzae .", {"entities": []}], ["Five patients (6.9%) had both positive sputum cultures and virus identification.", {"entities": []}], ["The WBC, CRP, and PCT levels of the bacteria-positive and bacteria-negative groups were not statistically different.", {"entities": [[9, 12, "GENE"]]}], ["Multivariate analysis showed that patients with increased sputum volumes during the COPD exacerbations had higher risks of recurrent exacerbations in the 1-year period following the first exacerbation.", {"entities": []}], ["WBC, CRP, or PCT could not differentiate between bacterial and viral infections in patients with COPD exacerbation requiring ED visits.", {"entities": [[5, 8, "GENE"]]}], ["Those with increased sputum during a COPD exacerbation had higher risks for recurrent exacerbations.", {"entities": []}], ["Many of the current standard therapies employed for the management of primary malignant brain cancers are largely viewed as palliative, ultimately because these conventional strategies have been shown, in many instances, to decrease patient quality of life while only offering a modest increase in the length of survival.", {"entities": []}], ["We propose that caloric restriction (CR) is an alternative metabolic therapy for brain cancer management that will not only improve survival but also reduce the morbidity associated with disease.", {"entities": [[81, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Although we have shown that CR manages tumor growth and improves survival through multiple molecular and biochemical mechanisms, little information is known about the role that CR plays in modulating inflammation in brain tumor tissue.", {"entities": []}], ["Phosphorylation and activation of nuclear factor \u03baB (NF-\u03baB) results in the transactivation of many genes including those encoding cycloxygenase-2 (COX-2) and allograft inflammatory factor-1 (AIF-1), both of which are proteins that are primarily expressed by inflammatory and malignant cancer cells.", {"entities": [[285, 291, "DISEASE"], [191, 196, "GENE"]]}], ["COX-2 has been shown to enhance inflammation and promote tumor cell survival in both in vitro and in vivo studies.", {"entities": []}], ["In the current report, we demonstrate that the p65 subunit of NF-\u03baB was expressed constitutively in the CT-2A tumor compared with contra-lateral normal brain tissue, and we also show that CR reduces (i) the phosphorylation and degree of transcriptional activation of the NF-\u03baB-dependent genes COX-2 and AIF-1 in tumor tissue, as well as (ii) the expression of proinflammatory markers lying downstream of NF-\u03baB in the CT-2A malignant mouse astrocytoma, [e.g.", {"entities": [[439, 450, "DISEASE"], [303, 308, "GENE"]]}], ["macrophage inflammatory protein-2 (MIP-2)].", {"entities": []}], ["On the whole, our date indicate that the NF-\u03baB inflammatory pathway is constitutively activated in the CT-2A astrocytoma and that CR targets this pathway and inflammation.", {"entities": [[109, 120, "DISEASE"]]}], ["CR could be effective in reducing malignant brain tumor growth in part by inhibiting inflammation in the primary brain tumor.", {"entities": []}], ["In the UK, free smoking cessation support is available to pregnant women; only a minority accesses this.", {"entities": []}], ["\u2018Opt-out\u2019 referrals to stop smoking services (SSS) are recommended by UK guidelines.", {"entities": []}], ["These involve identifying pregnant smokers using exhaled carbon monoxide (CO) and referring them for support unless they object.", {"entities": []}], ["To assess the impact of \u2018opt-out\u2019 referrals for pregnant smokers on SSS uptake and effectiveness, we conducted a \u2018before\u2013after\u2019 service development evaluation.", {"entities": []}], ["In the 6-month \u2018before\u2019 period, there was a routine \u2018opt-in\u2019 referral system for self-reported smokers at antenatal \u2018booking\u2019 appointments.", {"entities": []}], ["In the 6-month \u2018after\u2019 period, additional \u2018opt-out\u2019 referrals were introduced at the 12-week ultrasound appointments; women with CO\u22654\u2005ppm were referred to, and outcome data were collected from, local SSS.", {"entities": []}], ["Approximately 2300 women attended antenatal care in each period.", {"entities": []}], ["Before the implementation, 536 (23.4%) women reported smoking at \u2018booking\u2019 and 290 (12.7%) were referred to SSS.", {"entities": []}], ["After the implementation, 524 (22.9%) women reported smoking at \u2018booking\u2019, an additional 156 smokers (6.8%) were identified via the \u2018opt-out\u2019 referrals and, in total, 421 (18.4%) were referred to SSS.", {"entities": []}], ["Over twice as many women set a quit date with the SSS after \u2018opt-out\u2019 referrals were implemented (121 (5.3%, 95% CI 4.4% to 6.3%) compared to 57 (2.5%, 95% CI 1.9% to 3.2%) before implementation) and reported being abstinent 4\u2005weeks later (93 (4.1%, 95% CI 3.3% to 4.9%) compared to 46 (2.0%, 1.5% to 2.7%) before implementation).", {"entities": []}], ["In a hospital with an \u2018opt-in\u2019 referral system, adding CO screening with \u2018opt-out\u2019 referrals as women attended ultrasound examinations doubled the numbers of pregnant smokers setting quit dates and reporting smoking cessation.", {"entities": []}], ["Medical record review (MRR) is one of the most commonly used research methods in clinical studies because it provides rich clinical detail.", {"entities": []}], ["However, because MRR involves subjective interpretation of information found in the medical record, it is critically important to understand the reproducibility of data obtained from MRR.", {"entities": []}], ["Furthermore, because medical record review is both technically demanding and time intensive, it is important to establish whether trained research staff with no clinical training can abstract medical records reliably.", {"entities": []}], ["We assessed the reliability of abstraction of medical record information in a sample of patients who underwent total knee replacement (TKR) at a referral center.", {"entities": []}], ["An orthopedic surgeon instructed two research coordinators (RCs) in the abstraction of inpatient medical records and operative notes for patients undergoing primary TKR.", {"entities": []}], ["The two RCs and the surgeon each independently reviewed 75 patients\u2019 records and one RC reviewed the records twice.", {"entities": []}], ["Agreement was assessed using the proportion of items on which reviewers agreed and the kappa statistic.", {"entities": []}], ["The kappa for agreement between the surgeon and each RC ranged from 0.59 to 1 for one RC and 0.49 to 1 for the other; the percent agreement ranged from 82% to 100% for one RC and 70% to 100% for the other.", {"entities": []}], ["The repeated abstractions by the same RC showed high intra-rater agreement, with kappas ranging from 0.66 to 1 and percent agreement ranging from 97% to 100%.", {"entities": []}], ["Inter-rater agreement between the two RCs was moderate with kappa ranging from 0.49 to 1 and percent agreement ranging from 76% to 100%.", {"entities": []}], ["The MRR method used in this study showed excellent reliability for abstraction of information that had low technical complexity and moderate to good reliability for information that had greater complexity.", {"entities": []}], ["Overall, these findings support the use of non-surgeons to abstract surgical data from operative notes.", {"entities": []}], ["Interstitial lung disease (ILD) can be a severe extra-articular disease manifestation in Rheumatoid Arthritis (RA).", {"entities": [[13, 25, "DISEASE"]]}], ["A potential role of fibrocytes in RA associated ILD (RA-ILD) has not previously been described.", {"entities": []}], ["We present a modified faster method for measuring circulating fibrocytes, without intracellular staining.", {"entities": []}], ["The results are compared to the traditional culture method, where the number of monocytes that differentiate into mature fibrocytes in vitro are counted.", {"entities": []}], ["The results are following compared to disease activity in patients with severe asthma, ILD, RA (without diagnosed ILD) and RA with verified ILD (RA-ILD).", {"entities": [[79, 85, "DISEASE"]]}], ["CD45 90.2% (mean, SD\u00a0=\u00a01.5%) of the sorted cells were pro-collagen type 1 positive and thereby fulfilled the criteria for being circulating fibrocytes.", {"entities": []}], ["The ILD and RA-ILD groups had increased levels of circulating fibrocytes compared to HC ( p \u00a0<\u00a00.05).", {"entities": []}], ["Levels of circulating fibrocytes correlated overall to number of monocytes that subsequently in vitro differentiated to mature fibrocytes ( r \u00a0=\u00a00.81, p \u00a0<\u00a00.001).", {"entities": []}], ["RA patients with pathologically reduced diffusion capacity for carbon monoxide adjusted for hemoglobin (DLCO c ) in both the RA and in the combined RA\u00a0+\u00a0RA-ILD group, had significantly higher levels of both circulating and number of cultured mature fibrocytes (both p \u00a0<\u00a00.05).", {"entities": []}], ["In both groups, the level of circulating fibrocytes and number of mature fibrocytes in culture also correlated to a reduction in DLCO c ( r \u00a0=\u00a0\u22120.61 an r \u00a0=\u00a0\u22120.58 both p \u00a0<\u00a00.05).", {"entities": []}], ["We presented a fast and valid method for measuring circulating fibrocytes using flow cytometry on lysed peripheral blood.", {"entities": []}], ["Further, we showed for the first time, that the level of circulating fibrocytes correlated with the number of peripheral blood mononuclear cells, that differentiated into mature fibrocytes in vitro.", {"entities": []}], ["Reduced DLCO c was correlated with high levels of circulating and mature fibrocytes in RA, which have not been reported previously.", {"entities": []}], ["In such, this study suggests that fibrocytes may exhibit an important role in the pathogenesis of RA-ILD, which requires further clarification in future studies.", {"entities": []}], ["ClinicalTrials.gov : NCT02711657 , registered 13/3\u20132016, retrospectively registered.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0623-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic damage and repair of the bronchial epithelium are features of asthma.", {"entities": [[70, 76, "DISEASE"]]}], ["We have previously reported that ex vivo stimulation of normal bronchial epithelial cells with epidermal growth factor (EGF), a key factor of epithelial repair, enhances the mechanisms of neutrophil accumulation, thereby promoting neutrophil defences during acute injury but potentially enhancing inflammation in chronic airway diseases.", {"entities": [[120, 123, "GENE"]]}], ["We have now sought to (i) determine whether this EGF-dependent pro-neutrophil activity is increased in asthma, where EGF and its epithelial receptor are over-expressed, and (ii) elucidate some of the mechanisms underlying this asthmatic epithelial-neutrophil interaction.", {"entities": [[103, 109, "DISEASE"], [49, 52, "GENE"], [117, 120, "GENE"]]}], ["Primary bronchial epithelial cells (PBEC) from healthy subjects, mild asthmatics and moderate-to-severe asthmatics (Mod/Sev) were stimulated with EGF, a model that mimics a repairing epithelium.", {"entities": [[146, 149, "GENE"]]}], ["Conditioned culture media (EGF-CM) were assessed for neutrophil chemotactic and anti-apoptotic activities and inflammatory mediator production.", {"entities": []}], ["EGF induced the epithelium to produce soluble mediators with neutrophil chemotactic (p<0.001) and pro-survival (p\u200a=\u200a0.021) activities which were related to the clinical severity of asthma (trend p\u200a=\u200a0.010 and p\u200a=\u200a0.009, respectively).", {"entities": [[181, 187, "DISEASE"], [0, 3, "GENE"]]}], ["This was associated with enhanced IL-6, IL-8, GM-CSF and TNF-\u03b1 release, and cytokine-neutralising experiments using EGF-CM from Mod/Sev asthmatics demonstrated a role for GM-CSF in neutrophil survival (p<0.001).", {"entities": []}], ["Pre-treatment of neutrophils with specific inhibitors of the myeloid-restricted class I phosphatidylinositol-3-OH kinase (PI(3)K) isoforms showed that the EGF-CM from Mod/Sev asthmatics depended on the \u03b3 (p<0.021) but not \u03b4 isoforms, while neutrophil survival required multiple class I PI(3)Ks.", {"entities": []}], ["The EGF-induced chemotactic, but not pro-survival activity, involved RhoA signaling in neutrophils (p\u200a=\u200a0.012).", {"entities": [[69, 73, "GENE"]]}], ["EGF whose activity is upregulated in asthma induces ex vivo the epithelium from asthmatic patients to produce pro-neutrophil activities; these are related to asthma severity and, in moderate-to-severe asthmatics, involves class IB PI(3)K\u03b3 signaling, providing a potential therapeutic target for neutrophilic forms of asthma.", {"entities": [[37, 43, "DISEASE"], [158, 164, "DISEASE"], [317, 323, "DISEASE"], [0, 3, "GENE"]]}], ["Tussilagone, extracted from Tussilago farfara is an oriental medicine used for asthma and bronchitis.", {"entities": [[79, 85, "DISEASE"], [90, 100, "DISEASE"]]}], ["We investigated its mechanism of action, its inhibitory effects on lipopolysaccharide-induced inflammation in macrophages, and its impact on viability in a cecal ligation and puncture (CLP)-induced mouse model of sepsis.", {"entities": []}], ["Tussilagone suppressed the expression of the inflammatory mediators, nitric oxide and prostaglandin E2, and the inflammatory cytokines, tumor necrosis factor-alpha (TNF-\u03b1) and high-mobility group box 1 (HMGB1), in lipopolysaccharide-stimulated RAW 264.7 cells and peritoneal macrophages.", {"entities": [[203, 208, "GENE"]]}], ["Tussilagone also reduced the activation of the mitogen-activated protein kinases and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) involved in the activation of various inflammatory mediators in activated macrophages.", {"entities": []}], ["Moreover, tussilagone administration (1 mg/kg and 10 mg/kg) produced decreased mortality and lung injury in CLP-activated septic mice.", {"entities": []}], ["Augmented expression of cyclooxygenase (COX)-2 and TNF-\u03b1 in pulmonary alveolar macrophages of septic mice were attenuated by tussilagone administration.", {"entities": []}], ["Tussilagone also suppressed the induction of nitric oxide, prostaglandin E2, TNF-\u03b1 and HMGB1 in the serum of the septic mice.", {"entities": [[87, 92, "GENE"]]}], ["Overall, tussilagone exhibited protective effects against inflammation and polymicrobial sepsis by suppressing inflammatory mediators possibly via the inhibition of NF-\u03baB activation and the MAP kinase pathway.", {"entities": []}], ["These results suggest the possible use of tussilagone for developing novel therapeutic modalities for sepsis and other inflammatory diseases.", {"entities": []}], ["There is limited research on the effect of immigration on biological markers of nutrition among children of Mexican origin in the United States.", {"entities": []}], ["The purpose of this cross-sectional study was to examine data from the Third National Health and Nutrition Examination Survey (NHANES III) (1988\u20131994), on a national and representative sample of 1559 Mexican American children, 4\u201316 years of age, and assess the associations of country of birth with serum concentrations of carotenoids, vitamin A, and vitamin E. In multiple regression analyses, Mexico-born Mexican American children had significantly higher serum concentrations of \u03b1-carotene, \u03b2-carotene, \u03b2-cryptoxanthin, lutein/zeaxanthin, vitamin A, and vitamin E than their counterparts who were born in the United States after adjustment for age, sex, poverty income ratio, level of education of family reference person, body mass index, total serum cholesterol, serum cotinine, total energy intake, and vitamin/mineral consumption.", {"entities": []}], ["Our findings confirm evidence for a negative effect of immigration/acculturation on dietary quality in this population.", {"entities": []}], ["These findings also suggest that immigrant Mexican families should be encouraged to maintain their consumption of fruits and vegetables.", {"entities": []}], ["Prospective studies are needed to further assess the effects of immigration/acculturation on diet and other health outcomes in children of Mexican origin and immigrants.", {"entities": []}], ["Acetylation of lysine residues is a post-translational modification with broad relevance to cellular signalling and disease biology.", {"entities": []}], ["Enzymes that \u2018write\u2019 (histone acetyltransferases, HATs) and \u2018erase\u2019 (histone deacetylases, HDACs) acetylation sites are an area of extensive research in current drug development, but very few potent inhibitors that modulate the \u2018reading process\u2019 mediated by acetyl lysines have been described.", {"entities": []}], ["The principal readers of \u025b- N -acetyl lysine ( K ac ) marks are bromodomains (BRDs), which are a diverse family of evolutionary conserved protein-interaction modules.", {"entities": []}], ["The conserved BRD fold contains a deep, largely hydrophobic acetyl lysine binding site, which represents an attractive pocket for the development of small, pharmaceutically active molecules.", {"entities": []}], ["Proteins that contain BRDs have been implicated in the development of a large variety of diseases.", {"entities": []}], ["Recently, two highly potent and selective inhibitors that target BRDs of the BET (bromodomains and extra-terminal) family provided compelling data supporting targeting of these BRDs in inflammation and in an aggressive type of squamous cell carcinoma.", {"entities": [[241, 250, "DISEASE"], [227, 250, "DISEASE"]]}], ["It is likely that BRDs will emerge alongside HATs and HDACs as interesting targets for drug development for the large number of diseases that are caused by aberrant acetylation of lysine residues.", {"entities": []}], ["Although sudden cardiac death (SCD) is one of the most important modes of death in Western countries, pathologists and public health physicians have not given this problem the attention it deserves.", {"entities": [[31, 34, "GENE"]]}], ["New methods of preventing potentially fatal arrhythmias have been developed and the accurate diagnosis of the causes of SCD is now of particular importance.", {"entities": [[120, 123, "GENE"]]}], ["Pathologists are responsible for determining the precise cause and mechanism of sudden death but there is still considerable variation in the way in which they approach this increasingly complex task.", {"entities": []}], ["The Association for European Cardiovascular Pathology has developed these guidelines, which represent the minimum standard that is required in the routine autopsy practice for the adequate investigation of SCD.", {"entities": [[206, 209, "GENE"]]}], ["The present version is an update of our original article, published 10\u00a0years ago.", {"entities": []}], ["This is necessary because of our increased understanding of the genetics of cardiovascular diseases, the availability of new diagnostic methods, and the experience we have gained from the routine use of the original guidelines.", {"entities": []}], ["The updated guidelines include a detailed protocol for the examination of the heart and recommendations for the selection of histological blocks and appropriate material for toxicology, microbiology, biochemistry, and molecular investigation.", {"entities": []}], ["Our recommendations apply to university medical centers, regionals hospitals, and all healthcare professionals practicing pathology and forensic medicine.", {"entities": []}], ["We believe that their adoption throughout Europe will improve the standards of autopsy practice, allow meaningful comparisons between different communities and regions, and permit the identification of emerging patterns of diseases causing SCD.", {"entities": [[240, 243, "GENE"]]}], ["Finally, we recommend the development of regional multidisciplinary networks of cardiologists, geneticists, and pathologists.", {"entities": []}], ["Their role will be to facilitate the identification of index cases with a genetic basis, to screen appropriate family members, and ensure that appropriate preventive strategies are implemented.", {"entities": []}], ["An evolutionary and functional analysis of mammalian AIM2-like receptors reveals remarkable diversity and redundancy.", {"entities": []}], ["Innate immune detection of nucleic acids is important for initiation of antiviral responses.", {"entities": []}], ["Detection of intracellular DNA activates STING-dependent type I interferons (IFNs) and the ASC-dependent inflammasome.", {"entities": []}], ["Certain members of the AIM2-like receptor (ALR) gene family contribute to each of these pathways, but most ALRs remain uncharacterized.", {"entities": []}], ["Here, we identify five novel murine ALRs and perform a phylogenetic analysis of mammalian ALRs, revealing a remarkable diversification of these receptors among mammals.", {"entities": []}], ["We characterize the expression, localization, and functions of the murine and human ALRs and identify novel activators of STING-dependent IFNs and the ASC-dependent inflammasome.", {"entities": []}], ["These findings validate ALRs as key activators of the antiviral response and provide an evolutionary and functional framework for understanding their roles in innate immunity.", {"entities": []}], ["Psychological stress has been shown to trigger systemic lupus erythematosus (SLE).", {"entities": [[56, 75, "DISEASE"], [47, 75, "DISEASE"]]}], ["However, objective evidence of symptom aggravation due to mental stress is difficult to identify.", {"entities": []}], ["We aimed to investigate the relationship between SLE disease activity and mental stress, and the usefulness of saliva as an assessment index for stress in patients with SLE.", {"entities": []}], ["We prospectively assessed the salivary stress hormone and disease-related biomarkers, and questionnaire data regarding stress and depression in 100 patients with SLE and 49 sex- and age-matched normal controls (NCs).", {"entities": []}], ["Patients with SLE had higher mean salivary \u03b1-amylase levels (5.7\u200a\u00b1\u200a4.6\u200aU/mL vs 2.7\u200a\u00b1\u200a2.5\u200aU/mL, P \u200a<\u200a0.001), anti-chromatin antibody levels (25.3\u200a\u00b1\u200a22.9\u200aU/mL vs 15.9\u200a\u00b1\u200a10.9\u200aU/mL, P \u200a<\u200a0.001), and Beck Depression Index (BDI) scores (11.1\u200a\u00b1\u200a9.2 vs 5.3\u200a\u00b1\u200a5.1, P \u200a<\u200a0.001) than NCs.", {"entities": []}], ["However, salivary cortisol levels and Perceived Stress Scale (PSS) scores did not differ between the groups.", {"entities": []}], ["The BDI scores correlated with the SLE disease activity index (SLEDAI) scores ( r \u200a=\u200a0.253, P \u200a=\u200a0.011) and erythrocyte sedimentation rates ( r \u200a=\u200a0.234, P \u200a=\u200a0.019).", {"entities": []}], ["SLE patients with the highest-quartile PSS scores had significantly increased SLEDAI scores compared to those with the lowest-quartile PSS scores after 4 to 5 months\u2019 follow-up.", {"entities": []}], ["Moreover, SLE patients with elevated SLEDAI scores had higher baseline PSS scores.", {"entities": []}], ["Patients with SLE showed uncoupling of the sympathetic nervous system and hypothalamic\u2013pituitary\u2013adrenal axis; higher salivary \u03b1-amylase and no different cortisol levels compared with NCs.", {"entities": []}], ["Also, patients with SLE were more depressed, which correlated with disease activity.", {"entities": []}], ["Furthermore, perceived stress was not correlated with disease activity; however, disease activity worsened several months later with elevated perceived stress levels.", {"entities": []}], ["The gut is the most extensively studied niche of the human microbiome.", {"entities": []}], ["The aim of this study was to characterise the initial gut microbiota development of a cohort of breastfed infants ( n \u2009=\u2009192\ufeff) from 1 to 24 weeks of age.", {"entities": []}], ["V4-V5 region 16S rRNA amplicon Illumina sequencing and, in parallel, bacteriological culture.", {"entities": []}], ["The metabolomic profile of infant urine at 4 weeks of age was also examined by LC-MS. Full-term (FT), spontaneous vaginally delivered (SVD) infants\u2019 microbiota remained stable at both phylum and genus levels during the 24-week period examined.", {"entities": []}], ["FT Caesarean section (CS) infants displayed an increased faecal abundance of Firmicutes ( p \u2009<\u20090.01) and lower abundance of Actinobacteria ( p \u2009<\u20090.001) after the first week of life compared to FT-SVD infants.", {"entities": [[22, 24, "GENE"]]}], ["FT-CS infants gradually progressed to harbouring a microbiota closely resembling FT-SVD (which remained stable) by week 8 of life, which was maintained at week 24.", {"entities": []}], ["The gut microbiota of preterm (PT) infants displayed a significantly greater abundance of Proteobacteria compared to FT infants ( p \u2009<\u20090.001) at week 1.", {"entities": []}], ["Metabolomic analysis of urine at week 4 indicated PT-CS infants have a functionally different metabolite profile than FT (both CS and SVD) infants.", {"entities": [[53, 55, "GENE"], [127, 129, "GENE"]]}], ["Co-inertia analysis showed co-variation between the urine metabolome and the faecal microbiota of the infants.", {"entities": []}], ["Tryptophan and tyrosine metabolic pathways, as well as fatty acid and bile acid metabolism, were found to be affected by delivery mode and gestational age.", {"entities": []}], ["These findings confirm that mode of delivery and gestational age both have significant effects on early neonatal microbiota composition.", {"entities": []}], ["There is also a significant difference between the metabolite profile of FT and PT infants.", {"entities": []}], ["Prolonged breastfeeding was shown to have a significant effect on the microbiota composition of FT-CS infants at 24 weeks of age, but interestingly not on that of FT-SVD infants.", {"entities": []}], ["Twins had more similar microbiota to one another than between two random infants, reflecting the influence of similarities in both host genetics and the environment on the microbiota.\ufeff The online version of this article (doi:10.1186/s40168-016-0213-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To investigate geographic variation in guideline-indicated treatments for non-ST-elevation myocardial infarction (NSTEMI) in the English National Health Service (NHS).", {"entities": [[91, 112, "DISEASE"], [162, 165, "GENE"]]}], ["Cohort study using registry data from the Myocardial Ischaemia National Audit Project.", {"entities": []}], ["All Clinical Commissioning Groups (CCGs) (n=211) in the English NHS.", {"entities": [[64, 67, "GENE"]]}], ["357\u2005228 patients with NSTEMI between 1 January 2003 and 30 June 2013.", {"entities": []}], ["Proportion of eligible NSTEMI who received all eligible guideline-indicated treatments (optimal care) according to the date of guideline publication.", {"entities": []}], ["The proportion of NSTEMI who received optimal care was low (48\u2005257/357\u2005228; 13.5%) and varied between CCGs (median 12.8%, IQR 0.7\u201318.1%).", {"entities": []}], ["The greatest geographic variation was for aldosterone antagonists (16.7%, 0.0\u201340.0%) and least for use of an ECG (96.7%, 92.5\u201398.7%).", {"entities": []}], ["The highest rates of care were for acute aspirin (median 92.8%, IQR 88.6\u201397.1%), and aspirin (90.1%, 85.1\u201393.3%) and statins (86.4%, 82.3\u201391.2%) at hospital discharge.", {"entities": []}], ["The lowest rates were for smoking cessation advice (median 11.6%, IQR 8.7\u201316.6%), dietary advice (32.4%, 23.9\u201341.7%) and the prescription of P2Y 12 inhibitors (39.7%, 32.4\u201346.9%).", {"entities": []}], ["After adjustment for case mix, nearly all (99.6%) of the variation was due to between-hospital differences (median 64.7%, IQR 57.4\u201370.0%; between-hospital variance: 1.92, 95% CI 1.51 to 2.44; interclass correlation 0.996, 95% CI 0.976 to 0.999).", {"entities": []}], ["Across the English NHS, the optimal use of guideline-indicated treatments for NSTEMI was low.", {"entities": [[19, 22, "GENE"]]}], ["Variation in the use of specific treatments for NSTEMI was mostly explained by between-hospital differences in care.", {"entities": []}], ["Performance-based commissioning may increase the use of NSTEMI treatments and, therefore, reduce premature cardiovascular deaths.", {"entities": []}], ["NCT02436187.", {"entities": []}], ["There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological features, including inflammation, smooth muscle contraction and remodeling.", {"entities": [[51, 63, "DISEASE"], [82, 119, "DISEASE"], [71, 77, "DISEASE"]]}], ["No existing drug provides the combined potential advantages of reducing vascular- and bronchial-constriction, and anti-inflammation.", {"entities": []}], ["Vasoactive intestinal peptide (VIP) is widely expressed throughout the cardiopulmonary system and exerts a variety of biological actions, including potent vascular and airway dilatory actions, potent anti-inflammatory actions, improving blood circulation to the heart and lung, and modulation of airway secretions.", {"entities": [[31, 34, "GENE"]]}], ["VIP has emerged as a promising drug candidate for the treatment of cardiopulmonary disorders such as PAH, asthma, and COPD.", {"entities": [[106, 112, "DISEASE"], [0, 3, "GENE"]]}], ["Clinical application of VIP has been limited in the past for a number of reasons, including its short plasma half-life and difficulty in administration routes.", {"entities": [[24, 27, "GENE"]]}], ["The development of long-acting VIP analogues, in combination with appropriate drug delivery systems, may provide clinically useful agents for the treatment of PAH, asthma, and COPD.", {"entities": [[164, 170, "DISEASE"], [31, 34, "GENE"]]}], ["This article reviews the physiological significance of VIP in cardiopulmonary system and the therapeutic potential of VIP-based agents in the treatment of pulmonary diseases.", {"entities": [[55, 58, "GENE"], [118, 121, "GENE"]]}], ["Vernonia cinerea (VC) Less has been proposed as a medicinal plant with interesting activities, such as an aid for smoking cessation worldwide.", {"entities": []}], ["Despite its previous clinical success in smoking cessation by exhibiting reduced oxidative stress, it has not been approved.", {"entities": []}], ["The aim of this study was to investigate various antioxidant activity and active compounds that have not been approved, including the protective activity in human red blood cells (RBCs), from the stem, flower, and leaf extracts of VC Less in vitro.", {"entities": []}], ["These extracts were tested for their antioxidant activity in scavenging 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals and analyzed by high-performance liquid chromatography (HPLC) for their active compounds: total tannin, five catechin (C) compounds (epicatechin gallate [ECG], C, epicatechin [EC], epigallocatechin gallate [EGCG], and (\u2212)-epigallocatechin [EGC]), flavonoid, nitrite, nitrate, caffeine, and nicotine.", {"entities": []}], ["Moreover, antioxidant activities of the extracts were evaluated in 2,2\u2032-azobis(2-amidinopropane) dihydrochloride (AAPH)-treated RBCs.", {"entities": []}], ["The results showed that the flower and leaf of VC Less had higher activity than the stem in scavenging DPPH radicals.", {"entities": []}], ["The tannin content in the flower and leaf was higher than that in the stem.", {"entities": []}], ["The leaf had the highest content of the five catechins (C, EC, EGCG, ECG, and EGC), the same as in the flavonoid, when compared to the stem and flower.", {"entities": []}], ["Furthermore, the leaf extract had higher nitrate and nitrite than the stem.", {"entities": []}], ["Nicotine content was found to be higher in the leaf when compared to the flower.", {"entities": []}], ["In addition, the leaf showed protective activity in glutathione (GSH), malondialdehyde (MDA), and protein carbonyl, with a dose response in AAPH-oxidized RBCs, the same as in standard EGCG.", {"entities": []}], ["Thus, this study concluded that radical scavenging and antioxidant compounds such as catechins, flavonoid, nitrate and nitrite, and nicotine are present in different VC Less parts and are included in the AAPH-oxidized RBC model.", {"entities": []}], ["The aims of this study were to understand patients' willingness to use different types of health-related smartphone apps and to explore their attitudes on the overall value, usability, feasibility, credibility, intrusiveness, and obtrusiveness of these apps.", {"entities": []}], ["Questionnaires were distributed to adult patients presenting to gastroenterology clinics at an academic medical center.", {"entities": []}], ["The 25-question survey consisted of 5-point Likert-type scale statements, multiple-choice questions, and open-ended questions.", {"entities": []}], ["Participants were mainly White ( N =94, 78%) and smartphone owners ( N =125, 93%).", {"entities": []}], ["The mean age was 40.8 years ( N =121, s.d.=13.2).", {"entities": []}], ["Participants were willing to use most types of apps unless it monitored their location or social networking activity.", {"entities": []}], ["Half were less willing to use an app if it required a visible accessory.", {"entities": [[33, 36, "GENE"]]}], ["Most participants were willing to use a health-related app up to 5\u2009min a day indefinitely but unwilling to pay out-of-pocket for it.", {"entities": [[55, 58, "GENE"]]}], ["Participants generally disagreed that an app would be hard to learn how to use, interfere with their daily routine, or be embarrassing to use in public.", {"entities": [[41, 44, "GENE"]]}], ["Overall, participants felt that health-related apps could help them and their doctors better manage their medical problems, but were neutral in trusting their quality.", {"entities": []}], ["Most worried that personal information used for an app would fall into the wrong hands.", {"entities": [[51, 54, "GENE"]]}], ["Gastroenterology patients were willing to use and valued most types of health-related apps.", {"entities": []}], ["They perceived this technology as feasible, usable, and relatively unobtrusive unless a visible accessory was required.", {"entities": []}], ["However, many were concerned about their privacy.", {"entities": []}], ["Th9 cells are a newly discovered CD4 Female C57BL/6 mice were randomly divided into three groups ( n = 5 in each group): mice with myelin oligodendrocyte glycoprotein (MOG)-induced EAE (EAE group), EAE mice treated with anti-IL-9 antibody (anti-IL-9 Abs group), and EAE mice treated with IgG isotype control (IgG group).", {"entities": [[33, 36, "GENE"]]}], ["EAE clinical score was evaluated.", {"entities": []}], ["Mast cells from central nervous system (CNS) were detected by flow cytometry.", {"entities": []}], ["The production of chemokine recruiting mast cells in the CNS was explored by reverse transcription-polymerase chain reaction (RT-PCR).", {"entities": []}], ["In mice with MOG-induced EAE, the expression of IL-9 receptor (IL-9R) complexes in CNS and spleen mast cells was also explored by RT-PCR, and then was repeating validated by immunocytochemistry.", {"entities": []}], ["In vitro , spleen cells from EAE mice were cultured with anti-IL-9 antibody, and quantity of mast cells was counted by flow cytometry after co-culture.", {"entities": []}], ["Compared with IgG group, IL-9 blockade delayed clinical disease onset and ameliorated EAE severity ( t = \u22122.217, P = 0.031), accompany with mast cells infiltration decreases (day 5: t = \u22128.005, P < 0.001; day 15: t = \u221211.857, P < 0.001; day 20: t = \u22125.243, P = 0.001) in anti-IL-9 Abs group.", {"entities": []}], ["The messenger RNA expressions of C-C motif chemokine ligand 5 ( t = \u22125.932, P = 0.003) and vascular cell adhesion molecule-1 ( t = \u22124.029, P = 0.004) were significantly decreased after IL-9 neutralization in anti-IL-9 Abs group, compared with IgG group.", {"entities": []}], ["In MOG-induced EAE, the IL-9R complexes were expressed in CNS and spleen mast cells.", {"entities": []}], ["In vitro , splenocytes cultured with anti-IL-9 antibody showed significantly lower levels of mast cells in a dose-dependent manner, compared with splenocytes cultured with anti-mouse IgG (5 \u03bcg/ml: t = \u22120.894, P = 0.397; 10 \u03bcg/ml: t = \u22123.348, P = 0.019; 20 \u03bcg/ml: t = \u22127.639, P < 0.001).", {"entities": []}], ["This study revealed that IL-9 neutralization reduced mast cell infiltration in CNS and ameliorated EAE, which might be relate to the interaction between IL-9 and mast cells.", {"entities": []}], ["Glucocorticoids are potent anti-inflammatory agents, acting through the glucocorticoid receptor (GR) to regulate target gene transcription.", {"entities": []}], ["However, GR may also exert acute effects, including activation of signaling kinases such as c-Src and protein kinase B, possibly via the scaffold protein, modulator of nongenomic action of the estrogen receptor (MNAR).", {"entities": []}], ["MNAR inhibited GR transactivation in A549 cells, but in HEK293 cells there was a ligand concentration-dependent biphasic effect.", {"entities": []}], ["Transactivation driven by low ligand concentrations was inhibited by MNAR expression, whereas higher ligand concentrations were potentiating.", {"entities": []}], ["Further analysis revealed that MNAR inhibited transactivation by the ligand-independent activation function (AF)1 but potentiated the COOH-terminal AF2 domain.", {"entities": []}], ["The effect of MNAR was independent of c-Src activity, demonstrated by inhibitors and c-Src knockdown studies.", {"entities": []}], ["In support of the role of MNAR in modulating GR transactivation, coimmunoprecipitation studies showed interaction between MNAR and GR in the nucleus but not the cytoplasm.", {"entities": []}], ["Furthermore, MNAR and c-Src were also found to physically interact in the nucleus.", {"entities": []}], ["Immunofluorescence studies showed MNAR to be predominantly a nuclear protein, with significant colocalization with GR.", {"entities": []}], ["Deletion studies revealed that MNAR 884-1130 was coimmunoprecipitated with GR, and furthermore this fragment inhibited GR transactivation function when overexpressed.", {"entities": []}], ["In addition, MNAR 1-400, which contains multiple LxxLL motifs, also inhibited GR transactivation.", {"entities": []}], ["Taken together, MNAR interacts with GR in the nucleus but not cytoplasm and regulates GR transactivation in a complex manner depending on cell type.", {"entities": []}], ["MNAR is capable of regulating both AF1 and AF2 functions of the GR independently.", {"entities": []}], ["MNAR expression is likely to mediate important cell variation in glucocorticoid responsiveness, in a c-Src-independent mechanism.", {"entities": []}], ["Excretory-secretory products (ESPs) released by helminths are well-known to regulate T cell responses in the host.", {"entities": []}], ["However, their direct influence in the differentiation of na\u00efve T cells, and especially B cells, remains largely unknown.", {"entities": []}], ["This study investigated the effects of Echinococcus granulosus protoscoleces ESPs (EgPSC-ESPs) on the differentiation of IL-10-producing B cells (B10), IL-17A-producing B cells (B17) and Th17 cells.", {"entities": []}], ["BALB/c mice injected with EgPSC were used to evaluate the in vivo profiles of B10, B17 and Th17 cells.", {"entities": []}], ["In vitro purified CD19 In contrast to the control group, infected mice showed higher frequencies of B10, B17 and Th17 cells, and higher levels of IL-10 and IL-17A in the sera.", {"entities": [[18, 22, "GENE"]]}], ["Interestingly, B17 cells were first identified to express CD19 Our findings indicate that ESPs released by EgPSC can directly regulate the differentiation of B10, B17 and Th17 cells, which appear to be heat-labile and carbohydrate-dependent.", {"entities": [[58, 62, "GENE"]]}], ["The online version of this article (doi:10.1186/s13071-017-2263-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Frailty is a highly prevalent condition in old age leading to vulnerability and greater risk of adverse health outcomes and disability.", {"entities": []}], ["Detecting and tackling frailty at an early stage can prevent disability.", {"entities": []}], ["The purpose of this study is to evaluate the effectiveness of a multifactorial intervention program to modify frailty parameters, muscle strength, and physical and cognitive performance in people aged 65 years or more.", {"entities": []}], ["It also assesses changes from baseline in falls, hospitalizations, nutritional risk, disability, institutionalization, and home-care.", {"entities": []}], ["The current study is a randomised single-blind, parallel-group clinical trial, with a one and a half year follow-up, conducted in eight Primary Health Care Centres located in the city of Barcelona.", {"entities": []}], ["Inclusion criteria are to be aged 65 years or older with positive frailty screening, timed get-up-and-go test between 10 to 30 seconds, and Cognition Mini-Exam (MEC-35) of Lobo greater than or equal to 18.", {"entities": []}], ["A total of 352 patients have been equally divided into two groups: intervention and control.", {"entities": []}], ["Sample size calculated to detect a 0.5 unit difference in the Short Physical Performance Battery (Common SD: 1.42, 20% lost to follow-up).", {"entities": []}], ["In the intervention group three different actions on frailty dimensions: rehabilitative therapy plus intake of hyperproteic nutritional shakes, memory workshop, and medication review are applied to sets of 16 patients.", {"entities": []}], ["Participants in both intervention and control groups receive recommendations on nutrition, healthy lifestyles, and home risks.", {"entities": []}], ["Evaluations are blinded and conducted at 0, 3, and 18 months.", {"entities": []}], ["Intention to treat analyses will be performed.", {"entities": []}], ["Multivariate analysis will be carried out to assess time changes of dependent variables.", {"entities": []}], ["It is expected that this study will provide evidence of the effectiveness of a multidisciplinary intervention on delaying the progression from frailty to disability in the elderly.", {"entities": []}], ["It will help improve the individual\u2019s quality of life and also reduce the rates of falls, hospital admissions, and institutionalizations, thus making the health care system more efficient.", {"entities": []}], ["This preventive intervention can be adapted to diverse settings and be routinely included in Primary Care Centres as a Preventive Health Programme.", {"entities": []}], ["ClinicalTrials.gov PRS: NCT01969526 .", {"entities": []}], ["Date of registration: 10/21/2013.", {"entities": []}], ["Airway remodeling in COPD includes reorganization of the extracellular matrix.", {"entities": []}], ["Proteoglycans play a crucial role in this process as regulators of the integrity of the extracellular matrix.", {"entities": []}], ["Altered proteoglycan immunostaining has been demonstrated in COPD lungs and this has been suggested to contribute to the pathogenesis.", {"entities": []}], ["The major cell type responsible for production and maintenance of ECM constituents, such as proteoglycans, are fibroblasts.", {"entities": []}], ["Interestingly, it has been proposed that central airways and alveolar lung parenchyma contain distinct fibroblast populations.", {"entities": []}], ["This study explores the hypothesis that altered depositions of proteoglycans in COPD lungs, and in particular versican and perlecan, is a result of dysregulated fibroblast proteoglycan production.", {"entities": []}], ["Proliferation, proteoglycan production and the response to TGF-\u03b2 1 were examined in vitro in centrally and distally derived fibroblasts isolated from COPD patients (GOLD stage IV) and from control subjects.", {"entities": []}], ["Phenotypically different fibroblast populations were identified in central airways and in the lung parenchyma.", {"entities": []}], ["Versican production was higher in distal fibroblasts from COPD patients than from control subjects (p < 0.01).", {"entities": []}], ["In addition, perlecan production was lower in centrally derived fibroblasts from COPD patients than from control subjects (p < 0.01).", {"entities": []}], ["TGF-\u03b2 1 triggered similar increases in proteoglycan production in distally derived fibroblasts from COPD patients and control subjects.", {"entities": []}], ["In contrast, centrally derived fibroblasts from COPD patients were less responsive to TGF-\u03b2 1 than those from control subjects.", {"entities": []}], ["The results show that fibroblasts from COPD patients have alterations in proteoglycan production that may contribute to disease development.", {"entities": []}], ["Distally derived fibroblasts from COPD patients have enhanced production of versican that may have a negative influence on the elastic recoil.", {"entities": []}], ["In addition, a lower perlecan production in centrally derived fibroblasts from COPD patients may indicate alterations in bronchial basement membrane integrity in severe COPD.", {"entities": []}], ["Degranulation of mast cells and basophils, with release of agents of the allergic response, ensues when multivalent antigens bind to and cross-link the cells\u2019 receptor-bound IgE antibodies.", {"entities": []}], ["A widely used commercial monoclonal IgE antibody, SPE-7 IgE from Sigma, was found to possess the radically anomalous property, termed \u201ccytokinergic\u201d, of inducing basophil degranulation without the intervention of an antigen.", {"entities": []}], ["We show here that the IgE monomer, freed of protein contaminants, is devoid of this activity, and that the source of the anomaly is a trace impurity, identified as a dissociation-resistant IgE trimer.", {"entities": []}], ["Possible models for the formation of IgE trimers and the manner in which they cross-link cell surface receptors are suggested herein.", {"entities": []}], ["Scientifically based clinical guidelines have become increasingly used to educate physicians and improve quality of care.", {"entities": []}], ["While individual guidelines are potentially useful, repeated studies have shown that guidelines are ineffective in changing physician behavior.", {"entities": []}], ["The Internet has evolved as a potentially useful tool for guideline education, dissemination, and implementation because of its open standards and its ability to provide concise, relevant clinical information at the location and time of need.", {"entities": []}], ["Our objective was to develop and test decision support systems (DSS) based on clinical guidelines which could be delivered over the Internet for two disease models: asthma and tuberculosis (TB) preventive therapy.", {"entities": [[176, 188, "DISEASE"], [165, 171, "DISEASE"]]}], ["Using open standards of HTML and CGI, we developed an acute asthma severity assessment DSS and a preventative tuberculosis treatment DSS based on content from national guidelines that are recognized as standards of care.", {"entities": [[110, 122, "DISEASE"], [60, 66, "DISEASE"]]}], ["Both DSS's are published on the Internet and operate through a decision algorithm developed from the parent guidelines with clinical information provided by the user at the point of clinical care.", {"entities": []}], ["We tested the effectiveness of each DSS in influencing physician decisions using clinical scenario testing.", {"entities": []}], ["We first validated the asthma algorithm by comparing asthma experts' decisions with the decisions reached by nonpulmonary nurses using the computerized DSS.", {"entities": [[23, 29, "DISEASE"], [53, 59, "DISEASE"]]}], ["Using the DSS, nurses scored the same as experts (89% vs. 88%; p = NS).", {"entities": []}], ["Using the same scenario test instrument, we next compared internal medicine residents using the DSS with residents using a printed version of the National Asthma Education Program-2 guidelines.", {"entities": [[155, 161, "DISEASE"]]}], ["Residents using the computerized DSS scored significantly better than residents using the paper-based guidelines (92% vs. 84%; p <0.002).", {"entities": []}], ["We similarly compared residents using the computerized TB DSS to residents using a printed reference card; the residents using the computerized DSS scored significantly better (95.8% vs. 56.6% correct; p<0.001).", {"entities": []}], ["Previous work has shown that guidelines disseminated through traditional educational interventions have minimal impact on physician behavior.", {"entities": []}], ["Although computerized DSS have been effective in altering physician behavior, many of these systems are not widely available.", {"entities": []}], ["We have developed two clinical DSS's based on national guidelines and published them on the Internet.", {"entities": []}], ["Both systems improved physician compliance with national guidelines when tested in clinical scenarios.", {"entities": []}], ["By providing information that is coupled to relevant activity, we expect that these widely available DSS's will serve as effective educational tools to positively impact physician behavior.", {"entities": []}], ["The association between pain and diabetes in older people has been largely unexplored.", {"entities": []}], ["The aim of this survey was to analyze the prevalence and characteristics of pain among Finnish men and women 65 or older with and without diabetes in primary care.", {"entities": []}], ["All home-dwelling persons 65\u00a0years or older with diabetes ( N \u2009=\u2009527) and age and gender matched controls ( N \u2009=\u2009890) were identified from electronic patient records.", {"entities": []}], ["Frequent pain was regarded as any pain experienced more often than once a week, and it was divided into pain experienced several times a week but not daily and pain experienced daily or continuously.", {"entities": []}], ["The Numeric Rating Scale (0\u201310) (NRS) was used to assess the intensity and interference of the pain.", {"entities": []}], ["The number of subjects who returned the questionnaire was 1084 (76.5%).", {"entities": []}], ["The prevalence of frequent pain in the preceding week was 50% among women without diabetes and 63% among women with diabetes (adjusted, p \u2009=\u20090.22).", {"entities": []}], ["In men, the corresponding proportions were 42% without diabetes and 47% with diabetes (adjusted, p \u2009=\u20090.58).", {"entities": []}], ["In both genders, depressive symptoms and the number of comorbidities were associated with pain experienced more often than once a week and with daily pain.", {"entities": []}], ["Diabetes was not associated with pain intensity or pain interference in either women or men.", {"entities": []}], ["Pain in older adults is associated with depressive symptoms and the number of comorbidities more than with diabetes itself.", {"entities": []}], ["Medication side effects are an important cause of morbidity, mortality and costs in older people.", {"entities": []}], ["The aim of our study was to examine prevalence and risk factors for self-reported medication side effects in an older cohort living independently in the community.", {"entities": []}], ["The Melbourne Longitudinal Study on Healthy Ageing (MELSHA), collected information on those aged 65 years or older living independently in the community and commenced in 1994.", {"entities": []}], ["Data on medication side effects was collected from the baseline cohort (n = 1000) in face-to-face baseline interviews in 1994 and analysed as cross-sectional data.", {"entities": []}], ["Risk factors examined were: socio-demographics, health status and medical conditions; medication use and health service factors.", {"entities": []}], ["Analysis included univariate logistic regression to estimate unadjusted risk and multivariate logistic regression analysis to assess confounding and estimate adjusted risk.", {"entities": []}], ["Self-reported medication side effects were reported by approximately 6.7% (67/1000) of the entire baseline MELSHA cohort, and by 8.5% (65/761) of those on medication.", {"entities": []}], ["Identified risk factors were increased education level, co-morbidities and health service factors including recency of visiting the pharmacist, attending younger doctors, and their doctor's awareness of their medications.", {"entities": []}], ["The greatest increase in risk for medication side effects was associated with liver problems and their doctor's awareness of their medications.", {"entities": []}], ["Aging and gender were not risk factors.", {"entities": []}], ["Prevalence of self-reported medication side effects was comparable with that reported in adults attending General Practices in a primary care setting in Australia.", {"entities": []}], ["The prevalence and identified risk factors provide further insight and opportunity to develop strategies to address the problem of medication side effects in older people living independently in the community setting.", {"entities": []}], ["Non-celiac gluten sensitivity (NCGS) is still an undefined syndrome with several unsettled issues despite the increasing awareness of its existence.", {"entities": [[59, 67, "DISEASE"]]}], ["We carried out a prospective survey on NCGS in Italian centers for the diagnosis of gluten-related disorders, with the aim of defining the clinical picture of this new syndrome and to establish roughly its prevalence compared with celiac disease.", {"entities": [[231, 245, "DISEASE"], [168, 176, "DISEASE"]]}], ["From November 2012 to October 2013, 38 Italian centers (27 adult gastroenterology, 5 internal medicine, 4 pediatrics, and 2 allergy) participated in this prospective survey.", {"entities": []}], ["A questionnaire was used in order to allow uniform and accurate collection of clinical, biochemical, and instrumental data.", {"entities": []}], ["In total, 486 patients with suspected NCGS were identified in this 1-year period.", {"entities": []}], ["The female/male ratio was 5.4 to 1, and the mean age was 38\u00a0years (range 3\u201381).", {"entities": []}], ["The clinical picture was characterized by combined gastrointestinal (abdominal pain, bloating, diarrhea and/or constipation, nausea, epigastric pain, gastroesophageal reflux, aphthous stomatitis) and systemic manifestations (tiredness, headache, fibromyalgia-like joint/muscle pain, leg or arm numbness, 'foggy mind,' dermatitis or skin rash, depression, anxiety, and anemia).", {"entities": [[111, 123, "DISEASE"], [95, 103, "DISEASE"], [175, 194, "DISEASE"], [184, 194, "DISEASE"], [246, 258, "DISEASE"], [368, 374, "DISEASE"], [318, 328, "DISEASE"]]}], ["In the large majority of patients, the time lapse between gluten ingestion and the appearance of symptoms varied from a few hours to 1\u00a0day.", {"entities": []}], ["The most frequent associated disorders were irritable bowel syndrome (47%), food intolerance (35%) and IgE-mediated allergy (22%).", {"entities": [[44, 68, "DISEASE"], [60, 68, "DISEASE"]]}], ["An associated autoimmune disease was detected in 14% of cases.", {"entities": []}], ["Regarding family history, 18% of our patients had a relative with celiac disease, but no correlation was found between NCGS and positivity for HLA-DQ2/-DQ8.", {"entities": [[66, 80, "DISEASE"]]}], ["IgG anti-gliadin antibodies were detected in 25% of the patients tested.", {"entities": []}], ["Only a proportion of patients underwent duodenal biopsy; for those that did, the biopsies showed normal intestinal mucosa (69%) or mild increase in intraepithelial lymphocytes (31%).", {"entities": []}], ["The ratio between suspected NCGS and new CD diagnoses, assessed in 28 of the participating centers, was 1.15 to 1.", {"entities": []}], ["This prospective survey shows that NCGS has a strong correlation with female gender and adult age.", {"entities": []}], ["Based on our results, the prevalence of NCGS seems to be only slightly higher than that of celiac disease.", {"entities": [[91, 105, "DISEASE"]]}], ["Please see related article http://www.biomedcentral.com/1741-7015/12/86 .", {"entities": []}], ["Exhaled nitric oxide (NO) is one of the most promising breath markers for respiratory diseases.", {"entities": []}], ["Its profile for exhalation and the respiratory NO production sites can provide useful information for medical disease diagnosis and therapeutic procedures.", {"entities": []}], ["However, the high-level moisture in exhaled gas always leads to the poor selectivity and sensitivity for ion spectrometric techniques.", {"entities": []}], ["Herein, a method based on fast non-equilibrium dilution ion mobility spectrometry (NED-IMS) was firstly proposed to directly monitor the exhaled NO profile on line.", {"entities": []}], ["The moisture interference was eliminated by turbulently diluting the original moisture to 21% of the original with the drift gas and dilution gas.", {"entities": []}], ["Weak enhancement was observed for humid NO response and its limit of detection at 100% relative humidity was down to 0.58\u2009ppb.", {"entities": []}], ["The NO concentrations at multiple exhalation flow rates were measured, while its respiratory production sites were determined by using two-compartment model (2CM) and H\u00f6gman and Meril\u00e4inen algorithm (HMA).", {"entities": []}], ["Last but not the least, the NO production sites were analyzed hourly to tentatively investigate the daily physiological process of NO.", {"entities": []}], ["The results demonstrated the capacity of NED-IMS in the real-time analysis of exhaled NO and its production sites for clinical diagnosis and assessment.", {"entities": []}], ["Fibroblast migration, proliferation, extracellular matrix protein synthesis and degradation are the key events in various biological and pathological processes in pulmonary fibrosis.", {"entities": [[163, 181, "DISEASE"]]}], ["In addition, biopsy specimens from the lungs of patients with pulmonary fibrosis show increased numbers of mast cells which have metachromatic granules containing heparin, histamine and proteases.", {"entities": [[62, 80, "DISEASE"]]}], ["Little is known about how these products influence pulmonary fibrosis.", {"entities": [[51, 69, "DISEASE"]]}], ["In the present study, we investigated the effect of heparin and related glycosaminoglycans on PDGF-induced lung fibroblast proliferation and chemotactic response in vitro.", {"entities": []}], ["In addition, we examined the effect of heparin on both the induction of matrix metalloproteinases (MMPs) and MMPs activity in lung fibroblasts in vitro.", {"entities": []}], ["Heparin, de-N-sulphated heparin but not heparan sulphate inhibited PDGF-induced lung fibroblast proliferation.", {"entities": []}], ["In contrast, only heparin inhibited PDGF-stimulated human lung fibroblast chemotaxis.", {"entities": []}], ["Negatively charged poly-L-glutamic acid had no effect on either fibroblast proliferation or chemotaxis.", {"entities": []}], ["Thus the negative charge alone cannot account for the ant-proliferative and anti-chemotactic effects of heparin.", {"entities": []}], ["Furthermore, heparin and heparan sulphate also had no inhibitory effect on induction of MMPS, including MMP-1 (interstitial collagenase), MMP-2 (gelatinase A) and MMP-9 (gelatinase B).", {"entities": []}], ["Only heparin inhibited both MMP-1 and MMP-2/MMP-9 activity.", {"entities": []}], ["Additionally, tissue inhibitor of metalloproteinase type 1 (TIMP-1) and type 2 (TIMP-2) inhibited PDGF-stimulated human lung fibroblast chemotaxis.", {"entities": []}], ["The ability of heparin to inhibit fibroblast chemotaxis may account for the inhibitory effect of heparin on MMP activity.", {"entities": []}], ["The above results suggested that heparin and related glycosaminoglycans differentially regulate PDGF-induced lung fibroblast proliferation, chemotaxis and MMPs activity and further that these effects may have a key role in extracellular matrix remodeling in inflammatory lung disease.", {"entities": [[271, 283, "DISEASE"]]}], ["To evaluate peripheral respiratory system resistance and reactance (Rrs and Xrs, respectively) in obese individuals.", {"entities": []}], ["We recruited 99 individuals, dividing them into four groups by body mass index (BMI): < 30.0 kg/m Of the 99 individuals recruited, 14 were excluded because they failed to perform forced expiratory maneuvers correctly during spirometry.", {"entities": []}], ["The individuals in the severe obesity and morbid obesity groups showed higher peripheral Rrs and lower Xrs in comparison with those in the two other groups.", {"entities": [[30, 37, "DISEASE"], [49, 56, "DISEASE"], [42, 56, "DISEASE"]]}], ["Having a BMI \u2265 40 kg/m Avaliar a resist\u00eancia do sistema respirat\u00f3rio (Rsr) perif\u00e9rica e a reat\u00e2ncia (Xsr) em indiv\u00edduos obesos.", {"entities": []}], ["Recrutamos 99 indiv\u00edduos, divididos em quatro grupos pelo \u00edndice de massa corp\u00f3rea (IMC): < 30,0 kg/m Entre os 99 indiv\u00edduos recrutados, 14 foram exclu\u00eddos por incapacidade de executar corretamente as manobras expirat\u00f3rias for\u00e7adas na espirometria.", {"entities": [[53, 57, "GENE"], [156, 159, "GENE"]]}], ["Os indiv\u00edduos dos grupos obesidade grave e obesidade m\u00f3rbida apresentaram aumento da Rsr perif\u00e9rica e redu\u00e7\u00e3o da Xsr quando comparados aos dos outros grupos.", {"entities": []}], ["Ter IMC \u2265 40 kg/m", {"entities": []}], ["An important precursor to lung cancer development is chronic obstructive pulmonary disease (COPD), independent of exposure to tobacco smoke.", {"entities": [[26, 37, "DISEASE"], [53, 90, "DISEASE"], [31, 37, "DISEASE"]]}], ["Both diseases are associated with increased host susceptibility, inflammation, and genomic instability.", {"entities": []}], ["However, validation of the candidate genes and functional confirmation to test shared genetic contribution and cellular mechanisms to the development of lung cancer in patients with COPD remains underexplored.", {"entities": [[153, 164, "DISEASE"], [158, 164, "DISEASE"]]}], ["Here, we show that loss of PARK2 (encoding Parkin) increases the expression of proinflammation factors as well as nuclear NF-\u03baB localization, suggesting a role of PARK2 loss in inflammation.", {"entities": [[27, 32, "GENE"], [163, 168, "GENE"], [27, 32, "GENE"], [163, 168, "GENE"]]}], ["Additional exploration showed that PARK2 deficiency promotes genomic instability and cell transformation.", {"entities": [[35, 40, "GENE"]]}], ["This role of PARK2 in inflammation and chromosome instability provides a potential link among Parkin, COPD and lung cancer.", {"entities": [[111, 122, "DISEASE"], [116, 122, "DISEASE"], [13, 18, "GENE"]]}], ["A further comprehensive validation of 114 informative single nucleotide polymorphism (SNP) variants of PARK2, in 2,484 cases and controls with well-defined lung cancer and COPD phenotypes, found rs577876, rs6455728 and rs9346917 ( p<0.01 ) to be significantly associated with lung cancer development in people with COPD.", {"entities": [[156, 167, "DISEASE"], [276, 287, "DISEASE"], [161, 167, "DISEASE"], [281, 287, "DISEASE"], [103, 108, "GENE"]]}], ["Our findings support the evidence that PARK2 might have a tumor suppressor role in the development of COPD and lung cancer.", {"entities": [[111, 122, "DISEASE"], [116, 122, "DISEASE"], [39, 44, "GENE"]]}], ["Ranolazine is a new anti-anginal drug that acts via late sodium current inhibition, and has been shown to improve diastolic dysfunction in isolated myocytes.", {"entities": []}], ["Diastolic dysfuntion is common in patients with aortic stenosis (AS), and precedes symptom development and systolic dysfunction.", {"entities": []}], ["The purpose of this study was to assess the effects of ranolazine on peak early diastolic strain rate (PEDSR) and exercise capacity in patients with AS.", {"entities": []}], ["Patients with asymptomatic moderate to severe AS and diastolic dysfunction underwent trans-thoracic echocardiography, exercise testing and cardiac magnetic resonance\u00a0(CMR) imaging at baseline, 6\u00a0weeks after commencing ranolazine and at 10\u00a0weeks (4\u00a0weeks after discontinuation).", {"entities": []}], ["Diastolic function was assessed using PEDSR measured on tagged CMR images.", {"entities": []}], ["Fifteen patients (peak pressure gradient 48.8\u00a0\u00b1\u00a012.4\u00a0mmHg, mean pressure gradient 27.1\u00a0\u00b1\u00a07.5\u00a0mmHg, aortic valve area 1.26\u00a0\u00b1\u00a00.31\u00a0cm This small pilot study did not show a significant improvement in diastolic function with the use of ranolazine in asymptomatic patients with moderate-severe AS.", {"entities": []}], ["Further studies with a larger population may be indicated.", {"entities": []}], ["EduraCT number 2011 - 000111 - 26 The online version of this article (doi:10.1186/s13104-016-1874-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["While adverse effects of exposure to air pollutants on respiratory health are well studied, little is known about the effect of a reduction in air pollutants on chronic respiratory symptoms and diseases.", {"entities": []}], ["We investigated whether different declines in air pollution levels in industrialised and rural areas in Germany were associated with changes in respiratory health over a period of about 20 years.", {"entities": []}], ["We used data from the SALIA cohort study in Germany ( S tudy on the influence of A ir pollution on L ung function, I nflammation and A ging) to assess the association between the prevalence of chronic obstructive pulmonary disease (COPD) and chronic respiratory symptoms and the decline in air pollution exposure.", {"entities": [[193, 230, "DISEASE"], [101, 104, "GENE"]]}], ["In 1985-1994, 4874 women aged 55-years took part in the baseline investigation.", {"entities": []}], ["Of these, 2116 participated in a questionnaire follow-up in 2006 and in a subgroup of 402 women lung function was tested in 2008-2009.", {"entities": []}], ["Generalized estimating equation (GEE) models were used to estimate the effect of a reduction in air pollution on respiratory symptoms and diseases.", {"entities": []}], ["Ambient air concentrations of particulate matter with aerodynamic size < 10 \u03bcm (PM 10 ) declined in average by 20 \u03bcg/m 10 was observed in the industrialized areas in comparison to the rural area, this was associated with a weaker increase in prevalence of respiratory symptoms and COPD.", {"entities": []}], ["Among women who never smoked, the prevalence of chronic cough with phlegm and mild COPD was estimated at 21.4% and 39.5%, respectively, if no air pollution reduction was assumed, and at 13.3% and 17.5%, respectively, if air pollution reduction was assumed.", {"entities": []}], ["We concluded that parallel to the decline of ambient air pollution over the last 20 years in the Ruhr area the age-related increase in chronic respiratory diseases and symptoms appears to attenuate in the population of elderly women.", {"entities": []}], ["Dichrostachys cinerea (L.) Wight et Arn.", {"entities": []}], ["(Mimosaceae) is largely used in ethno-medically across Africa, and mainly employed for the treatment of asthma in Ivory Coast and Gabon.", {"entities": [[104, 110, "DISEASE"]]}], ["The paper analyses the relaxation induced by the methanolic extract of D. cinerea (Edici) in the guinea-pig trachea preparations (GPTPs).", {"entities": []}], ["Purpose: This study aimed to bring out the scientific basis to the use of this plant leading to the validation of this phytomedicine.", {"entities": []}], ["The aorta obtained from guinea-pigs was immediately placed in a Mac Ewen solution.", {"entities": []}], ["Experiments were performed in preparations suspended between two L-shaped stainless steel hooks in a 10 ml organ bath containing Mac Ewen solution.", {"entities": []}], ["The isometric contractile force of the aorta strips of guinea-pig were recorded by using a strain gauge.", {"entities": []}], ["The different drugs were directly administered into the organ bath and the magnitude of GPTPs was evaluated.", {"entities": []}], ["Phytochemical analysis of the methanolic extract of Dichrostachys cinerea (Edici) using chemical methods revealed the presence of flavenoids, tannins, sterols, triterpenes and polyphenols.", {"entities": []}], ["Pharmacological studies performed in GPTPs show that of Dichrostachys cinerea (0.1 mg/ml - 2 mg/ml) evoked a broncho-constriction in GPTPs.", {"entities": []}], ["Whereas, at concentration up to 2 mg/ml, Edici induced a significant dose-dependent relaxation in the GPTPs.", {"entities": []}], ["KCl-, ACh- or histamine-evoked contractions of isolated trachea was significantly inhibited by increasing concentrations of Edici (3.5-10 mg/ml).", {"entities": []}], ["Edici (10 mg/ml) as well as promethazine (0.25 mg/ml) significantly inhibited contractions induced by increasing concentrations of histamine (1\u00d710 These observations suggest that Edici could act through two mechanisms: firstly by activation of \u03b2-adrenergic or histaminergic receptors; and secondly muscarinic receptors may not be greatly involved, that justifying the use of the extract in traditional Medicine in Africa.", {"entities": []}], ["Unlike some organs, the heart is unable to repair itself after injury.", {"entities": []}], ["Human embryonic stem cells (hESCs) grow and divide indefinitely while maintaining the potential to develop into many tissues of the body.", {"entities": []}], ["As such, they provide an unprecedented opportunity to treat human diseases characterized by tissue loss.", {"entities": []}], ["We have identified early myocardial precursors derived from hESCs (hMPs) using an \u03b1-myosin heavy chain (\u03b1MHC)-GFP reporter line.", {"entities": []}], ["We have demonstrated by immunocytochemistry and quantitative real-time PCR (qPCR) that reporter activation is restricted to hESC-derived cardiomyocytes (CMs) differentiated in vitro , and that hMPs give rise exclusively to muscle in an in vivo teratoma formation assay.", {"entities": [[244, 252, "DISEASE"]]}], ["We also demonstrate that the reporter does not interfere with hESC genomic stability.", {"entities": []}], ["Importantly, we show that hMPs give rise to atrial, ventricular and specialized conduction CM subtypes by qPCR and microelectrode array analysis.", {"entities": []}], ["Expression profiling of hMPs over the course of differentiation implicate Wnt and transforming growth factor-\u03b2 signaling pathways in CM development.", {"entities": []}], ["The identification of hMPs using this \u03b1MHC-GFP reporter line will provide important insight into the pathways regulating human myocardial development, and may provide a novel therapeutic reagent for the treatment of cardiac disease.", {"entities": []}], ["Geographic tongue is a chronic, inflammatory, and immune-mediated oral lesion of unknown etiology.", {"entities": []}], ["It is characterized by serpiginous white areas around the atrophic mucosa, which alternation between activity, remission and reactivation at various locations gave the names benign migratory glossitis and wandering rash of the tongue.", {"entities": [[191, 200, "DISEASE"], [174, 200, "DISEASE"]]}], ["Psoriasis is a chronic inflammatory disease with frequent cutaneous involvement and an immunogenetic basis of great importance in clinical practice.", {"entities": [[0, 9, "DISEASE"]]}], ["The association between geographic tongue and psoriasis has been demonstrated in various studies, based on observation of its fundamental lesions, microscopic similarity between the two conditions and the presence of a common genetic marker, human leukocyte antigen (HLA) HLA-C*06.", {"entities": [[46, 55, "DISEASE"], [267, 270, "GENE"], [272, 275, "GENE"]]}], ["The difficulty however in accepting the diagnosis of geographic tongue as oral psoriasis is the fact that not all patients with geographic tongue present psoriasis.", {"entities": [[79, 88, "DISEASE"], [154, 163, "DISEASE"]]}], ["Some authors believe that the prevalence of geographic tongue would be much greater if psoriatic patients underwent thorough oral examination.", {"entities": []}], ["This study aimed to develop a literature review performed between 1980 and 2014, in which consultation of theses, dissertations and selected scientific articles were conducted through search in Scielo and Bireme databases, from Medline and Lilacs sources, relating the common characteristics between geographic tongue and psoriasis.", {"entities": [[322, 331, "DISEASE"]]}], ["We observed that the frequency of oral lesions is relatively common, but to establish a correct diagnosis of oral psoriasis, immunohistochemical and genetic histopathological analyzes are necessary, thus highlighting the importance of oral examination in psoriatic patients and cutaneous examination in patients with geographic tongue.", {"entities": [[114, 123, "DISEASE"]]}], ["Polymorphonuclear eosinophil leucocytes (eosinophils) are found in increased numbers in the circulation and sputum in asthma patients, usually in relation to the severity of asthma but it is the question whether they have a significant role in the development and level of bronchial hyperreactivity in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[316, 353, "DISEASE"], [118, 124, "DISEASE"], [174, 180, "DISEASE"]]}], ["to show the role of the eosinophils in the development and level of BHR in patients with COPD and so in the severity of illness.", {"entities": []}], ["We observed 240 patients with COPD treated in Clinic for Pulmonary Diseases and TB \u00abPodhrastovi\u00bb Sarajevo during five years: from 2012 to 2016.", {"entities": []}], ["They were divided into groups and subgroups according to the first registration of BHR in the course of illness and to the number of exacerbations of the disease in one year.", {"entities": []}], ["The number of blood eosinophils was measured at the onset of exacerbation of the disease before switching on any therapy, at the beginning and at the end of the research.", {"entities": []}], ["we did not find any significant difference in the eosinophil blood count between the COPD patients with and without BHR, nor according to the time of the first registration of BHR in the course of illness nor according to the number of exacerbations of illness per one year.", {"entities": []}], ["There was not statistically significant difference in eosinophil count (increase-drop) within any of the groups or subgroups, or between the groups and subgroups between the first and last test.", {"entities": []}], ["There is not significant correlation between the eosinophil blood count and the level of BHR, number of exacerbations and the severity of COPD.", {"entities": []}], ["We investigated how rosiglitazone attenuated cigarette smoke (CS)-induced emphysema in a rat model.", {"entities": [[62, 64, "GENE"]]}], ["In particular, we focused on its possible effects on the imbalance between metalloprotease (MMP) and anti-MMP activity, mitogen-activated protein kinase (MAPK) phosphorylation, and nuclear factor kappa-light-chain-enhancer of activated B cell (NF\u03baB) signaling pathway over-activation.", {"entities": []}], ["A total of 36 Wistar rats were divided into three groups (n=12 each): animals were exposed to CS for 12 weeks in the absence (the CS group) or presence of 30 mg/kg rosiglitazone (the rosiglitazone-CS [RCS] group); a control group was treated with the rosiglitazone vehicle only, without any CS exposure.", {"entities": [[94, 96, "GENE"], [130, 132, "GENE"], [197, 199, "GENE"], [291, 293, "GENE"], [94, 96, "GENE"], [130, 132, "GENE"], [197, 199, "GENE"], [291, 293, "GENE"], [94, 96, "GENE"], [130, 132, "GENE"], [197, 199, "GENE"], [291, 293, "GENE"]]}], ["Histopathology of lung tissue in all groups was evaluated to grade severity of the disease.", {"entities": []}], ["Expression levels of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3), MMP2, and MMP9 in lung tissue were determined and compared using Western blotting and immunohistochemistry.", {"entities": [[75, 79, "GENE"], [85, 89, "GENE"]]}], ["Activation of MAPKs, NF\u03baB, and the nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor, alpha (I\u03baB\u03b1) phosphorylation in lung tissue was examined by Western blotting.", {"entities": []}], ["Emphysema-related pathology, based on inter-alveolar wall distance and alveolar density, was less severe in the RCS group than in the CS group.", {"entities": [[134, 136, "GENE"]]}], ["Compared with the CS group, levels of PPAR\u03b3 were higher in the RCS group, and levels of MMP2 and MMP9 proteins were lower in the RCS rats.", {"entities": [[18, 20, "GENE"], [88, 92, "GENE"], [97, 101, "GENE"]]}], ["Levels of activated MAPKs and NF\u03baB were also lower, while the I\u03baB\u03b1phosphorylation was increased in the lung tissue of RCS rats.", {"entities": []}], ["Our findings suggest that oral administration of rosiglitazone attenuates the metalloprotease activity induced by CS, and the underlying mechanism might involve the activation of signaling pathways dependent on MAPKs or NF\u03baB.", {"entities": [[114, 116, "GENE"]]}], ["Our results further suggest that PPAR\u03b3 contributes to the pathogenesis of emphysema as well as airway inflammation induced by CS.", {"entities": [[126, 128, "GENE"]]}], ["Fibroblast growth factor 2 (FGF-2) is a multifunctional protein synthesized as high (Hi-) and low (Lo-) molecular weight isoforms.", {"entities": []}], ["Studies using rodent models showed that Hi- and Lo-FGF-2 exert distinct biological activities: after myocardial infarction, rat Lo-FGF-2, but not Hi-FGF-2, promoted sustained cardioprotection and angiogenesis, while Hi-FGF-2, but not Lo-FGF-2, promoted myocardial hypertrophy and reduced contractile function.", {"entities": [[101, 122, "DISEASE"]]}], ["Because there is no information regarding Hi-FGF-2 in human myocardium, we undertook to investigate expression, regulation, secretion and potential tissue remodeling-associated activities of human cardiac (atrial) Hi-FGF-2.", {"entities": []}], ["Human patient-derived atrial tissue extracts, as well as pericardial fluid, contained Hi-FGF-2 isoforms, comprising, respectively, 53%(\u00b120 SD) and 68% (\u00b125 SD) of total FGF-2, assessed by western blotting.", {"entities": []}], ["Human atrial tissue-derived primary myofibroblasts (hMFs) expressed and secreted predominantly Hi-FGF-2, at about 80% of total.", {"entities": []}], ["Angiotensin II (Ang II) up-regulated Hi-FGF-2 in hMFs, via activation of both type 1 and type 2 Ang II receptors; the ERK pathway; and matrix metalloprotease-2.", {"entities": [[16, 19, "GENE"], [96, 99, "GENE"], [16, 19, "GENE"], [96, 99, "GENE"]]}], ["Treatment of hMFs with neutralizing antibodies selective for human Hi-FGF-2 (neu-Ab in vitro .", {"entities": []}], ["In conclusion, we have documented that Hi-FGF-2 represents a substantial fraction of FGF-2 in human cardiac (atrial) tissue and in pericardial fluid, and have shown that human Hi-FGF-2, unlike Lo-FGF-2, promotes deleterious (pro-fibrotic, pro-inflammatory, and pro-hypertrophic) responses in vitro.", {"entities": []}], ["Selective targeting of Hi-FGF-2 production may, therefore, reduce pathological remodelling in the human heart.", {"entities": []}], ["Caesarean section (CS) has been reported to increase the risk of asthma in offspring.", {"entities": [[65, 71, "DISEASE"], [19, 21, "GENE"]]}], ["This may be due to that infants delivered by CS are unexposed to vaginal flora, according to the \u2018hygiene hypothesis\u2019.", {"entities": [[45, 47, "GENE"]]}], ["Our aim was to investigate if CS increases risk of childhood asthma, and if the risk increase remains after adjustment for familial confounding using sibling design.", {"entities": [[61, 67, "DISEASE"], [30, 32, "GENE"]]}], ["A register-based cohort study with 87 500 Swedish sibling pairs was undertaken.", {"entities": []}], ["Asthma outcome variables were collected from national health registers as diagnosis or asthma medication (ICD-10 J45-J46; ATC code R03) during the 10th or 13th year of life (year of follow-up).", {"entities": [[0, 6, "DISEASE"], [87, 93, "DISEASE"]]}], ["Mode of delivery and confounders were retrieved from the Medical Birth Register.", {"entities": []}], ["The data were analysed both as a cohort and with sibling control analysis which adjusts for unmeasured familial confounding.", {"entities": []}], ["In the cohort analyses, there was an increased risk of asthma medication and asthma diagnosis during year of follow-up in children born with CS (adjusted ORs, 95% CI 1.13, 1.04\u20131.24 and 1.10, 1.03\u20131.18 respectively).", {"entities": [[55, 61, "DISEASE"], [77, 83, "DISEASE"], [141, 143, "GENE"]]}], ["When separating between emergency and elective CS the effect on asthma medication remained for emergency CS, but not for elective CS, while both groups had significant effects on asthma diagnosis compared with vaginal delivery.", {"entities": [[64, 70, "DISEASE"], [179, 185, "DISEASE"], [47, 49, "GENE"], [105, 107, "GENE"], [130, 132, "GENE"], [47, 49, "GENE"], [105, 107, "GENE"], [130, 132, "GENE"], [47, 49, "GENE"], [105, 107, "GENE"], [130, 132, "GENE"]]}], ["In sibling control analyses, the effect of elective CS on asthma disappeared, while similar but non-significant ORs of medication were obtained for emergency CS.", {"entities": [[58, 64, "DISEASE"], [52, 54, "GENE"], [158, 160, "GENE"], [52, 54, "GENE"], [158, 160, "GENE"]]}], ["An increased risk of asthma medication in the group born by emergency CS, but not elective, suggests that there is no causal effect due to vaginal microflora.", {"entities": [[21, 27, "DISEASE"], [70, 72, "GENE"]]}], ["A more probable explanation should be sought in the indications for emergency CS.", {"entities": [[78, 80, "GENE"]]}], ["Mild traumatic brain injury (mTBI) has high prevalence in the military, among athletes, and in the general population worldwide (largely due to falls).", {"entities": []}], ["Consequences can include a range of neuropsychological disorders.", {"entities": []}], ["Unfortunately, such neural injury often goes undiagnosed due to the difficulty in identifying symptoms, so the discovery of an effective biomarker would greatly assist diagnosis; however, no single biomarker has been identified.", {"entities": []}], ["We identify several body substances as potential components of a panel of biomarkers to support the diagnosis of mild traumatic brain injury.", {"entities": []}], ["Our approach to diagnostic biomarker discovery combines ideas and techniques from systems medicine, natural language processing, and graph theory.", {"entities": []}], ["We create a molecular interaction network that represents neural injury and is composed of relationships automatically extracted from the literature.", {"entities": []}], ["We retrieve citations related to neurological injury and extract relationships (semantic predications) that contain potential biomarkers.", {"entities": []}], ["After linking all relationships together to create a network representing neural injury, we filter the network by relationship frequency and concept connectivity to reduce the set to a manageable size of higher interest substances.", {"entities": []}], ["99,437 relevant citations yielded 26,441 unique relations.", {"entities": []}], ["18,085 of these contained a potential biomarker as subject or object with a total of 6246 unique concepts.", {"entities": []}], ["After filtering by graph metrics, the set was reduced to 1021 relationships with 49 unique concepts, including 17 potential biomarkers.", {"entities": []}], ["We created a network of relationships containing substances derived from 99,437 citations and filtered using graph metrics to provide a set of 17 potential biomarkers.", {"entities": []}], ["We discuss the interaction of several of these (glutamate, glucose, and lactate) as the basis for more effective diagnosis than is currently possible.", {"entities": []}], ["This method provides an opportunity to focus the effort of wet bench research on those substances with the highest potential as biomarkers for mTBI.", {"entities": []}], ["Home telehealth has the potential to benefit heart failure (HF) and chronic obstructive pulmonary disease (COPD) patients, however large-scale deployment is yet to be achieved.", {"entities": [[68, 105, "DISEASE"]]}], ["The aim of this review was to assess levels of uptake of home telehealth by patients with HF and COPD and the factors that determine whether patients do or do not accept and continue to use telehealth.", {"entities": []}], ["This research performs a narrative synthesis of the results from included studies.", {"entities": []}], ["Thirty-seven studies met the inclusion criteria.", {"entities": []}], ["Studies that reported rates of refusal and/or withdrawal found that almost one third of patients who were offered telehealth refused and one fifth of participants who did accept later abandoned telehealth.", {"entities": []}], ["Seven barriers to, and nine facilitators of, home telehealth use were identified.", {"entities": []}], ["Research reports need to provide more details regarding telehealth refusal and abandonment, in order to understand the reasons why patients decide not to use telehealth.", {"entities": []}], ["The online version of this article (doi:10.1007/s12160-014-9607-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The use of complementary and alternative medicine (CAM) is on the increase globally with a high prevalence in children and adults with chronic illnesses.", {"entities": []}], ["Many studies have evaluated the epidemiology of medicine use for children in developing countries but none has evaluated the use of CAM for children with chronic illnesses.", {"entities": []}], ["The aim of this study was therefore to determine the prevalence, pattern of use, parental sources of information, perceived benefits, cost, and adverse effects of CAM in children with epilepsy, sickle cell anaemia and asthma in Lagos, Nigeria.", {"entities": [[218, 224, "DISEASE"]]}], ["Parents of children with epilepsy (122), asthma (78) or sickle cell anaemia (118) who presented consecutively to the paediatric neurology, respiratory and haematology clinics of the Lagos State University Teaching Hospital (LASUTH), Ikeja were interviewed with a structured open- and close-ended questionnaire.", {"entities": [[41, 47, "DISEASE"]]}], ["The information obtained comprised the demography of both the patients and their parents; past and present treatments received by the patients; the type of CAM, if any, used by the patients; and the sources, cost, benefits and adverse effects of the CAM used.", {"entities": []}], ["A total of 303 CAMs were used by the patients, either alone or in combination witother CAM.", {"entities": []}], ["CAM was reportedly used by 99 (31%) patients (epilepsy -38%, sickle cell anaemia \u2013 36% and asthma \u2013 25%).", {"entities": [[91, 97, "DISEASE"]]}], ["The majority (84%) of these patients were currently using CAM.", {"entities": []}], ["The use of CAM was stopped six months prior to the study by 16 patients (16%).", {"entities": []}], ["Biological products were the most frequently used CAMs (58%), followed by alternative medical systems (27%) and mind-body interventions (14%).", {"entities": []}], ["Relations, friends and neighbours had a marked influence on 76% of the parents who used CAM for their children.", {"entities": []}], ["Eighty-five (86%) parents were willing to discuss the use of CAM with their doctors but were not asked.", {"entities": []}], ["CAM use was associated with adverse reactions in 7.1% of the patients.", {"entities": []}], ["Parental use of CAMs to treat their children with epilepsy, asthma and sickle cell anaemia is common in Nigeria.", {"entities": [[60, 66, "DISEASE"]]}], ["Efforts should be made by doctors taking care of these patients to identify those CAM therapies that are beneficial, harmless and cheap for possible integration with conventional therapy.", {"entities": []}], ["A wide variety of research studies suggest that breakdowns in the diagnostic process result in a staggering toll of harm and patient deaths.", {"entities": []}], ["These include autopsy studies, case reviews, surveys of patient and physicians, voluntary reporting systems, using standardised patients, second reviews, diagnostic testing audits and closed claims reviews.", {"entities": []}], ["Although these different approaches provide important information and unique insights regarding diagnostic errors, each has limitations and none is well suited to establishing the incidence of diagnostic error in actual practice, or the aggregate rate of error and harm.", {"entities": []}], ["We argue that being able to measure the incidence of diagnostic error is essential to enable research studies on diagnostic error, and to initiate quality improvement projects aimed at reducing the risk of error and harm.", {"entities": []}], ["Three approaches appear most promising in this regard: (1) using \u2018trigger tools\u2019 to identify from electronic health records cases at high risk for diagnostic error; (2) using standardised patients (secret shoppers) to study the rate of error in practice; (3) encouraging both patients and physicians to voluntarily report errors they encounter, and facilitating this process.", {"entities": []}], ["Today, exhaled nitric oxide has been studied the most, and most researches have now focusd on asthma.", {"entities": [[94, 100, "DISEASE"]]}], ["More than a thousand different volatile organic compounds have been observed in low concentrations in normal human breath.", {"entities": []}], ["Alkanes and methylalkanes, the majority of breath volatile organic compounds, have been increasingly used by physicians as a novel method to diagnose many diseases without discomforts of invasive procedures.", {"entities": []}], ["None of the individual exhaled volatile organic compound alone is specific for disease.", {"entities": []}], ["Exhaled breath analysis techniques may be available to diagnose and monitor the diseases in home setting when their sensitivity and specificity are improved in the future.", {"entities": []}], ["Self-management skills, including medication management, are vital to the health of adolescents and young adults with systemic lupus erythematosus (SLE).", {"entities": [[127, 146, "DISEASE"], [118, 146, "DISEASE"]]}], ["The purpose of this study was to assess the feasibility and preliminary effects of an online educational program in a cohort of adolescent and young adults with SLE with and without a social media (SM) experience.", {"entities": []}], ["Adolescents and young adults with SLE participated weekly for 8 sessions on a web-based educational program about SLE created specifically for this project.", {"entities": []}], ["Subjects were randomized to respond to questions at the end of each weekly module in a journal or on a SM forum with other SLE subjects.", {"entities": []}], ["Patients were surveyed prior to initiating the study, (T0) and 6\u00a0weeks after completion of the sessions (T1).", {"entities": []}], ["Medication adherence for hydroxychloroquine, utilizing the medication possession ratio (MPR), was compared for the 3 months preceding T0 and for the 3\u00a0months following T1.", {"entities": []}], ["Twenty-seven of the 37 subjects (73%) enrolled completed the study, including the two required sets of surveys.", {"entities": []}], ["Reasons for being lost to follow up included being too busy, forgetting, and/or not seeing email reminders.", {"entities": []}], ["Medication adherence improved in all subjects ( p \u00a0<\u20090.001).", {"entities": []}], ["The percentage of the SM intervention group that was adherent (MPR\u2009\u2265\u200980%) significantly improved from 50% to 92% ( p \u00a0=\u20090.03), while the control group did not.", {"entities": []}], ["Secondary outcome measures that improved, only in the SM group, included self-efficacy, sense of agency (SOA), sense of community (SOC), and empowerment.", {"entities": []}], ["There was a strong correlation between empowerment with SOA and SOC and in turn a strong correlation with SOA and SOC with MPR, providing a possible explanation for why social media participation helped to improve medication adherence.", {"entities": []}], ["Subjective reporting of medication adherence was not reliably correlated to MPR.", {"entities": []}], ["This pilot study has demonstrated feasibility for the use of an online educational SLE website, recruitment, and measurement of chosen outcome measures.", {"entities": []}], ["This study provides evidence for a larger multi-site trial which has the potential to address an important service gap by delivering self-management education and peer interactions in a format that is accessible, and engaging to young people with SLE.", {"entities": []}], ["Trial registration: NCT03218033 .", {"entities": []}], ["Retrospectively registered 14 July 2017.", {"entities": []}], ["The online version of this article (10.1186/s12969-018-0232-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Gastric cancer is the second most common cause of cancer death worldwide and is usually detected at a late stage, except in Korea and Japan where early screening is in effect.", {"entities": [[8, 14, "DISEASE"], [50, 56, "DISEASE"]]}], ["Results from animal and epidemiological studies suggest that Helicobacter pylori infection, and subsequent gastritis, promote development of gastric cancer in the infected mucosa.", {"entities": [[107, 116, "DISEASE"], [149, 155, "DISEASE"]]}], ["Relatively effective treatment regimens are available to treat H. pylori infection, and in general, mass eradication of the organism is not currently recommended as a gastric cancer prevention strategy.", {"entities": [[175, 181, "DISEASE"]]}], ["However, regional guidelines vary regarding the indications and recommendations for H. pylori treatment for gastric cancer prevention.", {"entities": [[116, 122, "DISEASE"]]}], ["In this review, we discuss the results from intervention studies, provide insight regarding current guideline recommendations, and discuss future study directions.", {"entities": []}], ["Over the past two decades, 12 large epidemiologic studies and 2 registries have focused on U.S. veterans of the 1990\u20131991 Gulf War Era.", {"entities": []}], ["We conducted a review of these studies\u2019 research tools to identify existing gaps and overlaps of efforts to date, and to advance development of the next generation of Gulf War Era survey tools.", {"entities": []}], ["Overall, we found that many of the studies used similar instruments.", {"entities": []}], ["Questions regarding exposures were more similar across studies than other domains, while neurocognitive and psychological tools were the most variable.", {"entities": []}], ["Many studies focused on self-reported survey results, with a range of validation practices.", {"entities": []}], ["However, physical exams, biomedical assessments, and specimen storage were not common.", {"entities": []}], ["This review suggests that while research may be able to pool data from past surveys, future surveys need to consider how their design can yield data comparable with previous surveys.", {"entities": []}], ["Additionally, data that incorporate recent technologies in specimen and genetic analyses would greatly enhance such survey data.", {"entities": []}], ["When combined with existing data on deployment-related exposures and post-deployment health conditions, longitudinal follow-up of existing studies within this collaborative framework could represent an important step toward improving the health of veterans.", {"entities": []}], ["Reduced neutrophil apoptosis plays an important role in the pathogenesis of acute exacerbation chronic obstructive pulmonary disease (AECOPD).", {"entities": [[95, 132, "DISEASE"]]}], ["The p38 mitogen-activated protein kinase (MAPK) signaling pathway is involved in neutrophil apoptosis.", {"entities": []}], ["1\u03b1,25-Dihydroxyvitamin D3 (1\u03b1,25VitD3) can induce tumor cell apoptosis.", {"entities": []}], ["The aim of this study was to assess the effects of 1\u03b1,25VitD3 on peripheral blood neutrophil apoptosis in AECOPD and examine the role of the p38 MAPK signaling pathway.", {"entities": []}], ["The study enrolled 36 AECOPD patients and 36 healthy volunteers.", {"entities": []}], ["Venous blood samples were obtained from both groups.", {"entities": []}], ["Serum 25-hydroxyvitamin D (25-(OH) D) levels in peripheral venous blood were assayed using liquid chromatography-tandem mass spectrometry (LC-MS/MS); the neutrophils were separated and cultured with SB203580 (a p38 inhibitor) and 1\u03b1,25VitD3.", {"entities": []}], ["Neutrophil apoptosis was measured using flow cytometry, and phospho-p38 MAPK protein expression was detected by Western blot.", {"entities": []}], ["Statistical analysis was performed using analysis of variance.", {"entities": []}], ["Student's t-test and Pearson's correlation coefficient were used for the between-group differences and correlation analysis, respectively.", {"entities": []}], ["The 25-(OH) D levels were lower in AECOPD patients than in healthy controls, and the peripheral blood neutrophil apoptosis results were similar.", {"entities": []}], ["1\u03b1,25VitD3 increased the apoptosis rate and the level of phospho-p38 MAPK in peripheral blood neutrophils of AECOPD patients.", {"entities": []}], ["SB203580 partly inhibited 1\u03b1,25VitD3-induced peripheral blood neutrophil apoptosis and phospho-p38 MAPK overexpression.", {"entities": []}], ["The 25-(OH) D levels were positively correlated with increased peripheral blood neutrophil apoptosis and phospho-p38 MAPK levels.", {"entities": []}], ["In addition, expression of the phospho-p38 MAPK protein was also positively correlated with peripheral blood neutrophil apoptosis.", {"entities": []}], ["Our results suggest that 1\u03b1,25VitD3 induces peripheral blood neutrophil apoptosis through the p38 MAPK signaling pathway in AECOPD patients.", {"entities": []}], ["Natural killer T (NKT) cells are a subset of T cells that help potentiate and regulate immune responses.", {"entities": []}], ["Although human NKT cell subsets with distinct effector functions have been identified, it is unclear whether the effector functions of these subsets are imprinted during development or can be selectively reprogrammed in the periphery.", {"entities": []}], ["We found that neonatal NKT cells are predominantly CD4+ and express higher levels of CCR7 and CD62L and lower levels of CD94 and CD161 than adult CD4+ or CD4\u2212 NKT cell subsets.", {"entities": [[85, 89, "GENE"]]}], ["Accordingly, neonatal NKT cells were more flexible than adult CD4+ NKT cells in their capacity to acquire Th1- or Th2-like functions upon either cytokine-mediated polarization or ectopic expression of the Th1 or Th2 transcription factors T-bet and GATA-3, respectively.", {"entities": []}], ["Consistent with their more differentiated phenotype, CD4- NKT cells were predominantly resistant to functional reprogramming and displayed higher cytotoxic function.", {"entities": []}], ["In contrast to conventional T cells, neither the expression of CXCR3 nor the cytotoxic capacity of neonatal NKT cells could be reprogrammed.", {"entities": [[63, 68, "GENE"]]}], ["Together, these results suggest that neonatal CD4+, adult CD4+, and adult CD4\u2212 NKT may represent unique states of maturation and that some functions of human NKT cells may be developmentally imprinted, while others are acquired similar to conventional T cell subsets during peripheral maturation and differentiation.", {"entities": []}], ["Given the potent immuno-regulatory functions of NKT cells, these findings have important implications for the development of novel NKT cell-based therapeutics and vaccines.", {"entities": []}], ["Background : When H1N1 emerged in 2009, institutions of higher education were immediately faced with questions about how best to protect their community from the virus, yet limited information existed to help predict student preventive behaviors.", {"entities": []}], ["Methods : The authors surveyed students at a large urban university in November 2009 to better understand how students perceived their susceptibility to and the severity of H1N1, which preventive behaviors they engaged in, and if policies impacted their preventive health decisions.", {"entities": []}], ["Results : Preventive health behavior messaging had a mixed impact on students.", {"entities": []}], ["Students made simple behavior changes to protect themselves from H1N1, especially if they perceived a high personal risk of contracting H1N1.", {"entities": []}], ["Although policies were instituted to enable students to avoid classes when ill, almost no student self-isolated for the entire duration of their illness.", {"entities": []}], ["Conclusions : These findings can help inform future decision making in a university setting to best influence preventive health behaviors.", {"entities": []}], ["Conventional dendritic cells (DCs) are considered to be the prime initiators of airway allergy.", {"entities": []}], ["Yet, it remains unclear whether specific DC subsets are preferentially involved in allergic airway sensitization.", {"entities": []}], ["Here, we systematically assessed the respective pro-allergic potential of individually sorted lung DC subsets isolated from house dust mite antigen (HDM)-treated donor mice, following transfer to na\u00efve recipients.", {"entities": []}], ["Transfer of lung CD11c", {"entities": []}], ["Only a few large-scale studies have investigated the association between health-related quality of life (HRQOL) and renal function.", {"entities": []}], ["Moreover, the HRQOL of patients with moderate renal dysfunction is frequently underestimated by healthcare providers.", {"entities": []}], ["This study assessed the impact of renal function on preference-based HRQOL in Korean adult population.", {"entities": []}], ["We analyzed data for 5,555 adults from the 3 The proportions of participants who reported problems in each of the five EQ-5D dimensions increased significantly with decreasing eGFR.", {"entities": [[176, 180, "GENE"]]}], ["However, a significant decrease in the EQ-5D utility score was observed among participants with an eGFR of 30.0-59.9 mL/min/1.73 m Although age affects the association between renal dysfunction and the EQ-5D, moderate renal dysfunction seems to be an important determinant of impaired health utility in a general population and may affect the mobility and pain/discomfort dimensions of health utility.", {"entities": [[99, 103, "GENE"]]}], ["Extrinsic compression of the left main coronary artery (LMCA) secondary to pulmonary artery dilatation is a rare syndrome.", {"entities": [[113, 121, "DISEASE"]]}], ["Most cases of pulmonary artery hypertension but no atherosclerotic risk factors rarely undergo coronary angiography, and hence, diagnoses are seldom made and proper management is often delayed in these patients.", {"entities": [[31, 43, "DISEASE"]]}], ["We describe a patient that presented with pulmonary hypertension, clinical angina, and extrinsic compression of the LMCA by the pulmonary artery, who was treated successfully by percutaneous coronary intervention.", {"entities": [[52, 64, "DISEASE"], [42, 64, "DISEASE"]]}], ["Follow-up coronary angiography showed patent stent in the LMCA in the proximity of the dilated main pulmonary artery.", {"entities": []}], ["This case reminds us that coronary angiography and percutaneous coronary intervention should be considered in pulmonary hypertension patients presenting with angina or left ventricular dysfunction.", {"entities": [[120, 132, "DISEASE"], [110, 132, "DISEASE"]]}], ["Online communities hold great potential as interventions for health, particularly for the management of chronic illness.", {"entities": []}], ["The social support that online communities can provide has been associated with positive treatment outcomes, including medication adherence.", {"entities": []}], ["There are few studies that have attempted to assess whether membership of an online community improves health outcomes using rigorous designs.", {"entities": []}], ["Our objective was to conduct a rigorous proof-of-concept randomized controlled trial of an online community intervention for improving adherence to asthma medicine.", {"entities": [[148, 154, "DISEASE"]]}], ["This 9-week intervention included a sample of asthmatic adults from the United Kingdom who were prescribed an inhaled corticosteroid preventer.", {"entities": []}], ["Participants were recruited via email and randomized to either an \u201conline community\u201d or \u201cno online community\u201d (diary) condition.", {"entities": []}], ["After each instance of preventer use, participants (N=216) were required to report the number of doses of medication taken in a short post.", {"entities": []}], ["Those randomized to the online community condition (n=99) could read the posts of other community members, reply, and create their own posts.", {"entities": []}], ["Participants randomized to the no online community condition (n=117) also posted their medication use, but could not read others\u2019 posts.", {"entities": []}], ["The main outcome measures were self-reported medication adherence at baseline and follow-up (9 weeks postbaseline) and an objective measure of adherence to the intervention (visits to site).", {"entities": []}], ["In all, 103 participants completed the study (intervention: 37.8%, 39/99; control: 62.2%, 64/117).", {"entities": []}], ["MANCOVA of self-reported adherence to asthma preventer medicine at follow-up was not significantly different between conditions in either intention-to-treat ( P =.92) or per-protocol ( P =.68) analysis.", {"entities": [[38, 44, "DISEASE"]]}], ["Site use was generally higher in the control compared to intervention conditions.", {"entities": []}], ["Joining an online community did not improve adherence to preventer medication for asthma patients.", {"entities": [[82, 88, "DISEASE"]]}], ["Without the encouragement of greater community support or more components to sustain engagement over time, the current findings do not support the use of an online community to improve adherence.", {"entities": []}], ["International Standard Randomized Controlled Trial Number (ISRCTN): 29399269; http://www.isrctn.com/ISRCTN29399269/29399269 (Archived by WebCite at http://www.webcitation.org/6fUbEuVoT)", {"entities": []}], ["In this research, we investigated the sorptive behavior of a mixture of 14 volatile and semi-volatile organic compounds (four aromatic hydrocarbons (benzene, toluene, p-xylene, and styrene), six C 2 -C 5 volatile fatty acids (VFAs), two phenols, and two indoles) against three metal-organic frameworks (MOFs), i.e., MOF-5, Eu-MOF, and MOF-199 at 5 to 10\u2009mPa VOC partial pressures (25\u2009\u00b0C).", {"entities": []}], ["The selected MOFs exhibited the strongest affinity for semi-volatile (polar) VOC molecules (skatole), whereas the weakest affinity toward was volatile (non-polar) VOC molecules (i.e., benzene).", {"entities": []}], ["Our experimental results were also supported through simulation analysis in which polar molecules were bound most strongly to MOF-199, reflecting the presence of strong interactions of Cu", {"entities": []}], ["The electronic nicotine delivery system, also known as the electronic cigarette, is generating considerable controversy, not only in the general population but also among health professionals.", {"entities": []}], ["Smokers the world over have been increasingly using electronic cigarettes as an aid to smoking cessation and as a substitute for conventional cigarettes.", {"entities": []}], ["There are few available data regarding the safety of electronic cigarettes.", {"entities": []}], ["There is as yet no evidence that electronic cigarettes are effective in treating nicotine addiction.", {"entities": []}], ["Some smokers have reported using electronic cigarettes for over a year, often combined with conventional cigarettes, thus prolonging nicotine addiction.", {"entities": []}], ["In addition, the increasing use of electronic cigarettes by adolescents is a cause for concern.", {"entities": []}], ["The objective of this study was to describe electronic cigarettes and their components, as well as to review the literature regarding their safety; their impact on smoking initiation and smoking cessation; and regulatory issues related to their use.", {"entities": []}], ["Clinical manifestations of chronic obstructive pulmonary disease (COPD), including airflow limitation, dyspnea, and activity limitation, ultimately lead to impaired health-related quality of life (HRQoL).", {"entities": [[27, 64, "DISEASE"]]}], ["This 9-month, randomized, double-blind, multicenter study compared the effect of once-daily tiotropium 18 \u03bcg and placebo on HRQoL, spirometric parameters, and exacerbations in 554 patients with moderate-to-severe COPD.", {"entities": []}], ["HRQoL was assessed using the St. George\u2019s Respiratory Questionnaire (SGRQ) and the new 8-item Visual Simplified Respiratory Questionnaire (VSRQ), which is currently being validated.", {"entities": []}], ["The primary efficacy endpoint was the proportion of patients achieving a reduction of at least 4 units in the SGRQ total score at study end (Month 9).", {"entities": []}], ["Mean \u00b1 SD baseline SGRQ total score was 47.4 \u00b1 18.1.", {"entities": []}], ["Significantly more tiotropium-treated patients achieved a reduction of at least 4 units in the SGRQ score vs placebo at study end (59.1% vs 48.2%, respectively; p = 0.029).", {"entities": []}], ["Tiotropium significantly improved spirometric parameters (forced expiratory volume in 1 second [FEV 1 ]: 0.11 \u00b1 0.02 L vs 0.01 \u00b1 0.02 L; between-group difference: 0.10 \u00b1 0.03 L, p = 0.0001) and reduced exacerbations vs placebo.", {"entities": [[96, 99, "GENE"]]}], ["Maintenance treatment with tiotropium provided significant and clinically relevant improvements in HRQoL, as measured by the SGRQ.", {"entities": []}], ["SETTING: There is a high burden of respiratory disease in sub-Saharan Africa.", {"entities": []}], ["To address this problem, the World Health Organization launched the \u2018Practical approach to Lung Health\u2019 (PAL), i.e., locally applicable integrated syndromic algorithms, to improve primary care management of these diseases.", {"entities": []}], ["OBJECTIVE: To examine the evidence for the impact of PAL on the diagnosis and management of tuberculosis (TB) and other common respiratory problems in sub-Saharan Africa.", {"entities": [[92, 104, "DISEASE"]]}], ["DESIGN: A systematic review of MEDLINE (1998\u20132015), EMBASE (1998\u20132015) and CINAHL (1998\u20132015) was conducted to find trials evaluating PAL implementation in sub-Saharan Africa.", {"entities": []}], ["RESULTS: Five studies were found, evaluating three PAL variations: PAL in South Africa (PALSA), PALSA with integrated human immunodeficiency virus treatment (PALSA PLUS) and PAL in Malawi using lay health workers (PALM/LHW).", {"entities": []}], ["PALSA increased TB diagnosis (OR 1.72, 95%CI 1.04\u20132.85), as did PALSA PLUS (OR 1.25, 95%CI 1.01\u20131.55).", {"entities": []}], ["Cure or completion rates in retreatment cases in PALSA and PALSA PLUS were significantly improved (OR 1.78, 95%CI 1.13\u20132.76).", {"entities": []}], ["PALM/LHW, which examined TB treatment success, found no significant improvement ( P = 0.578).", {"entities": []}], ["CONCLUSION: The limited research performed shows that PAL can be effective in TB diagnosis and partial treatment success; however, more evidence is needed to assess its effects on other respiratory diseases, especially in wider sub-Saharan Africa.", {"entities": []}], ["The association between exposure to ambient particles with a median aerodynamic diameter less than 10/2.5\u2005\u00b5m (particulate matter, PM 10 / 2.5 ) and COPD remains unclear.", {"entities": []}], ["Our study objective was to examine the association between ambient PM 10 / 2.5 concentrations and lung functions in adults.", {"entities": []}], ["A cross-sectional study was conducted in southern China.", {"entities": []}], ["Seven clusters were randomly selected from four cities across Guangdong province.", {"entities": []}], ["Residents aged \u226520\u2005years in the participating clusters were randomly recruited; all eligible participants were examined with a standardised questionnaire and spirometry.", {"entities": []}], ["COPD was defined as a post-bronchodilator FEV 1 /FVC less than 70%.", {"entities": [[42, 45, "GENE"]]}], ["Atmosphere PM sampling was conducted across the clusters along with our survey.", {"entities": []}], ["Of the subjects initially recruited, 84.4% (n=5993) were included for analysis.", {"entities": []}], ["COPD prevalence and atmosphere PM concentration varied significantly among the seven clusters.", {"entities": []}], ["COPD prevalence was significantly associated with elevated PM concentration levels: adjusted OR 2.416 (95% CI 1.417 to 4.118) for >35 and \u226475\u2005\u00b5g/m 2.5 ; adjusted OR 2.442 (95% CI 1.449 to 4.117) for >50 and \u2264150\u2005\u00b5g/m 1 .", {"entities": []}], ["A 10\u2005\u00b5g/m 2.5 concentrations was associated with a 26\u2005mL (95% CI \u221243 to \u22129) decrease in FEV 1 , a 28\u2005mL (\u221249 to \u22128) decrease in FVC and a 0.09% decrease (\u22120.170 to \u22120.010) in FEV 1 /FVC ratio.", {"entities": [[88, 91, "GENE"], [175, 178, "GENE"], [88, 91, "GENE"], [175, 178, "GENE"]]}], ["The associations of COPD with PM 10 were consistent with PM 2.5 but slightly weaker.", {"entities": []}], ["Exposure to higher PM concentrations was strongly associated with increased COPD prevalence and declined respiratory function.", {"entities": []}], ["ChiCTR-OO-14004264 ; Post-results.", {"entities": []}], ["Reactive oxide species are the middle products of normal metabolism, and play a crucial role in cell signaling transduction.", {"entities": []}], ["On the contrary, accumulation of excess reactive oxide species results in oxidative stress that often brings multifarious impairment to cells, including decrease of ATP level in cells, elevation of cytosolic Ca", {"entities": []}], ["The U.S. National Climate Assessment concluded that climate change is harming the health of many Americans and identified people in some communities of color as particularly vulnerable to these effects.", {"entities": []}], ["In Spring 2014, we surveyed members of the National Medical Association, a society of African American physicians who care for a disproportionate number of African American patients, to determine whether they were seeing the health effects of climate change in their practices; the response rate was 30% ( n = 284).", {"entities": []}], ["Over 86% of respondents indicated that climate change was relevant to direct patient care , and 61% that their own patients were already being harmed by climate change moderately or a great deal .", {"entities": []}], ["The most commonly reported health effects were injuries from severe storms, floods, and wildfires (88%), increases in severity of chronic disease due to air pollution (88%), and allergic symptoms from prolonged exposure to plants or mold (80%) .", {"entities": []}], ["The majority of survey respondents support medical training, patient and public education regarding the impact of climate change on health, and advocacy by their professional society; nearly all respondents indicated that the US should invest in significant efforts to protect people from the health effects of climate change (88%), and to reduce the potential impacts of climate change (93%).", {"entities": []}], ["These findings suggest that African American physicians are currently seeing the health impacts of climate change among their patients, and that they support a range of responses by the medical profession, and public policy makers, to prevent further harm.", {"entities": []}], ["Glucocorticosteroids are a very effective treatment for asthma and other chronic inflammatory diseases.", {"entities": [[56, 62, "DISEASE"]]}], ["However, a small proportion of patients is resistant to the therapeutic effects of glucocorticoids.", {"entities": []}], ["Pharmacokinetic and ligand binding studies suggest that the molecular abnormality in steroid resistance lies distal to nuclear translocation.", {"entities": []}], ["We have previously reported that there is a decreased ability of glucocorticoid receptors (GR) to bind to the DNA-binding site in peripheral blood mononuclear cells (PBMC) after dexamethasone treatment.", {"entities": []}], ["This reduced DNA binding was due to a decrease in the number of receptors available rather than an alteration in affinity for DNA.", {"entities": []}], ["To study this reduced DNA binding, we examined the ability of the nuclear translocated transcription factors activator protein 1 (AP-1), nuclear factor kappa B (NF-kappa B) and cyclic AMP response element- binding protein (CREB) to bind to their DNA-binding sites and to interact with GR in PBMC from patients with steroid-sensitive and steroid-resistant asthma.", {"entities": [[355, 361, "DISEASE"]]}], ["There was a significant reduction in the interaction between GR and AP-1 in these steroid-resistant patients, although interaction with other transcription factors activated in inflammation (NF-kappa B and CREB) was unaffected.", {"entities": []}], ["An increase in the basal levels of AP-1 DNA binding was also detected in the nuclei from steroid-resistant asthmatic patients.", {"entities": []}], ["There were no differences in the amount of messenger RNA detected for the components of AP-1, c-Fos and c-Jun, nor in the sequences of these messenger RNAs.", {"entities": []}], ["These results suggest either that the ability of the GR to bind to glucocorticoid response elements and AP-1 is altered in steroid-resistant patients or that increased levels of AP-1 prevent GR DNA binding, and that this may be the molecular basis of resistance to the antiinflammatory effect of steroids in these cells.", {"entities": []}], ["Presence of antigen presenting cells, expression of costimulatory molecules, the strength of first signal and cytokine milieu are quite important in influencing the reactivation of differentiated Th1 and Th2 cells.", {"entities": []}], ["In the present study, we have analyzed the concerted action of pro-Th1 and pro-Th2 cytokines in the presence of B cells, peritoneal and splenic macrophages as antigen presenting cells and varied concentration of first (anti-CD3 Ab) and second (B7-1 transfectant) signals on the proliferation and cytokine secretion by Th1 and Th2 cells.", {"entities": []}], ["Interesting observations were made that IFN-\u03b3 significantly augmented the secretion of IL-4 by Th2 cells when either B cells or splenic or peritoneal macrophages were used as APC.", {"entities": [[175, 178, "GENE"]]}], ["Further, IFN-\u03b3 significantly inhibited the proliferation of Th1 cells only in the presence of peritoneal macrophages.", {"entities": []}], ["We have also observed that B cells could significantly respond to cytokines to further enhance the proliferation and cytokine release by Th1 and Th2 cells.", {"entities": []}], ["But not much effect on addition of exogenous cytokines IL-1, IL-4, IL-5, IL-12 was observed on the proliferation of Th1 and Th2 cells in the presence of macrophages.", {"entities": []}], ["In contrast, both IFN-\u03b3 and IL-2 significantly enhanced the production of IL-4 and IL-5 respectively, by Th2 cells in presence of B cells, splenic and peritoneal macrophages.", {"entities": []}], ["Another important observation was that the addition of B7-1 transfectants in the cultures, which were stimulated with low dose of anti-CD3 Ab significantly, enhanced the proliferation and cytokine secretion.", {"entities": []}], ["This study indicates involvement of different type of APCs, cytokine milieu, dose of first and second signals in a concerted manner in the outcome of the immune response.", {"entities": [[54, 58, "GENE"]]}], ["The significance of this study is that the immunization with antigen along with costimulatory molecules may significantly reduce the dose of antigen and can generate better immune response than antigen alone.", {"entities": []}], ["Cigarette smokers have an increased risk of infectious diseases involving the respiratory tract.", {"entities": []}], ["Some effects of smoking on specific respiratory tract bacteria have been described, but the consequences for global airway microbial community composition have not been determined.", {"entities": []}], ["Here, we used culture-independent high-density sequencing to analyze the microbiota from the right and left nasopharynx and oropharynx of 29 smoking and 33 nonsmoking healthy asymptomatic adults to assess microbial composition and effects of cigarette smoking.", {"entities": []}], ["Bacterial communities were profiled using 454 pyrosequencing of 16S sequence tags (803,391 total reads), aligned to 16S rRNA databases, and communities compared using the UniFrac distance metric.", {"entities": []}], ["A Random Forest machine-learning algorithm was used to predict smoking status and identify taxa that best distinguished between smokers and nonsmokers.", {"entities": []}], ["Community composition was primarily determined by airway site, with individuals exhibiting minimal side-of-body or temporal variation.", {"entities": []}], ["Within airway habitats, microbiota from smokers were significantly more diverse than nonsmokers and clustered separately.", {"entities": []}], ["The distributions of several genera were systematically altered by smoking in both the oro- and nasopharynx, and there was an enrichment of anaerobic lineages associated with periodontal disease in the oropharynx.", {"entities": [[175, 194, "DISEASE"]]}], ["These results indicate that distinct regions of the human upper respiratory tract contain characteristic microbial communities that exhibit disordered patterns in cigarette smokers, both in individual components and global structure, which may contribute to the prevalence of respiratory tract complications in this population.", {"entities": []}], ["Ticagrelor is a P2Y 12 receptor inhibitor used in acute coronary syndromes to reduce platelet activity and to decrease thrombus formation.", {"entities": []}], ["Ticagrelor is associated with a reduction in mortality incremental to that observed with clopidogrel, potentially related to its non\u2013antiplatelet effects.", {"entities": []}], ["Evidence from animal models indicates that ticagrelor potentiates adenosine\u2010induced myocardial blood flow ( MBF ) increases.", {"entities": []}], ["We investigated MBF at rest and during adenosine\u2010induced hyperemia in patients with stable coronary artery disease treated with ticagrelor versus clopidogrel.", {"entities": []}], ["This randomized double\u2010blinded crossover study included 22 patients who received therapeutic interventions of ticagrelor 90\u00a0mg orally twice a day for 10\u00a0days and clopidogrel 75\u00a0mg orally once a day for 10\u00a0days, with a washout period of at least 10\u00a0days between the treatments.", {"entities": []}], ["Global and regional MBF and myocardial flow reserve were measured using rubidium 82 positron emission tomography/computed tomography at baseline and during intermediate\u2010 and high\u2010dose adenosine.", {"entities": []}], ["Global MBF was significantly greater with ticagrelor versus clopidogrel (1.28\u00b10.55 versus 1.13\u00b10.47\u00a0mL/min per gram, P =0.002) at intermediate\u2010dose adenosine and not different at baseline (0.65\u00b10.19 versus 0.60\u00b10.15\u00a0mL/min per gram, P =0.084) and at high\u2010dose adenosine (1.64\u00b10.40 versus 1.61\u00b10.19\u00a0mL/min per gram, P =0.53).", {"entities": []}], ["In regions with impaired myocardial flow reserve (<2.5), MBF was greater with ticagrelor compared with clopidogrel during intermediate and high doses of adenosine ( P <0.0001), whereas the differences were not significant at baseline.", {"entities": []}], ["Ticagrelor potentiates global and regional adenosine\u2010induced MBF increases in patients with stable coronary artery disease.", {"entities": []}], ["This effect may contribute to the incremental mortality benefit compared with clopidogrel.", {"entities": []}], ["URL : http://www.clinicaltrials.gov .", {"entities": []}], ["Unique identifier: NCT 01894789.", {"entities": []}], ["The increase of chronic diseases prevalence has created the need to adapt care models and to provide greater home supervision.", {"entities": []}], ["The objective of our study was to evaluate the impact of telemonitoring on patients with long-term conditions at high risk for rehospitalization or an emergency department visit, in terms of target disease control (diabetes, hypertension, heart failure, and chronic obstructive pulmonary disease).", {"entities": [[225, 237, "DISEASE"], [258, 295, "DISEASE"]]}], ["We conducted a quasi-experimental study with a before-and-after analysis to assess the effectiveness of the ValCr\u00f2nic program after 1 year of primary care monitoring.", {"entities": []}], ["The study included high-risk patients with 1 or more of the following conditions: diabetes, high blood pressure, heart failure, and chronic obstructive pulmonary disease.", {"entities": [[132, 169, "DISEASE"]]}], ["We assessed risk according to the Community Assessment Risk Screen.", {"entities": []}], ["Participants used an electronic device (tablet) to self-report relevant health information, which was then automatically entered into their eHealth record for consultation.", {"entities": []}], ["The total sample size was 521 patients.", {"entities": []}], ["Compared with the preintervention year, there were significant reductions in weight (82.3 kg before vs 80.1 kg after; P =.001) and in the proportion of people with high systolic (\u2265140 mmHg; 190, 36.5% vs 170, 32.6%; P =.001) and diastolic (\u226590 mmHg; 72, 13.8% vs 40, 7.7%; P =.01) blood pressures, and hemoglobin A 1c \u22658% (186, 35.7% vs 104, 20.0%; P =.001).", {"entities": []}], ["There was also a decrease in the proportion of participants who used emergency services in primary care (68, 13.1% vs 33, 6.3%; P <.001) and in hospital (98, 18.8% vs 67, 12.8%; P <.001).", {"entities": []}], ["Likewise, fewer participants required hospital admission due to an emergency (105, 20.2% vs 71, 13.6%; P <.001) or disease exacerbation (55, 10.5% vs 42, 8.1%; P <.001).", {"entities": []}], ["The ValCr\u00f2nic telemonitoring program in patients at high risk for rehospitalization or an emergency department visit appears to be useful to improve target disease control and to reduce the use of resources.", {"entities": []}], ["Airway wall remodeling in allergic asthma is reduced after treatment with humanized anti-IgE-antibodies.", {"entities": [[26, 41, "DISEASE"], [35, 41, "DISEASE"]]}], ["We reported earlier that purified IgE, without the presence of allergens, is sufficient to induce airway wall remodeling due to airway smooth muscle cell (ASMC) activity deposing extracellular matrix.", {"entities": []}], ["We postulate that IgE contained in serum of allergic asthma patients, in the absence of allergens, stimulates ASMC remodeling activities and can be prevented by anti-IgE antibodies.", {"entities": [[44, 59, "DISEASE"], [53, 59, "DISEASE"]]}], ["Isolated human ASMC were exposed to serum obtained from: (i) healthy controls, or patients with (ii) allergic asthma, (iii) non-allergic asthma, and (iv) atopic non-asthma patients.", {"entities": [[101, 116, "DISEASE"], [128, 143, "DISEASE"], [110, 116, "DISEASE"], [137, 143, "DISEASE"], [165, 171, "DISEASE"]]}], ["Proliferation and the deposition of collagens and fibronectin were determined after 3 and 5 days.", {"entities": []}], ["Serum from patients with allergies significantly stimulated: (i) ASMC proliferation, (ii) deposition of collagen type-I (48 hours) and (iii) of fibronectin (24 hours).", {"entities": []}], ["One hour pre-incubation with Omalizumab prevented these three effects of allergic serum, but had no significant effect on serum from healthy donors or non-allergic asthma patients.", {"entities": [[155, 170, "DISEASE"], [164, 170, "DISEASE"]]}], ["Interestingly, the addition of allergens did not further increase any of the IgE effects.", {"entities": []}], ["Our data provides experimental evidence that the beneficial effect of Omalizumab on airway wall remodeling and improved lung function may be due to its direct action on IgE bound ASMC.", {"entities": []}], ["To present self-assessments of knowledge about mechanical ventilation made by final-year medical students, residents, and physicians taking qualifying courses at the Brazilian Society of Internal Medicine who work in urgent and emergency settings.", {"entities": []}], ["A 34-item questionnaire comprising different areas of knowledge and training in mechanical ventilation was given to 806 medical students, residents, and participants in qualifying courses at 11 medical schools in Brazil.", {"entities": []}], ["The questionnaire\u2019s self-assessment items for knowledge were transformed into scores.", {"entities": []}], ["The average score among all participants was 21% (0-100%).", {"entities": []}], ["Of the total, 85% respondents felt they did not receive sufficient information about mechanical ventilation during medical training.", {"entities": []}], ["Additionally, 77% of the group reported that they would not know when to start noninvasive ventilation in a patient, and 81%, 81%, and 89% would not know how to start volume control, pressure control and pressure support ventilation modes, respectively.", {"entities": []}], ["Furthermore, 86.4% and 94% of the participants believed they would not identify the basic principles of mechanical ventilation in patients with obstructive pulmonary disease and acute respiratory distress syndrome, respectively, and would feel insecure beginning ventilation.", {"entities": [[205, 213, "DISEASE"]]}], ["Finally, 77% said they would fear for the safety of a patient requiring invasive mechanical ventilation under their care.", {"entities": []}], ["Self-assessment of knowledge and self-perception of safety for managing mechanical ventilation were deficient among residents, students and emergency physicians from a sample in Brazil.", {"entities": []}], ["The pandemic novel influenza A (H1N1) infection was considered widespread in Brazil on July, 2009.", {"entities": [[19, 28, "DISEASE"]]}], ["Since then, 9.249 cases were confirmed in Brazil, most of them concentrated in S\u00e3o Paulo.", {"entities": []}], ["The Hospital das Cl\u00ednicas of the University of S\u00e3o Paulo is a reference center for H1N1 cases in S\u00e3o Paulo.", {"entities": []}], ["The purpose of this review is to analyze the evidence concerning diagnosis, prevention, and treatment of novel influenza A (H1N1) infection.", {"entities": [[111, 120, "DISEASE"]]}], ["In addition, we propose guidelines for the management of this pandemic emphasizing Hospital das Cl\u00ednicas \u201cbundles\u201d for the control of the pandemic novel influenza A (H1N1).", {"entities": [[153, 162, "DISEASE"]]}], ["An economic analysis of housing\u2019s linkages to health can assist policy makers and researchers to make better decisions about which housing interventions and policies are the most cost-beneficial.", {"entities": []}], ["The challenge is to include cobenefits.", {"entities": []}], ["The adoption in 2015 of the UN Sustainable Development Goals underscores the importance of understanding how policies interact, and the merit of comprehensively evaluating cobenefits.", {"entities": []}], ["We explain our approach to the empirical assessment of such cobenefits in the housing and health context, and consider lessons from empirical economic appraisals of the impact of housing on health outcomes.", {"entities": []}], ["Critical assumptions relating to cobenefits are explicitly examined.", {"entities": []}], ["A key finding is that when wider policy outcome measures are included, such as mental health impacts and carbon emission reductions, it is important that effects of assumptions on outcomes are considered.", {"entities": []}], ["Another is that differing values underlie appraisal, for example, the weight given to future generations through the discount rate.", {"entities": []}], ["Cost-benefit analyses (CBAs) can better facilitate meaningful debate when they are based on explicit assumptions about values.", {"entities": []}], ["In short, the insights drawn from an economic framework for housing-and-health studies are valuable, but nonetheless contingent.", {"entities": []}], ["Given that housing interventions typically have both health and other cobenefits, and incorporate social value judgements, it is important to take a broad view but be explicit about how such interventions are assessed.", {"entities": []}], ["The first generation of adolescents born with HIV infection has reached young adulthood due to advances in treatment.", {"entities": []}], ["It is important to continue follow-up of these individuals to assess their long-term medical, behavioural and mental health and ability to successfully transition to adulthood while coping with a chronic, potentially stigmatising condition.", {"entities": []}], ["To accomplish this, and to maintain their interest in long-term research participation, we need to accommodate the changing lifestyles and interests of young adult study participants while ensuring valid data collection.", {"entities": []}], ["We report the protocol for Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) Up, a prospective cohort study enrolling young adult participants for long-term follow-up.", {"entities": []}], ["AMP Up is recruiting 850 young men and women 18\u2005years of age and older\u2014600 perinatally HIV-infected and a comparison group of 250 perinatally HIV-exposed, uninfected\u2014at 14 clinical research sites in the USA and Puerto Rico.", {"entities": []}], ["Recruitment began in April 2014 and is ongoing, with 305 participants currently enrolled.", {"entities": []}], ["Planned follow-up is \u22656\u2005years.", {"entities": []}], ["Data are collected with a flexible hybrid of online and in-person methods.", {"entities": []}], ["Outcomes include: transition to adult clinical care and retention in care; end-organ diseases; malignancies; metabolic complications; sexually transmitted infections; reproductive health; mental health and neurocognitive functioning; adherence to antiretroviral treatment; sexual behaviour and substance use; hearing and language impairments; and employment and educational achievement.", {"entities": []}], ["The study received ethical approval from the Harvard T.H.", {"entities": []}], ["Chan School of Public Health's institutional review board (IRB), and from the IRBs of each clinical research site.", {"entities": []}], ["All participants provide written informed consent; for cognitively impaired individuals with legally authorised representatives, legal guardian permission and participant assent is obtained.", {"entities": []}], ["Findings will be disseminated through peer-reviewed journals, conference presentations and participant summaries.", {"entities": []}], ["Previous studies suggested that genetic polymorphisms in the epidermal growth factor receptor (EGFR) gene had been implicated in the susceptibility to some tumors and inflammatory diseases.", {"entities": [[95, 99, "GENE"]]}], ["EGFR has been recently implicated in vascular pathophysiological processes associated with excessive remodeling and atherosclerosis.", {"entities": [[116, 131, "DISEASE"], [0, 4, "GENE"]]}], ["Acute coronary syndrome (ACS) is a clinical manifestation of preceding atherosclerosis.", {"entities": [[71, 86, "DISEASE"], [15, 23, "DISEASE"]]}], ["Our purpose was to investigate the association of the EGFR polymorphism with the risk of ACS.", {"entities": [[54, 58, "GENE"]]}], ["In this context, we analyzed the HER-1 R497K and EGFR intron 1 (CA) n repeat polymorphisms in 191 patients with ACS and 210 age- and sex-matched controls in a Chinese population, using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) strategy and direct sequencing.", {"entities": [[49, 53, "GENE"]]}], ["There were significant differences in the genotype and allele distribution of R497K polymorphism of the EGFR gene between cases and controls.", {"entities": [[104, 108, "GENE"]]}], ["The Lys allele had a significantly increased risk of ACS compared with the Arg allele (adjusted OR = 1.49, 95% CI: 1.12\u20131.98, adjusted P = 0.006).", {"entities": []}], ["However, no significant relationship between the number of (CA) n repeats of EGFR intron 1 (both alleles < 20 or any allele \u2265 20) and the risk of ACS was observed (adjusted OR = 0.97, 95% CI: 0.58\u20131.64, adjusted P = 0.911).", {"entities": [[77, 81, "GENE"]]}], ["Considering these two polymorphisms together, there was no statistically significant difference between the two groups.", {"entities": []}], ["R497K polymorphism of the EGFR gene is significantly associated with the risk of ACS.", {"entities": [[26, 30, "GENE"]]}], ["Our data suggests that R497K polymorphism may be used as a genetic susceptibility marker of the ACS.", {"entities": []}], ["Timing of solid food introduction in infancy has been associated with several chronic diseases.", {"entities": []}], ["To explore potential mechanisms, we investigated the relationship between timing of solid food introduction and F 2 -isoprostanes \u2013 a marker of oxidative stress.", {"entities": []}], ["Urinary F 2 -isoprostanes were assessed in 336 healthy children <age 11.5 years with 1,266 clinic visits (mean=3.8 visits per child) in the Diabetes Autoimmunity Study in the Young.", {"entities": []}], ["We analyzed the association between F 2 -isoprostane concentrations and infant diet exposures using linear mixed models adjusted for age, age in utero cigarette smoke.", {"entities": []}], ["Later solid food introduction was associated with lower F 2 -isoprostane concentrations in childhood (on average, 0.10 ng/mg per month of age at introduction) (estimate: \u22120.10, 95% CI: \u22120.18, \u22120.02, P -value=0.02).", {"entities": []}], ["Moreover, childhood F 2 -isoprostane concentrations were, on average, 0.24 ng/mg lower in individuals breastfed at solid food introduction (estimate: \u22120.24, 95% CI: \u22120.47, \u22120.01, P -value=0.04) compared with those who were not.", {"entities": []}], ["Associations remained significant after limiting analyses to F 2 -isoprostanes after age 2 years.", {"entities": []}], ["Our results suggest a long-term protective effect of later solid food introduction and breastfeeding at solid food introduction against increased F 2 -isoprostane concentrations throughout childhood.", {"entities": []}], ["Propionibacterium acnes ( P. acnes ) is a gram-positive anaerobic bacillus present in normal human skin microbiota, which exerts important immunomodulatory effects, when used as heat- or phenol-killed suspensions.", {"entities": []}], ["We previously demonstrated that heat-killed P. acnes or its soluble polysaccharide (PS), extracted from the bacterium cell wall, suppressed or potentiated the Th2 response to ovalbumin (OVA) in an immediate hypersensitivity model, depending on the treatment protocol.", {"entities": []}], ["Herein, we investigated the mechanisms responsible for these effects, using the same model and focusing on the activation status of antigen-presenting cells (APCs).", {"entities": [[158, 162, "GENE"]]}], ["We verified that higher numbers of APCs expressing costimulatory molecules and higher expression levels of these molecules are probably related to potentiation of the Th2 response to OVA induced by P. acnes or PS, while higher expression of toll-like receptors (TLRs) seems to be related to Th2 suppression.", {"entities": [[35, 39, "GENE"]]}], ["In vitro cytokines production in cocultures of dendritic cells and T lymphocytes indicated that P. acnes and PS seem to perform their effects by acting directly on APCs.", {"entities": [[164, 168, "GENE"]]}], ["Our data suggest that P. acnes and PS directly act on APCs, modulating the expression of costimulatory molecules and TLRs, and these differently activated APCs drive distinct T helper patterns to OVA in our model.", {"entities": [[54, 58, "GENE"], [155, 159, "GENE"], [54, 58, "GENE"], [155, 159, "GENE"]]}], ["Crotoxin B (CB) is a catalytically active group IIA sPLA 2 from Crotalus durissus terrificus snake venom.", {"entities": []}], ["In contrast to most GIIA sPLA 2 s, CB exhibits anti-inflammatory effects, including the ability to inhibit leukocyte functions.", {"entities": []}], ["Lipid droplets (LDs) are lipid-rich organelles associated with inflammation and recognized as a site for the synthesis of inflammatory lipid mediators.", {"entities": []}], ["Here, the ability of CB to induce formation of LDs and the mechanisms involved in this effect were investigated in isolated macrophages.", {"entities": []}], ["The profile of CB-induced 15-d-PGJ 2 (15-Deoxy-Delta-12,14-prostaglandin J 2 ) production and involvement of LDs in 15-d-PGJ 2 biosynthesis were also investigated.", {"entities": []}], ["Stimulation of murine macrophages with CB induced increased number of LDs and release of 15-d-PGJ 2 .", {"entities": []}], ["LDs induced by CB were associated to PLIN2 recruitment and expression and required activation of PKC, PI3K, MEK1/2, JNK, iPLA 2 and PLD.", {"entities": [[37, 42, "GENE"]]}], ["Both 15-d-PGJ 2 and COX-1 were found in CB-induced LDs indicating that LDs contribute to the inhibitory effects of CB by acting as platform for synthesis of 15-d-PGJ 2 , a pro-resolving lipid mediator.", {"entities": []}], ["Together, our data indicate that an immunomodulatory GIIA sPLA 2 can directly induce LD formation and production of a pro-resolving mediator in an inflammatory cell and afford new insights into the roles of LDs in resolution of inflammatory processes.", {"entities": []}], ["Human plasmacytoid dendritic cells (PDCs) can produce interferon (IFN)-\u03b1 and/or mature and participate in the adaptive immune response.", {"entities": []}], ["Three classes of CpG oligonucleotide ligands for Toll-like receptor (TLR)9 can be distinguished by different sequence motifs and different abilities to stimulate IFN-\u03b1 production and maturation of PDCs.", {"entities": []}], ["We show that the nature of the PDC response is determined by the higher order structure and endosomal location of the CpG oligonucleotide.", {"entities": [[31, 34, "GENE"]]}], ["Activation of TLR9 by the multimeric CpG-A occurs in transferrin receptor (TfR)-positive endosomes and leads exclusively to IFN-\u03b1 production, whereas monomeric CpG-B oligonucleotides localize to lysosome-associated membrane protein (LAMP)-1\u2013positive endosomes and promote maturation of PDCs.", {"entities": [[14, 18, "GENE"]]}], ["However, CpG-B, when complexed into microparticles, localizes in TfR-positive endosomes and induces IFN-\u03b1 from PDCs, whereas monomeric forms of CpG-A localize to LAMP-1\u2013positive endosomes accompanied by the loss of IFN-\u03b1 production and a gain in PDC maturation activity.", {"entities": [[246, 249, "GENE"]]}], ["CpG-C sequences, which induce both IFN-\u03b1 and maturation of PDCs, are distributed in both type of endosomes.", {"entities": []}], ["Encapsulation of CpG-C in liposomes stable above pH 5.75 completely abrogated the IFN-\u03b1 response while increasing PDC maturation.", {"entities": [[114, 117, "GENE"]]}], ["This establishes that the primary determinant of TLR9 signaling is not valency but endosomal location and demonstrates a strict compartmentalization of the biological response to TLR9 activation in PDCs.", {"entities": [[49, 53, "GENE"], [179, 183, "GENE"], [49, 53, "GENE"], [179, 183, "GENE"]]}], ["To compare the performance of the natriuretic peptides (NPs) NT\u2010proBNP and MR\u2010proANP for the diagnosis of acute heart failure (AHF) in subsets of conditions potentially confounding the interpretation of NPs.", {"entities": [[56, 59, "GENE"], [203, 206, "GENE"], [56, 59, "GENE"], [203, 206, "GENE"]]}], ["We studied 312 patients, presenting to the emergency department with new onset of dyspnoea or worsening of chronic dyspnoea within the last 2\u00a0weeks.", {"entities": []}], ["Performance of NPs for the diagnosis of AHF was tested and compared using C\u2010statistics in the entire cohort and in conditions previously described to confound interpretation of NPs such as older age, renal failure, obesity, atrial fibrillation or paced rhythm, and in the NT\u2010proBNP grey zone.", {"entities": [[215, 222, "DISEASE"], [15, 18, "GENE"], [177, 180, "GENE"], [15, 18, "GENE"], [177, 180, "GENE"]]}], ["AHF was diagnosed in 139 patients.", {"entities": []}], ["In the entire cohort, the diagnostic performance of NT\u2010proBNP was comparable with that of MR\u2010proANP.", {"entities": []}], ["Receiver operating characteristic analysis demonstrated that optimal diagnostic cut\u2010offs were higher in the presence of older age, kidney failure or rhythm disorder.", {"entities": [[131, 145, "DISEASE"]]}], ["However, there were no statistically relevant differences between the receiver operating characteristic curves analysed in the total population and those studied in the pre\u2010specified subsets severe kidney failure, advanced age, obesity, atrial fibrillation and paced rhythm, and grey zone NT\u2010proBNP values.", {"entities": [[198, 212, "DISEASE"], [228, 235, "DISEASE"]]}], ["Moreover, the diagnostic performance of NT\u2010proBNP was comparable with that of MR\u2010proANP in the subsets.", {"entities": []}], ["The performance of NT\u2010proBNP and MR\u2010proANP for AHF is comparable in the total population as well as in the subsets with potentially confounding characteristics such as older age, renal dysfunction, obesity, atrial fibrillation and paced rhythm, or those with NT\u2010proBNP values in the grey zone.", {"entities": [[198, 205, "DISEASE"]]}], ["The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.", {"entities": [[154, 171, "DISEASE"], [154, 166, "DISEASE"]]}], ["Patients receiving cytoreductive drugs for polycythemia vera or essential thrombocythemia were recruited at our institution ( Observatoire Brestois des N\u00e9oplasies My\u00e9loprolif\u00e9ratives registry).", {"entities": [[43, 60, "DISEASE"], [43, 55, "DISEASE"], [148, 151, "GENE"]]}], ["They completed a one-shot questionnaire designed by investigators ( Etude de l\u2019Observance Th\u00e9rapeutique et des Effets Secondaires des Traitements study).", {"entities": [[107, 110, "GENE"], [130, 133, "GENE"], [107, 110, "GENE"], [130, 133, "GENE"]]}], ["Data about complications (thrombosis, transformation and death) at any time in the patient\u2019s life (before diagnosis, up until consultation and after the completion of the questionnaire) were collected.", {"entities": []}], ["Sixty-five (22.7%) of 286 patients reported poor adherence (<90%) to their treatment with cytoreductive drugs and 46/255/18%) also declared non-adherence to antithrombotic drugs.", {"entities": []}], ["In total, 85/286 patients (29.7%) declared they did not adhere to their treatment.", {"entities": []}], ["Missing an intake was rare and was mostly due to forgetfulness especially during occupational travel and holidays.", {"entities": []}], ["Patients who did not adhere to their treatment were characterized by younger age, living alone, having few medications but a high numbers of pills and determining their own schedule of drug intake.", {"entities": []}], ["Having experienced thrombosis or hematologic evolution did not influence the adherence rate.", {"entities": []}], ["Non-adherence to oral therapy was associated with a higher risk of phenotypic evolution (7.3 versus 1.8%, P =0.05).", {"entities": []}], ["For patients treated for polycythemia vera or essential thrombocythemia, non-adherence to cytoreductive and/or antithrombotic therapies is frequent and is influenced by age, habitus and concomitant treatments, but not by disease history or treatment side effects.", {"entities": [[25, 42, "DISEASE"], [25, 37, "DISEASE"]]}], ["Phenotypic evolution seems to be more frequent in the non-adherent group.", {"entities": []}], ["Patient: Male, 35 Final Diagnosis: Rhabdomyolysis Symptoms: Muscle pain \u2022 nausea Medication: \u2014 Clinical Procedure: Intravenous fluids Specialty: Family Medicine Unusual or unexpected effect of treatment Rhabdomyolysis is a syndrome characterized by skeletal muscle breakdown, that involves the release of intracellular contents into the circulation, including creatine kinase (CK), myoglobin, electrolytes, organic acids, and purines.", {"entities": [[223, 231, "DISEASE"]]}], ["Causes of rhabdomyolysis include trauma, exertion, drugs, and toxins (including alcohol), and electrolyte abnormalities.", {"entities": []}], ["The treatment of rhabdomyolysis is to remove the cause and use intravenous (IV) fluids.", {"entities": []}], ["When this treatment strategy fails to work, high-dose IV steroids may be used.", {"entities": []}], ["We present a case of rhabdomyolysis following the use of 3,4-methylenedioxy-methamphetamine (MDMA) or \u2018ecstasy\u2019 with hypophosphatemia, which was found to be refractory to intravenous hydration.", {"entities": [[117, 133, "DISEASE"]]}], ["In this case, pulsed dosing of steroid therapy was found to be effective.", {"entities": []}], ["Rhabdomyolysis that is refractory to treatment with IV fluids may respond to a short-term, high-dose course of IV steroids.", {"entities": []}], ["The Finnish Medicines Agency (Fimea) initiated a programme in 2012 for enhancing interprofessional networking in the medication management of the aged.", {"entities": []}], ["The goal is to develop national guidelines for interprofessional collaboration with respect to medication management.", {"entities": []}], ["This study aims to explore the challenges and potential solutions experienced by existing health care teams in managing medication of the aged: (1) at the individual and team level (micro level), (2) organisational level (meso level) and (3) structural level (macro level).", {"entities": []}], ["Group discussions ( n \u2009=\u200910), pair ( n \u2009=\u20093) and individual interviews ( n \u2009=\u20092).", {"entities": []}], ["Abductive content analysis combining data and theory was applied.", {"entities": []}], ["Networking was used as a theoretical framework.", {"entities": []}], ["Meetings ( n \u2009=\u200915) organised by Fimea in the formation phase of the interprofessional network in 2012.", {"entities": []}], ["Health care professionals ( n \u2009=\u200955).", {"entities": []}], ["Challenges and solutions in the medication management of the aged at the micro, meso and macro levels.", {"entities": []}], ["Challenges in interprofessional collaboration, problems with patient record systems, and the organisation of work and lack of resources were present at all the levels contributing to patients\u2019 medication problems.", {"entities": []}], ["Participants suggested multiple potential solutions to improve interprofessional collaboration, sharing of tasks and responsibilities, better exploitation of pharmaceutical knowledge and developing tools as being the most commonly mentioned.", {"entities": []}], ["Optimising medication use of the aged requires new systemic solutions within and between different system levels.", {"entities": []}], ["The main challenges can be solved by clarifying responsibilities, enhancing communication and applying operational models that involve pharmacists and the use of information technology in medication management.", {"entities": []}], ["KEY POINTS An interprofessional team approach has been suggested as a solution to promote rational medicine use among the aged.", {"entities": []}], ["Fragmented health care system and lack of coordinated patient care are reasons for medication related problems of the aged.", {"entities": []}], ["Challenges in the implementation of interprofessional collaboration in medication management appear in legislation, information systems, operational models and individuals\u2019 attitudes.", {"entities": []}], ["Optimising medications requires better interprofessional networking and new systemic solutions within and between macro, meso and micro levels.", {"entities": []}], ["An interprofessional team approach has been suggested as a solution to promote rational medicine use among the aged.", {"entities": []}], ["Fragmented health care system and lack of coordinated patient care are reasons for medication related problems of the aged.", {"entities": []}], ["Challenges in the implementation of interprofessional collaboration in medication management appear in legislation, information systems, operational models and individuals\u2019 attitudes.", {"entities": []}], ["Optimising medications requires better interprofessional networking and new systemic solutions within and between macro, meso and micro levels.", {"entities": []}], ["The etiology of pre-eclampsia (PE) is not yet fully understood, though current literature indicates an upregulation of inflammatory mediators produced by the placenta as a potential causal mechanism.", {"entities": [[20, 29, "DISEASE"], [16, 29, "DISEASE"]]}], ["Vitamin D is known to have anti-inflammatory properties and there is evidence of an inverse relationship between dietary calcium intake and the incidence of PE.", {"entities": []}], ["Evidence of the role of vitamin D status and supplementation in the etiology and prevention of PE is reviewed in this article along with identification of research gaps to inform future studies.", {"entities": []}], ["We conducted a structured literature search using MEDLINE electronic databases to identify published studies until February 2015.", {"entities": []}], ["These sources were retrieved, collected, indexed, and assessed for availability of pregnancy-related data on PE and vitamin D. Several case-control studies and cross-sectional studies have shown an association between vitamin D status and PE, although evidence has been inconsistent.", {"entities": []}], ["Clinical trials to date have been unable to show an independent effect of vitamin D supplementation in preventing PE.", {"entities": []}], ["The included clinical trials do not show an independent effect of vitamin D supplementation in preventing PE; however, issues with dose, timing, and duration of supplementation have not been completely addressed.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-017-1408-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma and rhinitis are often co-morbid conditions.", {"entities": [[11, 19, "DISEASE"], [0, 6, "DISEASE"]]}], ["As rhinitis often precedes asthma it is possible that effective treatment of allergic rhinitis may reduce asthma progression.", {"entities": [[77, 94, "DISEASE"], [3, 11, "DISEASE"], [86, 94, "DISEASE"], [27, 33, "DISEASE"], [106, 112, "DISEASE"]]}], ["The aim of our study is to investigate history of allergic rhinitis as a risk factor for asthma and the potential effect of allergen immunotherapy in attenuating the incidence of asthma.", {"entities": [[50, 67, "DISEASE"], [59, 67, "DISEASE"], [89, 95, "DISEASE"], [179, 185, "DISEASE"]]}], ["Hospital-referred non-asthmatic adults, aged 18\u201340 years between 1990 and 1991, were retrospectively followed up until January and April 2000.", {"entities": []}], ["At the end of follow up, available subjects were clinically examined for asthma diagnosis and history of allergen specific immunotherapy, second-hand smoking and the presence of pets in the household.", {"entities": [[73, 79, "DISEASE"]]}], ["A total of 436 non-asthmatic adults (332 subjects with allergic rhinitis and 104 with no allergic rhinitis nor history of atopy) were available for final analyses.", {"entities": [[55, 72, "DISEASE"], [89, 106, "DISEASE"], [64, 72, "DISEASE"], [98, 106, "DISEASE"]]}], ["The highest OR (odds ratio) associated with a diagnosis of asthma at the end of follow-up was for the diagnosis of allergic rhinitis at baseline (OR, 7.8; 95%CI, 3.1\u201320.0 in the model containing the covariates of rhinitis diagnosis, sex, second-hand smoke exposure, presence of pets at home, family history of allergic disorders, sensitization to Parietaria judaica ; grass pollen; house dust mites; Olea europea : orchard; perennial rye; and cat allergens).", {"entities": [[115, 132, "DISEASE"], [124, 132, "DISEASE"], [213, 221, "DISEASE"], [59, 65, "DISEASE"]]}], ["Female sex, sensitization to Parietaria judaica and the presence of pets in the home were also significantly predictive of new onset asthma in the same model.", {"entities": [[133, 139, "DISEASE"]]}], ["Treatment with allergen immunotherapy was significantly and inversely related to the development of new onset asthma (OR, 0.53; 95%CI, 0.32\u20130.86).", {"entities": [[110, 116, "DISEASE"]]}], ["In the present study we found that allergic rhinitis is an important independent risk factor for asthma.", {"entities": [[35, 52, "DISEASE"], [44, 52, "DISEASE"], [97, 103, "DISEASE"]]}], ["Moreover, treatment with allergen immunotherapy lowers the risk of the development of new asthma cases in adults with allergic rhinitis.", {"entities": [[118, 135, "DISEASE"], [127, 135, "DISEASE"], [90, 96, "DISEASE"]]}], ["Disparities in the rates of matriculation and graduation are of concern to Alaska Native (AN) students and the universities committed to their academic success.", {"entities": []}], ["Efforts to reduce attrition require a keen understanding of the factors that impact quality of life (QOL) at college.", {"entities": []}], ["Yet, a long-standing legacy of mistrust towards research poses challenges to conducting inquiry among AN students.", {"entities": []}], ["We introduced a partnership between the University of Alaska Fairbank's Rural Student Services (RSS) and the Center for Alaska Native Health Research (CANHR) within which we conducted the \u201cWhat makes life good?\u201d study aimed towards developing a QOL measure for AN students.", {"entities": []}], ["Equally important was building a legacy of research trust among AN partners.", {"entities": []}], ["We describe Phase I of a 2-phase study that employed a sequential mixed methods approach.", {"entities": []}], ["Discussed are facilitators, challenges and lessons learned while striving to adhere to the principles of community-based participatory research (CBPR).", {"entities": []}], ["Phase I included formative focus groups and QOL measurement development.", {"entities": []}], ["The research involved the interplay among activities that were co-developed with the goal of enhancing trust and research capacity.", {"entities": []}], ["Emphasis was placed on ensuring that data collection and analyses were student driven.", {"entities": []}], ["All partners resided at the same university.", {"entities": []}], ["However, trust and collaboration could not be assumed.", {"entities": []}], ["Working within a collaborative framework, our partnership achieved the aim of developing a culturally informed QOL measure, while also creating an empowering experience for all partners who became co-investigators in a process that might normally be regarded with mistrust.", {"entities": []}], ["This opinion deals critically with the so-called complementary and alternative medical (CAM) therapy on the basis of current data.", {"entities": []}], ["From the authors\u2019 perspective, CAM prescriptions and most notably the extensive current endeavours to the \u201cintegration\u201d of CAM into conventional patient care is problematic in several respects.", {"entities": []}], ["Thus, several CAM measures are used, although no specific effects of medicines can be proved in clinical studies.", {"entities": []}], ["It is extensively explained that the methods used in this regard are those of evidence-based medicine, which is one of the indispensable pillars of science-oriented medicine.", {"entities": []}], ["This standard of proof of efficacy is fundamentally independent of the requirement of being able to explain efficacy of a therapy in a manner compatible with the insights of the natural sciences, which is also essential for medical progress.", {"entities": []}], ["Numerous CAM treatments can however never conceivably satisfy this requirement; rather they are justified with pre-scientific or unscientific paradigms.", {"entities": []}], ["The high attractiveness of CAM measures evidenced in patients and many doctors is based on a combination of positive expectations and experiences, among other things, which are at times unjustified, at times thoroughly justified, from a science-oriented view, but which are non-specific (context effects).", {"entities": []}], ["With a view to the latter phenomenon, the authors consider the conscious use of CAM as unrevealed therapeutic placebos to be problematic.", {"entities": []}], ["In addition, they advocate that academic medicine should again systematically endeavour to pay more attention to medical empathy and use context effects in the service of patients to the utmost.", {"entities": []}], ["The subsequent opinion discusses the following after an introduction to medical history: the definition of CAM; the efficacy of most common CAM procedures; CAM utilisation and costs in Germany; characteristics of science-oriented medicine; awareness of placebo research; pro and contra arguments about the use of CAM, not least of all in terms of aspects related to medical ethics.", {"entities": []}], ["It is not inconceivable that by 2035 the substantial gaps in child health across the Pacific can close significantly.", {"entities": []}], ["Currently, Australia and New Zealand have child mortality rates of 5 and 6 per 1000 live births, respectively, while Pacific island developing nations have under 5 mortality rates ranging from 13 to 16 (Vanuatu, Fiji and Tonga) to 47 and 58 per 1000 live births (Kiribati and Papua New Guinea, respectively).", {"entities": []}], ["However, these Pacific child mortality rates are falling, by an average of 1.4% per year since 1990, and more rapidly (1.9% per year) since 2000.", {"entities": []}], ["Based on progress elsewhere, there is a need to (i) define the specific things needed to close the gaps in child health; (ii) be far more ambitious and hopeful than ever before; and (iii) form a new regional compact based on solidarity and interdependence.", {"entities": []}], ["Since the publication of the US Surgeon General Reports in 1996 and 2006 and the report of the California Environmental Protection Agency in 1999, many reports have appeared on the contribution of air and biomarkers to different facets of the secondhand smoke (SHS) issue, which are the targets of this review.", {"entities": []}], ["These recent studies have allowed earlier epidemiological surveys to be biologically validated, and their plausibility demonstrated, quantified the levels of exposure to SHS before the bans in various environments, showed the deficiencies of mechanical control methods and of partial bans and the frequently correct implementation of the efficient total bans.", {"entities": []}], ["More stringent regulation remains necessary in the public domain (workplaces, hospitality venues, transport sector, etc. )", {"entities": []}], ["in many countries.", {"entities": []}], ["Personal voluntary protection efforts against SHS are also needed in the private domain (homes, private cars).", {"entities": [[104, 108, "GENE"]]}], ["The effects of SHS on the cardiovascular, respiratory and neuropsychic systems, on pregnancy and fertility, on cancers and on SHS genotoxicity are confirmed through experimental human studies and through the relationship between markers and prevalence of disease or of markers of disease risk.", {"entities": []}], ["Despite an overwhelming evidence base, supported self-management of asthma is poorly implemented into routine practice.", {"entities": [[68, 74, "DISEASE"]]}], ["Strategies for implementation must address organisational routines, as well as provide resources for patients and training to improve professionals\u2019 skills.", {"entities": []}], ["We aimed to explore the priority that primary care practices attach to asthma self-management, to describe their existing asthma management routines, and to generate innovative implementation strategies.", {"entities": [[71, 77, "DISEASE"], [122, 128, "DISEASE"]]}], ["We recruited 33 participants (23 general practitioners; seven nurses; three administrative staff) from 14 general practices.", {"entities": []}], ["The 12 interviews and three focus groups were transcribed, coded and analysed thematically.", {"entities": []}], ["Supported self-management was largely a nurse-led task within clinic-based annual reviews.", {"entities": []}], ["Barriers included poor attendance at asthma clinics, lack of time, demarcation of roles, limited access to a range of tailored resources, and competing agendas in consultation, often due to multimorbidity.", {"entities": [[37, 43, "DISEASE"]]}], ["Suggestions for initiatives to improve the provision of supported self-management included emphasising the evidence for benefit (to influence prioritisation), improving teamwork (including team-based education), organisational strategies (including remote consulting) which need to fit within existing practice routines.", {"entities": []}], ["Technology offers some potential solutions (e.g., improved templates, \u2018app\u2019-based plans), but must be integrated with the practice information technology systems.", {"entities": [[71, 74, "GENE"]]}], ["Building on these insights, we will now develop a theoretically-based implementation strategy that will address patient, professional, and organisational buy-in, provide team-based education and offer a range of practical options and tools, which can be adapted and integrated within existing routines of individual practices.", {"entities": []}], ["Understanding the routines of primary care practices can suggest strategies to implement supported self-management in general practice.", {"entities": []}], ["Supported self-management of asthma including provision of individual action plans improves patient health and reduces the burden on healthcare services, but is not well implemented in routine practice.", {"entities": [[29, 35, "DISEASE"]]}], ["As part of a large-scale programme to implement self-management into UK general practice, Hilary Pinnock at the University of Edinburgh and co-workers conducted interviews and focus groups with 33 participants from 14 general practices to explore the organisational routines that hinder or enable professionals to provide support asthma self-management.", {"entities": [[330, 336, "DISEASE"]]}], ["Poor attendance at asthma clinics, demarcation of roles, lack of time and limited access to tailored resources were identified as specific barriers.", {"entities": [[19, 25, "DISEASE"]]}], ["Improvements suggested included improved teamwork between doctors and other medical healthcare professionals, comprehensive training, and improvements to IT systems.", {"entities": []}], ["Frail older people often receive fragmented care from multiple providers.", {"entities": []}], ["According to the literature, there is an urgent need for coordination of care.", {"entities": []}], ["Online and eHealth tools are increasingly used to improve coordination.", {"entities": []}], ["However, there are significant barriers to their implementation in frail older people.", {"entities": []}], ["Our aim was to (1) evaluate differences in use of a personal online health community (POHC) for frail older people in relation to personal characteristics, and (2) explore barriers and facilitators for use as experienced by older people and their informal caregivers, using the case of the Health and Welfare Information Portal (ZWIP).", {"entities": []}], ["This is a mixed methods study.", {"entities": []}], ["For the quantitative analysis, we used POHC usage information (2 years follow-up) and baseline characteristics of frail older people.", {"entities": []}], ["For the qualitative analysis, we used semistructured interviews with older people and their informal caregivers.", {"entities": []}], ["Participants were recruited from 11 family practices in the east of the Netherlands and frail older people over 70 years.", {"entities": []}], ["The ZWIP intervention is a personal online health community for frail older people, their informal caregivers, and their providers.", {"entities": []}], ["ZWIP was developed at the Geriatrics Department of Radboud University Medical Center.", {"entities": []}], ["We collected data on POHC use for 2 years as well as relevant patient characteristics.", {"entities": []}], ["Interview topics were description of use, reasons for use and non-use, and user profiles.", {"entities": []}], ["Of 622 frail patients in the intervention group, 290 were connected to ZWIP; 79 used ZWIP regularly (at least monthly).", {"entities": []}], ["Main predictors for use were having an informal caregiver, having problems with activities of daily living, and having a large number of providers.", {"entities": []}], ["Family practice level predictors were being located in a village, and whether the family practitioners had previously used electronic consultation and cared for a large percentage of frail older people.", {"entities": []}], ["From 23 interviews, main reasons for use were perceiving ZWIP to be a good, quick, and easy way of communicating with providers and the presence of active health problems.", {"entities": []}], ["Important reasons for non-use were lack of computer skills and preferring traditional means of consultation.", {"entities": []}], ["Only 27.2% (79/290) of frail older enrolled in the POHC intervention used the POHC frequently.", {"entities": []}], ["For implementation of personal online health communities, older people with active health problems and a sizable number of health care providers should be targeted, and the informal caregiver, if present, should be involved in the implementation process.", {"entities": []}], ["International Standard Randomized Controlled Trial Number (ISRCTN): 11165483; http://www.controlled-trials.com/isrctn/pf/11165483 (Archived by WebCite at http://www.webcitation.org/6U3fZovoU).", {"entities": []}], ["High levels of cytokines, such as interleukin (IL)-1\u03b2, tumor necrosis factor (TNF)-\u03b1 and IL-6, are associated with chronic diseases like rheumatoid arthritis, asthma, atherosclerosis, Alzheimer\u2019s disease and cancer; therefore cytokine inhibition might be an important target for the treatment of these diseases.", {"entities": [[167, 182, "DISEASE"], [137, 157, "DISEASE"], [148, 157, "DISEASE"], [159, 165, "DISEASE"], [208, 214, "DISEASE"], [78, 81, "GENE"]]}], ["Most drugs used to alleviate some inflammation-related symptoms act by inhibiting cyclooxygenases activity or by blocking cytokine receptors.", {"entities": []}], ["Nevertheless, these drugs have secondary effects when used on a long-term basis.", {"entities": []}], ["It has been mentioned that flavonoids, namely quercetin, apigenin and luteolin, reduce cytokine expression and secretion.", {"entities": []}], ["In this regard, flavonoids may have therapeutical potential in the treatment of inflammation-related diseases as cytokine modulators.", {"entities": []}], ["This review is focused on current research about the effect of flavonoids on cytokine modulation and the description of the way these compounds exert their effect.", {"entities": []}], ["Accumulating data, including those from our laboratory, have shown that the opening of ATP \u2010sensitive potassium channels ( K ATP ) plays a protective role in pulmonary vascular diseases ( PVD ).", {"entities": []}], ["As maintainers of the endothelial framework, endothelial colony\u2010forming cells ( ECFC s) are considered excellent candidates for vascular regeneration in cases of PVD .", {"entities": []}], ["Although K ATP openers ( KCO s) have been demonstrated to have beneficial effects on endothelial cells, the impact of K ATP on ECFC function remains unclear.", {"entities": []}], ["Herein, this study investigated whether there is a distribution of K ATP in ECFC s and what role K ATP play in ECFC modulation.", {"entities": []}], ["By human ECFC s isolated from adult peripheral blood, K ATP were confirmed for the first time to express in ECFC s, comprised subunits of Kir (Kir6.1, Kir6.2) and SUR 2b.", {"entities": []}], ["KCO s such as the classical agent nicorandil (Nico) and the novel agent iptakalim (Ipt) notably improved the function of ECFC s, promoting cell proliferation, migration and angiogenesis, which were abolished by a non\u2010selective K ATP blocker glibenclamide (Gli).", {"entities": []}], ["To determine the underlying mechanisms, we investigated the impacts of KCO s on Ca MKII , Akt and endothelial nitric oxide synthase pathways.", {"entities": []}], ["Enhanced levels were detected by western blotting, which were abrogated by Gli.", {"entities": []}], ["This suggested an involvement of Ca ECFC s by K ATP .", {"entities": []}], ["Our findings demonstrated for the first time that there is a distribution of K ATP in ECFC s and K ATP play a vital role in ECFC function.", {"entities": []}], ["The present work highlighted a novel profile of K ATP as a potential target for ECFC modulation, which may hold the key to the treatment of PVD .", {"entities": []}], ["Background .", {"entities": []}], ["Whether there is heterogeneity in the development of BMI from middle-age onward is still unknown.", {"entities": []}], ["The primary aim of this study is to analyze long-term obesity and how BMI trajectories are associated with health outcomes in midlife.", {"entities": [[54, 61, "DISEASE"]]}], ["Latent Class Growth Modelling was used to capture the changes in BMI over time.", {"entities": []}], ["In this study, 3070 individuals from the National Population Health Survey (NPHS), aged 40\u201355 years at baseline, were included.", {"entities": []}], ["Four BMI trajectory groups, \u201cNormal-Stable\u201d (N-S), \u201cOverweight-Stable\u201d (OV-S), \u201cObese I-Stable\u201d (OB I-S), and \u201cObese II-Stable\u201d (OB II-S), were identified.", {"entities": []}], ["Men, persons of White ancestry, and individuals who had no postsecondary education had higher odds of being in the latter three groups.", {"entities": []}], ["Moreover, members of the OV-S, OB I-S, and OB II-S groups experienced more asthma, arthritis, hypertension, diabetes, heart disease, cognitive impairment, and reduced self-rated overall health.", {"entities": [[94, 106, "DISEASE"], [118, 131, "DISEASE"], [83, 92, "DISEASE"], [75, 81, "DISEASE"]]}], ["Individuals in the OB II-S group were at greater risk for back problems, chronic bronchitis or emphysema, and emotional issues when compared to the N-S group.", {"entities": [[81, 91, "DISEASE"]]}], ["Conclusion .", {"entities": []}], ["Understanding different BMI trajectories is important in order to identify people who are at the highest risk of developing comorbidities due to obesity and to establish programs to intervene appropriately.", {"entities": [[145, 152, "DISEASE"]]}], ["The bronchial asthma, a clinical complication of persistent inflammation of the airway and subsequent airway hyper-responsiveness, is a leading cause of morbidity and mortality in critically ill patients.", {"entities": [[14, 20, "DISEASE"]]}], ["Several studies have shown that oxidative stress plays a key role in initiation as well as amplification of inflammation in airways.", {"entities": []}], ["However, still there are no good anti-oxidant strategies available for therapeutic intervention in asthma pathogenesis.", {"entities": [[99, 105, "DISEASE"]]}], ["Most recent studies suggest that polyol pathway enzyme, aldose reductase (AR), contributes to the pathogenesis of oxidative stress\u2013induced inflammation by affecting the NF-\u03baB-dependent expression of cytokines and chemokines and therefore inhibitors of AR could be anti-inflammatory.", {"entities": []}], ["Since inhibitors of AR have already gone through phase-III clinical studies for diabetic complications and found to be safe, our hypothesis is that AR inhibitors could be novel therapeutic drugs for the prevention and treatment of asthma.", {"entities": [[231, 237, "DISEASE"]]}], ["Hence, we investigated the efficacy of AR inhibition in the prevention of allergic responses to a common natural airborne allergen, ragweed pollen that leads to airway inflammation and hyper-responsiveness in a murine model of asthma.", {"entities": [[227, 233, "DISEASE"]]}], ["Primary Human Small Airway Epithelial Cells (SAEC) were used to investigate the in vitro effects of AR inhibition on ragweed pollen extract (RWE)-induced cytotoxic and inflammatory signals.", {"entities": []}], ["Our results indicate that inhibition of AR prevents RWE -induced apoptotic cell death as measured by annexin-v staining, increase in the activation of NF-\u03baB and expression of inflammatory markers such as inducible nitric oxide synthase (iNOS), cycloxygenase (COX)-2, Prostaglandin (PG) E 2 , IL-6 and IL-8.", {"entities": []}], ["Further, BALB/c mice were sensitized with endotoxin-free RWE in the absence and presence of AR inhibitor and followed by evaluation of perivascular and peribronchial inflammation, mucin production, eosinophils infiltration and airway hyperresponsiveness.", {"entities": []}], ["Our results indicate that inhibition of AR prevents airway inflammation and production of inflammatory cytokines, accumulation of eosinophils in airways and sub-epithelial regions, mucin production in the bronchoalveolar lavage fluid and airway hyperresponsiveness in mice.", {"entities": []}], ["These results suggest that airway inflammation due to allergic response to RWE, which subsequently activates oxidative stress-induced expression of inflammatory cytokines via NF-\u03baB-dependent mechanism, could be prevented by AR inhibitors.", {"entities": []}], ["Therefore, inhibition of AR could have clinical implications, especially for the treatment of airway inflammation, a major cause of asthma pathogenesis.", {"entities": [[132, 138, "DISEASE"]]}], ["Exposure to cephalosporins could cause occupational allergic diseases in health care workers (HCWs).", {"entities": []}], ["We evaluated the prevalence of serum specific IgE and IgG antibodies to cephalosporin-human serum albumin (HSA) conjugate and to identify potential genetic risk factors associated with sensitization to cephalosporins in exposed HCWs.", {"entities": []}], ["The study population consisted of 153 HCWs who had been exposed to antibiotics in a single university hospital and 86 unexposed healthy controls.", {"entities": []}], ["A questionnaire survey of work-related symptoms (WRS) was administered.", {"entities": []}], ["A skin-prick test (SPT) was performed, and serum-specific IgE and IgG antibodies to 3 commonly prescribed cephalosporins were measured by ELISA.", {"entities": []}], ["Four single-nucleotide polymorphisms of the candidate genes related to IgE sensitization were genotyped.", {"entities": []}], ["The prevalence of WRS to cephalosporins was 2.6%.", {"entities": []}], ["The prevalence rates of serum-specific IgE and IgG antibodies to cephalosporins were 20.3% and 14.7%, respectively.", {"entities": []}], ["The Fc\u03b5R1\u03b2 -109T > C polymorphism was significantly associated with IgE sensitization to cephalosporins in HCWs ( P = 0.036, OR = 3.553; CI, 1.324-9.532).", {"entities": []}], ["The in vitro functional assay demonstrated that the T allele of Fc\u03b5R1\u03b2 -109T had greater promoter activity than did the C allele ( P < 0.001).", {"entities": []}], ["The Fc\u03b5R1\u03b2 -109T > C polymorphism may be a potential genetic risk factor for increased IgE sensitization to cephalosporins.", {"entities": []}], ["It is estimated that over 80% of respirable particulate matter (PM 10 ) in cities comes from road transport and that tire and brake wear are responsible for the 3\u20137% emission of it.", {"entities": []}], ["Data on the indicators of environmental impact of tire debris (TD), originated from the tire abrasion on roads, are extremely scarce, even though TD contains chemicals (zinc and organic compounds) which can be released in the environment.", {"entities": []}], ["TD particle morphology was analysed with SEM, TEM and FIB instruments.", {"entities": []}], ["TD eluates and TD organic extracts were tested at dilution series on human cell lines and Xenopus laevis embryos.", {"entities": []}], ["50 and 100 g/L TD were used for the eluates obtained after 24 h at pH 3 and the quantity of zinc present was measured with a ICP-AES.", {"entities": []}], ["Eluates diluted to 1%, 10%, 50% in culture media and undiluted were used on X. laevis embryos in the FETAX test.", {"entities": []}], ["HepG2 cells were exposed for 24 h to 0.05 \u2013 50 \u03bcg/ml of zinc salt while A549 cells were exposed for 24, 48 and 72 h to 10, 50, 60, or 75 \u03bcg/ml of TD extract.", {"entities": []}], ["X. laevis embryos were exposed to 50, 80, 100, or 120 \u03bcg/ml TD extract.", {"entities": []}], ["The solution of undiluted 50 g/L TD produced 80.2% mortality (p < 0.01) in X. laevis embryos and this toxic effect was three times greater than that produced by 100 g/L TD.", {"entities": []}], ["Zn accumulation in HepG2 cells was evident after 4 h exposure.", {"entities": []}], ["A549 cells exposed to TD organic extract for 72 h presented a modified morphology, a decrease in cell proliferation and an increase in DNA damage as shown by comet assay.", {"entities": []}], ["The dose 80 \u03bcg/ml of TD extract produced 14.6% mortality in X. laevis embryos and 15.9% mortality at 120 \u03bcg/ml.", {"entities": []}], ["Treatment with 80, 100, or 120 \u03bcg/ml TD organic extract increased from 14.8% to 37.8% malformed larvae percentages compared to 5.6% in the control.", {"entities": []}], ["Since the amount of Zn leached from TD is related to pH, aggregation of particles and elution process, the quantity of TD present in the environment has to be taken into account.", {"entities": []}], ["Moreover the atmospheric conditions, which may deeply influence the particle properties, have to be considered.", {"entities": []}], ["The TD organic fraction was toxic for cells and organisms.", {"entities": []}], ["Thus, because of its chemical components, TD may have a potential environmental impact and has to be further investigated.", {"entities": []}], ["Paclitaxel-based chemotherapy continues to be an integral component in the treatment of many solid tumors.", {"entities": []}], ["Prolonged use of paclitaxel may result in repeated doses of premedications and potential unwanted side effects.", {"entities": []}], ["Infusion hypersensitivity reactions occurring beyond the second dose are infrequent and not well characterized.", {"entities": []}], ["We hypothesized that patients whose paclitaxel premedications were discontinued after two doses were unlikely to experience infusion hypersensitivity reactions with subsequent paclitaxel doses.", {"entities": []}], ["Patients receiving paclitaxel-based chemotherapy who did not experience an infusion hypersensitivity reaction with their first or second dose had their paclitaxel premedications discontinued.", {"entities": []}], ["The primary endpoint was to estimate the incidence of rescue medication for the treatment of paclitaxel infusion hypersensitivity during doses 3 to 6 for patients whose paclitaxel premedications had been discontinued.", {"entities": []}], ["After receiving the first two doses of paclitaxel-based chemotherapy without experiencing an infusion hypersensitivity reaction (any grade), 55 breast cancer patients had their premedications discontinued for all remaining paclitaxel doses.", {"entities": [[144, 157, "DISEASE"], [151, 157, "DISEASE"]]}], ["None of these patients required rescue medication to treat an infusion hypersensitivity reaction with subsequent doses.", {"entities": []}], ["In patients who have not experienced an infusion hypersensitivity reaction with the first two doses of paclitaxel, discontinuation of paclitaxel premedications may be considered an option without an increased risk of infusion hypersensitivity requiring rescue medication.", {"entities": []}], ["Th2 and Th17 cells are both associated with developing ankylosing spondylitis (AS) and asthma.", {"entities": [[66, 77, "DISEASE"], [87, 93, "DISEASE"], [55, 77, "DISEASE"]]}], ["Th2 cells are also associated with allergic rhinitis and atopic dermatitis (AD).", {"entities": [[35, 52, "DISEASE"], [57, 74, "DISEASE"], [44, 52, "DISEASE"], [64, 74, "DISEASE"]]}], ["The prevalence of such allergic diseases in AS patients is unknown.", {"entities": []}], ["In this study, we intended to study the risk of allergic diseases in a 10-year follow-up population of newly diagnosed patients with AS.", {"entities": []}], ["We used a nationwide 10-year population-based database retrieved from the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan.", {"entities": []}], ["The study cohort comprised 857 patients with AS who had at least 1 claim of inpatient admission or at least 2 claims of ambulatory visit.", {"entities": []}], ["The comparison cohort consisted of 4285 randomly selected subjects matched with AS group at a ratio of 5:1.", {"entities": []}], ["We used Cox proportional-hazards regression to determine the 10-year disease-free survival rates after adjusting for potentially confounding factors.", {"entities": []}], ["The AS patients had a 1.31 times greater risk of developing asthma within 10 years of diagnosis when compared with non-AS age- and sex-matched subjects, after adjusting for other risk factors (95% confidence interval\u200a=\u200a1.00\u20131.75).", {"entities": [[60, 66, "DISEASE"]]}], ["But the difference was not significantly different.", {"entities": []}], ["The AS patients also had a 1.46 times and a 1.22 times greater risk of developing allergic rhinitis and AD significantly.", {"entities": [[82, 99, "DISEASE"], [91, 99, "DISEASE"]]}], ["AS patients also had a lower allergic disease-free survival rate compared to non-AS group.", {"entities": []}], ["Our results showed that patients with AS had a higher risk of developing allergic diseases later in life.", {"entities": []}], ["Controversy has attended the relationship between risk-adjusted mortality and process-of-care.", {"entities": []}], ["There would be advantage in the establishment, at the data-base level, of global quantitative indices subsuming the diversity of process-of-care.", {"entities": []}], ["A retrospective, cohort study of patients identified in the Australian and New Zealand Intensive Care Society Adult Patient Database, 1993-2003, at the level of geographic and ICU-level descriptors (n = 35), for both hospital survivors and non-survivors.", {"entities": []}], ["Process-of-care indices were established by analysis of: (i) the smoothed time-hazard curve of individual patient discharge and determined by pharmaco-kinetic methods as area under the hazard-curve (AUC), reflecting the integrated experience of the discharge process, and time-to-peak-hazard (TMAX, in days), reflecting the time to maximum rate of hospital discharge; and (ii) individual patient ability to optimize output (as length-of-stay) for recorded data-base physiological inputs; estimated as a technical production-efficiency (TE, scaled [0,(maximum)1]), via the econometric technique of stochastic frontier analysis.", {"entities": []}], ["For each descriptor, multivariate correlation-relationships between indices and summed mortality probability were determined.", {"entities": []}], ["The data-set consisted of 223129 patients from 99 ICUs with mean (SD) age and APACHE III score of 59.2(18.9) years and 52.7(30.6) respectively; 41.7% were female and 45.7% were mechanically ventilated within the first 24 hours post-admission.", {"entities": []}], ["For survivors, AUC was maximal in rural and for-profit ICUs, whereas TMAX (\u2265 7.8 days) and TE (\u2265 0.74) were maximal in tertiary-ICUs.", {"entities": []}], ["For non-survivors, AUC was maximal in tertiary-ICUs, but TMAX (\u2265 4.2 days) and TE (\u2265 0.69) were maximal in for-profit ICUs.", {"entities": []}], ["Across descriptors, significant differences in indices were demonstrated (analysis-of-variance, P \u2264 0.0001).", {"entities": []}], ["Total explained variance, for survivors (0.89) and non-survivors (0.89), was maximized by combinations of indices demonstrating a low correlation with mortality probability.", {"entities": []}], ["Global indices reflecting process of care may be formally established at the level of national patient data-bases.", {"entities": []}], ["These indices appear orthogonal to mortality outcome.", {"entities": []}], ["The abnormal regulation of neutrophil apoptosis may contribute to the ineffective resolution of inflammation in chronic lung diseases.", {"entities": []}], ["Multiple signalling pathways are implicated in regulating granulocyte apoptosis, in particular, NF\u03baB (nuclear factor-kappa B) signalling which delays constitutive neutrophil apoptosis.", {"entities": []}], ["Although some studies have suggested a dysregulation in the apoptosis of airway cells in chronic obstructive pulmonary disease (COPD), no studies to date have directly investigated if NF\u03baB is associated with apoptosis of airway neutrophils from COPD patients.", {"entities": [[89, 126, "DISEASE"]]}], ["The objectives of this study were to examine spontaneous neutrophil apoptosis in stable COPD subjects (n = 13), healthy smoking controls (n = 9) and non-smoking controls (n = 9) and to investigate whether the neutrophil apoptotic process in inflammatory conditions is associated with NF\u03baB activation.", {"entities": []}], ["Analysis of apoptosis in induced sputum was carried out by 3 methods; light microscopy, Annexin V/Propidium iodide and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method.", {"entities": []}], ["Activation of NF\u03baB was assessed using a flow cytometric method and the phosphorylation state of I\u03baB\u03b1 was carried out using the Bio-Rad Bio-Plex phosphoprotein I\u03baB\u03b1 assay.", {"entities": []}], ["Flow cytometric analysis showed a significant reduction in the percentage of sputum neutrophils undergoing spontaneous apoptosis in healthy smokers and subjects with COPD compared to non-smokers (p < 0.001).", {"entities": []}], ["Similar findings were demonstrated using the Tunel assay and in the morphological identification of apoptotic neutrophils.", {"entities": []}], ["A significant increase was observed in the expression of both the p50 (p = 0.006) and p65 (p = 0.006) subunits of NF\u03baB in neutrophils from COPD subjects compared to non-smokers.", {"entities": []}], ["These results demonstrate that apoptosis is reduced in the sputum of COPD subjects and in healthy control smokers and may be regulated by an associated activation of NF\u03baB.", {"entities": []}], ["Naja naja atra venom (NNAV) is composed of various proteins, peptides, and enzymes with different biological and pharmacological functions.", {"entities": []}], ["A number of previous studies have reported that NNAV exerts potent analgesic effects on various animal models of pain.", {"entities": []}], ["The clinical studies using whole venom or active components have confirmed that NNAV is an effective and safe medicine for treatment of chronic pain.", {"entities": []}], ["Furthermore, recent studies have demonstrated that NNAV has anti-inflammatory and immune regulatory actions in vitro and in vivo.", {"entities": []}], ["In this review article, we summarize recent studies of NNAV and its components on inflammation and immunity.", {"entities": []}], ["The main new findings in NNAV research show that it may enhance innate and humoral immune responses while suppressing T lymphocytes-mediated cellular immunity, thus suggesting that NNAV and its active components may have therapeutic values in the treatment of inflammatory and autoimmune diseases.", {"entities": []}], ["The aim of this population-based study was to investigate the risk of developing noninfectious rhinitis (NIR) in subjects with chronic obstructive pulmonary disease (COPD).", {"entities": [[95, 103, "DISEASE"], [127, 164, "DISEASE"]]}], ["This is a longitudinal population-based study comprising 3,612 randomly selected subjects from Gothenburg, Sweden, aged 25\u201375 years.", {"entities": []}], ["Lung function was measured at baseline with spirometry and the included subjects answered a questionnaire on respiratory symptoms.", {"entities": []}], ["At follow-up, the subjects answered a questionnaire with a response rate of 87%.", {"entities": []}], ["NIR was defined as symptoms of nasal obstruction, nasal secretion, and/or sneezing attacks without having a cold, during the last 5 years.", {"entities": []}], ["COPD was defined as a spirometry ratio of forced expiratory volume in 1 second divided by forced vital capacity (FEV 1 /FVC) <0.7.", {"entities": [[113, 116, "GENE"]]}], ["Subjects who reported asthma and NIR at baseline were excluded from the study.", {"entities": [[22, 28, "DISEASE"]]}], ["The odds ratios for developing NIR (ie, new-onset NIR) in relation to age, gender, body mass index, COPD, smoking, and atopy were calculated.", {"entities": []}], ["In subjects with COPD, the 5-year incidence of NIR was significantly increased (10.8% vs 7.4%, P =0.005) and was higher among subjects aged >40 years.", {"entities": []}], ["Smoking, atopy, and occupational exposure to gas, fumes, or dust were also associated with new-onset NIR.", {"entities": []}], ["COPD, smoking, and atopy remained individual risk factors for new-onset NIR in the logistic regression analysis.", {"entities": []}], ["This longitudinal population-based study of a large cohort showed that COPD is a risk factor for developing NIR.", {"entities": []}], ["Smoking and atopy are also risk factors for NIR.", {"entities": []}], ["The results indicate that there is a link present between upper and lower respiratory inflammation in NIR and COPD.", {"entities": []}], ["The Diagnostic and Statistical Manual of Mental Disorders (DSM) is universally acknowledged as the prominent reference textbook for the diagnosis and assessment of psychiatric diseases.", {"entities": []}], ["However, since the publication of its first version in 1952, controversies have been raised concerning its reliability and validity and the need for other novel clinical tools has emerged.", {"entities": []}], ["Currently the DSM is in its fourth edition and a new fifth edition is expected for release in 2013, in an intense intellectual debate and in a call for new proposals.", {"entities": []}], ["Since 1952, psychiatry has undergone many changes and is emerging as unique field in the medical area in which a novel approach is being demanded for properly treating patients: not the classical \u201cone-size-fits-all\u201d approach, but a more targeted and tailored diagnosis and therapeutics, taking into account the complex interactions among genes and their products, environment, culture and the psychological apparatus of the subject.", {"entities": []}], ["OMICS sciences, being based on high-throughput technologies, are systems biology related fields (like genomics, proteomics, transcriptomics and so on).", {"entities": []}], ["In the frame of the P5 medicine (personalized, participatory, predictive, preventive, psycho-cognitive), they could establish links between psychiatric diseases, which are disorders with a final common symptomatology with vastly heterogeneous biological, environmental and sociological underpinnings, and by understanding the psychiatric diseases beyond their classic symptomatic or syndromal definitions using OMICS research, one can have a broader picture and unprecedented links and reclassification of psychiatric nosology.", {"entities": []}], ["Importantly, by understanding the basis of heterogeneity in diseases through OMICS research, one could also personalize treatment of psychiatric illnesses.", {"entities": []}], ["In this manuscript, we discuss a gap in the current psychiatric research, namely the missing logical link among OMICS, personalized medicine and reclassification of diseases.", {"entities": []}], ["Moreover, we explore the importance of incorporating OMICS-based quantitative dimensional criteria, besides the classical qualitative and categorical approach.", {"entities": []}], ["We conducted the present study to determine whether a combination of the mechanical ventilation weaning predictors proposed by the collective Task Force of the American College of Chest Physicians (TF) and weaning endurance indices enhance prediction of weaning success.", {"entities": [[198, 200, "GENE"]]}], ["Conducted in a tertiary paediatric intensive care unit at a university hospital, this prospective study included 54 children receiving mechanical ventilation (\u22656 hours) who underwent 57 episodes of weaning.", {"entities": []}], ["We calculated the indices proposed by the TF (spontaneous respiratory rate, paediatric rapid shallow breathing, rapid shallow breathing occlusion pressure [ROP] and maximal inspiratory pressure during an occlusion test [Pi max ]) and weaning endurance indices (pressure-time index, tension-time index obtained from P 0.1 [TTI 1 ] and from airway pressure [TTI 2 ]) during spontaneous breathing.", {"entities": [[42, 44, "GENE"], [223, 226, "GENE"]]}], ["Performances of each TF index and combinations of them were calculated, and the best single index and combination were identified.", {"entities": [[21, 23, "GENE"]]}], ["Weaning endurance parameters (TTI 1 and TTI 2 ) were calculated and the best index was determined using a logistic regression model.", {"entities": []}], ["Regression coefficients were estimated using the maximum likelihood ratio (LR) method.", {"entities": []}], ["Hosmer\u2013Lemeshow test was used to estimate goodness-of-fit of the model.", {"entities": []}], ["An equation was constructed to predict weaning success.", {"entities": []}], ["Finally, we calculated the performances of combinations of best TF indices and best endurance index.", {"entities": [[64, 66, "GENE"]]}], ["The best single TF index was ROP, the best TF combination was represented by the expression (0.66 \u00d7 ROP) + (0.34 \u00d7 Pi max ), and the best endurance index was the TTI 2 , although their performance was poor.", {"entities": [[16, 18, "GENE"], [43, 45, "GENE"], [16, 18, "GENE"], [43, 45, "GENE"], [118, 121, "GENE"]]}], ["The best model resulting from the combination of these indices was defined by the following expression: (0.6 \u00d7 ROP) \u2013 (0.1 \u00d7 Pi max ) + (0.5 \u00d7 TTI 2 ).", {"entities": [[128, 131, "GENE"]]}], ["This integrated index was a good weaning predictor ( P < 0.01), with a LR The proposed combined index, incorporating endurance, was of modest value in predicting weaning outcome.", {"entities": []}], ["This is the first report of the value of endurance parameters in predicting weaning success in children.", {"entities": []}], ["Currently, clinical judgement associated with spontaneous breathing trials apparently remain superior.", {"entities": []}], ["Several pregnancy complications have disparities based on the sex of the fetus.", {"entities": []}], ["It is unknown whether the sex of the fetus differentially alters the maternal immune milieu, potentially contributing to the observed differences.", {"entities": []}], ["Using maternal plasma collected during 38 uncomplicated pregnancies (19 males, 19 females), we compared levels of cytokines, sex hormones, and angiogenic factors throughout gestation and postpartum.", {"entities": []}], ["Male fetal sex was associated with higher levels of proinflammatory cytokines (G-CSF, IL-12p70, IL-21, and IL-33) and angiogenic factors (PlGF and VEGF-A) compared with female fetal sex at multiple timepoints.", {"entities": []}], ["Female fetal sex was associated with higher levels of regulatory cytokines (IL-5, IL-9, IL-17, and IL-25).", {"entities": []}], ["IL-27 increased throughout pregnancy regardless of fetal sex.", {"entities": []}], ["There was no fetal sex-based difference in analyte concentrations at the postpartum measurement.", {"entities": []}], ["Women carrying a male fetus exhibit a more proinflammatory/proangiogenic immune milieu than women carrying a female fetus.", {"entities": []}], ["Many inflammatory diseases have an oxidative aetiology, which leads to oxidative damage to biomolecules, including proteins.", {"entities": []}], ["It is now increasingly recognized that oxidative post-translational modifications (oxPTMs) of proteins affect cell signalling and behaviour, and can contribute to pathology.", {"entities": []}], ["Moreover, oxidized proteins have potential as biomarkers for inflammatory diseases.", {"entities": []}], ["Although many assays for generic protein oxidation and breakdown products of protein oxidation are available, only advanced tandem mass spectrometry approaches have the power to localize specific oxPTMs in identified proteins.", {"entities": []}], ["While much work has been carried out using untargeted or discovery mass spectrometry approaches, identification of oxPTMs in disease has benefitted from the development of sophisticated targeted or semi-targeted scanning routines, combined with chemical labeling and enrichment approaches.", {"entities": []}], ["Nevertheless, many potential pitfalls exist which can result in incorrect identifications.", {"entities": []}], ["This review explains the limitations, advantages and challenges of all of these approaches to detecting oxidatively modified proteins, and provides an update on recent literature in which they have been used to detect and quantify protein oxidation in disease.", {"entities": []}], ["An important public health goal is to decrease the prevalence of key behavioural risk factors, such as tobacco use and obesity.", {"entities": [[119, 126, "DISEASE"]]}], ["Survey information is often available at the regional level, but heterogeneity within large geographic regions cannot be assessed.", {"entities": []}], ["Advanced spatial analysis techniques are demonstrated to produce sensible micro area estimates of behavioural risk factors that enable identification of areas with high prevalence.", {"entities": []}], ["A spatial Bayesian hierarchical model was used to estimate the micro area prevalence of current smoking and excess bodyweight for the Erie-St. Clair region in southwestern Ontario.", {"entities": []}], ["Estimates were mapped for male and female respondents of five cycles of the Canadian Community Health Survey (CCHS).", {"entities": []}], ["The micro areas were 2006 Census Dissemination Areas, with an average population of 400\u2013700 people.", {"entities": []}], ["Two individual-level models were specified: one controlled for survey cycle and age group (model 1), and one controlled for survey cycle, age group and micro area median household income (model 2).", {"entities": []}], ["Post-stratification was used to derive micro area behavioural risk factor estimates weighted to the population structure.", {"entities": []}], ["SaTScan analyses were conducted on the granular, postal-code level CCHS data to corroborate findings of elevated prevalence.", {"entities": []}], ["Current smoking was elevated in two urban areas for both sexes (Sarnia and Windsor), and an additional small community (Chatham) for males only.", {"entities": []}], ["Areas of excess bodyweight were prevalent in an urban core (Windsor) among males, but not females.", {"entities": []}], ["Precision of the posterior post-stratified current smoking estimates was improved in model 2, as indicated by narrower credible intervals and a lower coefficient of variation.", {"entities": []}], ["For excess bodyweight, both models had similar precision.", {"entities": []}], ["Aggregation of the micro area estimates to CCHS design-based estimates validated the findings.", {"entities": []}], ["This is among the first studies to apply a full Bayesian model to complex sample survey data to identify micro areas with variation in risk factor prevalence, accounting for spatial correlation and other covariates.", {"entities": []}], ["Application of micro area analysis techniques helps define areas for public health planning, and may be informative to surveillance and research modeling of relevant chronic disease outcomes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-016-3144-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Information extraction techniques that get structured representations out of unstructured data make a large amount of clinically relevant information about patients accessible for semantic applications.", {"entities": []}], ["These methods typically rely on standardized terminologies that guide this process.", {"entities": []}], ["Many languages and clinical domains, however, lack appropriate resources and tools, as well as evaluations of their applications, especially if detailed conceptualizations of the domain are required.", {"entities": []}], ["For instance, German transthoracic echocardiography reports have not been targeted sufficiently before, despite of their importance for clinical trials.", {"entities": []}], ["This work therefore aimed at development and evaluation of an information extraction component with a fine-grained terminology that enables to recognize almost all relevant information stated in German transthoracic echocardiography reports at the University Hospital of W\u00fcrzburg.", {"entities": []}], ["A domain expert validated and iteratively refined an automatically inferred base terminology.", {"entities": []}], ["The terminology was used by an ontology-driven information extraction system that outputs attribute value pairs.", {"entities": []}], ["The final component has been mapped to the central elements of a standardized terminology, and it has been evaluated according to documents with different layouts.", {"entities": []}], ["The final system achieved state-of-the-art precision (micro average.996) and recall (micro average.961) on 100 test documents that represent more than 90 % of all reports.", {"entities": []}], ["In particular, principal aspects as defined in a standardized external terminology were recognized with f 1 =.989 (micro average) and f 1 =.963 (macro average).", {"entities": []}], ["As a result of keyword matching and restraint concept extraction, the system obtained high precision also on unstructured or exceptionally short documents, and documents with uncommon layout.", {"entities": []}], ["The developed terminology and the proposed information extraction system allow to extract fine-grained information from German semi-structured transthoracic echocardiography reports with very high precision and high recall on the majority of documents at the University Hospital of W\u00fcrzburg.", {"entities": []}], ["Extracted results populate a clinical data warehouse which supports clinical research.", {"entities": []}], ["The online version of this article (doi:10.1186/s12911-015-0215-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Impaired driving is a recognized cause of major injury.", {"entities": []}], ["Contemporary data are lacking on exposures to impaired driving behaviours and related injury among young adolescents, as well as inequities in these youth risk behaviours.", {"entities": []}], ["Cycle 6 (2009/10) of the Health Behaviour in School-Aged Children survey involved 26,078 students enrolled in 436 Canadian schools.", {"entities": []}], ["We profiled cross-sectionally the reported use of alcohol, marijuana, or other illicit drugs by on-road and off-road vehicle operators when young adolescents (mean age 13.3 (\u00b11.6) years) were either driving or riding as a passenger.", {"entities": []}], ["Comparisons were made across vulnerable subgroups.", {"entities": []}], ["Multi-level logistic regression analyses were used to quantify the effects of the driving behaviours on risks for motor vehicle-related injury.", {"entities": []}], ["Attributable risk fractions were also estimated.", {"entities": []}], ["A total of 10% (\u00b13%) of participants reported recent operation of an on-road or off-road motor vehicle after consuming alcohol, marijuana, or other illicit drugs, while 21% (\u00b13%) reported riding as a passenger with a driver under the same conditions.", {"entities": []}], ["Larger proportions of youth reporting these risk behaviours were males, and from older age groups, rural communities, and socio-economically disadvantaged populations.", {"entities": []}], ["The behaviours were consistently associated with increased risks for motor vehicle-related injury at the individual level (RR 2.35; 95% CI: 1.54 to 3.58 for frequent vs. no exposure as a driver; RR 1.68; 95% CI: 1.20 to 2.36 for frequent vs. no exposure as a passenger) and at the population level (Attributable Risk Fraction: 7.1% for drivers; 14.0% for passengers).", {"entities": []}], ["The study was limited mainly by its reliance on self-reported data.", {"entities": []}], ["Impaired driving is an important health priority among young adolescents in Canada.", {"entities": []}], ["Inequities in the involvement of younger adolescents in these risk behaviours suggest the need for targeted interventions for specific subgroups such as youth from rural communities, and among socially disadvantaged populations.", {"entities": []}], ["Sensory nerves innervating the airways play an important role in regulating various cardiopulmonary functions, maintaining homeostasis under healthy conditions and contributing to pathophysiology in disease states.", {"entities": []}], ["Hypo-osmotic solutions elicit sensory reflexes, including cough, and are a potent stimulus for airway narrowing in asthmatic patients, but the mechanisms involved are not known.", {"entities": []}], ["Transient receptor potential cation channel, subfamily V, member 4 (TRPV4) is widely expressed in the respiratory tract, but its role as a peripheral nociceptor has not been explored.", {"entities": [[68, 73, "GENE"]]}], ["We hypothesized that TRPV4 is expressed on airway afferents and is a key osmosensor initiating reflex events in the lung.", {"entities": [[21, 26, "GENE"]]}], ["We used guinea pig primary cells, tissue bioassay, in\u00a0vivo electrophysiology, and a guinea pig conscious cough model to investigate a role for TRPV4 in mediating sensory nerve activation in vagal afferents and the possible downstream signaling mechanisms.", {"entities": [[143, 148, "GENE"]]}], ["Human vagus nerve was used to confirm key observations in animal tissues.", {"entities": []}], ["Here we show TRPV4-induced activation of guinea pig airway\u2013specific primary nodose ganglion cells.", {"entities": []}], ["TRPV4 ligands and hypo-osmotic solutions caused depolarization of murine, guinea pig, and human vagus and firing of A\u03b4-fibers (not C-fibers), which was inhibited by TRPV4 and P2X3 receptor antagonists.", {"entities": [[0, 5, "GENE"], [165, 170, "GENE"], [0, 5, "GENE"], [165, 170, "GENE"]]}], ["Both antagonists blocked TRPV4-induced cough.", {"entities": []}], ["This study identifies the TRPV4-ATP-P2X3 interaction as a key osmosensing pathway involved in airway sensory nerve reflexes.", {"entities": []}], ["The absence of TRPV4-ATP\u2013mediated effects on C-fibers indicates a distinct neurobiology for this ion channel and implicates TRPV4 as a novel therapeutic target for neuronal hyperresponsiveness in the airways and symptoms, such as cough.", {"entities": [[15, 20, "GENE"], [124, 129, "GENE"]]}], ["Research on lesbian, gay, and bisexual (LGB) individuals\u2019 health and health practices has primarily consisted of convenience studies focused on HIV/AIDS, substance use, or mental illness.", {"entities": []}], ["We examined health-related disparities among Oregon LGB men and women compared with heterosexual men and women using data from a population-based survey.", {"entities": []}], ["Data from the 2005 through 2008 Oregon Behavioral Risk Factor Surveillance System were used to examine associations between sexual orientation and chronic conditions, health limitations, health risk factors, and protective health practices.", {"entities": []}], ["Compared with heterosexual women, lesbian and bisexual women were significantly more likely to smoke cigarettes, be obese, binge drink, and have chronic conditions, and less likely to engage in protective health practices.", {"entities": []}], ["Compared with heterosexual men, gay men were significantly less likely to be obese, more likely to binge drink, and more likely to engage in protective health practices.", {"entities": []}], ["Compared with heterosexual men, bisexual men were significantly more likely to have a physical disability, smoke cigarettes, binge drink, and more likely to get an HIV test.", {"entities": []}], ["Health disparities among Oregon LGB individuals were most prominent among lesbian and bisexual women.", {"entities": []}], ["Gay men had the most protective health practices, but they were more likely than heterosexual men to engage in risky behaviors that lead to chronic diseases later in life.", {"entities": []}], ["Targeted public health interventions should be provided in environments that avoid stigmatizing and discriminating against LGB individuals where they live, work, learn, and socialize.", {"entities": []}], ["Reactive oxygen species (ROS) and nitric oxide (NO) are major pathogenic molecules produced during viral lung infections, including influenza.", {"entities": [[132, 141, "DISEASE"]]}], ["While fluoroquinolones are widely used as antimicrobial agents for treating a variety of bacterial infections, including secondary infections associated with the influenza virus, it has been reported that they also function as anti-oxidants against ROS and as a NO regulator.", {"entities": [[162, 171, "DISEASE"]]}], ["Therefore, we hypothesized that levofloxacin (LVFX), one of the most frequently used fluoroquinolone derivatives, may attenuate pulmonary injuries associated with influenza virus infections by inhibiting the production of ROS species such as hydroxyl radicals and neutrophil-derived NO that is produced during an influenza viral infection.", {"entities": [[163, 172, "DISEASE"], [313, 322, "DISEASE"]]}], ["The therapeutic impact of LVFX was examined in a PR8 (H1N1) influenza virus-induced lung injury mouse model.", {"entities": [[60, 69, "DISEASE"]]}], ["ESR spin-trapping experiments indicated that LVFX showed scavenging activity against neutrophil-derived hydroxyl radicals.", {"entities": []}], ["LVFX markedly improved the survival rate of mice that were infected with the influenza virus in a dose-dependent manner.", {"entities": [[77, 86, "DISEASE"]]}], ["In addition, the LVFX treatment resulted in a dose-dependent decrease in the level of 8-hydroxy-2\u2019-deoxyguanosine (a marker of oxidative stress) and nitrotyrosine (a nitrative marker) in the lungs of virus-infected mice, and the nitrite/nitrate ratio (NO metabolites) and IFN-\u03b3 in BALF.", {"entities": []}], ["These results indicate that LVFX may be of substantial benefit in the treatment of various acute inflammatory disorders such as influenza virus-induced pneumonia, by inhibiting inflammatory cell responses and suppressing the overproduction of NO in the lungs.", {"entities": [[128, 137, "DISEASE"], [152, 161, "DISEASE"]]}], ["The prevalence of allergic diseases in children has increased for several decades.", {"entities": []}], ["We evaluated the correlation between pollen count of weeds and their sensitization rate in Seoul, 1997-2009.", {"entities": []}], ["Airborne particles carrying allergens were collected daily from 3 stations around Seoul.", {"entities": []}], ["Skin prick tests to pollen were performed on children with allergic diseases.", {"entities": []}], ["Ragweed pollen gradually increased between 1999 and 2005, decreased after 2005 and plateaued until 2009 (peak counts, 67 in 2003, 145 in 2005 and 83 grains/m", {"entities": []}], ["Compare respiratory health in children born extremely preterm (EP) or with extremely low birthweight (ELBW) nearly one decade apart, hypothesizing that better perinatal management has led to better outcome.", {"entities": []}], ["Fifty-seven (93%) of 61 eligible 11-year old children born in Western Norway in 1999\u20132000 with gestational age (GA) <28 weeks or birthweight <1000 gram (EP 1999\u20132000 ) and matched term-controls were assessed with comprehensive lung function tests and standardized questionnaires.", {"entities": []}], ["Outcome was compared with data obtained at 10 years of age from all (n = 35) subjects born at GA <29 weeks or birthweight <1001 gram within a part of the same region in 1991\u201392 (EP 1991\u20131992 ) and their matched term-controls.", {"entities": []}], ["EP 1999\u20132000 had significantly reduced forced expiratory flow in 1 second (FEV 1 ), FEV 1 to forced vital capacity (FEV 1 /FVC) and forced expiratory flow between 25\u201375% of FVC (FEF 25\u201375 ), with z-scores respectively -0.34, -0.50 and -0.61 below those of the term-control group, and more bronchial hyperresponsiveness to methacholine (dose-response-slope 13.2 vs. 3.5; p<0.001), whereas other outcomes did not differ.", {"entities": [[75, 78, "GENE"], [84, 87, "GENE"], [116, 119, "GENE"], [75, 78, "GENE"], [84, 87, "GENE"], [116, 119, "GENE"], [75, 78, "GENE"], [84, 87, "GENE"], [116, 119, "GENE"]]}], ["Low birthweight z-scores, but not neonatal bronchopulmonary dysplasia (BPD) or low GA, predicted poor outcome.", {"entities": []}], ["For children with neonatal BPD, important lung-function variables were better in EP 1999\u20132000 compared to EP 1991\u20131992 .", {"entities": []}], ["In regression models, improvements were related to more use of antenatal corticosteroids and surfactant treatment in the EP 1999\u20132000 .", {"entities": []}], ["Small airway obstruction and bronchial hyperresponsiveness were still present in children born preterm in 1999\u20132000, but outcome was better than for children born similarly preterm in 1991\u201392, particularly after neonatal BPD.", {"entities": []}], ["The findings suggest that better neonatal management not only improves survival, but also long-term pulmonary outcome.", {"entities": []}], ["Outpatient reimbursement levels of the New Rural Cooperative Medical Scheme have changed in recent years in China, and those changes may have a greater impact on patients with chronic diseases due to their higher outpatient expenses.", {"entities": []}], ["This study represents the first attempt to identify the effects of reimbursement level on outpatient service utilization for chronic patients in rural China and it also gives strong estimation results by conducting a tracer illness study in order to control for possible biases associated with studying several diseases together.", {"entities": []}], ["This study used difference-in-differences models to examine how changes in yearly maximum reimbursement amount and outpatient reimbursement rates affected rural residents with type 2 diabetes in three counties in Jiangsu Province, China.", {"entities": []}], ["Other factors, such as sex, age and severity of illness, were also included in the model estimations.", {"entities": []}], ["To make sure the treated group and control group are comparable, Propensity Score Match (PSM) was used to analysis the gender, age and severity of illness of the two groups.", {"entities": []}], ["The results indicate that an increase in yearly maximum reimbursement amount for outpatient visits could cause an increase in yearly total outpatient expenses for patients with type 2 diabetes mellitus.", {"entities": [[184, 201, "DISEASE"], [177, 201, "DISEASE"]]}], ["However, changes in outpatient reimbursement rates between 2010 and 2011 did not significantly affect the utilization of different types of health institution.", {"entities": []}], ["The reimbursement rates of village clinics should be substantially increased from the existing basis and the gap of reimbursement rates among different institutions should be further widened.", {"entities": []}], ["It is also important for village clinics to improve their services.", {"entities": []}], ["Moreover, measures to improve the quality of care and scope of services at lower-level healthcare institutions, and promote the health service utilization of rural women should be considered.", {"entities": []}], ["This study explored the effects of microRNA-19b (miR-19b) on airway remodeling, airway inflammation, and degree of oxidative stress in a mouse model of asthma.", {"entities": [[152, 158, "DISEASE"], [49, 56, "GENE"]]}], ["Bioinformatics analyses and dual luciferase reporter gene assays revealed that thymic stromal lymphopoietin ( TSLP ) is a direct target of miR-19b.", {"entities": [[110, 114, "GENE"], [139, 146, "GENE"]]}], ["An asthma model was established via ovalbumin (OVA) sensitization and challenge in 72 female BALB/c mice.", {"entities": [[3, 9, "DISEASE"]]}], ["Mice were then assigned to saline, OVA-sensitized, saline+miR-19b mimics, saline+anti-TSLP, OVA-sensitized+miR-19b mimics, OVA-sensitized+mimics scramble, OVA-sensitized+anti-TSLP, and OVA-sensitized+IgG2a groups.", {"entities": []}], ["Pathological morphology changes were detected through hematoxylin/eosin, Masson, and periodic acid-Schiff staining.", {"entities": []}], ["miR-19b was downregulated while TSLP and Stat3 were upregulated in the OVA-sensitized group compared with the saline group.", {"entities": [[0, 7, "GENE"], [32, 36, "GENE"], [41, 46, "GENE"]]}], ["Bronchoalveolar lavage fluid samples from OVA-sensitized mice showed increased total protein, IL-4, IL-5 and IL-6 levels, numbers of inflammatory cells, eosinophils, neutrophils, mononuclear macrophages and lymphocytes, and eosinophil% compared to controls.", {"entities": []}], ["Lung tissues from sensitized mice exhibited decreased superoxide dismutase activity and increased methane dicarboxylic aldehyde levels.", {"entities": []}], ["The effects of OVA sensitization were reversed in the OVA-sensitized+miR-19b mimics and OVA-sensitized+anti-TSLP groups.", {"entities": []}], ["These findings suggest miR-19b reduces airway remodeling, airway inflammation, and degree of oxidative stress by inhibiting Stat3 signaling through TSLP downregulation in a mouse asthma model.", {"entities": [[179, 185, "DISEASE"], [23, 30, "GENE"], [124, 129, "GENE"], [148, 152, "GENE"]]}], ["To determine factors associated with a serious outcome (hospital admission or severe outcome: critical care or death) and associated with illness caused by laboratory\u2010confirmed influenza, with a specific interest in low\u2010 and middle\u2010income countries ( LMIC ).", {"entities": [[177, 186, "DISEASE"]]}], ["Databases were searched on 11 March 2016 for reports of influenza and factors associated with mortality or morbidity in humans, with no language restrictions.", {"entities": [[56, 65, "DISEASE"]]}], ["Pooled risks were estimated using random\u2010effects models.", {"entities": []}], ["Despite the heterogeneity of results across studies, known risk factors for serious disease were associated with both hospital admission and severe outcomes (critical care and/or death).", {"entities": []}], ["In LMIC , but not in high income countries ( HIC ), pregnant women, people with HIV / AIDS and children < 5\u00a0years old (compared with older children) were at increased risk of a severe outcome.", {"entities": []}], ["Also, although all patients with neurological conditions were at higher risk of severe outcomes than those without, children were at higher risk than adults and children who lived in a LMIC were at significantly higher risk than those living in HIC .", {"entities": []}], ["Adults were more likely than children to suffer a severe outcome if they had diabetes or a hematologic condition, were obese or had liver disease.", {"entities": [[132, 145, "DISEASE"]]}], ["Asthma is a risk factor for hospital admission but not for severe outcomes.", {"entities": []}], ["Known risk factors for serious disease remain important predictors of hospital admission and severe outcomes with few differences between HIC and LMIC countries.", {"entities": []}], ["These differences likely reflect differences in health\u2010seeking behaviours and health services, but high heterogeneity between studies limits conclusions about the effect size.", {"entities": []}], ["Aberrant activation of the transcription factor NF- \u03ba B, as well as uncontrolled inflammation, has been linked to autoimmune diseases, development and progression of cancer, and neurological disorders like Alzheimer's disease.", {"entities": [[166, 172, "DISEASE"]]}], ["Reporter cell lines are a valuable state-of-the art tool for comparative analysis of in vitro drug screening.", {"entities": []}], ["However, a reporter cell line for the investigation of NF- \u03ba B-driven neuroinflammation has not been available.", {"entities": []}], ["Thus, we developed a stable neural NF- \u03ba B-reporter cell line to assess the potency of proinflammatory molecules and peptides, as well as anti-inflammatory pharmaceuticals.", {"entities": []}], ["We used lentivirus to transduce the glioma cell line U251-MG with a tandem NF- \u03ba B reporter construct containing GFP and firefly luciferase allowing an assessment of NF- \u03ba B activity via fluorescence microscopy, flow cytometry, and luminometry.", {"entities": []}], ["We observed a robust activation of NF- \u03ba B after exposure of the reporter cell line to tumour necrosis factor alpha (TNF \u03b1 ) and amyloid- \u03b2 peptide [1-42] as well as to LPS derived from Salmonella minnesota and Escherichia coli .", {"entities": [[117, 120, "GENE"]]}], ["Finally, we demonstrate that the U251-NF- \u03ba B-GFP-Luc reporter cells can be used for assessing the anti-inflammatory potential of pharmaceutical compounds using Bay11-7082 and IMD0354.", {"entities": []}], ["In summary, our newly generated cell line is a robust and cost-efficient tool to study pro- and anti-inflammatory potential of drugs and biologics in neural cells.", {"entities": []}], ["The present study aims to investigate and compare the diagnostic and prognostic value of cavernosography with 320-row dynamic volume computed tomography (DVCT) versus conventional cavernosography in men with erectile dysfunction (ED) caused by venous leakage.", {"entities": []}], ["A total of 174 patients diagnosed with ED were enrolled and received cavernosography with 320-row DVCT (DVCT group) and conventional cavernosography scans (control group) respectively.", {"entities": []}], ["The diagnosis, complications, and prognosis of patients were evaluated.", {"entities": []}], ["The DVCT group provided high-resolution images with less processing and testing time, as well as lowered radiological agent and contrast agent compared with the control group.", {"entities": []}], ["In the DVCT group, 89 patients who were diagnosed with venous ED had six various venous leakage, namely superficial venous leakage, profundus venous leakage, the mixed type, cavernosal venous leakage, crural venous leakage, and also venous leakage between the penis and urethra cavernosum (9, 21, 32, 6, 18, and 3 cases respectively).", {"entities": []}], ["Similarly, 74 patients out of the 81 who suffered from venous ED were classified to have superficial venous leakage (11), profundus venous leakage (14), the mixed type venous leakage (26), and middle venous leakage (23).", {"entities": []}], ["Six out of 25 patients in the DVCT group, had improvements in ED while the remaining 19 achieved full erectile function recovery with no penile fibrosis and erectile pain.", {"entities": []}], ["Cavernosography with 320-row DVCT is a reliable system that can be used to diagnose ED caused by venous leakage.", {"entities": []}], ["This is especially useful in accurately determining the type of venous and allows for a better prognosis and direction of treatment.", {"entities": []}], ["The aim of the bone metastases (BM) treatment is to prevent the occurrence of skeletal-related events (SREs).", {"entities": []}], ["In clinical, physicians could only predict the occurrence of SREs by subjective experience.", {"entities": []}], ["Machine learning (ML) could be used as predictive models in the medical field.", {"entities": []}], ["But there is no published research using ML to predict SREs in cancer patients with BM.", {"entities": [[63, 69, "DISEASE"]]}], ["The purpose of this study was to assess the associations of clinical variables with the occurrence of SREs and to subsequently develop prediction models to help identify SREs risk groups.", {"entities": []}], ["We analyzed 1143 cancer patients with BM.", {"entities": [[17, 23, "DISEASE"]]}], ["We used the statistical package of SPSS and SPSS Modeler for data analysis and the development of the prediction model.", {"entities": []}], ["We compared the performance of logistic regression (LR), decision tree (DT) and support vector machine(SVM).", {"entities": []}], ["The results suggested that Visual Analog Scale (VAS) scale was a key factor to SREs in LR, DT and SVM model.", {"entities": []}], ["Modifiable factors such as Frankel classification, Mirels score, Ca, aminoterminal propeptide of type I collagen (PINP) and bone-specific alkaline phosphatase (BALP) were identified.", {"entities": []}], ["We found that the result of applying LR, DT and SVM classification accuracy was 79.2%, 85.8% and 88.2%, with 9, 4 and 8 variables, respectively.", {"entities": []}], ["In conclusion, DT and SVM achieved higher accuracies with smaller number of variables than the number of variables used in LR.", {"entities": []}], ["ML techniques can be used to build model to predict SREs in cancer patients with BM.", {"entities": [[60, 66, "DISEASE"]]}], ["Obesity is frequently complicated by comorbid conditions, yet how excess adipose contributes is poorly understood.", {"entities": []}], ["Although adipocytes in obese individuals induce systemic inflammation via secreted cytokines, another potential mediator has recently been identified (i.e.", {"entities": []}], ["adipocyte-derived exosomes).", {"entities": []}], ["We hypothesized that adipocyte-derived exosomes contain mediators capable of activating end-organ inflammatory and fibrotic signaling pathways.", {"entities": []}], ["We developed techniques to quantify and characterize exosomes shed by adipocytes from 7 obese (age: 12\u201317.5 years, BMI: 33\u201350 kg/m Abundant exosomal miRNAs, but no mRNAs, were detected.", {"entities": []}], ["Comparison of obese vs. lean visceral adipose donors detected 55 differentially-expressed miRNAs (p<0.05; fold change\u2265|1.2|).", {"entities": []}], ["qRT-PCR confirmed downregulation of miR-148b (ratio = 0.2 [95% confidence interval = 0.1, 0.6]) and miR-4269 (0.3 [0.1, 0.8]), and upregulation of miR-23b (6.2 [2.2, 17.8]) and miR-4429 (3.8 [1.1 to 13.4]).", {"entities": [[36, 44, "GENE"], [147, 154, "GENE"]]}], ["Pathways analysis identified TGF-\u03b2 signaling and Wnt/ \u03b2-catenin signaling among the top canonical pathways expected to be altered with visceral adiposity based on projected mRNA targets for the 55 differentially expressed miRNAs.", {"entities": []}], ["A select mRNA target was validated in vitro .", {"entities": []}], ["These data show that visceral adipocytes shed exosomal-mediators predicted to regulate key end-organ inflammatory and fibrotic signaling pathways.", {"entities": []}], ["The vulnerability of clinical trials to volunteer bias is under-reported.", {"entities": []}], ["Volunteer bias is systematic error due to differences between those who choose to participate in studies and those who do not.", {"entities": []}], ["This paper extends the applications of the concept of volunteer bias by using data from a trial of probiotic supplementation for childhood atopy in healthy dyads to explore 1) differences between a) trial participants and aggregated data from publicly available databases b) participants and non-participants as the trial progressed 2) impact on trial findings of weighting data according to deprivation (Townsend) fifths in the sample and target populations.", {"entities": []}], ["1) a) Recruits (n\u200a=\u200a454) were less deprived than the target population, matched for area of residence and delivery dates (n\u200a=\u200a6,893) (mean [SD] deprivation scores 0.09[4.21] and 0.79[4.08], t\u200a=\u200a3.44, df\u200a=\u200a511, p<0.001).", {"entities": []}], ["b) i)As the trial progressed, representation of the most deprived decreased.", {"entities": []}], ["These participants and smokers were less likely to be retained at 6 months (n\u200a=\u200a430[95%]) (OR 0.29,0.13\u20130.67 and 0.20,0.09\u20130.46), and 2 years (n\u200a=\u200a380[84%]) (aOR 0.68,0.50\u20130.93 and 0.55,0.28\u20131.09), and consent to infant blood sample donation (n\u200a=\u200a220[48%]) (aOR 0.72,0.57\u20130.92 and 0.43,0.22\u20130.83).", {"entities": []}], ["ii)Mothers interested in probiotics or research or reporting infants\u2019 adverse events or rashes were more likely to attend research clinics and consent to skin-prick testing.", {"entities": []}], ["Mothers participating to help children were more likely to consent to infant blood sample donation.", {"entities": []}], ["2) In one trial outcome, atopic eczema, the intervention had a positive effect only in the over-represented, least deprived group.", {"entities": []}], ["Here, data weighting attenuated risk reduction from 6.9%(0.9\u201313.1%) to 4.6%(\u22121.4\u2013+10.5%), and OR from 0.40(0.18\u20130.91) to 0.56(0.26\u20131.21).", {"entities": []}], ["Other findings were unchanged.", {"entities": []}], ["Potential for volunteer bias intensified during the trial, due to non-participation of the most deprived and smokers.", {"entities": []}], ["However, these were not the only predictors of non-participation.", {"entities": []}], ["Data weighting quantified volunteer bias and modified one important trial outcome.", {"entities": []}], ["This randomised, double blind, parallel group, placebo controlled trial is registered with the International Standard Randomised Controlled Trials Register, Number (ISRCTN) 26287422.", {"entities": []}], ["Registered title: Probiotics in the prevention of atopy in infants and children.", {"entities": []}], ["The burden of non-communicable disease (NCDs) has grown rapidly in low- and middle-income countries (LMICs), where populations are ageing, with rising prevalence of multimorbidity (more than two co-existing chronic conditions) that will significantly increase pressure on already stretched health systems.", {"entities": []}], ["We assess the impact of NCD multimorbidity on healthcare utilisation and out-of-pocket expenditures in six middle-income countries: China, Ghana, India, Mexico, Russia and South Africa.", {"entities": []}], ["Secondary analyses of cross-sectional data from adult participants (>18 years) in the WHO Study on Global Ageing and Adult Health (SAGE) 2007\u20132010.", {"entities": []}], ["We used multiple logistic regression to determine socio-demographic correlates of multimorbidity.", {"entities": []}], ["Association between the number of NCDs and healthcare utilisation as well as out-of-pocket spending was assessed using logistic, negative binominal and log-linear models.", {"entities": []}], ["The prevalence of multimorbidity in the adult population varied from 3\u22199% in Ghana to 33\u22196% in Russia.", {"entities": []}], ["Number of visits to doctors in primary and secondary care rose substantially for persons with increasing numbers of co-existing NCDs.", {"entities": []}], ["Multimorbidity was associated with more outpatient visits in China (coefficient for number of NCD = 0\u221956, 95% CI = 0\u221946, 0\u221966), a higher likelihood of being hospitalised in India (AOR = 1\u221959, 95% CI = 1\u221945, 1\u221975), higher out-of-pocket expenditures for outpatient visits in India and China, and higher expenditures for hospital visits in Russia.", {"entities": []}], ["Medicines constituted the largest proportion of out-of-pocket expenditures in persons with multimorbidity (88\u22193% for outpatient, 55\u22199% for inpatient visit in China) in most countries.", {"entities": []}], ["Multimorbidity is associated with higher levels of healthcare utilisation and greater financial burden for individuals in middle-income countries.", {"entities": []}], ["Our study supports the WHO call for universal health insurance and health service coverage in LMICs, particularly for vulnerable groups such as the elderly with multimorbidity.", {"entities": []}], ["Common variable immunodeficiency (CVID) is one of the most common symptomatic primary immunodeficiency syndromes.", {"entities": []}], ["The purpose of this article was to broaden our knowledge about CVID for better diagnosis and treatment.", {"entities": []}], ["Clinical and immunological features of 40 Chinese patients with CVID were analyzed retrospectively.", {"entities": []}], ["The median age at onset was 11-year-old (range 4\u201351 years).", {"entities": []}], ["The median age at diagnosis was 14.5-year-old (range 5\u201366 years).", {"entities": []}], ["The average time of delay in diagnosis was 5.3 years (range 1\u201341 years).", {"entities": []}], ["The most common main complaint was fever due to infections (35 cases, 87.5%).", {"entities": []}], ["Pneumonia (28 cases, 70%) was the most common type of infections.", {"entities": []}], ["Bronchiectasis was present in 6 patients (15%).", {"entities": []}], ["Autoimmune disease was detected in 6 cases of CVID, and malignancy in 2 cases.", {"entities": []}], ["The median total serum levels of IgG, IgA, and IgM at diagnosis were 1.07 g/L, 0.07 g/L, and 0.28 g/L, respectively.", {"entities": []}], ["The percentages of CD3 Infection is the most frequent presentation of CVID.", {"entities": []}], ["Patients with unexplainable infections should receive further examination including serum immunoglobulin (Ig) and lymphocyte subset analysis.", {"entities": []}], ["Regular and sufficient substitution with Ig is recommended.", {"entities": []}], ["It is widely accepted that chronic inflammation plays an active role in cancer.", {"entities": [[72, 78, "DISEASE"]]}], ["Inflammatory immunocytes and related cytokines in the tumor microenvironment are supposed to be a \u201cdouble-edged sword\u201d in colorectal cancer (CRC) initiation and progression.", {"entities": [[122, 139, "DISEASE"], [133, 139, "DISEASE"]]}], ["Interleukin-17 (IL-17), a pleiotropic proinflammatory cytokine, can promote cancer-elicited inflammation and prevent cancer cells from immune surveillance.", {"entities": [[76, 82, "DISEASE"], [117, 123, "DISEASE"]]}], ["Despite controversy, IL-17 is generally considered to be a promoter in CRC progression.", {"entities": []}], ["In this review, we devote to summarize the current progress regarding the role of IL-17 in tumor initiation and progression, as well as the prognostic value in CRC.", {"entities": []}], ["It has been suggested that delayed intensive care unit (ICU) transfer is associated with increased mortality for patients with community-acquired pneumonia (CAP).", {"entities": [[146, 155, "DISEASE"]]}], ["However, ICU admission policies and patient epidemiology vary widely across the world depending on local hospital practices and organizational constraints.", {"entities": []}], ["We hypothesized that the time from the onset of CAP symptoms to invasive mechanical ventilation could be a relevant prognostic factor.", {"entities": []}], ["One hundred patients with a CAP and necessitating invasive mechanical ventilation were included.", {"entities": []}], ["Prospectively collected data were retrospectively analysed.", {"entities": []}], ["Two study groups were identified based on the time of the initiation of invasive mechanical ventilation (rapid respiratory failure requiring mechanical ventilation within 72 h of the onset of CAP and progressive respiratory failure requiring invasive mechanical ventilation 4 or more days after the onset of CAP).", {"entities": [[111, 130, "DISEASE"], [212, 231, "DISEASE"]]}], ["Excepting more COPD patients in the rapid respiratory failure group and more patients with diabetes in the progressive respiratory failure group, these patients had similar characteristics.", {"entities": [[42, 61, "DISEASE"], [119, 138, "DISEASE"]]}], ["The overall in-hospital mortality rate was 28% in the rapid respiratory failure group and 51% in the progressive respiratory failure group ( P \u200a=\u200a0.03).", {"entities": [[60, 79, "DISEASE"], [113, 132, "DISEASE"]]}], ["The ICU and the day 30 mortality rates were higher in the progressive respiratory failure group (47% vs. 23%, P \u200a=\u200a0.02; and 37.7% vs. 21.3%, P \u200a=\u200a0.03; respectively).", {"entities": [[70, 89, "DISEASE"]]}], ["After adjusting for the propensity score and other potential confounding factors, progressive respiratory failure remained associated with hospital mortality only after 12 days of invasive mechanical ventilation.", {"entities": [[94, 113, "DISEASE"]]}], ["This study suggested that the duration or delay in the time to intubation from the onset of CAP symptoms was associated with the outcomes in those patients who ultimately required invasive mechanical ventilation.", {"entities": []}], ["Objective .", {"entities": []}], ["The aim of the study was to assess adrenomedullin (AM) as a predictor for development of severe sepsis and septic shock in emergency department (ED).", {"entities": []}], ["From December 2011 to October 2012, 372 consecutive septic patients admitted to ED were enrolled.", {"entities": []}], ["AM was examined in every patient.", {"entities": []}], ["All patients were followed up for 3 days.", {"entities": []}], ["The outcome variable was development of severe sepsis or septic shock.", {"entities": []}], ["The predictive ability of AM was evaluated by binary logistic regression analysis and receiver operating characteristic (ROC) curve.", {"entities": []}], ["On admission, the differences of AM among patients with different comorbidities, infections, and culture results were not significant.", {"entities": []}], ["AM level was higher in patients who progressed than in who did not (41.63 \u00b1 6.55 versus 31.31 \u00b1 7.71\u2009ng/L, P < 0.001).", {"entities": []}], ["AM was the only independent predictor of outcome.", {"entities": []}], ["The area under ROC curve of AM was 0.847.", {"entities": []}], ["With a cutoff value of 41.24\u2009ng/L, the sensitivity was 67.6%, the specificity was 90.0%, the positive predictive value was 61.5%, the negative predictive value was 92.2%, the positive likelihood ratio was 6.78, and the negative likelihood ratio was 0.36.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Adrenomedullin is valuable for predicting development of severe sepsis and septic shock in ED.", {"entities": []}], ["Computer assisted telephone interviewing (CATI) is widely used for health surveys.", {"entities": []}], ["The advantages of CATI over face-to-face interviewing are timeliness and cost reduction to achieve the same sample size and geographical coverage.", {"entities": []}], ["Two major CATI sampling procedures are used: sampling directly from the electronic white pages (EWP) telephone directory and list assisted random digit dialling (LA-RDD) sampling.", {"entities": []}], ["EWP sampling covers telephone numbers of households listed in the printed white pages.", {"entities": []}], ["LA-RDD sampling has a better coverage of households than EWP sampling but is considered to be more expensive due to interviewers dialling more out-of-scope numbers.", {"entities": []}], ["This study compared an EWP sample and a LA-RDD sample from the New South Wales Population Health Survey in 2003 on demographic profiles, health estimates, coefficients of variation in weights, design effects on estimates, and cost effectiveness, on the basis of achieving the same level of precision of estimates.", {"entities": []}], ["The LA-RDD sample better represented the population than the EWP sample, with a coefficient of variation of weights of 1.03 for LA-RDD compared with 1.21 for EWP, and average design effects of 2.00 for LA-RDD compared with 2.38 for EWP.", {"entities": []}], ["Also, a LA-RDD sample can save up to 14.2% in cost compared to an EWP sample to achieve the same precision for health estimates.", {"entities": []}], ["A LA-RDD sample better represents the population, which potentially leads to reduced bias in health estimates, and rather than costing more than EWP actually costs less.", {"entities": []}], ["Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly in industrialized countries.", {"entities": [[76, 85, "DISEASE"], [12, 32, "DISEASE"]]}], ["The \u201cwet\u201d AMD, characterized by the development of choroidal neovacularization (CNV), could result in rapid and severe loss of central vision.", {"entities": []}], ["The critical role of vascular endothelial growth factor A (VEGF-A) in CNV development has been established and VEGF-A neutralization has become the standard care for wet AMD.", {"entities": []}], ["Recently, CCR3 was reported to play an important role in CNV development and that CCR3 targeting was reported to be superior to VEGF-A targeting in CNV suppression.", {"entities": [[10, 14, "GENE"], [82, 86, "GENE"], [10, 14, "GENE"], [82, 86, "GENE"]]}], ["We investigated the role of CCR3 in CNV development using the Matrigel induced CNV and found that in both rats and mice, CNV was well-developed in the control eyes as well as in eyes treated with CCR3 antagonist SB328437 or CCR3 neutralizing antibodies.", {"entities": [[28, 32, "GENE"], [196, 200, "GENE"], [224, 228, "GENE"], [28, 32, "GENE"], [196, 200, "GENE"], [224, 228, "GENE"], [28, 32, "GENE"], [196, 200, "GENE"], [224, 228, "GENE"]]}], ["No statistically significant difference in CNV areas was found between the control and SB328437 or CCR3-ab treated eyes.", {"entities": []}], ["Immunostaining showed no specific expression of CCR3 in or near CNV.", {"entities": [[48, 52, "GENE"]]}], ["In contrast, both VEGF-A neutralizing antibodies and rapamycin significantly suppressed CNV.", {"entities": []}], ["These results indicate that CCR3 plays no significant role in CNV development and question the therapeutic approach of CCR3 targeting to suppress CNV.", {"entities": [[28, 32, "GENE"], [119, 123, "GENE"], [28, 32, "GENE"], [119, 123, "GENE"]]}], ["On the other hand, our data support the therapeutic strategies of VEGF-A and mTOR (mammalian target of rapamycin) targeting for CNV.", {"entities": [[77, 81, "GENE"]]}], ["With the development of society along with an escalating population, the concerns regarding public health have cropped up.", {"entities": []}], ["The quality of air becomes primary concern regarding constant increase in the number of vehicles and industrial development.", {"entities": []}], ["With this concern, several indices have been proposed to indicate the pollutant concentrations.", {"entities": []}], ["In this paper, we present a mathematical framework to formulate a Cumulative Index (CI) on the basis of an individual concentration of four major pollutants (SO 2 , NO 2 , PM 2.5 , and PM 10 ).", {"entities": []}], ["Further, a supervised learning algorithm based classifier is proposed.", {"entities": []}], ["This classifier employs support vector machine (SVM) to classify air quality into two types, that is, good or harmful.", {"entities": []}], ["The potential inputs for this classifier are the calculated values of CIs.", {"entities": []}], ["The efficacy of the classifier is tested on the real data of three locations: Kolkata, Delhi, and Bhopal.", {"entities": []}], ["It is observed that the classifier performs well to classify the quality of air.", {"entities": []}], ["This study intended to search for potential correlations between anaemia in patients with severe chronic obstructive pulmonary disease (COPD; GOLD stage III) and pulmonary function at rest, exercise capacity as well as ventilatory efficiency, using pulmonary function test (PFT) and cardiopulmonary exercise testing (CPET).", {"entities": [[97, 134, "DISEASE"]]}], ["The study was undertaken at Shanghai Pulmonary Hospital, a tertiary-level centre affiliated to Tongji University.", {"entities": []}], ["It caters to a large population base within Shanghai and referrals from centres in other cities as well.", {"entities": []}], ["157 Chinese patients with stable severe COPD were divided into 2 groups: the anaemia group (haemoglobin (Hb) <12.0\u2005g/dL for males, and <11\u2005g/dL for females (n=48)) and the non-anaemia group (n=109).", {"entities": []}], ["Arterial blood gas, PFT and CPET were tested in all patients.", {"entities": []}], ["(1) Diffusing capacity for carbon monoxide (DLCO) corrected by Hb was significantly lower in the anaemia group ((15.3\u00b11.9) mL/min/mm\u2005Hg) than in the non-anaemia group ((17.1\u00b12.1) mL/min/mm\u2005Hg) (p<0.05).", {"entities": []}], ["A significant difference did not exist in the level of forced expiratory volume in 1\u2005s (FEV 1 ), FEV 1 %pred, FEV 1 /forced vital capacity (FVC), inspiratory capacity (IC), residual volume (RV), total lung capacity (TLC) and RV/TLC (p>0.05).", {"entities": [[88, 91, "GENE"], [97, 100, "GENE"], [110, 113, "GENE"], [88, 91, "GENE"], [97, 100, "GENE"], [110, 113, "GENE"], [88, 91, "GENE"], [97, 100, "GENE"], [110, 113, "GENE"]]}], ["(2) Peak Load, Peak oxygen uptake ( ), Peak %pred, Peak , Peak pulse and the ratio of increase to WR increase ( ) were significantly lower in the anaemia group (p<0.05); however, Peak minute ventilation (VE), Lowest /carbon dioxide output ( ) and Peak dead space/tidal volume ratio (VD/VT) were similar between the 2 groups (p>0.05).", {"entities": []}], ["(3) A strong positive correlation was found between Hb concentration and Peak in patients with anaemia (r=0.702, p<0.01).", {"entities": []}], ["Anaemia has a negative impact on gas exchange and exercise tolerance during exercise in patients with severe COPD.", {"entities": []}], ["The decrease in amplitude of Hb levels is related to the quantity of oxygen uptake.", {"entities": []}], ["The common cold, the most prevalent contagious viral disease in humans still lacks a safe and effective antiviral treatment.", {"entities": [[4, 15, "DISEASE"]]}], ["Iota-Carrageenan is broadly active against respiratory viruses in-vitro and has an excellent safety profile.", {"entities": []}], ["This study investigated the efficacy and safety of an Iota-Carrageenan nasal spray in patients with common cold symptoms.", {"entities": [[100, 111, "DISEASE"]]}], ["In a randomized, double-blind, placebo-controlled exploratory trial, 35 human subjects suffering from early symptoms of common cold received Iota-Carrageenan (0.12%) in a saline solution three times daily for 4 days, compared to placebo.", {"entities": [[120, 131, "DISEASE"]]}], ["Administration of Iota-Carrageenan nasal spray reduced the symptoms of common cold (p = 0.046) and the viral load in nasal lavages (p = 0.009) in patients with early symptoms of common cold.", {"entities": [[71, 82, "DISEASE"], [178, 189, "DISEASE"]]}], ["Pro-inflammatory mediators FGF-2, Fractalkine, GRO, G-CSF, IL-8, IL-1\u03b1, IP-10, IL-10, and IFN-\u03b12 were reduced in the Iota-Carrageenan group.", {"entities": []}], ["Iota-Carrageenan nasal spray appears to be a promising treatment for safe and effective treatment of early symptoms of common cold.", {"entities": [[119, 130, "DISEASE"]]}], ["Larger trials are indicated to confirm the results.", {"entities": []}], ["An urge of biomarker identification is needed to better monitor lupus nephritis (LN) disease activity, guide clinical treatment, and predict patient's long-term outcome.", {"entities": [[70, 79, "DISEASE"]]}], ["With the proinflammatory effect and its association with inflammasomes, the significance of interleukin-18 (IL-18) among pediatric-onset systemic lupus erythematous (pSLE) patient, especially, its importance in predicting long-term renal outcome was investigated.", {"entities": []}], ["In a pSLE cohort of 96 patients with an average follow-up period of 10.39\u200a\u00b1\u200a3.31 years, clinical data and laboratory workups including serum IL-18 were collected at time of disease onset and 6 months after treatment despite their initial renal status.", {"entities": []}], ["Through Cox regression analysis, the parameters at baseline and at 6 months posttreatment were carefully analyzed.", {"entities": []}], ["Average age of all cases was 12.74\u200a\u00b1\u200a3.01 years old and 65 of them underwent renal biopsy at the time of diagnosis.", {"entities": []}], ["Nine subjects (9.38%) progressed to end-stage renal disease (ESRD) and 2 cases (2.08%) died during follow-up.", {"entities": []}], ["Through multivariate analysis, serum IL-18 level 6 months posttreatment was found to be the most unfavorable factor associating poor clinical outcome despite patient's initial renal status.", {"entities": []}], ["In addition, the presentation of serum IL-18 in its correlation with SLE global disease activity as well as the presence and severity of LN were all significant ( P \u200a<\u200a0.001, P \u200a=\u200a0.03, and P \u200a=\u200a0.02, respectively).", {"entities": []}], ["The histological classification of LN, however, was not associated with the level of IL-18 among the pSLE patients ( P \u200a=\u200a0.64).", {"entities": []}], ["The role of serum IL-18 as biomarker representing global disease activity and status of renal flares among pSLE population was shown for the first time.", {"entities": []}], ["Additionally, we have identified IL-18 at 6 months posttreatment a novel marker for long-term renal outcome prediction.", {"entities": []}], ["Inhaled umeclidinium (UMEC) and the combination of inhaled UMEC with vilanterol (UMEC/VI) are approved maintenance treatments for chronic obstructive pulmonary disease in the US and EU.", {"entities": [[130, 167, "DISEASE"]]}], ["This was a randomized, open-label, three-period crossover, single- and repeat-dose study to assess the pharmacokinetics (PK), safety, and tolerability of inhaled UMEC/VI 62.5/25 \u03bcg (delivering 55/22 \u03bcg) and UMEC/VI 125/25 \u03bcg (delivering 113/22 \u03bcg) compared with their monotherapy components (UMEC 62.5 \u03bcg, UMEC 125 \u03bcg and, VI 25 \u03bcg [delivering 55, 113, and 22 \u03bcg, respectively]) in healthy Chinese subjects (n=20).", {"entities": []}], ["UMEC and VI were rapidly absorbed following single and repeat dosing (time to maximum plasma concentration [t max ]: UMEC = 5 min; VI = 5 min).", {"entities": [[110, 113, "GENE"]]}], ["The median t last was 2\u20134 h for UMEC and 1\u20132 h for VI following single doses of UMEC/VI and UMEC monotherapy (both doses).", {"entities": []}], ["UMEC reached steady-state prior to Day 10; steady-state for VI could not be assessed.", {"entities": []}], ["UMEC accumulation following repeat dosing was 11\u201334% based on C max and 19\u201359% based on area under the concentration-time curve from time zero to 2 h (AUC (0-2) ).", {"entities": [[64, 67, "GENE"]]}], ["VI accumulation following repeat dosing was 25\u201366% based on C max and 17\u201343% based on AUC (0-2) .", {"entities": [[62, 65, "GENE"]]}], ["The evidence was not sufficient to suggest that systemic exposure was substantially different between UMEC/VI combination therapy and the constituent monotherapies following single or repeat dosing.", {"entities": []}], ["Following both single- and repeat-dose administration, the inter-subject coefficient of variation for all UMEC PK parameter estimates ranged from 12% to 165% for all treatments, indicating a wide range of variability in inhaled PK parameters.", {"entities": []}], ["Twelve subjects experienced \u22651 adverse event (AE).", {"entities": []}], ["Six subjects experienced \u22651 treatment-related AE; the most commonly reported treatment-related AE was chest discomfort (n=3 [15%]).", {"entities": []}], ["No clinically important changes in vital signs or electrocardiogram parameters were reported.", {"entities": []}], ["These data suggest that single- and repeat-dose administration of UMEC/VI combination therapy in healthy Chinese subjects did not result in substantial differences in systemic exposure compared with UMEC and VI as monotherapies.", {"entities": []}], ["Clinicaltrials.gov NCT01899638 NCT01899638", {"entities": []}], ["To investigate the impact in an aging society of the 2011 Great East Japan earthquake on hospitalisation for respiratory disease at the disaster base hospital.", {"entities": []}], ["Descriptive and cross-sectional study.", {"entities": []}], ["Emergency care in Japanese Red Cross Ishinomaki Hospital, a regional disaster base hospital in Miyagi, Japan.", {"entities": []}], ["322 emergency patients who were hospitalised for respiratory disease from 11 March to 9 May 2011, and 99 and 105 emergency patients who were hospitalised in the corresponding periods in 2009 and 2010, respectively.", {"entities": []}], ["Description and comparison of patient characteristics and disease distribution in terms of age, time after the disaster and activities of daily living (ADL).", {"entities": []}], ["1769 patients were admitted to our hospital during the study period (compared to 850 in 2009 and 1030 in 2010), among whom 322 were hospitalised for respiratory disease (compared to 99 in 2009 and 105 in 2010).", {"entities": []}], ["Pneumonia (n=190, 59.0%) was the most frequent cause of admission for pulmonary disease, followed by acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) (n=53, 16.5%), asthma attacks (n=27, 8.4%) and progression of lung cancer (n=22, 6.8%).", {"entities": [[233, 244, "DISEASE"], [0, 9, "DISEASE"], [123, 160, "DISEASE"], [186, 192, "DISEASE"], [238, 244, "DISEASE"]]}], ["Compared with the corresponding periods in 2009 and 2010, the increase in the absolute numbers of admissions was highest for pneumonia, followed by AE-COPD and asthma attacks.", {"entities": [[125, 134, "DISEASE"], [160, 166, "DISEASE"]]}], ["At hospitalisation, 195 patients were \u2018dependent\u2019 and 54 patients were \u2018partially dependent\u2019.", {"entities": []}], ["Respiratory admissions accompanied by deterioration of ADL after the disaster were more frequent in elderly and female patients.", {"entities": []}], ["After the Great East Japan Earthquake, admissions for pneumonia and exacerbation of chronic respiratory disease in the elderly increased at the disaster base hospital.", {"entities": [[54, 63, "DISEASE"]]}], ["Asthma exacerbations are frequent in patients with severe disease.", {"entities": [[0, 6, "DISEASE"]]}], ["This report describes results from two retrospective cohort studies describing exacerbation frequency and risk, emergency department (ED)/hospital re-admissions, and asthma-related costs by asthma severity in the US and UK.", {"entities": [[166, 172, "DISEASE"], [190, 196, "DISEASE"]]}], ["Patients with asthma in the US-based Clinformatics\u2122 DataMart Multiplan IMPACT (2010\u20132011; WEUSKOP7048) and the UK-based Clinical Practice Research Datalink (2009\u20132011; WEUSKOP7092) databases were categorized by disease severity (Global Initiative for Asthma [GINA]; Step and exacerbation history) during the 12\u00a0months pre-asthma medical code (index date).", {"entities": [[14, 20, "DISEASE"], [251, 257, "DISEASE"], [322, 328, "DISEASE"]]}], ["Outcomes included: frequency of exacerbations (asthma-related ED visit, hospitalization, or oral corticosteroid use with an asthma medical code recorded within \u00b12\u00a0weeks) 12\u00a0months post-index, asthma-related ED visits/hospitalization, and asthma-related costs 30\u00a0days post-index.", {"entities": [[47, 53, "DISEASE"], [124, 130, "DISEASE"], [192, 198, "DISEASE"], [238, 244, "DISEASE"]]}], ["Risk of a subsequent exacerbation was determined by proportional hazard model.", {"entities": []}], ["Of the 222,817 and 211,807 patients with asthma included from the US and UK databases, respectively, 12.5 and 8.4% experienced \u22651 exacerbation during the follow-up period.", {"entities": [[41, 47, "DISEASE"]]}], ["Exacerbation frequency increased with disease severity.", {"entities": []}], ["Among the 5,167 and 2,904 patients with an asthma-related ED visit/hospitalization in the US and UK databases, respectively, 9.2 and 4.7% had asthma-related re-admissions within 30\u00a0days.", {"entities": [[43, 49, "DISEASE"], [142, 148, "DISEASE"]]}], ["Asthma-related re-admission rates and costs increased with disease severity, approximately doubling between GINA Step 1 and 5 and in patients with \u22652 versus <2 exacerbations in the previous year.", {"entities": [[0, 6, "DISEASE"]]}], ["Risk of a subsequent exacerbation increased 32\u201335% for an exacerbation requiring ED visit/hospitalization versus oral corticosteroids.", {"entities": []}], ["Increased disease severity was associated with higher exacerbation frequency, ED/hospitalization re-admission, costs and risk of subsequent exacerbation, indicating that these patients require high-intensity post-exacerbation management.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-017-0409-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In patients with epilepsy, poor adherence to anti-epileptic drugs has been shown to be the most important cause of poorly controlled epilepsy.", {"entities": []}], ["Furthermore, it has been noted that the quality of life among patients with epilepsy can be improved by counseling and treatments aimed at increasing their self-efficacy and concordance, thus stimulating self-management skills.", {"entities": []}], ["However, there is a need for evidence on the effectiveness of such programs, especially within epilepsy care.", {"entities": []}], ["Therefore, we have developed a multi-component intervention (MCI) which combines a self-management/education program with e-Health interventions.", {"entities": []}], ["Accordingly, the overall objective of this study is to assess the (cost)-effectiveness and feasibility of the MCI, aiming to improve self-efficacy and concordance in patients with epilepsy.", {"entities": []}], ["A RCT in two parallel groups will be conducted to compare the MCI with a control condition in epilepsy patients.", {"entities": []}], ["One hundred eligible epilepsy patients will be recruited and allocated to either the intervention or control group.", {"entities": []}], ["The intervention group will receive the MCI consisting of a self-management/education program of six meetings, including e-Health interventions, and will be followed for 12 months.", {"entities": []}], ["The control group will receive care as usual and will be followed for 6 months, after which patients will be offered the possibility of participating in the MCI.", {"entities": []}], ["The study will consist of three parts: 1) a clinical effectiveness study, 2) a cost-effectiveness study, and 3) process evaluation.", {"entities": []}], ["The primary outcome will be self-efficacy.", {"entities": []}], ["Secondary outcomes include adherence, side effects, change in seizure severity & frequency, improved quality of life, proactive coping, and societal costs.", {"entities": []}], ["Outcome assessments will be done using questionnaires at baseline and after 3, 6, 9, and 12 months (last two applicable only for intervention group).", {"entities": []}], ["In times of budget constraints, MCI could be a valuable addition to the current healthcare provision for epilepsy, as it is expected that higher concordance and self-efficacy will result in reduced use of healthcare resources and an increased QOL.", {"entities": []}], ["Accordingly, this study is aimed helping patients to be their own provider of health care, shifting epilepsy management from professionals to self-care by patients equipped with appropriate skills and tools.", {"entities": []}], ["Background: The evidence on the health effects related to residing close to landfills is controversial.", {"entities": []}], ["Nine landfills for municipal waste have been operating in the Lazio region (Central Italy) for several decades.", {"entities": []}], ["We evaluated the potential health effects associated with contamination from landfills using the estimated concentration of hydrogen sulphide (H 2 S) as exposure.", {"entities": []}], ["Methods : A cohort of residents within 5\u2009km of landfills was enrolled (subjects resident on 1 January 1996 and those who subsequently moved into the areas until 2008) and followed for mortality and hospitalizations until 31 December 2012.", {"entities": []}], ["Assessment of exposure to the landfill (H 2 S as a tracer) was performed for each subject at enrolment, using a Lagrangian dispersion model.", {"entities": []}], ["Information on several confounders was available (gender, age, socioeconomic position, outdoor PM 10 concentration, and distance from busy roads and industries).", {"entities": []}], ["Cox regression analysis was performed [Hazard Ratios (HRs), 95% confidence intervals (CIs)].", {"entities": []}], ["Results: The cohort included 242\u00a0409 individuals.", {"entities": []}], ["H 2 S exposure was associated with mortality from lung cancer and respiratory diseases (e.g.", {"entities": [[50, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["HR for increment of 1\u2009ng/m 2 S: 1.10, 95% CI 1.02\u20131.19; HR 1.09, 95% CI 1.00\u20131.19, respectively).", {"entities": [[0, 2, "GENE"], [56, 58, "GENE"], [0, 2, "GENE"], [56, 58, "GENE"]]}], ["There were also associations between H 2 S and hospitalization for respiratory diseases (HR\u2009=\u20091.02, 95% CI 1.00\u20131.03), especially acute respiratory infections among children (0\u201314 years) (HR\u2009=\u20091.06, 95% CI 1.02\u20131.11).", {"entities": [[89, 91, "GENE"], [188, 190, "GENE"], [89, 91, "GENE"], [188, 190, "GENE"]]}], ["Conclusions: Exposure to H 2 S, a tracer of airborne contamination from landfills, was associated with lung cancer mortality as well as with mortality and morbidity for respiratory diseases.", {"entities": [[103, 114, "DISEASE"], [108, 114, "DISEASE"]]}], ["The link with respiratory disease is plausible and coherent with previous studies, whereas the association with lung cancer deserves confirmation.", {"entities": [[112, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["The superior temporal gyrus (STG), which encompasses the primary auditory cortex, is believed to be a major anatomical substrate for speech, language and communication.", {"entities": []}], ["The STG connects to the limbic system (hippocampus and amygdala), the thalamus and neocortical association areas in the prefrontal cortex, all of which have been implicated in schizophrenia.", {"entities": [[176, 189, "DISEASE"]]}], ["To identify altered mRNA expression in the superior temporal gyrus (STG) in schizophrenia, oligonucleotide microarrays were used with RNA from postmortem STG tissue from 7 individuals with schizophrenia and 7 matched non-psychiatric controls.", {"entities": [[76, 89, "DISEASE"], [189, 202, "DISEASE"]]}], ["Overall, there was a trend towards down-regulation in gene expression, and altered expression of genes involved in neurotransmission, neurodevelopment, and presynaptic function was identified.", {"entities": []}], ["To confirm altered expression identified by microarray analysis, the mRNA expression levels of four genes, IPLA2\u03b3, PIK31R1, Lin-7b and ATBF1, were semi-quantitatively measured using relative real-time PCR.", {"entities": []}], ["A number of genes with altered expression in the STG were also shown to have similar changes in expression as shown in our previous study of peripheral blood lymphocytes in schizophrenia.", {"entities": [[173, 186, "DISEASE"]]}], ["This study has identified altered expression of genes in the STG involved in neurotransmission and neurodevelopment, and to a lesser extent presynaptic function, which further support the notion of these functions playing an integral role in the development of schizophrenia.", {"entities": [[261, 274, "DISEASE"]]}], ["Coronary angiography and heart catheterization are invaluable tests for the detection and quantification of coronary artery disease, identification of valvular and other structural abnormalities, and measurement of hemodynamic parameters.", {"entities": []}], ["The risks and complications associated with these procedures relate to the patient\u2019s concomitant conditions and to the skill and judgment of the operator.", {"entities": []}], ["In this review, we examine in detail the major complications associated with invasive cardiac procedures and provide the reader with a comprehensive bibliography for advanced reading.", {"entities": []}], ["Rho family GTPases are critical regulators of the cytoskeleton and affect cell migration, cell-cell adhesion, and cell-matrix adhesion.", {"entities": []}], ["As with all GTPases, their activity is determined by their guanine nucleotide-bound state.", {"entities": []}], ["Understanding how Rho proteins are activated and inactivated has largely focused on regulatory proteins such as guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs).", {"entities": []}], ["However, recent in vitro studies have indicated that GTPases may also be directly regulated by redox agents.", {"entities": []}], ["We hypothesized that this redox-based mechanism occurs in cells and affects cytoskeletal dynamics, and in this report we conclude this is indeed a novel mechanism of regulating the GTPase RhoA.", {"entities": [[188, 192, "GENE"]]}], ["In this report, we show that RhoA can be directly activated by reactive oxygen species (ROS) in cells, and that this requires two critical cysteine residues located in a unique redox-sensitive motif within the phosphoryl binding loop.", {"entities": [[29, 33, "GENE"]]}], ["First, we show that ROS can reversibly activate RhoA and induce stress fiber formation, a well characterized readout of RhoA activity.", {"entities": [[48, 52, "GENE"], [120, 124, "GENE"], [48, 52, "GENE"], [120, 124, "GENE"]]}], ["To determine the role of cysteine residues in this mechanism of regulation, we generated cysteine to alanine RhoA mutants.", {"entities": [[109, 113, "GENE"]]}], ["Mutation of these cysteines abolishes ROS-mediated activation and stress fiber formation, indicating that these residues are critical for redox-regulation of RhoA.", {"entities": [[158, 162, "GENE"]]}], ["Importantly, these mutants maintain the ability to be activated by GEFs.", {"entities": []}], ["Our findings identify a novel mechanism for the regulation of RhoA in cells by ROS, which is independent of classical regulatory proteins.", {"entities": [[62, 66, "GENE"]]}], ["This mechanism of regulation may be particularly relevant in pathological conditions where ROS are generated and the cellular redox-balance altered, such as in asthma and ischemia-reperfusion injury.", {"entities": [[171, 179, "DISEASE"], [160, 166, "DISEASE"]]}], ["Renal transplantation is the best treatment for kidney failure, in terms of length and quality of life and cost-effectiveness.", {"entities": [[48, 62, "DISEASE"]]}], ["However, most transplants fail after 10 to 12 years, consigning patients back onto dialysis.", {"entities": []}], ["Damage by the immune system accounts for approximately 50% of failing transplants and it is possible to identify patients at risk by screening for the presence of antibodies against human leukocyte antigens.", {"entities": []}], ["However, it is not clear how best to treat patients with antibodies.", {"entities": []}], ["This trial will test a combined screening and treatment protocol in renal transplant recipients.", {"entities": []}], ["Recipients >1 year post-transplantation, aged 18 to 70 with an estimated glomerular filtration rate >30 mL/min will be randomly allocated to blinded or unblinded screening arms, before being screened for the presence of antibodies.", {"entities": []}], ["In the unblinded arm, test results will be revealed.", {"entities": []}], ["Those with antibodies will have biomarker-led care, consisting of a change in their anti-rejection drugs to prednisone, tacrolimus and mycophenolate mofetil.", {"entities": []}], ["In the blinded arm, screening results will be double blinded and all recruits will remain on current therapy (standard care).", {"entities": []}], ["In both arms, those without antibodies will be retested every 8 months for 3 years.", {"entities": []}], ["The primary outcome is the 3-year kidney failure rate for the antibody-positive recruits, as measured by initiation of long-term dialysis or re-transplantation, predicted to be approximately 20% in the standard care group but <10% in biomarker-led care.", {"entities": [[34, 48, "DISEASE"]]}], ["The secondary outcomes include the rate of transplant dysfunction, incidence of infection, cancer and diabetes mellitus, an analysis of adherence with medication and a health economic analysis of the combined screening and treatment protocol.", {"entities": [[91, 97, "DISEASE"], [102, 119, "DISEASE"]]}], ["Blood samples will be collected and stored every 4 months and will form the basis of separately funded studies to identify new biomarkers associated with the outcomes.", {"entities": []}], ["We have evidence that the biomarker-led care regime will be effective at preventing graft dysfunction and expect this to feed through to graft survival.", {"entities": []}], ["This trial will confirm the benefit of routine screening and lead to a greater understanding of how to keep kidney transplants working longer.", {"entities": []}], ["Current Controlled Trials ISRCTN46157828 .", {"entities": []}], ["FLG null variants of which 2282del4 and R501X are the most frequent in Caucasians are established risk factors for atopic dermatitis (AD) with an effect probably mediated through impairment of epidermal barrier.", {"entities": [[115, 132, "DISEASE"], [122, 132, "DISEASE"], [0, 3, "GENE"]]}], ["Among subjects with AD FLG defects are also consistently associated with asthma and allergic rhinitis (AR) but it is less clear to what extent these associations are also present independently from skin disease.", {"entities": [[84, 101, "DISEASE"], [93, 101, "DISEASE"], [73, 79, "DISEASE"], [198, 210, "DISEASE"], [23, 26, "GENE"]]}], ["The aim of the present study was to evaluate the role of 2282del4 and R501X in predisposing to these allergic phenotypes in a Polish population.", {"entities": []}], ["2282del4 and R501X were typed among 3,802 participants of the Epidemiology of Allergic Diseases in Poland (ECAP) survey, a cross-sectional population-based study using ECRHS II and ISAAC questionnaires, and ambulatory examination.", {"entities": []}], ["The FLG null variants were associated with AD (OR\u200a=\u200a2.01, CI: 1.20\u20133.36, P\u200a=\u200a0.007), allergic rhinitis (in particular persistent form, OR\u200a=\u200a1.69, CI:1.12\u20132.54, P\u200a=\u200a0.011), and asthma (in particular atopic asthma, OR\u200a=\u200a2.22, CI:1.24\u20133.96, P\u200a=\u200a0.006).", {"entities": [[85, 102, "DISEASE"], [94, 102, "DISEASE"], [176, 182, "DISEASE"], [205, 211, "DISEASE"], [4, 7, "GENE"]]}], ["Association with atopic asthma (but not persistent allergic rhinitis) was also present in the absence of AD, (OR\u200a=\u200a2.02, CI: 1.07\u20133.81, P\u200a=\u200a0.027) as well as in the absence of AD and history of broadly defined inflammatory skin disease (OR\u200a=\u200a2.30, CI: 1.07\u20134.93, P\u200a=\u200a0.03).", {"entities": [[51, 68, "DISEASE"], [60, 68, "DISEASE"], [24, 30, "DISEASE"], [223, 235, "DISEASE"]]}], ["Association to atopic asthma would have not been found if diagnosis was made by questionnaire only (OR\u200a=\u200a1.15, CI: 0.58\u20132.32, P\u200a=\u200a0.8).", {"entities": [[22, 28, "DISEASE"]]}], ["We did not observe an association between FLG variants and allergic sensitizations (P\u200a=\u200a0.8) or total IgE.", {"entities": [[42, 45, "GENE"]]}], ["In a Polish population FLG 2282del4 and R501X carriage increases risk for development of AD and atopic asthma (also in the absence of AD or history thereof).", {"entities": [[103, 109, "DISEASE"], [23, 26, "GENE"]]}], ["This suggests that interventions aimed at restoring epidermal barrier may have a general role in asthma prophylaxis/treatment.", {"entities": [[97, 103, "DISEASE"]]}], ["The RAS pathway is central to epidermal homeostasis, and its activation in tumors or in Rasopathies correlates with hyperproliferation.", {"entities": []}], ["Downstream of RAS, RAF kinases are actionable targets regulating keratinocyte turnover; however, chemical RAF inhibitors paradoxically activate the pathway, promoting epidermal proliferation.", {"entities": []}], ["We generated mice with compound epidermis-restricted BRAF/RAF1 ablation.", {"entities": []}], ["In these animals, transient barrier defects and production of chemokines and Th2-type cytokines by keratinocytes cause a disease akin to human atopic dermatitis, characterized by IgE responses and local and systemic inflammation.", {"entities": [[143, 160, "DISEASE"], [150, 160, "DISEASE"]]}], ["Mechanistically, BRAF and RAF1 operate independently to balance MAPK signaling: BRAF promotes ERK activation, while RAF1 dims stress kinase activation.", {"entities": [[17, 21, "GENE"], [80, 84, "GENE"], [26, 30, "GENE"], [116, 120, "GENE"], [17, 21, "GENE"], [80, 84, "GENE"], [26, 30, "GENE"], [116, 120, "GENE"]]}], ["In vivo, JNK inhibition prevents disease onset, while MEK/ERK inhibition in mice lacking epidermal RAF1 phenocopies it.", {"entities": [[99, 103, "GENE"]]}], ["These results support a primary role of keratinocytes in the pathogenesis of atopic dermatitis, and the animals lacking BRAF and RAF1 in the epidermis represent a useful model for this disease.", {"entities": [[77, 94, "DISEASE"], [84, 94, "DISEASE"], [120, 124, "GENE"], [129, 133, "GENE"]]}], ["DOI: http://dx.doi.org/10.7554/eLife.14012.001 The skin is the largest organ of the body and shields it from damage.", {"entities": []}], ["It is also home to cells of the immune system, which protect the body from infections.", {"entities": []}], ["To maintain its role as a barrier, the skin regenerates throughout life, constantly producing new cells to replace the old ones.", {"entities": []}], ["If this process goes wrong and the skin regenerates too much, the skin may produce tumors.", {"entities": []}], ["Likewise, disrupting the immune barrier can lead to autoimmune or allergic skin diseases such as psoriasis or atopic dermatitis (also known as eczema).", {"entities": [[97, 106, "DISEASE"], [110, 127, "DISEASE"], [117, 127, "DISEASE"]]}], ["The outer layer of the skin is called the epidermis, and is made up of cells known as keratinocytes.", {"entities": []}], ["A family of proteins called RAF plays an important role in controlling how keratinocytes behave.", {"entities": []}], ["These proteins are part of a signaling pathway that controls the production of new cells and is disrupted in skin tumors.", {"entities": []}], ["Therapies that inhibit RAF are effective treatments for these tumors but have side effects that can affect the skin so severely that the treatment must be interrupted.", {"entities": []}], ["Keratinocytes also play a role in the development of allergic skin diseases.", {"entities": []}], ["However, it is not known whether they do so by triggering the disease themselves, or by responding to stimuli produced by immune cells.", {"entities": []}], ["Raguz et al.", {"entities": []}], ["investigated what would happen if RAF proteins were removed from keratinocytes in the epidermis of mice.", {"entities": []}], ["This caused the mice to develop an allergic disease similar to human atopic dermatitis.", {"entities": [[69, 86, "DISEASE"], [76, 86, "DISEASE"]]}], ["This was an unexpected effect and different from the side effects caused by drugs that inhibit RAF proteins.", {"entities": []}], ["By analyzing the signaling pathway that RAF is part of, Raguz et al.", {"entities": []}], ["discovered that removing RAF from the epidermis reduces the pathway\u2019s ability to prevent excessive stress signals being sent throughout the skin.", {"entities": []}], ["Under these conditions, the keratinocytes bring about inflammation and allergy by activating the immune cells in the skin and elsewhere.", {"entities": []}], ["Overall, the results presented by Raguz et al.", {"entities": []}], ["indicate that allergic dermatitis can be triggered by defects in keratinocytes rather than in immune cells.", {"entities": [[23, 33, "DISEASE"]]}], ["Furthermore, RAF in the epidermis appears to prevent allergic skin diseases.", {"entities": []}], ["Future studies could use mice that lack RAF in their epidermis to further understand atopic dermatitis and to investigate the way in which drugs that target RAF can damage the skin.", {"entities": [[85, 102, "DISEASE"], [92, 102, "DISEASE"]]}], ["DOI: http://dx.doi.org/10.7554/eLife.14012.002", {"entities": []}], ["Ammonium persulfate (APS), a low molecular weight chemical compound with strong oxidizing properties, should to be totally removed during preparation of nanomaterials due to its cytotoxicity.", {"entities": []}], ["APS exerts its oxidative stress effects mainly on cell membrane, but its intracellular influence remains unclear.", {"entities": []}], ["Here, we designed a facile negatively-charged carboxylic gelatin-methyacrylate (carbox-GelMA) nanoparticle (NP) as a cargo-carrier through the catalytic and oxidizing action of APS in W/O system.", {"entities": []}], ["The formed APS-loaded carbox-GelMA NPs (APS/NPs) were transported into the lysosome in MCF-7 breast cancer cells.", {"entities": [[93, 106, "DISEASE"], [100, 106, "DISEASE"], [35, 38, "GENE"], [44, 47, "GENE"]]}], ["The intracellular APS/NPs produced a high level of oxidative stress in lysosome and induced epithelial-mesenchymal transition (EMT).", {"entities": []}], ["Consequently, the MCF-7 cells challenged with APS/NPs had a strong metastatic and invasive capability in vitro and in vivo .", {"entities": []}], ["This study highlights that a facile APS-loaded nanocarrier has cyctotoxicity on cells through EMT.", {"entities": []}], ["Unexpectedly, we found a novel pathway inducing EMT via lysosomal oxidative stress.", {"entities": []}], ["Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[64, 73, "DISEASE"], [91, 128, "DISEASE"]]}], ["It is unclear whether the risk of pneumonia varies for different inhaled agents, particularly fluticasone and budesonide, and increases with the dose and long-term duration of use.", {"entities": [[34, 43, "DISEASE"]]}], ["We formed a new-user cohort of patients with COPD treated during 1990\u20132005.", {"entities": []}], ["Subjects were identified using the Quebec health insurance databases and followed through 2007 or until a serious pneumonia event, defined as a first hospitalisation for or death from pneumonia.", {"entities": [[114, 123, "DISEASE"], [184, 193, "DISEASE"]]}], ["A nested case\u2013control analysis was used to estimate the rate ratio (RR) of serious pneumonia associated with current ICS use, adjusted for age, sex, respiratory disease severity and comorbidity.", {"entities": [[83, 92, "DISEASE"]]}], ["The cohort included 163\u2005514 patients, of which 20\u2005344 had a serious pneumonia event during the 5.4\u2005years of follow-up (incidence rate 2.4/100/year).", {"entities": [[68, 77, "DISEASE"]]}], ["Current use of ICS was associated with a 69% increase in the rate of serious pneumonia (RR 1.69; 95% CI 1.63 to 1.75).", {"entities": [[77, 86, "DISEASE"]]}], ["The risk was sustained with long-term use and declined gradually after stopping ICS use, disappearing after 6\u2005months (RR 1.08; 95% CI 0.99 to 1.17).", {"entities": []}], ["The rate of serious pneumonia was higher with fluticasone (RR 2.01; 95% CI 1.93 to 2.10), increasing with the daily dose, but was much lower with budesonide (RR 1.17; 95% CI 1.09 to 1.26).", {"entities": [[20, 29, "DISEASE"]]}], ["ICS use by patients with COPD increases the risk of serious pneumonia.", {"entities": [[60, 69, "DISEASE"]]}], ["The risk is particularly elevated and dose related with fluticasone.", {"entities": []}], ["While residual confounding cannot be ruled out, the results are consistent with those from recent randomised trials.", {"entities": []}], ["We aimed to follow diary-registered symptoms from eyes and airways in mild steel welders and relate them to different exposure measures.", {"entities": []}], ["Furthermore, we would clarify the influence of possible effect modifiers.", {"entities": []}], ["Non-smoking welders with ( N \u00a0=\u00a074) and without ( N \u00a0=\u00a032) work-related symptoms the last month were enroled.", {"entities": []}], ["Symptoms and work tasks each day for three two-week periods during 1\u00a0year were obtained.", {"entities": []}], ["Respirable dust (RD) was measured 1\u00a0day each period for each worker.", {"entities": [[17, 19, "GENE"]]}], ["The personal daily exposure was assessed as: (1) days at work, (2) welding time and (3) estimates of RD from welding and grinding, calculated from diary entries and measurements.", {"entities": [[101, 103, "GENE"]]}], ["Only 9.2\u00a0% of the particle measurements exceed the Swedish occupational exposure limit (OEL; 5\u00a0mg/m The current Swedish OEL may not protect welders against eye and airway symptoms.", {"entities": []}], ["The results add to the evidence that welders should be offered regular medical surveillance from early in the career.", {"entities": []}], ["Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock.", {"entities": []}], ["At the same time, PCT has also been used to guide antibiotic therapy.", {"entities": []}], ["This review outlines the main indications for PCT measurement and points out possible pitfalls.", {"entities": []}], ["The classic indications for PCT measurement are: (i) confirmation or exclusion of diagnosis of sepsis, severe sepsis, or septic shock, (ii) severity assessment and follow up of systemic inflammation mainly induced by microbial infection, and (iii) individual, patient adapted guide of antibiotic therapy and focus treatment.", {"entities": []}], ["Using serially monitored PCT levels, the duration and need of antibiotic therapy can be better adapted to the individual requirements of the patient.", {"entities": []}], ["This individualized approach has been evaluated in various studies, and it is recommended to be a part of an antibiotic stewardship program.", {"entities": []}], ["Glutamate cysteine ligase (GCL) is a rate-limiting enzyme in synthesis of glutathione.", {"entities": []}], ["Evidence suggests that genetic variations in the promoter region of genes coding a catalytic subunit (GCLC -129T/C) and a modifier subunit (GCLM -588C/T) of GCL have a functional impact on their transcriptional activity and were associated with various disorders.", {"entities": [[102, 106, "GENE"], [140, 144, "GENE"]]}], ["Hence, we hypothesize whether these two polymorphic variants of GCLM and GCLC genes are associated with the risk of ischemic heart disease (IHD) development in the population of Kazakhstan.", {"entities": [[116, 138, "DISEASE"], [125, 138, "DISEASE"], [64, 68, "GENE"], [73, 77, "GENE"]]}], ["We evaluated 360 patients with IHD and 341 control subjects.", {"entities": []}], ["Allele frequencies of studied promoters' polymorphisms were detected by PCR-RFLP analysis.", {"entities": []}], ["Multiple logistic regression analysis was applied to assess the risk for different genotypes obtained.", {"entities": []}], ["The presence of -588T allele in GCLM and -129T allele in GCLC gene genotypes was associated with an increased risk of IHD (GCLM -588T: OR = 3.92, p = 0.003; GCLC -129T: OR = 3.22, p = 0.03) for general ethnically mixed group.", {"entities": [[32, 36, "GENE"], [123, 127, "GENE"], [57, 61, "GENE"], [157, 161, "GENE"], [32, 36, "GENE"], [123, 127, "GENE"], [57, 61, "GENE"], [157, 161, "GENE"]]}], ["Analysis of each ethnical groups separately showed the higher risk tendency for Kazakhs as for GCLM -588T (OR = 4.79; p = 0.03) and as for GCLC -129T (OR = 4.79, p = 0.03).", {"entities": [[95, 99, "GENE"], [139, 143, "GENE"]]}], ["For Russians, statistically differences for two polymorphisms were not observed.", {"entities": []}], ["The two promoter polymorphisms of GCLM (-588C/T) and GCLC (-128T/C) are associated with an increased risk of IHD in Kazakhstan population.", {"entities": [[34, 38, "GENE"], [53, 57, "GENE"]]}], ["To resolve the current shortage of donor hearts, we established the Adonhers protocol.", {"entities": []}], ["An upward shift of the donor age cut-off limit (from the present 55 to 65 years) is acceptable if a stress echo screening on the candidate donor heart is normal.", {"entities": []}], ["This study aimed to verify feasibility of a \"second opinion\" of digitally transferred images of stress echo results to minimize technical variability in selection of aged donor hearts for heart transplant.", {"entities": []}], ["The informatics infrastructure was created for a core lab reading with a second opinion from the Pisa stress echo lab.", {"entities": []}], ["To test the system, simulation standard stress echo cineloops were sent digitally from 5 peripheral labs to the central core lab.", {"entities": []}], ["Starting January 2009, real marginal donor stress echos were sent via internet to the central core echo lab, Pisa, for a second opinion before heart transplant.", {"entities": []}], ["In the simulation protocol, 30 dipyridamole stress echocardiograms were sent from the five peripheral echo labs to the central core lab in Pisa.", {"entities": []}], ["Both the echo images and reports were correctly uploaded in the web system and sent to the core echo lab; the second opinion evaluation was obtained in all cases (100% feasibility).", {"entities": []}], ["In the transplant protocol, eight donor cases were sent to the Pisa core lab for the second opinion protocol, and six of them were transplanted in marginal recipients.", {"entities": []}], ["Second-Opinion Stress Tele-Echocardiography can effectively be performed in a network aimed to safely expand the heart donor pool for heart transplant.", {"entities": []}], ["Planarians have recently become a popular model system for the study of adult stem cells, regeneration and polarity.", {"entities": []}], ["The system is attractive for both undergraduate and graduate research labs, since planarian colonies are low cost and easy to maintain.", {"entities": []}], ["Also in situ hybridization, immunofluorescence and RNA-interference (RNAi) gene knockdown techniques have been developed for planarian studies.", {"entities": []}], ["However, imaging of live worms (particularly at high magnifications) is difficult because animals are strongly photophobic; they quickly move away from light sources and out of frame.", {"entities": []}], ["The current methods available to inhibit movement in planarians include RNAi injection and exposure to cold temperatures.", {"entities": []}], ["The former is labor and time intensive, while the latter precludes the use of many fluorescent reporter dyes.", {"entities": []}], ["Here, we report a simple, inexpensive and reversible method to immobilize planarians for live imaging.", {"entities": []}], ["Our data show that a short 1 hour treatment with 3% ethanol (EtOH) is sufficient to inhibit both the fine and gross movements of Schmidtea mediterranea planarians, of the typical size used (4\u20136 mm), with full recovery of movement within 3\u20134 hours.", {"entities": []}], ["Importantly, EtOH treatment did not interfere with regeneration, even after repeated exposure, nor lyse epithelial cells (as assayed by H&E staining).", {"entities": []}], ["We demonstrate that a short exposure to a low concentration of EtOH is a quick and effective method of immobilizing planarians, one that is easily adaptable to planarians of all sizes and will increase the accessibility of live imaging assays to planarian researchers.", {"entities": []}], ["The surfactant proteins B (SP-B) and C (SP-C) are important for the stability and function of the alveolar surfactant film.", {"entities": []}], ["Their involvement and down-regulation in inflammatory processes has recently been proposed, but their level during neutrophilic human airway diseases are not yet known.", {"entities": []}], ["We used 1D-electrophoresis and Western blotting to determine the concentrations and molecular forms of SP-B and SP-C in bronchoalveolar lavage (BAL) fluid of children with different inflammatory airway diseases.", {"entities": []}], ["21 children with cystic fibrosis, 15 with chronic bronchitis and 14 with pneumonia were included and compared to 14 healthy control children.", {"entities": [[73, 82, "DISEASE"], [17, 32, "DISEASE"], [50, 60, "DISEASE"]]}], ["SP-B was detected in BAL of all 64 patients, whereas SP-C was found in BAL of all but 3 children; those three BAL fluids had more than 80% neutrophils, and in two patients, who were re-lavaged later, SP-C was then present and the neutrophil count was lower.", {"entities": []}], ["SP-B was mainly present as a dimer, SP-C as a monomer.", {"entities": []}], ["For both qualitative and quantitative measures of SP-C and SP-B, no significant differences were observed between the four evaluated patient groups.", {"entities": []}], ["Concentration or molecular form of SP-B and SP-C is not altered in BAL of children with different acute and chronic inflammatory lung diseases.", {"entities": []}], ["We conclude that there is no down-regulation of SP-B and SP-C at the protein level in inflammatory processes of neutrophilic airway disease.", {"entities": []}], ["COPD is a multi-pathogenesis disease mainly caused by smoking.", {"entities": []}], ["A further understanding of the mechanism of smoking-related COPD might contribute to preventions and treatments of this disease in the early stages.", {"entities": []}], ["This study was designed to identify the characteristics of M2 macrophages in COPD for a better understanding about their potential role.", {"entities": []}], ["COPD models were built in the C57BL/6 mouse by cigarette smoke (CS) exposure combined with intraperitoneal injection of cigarette smoke extract (CSE).", {"entities": [[64, 66, "GENE"]]}], ["The modeling efficiency was evaluated by lung function and hematoxylin and eosin (H&E) staining.", {"entities": []}], ["The number of different macrophage phenotypes was detected by immunohistochemical staining (IHS) of CD206, CD86 and CD68 on the lung tissue paraffin section.", {"entities": [[107, 111, "GENE"], [116, 120, "GENE"]]}], ["The RAW264.7 cells were polarized toward the M2 phenotype by interleukin IL-4 and confirmed by a flow cytometer.", {"entities": []}], ["The gene expression levels of TGF-\u03b2RII, Smad2, Smad3 and Smad7 in CSE-treated M2 macrophages were detected by real-time reverse transcription polymerase chain reaction (RT-PCR).", {"entities": [[40, 45, "GENE"], [47, 52, "GENE"], [57, 62, "GENE"]]}], ["The expression levels of TGF-\u03b2/Smad pathway-related makers (TGF-\u03b2RII, p-Smad2, p-Smad3, Smad7 and TGF-\u03b2) in alveolar M2 macrophages were detected by two consecutive paraffin section IHS.", {"entities": [[88, 93, "GENE"]]}], ["The COPD model is well established, which is confirmed by the lung function test and lung H&E staining.", {"entities": []}], ["The whole number of macrophages and the ratio of M2/M1 phenotype are both increased ( p <0.05).", {"entities": []}], ["The level of CD206 p <0.05) in CES-treated M2 macrophages, which is detected by RT-PCR.", {"entities": []}], ["The protein levels of TGF-\u03b2/Smad pathway-related markers are all increased in alveolar M2 macrophages of the model group.", {"entities": []}], ["This study found an increased deposition of alveolar M2 macrophages in the mouse COPD model and an increased expression level of TGF-\u03b2/Smad pathway in M2 macrophages, both in vitro and in vivo, induced by CSE and/or CS exposure, indicating that M2 macrophages might contribute to COPD through changing of phenotype and TGF-\u03b2/Smad pathway.", {"entities": [[216, 218, "GENE"]]}], ["Heightened body awareness can be adaptive and maladaptive.", {"entities": []}], ["Improving body awareness has been suggested as an approach for treating patients with conditions such as chronic pain, obesity and post-traumatic stress disorder.", {"entities": [[131, 161, "DISEASE"], [119, 126, "DISEASE"]]}], ["We assessed the psychometric quality of selected self-report measures and examined their items for underlying definitions of the construct.", {"entities": []}], ["PubMed, PsychINFO, HaPI, Embase, Digital Dissertations Database.", {"entities": []}], ["Abstracts were screened; potentially relevant instruments were obtained and systematically reviewed.", {"entities": []}], ["Instruments were excluded if they exclusively measured anxiety, covered emotions without related physical sensations, used observer ratings only, or were unobtainable.", {"entities": []}], ["We restricted our study to the proprioceptive and interoceptive channels of body awareness.", {"entities": []}], ["The psychometric properties of each scale were rated using a structured evaluation according to the method of McDowell.", {"entities": []}], ["Following a working definition of the multi-dimensional construct, an inter-disciplinary team systematically examined the items of existing body awareness instruments, identified the dimensions queried and used an iterative qualitative process to refine the dimensions of the construct.", {"entities": []}], ["From 1,825 abstracts, 39 instruments were screened.", {"entities": []}], ["12 were included for psychometric evaluation.", {"entities": []}], ["Only two were rated as high standard for reliability, four for validity.", {"entities": []}], ["Four domains of body awareness with 11 sub-domains emerged.", {"entities": []}], ["Neither a single nor a compilation of several instruments covered all dimensions.", {"entities": []}], ["Key domains that might potentially differentiate adaptive and maladaptive aspects of body awareness were missing in the reviewed instruments.", {"entities": []}], ["Existing self-report instruments do not address important domains of the construct of body awareness, are unable to discern between adaptive and maladaptive aspects of body awareness, or exhibit other psychometric limitations.", {"entities": []}], ["Restricting the construct to its proprio- and interoceptive channels, we explore the current understanding of the multi-dimensional construct and suggest next steps for further research.", {"entities": []}], ["Background : Syrian migrant farmworkers are among the most marginalized populations in Lebanon, living in poverty, lacking basic legal protections and frequent targets of discrimination.", {"entities": []}], ["These realities produce living conditions that undermine their basic health and wellbeing.", {"entities": []}], ["This study explores associations between household living conditions and acute and chronic health problems among Syrian migrant agricultural workers in the Bekaa region of Lebanon.", {"entities": []}], ["Methods : A survey was carried out in summer of 2011 with a sample of 290 migrant agriculture workers and members of their household living in a migrant farmworker camp.", {"entities": []}], ["The survey assessed participants living conditions, assets and health conditions.", {"entities": []}], ["Regression analyses were carried out to examine associations between multi-morbidity and quality of household and neighborhood living conditions.", {"entities": []}], ["Results : The mean age for the population was 20 years.", {"entities": []}], ["Forty-seven percent of participants reported health problems.", {"entities": []}], ["Almost 20% reported either one acute or chronic illness, 15% reported two health problems and 13% reported three or more.", {"entities": []}], ["The analysis showed a significant positive association between multi-morbidity and poor housing and infrastructure conditions among study participants.", {"entities": []}], ["Conclusion : The situation for migrant communities in Lebanon has likely further deteriorated since the study was conducted, as hundreds of thousands of new migrants have entered Lebanon since the outbreak of the Syrian armed conflict in 2011.", {"entities": []}], ["These findings should inspire multi-faceted community development initiatives that provide basic minimums of neighborhood infrastructure and housing quality for Syrian migrant informal settlements across Lebanon, safeguarding the health and wellbeing of community residents.", {"entities": []}], ["Recent studies have identified novel lymphocyte subsets named innate lymphoid cells (ILCs) lacking antigen-specific receptors.", {"entities": []}], ["ILCs are present in a wide variety of epithelial compartments and occupy an intermediate position between acquired immune cells and myeloid cells.", {"entities": []}], ["ILCs are now classified into three groups: group 1 ILC, group 2 ILC, and group 3 ILC based on their cytokine production patterns that correspond to the helper T cell subsets Th1, Th2, and Th17, respectively.", {"entities": []}], ["ILCs play important roles in protection against various invading microbes including multicellular parasites, and in the maintenance of homeostasis and repair of epithelial layers.", {"entities": []}], ["Excessive activation of ILCs, however, leads to various inflammatory disease conditions.", {"entities": []}], ["ILCs have thus attracted interests of many researchers in the fields of infectious immunity, inflammatory diseases, and allergic diseases.", {"entities": []}], ["Because epithelial cells sense alterations in environmental cues, it is important to understand the functional interaction between epithelial cells, ILCs, and environmental factors such as commensal microbiota.", {"entities": []}], ["We discuss in this review developmental pathways of ILCs, their functions, and contribution of commensal microbiota to the differentiation and function of ILCs.", {"entities": []}], ["Older adults comprise an increasing proportion of the prison and homeless populations.", {"entities": []}], ["While older age is associated with adverse post-release health events and incarceration is a risk factor for homelessness, the health status and homelessness risk of older pre-release prisoners are unknown.", {"entities": []}], ["Moreover, most post-release services are geared towards veterans; it is unknown whether the needs of non-veterans differ from those of veterans.", {"entities": []}], ["To assess health status and risk of homelessness of older pre-release prisoners, and to compare veterans with non-veterans.", {"entities": []}], ["Cross-sectional study of 360 prisoners (\u226555\u00a0years of age) within 2\u00a0years of release from prison using data from the 2004 Survey of Inmates in State and Federal Correctional Facilities.", {"entities": []}], ["Veteran status, health status (based on self-report), and risk of homelessness (homelessness before arrest).", {"entities": []}], ["Mean age was 61\u00a0years; 93.8% were men and 56.5% were white.", {"entities": []}], ["Nearly 40% were veterans, of whom 77.2% reported likely VA service eligibility.", {"entities": []}], ["Veterans were more likely to be white and to have obtained a high school diploma or GED.", {"entities": []}], ["Overall, 79.1% reported a medical condition and 13.6% reported a serious mental illness.", {"entities": []}], ["There was little difference in health status between veterans and non-veterans.", {"entities": []}], ["Although 1 in 12 prisoners reported a risk factor for homelessness, the risk factors did not differ according to veteran status.", {"entities": []}], ["Older pre-release prisoners had a high burden of medical and mental illness and were at risk for post-release homelessness regardless of veteran status.", {"entities": []}], ["Reentry programs linking pre-release older prisoners to medical and psychiatric services and to homelessness prevention programs are needed for both veterans and non-veterans.", {"entities": []}], ["The aryl hydrocarbon receptor (AhR) has gradually emerged as a regulator of inflammation in the lung and other tissues.", {"entities": [[31, 34, "GENE"]]}], ["AhR may interact with the p65-subunit of the nuclear factor (NF)-\u03baB transcription factors, but reported outcomes of AhR/NF-\u03baB-interactions are conflicting.", {"entities": [[0, 3, "GENE"], [116, 119, "GENE"]]}], ["Some studies suggest that AhR possess pro-inflammatory activities while others suggest that AhR may be anti-inflammatory.", {"entities": [[26, 29, "GENE"], [92, 95, "GENE"], [26, 29, "GENE"], [92, 95, "GENE"]]}], ["The present study explored the impact of AhR and its binding partner AhR nuclear translocator (Arnt) on p65-activation and two differentially regulated chemokines, CXCL8 (IL-8) and CCL5 (RANTES), in human bronchial epithelial cells (BEAS-2B).", {"entities": [[41, 44, "GENE"], [69, 72, "GENE"], [41, 44, "GENE"], [69, 72, "GENE"], [95, 99, "GENE"], [181, 185, "GENE"]]}], ["Cells were exposed to CXCL8- and CCL5-inducing chemicals, 1-nitropyrene (1-NP) and 1-aminopyrene (1-AP) respectively, or the synthetic double-stranded RNA analogue, polyinosinic-polycytidylic acid (Poly I:C) which induced both chemokines.", {"entities": []}], ["Only CXCL8, and not CCL5, appeared to be p65-dependent.", {"entities": [[20, 24, "GENE"]]}], ["Yet, constitutively active unligated AhR suppressed both CXCL8 and CCL5, as shown by siRNA knock-down and the AhR antagonist \u03b1-naphthoflavone.", {"entities": [[37, 40, "GENE"], [110, 113, "GENE"], [67, 71, "GENE"], [37, 40, "GENE"], [110, 113, "GENE"]]}], ["Moreover, AhR suppressed activation of p65 by TNF-\u03b1 and Poly I:C as assessed by luciferase-assay and p65-phosphorylation at serine 536, without affecting basal p65-activity.", {"entities": [[10, 13, "GENE"]]}], ["In contrast, Arnt suppressed only CXCL8, but did not prevent the p65-activation directly.", {"entities": [[13, 17, "GENE"]]}], ["However, Arnt suppressed expression of the NF-\u03baB-subunit RelB which is under transcriptional regulation by p65.", {"entities": [[9, 13, "GENE"], [57, 61, "GENE"]]}], ["Furthermore, AhR-ligands alone at high concentrations induced a moderate CXCL8-response, without affecting CCL5, but suppressed both CXCL8 and CCL5-responses by Poly I:C. AhR and Arnt may differentially and independently regulate chemokine-responses induced by both inhaled pollutants and pulmonary infections.", {"entities": [[107, 111, "GENE"], [143, 147, "GENE"], [13, 16, "GENE"], [171, 174, "GENE"], [179, 183, "GENE"]]}], ["Constitutively active, unligated AhR suppressed the activation of p65, while Arnt may possibly interfere with the action of activated p65.", {"entities": [[33, 36, "GENE"], [77, 81, "GENE"]]}], ["Moreover, ligand-activated AhR suppressed CXCL8 and CCL5 responses by other agents, but AhR ligands alone induced CXCL8 responses when given at sufficiently high concentrations, thus underscoring the duality of AhR in regulation of inflammation.", {"entities": [[27, 30, "GENE"], [88, 91, "GENE"], [211, 214, "GENE"], [52, 56, "GENE"], [27, 30, "GENE"], [88, 91, "GENE"], [211, 214, "GENE"], [27, 30, "GENE"], [88, 91, "GENE"], [211, 214, "GENE"]]}], ["We propose that AhR-signaling may be a weak activator of p65-signaling that suppresses p65-activity induced by strong activators of NF-\u03baB, but that its anti-inflammatory properties also are due to interference with additional pathways.", {"entities": []}], ["Platelets are anuclear cells that are essential for blood clotting.", {"entities": []}], ["They are produced by large polyploid precursor cells called megakaryocytes.", {"entities": []}], ["Previous genome-wide association studies in nearly 70,000 individuals indicated that single nucleotide variants (SNVs) in the gene encoding the actin cytoskeletal regulator tropomyosin 4 (TPM4) exert an effect on the count and volume of platelets.", {"entities": [[188, 192, "GENE"]]}], ["Platelet number and volume are independent risk factors for heart attack and stroke.", {"entities": []}], ["Here, we have identified 2 unrelated families in the BRIDGE Bleeding and Platelet Disorders (BPD) collection who carry a TPM4 variant that causes truncation of the TPM4 protein and segregates with macrothrombocytopenia, a disorder characterized by low platelet count.", {"entities": [[121, 125, "GENE"], [164, 168, "GENE"], [121, 125, "GENE"], [164, 168, "GENE"]]}], ["N -Ethyl- N -nitrosourea\u2013induced (ENU-induced) missense mutations in Tpm4 or targeted inactivation of the Tpm4 locus led to gene dosage\u2013dependent macrothrombocytopenia in mice.", {"entities": [[69, 73, "GENE"], [106, 110, "GENE"], [69, 73, "GENE"], [106, 110, "GENE"]]}], ["All other blood cell counts in Tpm4 -deficient mice were normal.", {"entities": [[31, 35, "GENE"]]}], ["Insufficient TPM4 expression in human and mouse megakaryocytes resulted in a defect in the terminal stages of platelet production and had a mild effect on platelet function.", {"entities": [[13, 17, "GENE"]]}], ["Together, our findings demonstrate a nonredundant role for TPM4 in platelet biogenesis in humans and mice and reveal that truncating variants in TPM4 cause a previously undescribed dominant Mendelian platelet disorder.", {"entities": [[59, 63, "GENE"], [145, 149, "GENE"], [59, 63, "GENE"], [145, 149, "GENE"]]}], ["IL-9 acts as an autocrine amplifier of type 2 innate lymphoid cell function to promote tissue repair in the recovery phase of helminth-induced lung infection.", {"entities": []}], ["IL-9 fate reporter mice established type 2 innate lymphoid cells (ILC2s) as major producers of this cytokine in vivo.", {"entities": []}], ["Here we focus on the role of IL-9 and ILC2s during the lung stage of infection with Nippostrongylus brasiliensis , which results in substantial tissue damage.", {"entities": []}], ["IL-9 receptor (IL-9R)\u2013deficient mice displayed reduced numbers of ILC2s in the lung after infection, resulting in impaired IL-5, IL-13, and amphiregulin levels, despite undiminished numbers of Th2 cells.", {"entities": []}], ["As a consequence, the restoration of tissue integrity and lung function was strongly impaired in the absence of IL-9 signaling.", {"entities": []}], ["ILC2s, in contrast to Th2 cells, expressed high levels of the IL-9R, and IL-9 signaling was crucial for the survival of activated ILC2s in vitro.", {"entities": []}], ["Furthermore, ILC2s in the lungs of infected mice required the IL-9R to up-regulate the antiapoptotic protein BCL-3 in vivo.", {"entities": []}], ["This highlights a unique role for IL-9 as an autocrine amplifier of ILC2 function, promoting tissue repair in the recovery phase after helminth-induced lung inflammation.", {"entities": []}], ["Gas sensors play an important role in our life, providing control and security of technical processes, environment, transportation and healthcare.", {"entities": []}], ["Consequently, the development of high performance gas sensor devices is the subject of intense research.", {"entities": []}], ["TiO 2 , with its excellent physical and chemical properties, is a very attractive material for the fabrication of chemical sensors.", {"entities": []}], ["Meanwhile, the emerging technologies are focused on the fabrication of more flexible and smart systems for precise monitoring and diagnosis in real-time.", {"entities": []}], ["The proposed cyber chemical systems in this paper are based on the integration of cyber elements with the chemical sensor devices.", {"entities": []}], ["These systems may have a crucial effect on the environmental and industrial safety, control of carriage of dangerous goods and medicine.", {"entities": []}], ["This review highlights the recent developments on fabrication of porous TiO 2 -based chemical gas sensors for their application in cyber chemical system showing the convenience and feasibility of such a model to provide the security and to perform the diagnostics.", {"entities": []}], ["The most of reports have demonstrated that the fabrication of doped, mixed and composite structures based on porous TiO 2 may drastically improve its sensing performance.", {"entities": []}], ["In addition, each component has its unique effect on the sensing properties of material.", {"entities": []}], ["Studies involving animal models of experimental tuberculosis have elucidated the predominant role of cytokines secreted by T cells and macrophages to be an essential component of the immune response against Mycobacterium tuberculosis infection.", {"entities": [[48, 60, "DISEASE"], [221, 233, "DISEASE"]]}], ["The immune activities of CD4+ T cells are mediated in part by Th1 cytokine interferon gamma ( IFN-\u03b3 ) which is produced primarily by T cells and natural killer (NK) cells and critical for initiating the immune response against intracellular pathogen such as M. tuberculosis .", {"entities": [[261, 273, "DISEASE"]]}], ["Nuclear matrix protein SMAR1 plays an important role in V(D)J recombination, T helper cell differentiation and inflammatory diseases.", {"entities": []}], ["In this study a transgenic mouse model was used to study the role of SMAR1 in M. tuberculosis infection.", {"entities": [[81, 93, "DISEASE"]]}], ["Wild type BALB/c, C57BL/6, BALB/c-EGFP-SMAR1 and C57BL/6-SMAR1 transgenic mice were infected with M. tuberculosis (H37Rv).", {"entities": [[101, 113, "DISEASE"]]}], ["A dose of 100 bacilli was used for infection via respiratory route.", {"entities": []}], ["Bacterial load in lung and spleen of infected mice was determined at 2, 4, 6 and 8 wk post-infection.", {"entities": []}], ["Gene expression analysis for Th1 cytokines and inducible nitric oxide synthase ( iNOS ) was performed in infected lung tissues by quantitative reverse transcription (RT)-PCR.", {"entities": []}], ["SMAR1 transgenic mice from both BALB/c and C57BL/6 genetic background displayed higher bacillary load and susceptibility to M. tuberculosis infection compared to wild type mice.", {"entities": [[127, 139, "DISEASE"]]}], ["This susceptibility was attributed due to compromised of Th1 response exhibited by transgenic mice.", {"entities": []}], ["SMAR1 transgenic mice exhibited susceptibility to M. tuberculosis infection in vivo irrespective of genetic background.", {"entities": [[53, 65, "DISEASE"]]}], ["This susceptibility was attributed to downregulation of Th1 response and its hallmark cytokine IFN-\u03b3.", {"entities": []}], ["Hence, SMAR1 plays an important role in modulating host immune response after M. tuberculosis infection.", {"entities": [[81, 93, "DISEASE"]]}], ["Serum procalcitonin and high-sensitivity C-reactive protein (hs-CRP) elevations have been associated with pneumonia in adults.", {"entities": [[106, 115, "DISEASE"]]}], ["Our aim was to establish their diagnostic usefulness in a cohort of hospitalized multimorbid patients \u226565\u00a0years old admitted to hospital with acute respiratory symptoms.", {"entities": []}], ["With a retrospective cohort study design, all multimorbid patients \u226565\u00a0years-old with acute respiratory symptoms admitted to an internal medicine hospital ward in Italy from January to August 2013 were evaluated.", {"entities": []}], ["Pneumonia diagnosis, comorbidities expressed through Cumulative Illness Rating Scale (CIRS), setting of living, length of stay, serum hs-CRP and procalcitonin at admission were collected for each patient.", {"entities": [[0, 9, "DISEASE"]]}], ["Data were analyzed with Mann-Whitney\u2019s U test and multivariate Cox logistic regression analysis.", {"entities": []}], ["A Receiver Operating Characteristic (ROC) curve was used to verify each biomarker\u2019s association with pneumonia diagnosis.", {"entities": [[101, 110, "DISEASE"]]}], ["Four hundred fifty five patients (227 M) were included in the study, of whom 239 with pneumonia (138 M, mean age 80\u2009\u00b1\u200913) and 216 without pneumonia (89 M, mean age 80\u2009\u00b1\u200914).", {"entities": [[86, 95, "DISEASE"], [138, 147, "DISEASE"]]}], ["After adjustment for age and sex, median levels of hs-CRP were significantly higher in patients with pneumonia (116\u00a0mg/L, IQR 46.5\u2013179.0, vs 22.5\u00a0mg/dl, IQR 6.9\u201384.4, p \u2009<\u20090.0001), while procalcitonin median levels were not (0.22\u00a0ng/ml IQR 0.12\u20130.87, vs 0.15\u00a0ng/ml, IQR 0.10\u20130.35, p \u2009=\u20090.08).", {"entities": [[101, 110, "DISEASE"]]}], ["The ROC analysis showed that, unlike procalcitonin, hs-CRP values were predictive of pneumonia (AUC 0.76, 95\u00a0% CI 0.72\u20130.79, p \u2009<\u20090.0001, cut-off value 61\u00a0mg/L), even after adjustment for possible confounders including nursing home residence and dementia.", {"entities": [[246, 254, "DISEASE"], [85, 94, "DISEASE"]]}], ["Serum hs-CRP levels >61\u00a0mg/L were independently associated with a 3.59-fold increased risk of pneumonia (OR 3.59, 95 % CI 2.35\u20135.48, p \u2009<\u20090.0001).", {"entities": [[94, 103, "DISEASE"]]}], ["In elderly multimorbid patients who require hospital admission for respiratory symptoms, serum hs-CRP testing seems to be more useful than procalcitonin for guiding the diagnostic process when clinical suspicion of pneumonia is present.", {"entities": [[215, 224, "DISEASE"]]}], ["Procalcitonin testing might hence be not recommended in this setting.", {"entities": []}], ["Filaggrin ( FLG ) mutation is a well-confirmed genetic aberration in atopic dermatitis (AD).", {"entities": [[69, 86, "DISEASE"], [76, 86, "DISEASE"], [12, 15, "GENE"]]}], ["Genome-wide association studies on AD have revealed other susceptibility genes, for example, Ovo-like 1 (OVOL1).", {"entities": [[105, 110, "GENE"]]}], ["Nonetheless, the relation between FLG and OVOL1 is unclear.", {"entities": [[34, 37, "GENE"], [42, 47, "GENE"]]}], ["Because aryl hydrocarbon receptor (AHR; a ligand-activated transcription factor), plays a role in FLG expression in keratinocytes, we hypothesized that AHR regulates FLG expression via OVOL1.", {"entities": [[35, 38, "GENE"], [152, 155, "GENE"], [98, 101, "GENE"], [166, 169, "GENE"], [35, 38, "GENE"], [152, 155, "GENE"], [98, 101, "GENE"], [166, 169, "GENE"], [185, 190, "GENE"]]}], ["To demonstrate this mechanism, we analyzed FLG expression in OVOL1-overexpressing or OVOL1-knockdown normal human epidermal keratinocytes (NHEKs).", {"entities": [[43, 46, "GENE"]]}], ["Furthermore, we tested whether AHR activation by 6-formylindolo(3,2-b)carbazole (FICZ), an endogenous AHR ligand, or Glyteer, clinically used soybean tar, upregulates FLG and OVOL1 expression in NHEKs.", {"entities": [[31, 34, "GENE"], [102, 105, "GENE"], [31, 34, "GENE"], [102, 105, "GENE"], [167, 170, "GENE"], [175, 180, "GENE"]]}], ["We found that (1) OVOL1 regulates FLG expression; (2) AHR activation upregulates OVOL1; and (3) AHR activation upregulates FLG via OVOL1.", {"entities": [[18, 23, "GENE"], [81, 86, "GENE"], [131, 136, "GENE"], [34, 37, "GENE"], [123, 126, "GENE"], [54, 57, "GENE"], [96, 99, "GENE"], [18, 23, "GENE"], [81, 86, "GENE"], [131, 136, "GENE"], [54, 57, "GENE"], [96, 99, "GENE"], [34, 37, "GENE"], [123, 126, "GENE"], [18, 23, "GENE"], [81, 86, "GENE"], [131, 136, "GENE"]]}], ["Moreover, nuclear translocation of OVOL1 was less pronounced in AD skin compared with normal skin.", {"entities": [[35, 40, "GENE"]]}], ["IL-4-treated NHEKs, an in vitro AD skin model, also showed inhibition of the OVOL1 nuclear translocation, which was restored by FICZ and Glyteer.", {"entities": [[77, 82, "GENE"]]}], ["Thus, targeting the AHR\u2013OVOL1\u2013FLG axis may provide new therapeutics for AD.", {"entities": []}], ["The aim of this study was to evaluate the association of sex hormones with anthropometry in a large population-based cohort, with liquid chromatography-mass spectrometry (LCMS)-based sex hormone measurements and imaging markers.", {"entities": []}], ["Cross-sectional data from 957 men and women from the population-based Study of Health in Pomerania (SHIP) were used.", {"entities": []}], ["Associations of a comprehensive panel of LCMS-measured sex hormones with anthropometric parameters, laboratory, and imaging markers were analyzed in multivariable regression models for the full sample and stratified by sex.", {"entities": []}], ["Sex hormone measures included total testosterone (TT), free testosterone (fT), estrone and estradiol, androstenedione (ASD), dehydroepiandrosterone sulfate (DHEAS), and sex hormone-binding globulin (SHBG).", {"entities": [[199, 203, "GENE"]]}], ["Domains of anthropometry included physical measures (body-mass-index (BMI), waist circumference, waist-to-height-ratio, waist-to-hip-ratio, and hip circumference), laboratory measures of adipokines (leptin and vaspin), and magnet resonance imaging-based measures (visceral and subcutaneous adipose tissue).", {"entities": []}], ["In men, inverse associations between all considered anthropometric parameters with TT were found: BMI (\u03b2-coefficient, standard error (SE): -0.159, 0.037), waist-circumference (\u03b2-coefficient, SE: -0.892, 0.292), subcutaneous adipose tissue (\u03b2-coefficient, SE: -0.156, 0.023), and leptin (\u03b2-coefficient, SE: -0.046, 0.009).", {"entities": []}], ["In women TT (\u03b2-coefficient, SE: 1.356, 0.615) and estrone (\u03b2-coefficient, SE: 0.014, 0.005) were positively associated with BMI.", {"entities": []}], ["In analyses of variance, BMI and leptin were inversely associated with TT, ASD, and DHEAS in men, but positively associated with estrone.", {"entities": []}], ["In women, BMI and leptin were positively associated with all sex hormones.", {"entities": []}], ["The present population-based study confirmed and extended previously reported sex-specific associations between sex hormones and various anthropometric markers of overweight and obesity.", {"entities": [[178, 185, "DISEASE"]]}], ["It has been shown that the proportion of natural killer T cells is markedly elevated during liver regeneration and their activation under different conditions can modulate this process.", {"entities": []}], ["As natural killer T cells and liver injury are central in liver regeneration, elucidating their role is important.", {"entities": []}], ["The aim of the current study is to explore the role of natural killer T cells in impaired liver regeneration.", {"entities": []}], ["Concanvalin A was injected 4\u00a0days before partial hepatectomy to natural killer T cells- deficient mice or to anti CD1d1-treated mice.", {"entities": []}], ["Ki-67 and proliferating cell nuclear antigen were used to measure hepatocytes proliferation.", {"entities": []}], ["Expression of hepatic cyclin B1 and proliferating cell nuclear antigen were evaluated by Western Blot and liver injury was assessed by ALT and histology.", {"entities": []}], ["Natural killer T cells- deficient or mice injected with anti CD1d antibodies exhibited reduced liver regeneration.", {"entities": [[61, 65, "GENE"]]}], ["These mice were considerably resistant to ConA-induced liver injury.", {"entities": []}], ["In the absence of NKT cells hepatic proliferating cell nuclear antigen and cyclin B1 decreased in mice injected with Concanvalin A before partial hepatectomy.", {"entities": []}], ["This was accompanied with reduced serum interleukin-6 levels.", {"entities": []}], ["Natural killer T cells play an important role in liver regeneration, which is associated with cyclin B1 and interleukin-6.", {"entities": []}], ["Large-conductance voltage- and calcium-activated potassium (BK) channels contain four pore-forming \u03b1 subunits and four modulatory \u03b2 subunits.", {"entities": []}], ["From the extents of disulfide cross-linking in channels on the cell surface between cysteine (Cys) substituted for residues in the first turns in the membrane of the S0 transmembrane (TM) helix, unique to BK \u03b1, and of the voltage-sensing domain TM helices S1\u2013S4, we infer that S0 is next to S3 and S4, but not to S1 and S2.", {"entities": []}], ["Furthermore, of the two \u03b21 TM helices, TM2 is next to S0, and TM1 is next to TM2.", {"entities": []}], ["Coexpression of \u03b1 with two substituted Cys\u2019s, one in S0 and one in S2, and \u03b21 also with two substituted Cys\u2019s, one in TM1 and one in TM2, resulted in two \u03b1s cross-linked by one \u03b2.", {"entities": []}], ["Thus, each \u03b2 lies between and can interact with the voltage-sensing domains of two adjacent \u03b1 subunits.", {"entities": []}], ["Atopic dermatitis is a multifactorial allergic skin disease in humans and dogs.", {"entities": [[0, 17, "DISEASE"], [47, 59, "DISEASE"], [7, 17, "DISEASE"]]}], ["Genetic predisposition, immunologic hyperreactivity, a defective skin barrier, and environmental factors play a role in its pathogenesis.", {"entities": []}], ["The aim of this study was to analyze gene expression in the skin of dogs sensitized to house dust mite antigens.", {"entities": []}], ["Skin biopsy samples were collected from six sensitized and six nonsensitized Beagle dogs before and 6 hr and 24 hr after challenge using skin patches with allergen or saline as a negative control.", {"entities": [[102, 104, "GENE"], [112, 114, "GENE"], [102, 104, "GENE"], [112, 114, "GENE"]]}], ["Transcriptome analysis was performed by the use of DNA microarrays and expression of selected genes was validated by quantitative real-time RT-PCR.", {"entities": []}], ["Expression data were compared between groups (unpaired design).", {"entities": []}], ["After 24 hr, 597 differentially expressed genes were detected, 361 with higher and 226 with lower mRNA concentrations in allergen-treated skin of sensitized dogs compared with their saline-treated skin and compared with the control specimens.", {"entities": [[9, 11, "GENE"]]}], ["Functional annotation clustering and pathway- and co-citation analysis showed that the genes with increased expression were involved in inflammation, wound healing, and immune response.", {"entities": []}], ["In contrast, genes with decreased expression in sensitized dogs were associated with differentiation and barrier function of the skin.", {"entities": []}], ["Because the sensitized dogs did not show differences in the untreated skin compared with controls, inflammation after allergen patch test probably led to a decrease in the expression of genes important for barrier formation.", {"entities": []}], ["Our results further confirm the similar pathophysiology of human and canine atopic dermatitis and revealed genes previously not known to be involved in canine atopic dermatitis.", {"entities": [[76, 93, "DISEASE"], [159, 176, "DISEASE"], [83, 93, "DISEASE"], [166, 176, "DISEASE"]]}], ["A treatment strategy of a difficult and unusual problem is presented.", {"entities": []}], ["We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure.", {"entities": []}], ["The anticoagulation regime used during cardiopulmonary bypass was lepirudin based.", {"entities": []}], ["This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered.", {"entities": []}], ["Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available.", {"entities": []}], ["Dysregulation of the hypothalamic\u2010pituitary\u2010adrenal ( HPA ) axis occurs in horses with systemic inflammatory response syndrome ( SIRS ).", {"entities": [[118, 126, "DISEASE"]]}], ["Peripheral resistance to glucocorticoids has not been investigated in horses.", {"entities": []}], ["To determine if glucocorticoid receptor ( GR ) function in horses can be measured using flow cytometry, and to use this information to evaluate HPA axis dynamics.", {"entities": []}], ["Eleven healthy adult horses in parts 1 and 2.", {"entities": []}], ["Ten horses with SIRS and 10 age and sex matched controls in part 3.", {"entities": []}], ["Flow cytometry was used to evaluate GR density and binding affinity ( BA ) in 3 healthy horses in part 1.", {"entities": []}], ["In part 2, exogenous ACTH was administered to eight healthy horses.", {"entities": []}], ["Their cortisol response and GR properties were measured.", {"entities": []}], ["In part 3, CBC , serum biochemistry, cortisol and ACTH , and GR properties were compared between controls without SIRS (n\u00a0=\u00a010) and horses with SIRS (n\u00a0=\u00a010), and between survivors and nonsurvivors (n\u00a0=\u00a04 and n\u00a0=\u00a06 respectively).", {"entities": []}], ["Flow cytometry can be used to measure GR properties in equine PBMC s. No correlation was observed between plasma cortisol concentration and GR density or BA in healthy horses (r\u00a0=\u00a0\u22120.145, P\u00a0=\u00a0 .428 and r\u00a0=\u00a00.046, P\u00a0=\u00a0 .802 respectively).", {"entities": []}], ["Nonsurvivors with SIRS had significantly decreased GR BA ( P\u00a0=\u00a0 .008).", {"entities": []}], ["Horses with triglyceride concentration > 28.5\u00a0mg/dL had increased odds of nonsurvival ( OR =117; 95% CI , 1.94\u20137,060).", {"entities": []}], ["GR BA <35.79% was associated with nonsurvival ( OR \u00a0=\u00a030.33; 95% CI , 0.96\u2013960.5).", {"entities": []}], ["Tissue resistance to glucocorticoids contributes to HPA axis dysfunction in adult horses with SIRS .", {"entities": []}], ["These horses might benefit from treatment with exogenous glucocorticoids.", {"entities": []}], ["Malaysia's stable health care system is facing challenges with increasing medicine costs.", {"entities": []}], ["To investigate these issues a survey was carried out to evaluate medicine prices, availability, affordability, and the structure of price components.", {"entities": []}], ["The methodology developed by the World Health Organization (WHO) and Health Action International (HAI) was used.", {"entities": []}], ["Price and availability data for 48 medicines was collected from 20 public sector facilities, 32 private sector retail pharmacies and 20 dispensing doctors in four geographical regions of West Malaysia.", {"entities": []}], ["Medicine prices were compared with international reference prices (IRPs) to obtain a median price ratio.", {"entities": []}], ["The daily wage of the lowest paid unskilled government worker was used to gauge the affordability of medicines.", {"entities": []}], ["Price component data were collected throughout the supply chain, and markups, taxes, and other distribution costs were identified.", {"entities": []}], ["In private pharmacies, innovator brand (IB) prices were 16 times higher than the IRPs, while generics were 6.6 times higher.", {"entities": []}], ["In dispensing doctor clinics, the figures were 15 times higher for innovator brands and 7.5 for generics.", {"entities": []}], ["Dispensing doctors applied high markups of 50%\u201376% for IBs, and up to 316% for generics.", {"entities": []}], ["Retail pharmacy markups were also high\u201425%\u201338% and 100%\u2013140% for IBs and generics, respectively.", {"entities": []}], ["In the public sector, where medicines are free, availability was low even for medicines on the National Essential Drugs List.", {"entities": []}], ["For a month's treatment for peptic ulcer disease and hypertension people have to pay about a week's wages in the private sector.", {"entities": [[53, 65, "DISEASE"], [28, 40, "DISEASE"]]}], ["The free market by definition does not control medicine prices, necessitating price monitoring and control mechanisms.", {"entities": []}], ["Markups for generic products are greater than for IBs.", {"entities": []}], ["Reducing the base price without controlling markups may increase profits for retailers and dispensing doctors without reducing the price paid by end users.", {"entities": []}], ["To increase access and affordability, promotion of generic medicines and improved availability of medicines in the public sector are required.", {"entities": []}], ["Drug price and availability data were collected from West Malaysian public sector facilities, private sector retail pharmacies, and dispensing doctors.", {"entities": []}], ["Mark-ups were higher on generic drugs than on innovator brands.", {"entities": []}], ["The World Health Organization has said that one-third of the people of the world cannot access the medicines they need.", {"entities": []}], ["An important reason for this problem is that prices are often too high for people or government-funded health systems to afford.", {"entities": []}], ["In developing countries, most people who need medicines have to pay for them out of their own pockets.", {"entities": []}], ["Where the cost of drugs is covered by health systems, spending on medicines is a major part of the total healthcare budget.", {"entities": []}], ["Governments use a variety of approaches to try to control the cost of drugs and make sure that essential medicines are affordable and not overpriced.", {"entities": []}], ["According to the theory of \u201cfree market economics,\u201d the costs of goods and services are determined by interactions between buyers and sellers and not by government intervention.", {"entities": []}], ["However, free market economics does not work well at containing the costs of medicines, particularly new medicines, because new medicines are protected by patent law, which legally prevents others from making, using, or selling the medicine for a particular period of time.", {"entities": []}], ["Therefore, without government intervention, there is nothing to help to push down prices.", {"entities": []}], ["Malaysia is a middle-income country with a relatively effective public health system, but it is facing a rapid rise in drug costs.", {"entities": []}], ["In Malaysia, medicine prices are determined by free-market economics, without any control by government.", {"entities": []}], ["Government hospitals are expected to provide drugs free, but a substantial proportion of medicines are paid for by patients who buy them directly from private pharmacies or prescribing doctors.", {"entities": []}], ["There is evidence that Malaysian patients have difficulties accessing the drugs they need and that cost is an important factor.", {"entities": []}], ["Therefore, the researchers who wrote this paper wanted to examine the cost of different medicines in Malaysia, and their availability and affordability from different sources.", {"entities": []}], ["In this research project, 48 drugs were studied, of which 28 were part of a \u201ccore list\u201d identified by the World Health Organization as \u201cessential drugs\u201d on the basis of the global burden of disease.", {"entities": []}], ["The remaining 20 reflected health care needs in Malaysia itself.", {"entities": []}], ["The costs of each medicine were collected from government hospitals, private pharmacies, and dispensing doctors in four different regions of Malaysia.", {"entities": []}], ["Data were collected for the \u201cinnovator brand\u201d (made by the original patent holder) and for \u201cgeneric\u201d brands (an equivalent drug to the innovator brand, produced by a different company once the innovator brand no longer has an exclusive patent).", {"entities": []}], ["The medicine prices were compared against international reference prices (IRP), which are the average prices offered by not-for-profit drug companies to developing countries.", {"entities": []}], ["Finally, the researchers also compared the cost of the drugs with daily wages, in order to work out their \u201caffordability.\u201d The researchers found that, irrespective of the source of medicines, prices were on average very much higher than the international reference price, ranging from 2.4 times the IRP for innovator brands accessed through public hospitals, to 16 times the IRP for innovator brands accessed through private pharmacies.", {"entities": []}], ["The availability of medicines was also very poor, with only 25% of generic medicines available on average through the public sector.", {"entities": []}], ["The affordability of many of the medicines studied was again very poor.", {"entities": []}], ["For example, one month's supply of ranitidine (a drug for stomach ulcers) was equivalent to around three days' wages for a low-paid government worker, and one month's supply of fluoxetine (an antidepressant) would cost around 26 days' wages.", {"entities": []}], ["These results show that essential drugs are very expensive in Malaysia and are not universally available.", {"entities": []}], ["Many people would not be able to pay for essential medicines.", {"entities": []}], ["The cost of medicines in Malaysia seems to be much higher than in areas of India and Sri Lanka, although the researchers did not attempt to collect data in order to carry out an international comparison.", {"entities": []}], ["It is possible that the high cost and low availability in Malaysia are the result of a lack of government regulation.", {"entities": []}], ["Overall, the findings suggest that the government should set up mechanisms to prevent drug manufacturers from increasing prices too much and thus ensure greater access to essential medicines.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0040082 .", {"entities": []}], ["Read a related PLoS Medicine Perspective article by Suzanne Hill Information is available from the World Health Organization on Improving Access to Medicines Information on medicine prices is available from Health Action International Wikipedia has an entry on Patent (a type of intellectual property that is normally used to prevent other companies from selling a newly invented medicine).", {"entities": []}], ["(Wikipedia is an internet encyclopedia anyone can edit.)", {"entities": []}], ["The Drugs for Neglected Diseases Initiative is an international collaboration between public organizations that aims to develop drugs for people suffering from neglected diseases", {"entities": []}], ["To determine the effectiveness of integrated care interventions in improving the Quality of Life (QoL) for patients with chronic conditions.", {"entities": []}], ["A review of the systematic reviews evidence (umbrella review).", {"entities": []}], ["Medline, Embase, ASSIA, PsychINFO, HMIC, CINAHL, Cochrane Library (including HTA database), DARE, and Cochrane Database of Systematic Reviews), EPPI-Centre, TRIP and Health Economics Evaluations databases.", {"entities": [[77, 80, "GENE"]]}], ["Reference lists of included reviews were searched for additional references not returned by electronic searches.", {"entities": []}], ["English language systematic reviews or meta-analyses published since 2000 that assessed the effectiveness of interventions in improving the QoL of patients with chronic conditions.", {"entities": []}], ["Two reviewers independently assessed reviews for eligibility, extracted data, and assessed the quality of included studies.", {"entities": []}], ["A total of 41 reviews assessed QoL.", {"entities": []}], ["Twenty one reviews presented quantitative data, 17 reviews were narrative and three were reviews of reviews.", {"entities": []}], ["The intervention categories included case management, Chronic care model (CCM), discharge management, multidisciplinary teams (MDT), complex interventions, primary vs. secondary care follow-up, and self-management.", {"entities": []}], ["Taken together, the 41 reviews that assessed QoL provided a mixed picture of the effectiveness of integrated care interventions.", {"entities": []}], ["Case management interventions showed some positive findings as did CCM interventions, although these interventions were more likely to be effective when they included a greater number of components.", {"entities": []}], ["Discharge management interventions appeared to be particularly successful for patients with heart failure.", {"entities": []}], ["MDT and self-management interventions showed a mixed picture.", {"entities": []}], ["In general terms, interventions were typically more effective in improving condition-specific QoL rather than global QoL.", {"entities": []}], ["This review provided the first overview of international evidence for the effectiveness of integrated care interventions for improving the QoL for patients with chronic conditions.", {"entities": []}], ["The online version of this article (10.1186/s12955-017-0765-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background.", {"entities": []}], ["Cystic fibrosis (CF) is characterized by hypoxia that affects several organic tissues.", {"entities": []}], ["Retinal ganglion cells may suffer from the hypoxic status, and this may lead to alterations of retinal nerve fiber.", {"entities": []}], ["Twenty-two eyes in CF patients were analyzed.", {"entities": []}], ["A complete ocular evaluation and visual field exams of the 30 central degrees were performed using the frequency doubling technology (FDT).", {"entities": []}], ["Forced expiratory volume in one second (FEV1%), forced vital capacity (FVC%), oxyhaemoglobin saturation (SpO 2 %), and hematocrit (Ht%) have been calculated.", {"entities": []}], ["FDT analyzed parameters were mean deviation (MD) and pattern standard deviation (PSD).", {"entities": [[81, 84, "GENE"]]}], ["Pearson's correlation was chosen as statistical analysis.", {"entities": []}], ["Data showed statistically significant relationship between MD and Ht% ( r value \u22120.18; P = 0.04), MD and FEV1% ( r value \u22120.68; P = 0.001), and MD and FVC% ( r value \u22120.45; P = 0.005).", {"entities": []}], ["Moreover, there were correlations between PSD and Ht% ( r value 0.29; P = 0.03), PSD and SpO 2 % ( r value \u22120.31; P = 0.01), PSD and FEV1% ( r value 0.71; P = 0.0005), and PSD and FVC% ( r value 0.63; P = 0.003).", {"entities": [[42, 45, "GENE"], [81, 84, "GENE"], [125, 128, "GENE"], [172, 175, "GENE"], [42, 45, "GENE"], [81, 84, "GENE"], [125, 128, "GENE"], [172, 175, "GENE"], [42, 45, "GENE"], [81, 84, "GENE"], [125, 128, "GENE"], [172, 175, "GENE"], [42, 45, "GENE"], [81, 84, "GENE"], [125, 128, "GENE"], [172, 175, "GENE"]]}], ["Conclusions.", {"entities": []}], ["The oxygen supply alterations might determine hypoxia of the ganglion cells causing a decrease of receptive optic nerve fiber activity.", {"entities": []}], ["This method could be also useful to evaluate indirectly pulmonary activity of the CF disease.", {"entities": []}], ["Persistent bacterial bronchitis (PBB) is a leading cause of chronic wet cough in young children.", {"entities": [[21, 31, "DISEASE"]]}], ["This study aimed to characterise the respiratory bacterial microbiota of healthy children and to assess the impact of the changes associated with the development of PBB.", {"entities": []}], ["Blind, protected brushings were obtained from 20 healthy controls and 24 children with PBB, with an additional directed sample obtained from PBB patients.", {"entities": []}], ["DNA was extracted, quantified using a 16S rRNA gene quantitative PCR assay prior to microbial community analysis by 16S rRNA gene sequencing.", {"entities": []}], ["No significant difference in bacterial diversity or community composition (R P = 0.36) was observed between paired blind and non-blind brushes, showing that blind brushings are a valid means of accessing the airway microbiota.", {"entities": []}], ["This has important implications for collecting lower respiratory samples from healthy children.", {"entities": []}], ["A significant decrease in bacterial diversity ( P < 0.001) and change in community composition (R P = 0.004) was observed among controls, in comparison with patients.", {"entities": []}], ["Bacterial communities within patients with PBB were dominated by Proteobacteria , and indicator species analysis showed that Haemophilus and Neisseria were significantly associated with the patient group.", {"entities": []}], ["In 15 (52.9%) cases the dominant organism by sequencing was not identified by standard routine clinical culture.", {"entities": []}], ["The bacteria present in the lungs of patients with PBB were less diverse in terms of richness and evenness.", {"entities": []}], ["The results validate the clinical diagnosis, and suggest that more attention to bacterial communities in children with chronic cough may lead to more rapid recognition of this condition with earlier treatment and reduction in disease burden.", {"entities": []}], ["Bistability has important implications in signaling pathways, since it indicates a potential cell decision between alternative outcomes.", {"entities": []}], ["We present two approaches developed in the framework of the Chemical Reaction Network Theory for easy and efficient search of multiple steady state behavior in signaling networks (both with and without mass conservation), and apply them to search for sources of bistability at different levels of the interferon signaling pathway.", {"entities": []}], ["Different type I interferon subtypes and/or doses are known to elicit differential bioactivities (ranging from antiviral, antiproliferative to immunomodulatory activities).", {"entities": []}], ["How different signaling outcomes can be generated through the same receptor and activating the same JAK/STAT pathway is still an open question.", {"entities": []}], ["Here, we detect bistability at the level of early STAT signaling, showing how two different cell outcomes are achieved under or above a threshold in ligand dose or ligand-receptor affinity.", {"entities": []}], ["This finding could contribute to explain the differential signaling (antiviral vs apoptotic) depending on interferon dose and subtype ( \u03b1 vs \u03b2 ) observed in type I interferons.", {"entities": []}], ["Type I interferons (IFNs) regulate a variety of cell functions, exhibiting, amongst others, antiviral, antiproliferative and immunomodulatory activities.", {"entities": []}], ["Due to their anticancer effects, type I IFNs have a long record of applications in clinical oncology.", {"entities": []}], ["It is still an open question how type I IFNs generate so diverse signaling outcomes by activating the same receptor at the cell membrane and triggering the same JAK/STAT pathway.", {"entities": []}], ["It has been experimentally shown that differences in ligand affinity towards the receptor, IFN dose and receptor density are translated into different activities, but the underlying mechanisms of differential responses remain elusive.", {"entities": []}], ["Looking for potential cell decision processes that could help answering this question, we explore the capacity for bistability at different levels of the IFN pathway.", {"entities": []}], ["The search for bistability sources in interferon signaling is performed within the framework of Chemical Reaction Network Theory, by adapting previous results to the specific context of signaling pathways.", {"entities": []}], ["Surprisingly, we find a source of bistability already at the early STAT signaling level.", {"entities": []}], ["As a result, we show that the pathway has the capacity to translate a difference in affinity or IFN dose into a binary decision between High/Low or Low/High activation profiles of two IFN transcription factors (ISGF3 and STAT1-STAT1 homodimers) responsible for the upregulation of two different families of interferon stimulated genes: ISRE and GAS.", {"entities": []}], ["The endoplasmic reticulum (ER) is essential to many cellular processes including protein processing, lipid metabolism and calcium storage.", {"entities": []}], ["The ability to longitudinally monitor ER homeostasis in the same organism would offer insight into progressive molecular and cellular adaptations to physiologic or pathologic states, but has been challenging.", {"entities": []}], ["We recently described the creation of a Gaussia luciferase (GLuc)-based secreted ER calcium-modulated protein (SERCaMP or GLuc-SERCaMP) to longitudinally monitor ER calcium homeostasis.", {"entities": []}], ["Here we describe a complementary tool to measure the unfolded protein response (UPR), utilizing a UPRE-driven secreted Nano luciferase (UPRE-secNLuc) to examine the activating transcription factor-6 (ATF6) and inositol-requiring enzyme 1 (IRE1) pathways of the UPR.", {"entities": [[200, 204, "GENE"]]}], ["We observed an upregulation of endogenous ATF6- and XBP1-regulated genes following pharmacologically-induced ER stress that was consistent with responsiveness of the UPRE sensor.", {"entities": []}], ["Both GLuc and NLuc-based reporters have favorable properties for in vivo studies, however, they are not easily used in combination due to overlapping substrate activities.", {"entities": []}], ["We describe a method to measure the enzymatic activities of both reporters from a single sample and validated the approach using culture medium and rat blood samples to measure GLuc-SERCaMP and UPRE-secNLuc.", {"entities": []}], ["Measuring GLuc and NLuc activities from the same sample allows for the robust and quantitative measurement of two cellular events or cell populations from a single biological sample.", {"entities": []}], ["This study is the first to describe the in vivo measurement of UPRE activation by sampling blood, using an approach that allows concurrent interrogation of two components of ER homeostasis.", {"entities": []}], ["As in many European countries, undocumented migrants in Denmark have restricted access to healthcare.", {"entities": []}], ["The aim of this study is to describe and analyse undocumented migrants' experiences of access to healthcare, use of alternative health-seeking strategies; and ER nurses' experiences in encounters with undocumented migrants.", {"entities": []}], ["Qualitative design using semi-structured interviews and observations.", {"entities": []}], ["The participants included ten undocumented South Asian migrants and eight ER nurses.", {"entities": []}], ["Undocumented migrants reported difficulties accessing healthcare.", {"entities": []}], ["The barriers to healthcare were: limited medical rights, arbitrariness in healthcare professionals' attitudes, fear of being reported to the police, poor language skills, lack of network with Danish citizens, lack of knowledge about the healthcare system and lack of knowledge about informal networks of healthcare professionals.", {"entities": []}], ["These barriers induced alternative health-seeking strategies, such as self-medication, contacting doctors in home countries and borrowing health insurance cards from Danish citizens.", {"entities": []}], ["ER nurses expressed willingness to treat all patients regardless of their migratory status, but also reported challenges in the encounters with undocumented migrants.", {"entities": []}], ["The challenges for ER nurses were: language barriers, issues of false identification, insecurities about the correct standard procedures and not always being able to provide appropriate care.", {"entities": []}], ["Undocumented migrants face formal and informal barriers to the Danish healthcare system, which lead to alternative health-seeking strategies that may have adverse effects on their health.", {"entities": []}], ["This study shows the need for policies and guidelines, which in accordance with international human rights law, ensure access to healthcare for undocumented migrants and give clarity to healthcare professionals.", {"entities": []}], ["In 2010, there were approximately 8.8 million incident cases of tuberculosis (TB) worldwide.", {"entities": [[64, 76, "DISEASE"]]}], ["The treatment of TB is at least six months long and may be complicated by a high pill burden.", {"entities": []}], ["In addition, TB patients often do not take their medication on schedule simply because they forget.", {"entities": []}], ["Mobile phone text messaging has the potential to help promote TB treatment adherence.", {"entities": []}], ["We, therefore, propose to conduct a review of current best evidence for the use of mobile phone text messaging to promote patient adherence to TB treatment.", {"entities": []}], ["This is a systematic review of the literature.", {"entities": []}], ["We will preferably include randomized controlled trials (RCTs).", {"entities": []}], ["However, non-randomized studies (NRS) will be considered if there is an inadequate number of RCTs.", {"entities": []}], ["We will search PubMed, EMBASE, CINAHL, CENTRAL, Science Citation Index, Africa-Wide Information, and WHOLIS electronic databases for eligible studies available by 30 November 2012 regardless of language or publication status.", {"entities": []}], ["We will also check reference lists for additional studies, identify abstracts from conference proceedings and communicate with authors for any relevant material.", {"entities": []}], ["At least two authors will independently screen search outputs, select studies, extract data and assess the risk of bias (using separate criteria for RCTs and NRS); resolving discrepancies by discussion and consensus.", {"entities": []}], ["We will assess clinical heterogeneity by examining the types of participants, interventions and outcomes in each study and pool studies judged to be clinically homogenous.", {"entities": []}], ["We will also assess statistical heterogeneity using the chi-square test of homogeneity and quantify it using the I-square statistic.", {"entities": []}], ["If study results are found to be statistically homogeneous (that is heterogeneity P > 0.1), we will pool them using the fixed-effect meta-analysis.", {"entities": []}], ["Otherwise, we will use random-effects meta-analysis.", {"entities": []}], ["We will calculate risk ratios and their corresponding 95% confidence intervals for dichotomous outcomes, and mean differences for continuous outcomes.", {"entities": []}], ["For other outcomes without quantitative data, a descriptive analysis will be used.", {"entities": []}], ["Our results can be used by researchers and policy-makers to help inform them of the efficacy of mobile phone text messaging interventions to promote patient adherence to TB treatment.", {"entities": []}], ["Much research worldwide is focussed on cost containment and better adherence to guidelines in healthcare.", {"entities": []}], ["The research focussing on professional behaviour is often performed in a well-controlled research setting.", {"entities": []}], ["In this study a large-scale implementation of a peer review strategy was tested on both test ordering and prescribing behaviour in primary care in the normal quality improvement setting.", {"entities": []}], ["We planned a cluster-RCT in existing local quality improvement collaboratives (LQICs) in primary care.", {"entities": []}], ["The study ran from January 2008 to January 2011.", {"entities": []}], ["LQICs were randomly assigned to one of two trial arms, with each arm receiving the same intervention of audit and feedback combined with peer review.", {"entities": []}], ["Both arms were offered five different clinical topics and acted as blind controls for the other arm.", {"entities": []}], ["The differences in test ordering rates and prescribing rates between both arms were analysed in an intention-to-treat pre-post analysis and a per-protocol analysis.", {"entities": []}], ["Twenty-one LQIC groups, including 197 GPs working in 88 practices, entered the trial.", {"entities": []}], ["The intention-to-treat analysis did not show a difference in the changes in test ordering or prescribing performance between intervention and control groups.", {"entities": []}], ["The per-protocol analysis showed positive results for half of the clinical topics.", {"entities": []}], ["The increase in total tests ordered was 3% in the intervention arm and 15% in the control arm.", {"entities": []}], ["For prescribing the increase in prescriptions was 20% in the intervention arm and 66% in the control group.", {"entities": []}], ["It was observed that the groups with the highest baseline test ordering and prescription volumes showed the largest improvements.", {"entities": []}], ["Our study shows that the results from earlier work could not be confirmed by our attempt to implement the strategy in the field.", {"entities": []}], ["We did not see a decrease in the volumes of tests ordered or of the drugs prescribed but were able to show a lesser increase instead.", {"entities": []}], ["Implementing the peer review with audit and feedback proved to be not feasible in primary care in the Netherlands.", {"entities": []}], ["This trial was registered at the Dutch trial register under number ISRCTN40008171 on August 7 The online version of this article (doi:10.1186/s12875-017-0605-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to investigate the prevalence of xenobiotic substances, such as caffeine, nicotine and illicit drugs (eg, cannabis and cocaine), in blood samples from first-trimester Danish pregnant women unaware of the screening.", {"entities": []}], ["A cross - sectional study examined 436 anonymised residual blood samples obtained during 2014 as part of the nationwide prenatal first-trimester screening programme.", {"entities": []}], ["The samples were analysed by ultra performance liquid chromatography with high-resolution time-of-flight mass spectrometry.", {"entities": []}], ["An antenatal clinic in a Danish city with 62\u2009000 inhabitants, where >95% of pregnant women joined the screening programme.", {"entities": []}], ["The prevalence and patterns of caffeine, nicotine, medication and illicit drug intake during the first trimester of pregnancy.", {"entities": []}], ["The prevalence of prescription and over-the-counter drug detection was 17.9%, including acetaminophen (8.9%) and antidepressants (3.0%), of which citalopram (0.9%) was the most frequent.", {"entities": []}], ["The prevalence of illegal drugs, indicators of smoking (nicotine/cotinine) and caffeine was 0.9%, 9.9%, and 76.4%, respectively.", {"entities": []}], ["Only 17.4% of women had no substance identified in their sample.", {"entities": []}], ["This study emphasises the need for further translational studies investigating lifestyle habits during pregnancy, as well as the underlying molecular mechanisms through which xenobiotic substances may affect placental function and fetal development.", {"entities": []}], ["Human migration implies adaptations to new environments, such as ways to benefit from the available biodiversity.", {"entities": []}], ["This study focused on the use of animal-derived remedies, and we investigated the effects of migration on the traditional medical system of the indigenous Truk\u00e1 people.", {"entities": []}], ["This ethnic group lives in Northeast Brazil and is currently distributed in four distinct villages.", {"entities": []}], ["In these villages, the zootherapeutic knowledge of 54 indigenous people was determined through semi-structured questionnaires given from September 2013 to January 2014.", {"entities": []}], ["The interviewees indicated 137 zootherapeutic uses involving 21 animal species.", {"entities": []}], ["The variety of species and their uses have a higher similarity between villages that are closer to each other, which can be a reflection of geographic and environmental factors.", {"entities": []}], ["However, even close villages showed a low similarity in the zootherapeutic uses recorded, which reflects a strong idiosyncrasy regarding the knowledge of each village.", {"entities": []}], ["Hence, each village may be influenced by the physical environment and contact with other cultures, which may maintain or reduce the contact of younger villages with the original village.", {"entities": []}], ["Although humans vary in their response to chemicals, comprehensive measures of susceptibility have generally not been incorporated into human risk assessment.", {"entities": []}], ["The U.S. EPA dose-response-based risk assessments for cancer and the RfD/RfC (reference dose-reference concentration) approach for noncancer risk assessments are assumed to protect vulnerable human subgroups.", {"entities": [[54, 60, "DISEASE"]]}], ["However, these approaches generally rely on default assumptions and do not consider the specific biological basis for potential susceptibility to a given toxicant.", {"entities": []}], ["In an effort to focus more explicitly on this issue, this article addresses biological factors that may affect human variability and susceptibility to trichloroethylene (TCE), a widely used halogenated industrial solvent.", {"entities": []}], ["In response to Executive Order 13045, which requires federal agencies to make protection of children a high priority in implementing their policies and to take special risks to children into account when developing standards, this article examines factors that may affect risk of exposure to TCE in children.", {"entities": []}], ["The influence of genetics, sex, altered health state, coexposure to alcohol, and enzyme induction on TCE toxicity are also examined.", {"entities": []}], ["In humans, allelic variants in Toll-like receptors (TLRs) associate with several pathologies.", {"entities": []}], ["However, the underlying cellular and molecular mechanisms of this association remain largely unknown.", {"entities": []}], ["Analysis of the human TLR9 promoter revealed that the C allele of the rs5743836 polymorphism generates several regulatory sites, including an IL-6-responding element.", {"entities": [[22, 26, "GENE"]]}], ["Here, we show that, in mononuclear cells carrying the TC genotype of rs5743836, IL-6 up-regulates TLR9 expression, leading to exacerbated cellular responses to CpG, including IL-6 production and B-cell proliferation.", {"entities": [[98, 102, "GENE"]]}], ["Our study uncovers a role for the rs5743836 polymorphism in B-cell biology with implications on TLR9-mediated diseases and on the therapeutic usage of TLR9 agonists/antagonists.", {"entities": [[96, 100, "GENE"], [151, 155, "GENE"]]}], ["Pneumonia is the largest cause of child deaths in Papua New Guinea (PNG), and hypoxaemia is the major complication causing death in childhood pneumonia, and hypoxaemia is a major factor in deaths from many other common conditions, including bronchiolitis, asthma, sepsis, malaria, trauma, perinatal problems, and obstetric emergencies.", {"entities": [[0, 9, "DISEASE"], [142, 151, "DISEASE"], [272, 279, "DISEASE"], [256, 262, "DISEASE"], [241, 254, "DISEASE"]]}], ["A reliable source of oxygen therapy can reduce mortality from pneumonia by up to 35%.", {"entities": [[62, 71, "DISEASE"]]}], ["However, in low and middle income countries throughout the world, improved oxygen systems have not been implemented at large scale in remote, difficult to access health care settings, and oxygen is often unavailable at smaller rural hospitals or district health centers which serve as the first point of referral for childhood illnesses.", {"entities": []}], ["These hospitals are hampered by lack of reliable power, staff training and other basic services.", {"entities": []}], ["We report the methodology of a large implementation effectiveness trial involving sustainable and renewable oxygen and power systems in 36 health facilities in remote rural areas of PNG.", {"entities": []}], ["The methodology is a before\u2013and after evaluation involving continuous quality improvement, and a health systems approach.", {"entities": []}], ["We describe this model of implementation as the considerations and steps involved have wider implications in health systems in other countries.", {"entities": []}], ["The implementation steps include: defining the criteria for where such an intervention is appropriate, assessment of power supplies and power requirements, the optimal design of a solar power system, specifications for oxygen concentrators and other oxygen equipment that will function in remote environments, installation logistics in remote settings, the role of oxygen analyzers in monitoring oxygen concentrator performance, the engineering capacity required to sustain a program at scale, clinical guidelines and training on oxygen equipment and the treatment of children with severe respiratory infection and other critical illnesses, program costs, and measurement of processes and outcomes to support continuous quality improvement.", {"entities": []}], ["This study will evaluate the feasibility and sustainability issues in improving oxygen systems and providing reliable power on a large scale in remote rural settings in PNG, and the impact of this on child mortality from pneumonia over 3 years post\u2013intervention.", {"entities": [[221, 230, "DISEASE"]]}], ["Taking a continuous quality improvement approach can be transformational for remote health services.", {"entities": []}], ["Bronchus-associated lymphoid tissue (BALT) is the secondary lymphoid tissue in bronchial mucosa and is involved in the development of bronchopulmonary immune responses.", {"entities": []}], ["Although migration of lymphocytes from blood vessels into secondary lymphoid tissues is critical for the development of appropriate adaptive immunity, the endothelia and lymphocyte adhesion molecules that recruit specific subsets of lymphocytes into human BALT are not known.", {"entities": []}], ["The aim of this study was to determine which adhesion molecules are expressed on lymphocytes and high endothelial venules (HEVs) in human BALT.", {"entities": []}], ["We immunostained frozen sections of BALT from lobectomy specimens from 17 patients with lung carcinoma with a panel of monoclonal antibodies to endothelia and lymphocyte adhesion molecules.", {"entities": [[93, 102, "DISEASE"], [88, 102, "DISEASE"]]}], ["Sections of BALT showed B cell follicles surrounded by T cells.", {"entities": []}], ["Most BALT CD4 4 integrin and L-selectin.", {"entities": [[10, 13, "GENE"]]}], ["In contrast, 43% of BALT T cells expressed \u03b1 4 integrin and 20% of BALT T cells expressed L-selectin.", {"entities": []}], ["Almost all BALT lymphocytes expressed LFA-1.", {"entities": []}], ["HEVs, which support the migration of lymphocytes from the bloodstream into secondary lymphoid tissues, were prominent in BALT.", {"entities": []}], ["All HEVs expressed peripheral node addressin, most HEVs expressed vascular cell adhesion molecule-1, and no HEVs expressed mucosal addressin cell adhesion molecule-1.", {"entities": []}], ["Human BALT expresses endothelia and lymphocyte adhesion molecules that may be important in recruiting naive and memory/effector lymphocytes to BALT during protective and pathologic bronchopulmonary immune responses.", {"entities": []}], ["Nanoparticles are materials with overall dimensions in the nanoscale, ie, under 100 nm.", {"entities": []}], ["In recent years, these materials have emerged as important players in modern medicine, with clinical applications ranging from contrast agents in imaging to carriers for drug and gene delivery into tumors.", {"entities": []}], ["Indeed, there are some instances where nanoparticles enable analyses and therapies that simply cannot be performed otherwise.", {"entities": []}], ["However, nanoparticles also bring with them unique environmental and societal challenges, particularly in regard to toxicity.", {"entities": []}], ["This review aims to highlight the major contributions of nanoparticles to modern medicine and also discuss environmental and societal aspects of their use.", {"entities": []}], ["In contrast to other Bet v 1\u2010related food allergens, the major carrot allergen, Dau c 1, has been suggested to induce food allergy independently from Bet v 1.", {"entities": [[118, 130, "DISEASE"]]}], ["As T cells are crucial in the sensitization process, we sought to characterize the T\u2010cell response to Dau c 1 and its cross\u2010reactivity with Bet v 1.", {"entities": []}], ["Dau c 1\u2010specific T\u2010cell lines ( TCL ) and clones ( TCC ) established from PBMC of birch pollen\u2010allergic patients with carrot allergy were analyzed for reactivity to Bet v 1, epitope specificity, allergen\u2010induced cytokine secretion, and expression of integrins \u03b14\u03b27 and \u03b14\u03b21, critical for gut and lung homing, respectively.", {"entities": []}], ["mRNA expression of GATA 3 and Tbet was analyzed in sorted CD 3 CD 4 CFSE PBMC with Dau c 1 or Bet v 1.", {"entities": []}], ["Dau c 1 was incubated with endolysosomal proteases, and the resulting fragments were identified by mass spectrometry.", {"entities": []}], ["Among 14 distinct T\u2010cell\u2010activating regions, Dau c 1 139\u2013153 was recognized by 55% of the patients.", {"entities": []}], ["Only 6 of 15 (40%) Dau c 1\u2010specific TCL and 9 of 21 (43%) TCC reacted with Bet v 1.", {"entities": []}], ["Bet v 1\u2010nonreactive TCC were mainly Th1\u2010like and showed a higher expression of the integrin \u03b27 and a significantly lower expression of the integrin \u03b21 than Bet v 1\u2010positive TCC .", {"entities": []}], ["A Th1\u2010like response was also detected in Dau c 1\u2010reactive CD 3 CD 4 CFSE Dau c 1 displays several characteristics of sensitizing allergens, namely a major T\u2010cell\u2010activating region, low susceptibility to endolysosomal degradation, and induction of a Bet v 1\u2010independent T\u2010cell response.", {"entities": []}], ["These cellular insights confirm that the major carrot allergen has a special status among Bet v 1\u2010related food allergens.", {"entities": []}], ["General practitioners can record patients\u2019 presenting symptoms by using a code or free text.", {"entities": []}], ["We compared breathlessness and wheeze symptom codes and free text recorded prior to diagnosis of ischaemic heart disease (IHD), chronic obstructive pulmonary disease (COPD) and asthma.", {"entities": [[107, 120, "DISEASE"], [128, 165, "DISEASE"], [177, 183, "DISEASE"]]}], ["A case\u2013control study.", {"entities": []}], ["11 general practices in North Staffordshire, UK, contributing to the Consultations in Primary Care Archive consultation database.", {"entities": []}], ["Cases with an incident diagnosis of IHD, COPD or asthma in 2010 were matched to controls (four per case) with no such diagnosis.", {"entities": [[49, 55, "DISEASE"]]}], ["All prior consultations with codes for breathlessness or wheeze symptoms between 2004 and 2010 were identified.", {"entities": []}], ["Free text of cases and controls were also searched for mention of these symptoms.", {"entities": []}], ["592 cases were identified, 194 (33%) with IHD, 182 (31%) with COPD and 216 (37%) with asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["148 (25%) cases and 125 (5%) controls had a prior coded consultation for breathlessness.", {"entities": []}], ["Prevalence of a prior coded symptom of breathlessness or wheeze was 30% in cases, 6% in controls.", {"entities": []}], ["Median time from first coded symptom to diagnosis among cases was 57\u2005weeks.", {"entities": []}], ["After adding symptoms recorded in text, prevalence rose to 62% in cases and 25% in controls.", {"entities": []}], ["Median time from first recorded symptom increased to 144\u2005weeks.", {"entities": []}], ["The associations between diagnosis of cases and prior symptom codes was strong IHD relative risk ratio (RRR) 3.21 (2.15 to 4.79); COPD RRR 9.56 (6.74 to 13.60); asthma RRR 10.30 (7.17 to 14.90).", {"entities": [[161, 167, "DISEASE"]]}], ["There is an association between IHD, COPD and asthma diagnosis and earlier consultation for respiratory symptoms.", {"entities": [[46, 52, "DISEASE"]]}], ["Symptoms are often noted in free text by GPs long before they are coded.", {"entities": []}], ["Free text searching may aid investigation of early presentation of long-term conditions using GP databases, and may be an important direction for future research.", {"entities": []}], ["Registry studies provide a valuable source of comparative safety data for tumor necrosis factor inhibitors (TNFi) used in rheumatoid arthritis (RA), but they are subject to channeling bias.", {"entities": [[122, 142, "DISEASE"], [133, 142, "DISEASE"]]}], ["Comparing safety outcomes without accounting for channeling bias can lead to inaccurate comparisons between TNFi prescribed at different stages of the disease.", {"entities": []}], ["In the present study, we examined the incidence of serious infection and other adverse events during certolizumab pegol (CZP) use vs other TNFi in a U.S. RA cohort before and after using a methodological approach to minimize channeling bias.", {"entities": []}], ["Patients with RA enrolled in the Corrona registry, aged \u2265\u200918\u00a0years, initiating CZP or other TNFi (etanercept, adalimumab, golimumab, or infliximab) after May 1, 2009 ( n \u2009=\u20096215 initiations), were followed for \u2264\u200912\u00a0months.", {"entities": []}], ["A propensity score (PS) model was used to control for baseline characteristics associated with the probability of receiving CZP vs other TNFi.", {"entities": []}], ["Incidence rate ratios (IRRs) of serious infectious events (SIEs), malignancies, and cardiovascular events (CVEs) in the CZP group vs other TNFi group were calculated with 95% CIs, before and after PS matching.", {"entities": []}], ["Patients were more likely to initiate CZP later in the course of therapy than those initiating other TNFi.", {"entities": []}], ["CZP initiators ( n \u2009=\u2009975) were older and had longer disease duration, more active disease, and greater disability than other TNFi initiators ( n \u2009=\u20095240).", {"entities": []}], ["After PS matching, there were no clinically important differences between CZP ( n \u2009=\u2009952) and other TNFi ( n \u2009=\u2009952).", {"entities": []}], ["Before PS matching, CZP was associated with a greater incidence of SIEs (IRR 1.53 [95% CI 1.13, 2.05]).", {"entities": []}], ["The risk of SIEs was not different between groups after PS matching (IRR 1.26 [95% CI 0.84, 1.90]).", {"entities": []}], ["The 95% CI of the IRRs for malignancies or CVEs included unity, regardless of PS matching, suggesting no difference in risk between CZP and other TNFi.", {"entities": []}], ["After using PS matching to minimize channeling bias and compare patients with a similar likelihood of receiving CZP or other TNFi, the 1-year risk of SIEs, malignancies, and CVEs was not distinguishable between the two groups.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-017-1496-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Biomarkers are considered the method of choice for determining exposure to environmental contaminants and relating such exposures to health outcomes.", {"entities": []}], ["However, the association between many biomarkers and outcome is not direct because of variability in sensitivity and susceptibility in the individual.", {"entities": []}], ["We explore the relationship between environmental exposures and health outcomes as mitigated by differential susceptibility in individuals or populations and address the question \u201cCan biomarkers enable us to understand and quantify better the population burden of disease and health effects attributable to environmental exposures?\u201d We use a case\u2013study approach to develop the thesis that biomarkers offer a pathway to disaggregation of health effects into specific, if multiple, risk factors.", {"entities": []}], ["We offer the point of view that a series or array of biomarkers, including biomarkers of exposure, biomarkers of susceptibility, and biomarkers of effect, used in concert offer the best means by which to effect this disaggregation.", {"entities": []}], ["We commence our discussion by developing the characteristics of an ideal biomarker, then give some examples of commonly used biomarkers to show the strengths and weaknesses of current usage.", {"entities": []}], ["We follow this by more detailed case-study assessment outlining the state-of-the-science in specific cases.", {"entities": []}], ["We complete our work with recommendations regarding the future use of biomarkers and areas for continued development.", {"entities": []}], ["The case studies provide examples of when and how biomarkers can be used to infer the source and magnitude of exposure among a set of competing sources and pathways.", {"entities": []}], ["The answer to this question is chemical specific and relates to how well the biomarker matches the characteristics of an \u201cideal\u201d biomarker\u2013in particular ease of collection and persistence.", {"entities": []}], ["The use of biomarkers in combination provides a better opportunity to disaggregate both source and pathway contributions.", {"entities": []}], ["This systematic literature review aimed to summarize evidence for the added value of drug sales data analysis for the surveillance of infectious diseases.", {"entities": []}], ["A search for relevant publications was conducted in Pubmed, Embase, Scopus, Cochrane Library, African Index Medicus and Lilacs databases.", {"entities": []}], ["Retrieved studies were evaluated in terms of objectives, diseases studied, data sources, methodologies and performance for real-time surveillance.", {"entities": []}], ["Most studies compared drug sales data to reference surveillance data using correlation measurements or indicators of outbreak detection performance (sensitivity, specificity, timeliness of the detection).", {"entities": []}], ["We screened 3266 articles and included 27 in the review.", {"entities": []}], ["Most studies focused on acute respiratory and gastroenteritis infections.", {"entities": [[46, 61, "DISEASE"]]}], ["Nineteen studies retrospectively compared drug sales data to reference clinical data, and significant correlations were observed in 17 of them.", {"entities": []}], ["Four studies found that over-the-counter drug sales preceded clinical data in terms of incidence increase.", {"entities": []}], ["Five studies developed and evaluated statistical algorithms for selecting drug groups to monitor specific diseases.", {"entities": []}], ["Another three studies developed models to predict incidence increase from drug sales.", {"entities": []}], ["Drug sales data analyses appear to be a useful tool for surveillance of gastrointestinal and respiratory disease, and OTC drugs have the potential for early outbreak detection.", {"entities": [[118, 121, "GENE"]]}], ["Their utility remains to be investigated for other diseases, in particular those poorly surveyed.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-014-0604-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Earlier, the association of single nucleotide polymorphisms (SNPs) with toxicity and efficacy of sunitinib has been explored in patients with metastatic renal cell carcinoma (mRCC).", {"entities": [[164, 173, "DISEASE"], [153, 173, "DISEASE"]]}], ["Recently, additional SNPs have been suggested as potential biomarkers.", {"entities": []}], ["We investigated these novel SNPs for association with sunitinib treatment outcome in mRCC patients.", {"entities": []}], ["In this exploratory study, we selected SNPs in genes CYP3A4 , NR1I2 , POR , IL8 , IL13 , IL4-R , HIF1A and MET that might possibly be associated with sunitinib treatment outcome.", {"entities": [[53, 59, "GENE"], [62, 67, "GENE"], [70, 73, "GENE"], [76, 79, "GENE"], [82, 86, "GENE"], [97, 102, "GENE"]]}], ["Each SNP was tested for association with progression-free survival (PFS) and overall survival (OS) by Cox-regression analysis and for clinical response and toxicity using logistic regression.", {"entities": []}], ["We included 374 patients for toxicity analyses, of which 38 patients with non-clear cell renal cell cancer were excluded from efficacy analyses.", {"entities": [[100, 106, "DISEASE"]]}], ["The risk for hypertension was increased in the presence of the T allele in IL8 rs1126647 (OR\u2009=\u20091.69, 95\u00a0% CI\u2009=\u20091.07\u20132.67, P \u2009=\u20090.024).", {"entities": [[13, 25, "DISEASE"], [75, 78, "GENE"]]}], ["The T allele in IL13 rs1800925 was associated with an increase in the risk of leukopenia (OR\u2009=\u20096.76, 95\u00a0% CI\u2009=\u20091.35\u201333.9, P \u2009=\u20090.020) and increased prevalence of any toxicity > grade 2 (OR\u2009=\u20091.75, 95\u00a0% CI\u2009=\u20091.06\u20132.88, P \u2009=\u20090.028).", {"entities": [[78, 88, "DISEASE"], [16, 20, "GENE"]]}], ["No significant associations were found with PFS, OS or clinical response.", {"entities": []}], ["We show that polymorphisms in IL8 rs1126647 and IL13 rs1800925 are associated with sunitinib-induced toxicities.", {"entities": [[30, 33, "GENE"], [48, 52, "GENE"]]}], ["Validation in an independent cohort is required.", {"entities": []}], ["The online version of this article (doi:10.1007/s00228-015-1935-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Food allergies are caused by immunological reactions in individuals sensitized to normal protein components of foods.", {"entities": []}], ["For any given sensitized individual, the severity of a reaction is generally assumed to be proportional to the dose of allergenic protein.", {"entities": []}], ["There is substantial clinical evidence that \u201cthreshold\u201d doses exist for the elicitation of an allergic reaction; however, the threshold (i.e., lowest dose that elicits a reaction) varies substantially across the sensitized population.", {"entities": []}], ["Current approaches to protecting sensitized individuals from exposure to food allergens are highly qualitative (i.e., they rely on food avoidance).", {"entities": []}], ["The Key Events Dose-Response Framework is an analytical approach for refining understanding of the biological basis of the dose-response.", {"entities": []}], ["Application of this approach to food allergy provides a foundation for a more rigorous quantitative understanding of variability in allergic response.", {"entities": [[32, 44, "DISEASE"]]}], ["This study reviews the allergic disease process and the current approaches to identifying thresholds for food allergens.", {"entities": []}], ["The pathway of key biological events occurring between food intake and allergic response is considered, along with factors that may determine the nature and severity of response to food allergens.", {"entities": []}], ["Data needs, as well as implications for identifying thresholds, and for characterizing variability in thresholds, are also discussed.", {"entities": []}], ["The AGREE II instrument is the most commonly used guideline appraisal tool.", {"entities": []}], ["It includes 23 appraisal criteria (items) organized within six domains.", {"entities": []}], ["AGREE II also includes two overall assessments (overall guideline quality, recommendation for use).", {"entities": []}], ["Our aim was to investigate how strongly the 23 AGREE II items influence the two overall assessments.", {"entities": []}], ["An online survey of authors of publications on guideline appraisals with AGREE II and guideline users from a German scientific network was conducted between 10th February 2015 and 30th March 2015.", {"entities": []}], ["Participants were asked to rate the influence of the AGREE II items on a Likert scale (0\u2009=\u2009no influence to 5\u2009=\u2009very strong influence).", {"entities": []}], ["The frequencies of responses and their dispersion were presented descriptively.", {"entities": []}], ["Fifty-eight of the 376 persons contacted (15.4%) participated in the survey and the data of the 51 respondents with prior knowledge of AGREE II were analysed.", {"entities": []}], ["Items 7\u201312 of Domain 3 (rigour of development) and both items of Domain 6 (editorial independence) had the strongest influence on the two overall assessments.", {"entities": []}], ["In addition, Items 15\u201317 (clarity of presentation) had a strong influence on the recommendation for use.", {"entities": []}], ["Great variations were shown for the other items.", {"entities": []}], ["The main limitation of the survey is the low response rate.", {"entities": []}], ["In guideline appraisals using AGREE II, items representing rigour of guideline development and editorial independence seem to have the strongest influence on the two overall assessments.", {"entities": []}], ["In order to ensure a transparent approach to reaching the overall assessments, we suggest the inclusion of a recommendation in the AGREE II user manual on how to consider item and domain scores.", {"entities": []}], ["For instance, the manual could include an a-priori weighting of those items and domains that should have the strongest influence on the two overall assessments.", {"entities": []}], ["The relevance of these assessments within AGREE II could thereby be further specified.", {"entities": []}], ["The online version of this article (10.1186/s12913-018-2954-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Empiric antimicrobial selection for critical care infections must balance the need for timely adequate coverage with the resistance pressure exerted by broadspectrum agents.", {"entities": []}], ["We estimated the potential of weighted incidence syndromic combination antibiograms (WISCAs) to improve time to adequate coverage for critical care infections.", {"entities": []}], ["In contrast to traditional antibiograms, WISCAs display the likelihood of coverage for a specific infectious syndrome (rather than individual pathogens), and also take into account the potential for poly-microbial infections and the use of multi-drug regimens.", {"entities": [[109, 117, "DISEASE"]]}], ["Cases of ventilator-associated pneumonia (VAP) and catheter-related bloodstream infection (CRBSI) were identified over three years using stringent surveillance criteria.", {"entities": [[31, 40, "DISEASE"]]}], ["Based on the susceptibility profile of the culprit pathogens, we calculated the WISCA percentages of infections that would have been adequately covered by common antimicrobial(s).", {"entities": []}], ["We then computed the excess percentage coverage offered by WISCA regimens compared to the actual antimicrobials administered to patients by 12\u00a0h, 24\u00a0h, and 48\u00a0h from culture collection.", {"entities": []}], ["Among 163 patients with critical care infection, standard practice only resulted in adequate coverage of 35% of patients by 12\u00a0h, 52% by 24\u00a0h, and 75% by 48\u00a0h. No WISCA mono-therapy regimen offered greater than 85% adequate overall coverage for VAP and CRBSI.", {"entities": []}], ["A wide range of dual therapy regimens would have conferred greater than 90% adequate coverage, with excess coverage estimated to be as high as +56%, +42% and +18% at 12\u00a0h, 24\u00a0h and 48\u00a0h, respectively.", {"entities": []}], ["We did not detect a decrease in mortality associated with early adequate treatment, and so could not estimate potential downstream benefits.", {"entities": []}], ["WISCA-derived empiric antimicrobial regimens can be calculated for patients with intensive care unit (ICU)-acquired infections, and have the potential to reduce time to adequate treatment.", {"entities": []}], ["Prospective research must confirm whether implementation of WISCA prescribing aids facilitate timely adequate treatment and improved ICU outcomes.", {"entities": []}], ["Multimorbidity is a phenomenon with high burden and high prevalence in the elderly.", {"entities": []}], ["Our previous research has shown that multimorbidity can be divided into the multimorbidity patterns of 1) anxiety, depression, somatoform disorders (ADS) and pain, and 2) cardiovascular and metabolic disorders.", {"entities": []}], ["However, it is not yet known, how these patterns are influenced by patient characteristics.", {"entities": []}], ["The objective of this paper is to analyze the association of socio-demographic variables, and especially socio-economic status with multimorbidity in general and with each multimorbidity pattern.", {"entities": []}], ["The MultiCare Cohort Study is a multicentre, prospective, observational cohort study of 3.189 multimorbid patients aged 65+ randomly selected from 158 GP practices.", {"entities": []}], ["Data were collected in GP interviews and comprehensive patient interviews.", {"entities": []}], ["Missing values have been imputed by hot deck imputation based on Gower distance in morbidity and other variables.", {"entities": []}], ["The association of patient characteristics with the number of chronic conditions is analysed by multilevel mixed-effects linear regression analyses.", {"entities": []}], ["Multimorbidity in general is associated with age (+0.07 chronic conditions per year), gender (-0.27 conditions for female), education (-0.26 conditions for medium and -0.29 conditions for high level vs. low level) and income (-0.27 conditions per logarithmic unit).", {"entities": []}], ["The pattern of cardiovascular and metabolic disorders shows comparable associations with a higher coefficient for gender (-1.29 conditions for female), while multimorbidity within the pattern of ADS and pain correlates with gender (+0.79 conditions for female), but not with age or socioeconomic status.", {"entities": []}], ["Our study confirms that the morbidity load of multimorbid patients is associated with age, gender and the socioeconomic status of the patients, but there were no effects of living arrangements and marital status.", {"entities": []}], ["We could also show that the influence of patient characteristics is dependent on the multimorbidity pattern concerned, i.e.", {"entities": []}], ["there seem to be at least two types of elderly multimorbid patients.", {"entities": []}], ["First, there are patients with mainly cardiovascular and metabolic disorders, who are more often male, have an older age and a lower socio-economic status.", {"entities": []}], ["Second, there are patients mainly with ADS and pain-related morbidity, who are more often female and equally distributed across age and socio-economic groups.", {"entities": []}], ["ISRCTN89818205", {"entities": []}], ["Mucosal tissues contain large numbers of memory CD4", {"entities": [[48, 51, "GENE"]]}], ["Camel milk (CM) is gaining increasing recognition due to its beneficial effects in the control and prevention of multiple health problems.", {"entities": []}], ["The current study aimed to investigate the effects of CM on the hepatic biochemical and cellular alterations induced by a high-fat, cholesterol-rich diet (HCD), specifically, non-alcoholic fatty liver disease (NAFLD).", {"entities": [[189, 208, "DISEASE"], [195, 208, "DISEASE"]]}], ["Seventy male Wistar rats were divided into four groups: the Control (C) Group fed a standard diet; the Control\u2009+\u2009camel milk (CCM) Group fed a standard diet and CM, the Cholesterol (Ch) Group fed a HCD with no CM, and the Cholesterol\u2009+\u2009camel milk (ChM) Group fed a HCD and CM.", {"entities": [[247, 250, "GENE"]]}], ["The following parameters were investigated in the studied groups; basal, weekly random and final fasting blood glucose levels, intraperitoneal glucose tolerance test (GTT) and insulin tolerance test (ITT), serum insulin, serum lipids, liver functions, lipid peroxidation products, the antioxidant activity of catalase (CAT) and the levels of reduced glutathione (GSH).", {"entities": []}], ["In addition, HOMA-IR as an index of insulin resistance (IR) and the histopathology of the hepatic tissue were assessed.", {"entities": []}], ["The Ch Group developed features similar to those of non-alcoholic steatohepatitis (NASH), characterized by hepatic steatosis; inflammatory cellular infiltration in liver tissue; altered liver functions; and increased total cholesterol, triglycerides, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, atherogenic index (AI), blood glucose, IR, and malondialdehyde (MDA) levels.", {"entities": []}], ["Additionally, feeding the HCD to animals in the Ch Group decreased CAT activity and the GSH and high-density lipoprotein (HDL) cholesterol levels.", {"entities": []}], ["Camel milk intake for eight weeks decreased hepatic fat accumulation and inflammatory cellular infiltration, preserved liver function, increased the GSH levels and CAT activity, decreased the MDA levels, and ameliorated the changes in the lipid profile, AI, and IR in animals from the ChM Group.", {"entities": [[285, 288, "GENE"]]}], ["CM has a unique composition that is rich in minerals; vitamins, insulin and insulin-like protein, and it increased HDL-cholesterol and ameliorated the biochemical and cellular features of NAFLD in rats that received a HCD.", {"entities": []}], ["The antioxidant effect of CM is a likely mechanism for the altered metabolism and absorption of HCD in the presence of CM.", {"entities": []}], ["Regular consumption of CM could provide a natural way to protect against NAFLD induced by a high-fat diet.", {"entities": []}], ["Random Forest is a prediction technique based on growing trees on bootstrap samples of data, in conjunction with a random selection of explanatory variables to define the best split at each node.", {"entities": []}], ["In the case of a quantitative outcome, the tree predictor takes on a numerical value.", {"entities": []}], ["We applied Random Forest to the first replicate of the Genetic Analysis Workshop 13 simulated data set, with the sibling pairs as our units of analysis and identity by descent (IBD) at selected loci as our explanatory variables.", {"entities": []}], ["With the knowledge of the true model, we performed two sets of analyses on three phenotypes: HDL, triglycerides, and glucose.", {"entities": []}], ["The goal was to approach the mapping of complex traits from a multivariate perspective.", {"entities": []}], ["The first set of analyses mimics a candidate gene approach with a high proportion of true genes among the predictors while the second set represents a genome scan analysis using microsatellite markers.", {"entities": []}], ["Random Forest was able to identify a few of the major genes influencing the phenotypes, such as baseline HDL and triglycerides, but failed to identify the major genes regulating baseline glucose levels.", {"entities": []}], ["Associations between measures of subjective health and mortality risk have previously been shown.", {"entities": []}], ["We assessed the impact and comparative predictive performance of a multi-biomarker panel on this association.", {"entities": []}], ["Data from 4,261 individuals aged 20-79 years recruited for the population-based Study of Health in Pomerania was used.", {"entities": []}], ["During an average 9.7 year follow-up, 456 deaths (10.7%) occurred.", {"entities": []}], ["Subjective health was assessed by SF-12 derived physical (PCS-12) and mental component summaries (MCS-12), and a single-item self-rated health (SRH) question.", {"entities": []}], ["We implemented Cox proportional-hazards regression models to investigate the association of subjective health with mortality and to assess the impact of a combination of 10 biomarkers on this association.", {"entities": []}], ["Variable selection procedures were used to identify a parsimonious set of subjective health measures and biomarkers, whose predictive ability was compared using receiver operating characteristic (ROC) curves, C-statistics, and reclassification methods.", {"entities": []}], ["In age- and gender-adjusted Cox models, poor SRH (hazard ratio (HR), 2.07; 95% CI, 1.34-3.20) and low PCS-12 scores (lowest vs. highest quartile: HR, 1.75; 95% CI, 1.31-2.33) were significantly associated with increased risk of all-cause mortality; an association independent of various covariates and biomarkers.", {"entities": [[64, 66, "GENE"], [146, 148, "GENE"], [64, 66, "GENE"], [146, 148, "GENE"]]}], ["Furthermore, selected subjective health measures yielded a significantly higher C-statistic (0.883) compared to the selected biomarker panel (0.872), whereas a combined assessment showed the highest C-statistic (0.887) with a highly significant integrated discrimination improvement of 1.5% (p < 0.01).", {"entities": []}], ["Adding biomarker information did not affect the association of subjective health measures with mortality, but significantly improved risk stratification.", {"entities": []}], ["Thus, a combined assessment of self-reported subjective health and measured biomarkers may be useful to identify high-risk individuals for intensified monitoring.", {"entities": []}], ["Kiran Jobanputra and colleagues argue that better evidence, guidance, and tools are needed to improve the effectiveness and feasibility of noncommunicable disease care in humanitarian settings.", {"entities": []}], ["There is an increasing recognition of epidemics of primarily tubular-interstitial chronic kidney disease (CKD) clustering in agricultural communities in low-\u00a0and\u00a0middle-income countries (LMICs).", {"entities": [[90, 104, "DISEASE"]]}], ["Although it is currently unclear whether there is a unified underlying aetiology, these conditions have been collectively termed CKD of undetermined cause (CKDu).", {"entities": []}], ["CKDu is estimated to have led to the premature deaths of tens to hundreds of thousands of young men and women over the last 2 decades.", {"entities": []}], ["Thus, there is an urgent need to understand the aetiology and pathophysiology of these condition (s).", {"entities": []}], ["International comparisons have provided the first steps in understanding many chronic diseases, but such comparisons rely on the availability of standardised tools to estimate disease prevalence.", {"entities": []}], ["This is a particular problem with CKD, since the disease is asymptomatic until the late stages, and the biases inherent in the methods used to estimate the glomerular filtration rate (GFR) in population studies are highly variable across populations.", {"entities": []}], ["We therefore propose a simple standardised protocol to estimate the distribution of GFR in LMIC populations \u2013 The Disadvantaged Populations eGFR Epidemiology (DEGREE) Study.", {"entities": [[140, 144, "GENE"]]}], ["This involves the quantification of renal function in a representative adult population-based sample and a requirement for standardisation of serum creatinine measurements, along with storage of samples for future measurements of cystatin C and ascertainment of estimates of body composition, in order to obtain valid comparisons of estimated GFR (eGFR) within and between populations.", {"entities": [[348, 352, "GENE"]]}], ["The methodology we present is potentially applicable anywhere, but our particular focus is on disadvantaged populations in LMICs, since these appear to be most susceptible to CKDu.", {"entities": []}], ["Although the protocol could also be used in specific groups (e.g.", {"entities": []}], ["occupational groups, thought to be at excess risk of CKDu) the primary aim of the DEGREE project is characterise the population distribution of eGFR in multiple regions so that international comparisons can be performed.", {"entities": [[144, 148, "GENE"]]}], ["It is only with a standardised approach that it will be possible to estimate the scale of, and variation in, impaired kidney function between affected areas.", {"entities": []}], ["These data should then provide insights into important social, demographic and environmental risk factors for this increasingly recognised disease.", {"entities": []}], ["The online version of this article (doi:10.1186/s12882-016-0417-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asylum seekers, refugees and persons without legal status have been reported to experience a range of difficulties when accessing public services and supports in the UK.", {"entities": []}], ["While research has identified health care barriers to equitable access such as language difficulties, it has not considered the broader social contexts of marginalization experienced through the dynamics of \u2018othering\u2019.", {"entities": []}], ["The current study explores health and health care experiences of Somali and Iraqi asylum seekers, refugees and persons without legal status, highlighting \u2018minoritization\u2019 processes and the \u2018pathologization\u2019 of difference as analytical lenses to understand the multiple layers of oppression that contribute to health inequities.", {"entities": []}], ["For the study, qualitative methods were used to document the lived experiences of asylum seekers, refugees and persons without legal status.", {"entities": []}], ["Thirty-five in-depth interviews and five focus groups were used to explore personal accounts, reveal shared understandings and enable social, cognitive and emotional understandings of on-going health problems and challenges when seeking treatment and care.", {"entities": []}], ["A participatory framework was undertaken which inspired collaborative workings with local organizations that worked directly with asylum seekers, refugees and persons without legal status.", {"entities": []}], ["The analysis revealed four key themes: 1) pre-departure histories and post-arrival challenges; 2) legal status; 3) health knowledges and procedural barriers as well as 4) language and cultural competence.", {"entities": []}], ["Confidentiality, trust, wait times and short doctor-patient consultations were emphasized as being insufficient for culturally specific communications and often translating into inadequate treatment and care.", {"entities": []}], ["Barriers to accessing health care was associated with social disadvantage and restrictions of the broader welfare system suggesting that a re-evaluation of the asylum seeking process is required to improve the situation.", {"entities": []}], ["Macro- and micro-level intersections of accustomed societal beliefs, practices and norms, broad-levellegislation and policy decisions, and health care and social services delivery methods have affected the health and health care experiences of forced migrants that reside in the UK.", {"entities": []}], ["Research highlights how \u2018minoritization processes,\u2019 influencing the intersections between social identities, can hinder access to and delivery of health and social services to vulnerable groups.", {"entities": []}], ["Similar findings were reported here; and the most influential mechanism directly impacting health and access to health and social services was legal status.", {"entities": []}], ["Equitable health care provision requires systemic change that incorporate understandings of marginalization, \u2018othering\u2019 processes and the intersections between the past histories and everyday realities of asylum seekers, refugees and persons without legal status.", {"entities": []}], ["We aimed to evaluate the risk factors in preschool children admitted to inpatient services with a diagnosis of recurrent attacks of wheezing.", {"entities": []}], ["The medical files of 44 preschool children with 2 or more recurrent hospitalizations resulting from wheezing between November 2011 and January 2012 were retrospectively investigated.", {"entities": []}], ["There were 28 males (64 %) and 16 females.", {"entities": []}], ["The median age was 14 months (2.0\u201350).", {"entities": []}], ["The median numbers of previous wheezing attacks and hospitalizations were 4 (2\u201310) and 2 (2\u20138), respectively.", {"entities": []}], ["Fourteen patients (32 %) had been treated for gastroesophageal reflux (GER).", {"entities": []}], ["The previous and recent hospital evaluations were investigated.", {"entities": []}], ["Bronchopulmonary dysplasia and anemia were significantly more common in patients with 3 or more hospitalizations for wheezing than in those with 2 hospitalizations ( p = 0.010 and p < 0.001, respectively).", {"entities": [[31, 37, "DISEASE"]]}], ["A review of the cases with 3 or more hospitalizations revealed that a history of GER and anemia were significant risk factors.", {"entities": [[89, 95, "DISEASE"]]}], ["Anemia and GER are risk factors for recurrent hospitalizations resulting from wheezing and should be treated.", {"entities": [[0, 6, "DISEASE"]]}], ["If the history and physical examination suggest asthma, inhaler therapy treatment should be administered, with other investigations planned for patients who do not respond to treatment as expected.", {"entities": [[48, 54, "DISEASE"]]}], ["Oropharyngeal mucosal epithelia of fetuses/neonates/infants and the genital epithelia of adults play a critical role in HIV-1 mother-to-child transmission and sexual transmission of virus, respectively.", {"entities": []}], ["To study the mechanisms of HIV-1 transmission through mucosal epithelium, we established polarized tonsil, cervical and foreskin epithelial cells.", {"entities": []}], ["Analysis of HIV-1 transmission through epithelial cells showed that approximately 0.05% of initially inoculated virions transmigrated via epithelium.", {"entities": []}], ["More than 90% of internalized virions were sequestered in the endosomes of epithelial cells, including multivesicular bodies (MVBs) and vacuoles.", {"entities": []}], ["Intraepithelial HIV-1 remained infectious for 9 days without viral release.", {"entities": []}], ["Release of sequestered intraepithelial HIV-1 was induced by the calcium ionophore ionomycin and by cytochalasin D, which increase intracellular calcium and disrupt the cortical actin of epithelial cells, respectively.", {"entities": []}], ["Cocultivation of epithelial cells containing HIV-1 with activated peripheral blood mononuclear cells and CD4+ T lymphocytes led to the disruption of epithelial cortical actin and spread of virus from epithelial cells to lymphocytes.", {"entities": []}], ["Treatment of epithelial cells with proinflammatory cytokines tumor necrosis factor-alpha and interferon gamma also induced reorganization of cortical actin and release of virus.", {"entities": []}], ["Inhibition of MVB formation by small interfering RNA (siRNA)-mediated silencing of its critical protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) expression reduced viral sequestration in epithelial cells and its transmission from epithelial cells to lymphocytes by ~60\u201370%.", {"entities": []}], ["Furthermore, inhibition of vacuole formation of epithelial cells by siRNA-inactivated rabankyrin-5 expression also significantly reduced HIV-1 sequestration in epithelial cells and spread of virus from epithelial cells to lymphocytes.", {"entities": []}], ["Interaction of the intercellular adhesion molecule-1 of epithelial cells with the function-associated antigen-1 of lymphocytes was important for inducing the release of sequestered HIV-1 from epithelial cells and facilitating cell-to-cell spread of virus from epithelial cells to lymphocytes.", {"entities": []}], ["This mechanism may serve as a pathway of HIV-1 mucosal transmission.", {"entities": []}], ["Although the majority of HIV-1 transmissions occur through the mucosal epithelium, the mechanism of initial events of viral spread from epithelia to HIV-1-susceptible CD4+ lymphocytes, macrophages, and Langerhans/dendritic cells is not well understood.", {"entities": []}], ["In this study we observed that >90% of virions internalized in tonsil, cervical and foreskin epithelial cells did not cross the epithelium but rather were retained in the endosomal compartments for several days.", {"entities": []}], ["These sequestered virions in the epithelium were infectious and were released by the interaction of activated PBMC and CD4+ T lymphocytes with epithelial cells containing the virus.", {"entities": []}], ["The specific interaction of lymphocyte receptor function-associated antigen-1 (LFA-1) with the epithelial cell receptor intercellular adhesion molecule-1 (ICAM-1) was critical for the induction of HIV-1 release and the cell-to-cell spread of HIV-1 from epithelial cells to lymphocytes.", {"entities": []}], ["This finding may explain the initial step of HIV-1 transmission from mucosal epithelia to virus-susceptible lymphocytes, macropages and Langerhans/dendritic cells, which migrate into oral and genital epithelia and capture virus from epithelial cells.", {"entities": []}], ["Pseudomonas aeruginosa produces quorum sensing signal molecules that are potential biomarkers for infection.", {"entities": []}], ["A prospective study of 60 cystic fibrosis patients with chronic P. aeruginosa, who required intravenous antibiotics for pulmonary exacerbations, was undertaken.", {"entities": [[26, 41, "DISEASE"]]}], ["Clinical measurements and biological samples were obtained at the start and end of the treatment period.", {"entities": []}], ["Additional data were available for 29 of these patients when they were clinically stable.", {"entities": []}], ["Cross-sectionally, quorum sensing signal molecules were detectable in the sputum, plasma and urine of 86%, 75% and 83% patients, respectively.", {"entities": []}], ["They were positively correlated between the three biofluids.", {"entities": []}], ["Positive correlations were observed for most quorum sensing signal molecules in sputum, plasma and urine, with quantitative measures of pulmonary P. aeruginosa load at the start of a pulmonary exacerbation.", {"entities": []}], ["Plasma concentrations of 2-nonyl-4-hydroxy-quinoline (NHQ) were significantly higher at the start of a pulmonary exacerbation compared to clinical stability (p<0.01).", {"entities": []}], ["Following the administration of systemic antibiotics, plasma 2-heptyl-4-hydroxyquinoline (p=0.02) and NHQ concentrations (p<0.01) decreased significantly.", {"entities": []}], ["In conclusion, quorum sensing signal molecules are detectable in cystic fibrosis patients with pulmonary P. aeruginosa infection and are positively correlated with quantitative measures of P. aeruginosa .", {"entities": [[65, 80, "DISEASE"]]}], ["NHQ correlates with clinical status and has potential as a novel biomarker for P. aeruginosa infection.", {"entities": []}], ["P. aeruginosa QS molecules correlate with clinical status in cystic fibrosis and are biomarkers for infection http://ow.ly/MhzZp", {"entities": [[61, 76, "DISEASE"]]}], ["To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[107, 144, "DISEASE"]]}], ["Cohort study using medical databases.", {"entities": []}], ["Northern Denmark.", {"entities": []}], ["On 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease (COPD) who had at least one AECOPD during 1 January 2005 to 31 December 2009.", {"entities": [[80, 117, "DISEASE"]]}], ["We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first.", {"entities": []}], ["We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency (0, 1, 2 or 3+) in the prior 12-month period.", {"entities": []}], ["Using Cox regression, we computed 0\u201330-day and 31\u2013365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios (MRRs) with 95% CIs entering exacerbation frequency as a time-varying exposure.", {"entities": []}], ["We identified 16\u2005647 eligible patients with prevalent COPD, of whom 6664 (40%) developed an AECOPD and were thus included in the study cohort.", {"entities": []}], ["The 0\u201330-day MRRs were 0.97 (95% CI 0.80 to 1.18), 0.90 (95% CI 0.70 to 1.15) and 1.03 (95% CI 0.81 to 1.32) among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12\u2005months, respectively.", {"entities": []}], ["The corresponding MRRs were 1.47 (95% CI 1.30 to 1.66), 1.89 (95% CI 1.59 to 2.25) and 1.59 (95% CI 1.23 to 2.05) for days 31\u2013365.", {"entities": []}], ["Among patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31\u2013365-day mortality.", {"entities": []}], ["Disparities in health exist among ethnic/racial groups, especially among members with limited English proficiency (LEP).", {"entities": [[115, 118, "GENE"]]}], ["The session described in this paper aimed to teach medical students the skills needed to communicate with patients with LEP.", {"entities": [[120, 123, "GENE"]]}], ["Description \u2013 We created a required session titled \u201c Cross-Cultural Communication-Using an Interpreter \u201d for third-year medical students with learning objectives and teaching strategies.", {"entities": []}], ["The session plans evolved over three years.", {"entities": []}], ["Program Evaluation \u2013 Students\u2019 perceived efficacy using retrospective pre/post test analysis (n = 110, 86% response rate) administered 7 weeks post-session revealed that 77.3% of students felt \u201cmore prepared to communicate with a patient with LEP\u201d, 77.3% to \u201cgive proper instructions to an untrained interpreter\u201d and 76.4% to \u201caccess a hospital language line\u201d.", {"entities": [[243, 246, "GENE"]]}], ["Conclusion \u2013 Our curricular intervention was effective in increasing students\u2019 perceived efficacy in communicating with a patient with LEP, using untrained interpreters and accessing a hospital language line.", {"entities": [[135, 138, "GENE"]]}], ["Skills practice and discussion of using interpreters should be a part of medical education.", {"entities": []}], ["Throughout evolution, plants have developed the ability to produce secondary phenolic metabolites, which are important for their interactions with the environment, reproductive strategies and defense mechanisms.", {"entities": []}], ["These (poly)phenolic compounds are a heterogeneous group of natural antioxidants found in vegetables, cereals and leguminous that exert beneficial and protective actions on human health, playing roles such as enzymatic reaction inhibitors and cofactors, toxic chemicals scavengers and biochemical reaction substrates, increasing the absorption of essential nutrients and selectively inhibiting deleterious intestinal bacteria.", {"entities": []}], ["Polyphenols present in some commodity grains, such as soy and cocoa beans, as well as in other vegetables considered security foods for developing countries, including cassava, taro and beetroot, all of them cropped in Brazil, have been identified and quantified in order to point out their bioavailability and the adequate dietary intake to promote health.", {"entities": []}], ["The effects of the flavonoid and non-flavonoid compounds present in these vegetables, their metabolism and their effects on preventing chronic and degenerative disorders like cancers, diabetes, osteoporosis, cardiovascular and neurological diseases are herein discussed based on recent epidemiological studies.", {"entities": [[194, 206, "DISEASE"]]}], ["Although evidence suggests that poor sleep is associated with chronic disease, little research has been conducted to assess the relationships between insufficient sleep, frequent mental distress (FMD \u226514 days during the past 30 days), obesity, and chronic disease including diabetes mellitus, coronary heart disease, stroke, high blood pressure, asthma, and arthritis.", {"entities": [[302, 315, "DISEASE"], [293, 315, "DISEASE"], [235, 242, "DISEASE"], [358, 367, "DISEASE"], [346, 352, "DISEASE"], [274, 291, "DISEASE"]]}], ["Data from 375,653 US adults aged\u2009\u2265\u200918 years in the 2009 Behavioral Risk Factor Surveillance System were used to assess the relationships between insufficient sleep and chronic disease.", {"entities": []}], ["The relationships were further examined using a multivariate logistic regression model after controlling for age, sex, race/ethnicity, education, and potential mediators (FMD and obesity).", {"entities": [[179, 186, "DISEASE"]]}], ["The overall prevalence of insufficient sleep during the past 30 days was 10.4% for all 30 days, 17.0% for 14\u201329 days, 42.0% for 1\u201313 days, and 30.6% for zero day.", {"entities": []}], ["The positive relationships between insufficient sleep and each of the six chronic disease were significant (p\u2009<\u20090.0001) after adjustment for covariates and were modestly attenuated but not fully explained by FMD.", {"entities": []}], ["The relationships between insufficient sleep and both diabetes and high blood pressure were also modestly attenuated but not fully explained by obesity.", {"entities": [[144, 151, "DISEASE"]]}], ["Assessment of sleep quantity and quality and additional efforts to encourage optimal sleep and sleep health should be considered in routine medical examinations.", {"entities": []}], ["Ongoing research designed to test treatments for obesity, mental distress, or various chronic diseases should also consider assessing the impact of these treatments on sleep health.", {"entities": [[49, 56, "DISEASE"]]}], ["Silicone implants are used widely in the field of plastic surgery and are used in a large population.", {"entities": []}], ["However, their safety profile, especially the silicone-induced immune response, has been a major concern for plastic surgeons for decades.", {"entities": []}], ["It has been hypothesized that there is a cause and effect relation between silicone and immunity, but this is controversial.", {"entities": []}], ["The objective of the present study was to determine the hub genes and key pathways related to silicone implant\u2013induced immune responses in a rat model.", {"entities": []}], ["In addition to cluster and enrichment analyses, we used weighted gene co-expression network analysis (WGCNA) to examine the gene expression profiles in a systematic context.", {"entities": []}], ["A total five genes ( Fes , Aif1 , Gata3 , Tlr6 , Tlr2 ) were identified as hub genes that are most likely related to the silicone-induced immune response, four of which ( Aif1 , Gata3 , Tlr6 , Tlr2 ) have been associated with autoimmunity as target genes or disease markers.", {"entities": [[21, 24, "GENE"], [27, 31, "GENE"], [171, 175, "GENE"], [34, 39, "GENE"], [178, 183, "GENE"], [42, 46, "GENE"], [186, 190, "GENE"], [49, 53, "GENE"], [193, 197, "GENE"], [27, 31, "GENE"], [171, 175, "GENE"], [34, 39, "GENE"], [178, 183, "GENE"], [42, 46, "GENE"], [186, 190, "GENE"], [49, 53, "GENE"], [193, 197, "GENE"]]}], ["The Toll-like receptor signaling pathway ( p < 0.01, fold enrichment: 7.01) and systemic lupus erythematosus signaling pathway ( p < 0.05, fold enrichment: 5.01), which are considered strongly associated with autoimmunity, were significantly enriched in the silicone-implanted skin samples.", {"entities": [[89, 108, "DISEASE"], [80, 108, "DISEASE"]]}], ["The results indicate that silicone implants might trigger the localized immune response, as various immune reaction genes were detected after silicone implantation.", {"entities": []}], ["The identified five hub genes will hopefully serve as novel therapeutic targets for silicone-related complications and the associated autoimmune diseases.", {"entities": []}], ["The Australian Institute of Health and Welfare\u2019s first report into acute kidney injury demonstrated a significant increase in the incidence of acute-tubulo interstitial nephritis, the ICD-10 code representing both acute interstitial nephritis and pyelonephritis, in women aged less than 55\u00a0years.", {"entities": [[156, 178, "DISEASE"], [220, 242, "DISEASE"], [169, 178, "DISEASE"], [233, 242, "DISEASE"], [247, 261, "DISEASE"]]}], ["In contrast, recent case series have reported rising rates of drug induced acute interstitial nephritis predominantly among elderly patients.", {"entities": [[81, 103, "DISEASE"], [94, 103, "DISEASE"]]}], ["Due to several limitations with the Australian Institute of Health and Welfare report, this new trend requires further investigation to determine if rates of acute interstitial nephritis are truly increasing among younger Australian women.", {"entities": [[164, 186, "DISEASE"], [177, 186, "DISEASE"]]}], ["Patients who underwent a renal biopsy at a single center from 2000 to 2015 were reviewed and those with biopsy confirmed acute interstitial nephritis were selected.", {"entities": [[127, 149, "DISEASE"], [140, 149, "DISEASE"]]}], ["Cause of acute interstitial nephritis, patient demographics, co-morbidities and renal indices for these patients when available were recorded and compared.", {"entities": [[15, 37, "DISEASE"], [28, 37, "DISEASE"]]}], ["Eight hundred ninety-eight patients who underwent renal biopsy from 2000 to 2015 were reviewed and 40 patients were identified with biopsy confirmed acute interstitial nephritis.", {"entities": [[155, 177, "DISEASE"], [168, 177, "DISEASE"]]}], ["The rate of acute interstitial nephritis increased significantly over the study period (4 patients/2.2% of biopsies performed in 2000\u201303 vs. 19 patients/6.7% of all biopsies performed in 2012\u201315; p \u00a0=\u00a00.002).", {"entities": [[18, 40, "DISEASE"], [31, 40, "DISEASE"]]}], ["There was a marked increase in the number of women with AIN in the last four years of the study (2 patients and 2.1% of biopsies performed in women in 2000\u20132003 compared with 13 patients and 9.0% of biopsies performed in women in 2012\u20132015).", {"entities": []}], ["Immune mediated causes of acute interstitial nephritis and NSAID associated AIN were more common in women (9 females vs. 3 males), occurred more frequently in the last eight years of the study and predominantly in patients under 55\u00a0years of age.", {"entities": [[32, 54, "DISEASE"], [45, 54, "DISEASE"]]}], ["Our study demonstrates a significant increase in the number of patients with biopsy confirmed AIN.", {"entities": []}], ["Also, we provide preliminary evidence in support of an increase in rates of younger women with immune mediated acute interstitial nephritis.", {"entities": [[117, 139, "DISEASE"], [130, 139, "DISEASE"]]}], ["These results support the findings of the Australian Institute of Health and Welfare and suggest that younger women may be at higher risk of immune mediated and NSAID associated acute interstitial nephritis.", {"entities": [[184, 206, "DISEASE"], [197, 206, "DISEASE"]]}], ["The mechanisms of transmigration of inflammatory cells through the sinusoids are still poorly understood.", {"entities": []}], ["This study aims to identify in vitro conditions (cytokine treatment) which may allow a better understanding of the changes in PECAM (platelet endothelial cell adhesion molecule)-1-gene-expression observed in vivo.", {"entities": []}], ["In this study we show by immunohistochemistry, that there is an accumulation of ICAM-1 (intercellular cell adhesion molecule-1) and ED1 positive cells in necrotic areas of livers of CCl 4 -treated rats, whereas there are few PECAM-1 positive cells observable.", {"entities": []}], ["After the administration of CCl 4 , we could detect an early rise of levels of IFN-\u03b3 followed by an enhanced TGF-\u03b2 protein level.", {"entities": []}], ["As shown by Northern blot analysis and surface protein expression analysed by flow cytometry, IFN-\u03b3-treatment decreased PECAM-1-gene-expression in isolated SECs (sinusoidal endothelial cells) and mononuclear phagocytes (MNPs) in parallel with an increase in ICAM-1-gene-expression in a dose and time dependent manner.", {"entities": []}], ["In contrast, TGF-\u03b2-treatment increased PECAM-1-expression.", {"entities": []}], ["Additional administration of IFN-\u03b3 to CCl 4 -treated rats and observations in IFN-\u03b3 The early decrease of PECAM-1-expression and the parallel increase of ICAM-1-expression following CCl 4 -treatment is induced by elevated levels of IFN-\u03b3 in livers and may facilitate adhesion and transmigration of inflammatory cells.", {"entities": []}], ["The up-regulation of PECAM-1-expression in SECs and MNPs after TGF-\u03b2-treatment suggests the involvement of PECAM-1 during the recovery after liver damage.", {"entities": []}], ["In a context of increasing ethnic diversity, culturally competent strategies have been recommended to improve care quality and access to health care for ethnic minorities and migrants; their implementation by health professionals, however, has remained patchy.", {"entities": []}], ["Most programs of cultural competence assume that health professionals accept that they have a responsibility to adapt to migrants, but this assumption has often remained at the level of theory.", {"entities": []}], ["In this paper, we surveyed health professionals\u2019 views on their responsibility to adapt.", {"entities": []}], ["Five hundred-and-sixty-nine health professionals from twenty-four inpatient and outpatient health services were selected according to their geographic location.", {"entities": []}], ["All health care professionals were requested to complete a questionnaire about who should adapt to ethnic diversity: health professionals or patients.", {"entities": []}], ["After a factorial analysis to identify the underlying responsibility dimensions, we performed a multilevel regression model in order to investigate individual and service covariates of responsibility attribution.", {"entities": []}], ["Three dimensions emerged from the factor analysis: responsibility for the adaptation of communication, responsibility for the adaptation to the negotiation of values, and responsibility for the adaptation to health beliefs.", {"entities": []}], ["Our results showed that the sense of responsibility for the adaptation of health care depended on the nature of the adaptation required: when the adaptation directly concerned communication with the patient, health professionals declared that they should be the ones to adapt; in relation to cultural preferences, however, the responsibility felt on the patient\u2019s shoulders.", {"entities": []}], ["Most respondents were unclear in relation to adaptation to health beliefs.", {"entities": []}], ["Regression indicated that being Belgian, not being a physician, and working in a primary-care service were associated with placing the burden of responsibility on the patient.", {"entities": []}], ["Health care professionals do not consider it to be their responsibility to adapt to ethnic diversity.", {"entities": []}], ["If health professionals do not feel a responsibility to adapt, they are less likely to be involved in culturally competent health care.", {"entities": []}], ["Meratrim is a blend of two plant extracts obtained from Sphaeranthus indicus flower heads and Garcinia mangostana fruit rinds.", {"entities": []}], ["Previous studies have demonstrated that Meratrim is effective for weight management in obese individuals.", {"entities": []}], ["The objective of this study was to assess the efficacy and tolerability of Meratrim in managing body weight in healthy overweight subjects.", {"entities": []}], ["Sixty participants with a mean BMI of 28.3\u00a0kg/m At study conclusion, statistically significant reductions in body weight (5.09 vs. 1.1\u00a0kg; p \u2009<\u20090.0001), BMI (1.91 vs. 0.43\u00a0kg/m p \u2009<\u20090.0001), waist (9.97 vs. 3.71\u00a0cm; p \u2009<\u20090.001) and hip size (10.38 vs. 5.11\u00a0cm; p \u2009<\u20090.0001) were observed in the Meratrim versus the placebo group.", {"entities": []}], ["Additionally, a significant change in serum LDL (\u221214.79 vs. 6.25\u00a0mg/dL; p \u2009<\u20090.0001), triglycerides (\u221243.62 vs. -13.68\u00a0mg/dL; p \u2009<\u20090.001) and total cholesterol (\u221220.0 vs. -0.75\u00a0mg/dL; p \u2009=\u20090.0002) was observed in the Meratrim cohort compared to the placebo.", {"entities": []}], ["No supplementation related adverse events were noted during the study.", {"entities": []}], ["The study findings suggest that Meratrim is well-tolerated and is an effective ingredient for weight management in healthy overweight subjects.", {"entities": []}], ["CTRI/2014/07/004727; www.CTRI.nic.in", {"entities": []}], ["An understanding of the molecular mechanisms by which microbial, plant or animal-secreted toxins exert their action provides the most important element for assessment of human health risks and opens new insights into therapies addressing a plethora of pathologies, ranging from neurological disorders to cancer, using toxinomimetic agents.", {"entities": [[304, 310, "DISEASE"]]}], ["Recently, molecular and cellular biology dissecting tools have provided a wealth of information on the action of these diverse toxins, yet, an integrated framework to explain their selective toxicity is still lacking.", {"entities": []}], ["In this review, specific examples of different toxins are emphasized to illustrate the fundamental mechanisms of toxicity at different biochemical, molecular and cellular- levels with particular consideration for the nervous system.", {"entities": []}], ["The target of primary action has been highlighted and operationally classified into 13 sub-categories.", {"entities": []}], ["Selected examples of toxins were assigned to each target category, denominated as portal , and the modulation of the different portal\u2019s signaling was featured.", {"entities": []}], ["The first portal encompasses the plasma membrane lipid domains, which give rise to pores when challenged for example with pardaxin, a fish toxin, or is subject to degradation when enzymes of lipid metabolism such as phospholipases A 2 (PLA 2 ) or phospholipase C (PLC) act upon it.", {"entities": []}], ["Several major portals consist of ion channels, pumps, transporters and ligand gated ionotropic receptors which many toxins act on, disturbing the intracellular ion homeostasis.", {"entities": []}], ["Another group of portals consists of G-protein-coupled and tyrosine kinase receptors that, upon interaction with discrete toxins, alter second messengers towards pathological levels.", {"entities": []}], ["Lastly, subcellular organelles such as mitochondria, nucleus, protein- and RNA-synthesis machineries, cytoskeletal networks and exocytic vesicles are also portals targeted and deregulated by other diverse group of toxins.", {"entities": []}], ["A fundamental concept can be drawn from these seemingly different toxins with respect to the site of action and the secondary messengers and signaling cascades they trigger in the host.", {"entities": []}], ["While the interaction with the initial portal is largely determined by the chemical nature of the toxin, once inside the cell, several ubiquitous second messengers and protein kinases/ phosphatases pathways are impaired, to attain toxicity.", {"entities": []}], ["Therefore, toxins represent one of the most promising natural molecules for developing novel therapeutics that selectively target the major cellular portals involved in human physiology and diseases.", {"entities": []}], ["The structure and composition of bacterial communities can compromise antibiotic efficacy.", {"entities": []}], ["For example, the secretion of \u03b2-lactamase by individual bacteria provides passive resistance for all residents within a polymicrobial environment.", {"entities": []}], ["Here, we uncover that collective resistance can also develop via intracellular antibiotic deactivation.", {"entities": []}], ["Real-time luminescence measurements and single-cell analysis demonstrate that the opportunistic human pathogen Streptococcus pneumoniae grows in medium supplemented with chloramphenicol (Cm) when resistant bacteria expressing Cm acetyltransferase (CAT) are present.", {"entities": []}], ["We show that CAT processes Cm intracellularly but not extracellularly.", {"entities": []}], ["In a mouse pneumonia model, more susceptible pneumococci survive Cm treatment when coinfected with a CAT-expressing strain.", {"entities": [[11, 20, "DISEASE"]]}], ["Mathematical modeling predicts that stable coexistence is only possible when antibiotic resistance comes at a fitness cost.", {"entities": []}], ["Strikingly, CAT-expressing pneumococci in mouse lungs were outcompeted by susceptible cells even during Cm treatment.", {"entities": []}], ["Our results highlight the importance of the microbial context during infectious disease as a potential complicating factor to antibiotic therapy.", {"entities": []}], ["Antibiotic-resistant bacterial infections are on the rise and pose a serious threat to society.", {"entities": []}], ["The influence of genetic resistance mechanisms on antibiotic therapy is well described.", {"entities": []}], ["However, other factors, such as epigenetic resistance or the impact of the environment on antibiotic therapy, are less well understood.", {"entities": []}], ["Here, we describe and characterize a mechanism of noninherited antibiotic resistance that enables the survival and outgrowth of genetically susceptible bacteria during antibiotic therapy.", {"entities": []}], ["We show that bacteria expressing the resistance factor chloramphenicol (Cm) acetyltransferase (CAT) can potently deactivate Cm in their immediate environment.", {"entities": []}], ["The reduced Cm concentration then allows for the outgrowth of genetically susceptible bacteria in the same environment.", {"entities": []}], ["Mathematical modeling demonstrates the presence of a parameter space in which stable coexistence between Cm-susceptible and -resistant bacteria is possible during antibiotic therapy, which we validated using single-cell analyses.", {"entities": []}], ["Strikingly, mixed culture experiments in which mice were infected with both Cm-susceptible and -resistant pneumococci revealed that Cm-sensitive \u201cfreeloader\u201d bacteria even outcompeted resistant bacteria during antibiotic therapy.", {"entities": []}], ["Together, we show that the microbial context during infection is a potential complicating factor to antibiotic treatment outcomes.", {"entities": []}], ["Bioaerosols generated at composting plants are released during processes that involve the vigorous movement of material such as shredding, compost pile turning, or compost screening.", {"entities": []}], ["Such bioaerosols are a cause of concern because of their potential impact on both occupational health and the public living in close proximity to such facilities.", {"entities": []}], ["The biological hazards potentially associated with bioaerosol emissions from composting activities include fungi, bacteria, endotoxin, and 1-3 \u03b2-glucans.", {"entities": []}], ["There is a major lack of knowledge concerning the dispersal of airborne microorganisms emitted by composting plants as well as the potential exposure of nearby residents.", {"entities": []}], ["This is due in part to the difficulty of tracing specifically these microorganisms in air.", {"entities": []}], ["In recent years, molecular tools have been used to develop new tracers which should help in risk assessments.", {"entities": []}], ["This review summarizes current knowledge of microbial diversity in composting aerosols and of the associated risks to health.", {"entities": []}], ["It also considers methodologies introduced recently to enhance understanding of bioaerosol dispersal, including new molecular indicators and modeling.", {"entities": []}], ["Deforestation due to tobacco farming began to raise concerns in the mid 1970s.", {"entities": []}], ["Over the next 40\u00a0years, tobacco growing increased significantly and shifted markedly to low- and middle-income countries.", {"entities": []}], ["The percentage of deforestation caused by tobacco farming reached 4\u00a0% globally by the early 2000s, although substantially higher in countries such as China (18\u00a0%), Zimbabwe (20\u00a0%), Malawi (26\u00a0%) and Bangladesh (>30\u00a0%).", {"entities": []}], ["Transnational tobacco companies (TTCs) have argued that tobacco-attributable deforestation is not a serious problem, and that the industry has addressed the issue through corporate social responsibility (CSR) initiatives.", {"entities": []}], ["After reviewing the existing scholarly literature on tobacco and deforestation, we analysed industry sources of public information to understand how the industry framed deforestation, its key causes, and policy responses.", {"entities": []}], ["To analyse industry strategies between the 1970s and early 2000s to shape understanding of deforestation caused by tobacco farming and curing, the Truth Tobacco Documents Library was systematically searched.", {"entities": []}], ["The above sources were compiled and triangulated, thematically and chronologically, to derive a narrative of how the industry has framed the problem of, and solutions to, tobacco-attributable deforestation.", {"entities": []}], ["The industry sought to undermine responses to tobacco-attributable deforestation by emphasising the economic benefits of production in LMICs, blaming alternative causes, and claiming successful forestation efforts.", {"entities": []}], ["To support these tactics, the industry lobbied at the national and international levels, commissioned research, and colluded through front groups.", {"entities": []}], ["There was a lack of effective action to address tobacco-attributable deforestation, and indeed an escalation of the problem, during this period.", {"entities": []}], ["The findings suggest the need for independent data on the varied environmental impacts of the tobacco industry, awareness of how the industry seeks to work with environmental researchers and groups to further its interests, and increased scrutiny of tobacco industry efforts to influence environmental policy.", {"entities": []}], ["Techniques have been devised for studying quantitatively the effects of air ions on microorganisms suspended in small drops.", {"entities": []}], ["In smog-contaminated atmospheres moderate concentrations of positive and negative air ions exerted a protective effect on staphylococci by delaying the drop in pH customarily observed and by diminishing the rate of evaporation.", {"entities": []}], ["In clean air higher concentrations of positive and negative air ions accelerated the rate of death of staphylococci apparently by direct action on the cells and by increasing the rate of evaporation.", {"entities": []}], ["Air ion action in these experiments did not involve cell agglutination or direct radiation from the radioactive isotopes employed.", {"entities": []}], ["Cigarette smoking (CS) is a principal contributor to a spectrum of devastating lung diseases whose occurrence and severity may vary between individuals and not appear for decades after prolonged use.", {"entities": [[19, 21, "GENE"]]}], ["One explanation for the variability and delay in disease onset is that nicotine, the addictive component of CS, acts through the ionotropic nicotinic acetylcholine receptor (nAChR) alpha7 (\u03b17) to modulate anti-inflammatory protection.", {"entities": [[108, 110, "GENE"]]}], ["In this study we measured the impact \u03b17 signaling has on the mouse distal lung response to side-stream CS exposure for mice of the control genotype (\u03b17", {"entities": [[103, 105, "GENE"]]}], ["Recent studies have shown significant associations of aberrant DNA methylation in spermatozoa with idiopathic male infertility, increased frequency of spontaneous abortions and imprinting disorders.", {"entities": [[110, 126, "DISEASE"], [115, 126, "DISEASE"]]}], ["Thus, the analysis of DNA methylation of specific genes in spermatozoa has the potential to become a new valuable diagnostic marker in clinical andrology.", {"entities": []}], ["This perspective article discusses the current state and value of DNA methylation analysis in the diagnostic setup of infertile men and outlines challenges and perspectives.", {"entities": []}], ["It highlights the potential of DNA methylation in andrological diagnostics and its putative benefit in the examination of hitherto idiopathic infertile patients is described.", {"entities": []}], ["People tend to underestimate their current weight and overestimate their height minimizing health risk factors.", {"entities": []}], ["The aim of this study was to assess body weight satisfaction, acceptance of body image, weight concern and dieting habits among a Mediterranean adult population.", {"entities": []}], ["Cross-sectional survey was carried out (2009\u20132010) in the Balearic Islands, Spain.", {"entities": []}], ["A random sample ( n \u2009=\u20091081) of young (18\u201335 y.o.)", {"entities": []}], ["and middle-aged adults (36\u201355 y.o.)", {"entities": []}], ["was interviewed and anthropometrically measured.", {"entities": []}], ["Women were more dissatisfied being overweight, less dissatisfied being underweight, and more worried about weight gain than men.", {"entities": []}], ["Middle-aged participants were more dissatisfied with body shape and underestimated body weight than young\u2019s.", {"entities": []}], ["Employed women defined better current weight than unemployed, but unemployed were more worried about body weight gain.", {"entities": []}], ["Overweight adults were more likely to underestimate their body weight but were also very worried about weight gain and more likely to report current dieting than their leaner counterparts.", {"entities": []}], ["Active participants self-reported better body weight and were more satisfied with body image than sedentary.", {"entities": []}], ["Most of studied population reported body image dissatisfaction, but half of them are not worried about it.", {"entities": []}], ["Women were more concerned about their body weight status.", {"entities": []}], ["Practice of physical activity is a positive factor in self-perception.", {"entities": []}], ["Holistic strategies are needed to avoid promoting unreal bodies, as well as the acceptance of the real body image.", {"entities": []}], ["Quantitative measurements of mould enrichment of indoor air or house dust might be suitable surrogates to evaluate present but hidden moisture damage.", {"entities": []}], ["Our intent was to develop a house-dust monitoring method to detect hidden moisture damage excluding the influence of outdoor air, accumulated old dust, and dust swirled up from room surfaces.", {"entities": []}], ["Based on standardized measurement of mould spores in the 63-\u03bcm fraction of house dust yielded by carpets, the background concentrations were determined and compared to simultaneously obtained colony numbers and total spore numbers of the indoor air in 80 non-mouldy living areas during summer and winter periods.", {"entities": []}], ["Additionally, sampling with a vacuum-cleaner or manual sieve was compared to sampling with a filter holder or sieving machine, and the evaluative power of an established two-step assessment model (lower and upper limits) was compared to that of a one-step model (one limit) in order to derive concentration limits for mould load in house dust.", {"entities": []}], ["Comparison with existing evaluation procedures proved the developed method to be the most reliable means of evaluating hidden moisture damage, yielding the lowest false-positive results (specificity 98.7%).", {"entities": []}], ["Background measurements and measurements in 14 mouldy rooms show that even by evaluating just the indicator genera in summer and winter, a relatively certain assessment of mould infestation is possible.", {"entities": []}], ["A one-step evaluation is finally possible for house dust.", {"entities": []}], ["The house-dust evaluation method is based on analysis of the indicator genera Aspergillus , Eurotium and Penicillium spp ., which depend on the total fungal count.", {"entities": []}], ["Inclusion of further moisture indicators currently appears questionable, because of outdoor air influence and the paucity of measurements.", {"entities": []}], ["Background: Environmental risks to health in the United Arab Emirates (UAE) have shifted rapidly from infectious to noninfectious diseases as the nation has developed at an unprecedented rate.", {"entities": []}], ["In response to public concerns over newly emerging environmental risks, the Environment Agency\u2013Abu Dhabi commissioned a multidisciplinary environmental health strategic planning project.", {"entities": []}], ["Objectives: In order to develop the environmental health strategic plan, we sought to quantify the illnesses and premature deaths in the UAE attributable to 14 environmental pollutant categories, prioritize these 14 risk factors, and identify interventions.", {"entities": []}], ["Methods: We estimated the disease burden imposed by each risk factor using an attributable fraction approach, and we prioritized the risks using an empirically tested stakeholder engagement process.", {"entities": []}], ["We then engaged government personnel, scientists, and other stakeholders to identify interventions.", {"entities": []}], ["Results: The UAE\u2019s environmental disease burden is low by global standards.", {"entities": []}], ["Ambient air pollution is the leading contributor to premature mortality [~ 650 annual deaths; 95% confidence interval (CI): 140, 1,400].", {"entities": []}], ["Risk factors leading to > 10,000 annual health care facility visits included occupational exposures, indoor air pollution, drinking water contamination, seafood contamination, and ambient air pollution.", {"entities": []}], ["Among the 14 risks considered, on average, outdoor air pollution was ranked by the stakeholders as the highest priority (mean rank, 1.4; interquartile range, 1\u20132) and indoor air pollution as the second-highest priority (mean rank 3.3; interquartile range, 2\u20134).", {"entities": []}], ["The resulting strategic plan identified 216 potential interventions for reducing environmental risks to health.", {"entities": []}], ["Conclusions: The strategic planning exercise described here provides a framework for systematically deciding how to invest public funds to maximize expected returns in environmental health, where returns are measured in terms of reductions in a population\u2019s environmental burden of disease.", {"entities": []}], ["Coping with chronic illness encapsulates both practical and emotional aspects of living life in relation to one's long\u2010term health condition(s).", {"entities": []}], ["Dominant health psychology approaches for understanding coping, which underpin a more recent policy discourse on \u2018self\u2010management\u2019, focus sharply on the person affected by illness and potentially mask the influence of overarching social structure.", {"entities": []}], ["In this paper we draw on qualitative interviews with 48 people living with long\u2010term conditions ( LTC s), in order to highlight the role that structural configurations such as healthcare systems may play in either helping or hindering people's efforts to cope with chronic illness.", {"entities": []}], ["We argue that coping is a social process in which health and related services, situated within their wider political\u2010economic contexts, play an active role in shaping people's attempts to live well with LTC s. More specifically, health systems are sites of social and cultural capital exchange that can differentially mobilise coping resources through access, continuity of care, and coordination across services.", {"entities": []}], ["Whilst it is essential to recognise the personal agency of people living with chronic illness, it is also vital to acknowledge the underlying inequalities that affect the ways in which services can support such resourcefulness.", {"entities": []}], ["Objective .", {"entities": []}], ["To investigate whether high-flow nasal cannula (HFNC) oxygen therapy is superior to conventional oxygen therapy for reducing hypoxemia and postoperative pulmonary complications (PPC) in patients with thoracoscopic lobectomy after extubation.", {"entities": []}], ["Patients with intermediate to high risk for PPC were enrolled in this study.", {"entities": []}], ["Subjects were randomly assigned to HFNC group (HFNCG) or conventional oxygen group (COG) following extubation.", {"entities": []}], ["Arterial blood samples were collected after extubation at 1, 2, 6, 12, 24, 48, and 72\u2009h. Patients with postoperative hypoxemia and PPC were recorded.", {"entities": []}], ["Adverse events were also documented.", {"entities": []}], ["Totally 110 patients were randomly assigned to HFNCG ( n = 56) and COG ( n = 54).", {"entities": []}], ["The occurrence rate of hypoxemia in COG was twice more than that in HFNCG (29.62% versus 12.51%, P < 0.05) and PaO 2 , PaO 2 /FiO 2 , and SaO 2 /FiO 2 were significantly improved in HFNCG ( P < 0.05) in the first 72\u2009h following extubation.", {"entities": []}], ["Respiratory rate and incidence of reintubation as well as needing noninvasive ventilation were also decreased in HFNCG ( P < 0.05), whereas the incidence of pneumonia and atelectasis were similar ( P > 0.05).", {"entities": [[157, 166, "DISEASE"]]}], ["Adverse effects as throat and nasal pain occurred more frequently in COG.", {"entities": []}], ["Conclusions .", {"entities": []}], ["HFNC application improves oxygenation and reduces the risk of reintubation following thoracoscopic lobectomy but cannot decrease the incidence of PPC.", {"entities": []}], ["We used Health Impact Assessment (HIA) to analyze the impact on a given population's health outcomes in terms of all-causes mortality and respiratory and cardiovascular hospitalizations attributable to short-term exposure to particulate matter less than 10\u2009 \u03bc m diameter (PM 10 ) in Bejaia city, for which health effects of air pollution have never been investigated.", {"entities": []}], ["Two scenarios of PM 10 reduction were considered: first, a scenario where the PM 10 annual mean is decreased by 5\u2009 \u00b5 g/m 10 mean is decreased to 20\u2009 \u00b5 g/m 10 (81.7\u2009 \u00b5 g/m in situ .", {"entities": []}], ["Each year, about 4 and 55 deaths could be postponed with the first and the second scenarios successfully.", {"entities": []}], ["Furthermore, decreasing PM 10 annual mean by 5\u2009 \u00b5 g/m 10 WHO-AQG (20\u2009 \u00b5 g/m 10 has a nonnegligible impact in terms of public health that it is expected to be higher in the case of long-term effects.", {"entities": []}], ["Very little of the increased attention towards chronic diseases in countries with low and middle incomes has been directed towards older people, who contribute 72% of all deaths, and 14% of all Disability Adjusted Life Years linked to this group of conditions in those regions.", {"entities": []}], ["We aimed to study the prevalence of physical, mental and cognitive diseases and impairments among older people in the Dominican Republic, their social patterning, and their relative contributions to disability.", {"entities": []}], ["A cross-sectional catchment area one-phase survey of chronic disease diagnoses, physical impairments, risk factors and associated disability among 2011 people aged 65 years and over (of whom 1451 gave fasting blood samples) in Santo Domingo, Dominican Republic.", {"entities": []}], ["The most prevalent diagnoses were hypertension (73.0%), anaemia (35.0%), diabetes (17.5%), depression (13.8%) and dementia (11.7%), with 39.6% meeting criteria for metabolic syndrome.", {"entities": [[34, 46, "DISEASE"], [114, 122, "DISEASE"], [174, 182, "DISEASE"]]}], ["After direct standardization (for age and sex) the prevalences of stroke (standardized morbidity ratio [SMR] 100) and hypertension (SMR 108) were similar to those in the United States of America National Health and Nutrition Examination Survey (NHANES reference SMR 100), while those of diabetes (SMR 83) and metabolic syndrome (SMR 72) were somewhat lower.", {"entities": [[118, 130, "DISEASE"], [319, 327, "DISEASE"]]}], ["Anaemia was three times more common than in the USA (SMR 310).", {"entities": []}], ["Diabetes, hypertension, dyslipidaemia, obesity and the metabolic syndrome were associated with affluence and female sex.", {"entities": [[10, 22, "DISEASE"], [39, 46, "DISEASE"], [65, 73, "DISEASE"]]}], ["Arthritis, anaemia, dementia and stroke were strongly age-associated and these conditions were also the main independent contributors to disability.", {"entities": [[20, 28, "DISEASE"]]}], ["The prevalence of many chronic diseases is similar in predominately low socioeconomic status neighbourhoods in the Dominican Republic to that in the USA.", {"entities": []}], ["Prevalence of age-associated conditions is likely to increase with demographic ageing.", {"entities": []}], ["There is also scope for increases in cardiovascular disease prevalence, if, as observed in other settings undergoing the epidemiologic transition, the burden of risk factors shifts towards the less affluent.", {"entities": []}], ["Monitoring future trends in the prevalence and social patterning of chronic diseases may help to assess the effectiveness and equity of primary and secondary prevention strategies.", {"entities": []}], ["Specific recommendations from our research include identifying and targeting the causes of anaemia among older people, and addressing women's health disadvantages.", {"entities": []}], ["SNOMED CT is the most comprehensive medical terminology.", {"entities": []}], ["However, its use for intelligent services based on formal reasoning is questionable.", {"entities": []}], ["The analysis of the structure of SNOMED CT is based on the formal top-level ontology DOLCE.", {"entities": []}], ["The analysis revealed several ontological and knowledge-engineering errors, the most important are errors in the hierarchy (mostly from an ontological point of view, but also regarding medical aspects) and the mixing of subsumption relations with other types (mostly 'part of').", {"entities": []}], ["The found errors impede formal reasoning.", {"entities": []}], ["The paper presents a possible way to correct these problems.", {"entities": []}], ["The aim of this study was to appraise the effect of community-acquired pneumonia (CAP) on inhospital mortality in critically ill acute exacerbation of COPD (AECOPD) patients admitted to a respiratory intensive care unit.", {"entities": [[71, 80, "DISEASE"]]}], ["A retrospective observational study was performed.", {"entities": []}], ["Consecutive critically ill AECOPD patients receiving treatment in a respiratory intensive care unit were reviewed from September 1, 2012, to August 31, 2015.", {"entities": []}], ["Categorical variables were analyzed using chi-square tests, and continuous variables were analyzed by Mann\u2013Whitney U -test.", {"entities": []}], ["Kaplan\u2013Meier analysis was used to assess the association of CAP with survival of critically ill AECOPD patients for univariate analysis.", {"entities": []}], ["Cox\u2019s proportional hazards regression model was performed to identify risk factors for multivariate analysis.", {"entities": []}], ["A total of 80 consecutive eligible individuals were reviewed.", {"entities": []}], ["These included 38 patients with CAP and 42 patients without CAP.", {"entities": []}], ["Patients with CAP had a higher inhospital rate of mortality than patients without CAP (42% vs 33.3%, P <0.05).", {"entities": []}], ["Kaplan\u2013Meier survival analysis showed that patients with CAP had a worse survival rate than patients without CAP ( P <0.05).", {"entities": []}], ["Clinical characteristics, including Acute Physiology and Chronic Health Evaluation II (APACHE II) score, C-reactive protein, and CAP, were found to be closely associated with survival of AECOPD individuals.", {"entities": []}], ["Further multivariate Cox regression analysis confirmed that CAP and APACHE II were independent risk factors for inhospital mortality in critically ill AECOPD patients (CAP: hazard ratio, 5.29; 95% CI, 1.50\u201318.47, P <0.01 and APACHE II: hazard ratio, 1.20; 95% CI, 1.06\u20131.37, P <0.01).", {"entities": []}], ["CAP may be an independent risk factor for higher inhospital mortality in critically ill AECOPD patients.", {"entities": []}], ["Obesity has been identified as a worldwide epidemic.", {"entities": [[0, 7, "DISEASE"]]}], ["In China, the highest prevalence of obesity is observed in adults aged \u226545\u00a0years old.", {"entities": [[36, 43, "DISEASE"]]}], ["This study aimed to describe the association between BMI and depressive symptoms among a large representative sample of middle-aged and elderly in China.", {"entities": []}], ["A longitudinal sample of the middle-aged and elderly (6,224 males and 6,883 females) who were interviewed in the 2011 China Health and Retirement Longitudinal Study was used.", {"entities": []}], ["A multivariate logistic regression analysis was used to examine the effects of socio-demographic characteristics, lifestyle, activity status, health status, physical exercise and body weight on depressive symptoms.", {"entities": []}], ["Approximately 6.94% of the males were underweight, 25.48% were overweight and 8.16% were obese.", {"entities": []}], ["A higher prevalence of obesity was found among women, with 6.89% being underweight, 31.98% overweight and 14.28% obese.", {"entities": [[23, 30, "DISEASE"]]}], ["The underweight subjects were more likely to be depressed (odds ratio; OR\u2009=\u20091.30 and 1.19) compared with the normal weight people, respectively, whereas overweight and obese men and women were less likely to be depressed (overweight: OR\u2009=\u20090.76 and 0.80; obesity: OR\u2009=\u20090.64 and 0.65, respectively) than people of normal weight.", {"entities": [[254, 261, "DISEASE"]]}], ["Our data are consistent with the \u201cfat and jolly\u201d hypothesis being valid in both middle-aged and elderly men and women.", {"entities": []}], ["Cerebral malaria induced by Plasmodium berghei ANKA infection is dependent on the sequestration of cytotoxic T cells within the brain and augmentation of the inflammatory response.", {"entities": [[9, 16, "DISEASE"]]}], ["Herein, we demonstrate that inhibition of protein tyrosine phosphatase (PTP) activity significantly attenuates T cell sequestration within the brain and prevents the development of neuropathology.", {"entities": []}], ["Mechanistically, the initial upregulation of CXCR3 on splenic T cells upon T cell receptor stimulation was critically decreased through the reduction of T cell-intrinsic PTP activity.", {"entities": [[45, 50, "GENE"]]}], ["Furthermore, PTP inhibition markedly increased IL-10 production by splenic CD4", {"entities": [[75, 78, "GENE"]]}], ["The Influenza A virus (IAV) is a major human pathogen that produces significant morbidity and mortality.", {"entities": [[4, 13, "DISEASE"]]}], ["To explore the contribution of alveolar macrophages (AlvM\u03a6s) in regulating the severity of IAV infection we employed a murine model in which the Core Binding Factor Beta gene is conditionally disrupted in myeloid cells.", {"entities": []}], ["These mice exhibit a selective deficiency in AlvM\u03a6s.", {"entities": []}], ["Following IAV infection these AlvM\u03a6 deficient mice developed severe diffuse alveolar damage, lethal respiratory compromise, and consequent lethality.", {"entities": []}], ["Lethal injury in these mice resulted from increased infection of their Type-1 Alveolar Epithelial Cells (T1AECs) and the subsequent elimination of the infected T1AECs by the adaptive immune T cell response.", {"entities": []}], ["Further analysis indicated AlvM\u03a6-mediated suppression of the cysteinyl leukotriene (cysLT) pathway genes in T1AECs in vivo and in vitro .", {"entities": []}], ["Inhibition of the cysLT pathway enzymes in a T1AECs cell line reduced the susceptibility of T1AECs to IAV infection, suggesting that AlvM\u03a6-mediated suppression of this pathway contributes to the resistance of T1AECs to IAV infection.", {"entities": []}], ["Furthermore, inhibition of the cysLT pathway enzymes, as well as blockade of the cysteinyl leukotriene receptors in the AlvM\u03a6 deficient mice reduced the susceptibility of their T1AECs to IAV infection and protected these mice from lethal infection.", {"entities": []}], ["These results suggest that AlvM\u03a6s may utilize a previously unappreciated mechanism to protect T1AECs against IAV infection, and thereby reduce the severity of infection.", {"entities": []}], ["The findings further suggest that the cysLT pathway and the receptors for cysLT metabolites represent potential therapeutic targets in severe IAV infection.", {"entities": []}], ["A primary feature of lethal influenza infection is viral pneumonia.", {"entities": [[28, 37, "DISEASE"], [57, 66, "DISEASE"], [51, 66, "DISEASE"]]}], ["Influenza viral pneumonia is caused by the direct infection of alveolar epithelial cells, which subsequently causes extensive alveolar inflammation and injury.", {"entities": [[0, 9, "DISEASE"], [16, 25, "DISEASE"], [10, 25, "DISEASE"]]}], ["Clinically this pathology manifests as diffuse alveolar damage leading to acute respiratory distress syndrome.", {"entities": [[101, 109, "DISEASE"]]}], ["As alveolar macrophages are positioned in the alveoli, they are the ideally localized to be a first-line of defense against alveolar invading pathogens, such as influenza.", {"entities": [[161, 170, "DISEASE"]]}], ["To explore the contribution of alveolar macrophages to the development of lethal influenza pneumonia, we generated a novel mouse model with a selective deficiency in alveolar macrophages.", {"entities": [[81, 90, "DISEASE"], [91, 100, "DISEASE"]]}], ["As a result of the alveolar macrophage deficiency, these mice developed severe diffuse alveolar damage and lethal respiratory compromise after influenza infection.", {"entities": [[143, 152, "DISEASE"]]}], ["Lethal injury resulted from increased infection of type-1 alveolar epithelial cells, and the elimination of these infected cells by effector T cells.", {"entities": []}], ["Further analysis indicated that in order to render type 1 cells resistant to influenza infection, alveolar macrophages suppress leukotrieneD4 production and autocrine-signaling in type 1 cells.", {"entities": [[77, 86, "DISEASE"]]}], ["These results suggest that alveolar macrophages play a previously unappreciated role in protecting type 1 alveolar epithelial cells against IAV infection, and thus the severity of infection.", {"entities": []}], ["The present study aimed to comprehensively assess if oats intake is beneficial for diabetic patients.", {"entities": []}], ["The literature search was conducted in PubMed database up to 23 August 2015.", {"entities": []}], ["Fourteen controlled trials and two uncontrolled observational studies were included.", {"entities": []}], ["Compared with the controls, oats intake significantly reduced the concentrations of glycosylated hemoglobin A1c (HbA1c) (MD, \u22120.42%; 95% CI, \u22120.61% to \u22120.23%), fasting blood glucose (FBG) (MD, \u22120.39 mmol/L; 95% CI, \u22120.58 to \u22120.19 mmol/L), total cholesterol (TC) (MD, \u22120.49 mmol/L; 95% CI, \u22120.86 to \u22120.12 mmol/L), low-density lipoprotein cholesterol (LDL-C) (MD, \u22120.29 mmol/L; 95% CI, \u22120.48 to \u22120.09 mmol/L).", {"entities": []}], ["Oatmeal significantly reduced the acute postprandial glucose and insulin responses compared with the control meal.", {"entities": []}], ["The present study has revealed a beneficial effect of oats intake on glucose control and lipid profiles in type 2 diabetic patients.", {"entities": []}], ["Further investigations of oats intake in patients with type 1 diabetes and the safety of oats consumption are required.", {"entities": []}], ["To review the incidence of respiratory conditions and their effect on mortality in HIV-infected and uninfected individuals prior to and during the era of highly active antiretroviral therapy (HAART).", {"entities": []}], ["Two large observational cohorts of HIV-infected and HIV-uninfected men (Multicenter AIDS Cohort Study [MACS]) and women (Women\u2019s Interagency HIV Study [WIHS]), followed since 1984 and 1994, respectively.", {"entities": []}], ["Adjusted odds or hazards ratios for incident respiratory infections or non-infectious respiratory diagnoses, respectively, in HIV-infected compared to HIV-uninfected individuals in both the pre-HAART (MACS only) and HAART eras; and adjusted Cox proportional hazard ratios for mortality in HIV-infected persons with lung disease during the HAART era.", {"entities": [[315, 327, "DISEASE"], [222, 226, "GENE"]]}], ["Compared to HIV-uninfected participants, HIV-infected individuals had more incident respiratory infections both pre-HAART (MACS, odds ratio [adjusted-OR], 2.4; 95% confidence interval [CI], 2.2\u20132.7; p<0.001) and after HAART availability (MACS, adjusted-OR, 1.5; 95%CI 1.3\u20131.7; p<0.001; WIHS adjusted-OR, 2.2; 95%CI 1.8\u20132.7; p<0.001).", {"entities": []}], ["Chronic obstructive pulmonary disease was more common in MACS HIV-infected vs. HIV-uninfected participants pre-HAART (hazard ratio [adjusted-HR] 2.9; 95%CI, 1.02\u20138.4; p\u200a=\u200a0.046).", {"entities": []}], ["After HAART availability, non-infectious lung diseases were not significantly more common in HIV-infected participants in either MACS or WIHS participants.", {"entities": []}], ["HIV-infected participants in the HAART era with respiratory infections had an increased risk of death compared to those without infections (MACS adjusted-HR, 1.5; 95%CI, 1.3\u20131.7; p<0.001; WIHS adjusted-HR, 1.9; 95%CI, 1.5\u20132.4; p<0.001).", {"entities": []}], ["HIV infection remained a significant risk for infectious respiratory diseases after the introduction of HAART, and infectious respiratory diseases were associated with an increased risk of mortality.", {"entities": []}], ["This study aims to analyze and record orally transmitted knowledge of medicinal plants from the indigenous people living in Hallasan National Park of Korea.", {"entities": []}], ["Data was collected through the participatory rural appraisal method involving interviews, informal meetings, open and group discussions, and overt observations with semi-structured questionnaires.", {"entities": []}], ["In this study, a total of 68 families, 141 genera, and 171 species of plants that showed 777 ways of usage were recorded.", {"entities": []}], ["Looking into the distribution of the families, 14 species of Asteraceae occupied 11.1% of the total followed by 13 species of Rosaceae, 10 species of Rutaceae, and nine species of Apiaceae which occupied 5.0%, 7.1% and 3.0% of the whole, respectively.", {"entities": []}], ["32 kinds of plant-parts were used for 47 various medicinal purposes.", {"entities": []}], ["Values for the informant consensus factor regarding the ailment categories were for birth related disorders (0.92), followed by respiratory system disorders (0.90), skin disease and disorders (0.89), genitourinary system disorders (0.87), physical pain (0.87), and other conditions.", {"entities": [[165, 177, "DISEASE"]]}], ["According to fidelity levels, 36 plant species resulted in fidelity levels of 100%.", {"entities": []}], ["Consequently, results of this study will legally utilize to provide preparatory measures against the Nagoya Protocol (2010) about benefit-sharing for traditional knowledge of genetic resources.", {"entities": []}], ["Limited epidemiological evidence suggests that low maternal iron status and anaemia in pregnancy may increase the risk of childhood respiratory and allergic outcomes.", {"entities": []}], ["To investigate the relation between maternal haemoglobin concentrations in pregnancy and childhood respiratory and allergic outcomes.", {"entities": []}], ["In the Avon Longitudinal Study of Parents and Children ( ALSPAC ), we examined associations of maternal haemoglobin concentrations (g/ dL ) in pregnancy with hayfever, eczema, wheezing, doctor\u2010diagnosed asthma, allergic sensitisation and total IgE at 7\u00a0years, and with lung function at 8\u20109\u00a0years in the offspring, after controlling for potential confounders (N\u00a0=\u00a03234\u20105335).", {"entities": [[203, 209, "DISEASE"]]}], ["Maternal haemoglobin was not associated with offspring hayfever, eczema, wheezing or asthma.", {"entities": [[85, 91, "DISEASE"]]}], ["However, the first haemoglobin measurement in pregnancy (<18\u00a0weeks' gestation) and the last measurement (>28\u00a0weeks' gestation) were negatively associated with allergic sensitisation (adjusted odds ratio [95% CI ] per g/dL 0.91 [0.83 to 0.99] and 0.90 [0.83 to 0.98], respectively).", {"entities": []}], ["The last haemoglobin measurement was also negatively associated with total IgE (adjusted geometric mean ratio 0.94 [0.88 to 0.99]).", {"entities": []}], ["Anaemia (haemoglobin <11\u00a0g/ dL ) in late pregnancy was negatively associated with forced vital capacity (difference in standard deviation score \u22120.07 [\u22120.13 to \u22120.01]).", {"entities": []}], ["Lower maternal haemoglobin in pregnancy may be a risk factor for allergic sensitisation, elevated IgE and lower FVC in childhood, which may reflect effects of lower prenatal iron status.", {"entities": []}], ["However, maternal haemoglobin was not associated with risk of childhood asthma or other allergic disorders.", {"entities": [[72, 78, "DISEASE"]]}], ["Among extremophiles, halophiles are defined as microorganisms adapted to live and thrive in diverse extreme saline environments.", {"entities": []}], ["These extremophilic microorganisms constitute the source of a number of hydrolases with great biotechnological applications.", {"entities": []}], ["The interest to use extremozymes from halophiles in industrial applications is their resistance to organic solvents and extreme temperatures.", {"entities": []}], ["Marinobacter lipolyticus SM19 is a moderately halophilic bacterium, isolated previously from a saline habitat in South Spain, showing lipolytic activity.", {"entities": []}], ["A lipolytic enzyme from the halophilic bacterium Marinobacter lipolyticus SM19 was isolated.", {"entities": []}], ["This enzyme, designated LipBL, was expressed in Escherichia coli .", {"entities": []}], ["LipBL is a protein of 404 amino acids with a molecular mass of 45.3 kDa and high identity to class C \u03b2-lactamases.", {"entities": []}], ["LipBL was purified and biochemically characterized.", {"entities": []}], ["The temperature for its maximal activity was 80\u00b0C and the pH optimum determined at 25\u00b0C was 7.0, showing optimal activity without sodium chloride, while maintaining 20% activity in a wide range of NaCl concentrations.", {"entities": []}], ["This enzyme exhibited high activity against short-medium length acyl chain substrates, although it also hydrolyzes olive oil and fish oil.", {"entities": []}], ["The fish oil hydrolysis using LipBL results in an enrichment of free eicosapentaenoic acid (EPA), but not docosahexaenoic acid (DHA), relative to its levels present in fish oil.", {"entities": []}], ["For improving the stability and to be used in industrial processes LipBL was immobilized in different supports.", {"entities": []}], ["The immobilized derivatives CNBr-activated Sepharose were highly selective towards the release of EPA versus DHA.", {"entities": []}], ["The enzyme is also active towards different chiral and prochiral esters.", {"entities": []}], ["Exposure of LipBL to buffer-solvent mixtures showed that the enzyme had remarkable activity and stability in all organic solvents tested.", {"entities": []}], ["In this study we isolated, purified, biochemically characterized and immobilized a lipolytic enzyme from a halophilic bacterium M. lipolyticus , which constitutes an enzyme with excellent properties to be used in the food industry, in the enrichment in omega-3 PUFAs.", {"entities": []}], ["Because of ageing populations, the growth in the number of people with multi-morbidity and greater compliance with disease-specific guidelines, polypharmacy is becoming increasingly common.", {"entities": []}], ["Although the correct drug treatment in patients with complex medical problems can improve clinical outcomes, quality of life and life expectancy, polypharmacy is also associated with an increased risk of adverse drug events, some severe enough to result in hospital admission and even death.", {"entities": []}], ["Hence, having systems in place to ensure that medications are started only when there is a suitable indication, ensuring patients are fully aware of the benefits and complications that may arise from their treatment, and reviewing patients regularly to ensure their medication regime remains appropriate, are essential.", {"entities": []}], ["The development and rapid uptake of electronic patient records \u2013 particularly in primary care settings where the majority of prescribing takes place \u2013 makes monitoring of patients more straightforward than in the past; and allows identification of sub-groups of patients at particularly high risk of adverse drug events and complications.", {"entities": []}], ["It also facilitates \u2018deprescribing\u2019 the process by which medications are reviewed and stopped if not clinically beneficial.", {"entities": []}], ["In recent years, we have also seen the development of smartphone \u2018apps\u2019 to improve communication between patients and healthcare professionals, improve people\u2019s understanding of their conditions and their treatment, and maintain a record of changes made to patient\u2019s medication.", {"entities": []}], ["In the longer term, developments such as the introduction of artificial intelligence and clinical decision support systems also have the potential to improve prescribing and minimise the risks from polypharmacy.", {"entities": []}], ["Finally, there is considerable scope to improve the quality of prescribing and reduce risks from poly-pharmacy using non-medical groups such as pharmacists, specialist nurses and physician assistants.", {"entities": []}], ["Polypharmacy has increased in recent decades and will continue to increase as populations age and the number of people with multiple long-term conditions increases.", {"entities": []}], ["As with all areas of medicine, the evidence-base in this area continues to evolve.", {"entities": []}], ["Further trials on the impact on patients with polypharmacy of new interventions such as technology-based solutions and the use of different professional groups are needed to improve the evidence-base in this area.", {"entities": []}], ["The association between air pollution and childhood respiratory disease is inconsistent.", {"entities": []}], ["In the present study, we investigated a short-term effect of ambient air pollutants and daily childhood lower respiratory diseases (CLRD).", {"entities": []}], ["Daily air pollutants, weather data, and CLRD data were collected from January 2014 to April 2015 (452 days) in Nanjing, China.", {"entities": []}], ["Time-series regression and generalized additive models were used to assess the effects of air pollutants (PM 10 , PM 2.5 , NO 2 , SO 2 , O 3 , and CO) on CLRD.", {"entities": []}], ["We observed that an interquartile range (IQR) increase in concentrations of PM 10 , NO 2 , and SO 2 significantly increased the daily CLRD with 6 days cumulative effects (difference of estimates: 2.8%, 95% CI: 0.6\u20135.0%; 4.1%, 1.2\u20137.0%; 5.6%, 2.6\u20138.6%, respectively).", {"entities": []}], ["However, no significant association was found in IQR concentrations of PM 2.5 , O 3 , and CO.", {"entities": []}], ["Specifically, elevated PM 10 , PM 2.5 , NO 2 , and SO 2 significantly increased the numbers of CLRD in cool season (3.6%, 1.5\u20135.7%; 2.4%, 0.3\u20134.5%; 4.9%, 2.9\u20137.0%; 6.3%, 3.7\u20139.0%, respectively).", {"entities": []}], ["Additionally, the effect estimates of PM 10 , NO 2 , and SO 2 in female and age >27 months were more pronounced than in male and age \u226427 months.", {"entities": []}], ["This study suggested that short-term exposure to ambient PM 10 , NO 2 , and SO 2 were associated with the increased CLRD numbers.", {"entities": []}], ["Complement C3a is an important protein in innate and adaptive immunity, but its specific roles in vivo remain uncertain because C3a degrades rapidly to form the C3a-desArg protein, which does not bind to the C3a receptor and is indistinguishable from C3a using antibodies.", {"entities": []}], ["Here we develop the most potent, stable and highly selective small molecule modulators of C3a receptor, using a heterocyclic hinge to switch between agonist and antagonist ligand conformations.", {"entities": []}], ["This enables characterization of C3 areceptor-selective pro- vs. anti-inflammatory actions in human mast cells and macrophages, and in rats.", {"entities": [[33, 35, "GENE"]]}], ["A C3a receptor-selective agonist induces acute rat paw inflammation by first degranulating mast cells before activating macrophages and neutrophils.", {"entities": []}], ["An orally administered C3a receptor-selective antagonist inhibits mast cell degranulation, thereby blocking recruitment and activation of macrophages and neutrophils, expression of inflammatory mediators and inflammation in a rat paw edema model.", {"entities": []}], ["These novel tools reveal the mechanism of C3a-induced inflammation and provide new insights to complement-based medicines.", {"entities": []}], ["Complement C3a is an important protein in innate and adaptive immunity, but its roles in vivo are unclear.", {"entities": []}], ["Here the authors develop novel chemical agonists and antagonists for the C3a receptor, and show that they modulate mast cell degranulation and inflammation in a rat paw edema model", {"entities": []}], ["On the final afternoon of the workshop \"Assessment of the Allergenic Potential of Genetically Modified Foods,\" held 10-12 December 2001 in Chapel Hill, North Carolina, USA, speakers and participants met in breakout groups to discuss specific questions in the areas of use of human clinical data, animal models to assess food allergy, biomarkers of exposure and effect, sensitive populations, dose-response assessment, and postmarket surveillance.", {"entities": [[320, 332, "DISEASE"]]}], ["Each group addressed general questions regarding allergenicity of genetically modified foods and specific questions for each subject area.", {"entities": []}], ["This article is a brief summary of the discussions of each of the six breakout groups regarding our current state of knowledge and what information is needed to advance the field.", {"entities": []}], ["The true incidence of chronic obstructive pulmonary disease is largely unknown, because the few longitudinal studies performed have used diagnostic criteria no longer recommended by either the European Respiratory Society or the American Thoracic Society (ATS).", {"entities": [[22, 59, "DISEASE"]]}], ["We studied the incidence and significance of airflow limitation in a population-based geriatric sample using both an age-dependent predicted lower limit of normal (LLN) value and a fixed-ratio spirometric criterion.", {"entities": []}], ["Out of 2025 subjects with acceptable spirometry at baseline, 984 subjects aged 65\u2013100\u2005years completed a 6-year follow-up visit.", {"entities": []}], ["Smoking habits were registered at baseline.", {"entities": []}], ["Exclusion criteria were non-acceptable spirometry performance according to ATS criteria and inability to communicate.", {"entities": []}], ["Airflow limitation was defined both according to forced expiratory volume in 1\u2005s (FEV 1 )/forced vital capacity ratio <0.7 and <LLN.", {"entities": [[82, 85, "GENE"]]}], ["The incidence of airflow limitation per 1000\u2005person-years was 28.2 using a fixed ratio and 11.7 with LLN, corresponding to a 1.41-fold higher incidence rate using a fixed ratio.", {"entities": []}], ["The incidence increased dramatically with age when using a fixed ratio, but less so when using LLN.", {"entities": []}], ["In addition, a sex effect was observed with the LLN criterion.", {"entities": []}], ["LLN airflow limitation was associated with increased 5-year mortality.", {"entities": []}], ["Presence of fixed-ratio airflow limitation in individuals classified by LLN as non-obstructive was not associated with increased mortality.", {"entities": []}], ["Female sex may be a risk factor for developing chronic obstructive pulmonary disease http://ow.ly/TdgEd", {"entities": [[47, 84, "DISEASE"]]}], ["The Rhinovirus C (RV-C), first identified in 2006, produce high symptom burdens in children and asthmatics, however, their primary target host cell in the airways remains unknown.", {"entities": []}], ["Our primary hypotheses were that RV-C target ciliated airway epithelial cells (AECs), and that cell specificity is determined by restricted and high expression of the only known RV-C cell-entry factor, cadherin related family member 3 (CDHR3).", {"entities": [[236, 241, "GENE"]]}], ["RV-C15 (C15) infection in differentiated human bronchial epithelial cell (HBEC) cultures was assessed using immunofluorescent and time-lapse epifluorescent imaging.", {"entities": []}], ["Morphology of C15-infected differentiated AECs was assessed by immunohistochemistry.", {"entities": []}], ["C15 produced a scattered pattern of infection, and infected cells were shed from the epithelium.", {"entities": []}], ["The percentage of cells infected with C15 varied from 1.4 to 14.7% depending on cell culture conditions.", {"entities": []}], ["Infected cells had increased staining for markers of ciliated cells (acetylated-alpha-tubulin [aat], p \u2009<\u20090.001) but not markers of goblet cells (wheat germ agglutinin or Muc5AC, p \u2009=\u2009ns).", {"entities": []}], ["CDHR3 expression was increased on ciliated epithelial cells, but not other epithelial cells ( p \u2009<\u20090.01).", {"entities": [[0, 5, "GENE"]]}], ["C15 infection caused a 27.4% reduction of ciliated cells expressing CDHR3 ( p \u2009<\u20090.01).", {"entities": [[68, 73, "GENE"]]}], ["During differentiation of AECs, CDHR3 expression progressively increased and correlated with both RV-C binding and replication.", {"entities": [[32, 37, "GENE"]]}], ["The RV-C only replicate in ciliated AECs in vitro, leading to infected cell shedding.", {"entities": []}], ["CDHR3 expression positively correlates with RV-C binding and replication, and is largely confined to ciliated AECs.", {"entities": [[0, 5, "GENE"]]}], ["Our data imply that factors regulating differentiation and CDHR3 production may be important determinants of RV-C illness severity.", {"entities": [[59, 64, "GENE"]]}], ["The online version of this article (doi:10.1186/s12931-017-0567-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Access to community-based primary health care (hereafter, \u2018primary care\u2019) is a priority in many countries.", {"entities": []}], ["Health care systems have emphasized policies that help the community \u2018get the right service in the right place at the right time\u2019.", {"entities": []}], ["However, little is known about organizational interventions in primary care that are aimed to improve access for populations in situations of vulnerability (e.g., socioeconomically disadvantaged) and how successful they are.", {"entities": []}], ["The purpose of this scoping review was to map the existing evidence on organizational interventions that improve access to primary care services for vulnerable populations.", {"entities": []}], ["Scoping review followed an iterative process.", {"entities": []}], ["Eligibility criteria: organizational interventions in Organisation for Economic Cooperation and Development (OECD) countries; aiming to improve access to primary care for vulnerable populations; all study designs; published from 2000 in English or French; reporting at least one outcome (avoidable hospitalization, emergency department admission, or unmet health care needs).", {"entities": []}], ["Sources: Main bibliographic databases (Medline, Embase, CINAHL) and team members\u2019 personal files.", {"entities": []}], ["Study selection: One researcher selected relevant abstracts and full text papers.", {"entities": []}], ["Theory-driven synthesis: The researcher classified included studies using (i) the \u2018Patient Centered Access to Healthcare\u2019 conceptual framework (dimensions and outcomes of access to primary care), and (ii) the classification of interventions of the Cochrane Effective Practice and Organization of Care.", {"entities": []}], ["Using pattern analysis, interventions were mapped in accordance with the presence/absence of \u2018dimension-outcome\u2019 patterns.", {"entities": []}], ["Out of 8,694 records (title/abstract), 39 studies with varying designs were included.", {"entities": []}], ["The analysis revealed the following pattern.", {"entities": []}], ["Results of 10 studies on interventions classified as \u2018Formal integration of services\u2019 suggested that these interventions were associated with three dimensions of access (approachability, availability and affordability) and reduction of hospitalizations (four/four studies), emergency department admissions (six/six studies), and unmet healthcare needs (five/six studies).", {"entities": []}], ["These 10 studies included seven non-randomized studies, one randomized controlled trial, one quantitative descriptive study, and one mixed methods study.", {"entities": []}], ["Our results suggest the limited breadth of research in this area, and that it will be feasible to conduct a full systematic review of studies on the effectiveness of the formal integration of services to improve access to primary care services for vulnerable populations.", {"entities": []}], ["Respiratory disease is a major cause of morbidity and mortality in HIV-infected children.", {"entities": []}], ["Despite antiretroviral therapy (ART), children suffer chronic symptoms.", {"entities": []}], ["We investigated symptom prevalence, lung function and exercise capacity among older children established on ART and an age-matched HIV-uninfected group.", {"entities": []}], ["A cross-sectional study in Zimbabwe of HIV-infected children aged 6\u201316 years receiving ART for over 6 months and HIV-uninfected children attending primary health clinics from the same area.", {"entities": []}], ["Standardized questionnaire, spirometry, incremental shuttle walk testing, CD4 A total of 202 HIV-infected and 150 uninfected participants (median age 11.1 years in each group) were recruited.", {"entities": [[74, 77, "GENE"]]}], ["Median age at HIV diagnosis and ART initiation was 5.5 (interquartile range 2.8\u20137.5) and 6.1 (interquartile range 3.6\u20138.4) years, respectively.", {"entities": []}], ["Median CD4 n \u200a=\u200a1 (0.7%)], but common in HIV-infected participants [51 (25%)], especially cough [30 (15%)] and dyspnoea [30 (15%)].", {"entities": [[7, 10, "GENE"]]}], ["HIV-infected participants were more commonly previously treated for tuberculosis [76 (38%) vs 1 (0.7%), P \u200a<\u200a0.001], had lower exercise capacity (mean incremental shuttle walk testing distance 771 vs 889\u200am, respectively, P \u200a<\u200a0.001) and more frequently abnormal spirometry [43 (24.3%) vs 15 (11.5%), P \u200a=\u200a0.003] compared with HIV-uninfected participants.", {"entities": [[68, 80, "DISEASE"]]}], ["HIV diagnosis at an older age was associated with lung function abnormality ( P \u200a=\u200a0.025).", {"entities": []}], ["No participant tested positive for Mycobacterium tuberculosis .", {"entities": [[49, 61, "DISEASE"]]}], ["In children, despite ART, HIV is associated with significant respiratory symptoms and functional impairment.", {"entities": []}], ["Understanding pathogenesis is key, as new treatment strategies are urgently required.", {"entities": []}], ["Although current therapies in chronic obstructive pulmonary disease (COPD) improve the quality of life, they do not satisfactorily reduce disease progression or mortality.", {"entities": [[30, 67, "DISEASE"]]}], ["There are still many gaps in knowledge about the cellular, molecular, and genetic mechanisms contributing to pathobiology of this disease.", {"entities": []}], ["However, increasing evidence suggests that accelerated aging, chronic systemic inflammation, and oxidative stress play major roles in pathogenesis in COPD, thus opening new opportunities in therapy.", {"entities": []}], ["Therefore, the aim of our review was to describe and discuss some of the most widely used therapeutics that affect the root cause of aging and oxidative stress (metformin, melatonin, sirolimus, statins, vitamin D, and testosterone) in context of COPD therapy.", {"entities": []}], ["This study aimed to measure the level and determinants of health-related quality of life (HRQoL) in adults in Kermanshah, a city in the western region of Iran.", {"entities": []}], ["Convenience sampling was employed to obtain a sample of 998 adults aged 18 years and older (646 males and 352 females) in the city of Kermanshah.", {"entities": []}], ["A 2-part self-administered questionnaire was used to collect data over the period between March 1 and May 30, 2017.", {"entities": []}], ["The first part was designed to collect information on socio-demographic characteristics, socioeconomic status, and lifestyle factors (10 items).", {"entities": []}], ["The second part consisted of the EuroQoL 5-dimensions (EQ-5D) EuroQoL-3-level and the EuroQoL visual analog scale (EQ-VAS) questions.", {"entities": []}], ["A multiple linear regression model was used to determine the factors associated with the EQ-5D index and EQ-VAS score among study participants.", {"entities": []}], ["The mean values for the EQ-5D index and the EQ-VAS score were 0.74 (standard deviation [SD], 0.19) and 80.9 (SD, 16.5), respectively.", {"entities": []}], ["The highest percentage of self-reported problems (\u2018some\u2019 and \u2018severe\u2019 problems) across the 5 dimensions of the EQ-5D index were associated with the dimensions of anxiety/depression (35.3%) and pain/discomfort (32.9%).", {"entities": []}], ["The percentage of self-reported problems for the dimensions of usual activities, mobility, and self-care were 19.0, 12.8, and 8.9%, respectively.", {"entities": []}], ["Our regression analyses indicated that there were statistically significant positive associations between being physically active, monthly household income per capita, and post-secondary education and the EQ-5D index and EQ-VAS score.", {"entities": []}], ["In contrast, negative associations were found between older age, being married, having a chronic disease, and smoking and the EQ-5D index and EQ-VAS score.", {"entities": []}], ["A negative association was also found between being uninsured and the EQ-5D index.", {"entities": []}], ["Our findings suggest that interventions aiming to improve physical activity, to prevent chronic diseases, and to reduce the smoking rate among adults living in the city of Kermanshah may improve their HRQoL.", {"entities": []}], ["Mount Oyama, on the Japanese island of Miyakejima, began erupting in June 2000, necessitating the evacuation of 3,000 island residents.", {"entities": []}], ["Volcanic gas emissions, primarily consisting of sulfur dioxide (SO 2 ), gradually decreased and residents returned to the island after the evacuation order was lifted in February 2005.", {"entities": []}], ["To assess the exposure-effect and exposure-response relationships between SO 2 exposure and effects on respiratory system in adult Miyakejima residents.", {"entities": []}], ["Health checkups focusing on pulmonary function and respiratory/irritative symptoms were conducted six times every November from 2006 to 2011.", {"entities": []}], ["The study population comprised 168 subjects who underwent all health checkups.", {"entities": []}], ["SO 2 concentrations were measured at six fixed monitoring stations in inhabitable areas.", {"entities": []}], ["Based on the annual mean SO 2 concentration, inhabitable areas were classified into three categories; namely, lower (L), higher (H-1), and highest (H-2) areas.", {"entities": []}], ["Average SO 2 concentrations (ppb) during 3 months prior to each health checkup dropped from 11.3 to 3.29, 32.2 to 13.4 and 75.1 to 12.6 from 2006 to 2010/2011 in L, H-1, and H-2.", {"entities": []}], ["No significant declines in pulmonary function were observed in all areas.", {"entities": []}], ["However, prevalence of subjective symptoms such as \"Cough,\" \"Irritation and/or pain in throat,\" \"Irritation, runny nose, and/or nasal sniffles,\" and \"Irritation and/or pain in the eyes,\" dependently increased on SO 2 concentration.", {"entities": []}], ["Odds ratios were statistically significant at approximately 70 ppb of SO 2 or above.", {"entities": []}], ["Adult residents of Miyakejima island showed no deterioration in pulmonary function at SO 2 levels, but complained of respiratory/irritative symptoms in an SO 2 concentration-dependent manner.", {"entities": []}], ["The aim of this study was to compare potential differences between the perception that COPD patients have of their disease and the perception that physicians have of how the disease affects their patients.", {"entities": []}], ["Surveys in COPD patients and physicians caring for COPD patients were conducted in Spain, Italy, and Germany.", {"entities": []}], ["Online questionnaires mirrored to explore the same domains, were administered to patients and physicians.", {"entities": []}], ["Physicians were asked to respond to the questionnaire taking a recently seen patient who represents the majority of COPD patients usually managed, as a reference.", {"entities": []}], ["Patients with COPD completed a survey containing the same questions offered to the physicians (Medical Investigation of Respiratory COPD Perception [MIRROR] survey).", {"entities": []}], ["Comparisons between the responses of patients and general practitioners (GPs) and between patients and pulmonologists (PULs) were run separately using the chi-square, Fisher\u2019s exact, or Student\u2019s t -tests.", {"entities": []}], ["A total of 334 COPD patients, 333 GPs, and 333 PULs participated in the surveys.", {"entities": []}], ["The typical perception that PULs have of the COPD patient was that of an older man with more severe disease and less likely to be a smoker, than the included COPD patients.", {"entities": []}], ["COPD was regarded as a major health problem by patients and physicians, but its impact on overall quality of life among more severe patients was less strongly perceived by physicians than by patients.", {"entities": []}], ["Instead, physicians paid more attention to domains related to clinical features (cough, phlegm, and dyspnea), while underestimating COPD impact on leisure and social activities.", {"entities": []}], ["The majority of patients stated not being completely frank with their doctors during visits.", {"entities": []}], ["Both GPs and PULs seemed to recognize this issue but underestimated its extent.", {"entities": []}], ["To improve the doctor\u2013patient communication, a more frank reporting by the patients of their symptoms and feelings and an increased awareness of physicians about the impact on nonconventional domains that patients perceive as importantly affected by COPD should be encouraged.", {"entities": []}], ["Bronchiectasis (BE) is a chronic structural lung disease with frequent exacerbations, some of which require hospital admission though no clear associated factors have been identified.", {"entities": [[44, 56, "DISEASE"]]}], ["We aimed to evaluate factors associated with hospitalization due to exacerbations during a 1-year follow-up period.", {"entities": []}], ["A prospective observational study was performed in patients recruited from specialized BE clinics.", {"entities": []}], ["We considered all exacerbations diagnosed and treated with antibiotics during a follow-up period of 1 year.", {"entities": []}], ["The protocol recorded baseline variables, usual treatments, Bronchiectasis Severity Index (BSI) and FACED scores, comorbid conditions and prior hospitalizations.", {"entities": []}], ["Two hundred and 65 patients were recruited, of whom 162 required hospital admission during the follow-up period.", {"entities": []}], ["Independent risk factors for hospital admission were age, previous hospitalization due to BE, use of proton pump inhibitors, heart failure, FACED and BSI, whereas pneumococcal vaccination was a protective factor.", {"entities": []}], ["The area under the receiver operator characteristic curve (AUC) was 0.799 for BSI model was 0.799, and 0.813 for FACED model.", {"entities": []}], ["Previous hospitalization, use of proton pump inhibitors, heart failure along with BSI or FACED scores is associated factors for developing exacerbations that require hospitalization.", {"entities": []}], ["Pneumococcal vaccination was protective.", {"entities": []}], ["This information may be useful for the design of preventive strategies and more intensive follow-up plans.", {"entities": []}], ["The active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D), plays an important immunomodulatory role, regulating transcription of genes in the innate and adaptive immune system.", {"entities": []}], ["The present study examines patterns of transcriptome-wide response to 1,25D, and the bacterial lipopolysaccharide (LPS) in primary human monocytes, to elucidate pathways underlying the effects of 1,25D on the immune system.", {"entities": []}], ["Monocytes obtained from healthy individuals of African-American and European-American ancestry were treated with 1,25D, LPS, or both, simultaneously.", {"entities": []}], ["The addition of 1,25D during stimulation with LPS induced significant upregulation of genes in the antimicrobial and autophagy pathways, and downregulation of proinflammatory response genes compared to LPS treatment alone.", {"entities": []}], ["A joint Bayesian analysis enabled clustering of genes into patterns of shared transcriptional response across treatments.", {"entities": []}], ["The biological pathways enriched within these expression patterns highlighted several mechanisms through which 1,25D could exert its immunomodulatory role.", {"entities": []}], ["Pathways such as mTOR signaling, EIF2 signaling, IL-8 signaling, and Tec Kinase signaling were enriched among genes with opposite transcriptional responses to 1,25D and LPS, respectively, highlighting the important roles of these pathways in mediating the immunomodulatory activity of 1,25D.", {"entities": [[17, 21, "GENE"]]}], ["Furthermore, a subset of genes with evidence of interethnic differences in transcriptional response was also identified, suggesting that in addition to the well-established interethnic variation in circulating levels of vitamin D, the intensity of transcriptional response to 1,25D and LPS also varies between ethnic groups.", {"entities": []}], ["We propose that dysregulation of the pathways identified in this study could contribute to immune-mediated disease risk.", {"entities": []}], ["Our previous study found that somatostatin (SST) inhibited the intestinal inflammatory injury in a macaque model of intestinal ischemia\u2013reperfusion (IIR); however, the underlying mechanism was unclear.", {"entities": [[127, 135, "DISEASE"], [44, 47, "GENE"]]}], ["The present study was aimed to investigate the effects of SST on IFN-\u03b3 and the systemic inflammatory response after IIR.", {"entities": [[58, 61, "GENE"]]}], ["Fifteen macaques were randomly divided into controls, IIR and SST+ IIR groups.", {"entities": []}], ["ELISA was performed to measure IFN-\u03b3 in ileum tissues, ileac epithelial cells (IECs) and ileal lymphocytes, as well as the systemic levels of IL-6, IL-1\u03b2, TNF-\u03b1 and IFN-\u03b3 in the peripheral circulation and the portal vein.", {"entities": []}], ["HE staining was performed to evaluate morphological changes in vital organs.", {"entities": []}], ["Immunohistochemistry was performed to identify the distribution of IFN-\u03b3, CD4, CD8 and CD57 in the ileum.", {"entities": [[74, 77, "GENE"]]}], ["After IIR, IFN-\u03b3 level was significantly increased in the IECs.", {"entities": []}], ["IL-6, IL-1\u03b2 and TNF-\u03b1 were significantly increased in both the portal vein and the peripheral circulation; in contrast, IFN-\u03b3 level was increased in the portal vein alone.", {"entities": []}], ["Prophylactic SST reversed the change in IFN-\u03b3 in the IECs and portal vein.", {"entities": [[13, 16, "GENE"]]}], ["SST led to an alleviation of the pathological changes in systemic vital organs.", {"entities": [[0, 3, "GENE"]]}], ["The distribution of CD4 IECs are the main source of IFN-\u03b3 production after IIR.", {"entities": [[20, 23, "GENE"]]}], ["SST may indirectly lead to mast cell deactivation through the inhibition of IFN-\u03b3 production by IECs.", {"entities": [[0, 3, "GENE"]]}], ["Pretreatment with SST may be beneficial for preventing a massive systemic inflammatory response in vital organs after IIR.", {"entities": [[18, 21, "GENE"]]}], ["CD38 is an enzyme that catalyzes the formation of cyclic ADP ribose and nicotinic acid adenine dinucleotide phosphate, both of which are involved in the mobilization of Ca The online version of this article (doi:10.1186/s13041-016-0195-5) contains supplementary material, which is available to authorized users.", {"entities": [[0, 4, "GENE"]]}], ["This study compares handgrip strength and its association with mortality across studies conducted in Moscow, Denmark, and England.", {"entities": []}], ["The data collected by the Study of Stress, Aging, and Health in Russia, the Study of Middle-Aged Danish Twins and the Longitudinal Study of Aging Danish Twins, and the English Longitudinal Study of Ageing was utilized.", {"entities": []}], ["Among the male participants, the age-standardized grip strength was 2 kg and 1 kg lower in Russia than in Denmark and in England, respectively.", {"entities": []}], ["The age-standardized grip strength among the female participants was 1.9 kg and 1.6 kg lower in Russia than in Denmark and in England, respectively.", {"entities": []}], ["In Moscow, a one-kilogram increase in grip strength was associated with a 4% (hazard ratio [HR] = 0.96, 95% confidence interval [CI]: 0.94, 0.99) reduction in mortality among men and a 10% (HR = 0.90, 95%CI: 0.86, 0.94) among women.", {"entities": [[92, 94, "GENE"], [190, 192, "GENE"], [92, 94, "GENE"], [190, 192, "GENE"]]}], ["Meanwhile, a one-kilogram increase in grip strength was associated with a 6% (HR = 0.94, 95%CI: 0.93, 0.95) and an 8% (HR = 0.92, 95%CI: 0.90, 0.94) decrease in mortality among Danish men and women, respectively, and with a 2% (HR = 0.98, 95%CI: 0.97, 0.99) and a 3% (HR = 0.97, 95%CI: 0.95, 0.98) reduction in mortality among the English men and women, respectively.", {"entities": [[78, 80, "GENE"], [119, 121, "GENE"], [228, 230, "GENE"], [268, 270, "GENE"], [78, 80, "GENE"], [119, 121, "GENE"], [228, 230, "GENE"], [268, 270, "GENE"], [78, 80, "GENE"], [119, 121, "GENE"], [228, 230, "GENE"], [268, 270, "GENE"], [78, 80, "GENE"], [119, 121, "GENE"], [228, 230, "GENE"], [268, 270, "GENE"]]}], ["The study suggests that, although absolute grip strength values appear to vary across the Muscovite, Danish, and English samples, the degree to which grip strength is predictive of mortality is comparable across national populations with diverse socioeconomic and health profiles and life expectancy levels.", {"entities": []}], ["Complement 5a receptor (C5aR) was demonstrated a receptor of complement 5a (C5a) which is involved in many inflammatory diseases.", {"entities": []}], ["The functional responses attributed to C5a results from its interaction with its receptors C5aR, which stimulates food intake, plays a role in increasing the inflammatory response in adipose tissue as well as the cardiovascular and neural systems.", {"entities": []}], ["However, There are unknown associations between the SNPs of C5aR1 gene and coronary artery disease (CAD).", {"entities": [[60, 65, "GENE"]]}], ["We examined the role of the tagging single nucleotide polymorphisms (SNPs) of C5aR1 gene for CAD using a case\u2013control design, and determined the prevalence of C5aR1 genotypes in 505 CAD patients and 469 age and sex-matched healthy control subjects of Han population.", {"entities": [[78, 83, "GENE"], [159, 164, "GENE"], [78, 83, "GENE"], [159, 164, "GENE"]]}], ["The rs10853784 was found to be associated with CAD in dominant model (CC vs TT + CT, P = 0.004).", {"entities": []}], ["The difference remained statistically significant after multivariate adjustment ( OR = 1.430, 95% CI : 1.087 ~ 1.882, P = 0.011).", {"entities": []}], ["There was no significant difference in genotype distributions of rs4577202 and rs7250152 between CAD patients and control subjects.", {"entities": []}], ["The frequency of the haplotype (A-T-C) was significantly higher in the CAD patients than in the controls ( P = 0.035), and the haplotype (A-C-T) was significantly lower in the CAD patients than in the control subjects in Chinese Han population ( P = 0.002).", {"entities": []}], ["The results of this study indicate that rs10853784 of C5aR1 gene are associated with CAD in Han population of China, and A-C-T haplotypes may be protective genetic marker and the A-T-C may be risk genetic marker for CAD in Chinese Han population.", {"entities": [[54, 59, "GENE"]]}], ["The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2054871241495194 .", {"entities": []}], ["Observational studies on smoking and risk of hay fever and asthma have shown inconsistent results.", {"entities": [[59, 65, "DISEASE"]]}], ["However, observational studies may be biased by confounding and reverse causation.", {"entities": []}], ["Mendelian randomization uses genetic variants as markers of exposures to examine causal effects.", {"entities": []}], ["We examined the causal effect of smoking on hay fever and asthma by using the smoking-associated single nucleotide polymorphism (SNP) rs16969968/rs1051730.", {"entities": [[58, 64, "DISEASE"]]}], ["We included 231,020 participants from 22 population-based studies.", {"entities": []}], ["Observational analyses showed that current vs never smokers had lower risk of hay fever (odds ratio (OR)\u2009=\u20090\u00b768, 95% confidence interval (CI): 0\u00b761, 0\u00b776; P\u2009<\u20090\u00b7001) and allergic sensitization (OR\u2009=\u20090\u00b774, 95% CI: 0\u00b764, 0\u00b786; P\u2009<\u20090\u00b7001), but similar asthma risk (OR\u2009=\u20091\u00b700, 95% CI: 0\u00b791, 1\u00b709; P\u2009=\u20090\u00b7967).", {"entities": [[249, 255, "DISEASE"]]}], ["Mendelian randomization analyses in current smokers showed a slightly lower risk of hay fever (OR\u2009=\u20090\u00b7958, 95% CI: 0\u00b7920, 0\u00b7998; P\u2009=\u20090\u00b7041), a lower risk of allergic sensitization (OR\u2009=\u20090\u00b792, 95% CI: 0\u00b784, 1\u00b702; P\u2009=\u20090\u00b7117), but higher risk of asthma (OR\u2009=\u20091\u00b706, 95% CI: 1\u00b701, 1\u00b711; P\u2009=\u20090\u00b7020) per smoking-increasing allele.", {"entities": [[243, 249, "DISEASE"]]}], ["Our results suggest that smoking may be causally related to a higher risk of asthma and a slightly lower risk of hay fever.", {"entities": [[77, 83, "DISEASE"]]}], ["However, the adverse events associated with smoking limit its clinical significance.", {"entities": []}], ["Descemet's membrane detachment (DMD) is an uncommon condition with a wide range of etiologies.", {"entities": [[32, 35, "GENE"]]}], ["More than likely, the most common cause is a localized detachment occurring after cataract surgery.", {"entities": [[82, 90, "DISEASE"]]}], ["We report three cases of Descemet's membrane detachment that occurred after uncomplicated phacoemulsification cataract surgeries.", {"entities": [[110, 118, "DISEASE"]]}], ["The first patient was managed without surgical intervention, the second patient was treated using an intracameral air injection, and the last patient was treated with an intracameral perfluoropropane (C3F8) gas injection.", {"entities": []}], ["All three patients recovered their vision following the reattachment of Descemet's membrane.", {"entities": []}], ["The three patients were treated according to the extent of the detachment.", {"entities": []}], ["People with chronic depression are frequently lost from effective care, with resulting psychological, physical and social morbidity and considerable social and financial societal costs.", {"entities": []}], ["This randomised controlled trial will evaluate whether regular structured practice nurse reviews lead to better mental health and social outcomes for these patients and will assess the cost-effectiveness of the structured reviews compared to usual care.", {"entities": []}], ["The hypothesis is that structured, pro-active care of patients with chronic depression in primary care will lead to a cost-effective improvement in medical and social outcomes when compared with usual general practitioner (GP) care.", {"entities": []}], ["Participants were recruited from 42 general practices throughout the United Kingdom.", {"entities": []}], ["Eligible participants had to have a history of chronic major depression, recurrent major depression or chronic dsythymia confirmed using the Composite International Diagnostic Interview (CIDI).", {"entities": []}], ["They also needed to score 14 or above on the Beck Depression Inventory (BDI-II) at recruitment.", {"entities": []}], ["Once consented, participants were randomised to treatment as usual from their general practice (controls) or the practice nurse led intervention.", {"entities": []}], ["The intervention includes a specially prepared education booklet and a comprehensive baseline assessment of participants' mood and any associated physical and psycho-social factors, followed by regular 3 monthly reviews by the nurse over the 2 year study period.", {"entities": []}], ["At these appointments intervention participants' mood will be reviewed, together with their current pharmacological and psychological treatments and any relevant social factors, with the nurse suggesting possible amendments according to evidence based guidelines.", {"entities": []}], ["This is a chronic disease management model, similar to that used for other long-term conditions in primary care.", {"entities": []}], ["The primary outcome is the BDI-II, measured at baseline and 6 monthly by self-complete postal questionnaire.", {"entities": []}], ["Secondary outcomes collected by self-complete questionnaire at baseline and 2 years include social functioning, quality of life and data for the economic analyses.", {"entities": []}], ["Health service data will be collected from GP notes for the 24 months before recruitment and the 24 months of the study.", {"entities": []}], ["558 participants were recruited, 282 to the intervention and 276 to the control arm.", {"entities": []}], ["The majority were recruited via practice database searches using relevant READ codes.", {"entities": []}], ["ISRCTN36610074", {"entities": []}], ["Nebulised dornase alfa is used off-label in critically ill patients.", {"entities": []}], ["We aimed to assess the benefits and harms of nebulised dornase alfa versus placebo, no prophylaxis, or hypertonic saline on patient-important outcome measures in adult critically ill patients.", {"entities": []}], ["We performed a systematic review with meta-analysis and trial sequential analysis (TSA) using the Cochrane Collaboration methodology.", {"entities": []}], ["Eligible trials were randomised clinical trials comparing nebulised dornase alfa with placebo, no prophylaxis, or hypertonic saline.", {"entities": []}], ["The predefined outcome measures were all-cause mortality, duration of mechanical ventilation, length of stay, and adverse events.", {"entities": []}], ["Two reviewers independently assessed trials for inclusion, data extraction, and risk of bias.", {"entities": []}], ["Risk ratios (RRs) with 95\u00a0% confidence intervals (CIs) were estimated by conventional cumulative meta-analysis, and the robustness of the primary estimate was assessed by TSA.", {"entities": []}], ["Two trials ( n \u2009=\u200963) were included; both were judged to have high risk of bias.", {"entities": []}], ["There was no statistically significant difference in mortality (random effects model RR (95\u00a0% CI) 0.73 (0.09\u20135.77); P \u2009=\u20090.24; I We found very low quantity and quality of evidence for use of nebulised dornase alfa in adult critically ill patients in this systematic review with meta-analysis.", {"entities": []}], ["The International Prospective Register of Systematic Reviews (PROSPERO), no.", {"entities": []}], ["CRD442015016047 .", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-015-0142-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["show that IL-22, which is produced mainly by CD4 Previous studies have shown that IL-22, one of the Th17 cell\u2013related cytokines, plays multiple roles in regulating allergic airway inflammation caused by antigen-specific Th2 cells; however, the underlying mechanism remains unclear.", {"entities": [[45, 48, "GENE"]]}], ["Here, we show that allergic airway inflammation and Th2 and Th17 cytokine production upon intratracheal administration of house dust mite (HDM) extract, a representative allergen, were exacerbated in IL-22-deficient mice.", {"entities": []}], ["We also found that IL-22 induces Reg3\u03b3 production from lung epithelial cells through STAT3 activation and that neutralization of Reg3\u03b3 significantly exacerbates HDM-induced eosinophilic airway inflammation and Th2 cytokine induction.", {"entities": [[85, 90, "GENE"]]}], ["Moreover, exostatin-like 3 (EXTL3), a functional Reg3\u03b3 binding protein, is expressed in lung epithelial cells, and intratracheal administration of recombinant Reg3\u03b3 suppresses HDM-induced thymic stromal lymphopoietin and IL-33 expression and accumulation of type 2 innate lymphoid cells in the lung.", {"entities": [[28, 33, "GENE"]]}], ["Collectively, these results suggest that IL-22 induces Reg3\u03b3 production from lung epithelial cells and inhibits the development of HDM-induced allergic airway inflammation, possibly by inhibiting cytokine production from lung epithelial cells.", {"entities": []}], ["Cheilitis granulomatosa is characterized by granulomatous lip swelling.", {"entities": [[0, 9, "DISEASE"]]}], ["We report a case of a 13-year-old girl who presented with orofacial swelling and arthralgia, who eventually was diagnosed with Crohn\u2019s disease, which was successfully treated with infliximab and azathioprine combination therapy.", {"entities": []}], ["Recurrent or persistent orofacial swelling should prompt consideration of cheilitis granulomatosa, and further diagnostic evaluation to exclude the presence of Crohn\u2019s disease seems warranted.", {"entities": [[74, 83, "DISEASE"]]}], ["Granzyme K (GrK) is a trypsin-like serine protease that is elevated in patients with sepsis and acute lung inflammation.", {"entities": []}], ["While GrK was originally believed to function exclusively as a pro-apoptotic protease, recent studies now suggest that GrK may possess other non-cytotoxic functions.", {"entities": []}], ["In the context of acute lung inflammation, we hypothesized that GrK induces pro-inflammatory cytokine release through the activation of protease-activated receptors.", {"entities": []}], ["The direct effect of extracellular GrK on PAR activation, intracellular signaling and cytokine was assessed using cultured human lung fibroblasts.", {"entities": []}], ["Extracellular GrK induced secretion of IL-6, IL-8 and MCP-1 in a dose- and time-dependent manner in lung fibroblasts.", {"entities": []}], ["Heat-inactivated GrK did not induce cytokine release indicating that protease activity is required.", {"entities": []}], ["Furthermore, GrK induced activation of both the ERK1/2 and p38 MAP kinase signaling pathways, and significantly increased fibroblast proliferation.", {"entities": []}], ["Inhibition of ERK1/2 abrogated the GrK-mediated cytokine release.", {"entities": []}], ["Through the use of PAR-1 and PAR-2 neutralizing antibodies, it was determined that PAR-1 is essential for GrK-induced IL-6, IL-8 and MCP-1 release.", {"entities": []}], ["In summary, extracellular GrK is capable of activating PAR-1 and inducing fibroblast cytokine secretion and proliferation.", {"entities": []}], ["Short dimeric or mulitmeric peptides derived from a highly conserved stretch of amino acids from gammaretroviral envelope proteins has been found to have immunosuppressive properties in vitro .", {"entities": []}], ["Here we test the hypothesis that such immunosuppressive peptides may serve as immunomodulatory reagents for treatment of inflammatory disorders.", {"entities": []}], ["The anti-inflammatory effect of a synthetic retrovirus-derived immunosuppressive peptide of 17 amino acids was tested in two murine skin inflammation models, a TPA-induced acute toxic contact eczema model and an oxazolone-induced allergic contact dermatitis.", {"entities": [[239, 257, "DISEASE"], [230, 257, "DISEASE"], [247, 257, "DISEASE"]]}], ["Overall, mice (n\u2009=\u200924) treated with a topically applied cream containing the dimeric immunosuppressive peptide exhibited a reduction of 28.8% in ear thickness (range 20.1-42.5), whereas the application of a scrambled peptide dimer or a monomer of the immunosuppressive peptide remained without effect (p\u2009=\u20090.028).", {"entities": []}], ["Furthermore, ear biopsies from mice treated with the dimeric immunosuppressive peptide showed a significant reduction in mRNA of the pro-inflammatory cytokines TNF-\u03b1, IL-17C, and IL-6 as well as the chemokine CXCL2 compared to mice treated with control peptides.", {"entities": [[209, 214, "GENE"]]}], ["Using two murine skin inflammation models, we show that an immunosuppressive retroviral peptide is capable of reducing inflammatory disorders.", {"entities": []}], ["The results indicate that virus-derived immunosuppressive peptides capable of down-regulating several proinflammatory cytokines may represent a novel class of drugs for the treatment of excess inflammation.", {"entities": []}], ["The steadily increasing knowledge regarding pathogenetic mechanisms in autoimmune rheumatic diseases has paved the way to different therapeutic approaches.", {"entities": []}], ["In particular, the market entry of biologics has dramatically modified the natural history of rheumatic chronic inflammatory diseases with a meaningful impact on patients\u2019 quality of life.", {"entities": []}], ["Among the wide spectrum of available biological treatments, rituximab (RTX), first used in the treatment of non-Hodgkin\u2019s lymphoma, was later approved for rheumatoid arthritis and anti-neutrophil cytoplasmic antibodies-associated vasculitis.", {"entities": [[155, 175, "DISEASE"], [122, 130, "DISEASE"], [230, 240, "DISEASE"], [166, 175, "DISEASE"]]}], ["Nowadays, in rheumatology, RTX is also used with off-label indications in patients with systemic sclerosis, Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus.", {"entities": [[140, 159, "DISEASE"], [118, 126, "DISEASE"], [131, 159, "DISEASE"]]}], ["RTX is a monoclonal antibody directed to CD20 molecules expressed on the surfaces of pre-B and mature B lymphocytes.", {"entities": []}], ["It acts by causing apoptosis of these cells with antibody- and complement-dependent cytotoxicity.", {"entities": []}], ["As inflammatory responses to cell-associated immune complexes are key elements in the pathogenesis of several autoimmune rheumatic diseases, such an approach might be effective in these patients.", {"entities": []}], ["In fact, RTX, by promoting the rapid and long-term depletion of circulating and lymphoid tissue-associated B cells, leads to a lower recruitment of these effector cells at sites of immune complex deposition, thus reducing inflammation and tissue damage.", {"entities": []}], ["RTX is of the most interest to rheumatologists as it represents an important additional therapeutic approach.", {"entities": []}], ["Thus, the advent in clinical practice of approved RTX biosimilars, such as CT-P10, may be of help in improving treatment access as well as in reducing costs.", {"entities": []}], ["Health-related quality of life (HRQoL) is a key measure for evaluating health status in populations.", {"entities": []}], ["Using the recent EQ-5D-5L for measurement, this study analyzed quality of life results and their stability over consecutive population surveys.", {"entities": []}], ["Three cross-section surveys for representative samples of the general German population from 2012, 2013, and 2014 were evaluated using the EQ-5D-5L descriptive system and valuation by the Visual Analog Scale (VAS).", {"entities": []}], ["Aggregated sample size reached 6074.", {"entities": []}], ["The dimension with the highest prevalence of problems was pain/discomfort (31.7%).", {"entities": []}], ["Compared with 2012 (59.3%), the percentage of participants in the best health state increased slightly in 2013 (63.4%) and 2014 (62%).", {"entities": []}], ["Over the 3-year period, diabetes and heart disease had the strongest negative influence on mean VAS result.", {"entities": [[37, 50, "DISEASE"]]}], ["The number of reported chronic diseases cumulatively reduced mean VAS.", {"entities": []}], ["Extreme problems in one or more dimensions were stated by only 0.1%\u20130.2% of patients.", {"entities": []}], ["Of the potential 247 health states with a problem score \u226520, only six were observed in the aggregated sample.", {"entities": []}], ["HRQoL results were fairly stable over the 3 years, but the share of the population with no problems was not.", {"entities": []}], ["Results from the aggregated sample may serve as updated reference values for the general German population.", {"entities": []}], ["This essay asks whether the global burden of diseases, injuries, and risk factors (GBD) should be measured in terms of their consequences for health, as maintained by most of those who are attempting to measure the GBD, or in terms of their consequences for well-being, as argued by John Broome.", {"entities": []}], ["It answers that the burden of disease should be understood in terms of the consequences of disease for health, and it defends the wider efforts to measure health by those who are in other ways skeptical of the project of measuring the GBD.", {"entities": []}], ["Advances in the treatment and life expectancy of cystic fibrosis (CF) patients mean that motherhood is now a realistic option for many women with CF.", {"entities": [[49, 64, "DISEASE"]]}], ["This qualitative study explored the psychosocial impact and adjustments made when women with CF become mothers.", {"entities": []}], ["Women with CF ( n = 11) were recruited via an online forum and participated in semistructured telephone interviews about their experiences of becoming a mother.", {"entities": []}], ["Transcriptions were analysed using Grounded Theory.", {"entities": []}], ["Analysis revealed three core categories: (i) \u201cLiving with CF\u201d: how becoming a mother impacted on health and treatment adherence, requiring a change in support from the CF team, (ii) \u201cBecoming a Mother\u201d: balancing issues common to new mothers with their CF, and (iii) \u201cPooling Personal Resources\u201d: coping strategies in managing the dual demands of child and CF care.", {"entities": []}], ["Participants experienced a variety of complex psychosocial processes.", {"entities": []}], ["Most participants acknowledged an initial negative impact on CF care; however over time they reported successful adaptation to managing dual commitments and that adherence and motivation to stay well had improved.", {"entities": []}], ["This study highlights the need for preconceptual psychosocial counselling and postpartum adjustment to CF care.", {"entities": []}], ["Efforts to improve the implementation of effective practice and to speed up improvements in quality and patient safety continue to pose challenges for researchers and policy makers.", {"entities": []}], ["Organisational research, and, in particular, case studies of quality improvement, offer methods to improve understanding of the role of organisational and microsystem contexts for improving care and the development of theories which might guide improvement strategies.", {"entities": []}], ["This paper reviews examples of such research and details the methodological issues in constructing and analysing case studies.", {"entities": []}], ["Case study research typically collects a wide array of data from interviews, documents and other sources.", {"entities": []}], ["Advances in methods for coding and analysing these data are improving the quality of reports from these studies.", {"entities": []}], ["Polyunsaturated fatty acids (PUFA) are thought to play important roles in inflammation.", {"entities": []}], ["The n-3 series is considered as anti-inflammatory, and some studies have reported increased plasma n-3 polyunsaturated fatty acid pattern in chronic inflammatory conditions.", {"entities": []}], ["In this study we sought to clarify relationships of the levels of arachidonic acid and the polyunsaturated n-3 fatty acid compositions of isolated LDL, HDL 2 and HDL 3 particles with matrix metalloproteinase-9 (MMP-9), a marker of inflammation.", {"entities": []}], ["The subjects were divided into two groups: those with lower and those with higher than the median serum MMP-9 concentration.", {"entities": []}], ["In all lipoprotein fractions, the mean percentage of docosapentaenoic acid (C22:5n-3) was higher in the group of subjects with higher MMP-9 level than in those with lower serum MMP-9 concentration (P < 0.01 for all).", {"entities": []}], ["Likewise, the ratio of docosapentaenoic acid to arachidonic acid (C20:4n-6) was higher in the subjects with higher MMP-9 compared with the lower MMP-9 group (P < 0.001 for all).", {"entities": []}], ["So far, the evidence for an anti-inflammatory role of the n-3 PUFA has come from dietary interventions.", {"entities": []}], ["Our results were obtained from a free-living population and indicate that there is a positive correlation between n-3 docosapentaenoic acid and MMP-9.", {"entities": []}], ["What had triggered the rise in MMP-9 is not known, since serum level of MMP-9 is raised in many inflammatory conditions.", {"entities": []}], ["These findings may indicate an increased biosynthesis of n-3 polyunsaturated fatty acids in subclinical inflammation.", {"entities": []}], ["Little information exists about the loss of all one\u2019s teeth (edentulism) among older adults in low- and middle-income countries.", {"entities": []}], ["This study examines the prevalence of edentulism and associated factors among older adults in a cross-sectional study across six such countries.", {"entities": []}], ["Data from the World Health Organization (WHO\u2019s) Study on global AGEing and adult health (SAGE) Wave 1 was used for this study with adults aged 50-plus from China ( N = 13,367), Ghana ( N = 4724), India ( N = 7150), Mexico ( N = 2315), Russian Federation ( N = 3938) and South Africa ( N = 3840).", {"entities": []}], ["Multivariate regression was used to assess predictors of edentulism.", {"entities": []}], ["The overall prevalence of edentulism was 11.7% in the six countries, with India, Mexico, and Russia has higher prevalence rates (16.3%\u201321.7%) than China, Ghana, and South Africa (3.0%\u20139.0%).", {"entities": []}], ["In multivariate logistic analysis sociodemographic factors (older age, lower education), chronic conditions (arthritis, asthma), health risk behaviour (former daily tobacco use, inadequate fruits and vegetable consumption) and other health related variables (functional disability and low social cohesion) were associated with edentulism.", {"entities": [[109, 118, "DISEASE"], [120, 126, "DISEASE"]]}], ["The national estimates and identified factors associated with edentulism among older adults across the six countries helps to identify areas for further exploration and targets for intervention.", {"entities": []}], ["Nucleostemin is a novel cell reprogramming factor that promotes self-renewal and pluripotency through effects on gene expression and cell cycle progression.", {"entities": []}], ["Nucleostemin (NS) is a nucleolar GTP-binding protein that was first identified in neural stem cells, the functions of which remain poorly understood.", {"entities": []}], ["Here, we report that NS is required for mouse embryogenesis to reach blastulation, maintenance of embryonic stem cell (ESC) self-renewal, and mammary epithelial cell (MEC) reprogramming to induced pluripotent stem (iPS) cells.", {"entities": []}], ["Ectopic NS also cooperates with OCT4 and SOX2 to reprogram MECs and mouse embryonic fibroblasts to iPS cells.", {"entities": [[41, 45, "GENE"]]}], ["NS promotes ESC self-renewal by sustaining rapid transit through the G1 phase of the cell cycle.", {"entities": []}], ["Depletion of NS in ESCs retards transit through G1 and induces gene expression changes and morphological differentiation through a mechanism that involves the MEK/ERK protein kinases and that is active only during a protracted G1.", {"entities": []}], ["Suppression of cell cycle inhibitors mitigates these effects.", {"entities": []}], ["Our results implicate NS in the maintenance of ESC self-renewal, demonstrate the importance of rapid transit through G1 for this process, and expand the known classes of reprogramming factors.", {"entities": []}], ["It is widely assumed that apoptosis of eosinophils is a central component of resolution of allergic airway disease.", {"entities": []}], ["However, this has not been demonstrated in human allergic airways in vivo.", {"entities": []}], ["Based on animal in vivo observations we hypothesised that steroid-induced resolution of human airway eosinophilic inflammation involves inhibition of CCL5 (RANTES), a CC-chemokine regulating eosinophil and lymphocyte traffic, and elimination of eosinophils without evident occurrence of apoptotic eosinophils in the diseased tissue.", {"entities": [[150, 154, "GENE"]]}], ["To determine mucosal eosinophilia, apoptotic eosinophils, general cell apoptosis and cell proliferation, and expression of CCL5 and CCL11 (eotaxin) in human allergic airway tissues in vivo at resolution of established symptomatic eosinophilic inflammation.", {"entities": [[21, 33, "DISEASE"], [123, 127, "GENE"], [132, 137, "GENE"]]}], ["Twenty-one patients with intermittent (birch and/or grass) allergic rhinitis received daily nasal allergen challenges for two seven days' periods separated by more than two weeks washout.", {"entities": [[59, 76, "DISEASE"], [68, 76, "DISEASE"]]}], ["Five days into these \"artificial pollen seasons\", nasal treatment with budesonide was instituted and continued for six days in a double blinded, randomized, placebo-controlled, and crossover design.", {"entities": []}], ["This report is a parallel group comparison of nasal biopsy histochemistry data obtained on the final day of the second treatment period.", {"entities": []}], ["Treatments were instituted when clinical rhinitis symptoms had been established.", {"entities": [[41, 49, "DISEASE"]]}], ["Compared to placebo, budesonide reduced tissue eosinophilia, and subepithelial more than epithelial eosinophilia.", {"entities": [[47, 59, "DISEASE"], [100, 112, "DISEASE"]]}], ["Steroid treatment also attenuated tissue expression of CCL5, but CCL11 was not reduced.", {"entities": [[55, 59, "GENE"], [65, 70, "GENE"]]}], ["General tissue cell apoptosis and epithelial cell proliferation were reduced by budesonide.", {"entities": []}], ["However, apoptotic eosinophils were not detected in any biopsies, irrespective of treatment.", {"entities": []}], ["Inhibition of CCL5-dependent recruitment of cells to diseased airway tissue, and reduced cell proliferation, reduced general cell apoptosis, but not increased eosinophil apoptosis, are involved in early phase steroid-induced resolution of human allergic rhinitis.", {"entities": [[245, 262, "DISEASE"], [254, 262, "DISEASE"]]}], ["To evaluate the association between chronic illness with complexity (CIC) and optimal glycemic control.", {"entities": [[69, 72, "GENE"]]}], ["Cross-sectional and longitudinal analyses of Diabetes Epidemiologic Cohort database of Veterans Health Administration (VHA) users with diabetes, less than 75\u00a0years old, with HbA1c tests in fiscal year (FY) 1999 and 2000, alive at FY2000 end ( N \u2009=\u200995,423).", {"entities": []}], ["Outcomes were HbA1c\u2009<\u20097% in each FY.", {"entities": []}], ["CIC included three domains: nondiabetes physical illness, diabetes-related, and mental illness/substance abuse conditions.", {"entities": [[95, 110, "DISEASE"], [0, 3, "GENE"]]}], ["Other independent variables included age, gender, race, marital status, VHA priority status, and diabetes severity.", {"entities": []}], ["Longitudinal analyses were restricted to patients with HbA1c \u2265 7% in FY1999 and included hospitalizations between final HbA1c\u2019s in FY1999 and FY2000.", {"entities": []}], ["Multiple logistic regressions examined associations between CIC categories and HbA1c.", {"entities": [[60, 63, "GENE"]]}], ["In FY1999, 33% had HbA1c <7%.", {"entities": []}], ["In multivariate analyses, patients with nondiabetes physical illness and mental illness/substance abuse were more likely to have HbA1c <7% in FY1999 [adjusted odds ratios for cancer (AOR), 1.31; 95% CI (1.25\u20131.37); mental illness only, 1.18; 95% CI (1.14\u20131.22)].", {"entities": [[88, 103, "DISEASE"], [175, 181, "DISEASE"]]}], ["Those with diabetes-related complications were less likely to have HbA1c <7% in FY1999.", {"entities": []}], ["Associations generally held in FY2000.", {"entities": []}], ["However, conditions in the mental illness/substance abuse complexity domain were less strongly associated with HbA1c <7%.", {"entities": [[42, 57, "DISEASE"]]}], ["Macrovascular-related hospitalizations were positively associated with HbA1c <7% [AOR, 1.41; 95% CI (1.34\u20131.49)].", {"entities": []}], ["The association between CIC and HbA1c <7% is heterogeneous and depends on the domain of complexity.", {"entities": [[24, 27, "GENE"]]}], ["The varying associations of CIC categories with optimal glycemic control suggest the need for appropriate risk adjustment when using HbA1c <7% as a valid performance measure for diabetes quality of care.", {"entities": [[28, 31, "GENE"]]}], ["In patients with chronic obstructive pulmonary disease (COPD), exercise capacity is reduced, resulting over time in physical inactivity and worsened health status.", {"entities": [[17, 54, "DISEASE"]]}], ["It is unknown whether ventilatory constraints occur during activities of daily life (ADL) in early stages of COPD.", {"entities": []}], ["The aim of this study was to assess respiratory mechanics during ADL and to study its consequences on dyspnoea, physical activity and health status in early-stage COPD compared with healthy controls.", {"entities": []}], ["In this cross-sectional study, 39 early-stage COPD patients (mean FEV 1 88\u00b1s.d.", {"entities": [[66, 69, "GENE"]]}], ["12% predicted) and 20 controls performed 3 ADL: climbing stairs, vacuum cleaning and displacing groceries in a cupboard.", {"entities": []}], ["Respiratory mechanics were measured during ADL.", {"entities": []}], ["Physical activity was measured with accelerometry.", {"entities": []}], ["Health status was assessed by the Nijmegen Clinical Screening Instrument.", {"entities": []}], ["Compared with controls, COPD patients had greater ventilatory inefficiency and higher ventilatory requirements during ADL ( P <0.05).", {"entities": []}], ["Dyspnoea scores were increased in COPD compared with controls ( P <0.001).", {"entities": []}], ["During ADL, >50% of the patients developed dynamic hyperinflation in contrast to 10\u201335% of the controls.", {"entities": []}], ["Higher dyspnoea was scored by patients with dynamic hyperinflation.", {"entities": []}], ["Physical activity was low but comparable between both groups.", {"entities": []}], ["From the patients, 55\u201384% experienced mild-to-severe problems in health status compared with 5\u201325% of the controls.", {"entities": []}], ["Significant ventilatory constraints already occur in early-stage COPD patients during common ADL and result in increased dyspnoea.", {"entities": []}], ["Physical activity level is not yet reduced, but many patients already experience limitations in health status.", {"entities": []}], ["These findings reinforce the importance of early diagnosis of COPD and assessment of more than just spirometry.", {"entities": []}], ["Near-road exposures of traffic-related air pollutants have been receiving increased attention due to evidence linking emissions from high-traffic roadways to adverse health outcomes.", {"entities": []}], ["To date, most epidemiological and risk analyses have utilized simple but crude exposure indicators, most typically proximity measures, such as the distance between freeways and residences, to represent air quality impacts from traffic.", {"entities": []}], ["This paper derives and analyzes a simplified microscale simulation model designed to predict short- (hourly) to long-term (annual average) pollutant concentrations near roads.", {"entities": []}], ["Sensitivity analyses and case studies are used to highlight issues in predicting near-road exposures.", {"entities": []}], ["Process-based simulation models using a computationally efficient reduced-form response surface structure and a minimum number of inputs integrate the major determinants of air pollution exposures: traffic volume and vehicle emissions, meteorology, and receptor location.", {"entities": []}], ["We identify the most influential variables and then derive a set of multiplicative submodels that match predictions from \"parent\" models MOBILE6.2 and CALINE4.", {"entities": []}], ["The assembled model is applied to two case studies in the Detroit, Michigan area.", {"entities": []}], ["The first predicts carbon monoxide (CO) concentrations at a monitoring site near a freeway.", {"entities": []}], ["The second predicts CO and PM 2.5 concentrations in a dense receptor grid over a 1 km Predicted CO concentrations showed reasonable agreement with annual average and 24-hour measurements, e.g., 59% of the 24-hr predictions were within a factor of two of observations in the warmer months when CO emissions are more consistent.", {"entities": []}], ["The highest concentrations of both CO and PM 2.5 were predicted to occur near intersections and downwind of major roads during periods of unfavorable meteorology (e.g., low wind speeds) and high emissions (e.g., weekday rush hour).", {"entities": []}], ["The spatial and temporal variation among predicted concentrations was significant, and resulted in unusual distributional and correlation characteristics, including strong negative correlation for receptors on opposite sides of a road and the highest short-term concentrations on the \"upwind\" side of the road.", {"entities": []}], ["The case study findings can likely be generalized to many other locations, and they have important implications for epidemiological and other studies.", {"entities": []}], ["The reduced-form model is intended for exposure assessment, risk assessment, epidemiological, geographical information systems, and other applications.", {"entities": []}], ["Baicalin, a Chinese herbal medicine, has anti-fibrotic and anti-inflammatory effects.", {"entities": []}], ["The aims of present study were to investigate the effects of baicalin on the myofibroblast differentiation, extracellular matrix production, migration, and collagen contraction of interleukin (IL)-1\u03b2-stimulated nasal fibroblasts and to determine the molecular mechanism of baicalin in nasal fibroblasts.", {"entities": []}], ["Nasal fibroblasts were isolated from the inferior turbinate of patients.", {"entities": []}], ["Baicalin was used to treat IL-1\u03b2-stimulated nasal fibroblasts.", {"entities": []}], ["To evaluate cytotoxicity, a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide assay was used.", {"entities": []}], ["The expression levels of \u03b1-smooth muscle actin (SMA), fibronectin, phospho-mitogen-activated protein kinase (p-MAPK), p-Akt, p-p50, p-p65, and p-I\u03baB\u03b1 were measured by western blotting, reverse transcription-polymerase chain reaction (RT\u2014PCR),or immunofluorescence staining.", {"entities": []}], ["Fibroblast migration was analyzed with scratch assays and transwell migration assays.", {"entities": []}], ["Total collagen was evaluated with the Sircol collagen assay.", {"entities": []}], ["Contractile activity was measured with a collagen gel contraction assay.", {"entities": []}], ["Baicalin (0\u201350 \u03bcM) had no significant cytotoxic effects in nasal fibroblasts.", {"entities": []}], ["The expression of \u03b1 \u2013 SMA and fibronectin were significantly down-regulated in baicalin-treated nasal fibroblasts.", {"entities": []}], ["Migration, collagen production, and contraction of IL-1\u03b2-stimulated nasal fibroblasts were significantly inhibited by baicalin treatment.", {"entities": []}], ["Baicalin also significantly down-regulated p-MAPK, p-Akt, p-p50, p-p65, and p-I\u03baB\u03b1 in IL-1\u03b2-stimulated nasal fibroblasts.", {"entities": []}], ["We showed that baicalin down-regulated myofibroblast differentiation, extracellular matrix production, migration, and collagen contraction via the MAPK and Akt/ NF-\u03baB pathways in IL-1\u03b2-stimulated nasal fibroblasts.", {"entities": []}], ["Anticholinergics are widely used for the treatment of COPD, and to a lesser extent for asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["Primarily used as bronchodilators, they reverse the action of vagally derived acetylcholine on airway smooth muscle contraction.", {"entities": []}], ["Recent novel studies suggest that the effects of anticholinergics likely extend far beyond inducing bronchodilation, as the novel anticholinergic drug tiotropium bromide can effectively inhibit accelerated decline of lung function in COPD patients.", {"entities": []}], ["Vagal tone is increased in airway inflammation associated with asthma and COPD; this results from exaggerated acetylcholine release and enhanced expression of downstream signaling components in airway smooth muscle.", {"entities": [[63, 69, "DISEASE"]]}], ["Vagally derived acetylcholine also regulates mucus production in the airways.", {"entities": []}], ["A number of recent research papers also indicate that acetylcholine, acting through muscarinic receptors, may in part regulate pathological changes associated with airway remodeling.", {"entities": []}], ["Muscarinic receptor signalling regulates airway smooth muscle thickening and differentiation, both in vitro and in vivo .", {"entities": []}], ["Furthermore, acetylcholine and its synthesizing enzyme, choline acetyl transferase (ChAT), are ubiquitously expressed throughout the airways.", {"entities": []}], ["Most notably epithelial cells and inflammatory cells generate acetylcholine, and express functional muscarinic receptors.", {"entities": []}], ["Interestingly, recent work indicates the expression and function of muscarinic receptors on neutrophils is increased in COPD.", {"entities": []}], ["Considering the potential broad role for endogenous acetylcholine in airway biology, this review summarizes established and novel aspects of muscarinic receptor signaling in relation to the pathophysiology and treatment of asthma and COPD.", {"entities": [[223, 229, "DISEASE"]]}], ["Food allergy in atopic dermatitis (AD) is debatable from decades.", {"entities": [[16, 33, "DISEASE"], [0, 12, "DISEASE"], [23, 33, "DISEASE"]]}], ["Role of diet in the cause and treatment of AD is controversial and is not well-defined.", {"entities": []}], ["Allergists and pediatricians are convinced about the food allergy in AD whereas many dermatologists are contrary for this.", {"entities": [[53, 65, "DISEASE"]]}], ["However, there are studies in the Indian and western literature supporting the evidence that elimination diet may improve the severe type of AD.", {"entities": []}], ["There is increasing awareness and lot of misconception among caregivers about food allergy and hence careful understanding about this concept is necessary to counsel parents.", {"entities": [[78, 90, "DISEASE"]]}], ["Recent evidence-based literature suggests avoidance of proven food allergens in AD could be beneficial in moderate to severe type of AD.", {"entities": []}], ["Pulmonary inflammation is a hallmark of many respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory syndrome distress (ARDS).", {"entities": [[82, 119, "DISEASE"], [150, 158, "DISEASE"], [74, 80, "DISEASE"]]}], ["Most of these diseases are treated with anti-inflammatory therapy in order to prevent or to reduce the pulmonary inflammation.", {"entities": []}], ["Herbal medicine-derived natural products have been used in folk medicine and scientific studies to evaluate the value of these compounds have grown in recent years.", {"entities": []}], ["Many substances derived from plants have the biological effects in vitro and in vivo , such as flavonoids, alkaloids, and terpenoids.", {"entities": []}], ["Among the biological activities of natural products derived from plants can be pointed out the anti-inflammatory, antiviral, antiplatelet, antitumor anti-allergic activities, and antioxidant.", {"entities": []}], ["Although many reports have evaluated the effects of these compounds in experimental models, studies evaluating clinical trials are scarce in the literature.", {"entities": []}], ["This review aims to emphasize the effects of these different natural products in pulmonary diseases in experimental models and in humans and pointing out some possible mechanisms of action.", {"entities": []}], ["Assess the longitudinal association between polypharmacy and falls and examine the differences in this association by different thresholds for polypharmacy definitions in a nationally representative sample of adults aged over 60 years from England.", {"entities": []}], ["Longitudinal cohort study.", {"entities": []}], ["The English Longitudinal Study of Ageing waves 6 and 7.", {"entities": []}], ["5213 adults aged 60 or older.", {"entities": []}], ["Rates, incidence rate ratio (IRR) and 95% CI for falls in people with and without polypharmacy.", {"entities": []}], ["A total of 5213 participants contributed 10\u2009502 person-years of follow-up, with a median follow-up of 2.02 years (IQR 1.9\u20132.1 years).", {"entities": []}], ["Of the 1611 participants with polypharmacy, 569 reported at least one fall within the past 2\u2009years (rate: 175 per 1000 person-years, 95%\u2009CI 161 to 190), and of the 3602 participants without polypharmacy 875 reported at least one fall (rate: 121 per 1000 person-years, 95%\u2009CI 113 to 129).", {"entities": []}], ["The rate of falls was 21% higher in people with polypharmacy compared with people without polypharmacy (adjusted IRR 1.21, 95%\u2009CI 1.11 to 1.31).", {"entities": []}], ["Using \u22654 drugs threshold the rate of falls was 18% higher in people with polypharmacy compared with people without (adjusted IRR 1.18, 95%\u2009CI 1.08 to 1.28), whereas using \u226510 drugs threshold polypharmacy was associated with a 50% higher rate of falls (adjusted IRR 1.50, 95%\u2009CI 1.34 to 1.67).", {"entities": []}], ["We found almost one-third of the total population using five or more drugs, which was significantly associated with 21% increased rate of falls over a 2-year period.", {"entities": []}], ["Further exploration of the effects of these complex drug combinations in the real world with a detailed standardised assessment of polypharmacy is greatly required along with pragmatic studies in primary care, which will help inform whether the threshold for a detailed medication review should be lowered.", {"entities": []}], ["Activated antigen-specific T cells produce a variety of effector molecules for clearing infection, but also contribute significantly to inflammation and tissue injury.", {"entities": []}], ["Here we report an anti-inflammatory property of anti-viral CD8", {"entities": []}], ["Mycobacterium tuberculosis , the cause of Tuberculosis (TB), infects one third of the world\u2019s population and causes substantial mortality worldwide.", {"entities": [[14, 26, "DISEASE"], [42, 54, "DISEASE"]]}], ["In its shortest format, treatment of TB requires six months of multidrug therapy with a mixture of broad spectrum and mycobacterial specific antibiotics, and treatment of multidrug resistant TB is longer.", {"entities": []}], ["The widespread use of this regimen makes this one of the largest exposures of humans to antimicrobials, yet the effects of TB treatment on intestinal microbiome composition and long-term stability are unknown.", {"entities": []}], ["We compared the microbiome composition, assessed by both 16S rDNA and metagenomic DNA sequencing, of TB cases during antimycobacterial treatment and following cure by 6 months of antibiotics.", {"entities": []}], ["TB treatment does not perturb overall diversity, but nonetheless dramatically depletes multiple immunologically significant commensal bacteria.", {"entities": []}], ["The microbiomic perturbation of TB therapy can persist for at least 1.2 years, indicating that the effects of TB treatment are long lasting.", {"entities": []}], ["These results demonstrate that TB treatment has dramatic effects on the intestinal microbiome and highlight unexpected durable consequences of treatment for the world\u2019s most common infection on human ecology.", {"entities": []}], ["Interleukin-17 (IL-17) is prevalent in tumor tissue and suppresses effective anti-tumor immune responses.", {"entities": []}], ["However, the source of the increased tumor-infiltrating IL-17 and its contribution to tumor progression in human gastric cancer remain poorly understood.", {"entities": [[121, 127, "DISEASE"]]}], ["In this study, we enrolled 112 gastric cancer patients, immunofluorescence was used to evaluate the colocalization of CD3, CD4, CD56, CD20, CD68, and mast cell tryptase (MCT) with IL-17.", {"entities": [[39, 45, "DISEASE"], [123, 126, "GENE"], [140, 144, "GENE"]]}], ["Immunohistochemistry was used to evaluate the distribution of microvessel density (CD34), CD66b", {"entities": [[83, 87, "GENE"]]}], ["Midazolam is used routinely to sedate patients in the intensive care unit (ICU).", {"entities": []}], ["We suspected that midazolam over-sedation was occurring in the ICU of the Guy's and St. Thomas' Trust and that it could be difficult to differentiate this from underlying neurological damage.", {"entities": []}], ["A sensitive assay for detecting midazolam and 1-hydroxymidazolam glucuronide (1-OHMG) in serum was developed and applied in the clinical setting.", {"entities": []}], ["In the present study we evaluated a series of cases managed in a mixed medical, surgical and trauma ICU.", {"entities": []}], ["Serum was collected from 26 patients who received midazolam, were 'slow to wake' and in whom there was suspicion of neurological damage.", {"entities": []}], ["Patient outcome was followed in terms of mortality, neurological recovery and neurological damage on discharge.", {"entities": []}], ["Out of 26 patients, 13 had detectable serum levels of midazolam and/or 1-OHMG after a median of 67 hours (range 36\u2013146 hours) from midazolam cessation.", {"entities": []}], ["Of these 13 patients in whom midazolam/1-OHMG was detectable, 10 made a full neurological recovery.", {"entities": []}], ["Of the remaining 13 patients with no detectable midazolam/1-OHMG, three made a full neurological recovery; 10 patients were subsequently found to have suffered neurological damage ( P < 0.002), eight of whom died and two were discharged from the ICU with profound neurological damage.", {"entities": []}], ["These findings confirm that prolonged sedation after midazolam therapy should be considered in the differential diagnosis of neurological damage in the ICU.", {"entities": []}], ["This can be reliably detected by the assay method described.", {"entities": []}], ["The effects of midazolam/1-OHMG persist days after administration of midazolam has ceased.", {"entities": []}], ["After prolonged sedation has been excluded in this patient group, it is highly likely that neurological damage has occurred.", {"entities": []}], ["Current use of microbes for metabolic engineering suffers from loss of metabolic output due to natural selection.", {"entities": []}], ["Rather than combat the evolution of bacterial populations, we chose to embrace what makes biological engineering unique among engineering fields \u2013 evolving materials.", {"entities": []}], ["We harnessed bacteria to compute solutions to the biological problem of metabolic pathway optimization.", {"entities": []}], ["Our approach is called Programmed Evolution to capture two concepts.", {"entities": []}], ["First, a population of cells is programmed with DNA code to enable it to compute solutions to a chosen optimization problem.", {"entities": []}], ["As analog computers, bacteria process known and unknown inputs and direct the output of their biochemical hardware.", {"entities": []}], ["Second, the system employs the evolution of bacteria toward an optimal metabolic solution by imposing fitness defined by metabolic output.", {"entities": []}], ["The current study is a proof-of-concept for Programmed Evolution applied to the optimization of a metabolic pathway for the conversion of caffeine to theophylline in E. coli .", {"entities": []}], ["Introduced genotype variations included strength of the promoter and ribosome binding site, plasmid copy number, and chaperone proteins.", {"entities": []}], ["We constructed 24 strains using all combinations of the genetic variables.", {"entities": []}], ["We used a theophylline riboswitch and a tetracycline resistance gene to link theophylline production to fitness.", {"entities": []}], ["After subjecting the mixed population to selection, we measured a change in the distribution of genotypes in the population and an increased conversion of caffeine to theophylline among the most fit strains, demonstrating Programmed Evolution.", {"entities": []}], ["Programmed Evolution inverts the standard paradigm in metabolic engineering by harnessing evolution instead of fighting it.", {"entities": []}], ["Our modular system enables researchers to program bacteria and use evolution to determine the combination of genetic control elements that optimizes catabolic or anabolic output and to maintain it in a population of cells.", {"entities": []}], ["Programmed Evolution could be used for applications in energy, pharmaceuticals, chemical commodities, biomining, and bioremediation.", {"entities": []}], ["The innate immune system is the first line of host defense against invading organisms.", {"entities": []}], ["Thus, pathogens have developed virulence mechanisms to evade the innate immune system.", {"entities": []}], ["Here, we report a novel means for inhibition of neutrophil recruitment by Group A Streptococcus (GAS).", {"entities": []}], ["Deletion of the secreted esterase gene (designated sse ) in M1T1 GAS strains with (MGAS5005) and without (MGAS2221) a null covS mutation enhances neutrophil ingress to infection sites in the skin of mice.", {"entities": []}], ["In trans expression of SsE in MGAS2221 reduces neutrophil recruitment and enhances skin invasion.", {"entities": []}], ["The sse deletion mutant of MGAS5005 (\u0394 sse M and k cat of SsE for hydrolysis of 2-thio-PAF were similar to those of the human plasma PAF acetylhydrolase.", {"entities": []}], ["Treatment of PAF with SsE abolishes the capacity of PAF to induce activation and chemotaxis of human neutrophils.", {"entities": []}], ["More importantly, PAF receptor-deficient mice significantly reduce neutrophil infiltration to the site of \u0394 sse GAS is a major human pathogen causing a variety of infections, including pharyngitis and necrotizing fasciitis.", {"entities": [[213, 222, "DISEASE"], [201, 222, "DISEASE"], [185, 196, "DISEASE"]]}], ["GAS pathogenesis is mediated by a large array of secreted and cell-surface virulence factors.", {"entities": []}], ["However, the functions of many GAS virulence factors are poorly understood.", {"entities": []}], ["Recently, we reported that the esterase secreted by GAS (SsE) is a CovRS (the c ontrol o f v irulence two component regulatory system)-regulated protective antigen and is critical for spreading in the skin and systemic dissemination of GAS in a mouse model of necrotizing fasciitis.", {"entities": [[272, 281, "DISEASE"], [260, 281, "DISEASE"]]}], ["This report presents three major findings regarding the function and functional mechanism of SsE: 1) SsE contributes to GAS inhibition of neutrophil recruitment; 2) SsE is a potent PAF acetylhydrolase and the first secreted bacterial PAF acetylhydrolase identified so far; and 3) the PAF receptor significantly contributes to neutrophil recruitment in skin GAS infection.", {"entities": []}], ["These findings support a novel mechanism for evasion of the innate immune system by GAS that may be relevant to other infections.", {"entities": []}], ["Human exposure to air pollution in many studies is represented by ambient concentrations from space-time kriging of observed values.", {"entities": []}], ["Space-time kriging techniques based on a limited number of ambient monitors may fail to capture the concentration from local sources.", {"entities": []}], ["Further, because people spend more time indoors, using ambient concentration to represent exposure may cause error.", {"entities": []}], ["To quantify the associated exposure error, we computed a series of six different hourly-based exposure metrics at 16,095 Census blocks of three Counties in North Carolina for CO, NO x , PM 2.5 , and elemental carbon (EC) during 2012.", {"entities": []}], ["These metrics include ambient background concentration from space-time ordinary kriging (STOK), ambient on-road concentration from the Research LINE source dispersion model (R-LINE), a hybrid concentration combining STOK and R-LINE, and their associated indoor concentrations from an indoor infiltration mass balance model.", {"entities": []}], ["Using a hybrid-based indoor concentration as the standard, the comparison showed that outdoor STOK metrics yielded large error at both population (67% to 93%) and individual level (average bias between \u221210% to 95%).", {"entities": []}], ["For pollutants with significant contribution from on-road emission (EC and NO x ), the on-road based indoor metric performs the best at the population level (error less than 52%).", {"entities": []}], ["At the individual level, however, the STOK-based indoor concentration performs the best (average bias below 30%).", {"entities": []}], ["For PM 2.5 , due to the relatively low contribution from on-road emission (7%), STOK-based indoor metric performs the best at both population (error below 40%) and individual level (error below 25%).", {"entities": []}], ["The results of the study will help future epidemiology studies to select appropriate exposure metric and reduce potential bias in exposure characterization.", {"entities": []}], ["A histologic and quantitative immunologic study was made on a large group of rabbits injected intravenously with a single dose of crystallized bovine albumin and bled and sacrificed at various intervals after injection.", {"entities": []}], ["Both cardiovascular and renal lesions were encountered in high incidence.", {"entities": []}], ["The various stages in the development of these lesions were observed from their first appearance until their complete regression.", {"entities": []}], ["The cardiac, vascular, and renal alterations were morphologically similar to those of rheumatic fever, polyarteritis nodosa, and acute glomerulonephritis, respectively, in man.", {"entities": [[135, 153, "DISEASE"], [103, 123, "DISEASE"], [86, 101, "DISEASE"]]}], ["In addition to those tissue changes ordinarily attributed to hypersensitivity, peculiar granulomatous lesions consisting of epithelioid and foreign body giant cells were encountered in the follicles of the spleen and in the lymph nodes of a large proportion of the animals receiving the antigen.", {"entities": []}], ["Similar granulomas in the spleen and lymph nodes as well as in other tissues have been described in polyarteritis nodosa.", {"entities": [[100, 120, "DISEASE"]]}], ["The present experimental demonstration that an epithelioid and giant cell reaction may result from hypersensitivity provides evidence for the allergic origin of those cases of polyarteritis nodosa of unknown etiology containing this type of lesion.", {"entities": [[176, 196, "DISEASE"]]}], ["In the present study the time of development of the cardiovascular, renal, and granulomatous lesions was determined in relation to the blood clearance of antigen and the time of appearance of circulating antibody.", {"entities": []}], ["All the tissue lesions developed during the \"immune\" phase of antigen elimination and regressed after the antigen had been completely eliminated and free antibody had appeared in the circulation.", {"entities": []}], ["These temporal relationships indicate that the tissue lesions which occur after the intravenous administration of foreign protein are the result of antigen-antibody combination.", {"entities": []}], ["Research involving minors has been the subject of much ethical debate.", {"entities": []}], ["The growing number of longitudinal, pediatric studies that involve genetic research present even more complex challenges to ensure appropriate protection of children and families as research participants.", {"entities": []}], ["Long-term studies with a genetic component involve collection, retention and use of biological samples and personal information over many years.", {"entities": []}], ["Cohort studies may be established to study specific conditions (e.g.", {"entities": []}], ["autism, asthma) or may have a broad aim to research a range of factors that influence the health and development of children.", {"entities": [[8, 14, "DISEASE"]]}], ["Studies are increasingly intended to serve as research platforms by providing access to data and biological samples to researchers over many years.", {"entities": []}], ["This study examines how six birth cohort studies in North America and Europe that involve genetic research handle key ethical, legal and social (ELS) issues: recruitment, especially parental authority to include a child in research; initial parental consent and subsequent assent and/or consent from the maturing child; withdrawal; confidentiality and sample/data protection; handling sensitive information; and disclosure of results.", {"entities": []}], ["Semi-structured telephone interviews were carried out in 2008/09 with investigators involved in six birth cohort studies in Canada, Denmark, England, France, the Netherlands and the United States.", {"entities": []}], ["Interviewees self-identified as being knowledgeable about ELS aspects of the study.", {"entities": []}], ["Interviews were conducted in English.", {"entities": []}], ["The studies vary in breadth of initial consent, but none adopt a blanket consent for future use of samples/data.", {"entities": []}], ["Ethics review of new studies is a common requirement.", {"entities": []}], ["Studies that follow children past early childhood recognise a need to seek assent/consent as the child matures.", {"entities": []}], ["All studies limit access to identifiable data and advise participants of the right to withdraw.", {"entities": []}], ["The clearest differences among studies concern handling of sensitive information and return of results.", {"entities": []}], ["In all studies, signs of child abuse require reports to authorities, but this disclosure duty is not always stated in consent materials.", {"entities": []}], ["Studies vary in whether they will return to participants results of routine tests/measures, but none inform participants about findings with unknown clinical significance.", {"entities": []}], ["Analysis of how cohort studies in various jurisdictions handle key ELS issues provides informative data for comparison and contrast.", {"entities": []}], ["Consideration of these and other examples and further scholarly exploration of ELS issues provides insight on how best to address these aspects in ways that respect the well-being of participants, especially children who become research subjects at the start of their lives.", {"entities": []}], ["Immonoglobulin G4-related ophthalmic disease (IgG4-ROD) is a IgG4-RD and exhibits two main characteristics: Fibrosis that is not necessarily marked histopathologically; and frequent formation of germinal centers (GCs).", {"entities": []}], ["Follicular B helper T (Tfh) cells are now recognized as the true helper cells for B cells in antibody responses.", {"entities": []}], ["In the present study, the profile and distribution of Tfh cells in involved tissues from patients with IgG4-ROD was compared to those of type 1 autoimmune pancreatitis (AIP) and patients with IgG4-related lymphadenopathy (IgG4-RL).", {"entities": [[155, 167, "DISEASE"], [169, 172, "GENE"]]}], ["A total of 7 patients with IgG4-ROD, 7 patients with type 1 AIP or IgG4-RL and 7 IgG4-negative controls were evaluated.", {"entities": [[60, 63, "GENE"]]}], ["The expression of Tfh-cell immunological proteins, the inducible T-cell costimulator, B-cell lymphoma 6 protein, C-X-C chemokine receptor type 5 (CXCR5) and interleukin-21 (IL-21) in affected tissues was analyzed using immunohistochemical staining and dual immunofluorescence.", {"entities": [[93, 101, "DISEASE"], [146, 151, "GENE"]]}], ["It was demonstrated that patients with IgG4-RD exhibited a significantly increased number of CD4", {"entities": [[93, 96, "GENE"]]}], ["Patient portals may improve communication between families of children with asthma and their primary care providers and improve outcomes.", {"entities": [[76, 82, "DISEASE"]]}], ["However, the feasibility of using portals to collect patient-reported outcomes from families and the barriers and facilitators of portal implementation across diverse pediatric primary care settings have not been established.", {"entities": []}], ["We evaluated the feasibility of using a patient portal for pediatric asthma in primary care, its impact on management, and barriers and facilitators of implementation success.", {"entities": [[69, 75, "DISEASE"]]}], ["We conducted a mixed-methods implementation study in 20 practices (11 states).", {"entities": []}], ["Using the portal, parents of children with asthma aged 6-12 years completed monthly surveys to communicate treatment concerns, treatment goals, symptom control, medication use, and side effects.", {"entities": [[43, 49, "DISEASE"]]}], ["We used logistic regression to evaluate the association of portal use with child characteristics and changes to asthma management.", {"entities": [[112, 118, "DISEASE"]]}], ["Ten clinician focus groups and 22 semistructured parent interviews explored barriers and facilitators of use in the context of an evidence-based implementation framework.", {"entities": []}], ["We invited 9133 families to enroll and 237 (2.59%) used the portal (range by practice, 0.6%-13.6%).", {"entities": []}], ["Children of parents or guardians who used the portal were significantly more likely than nonusers to be aged 6-9 years (vs 10-12, P =.02), have mild or moderate/severe persistent asthma ( P =.009 and P =.04), have a prescription of a controller medication ( P <.001), and have private insurance ( P =.002).", {"entities": [[179, 185, "DISEASE"]]}], ["Portal users with uncontrolled asthma had significantly more medication changes and primary care asthma visits after using the portal relative to the year earlier (increases of 14% and 16%, respectively).", {"entities": [[31, 37, "DISEASE"], [97, 103, "DISEASE"]]}], ["Qualitative results revealed the importance of practice organization (coordinated workflows) as well as family (asthma severity) and innovation (facilitated communication and ease of use) characteristics for implementation success.", {"entities": [[112, 118, "DISEASE"]]}], ["Although use was associated with higher treatment engagement, our results suggest that achieving widespread portal adoption is unlikely in the short term.", {"entities": []}], ["Implementation efforts should include workflow redesign and prioritize enrollment of symptomatic children.", {"entities": []}], ["Clinicaltrials.gov NCT01966068; https://clinicaltrials.gov/ct2/show/NCT01966068 (Archived by WebCite at http://www.webcitation.org/6i9iSQkm3)", {"entities": []}], ["To test Antarth, a polyherbal phytomedicine, for its efficacy and safety in patients with osteoarthritis (OA) and compared with placebo.", {"entities": [[90, 104, "DISEASE"]]}], ["A total of 90 male or female adult patients who were diagnosed clinically and radiologically with OA were recruited in the study.", {"entities": []}], ["Antarth or placebo was given 2 capsules b.i.d.", {"entities": []}], ["for 3 months and the patients were assessed every month for its efficacy.", {"entities": []}], ["Diclofenac sodium was allowed to be taken as rescue medication.", {"entities": []}], ["After 3 months of treatment, the reduction in severity of pain on Visual Analog Scale (VAS) was more in Antarth group compared to placebo but the difference between the two groups was not significant.", {"entities": []}], ["However, pain during functioning of disabled joints while walking distance, squatting, sitting cross-legged and climbing steps were significantly reduced in Antarth group compared to placebo ( P < 0.05).", {"entities": []}], ["Reduction in consumption of rescue medication, diclofenac sodium, was more in Antarth than in placebo group.", {"entities": []}], ["In Patients\u2019 Global Assessment, patients treated with Antarth were more satisfied than the ones treated with placebo.", {"entities": []}], ["Observations were similar in Physicians\u2019 Global Assessment too.", {"entities": []}], ["There were no adverse events in both the groups.", {"entities": []}], ["With over one million Syrian refugee children in the region, we undertook this study to characterize care\u2010seeking behaviors and health service utilization for child refugees with the aim of informing humanitarian programming for non\u2010camp settings in Jordan.", {"entities": []}], ["A survey of Syrian refugees living outside of camps in Jordan was conducted using a 125\u2009\u00d7\u200912 cluster design with probability proportional to size sampling to obtain a representative sample.", {"entities": []}], ["The questionnaire focused on access to health services, including a module on care seeking for children.", {"entities": []}], ["Care seeking was high with 90.9% of households with a child less than 18\u2009years seeking medical care the last time it was needed.", {"entities": []}], ["Households most often sought care for children in the public sector (54.6%), followed by private (36.5%) and charity sectors (8.9%).", {"entities": []}], ["Among child care seekers, 88.6% were prescribed medication during the most recent visit, 90.6% of which obtained the medication.", {"entities": []}], ["Overall, 49.4% of households reported out\u2010of\u2010pocket expenditures for either the consultation or prescribed medications at the most recent visit (mean $US21.1 and median $US0).", {"entities": []}], ["Syrian refugees had good access to care for their sick children at the time of the survey; however, this has likely deteriorated since the survey because of the withdrawal of free access for refugees.", {"entities": []}], ["The number of refugees in Jordan and relative accessibility of care has resulted in a large burden on the health system; the Jordanian government will require additional support if current levels of health access are to be maintained for Syrian refugees.", {"entities": []}], ["\u00a9 2016 The Authors.", {"entities": []}], ["The International Journal of Health Planning and Management published by John Wiley & Sons Ltd.", {"entities": []}], ["Today\u2019s industrial food production contributes significantly to environmental degradation.", {"entities": []}], ["Meat production accounts for the largest impact, including greenhouse gas emissions, land and water use.", {"entities": []}], ["While food production and consumption are important aspects when addressing climate change, this article focuses predominantly on dietary change that promotes both health for planet and people with focus on athletes.", {"entities": []}], ["Healthy, sustainable eating recommendations begin to appear in various governmental guidelines.", {"entities": []}], ["However, there remains resistance to the suggested reductions in meat consumption.", {"entities": []}], ["While food citizens are likely to choose what is good for them and the planet, others may not, unless healthy eating initiatives integrate creative food literacy approaches with experiential learning as a potential vehicle for change.", {"entities": []}], ["This concept paper is organized in three sections: (1) Environmental impact of food; (2) health and sustainability connections; and (3) application in sports and exercise.", {"entities": []}], ["For active individuals, this article focuses on the quantity of protein, highlighting meat and dairy, and quality of food, with topics such as organic production and biodiversity.", {"entities": []}], ["Finally, the timing of when to integrate sustainability principles in sport nutrition is discussed, followed by practical applications for education and inclusion in team, institutional, and event operations.", {"entities": []}], ["In asthma, mucus hypersecretion is thought to be a prominent pathological feature associated with widespread mucus plugging.", {"entities": [[3, 9, "DISEASE"]]}], ["However, the current treatments for mucus hypersecretion are often ineffective or temporary.", {"entities": []}], ["The potential therapeutic targets of mucus hypersecretion in asthma remain unknown.", {"entities": [[61, 67, "DISEASE"]]}], ["Here, we show that Lyn is a central effector of endoplasmic reticulum stress (ER stress) and mucous hypersecretion in asthma.", {"entities": [[118, 124, "DISEASE"], [19, 22, "GENE"]]}], ["In Lyn-transgenic mice (Lyn-TG) and wild-type (WT) C57BL/6J mice exposed to ovalbumin (OVA), Lyn overexpression attenuates mucus hypersecretion and ER stress.", {"entities": [[3, 6, "GENE"], [24, 27, "GENE"], [93, 96, "GENE"]]}], ["Interleukin 13 (IL-13) induced MUC5AC expression by enhancing ER stress in vitro .", {"entities": []}], ["Lyn serves as a negative regulator of IL-13-induced ER stress and MUC5AC expression.", {"entities": [[0, 3, "GENE"]]}], ["We further find that an inhibitor of ER stress, which is likely involved in the PI3K p85\u03b1/Akt pathway and NF\u03baB activity, blocked MUC5AC expression in Lyn-knockdown cells.", {"entities": []}], ["Furthermore, PI3K/Akt signaling is required for IL-13-induced ER stress and MUC5AC expression in airway epithelial cells.", {"entities": []}], ["The ER stress regulation of MUC5AC expression depends on NF\u03baB in Lyn-knockdown airway epithelial cells.", {"entities": []}], ["Our studies indicate not only a concept of mucus hypersecretion in asthma that involves Lyn kinase but also an important therapeutic candidate for asthma.", {"entities": [[67, 73, "DISEASE"], [147, 153, "DISEASE"], [88, 91, "GENE"]]}], ["\u2022 ER stress may be critical for the pathogenesis of bronchial asthma, especially the steroid-resistant neutrophilic asthma.", {"entities": [[62, 68, "DISEASE"], [116, 122, "DISEASE"]]}], ["\u2022 We confirmed that Lyn serves as a negative regulator of ER stress and MUC5AC through PI3K p85\u03b1/Akt/NF\u03baB pathway in asthma.", {"entities": [[117, 123, "DISEASE"], [20, 23, "GENE"]]}], ["\u2022 This indicates not only a concept of mucus hypersecretion that involves Lyn but also a therapeutic candidate for asthma.", {"entities": [[115, 121, "DISEASE"], [74, 77, "GENE"]]}], ["ER stress may be critical for the pathogenesis of bronchial asthma, especially the steroid-resistant neutrophilic asthma.", {"entities": [[60, 66, "DISEASE"], [114, 120, "DISEASE"]]}], ["We confirmed that Lyn serves as a negative regulator of ER stress and MUC5AC through PI3K p85\u03b1/Akt/NF\u03baB pathway in asthma.", {"entities": [[115, 121, "DISEASE"], [18, 21, "GENE"]]}], ["This indicates not only a concept of mucus hypersecretion that involves Lyn but also a therapeutic candidate for asthma.", {"entities": [[113, 119, "DISEASE"], [72, 75, "GENE"]]}], ["Previous studies of how parental atopy and exposure to dampness and molds contribute to the risk of asthma have been mainly cross-sectional or prevalent case\u2013control studies, where selection and information bias and temporality constitute problems.", {"entities": [[100, 106, "DISEASE"]]}], ["We assessed longitudinally the independent and joint effects of parental atopy and exposure to molds in dwellings on the development of asthma in childhood.", {"entities": [[136, 142, "DISEASE"]]}], ["We conducted a population-based, 6-year prospective cohort study of 1,984 children 1\u20137 years of age at the baseline in 1991 (follow-up rate, 77%).", {"entities": []}], ["The study population included 1,916 children without asthma at baseline and complete outcome information.", {"entities": [[53, 59, "DISEASE"]]}], ["The data collection included a baseline and follow-up survey.", {"entities": []}], ["The outcome of interest was development of asthma during the study period.", {"entities": [[43, 49, "DISEASE"]]}], ["The studied determinants were parental allergic diseases and four indicators of exposure at baseline: histories of water damage, presence of moisture and visible molds, and perceived mold odor in the home.", {"entities": []}], ["A total of 138 (7.2%) children developed asthma during the study period, resulting in an incidence rate of 125 cases per 10,000 person-years [95% confidence interval (CI), 104\u2013146].", {"entities": [[41, 47, "DISEASE"]]}], ["In Poisson regression adjusting for confounding, parental atopy [adjusted incidence rate ratio (IRR) 1.52; 95% CI, 1.08\u20132.13] and the presence of mold odor in the home reported at baseline (adjusted IRR 2.44; 95% CI, 1.07\u20135.60) were independent determinants of asthma incidence, but no apparent interaction was observed.", {"entities": [[261, 267, "DISEASE"]]}], ["The results of this cohort study with assessment of exposure before the onset of asthma strengthen the evidence on the independent effects of parental atopy and exposure to molds on the development of asthma.", {"entities": [[81, 87, "DISEASE"], [201, 207, "DISEASE"]]}], ["Despite more than a decade of research on hospitalists and their performance, disagreement still exists regarding whether and how hospital-based physicians improve the quality of inpatient care delivery.", {"entities": []}], ["This systematic review summarizes the findings from 65 comparative evaluations to determine whether hospitalists provide a higher quality of inpatient care relative to traditional inpatient physicians who maintain hospital privileges with concurrent outpatient practices.", {"entities": []}], ["Articles on hospitalist performance published between January 1996 and December 2010 were identified through MEDLINE, Embase, Science Citation Index, CINAHL, NHS Economic Evaluation Database and a hand-search of reference lists, key journals and editorials.", {"entities": [[158, 161, "GENE"]]}], ["Comparative evaluations presenting original, quantitative data on processes, efficiency or clinical outcome measures of care between hospitalists, community-based physicians and traditional academic attending physicians were included ( n = 65).", {"entities": []}], ["After proposing a conceptual framework for evaluating inpatient physician performance, major findings on quality are summarized according to their percentage change, direction and statistical significance.", {"entities": []}], ["The majority of reviewed articles demonstrated that hospitalists are efficient providers of inpatient care on the basis of reductions in their patients' average length of stay (69%) and total hospital costs (70%); however, the clinical quality of hospitalist care appears to be comparable to that provided by their colleagues.", {"entities": []}], ["The methodological quality of hospitalist evaluations remains a concern and has not improved over time.", {"entities": []}], ["Persistent issues include insufficient reporting of source or sample populations ( n = 30), patients lost to follow-up ( n = 42) and estimates of effect or random variability ( n = 35); inappropriate use of statistical tests ( n = 55); and failure to adjust for established confounders ( n = 37).", {"entities": []}], ["Future research should include an expanded focus on the specific structures of care that differentiate hospitalists from other inpatient physician groups as well as the development of better conceptual and statistical models that identify and measure underlying mechanisms driving provider-outcome associations in quality.", {"entities": []}], ["Interleukin (IL)-33 is the latest member of IL-1 cytokine family.", {"entities": []}], ["In this study, the cloning, expression, purification, and polyclonal antibody preparation of mouse IL-33 were described.", {"entities": []}], ["The coding region of IL-33 mature protein was cloned into the prokaryotic expression vector pET-44.", {"entities": []}], ["The recombinant protein, IL-33 containing a hexahistidine tag in the C-terminal, was expressed in Escherichia coli .", {"entities": []}], ["The expressed soluble protein was purified by immobilized metal-ion affinity chromatography using Ni", {"entities": []}], ["Calea zacatechichi Schltdl.", {"entities": []}], ["(Asteraceae alt.", {"entities": []}], ["Compositae) is a Mexican plant commonly used in folk medicine to treat respiratory and gastrointestinal (GI) disorders.", {"entities": []}], ["The objective of this study is to characterize the effect of C. zacatechichi extracts in mouse models mimicking the symptoms of irritable bowel syndrome (IBS).", {"entities": [[128, 152, "DISEASE"], [144, 152, "DISEASE"]]}], ["Powdered C. zacatechichi herb (leaves, stems, and flowers) was extracted with methanol.", {"entities": []}], ["Methanolic extract was filtered and evaporated giving methanolic fraction.", {"entities": []}], ["The residue was extracted with dichloromethane (DCM).", {"entities": []}], ["Methanolic and DCM (200\u00a0mg/kg, per os) extracts were screened for their effect on GI motility in several in vitro tests, and the antidiarrheal and antinociceptive effects were assessed using mouse models.", {"entities": []}], ["The influence of the DCM extract on motoric parameters and exploratory behaviors was also assessed.", {"entities": []}], ["Finally, the composition of C. zacatechichi DCM extract was qualitatively analyzed using liquid chromatography-mass spectrometry (LC-MS) method.", {"entities": []}], ["C. zacatechichi DCM extract significantly inhibited the contractility of mouse colon in vitro (IC 50 \u00a0=\u00a017\u00a0\u00b1\u00a02\u00a0\u03bcg/ml) .", {"entities": []}], ["Administration of the DCM extract in vivo (200\u00a0mg/kg, per os) significantly prolonged the time of whole GI transit (46\u00a0\u00b1\u00a01 vs. 117\u00a0\u00b1\u00a027\u00a0min for control and DCM-treated animals, respectively; P \u00a0=\u00a00.0023), inhibited hypermotility, and reduced pain in mouse models mimicking functional GI disorders.", {"entities": []}], ["Our findings suggest that constituents of the C. zacatechichi DCM extract exhibit antidiarrheal and analgesic activity.", {"entities": []}], ["The extract may thus become an attractive material for isolation of compounds that may be used as a supplementary treatment for pain and diarrhea associated with IBS in the future.", {"entities": [[137, 145, "DISEASE"]]}], ["Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their effectiveness largely depends on the patient\u2019s inhalation manoeuvre.", {"entities": []}], ["Children are an especially challenging target population for DPI development due to the large variability in understanding and inspiratory capacities.", {"entities": []}], ["We previously performed a study in which we determined the prerequisites for a paediatric DPI in a mostly healthy paediatric population, for which we used an empty test inhaler with variable internal airflow resistance and mouthpiece.", {"entities": []}], ["In the current study we investigated what specifications are required for a DPI for children with cystic fibrosis (CF), for which we expanded on our previous findings.", {"entities": [[98, 113, "DISEASE"]]}], ["We recorded flow profiles of 35 children with CF (aged 4.7\u201314.7 years) at three airflow resistances (0.031\u20130.045 kPa", {"entities": []}], ["Recent technological advances have created challenges for geneticists and a need to adapt to a wide range of new bioinformatics tools and an expanding wealth of publicly available data (e.g., mutation databases, and software).", {"entities": []}], ["This wide range of methods and a diversity of file formats used in sequence analysis is a significant issue, with a considerable amount of time spent before anyone can even attempt to analyse the genetic basis of human disorders.", {"entities": []}], ["Another point to consider that is although many possess \u201cjust enough\u201d knowledge to analyse their data, they do not make full use of the tools and databases that are available and also do not fully understand how their data was created.", {"entities": []}], ["The primary aim of this review is to document some of the key approaches and provide an analysis schema to make the analysis process more efficient and reliable in the context of discovering highly penetrant causal mutations/genes.", {"entities": []}], ["This review will also compare the methods used to identify highly penetrant variants when data is obtained from consanguineous individuals as opposed to nonconsanguineous; and when Mendelian disorders are analysed as opposed to common-complex disorders.", {"entities": []}], ["Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes.", {"entities": []}], ["Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3\u03b1 is expressed in the lung within hours of allergen challenge.", {"entities": [[136, 139, "GENE"]]}], ["To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3\u03b1, were studied for their response to CA.", {"entities": [[69, 73, "GENE"]]}], ["CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes.", {"entities": []}], ["However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3\u03b1 and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.", {"entities": [[428, 434, "DISEASE"], [64, 68, "GENE"], [290, 294, "GENE"]]}], ["Non-adherence to aminosalicylates is observed among 30% to 45% of patients with ulcerative colitis and increases the risk of relapse.", {"entities": [[80, 98, "DISEASE"]]}], ["The Health Belief Model is a theoretical model that could offer a broader perspective to improve patients\u2019 self-medication adherence.", {"entities": []}], ["This study aimed to develop a screening instrument based on the Health Belief Model to screen patients with ulcerative colitis who had a high possibility of current non-adherence to aminosalicylates.", {"entities": [[108, 126, "DISEASE"]]}], ["The study was also designed to allow examination of factors of non-adherence.", {"entities": []}], ["A multicenter, cross-sectional study was conducted in outpatients diagnosed with ulcerative colitis and prescribed aminosalicylates.", {"entities": [[81, 99, "DISEASE"]]}], ["Non-adherence was defined as taking less than 80% of the prescribed dose.", {"entities": []}], ["We hypothesized that there was a significant relationship between current aminosalicylate non-adherence and five components of the HBM: beliefs about taking aminosalicylates, disease characteristics, medication characteristics, abdominal symptoms, and sociodemographic characteristics.", {"entities": []}], ["A logistic regression model was applied and the coefficients converted to a numeric scores in order to develop a screening instrument which could reliably discriminate non-adherent and adherent subjects.", {"entities": []}], ["Non-adherence was observed in 127 (29.6%) of the 429 enrolled subjects.", {"entities": []}], ["Lower perceptions of belief in taking aminosalicylates, absence of visible bleeding, eight daily tablets or less taken, and no concomitant use of thiopurines were related to non-adherence.", {"entities": []}], ["We then developed a screening instrument comprising 22 items.", {"entities": []}], ["When the cut-off point was set at 60, the instrument showed 85.0% sensitivity and 69.2% specificity with an area under the curve of 0.84 (95% confidence interval\u2009=\u20090.79\u20130.91).", {"entities": []}], ["The instrument appeared to be reliable for identifying patients with a high possibility of current non-adherence to aminosalicylates.", {"entities": []}], ["Further, the instrument may provide useful information for detecting patients with a high possibility of current non-adherence and for assessing factors of non-adherence.", {"entities": []}], ["On the other hand, we need to evaluate disease activity more strictly and examine whether it is included in the screening instrument in the future.", {"entities": []}], ["The online version of this article (doi:10.1186/s12876-014-0220-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The rate of decline in forced expiratory volume in 1 second (FEV 1 ) is representative of the natural history of COPD.", {"entities": [[61, 64, "GENE"]]}], ["Sparse information exists regarding the associations between the magnitude of annualised loss of FEV 1 with other endpoints.", {"entities": [[97, 100, "GENE"]]}], ["Retrospective analysis of UPLIFT 1 was analysed with random co-efficient regression.", {"entities": []}], ["Patients were categorised according to quartiles based on the rate of decline (RoD) in post-bronchodilator FEV 1.", {"entities": [[107, 110, "GENE"]]}], ["The St George's Respiratory Questionnaire (SGRQ) total score, exacerbations and mortality were assessed within each quartile.", {"entities": []}], ["Mean (standard error [SE]) post-bronchodilator FEV 1 increased in the first quartile (Q1) by 37 (1) mL/year.", {"entities": [[47, 50, "GENE"]]}], ["The other quartiles showed annualised declines in FEV 1 (mL/year) as follows: Q2 = 24 (1), Q3 = 59 (1) and Q4 = 125 (2).", {"entities": [[50, 53, "GENE"]]}], ["Age, gender, respiratory medication use at baseline and SGRQ did not distinguish groups.", {"entities": []}], ["The patient subgroup with the largest RoD had less severe lung disease at baseline and contained a higher proportion of current smokers.", {"entities": [[58, 70, "DISEASE"]]}], ["The percentage of patients with \u2265 1 exacerbation showed a minimal difference from the lowest to the largest RoD, but exacerbation rates increased with increasing RoD.", {"entities": []}], ["The highest proportion of patients with \u2265 1 hospitalised exacerbation was in Q4 (Q1 = 19.5% [tiotropium], 26% [control]; Q4 = 33.8% [tiotropium] and 33.1% [control]).", {"entities": []}], ["Time to first exacerbation and hospitalised exacerbation was shorter with increasing RoD.", {"entities": []}], ["Rate of decline in SGRQ increased in direct proportion to each quartile.", {"entities": []}], ["The group with the largest RoD had the highest mortality.", {"entities": []}], ["Patients can be grouped into different RoD quartiles with the observation of different clinical outcomes indicating that specific (or more aggressive) approaches to management may be needed.", {"entities": []}], ["ClinicalTrials.gov number, NCT00144339", {"entities": []}], ["The neuropeptide S receptor (NPSR1) and its ligand neuropeptide S (NPS) have received increased attention in the last few years, as both establish a previously unknown system of neuromodulation.", {"entities": [[29, 34, "GENE"], [67, 70, "GENE"]]}], ["Animal research studies have suggested that NPS may be involved in arousal/wakefulness and may also have a crucial role in sleep regulation.", {"entities": [[44, 47, "GENE"]]}], ["The single nucleotide polymorphism (SNP) rs324981 in NPSR1 has begun to shed light on a function of the NPS-system in human sleep regulation.", {"entities": [[53, 58, "GENE"]]}], ["Due to an amino acid exchange, the T-allele leads to an increased sensitivity of the NPSR1.", {"entities": [[85, 90, "GENE"]]}], ["In the only genome-wide association study to date on circadian sleep parameters in humans, an association was found between rs324981 and regular bedtime.", {"entities": []}], ["However, the sleep parameters in this study were only measured by self-rating.", {"entities": []}], ["Therefore, our study aimed to replicate these findings using an objective measure of sleep.", {"entities": []}], ["The study included n\u200a=\u200a393 white subjects (62\u201379 years) who participated in an actigraphic assessment for determining sleep duration, rest duration, sleep onset, rest onset and sleep onset latency.", {"entities": []}], ["Genotyping of the SNP rs324981 was performed using the TaqMan OpenArray System.", {"entities": []}], ["The genotype at rs324981 was not significantly associated with rest onset (bedtime) or sleep onset (p\u200a=\u200a.146 and p\u200a=\u200a.199, respectively).", {"entities": []}], ["However, the SNP showed a significant effect on sleep- and rest duration (p\u200a=\u200a.007 and p\u200a=\u200a.003, respectively).", {"entities": []}], ["Subjects that were homozygous for the minor T-allele had a significantly decreased sleep- and rest duration compared to A-allele carriers.", {"entities": []}], ["The results of this study indicate that the sleep pattern in humans is influenced by the NPS-system.", {"entities": []}], ["However, the previously reported association between bedtime and rs324981 could not be confirmed.", {"entities": []}], ["The current finding of decreased sleep duration in T/T allele carriers is in accordance with studies in rodents reporting similar results after NPS application.", {"entities": [[144, 147, "GENE"]]}], ["The high prevalence of smoking (80%) in Greek correctional institutions is anticipated to result in high prevalence of COPD in such settings.", {"entities": []}], ["The aim of the Greek obstructive luNg disease epidemiOlogy and health economics Study In corrective institutionS (GNOSIS) is to determine the prevalence of smoking and COPD among inmates and to assess the health-related quality of life.", {"entities": []}], ["GNOSIS, a cross-sectional epidemiological study, was conducted between March 2011 and December 2011 in seven correctional institutions in Greece.", {"entities": []}], ["A total of 552 participants, 91.3% male, median age of 43.0 years (interquartile range: 35\u201353), were enrolled.", {"entities": []}], ["COPD prevalence was 6.0% and was found to increase with age (18.6% among those \u226560 years), length of prison stay, and length of sentence.", {"entities": []}], ["Of the participants diagnosed with COPD, 36.4% were diagnosed with Global initiative for chronic Obstructive Lung Disease (GOLD) stage I and 51.5% were diagnosed with stage II.", {"entities": []}], ["Dyspnea severity was assessed as grades 0\u20131 on the medical research council dyspnea scale for 88.3%, while 31% reported \u22652 COPD exacerbations in the past year.", {"entities": []}], ["Seventy-nine percent of the total number of the participants were smokers, with a median smoking of 20.0 cigarettes per day, while 42.9% were assessed as having a strong addiction to nicotine.", {"entities": []}], ["The median EuroQol visual analog scale score was 70.0 (interquartile range: 60.0\u201390.0).", {"entities": []}], ["Problems in the dimension of anxiety/depression were reported by 82.8%.", {"entities": []}], ["The results of the study support the notion that the prevalence of COPD among inmates of Greek correctional institutions may increase in the following years.", {"entities": []}], ["The findings underscore the importance of taking actions to limit COPD prevalence and its risk factors in the Greek correctional system.", {"entities": []}], ["It is time-consuming to obtain the square root of airway wall area of the hypothetical airway with an internal perimeter of 10 mm (\u221aAaw at Pi10), a comparable index of airway dimensions in chronic obstructive pulmonary disease (COPD), from all airways of the whole lungs using 3-dimensional computed tomography (CT) analysis.", {"entities": [[189, 226, "DISEASE"]]}], ["We hypothesized that \u221aAaw at Pi10 differs among the five lung lobes and \u221aAaw at Pi10 derived from one certain lung lobe has a high level of agreement with that derived from the whole lungs in smokers.", {"entities": []}], ["Pulmonary function tests and chest volumetric CTs were performed in 157 male smokers (102 COPD, 55 non-COPD).", {"entities": []}], ["All visible bronchial segments from the 3 Using a mixed-effects model, \u221aAaw at Pi10 differed significantly among the five lung lobes (R In male smokers, CT-derived airway wall area differs among the five lung lobes, and airway wall area derived from the right or left upper lobe is representative of the whole lungs.", {"entities": []}], ["Coarse particle matter, PM coarse , is associated with increased respiratory morbidity and mortality.", {"entities": []}], ["The aim of this study was to investigate the association between short-term changes in PM coarse and sub-clininal airway inflammation in children.", {"entities": []}], ["Healthy children aged 11 years from two northern Swedish elementary schools underwent fraction of exhaled nitrogen oxide (FENO) measurements to determine levels of airway inflammation twice weekly during the study period from 11 April\u20136 June 2011.", {"entities": []}], ["Daily exposure to PM coarse , PM 2.5 , NO 2 , NOx, NO and O 3 and birch pollen was estimated.", {"entities": []}], ["Multiple linear regression was used.", {"entities": []}], ["Personal covariates were included as fixed effects and subjects were included as a random effect.", {"entities": []}], ["In total, 95 children participated in the study, and in all 493 FENO measurements were made.", {"entities": []}], ["The mean level of PM coarse was 16.1 \u03bcg/m 3 was 75.0 \u03bcg/m 2 was 17.0 \u03bcg/m coarse was associated with increases in FENO by between 6.9 ppb (95% confidence interval 0.0\u201314) and 7.3 ppb (95% confidence interval 0.4\u201314.9).", {"entities": []}], ["PM coarse was associated with an increase in FENO, indicating sub-clinical airway inflammation in healthy children.", {"entities": []}], ["Cytokines play an important role in the immunopathogenesis of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, where they drive and regulate multiple aspects of intestinal inflammation.", {"entities": [[62, 88, "DISEASE"], [126, 144, "DISEASE"]]}], ["The imbalance between proinflammatory and anti-inflammatory cytokines that occurs in IBD results in disease progression and tissue damage and limits the resolution of inflammation.", {"entities": []}], ["Targeting cytokines have been novel strategies in the treatment of IBD.", {"entities": []}], ["Recent studies show the beneficial effects of anticytokine treatments to IBD patients, and multiple novel cytokines are found to be involved in the pathogenesis of IBD.", {"entities": []}], ["In this review, we will discuss the recent advances of novel biologics in clinics and clinical trials, and novel proinflammatory and anti-inflammatory cytokines found in IBD with focusing on IL-12 family and IL-1 family members as well as their relevance to the potential therapy of IBD.", {"entities": []}], ["Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and highly lethal fibrotic lung disease with poor treatment and unknown etiology.", {"entities": [[11, 29, "DISEASE"], [90, 102, "DISEASE"]]}], ["Emerging evidence suggests that epithelial\u2013mesenchymal transition (EMT) has an important role in repair and scar formation following epithelial injury during pulmonary fibrosis.", {"entities": [[158, 176, "DISEASE"]]}], ["Although some miRNAs have been shown to be dysregulated in the pathophysiological processes of IPF, limited studies have payed attention on the participation of miRNAs in EMT in lung fibrosis.", {"entities": []}], ["In our study, we identified and constructed a regulation network of differentially expressed IPF miRNAs and EMT genes.", {"entities": []}], ["Additionally, we found the downregulation of miR-26a in mice with experimental pulmonary fibrosis.", {"entities": [[79, 97, "DISEASE"], [45, 52, "GENE"]]}], ["Further studies showed that miR-26a regulated HMGA2, which is a key factor in the process of EMT and had the maximum number of regulating miRNAs in the regulation network.", {"entities": [[28, 35, "GENE"], [46, 51, "GENE"]]}], ["More importantly, inhibition of miR-26a resulted in lung epithelial cells transforming into myofibroblasts in vitro and in vivo , whereas forced expression of miR-26a alleviated TGF- \u03b2 1- and BLM-induced EMT in A549 cells and in mice, respectively.", {"entities": [[32, 39, "GENE"], [159, 166, "GENE"], [32, 39, "GENE"], [159, 166, "GENE"]]}], ["Taken together, our study deciphered the essential role of miR-26a in the pathogenesis of EMT in pulmonary fibrosis, and suggests that miR-26a may be a potential therapeutic target for IPF.", {"entities": [[97, 115, "DISEASE"], [59, 66, "GENE"], [135, 142, "GENE"], [59, 66, "GENE"], [135, 142, "GENE"]]}], ["Community acquired pneumonia (CAP) is a major cause of morbidity, hospitalization, and mortality worldwide.", {"entities": [[19, 28, "DISEASE"]]}], ["Management of CAP for many patients requires rapid initiation of empirical antibiotic treatment, based on the spectrum of activity of available antimicrobial agents and evidence on local antibiotic resistance.", {"entities": []}], ["Few data exist on the severity profile and treatment of hospitalized CAP patients in Eastern and Central Europe and the Middle East, in particular on use of moxifloxacin (Avelox\u00ae), which is approved in these regions.", {"entities": []}], ["CAPRIVI ( C ommunity A cquired P neumonia: t R eatment w I th A V elox\u00ae in hosp I talized patients) was a prospective observational study in 12 countries: Croatia, France, Hungary, Kazakhstan, Jordan, Kyrgyzstan, Lebanon, Republic of Moldova, Romania, Russia, Ukraine, and Macedonia.", {"entities": []}], ["Patients aged >18\u00a0years were treated with moxifloxacin 400\u00a0mg daily following hospitalization with a CAP diagnosis.", {"entities": []}], ["In addition to efficacy and safety outcomes, data were collected on patient history and disease severity measured by CRB-65 score.", {"entities": []}], ["2733 patients were enrolled.", {"entities": []}], ["A low severity index (i.e., CRB-65 score <2) was reported in 87.5% of CAP patients assessed (n\u2009=\u20091847), an unexpectedly high proportion for hospitalized patients.", {"entities": []}], ["Moxifloxacin administered for a mean of 10.0\u00a0days (range: 2.0 to 39.0\u00a0days) was highly effective: 96.7% of patients in the efficacy population (n\u2009=\u20092152) improved and 93.2% were cured of infection during the study.", {"entities": []}], ["Severity of infection changed from \u201cmoderate\u201d or \u201csevere\u201d in 91.8% of patients at baseline to \u201cno infection\u201d or \u201cmild\u201d in 95.5% at last visit.", {"entities": []}], ["In the safety population (n\u2009=\u20092595), 127 (4.9%) patients had treatment-emergent adverse events (TEAEs) and 40 (1.54%) patients had serious TEAEs; none of these 40 patients died.", {"entities": []}], ["The safety results were consistent with the known profile of moxifloxacin.", {"entities": []}], ["The efficacy and safety profiles of moxifloxacin at the recommended dose of 400\u00a0mg daily are characterized in this large observational study of hospitalized CAP patients from Eastern and Central Europe and the Middle East.", {"entities": []}], ["The high response rate in this study, which included patients with a range of disease severities, suggests that treatment with broader-spectrum drugs such as moxifloxacin is appropriate for patients with CAP who are managed in hospital.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT00987792", {"entities": []}], ["Therapeutic strategies for the prophylaxis of IgE-mediated allergy remain an unmet medical need.", {"entities": []}], ["Cell therapy is an emerging approach with high potential for preventing and treating immunological diseases.", {"entities": []}], ["We aimed to develop a cell-based therapy inducing permanent allergen-specific immunological tolerance for preventing IgE-mediated allergy.", {"entities": []}], ["Wild-type mice were treated with allergen-expressing bone marrow cells under a short course of tolerogenic immunosuppression (mTOR inhibition and costimulation blockade).", {"entities": [[126, 130, "GENE"]]}], ["Bone marrow was retrieved from a novel transgenic mouse ubiquitously expressing the major grass pollen allergen Phl p 5 as a membrane-anchored protein (BALB/c-Tg[Phlp5-GFP], here mPhl p 5).", {"entities": []}], ["After transplantation recipients were IgE-sensitized at multiple time points with Phl p 5 and control allergen.", {"entities": []}], ["Mice treated with mPhl p 5 bone marrow did not develop Phl p 5-specific IgE (or other isotypes) despite repeated administration of the allergen, while mounting and maintaining a strong humoral response towards the control allergen.", {"entities": []}], ["Notably, Phl p 5-specific T cell responses and allergic airway inflammation were also completely prevented.", {"entities": []}], ["Interestingly allergen-specific B cell tolerance was maintained independent of Treg functions indicating deletional tolerance as underlying mechanism.", {"entities": []}], ["This proof-of-concept study demonstrates that allergen-specific immunological tolerance preventing occurrence of allergy can be established through a cell-based therapy employing allergen-expressing leukocytes.", {"entities": []}], ["\u2022 Avoidance of IgE-mediated allergy is established by development of a tolerogenic cell-based protocol.", {"entities": []}], ["\u2022 Transplantation of syngeneic allergen-bearing bone marrow cells into recipients leads to tolerance towards the introduced allergen.", {"entities": []}], ["\u2022 Prevention of T-and B-cell responses and allergic asthma is induced by cell transfer with non-toxic pretreatment.", {"entities": [[43, 58, "DISEASE"], [52, 58, "DISEASE"]]}], ["Avoidance of IgE-mediated allergy is established by development of a tolerogenic cell-based protocol.", {"entities": []}], ["Transplantation of syngeneic allergen-bearing bone marrow cells into recipients leads to tolerance towards the introduced allergen.", {"entities": []}], ["Prevention of T-and B-cell responses and allergic asthma is induced by cell transfer with non-toxic pretreatment.", {"entities": [[41, 56, "DISEASE"], [50, 56, "DISEASE"]]}], ["IgE-mediated allergy affects about 30% of the population in industrialized countries.", {"entities": []}], ["To prevent allergy we developed a cell-based protocol with the concept to modify body's own cells to express an allergen and to reinfuse those modified cells.", {"entities": []}], ["This concept leads to avoidance of allergic reactions after allergen contact such as specific IgE production and the development of allergic asthma.", {"entities": [[132, 147, "DISEASE"], [141, 147, "DISEASE"]]}], ["This is demonstrated in a syngeneic model in mice (i.e.", {"entities": []}], ["autologous in human) by transplanting bone marrow cells of a unique allergen-expressing transgenic mouse into pretreated recipients.", {"entities": []}], ["In asthma, higher chymase positive mast cell (MC-C) numbers are associated with less airway obstruction.", {"entities": [[3, 9, "DISEASE"]]}], ["In COPD, the distribution of MC-C and tryptase positive mast cells (MC-T) in central and peripheral airways, and their relation with lung function, is unknown.", {"entities": []}], ["We compared MC-T and MC-C distributions in COPD and controls without airflow limitation, and determined their relation with lung function.", {"entities": []}], ["Lung tissue sections from 19 COPD patients (median [interquartile range] FEV 1 % predicted 56 [23\u201375]) and 10 controls were stained for tryptase and chymase.", {"entities": [[73, 76, "GENE"]]}], ["Numbers of MC-T and MC-C were determined in different regions of central and peripheral airways and percentage of degranulation was determined.", {"entities": []}], ["COPD patients had lower MC-T numbers in the subepithelial area of central airways than controls.", {"entities": []}], ["In COPD, MC-T numbers in the airway wall and more specifically in the epithelium and subepithelial area of peripheral airways correlated positively with FEV 1 /VC (Spearman's rho (r s ) 0.47, p = 0.05 and r s 0.48, p = 0.05, respectively); MC-C numbers in airway smooth muscle of peripheral airways correlated positively with FEV 1 % predicted (r s 0.57, p = 0.02).", {"entities": [[153, 156, "GENE"], [326, 329, "GENE"], [153, 156, "GENE"], [326, 329, "GENE"]]}], ["Both in COPD patients and controls the percentage of degranulated MC-T and MC-C mast cells was higher in peripheral than in central airways (all p < 0.05), but this was not different between the groups.", {"entities": []}], ["More MC-T and MC-C in peripheral airways correlate with better lung function in COPD patients.", {"entities": []}], ["It is yet to determine whether this reflects a protective association of mast cells with COPD pathogenesis, or that other explanations are to be considered.", {"entities": []}], ["The intuitive early diagnostic guess could play an important role in reaching a final diagnosis.", {"entities": []}], ["However, no study to date has attempted to quantify the importance of general practitioners' (GPs) ability to correctly appraise the origin of chest pain within the first minutes of an encounter.", {"entities": []}], ["The validation study was nested in a multicentre cohort study with a one year follow-up and included 626 successive patients who presented with chest pain and were attended by 58 GPs in Western Switzerland.", {"entities": []}], ["The early diagnostic guess was assessed prior to a patient's history being taken by a GP and was then compared to a diagnosis of chest pain observed over the next year.", {"entities": []}], ["Using summary measures clustered at the GP's level, the early diagnostic guess was confirmed by further investigation in 51.0% (CI 95%; 49.4% to 52.5%) of patients presenting with chest pain.", {"entities": []}], ["The early diagnostic guess was more accurate in patients with a life threatening illness (65.4%; CI 95% 64.5% to 66.3%) and in patients who did not feel anxious (62.9%; CI 95% 62.5% to 63.3%).", {"entities": []}], ["The predictive abilities of an early diagnostic guess were consistent among GPs.", {"entities": []}], ["The GPs early diagnostic guess was correct in one out of two patients presenting with chest pain.", {"entities": []}], ["The probability of a correct guess was higher in patients with a life-threatening illness and in patients not feeling anxious about their pain.", {"entities": []}], ["To evaluate pulmonary function and respiratory symptoms in workers engaged in the early manufacturing processes of tea and to identify the associated factors, we conducted a study in a tea production area in Taiwan.", {"entities": []}], ["We recruited tea workers who engaged in the early manufacturing process in the Mountain Ali area in Taiwan and a comparison group of local office workers who were matched for age, gender, and smoking habits.", {"entities": []}], ["We performed questionnaire interviews, pulmonary function tests, skin prick tests, and measurement of specific IgE for tea on the participants and assessed tea dust exposures in the tea factories.", {"entities": []}], ["The 91 participating tea workers had higher prevalence of respiratory symptoms than the comparison group (32 participants).", {"entities": []}], ["Among tea workers, ball-rolling workers had the highest prevalence of symptoms and the highest exposures of inhalable dusts.", {"entities": []}], ["At baseline, tea workers had similar pulmonary functions as the comparison group, but compared to the other tea workers ball-rolling workers had a lower ratio of the 1-second forced expiratory volume to forced vital capacity (FEV 1 /FVC) and a lower maximal mid-expiratory flow rate expressed as% of the predicted value--MMF (%pred).", {"entities": [[226, 229, "GENE"]]}], ["A total of 58 tea workers participated in the on-site investigation and the cross-shift lung function measurements.", {"entities": []}], ["We found ball-rolling yielded the highest inhalable dust level, panning yielded the highest respirable dust level, and withering yielded the lowest levels of both dusts.", {"entities": []}], ["Ball-rolling also yielded the highest coarse fraction (defined as inhalable dusts minus respirable dusts), which represented exposures from nose to tracheobronchial tract.", {"entities": []}], ["During the shift, we observed significant declines in pulmonary function, especially in ball-rolling workers.", {"entities": []}], ["Multiple regressions showed that age, height, work tasks, coarse fraction, and number of months working in tea manufacturing each year were independent predictors of certain pulmonary function parameters in tea workers.", {"entities": []}], ["Tea workers engaged in early manufacturing processes of tea have higher prevalence of respiratory symptoms and pulmonary function impairment, which might be related to tea dust exposures, especially the coarse fraction.", {"entities": []}], ["Omega-3 polyunsaturated fatty acids (n-3 PUFAs), commonly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been acknowledged as essential long-chain fatty acids imposing either optimal health promotion or the rescuing from chronic inflammatory diseases such as atherosclerosis, fatty liver, and various inflammatory gastrointestinal diseases.", {"entities": [[277, 292, "DISEASE"]]}], ["Recent studies dealing with EPA and DHA have sparked highest interests because detailed molecular mechanisms had been documented with the identification of its receptor, G protein coupled receptor, and GPR120.", {"entities": [[202, 208, "GENE"]]}], ["In this review article, we have described clear evidences showing that n-3 PUFAs could reduce various Helicobacter pylori - ( H. pylori -) associated gastric diseases and extended to play even cancer preventive outcomes including H. pylori -associated gastric cancer by influencing multiple targets, including proliferation, survival, angiogenesis, inflammation, and metastasis.", {"entities": [[193, 199, "DISEASE"], [260, 266, "DISEASE"]]}], ["Since our previous studies strongly concluded that nonantimicrobial dietary approach for reducing inflammation, for instance, application of phytoceuticals, probiotics, natural products including Korean red ginseng, and walnut plentiful of n-3 PUFAs, might be prerequisite step for preventing H. pylori -associated gastric cancer as well as facilitating the rejuvenation of precancerous atrophic gastritis, these beneficial lipids can restore or modify inflammation-associated lipid distortion and correction of altered lipid rafts to send right signaling to maintain healthy stomach even after chronic H. pylori infection.", {"entities": [[396, 405, "DISEASE"], [387, 405, "DISEASE"], [323, 329, "DISEASE"]]}], ["Physical function (PF) is a core patient-reported outcome domain in clinical trials in rheumatic diseases.", {"entities": []}], ["Frequently used PF measures have ceiling effects, leading to large sample size requirements and low sensitivity to change.", {"entities": []}], ["In most of these instruments, the response category that indicates the highest PF level is the statement that one is able to perform a given physical activity without any limitations or difficulty.", {"entities": []}], ["This study investigates whether using an item format with an extended response scale, allowing respondents to state that the performance of an activity is easy or very easy, increases the range of precise measurement of self-reported PF.", {"entities": []}], ["Three five-item PF short forms were constructed from the Patient-Reported Outcomes Measurement Information System (PROMIS\u00ae) wave 1 data.", {"entities": []}], ["All forms included the same physical activities but varied in item stem and response scale: format A (\u201cAre you able to \u2026\u201d; \u201cwithout any difficulty\u201d/\u201cunable to do\u201d); format B (\u201cDoes your health now limit you \u2026\u201d; \u201cnot at all\u201d/\u201ccannot do\u201d); format C (\u201cHow difficult is it for you to \u2026\u201d; \u201cvery easy\u201d/\u201cimpossible\u201d).", {"entities": []}], ["Each short-form item was answered by 2217\u20132835 subjects.", {"entities": []}], ["We evaluated unidimensionality and estimated a graded response model for the 15 short-form items and remaining 119 items of the PROMIS PF bank to compare item and test information for the short forms along the PF continuum.", {"entities": []}], ["We then used simulated data for five groups with different PF levels to illustrate differences in scoring precision between the short forms using different item formats.", {"entities": []}], ["Sufficient unidimensionality of all short-form items and the original PF item bank was supported.", {"entities": []}], ["Compared to formats A and B, format C increased the range of reliable measurement by about 0.5 standard deviations on the positive side of the PF continuum of the sample, provided more item information, and was more useful in distinguishing known groups with above-average functioning.", {"entities": []}], ["Using an item format with an extended response scale is an efficient option to increase the measurement range of self-reported physical function without changing the content of the measure or affecting the latent construct of the instrument.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-017-1273-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["As visual impairment (VI) due to adverse drug reactions (ADR) is rare in adults and children, there is an incomplete evidence base to inform guidance for screening and for counseling patients on the potential risks of medications.", {"entities": []}], ["We report on suspected drugs and the eye conditions found in a national study of incidence of diagnosis of visual impairment due to suspected ADR.", {"entities": []}], ["Case ascertainment was via the British Ophthalmological Surveillance Unit (BOSU), between March 2010 and February 2012, with follow-up after 6\u00a0months.", {"entities": []}], ["Case definition: any child or adult with bilateral or unilateral visual impairment due to a suspected ADR, using distance acuity worse than Snellen 6/18 (logMAR 0.48) in the better eye (bilateral) or affected eye (unilateral).", {"entities": []}], ["Anonymized patient information on potential cases was provided by managing ophthalmologists, comprising visual status before and after suspected ADR, ophthalmic condition attributable to the ADR, preexisting eye disease and prescribed medications at the time of the ADR.", {"entities": [[208, 219, "DISEASE"]]}], ["Permanency and causality of the visual impairment were confirmed by the managing clinician, after 6\u00a0months, using the WHO Uppsala Monitoring Committee criteria.", {"entities": []}], ["Over 2\u00a0years, 36 eligible cases were reported of whom 23 had permanent VI.", {"entities": []}], ["While most cases were due to drugs known to have adverse side-effects, some were unanticipated sporadic cases.", {"entities": []}], ["Visual impairment due to ADRs is rare.", {"entities": []}], ["However, with for example, increasing polypharmacy in the elderly, monitoring of ocular ADRs, although challenging, is necessary.", {"entities": []}], ["Urban South-Asian's are predisposed to early onset of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD).", {"entities": [[61, 78, "DISEASE"], [54, 78, "DISEASE"]]}], ["There is an urgent need for country specific primary prevention strategies to address the growing burden of cardio-metabolic disease in this population.", {"entities": []}], ["The aim of this clinical trial is to evaluate whether intensive (3-monthly) lifestyle modification advice is superior to a less-intensive (12 monthly; control group) lifestyle modification advice on a primary composite cardio-metabolic end point in 'at risk' urban subjects aged between 5-40 years.", {"entities": []}], ["This is an open randomised controlled parallel group clinical trial performed at a single centre in Colombo, Sri-Lanka.", {"entities": []}], ["A cluster sampling strategy was used to select a large representative sample of subjects aged between 5-40 years at high risk of T2DM and CVD for the intervention study.", {"entities": []}], ["We have screened 23,298 (males 47% females 53%) healthy subjects for four risk factors: obesity, elevated waist circumference, family history of diabetes and physical inactivity, using a questionnaire and anthropometry.", {"entities": [[88, 95, "DISEASE"]]}], ["Those with two or more risk-factors were recruited to the intervention trial.", {"entities": []}], ["We aim to recruit 4600 subjects for the intervention trial.", {"entities": []}], ["The primary composite cardio-metabolic end point is; new onset T2DM, impaired glucose tolerance, impaired fasting glycaemia, new onset hypertension and albuminuria, following 5 years of intervention.", {"entities": [[135, 147, "DISEASE"]]}], ["The effect of the intervention on pre-specified secondary endpoints will also be evaluated.", {"entities": []}], ["The study will be conducted according to good clinical and ethical practice, data analysis and reporting guidelines.", {"entities": []}], ["DIABRISK-SL is a large population based trial to evaluate the prevalence of diabetes, pre-diabetes and cardio-metabolic risk factors among young urban Sri-Lankans and the effect of a primary prevention strategy on cardio-metabolic disease end points.", {"entities": []}], ["This work will enable country specific and regional cardio-metabolic risk scores to be derived.", {"entities": []}], ["Further if the proposed intervention is successful the results of this study can be translated and implemented as a low-cost primary prevention tool in Sri-Lanka and other low/middle income developing countries.", {"entities": []}], ["The trial is registered with the World Health Organisation and Sri-Lanka clinical trial registry number SLCTR/2008/003", {"entities": []}], ["Animal models mimicking human diseases have been used extensively to study the pathogenesis of autoimmune diseases and the efficacy of potential therapeutics.", {"entities": []}], ["They are, however, limited with regard to their similarity to the human disease and cannot be used if the antagonist and its cognate receptor require high similarity in structure or binding.", {"entities": []}], ["Here, we examine the induction of oxazolone-mediated features of atopic dermatitis (AD) in NOD-scid IL2R\u03b3", {"entities": [[65, 82, "DISEASE"], [72, 82, "DISEASE"]]}], ["The mammalian microbiota plays a key role in host health and disease susceptibility.", {"entities": []}], ["However, knowledge of the early-age microbiota of pigs is lacking.", {"entities": []}], ["The purpose of this study was to use high-throughput next-generation sequencing to characterize the fecal and nasal microbiotas of pigs during early life.", {"entities": []}], ["Ten commercially-raised pigs were randomly enrolled at birth and sampled throughout the first 7\u00a0weeks of life.", {"entities": []}], ["DNA was extracted from fecal and nasal samples and the hypervariable region V4 of the 16S rRNA gene was amplified.", {"entities": []}], ["The product was sequenced using the Illumina MiSeq platform and 2 \u00d7 250 chemistry.", {"entities": []}], ["Sequencing data was processed and analyzed with the mothur algorithms using an operational taxonomic unit approach.", {"entities": []}], ["In total, 4.7 million and 5.4 million high-quality sequences were recovered from fecal and nasal samples, respectively.", {"entities": []}], ["Analysis revealed that these microbiotas contain a very rich and diverse population of bacteria that display a remarkable evolution during the first 7\u00a0weeks of life.", {"entities": []}], ["During this developmental period, a pig was exposed to an average of 1,976 and 6,257 species of bacteria by way of the gastrointestinal and respiratory tracts, respectively.", {"entities": []}], ["Aging was significantly associated with an increasing measure of richness and diversity as well as with distinct changes to the core microbiota.", {"entities": []}], ["At 2\u20133 weeks post-weaning, the rapidly developing microbiotas appeared to reach a developmental milestone as a relative degree of stability was evident.", {"entities": []}], ["Pigs are exposed to an incredibly rich and diverse mixture of bacteria during early-life as demonstrated by next-generation sequencing methodology.", {"entities": []}], ["These findings expand the knowledge of the developing porcine microbiota which is important for understanding susceptibility to disease, particularly for vulnerable neonatal pigs.", {"entities": []}], ["The online version of this article (doi:10.1186/s12866-015-0512-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The skin is under constant renewal and exposure to environmental challenges.", {"entities": []}], ["How homeostasis is maintained alongside protective mechanisms against damage is unclear.", {"entities": []}], ["Among the basal epithelial cells (ECs) is a population of resident intraepithelial lymphocytes (IELs) that provide host-protective immune surveillance.", {"entities": []}], ["Here we show that IELs cross-communicate with ECs via the production of IL-13.", {"entities": []}], ["Skin ECs are activated by IEL-derived IL-13, enabling a canonical EC stress response.", {"entities": []}], ["In the absence of IL-13, or canonical IEL, the skin has decreased ability to repair its barrier and increased susceptibility to cutaneous carcinogenesis.", {"entities": []}], ["IL-13 controls the rate of EC movement through the epidermis, which might explain the importance of IL-13 for epidermal integrity and its suppressive effect on skin carcinogenesis.", {"entities": []}], ["These findings show that IL-13 acts as a molecular bridge between IELs and ECs, and reveal a critical host-defensive role for type-2 immunity in regulating EC tissue homeostasis and carcinogenesis.", {"entities": []}], ["Epidermal intraepithelial lymphocytes (IEL) produce IL-13, but the physiological role of this cytokine production is not clear.", {"entities": []}], ["Here the authors show that IEL-production of IL-13 is a vital lymphoid stress surveillance mechanism driving crosstalk with epithelial cells to maintain tissue homeostasis and inhibit chemical carcinogenesis in mice.", {"entities": []}], ["Bronchopulmonary dysplasia (BPD) is the chronic lung disease of prematurity that affects very preterm infants.", {"entities": [[48, 60, "DISEASE"]]}], ["Although advances in perinatal care have changed the course of lung injury and enabled the survival of infants born as early as 23-24 weeks of gestation, BPD still remains a common complication of extreme prematurity, and there is no specific treatment for it.", {"entities": []}], ["Furthermore, children, adolescents, and adults who were born very preterm and developed BPD have an increased risk of persistent lung dysfunction, including early-onset emphysema.", {"entities": []}], ["Therefore, it is possible that early-life pulmonary insults, such as extreme prematurity and BPD, may increase the risk of COPD later in life, especially if exposed to secondary challenges such as respiratory infections and/or smoking.", {"entities": []}], ["Recent advances in our understanding of stem/progenitor cells and their potential to repair damaged organs offer the possibility of cell-based treatments for neonatal and adult lung injuries.", {"entities": []}], ["This paper summarizes the long-term pulmonary outcomes of preterm birth and BPD and discusses the recent advances of cell-based therapies for lung diseases, with a particular focus on BPD and COPD.", {"entities": []}], ["Gyeji-tang (GJT, Guizhi Tang in Chinese, Keishi-to in Japanese) is a traditional herbal decoction composed of 5 medicinal herbs.", {"entities": []}], ["GJT has been used to treat the common cold, headaches, and fever in Asian countries including Korea, China, and Japan.", {"entities": [[31, 42, "DISEASE"]]}], ["In the present study, we investigated the inhibitory effect of a water extract of GJT on inflammatory response using the murine macrophage cell line, RAW 264.7.", {"entities": []}], ["RAW 264.7 macrophages were treated with lipopolysaccharide (LPS) to upregulate inflammatory genes.", {"entities": []}], ["Cells were pretreated with various concentrations of GJT for 4\u00a0h and stimulated with LPS for an additional 20\u00a0h. Productions of tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6), cyclooxygenase-2 (COX-2), and prostaglandin E 2 (PGE 2 ) were measured by enzyme-linked immunosorbent assays (ELISAs).", {"entities": []}], ["Protein expressions of heme oxygenase (HO)-1, extracellular signal-regulated kinase (ERK), and nuclear factor kappa-B (NF-\u03baB) were analyzed by immunoblotting.", {"entities": []}], ["Treatment with the GJT extract enhanced expression of HO-1 in macrophages without cytotoxicity.", {"entities": []}], ["GJT extract significantly inhibited proinflammatory cytokines TNF-\u03b1 and IL-6 in LPS-stimulated cells.", {"entities": []}], ["GJT suppressed LPS-induced COX-2 expression, leading to a decrease in COX-2-derived PGE 2 level.", {"entities": []}], ["In addition, GJT extract prevented phosphorylation of ERK and NF-\u03baB translocalization to the nucleus in LPS-treated RAW 264.7 cells.", {"entities": []}], ["These data suggest that GJT has anti-inflammatory possibly through blocking ERK and NF-\u03baB signaling pathways.", {"entities": []}], ["Salamanders regenerate their limbs after amputation.", {"entities": []}], ["However, the molecular mechanism of this unique regeneration remains unclear.", {"entities": []}], ["In this study, isobaric tags for relative and absolute quantification (iTRAQ) coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS) was employed to quantitatively identify differentially expressed proteins in regenerating limbs 3, 7, 14, 30 and 42\u00a0days post amputation (dpa).", {"entities": []}], ["Of 2636 proteins detected in total, 253 proteins were differentially expressed during different regeneration stages.", {"entities": []}], ["Among these proteins, Asporin, Cadherin-13, Keratin, Collagen alpha-1(XI) and Titin were down-regulated.", {"entities": []}], ["CAPG, Coronin-1A, AnnexinA1, Cathepsin B were up-regulated compared with the control.", {"entities": [[0, 4, "GENE"]]}], ["The identified proteins were further analyzed to obtain information about their expression patterns and functions in limb regeneration.", {"entities": []}], ["Functional analysis indicated that the differentially expressed proteins were associated with wound healing, immune response, cellular process, metabolism and binding.", {"entities": []}], ["This work indicated that significant proteome alternations occurred during salamander limb regeneration.", {"entities": []}], ["The results may provide fundamental knowledge to understand the mechanism of limb regeneration.", {"entities": []}], ["The online version of this article (10.1186/s12864-017-4125-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Previous studies have reported that osteoporosis due to estrogen deficiency influences fracture healing.", {"entities": [[36, 48, "DISEASE"]]}], ["Transforming growth factor (TGF-\u03b2) has been found to be involved in fracture healing via the regulation of the differentiation and activation of osteoblasts and osteoclasts.", {"entities": []}], ["The current study aimed to determine the effects of estrogen on the expression of TGF-\u03b21 during fracture healing in ovariectomized rats.", {"entities": []}], ["Thirty female Sprague-Dawley rats weighing 200\u2013250 g were assigned to: (i) a sham-operated group that was given a normal saline; (ii) an ovariectomized control group that was given a normal saline; or (iii) an ovariectomized + estrogen (100 \u00b5g/kg/day) group that was treated with conjugated equine estrogen.", {"entities": []}], ["The right femur of all rats was fractured, and a Kirschner wire was inserted six weeks post-ovariectomy.", {"entities": []}], ["Treatment with estrogen was given for another six weeks post-fracture.", {"entities": []}], ["At the end of the study, blood samples were taken, and the right femur was harvested and subjected to biomechanical strength testing.", {"entities": []}], ["The percentage change in the plasma TGF-\u03b21 level before treatment was significantly lower in the ovariectomized control and estrogen groups when compared with the sham group ( p <0.001).", {"entities": []}], ["After six weeks of treatment, the percentage change in the plasma TGF-\u03b21 level in the estrogen group was significantly higher compared with the level in the ovariectomized control group ( p \u200a=\u200a0.001).", {"entities": []}], ["The mean ultimate force was significantly increased in the ovariectomized rats treated with estrogen when compared with the ovariectomized control group ( p \u200a=\u200a0.02).", {"entities": []}], ["These data suggest that treatment with conjugated equine estrogen enhanced the strength of the healed bone in estrogen-deficient rats by most likely inducing the expression of TGF-\u03b21.", {"entities": []}], ["To investigate the prevalence of multimorbidity in adults with intellectual disabilities with and without Down syndrome.", {"entities": [[111, 119, "DISEASE"]]}], ["Large, population-based cross-sectional study.", {"entities": []}], ["The geographical area of one Health Board, Scotland.", {"entities": []}], ["All adults (aged 16+ years) known to general practitioners to have intellectual disabilities and adults receiving services provided or paid by intellectual disabilities health or social work services.", {"entities": []}], ["1023/1562 potential participants took part (65.5%); 562 (54.9%) men and 461 (45.1%) women, aged 43.9 years (16\u201383 years).", {"entities": []}], ["186 had Down syndrome and 837 did not.", {"entities": [[13, 21, "DISEASE"]]}], ["The prevalence of International Statistical Classification of Diseases, 10th revision, physical health conditions and multimorbidity detected at a comprehensive health assessment.", {"entities": []}], ["The mean number of physical health conditions/participant was 11.04, and 98.7% had multimorbidity.", {"entities": []}], ["The most prevalent conditions are painful and/or disabling and, in some cases, life threatening.", {"entities": []}], ["The five most prevalent were visual impairment, obesity, epilepsy, constipation and ataxic/gait disorders.", {"entities": [[67, 79, "DISEASE"], [48, 55, "DISEASE"]]}], ["The pattern of multimorbidity differs from that seen in the general population and is spread across the entire adult life course.", {"entities": []}], ["The extent of multimorbidity in the adults with Down syndrome was similar to that of the adults without Down syndrome, while the prevalence of individual conditions differed.", {"entities": [[53, 61, "DISEASE"], [109, 117, "DISEASE"]]}], ["This robustly designed study with a large population found an extremely high prevalence of multimorbidity in adults with intellectual disabilities across the entire adult life course.", {"entities": []}], ["This increases complexity of medical management that secondary healthcare services and medical education are not yet geared towards, as these tend to focus on single conditions.", {"entities": []}], ["This is in addition to complexity due to limitations in communication and understanding.", {"entities": []}], ["As the physical conditions within their multimorbidity also differ from that seen in the older general population, urgent attention is needed to develop the care pathways and guidelines that are required to inform and so improve their healthcare.", {"entities": []}], ["Asthma is a complex phenotype that is influenced by both genetic and environmental factors.", {"entities": [[0, 6, "DISEASE"]]}], ["Genome-wide linkage and association studies have been performed to identify susceptibility genes for asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["These studies identified new genes and pathways implicated in this disease, many of which were previously unknown.", {"entities": []}], ["To perform a large-scale genotyping study to identify asthma-susceptibility genes in the Japanese population.", {"entities": [[54, 60, "DISEASE"]]}], ["We performed a large-scale, three-stage association study on 288 atopic asthmatics and 1032 controls, by using multiplex PCR-Invader assay methods at 82,935 single nucleotide polymorphisms (SNPs) (1 SNPs located in the 5' region of PEX19 (rs2820421) were significantly associated with P < 0.05 through the 1 P values did not reach statistically significant levels (combined, P = 3.8 \u00d7 10 P = 6.57 \u00d7 10 HPCAL1 (rs3771140) and on IL18R1 (rs3213733) were associated with asthma in the 1 No association attained genome-wide significance, but several loci for possible association emerged.", {"entities": [[468, 474, "DISEASE"], [232, 237, "GENE"], [402, 408, "GENE"], [428, 434, "GENE"]]}], ["Future studies are required to validate these results for the prevention and treatment of asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["Cigarette smoking cannot fully explain the epidemiologic characteristics of chronic obstructive pulmonary disease (COPD) in women, particularly for those who rarely smoke, but COPD risk is not less than men.", {"entities": [[76, 113, "DISEASE"]]}], ["The aim of our study is to investigate the relationship between second-hand smoke (SHS) exposure and chronic bronchitis in Taiwanese women.", {"entities": [[109, 119, "DISEASE"]]}], ["We used Taiwan's National Health Insurance Bureau claims data in 1999, and cross-checked using criteria set by the American Thoracic Society; there were 33 women with chronic bronchitis, 182 with probable chronic bronchitis, and 205 with no chronic bronchitis during our interview time between 2000 and 2005.", {"entities": [[175, 185, "DISEASE"], [213, 223, "DISEASE"], [249, 259, "DISEASE"]]}], ["We measured second-hand smoke (SHS) exposure by self-reported measures (household users and duration of exposure), and validated this by measuring urinary cotinine levels of a subset subjects.", {"entities": []}], ["Classification of chronic bronchitis was also based on spirometry defined according to the GOLD guidelines to get the severity of COPD.", {"entities": [[26, 36, "DISEASE"]]}], ["Women who smoked and women who had been exposed to a lifetime of SHS were 24.81-fold (95% CI: 5.78-106.38) and 3.65-fold (95% CI: 1.19-11.26) more likely to have chronic bronchitis, respectively, than those who had not been exposed to SHS.", {"entities": [[170, 180, "DISEASE"]]}], ["In addition, there was a significant increasing trend between the severity of COPD and exposure years of SHS ( p < 0.01).", {"entities": []}], ["The population attributable risk percentages of chronic bronchitis for smokers and those exposed to SHS were 23.2 and 47.3% respectively.", {"entities": [[56, 66, "DISEASE"]]}], ["These findings indicate that, besides cigarette smoking, exposure to SHS is a major risk factor for chronic bronchitis in Taiwanese women.", {"entities": [[108, 118, "DISEASE"]]}], ["Consistent evidence has demonstrated that smoking ban policies save lives, but impacts on health inequalities are uncertain as few studies have assessed post-ban effects by socioeconomic status (SES) and findings have been inconsistent.", {"entities": []}], ["The aim of this study was to assess the effects of the national Irish smoking ban on ischemic heart disease (IHD), stroke, and chronic obstructive pulmonary disease (COPD) mortality by discrete and composite SES indicators to determine impacts on inequalities.", {"entities": [[85, 107, "DISEASE"], [94, 107, "DISEASE"], [127, 164, "DISEASE"]]}], ["Census data were used to assign frequencies of structural and material SES indicators to 34 local authorities across Ireland with a 2000\u20132010 study period.", {"entities": []}], ["Discrete indicators were jointly analysed through principal component analysis to generate a composite index, with sensitivity analyses conducted by varying the included indicators.", {"entities": []}], ["Poisson regression with interrupted time-series analysis was conducted to examine monthly age and gender-standardised mortality rates in the Irish population, ages \u226535 years, stratified by tertiles of SES indicators.", {"entities": []}], ["All models were adjusted for time trend, season, influenza, and smoking prevalence.", {"entities": [[49, 58, "DISEASE"]]}], ["Post-ban mortality reductions by structural SES indicators were concentrated in the most deprived tertile for all causes of death, while reductions by material SES indicators were more equitable across SES tertiles.", {"entities": []}], ["The composite indices mirrored the results of the discrete indicators, demonstrating that post-ban mortality decreases were either greater or similar in the most deprived when compared to the least deprived for all causes of death.", {"entities": []}], ["Overall findings indicated that the national Irish smoking ban reduced inequalities in smoking-related mortality.", {"entities": []}], ["Due to the higher rates of smoking-related mortality in the most deprived group, even equitable reductions across SES tertiles resulted in decreases in inequalities.", {"entities": []}], ["The choice of SES indicator was influential in the measurement of effects, underscoring that a differentiated analytical approach aided in understanding the complexities in which structural and material factors influence mortality.", {"entities": []}], ["Spores of the genus Alternaria belong to one of the most prevailing constituents of the air in all regions of the world.", {"entities": []}], ["They form infectious inoculum of numerous plant species as well as severe inhaled allergies.", {"entities": []}], ["The aim of this study was to compare the biological pollution with Alternaria spores of the air of 12 cities located in central and eastern Europe.", {"entities": []}], ["The experiment was done in 2010 and it covered the territory of Latvia (LV), Lithuania (LT), Poland (PL) and Ukraine (UA).", {"entities": [[88, 90, "GENE"]]}], ["The spores were counted using an identical method and standard equipment (7-day Lanzoni volumetric sampler) followed by extensive statistical calculations.", {"entities": []}], ["The timing of the day of maximum concentration changed mainly along the N-S direction and had a positive correlation with latitude.", {"entities": []}], ["The most important factor determining the increase in Alternaria spore concentration was the temperature, whereas other weather parameters were not related or of low significance.", {"entities": []}], ["Regardless of geographical location, the first phase of the season (0\u20130.9\u00a0% of Alternaria spores in the air) was the longest (up to 60\u00a0days) and the last (97.5 to 99\u00a0%) was the shortest (22\u00a0days or less).", {"entities": []}], ["The means of daily concentrations of Alternaria spores ranged from 11\u00a0spores\u00a0m Alternaria spores in several places of central and eastern Europe was high; the number of days exceeding the threshold value of 300\u00a0spores\u00a0m", {"entities": []}], ["The new member of the IL-1 family, interleukin-33 (IL-33), participates in the progression of a variety of diseases through binding with its receptor ST2.", {"entities": []}], ["Recently, much clinical evidence and experimental data have indicated that IL-33 is associated with various liver diseases.", {"entities": []}], ["This review primarily addresses the relationship between IL-33 and several hepatic diseases.", {"entities": []}], ["IL-33 can alleviate high-fat diet- (HFD-) induced hepatic steatosis and insulin resistance, and IL-33 acts as an alarmin, which quickly triggers the immune system to respond to virus invasion and toxic damage to the liver.", {"entities": []}], ["However, when liver injury is chronic, IL-33 promotes Th2 reactions and hepatic stellate cell (HSC) activity, facilitating progression to liver fibrosis.", {"entities": []}], ["The complicated functions of IL-33 should be considered before its clinical application.", {"entities": []}], ["Vaccination, designed to trigger a protective immune response against infection, is a trigger for mild inflammatory responses.", {"entities": []}], ["Vaccination studies can address the question of inflammation initiation, levels, and resolution as well as its regulation for respective studied pathogens.", {"entities": []}], ["Such studies largely based on analyzing the blood components including specific antibodies and cytokines were usually constrained by number of participants and volume of collected blood sample.", {"entities": []}], ["Hence, blood-based studies may not be able to cover the full dynamic range of inflammation responses induced by vaccination.", {"entities": []}], ["In this review, the potential of using saliva in addition to blood for studying the kinetics of inflammatory response studies was assessed.", {"entities": []}], ["Saliva sampling is noninvasive and has a great potential to be used for studies aimed at analysing the magnitude, time course, and variance in immune responses, including inflammation after vaccination.", {"entities": []}], ["Based on a literature survey of inflammatory biomarkers that can be determined in saliva and an analysis of how these biomarkers could help to understand the mechanisms and dynamics of immune reactivity and inflammation, we propose that the saliva-based approach might have potential to add substantial value to clinical studies, particularly in vulnerable populations such as infants, toddlers, and ill individuals.", {"entities": []}], ["Maternal allergic disease history and impaired regulatory T-cells (Tregs) are critical risk factors for allergy development in children.", {"entities": []}], ["However, the mechanisms that underlie these risk factors remain poorly defined.", {"entities": []}], ["Therefore, the aim of this study was to assess whether maternal allergies affect the Tregs of offspring and lead to allergy development in childhood.", {"entities": []}], ["A total of 332 mothers of healthy newborns (234 from no allergic mothers, 98 from allergic mothers) were recruited to this study.", {"entities": []}], ["Detailed questionnaires were administered yearly to determine the allergy status of the mothers and the newborns from birth to 3\u00a0years of age.", {"entities": []}], ["Cord blood samples obtained at the time of birth were analysed for Treg counts, as well Treg activity, based on their response to Toll-like receptor (TLR) stimuli such as lipid A (LPA) and peptidoglycans (PPG).", {"entities": [[180, 183, "GENE"]]}], ["Surface markers, associated genes, suppressive capacity, and cytokine levels of Tregs were also measured.", {"entities": []}], ["Possible correlations between Treg activity and maternal or neonate allergies were assessed.", {"entities": []}], ["In addition, environmental microbial content and other known risk factors for allergies were measured.", {"entities": []}], ["Cord blood mononuclear cells (CBMCs) from offspring with allergic mothers showed fewer CD4 P \u2009<\u20090.05), especially via the PPG-TLR2 pathway.", {"entities": [[87, 90, "GENE"]]}], ["Suppression of effector T cells by Tregs from children of mothers with allergies was impaired, especially IL-13 production by Type 2\u00a0T helper (Th2) cells ( P \u2009=\u20090.026).", {"entities": []}], ["Children who developed allergies in the first 3\u00a0years of life had lower numbers of CD4 FOXP3 expression and IL-10 production as newborns ( P \u2009<\u20090.05).", {"entities": [[83, 86, "GENE"], [87, 92, "GENE"]]}], ["Maternal allergic background was identified as a risk factor for allergy development in the children ( Odds ratio (OR) \u2009=\u20092.46, 95\u00a0% CI\u2009=\u20091.05\u20135.79); while declining Treg numbers, IL-10 production, and FOXP3 expression in neonates (PPG and LPA stimulated) were identified as independent risk factors for allergic diseases in offspring at 3\u00a0years of age after adjusting for maternal allergic history and environmental factors ( P \u2009<\u20090.05).", {"entities": [[202, 207, "GENE"], [240, 243, "GENE"]]}], ["Maternal allergy correlated with impaired Tregs in neonates, and this could enhance the susceptibility of offspring to allergic diseases in early childhood due to an imbalance of Th1 and Th2 cells.", {"entities": []}], ["Certain benzo[ f ]indole-4,9-dione derivatives were synthesized and evaluated for their inhibitory effects on superoxide anion generation and neutrophil elastase (NE) release in formyl- l -methionyl- l -leucyl- l -phenylalanine (fMLF)-activated human neutrophils.", {"entities": []}], ["Results indicated that ( Z )-1-benzyl-4-(hydroxyimino)-1 H -benzo[ f ]indol-9(4 H )-one ( 10 ) showed a potent dual inhibitory effect on NE release and superoxide anion generation with IC 50 value of 2.78 and 2.74 \u03bcM respectively.", {"entities": []}], ["The action mechanisms of 10 in human neutrophils were further investigated.", {"entities": []}], ["Our results showed that compound 10 did not alter fMLF-induced phosphorylation of Src (Src family Y416).", {"entities": [[82, 85, "GENE"], [87, 90, "GENE"], [82, 85, "GENE"], [87, 90, "GENE"]]}], ["Notably, phosphorylation of Akt (S473) and mobilization of [Ca i caused by fMLF was inhibited by compound 10 .", {"entities": []}], ["Further structural optimization of 10 is ongoing.", {"entities": []}], ["We aimed to evaluate the effect of chronic hypergravity in a mouse model of allergic asthma and rhinitis.", {"entities": [[76, 91, "DISEASE"], [96, 104, "DISEASE"], [85, 91, "DISEASE"]]}], ["Forty BALB/c mice were divided as: group A (n\u2009=\u200910, control) sensitized and challenged with saline, group B (n\u2009=\u200910, asthma) challenged by intraperitoneal and intranasal ovalbumin (OVA) to induce allergic asthma and rhinitis, and groups C (n\u2009=\u200910, asthma/rotatory control) and D (n\u2009=\u200910, asthma/hypergravity) exposed to 4 weeks of rotation with normogravity (1G) or hypergravity (5G) during induction of asthma/rhinitis.", {"entities": [[196, 211, "DISEASE"], [216, 224, "DISEASE"], [411, 419, "DISEASE"], [117, 123, "DISEASE"], [205, 211, "DISEASE"], [248, 254, "DISEASE"], [288, 294, "DISEASE"], [404, 410, "DISEASE"]]}], ["Group D showed significantly decreased eosinophils, neutrophils, and lymphocytes in their BAL fluid compared with groups B and C ( p \u2009<\u20090.05).", {"entities": []}], ["In real-time polymerase chain reaction using lung homogenate, the expression of IL-1\u03b2 was significantly upregulated ( p \u2009<\u20090.001) and IL-4 and IL-10 significantly downregulated ( p \u2009<\u20090.05) in group D. Infiltration of inflammatory cells into lung parenchyma and turbinate, and the thickness of respiratory epithelium was significantly reduced in group D ( p \u2009<\u20090.05).", {"entities": []}], ["The expression of Bcl-2 and heme oxygenase-1 were significantly downregulated, Bax and extracellular dismutase significantly upregulated in Group D. Therefore, chronic hypergravity could have a hormetic effect for allergic asthma and rhinitis via regulation of genes involved in antioxidative and proapoptotic pathways.", {"entities": [[214, 229, "DISEASE"], [234, 242, "DISEASE"], [223, 229, "DISEASE"], [79, 82, "GENE"]]}], ["It is possible that we could use hypergravity machinery for treating allergic respiratory disorders.", {"entities": []}], ["The differential expression of two closelyassociated cyclooxygenase isozymes, COX-1 and COX-2, exhibited functions beyond eicosanoid metabolism.", {"entities": []}], ["We hypothesized that COX-1 or COX-2 knockout lung fibroblasts may display altered protein profiles which may allow us to further differentiate the functional roles of these isozymes at the molecular level.", {"entities": []}], ["Proteomic analysis shows constitutive production of macrophage migration inhibitory factor ( MIF ) in lung fibroblasts derived from COX-2 MIF .", {"entities": [[93, 96, "GENE"], [138, 141, "GENE"], [93, 96, "GENE"], [138, 141, "GENE"]]}], ["The secretion and regulation of MIF in COX-2 p53 , as well as in the expression of oncogenes and related transcripts.", {"entities": [[32, 35, "GENE"]]}], ["Integrative Oncogenomics Cancer Browser (IntroGen) analysis shows downregulation of COX-2 and amplification of MIF and/or p53 activity during development of glioblastomas, ependymoma, and colon adenomas.", {"entities": [[25, 31, "DISEASE"], [111, 114, "GENE"]]}], ["These data indicate the functional role of the MIF-COX-p53 axis in inflammation and cancer at the genomic and proteomic levels in COX-2-ablated cells.", {"entities": [[84, 90, "DISEASE"]]}], ["This systematic analysis not only shows the proinflammatory state but also unveils a molecular signature of a pro-oncogenic state of COX-1 in COX-2 ablated cells.", {"entities": []}], ["In sickle cell disease, sickle erythrocyte (SSRBC) interacts with endothelial cells, leukocytes, and platelets, and activates coagulation and inflammation, promoting vessel obstruction, which leads to serious life-threatening complications, including acute painful crises and irreversible damage to multiple organs.", {"entities": []}], ["The mitogen-activated protein kinase, ERK1/2, is abnormally activated in SSRBCs.", {"entities": []}], ["However, the therapeutic potential of SSRBC ERK1/2 inactivation has never been investigated.", {"entities": []}], ["I tested four different inhibitors of MEK1/2 (MEK), the kinase that activates ERK1/2, in a model of human SSRBC adhesion to TNF\u03b1-activated endothelial cells (ECs).", {"entities": []}], ["SSRBC MEK inhibition abrogated adhesion to non-activated and TNF\u03b1-activated ECs to levels below baseline SSRBC adhesion to non-activated ECs in vitro .", {"entities": []}], ["SSRBC MEK inhibition also prevented SSRBCs from activating na\u00efve neutrophils to adhere to endothelium.", {"entities": []}], ["To determine the effect of MEK inhibitors on SSRBC adherence in vivo , sham-treated or MEK inhibitor-treated SSRBCs were infused to nude mice previously treated with TNF\u03b1.", {"entities": []}], ["Sham-treated SSRBCs displayed marked adhesion and occlusion of enflamed vessels, both small and large.", {"entities": []}], ["However, SSRBC treatment with MEK inhibitors ex vivo showed poor SSRBC adhesion to enflamed vessels with no visible vasoocclusion in vivo .", {"entities": []}], ["In addition, MEK inhibitor treatment of SSRBCs reduced SSRBC organ trapping and increased the number of SSRBCs circulating in bloodstream.", {"entities": []}], ["Thus, these data suggest that SSRBC ERK1/2 plays potentially a critical role in sickle pathogenesis, and that MEK inhibitors may represent a valuable intervention for acute sickle cell crises.", {"entities": []}], ["While the effectiveness of teleophthalmology is generally accepted, its ability to diagnose glaucomatous eye disease remains relatively unknown.", {"entities": [[105, 116, "DISEASE"]]}], ["This study aimed to compare a web-based teleophthalmology assessment with clinical slit lamp examination to screen for glaucoma among diabetics in a rural African district.", {"entities": [[119, 127, "DISEASE"]]}], ["Three hundred and nine diabetic patients underwent both the clinical slit lamp examination by a comprehensive ophthalmologist and teleglaucoma (TG) assessment by a glaucoma subspecialist.", {"entities": [[164, 172, "DISEASE"], [144, 146, "GENE"]]}], ["Both assessments were compared for any focal glaucoma damage; for TG, the quality of photographs was assessed, and vertical cup-to-disk ratio (VCDR) was calculated in a semi-automated manner.", {"entities": [[45, 53, "DISEASE"], [66, 68, "GENE"]]}], ["In patients with VCDR > 0.7, the diagnostic precision of the Frequency Doubling Technology (FDT) C-20 screening program was assessed.", {"entities": []}], ["Of 309 TG assessment photos, 74 (24%) were deemed unreadable due to media opacities, patient cooperation, and unsatisfactory photographic technique.", {"entities": [[7, 9, "GENE"]]}], ["While the identification of individual optic nerve factors showed either fair or moderate agreement, the ability to diagnose glaucoma based on the overall assessment showed moderate agreement (Kappa [\u03ba] statistic 0.55% and 95% confidence interval [CI]: 0.48-0.62).", {"entities": [[125, 133, "DISEASE"]]}], ["The use of FDT to detect glaucoma in the presence of disc damage (VCDR > 0.7) showed substantial agreement (\u03ba statistic of 0.84 and 95% CI 0.79-0.90).", {"entities": [[25, 33, "DISEASE"]]}], ["A positive TG diagnosis of glaucoma carried a 77.5% positive predictive value, and a negative TG diagnosis carried an 82.2% negative predicative value relative to the clinical slit lamp examination.", {"entities": [[27, 35, "DISEASE"], [11, 13, "GENE"], [94, 96, "GENE"], [11, 13, "GENE"], [94, 96, "GENE"]]}], ["There was moderate agreement between the ability to diagnose glaucoma using TG relative to clinical slit lamp examination.", {"entities": [[61, 69, "DISEASE"], [76, 78, "GENE"]]}], ["Poor quality photographs can severely limit the ability of TG assessment to diagnose optic nerve damage and glaucoma.", {"entities": [[108, 116, "DISEASE"], [59, 61, "GENE"]]}], ["Although further work and validation is needed, the TG approach provides a novel, and promising method to diagnose glaucoma, a major cause of ocular morbidity throughout the world.", {"entities": [[115, 123, "DISEASE"], [52, 54, "GENE"]]}], ["Children are more sensitive to pollutants than adults and yet they spend large amounts of time in school environments where they are exposed to unknown levels of indoor pollutants.", {"entities": []}], ["This study investigated the concentrations of the most abundant volatile organic compounds (VOCs) in eight naturally ventilated school buildings in Italy.", {"entities": []}], ["The schools were chosen to include areas with different urbanization and traffic density characteristics in order to gather a more diverse picture of exposure risks in the different areas of the city.", {"entities": []}], ["VOCs were sampled for one week in the presence/absence of pupils using diffusive samplers suitable for thermal desorption inside three classrooms at each school.", {"entities": []}], ["The samples were then analyzed with thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS).", {"entities": []}], ["In addition, outdoor measurements were carried out in the yard at each school.", {"entities": []}], ["VOC identification and quantification, and indoor/outdoor concentration plots were used to identify pollutant sources.", {"entities": []}], ["While some classrooms were found to have very low VOC levels, others had a significant indoor contribution or a prevalent outdoor contribution.", {"entities": []}], ["High concentrations of terpenes were found in all monitored classrooms: \u03b1-pinene and limonene were in the range of 6.55\u201334.18 \u00b5g/m", {"entities": []}], ["Multiple sclerosis is associated with prolonged cardiac repolarization but the underlying physiology has remained unknown.", {"entities": [[0, 18, "DISEASE"]]}], ["In this study, we compared cardiac repolarization during the relapsing\u2010remitting multiple sclerosis ( RRMS ) disease course in patients with motor and sensory onset symptom.", {"entities": [[81, 99, "DISEASE"]]}], ["Twenty\u2010five RRMS patients with motor and 33 RRMS patients with sensory onset symptom having 12\u2010lead electrocardiogram ( ECG ) recorded at the time of the first demyelinating event ( ECG 1) as well as at the later disease course ( ECG 2) were identified from the patient records.", {"entities": []}], ["The average time interval between ECG 1 and ECG 2 was 8.6\u00a0\u00b1\u00a05.9 y.", {"entities": []}], ["Heart rate\u2010corrected QT intervals reflecting cardiac repolarization were calculated by Bazett ( QT cBaz), Fridericia ( QT cFri), and Karjalainen ( QT cKar) formulas.", {"entities": []}], ["Heart rate\u2010corrected QT intervals as well as heart rate were similar in patients with motor and sensory onset symptom in ECG 1.", {"entities": []}], ["However, QT cBaz ( p \u00a0=\u00a0.002), QT cFri ( p \u00a0=\u00a0.019), and QT cKar ( p \u00a0=\u00a0.026) were longer and heart rate was higher ( p \u00a0=\u00a0.035) in patients with motor than sensory onset symptom in ECG 2.", {"entities": []}], ["Correspondingly, QT cBaz ( p \u00a0=\u00a0.002), QT cFri ( p \u00a0=\u00a0.033), and QT cKar ( p \u00a0=\u00a0.043) prolonged and heart rate tended to increase ( p \u00a0=\u00a0.060) during the disease course only in the patients with motor onset symptom.", {"entities": []}], ["Cardiac repolarization prolonged and heart rate increased during the disease course in RRMS patients with motor but not with sensory onset symptom.", {"entities": []}], ["This suggests different traits in RRMS according to its initial manifestation and also association of motor onset symptom with more unfavorable cardiovascular prognostic determinants.", {"entities": []}], ["Mast cells secrete various substances that initiate and perpetuate allergic responses.", {"entities": []}], ["Cross-linking of the high-affinity receptor for IgE (Fc\u025bRI) in RBL-2H3 and bone marrow\u2013derived mast cells activates sphingosine kinase (SphK), which leads to generation and secretion of the potent sphingolipid mediator, sphingosine-1\u2013phosphate (S1P).", {"entities": []}], ["In turn, S1P activates its receptors S1P 1 and S1P 2 that are present in mast cells.", {"entities": []}], ["Moreover, inhibition of SphK blocks Fc\u025bRI-mediated internalization of these receptors and markedly reduces degranulation and chemotaxis.", {"entities": []}], ["Although transactivation of S1P 1 and Gi signaling are important for cytoskeletal rearrangements and migration of mast cells toward antigen, they are dispensable for Fc\u025bRI-triggered degranulation.", {"entities": []}], ["However, S1P 2 , whose expression is up-regulated by Fc\u025bRI cross-linking, was required for degranulation and inhibited migration toward antigen.", {"entities": []}], ["Together, our results suggest that activation of SphKs and consequently S1PRs by Fc\u025bRI triggering plays a crucial role in mast cell functions and might be involved in the movement of mast cells to sites of inflammation.", {"entities": []}], ["RNA interference has been considered as an effective gene silencing method in basic and preclinical investigations.", {"entities": []}], ["The aims of the present study were to construct a lentiviral vector expressing a short hairpin RNA (shRNA) targeting the murine CC chemokine receptor 3 (mCCR3), and to investigate its effects on the proliferation and apoptosis of mouse eosinophils.", {"entities": []}], ["A recombinant lentiviral vector expressing four fragments of mouse CCR3 shRNA (pLVX-mCCR3-1+2+3+4-shRNA) was constructed using subcloning techniques.", {"entities": [[67, 71, "GENE"]]}], ["This novel lentivirus was then packaged into 293T cells by co-transduction with plasmids, including Baculo p35, pCMV R8.2 and VSV.", {"entities": []}], ["The interference effects of the vector were verified using polymerase chain reaction (PCR) and western blot analyses.", {"entities": []}], ["The effects of the interference on the proliferation and apoptosis of mouse eosinophils were investigated using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and terminal deoxynucleotidyl transferase dUTP nick end labeling methods, respectively.", {"entities": []}], ["The results of the PCR and western blot analyses confirmed that the novel recombinant vector, pLVX-mCCR3-1+2+3+4-shRNA, had high efficiency in inhibiting the mRNA and protein expression levels of mCCR3 in mouse eosinophils.", {"entities": []}], ["The downregulation of mCCR3 significantly inhibited proliferation of the eosinophils.", {"entities": []}], ["Furthermore, the present study found that the downregulation of mCCR3 significantly promoted apoptosis of the eosinophils.", {"entities": []}], ["Therefore, the downregulation of mCCR3 led to the inhibition of proliferation and induction of apoptosis in mouse eosinophils.", {"entities": []}], ["The predominant characteristics of allergic rhinitis are eosinophil infiltration and release of inflammatory mediators, which appear in a variety of clinical manifestations.", {"entities": [[35, 52, "DISEASE"], [44, 52, "DISEASE"]]}], ["The results of the present study indicate that mCCR3 silencing may serve as a putative approach for the treatment of allergic rhinitis.", {"entities": [[117, 134, "DISEASE"], [126, 134, "DISEASE"]]}], ["Background.", {"entities": []}], ["Applications of cost-effectiveness analysis do not typically incorporate effects on caregiver quality of life despite increasing evidence that these effects are measurable.", {"entities": []}], ["Using a national sample of US adults, we conducted 2 cross-sectional surveys during December 2011 and January 2012.", {"entities": []}], ["One version asked respondents to value their own experience as the family member of a person with a chronic illness (experienced sample), and the other version asked respondents to value hypothetical scenarios describing the experience of having a family member with a chronic illness (community sample).", {"entities": []}], ["Conditions included Alzheimer\u2019s disease/dementia, arthritis, cancer, and depression.", {"entities": [[40, 48, "DISEASE"], [50, 59, "DISEASE"], [61, 67, "DISEASE"]]}], ["Using standard gamble questions, respondents were asked to value the spillover effects of a family member\u2019s illness.", {"entities": []}], ["We used regression analysis to evaluate the disutility (loss in health-related quality of life) of having a family member with a chronic illness by condition and relationship type, controlling for the respondent\u2019s own conditions and sociodemographic characteristics.", {"entities": []}], ["For the experienced sample ( n = 1389), regression analyses suggested that greater spillover was associated with certain conditions (arthritis, depression) compared with other conditions (Alzheimer\u2019s disease, cancer).", {"entities": [[133, 142, "DISEASE"], [209, 215, "DISEASE"]]}], ["For the community sample ( n = 1205), regression analyses indicated that lower spillover was associated with condition (cancer) but not the type of relationship with the ill family member (parent, child, spouse).", {"entities": [[120, 126, "DISEASE"]]}], ["Conclusions.", {"entities": []}], ["The effects of illness extend beyond the individual patient to include effects on caregivers of patients, parents of ill children, spouses, and other close family and household members.", {"entities": []}], ["Cost-effectiveness analyses should consider the inclusion of health-related quality of life spillover effects in addition to caregiving time costs incurred by family members of ill individuals.", {"entities": []}], ["The promotion of safe firearm practices, or firearms means restriction, is a promising but infrequently used suicide prevention strategy in the USA.", {"entities": []}], ["Safety Check is an evidence-based practice for improving parental firearm safety behaviour in paediatric primary care.", {"entities": []}], ["However, providers rarely discuss firearm safety during visits, suggesting the need to better understand barriers and facilitators to promoting this approach.", {"entities": []}], ["This study, Adolescent Suicide Prevention In Routine clinical Encounters, aims to engender a better understanding of how to implement the three firearm components of Safety Check as a suicide prevention strategy in paediatric primary care.", {"entities": []}], ["The National Institute of Mental Health-funded Mental Health Research Network (MHRN), a consortium of 13 healthcare systems across the USA, affords a unique opportunity to better understand how to implement a firearm safety intervention in paediatric primary care from a system-level perspective.", {"entities": []}], ["We will collaboratively develop implementation strategies in partnership with MHRN stakeholders.", {"entities": []}], ["First, we will survey leadership of 82 primary care practices (ie, practices serving children, adolescents and young adults) within two MHRN systems to understand acceptability and use of the three firearm components of Safety Check (ie, screening, brief counselling around firearm safety and provision of firearm locks).", {"entities": []}], ["Then, in collaboration with MHRN stakeholders, we will use intervention mapping and the Consolidated Framework for Implementation Research to systematically develop and evaluate a multilevel menu of implementation strategies for promoting firearm safety as a suicide prevention strategy in paediatric primary care.", {"entities": []}], ["Study procedures have been approved by the University of Pennsylvania.", {"entities": []}], ["Henry Ford Health System and Baylor Scott & White institutional review boards (IRBs) have ceded IRB review to the University of Pennsylvania IRB.", {"entities": []}], ["Results will be submitted for publication in peer-reviewed journals.", {"entities": []}], ["Non-adherence to medications is prevalent across all medical conditions that include ambulatory pharmacotherapy and is thus a major barrier to achieving the benefits of otherwise effective medicines.", {"entities": []}], ["The objective of this systematic review was to identify and to compare the efficacy of strategies and components thereof that improve implementation of the prescribed drug dosing regimen and maintain long-term persistence, based on quantitative evaluation of effect sizes across the aggregated trials.", {"entities": []}], ["MEDLINE, EMBASE, CINAHL, the Cochrane Library, and PsycINFO were systematically searched for randomized controlled trials that tested the efficacy of adherence-enhancing strategies with self-administered medications.", {"entities": []}], ["The searches were limited to papers in the English language and were included from database inception to 31 December 2011.", {"entities": []}], ["Our review included randomized controlled trials in which adherence was assessed by electronically compiled drug dosing histories.", {"entities": []}], ["Five thousand four hundred studies were screened.", {"entities": []}], ["Eligibility assessment was performed independently by two reviewers.", {"entities": []}], ["A structured data collection sheet was developed to extract data from each study.", {"entities": []}], ["The adherence-enhancing components were classified in eight categories.", {"entities": []}], ["Quality of the papers was assessed using the criteria of the Cochrane Handbook for Systematic Reviews of Interventions guidelines to assess potential bias.", {"entities": []}], ["A combined adherence outcome was derived from the different adherence variables available in the studies by extracting from each paper the available adherence summary variables in a pre-defined order (correct dosing, taking adherence, timing adherence, percentage of adherent patients).", {"entities": []}], ["To study the association between the adherence-enhancing components and their effect on adherence, a linear meta-regression model, based on mean adherence point estimates, and a meta-analysis were conducted.", {"entities": []}], ["Seventy-nine clinical trials published between 1995 and December 2011 were included in the review.", {"entities": []}], ["Patients randomized to an intervention group had an average combined adherence outcome of 74.3\u00a0%, which was 14.1\u00a0% higher than in patients randomized to the control group (60.2\u00a0%).", {"entities": []}], ["The linear meta-regression analysis with stepwise variable selection estimated an 8.8\u00a0% increase in adherence when the intervention included feedback to the patients of their recent dosing history (EM-feedback) ( p \u00a0<\u00a00.01) and a 5.0\u00a0% increase in adherence when the intervention included a cognitive-educational component ( p \u00a0=\u00a00.02).", {"entities": []}], ["In addition, the effect of interventions on adherence decreased by 1.1\u00a0% each month.", {"entities": []}], ["Sensitivity analysis by selecting only high-quality papers confirmed the robustness of the model.", {"entities": []}], ["The random effects model in the meta-analysis, conducted on 48 studies, confirmed the above findings and showed that the improvement in adherence was 19.8\u00a0% (95\u00a0% CI 10.7\u201328.9\u00a0%) among patients receiving EM-feedback, almost double the improvement in adherence for studies that did not include this type of feedback [10.3\u00a0% (95\u00a0% CI 7.5\u201313.1\u00a0%)] ( p \u00a0<\u00a00.01).", {"entities": []}], ["The improvement in adherence was 16.1\u00a0% (95\u00a0% CI 10.7\u201321.6\u00a0%) in studies that tested cognitive-educational components versus 10.1\u00a0% (95\u00a0% CI 6.6\u201313.6\u00a0%) in studies that did not include this type of intervention ( p \u00a0=\u00a00.04).", {"entities": []}], ["Among 57 studies measuring clinical outcomes, only 8 reported a significant improvement in clinical outcome.", {"entities": []}], ["Despite a common measurement, the meta-analysis was limited by the heterogeneity of the pooled data and the different measures of medication adherence.", {"entities": []}], ["The funnel plot showed a possible publication bias in studies with high variability of the intervention effect.", {"entities": []}], ["Notwithstanding the statistical heterogeneity among the studies identified, and potential publication bias, the evidence from our meta-analysis suggests that EM-feedback and cognitive-educational interventions are potentially effective approaches to enhance patient adherence to medications.", {"entities": []}], ["The limitations of this research highlight the urgent need to define guidelines and study characteristics for research protocols that can guide researchers in designing studies to assess the effects of adherence-enhancing interventions.", {"entities": []}], ["The online version of this article (doi:10.1007/s40265-013-0041-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Handheld inhalers are used to deliver treatment for COPD.", {"entities": []}], ["Incorrect usage leads to suboptimal disease control.", {"entities": []}], ["Complex treatment regimens and use of multiple inhalers may reduce patient compliance.", {"entities": []}], ["The Anoro Ellipta\u2122 dry powder inhaler (DPI) simultaneously delivers umeclidinium bromide (UMEC) and vilanterol (VI) without coformulation being required.", {"entities": []}], ["To assess the correct usage and ease of use of the Ellipta\u2122 DPI administering UMEC/VI and to compare patient preference for Ellipta\u2122 with the HandiHaler Two Phase III, 3-month double-blind, placebo-controlled studies assessed the correct usage of the Ellipta\u2122 DPI at Day 1 and after 6 weeks, and ease of use of the Ellipta\u2122 DPI using a nonvalidated patient questionnaire after 6 weeks or early withdrawal.", {"entities": []}], ["In three 6-month, blinded double-dummy, active comparator studies (two Phase IIIa and one Phase IIIb), patients completed a COPD device preference questionnaire between the Ellipta\u2122 DPI and the Handi-Haler In the 3-month placebo-controlled studies, \u226598% of patients used the Ellipta\u2122 DPI correctly and 99% of patients found the inhaler easy/very easy-to-use and the dose counter easy/very easy to read.", {"entities": []}], ["Across the two Phase IIIa active comparator studies, patients consistently stated a preference for the Ellipta\u2122 DPI over HandiHaler Delivery of UMEC/VI via the Ellipta\u2122 DPI was considered easy-to-use, and patients with COPD demonstrated clear preference for this inhaler compared with HandiHaler", {"entities": []}], ["Obesity can be considered a global public health problem that affects virtually all countries worldwide and results in greater use of healthcare services and higher healthcare costs.", {"entities": [[0, 7, "DISEASE"]]}], ["We aimed to describe average monthly household medicine expenses according to source of funding, public or private, and to estimate the influence of the presence of obese residents in households on total medicine expenses.", {"entities": []}], ["This study was based on data from the 2008\u20132009 Brazilian Household Budget Survey, with a representative population sample of 55,970 households as study units.", {"entities": []}], ["Information on nutritional status and medicines acquired and their cost in the past 30\u00a0days were analyzed.", {"entities": []}], ["A two-part model was employed to assess the influence of obesity on medicine expenses, with monthly household medicine expenses per capita as outcome, presence of obese in the household as explanatory variable, and adjustment for confounding variables.", {"entities": [[57, 64, "DISEASE"]]}], ["Out-of-pocket expenses on medicines were always higher than the cost of medicines obtained through the public sector, and 32\u00a0% of households had at least one obese as resident.", {"entities": []}], ["Monthly household expenses on medicines per capita in households with obese was US$ 20.40, 16\u00a0% higher than in households with no obese.", {"entities": []}], ["An adjusted model confirmed that the presence of obese in the households increased medicine expenses.", {"entities": []}], ["Obesity is associated with additional medicine expenses, increasing the negative impact on household budgets and public expenditure.", {"entities": [[0, 7, "DISEASE"]]}], ["Interstitial lung disease (ILD) is a common extra-articular condition in rheumatoid arthritis (RA), but few studies have systematically investigated its incidence and risk factors in patients receiving anti-tumor necrosis factor-alpha (anti-TNF\u03b1) agents or alternate mechanisms of action (MOAs) (e.g., T-cell, B-cell, and interleukin-6 inhibitors).", {"entities": [[73, 93, "DISEASE"], [84, 93, "DISEASE"], [13, 25, "DISEASE"]]}], ["RA patients at least 18\u00a0years old were selected from the MarketScan databases (2010\u20132012) if they had at least one prescription/administration of abatacept, rituximab, tocilizumab, or anti-TNF after having discontinued a different biologic agent and meeting enrollment criteria.", {"entities": []}], ["Cox models estimated the risk of incident ILD and ILD-related hospitalization.", {"entities": []}], ["Sensitivity analyses used an alternate ILD case definition.", {"entities": []}], ["We identified 13,795 episodes of biologic exposure in 11,219 patients.", {"entities": []}], ["Mean (standard deviation) follow-up was 0.7 (0.5) years.", {"entities": []}], ["Patients receiving alternate MOA agents were more likely to have had recent exposure to steroids, prior exposure to a greater number of biologics, and history of ILD, anemia, chronic obstructive pulmonary disease, and other pulmonary conditions.", {"entities": [[175, 212, "DISEASE"], [167, 173, "DISEASE"]]}], ["When the sensitive definition was used, unadjusted ILD incidence rates (95\u00a0% confidence interval, or CI) ranged from 4.0 (1.6\u20138.2, abatacept) to 12.2 (5.6\u201323.2, infliximab) per 1000 person-years.", {"entities": []}], ["Being older (hazard ratio (HR) 3.5; 95\u00a0% CI 2.1\u20136.0), being male (HR 3.1; 95\u00a0% CI 1.2\u20138.4), and having another pulmonary condition (HR 4.8; 95\u00a0% CI 1.7\u201313.7) were associated with increased ILD incidence\u00a0in either sensitive and/or specific models.", {"entities": [[27, 29, "GENE"], [66, 68, "GENE"], [132, 134, "GENE"], [27, 29, "GENE"], [66, 68, "GENE"], [132, 134, "GENE"], [27, 29, "GENE"], [66, 68, "GENE"], [132, 134, "GENE"]]}], ["There were no significant differences by biologic class.", {"entities": []}], ["Hospitalization rates (95\u00a0% CI) when the sensitive definition was used ranged from 55.6 (6.7\u2013200.7, tocilizumab) to 262.5 (71.5\u2013672.2, infliximab).", {"entities": []}], ["In Cox models, recent methotrexate exposure was associated with reduced ILD hospitalization (HR 0.16; 95\u00a0% CI 0.06\u20130.46), whereas being male (HR 2.5; 95\u00a0% CI 1.3\u20134.8) and having had a hospitalization for asthma (HR 3.4; 95\u00a0% CI 1.2\u20139.8) or ILD/pneumonia (HR 2.3; 95\u00a0% CI 1.1\u20134.7) in the 12\u00a0months prior to index were associated with increased hospitalization risk.", {"entities": [[244, 253, "DISEASE"], [204, 210, "DISEASE"], [93, 95, "GENE"], [142, 144, "GENE"], [212, 214, "GENE"], [255, 257, "GENE"], [93, 95, "GENE"], [142, 144, "GENE"], [212, 214, "GENE"], [255, 257, "GENE"], [93, 95, "GENE"], [142, 144, "GENE"], [212, 214, "GENE"], [255, 257, "GENE"], [93, 95, "GENE"], [142, 144, "GENE"], [212, 214, "GENE"], [255, 257, "GENE"]]}], ["There were no significant differences in the risk of ILD and its related complications between RA patients receiving anti-TNF\u03b1 agents and those receiving alternate MOA agents.", {"entities": []}], ["Further studies are needed that account for differences in baseline characteristics in order to fully evaluate the risk of ILD and its complications.", {"entities": []}], ["Many patients with several concurrent medical conditions (multimorbidity) are seen in the primary care setting.", {"entities": []}], ["A thorough understanding of outcomes associated with multimorbidity would benefit primary care workers of all disciplines.", {"entities": []}], ["The purpose of this systematic review was to clarify the relationship between the presence of multimorbidity and the quality of life (QOL) or health-related quality of life (HRQOL) of patients seen, or likely to be seen, in the primary care setting.", {"entities": []}], ["Medline and Embase electronic databases were screened using the following search terms for the reference period 1990 to 2003: multimorbidity, comorbidity, chronic disease, and their spelling variations, along with quality of life and health-related quality of life.", {"entities": []}], ["Only descriptive studies relevant to primary care were selected.", {"entities": []}], ["Of 753 articles screened, 108 were critically assessed for compliance with study inclusion and exclusion criteria.", {"entities": []}], ["Thirty of these studies were ultimately selected for this review, including 7 in which the relationship between multimorbidity or comorbidity and QOL or HRQOL was the main outcome measure.", {"entities": []}], ["Major limitations of these studies include the lack of a uniform definition for multimorbidity or comorbidity and the absence of assessment of disease severity.", {"entities": []}], ["The use of self-reported diagnoses may also be a weakness.", {"entities": []}], ["The frequent exclusion of psychiatric diagnoses and presence of potential confounding variables are other limitations.", {"entities": []}], ["Nonetheless, we did find an inverse relationship between the number of medical conditions and QOL related to physical domains.", {"entities": []}], ["For social and psychological dimensions of QOL, some studies reveal a similar inverse relationship in patients with 4 or more diagnoses.", {"entities": []}], ["Our findings confirm the existence of an inverse relationship between multimorbidity or comorbidy and QOL.", {"entities": []}], ["However, additional studies are needed to clarify this relationship, including the various dimensions of QOL affected.", {"entities": []}], ["Those studies must employ a clear definition of multimorbidity or comorbidity and valid ways to measure these concepts in a primary care setting.", {"entities": []}], ["Pursuit of this research will help to better understand the impact of chronic diseases on patients.", {"entities": []}], ["Sphingosine- 1-Phosphate (S1P) is a bioactive lipid and an intracellular as well as an extracellular signaling molecule.", {"entities": []}], ["S1P ligand specifically binds to five related cell surface G-protein-coupled receptors (S1P 1-5 ).", {"entities": []}], ["S1P levels are tightly regulated by its synthesis catalyzed by sphingosine kinases (SphKs) 1 & 2 and catabolism by S1P phosphatases, lipid phosphate phosphatases and S1P lyase.", {"entities": []}], ["We previously reported that knock down of SphK1 ( Sphk1 Two-way ANOVA analysis was performed and differentially expressed genes under hyperoxia were identified using Sphk1 Sphk1 Using SphK1 knockout mice and differential gene expression analysis, we have shown here that S1P/SphK1 signaling plays a key role in promoting hyperoxia induced DNA damage, inflammation, apoptosis and ECM remodeling in neonatal lungs.", {"entities": [[42, 47, "GENE"], [50, 55, "GENE"], [166, 171, "GENE"], [172, 177, "GENE"], [184, 189, "GENE"], [275, 280, "GENE"], [42, 47, "GENE"], [50, 55, "GENE"], [166, 171, "GENE"], [172, 177, "GENE"], [184, 189, "GENE"], [275, 280, "GENE"], [42, 47, "GENE"], [50, 55, "GENE"], [166, 171, "GENE"], [172, 177, "GENE"], [184, 189, "GENE"], [275, 280, "GENE"], [42, 47, "GENE"], [50, 55, "GENE"], [166, 171, "GENE"], [172, 177, "GENE"], [184, 189, "GENE"], [275, 280, "GENE"], [42, 47, "GENE"], [50, 55, "GENE"], [166, 171, "GENE"], [172, 177, "GENE"], [184, 189, "GENE"], [275, 280, "GENE"]]}], ["It also appears to suppress pro-survival cellular responses involved in normal lung development.", {"entities": []}], ["We therefore propose SphK1 as a therapeutic target for the development drugs to combat BPD.", {"entities": [[21, 26, "GENE"]]}], ["The online version of this article (doi:10.1186/s12864-017-4048-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Transforming growth factor-beta1 (TGF-\u03b21) is a multipotential cytokine with angiogenic activity.", {"entities": []}], ["There are only limited data about its role in airway remodeling in COPD.", {"entities": []}], ["We have previously shown that the reticular basement membrane (Rbm) is hypervascular in the airways of current smokers either with or without chronic obstructive pulmonary disease (COPD).", {"entities": [[142, 179, "DISEASE"], [63, 66, "GENE"]]}], ["This study evaluated TGF-\u03b21 immunostaining in the Rbm and its relationship to vascularity in smokers with or without COPD.", {"entities": [[50, 53, "GENE"]]}], ["Bronchial biopsies from 15 smokers with normal lung function, 19 current and 14 ex-smokers with COPD were immunostained for TGF-\u03b21 antibody and compared to 17 healthy controls.", {"entities": []}], ["The percentage area of tissue and also number and area of vessels staining positively for TGF-\u03b21 were measured and compared between groups.", {"entities": []}], ["Some bronchial biopsies from current smoking COPD subjects were also stained for phosphorylated (active) Smad2/3.", {"entities": []}], ["Epithelial TGF- \u03b21 staining was not different between COPD current smokers and normal controls.", {"entities": []}], ["TGF-\u03b21 stained vessels in the Rbm were increased in smokers with normal lung function, current smoking COPD and ex-smokers with COPD compared to controls [median (range) for number of vessels/mm Rbm 2.5 (0.0\u201312.7), 3.4 (0.0\u20138.1) and 1.0 (0.0\u20136.3) vs. 0.0 (0.0\u20137.0), p<0.05].", {"entities": [[30, 33, "GENE"], [195, 198, "GENE"], [30, 33, "GENE"], [195, 198, "GENE"]]}], ["Percentage of vessels stained was also increased in these clinical groups.", {"entities": []}], ["Preliminary data suggest that in current smoking COPD subjects endothelial cells and cells in the Rbm stain positively for phosphorylated Smad2/3 suggesting TGF-\u03b21 is functionally active in this situation.", {"entities": [[98, 101, "GENE"]]}], ["Vessel-associated TGF-\u03b21 activity is increased in the bronchial Rbm in smokers and especially those with COPD.", {"entities": [[64, 67, "GENE"]]}], ["Planning human resources for health (HRH) is a complex process for policy-makers and, as a result, many countries worldwide swing from surplus to shortage.", {"entities": []}], ["In-depth case studies can help appraising the challenges encountered and the solutions implemented.", {"entities": []}], ["This paper has two objectives: to identify the key challenges in HRH planning in Belgium and to formulate recommendations for an effective HRH planning, on the basis of the Belgian case study and lessons drawn from an international benchmarking.", {"entities": []}], ["In Belgium, a numerus clausus set up in 1997 and effective in 2004, aims to limit the total number of physicians working in the curative sector.", {"entities": []}], ["The assumption of a positive relationship between physician densities and health care utilization was a major argument in favor of medical supply restrictions.", {"entities": []}], ["This new regulation did not improve recurrent challenges such as specialty imbalances, with uncovered needs particularly among general practitioners, and geographical maldistribution.", {"entities": []}], ["New difficulties also emerged.", {"entities": []}], ["In particular, limiting national training of HRH turned out to be ineffective within the open European workforce market.", {"entities": []}], ["The lack of integration of policies affecting HRH was noteworthy.", {"entities": []}], ["We described in the paper what strategies were developed to address those challenges in Belgium and in neighboring countries.", {"entities": []}], ["Planning the medical workforce involves determining the numbers, mix, and distribution of health providers that will be required at some identified future point in time.", {"entities": []}], ["To succeed in their task, health policy planners have to take a broader perspective on the healthcare system.", {"entities": []}], ["Focusing on numbers is too restrictive and adopting innovative policies learned from benchmarking without integration and coordination is unfruitful.", {"entities": []}], ["Evolving towards a strategic planning is essential to control the effects of the complex factors impacting on human resources.", {"entities": []}], ["This evolution requires an effective monitoring of all key factors affecting supply and demand, a dynamic approach, and a system-level perspective, considering all healthcare professionals, and integrating manpower planning with workforce development.", {"entities": []}], ["To engage in an evidence-based action, policy-makers need a global manpower picture, from their own country and abroad, as well as reliable and comparable manpower databases allowing proper analysis and planning of the workforce.", {"entities": []}], ["Despite controversy regarding homeopathy, some patients consult homeopaths for depression.", {"entities": []}], ["Evidence is required to determine whether this is an effective, acceptable and safe intervention for these patients.", {"entities": []}], ["A pragmatic trial using the \u201ccohort multiple randomised controlled trial\u201d design was used to test the effectiveness of adjunctive treatment by homeopaths compared to usual care alone, over a period of 12\u00a0months in patients with self-reported depression.", {"entities": []}], ["One third of patients were randomly selected for an offer of treatment provided by a homeopath.", {"entities": []}], ["The primary outcome measure was the Patient Health Questionnaire (PHQ-9) at 6\u00a0months.", {"entities": []}], ["Secondary outcomes included depression scores at 12\u00a0months; and the Generalised Anxiety Disorder (GAD-7) outcome at 6 and 12\u00a0months.", {"entities": []}], ["The trial over-recruited by 17% with a total of 566 patients.", {"entities": []}], ["Forty percent took up the offer and received treatment.", {"entities": []}], ["An intention-to-treat analysis of the offer group at 6\u00a0months reported a 1.4-point lower mean depression score than the no offer group (95% CI 0.2, 2.5, p \u2009=\u20090.019), with a small standardized treatment effect size ( d \u2009=\u20090.30).", {"entities": []}], ["Using instrumental variables analysis, a moderate treatment effect size in favour of those treated was found ( d \u2009=\u20090.57) with a between group difference of 2.6 points (95% CI 0.5, 4.7, p \u2009=\u20090.018).", {"entities": []}], ["Results were maintained at 12\u00a0months.", {"entities": []}], ["Secondary analyses showed similar results.", {"entities": []}], ["Similar results were found for anxiety (GAD-7).", {"entities": []}], ["No evidence suggested any important risk involved with the intervention.", {"entities": []}], ["This trial provides preliminary support for both the acceptability and the effectiveness of treatment by a homeopath for patients with self-reported depression.", {"entities": []}], ["Our results provide support for further pragmatic research to provide more precise estimates of treatment effect.", {"entities": []}], ["ISRCTN registry, ISRCTN02484593 .", {"entities": []}], ["Registered on 7 January 2013.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2040-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Heliox, a mixture of helium and oxygen, has a density that is less than that of air.", {"entities": []}], ["Breathing heliox leads to a reduction in resistance to flow within the airways, and consequently to a decrease in the work of breathing (WOB), particularly in disorders that are characterized by increased airways resistance.", {"entities": []}], ["Beneficial effects have been observed in patients with asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis, bronchopulmonary dysplasia and upper airways obstruction.", {"entities": [[63, 100, "DISEASE"], [55, 61, "DISEASE"], [109, 122, "DISEASE"]]}], ["Until we have conclusive data that attest to the efficacy of heliox in such conditions, its use will remain controversial.", {"entities": []}], ["Meanwhile, it appears wise not to incorporate heliox therapy into routine practice because of technical complications and high costs.", {"entities": []}], ["Occupational allergy to rodents among laboratory animal workers is common.", {"entities": []}], ["Most patients generally experience allergic symptoms after the first few years of work.", {"entities": []}], ["Associated symptoms are usually mild, such as rhinoconjunctivits, urticaria, and asthma.", {"entities": [[66, 75, "DISEASE"], [81, 87, "DISEASE"]]}], ["Anaphylaxis, although rare, could be severe and life threatening.", {"entities": []}], ["We have described in this study two cases of laboratory workers that developed skin and respiratory reactions following laboratory rat and mouse bites, consistent with anaphylaxis.", {"entities": []}], ["Skin testing was found positive for rat epithelium in the patient with anaphylaxis due to rat bite.", {"entities": []}], ["Elevated levels of specific IgE antibodies against rat and mouse epitheliums were also detected in both the patients.", {"entities": []}], ["These cases illustrate a severe hypersensitivity reaction that could potentially occur in occupational workers that are in close contact with rodents.", {"entities": []}], ["Reduction of allergen exposure, regular screening, and job modification could be beneficial for affected individuals.", {"entities": []}], ["Health care workers should be made aware that anaphylaxis could be a serious consequence of laboratory animal bites, particularly in those already sensitized.", {"entities": []}], ["Protein Kinase C (PKC) dysfunction is implicated in a variety of smooth muscle disorders including detrusor overactivity associated with frequency and urgency of micturition.", {"entities": []}], ["In this study, we aimed to evaluate the modulatory effects of endogenous PKC-dependent pathways on bladder storage and emptying function.", {"entities": []}], ["We utilized in vivo cystometry and in vitro organ bath studies using isolated bladder muscle strips (BMS) from rats to measure contractility, intravesical pressure, and voided volume.", {"entities": []}], ["Both in vitro and in vivo results were statistically analyzed using one-way repeated measures ANOVA between the groups followed by Bonferroni\u2019s post-test, as appropriate (Systat Software Inc., San Jose, CA).", {"entities": []}], ["Effects of PKC activators, phorbol-12,13-dibutyrate (PDBu), and phorbol-12,13-myristate (PMA), were concentration-dependent, with high concentrations increasing frequency of micturition, and sensitivity of intramural nerves to electrical field stimulation (EFS), in vitro, while lower concentrations had no effect on BMS sensitivity to EFS.", {"entities": [[257, 260, "GENE"], [336, 339, "GENE"], [257, 260, "GENE"], [336, 339, "GENE"]]}], ["The PKC inhibitors, bisindolylmaleimide1 (Bim-1), (28 nM), and Ro318220 (50\u00a0\u03bcM) triggered an increase in the number of non-voiding contractions (NVC), and a decrease in the voided volume associated with reduced ability to maintain contractile force upon EFS, but did not affect peak force in vitro.", {"entities": [[254, 257, "GENE"]]}], ["Both low (50 nM) and high PDBu 1 micromolar (1uM) decreased the sensitivity of BMS to carbachol.", {"entities": []}], ["Application of a low concentration of PDBu inhibited spontaneous contractions, in vitro , and Bim-1-induced NVC, and restored normal voiding frequency during urodynamic recordings in vivo .", {"entities": []}], ["In summary, the effects of low PKC stimulation include inhibition of smooth muscle contractile responses, whereas high levels of PKC stimulation increased nerve-mediated contractions in vitro, and micturition contractions in vivo.", {"entities": []}], ["These results indicate that endogenous PKC signaling displays a concentration-dependent contraction profile in the urinary bladder via both smooth muscle and nerve-mediated pathways.", {"entities": []}], ["Our objective was to investigate the distributions of six single nucleotide polymorphisms (SNPs) MS4A2 E237G , MS4A2 C-109T , ADRB2 R16G , IL4RA I75V , IL4 C-590T , and IL13 C1923T in Mauritian Indian and Chinese Han children with asthma.", {"entities": [[231, 237, "DISEASE"], [97, 102, "GENE"], [111, 116, "GENE"], [97, 102, "GENE"], [111, 116, "GENE"], [126, 131, "GENE"], [152, 155, "GENE"], [169, 173, "GENE"]]}], ["This case-control association study enrolled 382 unrelated Mauritian Indian children, 193 with asthma and 189 healthy controls, and 384 unrelated Chinese Han children, 192 with asthma and 192 healthy controls.", {"entities": [[95, 101, "DISEASE"], [177, 183, "DISEASE"]]}], ["The SNP loci were genotyped using polymerase chain reaction (PCR)-restriction fragment length polymorphism for the Chinese Han samples and TaqMan real-time quantitative PCR for the Mauritian Indian samples.", {"entities": []}], ["In the Mauritian Indian children, there was a significant difference in the distribution of IL13 C1923T between the asthma and control groups (P=0.033).", {"entities": [[116, 122, "DISEASE"], [92, 96, "GENE"]]}], ["The frequency of IL13 C1923T T/T in the Mauritian Indian asthma group was significantly higher than in the control group [odds ratio (OR)=2.119, 95% confidence interval=1.048-4.285].", {"entities": [[57, 63, "DISEASE"], [17, 21, "GENE"]]}], ["The Chinese Han children with asthma had significantly higher frequencies of MS4A2 C-109T T/T (OR=1.961, P=0.001) and ADRB2 R16G A/A (OR=2.575, P=0.000) than the control group.", {"entities": [[30, 36, "DISEASE"], [77, 82, "GENE"], [118, 123, "GENE"]]}], ["The IL13 C1923T locus predisposed to asthma in Mauritian Indian children, which represents an ethnic difference from the Chinese Han population.", {"entities": [[37, 43, "DISEASE"], [4, 8, "GENE"]]}], ["The MS4A2 C-109T T/T and ADRB2 R16G A/A genotypes were associated with asthma in the Chinese Han children.", {"entities": [[71, 77, "DISEASE"], [4, 9, "GENE"], [25, 30, "GENE"]]}], ["The biochemical activity of a stunning diversity of cell types and organ systems is shaped by a 24-hour (circadian) clock.", {"entities": []}], ["This rhythmic drive to a good deal of the transcriptome (up to 15% of all coding genes) imparts circadian modulation over a wide range of physiological and behavioral processes (from cell division to cognition).", {"entities": []}], ["Further, dysregulation of the clock has been implicated in the pathogenesis of a large and diverse array of disorders, such as hypertension, cancer and depression.", {"entities": [[127, 139, "DISEASE"], [141, 147, "DISEASE"]]}], ["Indeed, the possibility of utilizing therapeutic approaches that target clock physiology (that is, chronotherapy) has gained broad interest.", {"entities": []}], ["However, a deeper understanding of the underlying molecular mechanisms that modulate the clock, and give rise to organ-specific clock transcriptomes, will be required to fully realize the power of chronotherapies.", {"entities": []}], ["Recently, microRNAs have emerged as significant players in circadian clock timing, thus raising the possibility that clock-controlled microRNAs could contribute to disorders of the human circadian timing system.", {"entities": []}], ["Here, we highlight recent work revealing a key role for microRNAs in clock physiology, and discuss potential approaches to unlocking their utility as effectors of circadian physiology and pathophysiology.", {"entities": []}], ["Acquired haemophilia A is a rare life- and limb-threatening bleeding disorder if left untreated.", {"entities": []}], ["Autoimmune thyroiditis is an autoimmune disorder that can be rarely associated with acquired haemophilia.", {"entities": [[0, 22, "DISEASE"], [11, 22, "DISEASE"]]}], ["Here we report a case of a 60-year-old woman presenting with cutaneous and muscle haematomas secondary to acquired haemophilia A in association with autoimmune thyroiditis, who was successfully treated with recombinant activated factor VII and immunosuppression.", {"entities": [[149, 171, "DISEASE"], [160, 171, "DISEASE"]]}], ["A 60-year-old Sri Lankan woman with a background of longstanding hypothyroidism, diabetes mellitus, hypertension, hyperlipidaemia and bronchial asthma developed spontaneous cutaneous purpura and a limb-threatening intramuscular haematoma.", {"entities": [[100, 112, "DISEASE"], [65, 79, "DISEASE"], [183, 190, "DISEASE"], [144, 150, "DISEASE"], [81, 98, "DISEASE"]]}], ["Initial coagulation screening revealed prolonged activated partial thromboplastin time of 66.4 seconds (normal range 26 to -36 seconds) and time-dependent inhibitors against factor VIII.", {"entities": []}], ["She had positive antinuclear antibody and antithyroid peroxidase (microsomal) antibody titre of over 1/80 and 1000IU/mL respectively.", {"entities": []}], ["The diagnosis was therefore made of acquired haemophilia A in association with autoimmune thyroiditis.", {"entities": [[79, 101, "DISEASE"], [90, 101, "DISEASE"]]}], ["Acute limb-threatening bleeding was managed with recombinant activated factor VII (NovoSeven Acquired haemophilia should be considered in the differential diagnosis of unexplained bleeding in adults.", {"entities": []}], ["Treatment of the acute coagulopathy with recombinant activated factor VII and immunosuppressive therapy was successful in this case.", {"entities": []}], ["At the present time, the government is considering to establish the independent financing system for essential medicines (EMs).", {"entities": []}], ["However, it is still in the exploration phase.", {"entities": []}], ["The objectives of this study were to calculate and estimate financing amount of EMs in China in 2014 and to provide data evidence for establishing financing mechanism of EMs.", {"entities": []}], ["Two approaches were adopted in this study.", {"entities": []}], ["First, we used a retrospective research to estimate the cost of EMs in China in 2014.", {"entities": []}], ["We identified all the 520 drugs listed in the latest national EMs list (2012) and calculated the total sales amount of these drugs in 2014.", {"entities": []}], ["The other approach included the steps that first selecting the 109 most common diseases in China, then identifying the EMs used to treat them, and finally estimating the total cost of these drugs.", {"entities": []}], ["The results of the two methods, which showed the estimated financing amounts of EMs in China in 2014, were 17,776.44 million USD and 19,094.09 million USD, respectively.", {"entities": []}], ["Comparing these two results, we concluded that the annual budget needed to provide for the EMs in China would be about 20 billion USD.", {"entities": []}], ["Our study also indicated that the irrational drug use continued to plague the health system with intravenous fluids and antibiotics being the typical examples, as observed in other studies.", {"entities": [[67, 73, "DISEASE"]]}], ["Since conflicting results have been published on the role of tobacco smoking on the risk of endometriosis, we provide an up-to-date summary quantification of this potential association.", {"entities": [[92, 105, "DISEASE"]]}], ["We performed a PubMed/MEDLINE search of the relevant publications up to September 2014, considering studies on humans published in English.", {"entities": []}], ["We searched the reference list of the identified papers to find other relevant publications.", {"entities": []}], ["Case\u2013control as well as cohort studies have been included reporting risk estimates on the association between tobacco smoking and endometriosis.", {"entities": [[130, 143, "DISEASE"]]}], ["38 of the 1758 screened papers met the inclusion criteria.", {"entities": []}], ["The selected studies included a total of 13\u2005129 women diagnosed with endometriosis.", {"entities": [[69, 82, "DISEASE"]]}], ["Academic hospitals.", {"entities": []}], ["Risk of endometriosis in tobacco smokers.", {"entities": [[8, 21, "DISEASE"]]}], ["We obtained the summary estimates of the relative risk (RR) using the random effect model, and assessed the heterogeneity among studies using the \u03c7 The present meta-analysis provided no evidence for an association between tobacco smoking and the risk of endometriosis.", {"entities": [[254, 267, "DISEASE"]]}], ["The results were consistent considering ever, former, current, moderate and heavy smokers, and across type of endometriosis and study design.", {"entities": [[110, 123, "DISEASE"]]}], ["Exposure to secondhand smoke increases risk for infant illness and death.", {"entities": []}], ["The objective of this study was to estimate the prevalence of complete smoke-free\u2013home rules (smoking not allowed anywhere in the home) among women with infants in the United States.", {"entities": []}], ["We analyzed 2004\u20132008 data from the Pregnancy Risk Assessment Monitoring System on 41,535 women who had recent live births in 5 states (Arkansas, Maine, New Jersey, Oregon, and Washington).", {"entities": []}], ["We calculated the prevalence of complete smoke-free\u2013home rules and partial or no rules by maternal smoking status, demographic characteristics, delivery year, and state of residence.", {"entities": []}], ["We used adjusted prevalence ratios (APRs) to estimate associations between complete rules and partial or no rules and variables.", {"entities": []}], ["During 2004\u20132008, the overall prevalence of complete rules was 94.6% (95% confidence interval [CI], 94.4\u201394.9), ranging from 85.4% (Arkansas) to 98.1% (Oregon).", {"entities": []}], ["The prevalence of complete rules increased significantly in 3 states from 2004 to 2008.", {"entities": []}], ["It was lowest among women who smoked during pregnancy and postpartum, women younger than 20 years, non-Hispanic black women, women with fewer than 12 years of education, women who had an annual household income of less than $10,000, unmarried women, and women enrolled in Medicaid during pregnancy.", {"entities": []}], ["The prevalence of complete smoke-free\u2013home rules among women with infants was high overall and increased in 3 of 5 states, signifying a public health success.", {"entities": []}], ["Sustained and targeted efforts among groups of women who are least likely to have complete smoke-free\u2013home rules are needed to protect infants from exposure to secondhand smoke.", {"entities": []}], ["Mast cell secretory granules are densely packed with various bioactive mediators including proteases of chymase, tryptase and CPA3 type.", {"entities": [[126, 130, "GENE"]]}], ["Previous studies have indicated that mast cells can affect the outcome of melanoma but the contribution of the mast cell granule proteases to such effects has not been clear.", {"entities": [[74, 82, "DISEASE"]]}], ["Here we addressed this issue by assessing mice lacking either the chymase Mcpt4, the tryptase Mcpt6 or carboxypeptidase A3 (Cpa3), as well as mice simultaneously lacking all three proteases, in a model of melanoma dissemination from blood to the lung.", {"entities": [[205, 213, "DISEASE"], [124, 128, "GENE"]]}], ["Although mice with individual deficiency in the respective proteases did not differ significantly from wildtype mice in the extent of melanoma colonization, mice with multiple protease deficiency (Mcpt4/Mcpt6/Cpa3-deficient) exhibited a higher extent of melanoma colonization in lungs as compared to wildtype animals.", {"entities": [[134, 142, "DISEASE"], [254, 262, "DISEASE"]]}], ["This was supported by higher expression of melanoma-specific genes in lungs of Mcpt4/Mcpt6/CPA3-deficient vs. wildtype mice.", {"entities": [[43, 51, "DISEASE"]]}], ["Cytokine profiling showed that the levels of CXCL16, a chemokine with effects on T cell populations and NKT cells, were significantly lower in lungs of Mcpt4/Mcpt6/Cpa3-deficient animals vs. controls, suggesting that multiple mast cell protease deficiency might affect T cell or NKT cell populations.", {"entities": [[45, 51, "GENE"]]}], ["In line with this, we found that the Mcpt4/Mcpt6/Cpa3-deficiency was associated with a reduction in cells expressing CD1d, a MHC class 1-like molecule that is crucial for presenting antigen to invariant NKT (iNKT) cells.", {"entities": [[117, 121, "GENE"]]}], ["Together, these findings indicate a protective role of mast cell-specific proteases in melanoma dissemination, and suggest that this effect involves a CXCL16/CD1d/NKT cell axis.", {"entities": [[87, 95, "DISEASE"]]}], ["To evaluate the prices and availability of paediatric essential medicines in Shaanxi Province, China.", {"entities": []}], ["Price and availability data for 28 paediatric essential medicines were collected from 60 public hospitals and 60 retail pharmacies in six areas of Shaanxi Province using a standardised methodology developed by the World Health Organization and Health Action International, during November to December 2012.", {"entities": []}], ["Affordability was measured as the number of days\u2019 wages required for the lowest-paid unskilled government worker to purchase standard treatments for common conditions.", {"entities": []}], ["Data on medicine price components were collected from hospitals, wholesalers and distributors to obtain price mark-ups.", {"entities": []}], ["The mean availabilities of originator brands (OBs) and lowest-priced generics (LPGs) were 10.8% and 27.3% in the public hospitals and 11.9% and 20.6% in the private pharmacies.", {"entities": []}], ["The public procurement and retail prices were 2.25 and 2.59 times the international reference prices (IRPs) for three OBs, and 0.52 and 0.93 times for 20 LPGs.", {"entities": []}], ["In the private sector, the final prices for OBs and LPGs were 3.89 and 1.25 times their IRPs.", {"entities": []}], ["The final price in the private sector was 2.7% lower than in the public sector for OBs, and 14.1% higher for LPGs.", {"entities": []}], ["Generally, standard treatments cost less than 1 day\u2019s wages in both sectors.", {"entities": []}], ["Distribution mark-ups applied to brand salbutamol in Xi'an was 65.5%, and up to 185.3% for generic.", {"entities": []}], ["Cumulative mark-ups for LPGs in Ankang were also high, from 33% to 50%.", {"entities": []}], ["The manufacturer\u2019s selling price is the largest contributor to the final price in both areas.", {"entities": []}], ["The government should approve a list of national paediatric essential medicines.", {"entities": []}], ["The availability, price and affordability of these should be improved in both public hospitals and private pharmacies to enable children to obtain effective treatment.", {"entities": []}], ["Measures should be taken to improve the efficiency of the centralised medicine purchasing system.", {"entities": []}], ["Calcium and diacylglycerol are critical second messengers that together effect mast cell degranulation after allergen cross-linking of immunoglobulin (Ig)E-bound Fc\u025bRI.", {"entities": []}], ["Diacylglycerol kinase (DGK)\u03b6 is a negative regulator of diacylglycerol-dependent signaling that acts by converting diacylglycerol to phosphatidic acid.", {"entities": []}], ["We reported previously that DGK\u03b6", {"entities": []}], ["Vibrio metschnikovii is a very rare species and can be fatal to patients with massive comorbidity.", {"entities": []}], ["Until now only eight other cases have been reported.", {"entities": []}], ["This case report describes a 78-year-old Danish man who presented with fever, hypotension and unconsciousness and he developed cardiac arrest.", {"entities": []}], ["Vibrio metschnikovii was identified in all his blood samples and effective antibiotics were initiated.", {"entities": []}], ["The human sources are believed to include shrimps, birds, water, sewage and seafood.", {"entities": []}], ["We report the first case of Vibrio metschnikovii from a Nordic country and the report shows that even though isolation of Vibrio metschnikovii from human clinical samples is very rare, it still infects humans and may be fatal, despite sufficient treatment.", {"entities": []}], ["Receipt of seasonal inactivated trivalent vaccine neither increased nor decreased the risk for pandemic influenza virus infection.", {"entities": [[104, 113, "DISEASE"]]}], ["We conducted a population-based study in Manitoba, Canada, to investigate whether use of inactivated trivalent influenza vaccine (TIV) during the 2008\u201309 influenza season was associated with subsequent infection with influenza A(H1N1)pdm09 virus during the first wave of the 2009 pandemic.", {"entities": [[111, 120, "DISEASE"], [154, 163, "DISEASE"], [217, 226, "DISEASE"]]}], ["Data were obtained from a provincewide population-based immunization registry and laboratory-based influenza surveillance system.", {"entities": [[99, 108, "DISEASE"]]}], ["The test-negative case\u2013control study included 831 case-patients with confirmed influenza A(H1N1)pdm09 virus infection and 2,479 controls, participants with test results negative for influenza A and B viruses.", {"entities": [[79, 88, "DISEASE"], [182, 191, "DISEASE"]]}], ["For the association of TIV receipt with influenza A(H1N1)pdm09 virus infection, the fully adjusted odds ratio was 1.0 (95% CI 0.7\u20131.4).", {"entities": [[40, 49, "DISEASE"]]}], ["Among case-patients, receipt of 2008\u201309 TIV was associated with a statistically nonsignificant 49% reduction in risk for hospitalization.", {"entities": []}], ["In agreement with study findings outside Canada, our study in Manitoba indicates that the 2008\u201309 TIV neither increased nor decreased the risk for infection with influenza A(H1N1)pdm09 virus.", {"entities": [[162, 171, "DISEASE"]]}], ["Wireless implanted devices can be used to interface patients with disabilities with the aim of restoring impaired motor functions.", {"entities": []}], ["Implanted devices that record and transmit electromyographic (EMG) signals have been applied for the control of active prostheses.", {"entities": []}], ["This simulation study investigates the propagation losses and the absorption rate of a wireless radio frequency link for in-to-on body communication in the medical implant communication service (MICS) frequency band to control myoelectric upper limb prostheses.", {"entities": []}], ["The implanted antenna is selected and a suitable external antenna is designed.", {"entities": []}], ["The characterization of both antennas is done by numerical simulations.", {"entities": []}], ["A heterogeneous 3D body model and a 3D electromagnetic solver have been used to model the path loss and to characterize the specific absorption rate (SAR).", {"entities": []}], ["The path loss parameters were extracted and the SAR was characterized, verifying the compliance with the guideline limits.", {"entities": []}], ["The path loss model has been also used for a preliminary link budget analysis to determine the feasibility of such system compliant with the IEEE 802.15.6 standard.", {"entities": []}], ["The resulting link margin of 11 dB confirms the feasibility of the system proposed.", {"entities": []}], ["Atherosclerosis is a chronic inflammatory process of the vessel walls, and CD4 The objective was to add a piece of information on the role of IL-17 in the genesis of atherosclerosis.", {"entities": [[0, 15, "DISEASE"], [166, 181, "DISEASE"], [75, 78, "GENE"]]}], ["Eighty obese patients with normal liver enzyme levels but presenting with ultrasonographic evidence of NAFLD formed the population of this cross-sectional study.", {"entities": []}], ["Anthropometric measures, data on excess adiposity, metabolic profile, serum concentrations of IL-17, eotaxin-3, IL-8, and CCL4/MIP1\u03b2, C-reactive protein, fibrinogen, ferritin, TNF-\u03b1, as well carotid intima-media thickness (IMT), a marker of atherosclerosis, and the main risk factors for CAD, such as blood pressure and smoking status, but also less determinant ones such as degree of NAFLD severity, Intramuscular Triglyceride storage and Resting Metabolic Rate were evaluated.", {"entities": [[241, 256, "DISEASE"]]}], ["Serum concentrations of Il-17 were detected as related to those of inflammatory cytokines, IL-6, IFN-\u03b3 and TNF-\u03b1.", {"entities": []}], ["Furthermore, circulating levels of IL-17 were linked to those mirroring allergic process, IL-8, CCL4/MIP1\u03b2 and eotaxin.", {"entities": []}], ["Early atherosclerosis, evidenced as increased IMT, was not associated with circulating IL-17 levels.", {"entities": [[6, 21, "DISEASE"]]}], ["At multiple regression, IMT was predicted, other than by age, by the amount of the visceral adiposity, expressed as visceral adipose tissue at ultrasonography, and by serum eotaxin.", {"entities": []}], ["In conclusion, a strong relationship was found between the IL-17-related chemokine eotaxin and IMT.", {"entities": []}], ["The association found between the amount of visceral fat and circulating levels of eotaxin on the one hand, and IMT on the other, could reinforce the hypothesis that IL-17, released by the visceral adipose tissue, induces eotaxin secretion via the smooth muscle cells present in the atheromatosus vessels.", {"entities": []}], ["Interleukin (IL)-33 is an IL-1 family alarmin released from damaged epithelial and endothelial barriers to elicit immune responses and allergic inflammation via its receptor ST2.", {"entities": []}], ["Serine proteases released from neutrophils, mast cells and cytotoxic lymphocytes have been proposed to process the N-terminus of IL-33 to enhance its activity.", {"entities": []}], ["Here we report that processing of full length IL-33 can occur in mice deficient in these immune cell protease activities.", {"entities": []}], ["We sought alternative mechanisms for the proteolytic activation of IL-33 and discovered that exogenous allergen proteases and endogenous calpains, from damaged airway epithelial cells, can process full length IL-33 and increase its alarmin activity up to ~60-fold.", {"entities": []}], ["Processed forms of IL-33 of apparent molecular weights ~18, 20, 22 and 23\u2009kDa, were detected in human lungs consistent with some, but not all, proposed processing sites.", {"entities": []}], ["Furthermore, allergen proteases degraded processed forms of IL-33 after cysteine residue oxidation.", {"entities": []}], ["We suggest that IL-33 can sense the proteolytic and oxidative microenvironment during tissue injury that facilitate its rapid activation and inactivation to regulate the duration of its alarmin function.", {"entities": []}], ["The Child Perceptions Questionnaire for children aged 11 to 14 years (CPQ 11\u201314 ) is a 37-item measure of oral-health-related quality of life (OHRQoL) encompassing four domains: oral symptoms, functional limitations, emotional and social well-being.", {"entities": []}], ["To facilitate its use in clinical settings and population-based health surveys, it was shortened to 16 and 8 items.", {"entities": []}], ["Item impact and stepwise regression methods were used to produce each version.", {"entities": []}], ["This paper describes the developmental process, compares the discriminative properties of the resulting four short-forms and evaluates their precision relative to the original CPQ 11\u201314 .", {"entities": []}], ["The item impact method used data from the CPQ 11\u201314 item reduction study to select the questions with the highest impact scores in each domain.", {"entities": []}], ["The regression method, where the dependent variable was the overall CPQ 11\u201314 score and the independent variables its individual questions, was applied to the data collected in the validity study for the CPQ 11\u201314 .", {"entities": []}], ["The measurement properties (i.e.", {"entities": []}], ["criterion validity, construct validity, internal consistency reliability and test-retest reliability) of all 4 short-forms were evaluated using the data from the validity and reliability studies for the CPQ 11\u201314 .", {"entities": []}], ["All short forms detected substantial variability in children's OHRQoL.", {"entities": []}], ["The mean scores on the two 16-item questionnaires were almost identical, while on the two 8-item questionnaires they differed by only one score point.", {"entities": []}], ["The mean scores standardized to 0\u2013100 were higher on the short forms than the original CPQ 11\u201314 (p < 0.001).", {"entities": []}], ["There were strong significant correlations between all short-form scores and CPQ 11\u201314 scores (0.87\u20130.98; p < 0.001).", {"entities": []}], ["Hypotheses concerning construct validity were confirmed: the short-forms' scores were highest in the oro-facial, lower in the orthodontic and lowest in the paediatric dentistry group; all short-form questionnaires were positively correlated with the ratings of oral health and overall well-being, with the correlation coefficient being higher for the latter.", {"entities": []}], ["The relative validity coefficients were 0.85 to 1.18.", {"entities": []}], ["Cronbach's alpha and intraclass correlation coefficients ranged 0.71\u20130.83 and 0.71\u20130.77, respectively.", {"entities": []}], ["All short forms demonstrated excellent criterion validity and good construct validity.", {"entities": []}], ["The reliability coefficients exceeded standards for group-level comparisons.", {"entities": []}], ["However, these are preliminary findings based on the convenience sampling and further testing in replicated studies involving clinical and general samples of children in various settings is necessary to establish measurement sensitivity and discriminative properties of these questionnaires.", {"entities": []}], ["The role of natural CD4", {"entities": [[20, 23, "GENE"]]}], ["Aspergillus fumigatus conidia can exacerbate asthma symptoms.", {"entities": [[45, 51, "DISEASE"]]}], ["Phagocytosis of conidia is a principal component of the host antifungal defense.", {"entities": []}], ["We investigated whether allergic airway inflammation (AAI) affects the ability of phagocytic cells in the airways to internalize the resting fungal spores.", {"entities": []}], ["Using BALB/c mice with experimentally induced AAI, we tested the ability of neutrophils, macrophages, and dendritic cells to internalize A. fumigatus conidia at various anatomical locations.", {"entities": []}], ["We used light microscopy and differential cell and conidium counts to determine the ingestion potential of neutrophils and macrophages present in bronchoalveolar lavage (BAL).", {"entities": []}], ["To identify phagocyte-conidia interactions in conducting airways, conidia labeled with tetramethylrhodamine-(5-(and-6))-isothiocyanate were administered to the oropharyngeal cavity of mice.", {"entities": []}], ["Confocal microscopy was used to quantify the ingestion potential of Ly-6G Allergen challenge induced transient neutrophil recruitment to the airways.", {"entities": []}], ["Application of A. fumigatus conidia at the acute phase of AAI provoked recurrent neutrophil infiltration, and consequently increased the number and the ingestion potential of the airway neutrophils.", {"entities": []}], ["In the absence of recurrent allergen or conidia provocation, both the ingestion potential and the number of BAL neutrophils decreased.", {"entities": []}], ["As a result, conidia were primarily internalized by alveolar macrophages in both AAI and control mice at 24 hours post-inhalation.", {"entities": []}], ["Transient influx of neutrophils to conducting airways shortly after conidial application was observed in mice with AAI.", {"entities": []}], ["In addition, the ingestion potential of conducting airway neutrophils in mice with induced asthma exceeded that of control mice.", {"entities": [[91, 97, "DISEASE"]]}], ["Although the number of neutrophils subsequently decreased, the ingestion capacity remained elevated in AAI mice, even at 24 hours post-conidia application.", {"entities": []}], ["Aspiration of allergen to sensitized mice enhanced the ingestion potential of conducting airway neutrophils.", {"entities": []}], ["Such activation primes neutrophils so that they are sufficient to control dissemination of non-germinating A. fumigatus conidia.", {"entities": []}], ["At the same time, it can be a reason for the development of sensitivity to fungi and subsequent asthma exacerbation.", {"entities": [[96, 102, "DISEASE"]]}], ["Sepsis, the syndrome of microbial infection complicated by systemic inflammation, is associated with significant morbidity and mortality.", {"entities": [[12, 20, "DISEASE"]]}], ["We sought to determine if obesity increases risk of sepsis events.", {"entities": [[26, 33, "DISEASE"]]}], ["We used data from the 30,239 subject population-based longitudinal cohort study RE asons for G eographic a nd R acial D ifferences in S troke (REGARDS).", {"entities": []}], ["Using measurements at the start of the study, we defined obesity using body mass index (BMI; <18.5 kg/m There were 975 incident sepsis events.", {"entities": [[57, 64, "DISEASE"]]}], ["Compared to those with a BMI of 18.5\u201324.9, sepsis risk was higher only for BMI \u226540 (HR 1.57, (1.16\u20132.14)).", {"entities": [[84, 86, "GENE"]]}], ["Risk of sepsis was associated with increased WC (HR 1.34 (1.14\u20131.56)).", {"entities": [[49, 51, "GENE"]]}], ["In a model with both BMI and WC, sepsis risk was associated with increased WC (HR 1.47 (1.20\u20131.79)) but not BMI.", {"entities": [[79, 81, "GENE"]]}], ["Obesity is independently associated with future sepsis events.", {"entities": [[0, 7, "DISEASE"]]}], ["WC is a better predictor of future sepsis risk than BMI.", {"entities": []}], ["Health status provides valuable information, complementary to spirometry and improvement of health status has become an important treatment goal in COPD management.", {"entities": []}], ["We compared the usefulness and validity of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ), two simple questionnaires, in comparison with the St. George Respiratory Questionnaire (SGRQ).", {"entities": []}], ["We administered the CAT, CCQ and SGRQ in patients with COPD stage I-IV during three visits.", {"entities": []}], ["Spirometry, 6 MWT, MRC scale, BODE index, and patients perspectives on questionnaires were recorded in all visits.", {"entities": []}], ["Standard Error of Measurement (SEM) was used to calculate the Minimal Clinical Important Difference (MCID) of all questionnaires.", {"entities": []}], ["We enrolled 90 COPD patients.", {"entities": []}], ["Cronbach's alpha for both CAT and CCQ was high (0.86 and 0.89, respectively).", {"entities": []}], ["Patients with severe COPD reported worse health status compared to milder subgroups.", {"entities": []}], ["CAT and CCQ correlated significantly (rho =0.64, p\u2009<\u20090.01) and both with the SGRQ (rho\u2009=\u20090.65; CAT and rho\u2009=\u20090.77; CCQ, p\u2009<\u20090.01).", {"entities": []}], ["Both questionnaires exhibited a weak correlation with lung function (rho\u2009=\u2009\u22120.35;CAT and rho\u2009=\u2009\u22120.41; CCQ, p\u2009<\u20090.01).", {"entities": []}], ["Their reproducibility was high; CAT: ICC\u2009=\u20090.94 (CI 0.92-0.96), total CCQ ICC\u2009=\u20090.95 (0.92-0.96) and SGRQ\u2009=\u20090.97 (CI 0.95-0.98).", {"entities": []}], ["The MCID calculated using the SEM method showed results similar to previous studies of 3.76 for the CAT, 0.41 for the CCQ and 4.84 for SGRQ.", {"entities": []}], ["Patients suggested both CAT and CCQ as easier tools than SGRQ in terms of complexity and time considerations.", {"entities": []}], ["More than half of patients preferred CCQ instead of CAT.", {"entities": []}], ["The CAT and CCQ have similar psychometric properties with a slight advantage for CCQ based mainly on patients\u2019 preference and are both valid and reliable questionnaires to assess health status in COPD patients.", {"entities": []}], ["Several phytoceuticals and extracts of medicinal plants are reported to mitigate deleterious effects of ionizing radiation.", {"entities": []}], ["The potential of hydro-alcoholic extract of Clerodendron infortunatum (CIE) for providing protection to mice exposed to gamma radiation was investigated.", {"entities": []}], ["Oral administration of CIE bestowed a survival advantage to mice exposed to lethal doses of gamma radiation.", {"entities": []}], ["Radiation-induced depletion of the total blood count and bone marrow cellularity were prevented by treatment with CIE. Damage to the cellular DNA (as was evident from the comet assay and the micronucleus index) was also found to be decreased upon CIE administration.", {"entities": []}], ["Radiation-induced damages to intestinal crypt cells was also reduced by CIE. Studies on gene expression in intestinal cells revealed that there was a marked increase in the Bax/Bcl-2 ratio in mice exposed to whole-body 4\u00a0Gy gamma radiation, and that administration of CIE resulted in significant lowering of this ratio, suggestive of reduction of radiation-induced apoptosis.", {"entities": []}], ["Also, in the intestinal tissue of irradiated animals, following CIE treatment, levels of expression of the DNA repair gene Atm were found to be elevated, and there was reduction in the expression of the inflammatory Cox-2 gene.", {"entities": [[123, 126, "GENE"]]}], ["Thus, our results suggest a beneficial use of Clerodendron infortunatum for mitigating radiation toxicity.", {"entities": []}], ["Background Errors in discharge prescriptions are problematic.", {"entities": []}], ["When hospital pharmacists write discharge prescriptions improvements are seen in the quality and efficiency of discharge.", {"entities": []}], ["There is limited information on the incidence of errors in pharmacists\u2019 medication orders.", {"entities": []}], ["Objective To investigate the extent and clinical significance of errors in pharmacist-written discharge medication orders.", {"entities": []}], ["Setting 1000-bed teaching hospital in London, UK.", {"entities": []}], ["Method Pharmacists in this London hospital routinely write discharge medication orders as part of the clinical pharmacy service.", {"entities": []}], ["Convenient days, based on researcher availability, between October 2013 and January 2014 were selected.", {"entities": []}], ["Pre-registration pharmacists reviewed all discharge medication orders written by pharmacists on these days and identified discrepancies between the medication history, inpatient chart, patient records and discharge summary.", {"entities": []}], ["A senior clinical pharmacist confirmed the presence of an error.", {"entities": []}], ["Each error was assigned a potential clinical significance rating (based on the NCCMERP scale) by a physician and an independent senior clinical pharmacist, working separately.", {"entities": []}], ["Main outcome measure Incidence of errors in pharmacist-written discharge medication orders.", {"entities": []}], ["Results 509 prescriptions, written by 51 pharmacists, containing 4258 discharge medication orders were assessed (8.4 orders per prescription).", {"entities": []}], ["Ten prescriptions (2%), contained a total of ten erroneous orders (order error rate\u20140.2%).", {"entities": []}], ["The pharmacist considered that one error had the potential to cause temporary harm (0.02% of all orders).", {"entities": []}], ["The physician did not rate any of the errors with the potential to cause harm.", {"entities": []}], ["Conclusion The incidence of errors in pharmacists\u2019 discharge medication orders was low.", {"entities": []}], ["The quality, safety and policy implications of pharmacists routinely writing discharge medication orders should be further explored.", {"entities": []}], ["Utilizing data from the Continuing to Confront COPD (chronic obstructive pulmonary disease) International Physician Survey, this study aimed to describe physicians\u2019 knowledge and application of the GOLD (Global initiative for chronic Obstructive Lung Disease) Global Strategy for the Diagnosis, Management and Prevention of COPD diagnosis and treatment recommendations and compare performance between primary care physicians (PCPs) and respiratory specialists.", {"entities": [[53, 90, "DISEASE"]]}], ["Physicians from 12 countries were sampled from in-country professional databases; 1,307 physicians (PCP to respiratory specialist ratio three to one) who regularly consult with COPD, emphysema, or chronic bronchitis patients were interviewed online, by telephone or face to face.", {"entities": [[205, 215, "DISEASE"]]}], ["Physicians were questioned about COPD risk factors, prognosis, diagnosis, and treatment, including knowledge and application of the GOLD global strategy using patient scenarios.", {"entities": []}], ["Physicians reported using spirometry routinely (PCPs 82%, respiratory specialists 100%; P <0.001) to diagnose COPD and frequently included validated patient-reported outcome measures (PCPs 67%, respiratory specialists 81%; P <0.001).", {"entities": []}], ["Respiratory specialists were more likely than PCPs to report awareness of the GOLD global strategy (93% versus 58%, P <0.001); however, when presented with patient scenarios, they did not always perform better than PCPs with regard to recommending GOLD-concordant treatment options.", {"entities": []}], ["The proportion of PCPs and respiratory specialists providing first- or second-choice treatment options concordant with GOLD strategy for a GOLD B-type patient was 38% versus 67%, respectively.", {"entities": []}], ["For GOLD C and D-type patients, the concordant proportions for PCPs and respiratory specialists were 40% versus 38%, and 57% versus 58%, respectively.", {"entities": []}], ["This survey of physicians in 12 countries practicing in the primary care and respiratory specialty settings showed high awareness of COPD-management guidelines.", {"entities": []}], ["Frequent use of guideline-recommended COPD diagnostic practices was reported; however, gaps in the application of COPD-treatment recommendations were observed, warranting further evaluation to understand potential barriers to adopt guideline recommendations.", {"entities": []}], ["To generate an item list for the assessment of joint awareness in shoulder patients and to collect patient feedback on the comprehensibility of the items and the forgotten joint concept.", {"entities": []}], ["Item content was generated on the basis of literature search and expert ratings following a stepwise refinement procedure, including final evaluation by an international expert board (n\u2009=\u200912) including members with various professional backgrounds.", {"entities": []}], ["Items were translated from English to German and evaluated in 30 German-speaking shoulder patients in Switzerland and 30 shoulder patients in the UK.", {"entities": []}], ["Literature search identified 45 questionnaires covering 805 issues potentially relevant for the assessment of joint awareness.", {"entities": []}], ["Stepwise item selection resulted in 97 items to be evaluated by the international expert board leaving 70 items for collecting patient feedback.", {"entities": []}], ["The majority of patients indicated that the introductory text explaining the forgotten joint concept was easy or very easy to understand (79.3%) and that the items were clear (91.4%).", {"entities": []}], ["We developed a list of 70 questions for the assessment of joint awareness in shoulder patients and obtained positive patient feedback for these.", {"entities": []}], ["In a next step, we will administer the items to a large international patient sample to obtain data for psychometric analysis and development of a measurement model, which is the basis for creation of computer-adaptive assessments or static short-forms.", {"entities": []}], ["Understanding the predictors of a quick death following diagnosis may improve timely access to palliative care.", {"entities": []}], ["The objective of this study was to explore whether factors in the 24\u00a0months prior to a colorectal cancer (CRC) diagnosis predict a quick death post-diagnosis.", {"entities": [[87, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["Data were from a longitudinal study of all adult persons diagnosed with CRC in Nova Scotia, Canada, from 01Jan2001-31Dec2005.", {"entities": []}], ["This study included all persons who died of any cause by 31Dec2010, except those who died within 30\u00a0days of CRC surgery (n\u2009=\u20091885 decedents).", {"entities": []}], ["Classification and regression tree models were used to explore predictors of time from diagnosis to death for the following time intervals: 2, 4, 6, 8, 12, and 26\u00a0weeks from diagnosis to death.", {"entities": []}], ["All models were performed with and without stage at diagnosis as a predictor variable.", {"entities": []}], ["Clinico-demographic and health service utilization data in the 24\u00a0months pre-diagnosis were provided via linked administrative databases.", {"entities": []}], ["The strongest, most consistent predictors of dying within 2, 4, 6, and 8\u00a0weeks of CRC diagnosis were related to health services utilization in the 24\u00a0months prior to diagnosis: i.e., number of specialist visits, number of days spent in hospital, and number of family physician visits.", {"entities": []}], ["Stage at diagnosis was the strongest predictor of dying within 12 and 26\u00a0weeks of diagnosis.", {"entities": []}], ["Identifying potential predictors of a short timeframe between cancer diagnosis and death may aid in the development of strategies to facilitate timely and appropriate referral to palliative care upon a cancer diagnosis.", {"entities": [[62, 68, "DISEASE"], [202, 208, "DISEASE"]]}], ["Techniques for measuring acid aerosols in the ambient environment have been developed only recently.", {"entities": []}], ["As part of the on-going Harvard Study on the Health Effects of Sulfur Dioxide and Respirable Particulates, we have developed monitoring equipment for acidic particles that can be used in multiple field settings.", {"entities": []}], ["Preliminary data suggest that these strong acid aerosol measurements may correlate with respiratory symptoms more closely than similar measurements of particulate matter less than 15 microns in size.", {"entities": []}], ["These results have led to the beginning of a U.S.-Canadian cooperative study to assess the chronic effects of acid aerosols on the health of North American children.", {"entities": []}], ["Communities are being selected on the basis of anticipated levels of H2SO4 in ambient air along with predicted levels of ozone and nitrates.", {"entities": []}], ["Each community will undergo a 1-year period of every other day, 24-hr monitoring with newly developed monitoring equipment that will allow for quantification of H+ ion concentrations, as well as for specific measures of ozone and acid fractions.", {"entities": []}], ["At the end of the 1-year period, while measurements are still being made, approximately 600 children aged 7 to 11 in each of up to 24 communities will be assessed with standardized questionnaires completed by parents, and pulmonary function will be measured in the children while in school.", {"entities": []}], ["By estimating chronic exposure from the year-long measurement of acid aerosols and consideration of specific criteria for selecting communities to study, we hope to minimize potential confounding to allow us to assess the chronic impact of strong acid in the atmosphere on the respiratory health of these children.", {"entities": []}], ["Therapeutic strategies exist for human pulmonary neoplasia, however due to the heterogeneity of the disease, most are not very effective.", {"entities": []}], ["The innate immunity gene, toll-like receptor 4 (TLR4), protects against chronic pulmonary inflammation and tumorigenesis in mice, but the mechanism is unclear.", {"entities": [[48, 52, "GENE"]]}], ["This study was designed to identify TLR4-mediated gene expression pathways that may be used as prognostic indicators of susceptibility to lung tumorigenesis in mice and provide insight into the mechanism.", {"entities": []}], ["Whole lung mRNA was isolated from C.C3H- Tlr4 Tlr4 mutant) and BALB/c ( Tlr4 normal) mice following butylated hydroxytoluene (BHT)-treatment (four weekly ip.", {"entities": [[41, 45, "GENE"], [46, 50, "GENE"], [72, 76, "GENE"], [41, 45, "GENE"], [46, 50, "GENE"], [72, 76, "GENE"], [41, 45, "GENE"], [46, 50, "GENE"], [72, 76, "GENE"]]}], ["injections; 150-200 mg/kg/each; \"promotion\").", {"entities": []}], ["mRNA from micro-dissected tumors (adenomas) and adjacent uninvolved tissue from both strains were also compared 27 wks after a single carcinogen injection (3-methylcholanthrene (MCA), 10 \u03bcg/g; \"control\") or followed by BHT (6 weekly ip.", {"entities": []}], ["injections; 125-200 mg/kg/each; \"progression\").", {"entities": []}], ["Bronchoalveolar lavage fluid was analyzed for inflammatory cell content and total protein determination, a marker of lung hyperpermeability; inflammation was also assessed using immunohistochemical staining for macrophages (F4/80) and lymphocytes (CD3) in mice bearing tumors (progression).", {"entities": []}], ["During promotion, the majority of genes identified in the BALB Ereg )), secreted phosphoprotein 1( Spp1 )), which can lead to cell growth and eventual tumor development.", {"entities": [[63, 67, "GENE"], [99, 103, "GENE"]]}], ["Inflammation was significantly higher in BALB Ereg , Spp1 ) were also observed during progression in addition to continued inflammation, chemotactic, and immune response gene expression in the BALB P < 0.05), which appears to provide more favorable conditions for cell growth and tumor development.", {"entities": [[46, 50, "GENE"], [53, 57, "GENE"]]}], ["In support of these findings, the BALB/c mice also had significantly reduced expression of many immune response and inflammatory genes in both the tumors and uninvolved tissue.", {"entities": []}], ["This transcriptomic study determined the protective effect of TLR4 in lung carcinogenesis inhibition of multiple pathways including EGFR (e.g.", {"entities": [[62, 66, "GENE"], [132, 136, "GENE"]]}], ["Ereg ), inflammatory response genes (e.g.", {"entities": [[0, 4, "GENE"]]}], ["Cxcl5) , chemotaxis (e.g.", {"entities": [[0, 5, "GENE"]]}], ["Ccr1 ) and other cell proliferation genes (e.g.", {"entities": [[0, 4, "GENE"]]}], ["Arg1 , Pthlh ).", {"entities": [[0, 4, "GENE"], [7, 12, "GENE"]]}], ["Future studies will determine the utility of these pathways as indicators of immune system deficiencies and tumorigenesis.", {"entities": []}], ["We compared the effect of intramuscular vs. inhaled 23-valent pneumococcal capsular polysaccharide vaccine (23-PPV) on pulmonary mucosal immunoglobulin levels.", {"entities": []}], ["Bronchoalveolar lavage (BAL) and serum were collected from 33 adults before and 1 month after injected ( n \u00a0=\u00a016) or inhaled ( n \u00a0=\u00a017) 23-PPV.", {"entities": []}], ["Levels of pneumococcal capsule-specific IgG and IgA to types 1, 9V and 14 were measured in each sample.", {"entities": []}], ["Injected 23-PPV produced a significant increase in types 1, 9V and 14 capsule-specific IgG and type 1 IgA in both serum and BAL (type 1 geometric mean BAL IgG 9.8\u00a0ng/ml post-vaccine vs. 5\u00a0ng/ml pre-vaccine, p \u00a0=\u00a00.01; type 9V geo mean 5.6\u00a0ng/ml vs. 2.7\u00a0ng/ml, p \u00a0=\u00a00.001; type 14 geo mean 23.6\u00a0ng/ml vs. 6.2\u00a0ng/ml, p \u00a0=\u00a00.02).", {"entities": []}], ["Inhaled vaccine produced no response in either BAL or serum.", {"entities": []}], ["In this paper, we report a new type of electrospinning collector that allows simultaneous collection and alignment of multiple poly(vinylidene fluoride-trifluoroethylene) piezoelectric fiber bundles with a controlled separation.", {"entities": []}], ["The key enabling feature is the serrated teeth along the edges across an inclined gap as a part of the conductive collector.", {"entities": []}], ["As a result, the electrical field across the gap is shaped to direct the electrospun fibers to merge into multiple bundles.", {"entities": []}], ["The sharp points on the serrated teeth provide favorable charge dissipation points and thus fibers are preferentially formed bridging two closest sharp points across the gap.", {"entities": []}], ["To investigate the effectiveness of serrated teeth on the formation of multiple fiber bundles, three-dimensional finite element simulations are conducted.", {"entities": []}], ["The corresponding collectors are implemented to experimentally study the resulting electrospun fibers.", {"entities": []}], ["Both simulation and experimental results suggest that multiple fiber bundles can be formed under the condition of a low teeth pitch to gap distance ratio.", {"entities": []}], ["Furthermore, a sharper tooth angle results in a higher preferential formation of fiber bundles.", {"entities": []}], ["Finally, the total electrospinning time should be less than 60\u2009seconds to maintain favorable electric field profile.", {"entities": []}], ["We also demonstrate that these piezoelectric fiber bundles can serve as ultra-flexible textile sensors.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is set to become the third most frequent cause of death and also the third largest cause of global morbidity by 2020.", {"entities": []}], ["In China, where the population is aging rapidly, COPD has become one of the leading causes of disability and a large economic burden.", {"entities": []}], ["An epidemiological assessment of the COPD in China is required, with a focus on the number of cases living with disease, main determinants of the disease and time trends.", {"entities": []}], ["We systematically searched large Chinese bibliographic databases and English databases to identify spirometry\u2013based epidemiological studies of the prevalence of COPD in China diagnosed according to GOLD criteria.", {"entities": []}], ["We estimated age\u2013 and gender\u2013specific prevalence of COPD using a multilevel mixed\u2013effect logistic regression.", {"entities": []}], ["We also presented the time trends of COPD between 1990 and 2010 by age, gender and setting (urban vs rural).", {"entities": []}], ["In 1990, the prevalence of COPD ranged from 0.49% (95% CI\u2009=\u20090.29\u20130.85) in <20 years group to 20.95% (95% CI\u2009=\u200914.04\u201327.04) in>\u2009=\u200980 years group, and the crude prevalence for China was 2.70% (95% CI\u2009=\u20091.86\u20133.51).", {"entities": []}], ["In 2010, the prevalence in <20 years was 0.55% (95% CI\u2009=\u20090.37\u20131.04) and in>\u2009=\u200980 years was 22.89% (95% CI\u2009=\u200918.13\u201328.96), with the crude prevalence for China of 3.84% (95% CI\u2009=\u20093.30\u20134.77).", {"entities": []}], ["The COPD prevalence in males was about two\u2013fold higher than in females, and it increased with increasing age.", {"entities": []}], ["Between 1990\u20132010, the total number of Chinese people living with COPD increased by 66.73%, from 30.90 million (95% CI\u2009=\u200921.28\u201340.02) in 1990 to 51.52 million (95% CI\u2009=\u200944.26\u201363.93) in 2010.", {"entities": []}], ["This increase was most striking in middle age, and greater in females than in males from 30 years up to 64 years.", {"entities": []}], ["Our estimates, which used an independent approach to acquiring data and development of analytical methods, and were based on a more complete data set, are remarkably similar to those produced recently by the GBD 2013 collaboration, differing by only about 5% in the estimated number of COPD cases in 1990 and by 1% in 2010.", {"entities": []}], ["COPD is a highly prevalent disease in China and its importance is growing steadily.", {"entities": []}], ["The number of people living with COPD has increased substantially between 1990 and 2010.", {"entities": []}], ["COPD is more frequent in males and in rural areas.", {"entities": []}], ["Optimised primary and secondary prevention and treatment is urgently needed to counter this growing trend.", {"entities": []}], ["Improved epidemiological studies will be required to assist development of more effective strategies of prevention and treatment of COPD in China in the next decade and beyond.", {"entities": []}], ["Chronic, non-healing wounds are a major complication of diabetes and are characterized by chronic inflammation and excessive protease activity.", {"entities": []}], ["Although once thought to function primarily as a pro-apoptotic serine protease, granzyme B (GzmB) can also accumulate in the extracellular matrix (ECM) during chronic inflammation and cleave ECM proteins that are essential for proper wound healing, including fibronectin.", {"entities": [[92, 96, "GENE"]]}], ["We hypothesized that GzmB contributes to the pathogenesis of impaired diabetic wound healing through excessive ECM degradation.", {"entities": [[21, 25, "GENE"]]}], ["In the present study, the murine serine protease inhibitor, serpina3n (SA3N), was administered to excisional wounds created on the dorsum of genetically induced type-II diabetic mice.", {"entities": []}], ["Wound closure was monitored and skin wound samples were collected for analyses.", {"entities": []}], ["Wound closure, including both re-epithelialization and contraction, were significantly increased in SA3N-treated wounds.", {"entities": []}], ["Histological and immunohistochemical analyses of SA3N-treated wounds revealed a more mature, proliferative granulation tissue phenotype as indicated by increased cell proliferation, vascularization, fibroblast maturation and differentiation, and collagen deposition.", {"entities": []}], ["Skin homogenates from SA3N-treated wounds also exhibited greater levels of full-length intact fibronectin compared with that of vehicle wounds.", {"entities": []}], ["In addition, GzmB-induced detachment of mouse embryonic fibroblasts correlated with a rounded and clustered phenotype that was prevented by SA3N.", {"entities": []}], ["In summary, topical administration of SA3N accelerated wound healing.", {"entities": []}], ["Our findings suggest that GzmB contributes to the pathogenesis of diabetic wound healing through the proteolytic cleavage of fibronectin that is essential for normal wound closure, and that SA3N promotes granulation tissue maturation and collagen deposition.", {"entities": [[26, 30, "GENE"]]}], ["Despite a greater burden of risk factors, atrial fibrillation (AF) is less common among African Americans than European-descent populations.", {"entities": []}], ["Genome-wide association studies (GWAS) for AF in European-descent populations have identified three predominant genomic regions associated with increased risk (1q21, 4q25, and 16q22).", {"entities": []}], ["The contribution of these loci to AF risk in African American is unknown.", {"entities": []}], ["We studied 73 African Americans with AF from the Vanderbilt-Meharry AF registry and 71 African American controls, with no history of AF including after cardiac surgery.", {"entities": []}], ["Tests of association were performed for 148 SNPs across the three regions associated with AF, and 22 SNPs were significantly associated with AF (P<0.05).", {"entities": []}], ["The SNPs with the strongest associations in African Americans were both different from the index SNPs identified in European-descent populations and independent from the index European-descent population SNPs (r Variable European admixture at known AF loci does not explain decreased AF susceptibility in African Americans.", {"entities": []}], ["These data support the role of 1q21, 4q25, and 16q22 variants in AF risk for African Americans, although the index SNPs differ from those identified in European-descent populations.", {"entities": []}], ["Last October, the 7th meeting of the Global Arthritis Research Network was held in Zurich, Switzerland.", {"entities": [[44, 53, "DISEASE"]]}], ["European and American experts who have made major recent contributions to molecular biology got together to provide insights into novel technologies and approaches useful for biomedical research, especially for research on arthritis and related conditions.", {"entities": [[223, 232, "DISEASE"]]}], ["Asthma is an inflammatory disease and interleukin 12 (IL-12) may play a regulatory role in allergen-induced inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["The aim of this study was to investigate the association of polymorphisms in IL-12A/IL-12B with asthma.", {"entities": [[96, 102, "DISEASE"]]}], ["The asthma group included 198 adult patients and the control group included 453 individuals without asthma that were frequency-matched by gender and age.", {"entities": [[4, 10, "DISEASE"], [100, 106, "DISEASE"]]}], ["The distribution of genotypic and allelic frequencies of IL-12A rs568408 demonstrated significant differences between case and control groups.", {"entities": []}], ["Specifically, the percentages of AA genotype of IL-12A rs568408 was significantly higher among asthmatic patients in Taiwan than healthy controls, compared to GG genotype.", {"entities": []}], ["No significant difference was observed among the IL-12A rs2243115 and IL-12B rs3212227 genotypes between case and control groups.", {"entities": []}], ["In addition, the A allele at IL-12A rs568408 was associated with more severe symptoms ( P \u2009=\u20090.0085) among asthmatic patients.", {"entities": []}], ["These results suggest that IL-12A rs568408 may contribute to the etiology and symptoms severity of asthma, indicating its usefulness as a predictive and diagnostic biomarker of asthma.", {"entities": [[99, 105, "DISEASE"], [177, 183, "DISEASE"]]}], ["The occurrence of allergic multimorbidity (coexistence of asthma, allergic rhinitis and eczema) has not been evaluated longitudinally from early childhood up to adulthood in a population\u2010based study sample.", {"entities": [[66, 83, "DISEASE"], [75, 83, "DISEASE"], [58, 64, "DISEASE"]]}], ["We aimed to determine the prevalence of allergic multimorbidity up to age 20 stratified by parental allergies and sex/gender using extensive prospective follow\u2010up data from two decades of a birth cohort study.", {"entities": []}], ["In 1990, we recruited 1314 healthy newborns from 6 maternity wards across Germany for the population\u2010based MAS birth cohort study.", {"entities": []}], ["The sample was purposely risk\u2010enriched by increasing the proportion of children at high allergy risk (i.e.", {"entities": []}], ["at least 2 allergic family members among parents and siblings) from 19% in the source population to 38% in the final sample.", {"entities": []}], ["The remaining 62% of all MAS children had a low or no allergy risk.", {"entities": []}], ["Symptoms, medication and doctor's diagnoses of allergic diseases have been assessed using standardized questionnaires including validated ISAAC questions in 19 follow\u2010up assessments up to age 20.", {"entities": []}], ["Allergic multimorbidity at each time point was defined as the coexistence of at least 2 of the following diseases in one participant: asthma, allergic rhinitis and eczema.", {"entities": [[142, 159, "DISEASE"], [151, 159, "DISEASE"], [134, 140, "DISEASE"]]}], ["Response at age 20 was 72% (n\u00a0=\u00a0942) of all recruited participants.", {"entities": []}], ["At age 20, 18.5% (95% CI , 15.0\u201322.5%) of all participants with allergic parents had 2 or 3 concurrent allergies as compared to only 6.3% (95% CI , 4.3\u20139.0%) of those with non\u2010allergic parents.", {"entities": []}], ["At this age, allergic multimorbidity was similar in women and men (12.7% (95% CI , 9.7\u201316.2%) vs. 11.6% (95% CI , 8.9\u201314.8%)), whereas single allergic diseases were slightly more common in women than men (24.2% (95% CI , 20.2\u201328.5%) vs. 20.1% (95% CI , 16.6\u201324.0%)).", {"entities": []}], ["Asthma occurred more frequently with coexisting allergic rhinitis and/or eczema than as a single entity from pre\u2010puberty to adulthood.", {"entities": [[48, 65, "DISEASE"], [57, 65, "DISEASE"], [0, 6, "DISEASE"]]}], ["Having parents with allergies is not only a strong predictor to develop any allergy, but it strongly increases the risk of developing allergic multimorbidity.", {"entities": []}], ["In males and females alike, coexisting allergies were increasingly common throughout adolescence up to adulthood.", {"entities": []}], ["Particularly asthma occurred in both sexes more frequently with coexisting allergies than as a single entity.", {"entities": [[13, 19, "DISEASE"]]}], ["We isolated Bordetella holmesii, generally associated with septicemia in patients with underlying conditions, from nasopharyngeal specimens of otherwise healthy young persons with a cough.", {"entities": []}], ["The proportion of B. holmesii-positive specimens submitted to the Massachusetts State Laboratory Institute increased from 1995 to 1998.", {"entities": []}], ["Lung diseases remain a serious problem for public health.", {"entities": []}], ["The immune status of the body is considered to be the main influencing factor for the progression of lung diseases.", {"entities": []}], ["HMGB1 (high\u2010mobility group box 1) emerges as an important molecule of the body immune network.", {"entities": [[0, 5, "GENE"]]}], ["Accumulating data have demonstrated that HMGB1 is crucially implicated in lung diseases and acts as independent biomarker and therapeutic target for related lung diseases.", {"entities": [[41, 46, "GENE"]]}], ["This review provides an overview of updated understanding of HMGB1 structure, release styles, receptors and function.", {"entities": [[61, 66, "GENE"]]}], ["Furthermore, we discuss the potential role of HMGB1 in a variety of lung diseases.", {"entities": [[46, 51, "GENE"]]}], ["Further exploration of molecular mechanisms underlying the function of HMGB1 in lung diseases will provide novel preventive and therapeutic strategies for lung diseases.", {"entities": [[71, 76, "GENE"]]}], ["Asthma is a chronic airway inflammation with a potential systemic impact.", {"entities": [[0, 6, "DISEASE"]]}], ["Atherosclerosis is a chronic inflammatory artery disease.", {"entities": []}], ["The aim of our study was to prove if there is a correlation between the occurrence of asthma and increased atherosclerotic vessel disorders.", {"entities": [[86, 92, "DISEASE"]]}], ["Vessel status was compared between mild-to-moderate, severe allergic asthma and matched controls.", {"entities": [[60, 75, "DISEASE"], [69, 75, "DISEASE"]]}], ["Measurements of artery stiffness were calculated by central pulse wave velocity, ultrasonographic strain imaging and ankle-brachial index.", {"entities": []}], ["Atherosclerotic plaque burden was assessed by colour-coded duplex sonography.", {"entities": []}], ["Additionally, analysis of cardiovascular and asthma blood markers was conducted.", {"entities": [[45, 51, "DISEASE"]]}], ["Arterial stiffness expressed as an increased central pulse wave velocity and decreased circumferential and radial strains as well as the prevalence of media sclerosis were significantly higher among asthma patients compared to controls.", {"entities": [[199, 205, "DISEASE"]]}], ["Atherosclerotic plaque burden was relevantly increased in asthma groups vs. controls (severe asthma: 43.1%, mild-to-moderate asthma: 25.0%, control: 14.3% of study participants).", {"entities": [[58, 64, "DISEASE"], [93, 99, "DISEASE"], [125, 131, "DISEASE"]]}], ["Except for the elevated IgE and fibrinogen concentrations as well as leukocyte number there were no relevant differences in the blood parameters between the groups.", {"entities": []}], ["Allergic asthma is associated with distinct atherosclerotic artery changes compared to the respectively matched control collective.", {"entities": [[0, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["The severity of asthma correlates with more pronounced pathological vessel alternations.", {"entities": [[16, 22, "DISEASE"]]}], ["Clostridium difficile infection (CDI), a complication of antibiotic-induced injury to the gut microbiome, is a prevalent and dangerous cause of infectious diarrhea.", {"entities": [[155, 163, "DISEASE"]]}], ["Antimicrobial therapy for CDI is typically effective for acute symptoms, but up to one third of patients later experience recurrent CDI.", {"entities": []}], ["Fecal-derived microbiota transplantation (FMT) can ameliorate the underlying dysbiosis and is highly effective for recurrent CDI.", {"entities": []}], ["Traditional methods of FMT are limited by patient discomfort, risk and inefficient procedures.", {"entities": []}], ["Many individuals with recurrent CDI have extensive comorbidities and advanced age.", {"entities": []}], ["Widespread use of FMT requires strategies that are non-invasive, scalable and applicable across healthcare settings.", {"entities": []}], ["A method to facilitate microbiota transfer was developed.", {"entities": []}], ["Fecal samples were collected and screened for potential pathogens.", {"entities": []}], ["Bacteria were purified, concentrated, cryopreserved and formulated into multi-layered capsules.", {"entities": []}], ["Capsules were administered to patients with recurrent CDI, who were then monitored for 90\u00a0days.", {"entities": []}], ["Thirteen women and six men with recurrent CDI were provided with microbiota transfer with orally administered capsules.", {"entities": []}], ["The procedure was well tolerated.", {"entities": []}], ["Thirteen individuals responded to a single course.", {"entities": []}], ["Four patients were cured after a second course.", {"entities": []}], ["There were 2 failures.", {"entities": []}], ["The cumulative clinical cure rate of 89% is similar to the rates achieved with reported fecal-derived transplantation procedures.", {"entities": []}], ["Recurrent CDI represents a profound dysbiosis and a debilitating chronic disease.", {"entities": []}], ["Stable cure can be achieved by restoring the gut microbiome with an effective, well-tolerated oral capsule treatment.", {"entities": []}], ["This strategy of microbiota transfer can be widely applied and is particularly appropriate for frail patients.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-015-0930-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There are few data focusing on the prevalence of vitamin D deficiency in tropical countries.", {"entities": []}], ["We determined the vitamin D status in pregnant women and examined the factors associated with vitamin D deficiency.", {"entities": []}], ["A cross-sectional study of 147 pregnant Thai women aged 18\u201345 years at Siriraj Hospital (a university hospital in Bangkok, Thailand) was undertaken.", {"entities": []}], ["Clinical data and plasma levels of 25-hydroxyvitamin D [25(OH)D], intact parathyroid hormone (iPTH), calcium, albumin, phosphate and magnesium were obtained in pregnant women at delivery.", {"entities": []}], ["The prevalence of hypovitaminosis D [defined as 25(OH)D <75 nmol/L] in pregnant women at delivery was 75.5% (95% confidence interval (CI), 67.7\u201382.2%).", {"entities": []}], ["Of these, vitamin D insufficiency [defined as 25(OH)D 50\u201374.9 nmol/L] was found in 41.5% (95% CI, 33.4\u201349.9%) and vitamin D deficiency [25(OH)D <50 nmol/L] was found in 34.0% (95% CI, 26.4\u201342.3%) of women.", {"entities": []}], ["The mean 25(OH)D concentration was 61.6\u00b119.3 nmol/L.", {"entities": []}], ["The correlation between 25(OH)D and iPTH was weak ( r = \u20130.29, P <0.01).", {"entities": []}], ["Factors associated with vitamin D deficiency by multiple logistic regression were: pre-pregnancy body mass index (BMI in kg/m P = 0.01) and season of blood collection (winter vs .", {"entities": []}], ["rainy, OR, 2.62, 95% CI 1.18\u20135.85, P = 0.02).", {"entities": []}], ["Vitamin D deficiency is common among pregnant Thai women.", {"entities": []}], ["The prevalence of vitamin D deficiency increased in women who had a lower pre-pregnancy BMI and whose blood was collected in the winter.", {"entities": []}], ["Vitamin D supplementation may need to be implemented as routine antenatal care.", {"entities": []}], ["Chronic allergic diseases and other disorders associated with mast cell activation can also be associated with tissue fibrosis, but a direct link between mast cell mediator release and fibroblast collagen gene expression has not been established.", {"entities": []}], ["Using in situ hybridization, we show that the elicitation of an IgE-dependent passive cutaneous anaphylaxis (PCA) reaction in mice results in a transient, but marked augmentation of steady state levels of type alpha-1 (I) collagen mRNA in the dermis.", {"entities": []}], ["While peak levels of collagen mRNA expression in the skin are observed 16-24 h after mast cell activation, substantial numbers of dermal cells are strongly positive for collagen mRNA at 1 and 2 h after antigen challenge, before circulating inflammatory cells are recruited into the tissues.", {"entities": []}], ["Furthermore, experiments in mast cell- reconstituted or genetically mast cell-deficient WBB6F1-W/Wv mice demonstrate that the increased expression of collagen mRNA at sites of PCA reactions is entirely mast cell dependent.", {"entities": []}], ["In vitro studies show that the supernatants of mouse serosal mast cells activated via the Fc epsilon RI markedly increase type alpha-1 (I) collagen mRNA levels in mouse embryonic skin fibroblasts, and also upregulate collagen secretion by these cells.", {"entities": []}], ["The ability of mast cell supernatants to induce increased steady state levels of collagen mRNA in mouse skin fibroblasts is markedly diminished by absorption with antibodies specific for either of two mast cell-derived cytokines, transforming growth factor beta (TGF-beta 1) or tumor necrosis factor alpha (TNF- alpha), and is eliminated entirely by absorption with antibodies against both cytokines.", {"entities": []}], ["Taken together, these findings demonstrate that IgE-dependent mouse mast cell activation can induce a transient and marked increase in steady state levels of type alpha-1 (I) collagen mRNA in dermal fibroblasts and that mast cell-derived TGF-beta 1 and TNF-alpha importantly contribute to this effect.", {"entities": []}], ["Because of relatively small treatment numbers together with low adverse drug reaction (ADR) reporting rates the timely identification of ADRs affecting children and young people is problematic.", {"entities": []}], ["The primary objective of this study was to assess the utility of unplanned medication discontinuation as a signal for possible ADRs in children and young people.", {"entities": []}], ["Using orlistat as an exemplar, all orlistat prescriptions issued to patients up to 18\u00a0years of age together with patient characteristics, prescription duration, co-prescribed medicines and recorded clinical (Read) codes were identified from the Primary Care Informatics Unit database between 1st Jan 2006-30th Nov 2009.", {"entities": [[310, 313, "GENE"]]}], ["Binary logistic regression was used to assess association between characteristics and discontinuation.", {"entities": []}], ["During the study period, 79 patients were prescribed orlistat (81% female, median age 17\u00a0years).", {"entities": []}], ["Unplanned medication discontinuation rates for orlistat were 52% and 77% at 1 and 3-months.", {"entities": []}], ["Almost 20% of patients were co-prescribed an anti-depressant.", {"entities": []}], ["One month unplanned medication discontinuation was significantly lower in the least deprived group (SIMD 1\u20132 compared to SIMD 9\u201310 OR 0.09 (95% CI0.01 \u2013 0.83)) and those co-prescribed at least one other medication.", {"entities": []}], ["At 3\u00a0months, discontinuation was higher in young people (\u226517\u00a0yr versus, OR 3.07 (95% CI1.03 \u2013 9.14)).", {"entities": []}], ["Read codes were recorded for digestive, respiratory and urinary symptoms around the time of discontinuation for 24% of patients.", {"entities": []}], ["Urinary retention was reported for 7.6% of patients.", {"entities": []}], ["Identification of unplanned medication discontinuation using large primary care datasets may be a useful tool for pharmacovigilance signal generation and detection of potential ADRs in children and young people.", {"entities": []}], ["Innate lymphoid cells (ILC) are a new family of innate immune cells that have emerged as important regulators of tissue homeostasis and inflammation.", {"entities": []}], ["However, limited data are available concerning the relative abundance and characteristics of ILC in the human lung.", {"entities": []}], ["The aim of this study was to characterize and enumerate the different ILC subsets in human lung by multi-color flow cytometry.", {"entities": []}], ["Within the CD45 We show that the three main ILC subsets are present in human lung.", {"entities": []}], ["Importantly, the relative abundance of ILC subsets tended to change in COPD patients in comparison to control individuals.", {"entities": []}], ["In the present study, methanol and aqueous extracts of Parkinsonia aculeata L. leaves were prepared and analyzed for phytochemical analysis and antioxidant potential in different in vitro assays.", {"entities": []}], ["Antioxidant activity was studied using DPPH, CUPRAC, reducing power assay, deoxyribose degradation (site and nonsite specific), ferric reducing antioxidant potential (FRAP), ferric thiocyanate (FTC), thiobarbituric acid (TBA), and molybdate ion reduction, respectively.", {"entities": []}], ["The total phenolic contents of the methanol and aqueous leaf extract were 39\u2009mg\u2009GAE/g and 38\u2009mg\u2009GAE/g, whereas flavonoid contents of these extracts were found to be 0.013\u2009mg\u2009RE/g and 0.006\u2009mg\u2009RE/g, respectively.", {"entities": []}], ["From the two extracts, the methanol extract shows maximum inhibition (%) of 57.82%, 71.23%, 48.26%, 69.85%, and 52.78% in DPPH, nonsite- and site-specific, FTC, and TBA assays and absorbance of 0.669 and 0.241 in reducing power and CUPRAC assays at the highest concentration tested.", {"entities": []}], ["UPLC analysis was done to determine the presence of various types of polyphenols present in plant extracts.", {"entities": []}], ["Recent studies suggest that human regulatory T (T reg) cells protect against the development of allergic and asthmatic disease and that their function is impaired during active disease.", {"entities": []}], ["Two new studies contribute to our understanding of the role that T reg cells play in the control of allergic airway disease in mice.", {"entities": []}], ["However, these studies also highlight several outstanding questions in the field.", {"entities": []}], ["Rho-associated kinase (ROCK) I mediates signaling from Rho to the actin cytoskeleton.", {"entities": []}], ["To investigate the in vivo functions of ROCK-I, we generated ROCK-I\u2013deficient mice.", {"entities": []}], ["Loss of ROCK-I resulted in failure of eyelid closure and closure of the ventral body wall, which gave rise to the eyes open at birth and omphalocele phenotypes in neonates.", {"entities": []}], ["Most ROCK-I", {"entities": []}], ["Noncommunicable diseases (NCDs) are a major and increasing global health issue.", {"entities": []}], ["The World Health Organization (WHO) estimates that NCDs represent 63% of all global deaths of which 3.9 million are due to chronic respiratory diseases (CRDs) and Chronic Obstructive Pulmonary Disease (COPD) in particular.", {"entities": []}], ["COPD is now the third most common cause of death globally; 90% of these deaths occur in Low and Middle Income Countries (LMICs).", {"entities": []}], ["COPD affects 329 million people, almost 5% of the world's population.", {"entities": []}], ["In addition, asthma affects 334 million people, again representing almost 5% of the world's population.", {"entities": [[13, 19, "DISEASE"]]}], ["There is limited literature published on the epidemiology of COPD and Asthma from Sub-Saharan Africa (SSA) and Middle East and North Africa (MENA).", {"entities": [[70, 76, "DISEASE"]]}], ["Both diseases are under-diagnosed and underestimated in both SSA and MENA regions.", {"entities": []}], ["The burden of COPD in sub-Saharan Africa is disputed and reports offer variable prevalence estimates, ranging from 4.1% to almost 22.2%.", {"entities": []}], ["SSA and MENA countries report similar mortality rates from COPD of 18 per 100,000 population (2001 data).", {"entities": []}], ["Asthma is a less common cause of death than COPD but is a major cause of morbidity; WHO estimates that there are 250,000 deaths per year from asthma, mainly in LMICs and it remains in the top twenty causes of disability in children globally.", {"entities": [[0, 6, "DISEASE"], [142, 148, "DISEASE"]]}], ["Risk factors for CRD are genetic and environmental; the latter dominated by air pollution exposures including tobacco smoke, household air pollution, outdoor air pollution and occupational exposures.", {"entities": []}], ["In the past three decades, nitric oxide has been well established as an important bioactive molecule implicated in regulation of cardiovascular, nervous, and immune systems.", {"entities": []}], ["Therefore, it is not surprising that much effort has been made to find specific inhibitors of nitric oxide synthases (NOS), the enzymes responsible for production of nitric oxide.", {"entities": []}], ["Among the many NOS inhibitors developed to date, inhibitors based on derivatives and analogues of arginine are of special interest, as this category includes a relatively high number of compounds with good potential for experimental as well as clinical application.", {"entities": []}], ["Though this group of inhibitors covers early nonspecific compounds, modern drug design strategies such as biochemical screening and computer-aided drug design have provided NOS-isoform-specific inhibitors.", {"entities": []}], ["With an emphasis on major advances in this field, a comprehensive list of inhibitors based on their structural characteristics is discussed in this paper.", {"entities": []}], ["We provide a summary of their biochemical properties as well as their observed effects both in vitro and in vivo .", {"entities": []}], ["Furthermore, we focus in particular on their pharmacology and use in recent clinical studies.", {"entities": []}], ["The potential of newly designed specific NOS inhibitors developed by means of modern drug development strategies is highlighted.", {"entities": []}], ["Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multi-center longitudinal, observational study to identify novel phenotypes and biomarkers of chronic obstructive pulmonary disease (COPD).", {"entities": [[166, 203, "DISEASE"]]}], ["In a subset of 300 subjects enrolled at six clinical centers, we are performing flow cytometric analyses of leukocytes from induced sputum, bronchoalveolar lavage (BAL) and peripheral blood.", {"entities": []}], ["To minimize several sources of variability, we use a \u201cjust-in-time\u201d design that permits immediate staining without pre-fixation of samples, followed by centralized analysis on a single instrument.", {"entities": []}], ["The Immunophenotyping Core prepares 12-color antibody panels, which are shipped to the six Clinical Centers shortly before study visits.", {"entities": []}], ["Sputum induction occurs at least two weeks before a bronchoscopy visit, at which time peripheral blood and bronchoalveolar lavage are collected.", {"entities": []}], ["Immunostaining is performed at each clinical site on the day that the samples are collected.", {"entities": []}], ["Samples are fixed and express shipped to the Immunophenotyping Core for data acquisition on a single modified LSR II flow cytometer.", {"entities": [[110, 113, "GENE"]]}], ["Results are analyzed using FACS Diva and FloJo software and cross-checked by Core scientists who are blinded to subject data.", {"entities": []}], ["Thus far, a total of 152 sputum samples and 117 samples of blood and BAL have been returned to the Immunophenotyping Core.", {"entities": []}], ["Initial quality checks indicate useable data from 126 sputum samples (83%), 106 blood samples (91%) and 91 BAL samples (78%).", {"entities": []}], ["In all three sample types, we are able to identify and characterize the activation state or subset of multiple leukocyte cell populations (including CD4+ and CD8+ T cells, B cells, monocytes, macrophages, neutrophils and eosinophils), thereby demonstrating the validity of the antibody panel.", {"entities": []}], ["Our study design, which relies on bi-directional communication between clinical centers and the Core according to a pre-specified protocol, appears to reduce several sources of variability often seen in flow cytometric studies involving multiple clinical sites.", {"entities": []}], ["Because leukocytes contribute to lung pathology in COPD, these analyses will help achieve SPIROMICS aims of identifying subgroups of patients with specific COPD phenotypes.", {"entities": []}], ["Future analyses will correlate cell-surface markers on a given cell type with smoking history, spirometry, airway measurements, and other parameters.", {"entities": []}], ["This study was registered with ClinicalTrials.gov as NCT01969344 .", {"entities": []}], ["Diabetic cardiomyopathy is a distinct primary disease process, independent of coronary artery disease, which leads to heart failure in diabetic patients.", {"entities": [[9, 23, "DISEASE"]]}], ["Epidemiological and clinical trial data have confirmed the greater incidence and prevalence of heart failure in diabetes.", {"entities": []}], ["Novel echocardiographic and MR (magnetic resonance) techniques have enabled a more accurate means of phenotyping diabetic cardiomyopathy.", {"entities": [[122, 136, "DISEASE"]]}], ["Experimental models of diabetes have provided a range of novel molecular targets for this condition, but none have been substantiated in humans.", {"entities": []}], ["Similarly, although ultrastructural pathology of the microvessels and cardiomyocytes is well described in animal models, studies in humans are small and limited to light microscopy.", {"entities": []}], ["With regard to treatment, recent data with thiazoledinediones has generated much controversy in terms of the cardiac safety of both these and other drugs currently in use and under development.", {"entities": []}], ["Clinical trials are urgently required to establish the efficacy of currently available agents for heart failure, as well as novel therapies in patients specifically with diabetic cardiomyopathy.", {"entities": [[179, 193, "DISEASE"]]}], ["Neurogenic inflammation is orchestrated by a large number of neuropeptides.", {"entities": []}], ["Tachykinins (substance P, neurokinin A and neurokinin B) are pro-inflammatory neuropeptides that may play an important role in some autoimmune neuroinflammatory diseases.", {"entities": []}], ["Autoimmunity may have a role in the pathogenesis of autism in some patients.", {"entities": []}], ["We are the first to measure serum neurokinin A levels in autistic children.", {"entities": []}], ["The relationship between serum levels of neurokinin A and anti-ribosomal P protein antibodies was also studied.", {"entities": []}], ["Serum neurokinin A and anti-ribosomal P protein antibodies were measured in 70 autistic children in comparison to 48 healthy-matched children.", {"entities": []}], ["Autistic children had significantly higher serum neurokinin A levels than healthy controls (P < 0.001).", {"entities": []}], ["Children with severe autism had significantly higher serum neurokinin A levels than patients with mild to moderate autism (P < 0.001).", {"entities": []}], ["Increased serum levels of neurokinin A and anti-ribosomal P protein antibodies were found in 57.1% and 44.3%, respectively of autistic children.", {"entities": []}], ["There was significant positive correlations between serum levels of neurokinin A and anti-ribosomal P protein antibodies (P = 0.004).", {"entities": []}], ["Serum neurokinin A levels were elevated in some autistic children and they were significantly correlated to the severity of autism and to serum levels of anti-ribosomal P protein antibodies.", {"entities": []}], ["However, this is an initial report that warrants further research to determine the pathogenic role of neurokinin A and its possible link to autoimmunity in autism.", {"entities": []}], ["The therapeutic role of tachykinin receptor antagonists, a potential new class of anti-inflammatory medications, should also be studied in autism.", {"entities": []}], ["Comorbidities are characteristic of COPD.", {"entities": []}], ["However, little is known about the secondary manifestations of COPD in the gastrointestinal tract.", {"entities": []}], ["Therefore, we aimed to explore the long-term effects of gastrectomy in patients with spirometry-defined COPD or those at risk of COPD.", {"entities": []}], ["Subjects included 87 patients either with COPD or at risk of COPD (symptomatic) who underwent gastrectomy between December 2003 and October 2013 (group A), and 174 patients either with COPD or at risk of COPD, matched by age (\u00b15 years), sex, and forced expiratory volume in 1 second (FEV 1 ) as percentage of predicted (FEV 1 % predicted) (\u00b15%) (group B).", {"entities": [[284, 287, "GENE"], [320, 323, "GENE"], [284, 287, "GENE"], [320, 323, "GENE"]]}], ["All patients underwent routine blood chemistry and pulmonary function tests, arterial blood gas analysis, 6-minute walk test (6MWT), high-resolution chest computed tomography scans, and nutritional assessments.", {"entities": []}], ["The mean duration postgastrectomy was 18.3\u00b115.4 years.", {"entities": []}], ["The mean FEV 1 and FEV 1 % predicted were 2.07\u00b10.76 L and 74.6\u00b124.5%, respectively.", {"entities": [[9, 12, "GENE"], [19, 22, "GENE"], [9, 12, "GENE"], [19, 22, "GENE"]]}], ["Univariate analysis indicated that group A patients had significantly lower body mass index, fat-free mass index, and serum hemoglobin and albumin concentration (all P =0.00), and walked a significantly shorter distance in the 6MWT ( P <0.05).", {"entities": []}], ["Multivariate linear regression analysis for the distance in the 6MWT indicated that increased residual volume (RV) to total lung capacity (TLC) as percentage of predicted (%RV/TLC) alone was an independent and significant predictor of reduced distances in the 6MWT.", {"entities": []}], ["We concluded that nutritional insufficiency in patients with COPD (or those at risk of COPD) who previously underwent gastrectomy might lead to hyperinflation and consequently, decreased exercise capacity.", {"entities": []}], ["It is unclear whether various bronchodilator reversibility (BDR) criteria affect the prognosis of chronic obstructive pulmonary disease (COPD).", {"entities": [[98, 135, "DISEASE"]]}], ["The aim of this study is to evaluate the impact of positive BDR defined according to various BDR criteria on the risk of severe acute exacerbation (AE) in COPD patients.", {"entities": []}], ["Patients from four prospective COPD cohorts in South Korea who underwent follow-up for at least 1\u00a0year were enrolled in this study.", {"entities": []}], ["The assessed BDR criteria included the Global Initiative for Chronic Obstructive Lung Disease (GOLD), American Thoracic Society (ATS), American College of Chest Physicians, (ACCP), major criteria of the Spanish definition of asthma-COPD overlap syndrome (ACOS), criteria compatible with ACOS in the Global Initiative for Asthma (GINA), and European Respiratory Society (ERS).", {"entities": [[245, 253, "DISEASE"], [225, 231, "DISEASE"], [321, 327, "DISEASE"]]}], ["The rate of patients with severe AE who required hospitalization within 1\u00a0year due to BDR results according to each set of criteria was analyzed using logistic regression models.", {"entities": []}], ["Among a total of 854 patients, the BDR-positive cases varied according to the criteria used.", {"entities": []}], ["There was a 3.5% positive BDR rate according to GINA and a 29.9% rate according to the ATS criteria.", {"entities": []}], ["Positive BDR according to the GOLD criteria was significantly associated with a decreased risk of severe AE (adjusted odds ratio (aOR)\u2009=\u20090.38; 95% Confidence interval (CI)\u2009=\u20090.15\u20130.93).", {"entities": []}], ["This result remained statistically significant even in a sensitivity analysis that included only participants with a smoking history of at least 10 pack-years and in the analysis for the propensity score-matched participants.", {"entities": []}], ["Among different criteria for positive BDR, the use of the GOLD ones was significantly associated with a decreased risk of severe AE in COPD patients.", {"entities": []}], ["Increase use of ICS/LABA may have affected this relationship.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0587-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This paper presents the findings of a rapid needs assessment conducted at the request of the local health authority responsible for health care services, the Toronto Central Local Health Integration Network (Ontario, Canada), to inform health and social service planning.", {"entities": []}], ["We utilized concept mapping methodology to facilitate engagement with diverse stakeholders\u2013more than 300 community members and service providers\u2013with a focus on hard to reach populations.", {"entities": []}], ["Key informant interviews with service providers were used to augment findings.", {"entities": []}], ["Participants identified 48 unique services or service approaches they believed would improve the health of residents in the area, including those addressing health care, mental health and addictions, youth, families, people experiencing homelessness, seniors, general social services, and services targeting specific populations.", {"entities": []}], ["While service providers consistently identified a critical need for mental health and addiction services, community members placed greater importance on the social determinants of health including access to housing, job placement supports and training and service accessibility.", {"entities": []}], ["Both groups agreed that services and programs for seniors and people experiencing homelessness would be highly important.", {"entities": []}], ["Our study provides a unique example of using concept mapping as a tool to aid a rapid service gap analysis and community engagement in a metropolitan area.", {"entities": []}], ["The findings also reinforce the importance of working cross-sectorally, using a Health in All Policies approach when planning services for underserved populations.", {"entities": []}], ["Influenza A virus is a significant public health threat, but little is understood about the viral RNA structure and function.", {"entities": [[0, 9, "DISEASE"]]}], ["Current vaccines and therapeutic options to control influenza A virus infections are mostly protein-centric and of limited effectiveness.", {"entities": [[52, 61, "DISEASE"]]}], ["Here, we report using an ensemble defect approach to design mutations to misfold regions of conserved mRNA structures in influenza A virus segments 7 and 8.", {"entities": [[121, 130, "DISEASE"]]}], ["Influenza A mutant viruses inhibit pre-mRNA splicing and attenuate viral replication in cell culture, thus providing evidence for functions of the targeted regions.", {"entities": [[0, 9, "DISEASE"]]}], ["Targeting these influenza A viral RNA regions provides new possibilities for designing vaccines and therapeutics against this important human respiratory pathogen.", {"entities": [[16, 25, "DISEASE"]]}], ["The results also demonstrate that the ensemble defect approach is an efficient way to test for function of RNA sequences.", {"entities": []}], ["Growing body of literature on sarcoidosis in India has led to an increased awareness of the disease.", {"entities": [[30, 41, "DISEASE"]]}], ["With the advent of better imaging tools hitherto under-recognized manifestations of sarcoidosis are likely to be better recognized.", {"entities": [[84, 95, "DISEASE"]]}], ["We sought to study the rare clinical and radiological manifestations (<5%) in patients with sarcoidosis.", {"entities": [[92, 103, "DISEASE"]]}], ["Retrospective review of records of 164 patients with histopathologically proven sarcoidosis seen over six years in a tertiary care centre in north India, was done.", {"entities": [[80, 91, "DISEASE"]]}], ["Fifty four rare manifestations were observed in 164 patients.", {"entities": []}], ["Acute presentation in the form of Lofgren syndrome was seen in eight (4.9%) and Heerfordt's syndrome in two (1.2%) patients.", {"entities": [[42, 50, "DISEASE"], [92, 100, "DISEASE"]]}], ["Musculoskeletal manifestations included chronic sarcoid arthritis in three (1.8%), deforming arthritis and bone erosion in one (0.6%) each.", {"entities": [[56, 65, "DISEASE"], [93, 102, "DISEASE"]]}], ["Rare initial presentation with dilated cardiomyopathy in one (0.6%), complete heart block in two (1.2%), bilateral sequential facial nerve palsy in two (1.2%), and pyrexia of unknown origin was seen in one (0.6%) patient.", {"entities": [[39, 53, "DISEASE"], [31, 53, "DISEASE"]]}], ["Other rare manifestations included chronic respiratory failure in one (0.6%), dysphagia in one (0.6%), sicca syndrome in five (3%), massive splenomegaly in one (0.6%), portal hypertension in two (1.2%), hypersplenism, gastric sarcoidosis, ninth and tenth cranial nerve palsies, moderate pericardial effusion and nephrocalcinosis in one (0.6%) each, and pulmonary artery hypertension in two (1.2%) patients.", {"entities": [[312, 328, "DISEASE"], [175, 187, "DISEASE"], [370, 382, "DISEASE"], [43, 62, "DISEASE"], [168, 187, "DISEASE"], [287, 307, "DISEASE"], [203, 216, "DISEASE"], [109, 117, "DISEASE"], [226, 237, "DISEASE"]]}], ["Rare radiological manifestations included moderate pleural effusion in two (1.2%), pleural thickening in five (3%), calcification of intrathoracic lymph nodes in four (2.4%), alveolar (nodular) sarcoidosis in three (1.8%), and myocardial uptake of 18F-fluorodeoxyglucose (F-18 FDG) in two (1.2%) patients.", {"entities": [[194, 205, "DISEASE"]]}], ["Fourteen patients had airways obstruction and behaved typically like seasonal bronchial asthma with excellent response to corticosteroids.", {"entities": [[88, 94, "DISEASE"]]}], ["Increased awareness of rare manifestations will facilitate better management of these patients.", {"entities": []}], ["With increasing use of modern diagnostic tools, manifestations hitherto considered rare, are likely to be recognized more frequently in the future.", {"entities": []}], ["the improved general therapy has led to reduced morbidity and mortality from Cystic Fibrosis (CF), and bone status may have a potentially greater clinical impact.", {"entities": []}], ["We investigated the correlation between the severity of the clinical condition, bone status and body composition parameters, in a group of children and young adults with CF.", {"entities": []}], ["we measured lumbar spine bone density and total body composition by dual energy x-ray absorptiometry (DXA) in 82 consecutive CF patients (42 males; median age: 13 years - range: 5-30).", {"entities": []}], ["Eighty-two healthy subjects, matched for age, gender, height and pubertal stage were recruited as a control group.", {"entities": []}], ["37 patients (45.1%) had a normal bone mineral density (BMD).", {"entities": []}], ["A BMD reduction were observed in 45 (54.8%) patients.", {"entities": []}], ["Lumbar spine Z score was positively related to Body Mass Index (BMI) and a higher Shwachman-Kulczycki score, and negatively related to Crispin-Norman score.", {"entities": []}], ["A positive and significant correlation was also observed between lumbar spine Z score and total body composition.", {"entities": []}], ["a significant BMD reduction can be present early in CF children and adolescents.", {"entities": []}], ["A careful follow up of bone status is required starting in childhood.", {"entities": []}], ["Schizophrenia (SCZ) is a common, disabling mental illness with high heritability but complex, poorly understood genetic etiology.", {"entities": []}], ["As the first phase of a genomic convergence analysis of SCZ, we generated 16.7 billion nucleotides of short read, shotgun sequences of cDNA from post-mortem cerebellar cortices of 14 patients and six, matched controls.", {"entities": []}], ["A rigorous analysis pipeline was developed for analysis of digital gene expression studies.", {"entities": []}], ["Sequences aligned to approximately 33,200 transcripts in each sample, with average coverage of 450 reads per gene.", {"entities": []}], ["Following adjustments for confounding clinical, sample and experimental sources of variation, 215 genes differed significantly in expression between cases and controls.", {"entities": []}], ["Golgi apparatus, vesicular transport, membrane association, Zinc binding and regulation of transcription were over-represented among differentially expressed genes.", {"entities": []}], ["Twenty three genes with altered expression and involvement in presynaptic vesicular transport, Golgi function and GABAergic neurotransmission define a unifying molecular hypothesis for dysfunction in cerebellar cortex in SCZ.", {"entities": []}], ["Exosomes are tiny membrane-bound vesicles that are over produced by most proliferating cell types during normal and pathological states.", {"entities": []}], ["Their levels are up-regulated during pregnancy and disease states such as cancer.", {"entities": [[74, 80, "DISEASE"]]}], ["Exosomes contain a wide variety of proteins, lipids, RNAs, non-transcribed RNAs, microRNAs and small RNAs that are representative to their cellular origin and shuttle from a donor cell to a recipient cell.", {"entities": []}], ["From intercellular communication to tumor proliferation, exosomes carry out a diverse range of functions, both helpful and harmful.", {"entities": []}], ["Useful as biomarkers, exosomes may be applicable in diagnostic assessments as well as cell-free anti-tumor vaccines.", {"entities": []}], ["Exosomes of ovarian cancer contain different set of proteins and miRNAs compared to exosomes of normal, cancer-free individuals.", {"entities": [[12, 26, "DISEASE"], [20, 26, "DISEASE"], [104, 110, "DISEASE"]]}], ["These molecules may be used as multiple \u201cbarcode\u201d for the development of a diagnostic tool for early detection of ovarian cancer.", {"entities": [[114, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["The development of the preterm gut microbiome is important for immediate and longer-term health following birth.", {"entities": []}], ["We aimed to determine if modifications to the preterm gut on the neonatal intensive care unit (NICU) impacted the gut microbiota and metabolome long-term.", {"entities": []}], ["Stool samples were collected from 29 infants ages 1\u20133 years post discharge (PD) from a single NICU.", {"entities": []}], ["Additional NICU samples were included from 14/29 infants.", {"entities": []}], ["Being diagnosed with disease or receiving increased antibiotics while on the NICU did not significantly impact the microbiome PD.", {"entities": []}], ["Significant decreases in common NICU organisms including K. oxytoca and E. faecalis and increases in common adult organisms including Akkermansia sp., Blautia sp., and Bacteroides sp.", {"entities": []}], ["and significantly different Shannon diversity was shown between NICU and PD samples.", {"entities": []}], ["The metabolome increased in complexity, but while PD samples had unique bacterial profiles we observed comparable metabolomic profiles.", {"entities": []}], ["The preterm gut microbiome is able to develop complexity comparable to healthy term infants despite limited environmental exposures, high levels of antibiotic administration, and of the presence of serious disease.", {"entities": []}], ["Further work is needed to establish the direct effect of weaning as a key event in promoting future gut health.", {"entities": []}], ["Objective measurement of airflow obstruction by spirometry is an essential part of the diagnosis of asthma or COPD.", {"entities": [[100, 106, "DISEASE"]]}], ["During exacerbations, the feasibility and utility of spirometry to confirm the diagnosis of asthma or chronic obstructive pulmonary disease (COPD) are unclear.", {"entities": [[102, 139, "DISEASE"], [92, 98, "DISEASE"]]}], ["Addressing these gaps in knowledge may help define the need for confirmatory testing in clinical care and quality improvement efforts.", {"entities": []}], ["This study was designed to determine the feasibility of spirometry and to determine its utility to confirm the diagnosis in patients hospitalized with a physician diagnosis of asthma or COPD exacerbation.", {"entities": [[176, 182, "DISEASE"]]}], ["Multi-center study of four academic healthcare institutions.", {"entities": []}], ["Spirometry was performed in 113 adults admitted to general medicine wards with a physician diagnosis of asthma or COPD exacerbation.", {"entities": [[104, 110, "DISEASE"]]}], ["Two board-certified pulmonologists evaluated the spirometry tracings to determine the proportion of patients able to produce adequate quality spirometry data.", {"entities": []}], ["Findings were interpreted to evaluate the utility of spirometry to confirm the presence of obstructive lung disease, according to the 2005 European Respiratory Society/American Thoracic Society recommendations.", {"entities": [[91, 115, "DISEASE"], [103, 115, "DISEASE"]]}], ["There was an almost perfect agreement for acceptability (\u03ba\u2009=\u20090.92) and reproducibility (\u03ba =0.93) of spirometry tracings.", {"entities": []}], ["Three-quarters (73%) of the tests were interpreted by both pulmonologists as being of adequate quality.", {"entities": []}], ["Of these adequate quality tests, 22% did not present objective evidence of obstructive lung disease.", {"entities": [[75, 99, "DISEASE"], [87, 99, "DISEASE"]]}], ["Obese patients (BMI \u226530 kg/m Adequate quality spirometry can be obtained in most hospitalized adults with a physician diagnosis of asthma or COPD exacerbation.", {"entities": [[131, 137, "DISEASE"]]}], ["Confirmatory spirometry could be a useful tool to help reduce overdiagnosis of obstructive lung disease, especially among obese patients.", {"entities": [[79, 103, "DISEASE"], [91, 103, "DISEASE"]]}], ["A global pandemic mortality study found prominent regional mortality variations in 2009 for Influenza A(H1N1)pdm09.", {"entities": [[92, 101, "DISEASE"]]}], ["Our study attempts to identify factors that explain why the pandemic mortality burden was high in some countries and low in others.", {"entities": []}], ["As a starting point, we identified possible risk factors worth investigating for Influenza A(H1N1)pdm09 mortality through a targeted literature search.", {"entities": [[81, 90, "DISEASE"]]}], ["We then used a modeling procedure (data simulations and regression models) to identify factors that could explain differences in respiratory mortality due to Influenza A(H1N1)pdm09.", {"entities": [[158, 167, "DISEASE"]]}], ["We ran sixteen models to produce robust results and draw conclusions.", {"entities": []}], ["In order to assess the role of each factor in explaining differences in excess pandemic mortality, we calculated the reduction in between country variance, which can be viewed as an effect-size for each factor.", {"entities": []}], ["The literature search identified 124 publications and 48 possible risk factors, of which we were able to identify 27 factors with appropriate global datasets.", {"entities": []}], ["The modelling procedure indicated that age structure (explaining 40% of the mean between country variance), latitude (8%), influenza A and B viruses circulating during the pandemic (3\u20138%), influenza A and B viruses circulating during the preceding influenza season (2\u20136%), air pollution (pm10; 4%) and the prevalence of other infections (HIV and TB) (4\u20136%) were factors that explained differences in mortality around the world.", {"entities": [[123, 132, "DISEASE"], [189, 198, "DISEASE"], [248, 257, "DISEASE"]]}], ["Healthcare expenditure, levels of obesity, the distribution of antivirals, and air travel did not explain global pandemic mortality differences.", {"entities": [[34, 41, "DISEASE"]]}], ["Our study found that countries with a large proportion of young persons had higher pandemic mortality rates in 2009.", {"entities": []}], ["The co-circulation of influenza viruses during the pandemic and the circulation of influenza viruses during the preceding season were also associated with pandemic mortality rates.", {"entities": [[22, 31, "DISEASE"], [83, 92, "DISEASE"]]}], ["We found that real time assessments of 2009 pandemic mortality risk factors (e.g.", {"entities": []}], ["obesity) probably led to a number of false positive findings.", {"entities": [[0, 7, "DISEASE"]]}], ["The online version of this article (10.1186/s12879-017-2730-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Functional Comorbidity Index (FCI) was recently developed to predict physical function in acute lung injury patients using comorbidity data.", {"entities": []}], ["Our objectives were to determine: (1) the inter-rater reliability of the FCI collected using in-patient discharge summaries (primary objective); and (2) the accuracy and predictive validity of the FCI collected using hospital discharge summaries and admission records versus complete chart review (secondary objectives).", {"entities": []}], ["For reliability, we evaluated the FCI\u2019s intraclass correlation coefficient (ICC) among trained research staff performing data collection for 421 acute lung injury patients enrolled in a prospective cohort study.", {"entities": []}], ["For validity and accuracy, we compared the detection of FCI comorbidities across three types of inpatient medical records, and the association of the respective FCI scores obtained with patients\u2019 SF-36 physical function subscale (PFS) scores at 1-year follow-up.", {"entities": []}], ["Inter-rater reliability was near-perfect (ICC 0.91; 95% CI 0.89-0.94).", {"entities": []}], ["Hospital admission records and discharge summaries (vs. complete chart review) significantly underestimated the total FCI score.", {"entities": []}], ["However, using multivariable linear regression, FCI scores collected using each of the three types of inpatient medical records had similar associations with PFS, suggesting similar predictive value.", {"entities": []}], ["Data collection using in-patient discharge summaries represents a reliable and valid method for collecting FCI comorbidity information.", {"entities": []}], ["In general the health of methadone clients has been found to be poorer than that of the general population.", {"entities": []}], ["In New Zealand specialist drug services are not funded to provide primary healthcare services.", {"entities": []}], ["Many health conditions could potentially be managed by community pharmacists who have frequent contact with this client group.", {"entities": []}], ["This study sought to explore the health problems suffered by methadone clients, who they sought help from, and the potential for greater involvement of pharmacists.", {"entities": []}], ["Self-completion questionnaire of methadone maintenance clients managed in specialist care in Auckland, New Zealand.", {"entities": []}], ["The most common health problem experienced by these clients in the past three months was sweating (70.0%), and more than half of the respondents also reported experiencing headache, fatigue and depression.", {"entities": []}], ["The least frequently experienced conditions were hay fever (12.9%) and abscesses (12.1%).", {"entities": []}], ["Respondents indicated that the top three choices from whom they would seek help were GP (56.7%), the client's partner (31.6%) and community pharmacists (27.9%).", {"entities": []}], ["Barriers to seeking help from pharmacists included issues around cost, perceptions of pharmacist knowledge and skills, privacy and confidentiality.", {"entities": []}], ["Methadone clients in this study indicated that they suffered a number of general health problems, and in many cases were likely to seek help from a GP or their own partner, before seeking help from pharmacists.", {"entities": []}], ["However, for over one quarter of respondents the pharmacist was in the top three from whom they would seek advice.", {"entities": []}], ["Any barriers towards consulting pharmacists, in the main seem to be resolvable.", {"entities": []}], ["Accumulation of activated eosinophils in tissue is a hallmark of allergic inflammation.", {"entities": []}], ["The endocannabinoid 2\u2010arachidonoylglycerol (2\u2010 AG ) has been proposed to elicit eosinophil migration in a CB 2 receptor/G i/o \u2010dependent manner.", {"entities": []}], ["However, it has been claimed recently that this process may also involve other mechanisms such as cytokine priming and the metabolism of 2\u2010 AG into eicosanoids.", {"entities": []}], ["Here, we explored the direct contribution of specific CB 2 receptor activation to human and mouse eosinophil effector function in vitro and in vivo .", {"entities": []}], ["In vitro studies including CB 2 expression, adhesion and migratory responsiveness, respiratory burst, degranulation, and calcium mobilization were conducted in human peripheral blood eosinophils and mouse bone marrow\u2010derived eosinophils.", {"entities": []}], ["Allergic airway inflammation was assessed in mouse models of acute OVA \u2010induced asthma and directed eosinophil migration.", {"entities": [[80, 86, "DISEASE"]]}], ["CB 2 expression was significantly higher in eosinophils from symptomatic allergic donors.", {"entities": []}], ["The selective CB 2 receptor agonist JWH \u2010133 induced a moderate migratory response in eosinophils.", {"entities": []}], ["However, short\u2010term exposure to JWH \u2010133 potently enhanced chemoattractant\u2010induced eosinophil shape change, chemotaxis, CD 11b surface expression, and adhesion as well as production of reactive oxygen species.", {"entities": []}], ["Receptor specificity of the observed effects was confirmed in eosinophils from CB 2 knockout mice and by using the selective CB 2 antagonist SR 144528.", {"entities": []}], ["Of note, systemic application of JWH \u2010133 clearly primed eosinophil\u2010directed migration in vivo and aggravated both AHR and eosinophil influx into the airways in a CB 2 \u2010specific manner.", {"entities": [[115, 118, "GENE"]]}], ["This effect was completely absent in eosinophil\u2010deficient \u2206dbl GATA mice.", {"entities": []}], ["Our data indicate that CB 2 may directly contribute to the pathogenesis of eosinophil\u2010driven diseases.", {"entities": []}], ["Moreover, we provide new insights into the molecular mechanisms underlying the CB 2 \u2010mediated priming of eosinophils.", {"entities": []}], ["Hence, antagonism of CB 2 receptors may represent a novel pharmacological approach for the treatment of allergic inflammation and other eosinophilic disorders.", {"entities": []}], ["The relationship between cesarean section (CS) and allergic disorders such as asthma and wheezing has been inconsistent, and the mechanisms for their connection remained largely unknown.", {"entities": [[78, 84, "DISEASE"], [43, 45, "GENE"]]}], ["We aimed to investigate whether CS is associated with infantile wheeze and to explore the connection between CS and several risk factors known to correlate with allergy development.", {"entities": [[32, 34, "GENE"], [109, 111, "GENE"], [32, 34, "GENE"], [109, 111, "GENE"]]}], ["Mononuclear cells were isolated from cord blood and assessed for cytokine responses by ELISA.", {"entities": []}], ["Bacteria from nasopharyngeal specimens were identified with traditional culture methods.", {"entities": []}], ["Infant lung function tests were performed at 6 and 12 months of age.", {"entities": []}], ["IgE levels and clinical outcomes were assessed at 12 months.", {"entities": []}], ["The result showed that children delivered by CS were associated with increased risk of wheezing (aHR 1.63; 95% CI: 1.01\u20132.62) and decreased compliance of the respiratory system at 12 months (p\u2009=\u20090.045).", {"entities": [[45, 47, "GENE"], [97, 100, "GENE"]]}], ["In addition, CS was associated with reduced TLR1\u20132- triggered TNF-\u03b1 and IL-6 responses at birth.", {"entities": [[13, 15, "GENE"]]}], ["By12 months of age, children delivered by CS had significantly less airway bacterial clearance.", {"entities": [[42, 44, "GENE"]]}], ["Our findings suggested that CS was associated with decreased pro-inflammatory cytokine response to TLR1\u20132 stimulation, followed by higher abundance of bacterial colonization in the airway during late infancy, thus increasing the risk of infantile wheezing.", {"entities": [[28, 30, "GENE"]]}], ["First described in 1962 in children hospitalized for pneumonia and bronchiolitis, the Enterovirus D68 (EV-D68) is an emergent viral pathogen.", {"entities": [[53, 62, "DISEASE"], [67, 80, "DISEASE"]]}], ["Since its discovery, during the long period of surveillance up to 2005, EV-D68 was reported only as a cause of sporadic outbreaks.", {"entities": []}], ["In recent years, many reports from different countries have described an increasing number of patients with respiratory diseases due to EV-D68 associated with relevant clinical severity.", {"entities": []}], ["In particular, an unexpectedly high number of children have been hospitalized for severe respiratory disease due to EV-D68, requiring intensive care such as intubation and mechanical ventilation.", {"entities": []}], ["Moreover, EV-D68 has been associated with acute flaccid paralysis and cranial nerve dysfunction in children, which has caused concerns in the community.", {"entities": []}], ["As no specific antiviral therapy is available, treatment is mainly supportive.", {"entities": []}], ["Moreover, because no vaccines are available, conventional infection control measures ( i.e.", {"entities": []}], [", standard, for contacts and droplets) in both community and healthcare settings are recommended.", {"entities": []}], ["However, further studies are required to fully understand the real importance of this virus.", {"entities": []}], ["Prompt diagnosis and continued surveillance of EV-D68 infections are essential to managing and preventing new outbreaks.", {"entities": []}], ["Moreover, if the association between EV-D68 and severe diseases will be confirmed, the development of adequate preventive and therapeutic approaches are a priority.", {"entities": []}], ["The aim of this study was to explore barriers among patients, general practitioners (GPs) and practice nurses to implement internet-based self-management support as provided by PatientCoach for asthma in primary care.", {"entities": [[194, 200, "DISEASE"]]}], ["Primary care within South Holland, the Netherlands.", {"entities": []}], ["Twenty-two patients (12 women, mean age 38 years), 21 GPs (6 women, mean age 52 years) and 13 practice nurses (all women, mean age 41 years).", {"entities": []}], ["A qualitative study using focus groups and interviews.", {"entities": []}], ["Barriers as perceived by patients, GPs and practice nurses to implementation of PatientCoach.", {"entities": []}], ["10 focus groups and 12 interviews were held to collect data: 4 patient focus groups, 4 GP focus groups, 2 practice nurse focus group, 2 patient interviews, 5 GP interviews and 5 practice nurse interviews.", {"entities": []}], ["A prototype of PatientCoach that included modules for coaching, personalised information, asthma self-monitoring, medication treatment plan, feedback, e-consultations and a forum was demonstrated.", {"entities": [[90, 96, "DISEASE"]]}], ["A semistructured topic guide was used.", {"entities": []}], ["Directed content analysis was used to analyse data.", {"entities": []}], ["Reported barriers were classified according to a framework by Grol and Wensing.", {"entities": []}], ["A variety of barriers emerged among all participant groups.", {"entities": []}], ["Barriers identified among patients include a lack of a patient\u2013professional partnership in using PatientCoach and a lack of perceived benefit in improving asthma symptoms.", {"entities": [[155, 161, "DISEASE"]]}], ["Barriers identified among GPs include a low sense of urgency towards asthma care and current work routines.", {"entities": [[69, 75, "DISEASE"]]}], ["Practice nurses identified a low level of structured asthma care and a lack of support by colleagues as barriers.", {"entities": [[53, 59, "DISEASE"]]}], ["Among all participant groups, insufficient ease of use of PatientCoach, lack of financial arrangements and patient characteristics such as a lack of asthma symptoms were reported as barriers.", {"entities": [[149, 155, "DISEASE"]]}], ["We identified a variety of barriers to implementation of PatientCoach.", {"entities": []}], ["An effective implementation strategy for internet-based self-management support in asthma care should focus on these barriers.", {"entities": [[83, 89, "DISEASE"]]}], ["Health system integration is a key component of health system reform with the goal of improving outcomes for patients, providers, and the health system.", {"entities": []}], ["Although health systems continue to strive for better integration, current delivery of health services continues to be fragmented.", {"entities": []}], ["A key gap in the literature is the lack of information on what successful integration looks like and how to measure achievement towards an integrated system.", {"entities": []}], ["This multi-site study protocol builds on a prior knowledge synthesis completed by two of the primary investigators which identified 10 key principles that collectively support health system integration.", {"entities": []}], ["The aim is to answer two research questions: What are appropriate indicators for each of the 10 key integration principles developed in our previous knowledge synthesis and what measurement tools are used to measure these indicators?", {"entities": []}], ["To enhance generalizability of the findings, a partnership between Canada and Brazil was created as health system integration is a priority in both countries and they share similar contexts.", {"entities": []}], ["This knowledge synthesis will follow an iterative scoping review process with emerging information from knowledge-user engagement leading to the refinement of research questions and study selection.", {"entities": []}], ["This paper describes the methods for each phase of the study.", {"entities": []}], ["Research questions were developed with stakeholder input.", {"entities": []}], ["Indicator identification and prioritization will utilize a modified Delphi method and patient/user focus groups.", {"entities": []}], ["Based on priority indicators, a search of the literature will be completed and studies screened for inclusion.", {"entities": []}], ["Quality appraisal of relevant studies will be completed prior to data extraction.", {"entities": []}], ["Results will be used to develop recommendations and key messages to be presented through integrated and end-of-grant knowledge translation strategies with researchers and knowledge-users from the three jurisdictions.", {"entities": []}], ["This project will directly benefit policy and decision-makers by providing an easy accessible set of indicators and tools to measure health system integration across different contexts and cultures.", {"entities": []}], ["Being able to evaluate the success of integration strategies and initiatives will lead to better health system design and improved health outcomes for patients.", {"entities": []}], ["This study used data from a large UK outbreak investigation, to develop and validate a new case definition for hypersensitivity pneumonitis due to metalworking fluid exposure (MWF-HP).", {"entities": []}], ["The clinical data from all workers with suspected MWF-HP were reviewed by an experienced panel of clinicians.", {"entities": []}], ["A new MWF-HP Score was then developed to match the \u201cgold standard\u201d clinical opinion as closely as possible, using standard diagnostic criteria that were relatively weighted by their positive predictive value.", {"entities": []}], ["The new case definition was reproducible, and agreed with expert panel opinion in 30/37 cases.", {"entities": []}], ["This level of agreement was greater than with any of the three previously utilized case definitions (agreement in 16\u201324 cases).", {"entities": []}], ["Where it was possible to calculate, the MWF-HP Score also performed well when applied to 50 unrelated MWF-HP cases.", {"entities": []}], ["The MWF-HP Score offers a new case definition for use in future outbreaks.", {"entities": []}], ["57:872\u2013880, 2014.", {"entities": []}], ["\u00a9 2014 The Authors.", {"entities": []}], ["American Journal of Industrial Medicine Published by Wiley Periodicals, Inc.", {"entities": []}], ["Picornaviruses are common human and animal pathogens, including polio and rhinoviruses of the enterovirus family, and hepatits A or food-and-mouth disease viruses.", {"entities": [[141, 154, "DISEASE"]]}], ["There are no effective countermeasures against the vast majority of picornaviruses, with the exception of polio and hepatitis A vaccines.", {"entities": [[116, 125, "DISEASE"]]}], ["Human rhinoviruses (HRV) are the most prevalent picornaviruses comprising more than one hundred serotypes.", {"entities": []}], ["The existing and also emerging HRVs pose severe health risks for patients with asthma or chronic obstructive pulmonary disease.", {"entities": [[89, 126, "DISEASE"], [79, 85, "DISEASE"]]}], ["Here, we developed a serotype-independent infection assay using a commercially available mouse monoclonal antibody (mabJ2) detecting double-strand RNA.", {"entities": []}], ["Immunocytochemical staining for RNA replication centers using mabJ2 identified cells that were infected with either HRV1A, 2, 14, 16, 37 or coxsackievirus (CV) B3, B4 or A21.", {"entities": []}], ["MabJ2 labeled-cells were immunocytochemically positive for newly synthesized viral capsid proteins from HRV1A, 14, 16, 37 or CVB3, 4.", {"entities": []}], ["We optimized the procedure for detection of virus replication in settings for high content screening with automated fluorescence microscopy and single cell analysis.", {"entities": []}], ["Our data show that the infection signal was dependent on multiplicity, time and temperature of infection, and the mabJ2-positive cell numbers correlated with viral titres determined in single step growth curves.", {"entities": []}], ["The mabJ2 infection assay was adapted to determine the efficacy of anti-viral compounds and small interfering RNAs (siRNAs) blocking enterovirus infections.", {"entities": []}], ["We report a broadly applicable, rapid protocol to measure infection of cultured cells with enteroviruses at single cell resolution.", {"entities": []}], ["This assay can be applied to a wide range of plus-sense RNA viruses, and hence allows comparative studies of viral infection biology without dedicated reagents or procedures.", {"entities": []}], ["This protocol also allows to directly compare results from small compound or siRNA infection screens for different serotypes without the risk of assay specific artifacts.", {"entities": []}], ["The aims of the study were: (1) to compare numerical parameters of specific airway resistance (total, sRaw tot , effective, sRaw eff and at 0.5 L \u00b7 s 0.5 ) and indices obtained from the forced oscillation technique (FOT: resistance extrapolated at 0 Hz [Rrs 0 Hz ], mean resistance [Rrs mean ], and resistance/frequency slope [Rrs slope ]) and (2) to assess their relationships with dyspnea in chronic obstructive pulmonary disease (COPD).", {"entities": [[394, 431, "DISEASE"]]}], ["A specific statistical approach, principal component analysis that also allows graphic representation of all correlations between functional parameters was used.", {"entities": []}], ["A total of 108 patients (mean \u00b1 SD age: 65 \u00b1 9 years, 31 women; GOLD stages: I, 14; II, 47; III, 39 and IV, 8) underwent spirometry, body plethysmography, FOT, and Medical Research Council (MRC) scale assessments.", {"entities": []}], ["Principal component analysis determined that the functional parameters were described by three independent dimensions (airway caliber, lung volumes and their combination, specific resistance) and that resistance parameters of the two techniques were not equivalent, obviously.", {"entities": []}], ["Correlative analyses further showed that Raw tot and Raw eff (and their specific resistances) can be considered as equivalent and correlated with indices that are considered to explore peripheral airways (residual volume (RV), RV/ total lung capacity (TLC), Rrs slope ), while Rrs mean and Raw 0.5 explored more central airways.", {"entities": []}], ["Only specific resistances taking into account the specific resistance loop area (sRaw tot and sRaw eff ) and Rrs slope were statistically linked to dyspnea.", {"entities": []}], ["Parameters obtained from both body plethysmography and FOT can explore peripheral airways, and some of these parameters (sRaw tot , sRaw eff, and Rrs slope ) are linked to activity-related dyspnea in moderate to severe COPD patients.", {"entities": []}], ["Using data from two population-based birth cohorts, Danielle Belgrave and colleagues examine the evidence for atopic march in developmental profiles for allergic disorders.", {"entities": []}], ["Please see later in the article for the Editors' Summary The term \u201catopic march\u201d has been used to imply a natural progression of a cascade of symptoms from eczema to asthma and rhinitis through childhood.", {"entities": [[177, 185, "DISEASE"], [166, 172, "DISEASE"]]}], ["We hypothesize that this expression does not adequately describe the natural history of eczema, wheeze, and rhinitis during childhood.", {"entities": [[108, 116, "DISEASE"]]}], ["We propose that this paradigm arose from cross-sectional analyses of longitudinal studies, and may reflect a population pattern that may not predominate at the individual level.", {"entities": []}], ["Data from 9,801 children in two population-based birth cohorts were used to determine individual profiles of eczema, wheeze, and rhinitis and whether the manifestations of these symptoms followed an atopic march pattern.", {"entities": [[129, 137, "DISEASE"]]}], ["Children were assessed at ages 1, 3, 5, 8, and 11 y.", {"entities": []}], ["We used Bayesian machine learning methods to identify distinct latent classes based on individual profiles of eczema, wheeze, and rhinitis.", {"entities": [[130, 138, "DISEASE"]]}], ["This approach allowed us to identify groups of children with similar patterns of eczema, wheeze, and rhinitis over time.", {"entities": [[101, 109, "DISEASE"]]}], ["Using a latent disease profile model, the data were best described by eight latent classes: no disease (51.3%), atopic march (3.1%), persistent eczema and wheeze (2.7%), persistent eczema with later-onset rhinitis (4.7%), persistent wheeze with later-onset rhinitis (5.7%), transient wheeze (7.7%), eczema only (15.3%), and rhinitis only (9.6%).", {"entities": [[205, 213, "DISEASE"], [257, 265, "DISEASE"], [324, 332, "DISEASE"]]}], ["When latent variable modelling was carried out separately for the two cohorts, similar results were obtained.", {"entities": []}], ["Highly concordant patterns of sensitisation were associated with different profiles of eczema, rhinitis, and wheeze.", {"entities": [[95, 103, "DISEASE"]]}], ["The main limitation of this study was the difference in wording of the questions used to ascertain the presence of eczema, wheeze, and rhinitis in the two cohorts.", {"entities": [[135, 143, "DISEASE"]]}], ["The developmental profiles of eczema, wheeze, and rhinitis are heterogeneous; only a small proportion of children (\u223c7% of those with symptoms) follow trajectory profiles resembling the atopic march.", {"entities": [[50, 58, "DISEASE"]]}], ["Please see later in the article for the Editors' Summary Our immune system protects us from viruses, bacteria, and other pathogens by recognizing specific molecules on the invader's surface and initiating a sequence of events that culminates in the death of the pathogen.", {"entities": []}], ["Sometimes, however, our immune system responds to harmless materials (allergens such as pollen) and triggers allergic, or atopic, symptoms.", {"entities": []}], ["Common atopic symptoms include eczema (transient dry itchy patches on the skin), wheeze (high pitched whistling in the chest, a symptom of asthma), and rhinitis (sneezing or a runny nose in the absence of a cold or influenza).", {"entities": [[215, 224, "DISEASE"], [152, 160, "DISEASE"], [139, 145, "DISEASE"]]}], ["All these symptoms are very common during childhood, but recent epidemiological studies (examinations of the patterns and causes of diseases in a population) have revealed age-related changes in the proportions of children affected by each symptom.", {"entities": []}], ["So, for example, eczema is more common in infants than in school-age children.", {"entities": []}], ["These findings have led to the idea of \u201catopic march,\u201d a natural progression of symptoms within individual children that starts with eczema, then progresses to wheeze and finally rhinitis.", {"entities": [[179, 187, "DISEASE"]]}], ["The concept of atopic march has led to the initiation of studies that aim to prevent the development of asthma in children who are thought to be at risk of asthma because they have eczema.", {"entities": [[104, 110, "DISEASE"], [156, 162, "DISEASE"]]}], ["Moreover, some guidelines recommend that clinicians tell parents that children with eczema may later develop asthma or rhinitis.", {"entities": [[119, 127, "DISEASE"], [109, 115, "DISEASE"]]}], ["However, because of the design of the epidemiological studies that support the concept of atopic march, children with eczema who later develop wheeze and rhinitis may actually belong to a distinct subgroup of children, rather than representing the typical progression of atopic diseases.", {"entities": [[154, 162, "DISEASE"]]}], ["It is important to know whether atopic march adequately describes the natural history of atopic diseases during childhood to avoid the imposition of unnecessary strategies on children with eczema to prevent asthma.", {"entities": [[207, 213, "DISEASE"]]}], ["Here, the researchers use machine learning techniques to model the developmental profiles of eczema, wheeze, and rhinitis during childhood in two large population-based birth cohorts by taking into account time-related (longitudinal) changes in symptoms within individuals.", {"entities": [[113, 121, "DISEASE"]]}], ["Machine learning is a data-driven approach that identifies structure within the data (for example, a typical progression of symptoms) using unsupervised learning of latent variables (variables that are not directly measured but are inferred from other observable characteristics).", {"entities": []}], ["The researchers used data from two UK birth cohorts\u2014the Avon Longitudinal Study of Parents and Children (ALSPAC) and the Manchester Asthma and Allergy Study (MAAS)\u2014for their study (9,801 children in total).", {"entities": [[132, 138, "DISEASE"]]}], ["Both studies enrolled children at birth and monitored their subsequent health at regular review clinics.", {"entities": []}], ["At each review clinic, information about eczema, wheeze, and rhinitis was collected from the parents using validated questionnaires.", {"entities": [[61, 69, "DISEASE"]]}], ["The researchers then used these data and machine learning methods to identify groups of children with similar patterns of onset of eczema, wheeze, and rhinitis over the first 11 years of life.", {"entities": [[151, 159, "DISEASE"]]}], ["Using a type of statistical model called a latent disease profile model, the researchers found that the data were best described by eight latent classes\u2014no disease (51.3% of the children), atopic march (3.1%), persistent eczema and wheeze (2.7%), persistent eczema with later-onset rhinitis (4.7%), persistent wheeze with later-onset rhinitis (5.7%), transient wheeze (7.7%), eczema only (15.3%), and rhinitis only (9.6%).", {"entities": [[282, 290, "DISEASE"], [334, 342, "DISEASE"], [401, 409, "DISEASE"]]}], ["These findings show that, in two large UK birth cohorts, the developmental profiles of eczema, wheeze, and rhinitis were heterogeneous.", {"entities": [[107, 115, "DISEASE"]]}], ["Most notably, the progression of symptoms fitted the profile of atopic march in fewer than 7% of children with symptoms.", {"entities": []}], ["The researchers acknowledge that their study has some limitations.", {"entities": []}], ["For example, small differences in the wording of the questions used to gather information from parents about their children's symptoms in the two cohorts may have slightly affected the findings.", {"entities": []}], ["However, based on their findings, the researchers propose that, because eczema, wheeze, and rhinitis are common, these symptoms often coexist in individuals, but as independent entities rather than as a linked progression of symptoms.", {"entities": [[92, 100, "DISEASE"]]}], ["Thus, using eczema as an indicator of subsequent asthma risk and assigning \u201cpreventative\u201d measures to children with eczema is flawed.", {"entities": [[49, 55, "DISEASE"]]}], ["Importantly, clinicians need to understand the heterogeneity of patterns of atopic diseases in children and to communicate this variability to parents when advising them about the development and resolution of atopic symptoms in their children.", {"entities": []}], ["Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001748 .", {"entities": []}], ["The UK National Health Service Choices website provides information about eczema (including personal stories), asthma (including personal stories), and rhinitis The US National Institute of Allergy and Infectious Diseases provides information about atopic diseases The UK not-for-profit organization Allergy UK provides information about atopic diseases and a description of the atopic march MedlinePlus encyclopedia has pages on eczema , wheezing , and rhinitis (in English and Spanish) MedlinePlus provides links to further resources about allergies , eczema , and asthma (in English and Spanish) Information about ALSPAC and MAAS is available Wikipedia has pages on machine learning and latent disease profile models (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)", {"entities": [[152, 160, "DISEASE"], [454, 462, "DISEASE"], [111, 117, "DISEASE"], [567, 573, "DISEASE"]]}], ["Few studies have investigated the drug utilization patterns and factors predicting drug use in pregnant women with migraine.", {"entities": [[115, 123, "DISEASE"]]}], ["This longitudinal drug utilization study aimed to describe patterns of analgesic use in a sample of Norwegian pregnant women according to their migraine history, and to identify predictors for analgesic use among these women.", {"entities": [[144, 152, "DISEASE"]]}], ["Pregnant women giving birth at Akershus University Hospital between 2008 and 2010 were recruited at ultrasound examination in gestational week 17.", {"entities": []}], ["Data were collected by questionnaires in gestational weeks 17 and 32, and at 8\u00a0weeks postpartum, and linked to birth records.", {"entities": []}], ["Women were grouped into four categories according to migraine history: no migraine history, previous migraine history, recent migraine history (within 1\u00a0year prior to pregnancy) and migraine in pregnancy.", {"entities": [[53, 61, "DISEASE"], [74, 82, "DISEASE"], [101, 109, "DISEASE"], [126, 134, "DISEASE"], [182, 190, "DISEASE"]]}], ["Patterns of use of analgesics were analyzed descriptively.", {"entities": []}], ["Multivariable logistic regression was used to identify factors predicting analgesic use.", {"entities": []}], ["Out of 1981 women, 5.0% reported having migraine in pregnancy, 13.2% had a recent history of migraine, 11.5% had a previous history of migraine, and 68.8% reported no history of migraine.", {"entities": [[40, 48, "DISEASE"], [93, 101, "DISEASE"], [135, 143, "DISEASE"], [178, 186, "DISEASE"]]}], ["Analgesic use declined during pregnancy.", {"entities": []}], ["Many women switched from triptans and non-steroidal anti-inflammatory drugs to paracetamol, which constituted most of the analgesic use.", {"entities": []}], ["Factors associated with analgesic use included recent migraine history (OR 1.6, 95% CI 1.2\u20132.2), more severe headache intensity (OR 1.3, 95% CI 1.3\u20131.4), smoking (OR 1.9, 95% CI 1.1\u20133.3) and multiparity (OR 1.4, 95% CI 1.1\u20131.7).", {"entities": [[54, 62, "DISEASE"]]}], ["Women with migraine stop or switch medications during pregnancy.", {"entities": [[11, 19, "DISEASE"]]}], ["Analgesic use in pregnancy is affected by migraine characteristics and intensity, and also by socio-demographic factors.", {"entities": [[42, 50, "DISEASE"]]}], ["Clinicians should bear this in mind when giving advice on adequate management of migraine in pregnancy and safe analgesic use.", {"entities": [[81, 89, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12884-017-1399-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Patients with visual vertigo ( VV ) report dizziness provoked by moving visual surroundings.", {"entities": []}], ["It has been suggested that these subjects develop a compensation strategy for a vestibulo\u2010proprioceptive deficit and rely excessively on visual input.", {"entities": []}], ["We have postulated that patients with VV might have brain abnormalities that interfere with appropriate processing of visual stimulation and performed a brain MRI study to verify this hypothesis.", {"entities": []}], ["Patients with VV of more than 3\u00a0months duration were included.", {"entities": []}], ["They were asked to complete the Situational Characteristic Questionnaire ( SCQ ) that scores for the symptoms of VV .", {"entities": []}], ["Dizzy patients without VV served as controls.", {"entities": []}], ["A brain MRI was performed with a Siemens 1.5 Tesla scanner in patients and controls.", {"entities": []}], ["Twenty\u2010four patients with VV were included.", {"entities": []}], ["Their mean SCQ score was 1.45\u00a0\u00b1\u00a00.9 (normal 0.16\u00a0\u00b1\u00a00.28).", {"entities": []}], ["In 50% of patients, abnormalities in MRI imaging were found.", {"entities": []}], ["Thirty\u2010three percent of 27 controls demonstrated an abnormal brain MRI .", {"entities": []}], ["The two groups were similar in respect to the prevalence of a localized hemispheric or posterior fossa lesion ( P \u00a0=\u00a00.13), but VV patients had more unspecific white matter brain changes than controls ( P \u00a0=\u00a00.009).", {"entities": []}], ["Patients and controls did not differ in age and gender distribution ( P \u00a0=\u00a00.9) or the history of a neurotological event preceding their symptoms ( P \u00a0=\u00a00.3).", {"entities": []}], ["Our study suggests that multiple white matter lesions might contribute to occurrence of the phenomenon of VV .", {"entities": []}], ["Future prospective large\u2010scale studies by specific MR techniques are indicated to validate our preliminary findings and elucidate the pathological mechanism of VV .", {"entities": []}], ["Obesity and related complications have now became epidemic both in developed and developing countries.", {"entities": [[0, 7, "DISEASE"]]}], ["Cafeteria type diet mainly composed of high fat high carbohydrate components which plays a significant role in the development of obesity and metabolic syndrome.", {"entities": [[130, 137, "DISEASE"], [152, 160, "DISEASE"]]}], ["This study investigated the effect of Syzygium cumini seed powder on fat accumulation and dyslipidemia in high carbohydrate high fat diet (HCHF) induced obese rats.", {"entities": []}], ["Male Wistar rats were fed with HCHF diet ad libitum, and the rats on HCHF diet were supplemented with Syzygium cumini seed powder for 56\u00a0days (2.5% w /w of diet).", {"entities": []}], ["Oral glucose tolerance test, lipid parameters, liver marker enzymes (AST, ALT and ALP) and lipid peroxidation products were analyzed at the end of 56\u00a0days.", {"entities": []}], ["Moreover, antioxidant enzyme activities were also measured in all groups of rats.", {"entities": []}], ["Supplementation with Syzygium cumini seed powder significantly reduced body weight gain, white adipose tissue (WAT) weights, blood glucose, serum insulin, and plasma lipids such as total cholesterol, triglyceride, LDL and HDL concentration.", {"entities": []}], ["Syzygium cumini seed powder supplementation in HCHF rats improved serum aspartate amino transferase (AST), alanine amino transferase (ALT), and alkaline phosphatase (ALP) activities.", {"entities": []}], ["Syzygium cumini seed powder supplementation also reduced the hepatic thiobarbituric acid reactive substances (TBARS) and elevated the antioxidant enzyme superoxide dismutase (SOD) and catalase (CAT) activities as well as increased glutathione (GSH) concentration.", {"entities": []}], ["In addition, histological assessment showed that Syzygium cumini seed powder supplementation prevented inflammatory cell infiltration; fatty droplet deposition and fibrosis in liver of HCHFD fed rats.", {"entities": []}], ["Our investigation suggests that Syzygium cumini seed powder supplementation prevents oxidative stress and showed anti-inflammatory and antifibrotic activity in liver of HCHF diet fed rats.", {"entities": []}], ["In addition, Syzygium cumini seed powder may be beneficial in ameliorating insulin resistance and dyslipidemia probably by increasing lipid metabolism in liver of HCHF diet fed rats.", {"entities": []}], ["Background : Hibernation involves periods of severely depressed metabolism (torpor) and decreases in body temperature (Tb).", {"entities": []}], ["Small arctic mammals (<5kg), in which Tb generally drop drastically, display leukopenia during hibernation.", {"entities": [[77, 87, "DISEASE"]]}], ["This raised the question of whether the decreased leukocyte counts in mammalian hibernators is due to torpor per se or is secondary to low Tb.", {"entities": []}], ["The present study examined immune cell counts in brown bears ( Ursus arctos ), where torpor is only associated with shallow decreases in Tb.", {"entities": []}], ["The results were compared across hibernator species for which immune and Tb data were available.", {"entities": []}], ["Methods and Results : The white blood cell counts were determined by flow cytometry in 13 bears captured in the field both during summer and winter over 2 years time.", {"entities": []}], ["Tb dropped from 39.6\u00b10.8 to 33.5\u00b11.1\u00b0C during hibernation.", {"entities": []}], ["Blood neutrophils and monocytes were lower during hibernation than during the active period (47%, p= 0.001; 43%, p=0.039, respectively), whereas no change in lymphocyte counts was detected (p=0.599).", {"entities": []}], ["Further, combining our data and those from 10 studies on 9 hibernating species suggested that the decline in Tb explained the decrease in innate immune cells (R Conclusions : Bears have fewer innate immune cells in circulation during hibernation, which may represent a suppressed innate immune system.", {"entities": []}], ["Across species comparison suggests that, both in small and large hibernators, Tb is the main driver of immune function regulation during winter dormancy.", {"entities": []}], ["The lack of a difference in lymphocyte counts in this context requires further investigations.", {"entities": []}], ["Pre-eclampsia (PE) remains a disease of theories despite extensive research into its etiology.", {"entities": [[4, 13, "DISEASE"], [0, 13, "DISEASE"]]}], ["Alteration in the production of vascular endothelial growth factor (VEGF), a biomarker of endothelial dysfunction, is associated with pre-eclampsia although conflicting reports have been reported.", {"entities": [[138, 147, "DISEASE"], [134, 147, "DISEASE"]]}], ["The aim of the study was to determine and compare maternal serum levels of VEGF among pre-eclamptics, normotensive non pregnant and pregnant women.", {"entities": []}], ["This was a cross-sectional study involving 100 women with pre-eclampsia, 102 women with normotensive pregnancy and 75 normotensives who were not pregnant.", {"entities": [[62, 71, "DISEASE"], [58, 71, "DISEASE"]]}], ["The study was carried out at Korle Bu Teaching Hospital (KBTH) from April to June in 2011.", {"entities": []}], ["Basic socio-demographic and obstetric data were obtained by means of structured questionnaire.", {"entities": []}], ["Following venesection, about 5mls of blood was sampled from the participants for the various tests.", {"entities": []}], ["Enzyme Linked Immunosorbent Assay was used to determine the maternal serum levels of free VEGF.", {"entities": []}], ["Data analysis was performed using SPSS version 20.", {"entities": []}], ["Significant reduction in median serum levels of free VEGF was seen in both, normal pregnant [84.06\u00a0pg/ml (IQR: 78.90\u201399.67)] and pre-eclamptic women [4.71\u00a0pg/ml, (IQR: 3.41\u20137.93)] compared to the non-pregnant (395.85\u00a0pg/ml, IQR 234.93\u2013625) with p \u2009<\u20090.001; the reduction was far greater in the pre-eclamptic group compared to that of normotensive pregnant group ( p \u2009<\u20090.001).", {"entities": []}], ["Early-onset pre-eclampsia had significantly more severe reduction in free VEGF levels (3.89, IQR: 2.60\u20135.67\u00a0pg/ml) compared to that of late onset PE (5.23, IQR: 3.78\u201316.97\u00a0pg/ml) with p <0.001 indicating a severer endothelial damage in former.", {"entities": [[16, 25, "DISEASE"], [12, 25, "DISEASE"]]}], ["Endothelial dysfunction contributes significantly to the pathogenesis of pre-eclampsia as demonstrated by profound decrease in maternal serum VEGF levels in PE compared to normotensive pregnancy and non-pregnancy state.", {"entities": [[77, 86, "DISEASE"], [73, 86, "DISEASE"]]}], ["The pathophysiology of early-onset pre-eclampsia may be partly explained by marked reduction in free serum VEGF levels with resultant severe endothelial dysfunction.", {"entities": [[39, 48, "DISEASE"], [35, 48, "DISEASE"]]}], ["Environmental factors are likely to have profound effects on the development of host immune responses, with serious implications for infectious diseases and inflammatory disorders such as asthma.", {"entities": [[188, 194, "DISEASE"]]}], ["This study was designed to investigate the effects of environmental exposures on the cytokine profile of children.", {"entities": []}], ["The study involved measurement of T helper (Th) 1 (interferon-gamma), 2 [interleukin (IL)-5 and IL-13], and the regulatory cytokine IL-10 in unstimulated peripheral blood leukocytes from 1,376 children 4\u201311 years of age living in a poor urban area of the tropics.", {"entities": []}], ["We also assessed the impact of environmental exposures in addition to biological characteristics recorded at the time of blood collection and earlier in childhood (0\u20133 years before blood collection).", {"entities": []}], ["The proportion of children producing IL-10 was greater among those without access to drinking water [ p < 0.05, chi-square test, odds ratio (OR) = 1.67].", {"entities": []}], ["The proportion of children producing IL-5 and IL-10 (OR = 10.76) was significantly greater in households that had never had a sewage system ( p < 0.05, trend test).", {"entities": []}], ["These data provide evidence for the profound effects of environmental exposures in early life as well as immune homeostasis in later childhood.", {"entities": []}], ["Decreased hygiene (lack of access to clean drinking water and sanitation) in the first 3 years of life is associated with higher spontaneous IL-10 production up to 8 years later in life.", {"entities": []}], ["Assessment of potential allergenicity of protein is necessary whenever transgenic proteins are introduced into the food chain.", {"entities": []}], ["Bioinformatics approaches in allergen prediction have evolved appreciably in recent years to increase sophistication and performance.", {"entities": []}], ["However, what are the critical features for protein's allergenicity have been not fully investigated yet.", {"entities": []}], ["We presented a more comprehensive model in 128 features space for allergenic proteins prediction by integrating various properties of proteins, such as biochemical and physicochemical properties, sequential features and subcellular locations.", {"entities": []}], ["The overall accuracy in the cross-validation reached 93.42% to 100% with our new method.", {"entities": []}], ["Maximum Relevance Minimum Redundancy (mRMR) method and Incremental Feature Selection (IFS) procedure were applied to obtain which features are essential for allergenicity.", {"entities": []}], ["Results of the performance comparisons showed the superior of our method to the existing methods used widely.", {"entities": []}], ["More importantly, it was observed that the features of subcellular locations and amino acid composition played major roles in determining the allergenicity of proteins, particularly extracellular/cell surface and vacuole of the subcellular locations for wheat and soybean.", {"entities": []}], ["To facilitate the allergen prediction, we implemented our computational method in a web application, which can be available at http://gmobl.sjtu.edu.cn/PREAL/index.php .", {"entities": []}], ["Our new approach could improve the accuracy of allergen prediction.", {"entities": []}], ["And the findings may provide novel insights for the mechanism of allergies.", {"entities": []}], ["In response to viral infection, bronchial epithelial cells increase inflammatory cytokine release to activate the immune response and curtail viral replication.", {"entities": []}], ["In atopic asthma, enhanced expression of Th2 cytokines is observed and we postulated that Th2 cytokines may augment the effects of rhinovirus-induced inflammation.", {"entities": [[10, 16, "DISEASE"]]}], ["Primary bronchial epithelial cell cultures from pediatric subjects were treated with Th2 cytokines for 24 h before infection with RV16.", {"entities": []}], ["Release of IL-8, IP-10 and GM-CSF was measured by ELISA.", {"entities": []}], ["Infection was quantified using RTqPCR and TCID 50 .", {"entities": []}], ["Phosphatidyl inositol 3-kinase (PI3K) and P38 mitogen activated protein kinase (MAPK) inhibitors and dexamethasone were used to investigate differences in signaling pathways.", {"entities": []}], ["The presence of Th2 cytokines did not affect RV replication or viral titre, yet there was a synergistic increase in IP-10 release from virally infected cells in the presence of Th2 cytokines.", {"entities": []}], ["Release of IL-8 and GM-CSF was also augmented.", {"entities": []}], ["IP-10 release was blocked by a PI3K inhibitor and IL-8 by dexamethasone.", {"entities": []}], ["Th2 cytokines increase release of inflammatory cytokines in the presence of rhinovirus infection.", {"entities": []}], ["This increase is independent of effects of virus replication.", {"entities": []}], ["Inhibition of the PI3K pathway inhibits IP-10 expression.", {"entities": []}], ["Human milk banks are a solution for mothers who cannot supply their own breast milk to their sick or hospitalized infants; premature infants, in particular, are unable to receive a full volume of breast milk for numerous reasons.", {"entities": []}], ["As of December 2015, there was only one milk bank in a university hospital in Korea.", {"entities": []}], ["We reviewed the basic characteristics of donors and recipients, and the amounts and contamination of breast milk donated at the Human Milk Bank in Kyung Hee University Hospital at Gangdong in Korea from 2008 to 2015.", {"entities": []}], ["The donor pool consisted of 463 first-time donors and 452 repeat donors who made 1,724 donations.", {"entities": []}], ["A total of 10,820 L of breast milk was collected, and 9,541.6 L were processed.", {"entities": []}], ["Detectable bacteria grew in 12.6% after pasteurization and 52.5% had cytomegalovirus DNA before pasteurization in donated milk.", {"entities": []}], ["There were 836 infant and 25 adult recipients; among new infant recipients, 48.5% were preterm; the groups received 8,009 and 165.7 L of donor milk, respectively.", {"entities": []}], ["There was an increase in the percentage of preterm infants among new infant recipients in 2015 (93.1%) compared to 2008 (8.5%).", {"entities": []}], ["Based on the number of premature infants in Korea, the number of potential recipients is not likely to diminish anytime soon, despite efforts to improve the breastfeeding rate.", {"entities": []}], ["Sustainability and quality improvement of the milk bank need long-term financial support by health authorities and a nationwide network similar to blood banking will further contribute to the progress of milk banking.", {"entities": []}], ["Cholesterol undergoes ozonolysis to afford a variety of oxysterol products, including cholesterol-5,6-epoxide (CholEp) and the isomeric aldehydes secosterol A (seco A) and secosterol B (seco B).", {"entities": []}], ["These oxysterols display numerous important biological activities, including protein adduction; however, much remains to be learned about the identity of the reactive species and the range of proteins modified by these oxysterols.", {"entities": []}], ["Here, we synthesized alkynyl derivatives of cholesterol-derived oxysterols and employed a straightforward detection method to establish secosterols A and B as the most protein-reactive of the oxysterols tested.", {"entities": []}], ["Model adduction studies with an amino acid, peptides, and proteins provide evidence for the potential role of secosterol dehydration products in protein adduction.", {"entities": []}], ["Hydrophobic separation methods\u2014Folch extraction and solid phase extraction (SPE)\u2014were successfully applied to enrich oxysterol-adducted peptide species, and LC-MS/MS analysis of a model peptide\u2013seco adduct revealed a unique fragmentation pattern (neutral loss of 390 Da) for that species.", {"entities": []}], ["Coupling a hydrophobic enrichment method with proteomic analysis utilizing characteristic fragmentation patterns facilitates the identification of secosterol-modified peptides and proteins in an adducted protein.", {"entities": []}], ["More broadly, these improved enrichment methods may give insight into the role of oxysterols and ozone exposure in the pathogenesis of a variety of diseases, including atherosclerosis, Alzheimer\u2019s disease, Parkinson\u2019s disease, and asthma.", {"entities": [[168, 183, "DISEASE"], [231, 237, "DISEASE"]]}], ["Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival.", {"entities": []}], ["We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay.", {"entities": []}], ["However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5\u2013dependent functional responses.", {"entities": []}], ["In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties.", {"entities": []}], ["This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5.", {"entities": []}], ["In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein.", {"entities": []}], ["This IL-5 mutant enables us to clearly distinguish between two IL-5\u2013dependent functional responses and reveals distinct mechanisms of receptor/cellular activation.", {"entities": []}], ["CD66b is a member of the carcinoembryonic antigen family, which mediates the adhesion between neutrophils and to endothelial cells.", {"entities": []}], ["Allergen-specific immunotherapy is widely used to treat allergic diseases, and the molecular mechanisms underlying this therapy are poorly understood.", {"entities": []}], ["The present work was undertaken to analyze A) the in vitro effect of allergens and immunotherapy on cell-surface CD66b expression of neutrophils from patients with allergic asthma and rhinitis and B) the in vivo effect of immunotherapy on cell-surface CD66b expression of neutrophils from nasal lavage fluid during the spring season.", {"entities": [[164, 179, "DISEASE"], [184, 192, "DISEASE"], [173, 179, "DISEASE"]]}], ["Myeloperoxidase expression and activity was also analyzed in nasal lavage fluid as a general marker of neutrophil activation.", {"entities": []}], ["CD66b cell-surface expression is upregulated in vitro in response to allergens, and significantly reduced by immunotherapy (p<0.001).", {"entities": []}], ["Myeloperoxidase activity in nasal lavage fluid was also significantly reduced by immunotherapy, as were the neutrophil cell-surface expression of CD66b and myeloperoxidase (p<0.001).", {"entities": []}], ["Interestingly, CD66b expression was higher in neutrophils from nasal lavage fluid than those from peripheral blood, and immunotherapy reduced the number of CD66", {"entities": []}], ["A lack of physical activity is common in older adults.", {"entities": []}], ["With the increasing Canadian senior population, identifying the minimum amount of physical activity required to maintain the health of older adults is essential.", {"entities": []}], ["This study determined whether relationships existed between the Physical Activity Scale for the Elderly (PASE) questionnaire scores and health-related measurements in community-dwelling older adults who were meal delivery volunteers.", {"entities": []}], ["Based on observed relationships between PASE scores and health parameters, the study attempted to predict an optimal PASE score that would ensure health parameters fell in desired ranges for older adults.", {"entities": []}], ["297 community-dwelling older adults (61.3% female) 60\u201388 years (72.1 \u00b1 6.5) completed the PASE and were measured for body composition, cardiovascular and blood parameters, flexibility, and handgrip strength.", {"entities": []}], ["Significant regression models using PASE were produced for the health-related measures, but the relationships were not meaningful due to low predictive capacity.", {"entities": []}], ["However, correlational data suggested that a minimum PASE score of ~140 for males and ~120 for females predicted a favorable waist circumference.", {"entities": []}], ["In conclusion, findings demonstrated that PASE scores cannot be used to predict healthy physical measures, although the relationships between PASE and WC could be used to encourage older adults to become more physically active.", {"entities": []}], ["Cardiopulmonary diseases are major causes of death worldwide, but currently recommended strategies for diagnosis and prevention may be outdated because of recent changes in risk factor patterns.", {"entities": []}], ["The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large\u2010scale \u2018omics\u2019 and epidemiological analyses to extensively characterize a Swedish cohort of 30\u00a0000 men and women aged between 50 and 64\u00a0years.", {"entities": []}], ["The information obtained will be used to improve risk prediction of cardiopulmonary diseases and optimize the ability to study disease mechanisms.", {"entities": []}], ["A comprehensive pilot study in 1111 individuals, which was completed in 2012, demonstrated the feasibility and financial and ethical consequences of SCAPIS.", {"entities": []}], ["Recruitment to the national, multicentre study has recently started.", {"entities": []}], ["Recent results suggest that adverse health effects of air pollution exist at levels of pollutants around or even below air quality standards set by national and international institutions.", {"entities": []}], ["Furthermore, there are indications that air pollution effects on health may be partly determined by specific mixtures of air pollutants and may be altered by other environmental, behavioral, and social patterns.", {"entities": []}], ["Southern European countries share some common characteristics in terms of climate, geography, and life activity patterns.", {"entities": []}], ["Results from studies undertaken in France, Greece, Italy, Portugal, and Spain investigating short- and long-term air pollution health effects are presented and their consistency demonstrated.", {"entities": []}], ["These results provide adequate evidence that health effects--particularly short-term--of the currently measured urban air pollution levels exist.", {"entities": []}], ["However, information available so far does not allow an assessment of regional differences in the health effects of air pollution as far as the Mediterranean region of Europe is concerned.", {"entities": []}], ["It is suggested that the interaction between the traditional pollution (mainly characterized by high levels of black smoke and SO2) and photochemical pollution must be investigated in this area, as well as the possible interaction between air pollution and high temperature and other meteorologic factors.", {"entities": []}], ["In addition, measurements of individual exposure to different pollutants, affected by the pollutant's levels in specific micro-environments and the individual's time-activity pattern, must be undertaken for a better understanding of the air pollution-health link.", {"entities": []}], ["Finally, the importance of the reported air pollution health effects in terms of public health must be addressed more closely.", {"entities": []}], ["Poly(ADP-ribose)polymerase and sirtuin 1 are both NAD In vitro oxidative stress activates poly(ADP-ribose)polymerase, decreases NAD in vitro .", {"entities": []}], ["In vitro sirtuin 1 induction protects neurons from cell loss induced by oxidative stress.", {"entities": []}], ["In this context, the role of sirtuin 1 and its involvement in beneficial effects of poly(ADP-ribose)polymerase inhibition were evaluated in vivo in a model of cerebral oxidative stress induced by intrastriatal infusion of malonate in rat.", {"entities": []}], ["Malonate promoted a NAD in vivo cerebral oxidative stress.", {"entities": []}], ["Furthermore sirtuin 1 activation is involved in the beneficial effects of poly(ADP-ribose)polymerase inhibition after in vivo cerebral oxidative stress.", {"entities": []}], ["T helper (Th)17 cells producing interleukin (IL)-17 play a role in autoimmune and allergic inflammation.", {"entities": []}], ["Here, we show that IL-23 induces IL-17 in the lung and IL-17 is required during antigen sensitization to develop allergic asthma, as shown in IL-17R\u2013deficient mice.", {"entities": [[113, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["Since IL-17 expression increased further upon antigen challenge, we addressed its function in the effector phase.", {"entities": []}], ["Most strikingly, neutralization of IL-17 augmented the allergic response in sensitized mice.", {"entities": []}], ["Conversely, exogenous IL-17 reduced pulmonary eosinophil recruitment and bronchial hyperreactivity, demonstrating a novel regulatory role of IL-17.", {"entities": []}], ["Mechanistically, IL-17 down modulated eosinophil-chemokine eotaxin (CCL11) and thymus- and activation-regulated chemokine/CCL17 (TARC) in lungs in vivo and ex vivo upon antigen restimulation.", {"entities": [[68, 73, "GENE"]]}], ["In vitro, IL-17 reduced TARC production in dendritic cells (DCs)\u2014the major source of TARC\u2014and antigen uptake by DCs and IL-5 and IL-13 production in regional lymph nodes.", {"entities": []}], ["Furthermore, IL-17 is regulated in an IL-4\u2013dependent manner since mice deficient for IL-4R\u03b1 signaling showed a marked increase in IL-17 concentration with inhibited eosinophil recruitment.", {"entities": []}], ["Therefore, endogenous IL-17 is controlled by IL-4 and has a dual role.", {"entities": []}], ["Although it is essential during antigen sensitization to establish allergic asthma, in sensitized mice IL-17 attenuates the allergic response by inhibiting DCs and chemokine synthesis.", {"entities": [[67, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["Deterioration of health related quality of life (HRQoL) is common in brain tumor patients.", {"entities": []}], ["This study evaluated validity and reliability of the Medical Outcomes Study 36-Item Short Form (SF-36) in patients with brain tumors.", {"entities": []}], ["Two hundred and seventy-seven patients admitted for brain tumor surgery were evaluated for HRQoL (SF-36 questionnaire); depressive symptoms (Beck Depression Inventory-II or BDI-II); and functional status (Barthel index or BI).", {"entities": []}], ["Final histological diagnosis was obtained from pathology reports.", {"entities": []}], ["Two-hundred and twenty-seven (completion rate of 82%) patients (69% women; mean age 55.8\u2009\u00b1\u200914.4\u00a0years) completed the SF-36 questionnaire.", {"entities": []}], ["The most common brain tumor diagnosis was meningioma (40%), followed high-grade glioma (19%).", {"entities": [[42, 52, "DISEASE"]]}], ["Missing data rates were \u22644%.", {"entities": []}], ["Internal consistency was adequate for all (Cronbach \u03b1\u2009\u2265\u2009.728) but Social Functioning (Cronbach \u03b1\u2009=\u2009.527) and General Health (Cronbach \u03b1\u2009=\u2009.693) subscales.", {"entities": []}], ["Ceiling (\u226536%) and floor (\u226522%) effect rates were the greatest for the Role Limitations subscales.", {"entities": []}], ["The SF-36 subscales pertaining physical health correlated the strongest with the BI score, while the SF-36 subscales pertaining emotional health correlated the strongest with the BDI-II score.", {"entities": []}], ["Patients with mild-moderate depressive symptoms (BDI-II score \u226520) scored lower across all SF-36 subscales, and handicap patients (BI score <90) scored the lower across all, but Mental Health, subscales.", {"entities": []}], ["The SF-36 is a valid and reliable instrument in brain tumor patients and therefore can be reliably applied for evaluation of HRQoL in neuro-oncology setting.", {"entities": []}], ["Further studies exploring other psychometric properties of the SF-36 in brain tumor patients across disease progression stages are warranted.", {"entities": []}], ["Pulmonary fibrosis (PF) is a group of devastating and largely irreversible diseases.", {"entities": [[0, 18, "DISEASE"]]}], ["Phosphodiesterase (PDE) 4 is involved in the processes of remodeling and inflammation, which play key role in tissue fibrosis.", {"entities": []}], ["The aim of the study was, therefore, to investigate the effect of PDE4 inhibition in experimental model of PF.", {"entities": []}], ["PF was induced in C57BL/6N mice by instillation of bleomycin.", {"entities": []}], ["Pharmacological inhibition of PDE4 was achieved by using cilomilast, a selective PDE4 inhibitor.", {"entities": []}], ["Changes in either lung inflammation or remodeling were evaluated at different stages of experimental PF.", {"entities": []}], ["Lung inflammation was assessed by bronchoalveolar lavage fluid (BALF) differential cell count and reverse transcription quantitative polymerase chain reaction (RT-qPCR) for inflammatory cytokines.", {"entities": []}], ["Changes in tissue remodeling were evaluated by pulmonary compliance measurement, quantified pathological examination, measurement of collagen deposition and RT-qPCR for late remodeling markers.", {"entities": []}], ["Survival in all groups was analyzed as well.", {"entities": []}], ["PDE4 inhibition significantly reduced the total number of alveolar inflammatory cells in BALF of mice with bleomycin-induced PF at early fibrosis stage (days 4 and 7).", {"entities": []}], ["Number of macrophages and lymphocytes, but not neutrophils, was significantly reduced as well.", {"entities": []}], ["Treatment decreased lung tumor necrosis factor (TNF)-\u03b1 mRNA level and increased mRNA level of interleukin (IL)-6 but did not influence IL-1\u03b2.", {"entities": [[48, 51, "GENE"]]}], ["At later stage (days 14 and 24) cilomilast improved lung function, which was shown by increase in lung compliance.", {"entities": []}], ["It also lowered fibrosis degree, as was shown by quantified pathological examination of Hematoxilin-Eosin stained lung sections.", {"entities": []}], ["Cilomilast had no significant effect on the expression of late remodeling markers such as transforming growth factor (TGF)-\u03b21 and collagen type Ia1 (COL(I)\u03b11).", {"entities": []}], ["However, it tended to restore the level of lung collagen, assessed by SIRCOL assay and Masson's trichrome staining, and to improve the overall survival.", {"entities": []}], ["Selective PDE4 inhibition suppresses early inflammatory stage and attenuates the late stage of experimental pulmonary fibrosis.", {"entities": [[108, 126, "DISEASE"]]}], ["WHO estimates suggest that age-specific death rates from non-communicable diseases are higher in sub-Saharan Africa than in high-income countries.", {"entities": []}], ["The objectives of this study were to examine, in Burkina Faso, the prevalence of non-communicable disease symptoms by age, gender, socioeconomic group and setting (rural/urban), and to assess gender and socioeconomic inequalities in the prevalence of these symptoms.", {"entities": []}], ["We obtained data from the Burkina Faso World Health Survey, which was conducted in an adult population (18 years and over) with a high response rate (4822/4880 selected individuals).", {"entities": []}], ["The survey used a multi-stage stratified random cluster sampling strategy to identify participants.", {"entities": []}], ["The survey collected information on socio-demographic and economic characteristics, as well as data on symptoms of a variety of health conditions.", {"entities": []}], ["Our study focused on joint disease, back pain, angina pectoris, and asthma.", {"entities": [[68, 74, "DISEASE"]]}], ["We estimated prevalence correcting for the sampling design.", {"entities": []}], ["We used multiple Poisson regression to estimate associations between non-communicable disease symptoms, gender, socioeconomic status and setting.", {"entities": []}], ["The overall crude prevalence and 95% confidence intervals (CI) were: 16.2% [13.5; 19.2] for joint disease, 24% [21.5; 26.6] for back pain, 17.9% [15.8; 20.2] for angina pectoris, and 11.6% [9.5; 14.2] for asthma.", {"entities": [[205, 211, "DISEASE"]]}], ["Consistent relationships between age and the prevalence of non-communicable disease symptoms were observed in both men and women from rural and urban settings.", {"entities": []}], ["There was markedly high prevalence in all conditions studied, starting with young adults.", {"entities": []}], ["Women presented higher prevalence rates of symptoms than men for all conditions: prevalence ratios and 95% CIs were 1.20 [1.01; 1.43] for joint disease, 1.42 [1.21; 1.66] for back pain, 1.68 [1.39; 2.04] for angina pectoris, and 1.28 [0.99; 1.65] for asthma.", {"entities": [[251, 257, "DISEASE"]]}], ["Housewives and unemployed women had the highest prevalence rates of non-communicable disease symptoms.", {"entities": []}], ["Our work suggests that social inequality extends into the distribution of non-communicable diseases among social groups and supports the thesis of a differential vulnerability in Burkinab\u00e8 women.", {"entities": []}], ["It raises the possibility of an abnormally high rate of premature morbidity that could manifest as a form of premature aging in the adult population.", {"entities": []}], ["Increased prevention, screening and treatment are needed in Burkina Faso to address high prevalence and gender inequalities in non-communicable diseases.", {"entities": []}], ["Lynx ( http://lynx.ci.uchicago.edu ) is a web-based database and a knowledge extraction engine.", {"entities": []}], ["It supports annotation and analysis of high-throughput experimental data and generation of weighted hypotheses regarding genes and molecular mechanisms contributing to human phenotypes or conditions of interest.", {"entities": []}], ["Since the last release, the Lynx knowledge base (LynxKB) has been periodically updated with the latest versions of the existing databases and supplemented with additional information from public databases.", {"entities": []}], ["These additions have enriched the data annotations provided by Lynx and improved the performance of Lynx analytical tools.", {"entities": []}], ["Moreover, the Lynx analytical workbench has been supplemented with new tools for reconstruction of co-expression networks and feature-and-network-based prioritization of genetic factors and molecular mechanisms.", {"entities": []}], ["These developments facilitate the extraction of meaningful knowledge from experimental data and LynxKB.", {"entities": []}], ["The Service Oriented Architecture provides public access to LynxKB and its analytical tools via user-friendly web services and interfaces.", {"entities": []}], ["Obstructive sleep apnea (OSA) is associated with systemic inflammation and induces various comorbid medical diseases.", {"entities": []}], ["To date, no study has explored the relationship between OSA and atopic dermatitis (AD), an inflammatory and autoimmune skin disorder.", {"entities": [[64, 81, "DISEASE"], [71, 81, "DISEASE"]]}], ["This study investigated the longitudinal risk for AD in patients with OSA.", {"entities": []}], ["A random sample of 1,000,000 individuals from Taiwan's National Health Insurance database was collected.", {"entities": []}], ["From this sample, 1222 patients with newly-diagnosed OSA between 2000 and 2005 were identified and compared with a matched cohort of 18330 patients without OSA.", {"entities": []}], ["All patients were tracked for 5.5 years from the index date in order to identify which patients subsequently developed AD.", {"entities": []}], ["During the 5.5-year follow-up period, the incidence rates of AD in the OSA cohort and comparison groups were 9.81 and 6.21 per 1000 person-years, respectively.", {"entities": []}], ["After adjustment for age, gender, diabetes, hypertension, coronary heart disease, obesity, allergy, allergic rhinitis, asthma, monthly income, and geographic location, patients with OSA were 1.5-times more likely to develop AD than patients without OSA (95% CI\u200a=\u200a1.15\u20131.95, p\u200a=\u200a0.0025).", {"entities": [[44, 56, "DISEASE"], [100, 117, "DISEASE"], [67, 80, "DISEASE"], [58, 80, "DISEASE"], [109, 117, "DISEASE"], [82, 89, "DISEASE"], [119, 125, "DISEASE"]]}], ["The hazard risk for AD was greater in male OSA patients and young OSA patients (0\u201318 and 19\u201334 years), adjusted HRs being 1.53 (95% CI\u200a=\u200a1.14\u20132.06, p\u200a=\u200a0.005), 4.01(95% CI\u200a=\u200a1.57\u201310.26, p\u200a=\u200a0.0038) and 1.75(95% CI\u200a=\u200a1.00\u20133.04, p\u200a=\u200a0.0483), respectively.", {"entities": []}], ["The log-rank test indicated that OSA patients <35-years-old had significantly higher cumulative incidence rates of AD than those patient of the same age in the comparison group (p\u200a=\u200a0.0001).", {"entities": []}], ["Patients with OSA, especially male patients and younger patients, are at an increased risk for AD later in life.", {"entities": []}], ["Unintentional non-adherence has been characterized as passively inconsistent medication-taking behavior (forgetfulness or carelessness).", {"entities": []}], ["Our objectives were to: (1) study the prevalence and predictors of unintentional non-adherence; and (2) explore the interrelationship between intentional and unintentional non-adherence in relation to patients\u2019 medication beliefs.", {"entities": []}], ["We conducted a cross-sectional survey of adults with asthma, hypertension, diabetes, hyperlipidemia, osteoporosis, or depression from the Harris Interactive Chronic Illness Panel.", {"entities": [[61, 73, "DISEASE"], [101, 113, "DISEASE"], [53, 59, "DISEASE"]]}], ["The analytic sample for this study included 24,017 adults who self-identified themselves as persistent to prescription medications for their index disease.", {"entities": []}], ["They answered three questions on unintentional non-adherence (forgot, ran out, being careless), 11 questions on intentional non-adherence, and three multi-item scales assessing perceived need for medication (k\u2009=\u200910), perceived medication concerns (k\u2009=\u20096), and perceived medication affordability (k\u2009=\u20094).", {"entities": []}], ["Logistic regression was used to model predictors of each unintentional non-adherence behavior.", {"entities": []}], ["Baron and Kenny\u2019s regression approach was used to test the mediational effect of unintentional non-adherence on the relationship between medication beliefs and intentional non-adherence.", {"entities": []}], ["Bootstrapping was employed to confirm the statistical significance of these results.", {"entities": []}], ["For the index disease, 62% forgot to take a medication, 37% had run out of the medication, and 23% were careless about taking the medication.", {"entities": []}], ["Common multivariate predictors (p\u2009<\u2009.001) of the three behaviors were: (1) lower perceived need for medications; (2) more medication affordability problems; (3) worse self-rated health; (4) diabetes or osteoporosis (relative to hypertension); and (5) younger age.", {"entities": [[228, 240, "DISEASE"], [202, 214, "DISEASE"]]}], ["Unique statistically-significant predictors of the three behaviors were: (a) \u2018forgot to take medications\u2019 - greater concerns about the index medication and male gender; (b) \u2018run out of medications\u2019 - non-white race, asthma, and higher number of total prescription medications; (c) \u2018being careless\u2019 - greater medication concerns.", {"entities": [[216, 222, "DISEASE"]]}], ["Mediational tests confirmed the hypothesis that the effect of medication beliefs (perceived need, concerns, and affordability) on intentional non-adherence is mediated through unintentional non-adherence.", {"entities": []}], ["For our study sample, unintentional non-adherence does not appear to be random and is predicted by medication beliefs, chronic disease, and sociodemographics.", {"entities": []}], ["The data suggests that the importance of unintentional non-adherence may lie in its potential prognostic significance for future intentional non-adherence.", {"entities": []}], ["Health care providers may consider routinely inquiring about unintentional non-adherence in order to proactively address patients\u2019 suboptimal medication beliefs before they choose to discontinue therapy all together.", {"entities": []}], ["Studies have shown that long-term sick leave is a strong predictor of disability pension.", {"entities": []}], ["However, few have aimed to disentangle the effect of sick leave and of health status.", {"entities": []}], ["The objective of this study was to investigate whether there is an association between long-term sick leave and disability pension and unemployment, when taking health status into account.", {"entities": []}], ["The study was based on the Stockholm Public Health Cohort, restricted to 13,027 employed individuals (45.9% men) aged 18\u201359 in 2002 and followed until 2007.", {"entities": []}], ["Hazard ratios (HR) with 95% Confidence Interval (CI) were estimated by Cox regression models adjusting for socio-demographic factors and five measures of health status.", {"entities": [[15, 17, "GENE"]]}], ["Having been on long-term sick leave increased the risk of disability pension (HR 4.01; 95% CI 3.19\u20135.05) and long-term unemployment (HR 1.45; 95% CI 1.05\u20132.00), after adjustment for health status.", {"entities": [[78, 80, "GENE"], [133, 135, "GENE"], [78, 80, "GENE"], [133, 135, "GENE"]]}], ["The analyses of long-term sick leave due to specific illness showed that the increased risk for long-term unemployment was confined to the group on sick leave due to musculoskeletal (HR 1.70 95% CI 1.00\u20132.89) and mental illness (HR 1.80 95% CI 1.13\u20132.88) and further that there was an increased risk for short-term unemployment in the group on sick leave due to mental illness (HR1.57 95%CI 1.09\u20132.26).", {"entities": [[183, 185, "GENE"], [229, 231, "GENE"], [183, 185, "GENE"], [229, 231, "GENE"]]}], ["Long-term sick leave increases the risks of both disability pension and unemployment even when taking health status into account.", {"entities": []}], ["The results support the hypothesis that long-term sick leave may start a process of marginalization from the labor market.", {"entities": []}], ["Several inflammatory diseases including scleroderma and atopic dermatitis display dermal thickening, epidermal hypertrophy, or excessive accumulation of collagen.", {"entities": [[56, 73, "DISEASE"], [63, 73, "DISEASE"], [40, 51, "DISEASE"]]}], ["Factors that might promote these features are of interest for clinical therapy.", {"entities": []}], ["We previously reported that LIGHT, a TNF superfamily molecule, mediated collagen deposition in the lungs in response to allergen.", {"entities": [[37, 40, "GENE"]]}], ["We therefore tested whether LIGHT might similarly promote collagen accumulation and features of skin fibrosis.", {"entities": []}], ["Strikingly, injection of recombinant soluble LIGHT into na\u00efve mice, either subcutaneously or systemically, promoted collagen deposition in the skin, and dermal and epidermal thickening.", {"entities": []}], ["This replicated the activity of bleomycin, an antibiotic that has been previously used in models of scleroderma in mice.", {"entities": [[100, 111, "DISEASE"]]}], ["Moreover skin fibrosis induced by bleomycin was dependent on endogenous LIGHT activity.", {"entities": []}], ["The action of LIGHT in vivo was mediated via both of its receptors, HVEM and LT\u03b2R, and was dependent on the innate cytokine TSLP and TGF-\u03b2.", {"entities": [[124, 128, "GENE"]]}], ["Furthermore, we found that HVEM and LT\u03b2R were expressed on human epidermal keratinocytes, and that LIGHT could directly promote TSLP expression in these cells.", {"entities": [[128, 132, "GENE"]]}], ["We reveal an unappreciated activity of LIGHT on keratinocytes and suggest that LIGHT may be an important mediator of skin inflammation and fibrosis in diseases such as scleroderma or atopic dermatitis.", {"entities": [[183, 200, "DISEASE"], [190, 200, "DISEASE"], [168, 179, "DISEASE"]]}], ["The use of online health-related social networks for support, peer-to-peer connections, and obtaining health information has increased dramatically.", {"entities": []}], ["Participation in an online health-related social network can enhance patients\u2019 self-efficacy and empowerment, as they are given knowledge and tools to manage their chronic health condition more effectively.", {"entities": []}], ["Thus, we can deduce that patient activation, the extent to which individuals are able to manage their own health care, also increases.", {"entities": []}], ["However, little is known about the effects of participation in online health-related social networks and patient activation on the perceived usefulness of a website across disease groups.", {"entities": []}], ["The intent of the study was to evaluate the effects and benefits of participation in an online health-related social network and to determine which variables predict perceived site usefulness, while examining patient activation.", {"entities": []}], ["Data were collected from \u201cCamoni\u201d, the first health-related social network in the Hebrew language.", {"entities": []}], ["It offers medical advice, including blogs, forums, support groups, internal mail, chats, and an opportunity to consult with experts.", {"entities": []}], ["This study focused on the site\u2019s five largest and most active communities: diabetes, heart disease, kidney disease, spinal injury, and depression/anxiety.", {"entities": [[100, 114, "DISEASE"], [85, 98, "DISEASE"]]}], ["Recruitment was conducted during a three-month period in which a link to the study questionnaire was displayed on the Camoni home page.", {"entities": []}], ["Three questionnaires were used: a 13-item measure of perceived usefulness (Cronbach alpha=.93) to estimate the extent to which an individual found the website helpful and informative, a 9-item measure of active involvement in the website (Cronbach alpha=.84), and The Patient Activation Measure (PAM-13, Cronbach alpha=.86), which assesses a patient\u2019s level of active participation in his or her health care.", {"entities": []}], ["There were 296 participants.", {"entities": []}], ["Men 30-39 years of age scored higher in active involvement than those 40-49 years ( P =.03), 50-64 years ( P =.004), or 65+ years ( P =.01).", {"entities": []}], ["Respondents 20-29 years of age scored higher in perceived usefulness than those 50-64 years ( P =.04) and those 65+ years ( P =.049).", {"entities": []}], ["Those aged 20-29 years scored significantly lower on the PAM-13 scale than those aged 30-39 years ( P =.01) and 50-64 years ( P =.049).", {"entities": []}], ["Men and women had similar PAM-13 scores ( F 9,283 =0.17, P =.76).", {"entities": []}], ["Several variables were significant predictors of perceived usefulness.", {"entities": []}], ["Age was a negative predictor; younger age was indicative of higher perceived usefulness.", {"entities": []}], ["Active involvement was a positive predictor.", {"entities": []}], ["There was a negative relationship found between PAM-13 scores and perceived usefulness, as taking a less active role in one\u2019s own medical care predicted higher perceived website usefulness.", {"entities": []}], ["A trend toward higher frequency of website activity was associated with increased perception of usefulness.", {"entities": []}], ["Online health-related social networks can be particularly helpful to individuals with lower patient activation.", {"entities": []}], ["Our findings add information regarding the social and medical importance of such websites, which are gradually becoming an inseparable part of day-to-day chronic disease management in the community.", {"entities": []}], ["Epidemiological studies have shown the associations of ambient temperature and particulate matter (PM) air pollution with respiratory morbidity and mortality.", {"entities": []}], ["However, the underlying mechanisms have not been well characterized.", {"entities": []}], ["The aim of this study is to investigate the associations of temperature and fine and coarse PM with fractional exhaled nitric oxide (FeNO), a well-established biomarker of respiratory inflammation.", {"entities": []}], ["We conducted a longitudinal panel study involving six repeated FeNO tests among 33 type 2 diabetes mellitus patients from April to June 2013 in Shanghai, China.", {"entities": [[90, 107, "DISEASE"], [83, 107, "DISEASE"]]}], ["Hourly temperature and PM concentrations were obtained from a nearby fixed-site monitoring station.", {"entities": []}], ["We then explored the associations between temperature, PM, and FeNO using linear mixed-effect models incorporated with distributed lag nonlinear models for the lagged and nonlinear associations.", {"entities": []}], ["The interactions between temperature and PM were evaluated using stratification analyses.", {"entities": []}], ["We found that both low and high temperature, as well as increased fine and coarse PM, were significantly associated with FeNO.", {"entities": []}], ["The cumulative relative risk of FeNO was 1.75% (95% confidence interval [CI], 1.04\u20132.94) comparing 15\u00a0\u00b0C to the referent temperature (24\u00a0\u00b0C) over lags 0\u20139 days.", {"entities": []}], ["A 10\u00a0\u03bcg/m This study suggested low ambient temperature, fine PM, and coarse PM might elevate the levels of respiratory inflammation.", {"entities": []}], ["Our findings may help understand the epidemiological evidence linking temperature, particulate air pollution, and respiratory health.", {"entities": []}], ["\u2022 Both low and high temperatures were significantly associated with FeNO.", {"entities": []}], ["\u2022 The increases of fine and coarse PM concentrations were associated with FeNO.", {"entities": []}], ["\u2022 Both fine and coarse PM had stronger effects in cool days.", {"entities": []}], ["Both low and high temperatures were significantly associated with FeNO.", {"entities": []}], ["The increases of fine and coarse PM concentrations were associated with FeNO.", {"entities": []}], ["Both fine and coarse PM had stronger effects in cool days.", {"entities": []}], ["To validate the performance of a set of risk prediction algorithms developed using the QResearch database, in an independent sample from general practices contributing to the Clinical Research Data Link (CPRD).", {"entities": []}], ["Prospective open cohort study using practices contributing to the CPRD database and practices contributing to the QResearch database.", {"entities": []}], ["The CPRD validation cohort consisted of 3.3 million patients, aged 25\u201399\u2005years registered at 357 general practices between 1 Jan 1998 and 31 July 2012.", {"entities": []}], ["The validation statistics for QResearch were obtained from the original published papers which used a one-third sample of practices separate to those used to derive the score.", {"entities": []}], ["A cohort from QResearch was used to compare incidence rates and baseline characteristics and consisted of 6.8 million patients from 753 practices registered between 1 Jan 1998 and until 31 July 2013.", {"entities": []}], ["Incident events relating to seven different risk prediction scores: QRISK2 (cardiovascular disease); QStroke (ischaemic stroke); QDiabetes (type 2 diabetes); QFracture (osteoporotic fracture and hip fracture); QKidney (moderate and severe kidney failure); QThrombosis (venous thromboembolism); QBleed (intracranial bleed and upper gastrointestinal haemorrhage).", {"entities": [[239, 253, "DISEASE"]]}], ["Measures of discrimination and calibration were calculated.", {"entities": []}], ["Overall, the baseline characteristics of the CPRD and QResearch cohorts were similar though QResearch had higher recording levels for ethnicity and family history.", {"entities": []}], ["The validation statistics for each of the risk prediction scores were very similar in the CPRD cohort compared with the published results from QResearch validation cohorts.", {"entities": []}], ["For example, in women, the QDiabetes algorithm explained 50% of the variation within CPRD compared with 51% on QResearch and the receiver operator curve value was 0.85 on both databases.", {"entities": []}], ["The scores were well calibrated in CPRD.", {"entities": []}], ["Each of the algorithms performed practically as well in the external independent CPRD validation cohorts as they had in the original published QResearch validation cohorts.", {"entities": []}], ["The aim of this study was to characterize the current practice of asthma among general practitioners (GPs) in Lebanon.", {"entities": [[66, 72, "DISEASE"]]}], ["Out of 2450 Lebanese registered GPs, a representative sample of 330 were stratified by region to fill out the questionnaire constructed on the basis of surveys developed mainly by the Chicago Asthma Surveillance Initiative Report Team in newly moderate persistent asthma patients aged 5 years and above.", {"entities": [[192, 198, "DISEASE"], [264, 270, "DISEASE"]]}], ["The questionnaire included information about ascertaining diagnostic techniques, pharmacotherapeutic approaches, formal patient education program; asthma related continuing medical education and asthma practice guidelines.", {"entities": [[147, 153, "DISEASE"], [195, 201, "DISEASE"]]}], ["Totally, 302 completed the questionnaire achieving a response rate of 91.5%.", {"entities": []}], ["Chest radiography was the most commonly used diagnostic test (98%), while stain for eosinophilia was the less commonly used (7.9%).", {"entities": [[84, 96, "DISEASE"]]}], ["For clinical monitoring, cough and wheezing (98.7%) were mostly assessed.", {"entities": []}], ["Short acting inhaled \u03b2 2 -agonists were often the most prescribed (94.3%) followed by inhaled corticosteroids (87.4%) then by long acting \u03b2-agonist (LABA) and theophylline (27.5% and 20.9%, respectively).", {"entities": []}], ["Moreover, 10% of GPs provided formal asthma education program, 72.2% attended professional education and 65% adopted guidelines.", {"entities": [[37, 43, "DISEASE"]]}], ["Based on current international guidelines, the overall Lebanese GPs practice of asthma management is not at an acceptable standard.", {"entities": [[80, 86, "DISEASE"]]}], ["Therefore, it is recommended to improve monitoring parameters, implement the asthma guidelines nationally and improve patient education.", {"entities": [[77, 83, "DISEASE"]]}], ["Objectives To study the effect of long term exposure to airborne pollutants on the incidence of acute coronary events in 11 cohorts participating in the European Study of Cohorts for Air Pollution Effects (ESCAPE).", {"entities": []}], ["Design Prospective cohort studies and meta-analysis of the results.", {"entities": []}], ["Setting Cohorts in Finland, Sweden, Denmark, Germany, and Italy.", {"entities": []}], ["Participants 100\u2009166 people were enrolled from 1997 to 2007 and followed for an average of 11.5 years.", {"entities": []}], ["Participants were free from previous coronary events at baseline.", {"entities": []}], ["Main outcome measures Modelled concentrations of particulate matter <2.5 \u03bcm (PM 2.5 ), 2.5-10 \u03bcm (PM coarse ), and <10 \u03bcm (PM 10 ) in aerodynamic diameter, soot (PM 2.5 absorbance), nitrogen oxides, and traffic exposure at the home address based on measurements of air pollution conducted in 2008-12.", {"entities": []}], ["Cohort specific hazard ratios for incidence of acute coronary events (myocardial infarction and unstable angina) per fixed increments of the pollutants with adjustment for sociodemographic and lifestyle risk factors, and pooled random effects meta-analytic hazard ratios.", {"entities": [[70, 91, "DISEASE"]]}], ["Results 5157 participants experienced incident events.", {"entities": []}], ["A 5 \u03bcg/m 2.5 was associated with a 13% increased risk of coronary events (hazard ratio 1.13, 95% confidence interval 0.98 to 1.30), and a 10 \u03bcg/m 10 was associated with a 12% increased risk of coronary events (1.12, 1.01 to 1.25) with no evidence of heterogeneity between cohorts.", {"entities": []}], ["Positive associations were detected below the current annual European limit value of 25 \u03bcg/m 2.5 (1.18, 1.01 to 1.39, for 5 \u03bcg/m 2.5 ) and below 40 \u03bcg/m 10 (1.12, 1.00 to 1.27, for 10 \u03bcg/m 10 ).", {"entities": []}], ["Positive but non-significant associations were found with other pollutants.", {"entities": []}], ["Conclusions Long term exposure to particulate matter is associated with incidence of coronary events, and this association persists at levels of exposure below the current European limit values.", {"entities": []}], ["Mitochondrial DNA (mtDNA) contains unmethylated CpG motifs that exhibit immune stimulatory capacities.", {"entities": []}], ["The aim of this study was to investigate whether mtDNA activates the Toll-like receptor 9 (TLR9)/nuclear factor-\u03baB (NF-\u03baB) pathway, thereby contributing to post-traumatic systemic inflammatory response syndrome (SIRS) and lung injury in rats.", {"entities": [[202, 210, "DISEASE"], [91, 95, "GENE"]]}], ["The effects of mtDNA on macrophage culture were examined in order to elucidate the putative cellular mechanisms.", {"entities": []}], ["Rats and macrophage cultures were treated with phosphate-buffered saline, nuclear DNA, or mtDNA for 2, 4, 8 and 24 h. Histological analysis of lung tissue was undertaken following hematoxylin and eosin staining, and cytokine levels were assessed by ELISA.", {"entities": []}], ["NF-\u03baB and I\u03baB-\u03b1 phosphorylation levels, as well as TLR9 protein expression were determined by western blot analysis; NF-\u03baB, I\u03baB-\u03b1 and TLR9 mRNA levels were analyzed by RT-PCR.", {"entities": [[51, 55, "GENE"], [134, 138, "GENE"], [51, 55, "GENE"], [134, 138, "GENE"]]}], ["A greater degree of inflammation and lung injury was observed in response to mtDNA.", {"entities": []}], ["In addition, mtDNA increased serum tumor necrosis factor-\u03b1, interleukin (IL)-6 and IL-10 levels in vivo and increased their secretion by cultured macrophages (p<0.05).", {"entities": []}], ["In lung tissue, mtDNA increased NF-\u03baB, I\u03baB-\u03b1 and TLR9 mRNA levels (p<0.05); it also increased phosphorylated NF-\u03baB p65 and TLR9 protein levels in the macrophage cultures.", {"entities": [[49, 53, "GENE"], [123, 127, "GENE"], [49, 53, "GENE"], [123, 127, "GENE"]]}], ["Thus, mtDNA may be part of the danger-associated molecular patterns, contributing to the initiation of sterile SIRS through the activation of the TLR9/NF-\u03baB pathway and the induction of pro-inflammatory cytokine production.", {"entities": []}], ["The aim of this study is to assess the influence of functional abdominal complaints (FAC) on health-related quality of life in a group of Dutch pre-school children.", {"entities": []}], ["Parents of children aged up to 6.0\u00a0 visiting the outpatient pediatric department, Erasmus MC-Sophia, Rotterdam, The Netherlands in the period January 2005\u2013December 2006 for functional abdominal complaints during at least 3\u00a0months were asked to complete the Infant/Toddler Quality of life Questionnaire (ITQOL), and questions of the abdominal pain index for use by parents to report pain symptoms in pre-school children.", {"entities": []}], ["ITQOL scale scores of children with FAC were compared against with Dutch reference values.", {"entities": []}], ["The abdominal pain index was tested for internal consistency and test\u2013retest reliability.", {"entities": []}], ["Correlations between ITQOL scale scores and abdominal pain index were assessed by Spearman\u2019s rank test.", {"entities": []}], ["Results are based on 81 questionnaires completed by parents of children with FAC (response rate 61%).", {"entities": []}], ["Children had a median age of 46\u00a0months (interquartile range 27\u201359), 48% girls.", {"entities": []}], ["A significant impact was observed on most aspects of quality of life, particularly for physical functioning, general development, bodily pain, temperament and moods, general health perceptions and parental emotional impact.", {"entities": []}], ["Parents of children with functional constipation tended to report lower scores than those of children with other FAC.", {"entities": [[36, 48, "DISEASE"]]}], ["The abdominal pain index appeared to be valid and was significantly correlated with ITQOL scales bodily pain and general health perceptions.", {"entities": []}], ["A substantial lower health-related quality of life is reported in pre-school children with functional abdominal complaints, with effects on physical, emotional and parental domains.", {"entities": []}], ["The 5-question severity index of abdominal pain appeared a valid tool and may be helpful to quickly assess the severity of abdominal pain in clinical practice.", {"entities": []}], ["Protein arginine methylation is a novel posttranslational modification regulating a diversity of cellular processes, including protein-protein interaction, signal transduction, or histone function.", {"entities": []}], ["It has recently been shown to be dysregulated in chronic renal, vascular, and pulmonary diseases, and metabolic products originating from protein arginine methylation have been suggested to serve as biomarkers in cardiovascular and pulmonary diseases.", {"entities": []}], ["Protein arginine methylation is performed by a class of enzymes called protein arginine methyltransferases (PRMT), which specifically methylate protein-incorporated arginine residues to generate protein-incorporated monomethylarginine (MMA), symmetric dimethylarginine (SDMA), or asymmetric dimethylarginine (ADMA).", {"entities": []}], ["Upon proteolytic cleavage of arginine-methylated proteins, free intracellular MMA, SDMA, or ADMA is generated, which, upon secretion into the extracellular space (including plasma), directly affects the methylarginine concentration in the plasma.", {"entities": []}], ["Free methylarginines are cleared from the body by renal excretion or hepatic metabolism.", {"entities": []}], ["In addition, MMA and ADMA, but not SDMA, can be degraded via a class of intracellular enzymes called dimethylarginine dimethylaminohydrolases (DDAH).", {"entities": [[143, 147, "GENE"]]}], ["ADMA and MMA are endogenous inhibitors of nitric oxide synthases (NOS) and ADMA has been suggested to serve as a biomarker of endothelial dysfunction in cardiovascular diseases.", {"entities": []}], ["This view has now been extended to the idea that, in addition to serum ADMA, the amount of free, as well as protein-incorporated, intracellular ADMA influences pulmonary cell function and determines the development of chronic lung diseases, including pulmonary arterial hypertension (PAH) or pulmonary fibrosis.", {"entities": [[270, 282, "DISEASE"], [292, 310, "DISEASE"]]}], ["This review will present and discuss the recent findings of dysregulated arginine methylation in chronic lung disease.", {"entities": [[105, 117, "DISEASE"]]}], ["We will highlight novel directions for future investigations evaluating the functional contribution of arginine methylation in lung homeostasis and disease with the outlook that modifying PRMT or DDAH activity presents a novel therapeutic option for the treatment of chronic lung disease.", {"entities": [[275, 287, "DISEASE"], [196, 200, "GENE"]]}], ["The methodological quality and completeness of reporting of the systematic reviews (SRs) is fundamental to optimal implementation of evidence-based health care and the reduction of research waste.", {"entities": []}], ["Methods exist to appraise SRs yet little is known about how they are used in SRs or where there are potential gaps in research best-practice guidance materials.", {"entities": []}], ["The aims of this study are to identify reports assessing the methodological quality (MQ) and/or reporting quality (RQ) of a cohort of SRs and to assess their number, general characteristics, and approaches to \u2018quality\u2019 assessment over time.", {"entities": []}], ["The Cochrane Library, MEDLINE\u00ae, and EMBASE\u00ae were searched from January 1990 to October 16, 2014, for reports assessing MQ and/or RQ of SRs.", {"entities": []}], ["Title, abstract, and full-text screening of all reports were conducted independently by two reviewers.", {"entities": []}], ["Reports assessing the MQ and/or RQ of a cohort of ten or more SRs of interventions were included.", {"entities": []}], ["All results are reported as frequencies and percentages of reports.", {"entities": []}], ["Of 20,765 unique records retrieved, 1189 of them were reviewed for full-text review, of which 76 reports were included.", {"entities": []}], ["Eight previously published approaches to assessing MQ or reporting guidelines used as proxy to assess RQ were used in 80% (61/76) of identified reports.", {"entities": []}], ["These included two reporting guidelines (PRISMA and QUOROM) and five quality assessment tools (AMSTAR, R-AMSTAR, OQAQ, Mulrow, Sacks) and GRADE criteria.", {"entities": []}], ["The remaining 24% (18/76) of reports developed their own criteria.", {"entities": []}], ["PRISMA, OQAQ, and AMSTAR were the most commonly used published tools to assess MQ or RQ.", {"entities": []}], ["In conjunction with other approaches, published tools were used in 29% (22/76) of reports, with 36% (8/22) assessing adherence to both PRISMA and AMSTAR criteria and 26% (6/22) using QUOROM and OQAQ.", {"entities": []}], ["The methods used to assess quality of SRs are diverse, and none has become universally accepted.", {"entities": []}], ["The most commonly used quality assessment tools are AMSTAR, OQAQ, and PRISMA.", {"entities": []}], ["As new tools and guidelines are developed to improve both the MQ and RQ of SRs, authors of methodological studies are encouraged to put thoughtful consideration into the use of appropriate tools to assess quality and reporting.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-017-0507-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Miniaturized microfluidic biosensors have recently been advanced for portable point-of-care diagnostics by integrating lab-on-a-chip technology and electrochemical analysis.", {"entities": []}], ["However, the design of a small, integrated, and reliable biosensor for multiple and simultaneous electrochemical analyses in a single device remains a challenge.", {"entities": []}], ["Here, we present a simultaneous microfluidic electrochemical biosensing system to detect multiple biomarkers of pulmonary hypertension diseases in a single device.", {"entities": [[122, 134, "DISEASE"], [112, 134, "DISEASE"]]}], ["The miniaturized biosensor, which is composed of five chambers, is precisely and individually controlled using in-house-built pneumatic microvalves to manipulate the flow pathway.", {"entities": []}], ["Each chamber is connected to an electrochemical sensor designed to detect four different biomarkers plus a reference control.", {"entities": []}], ["Our design allows for loading of multiple reagents for simultaneous analyses.", {"entities": []}], ["On the basis of the developed microfluidic electrochemical sensor system, we successfully detected four well-defined pulmonary hypertension-associated biomarkers, namely, fibrinogen, adiponectin, low-density lipoprotein, and 8-isoprostane.", {"entities": [[127, 139, "DISEASE"], [117, 139, "DISEASE"]]}], ["This novel approach offers a new platform for a rapid, miniaturized, and sensitive diagnostic sensor in a single device for various human diseases.", {"entities": []}], ["Despite progressive population health policies to reduce tobacco harm, smoking prevalence continues to be inequitable amongst key ethnic groups in New Zealand.", {"entities": []}], ["The purpose of this study is to describe the predictors of cigarette use amongst Pacific youth in New Zealand.", {"entities": []}], ["Data were collected as part of Youth\u201907, a nationally representative survey of the health and well-being of New Zealand adolescents.", {"entities": []}], ["The study sample comprised 5471 students and this includes 1,178 were Pacific youth.", {"entities": []}], ["The smoking prevalence rate for Pacific youth was twice that of New Zealand European youth.", {"entities": []}], ["Pacific girls and older age groups, ages 16\u201317, smoked more than Pacific boys and younger adolescents.", {"entities": []}], ["Pacific youth from higher and mid-deprivation neighbourhoods smoked at twice the rate of youth from low deprivation areas.", {"entities": []}], ["Local neighbourhood stores (dairies) were the most used location for purchasing cigarettes, and only 12.7% of under-aged adolescents were asked \u201cmost of the time\u201d for age identification.", {"entities": []}], ["Pacific adolescent smoking was associated with parental smoking, peer-group smoking and binge drinking.", {"entities": []}], ["Parents not knowing the whereabouts of adolescents during after-school hours and night-times were also associated with adolescent smoking.", {"entities": []}], ["A majority of Pacific adolescent smokers (70.2%) had tried to quit smoking.", {"entities": []}], ["The strategies for addressing ethically the issue of equal health for all is to allocate increased public health investments towards targeted quit-smoking treatment programmes for Pacific youth in New Zealand.", {"entities": []}], ["Further qualitative studies with Pacific youth to inform the development of culturally-appropriate youth-focused quit-substance interventions is recommended.", {"entities": []}], ["Emerging evidence demonstrated that the structure of fecal microbiome is associated with the likelihood of bronchiolitis in infants.", {"entities": [[107, 120, "DISEASE"]]}], ["However, no study has examined functional profiles of fecal microbiome in infants with bronchiolitis.", {"entities": [[87, 100, "DISEASE"]]}], ["In this context, we conducted a case\u2013control study.", {"entities": []}], ["As a part of multicenter prospective study, we collected stool samples from 40 infants hospitalized with bronchiolitis (cases).", {"entities": [[105, 118, "DISEASE"]]}], ["We concurrently enrolled 115 age-matched healthy controls.", {"entities": []}], ["First, by applying 16S rRNA gene sequencing to these 155 fecal samples, we identified the taxonomic profiles of fecal microbiome.", {"entities": []}], ["Next, based on the taxonomy data, we inferred the functional capabilities of fecal microbiome and tested for differences in the functional capabilities between cases and controls.", {"entities": []}], ["Overall, the median age was 3\u00a0months and 45% were female.", {"entities": []}], ["Among 274 metabolic pathways surveyed, there were significant differences between bronchiolitis cases and healthy controls for 37 pathways, including lipid metabolic pathways (false discovery rate [FDR]\u00a0<0.05).", {"entities": [[82, 95, "DISEASE"]]}], ["Particularly, the fecal microbiome of bronchiolitis cases had consistently higher abundances of gene function related to the sphingolipid metabolic pathways compared to that of controls (FDR\u00a0<0.05).", {"entities": [[38, 51, "DISEASE"]]}], ["These pathways were more abundant in infants with Bacteroides -dominant microbiome profile compared to the others (FDR\u00a0<0.001).", {"entities": []}], ["On the basis of the predicted metagenome in this case\u2013control study, we found significant differences in the functional potential of fecal microbiome between infants with bronchiolitis and healthy controls.", {"entities": [[171, 184, "DISEASE"]]}], ["Although causal inferences remain premature, our data suggest a potential link between the bacteria-derived metabolites, modulations of host immune response, and development of bronchiolitis.", {"entities": [[177, 190, "DISEASE"]]}], ["Maternal smoking and micronutrient intake during pregnancy are two strong biological candidates for impacting the developing epigenome.", {"entities": []}], ["The extent to which DNA methylation in offspring is modified by these intrauterine exposures has not been presented in parallel.", {"entities": []}], ["In this review, we summarize human studies which have investigated genome-wide DNA methylation in the offspring in relation to maternal smoking and one-carbon micronutrient exposure during pregnancy.", {"entities": []}], ["We contrast the primarily independent efforts for these two categories of exposure, and potential explanations for these differences.", {"entities": []}], ["We emphasize methodological considerations such as power to detect methylation signals, exposure assessment, control of sources of variability, causal inference and the role of observed methylation changes in mediating downstream outcomes in the offspring.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a debilitating pulmonary disorder with systemic effects, and it is the fourth leading cause of death in the United States.", {"entities": []}], ["COPD patients not only develop respiratory limitations, but can also demonstrate systemic wasting, features of depression, and can succumb to social isolation.", {"entities": []}], ["Smoking cessation is crucial, and pharmacotherapy with bronchodilators is helpful in symptom management.", {"entities": []}], ["Inhaled corticosteroids may be beneficial in some patients.", {"entities": []}], ["In addition, pulmonary rehabilitation and palliative care are important components under the right clinical circumstance.", {"entities": []}], ["This review highlights current guidelines and management strategies for COPD and emphasizes novel pharmacotherapy and minimally invasive (nonsurgical) lung-volume reduction interventions that may prove to be of significant benefit in the future.", {"entities": []}], ["To examine protocol adherence to structured intensive management in the Valsartan Intensified Primary carE Reduction of Blood Pressure (VIPER-BP) study involving 119 primary care clinics and 1562 randomized participants.", {"entities": []}], ["Prospective criteria for assessing adherence to treatment prescription, uptitration, and visit attendance at 6, 10, 14, and 18 weeks postrandomization were applied to 1038 intervention participants.", {"entities": []}], ["Protocol adherence scores of 1\u20135 (least to most adherent) were compared to blood pressure (BP) control during 26 weeks of follow-up.", {"entities": []}], ["Mean age was 59.3\u200a\u00b1\u200a12.0 years, 963 (62%) were men, and 1045 (67%) had longstanding hypertension.", {"entities": [[84, 96, "DISEASE"]]}], ["Clinic attendance dropped from 91 (week 6) to 83% (week 26) and pharmacological instructions were followed for 93% (baseline) to 61% at week 14 (uptitration failures commonly representing protocol deviations).", {"entities": []}], ["Overall, 26-week BP levels and BP target attainment ranged from 132\u200a\u00b1\u200a14/79\u200a\u00b1\u200a9 and 51% to 141\u200a\u00b1\u200a15/83\u200a\u00b1\u200a11\u200ammHg and 19% in those participants subject to the highest ( n\u200a =\u200a270, 26%) versus least ( n \u200a=\u200a148, 14%) per protocol adherence, respectively; adjusted relative risk (RR) 1.22 per unit protocol adherence score, 95% confidence interval (CI) 1.15\u20131.31; for achieving BP target ( P \u200a<\u200a0.001).", {"entities": []}], ["Participants with a per protocol score of 4 or 5 (512/1038, 49.3%) were 1.54-fold (95% CI 1.31\u20131.81; P \u200a<\u200a0.001) more likely to achieve their individual BP target compared with usual care.", {"entities": []}], ["Clinics equipped with a practice nurse significantly influenced protocol adherence (adjusted RR 1.20, 95% CI 1.06\u20131.37; P \u200a=\u200a0.004) and individual BP control (RR 1.21, 95% CI 1.04\u20131.41; P \u200a=\u200a0.015).", {"entities": []}], ["There is considerable potential for structured care management to improve BP control in primary care, especially when optimally applied.", {"entities": []}], ["The traditional backbones of mammalian sphingolipids are 2-amino, 1,3-diols made by serine palmitoyltransferase (SPT).", {"entities": []}], ["Many organisms additionally produce non-traditional, cytotoxic 1-deoxysphingoid bases and, surprisingly, mammalian SPT biosynthesizes some of them, too ( e.g.", {"entities": []}], ["1-deoxysphinganine from l -alanine).", {"entities": []}], ["These are rapidly N -acylated to 1-deoxy-\u201cceramides\u201d with very uncommon biophysical properties.", {"entities": []}], ["The functions of 1-deoxysphingolipids are not known, but they are certainly dangerous as contributors to sensory and autonomic neuropathies when elevated by inherited SPT mutations, and they are noticeable in diabetes, non-alcoholic steatohepatitis, serine deficiencies, and other diseases.", {"entities": []}], ["As components of food as well as endogenously produced, these substances are mysteries within an enigma.", {"entities": []}], ["Many efforts are undertaken in Switzerland to enable older and/or chronically ill patients to stay home longer at the end-of-life.", {"entities": []}], ["One of the consequences might be an increased need for hospitalisations at the end-of-life, which goes along with burdensome transitions for patients and higher health care costs for the society.", {"entities": []}], ["We aimed to examine the health care utilisation in the last six months of life, including transitions between health care settings, in a Swiss adult population.", {"entities": []}], ["The study population consisted of 11'310 decedents of 2014 who were insured at the Helsana Group, the leading health insurance in Switzerland.", {"entities": []}], ["Descriptive statistics were used to analyse the health care utilisation by age group, taking into account individual and regional factors.", {"entities": []}], ["Zero-inflated Poisson regression model was used to predict the number of transitions.", {"entities": []}], ["Mean age was 78.1 in men and 83.8 in women.", {"entities": []}], ["In the last six months of life, 94.7% of the decedents had at least one consultation; 61.6% were hospitalised at least once, with a mean length of stay of 28.3 days; and nursing home stays were seen in 47.4% of the decedents.", {"entities": []}], ["Over the same time period, 64.5% were transferred at least once, and 12.9% experienced at least one burdensome transition.", {"entities": []}], ["Main predictors for transitions were age, sex and chronic conditions.", {"entities": []}], ["A high density of home care nurses was associated with a decrease, whereas a high density of ambulatory care physicians was associated with an increase in the number of transitions.", {"entities": []}], ["Health care utilisation was high in the last six months of life and a considerable number of decedents were being transferred.", {"entities": []}], ["Advance care planning might prevent patients from numerous and particularly from burdensome transitions.", {"entities": []}], ["During inflammation, the kynurenine pathway (KP) metabolises the essential amino acid tryptophan (TRP) potentially contributing to excitotoxicity via the release of quinolinic acid (QUIN) and 3-hydroxykynurenine (3HK).", {"entities": []}], ["Despite the importance of excitotoxicity in the development of secondary brain damage, investigations on the KP in TBI are scarce.", {"entities": []}], ["In this study, we comprehensively characterised changes in KP activation by measuring numerous metabolites in cerebrospinal fluid (CSF) from TBI patients and assessing the expression of key KP enzymes in brain tissue from TBI victims.", {"entities": []}], ["Acute QUIN levels were further correlated with outcome scores to explore its prognostic value in TBI recovery.", {"entities": []}], ["Twenty-eight patients with severe TBI (GCS \u2264 8, three patients had initial GCS = 9\u201310, but rapidly deteriorated to \u22648) were recruited.", {"entities": []}], ["CSF was collected from admission to day 5 post-injury.", {"entities": []}], ["TRP, kynurenine (KYN), kynurenic acid (KYNA), QUIN, anthranilic acid (AA) and 3-hydroxyanthranilic acid (3HAA) were measured in CSF.", {"entities": []}], ["The Glasgow Outcome Scale Extended (GOSE) score was assessed at 6 months post-TBI.", {"entities": []}], ["Post-mortem brains were obtained from the Australian Neurotrauma Tissue and Fluid Bank and used in qPCR for quantitating expression of KP enzymes (indoleamine 2,3-dioxygenase-1 (IDO1), kynurenase (KYNase), kynurenine amino transferase-II (KAT-II), kynurenine 3-monooxygenase (KMO), 3-hydroxyanthranilic acid oxygenase (3HAO) and quinolinic acid phosphoribosyl transferase (QPRTase) and IDO1 immunohistochemistry.", {"entities": [[178, 182, "GENE"], [386, 390, "GENE"], [276, 279, "GENE"], [178, 182, "GENE"], [386, 390, "GENE"]]}], ["In CSF, KYN, KYNA and QUIN were elevated whereas TRP, AA and 3HAA remained unchanged.", {"entities": []}], ["The ratios of QUIN:KYN, QUIN:KYNA, KYNA:KYN and 3HAA:AA revealed that QUIN levels were significantly higher than KYN and KYNA, supporting increased neurotoxicity.", {"entities": []}], ["Amplified IDO1 and KYNase mRNA expression was demonstrated on post-mortem brains, and enhanced IDO1 protein coincided with overt tissue damage.", {"entities": [[10, 14, "GENE"], [95, 99, "GENE"], [10, 14, "GENE"], [95, 99, "GENE"]]}], ["QUIN levels in CSF were significantly higher in patients with unfavourable outcome and inversely correlated with GOSE scores.", {"entities": []}], ["TBI induced a striking activation of the KP pathway with sustained increase of QUIN.", {"entities": []}], ["The exceeding production of QUIN together with increased IDO1 activation and mRNA expression in brain-injured areas suggests that TBI selectively induces a robust stimulation of the neurotoxic branch of the KP pathway.", {"entities": [[57, 61, "GENE"]]}], ["QUIN\u2019s detrimental roles are supported by its association to adverse outcome potentially becoming an early prognostic factor post-TBI.", {"entities": []}], ["Leucopenia is a common side effect in patients treated with thiopurines.", {"entities": []}], ["Variants in the thiopurine S\u2010methyltransferase ( TPMT ) gene are the best\u2010known risk factor, but only explain up to 25% of leucopenia cases.", {"entities": [[49, 53, "GENE"]]}], ["To identify the clinical risk factors for thiopurine\u2010induced leucopenia in patients without a common TPMT variant, and explore if these patients are at increased risk for infections.", {"entities": [[101, 105, "GENE"]]}], ["Post hoc analysis of the Thiopurine response Optimisation by Pharmacogenetic testing in Inflammatory bowel disease Clinics ( TOPIC ) trial.", {"entities": []}], ["For this analysis, patients without a variant in TPMT ( *2 , *3A or *3C ) were included.", {"entities": [[49, 53, "GENE"]]}], ["Uni\u2010 and multivariate Cox\u2010proportional hazard models were used to identify risk factors for leucopenia and infections.", {"entities": []}], ["Leucopenia was defined as a white blood cell ( WBC ) count <3.0 \u00d7 10 Sixty hundred and ninety\u2010five patients (90.6%) included in the TOPIC \u2010trial had no variant in TPMT , of which 45 (6.5%) developed leucopenia.", {"entities": [[163, 167, "GENE"]]}], ["Median time to leucopenia was 56 (29\u2010112) days.", {"entities": []}], ["Multivariate analysis showed that use of mercaptopurine compared to azathioprine was associated with leucopenia (hazard ratio [ HR ] 2.61 [95% CI s, 1.39\u20104.88; P < .01]) and a higher baseline WBC count was protective ( HR 0.80 [95% CI s, 0.71\u20100.89; P < .01]).", {"entities": [[128, 130, "GENE"], [219, 221, "GENE"], [128, 130, "GENE"], [219, 221, "GENE"]]}], ["Risk factors for infections were older age (per 10 year; HR 2.07 [95% CI s, 1.18\u20103.63; P = .01]) and concomitant use of biologic drugs ( HR 2.15 [95% CI s, 1.14\u20104.07; P = .02]).", {"entities": [[57, 59, "GENE"], [137, 139, "GENE"], [57, 59, "GENE"], [137, 139, "GENE"]]}], ["Low baseline WBC count and mercaptopurine , due to a relatively higher dose, were risk factors for thiopurine\u2010induced leucopenia in patients without a TPMT variant.", {"entities": [[151, 155, "GENE"]]}], ["Since the late 1980s, federal legislation has required industries to publicly report their annual emissions of toxic compounds.", {"entities": []}], ["Industry reports show the largest contributor to toxic emission levels in Texas is the massive concentration of petrochemical industries along the Gulf Coast.", {"entities": []}], ["It is interesting to note that although Texas produces over 50% of the nation's synthetic chemicals, it discharges less than 8% of the nation's toxic emissions.", {"entities": []}], ["However, in response to growing concerns about the effects of these toxic emissions, the Texas Natural Resource Conservation Commission (TNRCC) initiated a long-term program for monitoring toxic chemicals in the air.", {"entities": []}], ["This article provides details of this monitoring program as well as industry-funded toxic monitoring networks in Texas.", {"entities": []}], ["This includes information on the technology currently being used for sample collection and analysis as well as plans for implementing methods that are on the technological horizon.", {"entities": []}], ["Finally, details of some key measurements from the state's air toxics monitoring network will be provided along with an explanation of how they impact current air quality trends in Texas.", {"entities": []}], ["This paper reviews the current evidence indicating that comorbid allergic rhinitis may have clinically relevant effects on asthma.", {"entities": [[65, 82, "DISEASE"], [74, 82, "DISEASE"], [123, 129, "DISEASE"]]}], ["Allergic rhinitis is very common in patients with asthma, with a reported prevalence of up to 100% in those with allergic asthma.", {"entities": [[0, 17, "DISEASE"], [113, 128, "DISEASE"], [9, 17, "DISEASE"], [50, 56, "DISEASE"], [122, 128, "DISEASE"]]}], ["While the temporal relation of allergic rhinitis and asthma diagnoses can be variable, the diagnosis of allergic rhinitis often precedes that of asthma.", {"entities": [[31, 48, "DISEASE"], [104, 121, "DISEASE"], [40, 48, "DISEASE"], [113, 121, "DISEASE"], [53, 59, "DISEASE"], [145, 151, "DISEASE"]]}], ["Rhinitis is an independent risk factor for the subsequent development of asthma in both atopic and nonatopic individuals.", {"entities": [[0, 8, "DISEASE"], [73, 79, "DISEASE"]]}], ["Controlled studies have provided conflicting results regarding the benefits for asthma symptoms of treating comorbid allergic rhinitis with intranasal corticosteroids.", {"entities": [[117, 134, "DISEASE"], [126, 134, "DISEASE"], [80, 86, "DISEASE"]]}], ["Effects of other treatments for comorbid allergic rhinitis, including antihistamines, allergen immunotherapy, systemic anti-IgE therapy, and antileukotriene agents, have been examined in a limited number of studies; anti-IgE therapy and antileukotriene agents such as the leukotriene receptor antagonists have benefits for treating both allergic rhinitis and asthma.", {"entities": [[41, 58, "DISEASE"], [337, 354, "DISEASE"], [50, 58, "DISEASE"], [346, 354, "DISEASE"], [359, 365, "DISEASE"]]}], ["Results of observational studies indicate that treating comorbid allergic rhinitis results in a lowered risk of asthma-related hospitalizations and emergency visits.", {"entities": [[65, 82, "DISEASE"], [74, 82, "DISEASE"], [112, 118, "DISEASE"]]}], ["Results of several retrospective database studies in the United States and in Europe indicate that, for patients with asthma, the presence of comorbid allergic rhinitis is associated with higher total annual medical costs, greater prescribing frequency of asthma-related medications, as well as increased likelihood of asthma-related hospital admissions and emergency visits.", {"entities": [[151, 168, "DISEASE"], [160, 168, "DISEASE"], [118, 124, "DISEASE"], [256, 262, "DISEASE"], [319, 325, "DISEASE"]]}], ["There is therefore evidence suggesting that comorbid allergic rhinitis is a marker for more difficult to control asthma and worsened asthma outcomes.", {"entities": [[53, 70, "DISEASE"], [62, 70, "DISEASE"], [113, 119, "DISEASE"], [133, 139, "DISEASE"]]}], ["These findings highlight the potential for improving asthma outcomes by following a combined therapeutic approach to comorbid allergic rhinitis and asthma rather than targeting each condition separately.", {"entities": [[126, 143, "DISEASE"], [135, 143, "DISEASE"], [53, 59, "DISEASE"], [148, 154, "DISEASE"]]}], ["The period of menstruation is an eventful one for a significant number of post-pubescent females as they experience lower abdominal pains referred to as dysmenorrhea.", {"entities": []}], ["This study conducted among female students of the Tamale campus of the University for Development Studies assessed the prevalence of dysmenorrhea, its impact on the students and treatment methods applied.", {"entities": []}], ["A cross-sectional study using a self-administered questionnaire was used to obtain data from 293 randomly selected female students.", {"entities": []}], ["Data was analyzed using Graph Pad 5.01.", {"entities": []}], ["Association between different variables was tested.", {"entities": []}], ["The prevalence rate of dysmenorrhea was 83.6% with more than half describing their pain which lasts less than 3\u00a0days as moderate.", {"entities": []}], ["This dysmenorrhea during menstruation affects the daily activities of up to 61.2% of respondents.", {"entities": []}], ["Lower chronological age (\u03c7 p \u2009=\u20090.016) and gynecological age (\u03c7 p \u2009=\u20090.006) were the factors that were significantly associated with the presence of dysmenorrhea.", {"entities": []}], ["Chronological and gynecological ages, age at menarche, menstrual duration or flow level do not influence the severity of dysmenorrhea but irregular menstrual flow is\u00a0significantly associated with severe dysmenorrhea (\u03c7 p \u2009=\u20090.005).", {"entities": []}], ["Only 16.3% ever reported their dysmenorrhea to the hospital but increasing pain level is significantly associated with respondents visiting a hospital (\u03c7 p \u2009<\u20090.0001) or use an allopathic medication (\u03c7 p \u2009<\u20090.0001).", {"entities": []}], ["Paracetamol preparation was the most common medication used notwithstanding the severity of the pain.", {"entities": []}], ["There is high prevalence of dysmenorrhea among the female students of the Tamale campus of the University for Development studies which negatively affects the daily activity of majority of them.", {"entities": []}], ["Although, bed rest was the most common treatment method practised, paracetamol preparation was the most common allopathic drug used in self- management of their dysmenorrhea.", {"entities": []}], ["Human chymase is a very important target for the treatment of cardiovascular diseases.", {"entities": []}], ["Using a series of theoretical methods like pharmacophore modeling, database screening, molecular docking and Density Functional Theory (DFT) calculations, an investigation for identification of novel chymase inhibitors, and to specify the key factors crucial for the binding and interaction between chymase and inhibitors is performed.", {"entities": []}], ["A highly correlating ( r = 0.942) pharmacophore model (Hypo1) with two hydrogen bond acceptors, and three hydrophobic aromatic features is generated.", {"entities": []}], ["After successfully validating \u201cHypo1\u201d, it is further applied in database screening.", {"entities": []}], ["Hit compounds are subjected to various drug-like filtrations and molecular docking studies.", {"entities": []}], ["Finally, three structurally diverse compounds with high GOLD fitness scores and interactions with key active site amino acids are identified as potent chymase hits.", {"entities": []}], ["Moreover, DFT study is performed which confirms very clear trends between electronic properties and inhibitory activity (IC 50 ) data thus successfully validating \u201cHypo1\u201d by DFT method.", {"entities": []}], ["Therefore, this research exertion can be helpful in the development of new potent hits for chymase.", {"entities": []}], ["In addition, the combinational use of docking, orbital energies and molecular electrostatic potential analysis is also demonstrated as a good endeavor to gain an insight into the interaction between chymase and inhibitors.", {"entities": []}], ["Highly prevalent and typically beginning in childhood, asthma is a burdensome disease, yet the risk factors for this condition are not clarified.", {"entities": [[55, 61, "DISEASE"]]}], ["To enhance understanding, this study assessed the cohort-specific and pooled risk of maternal education on asthma in children aged 3\u20138 across 10 European countries.", {"entities": [[107, 113, "DISEASE"]]}], ["Data on 47,099 children were obtained from prospective birth cohort studies across 10 European countries.", {"entities": []}], ["We calculated cohort-specific prevalence difference in asthma outcomes using the relative index of inequality (RII) and slope index of inequality (SII).", {"entities": [[55, 61, "DISEASE"]]}], ["Results from all countries were pooled using random-effects meta-analysis procedures to obtain mean RII and SII scores at the European level.", {"entities": []}], ["Final models were adjusted for child sex, smoking during pregnancy, parity, mother\u2019s age and ethnicity.", {"entities": []}], ["The higher the score the greater the magnitude of relative (RII, reference 1) and absolute (SII, reference 0) inequity.", {"entities": []}], ["The pooled RII estimate for asthma risk across all cohorts was 1.46 (95% CI 1.26, 1.71) and the pooled SII estimate was 1.90 (95% CI 0.26, 3.54).", {"entities": [[28, 34, "DISEASE"]]}], ["Of the countries examined, France, the United Kingdom and the Netherlands had the highest prevalence\u2019s of childhood asthma and the largest inequity in asthma risk.", {"entities": [[116, 122, "DISEASE"], [151, 157, "DISEASE"]]}], ["Smaller inverse associations were noted for all other countries except Italy, which presented contradictory scores, but with small effect sizes.", {"entities": []}], ["Tests for heterogeneity yielded significant results for SII scores.", {"entities": []}], ["Overall, offspring of mothers with a low level of education had an increased relative and absolute risk of asthma compared to offspring of high-educated mothers.", {"entities": [[107, 113, "DISEASE"]]}], ["Recent reports in mice demonstrate that basophils function as antigen presenting cells (APC).", {"entities": [[88, 91, "GENE"]]}], ["They express MHC class II and co-stimulatory molecules CD80 and CD86, capture and present soluble antigens or IgE-antigen complexes and polarize Th2 responses.", {"entities": [[55, 59, "GENE"], [64, 68, "GENE"]]}], ["Therefore, we explored whether human circulating basophils possess the features of professional APC.", {"entities": [[96, 99, "GENE"]]}], ["We found that unlike dendritic cells (DC) and monocytes, steady-state circulating human basophils did not express HLA-DR and co-stimulatory molecules CD80 and CD86.", {"entities": [[150, 154, "GENE"], [159, 163, "GENE"]]}], ["Basophils remained negative for these molecules following stimulation with soluble Asp f 1, one of the allergens of Aspergillus fumigatus ; Bet v 1, the major birch allergen; TLR2-ligand or even upon IgE cross-linking.", {"entities": []}], ["Unlike DC, Asp f 1-pulsed basophils did not promote Th2 responses as analyzed by the secretion of IL-4 in the basophil-CD4", {"entities": []}], ["Social change, intensified by industrialization and globalization, has not only changed people\u2019s work lives but also their personal lives, especially in developing countries.", {"entities": []}], ["The aim of this study was to provide evidence and recommendations regarding family structure, function, and mental health to actively respond to rapid social change.", {"entities": []}], ["A cross-sectional survey was conducted face-to-face and door-to-door from July 2011 to September 2012 in Hubei Province, central China.", {"entities": []}], ["Family structure comprised alone, couple, nuclear family, and extended family; family function was measured using the family APGAR (Adaptation, Partnership, Growth, Affection, and Resolve) scale, and mental health was measured using the Chinese version of the 12-item General Health Questionnaire (GHQ-12).", {"entities": []}], ["The urban-vs-rural difference of family structure among alone, couple, nuclear family, and extended family was statistically significant (5.21% vs 4.62%; 27.36% vs 13.14%; 33.22% vs 27.74%; 34.20% vs 54.50%, respectively; p \u2009<\u20090.0001); and those difference of family function was not statistically significant (8.11\u2009\u00b1\u20092.13 vs 8.09\u2009\u00b1\u20092.27, p \u2009=\u20090.9372).", {"entities": []}], ["The general linear regression showed that the effect of family structure on mental health, whether urban or rural, was not significant, however, the effect of family function was significant, especially regarding better family functioning with better mental health.", {"entities": []}], ["Combined the effects of family structure and function on mental health, the external form of family (family structure) may not be important; while the internal quality of role (family function) might be key.", {"entities": []}], ["Improving the residents\u2019 family function would be a priority strategy for family practice with their mental health.", {"entities": []}], ["In developing countries, investigating mortality levels and causes of death among all age female population despite the childhood and maternal related deaths is important to design appropriate and tailored interventions and to improve survival of female residents.", {"entities": []}], ["Under Kilite-Awlealo Health and Demographic Surveillance System, we investigated mortality rates and causes of death in a cohort of female population from 1st of January 2010 to 31st of December 2012.", {"entities": []}], ["At the baseline, 33,688 females were involved for the prospective follow-up study.", {"entities": []}], ["Households under the study were updated every six months by fulltime surveillance data collectors to identify vital events, including deaths.", {"entities": []}], ["Verbal Autopsy (VA) data were collected by separate trained data collectors for all identified deaths in the surveillance site.", {"entities": []}], ["Trained physicians assigned underlining causes of death using the 10th edition of International Classification of Diseases (ICD).", {"entities": []}], ["We assessed overall, age- and cause-specific mortality rates per 1000 person-years.", {"entities": []}], ["Causes of death among all deceased females and by age groups were ranked based on cause specific mortality rates.", {"entities": []}], ["Analysis was performed using Stata Version 11.1.", {"entities": []}], ["During the follow-up period, 105,793.9 person-years of observation were generated, and 398 female deaths were recorded.", {"entities": []}], ["This gave an overall mortality rate of 3.76 (95% confidence interval (CI): 3.41, 4.15) per 1,000 person-years.", {"entities": []}], ["The top three broad causes of death were infectious and parasitic diseases (1.40 deaths per 1000 person-years), non-communicable diseases (0.98 deaths per 1000 person-years) and external causes (0.36 per 1000 person-years).", {"entities": []}], ["Most deaths among reproductive age female were caused by Human Deficiency Virus/Acquired Immune Deficiency Virus (HIV/AIDS) and tuberculosis (0.14 per 1000 person-years for each cause).", {"entities": [[128, 140, "DISEASE"]]}], ["Pregnancy and childbirth related causes were responsible for few deaths among women of reproductive age\u20143 out of 73 deaths (4.1%) or 5.34 deaths per 1,000 person-years.", {"entities": []}], ["Communicable diseases are continued to be the leading causes of death among all age females.", {"entities": []}], ["HIV/AIDS and tuberculosis were major causes of death among women of reproductive age.", {"entities": [[13, 25, "DISEASE"]]}], ["Together with existing efforts to prevent pregnancy and childbirth related deaths, public health and curative interventions on other causes, particularly on HIV/AIDS and tuberculosis, should be strengthened.", {"entities": [[170, 182, "DISEASE"]]}], ["Interstitial cystitis/painful bladder syndrome (IC/PBS), is a severely debilitating chronic condition that is frequently unresponsive to conventional pain medications.", {"entities": [[38, 46, "DISEASE"], [13, 21, "DISEASE"]]}], ["The etiology is unknown, however evidence suggests that nervous system sensitization contributes to enhanced pain in IC/PBS.", {"entities": []}], ["In particular, central nervous system plasticity of glutamatergic signaling involving NMDA and metabotropic glutamate receptors (mGluRs) has been implicated in a variety of chronic pain conditions.", {"entities": []}], ["Here, we test the hypothesis that mGluR5 mediates both non-inflammatory and inflammatory bladder pain or nociception in a mouse model by monitoring the visceromotor response (VMR) during graded bladder distention.", {"entities": []}], ["Using a combination of genetic and pharmacologic approaches, we provide evidence indicating that mGluR5 is necessary for the full expression of VMR in response to bladder distention in the absence of inflammation.", {"entities": []}], ["Furthermore, we observed that mice infected with a uropathogenic strain of Escherichia coli (UPEC) develop inflammatory hyperalgesia to bladder distention, and that the selective mGluR5 antagonist fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl) urea], reduces the VMR to bladder distention in UPEC-infected mice.", {"entities": []}], ["Taken together, these data suggest that mGluR5 modulates both inflammatory and non-inflammatory bladder nociception, and highlight the therapeutic potential for mGluR5 antagonists in the alleviation of bladder pain.", {"entities": []}], ["The Work Productivity and Activity Impairment (WPAI) questionnaire is a well validated instrument to measure impairments in work and activities.", {"entities": []}], ["However, its validation among patients with rheumatoid arthritis (RA) has not been well established.", {"entities": [[44, 64, "DISEASE"], [55, 64, "DISEASE"]]}], ["The present study's purpose is to evaluate the construct validity of the WPAI-general health version among RA patients and its ability to differentiate between RA patients with varying health status.", {"entities": []}], ["Patients who were enrolled in the Early Rheumatoid Arthritis Network cohort and were employed at their most recent follow-up were recruited into this sub-study.", {"entities": [[40, 60, "DISEASE"], [51, 60, "DISEASE"]]}], ["A questionnaire battery incorporating the WPAI was administered along with a number of health outcomes including the Multidimensional Health Assessment Questionnaire, fatigue and patient assessment of disease activity.", {"entities": []}], ["The construct validity of the WPAI was tested by the correlations between the WPAI and the health outcomes and other measures of productivity.", {"entities": []}], ["Student's t tests were used to identify whether the WPAI outcomes differed between the two levels of heath status based on the median of health outcomes.", {"entities": []}], ["A total of 150 patients completed the WPAI questionnaire.", {"entities": []}], ["The average age was 52 years old and the disease duration was 37.5 months since the first rheumatology visit.", {"entities": []}], ["Of the 137 patients who were working for pay, 26 reported missing work in the past week due to their health problem, accounting for 45.5% of their working time (absenteeism).", {"entities": []}], ["While 123 patients were working, 24% of their work was impaired due to their health problem (presenteeism).", {"entities": []}], ["In addition, 33% of the patients' regular daily activities (activity impairment) had been prevented due to their health problems.", {"entities": []}], ["There were moderate correlations between the WPAI absenteeism and function, pain, fatigue, and disease severity (r = 0.34 to 0.39).", {"entities": []}], ["The WPAI presenteeism and activity impairment were strongly correlated with the health outcomes (0.67 to 0.77).", {"entities": []}], ["Patients with more severe disease status (for example, low/high functional disability by median) had significantly higher absenteeism (4%/15%), presenteeism (15%/39%), and activity impairment (19%/53%) than those with less severe disease status.", {"entities": []}], ["The WPAI is a valid questionnaire for assessing impairments in paid work and activities in RA patients and for measuring the relative differences between RA patients with different health status.", {"entities": []}], ["Passive immunotherapy with monoclonal antibodies is an indispensable cornerstone of clinical oncology.", {"entities": []}], ["Notably, all FDA-approved antibodies comprise the IgG class, although numerous research articles proposed monoclonal antibodies of the IgM, IgG, IgA and IgE classes directed specifically against tumor-associated antigens.", {"entities": []}], ["In particular, for the IgE isotype class, several recent studies could demonstrate high tumoricidic efficacy.", {"entities": []}], ["Therefore, this review specifically highlights the latest developments toward IgE-based immunotherapy of cancer.", {"entities": [[105, 111, "DISEASE"]]}], ["Possible mechanisms and safety aspects of IgE-mediated tumor cell death are discussed with special focus on the attracted immune cells.", {"entities": []}], ["An outlook is given on how especially comparative oncology could contribute to further developments.", {"entities": []}], ["Humans and dogs have a highly comparable IgE biology, suggesting that translational AllergoOncology studies in patients with canine cancer could have predictive value for the potential of IgE-based anticancer immunotherapy in human clinical oncology.", {"entities": [[132, 138, "DISEASE"]]}], ["Oxidative stress is one of the key mechanisms linking ambient particulate matter (PM) exposure with various adverse health effects.", {"entities": []}], ["The oxidative potential of PM has been used to characterize the ability of PM induced oxidative stress.", {"entities": []}], ["Hydroxyl radical (\u2022OH) is the most destructive radical produced by PM.", {"entities": []}], ["However, there is currently no high-throughput approach which can rapidly measure PM-induced \u2022OH for a large number of samples with an automated system.", {"entities": []}], ["This study evaluated four existing molecular probes (disodium terephthalate, 3\u2032- p -(aminophenyl)fluorescein, coumarin-3-carboxylic acid, and sodium benzoate) for their applicability to measure \u2022OH induced by PM in a high-throughput cell-free system using fluorescence techniques, based on both our experiments and on an assessment of the physicochemical properties of the probes reported in the literature.", {"entities": []}], ["Disodium terephthalate (TPT) was the most applicable molecular probe to measure \u2022OH induced by PM, due to its high solubility, high stability of the corresponding fluorescent product ( i.e.", {"entities": []}], [", 2-hydroxyterephthalic acid), high yield compared with the other molecular probes, and stable fluorescence intensity in a wide range of pH environments.", {"entities": []}], ["TPT was applied in a high-throughput format to measure PM (NIST 1648a)-induced \u2022OH, in phosphate buffered saline.", {"entities": []}], ["The formed fluorescent product was measured at designated time points up to 2 h. The fluorescent product of TPT had a detection limit of 17.59 nM.", {"entities": []}], ["The soluble fraction of PM contributed approximately 76.9% of the \u2022OH induced by total PM, and the soluble metal ions of PM contributed 57.4% of the overall \u2022OH formation.", {"entities": []}], ["This study provides a promising cost-effective high-throughput method to measure \u2022OH induced by PM on a routine basis.", {"entities": []}], ["Due to the lack of timely access to resources for critical care, strategic use of antiviral drugs is crucial for mitigating the impact of novel influenza viruses with pandemic potential in remote and isolated communities.", {"entities": [[144, 153, "DISEASE"]]}], ["We sought to evaluate the effect of antiviral treatment and prophylaxis of close contacts in a Canadian remote northern community.", {"entities": []}], ["We used an agent-based, discrete-time simulation model for disease spread in a remote community, which was developed as an in-silico population using population census data.", {"entities": []}], ["Relative and cumulative age-specific attack rates, and the total number of infections in simulated model scenarios were obtained.", {"entities": []}], ["We found that early initiation of antiviral treatment is more critical for lowering attack rates in a remote setting with a low population-average age compared to an urban population.", {"entities": []}], ["Our results show that a significant reduction in the relative, age-specific attack rates due to increasing treatment coverage does not necessarily translate to a significant reduction in the overall arrack rate.", {"entities": []}], ["When treatment coverage varies from low to moderate, targeted prophylaxis has a very limited impact in reducing attack rates and should be offered at a low level (below 10%) to avoid excessive waste of drugs.", {"entities": []}], ["In contrast to previous work, for conservative treatment coverages, our results do not provide any convincing evidence for the implementation of targeted prophylaxis.", {"entities": []}], ["The findings suggest that public health strategies in remote communities should focus on the wider availability (higher coverage) and timely distribution of antiviral drugs for treatment of clinically ill individuals.", {"entities": []}], ["Due to increased formaldehyde exposure, carcinogenic to humans, several researches have been studying the potential toxicity and the safe levels for human beings.", {"entities": []}], ["The aim of this study was to investigate mutagenicity and cytotoxicity in buccal epithelial exfoliated cells (BEC) of students subjected to formaldehyde (FA) during anatomy classes.", {"entities": []}], ["BEC were collected periodically from 17 volunteers of undergraduate programs, who had participated in practical anatomy classes, before and after FA exposure.", {"entities": []}], ["Cells were stained according to Feulgen method and then micronucleus test was applied.", {"entities": []}], ["A total of 1,500 cells were assessed per individual in this study for the micronucleus frequency and other parameters of cytotoxicity.", {"entities": []}], ["There was statistically significant increase in number of micronucleated BEC after FA exposure (after 1 month p =.034 and after 3.5 months p =.017).", {"entities": []}], ["However, FA exposure caused no significant increase in other nuclear alterations closely related to cytotoxicity ( p \u2265.05).", {"entities": []}], ["FA induced mutagenicity during anatomy classes.", {"entities": []}], ["Cell death increased, but it was not statistically significant.", {"entities": []}], ["Efforts have to be made to improve air quality and reduce exposures during anatomy classes.", {"entities": []}], ["Key words: Carcinogens, formaldehyde, micronucleus tests, mutagenicity tests.", {"entities": []}], ["Non-communicable diseases are a leading cause of death and can largely be prevented by healthy lifestyles.", {"entities": []}], ["Health care organizations are encouraged to integrate healthy lifestyle promotion in routine care.", {"entities": []}], ["This study evaluates the impact of a team initiative on healthy lifestyle promotion in primary care.", {"entities": []}], ["A quasi-experimental, cross-sectional design compared three intervention centres that had implemented lifestyle teams with three control centres that used a traditional model of care.", {"entities": []}], ["Outcomes were defined using the RE-AIM framework: reach, the proportion of patients receiving lifestyle promotion; effectiveness, self-reported attitudes and competency among staff; adoption, proportion of staff reporting regular practice of lifestyle promotion; implementation, fidelity to the original lifestyle team protocol.", {"entities": []}], ["Data collection methods included a patient questionnaire (n\u2009=\u2009888), a staff questionnaire (n\u2009=\u2009120) and structured interviews with all practice managers and, where applicable, team managers (n\u2009=\u20098).", {"entities": []}], ["The chi square test and problem-driven content analysis was used to analyse the questionnaire and interview data, respectively.", {"entities": []}], ["Reach: patients at control centres (48%, n\u2009=\u2009211) received lifestyle promotion significantly more often compared with patients at intervention centres (41%, n\u2009=\u2009169).", {"entities": []}], ["Effectiveness: intervention staff was significantly more positive towards the effectiveness of lifestyle promotion, shared competency and how lifestyle promotion was prioritized at their centre.", {"entities": []}], ["Adoption: 47% of staff at intervention centres and 58% at control centres reported that they asked patients about their lifestyle on a daily basis.", {"entities": []}], ["Implementation: all intervention centres had implemented multi-professional teams and team managers and held regular meetings but struggled to implement in-house referral structures for lifestyle promotion, which was used consistently among staff.", {"entities": []}], ["Intervention centres did not show higher rates than control centres on reach of patients or adoption among staff at this stage.", {"entities": []}], ["All intervention centres struggled to implement working referral structures for lifestyle promotion.", {"entities": []}], ["Intervention centres were more positive on effectiveness outcomes, attitudes and competency among staff, however.", {"entities": []}], ["Thus, lifestyle teams may facilitate lifestyle promotion practice in terms of increased responsiveness among staff, illustrated by positive attitudes and perceptions of shared competency.", {"entities": []}], ["More research is needed on lifestyle promotion referral structures in primary care regarding their configuration and implementation.", {"entities": []}], ["Patient: Female, 60 Final Diagnosis: Inflammatory pseudotumor of the lung Symptoms: Cough dry \u2022 fever Medication: \u2014 Clinical Procedure: \u2014 Specialty: \u2014 Rare disease Inflammatory pseudotumor of the lung involves a benign, non-neoplastic lung lesion of unknown etiology.", {"entities": []}], ["We present a case of a 60-year-old female smoker who had been under intermittent immunosuppressive medication for discoid lupus, who was admitted to hospital with fever of 39.5\u00b0C of 10-day duration, not responding to an oral cephalosporin.", {"entities": []}], ["Chest CT examination showed a cavitating opacity in the upper zone of the left lung.", {"entities": []}], ["It was not feasible to establish a diagnosis based on clinical and laboratory testing nor based on CT scanning and bronchoscopy.", {"entities": []}], ["Thus, the patient underwent left thoracotomy and sphenoid resection of the lesion, which was sent for biopsy.", {"entities": []}], ["The histopathologic features aided by immunohistochemical staining proved the lesion to be an inflammatory pseudotumor of the lung.", {"entities": []}], ["The case is reported because of the extremely rare radiologic presentation of the development of a lung pseudotumor emerging as a cavitated lesion, which relapsed during the follow-up period while the patient was still under immunosuppressive medication.", {"entities": []}], ["The diagnosis, treatment and prevention of osteoporosis is a national health emergency.", {"entities": [[43, 55, "DISEASE"]]}], ["Osteoporosis quietly progresses without symptoms until late stage complications occur.", {"entities": [[0, 12, "DISEASE"]]}], ["Older patients are more commonly at risk of fractures due to osteoporosis.", {"entities": [[61, 73, "DISEASE"]]}], ["The fracture risk increases when suppressive doses of levothyroxine are administered especially in postmenopausal women.", {"entities": []}], ["The question is; \"When should bone mass density be tested in postmenopausal women after the initiation of suppressive levothyroxine therapy?\".", {"entities": []}], ["Standard guidelines for the prevention of osteoporosis suggest that follow-up be done in 1 to 2 years.", {"entities": [[42, 54, "DISEASE"]]}], ["We were interested in predicting the level of bone mass density in postmenopausal women after the initiation of suppressive levothyroxine therapy with a novel approach.", {"entities": []}], ["The study used data from the literature on the influence of exogenous thyroid hormones on bone mass density.", {"entities": []}], ["Four cubic polynomial equations were obtained by curve fitting for Ward's triangle, trochanter, spine and femoral neck.", {"entities": []}], ["The behaviors of the models were investigated by statistical and mathematical analyses.", {"entities": []}], ["There are four points of inflexion on the graphs of the first derivatives of the equations with respect to time at about 6, 5, 7 and 5 months.", {"entities": []}], ["In other words, there is a maximum speed of bone loss around the 6 It seems reasonable to check bone mass density at the 6", {"entities": []}], ["Continuous positive airway pressure (CPAP) treatment improves the risk of cardiovascular events in patients suffering from severe sleep apnea-hypopnea syndrome (SAHS) but its effect on the link between delta power band that is related to deep sleep and the relative cardiac vagal component of heart rate variability, HF nu of HRV, is unknown.", {"entities": [[151, 159, "DISEASE"]]}], ["Therefore, we tested the hypothesis that CPAP restores the link between cardiac autonomic activity and delta sleep across the night.", {"entities": []}], ["Eight patients suffering from severe SAHS before and after 4 \u00b1 3 years of nasal CPAP treatment were matched with fourteen healthy controls.", {"entities": []}], ["Sleep EEG and ECG were analysed to obtain spectral sleep and HRV components.", {"entities": []}], ["Coherence analysis was applied between HF nu and delta power bands across the first three sleep cycles.", {"entities": []}], ["Sleep characteristics and spectral HRV components were similar between untreated patients, treated patients and controls, with the exception of decreased Rapid Eye Movement duration in untreated patients.", {"entities": []}], ["Coherence and gain values between HF nu and delta EEG variability were decreased in untreated patients while gain values normalized in treated patients.", {"entities": []}], ["In patients before and during long-term CPAP treatment, phase shift and delay between modifications in HF nu and delta EEG variability did not differ from controls but were not different from zero.", {"entities": []}], ["In healthy men, changes in cardiac vagal activity appeared 9\u2009\u00b1\u20097 minutes before modifications in delta sleep.", {"entities": []}], ["Long-term nasal CPAP restored, in severe SAHS, the information between cardiovascular and sleep brainstem structures by increasing gain, but did not improve its tightness or time shift.", {"entities": []}], ["The results of our experiments do not substantiate in full the theory of the power of selective action of Streptococcus viridans .", {"entities": []}], ["A few strains showed a remarkable constancy in location and type of lesion, but these strains were greatly in the minority.", {"entities": []}], ["The location of the lesions in animals seemed to bear no relation to the origin of the organism or to the lesions produced by it in the patient from which the strain was obtained.", {"entities": []}], ["Streptococcus viridans , regardless of site of origin in the patient, produced most lesions in the heart and joints.", {"entities": []}], ["Tiotropium is prescribed for the treatment of chronic obstructive pulmonary disease (COPD) and delivered via HandiHaler Pooled analysis of adverse event (AE) data from tiotropium HandiHaler In the 28 HandiHaler 1 ) was 1.16 L (41% predicted).", {"entities": [[46, 83, "DISEASE"]]}], ["The risk (RR [95% CI]) of AEs (0.90 [0.87, 0.93]) and of serious AEs (SAEs) (0.94 [0.89, 0.99]) was significantly lower in the tiotropium than in the placebo group (HandiHaler This analysis indicates that tiotropium is associated with lower rates of AEs, SAEs, and similar rates of FAEs than placebo when delivered via HandiHaler", {"entities": []}], ["Results of this study suggest that strategic laparoscopy for improved cosmesis cholecystectomy is feasible, safe, and decreases the cumulative incision length as well as the number of incisions in patients with favorable body habitus and previous surgical history.", {"entities": []}], ["Until the advent of single-incision laparoscopic surgery, few advances were aimed at improving cosmesis with laparoscopic cholecystectomy.", {"entities": []}], ["Criticisms of the single-incision laparoscopic surgery technique include a larger incision and increased incidence of wound-related complications.", {"entities": []}], ["We present our initial experience with a novel technique aimed at performing strategic laparoscopy for improved cosmesis (SLIC) for cholecystectomy.", {"entities": []}], ["Twenty-five patients with biliary symptoms were selected for SLIC cholecystectomy.", {"entities": []}], ["Access to the abdomen was obtained with a 5-mm optical trocar in the left upper quadrant and a 5-mm trocar in the umbilicus.", {"entities": []}], ["Retraction was performed by a transabdominal suture in the dome of the gallbladder and a needlescopic grasper.", {"entities": []}], ["Age, American Society of Anesthesiologists score, body mass index, operative time, length of stay, pathology results, and short-term complications at follow-up were prospectively recorded.", {"entities": []}], ["The 25 female patients had a mean age of 34.3 years and mean body mass index of 24 kg/m SLIC cholecystectomy is feasible and safe.", {"entities": []}], ["This technique decreases the cumulative incision length, as well as the number of incisions, leading to very desirable cosmetic results in patients with a favorable body habitus and surgical history.", {"entities": []}]]